Citrus Sinensis ID: 006668

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630------
Protein Sequence
MKDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAPLQP
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHccccccEEEEEccccccccccccEEEEcEEEEcccEEEccccccccEEEEEccccccccccccccccEEEEEcEEEEEEEEccccccccccEEEEEccccccccccccccccccccccccccccEEEEEEEcccccccccccccEEEEEccccccccEEEEEEEccccccEEEEEEcccccEEEEEEEEcccccccccccccccEEccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHEEEEEEEcHHHHHHHHHHHHHHHcccccEEcHHHHHHHHcccccccccccccccEEEEEEEcccccccccEEEEEEEcccccHHHHHHHHHHHHHHccccccccccccEEccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHHHHHHHHccccEEEEEcccccccccccccccccccccccccEEcccccccEEcEEccccccccccccccccccccccEEcHHHHHHHHHccccccccccccccccccHHHHHHHHHcccccHHHHcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccEEEcccEEccccEEEEcccccccccccEccccccEEccccccccccEEEEEEEEEEEEEcccccccccEEEEEEEcccccccccHHHHcEEEcccccHHHcccEEEEEEccccHHHccccccEEEEEEccccccEEEEccEEEccccccEEEEEEEccccEEEEEEcccccccccccccEEEEEEEEEccccccccccHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccccccEEEEEEEccccHccHHHHHHHHHHHHHcHHHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHcEEEEcccccHHHEEEcccccEEEccccccEEccccccccccEEEEcHHcccHHHHHcccccccHHHHHHHHHHHHHHccccccccccccccccEEEHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
MKDMLRLFLFIIVVAINfsispssaLDFLFNsfgsitngtdlilindcwvdstvirltndsnqfsfgrayyptklkmkrstatnssiLTSFSTSFVFSIlpeiasspgfgLCFVltnftsppgalasqyfglfsnatvvtVAPLLAvefdtgqnpefndpddnhigvdlnniesakhvpagyysssrnesfvpvrmrngqnihawidfdgfsasktNWIEARRVLAWSLsdtgvareinttnfptflppssssslsagAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWEleywphrfsyEELSKatkgfsndellgsggfgrvykgtlannnnnnsTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYdympngslnnwifgkpkkllgWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKsgnilldsemrgrlgdfglaklyqqgevpnttrvvgtlgylapelatvssptsasdvySFGVVILEVacgrrpldmgkgeeeEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLacchpdstrrptMREVVAVLVGQEVAATPKELLGDLargavdadfsggddsredaplqp
Flexible Loop (DISEMBL)
MKDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIrltndsnqfsfGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKlyqqgevpnTTRVVGTLGYLAPELAtvssptsasdvYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDadfsggddsredaplqp
Low Complexity Region (SEG)
MKDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNatvvtvapllavEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREInttnfptflppssssslsAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQeedeieeweleYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAnnnnnnSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAPLQP
Disordered region (IsUnstruct)
****LRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTG***********HIGVDLNNIESAKHVPAGYY******SFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFL*********AGAVAGIVIGCVMGFLIICASTGYYWYWRK****************EYWPHRFSYEE*************L***GFGRV***********************************I**MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDM*******EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLA**********************
Disordered Region (DISOPRED)
***MLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKR*********TSFSTSFVFSILPEIASSPGFGLCFVLTNFTSP**ALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAW**************************SLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKL**********WELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN*********FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDM***EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKE****************************
Disordered Region (DISEMBL)
MKDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADF**************
Disordered Region (DISPRO)
*KDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSG************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKDMLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAPLQP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	636	2.2.26 [Sep-21-2011]
Q9M9E0	656	L-type lectin-domain cont	yes	no	0.891	0.864	0.658	0.0
Q9M2S4	684	L-type lectin-domain cont	no	no	0.838	0.779	0.422	1e-129
Q9SZD5	669	L-type lectin-domain cont	no	no	0.894	0.850	0.380	1e-123
Q9M345	677	L-type lectin-domain cont	no	no	0.905	0.850	0.405	1e-121
O81292	674	L-type lectin-domain cont	no	no	0.889	0.839	0.377	1e-112
O49445	681	Probable L-type lectin-do	no	no	0.921	0.860	0.363	1e-111
O22833	658	L-type lectin-domain cont	no	no	0.830	0.802	0.390	1e-111
O81291	669	L-type lectin-domain cont	no	no	0.897	0.853	0.372	1e-111
Q9S9U1	686	L-type lectin-domain cont	no	no	0.883	0.819	0.374	1e-111
O80939	675	L-type lectin-domain cont	no	no	0.877	0.826	0.381	1e-111

>sp|Q9M9E0|LRKS1_ARATH L-type lectin-domain containing receptor kinase S.1 OS=Arabidopsis thaliana GN=LECRKS1 PE=1 SV=1

 Score =  769 bits (1986), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/620 (65%), Positives = 476/620 (76%), Gaps = 53/620 (8%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           S SSA+DFL+NSF S+TN TD+ILI D  V+STVI L NDS+  SFGR +YP KL +   
Sbjct: 25  SSSSAIDFLYNSFSSVTNRTDVILIEDSRVESTVISLINDSDPLSFGRVFYPQKLTIIPD 84

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
              N + L+SFSTSFVFSILP+I++SPGFGLCFVL+N TSPP A++SQYFGLF+NATV  
Sbjct: 85  PTRNPTRLSSFSTSFVFSILPDISTSPGFGLCFVLSNSTSPPNAISSQYFGLFTNATVRF 144

Query: 141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQ 200
            APLLAVEFDTG+N E ND DDNH+G+DLNNIES   V AGYY S  N SFV   MRNG 
Sbjct: 145 NAPLLAVEFDTGRNSEVNDIDDNHVGIDLNNIESTTSVTAGYYDSV-NGSFVRFNMRNGN 203

Query: 201 NIHAWIDFDG----------------------------------------FSASKTNWIE 220
           N+ AWIDFDG                                        FSASKTNW E
Sbjct: 204 NVRAWIDFDGPNFQINVSVAPVGVLRPRRPTLTFRDPVIANYVSADMYAGFSASKTNWNE 263

Query: 221 ARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGY 280
           ARR+LAWSLSDTG  REINTTN P F   +SSSSLS GA+AGIVIGCV+   +I    G 
Sbjct: 264 ARRILAWSLSDTGALREINTTNLPVFFLENSSSSLSTGAIAGIVIGCVVFVALI--GFGG 321

Query: 281 YWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL 340
           Y  W+K  ++ +EE+EIEEWELE+WPHRFSYEEL+ AT+ FSND LLGSGGFG+VY+G L
Sbjct: 322 YLIWKK-LMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDRLLGSGGFGKVYRGIL 380

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
           +NN     +E+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRGWCR+ NELMLVYD
Sbjct: 381 SNN-----SEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRRKNELMLVYD 435

Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           YMPNGSLN WIF  PK+ + W++RRQ++ DVAEGLNYLHHGWDQVV+HRDIKS NILLDS
Sbjct: 436 YMPNGSLNQWIFDNPKEPMPWRRRRQVINDVAEGLNYLHHGWDQVVIHRDIKSSNILLDS 495

Query: 461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
           EMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELA+ S+PT ASDVYSFGVV+LEV 
Sbjct: 496 EMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTEASDVYSFGVVVLEVV 555

Query: 521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA-EEMELVLKLGLAC 579
            GRRP++     EEE+ VL+DWVR+LYG G++ +AAD R+R E E  EE+EL+LKLGLAC
Sbjct: 556 SGRRPIEYA---EEEDMVLVDWVRDLYGGGRVVDAADERVRSECETMEEVELLLKLGLAC 612

Query: 580 CHPDSTRRPTMREVVAVLVG 599
           CHPD  +RP MRE+V++L+G
Sbjct: 613 CHPDPAKRPNMREIVSLLLG 632

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  461 bits (1186), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 255/604 (42%), Positives = 366/604 (60%), Gaps = 71/604 (11%)

Query: 55  IRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFV 114
           IRLT ++ Q   G A+Y   ++ K     N ++  SFSTSF  +++PE  +  G GL F 
Sbjct: 52  IRLTTET-QRVIGHAFYSLPIRFK-PIGVNRAL--SFSTSFAIAMVPEFVTLGGHGLAFA 107

Query: 115 LTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIES 174
           +T      G+L SQY GL +++ V   +   AVEFDT ++ EF D +DNH+G+D+N++ES
Sbjct: 108 ITPTPDLRGSLPSQYLGLLNSSRVNFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSMES 167

Query: 175 AKHVPAGYY--SSSRNESFVPVRMRNGQNIHAWIDFD----------------------- 209
           +   PAGY+  +S++ E F    +  G+ I AWID+D                       
Sbjct: 168 SISTPAGYFLANSTKKELF----LDGGRVIQAWIDYDSNKKRLDVKLSPFSEKPKLSLLS 223

Query: 210 ---------------GFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSS--- 251
                          GFSAS      +  +L W+ + +G A  ++  + P    PSS   
Sbjct: 224 YDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRI--PSSIKK 281

Query: 252 SSSLSAGAVAGIVIGC-VMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFS 310
                   + G+ + C ++ F ++ A++ +         K ++ED +EEWEL++ PHRFS
Sbjct: 282 RKKKRQSLILGVSLLCSLLIFAVLVAASLFVVR------KVKDEDRVEEWELDFGPHRFS 335

Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAE 370
           Y EL KAT GF + ELLGSGGFG+VYKG L  ++      +AVK ++H+S+QG++EFM+E
Sbjct: 336 YRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEF----VAVKRISHESRQGVREFMSE 391

Query: 371 ISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILA 429
           +SS+G L+H+NLVQ+ GWCR+ ++L+LVYD+MPNGSL+ ++F + P+ +L WKQR +I+ 
Sbjct: 392 VSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIK 451

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            VA GL YLH GW+Q V+HRDIK+ N+LLDSEM GR+GDFGLAKLY+ G  P  TRVVGT
Sbjct: 452 GVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGT 511

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            GYLAPEL      T+++DVY+FG V+LEVACGRRP++       EE V++DWV + +  
Sbjct: 512 FGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSA--LPEELVMVDWVWSRWQS 569

Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ----EVAAT 605
           G I +  D R+  EF+ EE+ +V+KLGL C +     RPTMR+VV  L  Q    EV   
Sbjct: 570 GDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQFPSPEVVPA 629

Query: 606 PKEL 609
           P  L
Sbjct: 630 PDFL 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  444 bits (1142), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 242/636 (38%), Positives = 377/636 (59%), Gaps = 67/636 (10%)

Query: 17  NFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLK 76
           N ++S S   +F FN  G + + + + + N       +++LTN S++FS+G  +Y + ++
Sbjct: 17  NKALSQSEEGEFGFN--GYLYDNSGIAITNS----KGLMKLTN-SSEFSYGHVFYNSPVR 69

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
            K S    +  ++SFST+FVF+I+  + +  G GL FV++     P + +SQY GLF+  
Sbjct: 70  FKNSP---NGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLT 126

Query: 137 TVVTVA-PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR 195
                +  ++AVEFDT QN EF+D D+NH+G+D+N++ S K   AGYY    + +F  +R
Sbjct: 127 NNGDPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDD-DGTFKNIR 185

Query: 196 MRNGQNIHAWIDFD---------------------------------------GFSASKT 216
           + N + I AWI++D                                       GF+++  
Sbjct: 186 LINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATG 245

Query: 217 NWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICA 276
               +  +L W+    G A  I+ +  P    P  S S S   +  I +      +++  
Sbjct: 246 RLRSSHYILGWTFKLNGTASNIDISRLPKL--PRDSRSTSVKKILAISLSLTSLAILVFL 303

Query: 277 STGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVY 336
           +  Y  + ++ KL     + +E+WE+++ PHRF+Y++L  ATKGF N ELLG GGFG+VY
Sbjct: 304 TISYMLFLKRKKLM----EVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVY 359

Query: 337 KGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM 396
           KGTL+ +N     ++AVK V+HDS+QG++EF+AEI+++GRL+H NLV++ G+CR+  EL 
Sbjct: 360 KGTLSTSN----MDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELY 415

Query: 397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
           LVYD MP GSL+ +++ +P++ L W QR +I+ DVA GL YLHH W QV++HRDIK  N+
Sbjct: 416 LVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANV 475

Query: 457 LLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI 516
           LLD  M G+LGDFGLAKL + G  P T+ V GT GY++PEL+     +++SDV++FG+++
Sbjct: 476 LLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILM 535

Query: 517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE--FEAEEMELVLK 574
           LE+ CGRRP+ + +     E VL DWV + + +  I +  D R++Q+  +  E++ LVLK
Sbjct: 536 LEITCGRRPV-LPRASSPSEMVLTDWVLDCW-EDDILQVVDERVKQDDKYLEEQVALVLK 593

Query: 575 LGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELL 610
           LGL C HP +  RP+M  V+  L G  VA  P  L 
Sbjct: 594 LGLFCSHPVAAVRPSMSSVIQFLDG--VAQLPNNLF 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  436 bits (1120), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 261/643 (40%), Positives = 371/643 (57%), Gaps = 67/643 (10%)

Query: 20  ISPSSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMK 78
           IS S  L+F +N F      TD+ L     V    +++LTN S Q + G A+   +++ K
Sbjct: 19  ISSSQNLNFTYNGFHPPL--TDISLQGLATVTPNGLLKLTNTSVQKT-GHAFCTERIRFK 75

Query: 79  RSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLF--SNA 136
            S   N   ++SFST+FVF+I  +I +  G G+ FV+      P AL SQY GLF  SN 
Sbjct: 76  DSQNGN---VSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNN 132

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRM 196
              T   + AVEFDT Q+ EF DP+DNH+G+DLN + SA +  AGY     ++ F  + +
Sbjct: 133 GNDT-NHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDD--HDKFQNLSL 189

Query: 197 RNGQNIHAWIDFD---------------------------------------GFSASKTN 217
            + + I  WID+D                                       GFS++  +
Sbjct: 190 ISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGS 249

Query: 218 WIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGI-VIGCVMGFLIICA 276
            +    ++ WS    G A  ++ +  P  LP      +S     G+ +I   + F II  
Sbjct: 250 VLSEHFLVGWSFRLNGEAPMLSLSKLPK-LPRFEPRRISEFYKIGMPLISLSLIFSIIFL 308

Query: 277 STGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVY 336
           +  +Y   RK K     E+E+++WE E+  +RF ++EL  ATKGF   +LLGSGGFGRVY
Sbjct: 309 A--FYIVRRKKKY----EEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVY 362

Query: 337 KGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM 396
           +G L         E+AVK V+HDSKQG+KEF+AEI S+GR+ H+NLV + G+CR+  EL+
Sbjct: 363 RGILPTTK----LEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELL 418

Query: 397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
           LVYDYMPNGSL+ +++  P+  L WKQR  I+  VA GL YLH  W+QVV+HRD+K+ N+
Sbjct: 419 LVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNV 478

Query: 457 LLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI 516
           LLD++  GRLGDFGLA+LY  G  P TT VVGTLGYLAPE +     T+ +DVY+FG  +
Sbjct: 479 LLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFL 538

Query: 517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKL 575
           LEV  GRRP++      ++  +L++WV +L+ +G I EA D ++    ++ EE+E+VLKL
Sbjct: 539 LEVVSGRRPIEF-HSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKL 597

Query: 576 GLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAV 618
           GL C H D   RP+MR+V+  L G    A P+    DL+ G+V
Sbjct: 598 GLLCSHSDPRARPSMRQVLQYLRGD--MALPELTPLDLSAGSV 638

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  404 bits (1039), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 234/620 (37%), Positives = 346/620 (55%), Gaps = 54/620 (8%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           S S +L+F +NSF      T++ +     V S  I    D    S G A+Y   ++ K S
Sbjct: 22  SSSQSLNFTYNSFHR--PPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDS 79

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
               +  ++SFST+FV  I   I +  G G+ F +        A+ASQY GLFS+     
Sbjct: 80  P---NDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGN 136

Query: 141 -VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
               +LAVEFDT  NPEF+D +DNH+G+++N++ S K    GY+       F  + + + 
Sbjct: 137 DTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEI--NQFNNLTLISR 194

Query: 200 QNIHAWIDFD---------------------------------------GFSASKTNWIE 220
           + +  W+D+D                                       GFSA+    + 
Sbjct: 195 KRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLS 254

Query: 221 ARRVLAWSLSDTG-VAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTG 279
              V  WS    G  A  +  +  P F P    +SL       + +  ++   ++   + 
Sbjct: 255 EHFVFGWSFMVKGKTAPPLTLSKVPKF-PRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSL 313

Query: 280 YYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGT 339
            +      + + +  +E E+WE E+  +R  +++L  ATKGF + +LLGSGGFGRVY+G 
Sbjct: 314 IFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGV 373

Query: 340 LANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY 399
           +         E+AVK V+++S+QGLKEF+AEI S+GR+ H+NLV + G+CR+ +EL+LVY
Sbjct: 374 MPTTKK----EIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVY 429

Query: 400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD 459
           DYMPNGSL+ +++  P+  L WKQR  ++  VA GL YLH  W+QVV+HRDIK+ N+LLD
Sbjct: 430 DYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLD 489

Query: 460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
           +E  GRLGDFGLA+L   G  P TTRVVGT GYLAP+       T+A+DV++FGV++LEV
Sbjct: 490 AEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEV 549

Query: 520 ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLAC 579
           ACGRRP+++ + E +E  +L+D V   + +G I +A D  +   ++  E+E VLKLGL C
Sbjct: 550 ACGRRPIEI-EIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLC 608

Query: 580 CHPDSTRRPTMREVVAVLVG 599
            H D   RPTMR+V+  L G
Sbjct: 609 SHSDPQVRPTMRQVLQYLRG 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49445|LRK72_ARATH Probable L-type lectin-domain containing receptor kinase VII.2 OS=Arabidopsis thaliana GN=LECRK72 PE=1 SV=2

 Score =  403 bits (1036), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 240/661 (36%), Positives = 373/661 (56%), Gaps = 75/661 (11%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDS--TVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           ++ ++F++NS  + TN    +L+ +  V S  +++ LTN +  FS GR  YP+++    S
Sbjct: 21  TTGIEFIYNSNFTTTN---TLLLGNATVKSPPSILTLTNQTT-FSIGRGLYPSRINASSS 76

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFS-NATVV 139
           +A+       F+TSF+FS+ P    SPG G  FV   F+    A +SQ+ GLF+      
Sbjct: 77  SASP----LPFATSFIFSMAPFKHLSPGHGFAFVFLPFSETSAASSSQHLGLFNFTNNGD 132

Query: 140 TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
             + + AVEFD   N EFND +DNH+GVD+N++ S     AG+Y     + F  +++ +G
Sbjct: 133 PNSRIFAVEFDVFANQEFNDINDNHVGVDVNSLTSVASETAGFYGGRDGQRFTELKLNSG 192

Query: 200 QNIHAWIDFDG-------------------------------------FSASKTNWIEAR 222
           +N  AWI+F+G                                     F+AS    +++ 
Sbjct: 193 ENYQAWIEFNGSAINVTMARASSRKPIRPLISIPLNLTGVLLDDMFVGFTASTGQLVQSH 252

Query: 223 RVLAWSLSDTG--VAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGY 280
           R+L+WS S++   +   + T N P+F     S   S G +AG+  G V+   +I     Y
Sbjct: 253 RILSWSFSNSNFSIGDALITRNLPSFKLSGDSVLKSKGFIAGVSSGVVLLVSVIGLLCFY 312

Query: 281 YWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL 340
               R+ +L    E ++E+WE EYWPHR  Y+++ +ATKGFS++ ++G GG  +VY+G L
Sbjct: 313 VVRRRRQRL----EGDVEDWETEYWPHRVQYKDVLEATKGFSDENMIGYGGNSKVYRGVL 368

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKNLVQMRGWCRKGNE-LM 396
                    E+AVK +    ++ +    EF+AE+SS+GRL+HKN+V ++GW +KG E L+
Sbjct: 369 EGK------EVAVKRIMMSPRESVGATSEFLAEVSSLGRLRHKNIVGLKGWSKKGGESLI 422

Query: 397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
           L+Y+YM NGS++  IF    ++L W++R +++ D+A G+ YLH GW+  V+HRDIKS N+
Sbjct: 423 LIYEYMENGSVDKRIF-DCNEMLNWEERMRVIRDLASGMLYLHEGWETKVLHRDIKSSNV 481

Query: 457 LLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVV 515
           LLD +M  R+GDFGLAKL     E+ +TT VVGT GY+APEL      ++ +DVYSFGV 
Sbjct: 482 LLDKDMNARVGDFGLAKLQNTSKEMVSTTHVVGTAGYMAPELVKTGRASAQTDVYSFGVF 541

Query: 516 ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE--FEAEEMELVL 573
           +LEV CGRRP++ G+        +++W+  L  + K+ +  D RI+    F  EE+E+ L
Sbjct: 542 VLEVVCGRRPIEEGR------EGIVEWIWGLMEKDKVVDGLDERIKANGVFVVEEVEMAL 595

Query: 574 KLGLACCHPDSTRRPTMREVVAVL-VGQEVAATPKELLGDLARGAVDADFSGGDDSREDA 632
           ++GL C HPD   RP MR+VV +L  G+ V    +  +  L R         G+ SR+  
Sbjct: 596 RIGLLCVHPDPRVRPKMRQVVQILEQGRLVEDGGEREISLLERVKSSYLLETGEGSRQQH 655

Query: 633 P 633
           P
Sbjct: 656 P 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22833|LRK54_ARATH L-type lectin-domain containing receptor kinase V.4 OS=Arabidopsis thaliana GN=LECRK54 PE=2 SV=1

 Score =  403 bits (1036), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 228/584 (39%), Positives = 336/584 (57%), Gaps = 56/584 (9%)

Query: 56  RLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVL 115
           R    + + ++G+A+    +  K S    +  +TSFS +F F+I PE       G+ FV+
Sbjct: 40  RTLTSTKKHAYGQAFEDEIVPFKNSA---NDTVTSFSVTFFFAIAPEDKHKGAHGMAFVI 96

Query: 116 TNFTSPPGALASQYFGLFSNATVVTVA-PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIES 174
           +      GA A QY G+F+ A     +  ++AVE D  ++ EF D +DNH+G+++N + S
Sbjct: 97  SPTRGITGASADQYLGIFNKANNGDSSNHVIAVELDINKDEEFGDINDNHVGININGMRS 156

Query: 175 AKHVPAGYYS---------------------------------SSRNESFVPVR--MRNG 199
            K  PAGYY                                  SS  E++ P +  +   
Sbjct: 157 IKFAPAGYYDQEGQFKDLSLISGSLLRVTILYSQMEKQLNVTLSSPEEAYYPNKPLLSLN 216

Query: 200 QNIHAWI---DFDGFSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLS 256
           Q++  +I    + GFSAS  +      +L+W +   GV         PTF P     SL 
Sbjct: 217 QDLSPYILENMYVGFSASTGSVRAMHYMLSWFVHG-GVDVPNLDLGIPTFPPYPKEKSLV 275

Query: 257 AGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSK 316
              V    +  V+   ++ ++   ++Y R  K+K    + +EEWE++  PHRF+Y+EL K
Sbjct: 276 YRIVLVTSLALVLFVALVASALSIFFYRRHKKVK----EVLEEWEIQCGPHRFAYKELFK 331

Query: 317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGR 376
           ATKGF   +LLG GGFG+V+KGTL  ++     E+AVK ++HDSKQG++EF+AEIS++GR
Sbjct: 332 ATKGFK--QLLGKGGFGQVFKGTLPGSD----AEIAVKRISHDSKQGMQEFLAEISTIGR 385

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGL 435
           L+H+NLV+++G+CR   EL LVYD+MPNGSL+ +++ +  ++ L W QR +I+ D+A  L
Sbjct: 386 LRHQNLVRLQGYCRYKEELYLVYDFMPNGSLDKYLYHRANQEQLTWNQRFKIIKDIASAL 445

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YLHH W QVV+HRDIK  N+L+D +M  RLGDFGLAKLY QG  P T+RV GT  Y+AP
Sbjct: 446 CYLHHEWVQVVIHRDIKPANVLIDHQMNARLGDFGLAKLYDQGYDPQTSRVAGTFWYIAP 505

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
           EL      T+ +DVY+FG+ +LEV+CGRR ++  +    +E VL +W    +  G I EA
Sbjct: 506 ELIRSGRATTGTDVYAFGLFMLEVSCGRRLIE--RRTASDEVVLAEWTLKCWENGDILEA 563

Query: 556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG 599
            +  IR E   E++ELVLKLG+ C H     RP M +VV +L G
Sbjct: 564 VNDGIRHEDNREQLELVLKLGVLCSHQAVAIRPDMSKVVQILGG 607

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  403 bits (1035), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 237/637 (37%), Positives = 353/637 (55%), Gaps = 66/637 (10%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           S S  +DF +N F        ++ I      + +++LTN + Q S G A+Y   ++ K S
Sbjct: 21  SSSQIIDFTYNGFRPPPTDISILGIATI-TPNGLLKLTNTTMQ-STGHAFYTKPIRFKDS 78

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
               +  ++SFST+FVF+I  +I  +   G+ FV+      P     QY GLF+      
Sbjct: 79  P---NGTVSSFSTTFVFAIHSQIPIA--HGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGN 133

Query: 141 VA-PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
           V   + AVE DT  N EFND ++NH+G+D+N++ S K  PAGY+    N+ F  + + + 
Sbjct: 134 VRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWD--ENDQFHNLTLISS 191

Query: 200 QNIHAWIDFDG---------------------------------------FSASKTNWIE 220
           + +  W+DFDG                                       FS++  N + 
Sbjct: 192 KRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVS 251

Query: 221 ARRVLAWSLSDTGVAREINTTNFPTF----LPPSSSSSLSAGAVAGIVIGCVMGFLIICA 276
              VL WS    G A+ +  +  P      L P+         V  I +  +        
Sbjct: 252 EIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIP----FLL 307

Query: 277 STGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVY 336
                 +  K + K  EE  +E+WE E+  +R  +++L  ATKGF +  +LGSGGFG VY
Sbjct: 308 IIFLVRFIMKRRRKFAEE--VEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVY 365

Query: 337 KGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM 396
           KG +         E+AVK V+++S+QGLKEF+AEI S+G++ H+NLV + G+CR+ +EL+
Sbjct: 366 KGIMPKTKK----EIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELL 421

Query: 397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
           LVYDYMPNGSL+ +++  P+  L WKQR +++  VA  L YLH  W+QVV+HRD+K+ N+
Sbjct: 422 LVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNV 481

Query: 457 LLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI 516
           LLD+E+ GRLGDFGLA+L   G  P TTRVVGT GYLAP+       T+ +DV++FGV++
Sbjct: 482 LLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLL 541

Query: 517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLG 576
           LEVACGRRP+++   +  E  VL+DWV   + +  I +A D  +  E++ +E+E+VLKLG
Sbjct: 542 LEVACGRRPIEI-NNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLG 600

Query: 577 LACCHPDSTRRPTMREVVAVLVGQEVAA--TPKELLG 611
           L C H D   RPTMR+V+  L G  +    +P +L G
Sbjct: 601 LLCSHSDPLARPTMRQVLQYLRGDAMLPDLSPLDLRG 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S9U1|LRK71_ARATH L-type lectin-domain containing receptor kinase VII.1 OS=Arabidopsis thaliana GN=LECRK71 PE=2 SV=1

 Score =  403 bits (1035), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 235/628 (37%), Positives = 356/628 (56%), Gaps = 66/628 (10%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           +P SA+DF+FN F   ++   L  I    ++S ++ LTN ++ F+ GRA Y   ++ K  
Sbjct: 16  NPISAIDFIFNGFNDSSSNVSLFGI--ATIESKILTLTNQTS-FATGRALYNRTIRTK-- 70

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
               SS+L  FSTSF+F++ P   + PG G+ F+    T   G+ ++Q+ GLF+      
Sbjct: 71  DPITSSVL-PFSTSFIFTMAPYKNTLPGHGIVFLFAPSTGINGSSSAQHLGLFNLTNNGN 129

Query: 141 VA-PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
            +  +  VEFD   N EF+D D NH+G+D+N++ S     +GY+S      F P+++ +G
Sbjct: 130 PSNHIFGVEFDVFANQEFSDIDANHVGIDVNSLHSVYSNTSGYWSDD-GVVFKPLKLNDG 188

Query: 200 QNIHAWID-------------------------------------FDGFSASKTNWIEAR 222
           +N   WID                                     F GF+A+    +++ 
Sbjct: 189 RNYQVWIDYRDFVVNVTMQVAGKIRPKIPLLSTSLNLSDVVEDEMFVGFTAATGRLVQSH 248

Query: 223 RVLAWSLSDTGVAREIN--TTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGY 280
           ++LAWS S++  +   +  TT  P+F+ P  S   +   V  +V+ C +  ++       
Sbjct: 249 KILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVFVLVLICFL--VVALVGLVL 306

Query: 281 YWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL 340
           +   RK   +A++   +E+WE+EYWPHR  YEE+   TKGF    ++G GG G+VYKG L
Sbjct: 307 FAVVRKRLERARKRALMEDWEMEYWPHRIPYEEIESGTKGFDEKNVIGIGGNGKVYKGLL 366

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-NELMLVY 399
                    E+AVK ++ +S  G++EF+AEISS+GRL+H+NLV +RGWC+K     MLVY
Sbjct: 367 ----QGGVVEVAVKRISQESSDGMREFVAEISSLGRLKHRNLVSLRGWCKKEVGSFMLVY 422

Query: 400 DYMPNGSLNNWIFGKPKKL--LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL 457
           DYM NGSL+ WIF   +K+  L  ++R +IL  VA G+ YLH GW+  V+HRDIK+ N+L
Sbjct: 423 DYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKVLHRDIKASNVL 482

Query: 458 LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVIL 517
           LD +M  RL DFGLA+++   +   TTRVVGT GYLAPE+      ++ +DV+++G+++L
Sbjct: 483 LDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKTGRASTQTDVFAYGILVL 542

Query: 518 EVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA----EEMELVL 573
           EV CGRRP++ GK        LMDWV  L  +G+I    D ++          +E E VL
Sbjct: 543 EVMCGRRPIEEGKKP------LMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEAERVL 596

Query: 574 KLGLACCHPDSTRRPTMREVVAVLVGQE 601
           +LGL C HPD  +RP+MR+VV V  G +
Sbjct: 597 QLGLLCAHPDPAKRPSMRQVVQVFEGDK 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  402 bits (1032), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 237/622 (38%), Positives = 347/622 (55%), Gaps = 64/622 (10%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMKR 79
           S S +L+F +N+       TDL +     V    +++LTN + Q + G A+Y   ++ K 
Sbjct: 20  SSSQSLNFAYNN--GFNPPTDLSIQGITTVTPNGLLKLTNTTVQKT-GHAFYTKPIRFKD 76

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
           S    +  ++SFSTSFVF+I  +IA   G G+ FV+    S P    SQY GLF+ A   
Sbjct: 77  SP---NGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNG 133

Query: 140 T-VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRN 198
                + AVE DT  + EFND +DNH+G+D+N+++S +  PAGY+       F  + + +
Sbjct: 134 NETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWD--EKGQFKNLTLIS 191

Query: 199 GQNIHAWIDFDG---------------------------------------FSASKTNWI 219
            + +  W+D+DG                                       FS++  + +
Sbjct: 192 RKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVL 251

Query: 220 EARRVLAWSLSDTGVAREINTTNFPTF--LPPSSSSSLSAGAVAGIVIGCVMGFLIICAS 277
               +L WS      A  +  +  P      P   S      +  I +  +  F+ +   
Sbjct: 252 SEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVC- 310

Query: 278 TGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYK 337
              Y   R+ K   + E+  +E    +  +RF +++L  ATKGF    LLG+GGFG VYK
Sbjct: 311 ---YIVRRRRKFAEELEEWEKE----FGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYK 363

Query: 338 GTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML 397
           G +         E+AVK V+H+S+QG+KEF+AEI S+GR+ H+NLV + G+CR+  EL+L
Sbjct: 364 GVMPGTK----LEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLL 419

Query: 398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL 457
           VYDYMPNGSL+ +++  P+  L WKQR +++  VA GL YLH  W+QVV+HRD+K+ N+L
Sbjct: 420 VYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVL 479

Query: 458 LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVIL 517
           LD E+ GRLGDFGLA+LY  G  P TT VVGTLGYLAPE       T A+DV++FG  +L
Sbjct: 480 LDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLL 539

Query: 518 EVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGL 577
           EVACGRRP++  + E +E  +L+DWV  L+ +G I  A D  +  E + +E+E+VLKLGL
Sbjct: 540 EVACGRRPIEF-QQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGL 598

Query: 578 ACCHPDSTRRPTMREVVAVLVG 599
            C H D   RP+MR+V+  L G
Sbjct: 599 LCSHSDPRARPSMRQVLHYLRG 620

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	636
255540529	666	carbohydrate binding protein, putative [	0.905	0.864	0.683	0.0
224135937	614	predicted protein [Populus trichocarpa]	0.902	0.934	0.682	0.0
359491213	708	PREDICTED: LOW QUALITY PROTEIN: L-type l	0.957	0.860	0.651	0.0
147863736	659	hypothetical protein VITISV_010063 [Viti	0.957	0.924	0.649	0.0
356562682	668	PREDICTED: L-type lectin-domain containi	0.932	0.887	0.662	0.0
224121766	602	predicted protein [Populus trichocarpa]	0.883	0.933	0.675	0.0
356513762	663	PREDICTED: L-type lectin-domain containi	0.926	0.888	0.649	0.0
297849982	651	hypothetical protein ARALYDRAFT_888945 [	0.910	0.889	0.646	0.0
15218220	656	concanavalin A-like lectin protein kinas	0.891	0.864	0.658	0.0
214011436	587	serine/threonine-specific protein kinase	0.833	0.902	0.703	0.0

>gi|255540529|ref|XP_002511329.1| carbohydrate binding protein, putative [Ricinus communis] gi|223550444|gb|EEF51931.1| carbohydrate binding protein, putative [Ricinus communis]

 Score =  841 bits (2172), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/629 (68%), Positives = 505/629 (80%), Gaps = 53/629 (8%)

Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATN 84
           ALDFLFNSF   T   D+ILI D  VDS+VIRLTND+NQ+S GR +YP++++MK +   N
Sbjct: 30  ALDFLFNSFN--TTNPDVILIGDARVDSSVIRLTNDTNQYSLGRVFYPSRIRMKPTQ--N 85

Query: 85  SSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPL 144
           S+ L+SFSTSFVFS+LPEIA+SPGFGL FVL+N+T+PP A+ASQYFGLF+N+TV + APL
Sbjct: 86  STTLSSFSTSFVFSVLPEIATSPGFGLTFVLSNWTNPPNAIASQYFGLFTNSTVPSQAPL 145

Query: 145 LAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHA 204
           L VEFDTG+NPEFNDPD NHIG+DLNNIES    PAGYY+SS  + FVP+ M  GQN+HA
Sbjct: 146 LVVEFDTGRNPEFNDPDGNHIGIDLNNIESIATEPAGYYNSS--DDFVPLAMNTGQNVHA 203

Query: 205 WIDFDG----------------------------------------FSASKTNWIEARRV 224
           WIDFDG                                        FSASKT W+EA+R+
Sbjct: 204 WIDFDGTNLEINVTVAPIGVSRPSVPTLSYKKSIIANYVSSDMFFGFSASKTTWVEAQRI 263

Query: 225 LAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYW 284
           LAWS SDTG AR+INTTN P F+ PSSS+SLSAGA+AGI IGCV  F++ICA  G+YW+W
Sbjct: 264 LAWSFSDTGNARDINTTNLPVFMLPSSSNSLSAGAIAGITIGCV-AFVLICA-YGFYWFW 321

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN 344
            K K   QEEDE+E+WELEYWPHRFSYEEL++AT GFS D+LLGSGGFG+VY+GTL+NN 
Sbjct: 322 LKKKFNNQEEDEMEDWELEYWPHRFSYEELTQATNGFSKDQLLGSGGFGKVYRGTLSNN- 380

Query: 345 NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN 404
               TE+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRGWCRK NELMLVYDYMPN
Sbjct: 381 ----TEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRKSNELMLVYDYMPN 436

Query: 405 GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG 464
           GSL+ +IF    K L W++RRQIL+DVAEGLNYLHHGWDQVV+HRDIKS NILLDSEMRG
Sbjct: 437 GSLDRYIFNSTNKSLNWQKRRQILSDVAEGLNYLHHGWDQVVIHRDIKSSNILLDSEMRG 496

Query: 465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR 524
           RLGDFGLAKLY   EVPNTTRVVGTLGYLAPELAT+++PT+ASDVYSFGVVILEVACGRR
Sbjct: 497 RLGDFGLAKLYSHNEVPNTTRVVGTLGYLAPELATLAAPTAASDVYSFGVVILEVACGRR 556

Query: 525 PLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDS 584
           P++MGK ++E++ VL++ VR LY +GK+ EAAD RI+ E+  EEME+VLKLGLA CHPD 
Sbjct: 557 PIEMGKDDDEDDRVLIECVRELYVEGKVVEAADERIQGEYGVEEMEMVLKLGLAACHPDP 616

Query: 585 TRRPTMREVVAVLVGQEVAATPKELLGDL 613
            RRPTM+EVVAVLVG++ AA P ELL +L
Sbjct: 617 QRRPTMKEVVAVLVGEDAAAAPAELLTEL 645

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224135937|ref|XP_002322198.1| predicted protein [Populus trichocarpa] gi|222869194|gb|EEF06325.1| predicted protein [Populus trichocarpa]

 Score =  827 bits (2137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/636 (68%), Positives = 500/636 (78%), Gaps = 62/636 (9%)

Query: 5   LRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQF 64
           L LFLF+I        SPS ALDFLF+SF +   G  +ILI D  VD++VIRL ND+NQ+
Sbjct: 1   LLLFLFLI--------SPSFALDFLFDSFNATNPG--VILIPDAIVDTSVIRLLNDTNQY 50

Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGA 124
           S GRA+YPT++KMK+ T  +++ L+SFSTSFVFSILP IASSPGFGL FVL+N+T+PPGA
Sbjct: 51  SLGRAFYPTRMKMKQ-TQNSTTTLSSFSTSFVFSILPNIASSPGFGLAFVLSNWTNPPGA 109

Query: 125 LASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYS 184
           LASQYFG+FSN TV +VAPLL VEFDTGQNPEFNDP+ NHIG+DLNNIESAK  P GY S
Sbjct: 110 LASQYFGVFSNPTVPSVAPLLVVEFDTGQNPEFNDPNRNHIGIDLNNIESAKTAPGGYNS 169

Query: 185 SSRNESFVPVRMRNGQNIHAWIDFDG---------------------------------- 210
           S+    FVPV M NGQN+ AWI+FDG                                  
Sbjct: 170 SA---GFVPVSMGNGQNVRAWIEFDGANFEINVTVAPVGVSRPSVPILSYKNPLIANYTS 226

Query: 211 ------FSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIV 264
                 FSASKT W+EA+R+LAWS SDTGVAR+IN TN P F  PSSS+SLSAGA++GI 
Sbjct: 227 EEMYVGFSASKTTWVEAQRILAWSFSDTGVARDINVTNLPVFSLPSSSNSLSAGAISGIT 286

Query: 265 IGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSND 324
           IGC + F++IC     Y  W KNK K  EEDEIE+WELEYWPHRFSYEELS+AT GFS D
Sbjct: 287 IGCAV-FVMICVFV-VYCLWYKNKSKDLEEDEIEDWELEYWPHRFSYEELSQATNGFSKD 344

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +LLGSGGFG+VY+G L+NN     +E+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQ
Sbjct: 345 QLLGSGGFGKVYRGILSNN-----SEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQ 399

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           MRGWCRK NELMLVYDYMPNGSL+ +IF KPKKLL W+QRRQ+LADVAEGLNYLHHGWDQ
Sbjct: 400 MRGWCRKSNELMLVYDYMPNGSLDRYIFHKPKKLLNWQQRRQVLADVAEGLNYLHHGWDQ 459

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           VVVHRDIKS NILLDS+MRGRLGDFGLAKLY   EVPNTTRVVGTLGYLAPEL T++  T
Sbjct: 460 VVVHRDIKSSNILLDSDMRGRLGDFGLAKLYSHNEVPNTTRVVGTLGYLAPELVTMAVAT 519

Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
           SASD+YSFGVVILEVACGRRP++MG   EEE++VL+D VR+L+ +GK  EAAD R++ EF
Sbjct: 520 SASDIYSFGVVILEVACGRRPIEMGS-TEEEDSVLIDLVRDLHAKGKAVEAADERMKGEF 578

Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
             EEME+VLKLGL CCHPD  RRP+MREVVAVLVG+
Sbjct: 579 VVEEMEMVLKLGLVCCHPDPQRRPSMREVVAVLVGE 614

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491213|ref|XP_003634242.1| PREDICTED: LOW QUALITY PROTEIN: L-type lectin-domain containing receptor kinase S.1-like [Vitis vinifera]

 Score =  826 bits (2133), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/674 (65%), Positives = 514/674 (76%), Gaps = 65/674 (9%)

Query: 4   MLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ 63
           ++ LF F+ V       SPS +++FL+NSF + ++ + L LIND  V+ +VIRLTNDSNQ
Sbjct: 55  LVPLFTFLFV-------SPSLSVNFLYNSFNA-SDASYLELINDARVEGSVIRLTNDSNQ 106

Query: 64  FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPG 123
           FSFGR +YPT+L MK ++  NS+ + SFSTSFVFSILP+I+ SPGFGL FVL+N TSPPG
Sbjct: 107 FSFGRVFYPTRLTMKPTS--NSTAVASFSTSFVFSILPDISDSPGFGLAFVLSNSTSPPG 164

Query: 124 ALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH--VPAG 181
           ALASQYFGLFSNATV +VAPLLAVEFDTGQNPEFND D NH+G+DLNNIES       AG
Sbjct: 165 ALASQYFGLFSNATVPSVAPLLAVEFDTGQNPEFNDIDGNHVGIDLNNIESESDGTQTAG 224

Query: 182 YYSSSRNESFVPVRMRNGQNIHAWIDFDG------------------------------- 210
           YY+SS +  FV V MRNGQNI AWI+FDG                               
Sbjct: 225 YYNSSGD--FVAVEMRNGQNIRAWIEFDGPQFEINVTIAPVAVSKPSRPLISYRNPKIAN 282

Query: 211 ---------FSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVA 261
                    FSASKTNW+EA+R+LAWSLSDTGVA +INTTN P F P ++SSSLSAGA+A
Sbjct: 283 YVSTEMYVGFSASKTNWVEAQRILAWSLSDTGVAADINTTNLPVFSPETASSSLSAGAIA 342

Query: 262 GIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGF 321
           GI I  V+ FL+IC S GY W+WRK K++ ++E E  E  LEYWPHRFSYEEL +AT GF
Sbjct: 343 GIAIASVV-FLLICLSGGY-WFWRKTKIEEEDEIEDWE--LEYWPHRFSYEELKQATDGF 398

Query: 322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN 381
           S +ELLG GGFGRVY+GTL NN     T++AVKCVNHDSKQGL+EFMAEI+SMGRLQH N
Sbjct: 399 SKNELLGLGGFGRVYRGTLPNN-----TQVAVKCVNHDSKQGLREFMAEIASMGRLQHIN 453

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           LVQMRGWCRKGNELMLVYD+MPNGSLN WIF  PK LLGW+ RR++LADVAEGLNYLH G
Sbjct: 454 LVQMRGWCRKGNELMLVYDFMPNGSLNRWIFDNPKTLLGWEGRRRVLADVAEGLNYLHQG 513

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
           WD+VV+HRDIKS NILLDSEMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELATV+
Sbjct: 514 WDKVVIHRDIKSSNILLDSEMRGRLGDFGLAKLYEHGAAPNTTRVVGTLGYLAPELATVT 573

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
           +PT+ASDVYSFGVV+LEVACGRRP++    EEE+  VL+DWVR  Y  G++CEAAD RI 
Sbjct: 574 APTAASDVYSFGVVVLEVACGRRPIETWAAEEEQ--VLIDWVREKYLDGRVCEAADKRIA 631

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDAD 621
            ++  EEME VLKLGLACCHPD   RPTM+EVV VLVG+E AA P  +L +LA+      
Sbjct: 632 GQYVVEEMERVLKLGLACCHPDPQHRPTMKEVVTVLVGEEAAAAPAAVLSELAQAGESVG 691

Query: 622 FSGGDDSREDAPLQ 635
            SGGD + E+ PLQ
Sbjct: 692 CSGGDTNAEEPPLQ 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147863736|emb|CAN79354.1| hypothetical protein VITISV_010063 [Vitis vinifera]

 Score =  820 bits (2119), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/674 (64%), Positives = 513/674 (76%), Gaps = 65/674 (9%)

Query: 4   MLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ 63
           ++ LF F+ V       SPS +++FL+NSF + ++ + L LIND  V+ +VIRLTNDSNQ
Sbjct: 6   LVPLFTFLFV-------SPSVSVNFLYNSFNA-SDASYLELINDARVEGSVIRLTNDSNQ 57

Query: 64  FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPG 123
           FSFGR +YPT+L MK ++  NS+ + SFSTSFVFSILP+I+ SPGFGL FVL+N TSPPG
Sbjct: 58  FSFGRVFYPTRLTMKPTS--NSTAVASFSTSFVFSILPDISDSPGFGLAFVLSNSTSPPG 115

Query: 124 ALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH--VPAG 181
           ALASQYFGLFSNATV +VAPLLAVEFDTGQNPEFND D NH+G+DLNNIES       AG
Sbjct: 116 ALASQYFGLFSNATVPSVAPLLAVEFDTGQNPEFNDIDGNHVGIDLNNIESESDGTQTAG 175

Query: 182 YYSSSRNESFVPVRMRNGQNIHAWIDFDG------------------------------- 210
           YY+SS +  FV V MRNGQNI AWI+FDG                               
Sbjct: 176 YYNSSGD--FVAVEMRNGQNIRAWIEFDGPQFEINVTIAPVAVSKPSRPLISYRNPKIAN 233

Query: 211 ---------FSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVA 261
                    FSASKTNW+EA+R+LAWSLSDTGVA +INTTN P F P ++SSSLSAGA+A
Sbjct: 234 YVSTEMYVGFSASKTNWVEAQRILAWSLSDTGVAADINTTNLPVFSPETASSSLSAGAIA 293

Query: 262 GIVIGCVMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGF 321
           GI I  V+ FL+IC S GY W+WRK K++ ++E E  E  LEYWPHRFSYEEL +AT GF
Sbjct: 294 GIAIASVV-FLLICLSGGY-WFWRKTKIEEEDEIEDWE--LEYWPHRFSYEELKQATDGF 349

Query: 322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN 381
           S +ELLG GGFGRVY+GTL NN     T++AVKCVNHDSKQGL+EFMAEI+SMGRLQH N
Sbjct: 350 SKNELLGLGGFGRVYRGTLPNN-----TQVAVKCVNHDSKQGLREFMAEIASMGRLQHIN 404

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           LVQMRGWCRKGNELMLVYD+MPNGSLN WIF  PK LLGW+ RR++LADVAEGLNYLH G
Sbjct: 405 LVQMRGWCRKGNELMLVYDFMPNGSLNRWIFDNPKTLLGWEXRRRVLADVAEGLNYLHQG 464

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
           WD+VV+HRDIKS NILLDSEMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELATV+
Sbjct: 465 WDKVVIHRDIKSSNILLDSEMRGRLGDFGLAKLYEHGAAPNTTRVVGTLGYLAPELATVT 524

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
           +PT+ASDVYSFGVV+LEVACGRRP++    EEE+  VL+DWVR  Y  G++ EAAD RI 
Sbjct: 525 APTAASDVYSFGVVVLEVACGRRPIETWAAEEEQ--VLIDWVREKYLDGRVYEAADKRIA 582

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDAD 621
            ++  EEME VLKLGLACCHPD   RPTM+EVV VLVG+E AA P  +L +LA+      
Sbjct: 583 GQYVVEEMERVLKLGLACCHPDPQHRPTMKEVVTVLVGEEAAAAPAAVLSELAQAGESVG 642

Query: 622 FSGGDDSREDAPLQ 635
            SGGD + E+ PLQ
Sbjct: 643 CSGGDTNAEEPPLQ 656

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356562682|ref|XP_003549598.1| PREDICTED: L-type lectin-domain containing receptor kinase S.1-like [Glycine max]

 Score =  808 bits (2086), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/657 (66%), Positives = 508/657 (77%), Gaps = 64/657 (9%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKM-KR 79
           +P+ +LDFLFNSF  +TN   L LI D  VD++VIR+ NDSNQ+S+GRA+YP K+ M K 
Sbjct: 30  TPALSLDFLFNSFAGVTN---LTLIKDARVDASVIRMNNDSNQYSYGRAFYPVKIPMLKT 86

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
           +T+ NSS ++SFSTSFVFSILP+I++SPGFGL FVL+N T PPGA+ASQYFGLF+NAT  
Sbjct: 87  NTSNNSSSISSFSTSFVFSILPQISTSPGFGLAFVLSNTTDPPGAIASQYFGLFTNATSP 146

Query: 140 TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
           +V PL+AVEFDTG+NPEFND DDNHIG+DLNNIES     AGY++SS   +FVPVRMR G
Sbjct: 147 SVFPLVAVEFDTGRNPEFNDIDDNHIGIDLNNIESINATTAGYFNSS--GAFVPVRMRTG 204

Query: 200 QNIHAWIDFDG----------------------------------------FSASKTNWI 219
           QNIHAWIDFDG                                        FSASKTNWI
Sbjct: 205 QNIHAWIDFDGENLEFNVTVAPIGVSRPTKPTLRYQNPAIADYVSSNMYVGFSASKTNWI 264

Query: 220 EARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTG 279
           EA+RVLAWS SD+G ARE+NTTN P F   SSSSSLS GA+AGIVIG  + F++ICAS G
Sbjct: 265 EAQRVLAWSFSDSGPARELNTTNLPVFELESSSSSLSNGAIAGIVIGSFI-FVLICAS-G 322

Query: 280 YYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGT 339
           +Y +WR NK   +E++  +  ELEYWPHRFSYEELS AT  F  + LLGSGGFGRVYKGT
Sbjct: 323 FYLWWRMNKANEEEDEIEDW-ELEYWPHRFSYEELSYATGEFRKEMLLGSGGFGRVYKGT 381

Query: 340 LANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY 399
           L NN     TE+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRGWCRKGNEL+LVY
Sbjct: 382 LPNN-----TEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRKGNELLLVY 436

Query: 400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD 459
           DYMPNGSLN W+F K  K+LGW+QRR+IL DVAEGLNYLHHGWDQVV+HRDIKS NILLD
Sbjct: 437 DYMPNGSLNKWVFDKSDKVLGWEQRRRILVDVAEGLNYLHHGWDQVVIHRDIKSSNILLD 496

Query: 460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
           ++MRGRLGDFGLAKLY  GEVPNTTRVVGTLGYLAPELATV++PTSA+DVYSFGVV+LEV
Sbjct: 497 ADMRGRLGDFGLAKLYTHGEVPNTTRVVGTLGYLAPELATVAAPTSATDVYSFGVVLLEV 556

Query: 520 ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLAC 579
           ACGRRP++      EEE VL+DWVR LY +G   EAAD RIR E++  ++E+VLKLGLAC
Sbjct: 557 ACGRRPIETSVA--EEEVVLIDWVRELYAKGCAREAADLRIRGEYDEGDVEMVLKLGLAC 614

Query: 580 CHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAPLQP 636
           CHPD  RRPTM+EVVA+L+G++    P ++L DL R        GG+DS E APLQP
Sbjct: 615 CHPDPQRRPTMKEVVALLLGEDPPEAPGKVLSDLVR--------GGEDSDEAAPLQP 663

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121766|ref|XP_002318667.1| predicted protein [Populus trichocarpa] gi|222859340|gb|EEE96887.1| predicted protein [Populus trichocarpa]

 Score =  799 bits (2063), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/616 (67%), Positives = 482/616 (78%), Gaps = 54/616 (8%)

Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATN 84
            LDFLFNSF +   G  + LI D  VD++VIRL ND+NQ S GRA+YPTK+KMK+ T  +
Sbjct: 1   GLDFLFNSFNATNPG--VTLIPDAGVDTSVIRLLNDTNQNSIGRAFYPTKIKMKQ-TQNS 57

Query: 85  SSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPL 144
           ++ L SFSTSFVFSILP IASSPGFGL FVL+N+T+PPGA   QYFGLF+N TV + APL
Sbjct: 58  TTTLFSFSTSFVFSILPNIASSPGFGLAFVLSNWTNPPGAFPGQYFGLFTNTTVSSAAPL 117

Query: 145 LAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHA 204
           LAVEFDTGQNPEFNDPD NHIG+DLNN  S+   P GY SS+    FVPV M NGQN+ A
Sbjct: 118 LAVEFDTGQNPEFNDPDRNHIGIDLNNPVSSLTKPGGYNSSA---GFVPVSMGNGQNVRA 174

Query: 205 WIDFDG----------------------------------------FSASKTNWIEARRV 224
           WIDFDG                                        FSASKT W+EA+R+
Sbjct: 175 WIDFDGPNFQINVTVAPVGVSRPSVPILSFKDPVIANYTSEEMYVGFSASKTTWVEAQRI 234

Query: 225 LAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYW 284
           LAWS SDTGVAR+IN TN P F  PSSS+SLSAG++AGI IGCV+ F +IC      W+W
Sbjct: 235 LAWSFSDTGVARDINVTNLPVFSLPSSSNSLSAGSIAGITIGCVVLF-VICVFV-VSWFW 292

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN 344
            K KL+  EEDEIE+WELEYWPHRFSY ELS+AT GFS D+LLGSGGFG+VY+GTL+NN 
Sbjct: 293 YKQKLRDSEEDEIEDWELEYWPHRFSYGELSQATNGFSIDQLLGSGGFGKVYRGTLSNN- 351

Query: 345 NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN 404
               +++AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK +ELMLVYDYMPN
Sbjct: 352 ----SDIAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKASELMLVYDYMPN 407

Query: 405 GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG 464
           GSL+ +IF KPKKLL W+QRRQ+LADVAEGLNYLHHGW++VVVHRD+KS NILLDS+MRG
Sbjct: 408 GSLDRYIFHKPKKLLNWQQRRQVLADVAEGLNYLHHGWEKVVVHRDVKSSNILLDSDMRG 467

Query: 465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR 524
           RLGDFGLAKLY   EVPNTTRVVGTLGYLAPE+AT++  TSASDVYSFGVVILEV CGR+
Sbjct: 468 RLGDFGLAKLYSHNEVPNTTRVVGTLGYLAPEMATMAIATSASDVYSFGVVILEVVCGRK 527

Query: 525 PLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDS 584
           P++MG   E+E++VL+D VR+LY  GK+ EA D R++ EF AEEMELVLKLGL CCHPDS
Sbjct: 528 PVEMGS-NEDEDSVLIDVVRDLYATGKVVEAVDERMKGEFVAEEMELVLKLGLVCCHPDS 586

Query: 585 TRRPTMREVVAVLVGQ 600
            RRP+MREVVA+LVG+
Sbjct: 587 QRRPSMREVVAILVGE 602

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513762|ref|XP_003525579.1| PREDICTED: L-type lectin-domain containing receptor kinase S.1-like [Glycine max]

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/656 (64%), Positives = 501/656 (76%), Gaps = 67/656 (10%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           +P+ +LDFLFNSF  +TN   L LI D  VD++VIR+ NDSNQ+S+GRA+YP K+ M ++
Sbjct: 30  TPTLSLDFLFNSFAGVTN---LTLIKDARVDASVIRMNNDSNQYSYGRAFYPIKIPMTKT 86

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
            ++ SS  TSF  S    ILP+I++SPGFGL FVL N T+PPGALASQYFGLF+NAT  +
Sbjct: 87  NSSISSFSTSFVFS----ILPQISTSPGFGLAFVLCNTTNPPGALASQYFGLFTNATSPS 142

Query: 141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQ 200
           V PL+AVEFDTG+NPEFND DDNHIG+DLNNIES     AGY++SS   +FVPVRMR GQ
Sbjct: 143 VFPLVAVEFDTGRNPEFNDIDDNHIGIDLNNIESINATTAGYFNSS--GAFVPVRMRTGQ 200

Query: 201 NIHAWIDFDG----------------------------------------FSASKTNWIE 220
           NIHAWIDF+G                                        FSASKTNWIE
Sbjct: 201 NIHAWIDFNGENLEFNVTVAPVGVSRPTKPSLSYQNPAIADYVSADMYVGFSASKTNWIE 260

Query: 221 ARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGY 280
           A+RVLAWS SD+G A+E+NTTN P F   SSSSS+S GA+AGIV+GC + F++ICAS G+
Sbjct: 261 AQRVLAWSFSDSGPAKELNTTNLPVFQLESSSSSISGGAIAGIVVGCFV-FVLICAS-GF 318

Query: 281 YWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL 340
           Y +WR NK K +E++  +  ELEYWPHRFSYEELS AT  F  + LLGSGGFGRVY+GTL
Sbjct: 319 YLWWRMNKAKEEEDEIEDW-ELEYWPHRFSYEELSSATGEFRKEMLLGSGGFGRVYRGTL 377

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
            N+     T++AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD
Sbjct: 378 PNH-----TQIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 432

Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           YMPNGSLN W+F K +KLLGW+QRR+IL DVAEGLNYLHHGWDQVV+HRDIKS NILLD+
Sbjct: 433 YMPNGSLNKWVFDKSEKLLGWEQRRRILVDVAEGLNYLHHGWDQVVIHRDIKSSNILLDA 492

Query: 461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
           +MRGRLGDFGLAKLY  GEVPNTTRVVGTLGYLAPELATV++PTSASDVYSFGVV+LEVA
Sbjct: 493 DMRGRLGDFGLAKLYTHGEVPNTTRVVGTLGYLAPELATVAAPTSASDVYSFGVVLLEVA 552

Query: 521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACC 580
           CGRRP++      EEE VL+DWVR LY +G   EAADA IR E++  ++E+VLKLGLACC
Sbjct: 553 CGRRPIETSVA--EEEVVLIDWVRELYAKGCAREAADAWIRGEYDEGDVEMVLKLGLACC 610

Query: 581 HPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAPLQP 636
           HPD  RRPTM+EVVA+L+G+E    P ++L DL RG  D D        E APLQP
Sbjct: 611 HPDPQRRPTMKEVVALLLGEEPQEAPGKVLSDLVRGGKDMD--------ETAPLQP 658

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849982|ref|XP_002892872.1| hypothetical protein ARALYDRAFT_888945 [Arabidopsis lyrata subsp. lyrata] gi|297338714|gb|EFH69131.1| hypothetical protein ARALYDRAFT_888945 [Arabidopsis lyrata subsp. lyrata]

 Score =  770 bits (1989), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/633 (64%), Positives = 481/633 (75%), Gaps = 54/633 (8%)

Query: 8   FLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFG 67
            L I++ A +  +  SSA+DFL+NSF S+TN TD+ILI D  VDS+VI   N+S+ FSFG
Sbjct: 9   LLLILIFAASL-LPSSSAIDFLYNSFSSVTNRTDVILIEDSRVDSSVISFINESDPFSFG 67

Query: 68  RAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALAS 127
           R +YP KL +      N + L+SFSTSFVFSILP+I+++PGFGLCFVL+N TSPP AL+S
Sbjct: 68  RVFYPQKLSIIPDPTRNPTRLSSFSTSFVFSILPDISTTPGFGLCFVLSNSTSPPNALSS 127

Query: 128 QYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSR 187
           QYFGLF+NATV   APLLAVEFDTG+N E ND DDNHIG+DLNNIES   V AGYY S  
Sbjct: 128 QYFGLFTNATVRFNAPLLAVEFDTGRNSEVNDIDDNHIGIDLNNIESTTSVTAGYYDSV- 186

Query: 188 NESFVPVRMRNGQNIHAWIDFDG------------------------------------- 210
           N SF+   MRNG N+ AWIDFDG                                     
Sbjct: 187 NGSFLRFNMRNGNNVRAWIDFDGPNFQINVSVAPVGVLRPRRPTLTFRDPVIANYVSADM 246

Query: 211 ---FSASKTNWIEARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGC 267
              FSASKTNW EARR+LAWSLSDTG  REINTTN P F   +SSSSLS GA+AGIVIGC
Sbjct: 247 YVGFSASKTNWNEARRILAWSLSDTGTLREINTTNLPVFFLENSSSSLSTGAIAGIVIGC 306

Query: 268 VMGFLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELL 327
           V+   +     G Y  WRK  ++ +EE+EIEEWELE+WPHRFSYEEL+ AT+ FSND LL
Sbjct: 307 VV--FVGLLGFGGYMIWRK-LMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDRLL 363

Query: 328 GSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRG 387
           GSGGFG+VY+G L+NN     +E+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRG
Sbjct: 364 GSGGFGKVYRGILSNN-----SEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRG 418

Query: 388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVV 447
           WCR+ NELMLVYDYMPNGSLN WIF  PK+ + W++RRQ++ DVAEGLNYLHHGWDQVV+
Sbjct: 419 WCRRKNELMLVYDYMPNGSLNQWIFDNPKEPMPWRRRRQVINDVAEGLNYLHHGWDQVVI 478

Query: 448 HRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS 507
           HRDIKS NILLDSEMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELA+ S+PT AS
Sbjct: 479 HRDIKSSNILLDSEMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTEAS 538

Query: 508 DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA- 566
           DVYSFGVV+LEV CGRRP++     EEE+ VL+DWVR+LY  G++ +AAD R+R E E  
Sbjct: 539 DVYSFGVVVLEVVCGRRPIEYA---EEEDMVLVDWVRDLYNGGRVVDAADERVRSECETM 595

Query: 567 EEMELVLKLGLACCHPDSTRRPTMREVVAVLVG 599
           EE+EL+LKLGLACCHPD  +RP MRE+V++L+G
Sbjct: 596 EEVELLLKLGLACCHPDPAKRPNMREIVSLLLG 628

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218220|ref|NP_173006.1| concanavalin A-like lectin protein kinase-like protein [Arabidopsis thaliana] gi|75336093|sp|Q9M9E0.1|LRKS1_ARATH RecName: Full=L-type lectin-domain containing receptor kinase S.1; Short=LecRK-S.1; Flags: Precursor gi|8072403|gb|AAF71991.1|AC013453_16 Putative serine/threonine-specific protein kinase [Arabidopsis thaliana] gi|91805789|gb|ABE65623.1| receptor lectin kinase [Arabidopsis thaliana] gi|332191212|gb|AEE29333.1| concanavalin A-like lectin protein kinase-like protein [Arabidopsis thaliana]

 Score =  769 bits (1986), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/620 (65%), Positives = 476/620 (76%), Gaps = 53/620 (8%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRS 80
           S SSA+DFL+NSF S+TN TD+ILI D  V+STVI L NDS+  SFGR +YP KL +   
Sbjct: 25  SSSSAIDFLYNSFSSVTNRTDVILIEDSRVESTVISLINDSDPLSFGRVFYPQKLTIIPD 84

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVT 140
              N + L+SFSTSFVFSILP+I++SPGFGLCFVL+N TSPP A++SQYFGLF+NATV  
Sbjct: 85  PTRNPTRLSSFSTSFVFSILPDISTSPGFGLCFVLSNSTSPPNAISSQYFGLFTNATVRF 144

Query: 141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQ 200
            APLLAVEFDTG+N E ND DDNH+G+DLNNIES   V AGYY S  N SFV   MRNG 
Sbjct: 145 NAPLLAVEFDTGRNSEVNDIDDNHVGIDLNNIESTTSVTAGYYDSV-NGSFVRFNMRNGN 203

Query: 201 NIHAWIDFDG----------------------------------------FSASKTNWIE 220
           N+ AWIDFDG                                        FSASKTNW E
Sbjct: 204 NVRAWIDFDGPNFQINVSVAPVGVLRPRRPTLTFRDPVIANYVSADMYAGFSASKTNWNE 263

Query: 221 ARRVLAWSLSDTGVAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGY 280
           ARR+LAWSLSDTG  REINTTN P F   +SSSSLS GA+AGIVIGCV+   +I    G 
Sbjct: 264 ARRILAWSLSDTGALREINTTNLPVFFLENSSSSLSTGAIAGIVIGCVVFVALI--GFGG 321

Query: 281 YWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL 340
           Y  W+K  ++ +EE+EIEEWELE+WPHRFSYEEL+ AT+ FSND LLGSGGFG+VY+G L
Sbjct: 322 YLIWKK-LMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDRLLGSGGFGKVYRGIL 380

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
           +NN     +E+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRGWCR+ NELMLVYD
Sbjct: 381 SNN-----SEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCRRKNELMLVYD 435

Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           YMPNGSLN WIF  PK+ + W++RRQ++ DVAEGLNYLHHGWDQVV+HRDIKS NILLDS
Sbjct: 436 YMPNGSLNQWIFDNPKEPMPWRRRRQVINDVAEGLNYLHHGWDQVVIHRDIKSSNILLDS 495

Query: 461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
           EMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELA+ S+PT ASDVYSFGVV+LEV 
Sbjct: 496 EMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTEASDVYSFGVVVLEVV 555

Query: 521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA-EEMELVLKLGLAC 579
            GRRP++     EEE+ VL+DWVR+LYG G++ +AAD R+R E E  EE+EL+LKLGLAC
Sbjct: 556 SGRRPIEYA---EEEDMVLVDWVRDLYGGGRVVDAADERVRSECETMEEVELLLKLGLAC 612

Query: 580 CHPDSTRRPTMREVVAVLVG 599
           CHPD  +RP MRE+V++L+G
Sbjct: 613 CHPDPAKRPNMREIVSLLLG 632

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|214011436|gb|ACJ61468.1| serine/threonine-specific protein kinasein [Gossypium barbadense]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/580 (70%), Positives = 467/580 (80%), Gaps = 50/580 (8%)

Query: 94  SFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQ 153
           +FVFS+LP+I++SPGFGLCFVL+N TSPPGALASQYFG+F+NAT  TVAPLLAVEFDTGQ
Sbjct: 16  AFVFSVLPQISTSPGFGLCFVLSNSTSPPGALASQYFGIFTNATSPTVAPLLAVEFDTGQ 75

Query: 154 NPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDG--- 210
           NPEFNDPD NHIG+DLN+I SA+   A Y +SS N SFVP+ MR GQN+HAWIDFDG   
Sbjct: 76  NPEFNDPDGNHIGIDLNSIISAQTATAQYINSS-NGSFVPLNMRTGQNVHAWIDFDGSNF 134

Query: 211 -------------------------------------FSASKTNWIEARRVLAWSLSDTG 233
                                                FSASKT W+EA+R+LAWS SDTG
Sbjct: 135 EINVTVAPVGVSKPSRPTLNYKDPVIANYVASEMFVGFSASKTQWVEAQRILAWSFSDTG 194

Query: 234 VAREINTTNFPTFLPPSSSSSLSAGAVAGIVIGCVMGFLIICASTGYYWYWRKNKLKAQE 293
           V REINTT  P F   SSSSSLS+GA+AGIVIGCV  F+IIC S G Y+ WRK K + + 
Sbjct: 195 VLREINTTGLPEFFIESSSSSLSSGAIAGIVIGCV-AFVIICGS-GCYFVWRK-KFREES 251

Query: 294 EDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAV 353
           E+EIE+WELEYWPHRFSY+EL +AT GFSN+ LLG+GGFGRV+K TL N     +TE+AV
Sbjct: 252 EEEIEDWELEYWPHRFSYDELKQATNGFSNENLLGAGGFGRVFKATLPN-----TTEVAV 306

Query: 354 KCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFG 413
           K VNHDSKQGL+EFMAEI SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLN WIF 
Sbjct: 307 KSVNHDSKQGLREFMAEIESMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNRWIFD 366

Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
           KP+KLLGWKQR  +LADVAEGLNYLHHGWDQVVVHRDIKS NILLDSEMRGRLGDFGLAK
Sbjct: 367 KPEKLLGWKQRLLVLADVAEGLNYLHHGWDQVVVHRDIKSSNILLDSEMRGRLGDFGLAK 426

Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           LY+ G+VPNTTRVVGTLGYLAPELATV+ PT++SDVYSFGVV+LEV CGRRPL+M   E+
Sbjct: 427 LYEHGQVPNTTRVVGTLGYLAPELATVAVPTASSDVYSFGVVVLEVVCGRRPLEMAL-EK 485

Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           EEE VL+DWVR LYG+G++ EAADAR+R+E+E EE+E++LKLGLACCHPD +RRPTM+EV
Sbjct: 486 EEEQVLIDWVRWLYGEGRLREAADARVREEYEGEEVEMMLKLGLACCHPDPSRRPTMKEV 545

Query: 594 VAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDAP 633
           VAVLVG+EV A   ELL +LARG      SG +DSRE+AP
Sbjct: 546 VAVLVGEEVGAASAELLNELARGGGSGSGSGREDSREEAP 585

Source: Gossypium barbadense

Species: Gossypium barbadense

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	636
TAIR|locus:2196608	656	AT1G15530 [Arabidopsis thalian	0.625	0.606	0.639	5.1e-201
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.595	0.554	0.454	3.4e-113
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.490	0.460	0.507	6.3e-110
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.614	0.584	0.404	1e-109
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.493	0.469	0.475	3.5e-107
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.490	0.462	0.501	1.2e-106
TAIR|locus:2138381	686	AT4G04960 [Arabidopsis thalian	0.597	0.553	0.407	1.9e-104
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.452	0.427	0.518	6.5e-104
TAIR|locus:2085587	669	AT3G45440 [Arabidopsis thalian	0.594	0.565	0.426	3.2e-100
TAIR|locus:2097493	661	HLECRK "lectin-receptor kinase	0.522	0.502	0.487	6.7e-100

TAIR|locus:2196608 AT1G15530 [Arabidopsis thaliana (taxid:3702)]

 Score = 1355 (482.0 bits), Expect = 5.1e-201, Sum P(2) = 5.1e-201
 Identities = 266/416 (63%), Positives = 316/416 (75%)

Query:   208 FDGFSASKTNWIEARRVLAWSLSDTGVAREIXXXXXXXXXXXXXXXXXXAGAVAGIVIGC 267
             + GFSASKTNW EARR+LAWSLSDTG  REI                   GA+AGIVIGC
Sbjct:   251 YAGFSASKTNWNEARRILAWSLSDTGALREINTTNLPVFFLENSSSSLSTGAIAGIVIGC 310

Query:   268 VMGFLIICASTGYYWYWRKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSNDELL 327
             V+ F+ +    GY   W+K  ++ +           +WPHRFSYEEL+ AT+ FSND LL
Sbjct:   311 VV-FVALIGFGGYL-IWKK-LMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDRLL 367

Query:   328 GSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRG 387
             GSGGFG+VY+G L+      ++E+AVKCVNHDSKQGL+EFMAEISSMGRLQHKNLVQMRG
Sbjct:   368 GSGGFGKVYRGILSN-----NSEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRG 422

Query:   388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVV 447
             WCR+ NELMLVYDYMPNGSLN WIF  PK+ + W++RRQ++ DVAEGLNYLHHGWDQVV+
Sbjct:   423 WCRRKNELMLVYDYMPNGSLNQWIFDNPKEPMPWRRRRQVINDVAEGLNYLHHGWDQVVI 482

Query:   448 HRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS 507
             HRDIKS NILLDSEMRGRLGDFGLAKLY+ G  PNTTRVVGTLGYLAPELA+ S+PT AS
Sbjct:   483 HRDIKSSNILLDSEMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPTEAS 542

Query:   508 DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA- 566
             DVYSFGVV+LEV  GRRP++     EEE+ VL+DWVR+LYG G++ +AAD R+R E E  
Sbjct:   543 DVYSFGVVVLEVVSGRRPIEYA---EEEDMVLVDWVRDLYGGGRVVDAADERVRSECETM 599

Query:   567 EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKE-LLGDLARGAVDAD 621
             EE+EL+LKLGLACCHPD  +RP MRE+V++L+G     +P+E LL  L   A  AD
Sbjct:   600 EEVELLLKLGLACCHPDPAKRPNMREIVSLLLG-----SPQEDLLTGLTPAAAAAD 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 867 (310.3 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
 Identities = 179/394 (45%), Positives = 251/394 (63%)

Query:   210 GFSASKTNWIEARRVLAWSLSDTGVAREIXXXXXXXX-XXXXXXXXXXAGAVAGIVIGC- 267
             GFSAS      +  +L W+ + +G A  +                      + G+ + C 
Sbjct:   239 GFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCS 298

Query:   268 VMGFLIICASTGYYWYWRKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSNDELL 327
             ++ F ++ A++ +       K+K +           + PHRFSY EL KAT GF + ELL
Sbjct:   299 LLIFAVLVAASLFV----VRKVKDEDRVEEWELD--FGPHRFSYRELKKATNGFGDKELL 352

Query:   328 GSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRG 387
             GSGGFG+VYKG L          +AVK ++H+S+QG++EFM+E+SS+G L+H+NLVQ+ G
Sbjct:   353 GSGGFGKVYKGKLPGSDEF----VAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLG 408

Query:   388 WCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
             WCR+ ++L+LVYD+MPNGSL+ ++F + P+ +L WKQR +I+  VA GL YLH GW+Q V
Sbjct:   409 WCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTV 468

Query:   447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
             +HRDIK+ N+LLDSEM GR+GDFGLAKLY+ G  P  TRVVGT GYLAPEL      T++
Sbjct:   469 IHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTS 528

Query:   507 SDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA 566
             +DVY+FG V+LEVACGRRP++       EE V++DWV + +  G I +  D R+  EF+ 
Sbjct:   529 TDVYAFGAVLLEVACGRRPIETSA--LPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDE 586

Query:   567 EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
             EE+ +V+KLGL C +     RPTMR+VV  L  Q
Sbjct:   587 EEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQ 620

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 6.3e-110, Sum P(2) = 6.3e-110
 Identities = 163/321 (50%), Positives = 221/321 (68%)

Query:   307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
             +RF ++EL  ATKGF   +LLGSGGFGRVY+G L         E+AVK V+HDSKQG+KE
Sbjct:   333 NRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTT----KLEVAVKRVSHDSKQGMKE 388

Query:   367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
             F+AEI S+GR+ H+NLV + G+CR+  EL+LVYDYMPNGSL+ +++  P+  L WKQR  
Sbjct:   389 FVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRST 448

Query:   427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
             I+  VA GL YLH  W+QVV+HRD+K+ N+LLD++  GRLGDFGLA+LY  G  P TT V
Sbjct:   449 IIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHV 508

Query:   487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             VGTLGYLAPE +     T+ +DVY+FG  +LEV  GRRP++     ++   +L++WV +L
Sbjct:   509 VGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDT-FLLVEWVFSL 567

Query:   547 YGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAAT 605
             + +G I EA D ++    ++ EE+E+VLKLGL C H D   RP+MR+V+  L G    A 
Sbjct:   568 WLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGD--MAL 625

Query:   606 PKELLGDLARGAVDADFSGGD 626
             P+    DL+ G+V  +  G D
Sbjct:   626 PELTPLDLSAGSV-MNLGGRD 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 804 (288.1 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
 Identities = 165/408 (40%), Positives = 247/408 (60%)

Query:   210 GFSASKTNWIEARRVLAWSLSDTGVAREIXXXXXXXXXXXXXXXXXXAGAVAGIVIGCVM 269
             GF+++      +  +L W+    G A  I                     +  I +    
Sbjct:   239 GFTSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKK--ILAISLSLTS 296

Query:   270 GFLIICASTGYYWYWRKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSNDELLGS 329
               +++  +  Y  + ++ KL              + PHRF+Y++L  ATKGF N ELLG 
Sbjct:   297 LAILVFLTISYMLFLKRKKLME----VLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGK 352

Query:   330 GGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC 389
             GGFG+VYKGTL+      + ++AVK V+HDS+QG++EF+AEI+++GRL+H NLV++ G+C
Sbjct:   353 GGFGKVYKGTLSTS----NMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYC 408

Query:   390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHR 449
             R+  EL LVYD MP GSL+ +++ +P++ L W QR +I+ DVA GL YLHH W QV++HR
Sbjct:   409 RRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHR 468

Query:   450 DIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDV 509
             DIK  N+LLD  M G+LGDFGLAKL + G  P T+ V GT GY++PEL+     +++SDV
Sbjct:   469 DIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDV 528

Query:   510 YSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE--FEAE 567
             ++FG+++LE+ CGRRP+ + +     E VL DWV + + +  I +  D R++Q+  +  E
Sbjct:   529 FAFGILMLEITCGRRPV-LPRASSPSEMVLTDWVLDCW-EDDILQVVDERVKQDDKYLEE 586

Query:   568 EMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLAR 615
             ++ LVLKLGL C HP +  RP+M  V+  L G  VA  P  L  D+ +
Sbjct:   587 QVALVLKLGLFCSHPVAAVRPSMSSVIQFLDG--VAQLPNNLF-DIVK 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 796 (285.3 bits), Expect = 3.5e-107, Sum P(3) = 3.5e-107
 Identities = 154/324 (47%), Positives = 222/324 (68%)

Query:   307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
             +R  +++L  ATKGF +  +LGSGGFG VYKG +         E+AVK V+++S+QGLKE
Sbjct:   336 NRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKT----KKEIAVKRVSNESRQGLKE 391

Query:   367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
             F+AEI S+G++ H+NLV + G+CR+ +EL+LVYDYMPNGSL+ +++  P+  L WKQR +
Sbjct:   392 FVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEVTLDWKQRFK 451

Query:   427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
             ++  VA  L YLH  W+QVV+HRD+K+ N+LLD+E+ GRLGDFGLA+L   G  P TTRV
Sbjct:   452 VINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRV 511

Query:   487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             VGT GYLAP+       T+ +DV++FGV++LEVACGRRP+++   +  E  VL+DWV   
Sbjct:   512 VGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINN-QSGERVVLVDWVFRF 570

Query:   547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAA-- 604
             + +  I +A D  +  E++ +E+E+VLKLGL C H D   RPTMR+V+  L G  +    
Sbjct:   571 WMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDAMLPDL 630

Query:   605 TPKELLGDLARGAVDADFSGGDDS 628
             +P +L G    G +    +G ++S
Sbjct:   631 SPLDLRGS---GIMLGTHNGSNES 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 817 (292.7 bits), Expect = 1.2e-106, Sum P(2) = 1.2e-106
 Identities = 160/319 (50%), Positives = 216/319 (67%)

Query:   307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
             +RF +++L  ATKGF    LLG+GGFG VYKG +         E+AVK V+H+S+QG+KE
Sbjct:   333 NRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGT----KLEIAVKRVSHESRQGMKE 388

Query:   367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
             F+AEI S+GR+ H+NLV + G+CR+  EL+LVYDYMPNGSL+ +++  P+  L WKQR +
Sbjct:   389 FVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIK 448

Query:   427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
             ++  VA GL YLH  W+QVV+HRD+K+ N+LLD E+ GRLGDFGLA+LY  G  P TT V
Sbjct:   449 VILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHV 508

Query:   487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             VGTLGYLAPE       T A+DV++FG  +LEVACGRRP++  + E +E  +L+DWV  L
Sbjct:   509 VGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQ-ETDETFLLVDWVFGL 567

Query:   547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAA-- 604
             + +G I  A D  +  E + +E+E+VLKLGL C H D   RP+MR+V+  L G       
Sbjct:   568 WNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL 627

Query:   605 TPKELLGDLARGAVDADFS 623
             +P +L G      V   FS
Sbjct:   628 SPLDLSGSGMMFGVHDGFS 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2138381 AT4G04960 [Arabidopsis thaliana (taxid:3702)]

 Score = 762 (273.3 bits), Expect = 1.9e-104, Sum P(2) = 1.9e-104
 Identities = 165/405 (40%), Positives = 238/405 (58%)

Query:   208 FDGFSASKTNWIEARRVLAWSLSDTG--VAREIXXXXXXXXXXXXXXXXXXAGAVAGIVI 265
             F GF+A+    +++ ++LAWS S++   ++  +                     V  +V+
Sbjct:   234 FVGFTAATGRLVQSHKILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVFVLVL 293

Query:   266 GCVMGFLIICASTGYYWYW--RKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSN 323
              C   FL++ A  G   +   RK   +A+           YWPHR  YEE+   TKGF  
Sbjct:   294 IC---FLVV-ALVGLVLFAVVRKRLERARKRALMEDWEMEYWPHRIPYEEIESGTKGFDE 349

Query:   324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
               ++G GG G+VYKG L         E+AVK ++ +S  G++EF+AEISS+GRL+H+NLV
Sbjct:   350 KNVIGIGGNGKVYKGLLQGGV----VEVAVKRISQESSDGMREFVAEISSLGRLKHRNLV 405

Query:   384 QMRGWCRKG-NELMLVYDYMPNGSLNNWIFGKPKKL--LGWKQRRQILADVAEGLNYLHH 440
              +RGWC+K     MLVYDYM NGSL+ WIF   +K+  L  ++R +IL  VA G+ YLH 
Sbjct:   406 SLRGWCKKEVGSFMLVYDYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHE 465

Query:   441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             GW+  V+HRDIK+ N+LLD +M  RL DFGLA+++   +   TTRVVGT GYLAPE+   
Sbjct:   466 GWESKVLHRDIKASNVLLDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKT 525

Query:   501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
                ++ +DV+++G+++LEV CGRRP++ GK        LMDWV  L  +G+I    D ++
Sbjct:   526 GRASTQTDVFAYGILVLEVMCGRRPIEEGKKP------LMDWVWGLMERGEILNGLDPQM 579

Query:   561 RQE---FEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQE 601
                    E  +E E VL+LGL C HPD  +RP+MR+VV V  G +
Sbjct:   580 MMTQGVTEVIDEAERVLQLGLLCAHPDPAKRPSMRQVVQVFEGDK 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 792 (283.9 bits), Expect = 6.5e-104, Sum P(2) = 6.5e-104
 Identities = 152/293 (51%), Positives = 210/293 (71%)

Query:   307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
             +R  +++L  ATKGF + +LLGSGGFGRVY+G +         E+AVK V+++S+QGLKE
Sbjct:   341 NRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTT----KKEIAVKRVSNESRQGLKE 396

Query:   367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
             F+AEI S+GR+ H+NLV + G+CR+ +EL+LVYDYMPNGSL+ +++  P+  L WKQR  
Sbjct:   397 FVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFN 456

Query:   427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
             ++  VA GL YLH  W+QVV+HRDIK+ N+LLD+E  GRLGDFGLA+L   G  P TTRV
Sbjct:   457 VIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRV 516

Query:   487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             VGT GYLAP+       T+A+DV++FGV++LEVACGRRP+++ + E +E  +L+D V   
Sbjct:   517 VGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEI-EIESDESVLLVDSVFGF 575

Query:   547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG 599
             + +G I +A D  +   ++  E+E VLKLGL C H D   RPTMR+V+  L G
Sbjct:   576 WIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRG 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)]

 Score = 786 (281.7 bits), Expect = 3.2e-100, Sum P(2) = 3.2e-100
 Identities = 167/392 (42%), Positives = 235/392 (59%)

Query:   208 FDGFSASKTNWIEARRVLAWSLSDTGVAREIXXXXXXXXXXXXXXXXXXAGAVAGIVIGC 267
             F GFS +    I  + +L WSLS   V+ +                      V  IV+  
Sbjct:   235 FLGFSGATGTLISYQYILGWSLSRNKVSLQTLDVTKLPRVPRHRAKNKGPSVVL-IVLLI 293

Query:   268 VMGFLIICASTGYYWYWRKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSNDELL 327
             ++  ++  A    Y Y R+   + +           Y PHRFSY++L  AT GF+ D LL
Sbjct:   294 LLAIIVFLALGAAYVYRRRKYAEIREEWEKE-----YGPHRFSYKDLYIATNGFNKDGLL 348

Query:   328 GSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRG 387
             G GGFG+VYKGTL         ++AVK V+HD+++G+K+F+AEI SMG L+HKN+V + G
Sbjct:   349 GKGGFGKVYKGTLPSKG-----QIAVKRVSHDAEEGMKQFVAEIVSMGNLKHKNMVPLLG 403

Query:   388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVV 447
             +CR+  EL+LV +YMPNGSL+ ++F   K    W++R  I+ D+A  LNY+H G  QVV+
Sbjct:   404 YCRRKGELLLVSEYMPNGSLDQYLFNDEKPPFSWRRRLLIIKDIATALNYMHTGAPQVVL 463

Query:   448 HRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS 507
             HRDIK+ N++LD+E  GRLGDFG+A+ +  G+ P TT  VGT+GY+APELATV + T A+
Sbjct:   464 HRDIKASNVMLDTEFNGRLGDFGMARFHDHGKDPATTAAVGTIGYMAPELATVGACT-AT 522

Query:   508 DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAE 567
             DVY FG  +LEV CGRRP++ G   E     ++ WV   +    +  A D R+R E  AE
Sbjct:   523 DVYGFGAFLLEVTCGRRPVEPGLSAERW--YIVKWVCECWKMASLLGARDPRMRGEISAE 580

Query:   568 EMELVLKLGLACCHPDSTRRPTMREVVAVLVG 599
             E+E+VLKLGL C +     RP+M ++V  L G
Sbjct:   581 EVEMVLKLGLLCTNGVPDLRPSMEDIVQYLNG 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2097493 HLECRK "lectin-receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 809 (289.8 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
 Identities = 169/347 (48%), Positives = 227/347 (65%)

Query:   271 FLIICAS-TGYYWYWRKNKLKAQXXXXXXXXXXXYWPHRFSYEELSKATKGFSNDELLGS 329
             F    AS  G+ +Y R  K+K             Y PHRF+Y+EL  ATKGF   +LLG 
Sbjct:   291 FAAFVASWIGFVFYLRHKKVKE----VLEEWEIQYGPHRFAYKELFNATKGFKEKQLLGK 346

Query:   330 GGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC 389
             GGFG+VYKGTL         E+AVK  +HDS+QG+ EF+AEIS++GRL+H NLV++ G+C
Sbjct:   347 GGFGQVYKGTLPGS----DAEIAVKRTSHDSRQGMSEFLAEISTIGRLRHPNLVRLLGYC 402

Query:   390 RKGNELMLVYDYMPNGSLNNWIF-GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVH 448
             R    L LVYDYMPNGSL+ ++   + ++ L W+QR +I+ DVA  L +LH  W QV++H
Sbjct:   403 RHKENLYLVYDYMPNGSLDKYLNRSENQERLTWEQRFRIIKDVATALLHLHQEWVQVIIH 462

Query:   449 RDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASD 508
             RDIK  N+L+D+EM  RLGDFGLAKLY QG  P T++V GT GY+APE       T+++D
Sbjct:   463 RDIKPANVLIDNEMNARLGDFGLAKLYDQGFDPETSKVAGTFGYIAPEFLRTGRATTSTD 522

Query:   509 VYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEE 568
             VY+FG+V+LEV CGRR ++    E EE   L+DW+  L+  GKI +AA+  IRQE    +
Sbjct:   523 VYAFGLVMLEVVCGRRIIERRAAENEE--YLVDWILELWENGKIFDAAEESIRQEQNRGQ 580

Query:   569 MELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLAR 615
             +ELVLKLG+ C H  ++ RP M  V+ +L G  V+  P  LL D+ R
Sbjct:   581 VELVLKLGVLCSHQAASIRPAMSVVMRILNG--VSQLPDNLL-DVVR 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0090333 "regulation of stomatal closure" evidence=IMP

GO:1900425 "negative regulation of defense response to bacterium" evidence=IMP

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9M9E0	LRKS1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6580	0.8915	0.8643	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	636
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	2e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-55
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-55
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	4e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-51
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-47
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-29
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-23
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-22
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-14
cd01951	223	cd01951, lectin_L-type, legume lectins	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.004
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.004

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  190 bits (485), Expect = 2e-56
 Identities = 87/250 (34%), Positives = 119/250 (47%), Gaps = 56/250 (22%)

Query: 26  LDFLFNSFGSITNGTDLILINDCWVDST-VIRLTND-SNQFSFGRAYYPTKLKMKRSTAT 83
           L F FN F S  + ++L L  D  + S   ++LTND S   S GRA Y   +++  ST  
Sbjct: 1   LSFNFNGFSS--DQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDST-- 56

Query: 84  NSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTV-A 142
            +  + SFSTSF FSI P   S  G GL F L    S P A +  Y GLF+++       
Sbjct: 57  -TGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSN 115

Query: 143 PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNI 202
            ++AVEFDT QNPEF DPDDNH+G+D+N++ S   V AGY+           ++++G+ +
Sbjct: 116 HIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVS---VKAGYWDDDG------GKLKSGKPM 166

Query: 203 HAWIDFD---------------------------------------GFSASKTNWIEARR 223
            AWID+D                                       GFSAS     E   
Sbjct: 167 QAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHY 226

Query: 224 VLAWSLSDTG 233
           +L+WS S  G
Sbjct: 227 ILSWSFSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  189 bits (482), Expect = 1e-55
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 25/277 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQ 378
           +     LGSG FG VYK             +AVK +    +  +  +    EI  + RL 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGK----IVAVKILKKRSEKSKKDQTARREIRILRRLS 56

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V++       + L LV +Y   G L +++       L   + ++I   +  GL YL
Sbjct: 57  HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYL 114

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      ++HRD+K  NILLD     ++ DFGLAK   +     TT  VGT  Y+APE+ 
Sbjct: 115 H---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVL 170

Query: 499 TVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD 557
              +      DV+S GV++ E+  G+ P   G+   ++  ++    R L    +  E   
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFS-GENILDQLQLI---RRILGPPLEFDEPKW 226

Query: 558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
           +   +E +    +L+ K    C + D ++RPT  E++
Sbjct: 227 SSGSEEAK----DLIKK----CLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  187 bits (477), Expect = 5e-55
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 29/277 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQH 379
           +   E LG G FG+VY       +      +A+K +     +  +E  + EI  + +L+H
Sbjct: 1   YEILEKLGEGSFGKVYLAR----DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH 56

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N+V++       ++L LV +Y   G L + +  K +  L   + R  L  +   L YLH
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114

Query: 440 -HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
             G    +VHRD+K  NILLD +   +L DFGLA+    GE   T   VGT  Y+APE+ 
Sbjct: 115 SKG----IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVL 168

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
                  A D++S GV++ E+  G+ P       +++   L   +          +    
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFP----GDDQLLELFKKIGK-------PKPPFP 217

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
               +   E  +L+ K        D  +R T  E + 
Sbjct: 218 PPEWDISPEAKDLIRK----LLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  179 bits (455), Expect = 4e-52
 Identities = 84/247 (34%), Positives = 121/247 (48%), Gaps = 56/247 (22%)

Query: 24  SALDFLFNSFGSITNGTDLILINDCWV-DSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTA 82
           S + F +N F    N ++L L  D  V  + +++LTN +N  S GRA Y   +++  S  
Sbjct: 1   STVSFNYNGFS---NVSNLTLQGDATVLPNGLLQLTNVTN-NSAGRALYSKPIRLWDS-- 54

Query: 83  TNSSILTSFSTSFVFSILPEIAS-SPGFGLCFVLTNFTSPPGALASQYFGLFSNATV-VT 140
            ++  + SFSTSFVF+I     S + G GL F L    + PGA +  Y GLF+++    +
Sbjct: 55  -STGKVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNS 113

Query: 141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQ 200
              ++AVEFDT  NPEFND DDNH+G+D+N+I S           S + SFVP+ + +G+
Sbjct: 114 SNHIVAVEFDTFLNPEFNDIDDNHVGIDVNSIISVA---------SESASFVPLDLNSGK 164

Query: 201 NIHAWIDFD-------------------------------------GFSASKTNWIEARR 223
            I  WID+D                                     GFSAS     E+  
Sbjct: 165 PIQVWIDYDGSSKRLSVTLAYPNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHY 224

Query: 224 VLAWSLS 230
           VL+WS S
Sbjct: 225 VLSWSFS 231

Length = 231

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 6e-51
 Identities = 77/273 (28%), Positives = 120/273 (43%), Gaps = 66/273 (24%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLVQM 385
           LG GGFG VY       +     ++A+K +  +    L E  + EI  + +L H N+V++
Sbjct: 1   LGEGGFGTVYLAR----DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HGWDQ 444
            G     N L LV +Y   GSL + +     K L   +  +IL  + EGL YLH +G   
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNG--- 112

Query: 445 VVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            ++HRD+K  NILLDS+  G+  L DFGL+KL    +    T  VGT  Y+APE+     
Sbjct: 113 -IIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKG 169

Query: 503 P-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
             +  SD++S GV++ E                     +  +++L             IR
Sbjct: 170 YYSEKSDIWSLGVILYE---------------------LPELKDL-------------IR 195

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
           +                    D  +RP+ +E++
Sbjct: 196 K----------------MLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (448), Expect = 9e-51
 Identities = 82/284 (28%), Positives = 133/284 (46%), Gaps = 35/284 (12%)

Query: 322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHK 380
           +  + LG G FG VYKGTL    +    E+AVK +  D S+Q ++EF+ E   M +L H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++ G C +   LM+V +YMP G L +++     K L           +A G+ YL  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG-----YLAP 495
              +  +HRD+ + N L+   +  ++ DFGL++     ++ +        G     ++AP
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSR-----DLYDDDYYKVKGGKLPIRWMAP 173

Query: 496 ELATVSSPTSASDVYSFGVVILEVA-CGRRP-LDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           E       TS SDV+SFGV++ E+   G  P   M    E     ++++++  Y      
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAE-----VLEYLKKGY------ 221

Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                R+ +         + KL L C   D   RPT  E+V +L
Sbjct: 222 -----RLPKPPNCPPE--LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 1e-50
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 34/280 (12%)

Query: 322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHK 380
           +  + LG G FG VYKG L         E+AVK +  D S+Q ++EF+ E   M +L H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++ G C +   L +V +YM  G L +++  K +  L           +A G+ YL  
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG---YLAPEL 497
              +  +HRD+ + N L+   +  ++ DFGL++     +     R  G      ++APE 
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPES 174

Query: 498 ATVSSPTSASDVYSFGVVILEVA-CGRRP-LDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
                 TS SDV+SFGV++ E+   G +P   M   EE     ++++++N Y        
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEE-----VLEYLKNGY-------- 220

Query: 556 ADARIRQEFEA-EEMELVLKLGLACCHPDSTRRPTMREVV 594
              R+ Q      E+  ++     C   D   RPT  E+V
Sbjct: 221 ---RLPQPPNCPPELYDLML---QCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (448), Expect = 1e-50
 Identities = 83/282 (29%), Positives = 135/282 (47%), Gaps = 35/282 (12%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
            + LG G FG VYKGTL  +     T++AVK +    S++  +EF+ E S M +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++ G C +G  L +V +YMP G L +++  K  + L  K   Q+   +A+G+ YL    
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE--- 119

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL-----APEL 497
            +  VHRD+ + N L+   +  ++ DFGL++   + +           G L     APE 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPES 175

Query: 498 ATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
                 TS SDV+SFGV++ E+   G +P      EE     +++ + + Y         
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLELLEDGY--------- 221

Query: 557 DARIRQEFEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             R+ +     +E+  ++     C   D   RPT  E+V  L
Sbjct: 222 --RLPRPENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 4e-48
 Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 48/291 (16%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
           + LG G FG VYKG L    +  +TE+AVK +  D S++  K+F+ E   M +L H N+V
Sbjct: 1   KKLGEGAFGEVYKGKL-KGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI-------FGKPKKLLGWKQRRQILADVAEGLN 436
           ++ G C +   L LV +YM  G L +++           K  L  K        +A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG----- 491
           YL     +  VHRD+ + N L+  ++  ++ DFGL++     +         T G     
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIR 172

Query: 492 YLAPELATVSSP--TSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           ++APE  ++     TS SDV+SFGV++ E+   G  P      EE     +++++R    
Sbjct: 173 WMAPE--SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYLRK--- 222

Query: 549 QGKICEAADARIRQ-EFEAEEM-ELVLKLGLACCHPDSTRRPTMREVVAVL 597
                     R+ + E+  +E+ EL+L     C   D   RPT  E+V  L
Sbjct: 223 --------GYRLPKPEYCPDELYELMLS----CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  166 bits (422), Expect = 4e-47
 Identities = 79/213 (37%), Positives = 108/213 (50%), Gaps = 28/213 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           ELLG G FG VY       + +    MAVK V    DS++ L+    EI  +  LQH N+
Sbjct: 6   ELLGRGSFGSVYLAL----DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61

Query: 383 VQMRGWCRK--GNELMLVYDYMPNGSLNNWI--FGKP-----KKLLGWKQRRQILADVAE 433
           V+  G  R    N L +  +Y+  GSL++ +  FGK      +K       RQIL    E
Sbjct: 62  VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT-----RQIL----E 112

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLGY 492
           GL YLH      +VHRDIK  NIL+DS+   +L DFG AK     E    T  V GT  +
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+        A+D++S G  ++E+A G+ P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  145 bits (369), Expect = 1e-39
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 16/209 (7%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   E +G GGFG VYK      +     E+A+K +  +SK+  ++ + EI  + + +H 
Sbjct: 2   FEILEKIGKGGFGEVYKAR----HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHP 57

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---LADVAEGLNY 437
           N+V+  G   K +EL +V ++   GSL + +    + L       QI     ++ +GL Y
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL----TESQIAYVCKELLKGLEY 113

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           LH      ++HRDIK+ NILL S+   +L DFGL+      +  NT   VGT  ++APE+
Sbjct: 114 LH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEV 168

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPL 526
                    +D++S G+  +E+A G+ P 
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPY 197

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 2e-37
 Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKEFMAEISSMGRLQHKNL 382
           +L+G G FG VYKG     N      +A+K +      ++ LK  M EI  +  L+H N+
Sbjct: 6   DLIGRGAFGVVYKGL----NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           V+  G     + L ++ +Y  NGSL   I  FG   + L      Q+L    +GL YLH 
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH- 116

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +Q V+HRDIK+ NIL   +   +L DFG+A         +   VVGT  ++APE+  +
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
           S  ++ASD++S G  ++E+  G  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  135 bits (341), Expect = 1e-35
 Identities = 65/198 (32%), Positives = 108/198 (54%), Gaps = 11/198 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V         +N   ++AVK +NH   +Q   +F  EI  +  L H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 386 RGWCRK--GNELMLVYDYMPNGSLNNWI-FGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +G C K  G  L L+ +Y+P+GSL +++   + +  +  K+     + + +G++YL    
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLG--- 126

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG--YLAPELATV 500
            Q  +HRD+ + NIL++SE   ++ DFGLAK+  + +     +  G     + APE    
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 501 SSPTSASDVYSFGVVILE 518
           S  +SASDV+SFGV + E
Sbjct: 187 SKFSSASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (325), Expect = 1e-33
 Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 15/202 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             +G G FG V  G           ++AVKC+  DS    + F+AE S M  L+H NLVQ
Sbjct: 12  ATIGKGEFGDVMLGDYRGQ------KVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQ 64

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G   +GN L +V +YM  GSL +++  + + ++   Q+     DV EG+ YL    ++
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EK 121

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             VHRD+ + N+L+  ++  ++ DFGLAK   QG+      V  T    APE       +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFS 177

Query: 505 SASDVYSFGVVILEV-ACGRRP 525
           + SDV+SFG+++ E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (325), Expect = 8e-33
 Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 30/290 (10%)

Query: 320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGR 376
            +     LG G FG VY          +   +A+K +        + ++ F+ EI  +  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-------DRKLVALKVLAKKLESKSKEVERFLREIQILAS 53

Query: 377 LQH-KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI-FGKPKKLLGWKQRRQILADVAEG 434
           L H  N+V++  + +    L LV +Y+  GSL + +     K  L   +   ILA +   
Sbjct: 54  LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTTR-----VVG 488
           L YLH    + ++HRDIK  NILLD +    +L DFGLAKL       ++        VG
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 489 TLGYLAPELATVSS---PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
           T GY+APE+    S    +S+SD++S G+ + E+  G  P + G+      +  +  +  
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILE 229

Query: 546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
           L     +         +       +L+ K        D   R +    ++
Sbjct: 230 L-PTPSLASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  125 bits (315), Expect = 3e-32
 Identities = 89/280 (31%), Positives = 133/280 (47%), Gaps = 40/280 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-----NHDSKQGLKEFMAEISSMGRLQH 379
           ELLGSG FG VY+G     N ++    AVK V         ++ +K+   EI+ + +LQH
Sbjct: 6   ELLGSGSFGSVYEGL----NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNY 437
            N+VQ  G  R+ + L +  + +P GSL   +  +G   + +     RQIL     GL Y
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEY 117

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE- 496
           LH   D+  VHRDIK  NIL+D+    +L DFG+AK  Q  E        G+  ++APE 
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEV 172

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
           +A       A+D++S G  +LE+A G+ P      + E  A +           KI  + 
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPW----SQLEGVAAVF----------KIGRSK 218

Query: 557 DA-RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
           +   I      E  + +LK    C   D + RPT  E++ 
Sbjct: 219 ELPPIPDHLSDEAKDFILK----CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (309), Expect = 2e-31
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 32/274 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           + +G G FG+VY         ++     +K ++  + S++  ++ + E+  + +L H N+
Sbjct: 6   KQIGKGSFGKVYLVR----RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           ++      +  +L +V +Y   G L+  I    K  K    +Q       +   L YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ-GEVPNTTRVVGTLGYLAPELAT 499
              + ++HRDIK  NI L S    +LGDFG++K+     ++  T  VVGT  YL+PEL  
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQ 176

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
                  SD++S G V+ E+   + P +   GE   E  L           KI +     
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLE--LAL---------KILKGQYPP 222

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           I  ++ +E   LV  L L     D   RP++ ++
Sbjct: 223 IPSQYSSELRNLVSSL-LQ---KDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  117 bits (295), Expect = 1e-29
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 13/207 (6%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   E LG G +G VYK      +      +A+K V  +    L+E + EIS + +    
Sbjct: 5   FDILEKLGEGSYGSVYKAI----HKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSP 58

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            +V+  G   K  +L +V +Y   GS+++ I     K L  ++   IL    +GL YLH 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLH- 116

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 +HRDIK+GNILL+ E + +L DFG++ +L       NT  V+GT  ++APE+  
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                + +D++S G+  +E+A G+ P 
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 1e-29
 Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 30/279 (10%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           ++++G G FG V +G L         ++A+K +   S    + +F+ E S MG+  H N+
Sbjct: 9   EKVIGGGEFGEVCRGRL-KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G   K   +M++ +YM NGSL+ ++     K     Q   +L  +A G+ YL    
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGMKYLS--- 123

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG---TLGYLAPELAT 499
           +   VHRD+ + NIL++S +  ++ DFGL++  +  E   TT+  G    + + APE   
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAIA 181

Query: 500 VSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
               TSASDV+SFG+V+ EV + G RP                W  ++  Q  + +A + 
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPY---------------W--DMSNQ-DVIKAVED 223

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             R     +    + +L L C   D   RPT  ++V+ L
Sbjct: 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  114 bits (287), Expect = 2e-28
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 13/208 (6%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLV 383
           E++G G    VY      NN      +A+K ++ +  Q  + E   E+ +M +  H N+V
Sbjct: 7   EVIGVGATAVVYAAICLPNNEK----VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI-FGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +       G+EL LV  Y+  GSL + +    P+  L       +L +V +GL YLH   
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--- 119

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTR--VVGTLGYLAPE-LA 498
               +HRDIK+GNILL  +   ++ DFG+ A L   G+     R   VGT  ++APE + 
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPL 526
            V      +D++SFG+  +E+A G  P 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 7e-28
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 37/222 (16%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTE--MAVKCVN-HDSKQGLKEF----MAEISSMGRLQH 379
           +G G +G+VYK        N  T   +A+K +   + K+G   F    + EI  + +L+H
Sbjct: 7   IGEGTYGQVYKA------RNKKTGELVALKKIRMENEKEG---FPITAIREIKLLQKLRH 57

Query: 380 KNLVQMRGWC--RKGNELMLVYDYMP---NGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
            N+V+++     +    + +V++YM     G L++     P+      Q +  +  + EG
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS-----PEVKFTESQIKCYMKQLLEG 112

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ-QGEVPNTTRVVGTLGYL 493
           L YLH      ++HRDIK  NIL++++   +L DFGLA+ Y  +     T RV+ TL Y 
Sbjct: 113 LQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYR 168

Query: 494 APEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
            PEL   AT   P    D++S G ++ E+  G +P+  G  E
Sbjct: 169 PPELLLGATRYGP--EVDMWSVGCILAELFLG-KPIFQGSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (284), Expect = 8e-28
 Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 22/211 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQ 378
           + N E +G G  G VYK T    +     E+A+K   +   +K+ +     EI  M   +
Sbjct: 21  YKNLEKIGEGASGEVYKAT----DRATGKEVAIKKMRLRKQNKELIIN---EILIMKDCK 73

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---LADVAEGL 435
           H N+V        G+EL +V +YM  GSL + I     ++       QI     +V +GL
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRM----NEPQIAYVCREVLQGL 129

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLA 494
            YLH    Q V+HRDIKS NILL  +   +L DFG  A+L +  E      VVGT  ++A
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK--EKSKRNSVVGTPYWMA 184

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRP 525
           PE+          D++S G++ +E+A G  P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  111 bits (280), Expect = 3e-27
 Identities = 69/199 (34%), Positives = 109/199 (54%), Gaps = 8/199 (4%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LG G FG V         +N    +AVK + H + + L++F  EI  +  LQH N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 385 MRGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
            +G C       L LV +Y+P GSL +++  K ++ L  ++     + + +G+ YL    
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
            +  VHRD+ + NIL++SE R ++GDFGL K+  Q +     R  G   + + APE  T 
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185

Query: 501 SSPTSASDVYSFGVVILEV 519
           S  + ASDV+SFGVV+ E+
Sbjct: 186 SKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 54/300 (18%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LGSG FG VYKG            +A+K +  ++  +  KE + E   M  + H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 386 RGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            G C   +++ L+   MP G L     N+      + LL W    QI    A+G++YL  
Sbjct: 75  LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQI----AKGMSYLE- 126

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL---------YQQGEVPNTTRVVGTLG 491
             ++ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        + 
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--------IK 176

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQG 550
           ++A E       T  SDV+S+GV + E+   G +P + G    E   +L    R    Q 
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLEKGER--LPQP 233

Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELL 610
            IC              ++ +VL   + C   D+  RPT +E++      ++A  P+  L
Sbjct: 234 PICTI------------DVYMVL---VKCWMIDAESRPTFKELINEF--SKMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 6e-27
 Identities = 71/206 (34%), Positives = 108/206 (52%), Gaps = 22/206 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSMGRLQHKNLV 383
           LG+G FG V+ GT      N +T++AVK +    K G    + F+ E   M +L+H  LV
Sbjct: 14  LGAGQFGEVWMGTW-----NGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           Q+   C +   + +V +YM  GSL +++     K L   Q   + A +AEG+ YL     
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---S 121

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELATV 500
           +  +HRD+ + NIL+   +  ++ DFGLA+L +  E   T R  G    + + APE A  
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAR-EGAKFPIKWTAPEAANY 178

Query: 501 SSPTSASDVYSFGVVILE-VACGRRP 525
              T  SDV+SFG+++ E V  GR P
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 10/200 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V++G       NN+T +AVK +   +    K+F+AE   M +L+H  L+Q+ 
Sbjct: 14  LGAGQFGEVWEGLW-----NNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLY 67

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
             C     + +V + M  GSL  ++ G   + L   Q   + A VA G+ YL     Q  
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N+L+      ++ DFGLA++ ++            + + APE A  +  +  
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 507 SDVYSFGVVILE-VACGRRP 525
           SDV+SFG+++ E V  GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (270), Expect = 3e-26
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 34/272 (12%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQM 385
           LG G  G VYK              A+K ++ D   +  K+ + E+ ++   +   +V+ 
Sbjct: 9   LGQGSSGVVYKVRHKPTGK----IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 386 RG-WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA----EGLNYLHH 440
            G + ++G E+ +V +YM  GSL + +    KK+    +   +LA +A    +GL+YLH 
Sbjct: 65  YGAFYKEG-EISIVLEYMDGGSLADLL----KKVGKIPE--PVLAYIARQILKGLDYLHT 117

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + ++HRDIK  N+L++S+   ++ DFG++K+ +       T  VGT+ Y++PE    
Sbjct: 118 --KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQG 174

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
            S + A+D++S G+ +LE A G+ P                +   +     IC+     +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFELMQ---AICDGPPPSL 223

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
             E  + E    +    AC   D  +RP+  E
Sbjct: 224 PAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 6e-26
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 24/220 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGL-KEFMAEISSMGRLQ 378
           +   E LG G +G VYK      +      +A+K +  D  ++G+    + EIS +  L+
Sbjct: 1   YEKLEKLGEGTYGVVYKAR----DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK 56

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL-LGWKQR--RQILADVAEGL 435
           H N+V++        +L LV++Y     L  ++  +P  L     +    Q+L     GL
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL----RGL 111

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            Y H      ++HRD+K  NIL++ +   +L DFGLA+ +       T  VV TL Y AP
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAP 167

Query: 496 EL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
           E+   +   S   A D++S G +  E+  G +PL  G  E
Sbjct: 168 EILLGSKHYST--AVDIWSVGCIFAEMITG-KPLFPGDSE 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  107 bits (268), Expect = 6e-26
 Identities = 81/287 (28%), Positives = 138/287 (48%), Gaps = 41/287 (14%)

Query: 322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQH 379
           +  +++G+G FG V++G L          +A+K +   +  KQ  ++F++E S MG+  H
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVA-VAIKTLKPGYTEKQ-RQDFLSEASIMGQFSH 65

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEG 434
            N++++ G   K    M++ +YM NG+L+ ++          +L+G      +L  +A G
Sbjct: 66  HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAG 119

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG--Y 492
           + YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +       T   G +   +
Sbjct: 120 MKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 493 LAPELATVSSPTSASDVYSFGVVILEV-ACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQG 550
            APE       TSASDV+SFG+V+ EV + G RP  DM   E                  
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------------------ 218

Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            + +A +   R     +    V +L L C   D  RRP   ++V +L
Sbjct: 219 -VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 8e-26
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 53/291 (18%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--------NHDSKQG--LKEFMAEISSM 374
           EL+G G +GRVY       N      MAVK V         HDS+Q   +K   +EI ++
Sbjct: 7   ELIGKGTYGRVYLAL----NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVA 432
             L H N+VQ  G+      L +  +Y+P GS+ + +  +G+ ++ L      Q+L    
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---- 118

Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK----LYQQGEVPNTTRVVG 488
           EGL YLH    + ++HRD+K+ N+L+D++   ++ DFG++K    +Y   +      + G
Sbjct: 119 EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ---NMSMQG 172

Query: 489 TLGYLAPELATVSSPT-SAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
           ++ ++APE+    S   SA  D++S G V+LE+  GRRP        +EEA+        
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAI-------- 218

Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGL----ACCHPDSTRRPTMREV 593
                + +  + R       +    +  + L    AC   +   RPT RE+
Sbjct: 219 ---AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 29/222 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
             LG G FG+V+ G   +    N  E+ AVK +   +    ++ F  E   +   QH+N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI------------FGKPKKLLGWKQRRQILAD 430
           V+  G C +G+  ++V++YM +G LN ++               P   L   Q  QI   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVG 488
           +A G+ YL     Q  VHRD+ + N L+  ++  ++GDFG+++     +V  T   RV G
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182

Query: 489 T----LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                + ++ PE       T+ SDV+SFGVV+ E+   G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (263), Expect = 2e-25
 Identities = 57/200 (28%), Positives = 109/200 (54%), Gaps = 11/200 (5%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F+ +  LGSG FG V++G   N        +A+K +  D     ++F  E+ ++ RL+HK
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-----VRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           +L+ +   C  G  + ++ + M  GSL  ++     ++L       +   VAEG+ YL  
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPELAT 499
             +Q  +HRD+ + NIL+  ++  ++ DFGLA+L ++   + +  ++     + APE A+
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAAS 177

Query: 500 VSSPTSASDVYSFGVVILEV 519
             + ++ SDV+SFG+++ E+
Sbjct: 178 HGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (263), Expect = 3e-25
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQG-LKEFMAEISSMGRLQHKNLVQ 384
           +G G FG+VY       N +    MAVK +   D+    +KE   E+  +  L+H NLV+
Sbjct: 8   IGGGTFGKVYTAV----NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HGWD 443
             G      ++ +  +Y   G+L      +  ++L     R     + EGL YLH HG  
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEGLAYLHSHG-- 119

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV-------VGTLGYLAPE 496
             +VHRDIK  NI LD     +LGDFG A   +     NTT +        GT  Y+APE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK----NNTTTMGEEVQSLAGTPAYMAPE 173

Query: 497 LATVSSPTS---ASDVYSFGVVILEVACGRRP 525
           + T         A+D++S G V+LE+A G+RP
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  104 bits (262), Expect = 3e-25
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 14/201 (6%)

Query: 328 GSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           G G FG+V          +     A+K +N      K  ++  + E   +  L H  LV 
Sbjct: 9   GKGAFGKVCIVQK----RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +    +    + LV D +  G L  +   +  K    +Q +  + ++   L YLH    +
Sbjct: 65  LWYSFQDEENMYLVVDLLLGGDLR-YHLSQKVKF-SEEQVKFWICEIVLALEYLH---SK 119

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
            ++HRDIK  NILLD +    + DF +A          TT   GT GY+APE+      +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYS 177

Query: 505 SASDVYSFGVVILEVACGRRP 525
            A D +S GV   E   G+RP
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 5e-25
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 32/224 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQG-LKEFMAEISSMGRL-QHK 380
           +++G G F  V            + E A+K ++     K+  +K    E   + RL  H 
Sbjct: 7   KIIGEGSFSTVVLAKE----KETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            ++++    +    L  V +Y PNG L    + +    L  K  R   A++   L YLH 
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGEL--LQYIRKYGSLDEKCTRFYAAEILLALEYLH- 119

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV-------------- 486
              + ++HRD+K  NILLD +M  ++ DFG AK+      P + +               
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 487 -----VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                VGT  Y++PEL        +SD+++ G +I ++  G+ P
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (259), Expect = 9e-25
 Identities = 65/217 (29%), Positives = 118/217 (54%), Gaps = 22/217 (10%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           +E++G+G FG V +G L          +A+K +    +++  ++F++E S MG+  H N+
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIF-VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNY 437
           + + G   K   +M++ ++M NG+L++++          +L+G      +L  +A G+ Y
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKY 121

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVG---TLGYL 493
           L    +   VHRD+ + NIL++S +  ++ DFGL++  +     P  T  +G    + + 
Sbjct: 122 LS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 494 APELATVSSPTSASDVYSFGVVILEV-ACGRRPL-DM 528
           APE       TSASDV+S+G+V+ EV + G RP  DM
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  103 bits (259), Expect = 1e-24
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 31/222 (13%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVK----CVNHDSKQG--LKEFMAEI 371
            KG    + LG+G F   Y       +    T MAVK      N  S+Q   ++    EI
Sbjct: 3   LKG----QQLGTGAFSSCY----QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEI 54

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILA 429
             M RL H ++++M G   + +   L  ++M  GS+++ +  +G  K+ +      Q+L 
Sbjct: 55  RLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL- 113

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLA-----KLYQQGEVPNT 483
               GL+YLH   +  ++HRD+K  N+L+DS  +  R+ DFG A     K    GE    
Sbjct: 114 ---RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG- 166

Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            +++GT+ ++APE+        + DV+S G VI+E+A  + P
Sbjct: 167 -QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG V KG      +    E+AVK +       G KEF+ E S M +L H  +V++
Sbjct: 3   LGHGNFGSVVKGVY-LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKP----KKLLGWKQRRQILADVAEGLNYLHHG 441
            G C KG  LMLV +  P G L  ++  +       L            VA G+ YL   
Sbjct: 62  IGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE-- 112

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELAT 499
             +  VHRD+ + N+LL +  + ++ DFG+++    G         G   L + APE   
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 500 VSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
               +S SDV+S+GV + E  + G +P    KG E
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (271), Expect = 2e-24
 Identities = 88/341 (25%), Positives = 156/341 (45%), Gaps = 30/341 (8%)

Query: 264 VIGCVMGFLIICA--STGYYWYWRKNKLKAQE-EDEIEEWELEYWPHRFSYEELSKATKG 320
            I C +G  ++ A  + G+ +   +N L+ +  E+E   WEL+++  + S          
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690

Query: 321 FSNDE-LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQ 378
              +E ++  G  G  YKG     +  N  +  VK +N  +S   +    +EI+ MG+LQ
Sbjct: 691 SLKEENVISRGKKGASYKG----KSIKNGMQFVVKEINDVNS---IPS--SEIADMGKLQ 741

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V++ G CR      L+++Y+   +L+  +       L W++RR+I   +A+ L +L
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFL 796

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      VV  ++    I++D +    L      +L   G +   T+   +  Y+APE  
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETR 850

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
                T  SD+Y FG++++E+  G+ P D   G       +++W R  Y    +    D 
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDP 907

Query: 559 RIRQEFEAEEMELV--LKLGLACCHPDSTRRPTMREVVAVL 597
            IR +    + E+V  + L L C   D T RP   +V+  L
Sbjct: 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 41/278 (14%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LGSG FG V+ G           ++A+K +  +      +F+ E   M +L H NLVQ+ 
Sbjct: 12  LGSGQFGVVHLGKW-----RGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---ADVAEGLNYLHHGWD 443
           G C K   + +V +YM NG L N++  +  KL        +L   +DV E + YL     
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLRERKGKL----GTEWLLDMCSDVCEAMEYLE---S 118

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELATV 500
              +HRD+ + N L+  +   ++ DFGLA+     +    T   GT   + +  PE+   
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDY 175

Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
           S  +S SDV+SFGV++ EV + G+ P +     E  E+V   +   LY + K+       
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY--RLY-RPKLA------ 226

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                   E+  ++     C H     RP  +++++ L
Sbjct: 227 ------PTEVYTIMYS---CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  102 bits (256), Expect = 3e-24
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLVQM 385
           LG G FG+V        N+     +AVK +  +  Q     +  EI+ +  L H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 386 RGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C +     L L+ +Y+P GSL +++   PK  L   Q       + EG+ YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH---S 125

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVS 501
           Q  +HRD+ + N+LLD++   ++GDFGLAK   +G      R  G   + + A E    +
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 502 SPTSASDVYSFGVVILEV 519
             + ASDV+SFGV + E+
Sbjct: 186 KFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 75/210 (35%), Positives = 106/210 (50%), Gaps = 20/210 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMA---EISSMGRLQH 379
           +LLG G FGRVY     +       E+AVK V    DS +  KE  A   EI  +  LQH
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNY 437
           + +VQ  G  R    L +  +YMP GS+ + +  +G   + +  K  RQIL    EG+ Y
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEY 119

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAP 495
           LH     ++VHRDIK  NIL DS    +LGDFG +K  Q      T    V GT  +++P
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRP 525
           E+ +       +DV+S G  ++E+   + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (252), Expect = 7e-24
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 41/284 (14%)

Query: 322 SNDEL-LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           + + + LG G +G VY    A  + +    +A+K +     + ++    EI+    L+H+
Sbjct: 10  NGERVVLGKGTYGIVY----AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR-----RQILADVAEGL 435
           N+VQ  G   +     +  + +P GSL+  +  K   L   +Q      +QIL    EGL
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGL 121

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            YLH   D  +VHRDIK  N+L+++   G  ++ DFG +K    G  P T    GTL Y+
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGINPCTETFTGTLQYM 176

Query: 494 APELAT--VSSPTSASDVYSFGVVILEVACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQG 550
           APE+         + +D++S G  I+E+A G+ P  ++G    E +A +        G  
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG----EPQAAMFK-----VGMF 227

Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
           KI       I +   AE    +L+    C  PD  +R +  +++
Sbjct: 228 KI----HPEIPESLSAEAKNFILR----CFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 8e-24
 Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 20/211 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG VYK      +   +  +A+K ++ + ++  +++   EI  + + + 
Sbjct: 3   FTLLECIGKGSFGEVYKAI----DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS 58

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   KG++L ++ +Y   GS  + +  KP KL        IL +V  GL YLH
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKL-DETYIAFILREVLLGLEYLH 115

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR----VVGTLGYLAP 495
              ++  +HRDIK+ NILL  E   +L DFG++     G++ +T       VGT  ++AP
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           E+   S     +D++S G+  +E+A G  PL
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPL 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 33/283 (11%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN ++    + EF+ E S M      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWI--------FGKPKKLLGWKQRRQILADVAEGLN 436
           + G    G   ++V + M  G L +++                  ++  Q+ A++A+G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
           YL     +  VHRD+ + N ++  ++  ++GDFG+ + +Y+        + +  + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 496 ELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
           E       T+ SDV+SFGVV+ E+A    +P   G   EE        V      G    
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEE--------VLKFVIDGGH-- 239

Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                +       +   +L+L   C   +   RPT  E+V+ L
Sbjct: 240 -----LDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 72/232 (31%), Positives = 120/232 (51%), Gaps = 31/232 (13%)

Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMA 369
           YEEL+           +G G +G VYK      + N    +A+K V    S++G+     
Sbjct: 1   YEELA----------EIGEGAYGTVYKAR----DLNTGRFVALKKVRVPLSEEGIPLSTL 46

Query: 370 -EISSMGRLQ---HKNLVQMRGWC---RKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLG 420
            EI+ + +L+   H N+V++   C   R   E  L LV++++ +  L  ++   PK  L 
Sbjct: 47  REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP 105

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
            +  + ++  +  G+++LH      +VHRD+K  NIL+ S+ + ++ DFGLA++Y   E+
Sbjct: 106 PETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EM 161

Query: 481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
             T+ VV TL Y APE+   SS  +  D++S G +  E+   RRPL  G  E
Sbjct: 162 ALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 75/219 (34%), Positives = 122/219 (55%), Gaps = 33/219 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTE-MAVKCV--------NHDSKQGLKEFMA-EISSMG 375
           L+GSG FG VY G      N +S E MAVK V        + D K+ + + +A EI+ + 
Sbjct: 7   LIGSGSFGSVYLGM-----NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGS----LNNWIFGKPKKLLGWKQRRQILADV 431
            LQH+N+VQ  G     + L +  +Y+P GS    LNN  +G  ++ L     RQIL   
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQIL--- 116

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-----V 486
            +GLNYLH   ++ ++HRDIK  NIL+D++   ++ DFG++K  +   +   T      +
Sbjct: 117 -KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            G++ ++APE+   +S T  +D++S G +++E+  G+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 59/308 (19%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNS-TEMAVKCV--NHDSKQGLKEFMA 369
           E+  +   F   E LG G FG+VYKG L   N   S T +A+K +  N + K   +EF  
Sbjct: 1   EIPLSAVRFL--EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-QEFRQ 57

Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--------------GKP 415
           E   M  LQH N+V + G C K     ++++Y+ +G L+ ++                  
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 416 KKLLGWKQRRQILADVAEGLNYL--HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
           K  L       I   +A G+ YL  HH      VHRD+ + N L+   +  ++ DFGL++
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR 172

Query: 474 LY-------QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                     Q +     R      ++ PE       T+ SD++SFGVV+ E+ + G +P
Sbjct: 173 DIYSADYYRVQSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 526 LDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDST 585
                G   +E + M   R L    + C A                V  L + C +    
Sbjct: 227 Y---YGFSNQEVIEMIRSRQLLPCPEDCPAR---------------VYALMIECWNEIPA 268

Query: 586 RRPTMREV 593
           RRP  +++
Sbjct: 269 RRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.7 bits (243), Expect = 9e-23
 Identities = 73/227 (32%), Positives = 118/227 (51%), Gaps = 21/227 (9%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEIS 372
            L K T G    E++G G FG V +G           ++AVK +  D     + F+ E +
Sbjct: 4   NLQKLTLG----EIIGEGEFGAVLQGEYTGQ------KVAVKNIKCDVTA--QAFLEETA 51

Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
            M +L HKNLV++ G     N L +V + M  G+L N++  + + L+   Q  Q   DVA
Sbjct: 52  VMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVA 110

Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
           EG+ YL     + +VHRD+ + NIL+  +   ++ DFGLA++   G   + +++   + +
Sbjct: 111 EGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKL--PVKW 163

Query: 493 LAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAV 538
            APE       +S SDV+S+GV++ EV + GR P      +E +E V
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 98.0 bits (244), Expect = 9e-23
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 15/209 (7%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQHKN 381
           ++++G+G FG V  G L          +A+K     +  KQ  ++F++E S MG+  H N
Sbjct: 9   EKVIGAGEFGEVCSGRL-KLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPN 66

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++ + G   K   +M+V +YM NGSL+ ++  K        Q   +L  +A G+ YL   
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLS-- 123

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVG---TLGYLAPEL 497
            D   VHRD+ + NIL++S +  ++ DFGL+++ +   E   TTR  G    + + APE 
Sbjct: 124 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTAPEA 180

Query: 498 ATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                 TSASDV+S+G+V+ EV + G RP
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG +G VYK      +      +A+K +  +     +    EIS +   +H N+V   
Sbjct: 11  IGSGTYGDVYKA----RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G   + ++L +V +Y   GSL + I+   +  L   Q   +  +  +GL YLH       
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGK 122

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT----TRVVGTLGYLAPELATVSS 502
           +HRDIK  NILL  +   +L DFG++      ++  T       +GT  ++APE+A V  
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 503 P---TSASDVYSFGVVILEVACGRRPL 526
                   D+++ G+  +E+A  + P+
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPM 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 22/233 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           F     +G G FG V+K         +    A+K ++         +E + E   + +L 
Sbjct: 2   FEILNKIGKGSFGVVFKVV----RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD 57

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG----WKQRRQILADVAEG 434
              +++         +L +V +Y  NG L+  +  +  + L     W+   QIL     G
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----G 113

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L +LH    + ++HRDIKS N+ LD+    ++GD G+AKL         T +VGT  YL+
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLS 169

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY 547
           PEL         SDV++ GVV+ E   G+ P D       + A+++  +R ++
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA----NNQGALILKIIRGVF 218

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK      +       A K +  +S++ L++FM EI  +   +H N+V + 
Sbjct: 13  LGDGAFGKVYKA----QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
                 N+L ++ ++   G+L++ I  + ++ L   Q R +   + E LN+LH      V
Sbjct: 69  EAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH---SHKV 124

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS 505
           +HRD+K+GNILL  +   +L DFG+ AK     +  +T   +GT  ++APE+    +   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKD 182

Query: 506 A-----SDVYSFGVVILEVACGRRP 525
                 +D++S G+ ++E+A    P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 2e-22
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLV 383
           LG G FG+V    L    +      A+K +       ++ ++  + E + + R+ H  +V
Sbjct: 1   LGKGSFGKVL---LVRKKDTG-KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV 56

Query: 384 QMRGWCRKGNE-LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HG 441
           ++  +  +  E L LV +Y P G L + +    +     ++ R   A++   L YLH  G
Sbjct: 57  KLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLG 113

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATV 500
               +++RD+K  NILLD++   +L DFGLAK L  +G   NT    GT  YLAPE+   
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLG 167

Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
                A D +S GV++ E+  G+ P
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 79/299 (26%), Positives = 124/299 (41%), Gaps = 59/299 (19%)

Query: 311 YEELSKATKGFSNDELLGSGGFGRVYK------GTLANNNNNNSTEMAVKCVNHDS---- 360
           YE L          E +G G FG V K      G +          +  K +++ +    
Sbjct: 2   YEVL----------ETIGKGSFGTVRKVRRKSDGKI----------LVWKEIDYGNMTEK 41

Query: 361 -KQGLKEFMAEISSMGRLQHKNLVQMRGWC--RKGNELMLVYDYMPNGSLNNWI--FGKP 415
            KQ L   ++E++ +  L+H N+V+       R    L +V +Y   G L   I    K 
Sbjct: 42  EKQQL---VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE 98

Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWD--QVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
           +K +  +   +IL  +   L   H+  D    V+HRD+K  NI LD+    +LGDFGLAK
Sbjct: 99  RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158

Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           +         T  VGT  Y++PE     S    SD++S G +I E+     P    + + 
Sbjct: 159 ILGHDSSFAKT-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-ARNQL 216

Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
           +    L           KI E    RI   + + E+  V+K   +  + D  +RP+  E
Sbjct: 217 Q----L---------ASKIKEGKFRRIPYRY-SSELNEVIK---SMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 30/280 (10%)

Query: 320 GFSNDELLGSGGFGRVYK-GTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
            F   + LG G +G VYK   L++N      E+ +  ++   ++   + + EI  +  + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE---DAVNEIRILASVN 57

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLN 436
           H N++  +     GN+L +V +Y P G L+  I    K +KL+  ++  +I   +  GL 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
            LH   +Q ++HRD+KS NILL +    ++GD G++K+ ++  +  T   +GT  Y+APE
Sbjct: 118 ALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKT--QIGTPHYMAPE 171

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
           +      +  SD++S G ++ E+A    P          EA  M  +R      K+    
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPF---------EARSMQDLRY-----KVQRGK 217

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV 596
              I   +  +    +     +        RP   +++A 
Sbjct: 218 YPPIPPIYSQDLQNFI----RSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 96.7 bits (240), Expect = 3e-22
 Identities = 75/212 (35%), Positives = 109/212 (51%), Gaps = 22/212 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMA---EISSMGRLQH 379
           +LLG G FGRVY       + +   E+A K V  D  S +  KE  A   EI  +  LQH
Sbjct: 8   KLLGQGAFGRVY----LCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 380 KNLVQMRGWCRKGNE--LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGL 435
           + +VQ  G  R   E  L +  +YMP GS+ + +  +G   + +  K  RQIL    EG+
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGM 119

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYL 493
           +YLH     ++VHRDIK  NIL DS    +LGDFG +K  Q   +  T    V GT  ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +PE+ +       +DV+S G  ++E+   + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.4 bits (237), Expect = 6e-22
 Identities = 55/202 (27%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 12  IGSGQFGLVWLGYWLEK-----RKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C + + + LV+++M +G L++++  + +     +    +  DV EG+ YL       V
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNV 121

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 507 SDVYSFGVVILEV-ACGRRPLD 527
           SDV+SFGV++ EV + G+ P +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.4 bits (237), Expect = 7e-22
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 29/222 (13%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL------KEFMAEI 371
           TKG    E+LG G +G VY G       N    +AVK V  D+   L      ++   E+
Sbjct: 3   TKG----EVLGKGAYGTVYCGLT-----NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEV 53

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILA 429
             +  L+H N+VQ  G C   N + +  +++P GS+++ +  FG   + +  K  +QIL 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL- 112

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK----LYQQGEVPNTTR 485
              +G+ YLH   +  VVHRDIK  N++L      +L DFG A+    +   G   N  +
Sbjct: 113 ---DGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 486 VV-GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            + GT  ++APE+   S     SD++S G  + E+A G+ PL
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 22/212 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKEFMA---EISSMGRLQH 379
           +LLG G FGRVY    A+       E+AVK V  + +S +  KE  A   EI  +  L H
Sbjct: 8   KLLGQGAFGRVYLCYDADTGR----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 380 KNLVQMRGWCRKGNE--LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGL 435
           + +VQ  G  R   E  L +  ++MP GS+ + +  +G   + +  K  RQIL    EG+
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYL 493
           +YLH     ++VHRDIK  NIL DS    +LGDFG +K  Q   +  T    V GT  ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +PE+ +       +D++S G  ++E+   + P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 17/203 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G      +    ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 12  QTIGKGEFGDVMLG------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63

Query: 385 MRG-WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           + G    +   L +V +YM  GSL +++  + + +LG     +   DV E + YL     
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---A 120

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
              VHRD+ + N+L+  +   ++ DFGL K  +     +T ++   + + APE       
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKF 176

Query: 504 TSASDVYSFGVVILEV-ACGRRP 525
           ++ SDV+SFG+++ E+ + GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 20/216 (9%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+     N +   +   +AVK +   +    K+F  E   +  LQH+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNW-----------IFGKPKKL---LGWKQRRQILADV 431
            G C  G+ L++V++YM +G LN +           + G+P++    LG  Q   I + +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTL 490
           A G+ YL     Q  VHRD+ + N L+ + +  ++GDFG+++ +Y           +  +
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
            ++ PE       T+ SDV+SFGV++ E+   G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT      N +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 14  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 67

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 68  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNLVQM 385
           LG G  G V K  L     N     A+K +  D    L K+ + E+      +   +V+ 
Sbjct: 9   LGEGAGGSVTKCRL----KNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKY 64

Query: 386 RGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE----GLNYLH 439
            G       + + +  +Y   GSL++ I+ K KK  G +   ++L  +AE    GL+YLH
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLH 122

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPEL 497
               + ++HRDIK  NILL  + + +L DFG++     GE+ N+      GT  Y+APE 
Sbjct: 123 ---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRP 525
                 +  SDV+S G+ +LEVA  R P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQH---K 380
           EL+G G +G VY+G     +      +A+K +N D+    + +   E++ + +L+     
Sbjct: 7   ELIGRGAYGAVYRGK----HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+ +  G   KG  L ++ +Y   GS+   +   P   +  K    I+ +V   L Y+H 
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYIHK 119

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT- 499
                V+HRDIK+ NIL+ +    +L DFG+A L  Q     +T  VGT  ++APE+ T 
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITE 175

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                + +D++S G+ I E+A G  P 
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.6 bits (230), Expect = 6e-21
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKN 381
           + LG+G FG V+ G       N  T++A+K +    KQG      F+AE + M +LQH  
Sbjct: 12  KKLGAGQFGEVWMGYY-----NGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPR 62

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           LV++     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++   
Sbjct: 63  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER- 120

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             +  +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 502 SPTSASDVYSFGVVILE-VACGRRP 525
           + T  SDV+SFG+++ E V  GR P
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.7 bits (230), Expect = 7e-21
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+     N     +   +AVK +   S+   ++F  E   +  LQH+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIF-------------GKPKKLLGWKQRRQILADVA 432
            G C +G  L++V++YM +G LN ++                    L   Q   I + +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 433 EGLNY---LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVG 488
            G+ Y   LH       VHRD+ + N L+   +  ++GDFG+++ +Y         R + 
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
            + ++ PE       T+ SD++SFGVV+ E+   G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 41/279 (14%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G      +     +A+K +   S     EF+ E   M +L H+ LVQ+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----VAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA---DVAEGLNYLHHGWD 443
           G C K   + +V +YM NG L N++    K+     Q  Q+L    DV EG+ YL     
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF----QPSQLLEMCKDVCEGMAYLE---S 118

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELATV 500
           +  +HRD+ + N L+D +   ++ DFGL++     E    T  VG+   + +  PE+   
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLY 175

Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
           S  +S SDV++FGV++ EV + G+ P +     E  E V       LY            
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG--LRLY------------ 221

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV 598
            R    +E++  ++    +C H  +  RPT +++++ + 
Sbjct: 222 -RPHLASEKVYAIM---YSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKE-FMAEISSMGRLQHKNLV 383
           LG GGFGRV    L    + N T  A+KCV   H  + G +E   +E   +    H  +V
Sbjct: 1   LGVGGFGRVE---LVKVKSKNRT-FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV 56

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++    +    + ++ +Y   G L  W   + + L      R  +A V     YLH+   
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGEL--WTILRDRGLFDEYTARFYIACVVLAFEYLHN--- 111

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           + +++RD+K  N+LLDS    +L DFG AK  + G+   T    GT  Y+APE+      
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGY 169

Query: 504 TSASDVYSFGVVILEVACGRRP 525
             + D +S G+++ E+  GR P
Sbjct: 170 DFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLV 383
           + LG G FG V +G   + +      +AVKC+  D     + +F+ E + M  L H+NL+
Sbjct: 1   KKLGDGSFGVVRRGE-WSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLG--WKQRRQILADVAEGLNYLH 439
           ++ G     + LM+V +  P GSL + +        L+        QI    A G+ YL 
Sbjct: 60  RLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLE 114

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPE 496
               +  +HRD+ + NILL S+ + ++GDFGL +   Q E   V      V    + APE
Sbjct: 115 S---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170

Query: 497 LATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                + + ASDV+ FGV + E+   G  P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V+ G       NNST++AVK +   +   ++ F+ E + M  LQH  LV++ 
Sbjct: 14  LGAGQFGEVWMGYY-----NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               K   + ++ +YM  GSL +++       +   +     A +AEG+ Y+     +  
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNY 124

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+++ N+L+   +  ++ DFGLA++ +  E          + + APE     S T  
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 507 SDVYSFGVVILEV 519
           SDV+SFG+++ E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 36/227 (15%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSMGRLQHKNLV 383
           +  G +GRV+   LA   +      A+K +          + + + E   + + Q   +V
Sbjct: 1   ISKGAYGRVF---LAKKKSTGDI-YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLL---GW---KQRRQILADVAEGLNY 437
           ++    +    L LV +Y+P G L          LL   G       R  +A++   L Y
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDL--------ASLLENVGSLDEDVARIYIAEIVLALEY 108

Query: 438 LH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-------TTRVVGT 489
           LH +G    ++HRD+K  NIL+DS    +L DFGL+K+       N         R+VGT
Sbjct: 109 LHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
             Y+APE+      +   D +S G ++ E   G  P     GE  EE
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH---GETPEE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMA--EISSMGRLQ 378
            + LG G +  VYK      +      +A+K +    ++  K+   F A  EI  +  L+
Sbjct: 5   GKKLGEGTYAVVYKAR----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 379 HKNLVQMRG-WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA----- 432
           H N++ +   +  K N + LV+++M    L        +K++  K      AD+      
Sbjct: 61  HPNIIGLLDVFGHKSN-INLVFEFME-TDL--------EKVIKDKSIVLTPADIKSYMLM 110

Query: 433 --EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
              GL YLH  W   ++HRD+K  N+L+ S+   +L DFGLA+ +       T +VV T 
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TR 166

Query: 491 GYLAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPL 526
            Y APEL   A         D++S G +  E+   R P 
Sbjct: 167 WYRAPELLFGA--RHYGVGVDMWSVGCIFAEL-LLRVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 93.0 bits (231), Expect = 2e-20
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 35/231 (15%)

Query: 315 SKATKGFSNDE---LLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKEFMA 369
             A K  S  E    +GSG  G VYK      +       A+K +  NH+     ++   
Sbjct: 67  PSAAKSLSELERVNRIGSGAGGTVYKVI----HRPTGRLYALKVIYGNHEDTV-RRQICR 121

Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
           EI  +  + H N+V+         E+ ++ ++M  GSL                  Q LA
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----------EQFLA 171

Query: 430 DVA----EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTT 484
           DVA     G+ YLH    + +VHRDIK  N+L++S    ++ DFG++++  Q   P N++
Sbjct: 172 DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 485 RVVGTLGYLAPE-----LATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
             VGT+ Y++PE     L   +    A D++S GV ILE   GR P  +G+
Sbjct: 229 --VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLV 383
           E +G G FG VYKG L  N     TE+AVK         LK  F+ E   + +  H N+V
Sbjct: 1   EKIGKGNFGDVYKGVLKGN-----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +P GSL  ++  K K  L  K+  Q+  D A G+ YL     
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE---S 111

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLGYLAPELATVS 501
           +  +HRD+ + N L+      ++ DFG+++  + G   V +  + +  + + APE     
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIKWTAPEALNYG 170

Query: 502 SPTSASDVYSFGVVILEV 519
             TS SDV+S+G+++ E 
Sbjct: 171 RYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 12/206 (5%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG     +N     +A+K ++  +++  +++   EI+ + +   
Sbjct: 6   FTKLERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   KG +L ++ +Y+  GS  + +   P       Q   +L ++ +GL+YLH
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF---QIATMLKEILKGLDYLH 118

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL  +   +L DFG+A      ++   T  VGT  ++APE+  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQ 174

Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.7 bits (227), Expect = 2e-20
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+     N     +   +AVK +   S    K+F  E   +  LQH+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIF-----------GKPKKLLGWKQRRQILADVAEG 434
            G C +G+ L++V++YM +G LN ++            G     L   Q   I   +A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL     Q  VHRD+ + N L+   +  ++GDFG+++ +Y           +  + ++
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 494 APELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
            PE       T+ SDV+S GVV+ E+   G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 18/205 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SKQGLKEFMAEISSMGRLQHK 380
           + LG+G FGRV    L  +  +     A+K ++       KQ ++  + E   +  ++H 
Sbjct: 7   KTLGTGSFGRV---MLVRHKGSGKY-YALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV + G  +  + L LV +Y+P G L + +  +          R   A V   L YLH 
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS 119

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                +V+RD+K  N+LLDS+   ++ DFG AK         T  + GT  YLAPE+   
Sbjct: 120 ---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR----VKGRTYTLCGTPEYLAPEIILS 172

Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
                A D ++ G++I E+  G  P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 34/223 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTE--MAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNL 382
            LGSG FG VY+GT  +     S    +AVK +   +  Q  KEF+ E   M    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNY 437
           V++ G C       ++ + M  G L +++           LL  K+   I  DVA+G  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGR-----LGDFGLAK-LYQ--------QGEVPNT 483
           L        +HRD+ + N L+  +         +GDFGLA+ +Y+        +G +P  
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP-- 176

Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                 + ++APE       T+ SDV+SFGV++ E+   G++P
Sbjct: 177 ------VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           ELLG G FG V+KGTL      + T +AVK    D  Q LK +F++E   + +  H N+V
Sbjct: 1   ELLGKGNFGEVFKGTL-----KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV 55

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +P G   +++  K K  L  KQ  +   D A G+ YL     
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE---S 111

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           +  +HRD+ + N L+      ++ DFG+++    G   ++      + + APE       
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 504 TSASDVYSFGVVILE 518
           +S SDV+S+G+++ E
Sbjct: 172 SSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 14/212 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA--EISSMGRLQHKNLVQ 384
           +G G +G VYK             +A+K +    +       A  EI  +  L H N+++
Sbjct: 7   IGEGTYGVVYKARDKLTGEI----VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +    R   +L LV+++M +  L   I  + ++ L     +  L  + +GL + H     
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG-- 118

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVSSP 503
            ++HRD+K  N+L+++E   +L DFGLA+ +     P T  VV T  Y APE L      
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176

Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           ++  D++S G +  E+   RRPL  GK E ++
Sbjct: 177 STPVDIWSVGCIFAELL-SRRPLFPGKSEIDQ 207

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 22/212 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKEFMA---EISSMGRLQH 379
           +LLG G FG VY    A+       E+AVK V  + DS++  KE  A   EI  +  L+H
Sbjct: 8   KLLGRGAFGEVYLCYDADTGR----ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 380 KNLVQMRGWCRKGNE--LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGL 435
             +VQ  G  R   E  L +  +YMP GS+ + +  +G   + +  +  RQIL    +G+
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGV 119

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYL 493
           +YLH     ++VHRDIK  NIL DS    +LGDFG +K  Q   +  T    V GT  ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +PE+ +       +DV+S    ++E+   + P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 48/194 (24%), Positives = 96/194 (49%), Gaps = 8/194 (4%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G     +      +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLT----VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 68

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNF 125

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 186 SDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEM-AVK--CVNHDSKQGLKEFMAEISSMGRLQHKN 381
            ++G G +G V K       N  + E+ A+K    + D +   K  + E+  + +L+H+N
Sbjct: 7   GVVGEGAYGVVLKC-----RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILADVAEG 434
           +V ++   R+   L LV++Y+   +L   +   P        +   W    Q+L    + 
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW----QLL----QA 112

Query: 435 LNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           + Y H H     ++HRDIK  NIL+      +L DFG A+  +       T  V T  Y 
Sbjct: 113 IAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168

Query: 494 APELATVSSPT--SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
           APEL  V         DV++ G ++ E+  G  PL  G  + ++  ++   +  L    +
Sbjct: 169 APEL-LVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226

Query: 552 ICEAADAR--------------IRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
              +++ R              + + +  +     L    AC   D   R T  E
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 9/198 (4%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V         +N   ++AVK +  +S    + +   EI  +  L H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 386 RGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C +  GN + L+ +++P+GSL  ++  + K  +  KQ+ +    + +G++YL  G  
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSR 128

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           Q V HRD+ + N+L++SE + ++GDFGL K  +  +   T +  +   + + APE    S
Sbjct: 129 QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 188 KFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 71/230 (30%), Positives = 108/230 (46%), Gaps = 38/230 (16%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKC--VNHDSKQGLKEFMAEISSMGRL- 377
           F   E++G G +G+VYK             +A+K   +  D ++ +KE   E + + +  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQL----VAIKIMDIIEDEEEEIKE---EYNILRKYS 60

Query: 378 QHKNLVQMRGWCRKGN------ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ----- 426
            H N+    G   K N      +L LV +    GS+ + +    K L    +R +     
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLKEEWIA 116

Query: 427 -ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTT 484
            IL +   GL YLH   +  V+HRDIK  NILL      +L DFG+ A+L       NT 
Sbjct: 117 YILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT- 172

Query: 485 RVVGTLGYLAPE-LATVSSP----TSASDVYSFGVVILEVACGRRPL-DM 528
             +GT  ++APE +A    P     + SDV+S G+  +E+A G+ PL DM
Sbjct: 173 -FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 17/216 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQHKNLV 383
           E LG G +  VYKG     N      +A+K ++ D+++G     + EIS M  L+H+N+V
Sbjct: 6   EKLGEGTYATVYKG----RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW--IFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++       N+LMLV++YM +  L  +    G    L      +     + +G+ + H  
Sbjct: 62  RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGAL-DPNTVKSFTYQLLKGIAFCH-- 117

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATV 500
            +  V+HRD+K  N+L++     +L DFGLA+ +  G   NT +  V TL Y AP++   
Sbjct: 118 -ENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           S   S S D++S G ++ E+  G RPL  G   E++
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQ 209

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 36/279 (12%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNLVQM 385
           LG+G  G V K           T MA K V+  +K  + K+ + E+  M   +   +V  
Sbjct: 13  LGAGNGGSVSKVKHIPTG----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYL--- 438
            G     N + +  ++M  GSL+  I+ K    P ++LG     +I   V EGL YL   
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILG-----KIAVAVVEGLTYLYNV 122

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPE 496
           H      ++HRDIK  NIL++S  + +L DFG++     GE+ N+     VGT  Y++PE
Sbjct: 123 HR-----IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE 172

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
                  T  SDV+S G+ I+E+A G+ P      +++ +   M  +  L    +I +  
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ---QIVQEP 229

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
             R+      E++   +    AC   D T RPT +++ A
Sbjct: 230 PPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 11/200 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V+ GT      N +T++AVK +   +    + F+ E   M +L+H  LVQ+ 
Sbjct: 14  LGNGQFGEVWMGTW-----NGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLY 67

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++     + L       + A VA G+ Y+        
Sbjct: 68  AVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNY 123

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD++S NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 507 SDVYSFGVVILE-VACGRRP 525
           SDV+SFG+++ E V  GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 50/221 (22%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEM-AVK-----------CVNHDSKQGLKEFMAEISSM 374
           LG G FG VY        N  + E+ A+K           C+N      L+E    + S+
Sbjct: 7   LGDGTFGSVYLAR-----NKETGELVAIKKMKKKFYSWEECMN------LRE----VKSL 51

Query: 375 GRLQ-HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
            +L  H N+V+++   R+ +EL  V++YM  G+L   +  +  K       R I+  + +
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 434 GLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV---PNTTRVVGT 489
           GL ++H HG+     HRD+K  N+L+      ++ DFGLA+     E+   P  T  V T
Sbjct: 111 GLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVST 161

Query: 490 LGYLAPEL----ATVSSPTSASDVYSFGVVILEVACGRRPL 526
             Y APE+     + SSP    D+++ G ++ E+    RPL
Sbjct: 162 RWYRAPEILLRSTSYSSPV---DIWALGCIMAELYTL-RPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 12/206 (5%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG     +N     +A+K ++  +++  +++   EI+ + +   
Sbjct: 6   FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L   Q   IL ++ +GL+YLH
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 118

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL      +L DFG+A      ++      VGT  ++APE+  
Sbjct: 119 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIK 174

Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLV 383
           ++G G FG V+          +   + +K +  +  +K        E   +  L H N++
Sbjct: 7   VVGRGAFGIVH----LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +      +   LM+V +Y P G+L  +I  +   LL       IL    + L  LHH   
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLL---DEDTILHFFVQILLALHHVHT 119

Query: 444 QVVVHRDIKSGNILLDS-EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           ++++HRD+K+ NILLD  +M  ++GDFG++K+        T  VVGT  Y++PEL     
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKP 177

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ 562
               SD+++ G V+ E+A  +R  +         A+++          KI     A I  
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFE----AANLPALVL----------KIMSGTFAPISD 223

Query: 563 EFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
            +  +  +L+L +     + D ++RP + +++A
Sbjct: 224 RYSPDLRQLILSM----LNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 76/248 (30%), Positives = 110/248 (44%), Gaps = 49/248 (19%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLK-EF 367
            YE L K          LG G FG VYK             +A+K +  H+ K G     
Sbjct: 9   DYEILGK----------LGEGTFGEVYKAR----QIKTGRVVALKKILMHNEKDGFPITA 54

Query: 368 MAEISSMGRLQHKNLVQM--------RGWCRKGNELMLVYDYMP---NGSLNNWIFGKPK 416
           + EI  + +L+H N+V +            RK   + +V  YM    +G L N     P 
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-----PS 109

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
             L   Q +  +  + EG+NYLH   +  ++HRDIK+ NIL+D++   ++ DFGLA+ Y 
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY- 165

Query: 477 QGEVPNT-----------TRVVGTLGYLAPEL-ATVSSPTSASDVYSFGVVILEVACGRR 524
            G  PN            T +V T  Y  PEL       T+A D++  G V  E+   RR
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRR 224

Query: 525 PLDMGKGE 532
           P+  GK +
Sbjct: 225 PILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.6 bits (217), Expect = 4e-19
 Identities = 59/210 (28%), Positives = 112/210 (53%), Gaps = 19/210 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG V +G L + ++ +  ++AVK +  D  +   ++EF++E + M    H N+
Sbjct: 5   KILGEGEFGSVMEGQL-SQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 383 VQMRGWCRKGNEL------MLVYDYMPNGSLNNWIF-----GKPKKLLGWKQRRQILADV 431
           +++ G C + + L      M++  +M +G L++++      G P+KL      +  + D+
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FMVDI 122

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT-L 490
           A G+ YL    ++  +HRD+ + N +L  +M   + DFGL+K    G+     R+    +
Sbjct: 123 ALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVA 520
            ++A E       TS SDV++FGV + E+A
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG VYKG     +N     +A+K ++  +++  +++   EI+ + +   
Sbjct: 6   FTKLERIGKGSFGEVYKGI----DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   KG +L ++ +Y+  GS  + +   P   L       IL ++ +GL+YLH
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH 118

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL  +   +L DFG+A      ++   T  VGT  ++APE+  
Sbjct: 119 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 174

Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+    +D++S G+  +E+A G  P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 34/287 (11%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN----HDSKQGLKEFMAEISS 373
              F  ++ +G G F  VYK     +       +A+K V      D+K   ++ + EI  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRV----VALKKVQIFEMMDAKA-RQDCLKEIDL 55

Query: 374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADV 431
           + +L H N+++      + NEL +V +    G L+  I  F K K+L+  +   +    +
Sbjct: 56  LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
              L ++H    + ++HRDIK  N+ + +    +LGD GL + +   +      +VGT  
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 171

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
           Y++PE    +     SD++S G ++ E+A  + P    K              NLY   K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------------MNLYSLCK 218

Query: 552 ICEAADAR--IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV 596
             E  D        +  E  +LV      C +PD  +RP +  V+ V
Sbjct: 219 KIEKCDYPPLPADHYSEELRDLV----SRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 53/176 (30%), Positives = 95/176 (53%), Gaps = 7/176 (3%)

Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           ++AVK ++   +Q  +    E+  M   QH+N+V+M      G EL ++ +++  G+L +
Sbjct: 48  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107

Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            +    +  L  +Q   +   V + L YLH    Q V+HRDIKS +ILL  + R +L DF
Sbjct: 108 IV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDF 161

Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           G      + +VP    +VGT  ++APE+ + +   +  D++S G++++E+  G  P
Sbjct: 162 GFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.5 bits (214), Expect = 9e-19
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLV 383
           +LLGSG FG V+KG      ++    +A+K + +   +Q  +E    + +MG L H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNYL 438
           ++ G C  G  L LV    P GSL + +        P++LL W         +A+G+ YL
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYL 125

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPEL 497
               +  +VHR++ + NILL S+   ++ DFG+A  LY   +    +     + ++A E 
Sbjct: 126 E---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 498 ATVSSPTSASDVYSFGVVILEV 519
                 T  SDV+S+GV + E+
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 28/271 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG   + TL     ++S  +  K VN    S++  ++ + EI  +  LQH N++ 
Sbjct: 8   LGKGAFG---EATLYRRTEDDS-LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
                   N L++  +Y   G+L + I  +  +L   +     L  +   ++Y+H     
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KA 120

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
            ++HRDIK+ NI L      +LGDFG++K+    E      VVGT  Y++PEL       
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPYYMSPELCQGVKYN 179

Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
             SD+++ G V+ E+   +R  D          V+           KI +     +   +
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFD---ATNPLNLVV-----------KIVQGNYTPVVSVY 225

Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
            +E + LV     +    D  +RPT  EV+ 
Sbjct: 226 SSELISLV----HSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 11/211 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LGSG FG V KG           ++A+K + N + K    E M E   M +L +  +V+M
Sbjct: 3   LGSGNFGCVKKGVY--KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G C     LMLV +    G LN ++ GK K  +      +++  V+ G+ YL     + 
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKN 115

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSSP 503
            VHRD+ + N+LL ++   ++ DFGL+K     +     R  G   L + APE       
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 504 TSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
           +S SDV+S+G+ + E  + G++P    KG E
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 42/286 (14%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C   + + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 69  PHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-------YQQ--GEVPNTTRVVGTL 490
              ++ +VHRD+ + N+L+ +    ++ DFGLAKL       Y    G+VP        +
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--------I 175

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 232

Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
             IC                  V  + + C   D+  RP  RE++ 
Sbjct: 233 PPICTID---------------VYMIMVKCWMIDADSRPKFRELII 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           ++ LG+G FG V+  T      N  T++AVK +   S   ++ F+AE + M  LQH  LV
Sbjct: 11  EKKLGAGQFGEVWMATY-----NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++     K   + ++ ++M  GSL +++           +     A +AEG+ ++     
Sbjct: 65  KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--- 120

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           +  +HRD+++ NIL+ + +  ++ DFGLA++ +  E          + + APE     S 
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 504 TSASDVYSFGVVILE-VACGRRP 525
           T  SDV+SFG++++E V  GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 19/206 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LGSG FG V+ G           ++A+K +N  +    ++F+ E   M +L H  LVQ+ 
Sbjct: 12  LGSGQFGVVHLGKW-----RAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLY 65

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL----ADVAEGLNYLHHGW 442
           G C +   L +V ++M NG L N++  +  KL      + +L     DV EG+ YL    
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKL-----SKDMLLSMCQDVCEGMEYLER-- 118

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               +HRD+ + N L+ S    ++ DFG+ +     E  +++     + +  PE+   S 
Sbjct: 119 -NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 503 PTSASDVYSFGVVILEVAC-GRRPLD 527
            +S SDV+SFGV++ EV   G+ P +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
              +G G FG VY+G    +  N    +AVK   + +   ++E F+ E   M +  H ++
Sbjct: 11  GRCIGEGQFGDVYQGVY-MSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHH 440
           V++ G   + N + +V +  P G L +++      L        IL    ++  L YL  
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSL---DLASLILYSYQLSTALAYLE- 124

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE    
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 501 SSPTSASDVYSFGVVILEV 519
              TSASDV+ FGV + E+
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 55/178 (30%), Positives = 98/178 (55%), Gaps = 9/178 (5%)

Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           ++AVK ++   +Q  +    E+  M   QH N+V+M      G+EL +V +++  G+L +
Sbjct: 46  QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105

Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            +       +  +Q   +   V + L++LH    Q V+HRDIKS +ILL S+ R +L DF
Sbjct: 106 IV---THTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDF 159

Query: 470 GL-AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           G  A++ +  EVP    +VGT  ++APE+ +     +  D++S G++++E+  G  P 
Sbjct: 160 GFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 14/204 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNST-EMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G     + +    ++AVK +    S+Q   +F+ E   M +  H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWI-FGKPKK----LLGWKQRRQILADVAEGLNYLH 439
           + G   +     ++ + M  G L +++   +P+      L  K       DVA+G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL  +  GR   + DFG+A+ +Y+        R +  + ++ P
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190

Query: 496 ELATVSSPTSASDVYSFGVVILEV 519
           E       TS +DV+SFGV++ E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           +   +   +G G  G V   T      +   ++AVK ++   +Q  +    E+  M    
Sbjct: 22  EYLDSFIKIGEGSTGIVCIAT----EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H+N+V M      G+EL +V +++  G+L + +       +  +Q   +   V   L+YL
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYL 134

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H   +Q V+HRDIKS +ILL S+ R +L DFG      + EVP    +VGT  ++APE+ 
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVI 190

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           +     +  D++S G++++E+  G  P
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 41/262 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA---EISSMGRLQHKN 381
           + +G G FG++Y   LA   +++     +K ++  +K  +KE  A   E+  + +++H N
Sbjct: 6   KKIGEGSFGKIY---LAKAKSDSE-HCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPN 60

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI------FGKPKKLLGWKQRRQILADVAEGL 435
           +V      ++   L +V +Y   G L   I           ++L W         ++ GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
            ++H   D+ ++HRDIKS NI L    M  +LGDFG+A+ L    E+  T   VGT  YL
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYL 169

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           +PE+       + +D++S G V+ E+   + P +   G    + VL           KIC
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLVL-----------KIC 215

Query: 554 EAADARIRQEFEAEEMELVLKL 575
           +   A I   F  +   L+ +L
Sbjct: 216 QGYFAPISPNFSRDLRSLISQL 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 29/211 (13%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNLVQM 385
           LG+G  G V K     +       MAVK +  +  + + K+ + E+  + +     +V  
Sbjct: 9   LGAGNSGVVSK---VLHRPTGKI-MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 386 RGWCRKGNELMLVYDYMPNGSLN-------NWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
            G      ++ +  +YM  GSL+         I   P+++LG     +I   V +GL YL
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRI---PERILG-----KIAVAVLKGLTYL 116

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPE 496
           H      ++HRD+K  NIL++S  + +L DFG++     G++ N+     VGT  Y+APE
Sbjct: 117 HE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE 169

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLD 527
               +  +  SD++S G+ ++E+A GR P  
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 69/239 (28%), Positives = 104/239 (43%), Gaps = 56/239 (23%)

Query: 328 GSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA---EISSMGRLQHKNLVQ 384
           G G +GRVYK    N  +    E A+K    D +Q      +   EI+ +  L+H+N+V 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGK--EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 385 MRGWC--RKGNELMLVYDY-------------------MPNGSLNNWIFGKPKKLLGWKQ 423
           +           + L++DY                   +P   +        K LL W  
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV--------KSLL-W-- 115

Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL--DSEMRGR--LGDFGLAKLYQQGE 479
             QIL     G++YLH  W   V+HRD+K  NIL+  +   RG   +GD GLA+L+    
Sbjct: 116 --QIL----NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 480 VP--NTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            P  +   VV T+ Y APEL   +   T A D+++ G +  E+     P+   KG E +
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPI--FKGREAK 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK      N       A K ++  S++ L+++M EI  +    H N+V++ 
Sbjct: 13  LGDGAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
                 N L ++ ++   G+++  +  + ++ L   Q R +     E LNYLH   +  +
Sbjct: 69  DAFYYENNLWILIEFCAGGAVDA-VMLELERPLTEPQIRVVCKQTLEALNYLH---ENKI 124

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS- 505
           +HRD+K+GNIL   +   +L DFG++    +  +      +GT  ++APE+    +    
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 506 ----ASDVYSFGVVILEVA 520
                +DV+S G+ ++E+A
Sbjct: 184 PYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 46/297 (15%)

Query: 325 ELLGSGGFGRV----------YKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISS 373
           E LG G FG V          + G  A   +     +AVK +  D +K    +F+ EI  
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--------FGKPKKL--LGWKQ 423
           M RL++ N++++ G C   + L ++ +YM NG LN ++        F     +  +    
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPN 482
              +   +A G+ YL        VHRD+ + N L+ +    ++ DFG+++ LY       
Sbjct: 131 LLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV--ACGRRPLDMGKGE---EEEEA 537
             R V  + ++A E   +   T+ASDV++FGV + E+   C  +P  +   E   E    
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247

Query: 538 VLMDWVRNLY-GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
              +  R +Y  Q  +C +                V KL + C   D   RPT  ++
Sbjct: 248 FFRNQGRQIYLSQTPLCPSP---------------VFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT      N +T++A+K +   +    + F+ E   M +L+H  LV + 
Sbjct: 14  LGQGCFGEVWMGTW-----NGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLY 67

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V ++M  GSL +++     K L   Q   + A +A+G+ Y+        
Sbjct: 68  AVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 507 SDVYSFGVVILE-VACGRRP 525
           SDV+SFG+++ E V  GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 8/206 (3%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG VYKG            +A+K +N  +  +   EFM E   M  + H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C     + LV   MP+G L +++  + K  +G +        +A+G+ YL    +
Sbjct: 73  RLLGVCLSPT-IQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---E 127

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSS 502
           + +VHRD+ + N+L+ S    ++ DFGLA+L +  E   N       + ++A E      
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 503 PTSASDVYSFGVVILEVAC-GRRPLD 527
            T  SDV+S+GV I E+   G +P D
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 70/287 (24%), Positives = 132/287 (45%), Gaps = 33/287 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKNLVQ 384
           +G G  G V+K   A +     T +A+K V     +G    + + EI ++   QH  +V+
Sbjct: 8   IGEGAHGIVFK---AKDRETGET-VALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +      G+  +LV +YMP   L+  +    ++ L   Q +  +  + +G+ Y+H     
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMH---AN 118

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP- 503
            ++HRD+K  N+L+ ++   ++ DFGLA+L+ + E    +  V T  Y APEL   +   
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD---------W--VRNLYGQGKI 552
               D+++ G +  E+  G  PL  G+ + E+ A++           W  + +L    KI
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237

Query: 553 C--EAADARIRQEF---EAEEMELVLKLGLACCHPDSTRRPTMREVV 594
              E+    + + F     E ++L+  L L     D ++R +  E +
Sbjct: 238 TFPESKPIPLEEIFPDASPEALDLLKGL-LVY---DPSKRLSAAEAL 280

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 59/211 (27%), Positives = 112/211 (53%), Gaps = 12/211 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHK 380
           + +LG+G FG + +G L    +     +A+  +     D ++  + F+AE  ++G+  H 
Sbjct: 10  ERILGTGRFGELCRGCL-KLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHS 66

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++ G   +GN +M+V +YM NG+L++++  K +  L   Q   +L  +A G+ YL  
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLS- 124

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +   VH+ + +  +L++S++  ++  F   +  +   +  T      + + APE    
Sbjct: 125 --EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPL-DMG 529
              +SASDV+SFG+V+ EV + G RP  DM 
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 26/216 (12%)

Query: 327 LGSGGFGRVYKGT-LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G FGRV++            T +AVK +  + S     +F  E + M    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWI--------------------FGKPKKLLGWKQR 424
           + G C  G  + L+++YM  G LN ++                     G     L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNT 483
             I   VA G+ YL    ++  VHRD+ + N L+   M  ++ DFGL+  +Y       +
Sbjct: 133 LCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                 + ++ PE    +  T+ SDV+++GVV+ E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN----------HDSKQGLKEFMAEISSM 374
           E LGSG FG VYK       NN    +A+K +N           +  + + + ++E++ +
Sbjct: 6   EHLGSGAFGCVYK---VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 375 G-RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR--QILADV 431
             +L+H N+V+      + + L +V D +    L        +K   + + R   I   +
Sbjct: 63  KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
              L YLH   ++ +VHRD+   NI+L  + +  + DFGLAK  Q+      T VVGT+ 
Sbjct: 123 VLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           Y  PE+         +DV++FG ++ ++ 
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 81/283 (28%), Positives = 132/283 (46%), Gaps = 41/283 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNL 382
            ++G G FG VY GTL +++       AVK +N   D ++ +++F+ E   M    H N+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQK-IHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNV 58

Query: 383 VQMRGWCRKGNEL-MLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C       ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKGME 112

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD     ++ DFGLA+     E   V N T     + ++
Sbjct: 113 YLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVDSFDITVYLLQGR-- 219

Query: 554 EAADARIRQ-EFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                R+ Q E+  + +  V+   L+C HP    RPT  E+V+
Sbjct: 220 -----RLLQPEYCPDPLYEVM---LSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 74/258 (28%), Positives = 119/258 (46%), Gaps = 21/258 (8%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LGSG FG V KG      +  +  +AVK + N ++   LK E + E + M +L +  +V+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT--VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           M G C +    MLV +    G LN ++  +  K +  K   +++  V+ G+ YL    + 
Sbjct: 61  MIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLE---ET 114

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             VHRD+ + N+LL ++   ++ DFGL+K     E     +  G   + + APE      
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 503 PTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGKIC 553
            +S SDV+SFGV++ E  + G++P    KG E        E           +Y   K+C
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234

Query: 554 EAADARIRQEFEAEEMEL 571
                  R  F   E+ L
Sbjct: 235 WTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK      N       A K +   S++ L+++M EI  +    H  +V++ 
Sbjct: 20  LGDGAFGKVYKA----KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G      +L ++ ++ P G+++  I  +  + L   Q + I   + E L YLH      +
Sbjct: 76  GAFYWDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVICRQMLEALQYLH---SMKI 131

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLA----KLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           +HRD+K+GN+LL  +   +L DFG++    K  Q+ +       +GT  ++APE+    +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD-----SFIGTPYWMAPEVVMCET 186

Query: 503 PTSA-----SDVYSFGVVILEVA 520
                    +D++S G+ ++E+A
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 53/301 (17%)

Query: 325 ELLGSGGFGRVY------------KGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEI 371
           E LG G FG V+            K    N+N +    +AVK +  D S    ++F+ E+
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW----IFGKPKKLLGWKQRRQ- 426
             + RL   N+ ++ G C     L ++ +YM NG LN +    +          K     
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 427 ----ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQ----- 476
               +   +A G+ YL        VHRD+ + N L+      ++ DFG+++ LY      
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 477 -QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA--CGRRPLDMGKGEE 533
            QG  P   R      ++A E   +   T+ SDV++FGV + E+   C  +P +      
Sbjct: 188 VQGRAPLPIR------WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE----HL 237

Query: 534 EEEAVLMDWVRNLYGQG-KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
            ++ V+ +        G +I         ++        + +L L C   D   RPT RE
Sbjct: 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKD--------IYELMLECWRRDEEDRPTFRE 289

Query: 593 V 593
           +
Sbjct: 290 I 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 7/175 (4%)

Query: 351 MAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW 410
           +AVK ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107

Query: 411 IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG 470
           +       +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG
Sbjct: 108 V---THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 161

Query: 471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                 + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 162 FCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 28/213 (13%)

Query: 330 GGFGRVYKGTLANNNNNNSTEMAVKCV---NHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           G FG VY   LA   +      A+K +   +  +K  +    AE + M        V   
Sbjct: 7   GAFGSVY---LAKKRSTGDY-FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 387 GWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLG-----WKQRRQILADVAEGLNYLHH 440
            +  +  + L LV +Y+  G   + I     K LG     W   +Q +A+V  G+  LH 
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWA--KQYIAEVVLGVEDLH- 114

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + ++HRDIK  N+L+D     +L DFGL++    G      + VGT  YLAPE    
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENK--KFVGTPDYLAPETILG 167

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
                 SD +S G VI E   G  P      + 
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRL-QHKN 381
           ++++G G FG+V +  +  +    +   A+K +    S+   ++F  E+  + +L  H N
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----------FGKPKKLLGWKQRRQIL-- 428
           ++ + G C     L +  +Y P G+L +++           F K          +Q+L  
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 429 -ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
            +DVA G+ YL    ++  +HRD+ + N+L+   +  ++ DFGL++    GE     + +
Sbjct: 125 ASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTM 177

Query: 488 GTLG--YLAPELATVSSPTSASDVYSFGVVILEV 519
           G L   ++A E    S  T+ SDV+SFGV++ E+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 13/208 (6%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA-EISSMGRL 377
           K ++  E +G G  G VY       +     E+A+K +N   +Q  KE +  EI  M   
Sbjct: 19  KKYTRFEKIGQGASGTVYTAI----DVATGQEVAIKQMNL-QQQPKKELIINEILVMREN 73

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEF 130

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           LH      V+HRDIKS NILL  +   +L DFG        +   +T +VGT  ++APE+
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEV 186

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRP 525
            T  +     D++S G++ +E+  G  P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 21/218 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLV 383
           LG GGFG V     A          A K ++      ++G +  + E   + ++  + +V
Sbjct: 1   LGKGGFGEVC----ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQIL--ADVAEGLNYLH 439
            +       ++L LV   M  G L   I+  G+P    G+ + R I   A +  GL +LH
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHLH 112

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + +V+RD+K  N+LLD     R+ D GLA   + G+        GT GY+APE+  
Sbjct: 113 ---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQ 167

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL-DMGKGEEEEE 536
                 + D ++ G  + E+  GR P     +  E+EE
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 23/227 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAE---ISSMGRLQHK 380
           LG G FG+V    LA          A+K +      ++  ++  M E     +    +H 
Sbjct: 7   LGRGHFGKV---LLAEYKKTGEL-YAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +  + +  V +Y   G L   I      +    +     A V  GL YLH 
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLH- 118

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +  +V+RD+K  N+LLD+E   ++ DFGL K    G    T+   GT  +LAPE+ T 
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTE 175

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE---AVLMDWVR 544
           +S T A D +  GV+I E+  G  P     G++EEE   +++ D VR
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPF---PGDDEEEVFDSIVNDEVR 219

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 69/281 (24%), Positives = 130/281 (46%), Gaps = 29/281 (10%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T    + ++   ++AVK +   +    +E  M+E+  M  L  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            + G C  G  ++++ +Y   G L N++  K +  L  +        VA+G+ +L     
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---S 159

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPELATV 500
           +  +HRD+ + N+LL      ++ DFGLA+         V    R+   + ++APE    
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFN 217

Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
              T  SDV+S+G+++ E+ + G  P            + +D     Y   K+ +     
Sbjct: 218 CVYTFESDVWSYGILLWEIFSLGSNPY---------PGMPVD--SKFY---KLIKEGYRM 263

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
            + E    E+  ++K    C   D  +RPT +++V ++  Q
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 39/227 (17%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDS-KQGLK-EFMAEISSMGRLQHKNLV 383
           +G G +G+VYK       + ++ E+ A+K V  D+ K+G     + EI  + +L H+N+V
Sbjct: 15  IGEGTYGQVYKA-----RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 384 QMRGWC-----------RKGNELMLVYDYMPN---GSLNNWI--FGKPKKLLGWKQRRQI 427
            ++               KG    LV++YM +   G L + +  F +          +  
Sbjct: 70  NLKEIVTDKQDALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSE-------DHIKSF 121

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRV 486
           +  + EGLNY H    +  +HRDIK  NILL+++ + +L DFGLA+LY   E  P T +V
Sbjct: 122 MKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 487 VGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGE 532
           + TL Y  PEL         A DV+S G ++ E+   ++P+     E
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 25/216 (11%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHK 380
            + LG G FG+V K      +N N ++ +AVK +  D +++ L + ++E+  M  + +HK
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQ 426
           N++ + G C +   L +V +Y  +G+L +++  +              P++ L  K    
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTR 485
               VA G+ +L     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT 
Sbjct: 137 FAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 486 VVGTLGY--LAPELATVSSPTSASDVYSFGVVILEV 519
             G L    +APE       T  SDV+SFGV++ E+
Sbjct: 194 --GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 57/213 (26%), Positives = 109/213 (51%), Gaps = 19/213 (8%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG V +G L  N +++  ++AVK +     ++  +++F++E   M    H N+++
Sbjct: 7   LGEGEFGSVMEGQL--NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 385 MRGWCRKGNEL------MLVYDYMPNGSLNNWIF----GKPKKLLGWKQRRQILADVAEG 434
           + G C +  E       +++  +M +G L++++     G   + L  +   + + D+A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT-LGYL 493
           + YL     +  +HRD+ + N +L+  M   + DFGL+K    G+     R+    + ++
Sbjct: 125 MEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 494 APELATVSSPTSASDVYSFGVVILEVAC-GRRP 525
           A E       T+ SDV+SFGV + E+A  G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMG 375
           K F++   +G G FG VY    A +   N   +A+K +++  KQ  +++   + E+  + 
Sbjct: 15  KLFTDLREIGHGSFGAVY---FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           +L+H N ++ +G   + +   LV +Y   GS ++ I    KK L   +   I     +GL
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASD-ILEVHKKPLQEVEIAAICHGALQGL 128

Query: 436 NYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
            YLH H      +HRDIK+GNILL      +L DFG A L     V      VGT  ++A
Sbjct: 129 AYLHSHE----RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFVGTPYWMA 179

Query: 495 PELATVSSP---TSASDVYSFGVVILEVACGRRPL 526
           PE+             DV+S G+  +E+A  + PL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 78.6 bits (193), Expect = 6e-16
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G V+       +     E+A+K +N   +   +  + EI  M  L+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAI----DVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFL 131

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS N+LL  +   +L DFG        +   +T +VGT  ++APE+ 
Sbjct: 132 HA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV 187

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 32/283 (11%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN----HDSKQGLKEFMAEISSMGR 376
           F  ++ +G G F  VY+ T   +       +A+K V      D+K    + + EI  + +
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDG----VPVALKKVQIFDLMDAK-ARADCIKEIDLLKQ 58

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEG 434
           L H N+++      + NEL +V +    G L+  I  F K K+L+  K   +    +   
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L ++H    + V+HRDIK  N+ + +    +LGD GL + +   +      +VGT  Y++
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMS 174

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
           PE    +     SD++S G ++ E+A  + P    K              NLY   K  E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------------MNLYSLCKKIE 221

Query: 555 AAD-ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV 596
             D   +  +  +EE+  ++ +   C +PD  +RP +  V  V
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 42/120 (35%), Positives = 69/120 (57%), Gaps = 12/120 (10%)

Query: 429 ADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRV 486
           A++  GL +LH  G    +++RD+K  N+LLDSE   ++ DFG+ K   +G +   TT  
Sbjct: 103 AEIVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155

Query: 487 -VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE-EAVLMDWVR 544
             GT  Y+APE+ +      A D ++ GV++ E+  G+ P + G  E+E  +++L D VR
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSILEDEVR 214

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 63/227 (27%), Positives = 118/227 (51%), Gaps = 20/227 (8%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLK-EFMAEISSMGRLQ---HKN 381
           +G G +G+V+K   A +  N    +A+K V     ++G+    + E++ +  L+   H N
Sbjct: 9   IGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 382 LVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           +V++   C      +  +L LV++++ +  L  ++   P+  +  +  + ++  +  GL+
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           +LH      VVHRD+K  NIL+ S  + +L DFGLA++Y        T VV TL Y APE
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 179

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
           +   SS  +  D++S G +  E+   R+PL  G  + ++   ++D +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 35/228 (15%)

Query: 309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNH-DSKQGLKE 366
           F    L + T        LG G FG V+             T + VK +     +    E
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54

Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL-------L 419
           F  E+    +L HKN+V++ G CR+     ++ +Y   G L  ++     K        L
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114

Query: 420 GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK------ 473
             KQ+  +   +A G+++L +      VHRD+ + N L+ S+   ++    L+K      
Sbjct: 115 STKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171

Query: 474 --LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
               +   +P        L +LAPE       ++ SDV+SFGV++ EV
Sbjct: 172 YYKLRNALIP--------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 18/207 (8%)

Query: 327 LGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G   +       T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 131

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 494 APELATVSSPTSASDVYSFGVVILEVA 520
           APE       T++SD++SFGVV+ E+ 
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 17/217 (7%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQ 378
           F   E +G G +G VYK   A N       +A+K +  D++ +G+    + EIS +  L 
Sbjct: 2   FQKVEKIGEGTYGVVYK---ARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V++       N+L LV++++ +  L  ++   P   +     +  L  + +GL + 
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP    T  V TL Y APE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTHEVVTLWYRAPE 170

Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
            L      ++A D++S G +  E+   RR L  G  E
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 54/240 (22%)

Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEF- 367
           YE+LSK          +G G +G V+K                 C N ++ Q   +K+F 
Sbjct: 3   YEKLSK----------IGEGSYGVVFK-----------------CRNRETGQIVAIKKFV 35

Query: 368 ------------MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
                       + EI  + +L+H NLV +    R+  +L LV++Y  +  LN     K 
Sbjct: 36  ESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKN 93

Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
            + +     ++I+    + +N+ H       +HRD+K  NIL+  + + +L DFG A++ 
Sbjct: 94  PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARIL 150

Query: 476 QQGEVPNTTRVVGTLGYLAPELA---TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
                 + T  V T  Y APEL    T   P    DV++ G V  E+  G +PL  GK +
Sbjct: 151 TGPG-DDYTDYVATRWYRAPELLVGDTQYGP--PVDVWAIGCVFAELLTG-QPLWPGKSD 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 27/213 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRL-QHKNL 382
           +++G G FG+V K  +    +    + A+K +  + SK   ++F  E+  + +L  H N+
Sbjct: 13  DVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQIL 428
           + + G C     L L  +Y P+G+L ++              I       L  +Q     
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
           ADVA G++YL     +  +HRD+ + NIL+      ++ DFGL++    G+     + +G
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183

Query: 489 TLG--YLAPELATVSSPTSASDVYSFGVVILEV 519
            L   ++A E    S  T+ SDV+S+GV++ E+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--NHDSKQGLKEFMAEISSMGRLQ 378
           + N  L+G G +G V K      +      +A+K    + D K   K  M EI  + +L+
Sbjct: 3   YENLGLVGEGSYGMVMKC----KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H+NLV +    R+   L LV++++ +  L++    K    L   + R+ L  +  G+ + 
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFC 116

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPEL 497
           H      ++HRDIK  NIL+      +L DFG A+ L   GEV   T  V T  Y APEL
Sbjct: 117 H---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPEL 171

Query: 498 ATVSSPT--SASDVYSFGVVILEVACGRRPL 526
             V       A D+++ G ++ E+  G  PL
Sbjct: 172 -LVGDTKYGRAVDIWAVGCLVTEMLTG-EPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 12/196 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G FG+     +   +  +  +  +K +N    S +  +E   E++ +  ++H N+VQ
Sbjct: 8   IGEGSFGK----AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
            +    +   L +V DY   G L   I  +   L       QIL    +    L H  D+
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF---PEDQILDWFVQICLALKHVHDR 120

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
            ++HRDIKS NI L  +   +LGDFG+A+ L    E+  T   +GT  YL+PE+      
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPY 178

Query: 504 TSASDVYSFGVVILEV 519
            + SD+++ G V+ E+
Sbjct: 179 NNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 327 LGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L     N  T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L +K     
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 77/245 (31%), Positives = 112/245 (45%), Gaps = 33/245 (13%)

Query: 303 EYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ 362
            Y       E L   T  +   E +G G +G+VYK T    N  + +  AVK ++  S  
Sbjct: 6   PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVT----NKKDGSLAAVKILDPISDV 61

Query: 363 GLKEFMAEISSMGRL-QHKNLVQMRGWCRK-----GNELMLVYDYMPNGSLNNWIFGKPK 416
             +E  AE + +  L  H N+V+  G   K     G +L LV +    GS+   +    K
Sbjct: 62  D-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----K 116

Query: 417 KLLGWKQRRQ------ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG 470
            LL   QR        IL     GL +LH   +  ++HRD+K  NILL +E   +L DFG
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFG 173

Query: 471 L-AKLYQQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRR 524
           + A+L       NT+  VGT  ++APE+         S  +  DV+S G+  +E+  G  
Sbjct: 174 VSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 525 PL-DM 528
           PL DM
Sbjct: 232 PLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLV 383
           E LG   FG++YKG L     +++  +A+K + + ++ Q   EF  E S M  L H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIF---------------GKPKKLLGWKQRRQIL 428
            + G   +   + ++++Y+  G L+ ++                G  K  L       I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             +A G+ YL        VH+D+ + NIL+  ++  ++ D GL++ +Y         + +
Sbjct: 131 IQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
             + ++ PE       +S SD++SFGVV+ E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 44/286 (15%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQM 385
           +G+G FG+V  G    +   +   + VK +   +       F+ E+     L H N++Q 
Sbjct: 3   IGNGWFGKVLLGEA--HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---ADVAEGLNYLHHGW 442
            G C +    +LV ++ P G L N++      +    Q+  +     +VA GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELAT-- 499
               +H D+   N  L +++  ++GD+GLA + Y +            L +LAPEL    
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 500 -----VSSPTSASDVYSFGVVILEVA-CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
                    T  S+++S GV + E+     +P      +  +E VL   VR         
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP----DLSDEQVLKQVVRE-------- 225

Query: 554 EAADARIRQEFEAEEMELVLKLG------LACCHPDSTRRPTMREV 593
                   Q+ +  + +L LK        +  C  D   RPT  EV
Sbjct: 226 --------QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 5e-15
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH------DSKQGLKEFMAEISSM 374
           +   + +GSG +G V        +     ++A+K +++      D+K+ L+E    I  +
Sbjct: 2   YELLKPIGSGAYGVVCSAV----DKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLL 53

Query: 375 GRLQHKNLVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
             L+H+N++ +    R       N++ +V + M    L+  I  K  + L     +  L 
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQYFLY 110

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ--QGEVPNTTRVV 487
            +  GL YLH      V+HRD+K  NIL++S    ++ DFGLA+     + E    T  V
Sbjct: 111 QILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 488 GTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPL 526
            T  Y APEL   SS  T A D++S G +  E+   R+PL
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEF-MAEISSMGRLQHKNL 382
           E +G G +G VYK   A +       +A+K +  ++  +G+    + EIS +  L H N+
Sbjct: 5   EKIGEGTYGVVYK---ARDKLTGEI-VALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++       N+L LV++++ +  L  ++   P   L     +  L  + +G+ Y H   
Sbjct: 61  VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--- 116

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPEL--- 497
              V+HRD+K  N+L+D E   +L DFGLA+ +    VP    T  V TL Y APE+   
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLG 173

Query: 498 -ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
               S+P    D++S G +  E+   RRPL  G  E ++
Sbjct: 174 SRQYSTPV---DIWSIGCIFAEM-VNRRPLFPGDSEIDQ 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 37/231 (16%)

Query: 327 LGSGGFGRVYKGTLANNNN--NNSTEMAVKCVNHDSKQGLKEFMA---EISSMGRLQHKN 381
           LG G F  +YKG L   ++         V  V        ++ +A     S M +L HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL-LGWKQRRQILADVAEGLNYLHH 440
           LV++ G C + +E ++V +Y+  G L+ ++  +   + L WK    +   +A  L+YL  
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYLE- 118

Query: 441 GWDQVVVHRDIKSGNILL--DSEMRG-----RLGDFG-----LAKLYQQGEVPNTTRVVG 488
             D+ +VH ++   NIL+       G     +L D G     L++  +   +P       
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 489 TLGYLAPEL--ATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEE 536
              ++APE      +S T A+D +SFG  +LE+   G  PL      E+E 
Sbjct: 170 ---WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 44/228 (19%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHD-SKQGLK-EFMAEISSMGRLQHKNLV 383
           +G G +G VY+       +  S E+ A+K V  D  + G+    + EI+ +  L+H N+V
Sbjct: 15  IGEGTYGIVYRA-----RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 384 QMR----GWCRKGNELMLVYDY-----------MPNGSLNNWIFGKPKKLLGWKQRRQIL 428
           +++    G  +  + + LV +Y           MP        F +        Q + ++
Sbjct: 70  ELKEVVVG--KHLDSIFLVMEYCEQDLASLLDNMPTP------FSES-------QVKCLM 114

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
             +  GL YLH  +   ++HRD+K  N+LL  +   ++ DFGLA+ Y     P T +VV 
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 489 TLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           TL Y APE L   ++ T+A D+++ G ++ E+    +PL  GK E E+
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 75.2 bits (185), Expect = 9e-15
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 19/224 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMG-RLQHKN 381
           +LG G FG+V    L   N       A+K +  D       ++  M E   +    +H  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEF----FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L  +    +    L  V +Y+  G L   I  +        + R   A++  GL +LH  
Sbjct: 58  LTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +++RD+K  N+LLD +   ++ DFG+ K    GE   +T   GT  Y+APE+    
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQ 171

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
               + D +SFGV++ E+  G+ P     GE+E+E  L D + N
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDE--LFDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 40/248 (16%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTE------------MAVKCVNHD-SKQGLKEFMAEI 371
           E LG G FG V+   + N  +  + +            +AVK +  D +K    +F+ E+
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK----------------- 414
             + RL+  N++++ G C   + L ++ +YM NG LN ++                    
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK- 473
               + +     +   +A G+ YL        VHRD+ + N L+   +  ++ DFG+++ 
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV--ACGRRPLDMGKG 531
           LY         R V  + ++A E   +   T+ASDV++FGV + E+   C  +P     G
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY----G 243

Query: 532 EEEEEAVL 539
           E  +E V+
Sbjct: 244 ELTDEQVI 251

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 23/186 (12%)

Query: 29  LFNSFGSITNGTDLILINDCWV--DSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSS 86
           L  S  S  N ++  L     +  DS V+RLT D+     G A+Y T +           
Sbjct: 3   LNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTG-NQAGSAWYKTPI----------D 51

Query: 87  ILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLA 146
           +   F+T+F F  L    ++   G+ FVL N   P GAL     G         +   +A
Sbjct: 52  LSKDFTTTFKFY-LGTKGTNGADGIAFVLQN--DPAGALGGGGGG--GGLGYGGIGNSVA 106

Query: 147 VEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWI 206
           VEFDT +N + NDP+ NHI +D+N   +   +     S+S            G      I
Sbjct: 107 VEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTG-----LGNEHTVRI 161

Query: 207 DFDGFS 212
            +D  +
Sbjct: 162 TYDPTT 167

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 32/229 (13%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTE-MAVKCVNHDSKQGLKE-FMAE 370
           E++ +T  F   E LG   FG+VYKG L        T+ +A+K +   ++  L+E F  E
Sbjct: 1   EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 371 ISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP--------------K 416
                RLQH N+V + G   K   L +++ Y  +  L+ ++  +               K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 417 KLLGWKQRRQILADVAEGLNYL--HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
             L       I+  +A G+ +L  HH     VVH+D+ + N+L+  ++  ++ D G   L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLG---L 170

Query: 475 YQQGEVPNTTRVVGT----LGYLAPELATVSSPTSASDVYSFGVVILEV 519
           +++    +  +++G     + +++PE       +  SD++S+GVV+ EV
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 23/205 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNLV 383
           E+LG G  G VYK             +AVK +  D    L K+ M+E+  + +     ++
Sbjct: 7   EILGHGNGGTVYKAYHLLTRR----ILAVKVIPLDITVELQKQIMSELEILYKCDSPYII 62

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGW 442
              G     N + +  ++M  GSL+  ++ K P+ +LG     +I   V +GL YL   W
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---W 112

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  N+L+++  + +L DFG++      ++ N+     VGT  Y+APE  + 
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISG 167

Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
                 SDV+S G+  +E+A GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 27/213 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRL-QHKNL 382
           +++G G FG+V K  +    +    + A+K +  + SK   ++F  E+  + +L  H N+
Sbjct: 1   DVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI-----------FGKPKKLLGWKQRRQIL--- 428
           + + G C     L L  +Y P+G+L +++           F            +Q+L   
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
           ADVA G++YL     +  +HRD+ + NIL+      ++ DFGL++    G+     + +G
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171

Query: 489 TLG--YLAPELATVSSPTSASDVYSFGVVILEV 519
            L   ++A E    S  T+ SDV+S+GV++ E+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 79/297 (26%), Positives = 135/297 (45%), Gaps = 59/297 (19%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLV 383
           +LL  G FGR++ G L +       E+ VK V +H S+  +   + E   +  L H+N++
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 384 QMRGWCRKGNEL-MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA---------DVAE 433
            +   C +  E   ++Y YM  G+L  ++  + +  LG     Q L+          +A 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCR--LGEANNPQALSTQQLVHMAIQIAC 128

Query: 434 GLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT-- 489
           G++YLH  G    V+H+DI + N ++D E++ ++ D  L++ L+     P     +G   
Sbjct: 129 GMSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLF-----PMDYHCLGDNE 179

Query: 490 ---LGYLAPELATVSSPTSASDVYSFGVVILE-VACGRRP---LDMGKGEEEEEAVLMDW 542
              + ++A E       +SASDV+SFGV++ E +  G+ P   +D      E  A L D 
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAYLKD- 234

Query: 543 VRNLYGQGKICEAADARIRQEFEA-EEMELVLKLGLACC-HPDSTRRPTMREVVAVL 597
                  G        R+ Q     +E+  V    +ACC   D   RP+  ++V  L
Sbjct: 235 -------GY-------RLAQPINCPDELFAV----MACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 47/302 (15%)

Query: 325 ELLGSGGFGRVY------------KGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEI 371
           E LG G FG V+            K    + + N    +AVK +  D+ K    +F+ EI
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI---------FGKPKKLLGWK 422
             M RL+  N++++   C   + L ++ +YM NG LN ++                + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 423 QRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVP 481
               +   +A G+ YL        VHRD+ + N L+      ++ DFG+++ LY      
Sbjct: 131 TLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187

Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA--CGRRPLDMGKGE---EEEE 536
              R V  + +++ E   +   T+ASDV++FGV + E+   C  +P      E   E   
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247

Query: 537 AVLMDWVRNLY-GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
               D  R +Y  +  +C                + + KL L+C   ++  RP+ +E+ A
Sbjct: 248 EFFRDQGRQVYLPKPALCP---------------DSLYKLMLSCWRRNAKERPSFQEIHA 292

Query: 596 VL 597
            L
Sbjct: 293 TL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 20/214 (9%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSMG 375
           K FS+   +G G FG VY    A +  N+   +A+K +++  KQ     ++ + E+  + 
Sbjct: 15  KLFSDLREIGHGSFGAVY---FARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           +L+H N +Q RG   + +   LV +Y   GS ++ +    KK L   +   +     +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YLH      ++HRD+K+GNILL      +LGDFG A +     +      VGT  ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAP 180

Query: 496 ELATVSSPTSAS---DVYSFGVVILEVACGRRPL 526
           E+             DV+S G+  +E+A  + PL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           +LGSG FG VYKG    +  N    +A+K +  + S +  KE + E   M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C   + + LV   MP G L +++  + K  +G +        +A+G++YL    + 
Sbjct: 74  LLGICLT-STVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE---EV 128

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTLGYLAP 495
            +VHRD+ + N+L+ S    ++ DFGLA+L            G+VP        + ++A 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP--------IKWMAL 180

Query: 496 ELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
           E       T  SDV+S+GV + E+   G +P D
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 327 LGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       +  +  N    +AVK +  D + + L + ++E+  M  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L +K     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     Q  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 14/205 (6%)

Query: 327 LGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G       +   T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG--------WKQRRQILADVAEGLN 436
           + G   +G   +++ + M  G L +++     ++           K+  Q+  ++A+G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
           YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + +++P
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 496 ELATVSSPTSASDVYSFGVVILEVA 520
           E       T+ SDV+SFGVV+ E+A
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 36/182 (19%)

Query: 370 EISSMGRLQHKNLVQMR----GWCRKGNELMLVYDYMPN---GSLNN----WIFGKPKKL 418
           EI+ + +LQH N+V ++    G     +++ +V +Y+ +     +      ++  + K L
Sbjct: 54  EINILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL 111

Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL--GDFGLAKLYQ 476
           +      Q+L     G+ +LH  W   ++HRD+K+ N+LL++  RG L   DFGLA+ Y 
Sbjct: 112 M-----LQLL----SGVAHLHDNW---ILHRDLKTSNLLLNN--RGILKICDFGLAREY- 156

Query: 477 QGEVPNTTRVVGTLGYLAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
              +   T++V TL Y APEL   A   S   A D++S G +  E+   ++PL  GK E 
Sbjct: 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYST--AIDMWSVGCIFAELLT-KKPLFPGKSEI 213

Query: 534 EE 535
           ++
Sbjct: 214 DQ 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 46/288 (15%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ 378
           F+   +LG G FG V +  L  + + +  ++AVK +  D  S   ++EF+ E + M    
Sbjct: 1   FTLGRMLGKGEFGSVREAQL-KSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 379 HKNLVQMRGWC---RKGNEL---MLVYDYMPNGSLNNWIF----GKPKKLLGWKQRRQIL 428
           H N++++ G     R    L   M++  +M +G L+ ++     G+    L  +   + +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK------LYQQGEVPN 482
            D+A G+ YL     +  +HRD+ + N +L+  M   + DFGL+K       Y+QG    
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMD 541
                  L  LA  + T       SDV++FGV + E+   G+ P     G E  E     
Sbjct: 177 LPVKWLALESLADNVYTTH-----SDVWAFGVTMWEIMTRGQTPY---AGVENSE----- 223

Query: 542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT 589
            + N   +G        R++Q  +   +E V +L   C  P+   RP+
Sbjct: 224 -IYNYLIKGN-------RLKQPPDC--LEDVYELMCQCWSPEPKCRPS 261

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY       +     E+A+K +N   +   +  + EI  M   +
Sbjct: 19  KKYTRFEKIGQGASGTVYTAI----DIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L++L
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFL 131

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        +   +T +VGT  ++APE+ 
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV 187

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 31/216 (14%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISS------------ 373
           ++G G FGR                + V+ VN D K  +KE     SS            
Sbjct: 7   VVGEGSFGRA---------------LLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL 51

Query: 374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
           + +++H N+V  +        L +V +Y   G L   I  +  KL       Q    +  
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ ++H   ++ V+HRDIKS NI L    + +LGDFG A+L            VGT  Y+
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYV 167

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
            PE+       + SD++S G ++ E+   + P    
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ---GLKEFMAEISSMGRLQHKNLV 383
           +G G FG VY    A N++ N   +AVK +++  KQ     ++ + E+  + +L+H N +
Sbjct: 29  IGHGSFGAVY---FATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           + +G   K +   LV +Y   GS ++ +    KK L   +   I     +GL YLH    
Sbjct: 85  EYKGCYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH---S 139

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
             ++HRDIK+GNILL    + +L DFG A              VGT  ++APE+      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVILAMDE 194

Query: 504 TSAS---DVYSFGVVILEVACGRRPL 526
                  DV+S G+  +E+A  + PL
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G+G FG+V  G +  N+     ++ VK +    S Q   +F+ E      LQH NL+Q 
Sbjct: 3   IGNGWFGKVILGEV--NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQR--RQILADVAEGLNYLHHGW 442
            G C +    +LV ++ P G L  ++    K +L+       +++  ++A GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPELA--- 498
               +H D+   N LL +++  ++GD+GL+   Y++       ++   L ++APEL    
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 499 ----TVSSPTSASDVYSFGVVILEV 519
                V   T  S+V+S GV I E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 20/214 (9%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSMG 375
           K F++   +G G FG VY    A +   N   +A+K +++  KQ     ++ + E+  + 
Sbjct: 25  KLFTDLREIGHGSFGAVY---FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           R++H N ++ +G   + +   LV +Y   GS ++ +    KK L   +   I     +GL
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGL 138

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YLH      ++HRDIK+GNILL    + +L DFG A +            VGT  ++AP
Sbjct: 139 AYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPYWMAP 190

Query: 496 ELATVSSPTSAS---DVYSFGVVILEVACGRRPL 526
           E+             DV+S G+  +E+A  + PL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 15/212 (7%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN----HDSKQGLKEFMAEISSMGR 376
           F  ++ +G G F  VY+ T   +       +A+K V      D+K   ++ + EI  + +
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRK----PVALKKVQIFEMMDAK-ARQDCVKEIDLLKQ 58

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEG 434
           L H N+++      + NEL +V +    G L+  I  F K K+L+  +   +    +   
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           + ++H    + V+HRDIK  N+ + +    +LGD GL + +   +      +VGT  Y++
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMS 174

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           PE    +     SD++S G ++ E+A  + P 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.0 bits (180), Expect = 7e-14
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 44/221 (19%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA------------EISSM 374
           LG G +G V+K   A +       +A+K          K F A            EI  +
Sbjct: 15  LGKGAYGIVWK---AIDRRTKEV-VALK----------KIFDAFRNATDAQRTFREIMFL 60

Query: 375 GRL-QHKNLVQMRGWCRKGN--ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADV 431
             L  H N+V++    +  N  ++ LV++YM    L+  I      +L    +R I+  +
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMYQL 116

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT----TRVV 487
            + L Y+H G    V+HRD+K  NILL+S+ R +L DFGLA+   + E        T  V
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 488 GTLGYLAPELATVSSP--TSASDVYSFGVVILEVACGRRPL 526
            T  Y APE+  + S   T   D++S G ++ E+  G +PL
Sbjct: 174 ATRWYRAPEI-LLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 8e-14
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 28/224 (12%)

Query: 321 FSNDEL-----LGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEI 371
           FS D+L     LG G FG+V       +  +    +  +AVK +  D +++ L + ++E+
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P 
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        VA G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 66/227 (29%), Positives = 115/227 (50%), Gaps = 25/227 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLK-EFMAEISSMGRLQ---HKN 381
           +G G +G VYK      + ++   +A+K V    ++ GL    + E++ + RL+   H N
Sbjct: 8   IGVGAYGTVYKA----RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 382 LVQMRGWC---RKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           +V++   C   R   E  + LV++++ +  L  ++   P   L  +  + ++     GL+
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLA 494
           +LH      +VHRD+K  NIL+ S  + +L DFGLA++Y  Q    P    VV TL Y A
Sbjct: 123 FLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP----VVVTLWYRA 175

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           PE+   S+  +  D++S G +  E+   R+PL  G  E ++   + D
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGKIFD 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 22/217 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           EL+G+G +G+VYKG   +        + V  V  D ++ +K+   EI+ + +   H+N+ 
Sbjct: 12  ELVGNGTYGQVYKGR--HVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIA 66

Query: 384 QMRGWCRKGN------ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
              G   K N      +L LV ++   GS+ + I       L  +    I  ++  GL++
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE- 496
           LH      V+HRDIK  N+LL      +L DFG++    +  V      +GT  ++APE 
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEV 182

Query: 497 LATVSSPTSA----SDVYSFGVVILEVACGRRPL-DM 528
           +A   +P +     SD++S G+  +E+A G  PL DM
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 23/230 (10%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQG----LKE-FMAEISSMGRL 377
           ++G GGFG VY    A+         A+KC++      KQG    L E  M  + S G  
Sbjct: 1   IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               +V M       ++L  + D M  G L+  +      +   K+ R    ++  GL +
Sbjct: 57  PF--IVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEH 112

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE- 496
           +H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY+APE 
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYMAPEV 166

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
           L   ++  S++D +S G ++ ++  G  P    K +++ E   M    N+
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 73.2 bits (179), Expect = 1e-13
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)

Query: 370 EISSMGRLQHKNLVQMRGWCR-KGNELML-------VYDYMPNGSLNNWIFGKPKKLLGW 421
           EI ++GRL H+N++++    R + N  M+       +Y +M + + + W   K + LL  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W---KDRPLL-- 266

Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP 481
           KQ R I+  +   + Y+H   D+ ++HRDIK  NI L+ + +  LGDFG A  +++    
Sbjct: 267 KQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323

Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                VGT+   +PE+         +D++S G+++L++
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 29/277 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           E +G G FG V+ G L  +N    T +AVK         LK +F+ E   + +  H N+V
Sbjct: 1   ERIGRGNFGEVFSGRLRADN----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +  G    ++  +  +L   K+  Q++ + A G+ YL     
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL-KVKELIQMVENAAAGMEYLE---S 112

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT-LGYLAPELATVSS 502
           +  +HRD+ + N L+  +   ++ DFG+++  + G   +T  +    + + APE      
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 503 PTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
            +S SDV+SFG+++ E  + G  P      ++  EA+          QG         +R
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI---------EQG---------VR 214

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV 598
                   + V +L   C   D  +RP+   V   L 
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 50/144 (34%), Positives = 74/144 (51%), Gaps = 19/144 (13%)

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
           QIL     GL YLH      ++HRDIK GN+L++S    ++ DFGLA++ +  E  + T+
Sbjct: 111 QIL----RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163

Query: 486 VVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            V T  Y APE+   S   TSA D++S G +  E+  GRR L   +   ++    +D + 
Sbjct: 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL-LGRRILFQAQSPIQQ----LDLIT 218

Query: 545 NLYG------QGKICEAADARIRQ 562
           +L G          CE A A I +
Sbjct: 219 DLLGTPSLEAMRSACEGARAHILR 242

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 39/109 (35%), Positives = 64/109 (58%), Gaps = 9/109 (8%)

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV-V 487
           A++A GL +LH    + +++RD+K  N++LD+E   ++ DFG+ K    G    TTR   
Sbjct: 108 AEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFC 162

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           GT  Y+APE+        + D ++FGV++ E+  G+ P D   GE+E+E
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD---GEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 11/207 (5%)

Query: 319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY       +     E+A++ +N   +   +  + EI  M   +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFL 132

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        E    + +VGT  ++APE+ 
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVV 188

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQ-HKN 381
           E +G G +G+V+K      N  N ++ AVK ++  HD  +   E  AE + +  L  H N
Sbjct: 24  ETIGKGTYGKVFK----VLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPN 76

Query: 382 LVQMRGWCRK-----GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA-EGL 435
           +V+  G   K     G++L LV +    GS+ + + G  K+  G +    I+A +  E L
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEAL 134

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLA 494
             L H      +HRD+K  NILL +E   +L DFG+ A+L       NT+  VGT  ++A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMA 192

Query: 495 PELATV-----SSPTSASDVYSFGVVILEVACGRRPL 526
           PE+        S+  +  DV+S G+  +E+  G  PL
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 14/214 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLV 383
           LG GGFG V     A          A K +N      ++G +  M E   + ++  + +V
Sbjct: 1   LGKGGFGEVS----ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHHG 441
            +    +   +L LV   M  G L   I+   ++  G+ + R     A +  GL +LH  
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ- 115

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + +++RD+K  N+LLD++   R+ D GLA   + G+   T    GT G++APEL    
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMAPELLQGE 172

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
               + D ++ GV + E+   R P    +GE+ E
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF-RARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHK 380
           +++G G FG+V    L     ++ +  AVK +   +   K+     MAE + + + L+H 
Sbjct: 1   KVIGKGSFGKV----LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP 56

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQILADVAEGL 435
            LV +    +   +L  V DY+  G L         F +P+        R   A+VA  +
Sbjct: 57  FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-------RFYAAEVASAI 109

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYL 493
            YLH      +++RD+K  NILLDS+    L DFGL K   +G  P   T+   GT  YL
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYL 163

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           APE+          D +  G V+ E+  G  P 
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 41/235 (17%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDSKQGLKEF-------------MAEIS 372
           LG G +G+V K      +      +A+K V   +    + +              + E+ 
Sbjct: 17  LGEGTYGKVEKAY----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
            M  ++H+N++ +     +G+ + LV D M    L   +    K  L   Q + IL  + 
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV--DRKIRLTESQVKCILLQIL 129

Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY-----------QQGEVP 481
            GLN LH  +    +HRD+   NI ++S+   ++ DFGLA+ Y            +    
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 482 N---TTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGE 532
               T++VV TL Y APEL   +     A D++S G +  E+  G +PL  G+ E
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENE 239

Length = 335

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 64/219 (29%), Positives = 116/219 (52%), Gaps = 20/219 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQ 378
           ++  E +G G +G VYKG     N      +A+K +  +S+ +G+    + EIS +  LQ
Sbjct: 2   YTKIEKIGEGTYGVVYKG----RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNY 437
           H N+V ++    + + L L+++++ +  L  ++   PK + +  +  +  L  + +G+ +
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLGYLA 494
            H    + V+HRD+K  N+L+D++   +L DFGLA+ +    +P    T  VV TL Y A
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG---IPVRVYTHEVV-TLWYRA 169

Query: 495 PELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGE 532
           PE+   S   S   D++S G +  E+A  ++PL  G  E
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G +G V   +L  +  +   +  +K +N  + S++  K    E   + +L+H N+V 
Sbjct: 8   VGKGSYGEV---SLVRHRTD-GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 385 MR-GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            R  W  +   L +V  +   G L + +  +  KLL   Q  +    +A  L YLH   +
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---E 120

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           + ++HRD+K+ N+ L      ++GD G+A+ L  Q ++ +T  ++GT  Y++PEL +   
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKP 178

Query: 503 PTSASDVYSFGVVILEVA 520
               SDV++ G  + E+A
Sbjct: 179 YNYKSDVWALGCCVYEMA 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEI 371
           L+   K F +           + K       N   T +AVK +N D  SK+ LK    EI
Sbjct: 3   LTLIGKCFED------LMIVHLAK---HKPTN---TLVAVKKINLDSCSKEDLKLLQQEI 50

Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQ 426
            +  +LQH N++         +EL +V   M  GS       ++  G P+  +       
Sbjct: 51  ITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI-----AF 105

Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGE-----V 480
           IL DV   L+Y+H    +  +HR +K+ +ILL  + +  L     +  + + G+      
Sbjct: 106 ILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 481 PNTTRVVGTLGYLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPL-DM 528
                 V  L +L+PE+    +      SD+YS G+   E+A G  P  DM
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 17/225 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LLG G FG+V    +      +    A+K +  +   +K  +   + E   +   +H  
Sbjct: 1   KLLGKGTFGKV----ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L  ++   +  + L  V +Y+  G L  +     +++    + R   A++   L+YLH G
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLGYLAPELAT 499
               +V+RD+K  N++LD +   ++ DFGL K   +G  +        GT  YLAPE+  
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLE 168

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            +    A D +  GVV+ E+ CGR P      E+  E +LM+ ++
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.4 bits (175), Expect = 8e-13
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 48/205 (23%)

Query: 348 STEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNLVQM--RGWCRKGNELMLVYDYM 402
             E+A+K +  D+ +   +   F  E +   RL H N+V +   G    G  L  V++Y+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61

Query: 403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEG--------------LNYLHHGWDQVVVH 448
           P  +L                 R++LA  A+G              L+ L    +Q +VH
Sbjct: 62  PGRTL-----------------REVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVH 102

Query: 449 RDIKSGNILL---DSEMRGRLGDFGLAKLYQQGE------VPNTTRVVGTLGYLAPELAT 499
           RD+K  NI++         ++ DFG+  L           +  TT V+GT  Y APE   
Sbjct: 103 RDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162

Query: 500 VSSPTSASDVYSFGVVILEVACGRR 524
               T  SD+Y++G++ LE   G+R
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 50/209 (23%)

Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMA 369
           YE+L+K          +G G FG V+K      +      +A+K V  ++ K+G     A
Sbjct: 14  YEKLAK----------IGQGTFGEVFKA----RHKKTKQIVALKKVLMENEKEGFP-ITA 58

Query: 370 --EISSMGRLQHKNLVQMRGWCRK----GN----ELMLVYDYMPN---GSLNN----WIF 412
             EI  +  L+H+N+V +   CR      N       LV+++  +   G L+N    +  
Sbjct: 59  LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118

Query: 413 GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
            + KK++     + +L     GL Y+H      ++HRD+K+ NIL+  +   +L DFGLA
Sbjct: 119 SEIKKVM-----KMLL----NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166

Query: 473 KLYQQGEVPN----TTRVVGTLGYLAPEL 497
           + +   +       T RVV TL Y  PEL
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 11/205 (5%)

Query: 325 ELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN 381
           E LG G F +++KG    + +    + TE+ +K ++   +   + F    S M +L HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           LV   G C  G+E ++V +Y+  GSL+ ++  K K L+    + ++   +A  L++L   
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLE-- 117

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG---EVPNTTRVVGTLGYLAPE-L 497
            D+ + H ++ + N+LL  E   + G+    KL   G    V     ++  + ++ PE +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176

Query: 498 ATVSSPTSASDVYSFGVVILEVACG 522
               + + A+D +SFG  + E+  G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 51/213 (23%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 327 LGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V +     +  +  + +  +AVK +  + + + L + ++E+  M  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L +K     
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       T+  
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFG+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 23/221 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQ 378
           +   E +GSG +G V        +  +  ++A+K + H  D     K  + E+  +   +
Sbjct: 7   YKPIENIGSGAYGVVCSAI----DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62

Query: 379 HKNLVQMRGWCR-KGNE---LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
           H N++ +R   R  G +   + +V D M +  L++ I     + L  +  R  L  +  G
Sbjct: 63  HDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD--QPLTEEHIRYFLYQLLRG 119

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLG 491
           L Y+H      V+HRD+K  N+L++ +   R+GDFG+A+        +    T  V T  
Sbjct: 120 LKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 492 YLAPELATVSSP--TSASDVYSFGVVILEVACGRRPLDMGK 530
           Y APEL  +S P  T+A D++S G +  E+  GRR L  GK
Sbjct: 177 YRAPEL-LLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPGK 215

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 22/218 (10%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKN 381
            + LG G FG+V K T          T +AVK +  ++    L++ ++E + + ++ H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK---KLLGWKQRRQILADVAEGLNYL 438
           ++++ G C +   L+L+ +Y   GSL +++    K     LG    R            L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 439 HHG------W----------DQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVP 481
             G      W          +  +VHRD+ + N+L+    + ++ DFGL++ +Y++    
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
             ++    + ++A E       T+ SDV+SFGV++ E+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 17/213 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G +  VYKG     +N     +A+K +  + ++G     + E+S +  L+H N+V +
Sbjct: 14  LGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
                    L LV++Y+ +  L  ++       +     +  L  +  GLNY H    + 
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHR---RK 124

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPELATVSSP 503
           V+HRD+K  N+L++     +L DFGLA+      +P  T    V TL Y  P++   S+ 
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 504 TSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
            S   D++  G +  E++ G RPL  G   EE+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQ-HKNLV 383
           LG G +G V      N   +    +A+K + +    K   K  + E+  +   + HKN+ 
Sbjct: 8   LGQGAYGIVCSAR--NAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 384 QMRG----WCRKGNELMLVYDYMPNGSLNNWI-FGKPKKLLGWKQRRQILADVAEGLNYL 438
            +      +    NEL L Y+ +    L+  I  G+P   L     +  +  +  GL Y+
Sbjct: 66  CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQP---LTDAHFQSFIYQILCGLKYI 121

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYLAP 495
           H      V+HRD+K GN+L++++   ++ DFGLA+ + +    N    T  V T  Y AP
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           E + +  S T A DV+S G ++ E+  GR+P+  GK
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMG-RLQHK 380
           ++LG G FG+V+   L   N       A+K +  D       ++  M E   +    +H 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQF----FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 56

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGL 435
            L  +    +    L  V +Y+  G L   I     F  P+            A++  GL
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-------YAAEIICGL 109

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            +LH    + +V+RD+K  NILLD++   ++ DFG+ K    G+   T    GT  Y+AP
Sbjct: 110 QFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGTPDYIAP 165

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           E+       ++ D +SFGV++ E+  G+ P     G +EEE
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 45/145 (31%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRDI 451
           + L LV +Y P G L + +  + +        +  LA++   ++ +H  G+    VHRDI
Sbjct: 74  DNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY----VHRDI 128

Query: 452 KSGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS--- 507
           K  N+L+D     +L DFG  A+L     V N+   VGT  Y+APE+ T  +        
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187

Query: 508 ---DVYSFGVVILEVACGRRPLDMG 529
              D +S GV+  E+  GR P   G
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQHKNLVQ 384
           ++G G +G V K     +          K  + +  + +KE  + E+  +  L+ +N+V+
Sbjct: 8   VVGEGAYGVVLK---CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVE 64

Query: 385 MRGWCRKGNELMLVYDY-----------MPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
           ++   R+  +L LV++Y           MPNG         P+K+      R  +  + +
Sbjct: 65  LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP-------PEKV------RSYIYQLIK 111

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            +++ H      +VHRDIK  N+L+      +L DFG A+   +G   N T  V T  Y 
Sbjct: 112 AIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
           +PEL   +    A D++S G ++ E++ G +PL  G+ E
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDG-QPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 20/225 (8%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK---EFMA--EISSMG 375
           F    +LG GGFG V    +       +T     C   + K+  K   E MA  E   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQV------RATGKMYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAE 433
           ++  + +V +       + L LV   M  G L   I+   +   G+++ R +   A++  
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA--GFEEGRAVFYAAEICC 113

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           GL  LH    + +V+RD+K  NILLD     R+ D GLA    +G+       VGT+GY+
Sbjct: 114 GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYM 168

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           APE+      T + D ++ G ++ E+  G+ P    K + + E V
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 17/215 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           E LG G +  V+KG      N     +A+K +  + ++G     + E+S +  L+H N+V
Sbjct: 12  EKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            +         L LV++Y+ +  L  ++      ++     +  L  +  GL Y H    
Sbjct: 68  TLHDIVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCHR--- 122

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPELATVS 501
           + V+HRD+K  N+L++     +L DFGLA+      VP  T    V TL Y  P++   S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 502 SPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           S  S   D++  G +  E+A G RPL  G   E+E
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 26/228 (11%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK---EFMA--EISSMG 375
           F +  +LG GGFG V    +       +T     C   + K+  K   E MA  E   + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQV------RATGKMYACKKLEKKRIKKRKGEAMALNEKRILE 55

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQIL--ADV 431
           ++  + +V +       + L LV   M  G L   I+  G P    G+ ++R I   A++
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAAEL 111

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTL 490
             GL  L     + +V+RD+K  NILLD     R+ D GLA    +GE   T R  VGT+
Sbjct: 112 CCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTV 165

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           GY+APE+      T + D +  G +I E+  G+ P    K   + E V
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 23/220 (10%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQG----LKE-FMAEISSMGRL 377
           ++G GGFG VY    A+         A+KC++      KQG    L E  M  + S G  
Sbjct: 1   IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               +V M       ++L  + D M  G L+  +      +    + R   A++  GL +
Sbjct: 57  PF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEH 112

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE- 496
           +H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY+APE 
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGYMAPEV 166

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           L    +  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 69/234 (29%), Positives = 103/234 (44%), Gaps = 28/234 (11%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK---EFMA--EISSMG 375
           F    +LG GGFG V    +       +T     C   + K+  K   E MA  E   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQV------RATGKMYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQIL--ADV 431
           ++  + +V +       + L LV   M  G L   I+  G P    G+++ R +   A++
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFEEERALFYAAEI 111

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             GL  LH    +  V+RD+K  NILLD     R+ D GLA    +GE       VGT+G
Sbjct: 112 LCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVG 166

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL----DMGKGEEEEEAVLMD 541
           Y+APE+      T + D +  G +I E+  G+ P     +  K EE +  VL  
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 40/102 (39%), Positives = 58/102 (56%), Gaps = 8/102 (7%)

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ---QGEVPNTTRVVGTLGYLA 494
           +HH   + ++HRDIKS NILL S    +LGDFG +K+Y      +V  T    GT  Y+A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT--FCGTPYYVA 213

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           PE+      +  +D++S GV++ E+   +RP D   GE  EE
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEE 252

Length = 496

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 16/218 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-----GLKEFMAEISSMGRLQHKN 381
           LG GGFG V    + N      T     C   D K+     G K  + E   + ++    
Sbjct: 1   LGKGGFGEVCAVQVKN------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V +         L LV   M  G L   I+   ++ L  ++     A +  G+ +LH  
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-- 112

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +V+RD+K  N+LLD +   RL D GLA   + G+    T+  GT GY+APE+    
Sbjct: 113 -SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEE 169

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
             +   D ++ G  I E+  GR P    K +  +E + 
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G +G V        N+  + ++A+K + +  D++   K  + EI  +  L H+N++ 
Sbjct: 13  IGRGAYGIVCSAK----NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 385 ----MRGWCRKG-NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
               M    R+  N++ +VY+ M +  L+  I  +  + L     +  L  +  GL Y+H
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 V+HRD+K  N+LL++    ++ DFGLA+   +     T  VV T  Y APEL  
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLL 181

Query: 500 VSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
             S  T+A DV+S G +  E+  GR+PL  GK
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPLFPGK 212

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 13/223 (5%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LLG G FG+V    +           A+K +  +   +K  +   + E   +   +H  
Sbjct: 1   KLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L YLH  
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 112

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + VV+RDIK  N++LD +   ++ DFGL K          T   GT  YLAPE+   +
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
               A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 24/218 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           E++G+G +G+VYKG      +  + ++A   V   ++   +E   EI+ + +   H+N+ 
Sbjct: 22  EVVGNGTYGQVYKG-----RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 384 QMRG-WCRKG-----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
              G + +K      ++L LV ++   GS+ + +       L       I  ++  GL +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPE 496
           LH      V+HRDIK  N+LL      +L DFG+ A+L +     NT   +GT  ++APE
Sbjct: 137 LHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 191

Query: 497 -LATVSSPTSA----SDVYSFGVVILEVACGRRPL-DM 528
            +A   +P +     SD++S G+  +E+A G  PL DM
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 14/224 (6%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LLG G FG+V    +           A+K +  +   +K  +   + E   +   +H  
Sbjct: 1   KLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+YLH  
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHS- 113

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPELATV 500
            ++ VV+RD+K  N++LD +   ++ DFGL K   + G    T    GT  YLAPE+   
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 170

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 10/152 (6%)

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H  LV +    +  + L  V +Y+  G L      + ++ L  +  R   A+++  LNYL
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPE 496
           H   ++ +++RD+K  N+LLDSE   +L D+G+ K   +G  P   T+   GT  Y+APE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 166

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDM 528
           +        + D ++ GV++ E+  GR P D+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 57/215 (26%), Positives = 109/215 (50%), Gaps = 22/215 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K +    +  +   MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 13  LGAGNGGVVFKVS----HKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 68

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWI--FGK-PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +   G+ P+++LG     ++   V +GL YL    
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 121

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 48/279 (17%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHKNLV 383
           LG G +G VYK     +     T MA+K +     +SK    + + E+  + +     +V
Sbjct: 9   LGKGNYGSVYK---VLHRPTGVT-MAMKEIRLELDESK--FNQIIMELDILHKAVSPYIV 62

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNN------WIFGKPKKLLGWKQRRQILADVAEGLNY 437
              G       + +  +YM  GSL+          G P+ +L     R+I   V +GL +
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL-----RRITYAVVKGLKF 117

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           L    +  ++HRD+K  N+L++   + +L DFG++              +G   Y+APE 
Sbjct: 118 LKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG---NLVASLAKTNIGCQSYMAPER 172

Query: 498 ATVSSPTSA------SDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ-G 550
                P         SDV+S G+ ILE+A GR P        E  A       N++ Q  
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYA-------NIFAQLS 220

Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT 589
            I +     +   +  +  + V K    C +    RRPT
Sbjct: 221 AIVDGDPPTLPSGYSDDAQDFVAK----CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 15/204 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG +G VYK      N N     A+K +  +  +       EI  M   +H N+V   
Sbjct: 17  IGSGTYGDVYKA----RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 387 GWCRKGNELMLVYDYMPNGSLNN-WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
           G   + ++L +  ++   GSL + +    P   L   Q   +  +  +GL YLH    + 
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH---SKG 126

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-- 503
            +HRDIK  NILL      +L DFG++       +      +GT  ++APE+A V     
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQI-TATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 504 -TSASDVYSFGVVILEVACGRRPL 526
                D+++ G+  +E+A  + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.4 bits (162), Expect = 8e-12
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSM-GRLQHKNL 382
           +G G FG+V    LA +  +     AVK +   +   K+  K  MAE + +   ++H  L
Sbjct: 3   IGKGSFGKVL---LAKHKADGKF-YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNY 437
           V +    +  ++L  V DY+  G L   +     F +P+        R   A++A  L Y
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-------RFYAAEIASALGY 111

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           LH      +++RD+K  NILLDS+    L DFGL K   +     T+   GT  YLAPE+
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEV 167

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRP 525
                     D +  G V+ E+  G  P
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 18/212 (8%)

Query: 317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA--EISSM 374
           A   + N E LG G +  VYKG     +  N   +A+K ++  +++G+  F A  E S +
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGI----SRINGQLVALKVISMKTEEGVP-FTAIREASLL 57

Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L+H N+V +         L  V++YM +  L  ++   P  L  +  R   +  +  G
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVR-LFMFQLLRG 115

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV--VGTLGY 492
           L Y+H    Q ++HRD+K  N+L+      +L DFGLA+      +P+ T    V TL Y
Sbjct: 116 LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWY 169

Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGR 523
             P+ L   +  +SA D++  G + +E+  G+
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 40/113 (35%), Positives = 64/113 (56%), Gaps = 7/113 (6%)

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
           LA++A  L++LH      +++RD+K  NILLD E   +L DFGL+K     E        
Sbjct: 104 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFC 159

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
           GT+ Y+APE+      T ++D +SFGV++ E+  G  P    +G++ +E + M
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF---QGKDRKETMTM 209

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 65/239 (27%), Positives = 98/239 (41%), Gaps = 64/239 (26%)

Query: 321 FSNDEL-----LGSGGFGRVYKGTLANNNNNNSTEMAVK-----CVNHDSKQGLKEFMAE 370
           F+ ++L     +G G FG V K      +  + T MAVK         + K+ L +    
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKML----HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV 56

Query: 371 ISSMGRLQHKNLVQMRG--------W-CRKGNELM---------LVYDYMPNGSLNNWIF 412
           + S        +V+  G        W C    ELM          VY+ +    +   I 
Sbjct: 57  MRSS---DCPYIVKFYGALFREGDCWICM---ELMDISLDKFYKYVYEVL-KSVIPEEIL 109

Query: 413 GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
           GK            I     + LNYL    +  ++HRD+K  NILLD     +L DFG++
Sbjct: 110 GK------------IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Query: 473 KLYQQGEVPNT---TRVVGTLGYLAPELATVSSPTS---ASDVYSFGVVILEVACGRRP 525
                G++ ++   TR  G   Y+APE    S+       SDV+S G+ + EVA G+ P
Sbjct: 156 -----GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 44/140 (31%), Positives = 75/140 (53%), Gaps = 19/140 (13%)

Query: 393 NELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVH 448
            E+ +  ++M  GSL+  +  K    P+ +LG     +I   V  GL YL       ++H
Sbjct: 72  GEISICMEHMDGGSLDQ-VLKKAGRIPENILG-----KISIAVLRGLTYLREKHK--IMH 123

Query: 449 RDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATVSSPTSA 506
           RD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    +  T  
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ 178

Query: 507 SDVYSFGVVILEVACGRRPL 526
           SD++S G+ ++E+A GR P+
Sbjct: 179 SDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 25/219 (11%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN- 381
           +LG G FG+V    LA     +    A+K +  D       ++  M E   +  LQ K  
Sbjct: 7   VLGKGSFGKV---MLAERKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLA-LQDKPP 61

Query: 382 -LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            L Q+    +  + L  V +Y+  G L   I    +++  +K+ + +   A+++ GL +L
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV-VGTLGYLAPEL 497
           H    + +++RD+K  N++LDSE   ++ DFG+ K +    V  TTR   GT  Y+APE+
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEI 172

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                   + D +++GV++ E+  G+ P D   GE+E+E
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 13/206 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEF-MAEISSMGRLQHKN- 381
           LG+G +G+V+       ++      A+K +   +   K    E    E   +  ++    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAG-KLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           LV +    +   +L L+ DY+  G L   ++ +        + R  +A++   L++LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIVLALDHLHQ- 123

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +++RDIK  NILLDSE    L DFGL+K +   E        GT+ Y+APE+    
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 502 SP--TSASDVYSFGVVILEVACGRRP 525
           S     A D +S GV+  E+  G  P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 22/227 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAE--ISSMGRLQH 379
            +LG G FG+V    L  +        AVK +  D       ++  M E  I S+ R  H
Sbjct: 1   RVLGKGSFGKVMLARLKESGR----LYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NH 55

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL-ADVAEGLNYL 438
             L Q+    +  + L  V +++  G L   +F   K     + R +   A++   L +L
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLGYLAPE 496
           H   D+ +++RD+K  N+LLD E   +L DFG+ K   +G      T+   GT  Y+APE
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPE 166

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
           +        + D ++ GV++ E+ CG  P +    ++  EA+L D V
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/151 (33%), Positives = 73/151 (48%), Gaps = 19/151 (12%)

Query: 395 LMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQIL--ADVAEGLNYLHHGWDQVVVHRD 450
           L LV   M  G L   I+  G P    G+ + R +   A++  GL  LH    + +V+RD
Sbjct: 75  LCLVLTLMNGGDLKFHIYNMGNP----GFDEERAVFYAAEITCGLEDLHR---ERIVYRD 127

Query: 451 IKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV---VGTLGYLAPELATVSSPTSAS 507
           +K  NILLD     R+ D GLA      E+P    +   VGT+GY+APE+      T + 
Sbjct: 128 LKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGYMAPEVVKNERYTFSP 182

Query: 508 DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           D +  G +I E+  G+ P    K + + E V
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-----QGLKEFMAEISSMGRLQHK 380
           ++G G + +V    L  N+   + ++  K + HD +     Q  K    + SS     + 
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NP 56

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +  + L LV +Y+  G L      + ++ L  +  R   A++   LN+LH 
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH- 113

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPELA 498
             ++ +++RD+K  N+LLD++   +L D+G+ K   +G  P   T+   GT  Y+APE+ 
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDM 528
                  + D ++ GV++ E+  GR P D+
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 29/213 (13%)

Query: 326 LLGSGGFGRVYK-GTLANNNNNNSTEMAV--KCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           +LG GG+G+V++   +   +      M V  K     +++      AE + +  ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVAE 433
           V +    + G +L L+ +Y+  G L   +           +R  I         L++++ 
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL-----------EREGIFMEDTACFYLSEISL 111

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGY 492
            L +LH    Q +++RD+K  NILLD++   +L DFGL K    +G V +T    GT+ Y
Sbjct: 112 ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEY 166

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+   S    A D +S G ++ ++  G  P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 32/232 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAE--ISSMGRLQH 379
           ++LG G FG+V    LA     +    A+K +  D       +   M E  I ++   +H
Sbjct: 1   KVLGKGSFGKV---MLAELKGTDEV-YAIKVLKKDVILQDDDVDCTMTEKRILALAA-KH 55

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEG 434
             L  +    +  + L  V +Y+  G L   I     F +P+        R   A+V   
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RFYAAEVTLA 108

Query: 435 LNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN--TTRVVGTLG 491
           L +LH HG    V++RD+K  NILLD+E   +L DFG+ K   +G +    TT   GT  
Sbjct: 109 LMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPD 161

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
           Y+APE+        + D ++ GV++ E+  G+ P +    ++  E++L D V
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDSK-QGLKEF 367
            YE+L K          +G G +G V+K       N  + E+ A+K V  D   +G+   
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKA-----KNRETHEIVALKRVRLDDDDEGVPSS 45

Query: 368 -MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNG------SLNNWIFGKPKKLLG 420
            + EI  +  L+HKN+V++        +L LV++Y          S N    G     + 
Sbjct: 46  ALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN----GDIDPEIV 101

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
                Q+L    +GL + H      V+HRD+K  N+L++     +L DFGLA+ +    +
Sbjct: 102 KSFMFQLL----KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG---I 151

Query: 481 P---NTTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGK 530
           P    +  VV TL Y  P++   +   S S D++S G +  E+A   RPL  G 
Sbjct: 152 PVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 47/193 (24%), Positives = 74/193 (38%), Gaps = 54/193 (27%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD------VAE---GLNYLHH-GW 442
             L LV +YMP G L           +    R+ +  +      +AE    L+ +H  G+
Sbjct: 74  EHLYLVMEYMPGGDL-----------MNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-----------LYQQGEVPNTTR------ 485
               +HRDIK  NIL+D++   +L DFGL K           L     +           
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 486 -----------VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                       VGT  Y+APE+   +      D +S GV++ E+  G  P       +E
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF-YSDTLQE 237

Query: 535 EEAVLMDWVRNLY 547
               +++W  +L 
Sbjct: 238 TYNKIINWKESLR 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 17/213 (7%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G +  V+KG      N     +A+K +  + ++G     + E+S +  L+H N+V +
Sbjct: 13  LGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
                    L LV++Y+ +  L  ++      L+     +  +  +  GL+Y H    + 
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RK 123

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPELATVSSP 503
           ++HRD+K  N+L++ +   +L DFGLA+      VP  T    V TL Y  P++   S+ 
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 504 TSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
            S   D++  G ++ E+A G RP+  G   +EE
Sbjct: 181 YSTPIDMWGVGCILYEMATG-RPMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 325 ELLGSGGFGRV----YKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRL 377
           E LG+G FGRV    +KGT            A+KC+       +K+      E S +  L
Sbjct: 24  ETLGTGSFGRVRIAKHKGT--------GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGK-PKKLLGWKQRRQILADVAEG 434
            H  +V M    +  N +  + +++  G L   +   G+ P  +  +     +LA     
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----- 130

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT-RVVGTLGYL 493
             YLH    + +++RD+K  N+LLD++   ++ DFG AK     +VP+ T  + GT  YL
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYL 182

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRP 525
           APE+        A D ++ GV++ E   G  P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 35/113 (30%), Positives = 62/113 (54%), Gaps = 4/113 (3%)

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
           A++  GL +LH      +++RD+K  N++LD +   ++ DFG+ K    G+   +T   G
Sbjct: 103 AEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCG 158

Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           T  Y+APE+      T + D +SFGV++ E+  G+ P      +E  E++ +D
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQHKNL 382
           E +G G +G VYK   A +   N T +A+K +  + + +G+    + EIS +  +QH N+
Sbjct: 8   EKIGEGTYGVVYK---ARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+++        L LV++Y+ +  L   +   P      +  +  L  +  G+ Y H   
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119

Query: 443 DQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL---- 497
              V+HRD+K  N+L+D      +L DFGLA+ +    V   T  V TL Y APE+    
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRAPEILLGS 178

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              S+P    D++S G +  E+   ++PL  G  E +E
Sbjct: 179 RHYSTPV---DIWSVGCIFAEMV-NQKPLFPGDSEIDE 212

Length = 294

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V K      +  +   MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 13  LGAGNGGVVTK----VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 68

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V  GL YL    
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE-- 121

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 64/236 (27%), Positives = 93/236 (39%), Gaps = 46/236 (19%)

Query: 325 ELLGSGGFGRVY----KGTLANNNNNNSTEMAV---KCVNHDSKQGLKEFMAEISSMGRL 377
           +LLG G  GRV+    KGT           + V   K +   +K  +K  + E   +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGT------GKLFALKVLDKKEMIKRNK--VKRVLTEQEILATL 58

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H  L  +    +    L LV DY P G L   +  +P K L  +  R   A+V   L Y
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL---------YQQGEVPNTTRV-- 486
           LH      +V+RD+K  NILL       L DF L+K              +    + V  
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 487 -----------------VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                            VGT  Y+APE+ +     SA D ++ G+++ E+  G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 14/201 (6%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           L  G  G V+  T   +      ++ VK V      G K    EI  +  + H+ ++ + 
Sbjct: 100 LTPGSEGEVFVCTKHGDEQR--KKVIVKAVT-----GGKTPGREIDILKTISHRAIINLI 152

Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
              R  + + +V   MP    + + +      L  +Q   I   + E L YLH    + +
Sbjct: 153 HAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGI 206

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS 505
           +HRD+K+ NI LD      LGDFG A KL    + P      GTL   +PEL  +    +
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA 266

Query: 506 ASDVYSFGVVILEVACGRRPL 526
            +D++S G+V+ E++     L
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 9e-11
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 19/208 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN----- 381
           +G G FG+VY        +      A+K ++       KE    I     L         
Sbjct: 1   IGKGTFGQVY---QVRKKDTRRI-YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 382 -LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            +V ++   +  ++L LV DYM  G L  W   K  +     + +  +A++   L +LH 
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRF-SEDRAKFYIAELVLALEHLH- 113

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE-LA 498
                +V+RD+K  NILLD+     L DFGL+K      +  NT    GT  YLAPE L 
Sbjct: 114 --KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLL 169

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPL 526
                T   D +S GV++ E+ CG  P 
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 32/218 (14%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQ-HKNL 382
           +G G F  V K      +       A+KC+       +Q     + EI ++ RL  H N+
Sbjct: 7   IGEGTFSEVLKA----QSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNI 60

Query: 383 VQMRGWC-----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +++         RK   L LV++ M + +L   I G+ K+ L  K+ +  +  + + L++
Sbjct: 61  LRL---IEVLFDRKTGRLALVFELM-DMNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDH 115

Query: 438 LH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
           +H +G    + HRDIK  NIL+  +   +L DFG  + +Y +   P  T  + T  Y AP
Sbjct: 116 MHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGIYSK---PPYTEYISTRWYRAP 167

Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
           E L T        D+++ G V  E+     PL  G  E
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL-SLFPLFPGTNE 204

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 23/218 (10%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN- 381
           +LG G FG+V    LA     +    A+K +  D       ++  M E   +  L  K  
Sbjct: 7   VLGKGSFGKV---MLAERKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPP 61

Query: 382 -LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            L Q+    +  + L  V +Y+  G L   I    +++  +K+   +   A++A GL +L
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +++RD+K  N++LDSE   ++ DFG+ K      V  T    GT  Y+APE+ 
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEII 173

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                  + D ++FGV++ E+  G+ P +   GE+E+E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 41/117 (35%), Positives = 61/117 (52%), Gaps = 6/117 (5%)

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV-V 487
           A++   L YLH      VV+RD+K  N++LD +   ++ DFGL K  +      T +   
Sbjct: 102 AEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           GT  YLAPE+   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 13/184 (7%)

Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-- 426
           +E+  +    H  +V+     +  ++L+L+ +Y   G LN  I  + K+ L +++     
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTR 485
           +   +   L+ +H    + ++HRD+KS NI L      +LGDFG +K Y     +   + 
Sbjct: 174 LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
             GT  YLAPEL      +  +D++S GV++ E+    RP    KG  + E  +M  V  
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQRE--IMQQV-- 283

Query: 546 LYGQ 549
           LYG+
Sbjct: 284 LYGK 287

Length = 478

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 42/129 (32%), Positives = 66/129 (51%), Gaps = 23/129 (17%)

Query: 415 PKKLLGWKQRRQILADVAEGLNYL--HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
           P+ +LG     ++   + + L+YL   HG    V+HRD+K  NILLD+    +L DFG++
Sbjct: 112 PEDILG-----KMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS 162

Query: 473 KLYQQGEVPNT---TRVVGTLGYLAPELATVSSPTSA----SDVYSFGVVILEVACGRRP 525
                G + ++   TR  G   Y+APE      P       +DV+S G+ ++E+A G+ P
Sbjct: 163 -----GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Query: 526 LDMGKGEEE 534
               K E E
Sbjct: 218 YKNCKTEFE 226

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 28/213 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHK 380
           +++G G FG+V    L   +       AVK +   +   K+  K  M+E + + + ++H 
Sbjct: 1   KVIGKGSFGKV----LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQILADVAEGL 435
            LV +    +  ++L  V DY+  G L         F +P+        R   A++A  L
Sbjct: 57  FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAEIASAL 109

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN--TTRVVGTLGYL 493
            YLH      +V+RD+K  NILLDS+    L DFGL K   +    N  T+   GT  YL
Sbjct: 110 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYL 163

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           APE+          D +  G V+ E+  G  P 
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)

Query: 325 ELLGSGGFGRVY---KGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHK 380
           ++LG+G +G+V+   K T  +     + ++  K       + ++    E + +  + Q  
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +   +L L+ DY+  G +   ++   +      + R    ++   L +LH 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLH- 122

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA-T 499
                +V+RDIK  NILLDSE    L DFGL+K +   E   T    GT+ Y+APE+   
Sbjct: 123 --KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
                 A D +S G++I E+  G  P  + +GE   ++
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTL-EGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNL 382
            +G+G FGRV+       +  +    A+K +       LK+      E   +  + H  +
Sbjct: 8   TVGTGTFGRVHLV----RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++         L ++ +Y+P G L +++  +              +++   L YLH   
Sbjct: 64  IRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH--- 118

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT-RVVGTLGYLAPELATVS 501
            + +V+RD+K  NILLD E   +L DFG AK     ++ + T  + GT  YLAPE+    
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 502 SPTSASDVYSFGVVILEVACGRRP 525
               A D ++ G++I E+  G  P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA---EISSMGRLQHKNLV 383
           +G G +G VYK      +  +  E A+K +     +G    M+   EI+ +  L+H N++
Sbjct: 9   VGRGTYGHVYKAK--RKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVI 61

Query: 384 QMRG--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKL------LGWKQRRQILADVAEGL 435
            ++         ++ L++DY  +   +   F +  K       L     + +L  + +G+
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSE--MRGR--LGDFGLAKLYQQGEVP--NTTRVVGT 489
           +YLH  W   V+HRD+K  NIL+  E   RGR  + D G A+L+     P  +   VV T
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 490 LGYLAPELAT-VSSPTSASDVYSFGVVILEV 519
             Y APEL       T A D+++ G +  E+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA 369
           SYE+L K          LG G +  VYKG     +  N   +A+K +    ++G   F A
Sbjct: 6   SYEKLEK----------LGEGSYATVYKG----KSKVNGKLVALKVIRLQEEEG-TPFTA 50

Query: 370 --EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
             E S +  L+H N+V +         L LV++Y+ +  L  ++   P  L   +  +  
Sbjct: 51  IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP-ENVKLF 108

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--R 485
           L  +  GL+Y+H  +   ++HRD+K  N+L+      +L DFGLA+      VP+ T   
Sbjct: 109 LFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSN 162

Query: 486 VVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACG 522
            V TL Y  P++   S+  S   D++  G + +E+  G
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMA-VKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +GSG +G VYK       N ++ E+A VK +  +          EI  +   +H N+V  
Sbjct: 17  VGSGTYGDVYKA-----RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71

Query: 386 RGWCRKGNELMLVYDYMPNGSLNN--WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            G      +L +  +Y   GSL +   + G   +L    Q   +  +  +GL YLH    
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLH---S 124

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           +  +HRDIK  NILL      +L DFG+A       +      +GT  ++APE+A V   
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 504 ---TSASDVYSFGVVILEVACGRRPL 526
                  D+++ G+  +E+A  + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
           +QIL    EGL YLH    Q ++HRD+K+ NI ++   +  +GD G A+       P   
Sbjct: 164 KQIL----EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFL 214

Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + GT+   APE+       S +D++S G+V+ E+
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 61/248 (24%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA 369
           +Y++L K          LG G +  VYKG            +A+K +  + ++G   F A
Sbjct: 6   TYKKLDK----------LGEGSYATVYKGRSKLTGQ----LVALKEIRLEHEEGAP-FTA 50

Query: 370 --EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM-----------PNG-SLNN---WIF 412
             E S +  L+H N+V +         L LV++Y+             G S++N   ++F
Sbjct: 51  IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF 110

Query: 413 GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
                        Q+L     GL Y H    + V+HRD+K  N+L+      +L DFGLA
Sbjct: 111 -------------QLL----RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLA 150

Query: 473 KLYQQGEVPNTT---RVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDM 528
           +      VP+ T    VV TL Y  P++   S+  S S D++  G +  E+A G RPL  
Sbjct: 151 R---AKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPLFP 205

Query: 529 GKGEEEEE 536
           G  + E++
Sbjct: 206 GSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA---EISSMGRLQHKNLV 383
           +G G +G VYK      +  +  + A+K +     +G    M+   EI+ +  L+H N++
Sbjct: 9   VGRGTYGHVYKAK--RKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVI 61

Query: 384 QMRG--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKL------LGWKQRRQILADVAEGL 435
            ++         ++ L++DY  +   +   F +  K       L     + +L  + +G+
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSE--MRGR--LGDFGLAKLYQQGEVP--NTTRVVGT 489
           +YLH  W   V+HRD+K  NIL+  E   RGR  + D G A+L+     P  +   VV T
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 490 LGYLAPELAT-VSSPTSASDVYSFGVVILEV 519
             Y APEL       T A D+++ G +  E+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI-LADVAEGLNYLHHGWDQVVVHRDIK 452
           +L L+ DY+  G L   +  + +     +Q  QI   ++   L +LH      +++RDIK
Sbjct: 79  KLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH---KLGIIYRDIK 132

Query: 453 SGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT--VSSPTSASDVY 510
             NILLDS     L DFGL+K + + EV       GT+ Y+AP++          A D +
Sbjct: 133 LENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192

Query: 511 SFGVVILEVACGRRPLDMGKGEEEEEA 537
           S GV++ E+  G  P  +  GE+  +A
Sbjct: 193 SMGVLMYELLTGASPFTV-DGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 39/228 (17%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           + N   +G G +G V   T    +     ++A+K ++    Q   +  + EI  + R +H
Sbjct: 7   YQNLSYIGEGAYGMVCSAT----HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62

Query: 380 KNLVQMRGWCRKG-----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD---- 430
           +N++ +    R       N++ +V + M    L         KL+    + Q L++    
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET-DLY--------KLI----KTQHLSNDHIQ 109

Query: 431 -----VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-- 483
                +  GL Y+H      V+HRD+K  N+LL++    ++ DFGLA++           
Sbjct: 110 YFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           T  V T  Y APE +      T A D++S G ++ E+    RPL  GK
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGR-LQHK 380
           +++G G FG+V    L      +    AVK +      +++  K  MAE + + + ++H 
Sbjct: 1   KVIGKGSFGKV----LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP 56

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +   +L  V D++  G L  +   + ++     + R   A++A  L YLH 
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH- 113

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLGYLAPELA 498
                +V+RD+K  NILLDS+    L DFGL K   +G  +   TT   GT  YLAPE+ 
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPL 526
                 +  D +  G V+ E+  G  P 
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 25/215 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G+G FG+V    +  +       +     N  SK+   EF+ +      LQH N++Q  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCL 61

Query: 387 GWCRKGNELMLVYDYMPNGSL------NNWIFGKPKKLLGWKQRRQILADVAEGLNYLH- 439
           G C +    +LV++Y   G L        W     + L      +++  ++A G+ ++H 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL----LLQRMACEIAAGVTHMHK 117

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELA 498
           H +    +H D+   N  L S++  ++GD+G+    Y++  +         L +LAPEL 
Sbjct: 118 HNF----LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173

Query: 499 T-------VSSPTSASDVYSFGVVILEV-ACGRRP 525
                    +  T  S+V++ GV + E+     +P
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 41/137 (29%), Positives = 73/137 (53%), Gaps = 12/137 (8%)

Query: 395 LMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS 453
           L  V +++  G L   +F  + ++ L  +  R   A+++  LN+LH      +++RD+K 
Sbjct: 71  LFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKL 124

Query: 454 GNILLDSEMRGRLGDFGLAKLYQQGEVPN--TTRVVGTLGYLAPELATVSSPTSASDVYS 511
            N+LLD+E   +L D+G+ K   +G  P   T+   GT  Y+APE+        + D ++
Sbjct: 125 DNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 512 FGVVILEVACGRRPLDM 528
            GV++ E+  GR P D+
Sbjct: 182 LGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 33/127 (25%)

Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG---- 470
           P+ +LG     +I   + + L YLH      V+HRD+K  N+L++   + +L DFG    
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 471 ----LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA------SDVYSFGVVILEVA 520
               +AK    G  P          Y+APE   ++   +       SDV+S G+ ++E+A
Sbjct: 154 LVDSVAKTIDAGCKP----------YMAPE--RINPELNQKGYDVKSDVWSLGITMIELA 201

Query: 521 CGRRPLD 527
            GR P D
Sbjct: 202 TGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 56/272 (20%), Positives = 108/272 (39%), Gaps = 44/272 (16%)

Query: 334 RVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGW----- 388
            +YKG     NN        K  +   K  +     EI ++ R+   N++++ G+     
Sbjct: 35  SIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91

Query: 389 ---CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
               R    L L+ +Y   G L   +    +K L +K +  +  D  +GL  L+   ++ 
Sbjct: 92  DDLPR----LSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP 145

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT--VSSP 503
             ++++ S + L+    + ++   GL K+       N    V  + Y + ++     S  
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN----VNFMVYFSYKMLNDIFSEY 199

Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE 563
           T   D+YS GVV+ E+  G+ P +                 NL  +  I +    +    
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFE-----------------NLTTKE-IYDLIINKNNSL 241

Query: 564 FEAEEMELVLK-LGLACCHPDSTRRPTMREVV 594
               +  L +K +  AC   DS +RP ++E++
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 24/218 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNL 382
           E++G G +G V     +  + +   ++A+K +N   +        + EI  +  L+H ++
Sbjct: 6   EVIGKGSYGVV----CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 383 VQMRGWC-----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           V+++        R+  ++ +V++ M    L+  I  K    L  +  +  L  +   L Y
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDDLTPEHHQFFLYQLLRALKY 118

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYLA 494
           +H      V HRD+K  NIL +++ + ++ DFGLA++    + P     T  V T  Y A
Sbjct: 119 IHTA---NVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRA 174

Query: 495 PEL--ATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           PEL  +  S  T A D++S G +  EV  G +PL  GK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGK 211

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 16/202 (7%)

Query: 327 LGSGGFGRVY----KGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKN 381
           LG G FG VY    K  +A        E+ V  +N +++ Q  +E  A++ S  +L H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE--AQLLS--KLDHPA 63

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +V+      + +   ++ +Y     L+  +       K L   Q  +    +  G++Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + ++HRD+K+ NI L + +  ++GDFG+++L   G     T   GT  Y++PE   
Sbjct: 124 ---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEALK 178

Query: 500 VSSPTSASDVYSFGVVILEVAC 521
                S SD++S G ++ E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 64/249 (25%), Positives = 108/249 (43%), Gaps = 58/249 (23%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G  G V+       +++    +AVK +     Q +K  + EI  + RL H N+V+  
Sbjct: 13  LGCGSNGLVFSAV----DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK-- 66

Query: 387 GWCRKGNELMLVYDYM-PNGSLNNWIFGKPKKL----LGWKQRRQILADVAE-------- 433
                      VY+ + P+GS      G   +L    +  +     LA+V E        
Sbjct: 67  -----------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH 115

Query: 434 ----------GLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQ----- 477
                     GL Y+H      V+HRD+K  N+ +++E +  ++GDFGLA++        
Sbjct: 116 ARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 478 GEVPNTTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           G +        T  Y +P L  + SP   T A D+++ G +  E+  G +PL  G  E E
Sbjct: 173 GYLSEGLV---TKWYRSPRL--LLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELE 226

Query: 535 EEAVLMDWV 543
           +  ++++ V
Sbjct: 227 QMQLILESV 235

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 26/228 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNN----STEMAVKC---VNHDSKQGLKEFMAEISSMGR- 376
           E LG G   ++Y G L   +++     S E  +K    V   S + +     E +SM R 
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL-LGWKQRRQILADVAEGL 435
           + HK++V + G C +  E ++V +++  G L+ ++  K   L   WK   ++   +A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASAL 118

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTT----RVVGTL 490
           +YL    D+ +VH ++ + NILL  E  G  G+ G   KL   G +P T       V  +
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLARE--GIDGECGPFIKLSDPG-IPITVLSRQECVERI 172

Query: 491 GYLAPELATVSSPTS-ASDVYSFGVVILEVAC--GRRPLDMGKGEEEE 535
            ++APE    S   S A+D +SFG  + E+ C  G  PL      E+E
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDKTLAEKE 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 46/139 (33%), Positives = 66/139 (47%), Gaps = 18/139 (12%)

Query: 395 LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRDI 451
           L +V +YMP G L N +  +  P+K   W   R   A+V   L+ +H  G+    +HRD+
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDIPEK---WA--RFYTAEVVLALDAIHSMGF----IHRDV 168

Query: 452 KSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS----A 506
           K  N+LLD     +L DFG   K+   G V   T  VGT  Y++PE+             
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 507 SDVYSFGVVILEVACGRRP 525
            D +S GV + E+  G  P
Sbjct: 228 CDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVK----CVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           LG+G FGRV    LA   N +   +A+K          KQ +    +E   +  + H   
Sbjct: 38  LGTGSFGRV---ILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILNYINHPFC 93

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL---LGWKQRRQILADVAEGLNYLH 439
           V + G  +  + L LV +++  G    ++  + K+    +G     QI+  + E L  L+
Sbjct: 94  VNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVL-IFEYLQSLN 151

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 +V+RD+K  N+LLD +   ++ DFG AK+        T  + GT  Y+APE+  
Sbjct: 152 ------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEILL 201

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                 A+D ++ G+ I E+  G  P 
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 343 NNNNNSTEMAV--KCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
             NNN  E+ V  K ++   +     F    S M ++ H +L  + G C +G+E ++V +
Sbjct: 37  EGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEE 96

Query: 401 YMPNGSLNNWIFGKPKKL-LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD 459
           ++ +G L+  +  +  ++ + WK    +   +A  L+YL    D+ +VH ++ + NILL 
Sbjct: 97  FVEHGPLDVCLRKEKGRVPVAWKI--TVAQQLASALSYLE---DKNLVHGNVCAKNILL- 150

Query: 460 SEMRGRLGDFGLA--KLYQQG---EVPNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFG 513
              R  L +      KL   G      +    V  + ++APE +   +S ++A+D +SFG
Sbjct: 151 --ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFG 208

Query: 514 VVILEVAC--GRRPLDMGKGEEEE 535
             +LE+ C  G  PL      E+E
Sbjct: 209 TTLLEI-CFDGEVPLKERTPSEKE 231

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.1 bits (137), Expect = 2e-08
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 49/236 (20%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-----FMAEISSMGRLQHKN 381
           +G+G FG V+   L  +           C    S +GLKE      + E++ M  L+HKN
Sbjct: 21  IGNGRFGEVF---LVKHKRTQE----FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73

Query: 382 LVQM--RGWCRKGNELMLVYDYMPNGSLNNWI------FGKPKKLLGWKQRRQILADVAE 433
           +V+   R   +   +L ++ ++   G L+  I      FGK ++       RQ+L     
Sbjct: 74  IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL----H 129

Query: 434 GLNYLHHGWD----QVVVHRDIKSGNILLDSEMR-----------------GRLGDFGLA 472
            L Y H+  D    + V+HRD+K  NI L + +R                  ++GDFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 473 KLYQQGEVPNTTRVVGTLGYLAPELA--TVSSPTSASDVYSFGVVILEVACGRRPL 526
           K    G        VGT  Y +PEL      S    SD+++ G +I E+  G+ P 
Sbjct: 190 K--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 27/224 (12%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNLV 383
           +G GG+G+V+   LA   +     +A+K +       L E    + E   +   + + LV
Sbjct: 9   VGQGGYGQVF---LAKKKDTGEI-VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV 64

Query: 384 QMRGWCRKGNELMLVYDYMPNGS----LNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
           ++    +    L L  +Y+P G     LNN        +L     R  +A++ E ++ LH
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNN------LGVLSEDHARFYMAEMFEAVDALH 118

Query: 440 H-GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
             G+    +HRD+K  N L+D+    +L DFGL+K    G V     VVG+  Y+APE+ 
Sbjct: 119 ELGY----IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW 542
                    D +S G ++ E  CG  P   G    E    L  W
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 77/240 (32%)

Query: 395 LMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRD 450
           L  V DY+P G + + +       + L      R  +A++   +  +H  G+    +HRD
Sbjct: 76  LYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIAELTCAIESVHKMGF----IHRD 126

Query: 451 IKSGNILLDSEMRGRLGDFGL---------AKLYQQG--------EVPNT---------- 483
           IK  NIL+D +   +L DFGL         +K YQ+G        E              
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 484 ----------TRV-----VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP-LD 527
                      R      VGT  Y+APE+   +  T   D +S GV++ E+  G+ P L 
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246

Query: 528 MGKGEEEEEAVLMDWVRNLY--GQGKIC-EAADARIRQEFEAEEMELVLKLGLACCHPDS 584
               E + +  +++W   L+   Q K+  EA+D             L+L+L   CC  + 
Sbjct: 247 DTPAETQLK--VINWETTLHIPSQAKLSREASD-------------LILRL---CCGAED 288

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 35/188 (18%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA G+ +L     +  +HRD+ + NILL      ++ DFGLA+ +Y+  +          
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T+ SDV+SFGV++ E+ + G  P    +  EE    L D  R    
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--- 296

Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKE 608
             +  E A   I             ++ LAC   D   RPT   +V             E
Sbjct: 297 --RAPENATPEIY------------RIMLACWQGDPKERPTFSALV-------------E 329

Query: 609 LLGDLARG 616
           +LGDL + 
Sbjct: 330 ILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 37/95 (38%), Positives = 48/95 (50%), Gaps = 1/95 (1%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
            AE L  L +     V++RD+K  NILLD +    L DFGL KL    +   T    GT 
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTP 157

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            YLAPEL      T A D ++ GV++ E+  G  P
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 26/218 (11%)

Query: 317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGR 376
             K +    ++G+G FG VY+    +     S ++A+K V  D +   +E +     M  
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDT----SEKVAIKKVLQDPQYKNRELLI----MKN 115

Query: 377 LQHKNLVQMRGW----CRKGNE----LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQ 426
           L H N++ ++ +    C K NE    L +V +++P  +++ ++  + +    L     + 
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174

Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTR 485
               +   L Y+H    + + HRD+K  N+L+D      +L DFG AK    G+   +  
Sbjct: 175 YSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVS 229

Query: 486 VVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACG 522
            + +  Y APEL   ++  T+  D++S G +I E+  G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 13/106 (12%)

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
           QIL     GL Y+H      VVHRD+K  NIL++     ++ DFGLA++    + P  T 
Sbjct: 116 QIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG 164

Query: 486 VVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
            V T  Y APE + T        D++S G +  E+  G +PL  GK
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGK 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 16/139 (11%)

Query: 395 LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           L +V +YMP G L N +  +  P+K   W   +   A+V   L+ +H      ++HRD+K
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEK---WA--KFYTAEVVLALDAIH---SMGLIHRDVK 169

Query: 453 SGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS----AS 507
             N+LLD     +L DFG   K+ + G V   T  VGT  Y++PE+              
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 508 DVYSFGVVILEVACGRRPL 526
           D +S GV + E+  G  P 
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 45/140 (32%), Positives = 63/140 (45%), Gaps = 11/140 (7%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           N L LV DY   G L   +  K +  L     R  +A++   ++ +H       VHRDIK
Sbjct: 74  NYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIK 129

Query: 453 SGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS---- 507
             N+LLD     RL DFG   K+ Q G V ++   VGT  Y++PE+              
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 508 -DVYSFGVVILEVACGRRPL 526
            D +S GV + E+  G  P 
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNLV 383
           E +G G +G+VYK   A + N        K      ++G+    + EIS +  L     +
Sbjct: 7   EKIGEGTYGKVYK---ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 384 QMRGWCRKGNE-------LMLVYDYMPNGSLNNWI---FGKPKKLLGWKQRRQILADVAE 433
            +R    +  E       L LV++Y+ +  L  ++      P + L  K  +  +  + +
Sbjct: 64  -VRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 434 GLNYLH-HGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVP--NTTRVVGT 489
           G+ + H HG    V+HRD+K  N+L+D +    ++ D GL + +    +P  + T  + T
Sbjct: 122 GVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS---IPVKSYTHEIVT 174

Query: 490 LGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           L Y APE+   S+  S   D++S G +  E++  ++PL  G  E ++
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 24/170 (14%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+ +Y+  +          
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-- 295

Query: 549 QGKICEAADARIRQ-EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                     R+R  ++   EM   +   L C H + ++RPT  E+V  L
Sbjct: 296 ------KEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 11/140 (7%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           N L LV DY   G L   +  K +  L     R  LA++   ++ +H       VHRDIK
Sbjct: 74  NNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIK 129

Query: 453 SGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS---- 507
             NIL+D     RL DFG   KL + G V ++   VGT  Y++PE+              
Sbjct: 130 PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDGKGKYGPE 188

Query: 508 -DVYSFGVVILEVACGRRPL 526
            D +S GV + E+  G  P 
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 18/151 (11%)

Query: 330 GGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMR 386
           G FG+VY G       NNS   AVK V      +K  + +  AE  ++   +   +V + 
Sbjct: 15  GAFGKVYLG----RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 387 GWCRKGNELMLVYDYMPNGSLNNW--IFGKPKKLLGWKQRRQILADVAEGLNYLH-HGWD 443
              +  N + LV +Y+  G + +   I+G        +   + +++VA  L+YLH HG  
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG-- 124

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
             ++HRD+K  N+L+ +E   +L DFGL+K+
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 15/140 (10%)

Query: 397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
           L+ DY+ +G L + +  K +  L   + ++I+  + E LN LH      ++H DIK  N+
Sbjct: 86  LIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENV 140

Query: 457 LLDSEM-RGRLGDFGLAKLYQQGEVPNTTRVV-GTLGYLAPELATVSSPTSAS-DVYSFG 513
           L D    R  L D+GL K      +  T     GTL Y +PE          S D ++ G
Sbjct: 141 LYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVG 193

Query: 514 VVILEVACGRRPLDMGKGEE 533
           V+  E+  G+ P    + EE
Sbjct: 194 VLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 7e-07
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 16/139 (11%)

Query: 395 LMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           L +V +YMP G L N +  +  P+K   W   R   A+V   L+ +H       +HRD+K
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEK---WA--RFYTAEVVLALDAIH---SMGFIHRDVK 169

Query: 453 SGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS----AS 507
             N+LLD     +L DFG   K+ ++G V   T  VGT  Y++PE+              
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 508 DVYSFGVVILEVACGRRPL 526
           D +S GV + E+  G  P 
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 38/228 (16%)

Query: 324 DELLGSGGFGRVYKGTLANNNN-NNSTEMAVKCVNHD---SKQGLKEFMAEISSMG---- 375
           D+L+G GGFG VY+   A+++  NN     ++ + ++    +  +   + +I  +     
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 376 --RLQHKNLVQMRG-----WCRKGNELMLVYD-YMPNGSLNNWIFGKPKKLLGWKQRRQI 427
              + H  + +  G      CR     +L+         +   I  K KKL+     + I
Sbjct: 77  IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI-----KNI 131

Query: 428 LADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--------QQG 478
           + D+   L Y+H HG    + H DIK  NI++D   RG + D+G+A  +           
Sbjct: 132 MKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           E  +  R  GTL Y   +    +  T   D+ S G  +L+ A     L
Sbjct: 188 EQKDLHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA--GIKL 231

Length = 294

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 10/98 (10%)

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPN 482
           RQ+L+ +    +Y+H    + ++HRDIK+ N+L++      LGDFG A  + +G    P 
Sbjct: 267 RQLLSAI----DYIHG---EGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPF 318

Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
              + GT+   APE+      T + D++S G+VI E A
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 41/128 (32%), Positives = 59/128 (46%), Gaps = 24/128 (18%)

Query: 425 RQILADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK---------L 474
           R   A+    L YLH +G    +VHRD+K  N+L+ S    +L DFGL+K         L
Sbjct: 104 RMYFAETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159

Query: 475 YQQGEVPNTTR------VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDM 528
           Y +G +   TR      V GT  Y+APE+          D ++ G+++ E   G  P   
Sbjct: 160 Y-EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-- 216

Query: 529 GKGEEEEE 536
             G+  EE
Sbjct: 217 -FGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 28/198 (14%)

Query: 349 TEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGS 406
           T + V+  + +  +++ LK    E+      +H N++        G+ L ++  +M  GS
Sbjct: 26  TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85

Query: 407 LNNWIF-----GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE 461
            N+ +      G  + L+G      IL     GLNYLH       +HR+IK+ +IL+  +
Sbjct: 86  ANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137

Query: 462 MRGRLGDFGLAKLYQQGEVPNTTRVV--------GTLGYLAPEL--ATVSSPTSASDVYS 511
             G +   GL+ LY         +VV          L +L+PEL    +      SD+YS
Sbjct: 138 --GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195

Query: 512 FGVVILEVACGRRPL-DM 528
            G+   E+A GR P  DM
Sbjct: 196 VGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 31/229 (13%)

Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVK--CVNHDSKQ 362
           F  EE++K      + +++ + +GSG +G V        +     ++A+K       S+ 
Sbjct: 1   FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAI----DKRTGEKVAIKKLSRPFQSEI 56

Query: 363 GLKEFMAEISSMGRLQHKNLVQMRGW---CRKGNELMLVYDYMPNGSLNNWIFGKPKKLL 419
             K    E++ +  +QH+N++ +         G+E    Y  MP      ++    +K++
Sbjct: 57  FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIM 110

Query: 420 GWK---QRRQILA-DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
           G      + Q L   +  GL Y+H      ++HRD+K GN+ ++ +   ++ DFGLA+  
Sbjct: 111 GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-- 165

Query: 476 QQGEVPNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGR 523
              +   T  VV T  Y APE +          D++S G ++ E+  G+
Sbjct: 166 -HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 71/240 (29%)

Query: 393 NELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHR 449
           + L  V DY+P G + + +      P+ L      R  +A++   +  +H       +HR
Sbjct: 74  DNLYFVMDYIPGGDMMSLLIRMEVFPEVL-----ARFYIAELTLAIESVH---KMGFIHR 125

Query: 450 DIKSGNILLDSEMRGRLGDFGL---------AKLYQQG---------------EVPN--- 482
           DIK  NIL+D +   +L DFGL         +K YQ+G               +V N   
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 483 -------------------TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR 523
                                 +VGT  Y+APE+      T   D +S GV++ E+  G+
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Query: 524 RPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPD 583
            P  +     E +  +++W   L+   ++          +   E ++L+ KL   CC  +
Sbjct: 246 PPF-LAPTPTETQLKVINWENTLHIPPQV----------KLSPEAVDLITKL---CCSAE 291

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 68/296 (22%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRL 377
           F   + LG G FG V    LA   +  +   A+K +       +  +    AE   +   
Sbjct: 3   FVKIKTLGIGAFGEV---CLARKVDTKAL-YAMKTLRKKDVLLRNQVAHVKAERDILAEA 58

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEG 434
            ++ +V++    +  + L  V DY+P G + + +      P+ L      R  +A++   
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL-----ARFYIAELTCA 113

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL---------AKLYQQG------- 478
           +  +H       +HRDIK  NIL+D +   +L DFGL         +K YQ G       
Sbjct: 114 VESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170

Query: 479 -------EVPNTTR-----------------------VVGTLGYLAPELATVSSPTSASD 508
                    P   R                       +VGT  Y+APE+   +  T   D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230

Query: 509 VYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY--GQGKIC-EAADARIR 561
            +S GV++ E+  G+ P  + +   E +  +++W  +L+   Q K+  EA+D  I+
Sbjct: 231 WWSVGVILYEMLVGQPPF-LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK 285

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 64/249 (25%), Positives = 97/249 (38%), Gaps = 64/249 (25%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGL--KEFMAEISSMGRLQHKNL 382
           L+G GG G VY       +   S  +A+K +  D S+  L  K F+ E      L H  +
Sbjct: 9   LIGKGGMGEVYLA----YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP-KKLLG--WKQRR-------------- 425
           V +   C  G+    VY  MP      +I G   K LL   W++                
Sbjct: 65  VPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 426 -QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG-----DFGLAKLYQQGE 479
             I   +   + Y+H    + V+HRD+K  NILL     G  G     D+G A   +  E
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEE 167

Query: 480 ---------VPNTT--------RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACG 522
                      N          ++VGT  Y+APE       + ++D+Y+ GV++ ++   
Sbjct: 168 EDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227

Query: 523 RRPLDMGKG 531
             P    KG
Sbjct: 228 SFPYRRKKG 236

Length = 932

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 12/99 (12%)

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
           QIL     GL Y+H      ++HRD+K  NI ++ +   ++ DFGLA+     +   T  
Sbjct: 126 QIL----RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGY 175

Query: 486 VVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGR 523
           V  T  Y APE +          D++S G ++ E+  G+
Sbjct: 176 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 3/96 (3%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
           V   + YLH   +  ++HRDIK+ NI ++      LGDFG A               GT+
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
              APEL        A D++S G+V+ E+A     L
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 18/162 (11%)

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V  R      NEL +V  +M  GS  + I       +       IL  V + L+Y+
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117

Query: 439 HH-GWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKLYQQGEV----PNTTRVVGT 489
           HH G+    VHR +K+ +IL+  +    + G   +  +    Q+  V    P  +  V  
Sbjct: 118 HHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS--VKV 171

Query: 490 LGYLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPL-DM 528
           L +L+PE+    +    + SD+YS G+   E+A G  P  DM
Sbjct: 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 46/140 (32%), Positives = 63/140 (45%), Gaps = 13/140 (9%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRDI 451
           N L LV DY   G L   +  K +  L     R  LA++   ++ +H  G+    VHRDI
Sbjct: 74  NNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY----VHRDI 128

Query: 452 KSGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS--- 507
           K  N+LLD     RL DFG   +L   G V +    VGT  Y++PE+             
Sbjct: 129 KPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGTPDYISPEILQAMEDGKGRYGP 187

Query: 508 --DVYSFGVVILEVACGRRP 525
             D +S GV + E+  G  P
Sbjct: 188 ECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA G+ +L     +  +HRD+ + NILL      ++ DFGLA+ +Y+  +          
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T+ SDV+SFGV++ E+ + G  P    + +EE       + R L  
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FCRRLKE 291

Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             ++          E+   E+  ++   L C H +   RPT  E+V +L
Sbjct: 292 GTRMRAP-------EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 42/187 (22%)

Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRDIKS 453
           L L+ +++P G +   +    K  L  ++ +  +A+    ++ +H  G+    +HRDIK 
Sbjct: 76  LYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLGF----IHRDIKP 129

Query: 454 GNILLDSEMRGRLGDFGL----------------------------------AKLYQQGE 479
            N+LLDS+   +L DFGL                                  A+ +++  
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
                  VGT  Y+APE+   +      D +S GV++ E+  G  P    +  +E    +
Sbjct: 190 RQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF-CSETPQETYKKV 248

Query: 540 MDWVRNL 546
           M+W   L
Sbjct: 249 MNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 10/110 (9%)

Query: 422 KQRRQILA-DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
           + R Q L   + +GL Y+H      ++HRD+K GN+ ++ +   ++ DFGLA+   Q + 
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDS 170

Query: 481 PNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
             T  VV T  Y APE +      T   D++S G ++ E+  G +PL  G
Sbjct: 171 EMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKG 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 3/97 (3%)

Query: 327 LGSGGFGRVYKGT-LANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T       +N   +AVK +   +    +E  M+E+  +  L QHKN+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG 420
            + G C  G  ++++ +Y   G L N++  K +  L 
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 3/88 (3%)

Query: 327 LGSGGFGRVYKGTLANNNNNNST-EMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LGSG FGRV + T    +++ ST ++AVK +   ++   K+  M+E+  M  L  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI 411
            + G C KG  + ++ +Y   G L +++
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 42/187 (22%)

Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH-GWDQVVVHRDIKS 453
           L L+ +++P G +   +    K  L  +  +  +A+    ++ +H  G+    +HRDIK 
Sbjct: 76  LYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLGF----IHRDIKP 129

Query: 454 GNILLDSEMRGRLGDFGL----------------------------------AKLYQQGE 479
            N+LLD++   +L DFGL                                  A+ +++  
Sbjct: 130 DNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNR 189

Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
                  VGT  Y+APE+   +      D +S GV++ E+  G  P    +  +E    +
Sbjct: 190 RQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF-CSETPQETYRKV 248

Query: 540 MDWVRNL 546
           M+W   L
Sbjct: 249 MNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 41/173 (23%), Positives = 57/173 (32%), Gaps = 49/173 (28%)

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLA-------------KLYQQGEVPNTTR-------- 485
           +HRDIK  NIL+D     +L DFGL+             KL Q     N           
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 486 -------------------------VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
                                     VGT  Y+APE+          D +S G ++ E  
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR--IRQEFEAEEMEL 571
            G  P    +   E    +++W   LY    I  + +A   IR+     E  L
Sbjct: 243 IGWPPF-CSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRL 294

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 32/170 (18%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV--G 488
           VA+G+++L     +  +HRD+ + N+LL      ++ DFGLA+     ++ N +  V  G
Sbjct: 221 VAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 489 T----LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWV 543
                + ++APE       T  SDV+S+G+++ E+ + G+ P            +L++  
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY---------PGILVN-- 321

Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
              Y   K+ +      R +F   E+  ++K    C + + T RPT  ++
Sbjct: 322 SKFY---KMVKRGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 11/144 (7%)

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V +  +    + + LV  +   G L  W        +  +  ++  A++   L+ LH 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDALH- 102

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELAT 499
              + +V RD+   NILLD     +L  F      +  EV  +         Y APE+  
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGG 155

Query: 500 VSSPTSASDVYSFGVVILEVACGR 523
           +S  T A D +S G ++ E+  G+
Sbjct: 156 ISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 12/132 (9%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           NE+ LV + M    LNN +  K +KL   +  + ++  +  GL Y+H      ++HRD+K
Sbjct: 93  NEVYLVTNLM-GADLNNIV--KCQKLSD-EHVQFLIYQLLRGLKYIHSAG---IIHRDLK 145

Query: 453 SGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYS 511
             N+ ++ +   R+ DFGLA+  Q  +    T  V T  Y APE+           D++S
Sbjct: 146 PSNVAVNEDCELRILDFGLAR--QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201

Query: 512 FGVVILEVACGR 523
            G ++ E+  G+
Sbjct: 202 VGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 25/171 (14%)

Query: 353 VKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF 412
           +KCVNH +  GL        S+   Q   +V          ELM       + +L   I 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM---------ELM-------DANLCQVI- 119

Query: 413 GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
              +  L  ++   +L  +  G+ +LH      ++HRD+K  NI++ S+   ++ DFGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR 523
           +    G     T  V T  Y APE+          D++S G ++ E+  G 
Sbjct: 174 R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 28/228 (12%)

Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A  +      +AVK ++   +  +
Sbjct: 3   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 58

Query: 365 --KEFMAEISSMGRLQHKNLVQM------RGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 59  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 115

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 116 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 170

Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 171 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 41/171 (23%), Positives = 69/171 (40%), Gaps = 44/171 (25%)

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HGWDQVVVHRDI 451
           N L L+ +Y+P G +   +    K     ++ R  +A+    ++ +H  G+    +HRDI
Sbjct: 74  NYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLGY----IHRDI 127

Query: 452 KSGNILLDSEMRGRLGDFGLAK---------LYQ--QGEVPNTTR--------------- 485
           K  N+LLD++   +L DFGL            Y+     +P+                  
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187

Query: 486 -----------VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                       VGT  Y+APE+   +      D +S GV++ E+  G  P
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 54/249 (21%), Positives = 87/249 (34%), Gaps = 70/249 (28%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQHKNLVQM 385
           LG G FG VYK +L N  +    +  +K           E+   EI    R++       
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLK--------KATEYGAVEIWMNERVRRA----C 187

Query: 386 RGWC-------------RKGNELMLVYDYMPNGSLNN-------------WIFGKPKKLL 419
              C             +K +E  LV+ Y    +L +             ++ GK + L 
Sbjct: 188 PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 420 GWKQR-----RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAK 473
              +R     + I+  +   L+ LH      +VHRD+K  NI+        ++ D G A 
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304

Query: 474 ------LYQQGEVPNTTRVVGTLGYL---------APELATVSSPT-------SASDVYS 511
                  Y   E     R      Y+         +  +AT  SP           D+YS
Sbjct: 305 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364

Query: 512 FGVVILEVA 520
            G++ L++A
Sbjct: 365 AGLIFLQMA 373

Length = 566

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 4/100 (4%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTE-MAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V + +      + S   +AVK +   +     K  M E+  +  +  H N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 384 QMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWK 422
            + G C + G  LM++ +Y   G+L+N++  K +    ++
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR 114

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA G+ +L     +  VHRD+ + N+L+      ++ DFGLA+ + +     +       
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV 519
           L ++APE    +  T+ SDV+SFG+++ E+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK--LYQQGEVPNTTRVVG 488
           VA G+ +L     +  VHRD+ + N+LL      ++ DFGLA+  ++    V   +  + 
Sbjct: 246 VARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL- 301

Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + ++APE    +  T+ SDV+S+G+++ E+
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNST-EMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNL 382
           +LGSG FG+V +GT    + +    ++AVK +   ++   K+  M+E+  M  L  H N+
Sbjct: 44  ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI 411
           V + G C K   + ++ +Y   G L N++
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.5 bits (94), Expect = 0.002
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 5/86 (5%)

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ +LH      ++HRD+K  NI++ S+   ++ DFGLA+    G     T  V T  Y 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185

Query: 494 APELATVSSPTSASDVYSFGVVILEV 519
           APE+          D++S G ++ E+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVV 487
           VA+G+++L     +  +HRD+ + NILL      ++ DFGLA+  +      V    R+ 
Sbjct: 223 VAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL- 278

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             + ++APE       T  SDV+S+G+++ E+ + G  P      + +   ++ +  R L
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337

Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
                           E    EM  ++K   +C   D  +RPT +++V ++  Q
Sbjct: 338 --------------SPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQ 374

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 29/113 (25%), Positives = 56/113 (49%), Gaps = 9/113 (7%)

Query: 321 FSNDEL-----LGSGGFGRVYKGTLANNNNNNSTE-MAVKCVNHDSKQG-LKEFMAEISS 373
           F  D L     LG G FG+V + +    +  +S   +AVK +   +     K  M+E+  
Sbjct: 4   FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI 63

Query: 374 MGRL-QHKNLVQMRGWCRKGN-ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR 424
           +  +  H N+V + G C K N  LM++ ++   G+L+N++  K +    ++++
Sbjct: 64  LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ +LH      ++HRD+K  NI++ S+   ++ DFGLA+      +   T  V T  Y 
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYR 189

Query: 494 APELATVSSPTSASDVYSFGVVILEVACG 522
           APE+          D++S G ++ E+  G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ +LH      ++HRD+K  NI++ S+   ++ DFGLA+    G     T  V T  Y 
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGR 523
           APE+          D++S G ++ E+  G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	636
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.03
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	98.81
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.74
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
KOG3839	351	consensus Lectin VIP36, involved in the transport	98.52
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
PRK09902	216	hypothetical protein; Provisional	98.49
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.48
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.16
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.14
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.0
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	97.99
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.98
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.91
PLN02876	822	acyl-CoA dehydrogenase	97.83
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.79
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.67
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	97.67
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.59
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.5
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.42
PRK10593	297	hypothetical protein; Provisional	97.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.33
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.22
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.21
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.1
PLN02236	344	choline kinase	97.06
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.05
PRK05231	319	homoserine kinase; Provisional	96.99
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.99
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.7
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.44
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.26
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.01
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.98
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.89
PLN02756	418	S-methyl-5-thioribose kinase	95.66
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.59
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.42
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.09
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.04

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-56  Score=467.63  Aligned_cols=288  Identities=46%  Similarity=0.809  Sum_probs=254.1

Q ss_pred             CCcccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceee
Q 006668          305 WPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       305 ~~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      ..+.|+|+++..||++|+..++||+|+||.||+|.+.++     ..||||++.....+..++|.+|+.++.+++|||||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-----~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-----TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-----CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCccc
Confidence            467899999999999999999999999999999999774     789999887664431466999999999999999999


Q ss_pred             eeccccccc-eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc
Q 006668          385 MRGWCRKGN-ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       385 l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~  463 (636)
                      |+|||.+.+ +.+||||||++|+|.++|+......|+|.+|++|+.++|+||+|||+.+.+.|+||||||+|||||++++
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            999999998 5999999999999999998754438999999999999999999999988889999999999999999999


Q ss_pred             EEEeccCCcccccC-CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQ-GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       464 ~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +||+|||+|+.... ....... ..||.+|+|||++..+..+.|+|||||||+|+||++|++|.+...  ......+.+|
T Consensus       216 aKlsDFGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w  292 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEW  292 (361)
T ss_pred             EEccCccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHH
Confidence            99999999976554 2221111 179999999999999999999999999999999999999987553  1223338999


Q ss_pred             HHHHhcCCcchhhhhhhhh-hccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIR-QEFEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ++.....+++.+.+|+++. .++.. ++...+..++.+|++++|.+||+|.||+++|+..
T Consensus       293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            9999999999999999998 66665 7889999999999999999999999999999554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-47  Score=397.74  Aligned_cols=250  Identities=36%  Similarity=0.549  Sum_probs=212.3

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccc-eEEEEEe
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-ELMLVYD  400 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~E  400 (636)
                      .+.||+|+||+||+|.++..     ..||||++.....  ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~-----~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGT-----DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhcccCCceeEEEEEeCCc-----eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            45599999999999999874     3499999986532  22679999999999999999999999999887 7999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc-EEeCCCCCCCEEEcCCC-cEEEeccCCcccccCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV-VVHRDIKSGNILLDSEM-RGRLGDFGLAKLYQQG  478 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~  478 (636)
                      ||++|+|.+++++..+..+++..+++++.|||.||.|||   +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999997766788999999999999999999999   677 99999999999999997 9999999999876543


Q ss_pred             CCccccccccCCccccccccc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELAT--VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      . ...+...||+.|||||++.  ...++.|+|||||||++|||+||+.||......     ....            ..+
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-----~~~~------------~v~  259 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-----QVAS------------AVV  259 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-----HHHH------------HHH
Confidence            2 2333468999999999999  569999999999999999999999999866321     1111            112


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ....+..++..+...+..|+.+||+.||..||++.+++..|+.
T Consensus       260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            2334455566688889999999999999999999999999974

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=391.21  Aligned_cols=250  Identities=32%  Similarity=0.503  Sum_probs=219.1

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      .+.||+|.||.||+|.+...     ..||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++.++||||||+
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~-----~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGS-----TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHhcCCccceEEEEEEcCC-----CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            57799999999999999775     579999997652 334778899999999999999999999999889999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      .|+|.+||.......+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||||+...++.....
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999999997766788999999999999999999999   89999999999999999999999999999996666555444


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhh
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ  562 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  562 (636)
                      ....-+..|.|||++..++++.|||||||||+||||+| |+.|+......                  ...+.++...+.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------------------ev~~~le~GyRl  423 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------------------EVLELLERGYRL  423 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------------------HHHHHHhccCcC
Confidence            44455779999999999999999999999999999998 88888655221                  233455666677


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          563 EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       563 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..+..|+..+.+|+..||+.+|++|||++.+...|+.-
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            77888999999999999999999999999999888764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-46  Score=370.72  Aligned_cols=261  Identities=25%  Similarity=0.343  Sum_probs=215.7

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeec
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ++..+|+.       .+.||+|..|+|||++++.++    +.+|+|.+... .....+++.+|++++++.+||+||+++|
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~yg  144 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTG----KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYG  144 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence            44555544       578999999999999998877    89999999655 3445678999999999999999999999


Q ss_pred             cccccc-eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          388 WCRKGN-ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       388 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      .|...+ +..++||||++|||++++.  ..+.+++...-+|+.+|++||.|||+  +++||||||||+|||++..|++||
T Consensus       145 aF~~~~~~isI~mEYMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKi  220 (364)
T KOG0581|consen  145 AFYSNGEEISICMEYMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKI  220 (364)
T ss_pred             EEEeCCceEEeehhhcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEe
Confidence            999988 5999999999999999984  33679999999999999999999995  499999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +|||.+..+-..   .....+||..|||||.+.+..|+.++||||||+.++|++.|+.|+.........-..+..+    
T Consensus       221 cDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----  293 (364)
T KOG0581|consen  221 CDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----  293 (364)
T ss_pred             ccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH----
Confidence            999999877654   3455789999999999999999999999999999999999999997642221222222222    


Q ss_pred             hcCCcchhhhhhhhhhccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                               +-..-....+. ....++..++..||++||.+||+++|++++-.-.
T Consensus       294 ---------Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  294 ---------IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             ---------HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence                     11111222232 3567789999999999999999999999875443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-45  Score=384.35  Aligned_cols=250  Identities=28%  Similarity=0.478  Sum_probs=212.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      +.|...++||+|||+.||+++....+    +.||+|++.+.   .....+...+||++.++|+|||||+++++|++.+..
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tg----e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV   93 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTG----EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV   93 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCC----cEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence            56888999999999999999986666    89999999874   334457788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |||.|+|++++|.+++  ++.+.+++.+++.++.||+.||.|||   +.+|+|||||..|+||+++.++||+|||||..+
T Consensus        94 YivLELC~~~sL~el~--Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELL--KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEEEEecCCccHHHHH--HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeee
Confidence            9999999999999998  36789999999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..+.....+ .|||+.|+|||++....++..+||||+||+||-|+.|++||+...-.+....+.               .
T Consensus       169 e~~~Erk~T-lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik---------------~  232 (592)
T KOG0575|consen  169 EYDGERKKT-LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK---------------L  232 (592)
T ss_pred             cCcccccce-ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH---------------h
Confidence            766544444 799999999999999999999999999999999999999998653332222111               0


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .+-.+    +........+|+.++|++||.+|||+.+|+..=
T Consensus       233 ~~Y~~----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  233 NEYSM----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             cCccc----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            11111    222334456677778999999999999999763

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-46  Score=396.93  Aligned_cols=272  Identities=29%  Similarity=0.507  Sum_probs=235.4

Q ss_pred             CcccCHHHHHHHhCCC---------CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhc
Q 006668          306 PHRFSYEELSKATKGF---------SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMG  375 (636)
Q Consensus       306 ~~~~~~~~l~~a~~~f---------~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~  375 (636)
                      -..++||+-..|-+.|         .+.++||.|.||+||+|+++-.+ +....||||.++.. +.+...+|+.|..+|.
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg-kre~~VAIKTLK~GytekqrrdFL~EAsIMG  685 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG-KREITVAIKTLKAGYTEKQRRDFLSEASIMG  685 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCC-CcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence            3457777765555443         46789999999999999998743 55678999999876 4556789999999999


Q ss_pred             cCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCC
Q 006668          376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGN  455 (636)
Q Consensus       376 ~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  455 (636)
                      ++.||||++|.|+.......+||.|||+||+|+.||+.+ .+.+++.++..++.+||.||+||.   +.++|||||.++|
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARN  761 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARN  761 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhh
Confidence            999999999999999999999999999999999999765 466999999999999999999999   8999999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccCCCCcccccccc--CCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCh
Q 006668          456 ILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGE  532 (636)
Q Consensus       456 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~  532 (636)
                      ||++.+..+|++||||+|.+.++.....+...|  ..+|.|||.+...+++.+||||||||+|||+++ |.+||..+...
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ  841 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ  841 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence            999999999999999999887665333333333  579999999999999999999999999999776 99998755322


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                                        +.+++++...+...+.+++..|.+|+++||++|..+||.+.+|+.+|.+-
T Consensus       842 ------------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  842 ------------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ------------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                              34456777778888899999999999999999999999999999999775

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=1.9e-44  Score=358.90  Aligned_cols=193  Identities=39%  Similarity=0.596  Sum_probs=169.8

Q ss_pred             eeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC--CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           26 LDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN--QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        26 ~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~--~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ++|+|++|...  ..+|+|+|+|.+..++.++||++.  ..++|||+|++||+||   +..++.++||+|+|+|.|.+.+
T Consensus         1 ~~f~f~~f~~~--~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~---~~~~~~~~sFst~F~F~i~~~~   75 (236)
T cd06899           1 LSFNFNGFSSD--QSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLW---DSTTGKVASFSTSFSFSITPPN   75 (236)
T ss_pred             CceecCCCCCC--CCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEee---cCCCCCceeEEEEEEEEEEcCC
Confidence            47999999752  479999999999767889999988  7899999999999999   6667789999999999999876


Q ss_pred             CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCC-CCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCcc
Q 006668          104 ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY  182 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~-~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~  182 (636)
                      ...+||||||+|+|....+++..|++|||++.++.+ ..+++|||||||++|.+++||++||||||||++.|..+..+..
T Consensus        76 ~~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~  155 (236)
T cd06899          76 PSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD  155 (236)
T ss_pred             CCCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc
Confidence            667899999999998765556789999999887665 6889999999999999999999999999999998887765432


Q ss_pred             ccCCCCCcceeeeecCCCeeEEEEEec---------------------------------------ccccCCCceeccee
Q 006668          183 YSSSRNESFVPVRMRNGQNIHAWIDFD---------------------------------------GFSASKTNWIEARR  223 (636)
Q Consensus       183 ~~~~~~~~~~~~~~~~g~~~~~~i~y~---------------------------------------gfsastg~~~~~~~  223 (636)
                               ..+.+.+|+.++|||+|+                                       ||||+||...|.|+
T Consensus       156 ---------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~  226 (236)
T cd06899         156 ---------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHY  226 (236)
T ss_pred             ---------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEE
Confidence                     133478999999999998                                       99999999999999


Q ss_pred             eeeccccCC
Q 006668          224 VLAWSLSDT  232 (636)
Q Consensus       224 il~wsf~~~  232 (636)
                      |++|+|+++
T Consensus       227 i~sWsF~s~  235 (236)
T cd06899         227 ILSWSFSSN  235 (236)
T ss_pred             EEEEEEEcC
Confidence            999999975

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=364.52  Aligned_cols=201  Identities=28%  Similarity=0.557  Sum_probs=182.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .+|...+.||+|.|++||+|+++..+    ..||||++.+.  .++..+.+..|+.+|+.++|||||++++++..++.++
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSG----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCC----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence            46777888999999999999998876    89999999877  5666777899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC------CcEEEeccC
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE------MRGRLGDFG  470 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~------~~~kl~DFG  470 (636)
                      ||||||.+|+|.+||+  ..+.+++...+.++.|||.||++||   +++||||||||+||||+..      -.+||+|||
T Consensus        86 lVMEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999995  4458999999999999999999999   8999999999999999765      568999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      +|+.+..+..  ....+|++-|||||++...+|+.|+|+||+|+|+|++++|+.||+...
T Consensus       161 fAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  161 FARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9998876543  334799999999999999999999999999999999999999998553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-45  Score=349.74  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=208.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecc-ccccce-EE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGW-CRKGNE-LM  396 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~-~~~~~~-~~  396 (636)
                      |.+.++||+|.||+|||++...++    ..+|.|.++-.  ..+..+.+.+|+.+|++|+|||||+++++ +.++.+ ++
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDG----KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCc----chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            556788999999999999987766    88999998744  45567789999999999999999999994 555555 89


Q ss_pred             EEEeecCCCChhhhHh--cCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ||||||..|+|...+.  ++.++.+++..+++++.|++.||.++|+.+. .-|+||||||.||+|+.+|.+||+||||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999983  4567789999999999999999999995332 239999999999999999999999999999


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .+..... -....+||+.||+||.+.+..|+.||||||+||++|||+.-+.||...+        +.+ +.....+|.. 
T Consensus       177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~-L~~KI~qgd~-  245 (375)
T KOG0591|consen  177 FLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLS-LCKKIEQGDY-  245 (375)
T ss_pred             HhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHH-HHHHHHcCCC-
Confidence            8876442 3445789999999999999999999999999999999999999997541        111 1111222211 


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          +.++   +.--.+.+.+|+..|+..||+.||+...+++.+..
T Consensus       246 ----~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 ----PPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----CCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                1111   13445678888999999999999996666655544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-44  Score=391.87  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=219.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +....+.||+|.||+||+|+...-. ......||||.++..... ..++|++|++++..++|||||+|+|.|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3445678999999999999976542 355688999999987555 78899999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCC------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEE
Q 006668          398 VYDYMPNGSLNNWIFGKP------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR  465 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  465 (636)
                      |+|||..|+|.+||....            ...|+..+.+.|+.|||.||.||.   ++.+|||||..+|+||.++..+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999995321            234889999999999999999999   89999999999999999999999


Q ss_pred             EeccCCcccccCCCCcccc-ccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHH
Q 006668          466 LGDFGLAKLYQQGEVPNTT-RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       466 l~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      |+||||++..-..+++... ...-.++|||||.+..+++|.+||||||||+||||++ |+.||.....++         |
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---------V  714 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---------V  714 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------H
Confidence            9999999865444443332 3455789999999999999999999999999999998 999997653322         1


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+....|++         .+.++.++..+..|+..||+.+|.+||+++||-..|+.-
T Consensus       715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            122222222         456778899999999999999999999999999999764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-44  Score=358.35  Aligned_cols=259  Identities=25%  Similarity=0.376  Sum_probs=209.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-------HHHHHHHHHHHhccCCCCceeeeecccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-------GLKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      .+.|.+.+.||+|+||.|-+|..+.++    +.||||++++....       ......+|+++|++|+|||||++.+++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tg----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTG----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccC----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            345677899999999999999977766    89999999864211       1234569999999999999999999999


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC---CcEEEe
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE---MRGRLG  467 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~  467 (636)
                      ..+..|+|||||.||+|.+++..  .+.+.+..-..+++|++.|+.|||   ++||+||||||+||||..+   ..+||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence            99999999999999999999854  456777888999999999999999   8999999999999999765   789999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCC---CCccchHHHHHHHHHHHhCCCCCCCCCChh-hHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKGEE-EEEAVLMDWV  543 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~-~~~~~l~~~v  543 (636)
                      |||+|+......  -+...|||+.|.|||++.+...   ..+.|+||+||+||-+++|.+||....... ..++++.   
T Consensus       322 DFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---  396 (475)
T KOG0615|consen  322 DFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---  396 (475)
T ss_pred             ccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc---
Confidence            999999877544  3445799999999999987653   347799999999999999999997654332 2222221   


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcc
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEV  602 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  602 (636)
                            |+...      ....-.+..++.+.|+.+||..||++|||+.|++++-+-.++
T Consensus       397 ------G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  397 ------GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ------Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                  11110      112223456778899999999999999999999998877643

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=6.1e-43  Score=349.20  Aligned_cols=194  Identities=38%  Similarity=0.633  Sum_probs=168.8

Q ss_pred             ceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC-CceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecC-
Q 006668           25 ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPE-  102 (636)
Q Consensus        25 ~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~-~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~-  102 (636)
                      +++|+|++|..   ..+++++|+|.+..++.|+||+... +++|||+|++||+||   +..++.++||+|+|+|.|... 
T Consensus         1 ~~~F~~~~F~~---~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~---d~~~~~~~sF~t~F~f~i~~~~   74 (236)
T PF00139_consen    1 SVSFSFPSFSN---SSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLW---DSTTGNVASFSTSFSFSITNGP   74 (236)
T ss_dssp             EEEEEESSBTT---GTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESB---ETTTTEBEEEEEEEEEEEEESS
T ss_pred             CceEEcCCCCC---CCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEe---CCCCcceeeeeeEEEEEEeccC
Confidence            36899999932   4899999999996689999999887 899999999999999   666777999999999999643 


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCC-CCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccC
Q 006668          103 -IASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPA  180 (636)
Q Consensus       103 -~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~-~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~  180 (636)
                       ....+||||||+|+|....+.++.|++||+++..+++ ..++.|||||||++|.+++||+.||||||+|++.+..+.++
T Consensus        75 ~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~  154 (236)
T PF00139_consen   75 GSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASA  154 (236)
T ss_dssp             SSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-
T ss_pred             CCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccc
Confidence             4566899999999999866777789999999987766 57889999999999999999999999999999999998877


Q ss_pred             ccccCCCCCcceeeeecCCCeeEEEEEec--------------------------------------ccccCCCceecce
Q 006668          181 GYYSSSRNESFVPVRMRNGQNIHAWIDFD--------------------------------------GFSASKTNWIEAR  222 (636)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~g~~~~~~i~y~--------------------------------------gfsastg~~~~~~  222 (636)
                      +++      ......+.+|+.++|||+||                                      |||||||...|.|
T Consensus       155 ~~~------~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h  228 (236)
T PF00139_consen  155 GYY------SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTH  228 (236)
T ss_dssp             ---------EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEE
T ss_pred             ccc------ccccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceE
Confidence            665      23567789999999999999                                      9999999999999


Q ss_pred             eeeecccc
Q 006668          223 RVLAWSLS  230 (636)
Q Consensus       223 ~il~wsf~  230 (636)
                      .|++|+|+
T Consensus       229 ~I~sW~F~  236 (236)
T PF00139_consen  229 DILSWSFS  236 (236)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEEEeC
Confidence            99999995

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=349.45  Aligned_cols=243  Identities=25%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .+.|+..++||+|+||+||.++.++.+    +.+|+|++++.   .+...+...+|..+|.+++||.||+++..|.+.+.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTG----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccC----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            456899999999999999999988665    89999999865   34456788899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +|||+||+.||.|..+|  ++++.+++..++-++.+|+.||.|||   +++||||||||+|||||++|+++|+||||++.
T Consensus       100 LylVld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEEEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            99999999999999999  45678999999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ...... .+...+||+.|||||++.+..++..+|.||||+++|||++|.+||...+.....+.++..         +   
T Consensus       175 ~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---------k---  241 (357)
T KOG0598|consen  175 DLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---------K---  241 (357)
T ss_pred             cccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC---------c---
Confidence            544332 334479999999999999999999999999999999999999999876433333322211         1   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP  588 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  588 (636)
                            ....+.-......+++.+.+..||++|-
T Consensus       242 ------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                  0111111233455666667999999995

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=383.16  Aligned_cols=261  Identities=29%  Similarity=0.462  Sum_probs=217.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCC-CceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNN-NSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++.+..+.||+|.||.||+|.+.+.... ....||+|.+++. +.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            3455678999999999999999875432 2567999999876 5566789999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC-----CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          397 LVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      +++|||++|+|..||++.+     ...|+....+.++.|||+|+.||+   ++++|||||.++|+||+....+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999996542     457899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCccc-cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          472 AKLYQQGEVPNT-TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       472 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      |+.+...+.... ....-...|||||.+..+.++.|+|||||||+||||++ |..||......    .++..+..    .
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~~~~~----g  920 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLLDVLE----G  920 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHHHHHh----C
Confidence            994443333222 22234579999999999999999999999999999998 88998654222    22222211    1


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      |          +.+.+..+++.+.+|+..||+.+|++||+++.|++.+...
T Consensus       921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            1          3455777889999999999999999999999999987654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.3e-42  Score=331.81  Aligned_cols=267  Identities=22%  Similarity=0.301  Sum_probs=205.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +.|+...++|+|.||.|||++.++++    +.||||++.....  ...+-.++||++|++|+|+|+|.|+.+|.....++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~Tg----qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh   77 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTG----QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH   77 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcc----cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence            35677788999999999999988877    9999999976533  33345689999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||+|||+.--|+++=  .....++.+.+.+++.|++.|+.|+|   +++++||||||+||||+.++.+||||||.|+.+.
T Consensus        78 LVFE~~dhTvL~eLe--~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELE--RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHH--hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            999999776666543  33567888999999999999999999   8999999999999999999999999999999887


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc-------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG-------  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~-------  548 (636)
                      . .....+..+.|.+|.|||++.+ .+|...+||||.||++.||++|..-|. +.++.+.--.+..-+..+.+       
T Consensus       153 ~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P-G~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  153 A-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP-GRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             C-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC-CcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            4 2235566789999999998887 689999999999999999999996664 33332221111111111111       


Q ss_pred             CCc------chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGK------ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...      +-+.-++.-.+.........+++++..|++.||.+|++-+|++..
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111      001111111111112233478999999999999999999998754

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-40  Score=350.33  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeecccccc-c
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG-N  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~  393 (636)
                      .++|+..++||+|+||.||+|..... ....+..||+|++.... ....+.+.+|+.++..+ +||||++++++|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            35688899999999999999986332 22334679999997543 33456789999999999 899999999988764 4


Q ss_pred             eEEEEEeecCCCChhhhHhcCC----------------------------------------------------------
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP----------------------------------------------------------  415 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  415 (636)
                      .+++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999986421                                                          


Q ss_pred             --CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC-ccccccccCCcc
Q 006668          416 --KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGY  492 (636)
Q Consensus       416 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y  492 (636)
                        ...+++.+++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++....... .......++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999   89999999999999999999999999999986533221 112223467889


Q ss_pred             cccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHH
Q 006668          493 LAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMEL  571 (636)
Q Consensus       493 ~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~  571 (636)
                      +|||++.+..++.++|||||||++|||++ |..||...........        ....+..         ...+......
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~--------~~~~~~~---------~~~~~~~~~~  305 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ--------RLKDGTR---------MRAPENATPE  305 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--------HHhcCCC---------CCCCCCCCHH
Confidence            99999999999999999999999999997 9999975432211111        1111111         0112233456


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          572 VLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       572 l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +.+|+.+||+.||++||++.|+++.|+.-
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            88999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=352.20  Aligned_cols=239  Identities=26%  Similarity=0.431  Sum_probs=205.5

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      .+-||+|+.|.||+|++..      +.||||+++.-.       ..+|+.|++|+|+||+.+.|+|.....+|||||||+
T Consensus       129 LeWlGSGaQGAVF~Grl~n------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeeccC------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            4679999999999999977      789999875322       257899999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      .|-|.+.|  +....++......+.++||.||+|||   .+.|||||||+-||||..+..+||+|||-++.....  ...
T Consensus       196 ~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk  268 (904)
T KOG4721|consen  196 QGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK  268 (904)
T ss_pred             cccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence            99999999  45677888999999999999999999   899999999999999999999999999999876543  233


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ..++||..|||||++.....+.|+||||||||||||+||..||..-+..    .    .+|   +-      -...|...
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----A----IIw---GV------GsNsL~Lp  331 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----A----IIW---GV------GSNSLHLP  331 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----e----eEE---ec------cCCccccc
Confidence            4579999999999999999999999999999999999999999754211    0    011   11      12234456


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+..+++-+.-|++.||+..|..||++++|+.+|.-
T Consensus       332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            677888899999999999999999999999999964

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=356.85  Aligned_cols=258  Identities=29%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEecc---CChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH---DSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ....++||+|+||.||+|+++..+......||||..+.   ..+..++++.+|.++|++++|||||+++|++.....+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            34458999999999999999876442223499999985   357778999999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||+|+||+|++||.+.. ..++..+++.++.+.|+||+|||   .++++||||.++|+|++.++.+||+||||++....
T Consensus       239 vmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             EEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            999999999999996543 37999999999999999999999   89999999999999999999999999999886541


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      -.. ......-...|+|||.+..+.++.++|||||||++||+++ |..||.......     ...++            +
T Consensus       315 ~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----v~~kI------------~  376 (474)
T KOG0194|consen  315 YVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----VKAKI------------V  376 (474)
T ss_pred             eee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----HHHHH------------H
Confidence            111 1111134679999999999999999999999999999998 888997653221     11211            1


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+...+...+..+..++.+||..+|++||+|.++.+.|+..
T Consensus       377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            22234445556778888899999999999999999999999765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=340.54  Aligned_cols=257  Identities=30%  Similarity=0.423  Sum_probs=205.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc--eEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--ELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~l  397 (636)
                      ++...+.||+|.||.||++.....+    ...|||..........+.+.+|+.+|.+++|||||+.+|......  .+++
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g----~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTG----ELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCC----cceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            3556788999999999999987654    889999998764444677899999999999999999999754444  6999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~  476 (636)
                      .|||+++|+|.+++.+... .|++..++.+..||++||.|||   +++|+||||||+|||++. ++.+||+|||+++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999965544 7999999999999999999999   899999999999999999 7999999999998766


Q ss_pred             C--CCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          477 Q--GEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       477 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .  ..........||+.|||||++..+ ....++|||||||++.||+||+.||...  ..     ..+++-..       
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~-----~~~~~~~i-------  235 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FE-----EAEALLLI-------  235 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cc-----hHHHHHHH-------
Confidence            3  122233457899999999999854 3345999999999999999999999642  00     11111111       


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ........++........+++.+|+..||++|||+.++++.....
T Consensus       236 --g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  236 --GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             --hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence              111111244445567788889999999999999999999986543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-40  Score=316.91  Aligned_cols=284  Identities=21%  Similarity=0.293  Sum_probs=215.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HH-HHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QG-LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|...++||+|.||.||+|+...++    +.||||+++.... ++ -....+||+.|+.++|+||+.+++++...+.+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~----~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~   77 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETG----KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLS   77 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCC----cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence            35777889999999999999987766    8999999986532 22 235689999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||+||| ..+|...+.+ ....++..++..++.++++||+|||   .+.|+||||||.|+|++++|.+||+|||+|+.+.
T Consensus        78 lVfEfm-~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   78 LVFEFM-PTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEEEec-cccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence            999999 5689988854 4678999999999999999999999   8999999999999999999999999999999887


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh--cCCcch
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY--GQGKIC  553 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~--~~~~~~  553 (636)
                      ....... ..+-|.+|.|||++.+. .|+...|+||.|||+.||+.|. ||-.+..+.++-..+......-.  ....+.
T Consensus       153 ~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  153 SPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             CCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            6554333 34779999999988765 5889999999999999999876 55455433333222211110000  000111


Q ss_pred             hhhh---hh-----hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhhhhhccc
Q 006668          554 EAAD---AR-----IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLAR  615 (636)
Q Consensus       554 ~~~d---~~-----l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~~  615 (636)
                      +.-|   -.     .....-..+....++|+..++..||.+|+++.|++++=.... .|.| ..+..+..
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~p-t~~~~lp~  298 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLP-TPPSKLPI  298 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCC-CChhhCcC
Confidence            1111   11     011122234456699999999999999999999999977663 3666 55555544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=334.95  Aligned_cols=262  Identities=26%  Similarity=0.369  Sum_probs=209.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +.|+..+.||.|..+.||+|+....+    +.||||++..+ ....++.+.+|+..|+.++||||++++..|..+..+|+
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~----e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTN----EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccC----CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            46788899999999999999998876    89999999876 44457899999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||.||.+||+.+.+...-...+++..+..|++++++||.|||   .+|.||||||+.||||+++|.+||+|||.+-.+-.
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999997766677999999999999999999999   89999999999999999999999999998754433


Q ss_pred             CCCccc---cccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          478 GEVPNT---TRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       478 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ......   ...+||+.|||||++..  ..|+.|+||||||+..+||++|..||.......    .+..-+.+... ...
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----vLl~tLqn~pp-~~~  253 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----VLLLTLQNDPP-TLL  253 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----HHHHHhcCCCC-Ccc
Confidence            222222   34689999999998443  458899999999999999999999997653221    12111111000 000


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ....+..    -.......+.+++..||+.||.+|||++++++.
T Consensus       254 t~~~~~d----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 TSGLDKD----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cccCChH----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1111111    111223478899999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-41  Score=350.07  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=212.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      .|....+||+|..|.||.++-...+    ..||||++........+-+.+|+.+|+..+|+|||++++.+..+++++.||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTK----QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCC----ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            4666788999999999999976655    789999998876665677889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      |||++|+|.+.+   ....+++.++..|+.++++||+|||   .++|+|||||..|||++.++.+||+|||+|..+....
T Consensus       350 Eym~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  350 EYMEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eecCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999999998   3456999999999999999999999   8999999999999999999999999999998876655


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      . .....+||+.|||||+.....|..|.||||||++++||+.|..||-....-.  ...+.      -..|      .+ 
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--AlyLI------a~ng------~P-  487 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLI------ATNG------TP-  487 (550)
T ss_pred             C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--HHHHH------hhcC------CC-
Confidence            4 3344689999999999999999999999999999999999999996432111  11110      0111      11 


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .....+.....+.++..+||+.|+++||++.|+|++---.
T Consensus       488 -~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  488 -KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             -CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence             1122334456788899999999999999999999874334

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-41  Score=344.18  Aligned_cols=269  Identities=27%  Similarity=0.366  Sum_probs=208.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeecccccc--ceEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NELM  396 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~  396 (636)
                      |+..++||+|.||.||||+...++    +.||+|++..+.  ........+||.+|++|+||||++|.+...+.  +.+|
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tg----kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETG----KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccC----cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            444577999999999999987776    899999998764  33455668999999999999999999988765  6899


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||+|||++ +|..++. ...-.++..++..+++||+.||.|+|   .++|+|||||.+|||||++|.+||+|||||+.+.
T Consensus       195 lVFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            99999955 7877773 23457999999999999999999999   8999999999999999999999999999999888


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH--------HHHHHHh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--------DWVRNLY  547 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~--------~~v~~~~  547 (636)
                      .......|..+-|++|.|||++.+. .|+.+.|+||.||||.||+.|+..|.....-+..+.++.        .|-...+
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            7776667778889999999988765 689999999999999999999988876543332222221        1211111


Q ss_pred             cCCcch---hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKIC---EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~---~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..-...   .....++.+. -.......++|+..+|..||.+|.|+.++++.=..
T Consensus       350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            100000   1111222222 11223556778888999999999999999876433

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-40  Score=337.84  Aligned_cols=254  Identities=31%  Similarity=0.553  Sum_probs=201.7

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      ..+.||.|.||.||+|.+..........|+||.++.. ..+..+++.+|++.+.+++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999998545566789999999764 444578999999999999999999999999988889999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC-
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-  480 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-  480 (636)
                      +++|+|.++|.......+++.++..|+.||+.||.|||   +.+++|+||+++||++++++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998766678999999999999999999999   78999999999999999999999999999987632221 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      ...........|+|||.+....++.++||||||+++|||++ |+.||......    . +..             .+...
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~----~-~~~-------------~~~~~  221 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE----E-IIE-------------KLKQG  221 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----H-HHH-------------HHHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc----c-ccc-------------ccccc
Confidence            12223456789999999999999999999999999999999 78888654211    1 111             11111


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .+...+...+..+.+++.+||+.||++||++.++++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11223334566788999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.2e-40  Score=333.96  Aligned_cols=258  Identities=26%  Similarity=0.462  Sum_probs=207.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|++.+.||+|+||.||+|.+... ......||+|.++... ......+.+|+..+.+++||||+++++++..++..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~-~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLP-SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecC-CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            4678889999999999999987542 2334789999998653 3445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+++||||||+|||++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998543 357899999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||.......     ....+    ..+      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~----~~~------  224 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKAV----EDG------  224 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH----HCC------
Confidence            22112222345678999999999999999999999999999775 999997542211     11111    111      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         .....+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus       225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence               1112233456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=390.54  Aligned_cols=261  Identities=28%  Similarity=0.510  Sum_probs=215.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+.+...++||+|+||.||+|+....+    ..||+|.+......    ..+|++.+++++|||||+++|+|.+.+..++
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNG----MQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCC----cEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            345778899999999999999986655    89999998654322    1246888999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.+++.     .++|.++.+++.|+++||+|||+.++++|+||||||+||+++.++..++. |+.......
T Consensus       761 v~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            999999999999993     38999999999999999999997777899999999999999999988876 666543322


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .     ....+|..|+|||++.+..++.++|||||||++|||++|+.||+....   ....+.+|++..+........+|
T Consensus       835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeC
Confidence            1     123678999999999999999999999999999999999999964322   22345667776665555555566


Q ss_pred             hhhhh--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQ--EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +.+..  ..+.++...+.+++.+||+.||++||+|+||++.|+..
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            66543  34556777899999999999999999999999999876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=350.84  Aligned_cols=265  Identities=25%  Similarity=0.480  Sum_probs=211.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +.+...+.||+|.||+||+|++.+       .||||+++.+  +.+..+.|++|+.++++-||.||+-+.|||..... .
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG-------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG-------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             HHhhccceeccccccceeeccccc-------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            445567899999999999999965       5999999865  55678899999999999999999999999998776 9


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||..+|++-+|+.||+-. +..+...+.+.|++|||+||.|||   .++|||||||+.||+|.+++.|||+||||+....
T Consensus       464 IiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            999999999999999765 467899999999999999999999   8999999999999999999999999999996432


Q ss_pred             CCC-CccccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGE-VPNTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~-~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .-. ........|...|||||++...   +++..+||||||+++|||++|..||.....+    +++     -..+.|-+
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIi-----fmVGrG~l  610 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QII-----FMVGRGYL  610 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heE-----EEeccccc
Confidence            211 1122234578899999988754   5889999999999999999999999733111    111     11122221


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhhhh
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLG  611 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~  611 (636)
                      +.    + .......++.+|.+|+..||..++++||.+.+|+..|+.. ...+| -+.+
T Consensus       611 ~p----d-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l-~~~~p-ki~R  662 (678)
T KOG0193|consen  611 MP----D-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL-LPSLP-KINR  662 (678)
T ss_pred             Cc----c-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh-hhccc-cccc
Confidence            11    0 1123345677899999999999999999999999988766 32366 4433

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-39  Score=335.19  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=198.7

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccc----cceE
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRK----GNEL  395 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~  395 (636)
                      ....||+|++|.||+|++.+      +.||+|.++....   ...+.+.+|+.++++++||||++++|++.+    ....
T Consensus        24 ~~~~i~~g~~~~v~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         24 TSVLIKENDQNSIYKGIFNN------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             CCeEEeeCCceEEEEEEECC------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            34679999999999999843      7899999976532   225778899999999999999999999866    3568


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++...+.++.+++.||.|||+  ..+++||||||+|||+++++.+||+|||+++..
T Consensus        98 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         98 SLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            999999999999999954  4578999999999999999999993  247889999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....    ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.......     +...+..   .    
T Consensus       174 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~~~~i~~---~----  237 (283)
T PHA02988        174 SSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----IYDLIIN---K----  237 (283)
T ss_pred             cccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh---c----
Confidence            4322    22467899999999876  678999999999999999999999997543211     1111100   0    


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           ..+...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       238 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        238 -----NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -----CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                 01111222345678999999999999999999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-39  Score=335.66  Aligned_cols=254  Identities=24%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +|+..+.||+|+||.||++....++    +.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~   76 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCC----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence            3677899999999999999987665    899999987542   223346788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++.......+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++....
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            9999999999998886554557899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...  ......||..|+|||++.+..++.++|||||||++|||++|+.||............. .    ...        
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-~----~~~--------  218 (285)
T cd05631         154 EGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-R----RVK--------  218 (285)
T ss_pred             CCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-H----Hhh--------
Confidence            322  2233578999999999999999999999999999999999999997543221111111 0    000        


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVL  597 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L  597 (636)
                        .....++......+.+|+.+||+.||++||+     +.++++.-
T Consensus       219 --~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         219 --EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             --cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence              0011222233456788999999999999997     78887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=341.84  Aligned_cols=269  Identities=22%  Similarity=0.351  Sum_probs=208.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHH--HHHHHHhccCC-CCceeeeeccccccc-
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF--MAEISSMGRLQ-HKNLVQMRGWCRKGN-  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l~-h~niv~l~g~~~~~~-  393 (636)
                      .++|...++||.|.||.||+|+-...+    ..||||+++..-.. +++.  ++|++.|++|+ ||||++|.+++.+.+ 
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~----~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETG----ELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCC----ceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            456777889999999999999987766    77999999765322 3333  68999999998 999999999999888 


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+++||||| ..+|.+++..+ .+.+++..++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+||||||
T Consensus        84 ~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   84 ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccc
Confidence            999999999 77999998665 789999999999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCccccccccCCccccccc-ccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH----HHHhc
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPEL-ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV----RNLYG  548 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v----~~~~~  548 (636)
                      .....  +..|..+.|.+|.|||+ ++.+-|+.+.|+|++|||++|+.+-+.-|.+...-+....+ .+-+    +..+.
T Consensus       159 ev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI-c~VLGtP~~~~~~  235 (538)
T KOG0661|consen  159 EVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI-CEVLGTPDKDSWP  235 (538)
T ss_pred             ccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH-HHHhCCCccccch
Confidence            76543  35667889999999996 56678999999999999999999988667544221111111 1100    01111


Q ss_pred             CC-cchhhhhhhhh-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          549 QG-KICEAADARIR-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       549 ~~-~~~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .| .+...+.-+++       ...-........+|+.+|+..||.+|||+.|++++--.
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff  294 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF  294 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence            11 11111111111       11112256778899999999999999999999987543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=344.98  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=209.6

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----Ch-HHHHHHHHHHHHhccCC-CCceeeeeccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SK-QGLKEFMAEISSMGRLQ-HKNLVQMRGWC  389 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~  389 (636)
                      ...++|...+.||+|.||+|+.|.....+    ..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCC----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            34568899999999999999999987766    89999977664    11 23456668999999999 99999999999


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEec
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGD  468 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~D  468 (636)
                      .....+++||||+.+|+|.+++.+  .+.+.+.+...++.|++.|++|||   +++|+||||||+|+|++.+ +++||+|
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEec
Confidence            999999999999999999999954  678899999999999999999999   8999999999999999999 9999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS-PT-SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..........+        
T Consensus       165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--------  235 (370)
T KOG0583|consen  165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--------  235 (370)
T ss_pred             cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--------
Confidence            99999874 2222344568999999999999977 75 7899999999999999999999864222111110        


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       ..+      ...++..+.   ...+..|+.+|+.+||.+|+++.+|++.=+-.
T Consensus       236 -~~~------~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  236 -RKG------EFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             -hcC------CccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence             000      011111111   56678888999999999999999999654443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=340.85  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=209.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .+.|...+.||.|.|++|++|+.+..+    +.+|||++.+.   .....+-...|-.+|.+| .||.|++|+-.|.+..
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATG----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCC----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            456778899999999999999987766    89999999764   222234456788889999 8999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+|+|+||+++|+|.++|.  +.+.+++...+.++.+|+.||+|||   +.|||||||||+|||||.++++||.|||-|+
T Consensus       148 sLYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             ceEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999994  4578999999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCC----------ccc--cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          474 LYQQGEV----------PNT--TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       474 ~~~~~~~----------~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+.....          ...  ...+||..|.+||++.....+..+|+|+|||+||+|+.|..||...+.-    .++..
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqk  298 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQK  298 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHHHH
Confidence            7653211          111  4479999999999999999999999999999999999999999866322    22211


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .           ..++-.+.+.++    +.+.+|+.+.|..||.+|++..||-++.-
T Consensus       299 I-----------~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  299 I-----------QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             H-----------HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCcc
Confidence            1           112333344444    66777777889999999999999988753

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-39  Score=336.38  Aligned_cols=267  Identities=24%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC------------CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeee
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN------------NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQM  385 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~------------~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l  385 (636)
                      ++|...++||+|+||.||++.+....            ......||+|.+... ......++.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            46778899999999999999864422            123357999999765 34456789999999999999999999


Q ss_pred             eccccccceEEEEEeecCCCChhhhHhcCC-----------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEe
Q 006668          386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKP-----------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVH  448 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  448 (636)
                      ++++.+.+..++||||+++|+|.+++....                 ...+++.++++++.||+.||+|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999984321                 134788899999999999999999   899999


Q ss_pred             CCCCCCCEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh--CCCC
Q 006668          449 RDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC--GRRP  525 (636)
Q Consensus       449 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~--G~~P  525 (636)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433221 1223345789999999998899999999999999999986  5567


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          526 LDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       526 f~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      |.......     ....+...+.....      ......+..++..+.+++.+||+.||++|||+.+|.+.|+.
T Consensus       242 ~~~~~~~~-----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQ-----VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHH-----HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            75432211     11111111111000      00011122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=338.56  Aligned_cols=269  Identities=29%  Similarity=0.420  Sum_probs=198.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHH--hccCCCCceeeeeccccccc---
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISS--MGRLQHKNLVQMRGWCRKGN---  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~g~~~~~~---  393 (636)
                      ......++||+|+||.||||++.+      +.||||+++...++   .|++|-++  +-.|+|+||+++++.-+...   
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~------~~VAVKifp~~~kq---s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDN------RLVAVKIFPEQEKQ---SFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccC------ceeEEEecCHHHHH---HHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            345567889999999999999976      78999999876554   44444444  45678999999999877665   


Q ss_pred             -eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc------CCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG------WDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                       +++||+||.+.|+|.+||   ....++|....+|+..+++||+|||++      .+++|+|||||++|||+.+|+.+.|
T Consensus       281 ~eywLVt~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cceeEEeeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence             899999999999999999   456899999999999999999999974      3678999999999999999999999


Q ss_pred             eccCCcccccCCCCc-cccccccCCcccccccccCCC------CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          467 GDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSS------PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       467 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      +|||||..+..+... .....+||.+|||||++.+.-      .-.+.||||+|.|||||++.-.-++... ..+....+
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp~Yqlpf  436 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VPEYQLPF  436 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CCcccCch
Confidence            999999887755432 233468999999999988753      2347899999999999998654332111 00111111


Q ss_pred             HHHHHHHhcCCcchhh-hhhhhhhccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          540 MDWVRNLYGQGKICEA-ADARIRQEFE-----AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~-~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..-+.....-+.+.+. +..+.+..++     ..-+..+.+.+..||..||+.|.|+.=+.+++..-
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            1111111100111111 1112222222     14467789999999999999999999888888654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-40  Score=343.67  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=208.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|...+.||+|.||.||||+.+.+.    +.||+|.+.+.  .++.++.+.+|++++++++|||||.++++|+...+++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~   77 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTI----QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW   77 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccce----eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence            56778889999999999999977765    89999999865  4456788999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|.||+.+ +|..+|  ...+.+++++++.|+.+++.||.|||   +.+|+|||+||+||||+.++.+|++|||+|+...
T Consensus        78 vVte~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             EEehhhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence            99999955 999999  45678999999999999999999999   8999999999999999999999999999999877


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .+. ...+.+.||+.|||||+..+..|+..+|.||+|||+||++.|++||...        .+...+.....+       
T Consensus       152 ~~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d-------  215 (808)
T KOG0597|consen  152 TNT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKD-------  215 (808)
T ss_pred             cCc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcC-------
Confidence            643 3445678999999999999999999999999999999999999999633        122222221111       


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      +.    .++.........++.-.+.+||.+|.+-.+++.+
T Consensus       216 ~v----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  216 PV----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CC----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            11    1122444556666667799999999999998875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-39  Score=331.24  Aligned_cols=268  Identities=20%  Similarity=0.278  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+++...++    ..||+|++....  ....+.+.+|+.++++++|+||+++++++..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETK----EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLY   76 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCC----cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEE
Confidence            36888999999999999999987655    789999987542  233466788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||++++.|..+..  ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999887765542  2456899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH--------HHHHHhc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD--------WVRNLYG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~--------~v~~~~~  548 (636)
                      ...........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....        +......
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhhhc
Confidence            443333344578999999999998889999999999999999999999997543221111 0000        0000000


Q ss_pred             CCcchhhhhhh------hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADAR------IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .........+.      ....+.......+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000      0001111234568999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-39  Score=329.00  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|...+.||+|++|.||+|.....+    ..|++|.+.... ...+++.+|++++++++|+||+++++++...+.+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCC----ceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            4677889999999999999987655    789999987543 34577899999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++.......+++..++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999999996655667899999999999999999999   8999999999999999999999999999998765433


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ...   .          +..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~---~----------~~~  220 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYE---L----------LEK  220 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH---H----------HHC
Confidence            222222334678999999999999999999999999999998 899986442111     101   0          011


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ......+...+..+.+++.+||..||++||++.++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            11112223345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-39  Score=347.20  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|+.... .......||||+++... ....+.+.+|+.++..+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3578889999999999999975321 22334689999997542 33456788999999999 899999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC------------------------------------------------------------
Q 006668          396 MLVYDYMPNGSLNNWIFGKP------------------------------------------------------------  415 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  415 (636)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999985421                                                            


Q ss_pred             -------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc
Q 006668          416 -------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN  482 (636)
Q Consensus       416 -------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  482 (636)
                                   ...+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         125788999999999999999999   8999999999999999999999999999998654332211


Q ss_pred             -ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          483 -TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       483 -~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||.......    ....++..    +         .
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~----~---------~  334 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKE----G---------Y  334 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHh----C---------c
Confidence             112335678999999999999999999999999999998 888886542221    11111111    1         0


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+...+..+.+|+.+||+.||++||++.||++.|+..
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111112245688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=334.55  Aligned_cols=250  Identities=24%  Similarity=0.278  Sum_probs=204.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   76 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISE----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL   76 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCC----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeE
Confidence            36888999999999999999987655    889999997542   23456688999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            999999999999999953  456899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    .....|++.|+|||++.+..++.++|||||||++|||++|+.||...........     +    ..++    
T Consensus       152 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-----i----~~~~----  214 (291)
T cd05612         152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-----I----LAGK----  214 (291)
T ss_pred             cCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----H----HhCC----
Confidence            432    2235689999999999999999999999999999999999999975432111111     0    0011    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L~~~  600 (636)
                            ..++......+.+++.+||+.||.+||+     +.++++.-.-.
T Consensus       215 ------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         215 ------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             ------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence                  1122223456788999999999999995     88888775443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-39  Score=337.45  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=209.7

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ..+.|+....||+|+||.||+++-++++    ..+|+|++++.   ....++..+.|-.+|...++++||+|+..|.+.+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg----~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTG----EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCC----cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            3467999999999999999999988877    89999999876   4455677889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+||||||+|||++..+|  ...+.|+++..+.++.+++.|+.-||   +.|+|||||||+|+|||..|++||+||||+.
T Consensus       215 ~LYLiMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             eeEEEEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence            999999999999999999  45688999999999999999999999   8999999999999999999999999999985


Q ss_pred             cccC----------------------CCCc-----c-------------------ccccccCCcccccccccCCCCCCcc
Q 006668          474 LYQQ----------------------GEVP-----N-------------------TTRVVGTLGYLAPELATVSSPTSAS  507 (636)
Q Consensus       474 ~~~~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~s  507 (636)
                      .+..                      .+..     .                   ....+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3211                      0011     0                   0124699999999999999999999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCC
Q 006668          508 DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR  587 (636)
Q Consensus       508 DV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R  587 (636)
                      |.||||||+|||+.|.+||........ ...+..|...+..+              -......+..+||.+|+. ||++|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQET-YRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999999987654433 33455554332111              111223567778888888 99999


Q ss_pred             CC---HHHHHHH
Q 006668          588 PT---MREVVAV  596 (636)
Q Consensus       588 Ps---~~evl~~  596 (636)
                      --   +.||-++
T Consensus       434 LG~~G~~EIK~H  445 (550)
T KOG0605|consen  434 LGSKGAEEIKKH  445 (550)
T ss_pred             cCcccHHHHhcC
Confidence            75   6666554

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.1e-39  Score=330.63  Aligned_cols=259  Identities=27%  Similarity=0.468  Sum_probs=209.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .|+..+.||+|+||.||+|...... ......|++|.+.... .....++.+|+..+.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            5777899999999999999876542 2344689999987553 3445678999999999999999999999999899999


Q ss_pred             EEeecCCCChhhhHhcCCC--------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc
Q 006668          398 VYDYMPNGSLNNWIFGKPK--------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~  463 (636)
                      +|||+++++|.+++.....              ..+++.+++.++.|++.||.|||   +.+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence            9999999999999954321              56888999999999999999999   899999999999999999999


Q ss_pred             EEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......     +..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-----~~~  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-----VIE  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH
Confidence            99999999986543322 12233456889999999998899999999999999999998 999997543221     111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+.             .......+...+..+.+|+.+||+.||.+||++.||+++|+.
T Consensus       238 ~i~-------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 MIR-------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH-------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111             111122334556789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-39  Score=340.43  Aligned_cols=247  Identities=24%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTG----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            46788899999999999999987665    78999999754   223456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            999999999999999953  456889999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....    ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........         ...+..   
T Consensus       169 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---------i~~~~~---  232 (329)
T PTZ00263        169 PDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---------ILAGRL---  232 (329)
T ss_pred             CCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH---------HhcCCc---
Confidence            4322    235789999999999999999999999999999999999999965421111110         011110   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L  597 (636)
                             .++......+.+|+.+||+.||.+||+     +++++++-
T Consensus       233 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        233 -------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence                   111122345788999999999999997     68887664

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-39  Score=340.43  Aligned_cols=243  Identities=25%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      +.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKATG----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence            46999999999999987655    88999999754   233456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      +++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        77 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~  150 (323)
T cd05571          77 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-A  150 (323)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-C
Confidence            999999999853  457899999999999999999999   8999999999999999999999999999987532211 1


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......     +...+.    .+      +.   
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~~~----~~------~~---  212 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL----ME------EI---  212 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----HHHHHH----cC------CC---
Confidence            2234579999999999999999999999999999999999999996542211     111110    00      01   


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                       .++......+.+++.+||+.||++||     ++.+++++
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence             12223345678899999999999999     79998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5e-39  Score=326.67  Aligned_cols=254  Identities=26%  Similarity=0.441  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..++||+|++|.||+|....+     ..||+|.+..... ..+.+.+|+.++++++|+||+++++.+...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNS-----TKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCC-----ceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            4678889999999999999986543     5799998875433 357888999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999999999997655667899999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++....++.++||||||+++|||++ |+.||.......     ...++..    +       
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~----~-------  220 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQR----G-------  220 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHc----C-------
Confidence            3222223345778999999998889999999999999999998 999996442111     1111111    0       


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        .........+..+.+++.+||..+|++||++.++.+.|+.
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         221 --YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              0011112234568899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.8e-39  Score=345.52  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+ ......||+|++... .......+.+|+.+++.+ +|+||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888999999999999999864432 233467999999764 333456788999999999 899999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC------------------------------------------------------------
Q 006668          396 MLVYDYMPNGSLNNWIFGKP------------------------------------------------------------  415 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  415 (636)
                      ++||||+++|+|.+++..+.                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999985321                                                            


Q ss_pred             --------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc-cccc
Q 006668          416 --------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRV  486 (636)
Q Consensus       416 --------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~  486 (636)
                              ...+++.++++++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++......... ....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    124788899999999999999999   8999999999999999999999999999997654332211 1122


Q ss_pred             ccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccC
Q 006668          487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE  565 (636)
Q Consensus       487 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  565 (636)
                      .++..|+|||++....++.++|||||||++|||++ |+.||........    ....+             ........+
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~-------------~~~~~~~~~  337 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMV-------------KRGYQMSRP  337 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHH-------------HcccCccCC
Confidence            35678999999998899999999999999999997 9999965422111    11100             000111111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          566 AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       566 ~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1224668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=313.13  Aligned_cols=201  Identities=27%  Similarity=0.424  Sum_probs=182.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .+|+..+.||.|.||+|.+.+.+.++    ..+|+|++++.   ..+..+...+|..+|+.+.||+++++++.|.+.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSG----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCC----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            35677899999999999999987765    89999999876   334456678899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      +|||||+++|.|..+|+  +.+.+++..++.++.+|+.||+|||   +..|++|||||+|||||.+|.+||.|||.|+..
T Consensus       120 ymvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            99999999999999994  4578999999999999999999999   899999999999999999999999999999976


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                      ..    .+...|||+.|+|||++....+..++|.|||||++|||++|..||......
T Consensus       195 ~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~  247 (355)
T KOG0616|consen  195 SG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI  247 (355)
T ss_pred             cC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence            54    355689999999999999999999999999999999999999999876543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.5e-39  Score=325.05  Aligned_cols=252  Identities=27%  Similarity=0.447  Sum_probs=202.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|+..+.||+|+||.||++.+...     ..+|+|.+..... ..+++.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC-----ceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            3477788999999999999987653     5799998865432 236788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++... ...+++..++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          78 TEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            9999999999998643 246899999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ....+..    +..     
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-----~~~~i~~----~~~-----  219 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-----VVEMISR----GFR-----  219 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHC----CCC-----
Confidence            3222223345678999999998889999999999999999999 899996542211     1111111    100     


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                          ...+......+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ----LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                0111122456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.6e-39  Score=327.54  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=211.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..+|+..++||.|+||.||+|+... +    ..+++|.+.........++.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-R----VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-C----CcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            3457788999999999999999866 3    7899999987766566788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++.+++.++.||+.||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999997666677999999999999999999999   89999999999999999999999999999986644


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .... .....++..|+|||.+....++.++||||||+++++|++ |+.||.......     ....+.            
T Consensus       157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~------------  218 (261)
T cd05148         157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-----VYDQIT------------  218 (261)
T ss_pred             cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHH------------
Confidence            3221 223346778999999988899999999999999999998 899996543111     111111            


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       .......+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 -AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             111112233445678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=324.10  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=206.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|++|.||+|....+     ..||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-----TPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-----eEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            34688889999999999999986442     6799999876432 34678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++.++..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999999996554457899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...........+..|+|||++.+..++.++||||||++++||++ |+.||.......    .+ ..+             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~-~~~-------------  217 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VL-QQV-------------  217 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HH-HHH-------------
Confidence            32222222233468999999999999999999999999999999 999986442111    11 111             


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +.......+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1111111223345678999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=335.53  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=212.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..|...++||+|.||.||||.....+    +.||+|++..+ .+..++++..|+.+|.+++++||.++++.+..+..+++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~----k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTK----KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeecccc----ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            34667789999999999999976655    89999999977 45567889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +||||.+|++.+.|  +....+++.++..|+.+++.||.|||   ..+.+|||||+.|||+..+|.+||+|||++.....
T Consensus        89 iMey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999998  34455688888999999999999999   89999999999999999999999999999988776


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..... ...+||+.|||||++....|+.|+||||||+..+||++|.+|+......                  +.+-.+-
T Consensus       164 ~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIp  224 (467)
T KOG0201|consen  164 TVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIP  224 (467)
T ss_pred             hhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEecc
Confidence            55444 5579999999999999889999999999999999999999999654221                  1122222


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..-+...+......+.+++..||..||+.||++.+++++
T Consensus       225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            222223333445678999999999999999999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=339.78  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=206.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+....+    +.||+|+++...   ....+.+.+|+.++..++||||+++++++...+..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~   76 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTG----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYL   76 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEE
Confidence            46888999999999999999987655    789999997542   23456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            999999999999999943  456899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+..|..      .+.. 
T Consensus       152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~------~~~~-  219 (333)
T cd05600         152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKE------TLQR-  219 (333)
T ss_pred             cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-HHHhccc------cccC-
Confidence            43    2234578999999999999999999999999999999999999997543221111 1111100      0000 


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        + ............+.+++.+||..+|++||++.+++++-.
T Consensus       220 --~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         220 --P-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             --C-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence              0 000000123456788889999999999999999998743

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-39  Score=305.79  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=212.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      +.|++.+.||+|.||.||.|+.+.+.    -.||+|++.+..   .+...++.+|+++-+.|+||||+++++++.+....
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSL----FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCC----cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            56889999999999999999987765    789999987652   22346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ||++||.++|+|...|.......+++.....++.|+|.||.|+|   .++|+||||||+|+|++..+..||+|||-+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999998777788999999999999999999999   899999999999999999999999999988754


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..   ......+||..|.+||...+..++...|+|++|++.||++.|..||+.....+...++.               .
T Consensus       175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------------k  236 (281)
T KOG0580|consen  175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------------K  236 (281)
T ss_pred             CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---------------H
Confidence            32   23344789999999999999999999999999999999999999998654222222111               1


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +|-    .++........+++.+|+..+|.+|.+..|++..-+
T Consensus       237 ~~~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 VDL----KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ccc----cCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            111    223344456788889999999999999999997654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=323.14  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=207.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+|++...+ .....|++|.++... .....++.+|+.++++++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPG-KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCC-CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46888999999999999999986532 223689999987653 3445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999998543 347899999999999999999999   89999999999999999999999999999987652


Q ss_pred             CCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ..+.+..    +     
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~~----~-----  224 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-----VIKAVED----G-----  224 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHc----C-----
Confidence            221 11222345678999999998999999999999999999998 999986442111     1111111    0     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          .........+..+.+++.+||+.+|++||++.||+++|+.
T Consensus       225 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         225 ----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                0111122345678999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-38  Score=335.05  Aligned_cols=267  Identities=22%  Similarity=0.283  Sum_probs=208.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+++....+    ..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSG----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            357888999999999999999987655    789999998653 344567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++....
T Consensus        80 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          80 ICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999999843  3468899999999999999999993  2469999999999999999999999999997653


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG------  550 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~------  550 (636)
                      ...   .....|+..|+|||++.+..++.++|||||||++|||++|+.||........     ...+......+      
T Consensus       156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-----EAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHhcccccccccCCcc
Confidence            321   2335689999999999999999999999999999999999999965432111     11110000000      


Q ss_pred             ------------------------cchhhhhhhh---hhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 ------------------------KICEAADARI---RQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 ------------------------~~~~~~d~~l---~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                                              ...+..+...   .... .......+.+++.+||+.||++|||++|+++...-.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                    0000000000   0000 112345689999999999999999999999886543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-38  Score=328.13  Aligned_cols=267  Identities=25%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhcc---CCCCceeeeecccc---
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGR---LQHKNLVQMRGWCR---  390 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~---l~h~niv~l~g~~~---  390 (636)
                      ++|+..+.||+|+||.||+|+....+   +..||+|.+....  ......+.+|+.+++.   ++||||++++++|.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCC---CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            36888999999999999999874321   2789999987542  1122345556666555   47999999999875   


Q ss_pred             --ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          391 --KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       391 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                        ....+++||||++ ++|.+++.......+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence              3456899999995 79999986655567899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............. +.... ..
T Consensus       154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~-~~~~~-~~  229 (290)
T cd07862         154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGL-PG  229 (290)
T ss_pred             ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH-HHhCC-CC
Confidence            9999865443  22334568999999999988899999999999999999999999997654322211111 11000 00


Q ss_pred             CCcch-------hhhhhhh---hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKIC-------EAADARI---RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~-------~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....       .......   ......+....+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            00000       0000000   001112234567899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-38  Score=326.91  Aligned_cols=260  Identities=24%  Similarity=0.424  Sum_probs=207.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +.|+..+.||+|+||.||+|+....+......+++|.+... ..+...++.+|+.++++++|+||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            35677899999999999999875544445588999999754 34455788899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCC---------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          398 VYDYMPNGSLNNWIFGKP---------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      ||||+++++|.+++....               ...+++.+++.++.|++.||+|||   +++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321               235888999999999999999999   79999999999999999999


Q ss_pred             cEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~  540 (636)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......     ...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            999999999976543221 11222345778999999988889999999999999999998 99898654211     111


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +.+.             .......+...+..+.+++.+||++||++||++.+|+++|..
T Consensus       237 ~~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVR-------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHH-------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111             111111222345678889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-39  Score=335.22  Aligned_cols=241  Identities=26%  Similarity=0.346  Sum_probs=195.4

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|+||.||+++....+    +.||+|++...   .......+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQ----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCC
Confidence            699999999999987655    78999999753   33445678899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +|+|.+++..  ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        77 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  150 (312)
T cd05585          77 GGELFHHLQR--EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT  150 (312)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence            9999999953  456899999999999999999999   8999999999999999999999999999998543222 223


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..    ..... +          ...
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~----~~~~~-~----------~~~  211 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MY----RKILQ-E----------PLR  211 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HH----HHHHc-C----------CCC
Confidence            34579999999999999999999999999999999999999997542111    11    11110 0          011


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPT---MREVVAV  596 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~evl~~  596 (636)
                      ++......+.+++.+||+.||.+||+   +.|++++
T Consensus       212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            22233456788999999999999986   5565554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-38  Score=332.66  Aligned_cols=259  Identities=26%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|+..+.||+|+||.||+|++...+......||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            458889999999999999999876665555679999997553 34557888999999999999999999999764 5789


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            99999999999999643 346889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... .....++..|+|||++....++.++||||||+++|||++ |+.||.......     +....    ..+     
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~----~~~-----  227 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSIL----EKG-----  227 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH----hCC-----
Confidence            32211 122234678999999999999999999999999999997 999986542111     11111    111     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          .....+..+...+.+++.+||..+|++||++.+++..|...
T Consensus       228 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         228 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                01111122345688899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-38  Score=335.49  Aligned_cols=243  Identities=26%  Similarity=0.347  Sum_probs=197.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      +.||+|+||.||+++....+    ..||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence            46999999999999976655    88999999754   234456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      +++|+|..++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....... .
T Consensus        77 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~  150 (323)
T cd05595          77 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  150 (323)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-C
Confidence            999999998843  457899999999999999999999   8999999999999999999999999999987532221 1


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........    ....     .      +..  
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~-----~------~~~--  213 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILM-----E------EIR--  213 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhc-----C------CCC--
Confidence            2233579999999999999999999999999999999999999997543221111    1000     0      011  


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                        ++......+.+++.+||+.||++||     ++.++++.
T Consensus       214 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              1222345678899999999999998     88888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=338.42  Aligned_cols=252  Identities=23%  Similarity=0.384  Sum_probs=218.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      .....+||-|.||.||.|.++...    ..||||.++.+. ...++|++|..+|+.++|||+|+|+|+|..+..+|||.|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkys----lTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccc----eeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            345688999999999999998766    889999997654 457999999999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      ||.+|+|.+||+...+..++.-..+.++.||+.||.||.   .+++|||||.++|+|+.++..+|++||||++++..+.+
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            999999999998877778888889999999999999999   89999999999999999999999999999999877665


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      .......-.+.|.|||-+....++.|+|||+|||+||||.| |..||...+..                  .+.+.++..
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------------qVY~LLEkg  482 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------------QVYGLLEKG  482 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------------HHHHHHhcc
Confidence            44443445778999999999999999999999999999988 88888654211                  112233444


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .+.+-+..|+..+.+|++.||+.+|.+||+++|+-+.++
T Consensus       483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            556667788999999999999999999999999887765

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=335.68  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=214.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      ..+.++||+|.||+|..+....     ...||||.++.+.. ...++|.+|+++|.+|+|||||+++|+|..++.+++|+
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             eehhhhhcCcccceeEEEEecC-----ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            4567899999999999998755     28999999998744 45689999999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      |||++|+|.+|+..+....+.-+...+|+.||+.||+||.   +.++|||||.++|+|++.++++||+|||+++.+-.++
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999997765555666778889999999999999   8999999999999999999999999999999655444


Q ss_pred             Cc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHH--HhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          480 VP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV--ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       480 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~el--l~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .. ...+.+-.++|||||.+..++++.++|||+||+.+||+  +|..+||.....+     ..++-.......+...   
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~~---  763 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGRQ---  763 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCcc---
Confidence            33 33455678999999999999999999999999999997  5688898654222     1222222222111110   


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .-...+.-++..+.+++++||..+.++||+++++...|...
T Consensus       764 ---~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 ---VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               11122455678899999999999999999999999999765

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-38  Score=340.77  Aligned_cols=263  Identities=23%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~  394 (636)
                      .++|.+.++||+|+||.||+|+..... ......||||++.... ....+.+.+|+.+++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            457888899999999999999864322 2233579999997543 334567899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC-----------------------------------------------------------
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP-----------------------------------------------------------  415 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  415 (636)
                      .+||||||++|+|.++|..+.                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999985421                                                           


Q ss_pred             -----------------------------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          416 -----------------------------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       416 -----------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                                                         ...+++.+++.++.||+.||+|||   +.+++||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124788889999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 006668          461 EMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAV  538 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~  538 (636)
                      ++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986543221 12222356788999999999999999999999999999997 9999865421111    


Q ss_pred             HHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       539 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +...+.    .         ......+...+..+.+++.+||+.||++||++.+|.++|+.-
T Consensus       349 ~~~~~~----~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 FYNKIK----S---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHHHHh----c---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            111110    0         111112234456789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-38  Score=334.88  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=198.4

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      ++||+|+||.||+++....+    ..||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKASG----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence            46999999999999976655    88999999754   234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      +++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        77 ~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~  150 (328)
T cd05593          77 VNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-A  150 (328)
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-c
Confidence            999999998843  456899999999999999999999   8999999999999999999999999999987533221 2


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........     +   . .      .+..+.
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~-----~---~-~------~~~~~p  215 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----I---L-M------EDIKFP  215 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH-----h---c-c------CCccCC
Confidence            22345799999999999999999999999999999999999999965422111110     0   0 0      011111


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                      .    .....+.+++.+||+.||++||     ++.|+++.-
T Consensus       216 ~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         216 R----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             C----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence            2    2335577888999999999997     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-38  Score=321.56  Aligned_cols=251  Identities=29%  Similarity=0.461  Sum_probs=202.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|...+.||+|++|.||+|+..+.     ..+|+|.+..... ..+++.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~-----~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCC-----CcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            467788999999999999987542     4699998875432 3467889999999999999999999999988999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++|+|.+++.... ..+++.+++.++.||+.||+|||   +.+++|+||||+||++++++.+||+|||+++......
T Consensus        79 e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          79 EYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999986533 36899999999999999999999   8999999999999999999999999999998654433


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ..+.+.    .+.       
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~----~~~-------  218 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEKVS----QGL-------  218 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHh----cCC-------
Confidence            222222345678999999998889999999999999999998 999986543211     111111    110       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        +..........+.+++.+||+.||++||++.++++.|+
T Consensus       219 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 --RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              01111123467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-38  Score=324.96  Aligned_cols=271  Identities=27%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeecccccc--ceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l  397 (636)
                      |+..+.||+|+||.||++.+.......+..||+|.+.... ......+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4788999999999999877544333445789999997653 33456788999999999999999999987653  46899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++..   ..+++.+++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999843   45999999999999999999999   89999999999999999999999999999986644


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......++..|+|||.+.+..++.++||||||++++||++|+.|+.........   ...+.........+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhhh
Confidence            3211  111224566799999999889999999999999999999999998654221100   00000000011111122


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+.......+...+..+.+++.+||+++|++||++.+++++|+.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            222222223334557899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-38  Score=348.55  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=204.9

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      .|...+.||+|++|.||+|......   ...|++|.+..........+.+|+.+++.++||||+++++++..++.++|||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~---~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDP---KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCC---CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            3788899999999999999865541   2678899887666665667888999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          400 DYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       400 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||+++|+|.++|...  ....+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999988542  3456889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+.. +.    .+..    
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~-~~----~~~~----  288 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQQ-VL----YGKY----  288 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HH----hCCC----
Confidence            322 1233457999999999999999999999999999999999999999654211    11111 00    0000    


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ..++......+.+++.+||+.||++||+++++++.
T Consensus       289 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 -----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                 01122234568889999999999999999998753

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.9e-38  Score=324.33  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=208.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +.|...+.||+|+||.||+|+.... .+.....||+|.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            3577788999999999999987543 1234478999999766443 5678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          397 LVYDYMPNGSLNNWIFGKP------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +||||+++++|.+++....            ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999996432            245889999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......     ..+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----~~~~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----VIEC  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHH
Confidence            9999999975433221 11223346788999999999999999999999999999998 999986543221     1111


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +.    .+.         ....+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       237 ~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 IT----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            11    111         11112234567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.6e-38  Score=323.54  Aligned_cols=262  Identities=24%  Similarity=0.440  Sum_probs=206.0

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ++++|+..+.||+|+||.||+|..... .......||+|.+... ......++.+|+.+++.++|+||+++++++.+++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            456788999999999999999986532 1223477999998654 23345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC--------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP--------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      .++||||+++++|.+++....        ...+++.+++.++.|++.||.|||   +.+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999985422        234678899999999999999999   789999999999999999999999


Q ss_pred             eccCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      +|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......     ....+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-----~~~~~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----VLRFVM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH
Confidence            9999987654332211 122345778999999998899999999999999999998 788886542211     111111


Q ss_pred             HHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          .+..         ...+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       236 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 ----EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ----cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                0100         11122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=312.80  Aligned_cols=283  Identities=22%  Similarity=0.289  Sum_probs=209.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HH-HHHHHHHHHhccCCCCceeeeecccc--ccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GL-KEFMAEISSMGRLQHKNLVQMRGWCR--KGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~  395 (636)
                      .|+..++|++|.||.||+|+.+.++    +.||+|+++.+... ++ -...+||.+|.+++|||||.+..+..  +-+.+
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~----eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTD----EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcc----eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4666789999999999999987776    89999999876432 21 24578999999999999999988764  34679


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |+|||||+. +|..++... ...+...+...++.|+++|++|||   ...|+|||||++|+|+...|.+||+||||||.+
T Consensus       153 y~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence            999999954 888888654 367889999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH------HHHHHhc
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD------WVRNLYG  548 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~------~v~~~~~  548 (636)
                      ... ....+..+-|.+|.|||++.+. .|++..|+||+|||+.||+++++-|.....-.....++..      -+|.-+.
T Consensus       228 gsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  228 GSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             cCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            764 3456677889999999987765 5899999999999999999998777544322222222211      0110000


Q ss_pred             CCc------chhhhhhhhhhccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhhhhhcc
Q 006668          549 QGK------ICEAADARIRQEFEAE-EMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLA  614 (636)
Q Consensus       549 ~~~------~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~  614 (636)
                      .-.      ..+.....++..|... ..+.-.+|+...+..||.+|-|+.|.++.=...+. |.| .-+..+.
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~-P~p-~~P~~~P  377 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET-PLP-IDPSMFP  377 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC-CCC-CChhhcC
Confidence            000      0000111222222221 23445566777899999999999999998665543 555 4444443

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.8e-38  Score=325.98  Aligned_cols=260  Identities=27%  Similarity=0.471  Sum_probs=209.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|...+.||+|+||.||+++.... .......+++|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            467778999999999999986432 2233467899998877666667899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          399 YDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      |||+++++|.+++....              ...+++.+++.++.||+.||+|||   +++++||||||+||+++.++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence            99999999999996432              245899999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ..+.
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----VIEC  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH
Confidence            9999999975543221 11223456788999999999999999999999999999998 999986543211     1111


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          ...+...         ......+..+.+++.+||+.||++||++++|+++|+..
T Consensus       238 ----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         238 ----ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             ----HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                1111111         11222456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.5e-38  Score=323.53  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +.|+..+.||+|+||.||+|++...+......+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            356778899999999999999876654444578899886543 3445678889999999999999999998864 55788


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ++||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999643 356899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ..+++.    .+...  
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~----~~~~~--  230 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLLE----KGERL--  230 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH----CCCcC--
Confidence            322 12233457789999999998899999999999999999998 999996542211     111111    11110  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                             .....+...+.+++.+||..||++||++.|+++.|..-
T Consensus       231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                   01111234577889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.5e-38  Score=316.16  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=207.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+++....+    ..|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADK----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI   76 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCC----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence            4677899999999999999987655    88999998643  34456788899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++.+++.++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            999999999999997655667999999999999999999999   89999999999999999999999999999986654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .... .....++..|+|||+..+..++.++||||||+++|||++|+.||......    . ....+    ..        
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~-~~~~~----~~--------  215 (256)
T cd08529         154 NTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----A-LILKI----IR--------  215 (256)
T ss_pred             ccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHH----Hc--------
Confidence            3322 22346889999999999999999999999999999999999999754311    1 11110    00        


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       .............+.+++.+||+.+|++||++.++++.
T Consensus       216 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 -GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             01112222345678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-39  Score=334.00  Aligned_cols=252  Identities=22%  Similarity=0.358  Sum_probs=215.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce-E
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE-L  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-~  395 (636)
                      ++|...+++|+|+||.++..+.+.++    ..+++|.+...  +....+....|+.++++++|||||.+.+.+.+++. +
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDD----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCC----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            46778899999999999999987766    79999999865  33334467889999999999999999999999988 9


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      +|||+||+||+|.+.|.+++...++++.+..++.|++.|++|||   +..|+|||||+.||+++.+..+||+|||+|+..
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            99999999999999997776778999999999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....... ..++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.......+.              ..
T Consensus       157 ~~~~~~a-~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~--------------~~  221 (426)
T KOG0589|consen  157 NPEDSLA-STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN--------------RG  221 (426)
T ss_pred             CCchhhh-heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh--------------hc
Confidence            7765333 34789999999999999999999999999999999999999998664332222211              11


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                          +....+......+..|+..|++.+|+.||++.+++.+
T Consensus       222 ----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1223344455678889999999999999999999987

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=322.95  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=204.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +|+..++||+|+||.||++.....+    +.||+|++....   ......+.+|+.++++++|+||+++++++..++.++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCC----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEE
Confidence            4778899999999999999976554    899999987542   222345678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999986555567999999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ....  .....|+..|+|||++.+..++.++||||||+++|||++|+.||........... +...+.            
T Consensus       154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-~~~~~~------------  218 (285)
T cd05605         154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-VERRVK------------  218 (285)
T ss_pred             CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-HHHHhh------------
Confidence            3322  2234689999999999988999999999999999999999999975432211111 111000            


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                        .....+.......+.+|+.+||+.||.+||     +++++++.-
T Consensus       219 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05605         219 --EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP  262 (285)
T ss_pred             --hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence              011122333456688999999999999999     777887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-38  Score=336.47  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=202.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|+....+   ...||+|++...   .....+.+.+|+.++..++||||+++++++.+.+.+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNED---FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL  106 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCC---CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence            46888999999999999999875432   258999998653   233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       107 ~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999999953  356899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........         ...+..   
T Consensus       182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---------i~~~~~---  245 (340)
T PTZ00426        182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK---------ILEGII---  245 (340)
T ss_pred             CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH---------HhcCCC---
Confidence            432    2335799999999999998899999999999999999999999975422111111         001110   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~  598 (636)
                             .++......+.+++.+|++.||++|+     +++++++.-.
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence                   11122234567889999999999995     8999887743

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=320.22  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=200.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|+..+.||+|++|.||+++....     ..+|+|.+..... ...++.+|++++++++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGK-----IDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCC-----ccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            467788999999999999987542     5799998865422 2356788999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..+. ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++......
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999986443 36899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||........     ...+             ..
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~-------------~~  216 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----VESV-------------SA  216 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHH-------------Hc
Confidence            212222234568999999999999999999999999999998 8999865422111     1101             00


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+...+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus       217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            111112223456799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-39  Score=321.49  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +|++.+.||+|.||.|-++.....+    +.||||.++++   .++.+-.+.+||++|+.|+||||++++.+|+..+.+.
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sg----R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSG----REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCC----cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            4666788999999999999865544    89999999876   4555667889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      |||||..+|.|.+|+  ..++.|++.+.+.++.||.+|+.|+|   .++++|||||.+|||||+++++||+||||+-++.
T Consensus       130 ivMEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  130 IVMEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999999  45678999999999999999999999   8999999999999999999999999999999887


Q ss_pred             CCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .+...  ..+||++.|.+||++.+..| .+..|-|||||+||.|+.|..||+..+..     .++..    ...|...  
T Consensus       205 ~~kfL--qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQ----Is~GaYr--  271 (668)
T KOG0611|consen  205 DKKFL--QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQ----ISRGAYR--  271 (668)
T ss_pred             cccHH--HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHH----hhccccc--
Confidence            76543  34799999999999999887 46899999999999999999999865322     12111    1122221  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                               .++.+.....|+.|||-.||++|.|+.+|..+.+-
T Consensus       272 ---------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 ---------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ---------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                     22334556778999999999999999999998753

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.3e-38  Score=319.11  Aligned_cols=253  Identities=29%  Similarity=0.455  Sum_probs=203.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..++||+|++|.||++.....     ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ +..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGN-----TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCC-----ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence            3577789999999999999986543     5699999876433 23568899999999999999999998854 568999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.+.....+++.+++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999997655567899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ..+.+.             
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~-------------  217 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQVE-------------  217 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH-------------
Confidence            3222222345678999999988899999999999999999999 888986542111     111111             


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .......+......+.+++.+|+.++|++|||+.++.+.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111112233345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.5e-38  Score=319.75  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=204.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|++.++||+|+||.||+|+...+     ..||+|++..... ..+++.+|+.++++++|+||+++++.+.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-----~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-----ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence            4588899999999999999987543     4699999975432 23578899999999999999999998754 558999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++.......+++.+++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999999996554557899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||+..+..++.++||||||+++|||++ |..||........    . .   . ...        
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~----~-~---~-~~~--------  218 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----L-D---Q-VER--------  218 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH----H-H---H-Hhc--------
Confidence            3322223346778999999998899999999999999999999 8888865422111    1 0   0 000        


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       ........+.+..+.+++.+|++.||++||++.++++.|+.-
T Consensus       219 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             011112334566789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4e-38  Score=332.25  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=202.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      +|+..+.||+|+||.||+++... +...+..||+|++...    .....+.+..|+.++..+ +|+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT-GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc-cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            47788999999999999988643 2234488999999753    223345678899999999 49999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999999853  456899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .............||..|+|||++.+. .++.++|||||||++|||++|+.||........... +...+   .      
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~---~------  224 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-VSRRI---L------  224 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-HHHHH---h------
Confidence            544333334446799999999998865 478899999999999999999999964422211111 11100   0      


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                       ..++    .++......+.+++.+||+.||++||     ++.++++.-
T Consensus       225 -~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         225 -KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             -cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence             0111    12222345678899999999999999     777887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.3e-38  Score=316.43  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=199.1

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      +.||+|+||.||+|+....+    ..+|+|.+... ..+....+.+|++++++++||||++++++|...+..++||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADN----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCC----ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            46999999999999987655    78999988654 34445678999999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++... ...+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++...........
T Consensus        77 ~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          77 GGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             CCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99999998543 346899999999999999999999   89999999999999999999999999999876543221111


Q ss_pred             c-ccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          484 T-RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       484 ~-~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      . ....+..|+|||.+.+..++.++||||||+++|||++ |..||.......     ...             .+.....
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~-------------~~~~~~~  214 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TRE-------------AIEQGVR  214 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHH-------------HHHcCCC
Confidence            1 1123457999999999999999999999999999997 888886432111     000             1111111


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2223334567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-38  Score=329.49  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=205.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..++||+|+||.||+++...++    ..+|+|++... .......+.+|++++++++|+||++++++|.+++..+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSG----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            357889999999999999999987655    78999998765 3344567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++..  ...+++..+..++.+++.||.|||+  ..+++||||||+|||+++++.+||+|||++....
T Consensus        80 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999999953  3568899999999999999999993  3479999999999999999999999999997653


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH----------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL----------  546 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~----------  546 (636)
                      ...   .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+.......          
T Consensus       156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence            321   22346899999999999888999999999999999999999999754321111 0000000000          


Q ss_pred             ---------hcCC-----cchhhhhhhhh---hccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 ---------YGQG-----KICEAADARIR---QEFE-AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ---------~~~~-----~~~~~~d~~l~---~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                               +...     ......+....   .... ......+.+++.+||+.||++||++.|+++.-.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence                     0000     00000000000   0000 0123568899999999999999999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.1e-38  Score=323.05  Aligned_cols=261  Identities=27%  Similarity=0.456  Sum_probs=208.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|.+.+.||+|+||.||++..... .......+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3577889999999999999986432 223346799999987766667789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCC-----------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          398 VYDYMPNGSLNNWIFGKP-----------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      ||||+++++|.+++....           ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999985322           235899999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       467 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      +|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..||.......    .. ..+ 
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----~~-~~i-  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VI-ECI-  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH-HHH-
Confidence            99999986543221 11222345778999999998899999999999999999998 899986543211    11 111 


Q ss_pred             HHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         ..+...         ..+......+.+++.+||++||.+||++.|+++.|+.-
T Consensus       236 ---~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         236 ---TQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             ---HcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence               111110         11112335689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-38  Score=322.59  Aligned_cols=271  Identities=28%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc--cceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~  396 (636)
                      +.|+..+.||+|+||.||++.....+...+..|++|.+........+.+.+|++++++++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677889999999999999986543334458899999987777777889999999999999999999998643  34689


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++.+. ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            999999999999998543 346899999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCCcc--ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc-CC---
Q 006668          477 QGEVPN--TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG-QG---  550 (636)
Q Consensus       477 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~-~~---  550 (636)
                      ......  .....++..|+|||++.+..++.++||||||++++||++|..|+......      ....+..... ..   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~  233 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccccccccchH
Confidence            432211  11122345699999999889999999999999999999988776432110      0000000000 00   


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+.+.+............+..+.+++.+||..+|++|||+.||++.|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            0001111111111222345679999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-38  Score=333.13  Aligned_cols=245  Identities=25%  Similarity=0.346  Sum_probs=197.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      +.||+|+||.||+++....+    ..||+|++...   .......+..|++++..++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATG----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence            46999999999999976655    89999999754   233456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      +++|+|.+++..  ...+++.++..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        77 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~  151 (325)
T cd05594          77 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A  151 (325)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-c
Confidence            999999998843  4578999999999999999999993  2799999999999999999999999999987533222 1


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........     +.    .+      ...+ 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~-----i~----~~------~~~~-  215 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----IL----ME------EIRF-  215 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH-----Hh----cC------CCCC-
Confidence            22335699999999999999999999999999999999999999965432111111     10    00      0111 


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                         +......+.+++.+||+.||++|+     ++.++++.-
T Consensus       216 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         216 ---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             ---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence               122235578899999999999996     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.2e-38  Score=334.33  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=195.8

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      |+..++||+|+||.||+++....+    +.||+|++.... ....+.+.+|+++++.++|+||+++++++...+.+++||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTG----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCC----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            344678999999999999987655    789999997553 334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++|+|.+..      .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999999987532      3567788899999999999999   8999999999999999999999999999998664322


Q ss_pred             CccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          480 VPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                       .......||..|+|||++..     ...+.++|||||||++|||++|+.||.........  .+...+           
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~-----------  288 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA--SLMCAI-----------  288 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHHH-----------
Confidence             12233578999999998753     23356899999999999999999999743211111  011000           


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ...............+.+++.+||+.||++||++.|++++-.-.
T Consensus       289 --~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        289 --CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             --hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence              00011112223445688999999999999999999999875444

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-37  Score=322.17  Aligned_cols=267  Identities=19%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...++||+|+||.||+|+...++    ..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCC----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            46888899999999999999977655    7899999875432 223567789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ ++|.+++... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            999996 5999988533 345789999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH----HHhcC---
Q 006668          478 GEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR----NLYGQ---  549 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~----~~~~~---  549 (636)
                      .. .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ...    ..+..   
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (288)
T cd07871         156 PT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR-LLGTPTEETWPGITS  233 (288)
T ss_pred             CC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCChHHhhcccc
Confidence            22 12233467999999998765 5688999999999999999999999975532222111110 000    00000   


Q ss_pred             -Ccchhhhhhhhhh----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 -GKICEAADARIRQ----EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 -~~~~~~~d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       ........+....    ...........+|+.+|++.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0000000000000    0001123457789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.1e-38  Score=330.26  Aligned_cols=262  Identities=28%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccc-cce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRK-GNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~-~~~  394 (636)
                      ++|++.++||+|+||.||+|..... +...++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            3678889999999999999976443 22345789999987543 34456788899999999 89999999998864 457


Q ss_pred             EEEEEeecCCCChhhhHhcCC-----------------------------------------------------------
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP-----------------------------------------------------------  415 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  415 (636)
                      ++++|||+++++|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            899999999999999985422                                                           


Q ss_pred             CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccc
Q 006668          416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLA  494 (636)
Q Consensus       416 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~a  494 (636)
                      ...+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++........ ......++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            126899999999999999999999   899999999999999999999999999999865433221 1222346778999


Q ss_pred             cccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHH
Q 006668          495 PELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVL  573 (636)
Q Consensus       495 PE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  573 (636)
                      ||++.+..++.++|||||||++|||++ |..||......+.....+        ..+.         ....+......+.
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------~~~~---------~~~~~~~~~~~~~  306 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------KEGT---------RMRAPEYATPEIY  306 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------hccC---------CCCCCccCCHHHH
Confidence            999999999999999999999999997 999996532221111111        1110         1111222345688


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          574 KLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       574 ~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +++.+||+.+|++||++.|++++|+..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.6e-38  Score=333.56  Aligned_cols=202  Identities=25%  Similarity=0.379  Sum_probs=175.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++.+++|+||+++++.+.+...+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~   76 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTG----HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL   76 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE
Confidence            36888999999999999999977655    89999999754   223345778899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            999999999999999953  457999999999999999999999   899999999999999999999999999998754


Q ss_pred             cCCCC----------------------------------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh
Q 006668          476 QQGEV----------------------------------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC  521 (636)
Q Consensus       476 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~  521 (636)
                      .....                                  ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            32110                                  00123579999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 006668          522 GRRPLDMG  529 (636)
Q Consensus       522 G~~Pf~~~  529 (636)
                      |+.||...
T Consensus       232 G~~Pf~~~  239 (363)
T cd05628         232 GYPPFCSE  239 (363)
T ss_pred             CCCCCCCC
Confidence            99999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=335.95  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++..++|+||+++++++.+++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   76 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTG----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHL   76 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCC----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeE
Confidence            46888999999999999999987655    89999999754   223456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            9999999999999999543  67899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCC----------------------------CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006668          476 QQGE----------------------------VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD  527 (636)
Q Consensus       476 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~  527 (636)
                      ....                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4432                            112233568999999999999999999999999999999999999997


Q ss_pred             CCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHh
Q 006668          528 MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-MREVVAVLV  598 (636)
Q Consensus       528 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~L~  598 (636)
                      ........ ..+..|..              .+...........+.+++.+|+. ||.+||+ +.++++...
T Consensus       232 ~~~~~~~~-~~i~~~~~--------------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         232 SDTLQETY-NKIINWKE--------------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CCCHHHHH-HHHhccCC--------------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            65322111 11111100              00000011134567888889997 9999999 999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.8e-38  Score=320.81  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=204.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      +++|...+.||+|++|.||+|.+... +......|++|.+.... ......+..|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            46788899999999999999998652 11234789999887553 33446789999999999999999999999988899


Q ss_pred             EEEEeecCCCChhhhHhcCC-----CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---cEEEe
Q 006668          396 MLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---RGRLG  467 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~  467 (636)
                      ++||||+++++|.+++....     ...+++.+++.++.||+.||+|||   +.+++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999985432     135899999999999999999999   78999999999999998754   59999


Q ss_pred             ccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       468 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||.......     ..+.+  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~--  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VMEFV--  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH--
Confidence            99999866332211 1112234568999999999999999999999999999997 999997542221     11111  


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       ...          .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       235 -~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 -TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             011          111222334567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=334.13  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=221.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      ....++||.|-||.||+|.+.+..++....||||.-+.+ +.+..+.|+.|..+|++++||||++|+|+|.+ ...+|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            345678999999999999998776666788999998875 44557889999999999999999999999976 5689999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      |.++-|.|..||..+ +..|+......++.||+.||.|||   +.+.|||||..+|||+...-.+||+||||++..+.+.
T Consensus       470 EL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999543 567999999999999999999999   8999999999999999999999999999999999888


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ....+...-.+.|||||.+.-.+++.++|||-|||.+|||+. |..||..-...                  ...-.++.
T Consensus       546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------------------DVI~~iEn  607 (974)
T KOG4257|consen  546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------------------DVIGHIEN  607 (974)
T ss_pred             hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------------------ceEEEecC
Confidence            777776667889999999999999999999999999999876 99999754221                  11122233


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .-+...++.|+..|..|+.+||..+|.+||++.|+...|+.
T Consensus       608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            33456677889999999999999999999999999988765

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.6e-38  Score=329.96  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=197.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++...+ ...++.||+|++...    .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG-ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEccc-CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999986432 234488999999753    12234567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++++|.+++..  ...+.+..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            9999999999843  456888899999999999999999   8999999999999999999999999999987543222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...    .. .+.         
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~----~~-~~~---------  216 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDK----IL-KGK---------  216 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----HHH----HH-cCC---------
Confidence            122335799999999999998899999999999999999999999975432111    111    00 010         


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                       ...+......+.+++.+||+.||++||     ++.++++.-
T Consensus       217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence             111222345678899999999999999     788887753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-37  Score=315.18  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=208.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+...++    ..||+|.+...   .......+.+|+.++++++||||+++++++...+..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDR----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNEL   77 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCC----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeE
Confidence            46888999999999999999987655    78999987642   334456788999999999999999999999998999


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++|+||+++++|.+++..  .....+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999999999998843  23456889999999999999999999   8999999999999999999999999999988


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........   .+...+.    ..   
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~~----~~---  223 (267)
T cd08228         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIE----QC---  223 (267)
T ss_pred             eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHHh----cC---
Confidence            6643221 12234688899999999988899999999999999999999999864422111   1111110    00   


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ..+..........+.+++.+||+.+|++||++.+|++.|+.-
T Consensus       224 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 -----DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -----CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                 011111223456789999999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-37  Score=316.30  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|+..++||+|+||.||+|....+     ..||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~-----~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGH-----TKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCC-----ceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            4678889999999999999986543     6799999876543 2467889999999999999999999874 4568999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999999997655667899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++....++.++||||||++++||++ |+.||.......     ....+             .
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-------------~  217 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNL-------------E  217 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHH-------------H
Confidence            3322233346778999999998899999999999999999998 999996543211     11111             0


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...........+..+.+++.+|+..+|++||+++++++.|+.
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            011111222334579999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-37  Score=328.10  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHH---hccCCCCceeeeeccccccce
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISS---MGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~---l~~l~h~niv~l~g~~~~~~~  394 (636)
                      |++.+.||+|+||.||++.....+    ..||+|+++...   ....+.+..|+.+   ++.++||||+++++++..++.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~   76 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTG----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH   76 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE
Confidence            567889999999999999987655    889999997542   2233455556554   567789999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|..++.   ...+++.+++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          77 VCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            999999999999998883   356999999999999999999999   89999999999999999999999999999875


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......    .......     +.   
T Consensus       151 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~~i~~-----~~---  217 (324)
T cd05589         151 GMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFDSIVN-----DE---  217 (324)
T ss_pred             CCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-----CC---
Confidence            33222 12234579999999999999999999999999999999999999997542211    1111000     00   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                         .    .++......+.+++.+||+.||.+||     ++.++++.-
T Consensus       218 ---~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         218 ---V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence               0    11222345678899999999999999     577776653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-38  Score=331.22  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=196.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++....+    +.+|+|++...   .....+.+..|+.++.++ +||||+++++++...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTE----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe
Confidence            47999999999999987665    78999999764   333456677888888776 79999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-  150 (329)
T cd05618          77 YVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  150 (329)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence            9999999998843  457899999999999999999999   8999999999999999999999999999997532221 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||..............+++........         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------  221 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------  221 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------
Confidence            12234579999999999999999999999999999999999999996322111111111112221111111         


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPT------MREVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs------~~evl~~  596 (636)
                       ..++......+.+++.+||+.||++||+      +.++++.
T Consensus       222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 -IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             1122233456778999999999999998      4666554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.2e-38  Score=336.74  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=197.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .|...+.||+|+||.||+|+....+    ..||+|++...   .....+.+.+|+.++.+++|+||+++++++.+.+.++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTH----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence            4778899999999999999987655    89999999754   2344567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        78 lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          78 FVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            99999999999999854  356889999999999999999999   8999999999999999999999999999976431


Q ss_pred             CCCC----------------------------------------------ccccccccCCcccccccccCCCCCCccchH
Q 006668          477 QGEV----------------------------------------------PNTTRVVGTLGYLAPELATVSSPTSASDVY  510 (636)
Q Consensus       477 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~  510 (636)
                      ....                                              ......+||..|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence            1000                                              001235799999999999988899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHH--ccCCCCCCCC
Q 006668          511 SFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLA--CCHPDSTRRP  588 (636)
Q Consensus       511 S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~--Cl~~dP~~RP  588 (636)
                      ||||++|||++|+.||........... ...|..      .+.    ......++.+    +.+++.+  |+.++|..||
T Consensus       233 SlG~il~elltG~~Pf~~~~~~~~~~~-i~~~~~------~~~----~~~~~~~s~~----~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTPTETQLK-VINWEN------TLH----IPPQVKLSPE----AVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCHHHHHHH-HHcccc------ccC----CCCCCCCCHH----HHHHHHHHccCcccccCCC
Confidence            999999999999999976532221111 111100      000    0000122333    3444444  6677888899


Q ss_pred             CHHHHHHHH
Q 006668          589 TMREVVAVL  597 (636)
Q Consensus       589 s~~evl~~L  597 (636)
                      ++.|++++-
T Consensus       298 ~~~~~l~hp  306 (381)
T cd05626         298 GADDIKAHP  306 (381)
T ss_pred             CHHHHhcCc
Confidence            999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=317.20  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHH--hccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISS--MGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++....+.||+|.||+||+|++++      +.||||++....+..   +.+|.++  -..|||+||+.+++.-..+   
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrG------e~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRG------EDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hheeEEEEEecCccccceeeccccC------CceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            3567788999999999999999987      679999998665543   3344444  4557999999999986554   


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc-----CCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG-----WDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                       .+++||.+|.++|||.|||   ....++-+..++++..+|+||++||.+     ..+.|.|||||+.|||+..++.+.|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             3789999999999999999   347899999999999999999999953     4778999999999999999999999


Q ss_pred             eccCCcccccCCCC---ccccccccCCcccccccccCCC------CCCccchHHHHHHHHHHHhC----------CCCCC
Q 006668          467 GDFGLAKLYQQGEV---PNTTRVVGTLGYLAPELATVSS------PTSASDVYSFGVVILEVACG----------RRPLD  527 (636)
Q Consensus       467 ~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~ell~G----------~~Pf~  527 (636)
                      +|+|||.....+..   ......+||.+|||||++...-      ....+||||||.|+||++..          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            99999987665431   1234468999999999987642      23468999999999999753          35654


Q ss_pred             CCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          528 MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       528 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..-+.++....+.+-|        ..+.+.+.++.. .+.+++..+.+|+..||..||..|-|+-.|-+.|.+.
T Consensus       438 d~Vp~DPs~eeMrkVV--------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVV--------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             cCCCCCCCHHHHhcce--------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            4322222111111100        001111222211 2457788899999999999999999998888888654

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-37  Score=320.00  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +++...++||+|+||.||++..... .......+++|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            3566788999999999999975431 223346899999887777777889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCC-------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          398 VYDYMPNGSLNNWIFGKPK-------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +|||+++++|.+++.....             ..+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999864321             35899999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.........     ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-----~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-----EC  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-----HH
Confidence            99999999755432211 1122345678999999999999999999999999999998 89998644221111     10


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +    ..+         .....+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus       237 ~----~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 I----TQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             H----HcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            0    000         0111122334568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=335.56  Aligned_cols=243  Identities=26%  Similarity=0.397  Sum_probs=203.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .++|...++||+|.||+|+++.++.++    +.+|||.++++   ..+.++..+.|.+++... +||.|++++.++..++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~----e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTN----EYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCC----cEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            457889999999999999999998877    89999999886   455667778888888777 5999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++++||||+.||++..+.   ..+.+++..++-++..|+.||+|||   +++|||||||..|||||.+|.+||+||||++
T Consensus       443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccc
Confidence            999999999999954443   4578999999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .--... ..+...+||+.|||||++.+..|+..+|.|||||+||||+.|..||...+.++..+.++.+            
T Consensus       517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------  583 (694)
T KOG0694|consen  517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------  583 (694)
T ss_pred             ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence            543222 2455689999999999999999999999999999999999999999866444333333322            


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM  590 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  590 (636)
                         |+    -++.....+...|+.+.+..+|++|.-+
T Consensus       584 ---~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ---EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence               12    2333444556677778899999999876

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=335.82  Aligned_cols=265  Identities=22%  Similarity=0.237  Sum_probs=201.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .+|+..+.||+|+||.||++.....+    +.||+|....      ..+.+|+.++++++||||+++++++......++|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~----~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTC----EHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCC----CEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            57999999999999999999987665    8899996532      3467899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +|++ .++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       162 ~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        162 LPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9999 5789888843  356899999999999999999999   789999999999999999999999999999754332


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChh---hHHHHHHHHHHHHhcCC-----
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE---EEEAVLMDWVRNLYGQG-----  550 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~---~~~~~l~~~v~~~~~~~-----  550 (636)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....+...+.. ....     
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~-~g~~p~~~~  314 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR-SGTHPNEFP  314 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH-hcCChhhcC
Confidence            2223334679999999999999999999999999999999999998875332110   011111111110 0000     


Q ss_pred             -----cchhhh---hhhh------hhc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 -----KICEAA---DARI------RQE--FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 -----~~~~~~---d~~l------~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           .+.+..   ....      +..  .....+..+.+|+.+||+.||++|||++|+++.-...
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                 000000   0000      000  0112345788999999999999999999999765544

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-38  Score=331.85  Aligned_cols=255  Identities=23%  Similarity=0.314  Sum_probs=203.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    ..||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~   76 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATG----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL   76 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE
Confidence            46888999999999999999987655    789999997542   23456788899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            9999999999999998543 357899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCccccccccc------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELAT------VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ............||+.|+|||++.      ...++.++|||||||++|||++|+.||..........        .....
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--------~i~~~  224 (330)
T cd05601         153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN--------NIMNF  224 (330)
T ss_pred             CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH--------HHHcC
Confidence            544333333457899999999886      4567789999999999999999999997553221111        11100


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .....     ...  .......+.+|+..|++ +|.+||++.++++.-
T Consensus       225 ~~~~~-----~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         225 QRFLK-----FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             CCccC-----CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence            00000     000  11223557778888997 999999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-37  Score=329.22  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=197.9

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc-----
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-----  392 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----  392 (636)
                      +|+..++||+|+||.||+|+....+    ..||+|++...  .......+.+|+.++++++||||+++++++...     
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   76 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF   76 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCC----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence            4778899999999999999976655    89999998743  223345788999999999999999999987533     


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      ...++||||+ +++|.+++..  ...+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          77 KDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             ceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence            3589999999 5789998843  456899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCC--ccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          473 KLYQQGEV--PNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       473 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +.......  .......||..|+|||++.+  ..++.++|||||||++|||++|+.||.........     ..+.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~-----~~~~~~~~  225 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-----DLITDLLG  225 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH-----HHHHHHhC
Confidence            85432221  11234578999999998876  67889999999999999999999999654321110     11111110


Q ss_pred             CC-----------cc---hhhhhhhhhhccC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QG-----------KI---CEAADARIRQEFE---AEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~-----------~~---~~~~d~~l~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..           ..   ...+.......+.   ......+.+++.+||+.||++||+++|+++.-.
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            00           00   0000000000000   012345788999999999999999999998743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.2e-38  Score=327.68  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=191.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhcc-CCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|+||.||+|+....+    +.||+|+++...   ....+.+..|..++.. .+||||+++++++..++..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTN----EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence            46999999999999987655    789999997542   2234455566666664 489999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          77 YLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence            9999999998843  456899999999999999999999   8999999999999999999999999999997543322 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..... +.   .           .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~-i~---~-----------~  211 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDS-IL---N-----------D  211 (316)
T ss_pred             CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHH-HH---c-----------C
Confidence            2233457999999999999999999999999999999999999999754221    11111 00   0           0


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMR-EVVA  595 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  595 (636)
                      ...++......+.+++.+||+.||++||++. ++++
T Consensus       212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            0112222345577889999999999999976 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-37  Score=322.95  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=202.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..++||+|+||.||+|+....+.  ...+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL--KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC--cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            468888999999999999998866431  245788888753 344556789999999999 7999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          397 LVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +|+||+++++|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence            9999999999999995432              135889999999999999999999   89999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||++.......  .......+..|+|||++....++.++|||||||++|||++ |+.||.......    ....
T Consensus       157 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~~~~  230 (297)
T cd05089         157 ASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----LYEK  230 (297)
T ss_pred             eEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH
Confidence            99999999987432211  1111223567999999998889999999999999999997 999996542211    1110


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                                    .........+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus       231 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         231 --------------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             --------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                          11111111222344668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=315.51  Aligned_cols=257  Identities=27%  Similarity=0.495  Sum_probs=203.4

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce----
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE----  394 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~----  394 (636)
                      |++.+.||+|+||.||+|++... ......||+|+++..  ......++.+|+..++.++|+||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD-DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC-CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56778999999999999987653 223478999999754  34456788999999999999999999998866544    


Q ss_pred             --EEEEEeecCCCChhhhHhcC----CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          395 --LMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       395 --~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                        .++++||+++|+|..++...    ....+++..++.++.|++.||.|||   +.+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence              79999999999999998542    2346899999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ..+++.. 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-----~~~~~~~-  230 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IYDYLRH-  230 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc-
Confidence            99998664433221 122235678999999998899999999999999999999 888886442111     1121111 


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         +.         ....+......+.+++.+||+.||++||++.|+++.|+.
T Consensus       231 ---~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 ---GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ---CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence               10         111222345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-37  Score=315.05  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=202.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|...+.||+|++|.||++.....     ..+++|.+..... ..+.+.+|+.++++++|+|++++++++.. +..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-----TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-----ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            3477788999999999999987553     4689998865432 23568889999999999999999998754 568899


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999999997655556899999999999999999999   889999999999999999999999999999866443


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||...+..++.++||||||+++|||++ |+.||.......     ...+....           
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~-----------  219 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-----VLEQVERG-----------  219 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcC-----------
Confidence            3222222346778999999998999999999999999999999 899986542211     11111110           


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        .....+...+..+.+++.+||+.||++||++.+++++|+.
T Consensus       220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 --YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              0111223345678999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-37  Score=316.07  Aligned_cols=258  Identities=29%  Similarity=0.504  Sum_probs=206.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|+..+.||+|+||.||+|+....+ .....+++|.+... .....+++..|++++++++|+|++++.+++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPG-RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCC-CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            45777899999999999999986533 22357999998765 34445778999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++..+ ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999998543 356899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCcccc--ccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTT--RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .......  ....+..|+|||++....++.++|||||||++|||++ |+.||.......     ...   ... .     
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~---~i~-~-----  225 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMK---AIN-D-----  225 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHH---HHh-c-----
Confidence            2221111  1223457999999998889999999999999999997 999996542211     111   110 0     


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          ........+.+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       226 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         226 ----GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                01111222345678999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-37  Score=321.20  Aligned_cols=260  Identities=24%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|...+.||+|+||.||+|+..... ......+++|.+.... .....++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3677889999999999999875321 2233578999887653 3445778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcC----------------------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCC
Q 006668          398 VYDYMPNGSLNNWIFGK----------------------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGN  455 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  455 (636)
                      ++||+++++|.+++...                      ....+++.+++.++.|++.||+|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            99999999999998532                      1235889999999999999999999   8999999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChh
Q 006668          456 ILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEE  533 (636)
Q Consensus       456 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~  533 (636)
                      ||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999976533221 11222345678999999988889999999999999999998 99998644211 


Q ss_pred             hHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       534 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          .+..++.    .         ......+......+.+++.+||+.+|++||++.|+++.|+.-
T Consensus       237 ----~~~~~~~----~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 ----RLFNLLK----T---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ----HHHHHHh----C---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                1111111    1         111112223345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=314.99  Aligned_cols=253  Identities=28%  Similarity=0.429  Sum_probs=204.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-----KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ++|+..+.||+|++|.||++.....+    ..+++|.+....     ....+.+.+|+.++++++||||+++++++.+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTG----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCC----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence            57889999999999999999876554    789999886432     223467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++|+||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            99999999999999999843  356889999999999999999999   8999999999999999999999999999997


Q ss_pred             cccCCCCccc--cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          474 LYQQGEVPNT--TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       474 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      ..........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........    .. .        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~-~--------  219 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----FK-I--------  219 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----HH-H--------
Confidence            6543221111  2345788999999999999999999999999999999999999654221110    00 0        


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                          ........++......+.+++.+||..+|++||++.+++++.
T Consensus       220 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         220 ----ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ----hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                001111223334456688899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=318.53  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|...+.||+|+||.||+|...... +.....|++|.+.... .....++.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            46778899999999999999886532 3345789999987553 344567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC--------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          397 LVYDYMPNGSLNNWIFGKP--------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      +||||+++|+|.+++....        ...+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999985422        234788999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......     ...++.  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~--  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-----VLKFVI--  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----HHHHHh--
Confidence            999976544322 12223456789999999988889999999999999999998 898986442211     111111  


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        .+.         ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       236 --~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 --DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              111         11122223567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-37  Score=312.58  Aligned_cols=247  Identities=28%  Similarity=0.453  Sum_probs=199.1

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ++||+|+||.||+|...+ +    ..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-K----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEecC-C----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            469999999999998654 2    689999987653 3334578899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++... ...+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++...........
T Consensus        76 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          76 GGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence            99999998543 346899999999999999999999   89999999999999999999999999999976543332222


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhh
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ  562 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  562 (636)
                      ....++..|+|||++.+..++.++||||||+++||+++ |..||.........     ..+.    .+         .+.
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-----~~~~----~~---------~~~  213 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-----EQVE----KG---------YRM  213 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----HHHH----cC---------CCC
Confidence            22334678999999999999999999999999999998 99999654221111     1010    11         111


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          563 EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       563 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            122234567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.5e-38  Score=337.65  Aligned_cols=256  Identities=23%  Similarity=0.294  Sum_probs=202.7

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ..++|+..++||+|+||.||+++....+    ..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSK----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3467889999999999999999987655    78999999653   2233455778999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+++||||+++|+|.+++..   ..++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            99999999999999999843   35788899999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVS----SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ..............||+.|+|||++.+.    .++.++|||||||++|||++|+.||...........+.    .   ..
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~---~~  263 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----D---HK  263 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH----c---CC
Confidence            7654333233345799999999988653    37889999999999999999999997543221111100    0   00


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVL  597 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L  597 (636)
                      ..+      ....  .......+.+++.+|+..+|.+  ||++.|+++.-
T Consensus       264 ~~~------~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         264 NSL------TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             CcC------CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            000      0001  1123456778889999999987  99999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-37  Score=323.38  Aligned_cols=272  Identities=20%  Similarity=0.286  Sum_probs=201.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    ..||+|++..... .....+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNG----KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCC----CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            357889999999999999999987655    7899999975432 22345678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+ .++|.+++... ...++++.+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        80 lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          80 LVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            999999 47888887543 456889999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc---c
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---I  552 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~---~  552 (636)
                      ... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............... .........   .
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  232 (303)
T cd07869         155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL-VLGTPNEDTWPGV  232 (303)
T ss_pred             CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhCCCChhhccch
Confidence            222 12233568999999998765 45788999999999999999999999754322111111100 000000000   0


Q ss_pred             hh--hhh---------hhhhhccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CE--AAD---------ARIRQEFE-AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~--~~d---------~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..  ..+         ..+...++ ......+.+|+.+|++.||.+|||+.|++++-.-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence            00  000         00000000 00124567899999999999999999999865554

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.8e-38  Score=329.32  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=197.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++....+    ..||+|+++..   .....+.+..|..++..+ +||||+++++++...+.+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTR----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence            46999999999999987655    88999999754   233456678899999888 79999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  .+.+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  150 (329)
T cd05588          77 FVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-  150 (329)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence            9999999998843  457999999999999999999999   8999999999999999999999999999987432211 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||..............++.........      ..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  224 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRI  224 (329)
T ss_pred             CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCC
Confidence            12234579999999999999999999999999999999999999996432111111111122221111111      111


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPT------MREVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs------~~evl~~  596 (636)
                          +......+.+++.+||+.||.+||+      ++++++.
T Consensus       225 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 ----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                1223345788999999999999997      6777755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6e-38  Score=329.32  Aligned_cols=243  Identities=23%  Similarity=0.371  Sum_probs=194.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++.+.++    +.||+|++...   .....+.+..|..++..+ +||||+++++++...+.+++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESG----RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCC----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence            46999999999999987655    88999999754   223456677888888876 69999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...... 
T Consensus        77 y~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-  150 (320)
T cd05590          77 FVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-  150 (320)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence            9999999998853  356899999999999999999999   8999999999999999999999999999987543222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........     ...+.    .+..        
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~----~~~~--------  213 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAIL----NDEV--------  213 (320)
T ss_pred             CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHh----cCCC--------
Confidence            122335799999999999999999999999999999999999999975432211     11110    1110        


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTM------REVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~~  596 (636)
                        .++......+.+++.+|++.||++||++      ++++++
T Consensus       214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence              1111234567889999999999999998      566554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-37  Score=322.75  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=208.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..+.||+|+||.||++...... ......+|+|.+... ..+...++.+|+.++.++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            346778899999999999999876432 233468999998764 334456788999999999 89999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcC--------------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          395 LMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      ++++|||+++|+|.+++...              ....+++..++.++.|++.||+|||   +.+|+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998532              2456899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 006668          461 EMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAV  538 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~  538 (636)
                      ++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.........   
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---  244 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF---  244 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH---
Confidence            999999999999866543221 1222335678999999998899999999999999999997 99998644221111   


Q ss_pred             HHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       539 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ..             +........+......+.+|+.+||..||++|||+.|+++.|+.
T Consensus       245 --~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         245 --KL-------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             --HH-------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence              10             00111112223345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.5e-38  Score=335.40  Aligned_cols=261  Identities=22%  Similarity=0.272  Sum_probs=203.0

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccc
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWC  389 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~  389 (636)
                      ++....++|+..+.||+|+||.||+++...++    +.+|+|++...   .....+.+.+|+.+++.++||||+++++++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            33444578999999999999999999987655    88999998642   222345678899999999999999999999


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      .+++.+++||||+++|+|.+++..   ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999843   35888999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS----PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |++...............||+.|+|||++....    ++.++|||||||++|||++|+.||........    ....+  
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~----~~~i~--  260 (370)
T cd05621         187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT----YSKIM--  260 (370)
T ss_pred             ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH----HHHHH--
Confidence            999876543332334467999999999887543    77899999999999999999999975432111    11100  


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVLV  598 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L~  598 (636)
                        ....       .+...........+.+++.+|+..++.+  ||++.|++++-.
T Consensus       261 --~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         261 --DHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             --hCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence              0000       0000011122455677788888755543  899999998854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-37  Score=319.09  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=196.9

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|+||+||++.....+    +.+|+|++....   ....+.+..|+.+++.++|+||+++.+++...+..++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRATG----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEccCC----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCC
Confidence            699999999999987655    789999987542   2234567889999999999999999999999999999999999


Q ss_pred             CCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          404 NGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       404 ~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      +|+|..++..  .....+++.+++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9999988753  23456899999999999999999999   89999999999999999999999999999976544322 


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ...   ... .+          .
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-~~~---~~~-~~----------~  217 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQ---RIL-ND----------S  217 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-HHH---hhc-cc----------C
Confidence            22335789999999999999999999999999999999999999975432211111 111   000 00          0


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                      ..++......+.+++.+||+.||++||     ++++++++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            112233456688899999999999999     66777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=314.80  Aligned_cols=255  Identities=30%  Similarity=0.479  Sum_probs=207.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|.+.++||+|++|.||++...+.     ..+++|.+..... ..+++.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~-----~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGT-----TKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCC-----ceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            35688899999999999999986543     6799999875432 34678899999999999999999999998889999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++.++..++.+++.||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999999997665567999999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...........+..|+|||.+.+..++.++||||||++++||++ |+.||......    ..+.. +.            
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~-~~------------  218 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQ-VE------------  218 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH-HH------------
Confidence            32222222334678999999998889999999999999999998 99998644211    11111 11            


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       .......+...+..+.+++.+|+..+|++||+++++++.|+.
T Consensus       219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 -RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             001111122235678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-38  Score=333.24  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++.++-||+|+.|.|-.|++..+|    +.+|||++.+..   ......+.+||-+|+-+.|||+++++++++++.++||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TG----qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETG----QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             eeccccccCCCCceehhhhccccc----ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            456788999999999999988776    899999998762   2224567789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |.||+++|-|.++|.  .++.+++.+..+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+...
T Consensus        90 vlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999999994  4678999999999999999999999   89999999999999999999999999999988766


Q ss_pred             CCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      +....  ..||.+.|.+||++.+.+| ..++||||.||||+.|++|+.||+..+     .+.+..-|.    .|..    
T Consensus       165 gklLe--TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LLlKV~----~G~f----  229 (786)
T KOG0588|consen  165 GKLLE--TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLLLKVQ----RGVF----  229 (786)
T ss_pred             Ccccc--ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHHHHHH----cCcc----
Confidence            55433  3589999999999999987 468999999999999999999998442     112222111    1111    


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                            +.+........+|+.+|+..||+.|.|++||+++-.
T Consensus       230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence                  112334456778888899999999999999999853

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=344.89  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=205.6

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG  392 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~  392 (636)
                      ....++|.+.++||+|+||.||+++....+    +.||+|++...  .......+.+|+..+..++|+|++++...+...
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDG----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCC----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            344578999999999999999999976655    89999999754  344566788999999999999999998776432


Q ss_pred             c--------eEEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          393 N--------ELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       393 ~--------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +        .+++||||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence            2        368999999999999998543  2357899999999999999999999   89999999999999999999


Q ss_pred             cEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .   
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~---  253 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----V---  253 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----H---
Confidence            999999999986543221 12234579999999999999999999999999999999999999997542111    1   


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +.... .+.         ....+......+.+++.+||+.||.+||++.+++++
T Consensus       254 -~~~~~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 -MHKTL-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -HHHHh-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             11110 010         111222344668899999999999999999999875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-38  Score=328.77  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=193.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      +.||+|+||.||+++... +...+..+|+|++....  ......+..|++++++++||||+++++++...+.+++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT-GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEec-cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            579999999999987642 12344889999997542  223455678999999999999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN  482 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  482 (636)
                      ++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~  154 (318)
T cd05582          81 RGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK  154 (318)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence            99999999843  456899999999999999999999   8999999999999999999999999999998654332 22


Q ss_pred             ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhh
Q 006668          483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ  562 (636)
Q Consensus       483 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  562 (636)
                      .....||..|+|||.+.+..++.++|||||||++|||++|+.||........    . ..+.    ...          .
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~-~~i~----~~~----------~  215 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET----M-TMIL----KAK----------L  215 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH----H-HHHH----cCC----------C
Confidence            3345789999999999988899999999999999999999999975422111    1 1000    000          0


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          563 EFEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       563 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      .++......+.+++.+||+.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            112223456788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-37  Score=314.30  Aligned_cols=248  Identities=29%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      .||+|+||.||+|.++..  ..+..+|+|+++...  ....+++.+|+.+++.++|+||+++++++.. +..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK--KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecC--CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999976432  123789999987543  3345788999999999999999999998854 56799999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc-
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-  482 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-  482 (636)
                      +|+|.+++..  ...+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++......... 
T Consensus        79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9999999843  356899999999999999999999   8999999999999999999999999999998664433211 


Q ss_pred             -ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          483 -TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       483 -~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.||.......     +...+.    .+         .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~----~~---------~  215 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIE----SG---------E  215 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----CC---------C
Confidence             122234578999999988889999999999999999997 999997542211     111111    11         1


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ....+...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            112223345668899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=335.58  Aligned_cols=254  Identities=23%  Similarity=0.365  Sum_probs=199.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||.||+++....+    +.||+|++...   .......+.+|+.++..++|+||+++++++.+++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~   76 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTG----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYL   76 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeE
Confidence            46888999999999999999987655    78999999753   233446678899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999999854  356899999999999999999999   899999999999999999999999999998754


Q ss_pred             cCCCCc-------------------------------------cccccccCCcccccccccCCCCCCccchHHHHHHHHH
Q 006668          476 QQGEVP-------------------------------------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILE  518 (636)
Q Consensus       476 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~e  518 (636)
                      ......                                     .....+||+.|+|||++....++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            321100                                     0112469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 006668          519 VACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT---MREVVA  595 (636)
Q Consensus       519 ll~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~evl~  595 (636)
                      |++|+.||......... .....|..      .+      ....  .......+.+++.+|+. +|.+|++   +.|+++
T Consensus       232 l~~G~~Pf~~~~~~~~~-~~i~~~~~------~~------~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         232 MLVGYPPFCSDNPQETY-RKIINWKE------TL------QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhcCCCCCCCCCHHHHH-HHHHcCCC------cc------CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999754322111 11111100      00      0000  00123456677778886 8999998   999887


Q ss_pred             HH
Q 006668          596 VL  597 (636)
Q Consensus       596 ~L  597 (636)
                      +-
T Consensus       296 h~  297 (364)
T cd05599         296 HP  297 (364)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=312.92  Aligned_cols=249  Identities=32%  Similarity=0.506  Sum_probs=205.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|++|.||++...+      +.|++|.+..... ..+++.+|+.++++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~------~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRG------QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecC------cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            467888999999999999998643      7899999987654 567889999999999999999999999988999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++.++..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999996655557999999999999999999999   899999999999999999999999999999866332


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..    ....+..|+|||.+....++.++||||||++++||++ |+.||.......     +...+..            
T Consensus       156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~------------  214 (256)
T cd05039         156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEK------------  214 (256)
T ss_pred             cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhc------------
Confidence            21    2334678999999998889999999999999999997 999986542111     1111110            


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       ......+...+..+.+++.+||..+|++||++.|++++|+.
T Consensus       215 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 -GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             01111122335678899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-37  Score=315.61  Aligned_cols=256  Identities=24%  Similarity=0.441  Sum_probs=199.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc------
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG------  392 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------  392 (636)
                      |.+.++||+|+||.||+|++...+  ....+|+|.++..  .....+.+.+|+.+++.++|+||++++++|...      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD--SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC--CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            356788999999999999986543  1247999988754  345567889999999999999999999987432      


Q ss_pred             ceEEEEEeecCCCChhhhHhc----CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 NELMLVYDYMPNGSLNNWIFG----KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      ...+++|||+++|+|.+++..    .....+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECC
Confidence            247899999999999998742    22345899999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||.......     +.+.    
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~----  226 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-----IYDY----  226 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH----
Confidence            99998764432211 122345778999999999999999999999999999999 788886432111     1111    


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+...         ......+..+.+++.+||+.||++||++.++++.|+.
T Consensus       227 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         227 LRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111110         1122334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.2e-38  Score=328.80  Aligned_cols=244  Identities=23%  Similarity=0.352  Sum_probs=195.9

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+|+....+    +.||+|++...   .....+.+..|..++..+ +||||+++++++...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTD----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECCCC----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence            46999999999999987655    78999999754   233445677888888766 79999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-  150 (321)
T cd05591          77 YVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-  150 (321)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence            9999999998843  456899999999999999999999   8999999999999999999999999999987543222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||........    + ..+.    .+..        
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~----~-~~i~----~~~~--------  213 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL----F-ESIL----HDDV--------  213 (321)
T ss_pred             ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH----H-HHHH----cCCC--------
Confidence            122345789999999999999999999999999999999999999975432211    1 1110    0000        


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRP-------TMREVVAVL  597 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-------s~~evl~~L  597 (636)
                        .++......+.+++.+||+.||++||       ++.++++.-
T Consensus       214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence              11112235677889999999999999       788888664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.7e-37  Score=321.64  Aligned_cols=261  Identities=24%  Similarity=0.409  Sum_probs=207.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||++..... .......||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4588889999999999999985321 22334689999987653 34456788999999999 799999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999996554455899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          476 QQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       476 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........    ....+.    .+   
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~~~~----~~---  260 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYKLIK----EG---  260 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHHHHH----cC---
Confidence            433211 1122345778999999999999999999999999999998 9999865432211    111111    11   


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                            ............+.+++.+||.++|++||++.|+++.|+.
T Consensus       261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                  1111112234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.7e-38  Score=334.65  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=206.4

Q ss_pred             CHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeee
Q 006668          310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMR  386 (636)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~  386 (636)
                      ..+++....++|+..+.||+|+||.||+++...++    +.+|+|++...   .....+.+.+|+.+++.++||||++++
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCC----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            34556666789999999999999999999987765    88999998642   223345677899999999999999999


Q ss_pred             ccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      +++.+++..++||||+++|+|.+++..   ..++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999843   35788899999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS----PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +|||+++.............+||+.|+|||++....    ++.++|||||||++|||++|+.||........    ....
T Consensus       184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i  259 (371)
T cd05622         184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----YSKI  259 (371)
T ss_pred             EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----HHHH
Confidence            999999876543333334567999999999987543    78899999999999999999999975422111    1110


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhc
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVLVG  599 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L~~  599 (636)
                          ......       +.-.........+.+++.+|+..++.+  ||++.|+++...-
T Consensus       260 ----~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         260 ----MNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             ----HcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence                000000       000001123456777888899844433  7899999987643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.7e-37  Score=317.41  Aligned_cols=248  Identities=26%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|+||.||+++.+..+    ..+|+|++....   ....+.+..|++++++++||||+++.+++..+...++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTG----KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEccCC----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCC
Confidence            699999999999987655    889999986431   1223445679999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  ..
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~  151 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TI  151 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--ee
Confidence            999999986655667899999999999999999999   8999999999999999999999999999997654332  22


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.............    .... ...        ... 
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~----~~~~-~~~--------~~~-  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK----RRTL-EDE--------VKF-  217 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----HHhh-ccc--------ccc-
Confidence            33468999999999999889999999999999999999999996543221111111    1110 000        000 


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ........+.+|+.+||+.||++||+++|+++.+
T Consensus       218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            0012244578899999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-37  Score=319.56  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             CCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |...+.||+|+||.||+|..... .......||+|+++..... ..+.+.+|+.++..++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            45567899999999999987543 2233478999999865433 346688999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcC--------------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          399 YDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +||+++++|.+++...              ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            9999999999998421              1245888899999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......     ..+.
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~  238 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----VIEM  238 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence            99999998865433221 1222345779999999988889999999999999999998 888886442111     1111


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +.    .+.         ....+.+.+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       239 i~----~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         239 IR----NRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HH----cCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            11    111         11223345667889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-37  Score=326.74  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=197.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCC-ceeeeeccccccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHK-NLVQMRGWCRKGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~g~~~~~~~~  395 (636)
                      +|+..+.||+|+||.||+|+....+    +.||+|++...   .....+.+..|+.++..++|+ +|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEE
Confidence            4778899999999999999987655    78999999754   233456778899999999764 688899999888999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            999999999999999843  356889999999999999999999   899999999999999999999999999998743


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .... +..    .     
T Consensus       152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~-i~~----~-----  216 (324)
T cd05587         152 IFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQS-IME----H-----  216 (324)
T ss_pred             CCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHH-HHc----C-----
Confidence            2211 12234579999999999999999999999999999999999999997543211    1111 100    0     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~~  596 (636)
                           ...++......+.+++.+||+.||.+|++.     .++++.
T Consensus       217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 -----NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 011122234567889999999999999986     566544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.6e-37  Score=316.52  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..++||+|+||.||+|++...+......||+|.+... .....+++.+|+.++..++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            46788899999999999999977665544557999999765 33445678899999999999999999999875 45789


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ++||+++|+|.+++..+ ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999998543 356899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......++..|+|||...+..++.++|||||||++|||++ |..||......     .+..++..    +.    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~----~~----  228 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLEK----GE----  228 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHC----CC----
Confidence            2211 1111234678999999998899999999999999999998 89998644211     12222211    10    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ...........+.+++.+||+.||++||++.++++.|+..
T Consensus       229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                 0111223345688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-37  Score=330.70  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=202.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc----
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----  393 (636)
                      +|+..+.||+|+||.||++.....+    +.||+|++...  .....+++.+|+.+++.++|+||+++++++...+    
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   76 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDG----KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF   76 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCC----CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence            4778899999999999999976554    88999998653  3344567889999999999999999999998776    


Q ss_pred             -eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                       ..++|+||+. ++|.+++.  ....+++.++..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          77 EEIYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             ceEEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence             7899999995 68888774  3457899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +..............++..|+|||++.+. .++.++|||||||++|||++|+.||...........     +........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----i~~~~g~~~  225 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL-----ITDLLGTPS  225 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHHHcCCCC
Confidence            87654433333445688999999988774 478899999999999999999999976532211111     111111110


Q ss_pred             chh----------hhhhh------h--hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          552 ICE----------AADAR------I--RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       552 ~~~----------~~d~~------l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+          .+...      .  ...........+.+|+.+||+.||++|||+.|++++-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            000          00000      0  0011122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-37  Score=326.48  Aligned_cols=247  Identities=22%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      +|...+.||+|+||.||+|+....+    ..||+|.+....   ....+.+..|..++..+ +|++|+++++++...+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRL   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEE
Confidence            4778899999999999999987655    789999997542   23344567788888777 589999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            999999999999998843  356899999999999999999999   899999999999999999999999999999754


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .. ..+..    ..    
T Consensus       152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~-~~i~~----~~----  217 (323)
T cd05616         152 MWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LF-QSIME----HN----  217 (323)
T ss_pred             CCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HH-HHHHh----CC----
Confidence            3222 12234579999999999999999999999999999999999999997542211    11 11110    00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVA  595 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~  595 (636)
                            ..++......+.+++.+|++.||++|++.     .++.+
T Consensus       218 ------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         218 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                  11222334567889999999999999984     56654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.4e-37  Score=318.36  Aligned_cols=266  Identities=24%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCC------------CCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeee
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNN------------NNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM  385 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~------------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l  385 (636)
                      ++|+..+.||+|+||.||+++....+.            .....||+|.+.... ....+++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            468889999999999999998765321            123578999998653 4456788999999999999999999


Q ss_pred             eccccccceEEEEEeecCCCChhhhHhcCC---------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCE
Q 006668          386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKP---------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI  456 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  456 (636)
                      ++++..++..++++||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence            999999999999999999999999985432         236899999999999999999999   89999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCChh
Q 006668          457 LLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC--GRRPLDMGKGEE  533 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~--G~~Pf~~~~~~~  533 (636)
                      +++.++.++|+|||+++....... .......++..|+|||.+....++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999976543322 12223456789999999998889999999999999999998  677775432111


Q ss_pred             hHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       534 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                           ....+...+..+..      ..........+..+.+++.+||+.||++||++.||++.|+
T Consensus       242 -----~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 -----VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -----HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                 11111111111110      0001112223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.7e-37  Score=333.07  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~  395 (636)
                      ++|...++||+|+||.||+|++... .......||+|+++... ....+.+.+|+.++.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            3567789999999999999997642 22344789999998653 333457889999999997 99999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC------------------------------------------------------------
Q 006668          396 MLVYDYMPNGSLNNWIFGKP------------------------------------------------------------  415 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  415 (636)
                      ++||||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999996432                                                            


Q ss_pred             ------------------------------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          416 ------------------------------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       416 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                                                          ...+++.+++.++.||+.||+|||   +.+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                124677888999999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      +++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||........   
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---  350 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---  350 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence            999999999999986533221 12223456789999999998889999999999999999998 8889865422211   


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       +...    ...+         .+...+......+.+++.+||+.+|++||++++|++.|+.
T Consensus       351 -~~~~----~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         351 -FYNA----IKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             -HHHH----HHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             1110    0111         1111122234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-37  Score=322.04  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|..+..+  ....+++|.++.. ......++.+|+.++.++ +|+||+++++++..++..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCC--ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            46788899999999999999976533  1245688877653 344556888999999999 8999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          397 LVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +||||+++++|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence            9999999999999996432              235889999999999999999999   89999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||++.......  .......+..|+|||.+.+..++.++|||||||+++||++ |..||........     ..
T Consensus       162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~  234 (303)
T cd05088         162 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YE  234 (303)
T ss_pred             cEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----HH
Confidence            99999999986432111  1111234668999999988889999999999999999998 9999964422111     11


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+    ..         .............+.+|+.+||+.+|++||++.++++.|+.
T Consensus       235 ~~----~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         235 KL----PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HH----hc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            00    00         01111112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.8e-37  Score=311.74  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||+|+||.||+++....+    ..+++|.++.. .....+.+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSD----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCC----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            4677899999999999999976655    78999998654 334456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++..++.++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            99999999999986555567899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......++..|+|||++.+..++.++||||||+++|+|++|+.||.......    ...    .. ..+..      
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~----~~-~~~~~------  217 (255)
T cd08219         154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----LIL----KV-CQGSY------  217 (255)
T ss_pred             cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----HHH----HH-hcCCC------
Confidence            21 2223568899999999999899999999999999999999999997542111    110    00 01111      


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         ...+......+.+++.+||+.||++||++.|++..
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               11122234567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-37  Score=321.39  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=206.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC---CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeecccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN---NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~  392 (636)
                      ..+|.+.+.||+|+||.||+++....   .......||+|.+... .....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            34577889999999999999986421   2233468999998754 344567889999999999 899999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL  458 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll  458 (636)
                      +..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999996532              245788999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeccCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 006668          459 DSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEE  536 (636)
Q Consensus       459 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~  536 (636)
                      ++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.......   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence            999999999999998664432221 222345678999999998889999999999999999998 788885432111   


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        +..   .. ..+         .....+...+..+.+++.+||+.+|++||++.|+++.|+.-
T Consensus       248 --~~~---~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         248 --LFK---LL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             --HHH---HH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence              111   11 111         11111223456788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-36  Score=309.89  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=208.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|++|.||+|.....+    ..|++|.++..   .....+.+.+|++++++++|+|++++++++...+..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~   77 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDG----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNEL   77 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCC----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            57888999999999999999987554    78999988642   233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++||||+++++|.+++..  .....+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999999999854  23456899999999999999999999   8999999999999999999999999999987


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ..+....        
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~--------  219 (267)
T cd08224         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK--------  219 (267)
T ss_pred             eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhh--------
Confidence            6543321 222346888999999999888999999999999999999999998644211      1111100        


Q ss_pred             hhhhhhhhhccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 EAADARIRQEFEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .........+. .....+.+++.+||..+|++||++.+|+++|+.-
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         220 --IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              00011111122 3456788999999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-37  Score=318.52  Aligned_cols=266  Identities=26%  Similarity=0.415  Sum_probs=203.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC----------CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeec
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN----------NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~----------~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ++|+..+.||+|+||.||+++....+          ......||+|.++.. .......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            46888899999999999998864321          112346899999765 3444567899999999999999999999


Q ss_pred             cccccceEEEEEeecCCCChhhhHhcCC----------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEE
Q 006668          388 WCRKGNELMLVYDYMPNGSLNNWIFGKP----------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL  457 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIl  457 (636)
                      ++...+..++||||+++++|.+++....          ...+++.+++.++.|++.||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999985321          124788999999999999999999   899999999999999


Q ss_pred             EcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCChhh
Q 006668          458 LDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC--GRRPLDMGKGEEE  534 (636)
Q Consensus       458 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~--G~~Pf~~~~~~~~  534 (636)
                      +++++.+||+|||++......... ......++..|+|||.+....++.++||||||++++||++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            999999999999999765432211 1222345778999999998899999999999999999988  566776442221 


Q ss_pred             HHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          535 EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       535 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                         .... +...+...      ........+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus       241 ---~~~~-~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIEN-TGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHH-HHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               1111 11111000      000001111223467999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-37  Score=323.87  Aligned_cols=242  Identities=25%  Similarity=0.406  Sum_probs=192.6

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhcc-CCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|+||.||+|+....+    ..||+|.++...   ....+.+..|..++.. ++||||+++++++.+.+.+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe
Confidence            46999999999999987655    789999997642   2234556677777775 489999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 y~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05619          77 YLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-  150 (316)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence            9999999999843  356889999999999999999999   8999999999999999999999999999987532222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||.......     +...+..    +      .+  
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~i~~----~------~~--  213 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----LFQSIRM----D------NP--  213 (316)
T ss_pred             CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----C------CC--
Confidence            12234578999999999999999999999999999999999999997542211     1111110    0      01  


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMR-EVVA  595 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  595 (636)
                        .++......+.+++.+||+.||++||++. ++.+
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              11112334577889999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=318.18  Aligned_cols=258  Identities=27%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------------HHHHHHHHHHHHhccCCCCc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------------QGLKEFMAEISSMGRLQHKN  381 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~h~n  381 (636)
                      +.-++|++.+.||+|.||.|-+|+....+    +.||||++.+...              ..++...+||.+|++++|+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~----~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDG----KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCC----cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            34567889999999999999999976665    8999999975311              12357889999999999999


Q ss_pred             eeeeecccccc--ceEEEEEeecCCCChhhhHhcCCCCC-cChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE
Q 006668          382 LVQMRGWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKL-LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL  458 (636)
Q Consensus       382 iv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll  458 (636)
                      ||+|+.+..+.  +.+|||+|||..|.+...=   .... |+..++++++.+++.||.|||   .++|+||||||+|+||
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLL  243 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEE
Confidence            99999998654  6799999999998886543   3334 999999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEeccCCcccccCCCC----ccccccccCCcccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          459 DSEMRGRLGDFGLAKLYQQGEV----PNTTRVVGTLGYLAPELATVSS----PTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       459 ~~~~~~kl~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      ++++.+||+|||.+.....+..    ......+||+.|+|||+..++.    .+.+.||||+||.||.|+.|+.||....
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999999999986633221    1223368999999999887743    3457899999999999999999996442


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .-.     +.+            +++...+.-.-..+..+++.+|++++|.+||+.|.+..+|..+.+-.
T Consensus       324 ~~~-----l~~------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  324 ELE-----LFD------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             HHH-----HHH------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            111     111            11111221122235678899999999999999999999999887643

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.2e-37  Score=311.17  Aligned_cols=248  Identities=30%  Similarity=0.471  Sum_probs=197.2

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNG  405 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  405 (636)
                      ||+|+||.||+|++...+  .+..||+|.+.... ....+++.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~--~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCC--CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            899999999999875322  22579999997653 3345678999999999999999999998864 5789999999999


Q ss_pred             ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc--c
Q 006668          406 SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN--T  483 (636)
Q Consensus       406 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~  483 (636)
                      +|.+++... ...+++.++++++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..........  .
T Consensus        80 ~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999998543 457899999999999999999999   7999999999999999999999999999998654332211  1


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhh
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ  562 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  562 (636)
                      ....++..|+|||.+....++.++||||||+++||+++ |..||.......     ....+    ..+         ...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~----~~~---------~~~  217 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VMSFI----EQG---------KRL  217 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH----HCC---------CCC
Confidence            11233578999999988889999999999999999996 999997542211     11111    111         112


Q ss_pred             ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          563 EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       563 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..+..+...+.+++.+||..||++||++.+|.+.|+.
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2333445778899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-37  Score=325.18  Aligned_cols=243  Identities=24%  Similarity=0.388  Sum_probs=196.3

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|+||.||+++...++    ..||+|+++..   .......+..|..++..+ +||||+++++++...+.+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTD----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence            46999999999999987655    78999999754   223455677888888877 69999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++.++..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  150 (318)
T cd05570          77 YVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-  150 (318)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence            9999999998843  357999999999999999999999   8999999999999999999999999999987532222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      ......+|+..|+|||++.+..++.++|||||||++|||++|+.||.......    .. ..+.    ...         
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~~-~~i~----~~~---------  212 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----LF-QSIL----EDE---------  212 (318)
T ss_pred             CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----HH-HHHH----cCC---------
Confidence            12233568999999999999999999999999999999999999997542111    11 1010    000         


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~~  596 (636)
                       ..++......+.+++.+||+.||.+||++     .++++.
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             11122234567899999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.9e-37  Score=312.38  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .+|+..+.||+|++|.||+++...++    ..+++|.+...   ......++.+|+.+++.++|+||+++++++.+++..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   77 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL   77 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCC----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeE
Confidence            35777889999999999999976555    78999988653   233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      +++|||+++++|.+++..  .....+++.+++.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999999998853  23456899999999999999999999   8999999999999999999999999999987


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++|..||.......  . .....+         .
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~~~~~---------~  221 (267)
T cd08229         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--Y-SLCKKI---------E  221 (267)
T ss_pred             ccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH--H-HHhhhh---------h
Confidence            6543322 1223468899999999998889999999999999999999999986432111  0 111100         0


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...   ............+.+++.+||+.||++||||.+|++.+..
T Consensus       222 ~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         222 QCD---YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             cCC---CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            000   0111112345678899999999999999999999998854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-37  Score=311.68  Aligned_cols=254  Identities=26%  Similarity=0.463  Sum_probs=204.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||++.....     ..+++|.+.... ...+.+.+|++++++++|+||+++.+.+.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~-----~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCC-----ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            35688899999999999999986543     569999887543 345678899999999999999999999877 77899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +|||+++++|.+++.......+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999999997655567899999999999999999999   78999999999999999999999999999986654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........++..|+|||++....++.++|+||||++++|+++ |+.||.......     ...++.    .+      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~----~~------  219 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALE----RG------  219 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHh----CC------
Confidence            33222222345678999999998889999999999999999998 899986542211     111111    11      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         .........+..+.+++.+|++++|++||++.++++.|+.
T Consensus       220 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               0111122344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.3e-37  Score=317.64  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=205.9

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|++.++||+|+||.||+|..++. .......||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            346788899999999999999976542 12234689999887553 2334567889999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC--------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP--------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||   +++++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999995421        234567788999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       467 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      +|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......     ..+.+ 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~-  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VLKFV-  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-
Confidence            999999865432221 1122345678999999998899999999999999999998 788886542211     11111 


Q ss_pred             HHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ...+.          ...+......+.+++.+|++.||++||++.++++.|...
T Consensus       235 --~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 --MDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --HcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence              11100          011223346799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-37  Score=310.80  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=200.0

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ++||+|+||.||+|++...+ .....+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS-GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccC-CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            46999999999999875532 2336899999986643 34567899999999999999999999876 456899999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +|+|.+++...  ..+++..++.++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++..........
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999999543  37899999999999999999999   88999999999999999999999999999986644332111


Q ss_pred             --cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          484 --TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       484 --~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......     .+..++..    +.         
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----~~~~~~~~----~~---------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----EVIAMLES----GE---------  215 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHc----CC---------
Confidence              11223568999999999999999999999999999998 99999654221     11222111    11         


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+...+..+.+++.+||.++|++||++.++++.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1112223446788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-37  Score=313.41  Aligned_cols=258  Identities=28%  Similarity=0.484  Sum_probs=205.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|++.+.||+|+||.||+|+....+ .....+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPG-KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCC-CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            35778899999999999999875432 223579999987643 3445688999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999999643 346899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccc--cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNT--TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ......  ....++..|+|||++.+..++.++||||||+++||+++ |+.||.......     ....+..    +    
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~~~----~----  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-----VIKAIEE----G----  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-----HHHHHhC----C----
Confidence            322111  11223568999999998899999999999999999886 999996543211     1111111    0    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           .........+..+.+++.+|++.+|++||+|.++++.|..
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         226 -----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                 0111122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-37  Score=327.27  Aligned_cols=238  Identities=27%  Similarity=0.366  Sum_probs=189.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHH-HhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEIS-SMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+|+...++    +.||+|++....   ....+++..|.. +++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADG----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence            46999999999999987655    889999997542   222344555554 5678999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (323)
T cd05575          77 YVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-  150 (323)
T ss_pred             CCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence            9999999999843  457899999999999999999999   8999999999999999999999999999987532222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||............        . .+.      ..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------~-~~~------~~~  215 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--------L-NKP------LRL  215 (323)
T ss_pred             CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--------H-cCC------CCC
Confidence            2233457999999999999999999999999999999999999999754221111110        0 000      011


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      ..    .....+.+++.+|++.||.+||+++
T Consensus       216 ~~----~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KP----NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11    2245678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.2e-37  Score=315.36  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccc-cceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-GNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~  395 (636)
                      .++|+..++||+|+||.||+|.....+......|++|.+... .....+.+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            457888899999999999999987643334588999998755 34446778899999999999999999998766 4678


Q ss_pred             EEEEeecCCCChhhhHhcCCC------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPK------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      ++++||+++++|.+++.....      ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999854322      46899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          470 GLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       470 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |+++......... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......     .+..++..  
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~--  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----EMAAYLKD--  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----HHHHHHHc--
Confidence            9998654332211 112345778999999998889999999999999999998 99999654221     12222111  


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        +         .........+..+.+++.+||+.||++||++.++++.|+.-
T Consensus       235 --~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 --G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0         00011122345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.4e-37  Score=316.08  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |+..++||+|+||.||++.....+    +.||+|.+....   ......+..|+.++++++|+|++++++.+...+..++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   77 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCC----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEE
Confidence            677889999999999999987765    899999986542   2233557789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.....
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            999999999999986555567999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..  ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .......             
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~-------------  218 (285)
T cd05630         155 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVK-------------  218 (285)
T ss_pred             Cc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhh-------------
Confidence            22  1223468999999999999999999999999999999999999997543211111 1111000             


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVLV  598 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L~  598 (636)
                       .....+.......+.+|+.+||+.||++||+     +.|++++-.
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         219 -EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             -hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence             0111122223455788999999999999999     788887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-37  Score=313.37  Aligned_cols=257  Identities=27%  Similarity=0.466  Sum_probs=205.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .|+..+.||+|+||.||+|.....++ ....|++|++... .....+++..|+.++++++||||+++.+++.+++..++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCC-CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            36678999999999999999876432 2357999998765 444567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999998543 356899999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCcc-ccc-cc--cCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          479 EVPN-TTR-VV--GTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       479 ~~~~-~~~-~~--gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .... ... ..  .+..|+|||.+.+..++.++||||||+++|||++ |..||......     ....++...       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~~-------  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQD-------  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHcC-------
Confidence            2111 111 11  2457999999999999999999999999999886 99999654221     112222110       


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                            .......+.+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                  1111122345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-37  Score=324.38  Aligned_cols=242  Identities=24%  Similarity=0.374  Sum_probs=192.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhcc-CCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++....+    ..||+|+++...   ....+....|..++.. ++||||+++++++.+.+..++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKG----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC
Confidence            46999999999999987655    789999997542   2234556677777765 489999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05620          77 FLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-  150 (316)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence            9999999999843  456889999999999999999999   8999999999999999999999999999987432222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||.......     +...+..    +      .+  
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-----~~~~~~~----~------~~--  213 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-----LFESIRV----D------TP--  213 (316)
T ss_pred             CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----C------CC--
Confidence            12334679999999999999999999999999999999999999997542211     1111100    0      01  


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMR-EVVA  595 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  595 (636)
                        .++......+.+++.+||+.||++||++. ++++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 --HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              11112334577899999999999999985 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=333.57  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=198.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||.||+++....+    +.||+|++...   .....+.+.+|++++.+++||||+++++++.+.+..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   76 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTG----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL   76 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee
Confidence            36888999999999999999987655    78999998653   233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999999853  456889999999999999999999   899999999999999999999999999999633


Q ss_pred             cCCCC-------------c---------------------------------cccccccCCcccccccccCCCCCCccch
Q 006668          476 QQGEV-------------P---------------------------------NTTRVVGTLGYLAPELATVSSPTSASDV  509 (636)
Q Consensus       476 ~~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV  509 (636)
                      .....             .                                 .....+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            21000             0                                 0012469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCC--
Q 006668          510 YSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR--  587 (636)
Q Consensus       510 ~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R--  587 (636)
                      |||||++|||++|+.||.......... ....|...      +      .+..  .......+.+++.+|+. +|.+|  
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~-~i~~~~~~------~------~~p~--~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYR-KIINWRET------L------YFPD--DIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHH-HHHccCCc------c------CCCC--CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            999999999999999997543221111 11111000      0      0000  00123456778888887 66664  


Q ss_pred             -CCHHHHHHHHh
Q 006668          588 -PTMREVVAVLV  598 (636)
Q Consensus       588 -Ps~~evl~~L~  598 (636)
                       +++.|++++-.
T Consensus       296 r~~~~~~l~hp~  307 (377)
T cd05629         296 RGGAHEIKSHPF  307 (377)
T ss_pred             CCCHHHHhcCCC
Confidence             69999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-37  Score=313.95  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=196.9

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      ++||+|+||.||+|+...++  ....+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC--CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            46899999999999986643  1245788888754 344557888999999999 7999999999999999999999999


Q ss_pred             CCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          403 PNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       403 ~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      ++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECC
Confidence            9999999986432              235789999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      ||++.......  .......+..|+|||++....++.++||||||++++||++ |+.||.......     ...   . .
T Consensus       156 fgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~---~-~  224 (270)
T cd05047         156 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYE---K-L  224 (270)
T ss_pred             CCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHH---H-H
Confidence            99986432111  1111234567999999988889999999999999999997 999996432111     111   0 0


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..         ....+........+.+++.+||+.||.+||++.++++.|+.
T Consensus       225 ~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         225 PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             hC---------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            01         01111122234568899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-37  Score=321.27  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=205.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++|.+.+.||+|+||.||+++....+.   .....+|+|.+... ......++..|+.++..+ +|+||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468889999999999999998654221   22357999999865 344556788999999999 7999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ..++||||+++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999996532              235899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence            99999999999997654322111 112234568999999998889999999999999999998 888885432111    


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +...+    ..         ....+.+......+.+++.+||+.+|++||+|.++++.|+.-
T Consensus       251 -~~~~~----~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         251 -LFKLL----KE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             -HHHHH----Hc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             11100    01         111122233456788899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2e-37  Score=325.43  Aligned_cols=238  Identities=27%  Similarity=0.378  Sum_probs=189.1

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHH-HhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEIS-SMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++....+    ..||+|++....   .....++..|.. +++.++||||+++++++.+.+..++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDG----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence            46999999999999987655    889999997542   222344555554 6788999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  150 (321)
T cd05603          77 YVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-  150 (321)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence            9999999988843  456888999999999999999999   8999999999999999999999999999987532222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     +.+.+.    .+          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~----~~----------  211 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNIL----HK----------  211 (321)
T ss_pred             CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHh----cC----------
Confidence            22334578999999999999899999999999999999999999997542111     111110    00          


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      ...++......+.+++.+|++.||.+||+..
T Consensus       212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            0112223345688899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.6e-37  Score=309.38  Aligned_cols=252  Identities=28%  Similarity=0.449  Sum_probs=203.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ++||+|++|.||+|.+... +.....||+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS-GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecC-CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            4689999999999998653 22335799999987755 667789999999999999999999999988 88999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc--
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--  481 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--  481 (636)
                      +++|.+++.+.....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.........  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999996544357899999999999999999999   899999999999999999999999999999876442211  


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    .... +..   .+         .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~-~~~---~~---------~  218 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKK-IDK---EG---------E  218 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-HHh---cC---------C
Confidence            1122456789999999999999999999999999999998 999996442211    1111 110   00         0


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            01112233567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.3e-37  Score=314.80  Aligned_cols=252  Identities=26%  Similarity=0.337  Sum_probs=201.2

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |+..++||+|+||+||+++....+    +.+|+|.+....   ......+.+|+.++++++|+|++++.+.+..++..++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   77 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATG----KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCL   77 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCC----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEE
Confidence            667789999999999999987655    789999986542   2233457789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            999999999999986655567999999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..  ......|+..|+|||++.+..++.++|+||||+++|||++|+.||.............    .. ...+       
T Consensus       155 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----~~-~~~~-------  220 (285)
T cd05632         155 GE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----RR-VLET-------  220 (285)
T ss_pred             CC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----Hh-hhcc-------
Confidence            22  1223468999999999998899999999999999999999999997542211111110    00 0000       


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                         ...+.......+.+|+.+|++.||++||+     +.++++.
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 ---EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence               01122223456788999999999999999     5566554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6e-37  Score=310.65  Aligned_cols=248  Identities=28%  Similarity=0.458  Sum_probs=200.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccc-cccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC-RKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||++...+      ..+++|.+.....  .+.+.+|+.++++++|+|++++++++ ..++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcC------CcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            367888999999999999998653      6789999865433  46788999999999999999999975 45567899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            999999999999997655556899999999999999999999   89999999999999999999999999999875433


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..    ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......     +..++..           
T Consensus       155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~-----------  214 (256)
T cd05082         155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEK-----------  214 (256)
T ss_pred             cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhc-----------
Confidence            21    12334678999999998899999999999999999997 999986432111     1111111           


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ..........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       215 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 --GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              11112223445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2e-37  Score=333.44  Aligned_cols=201  Identities=25%  Similarity=0.388  Sum_probs=173.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .|+..++||+|+||.||+|+....+    +.+|+|++...   .......+.+|+.++++++|+||+++++.+.+++.++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTK----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCC----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE
Confidence            5788899999999999999987655    88999998754   2334567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|||||++|+|.+++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        78 lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          78 FVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            99999999999999854  356889999999999999999999   8999999999999999999999999999975321


Q ss_pred             CCC----------------------------------------------CccccccccCCcccccccccCCCCCCccchH
Q 006668          477 QGE----------------------------------------------VPNTTRVVGTLGYLAPELATVSSPTSASDVY  510 (636)
Q Consensus       477 ~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~  510 (636)
                      ...                                              .......+||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence            100                                              0001224699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCC
Q 006668          511 SFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       511 S~Gvll~ell~G~~Pf~~~  529 (636)
                      ||||++|||++|+.||...
T Consensus       233 SlGvil~elltG~~Pf~~~  251 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             echHHHHHHHhCCCCCCCC
Confidence            9999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.6e-37  Score=314.10  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+|+...++    ..||+|++..........+.+|+.++++++|+||+++++++...+..++|
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTG----ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCC----eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            46888899999999999999976655    78999999766555556788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++..  ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          85 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            999999999999853  356899999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          479 EVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      . .......++..|+|||.+.   ...++.++|||||||++|||++|+.||........    ...+     ......  
T Consensus       160 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~~-----~~~~~~--  227 (267)
T cd06646         160 I-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLM-----SKSNFQ--  227 (267)
T ss_pred             c-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----heee-----ecCCCC--
Confidence            2 1222346889999999874   34577899999999999999999999854321110    0000     000000  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       .+...  ........+.+++.+||+.+|++||+++++++.|
T Consensus       228 -~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 -PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             00000  0112245788999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-37  Score=332.88  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .|++.+.||+|+||.||+++....+    +.||+|++....   ......+.+|+.++++++|+||+++++.+.+++.++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~   77 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTN----ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY   77 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCC----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE
Confidence            5888999999999999999977655    899999986532   223466788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus        78 lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          78 FVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            99999999999999954  456888999999999999999999   8999999999999999999999999999975321


Q ss_pred             CCC------------------------------------------CccccccccCCcccccccccCCCCCCccchHHHHH
Q 006668          477 QGE------------------------------------------VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGV  514 (636)
Q Consensus       477 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gv  514 (636)
                      ...                                          .......+||+.|+|||++.+..++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            100                                          00012347999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC---CHH
Q 006668          515 VILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP---TMR  591 (636)
Q Consensus       515 ll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP---s~~  591 (636)
                      ++|||++|+.||........... ...|...          .........+    ..+.+++.+|+ .+|.+|+   ++.
T Consensus       233 ilyell~G~~Pf~~~~~~~~~~~-i~~~~~~----------~~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQLK-VINWETT----------LHIPSQAKLS----REASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHHHH-HhccCcc----------ccCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            99999999999976532211111 1111000          0000011122    33455555555 4999999   889


Q ss_pred             HHHHHHh
Q 006668          592 EVVAVLV  598 (636)
Q Consensus       592 evl~~L~  598 (636)
                      |+++.-.
T Consensus       297 ell~h~~  303 (376)
T cd05598         297 EIKAHPF  303 (376)
T ss_pred             HHhCCCC
Confidence            9988743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.3e-37  Score=315.89  Aligned_cols=266  Identities=24%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccC---CCCceeeeeccccc---
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRL---QHKNLVQMRGWCRK---  391 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~---  391 (636)
                      +|+..+.||+|+||.||+|+...++    ..||+|.++.....  ....+.+|+.+++.+   +||||+++++++..   
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCC----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence            4778899999999999999987665    88999998754211  123445566666554   79999999998754   


Q ss_pred             --cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          392 --GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       392 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                        ....++||||++ ++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+||
T Consensus        77 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          77 DRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             CCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcc
Confidence              345899999996 58988886555566899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH----
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN----  545 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~----  545 (636)
                      |+++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.||........... .......    
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~  229 (288)
T cd07863         153 GLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLPPED  229 (288)
T ss_pred             CccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH-HHHHhCCCChh
Confidence            9998664322  22335689999999999988999999999999999999999999865432221111 1111000    


Q ss_pred             HhcC-Ccch-hhhh---hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          546 LYGQ-GKIC-EAAD---ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       546 ~~~~-~~~~-~~~d---~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .+.. .... ....   .........+..+.+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 0000 0000   000011112334567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-36  Score=310.05  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             HHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          314 LSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ++.+++++.....||+|+||.||+|+...++    ..|++|.+........+.+.+|+.++++++|+||+++++++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQ----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG   78 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCC----cEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence            3456677777889999999999999976654    789999998777667788999999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCc--ChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccC
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLL--GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFG  470 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG  470 (636)
                      ..++|+||+++++|.+++.... ..+  ++..+..++.||+.||+|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence            9999999999999999996432 334  78888999999999999999   899999999999999976 6789999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSS--PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ++........ ......++..|+|||++....  ++.++||||||+++|||++|+.||.........   .  +....  
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~--~~~~~--  226 (268)
T cd06624         155 TSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---M--FKVGM--  226 (268)
T ss_pred             hheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---H--hhhhh--
Confidence            9876543221 222245789999999886644  788999999999999999999998643211110   0  00000  


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                               ......++......+.+++.+||+.+|++||++.|+++.
T Consensus       227 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 ---------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                     001112233445668899999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-37  Score=315.27  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=201.1

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeecccccc--
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG--  392 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~--  392 (636)
                      .+++.|+..+.||+|+||.||+|.....+    +.||+|++..... ...++..|+.++.++ +|+||+++++++...  
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCC----cEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            45667888899999999999999987655    8999999876533 335778899999998 699999999998643  


Q ss_pred             ----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 ----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                          ..+++||||+++++|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence                46899999999999999996655567899999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      ||++....... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||.........   .  ..
T Consensus       155 fg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~--~~  228 (272)
T cd06637         155 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---F--LI  228 (272)
T ss_pred             CCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---H--HH
Confidence            99998654322 2233456899999999876     335788999999999999999999999643211110   0  00


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..   . .        .........+..+.+++.+||..||.+||++.++++.
T Consensus       229 ~~---~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 PR---N-P--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             hc---C-C--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00   0 0        0000111233567899999999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-37  Score=316.95  Aligned_cols=267  Identities=25%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeecccccc--ceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~  395 (636)
                      +.|+..+.||+|+||.||++++...+...+..||+|.++... ......+.+|+.++++++|+||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            346788999999999999998754444555899999987553 44456789999999999999999999998765  568


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++.+. ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999998543 346899999999999999999999   899999999999999999999999999999866


Q ss_pred             cCCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh-------HHHHHHHHHHHH
Q 006668          476 QQGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-------EEAVLMDWVRNL  546 (636)
Q Consensus       476 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~-------~~~~l~~~v~~~  546 (636)
                      ......  ......++..|+|||++.+..++.++||||||+++|||++++.|.........       .......++. .
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence            443221  11234567789999999888899999999999999999998876532211000       0000000110 0


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+         .........+..+.+++.+||+.||++||++.++++.|+.
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            0111         1111122345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-36  Score=315.50  Aligned_cols=266  Identities=26%  Similarity=0.432  Sum_probs=203.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC------------CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeee
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN------------NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQM  385 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~------------~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l  385 (636)
                      ++|+..++||+|+||.||++.....            .......+|+|.+... ......++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4688899999999999999864321            1223357999999765 34445788999999999999999999


Q ss_pred             eccccccceEEEEEeecCCCChhhhHhcCC---------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCE
Q 006668          386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKP---------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI  456 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  456 (636)
                      ++++...+..++||||+++++|.+++....         ...+++.+++.++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999986432         134778899999999999999999   89999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCChh
Q 006668          457 LLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC--GRRPLDMGKGEE  533 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~--G~~Pf~~~~~~~  533 (636)
                      |++.++.+||+|||+++........ ......++..|++||....+.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999999865433211 1222344678999999888889999999999999999998  778886442211


Q ss_pred             hHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       534 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                          .... ....+.....      ......+..++..+.+++.+||+.||++||++.||++.|+
T Consensus       242 ----~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ----VIEN-TGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ----HHHH-HHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                1111 1111100000      0000112234467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-36  Score=307.28  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=203.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc-cceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-GNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~  396 (636)
                      +|+..+.||+|++|.||+++...++    +.+++|.+...  .....+.+..|++++++++|+|++++++.+.. ...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDG----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCC----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence            4788899999999999999986654    78999998754  33445678899999999999999999988764 45689


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ++|||+++++|.+++.......+++.+++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            9999999999999997655567899999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .... ......+++.|+|||++.+..++.++||||||++++||++|+.||......    .......     .+.     
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~-----~~~-----  218 (257)
T cd08223         154 NQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN----SLVYRII-----EGK-----  218 (257)
T ss_pred             ccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH-----hcC-----
Confidence            3222 223346889999999999999999999999999999999999998643211    1111110     111     


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                          ....+......+.+++.+|++.||++||++.++++.
T Consensus       219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 ----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                111223345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=308.25  Aligned_cols=252  Identities=32%  Similarity=0.529  Sum_probs=205.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ++||+|+||.||++...... .....+++|.+...... ..+.+.+|++.++.++|+||+++++++......++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            46999999999999987541 22378999999876443 36788999999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCC-------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          404 NGSLNNWIFGKP-------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       404 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +++|.+++....       ...+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            999999995432       367999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          477 QGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       477 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .... .......++..|+|||.+....++.++||||||++++||++ |+.||.......     +.+.+.    .+    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~----~~----  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----VLEYLR----KG----  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH----cC----
Confidence            4321 22233457889999999998889999999999999999999 699997652111     111111    01    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                           .....+......+.+++.+||+.+|++||++.|+++.|+
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 111222333567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-36  Score=307.81  Aligned_cols=256  Identities=30%  Similarity=0.524  Sum_probs=206.8

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      |++.+.||+|+||.||+++....+......||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999987654444588999999766443 5678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999996544333899999999999999999999   8999999999999999999999999999998765543


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ........++..|+|||.+.+..++.++||||||++++||++ |+.||.......     ....+.    .+.       
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~----~~~-------  221 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-----VLEYLK----KGY-------  221 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHh----cCC-------
Confidence            322222336789999999988889999999999999999998 788886432111     111111    111       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ........+..+.+++.+|+..||++|||+.|+++.|
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              1111222456788899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.2e-37  Score=323.57  Aligned_cols=243  Identities=27%  Similarity=0.355  Sum_probs=190.6

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHH-HHhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEI-SSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|+||.||+++....+    ..||+|++....   .....++..|. .+++.++|+||+++++++...+..++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEE----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence            46999999999999987655    789999997532   22233444444 45678899999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-  150 (325)
T cd05602          77 YINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  150 (325)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence            9999999999853  456788889999999999999999   8999999999999999999999999999997543222 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ....+..    .          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~----~----------  211 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN----K----------  211 (325)
T ss_pred             CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHHh----C----------
Confidence            12334579999999999999999999999999999999999999997542211     1111110    0          


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...+.......+.+++.+|++.||.+||++.+.+..
T Consensus       212 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         212 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            001112234567888899999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.8e-37  Score=315.90  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=205.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||++..... .+.....||+|.+.... ....+++.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            35688889999999999999986431 12234789999987653 34456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC--------------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCC
Q 006668          396 MLVYDYMPNGSLNNWIFGKP--------------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGN  455 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  455 (636)
                      ++||||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999995321                    134788899999999999999999   8999999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChh
Q 006668          456 ILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEE  533 (636)
Q Consensus       456 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~  533 (636)
                      |++++++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875533221 11122234678999999998899999999999999999997 888886442111


Q ss_pred             hHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       534 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           .   .. ....+...         ..+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       241 -----~---~~-~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -----V---IY-YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----H---HH-HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 1   11 11111111         1122335678899999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.8e-37  Score=316.45  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|++|.||+|+....+    ..|++|.+........+.+.+|+.+++.++|+||+++++.+......++|
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCC----cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            57888899999999999999876554    78999999876555567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.   ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        96 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          96 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999984   345889999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||......   .. +..+..    .+.       
T Consensus       170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~-~~~~~~----~~~-------  233 (296)
T cd06654         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RA-LYLIAT----NGT-------  233 (296)
T ss_pred             cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---Hh-HHHHhc----CCC-------
Confidence            21 122346889999999999888999999999999999999999999654211   11 111110    000       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       .....+......+.+++.+||..||++||++.++++.-
T Consensus       234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         234 -PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             -CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence             00011223345688899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.7e-37  Score=319.12  Aligned_cols=261  Identities=25%  Similarity=0.438  Sum_probs=204.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC---CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .+|.+.+.||+|+||.||+++.....   ......+|+|++... ......++.+|+.++.++ +||||++++++|...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45778899999999999999753221   123367999998754 344567788999999999 6999999999999989


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ..++||||+++|+|.+++....              ...+++.++..++.|++.||.|||   +.+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999995432              245899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCcc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999999998654322111 111234567999999998899999999999999999999 888886442111    


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +....    ..+.         ....+......+.+++.+||+.+|++||++.|+++.|...
T Consensus       245 -~~~~~----~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 -LFKLL----REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             -HHHHH----HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             11111    1111         1112223345688899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.2e-37  Score=310.37  Aligned_cols=252  Identities=31%  Similarity=0.476  Sum_probs=202.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHH--HHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK--EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |+..+.||+|+||.||+++....+    ..+|+|++.........  ...+|+.++++++|+||+++++++......++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNG----QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTT----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCC----eEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccc
Confidence            456789999999999999987765    79999999887544322  345699999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.  ....+++.+++.++.|+++||.|||   +.+++|+||||+||++++++.++|+|||.+.... .
T Consensus        77 ~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~  150 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-E  150 (260)
T ss_dssp             EEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-S
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence            99999999999995  3567899999999999999999999   7899999999999999999999999999997541 2


Q ss_pred             CCccccccccCCccccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELAT-VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++. +...+.++||||+|+++++|++|..||...... ........-.             .
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~-------------~  216 (260)
T PF00069_consen  151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKIL-------------K  216 (260)
T ss_dssp             TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHH-------------H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhcc-------------c
Confidence            223344467899999999998 888999999999999999999999999755111 1111111100             0


Q ss_pred             hhhhhccC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFE--AEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..+.....  ......+.+++.+||+.||++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  217 RPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             THHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111110  1113789999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-37  Score=315.55  Aligned_cols=266  Identities=27%  Similarity=0.431  Sum_probs=208.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccc--cceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~  396 (636)
                      .|+..+.||+|+||.||++++...+...+..+|+|.+...... ..+++.+|+++++.++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4667789999999999999986554455689999999866443 56789999999999999999999999877  55789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++... ...+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999643 236999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhH-------HHHHHHHHHHHh
Q 006668          477 QGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE-------EAVLMDWVRNLY  547 (636)
Q Consensus       477 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~-------~~~l~~~v~~~~  547 (636)
                      .....  ......++..|+|||.+.+..++.++||||||++++||++|+.|+.........       ......+.    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  236 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL----  236 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH----
Confidence            32211  111223456799999999889999999999999999999999998643211100       00000110    


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                            +.+........+..++..+.+++.+||+.+|++||+|.||+++|+.
T Consensus       237 ------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         237 ------ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             ------HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence                  1111111112223345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=308.50  Aligned_cols=270  Identities=24%  Similarity=0.314  Sum_probs=204.6

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEecc--CChHHHHHHHHHHHHhccCCCCceeeeeccccc---
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK---  391 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~---  391 (636)
                      ....|...+.||+|+||.|+++..+.++    +.||+|++..  ......++..+|+++|+.++|+||+.+.+.+..   
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTG----EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCC----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            3445666788999999999999988776    8999999983  344456788899999999999999999998765   


Q ss_pred             --cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          392 --GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       392 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                        -+.+|+|+|+| .-+|...|.  ....|+.+....++.|+++||+|+|   +.+|+||||||+|++++.+..+||+||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence              35789999999 779999983  3455999999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCC-CccccccccCCcccccccc-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH----
Q 006668          470 GLAKLYQQGE-VPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV----  543 (636)
Q Consensus       470 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v----  543 (636)
                      |||+...... ....+..+.|.+|.|||++ ...+|+...||||.|||+.||++|+.-|.+.+.-. +-..+.+.+    
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLILELLGTPS  248 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHHHHhcCCCC
Confidence            9999875431 2234667899999999965 55679999999999999999999998786543221 111111100    


Q ss_pred             ---HHHhcCCcchhhhh---hhhhhcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          544 ---RNLYGQGKICEAAD---ARIRQEF---EAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       544 ---~~~~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                         .......+....+.   ..-+..+   -.......++|+.+||..||.+|+|++|.++.-
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence               00000000111000   0000111   012345677888999999999999999999874

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-36  Score=310.14  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=192.3

Q ss_pred             eeeeecCceEEEeeeecCCCC--------CCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          325 ELLGSGGFGRVYKGTLANNNN--------NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +.||+|+||.||+|++.....        .....|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998643221        233568999887665555667889999999999999999999999989999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc-------EEEecc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR-------GRLGDF  469 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~-------~kl~DF  469 (636)
                      +||||+++|+|+.++..+ ...+++..++.++.||++||+|||   +.+|+||||||+|||++.++.       +|++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999988543 356899999999999999999999   899999999999999987664       899999


Q ss_pred             CCcccccCCCCccccccccCCccccccccc-CCCCCCccchHHHHHHHHHHH-hCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELAT-VSSPTSASDVYSFGVVILEVA-CGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~ell-~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |++......     ....++..|+|||++. +..++.++|||||||++|||+ .|+.|+........  ..+       .
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~-------~  222 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERF-------Y  222 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHH-------H
Confidence            998754321     2245788999999886 466889999999999999997 58888754321110  000       0


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      . +..          .........+.+|+.+||+.||++||++.+|++.|+
T Consensus       223 ~-~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E-GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0 000          001112356788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.5e-37  Score=312.96  Aligned_cols=244  Identities=25%  Similarity=0.395  Sum_probs=191.3

Q ss_pred             eeeecCceEEEeeeecCC--------------------CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeee
Q 006668          326 LLGSGGFGRVYKGTLANN--------------------NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM  385 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~--------------------~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l  385 (636)
                      +||+|+||.||+|.+...                    +......|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999986432                    122335689999876655556678899999999999999999


Q ss_pred             eccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---
Q 006668          386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---  462 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---  462 (636)
                      +++|.+.+..++||||+++|+|+.++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999998543 456899999999999999999999   89999999999999997644   


Q ss_pred             ----cEEEeccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHH-hCCCCCCCCCChhhHH
Q 006668          463 ----RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVA-CGRRPLDMGKGEEEEE  536 (636)
Q Consensus       463 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell-~G~~Pf~~~~~~~~~~  536 (636)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......... 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-  231 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence                3899999988643221     12356788999998865 56889999999999999984 699998654222110 


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                          .....           ...+    +......+.+++.+||+.+|++||++.+|++.|.
T Consensus       232 ----~~~~~-----------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 ----RFYEK-----------KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ----HHHHh-----------ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                11000           0001    1111245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-36  Score=306.66  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=206.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|+||.||.++....+    ..+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+.+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDD----SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCC----cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence            4778899999999999999876654    78999988754  34456778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +|||+++++|.+++.......+++.++..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            999999999999996654567899999999999999999999   78999999999999999999999999999986644


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........    ...    . ..+..     
T Consensus       154 ~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----~~~----~-~~~~~-----  218 (256)
T cd08221         154 EYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL----VVK----I-VQGNY-----  218 (256)
T ss_pred             ccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH----HHH----H-HcCCC-----
Confidence            332 22335689999999999888899999999999999999999999965422111    111    0 01111     


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                          ..........+.+++.+||+.+|++||++.++++.+
T Consensus       219 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 ----TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                111123345688899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-37  Score=313.46  Aligned_cols=245  Identities=24%  Similarity=0.412  Sum_probs=193.7

Q ss_pred             eeeeecCceEEEeeeecCCC---CCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      +.||+|+||.||+|.....+   ......+++|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999875532   223456899988766656667888999999999999999999999998899999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--------EEEeccCCcc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--------GRLGDFGLAK  473 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~DFGla~  473 (636)
                      +++|+|.+++..+ ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999654 336899999999999999999999   899999999999999987765        6999999886


Q ss_pred             cccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGR-RPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~-~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      .....     ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... .. ...   ..    .  
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~-~~~---~~----~--  220 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KK-LQF---YE----D--  220 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HH-HHH---HH----c--
Confidence            54321     224578899999998864 5789999999999999999995 455432111 10 000   00    0  


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                               ...++......+.+++.+||+.||++||+++++++.|+
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     01122222356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=338.23  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=206.2

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccc-cc------c
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWC-RK------G  392 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~-~~------~  392 (636)
                      +++.+.|.+|||+.||.++....+    ..+|+|++-...+...+...+||++|++|+ |+|||.+++.. ..      .
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGG----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCC----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            456789999999999999987665    899999998888888999999999999997 99999999932 11      2


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      -+++|.||||++|.|-+++..+....|++.++++|+.++++|+++||. +..+|||||||-+||||..+++.||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            478999999999999999976666679999999999999999999995 3677999999999999999999999999998


Q ss_pred             ccccCCCC-ccc-------cccccCCcccccccc---cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          473 KLYQQGEV-PNT-------TRVVGTLGYLAPELA---TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       473 ~~~~~~~~-~~~-------~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      ...-.... ...       ....-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+.....         
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence            74433221 110       012358999999964   4667899999999999999999999999755111         


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                                  .++..+..-.-.......+..||..||++||++||++-+|+..+..
T Consensus       265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                        1112222212224667889999999999999999999999988754

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.6e-37  Score=311.51  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             eeeeecCceEEEeeeecCCC--CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANNN--NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      +.||+|+||.||+|+..+..  ......+++|.+.... .....++.+|+.+++.++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999976532  2334679999886543 23456888999999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcC-----CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-----cEEEeccCC
Q 006668          402 MPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-----RGRLGDFGL  471 (636)
Q Consensus       402 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~DFGl  471 (636)
                      +++++|.+++...     ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999643     2245889999999999999999999   78999999999999999877     899999999


Q ss_pred             cccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          472 AKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       472 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......     ....+.    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~----~  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVT----A  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHh----c
Confidence            9765432211 1122345778999999999999999999999999999998 999986442111     111110    0


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                               ..........+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       229 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ---------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                     0011122334567889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-37  Score=325.39  Aligned_cols=241  Identities=27%  Similarity=0.338  Sum_probs=190.1

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHH-HhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEIS-SMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|+||.||+++....+    ..+|+|++...   ......++..|.. +++.++||||+++++++...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDG----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence            46999999999999976655    88999999754   2233345555654 4677999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++.  ....+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  150 (325)
T cd05604          77 FVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-  150 (325)
T ss_pred             CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-
Confidence            999999999884  3457899999999999999999999   8999999999999999999999999999987532211 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||........    ...    ... +.      ..+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~----~~~-~~------~~~  215 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDN----ILH-KP------LVL  215 (325)
T ss_pred             CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHH----HHc-CC------ccC
Confidence            223345799999999999999999999999999999999999999975432211    111    000 00      001


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV  594 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  594 (636)
                      ..    .....+.+++.+|++.||.+||++++.+
T Consensus       216 ~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 RP----GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CC----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            11    2334567888999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-36  Score=311.34  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=207.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+.+... ......+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46788899999999999999976532 233467999988765443 4678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCC-------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          397 LVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      +||||+++|+|.+++.....       ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999965431       26899999999999999999999   889999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |++...............++..|+|||.+.+..++.++||||||++++||++ |..||......    . .....    .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~-~~~~~----~  232 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----E-VLNRL----Q  232 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----H-HHHHH----H
Confidence            9987543333223333456778999999988889999999999999999998 78888643211    1 11111    1


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .+..        ........+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       233 ~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111        11112234467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-36  Score=317.17  Aligned_cols=266  Identities=23%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+++....+    ..+++|.+.... .....++.+|++++.+++||||+++++++..++..++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSG----LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCC----eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            36888999999999999999977655    789999987653 3345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++..  ...+++..+..++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++.....
T Consensus        77 v~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          77 CMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999999954  3568999999999999999999993  35899999999999999999999999999875533


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc------
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK------  551 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~------  551 (636)
                      ..   .....++..|+|||++.+..++.++||||||+++|||++|+.||.......     ...+.........      
T Consensus       153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcc
Confidence            21   223468899999999988889999999999999999999999986443111     1111100000000      


Q ss_pred             --------------chhhhhhhhh---hccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          552 --------------ICEAADARIR---QEFE-AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       552 --------------~~~~~d~~l~---~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                                    ..+..+....   ...+ ......+.+++.+||..||++||+++++++...-.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence                          0000000000   0000 01234688999999999999999999999986544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-36  Score=311.57  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..++||+|+||.||+|+....+    ..||+|.+... .....+++.+|++++.+++||||+++++.+...+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTR----RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCC----cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            35778899999999999999876554    78999998765 34445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|..+.      .+++..+..++.|++.||+|||   +.+|+|+||||+|||++.++.+||+|||++.....
T Consensus        77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            99999999997653      4678889999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..   .....++..|+|||++.+..++.++||||||+++|||++|+.||........... ...+.......      ..
T Consensus       148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~------~~  217 (279)
T cd06619         148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDE------DP  217 (279)
T ss_pred             cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhcc------CC
Confidence            22   2235789999999999999999999999999999999999999964321111000 00100000000      00


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +.+   ........+.+++.+|++.||++||+++|+++...-.
T Consensus       218 ~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         218 PVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             CCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence            001   0112234678999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=336.26  Aligned_cols=256  Identities=30%  Similarity=0.442  Sum_probs=216.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      ....++||+|+||+||||.+-..++..+.+||+|.+... ..+...++.+|+.+|.+|+||||++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445789999999999999998888889999999999765 3445688999999999999999999999998766 89999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      +|||.|+|.+|++.+ +..+..+..+.++.|||+||+|||   +++++||||.++|||+.....+||.|||+++....+.
T Consensus       777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999764 567888999999999999999999   8999999999999999999999999999999887654


Q ss_pred             Ccc-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          480 VPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       480 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..- .....-.+.|||=|.+....++.++|||||||.+||++| |..|++....++                  +.+.+.
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------------I~dlle  914 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------------IPDLLE  914 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------------hhHHHh
Confidence            322 222334678999999999999999999999999999988 999997653221                  111222


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+...++-+...+..++.+||..|+..||+++++......
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            222334566677889999999999999999999999887654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.6e-37  Score=321.37  Aligned_cols=242  Identities=23%  Similarity=0.350  Sum_probs=193.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCC-CCceeeeeccccccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~  395 (636)
                      .|+..+.||+|+||.||+++...++    +.||+|++...   .....+.+..|..++..+. |++|+++.+++...+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence            3677899999999999999987655    78999999754   2233456778888888885 57788899999988999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            999999999999999843  456999999999999999999999   899999999999999999999999999998754


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ....+..    +.    
T Consensus       152 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~----~~----  217 (323)
T cd05615         152 MVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQSIME----HN----  217 (323)
T ss_pred             CCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CC----
Confidence            32221 2233568999999999999899999999999999999999999997543211     1111110    00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM  590 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  590 (636)
                            ..++......+.+++.+||+.+|.+|++.
T Consensus       218 ------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  01122234567889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-36  Score=310.09  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=205.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|...... .....|++|...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            35778899999999999999875531 223578999887664 4556788999999999999999999999875 45789


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999999543 346899999999999999999999   89999999999999999999999999999986654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........++..|+|||.+....++.++||||||++++|+++ |..||.......     ...++.    .+.     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~----~~~-----  225 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGRIE----NGE-----  225 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH----cCC-----
Confidence            43322333345568999999988889999999999999999986 999996553211     111111    111     


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          +.......+..+.+++.+|+..+|++||++.++++.|+..
T Consensus       226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                0111223456788999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9e-37  Score=313.21  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=202.6

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      |+..+.||+|+||.||+|.....+    ..||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++||
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTK----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCC----eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            455677999999999999876554    789999987543 445567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++.   ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          82 EYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999999883   356899999999999999999999   8999999999999999999999999999997654332


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      . ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........    . .+             +...
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~-~~-------------~~~~  216 (277)
T cd06642         156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----L-FL-------------IPKN  216 (277)
T ss_pred             h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----H-hh-------------hhcC
Confidence            1 12224578899999999998999999999999999999999999864321110    0 00             0001


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ............+.+++.+||+.+|++||++.++++.-
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            11122233456788999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-36  Score=308.35  Aligned_cols=251  Identities=25%  Similarity=0.468  Sum_probs=200.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      .|+..+.||+|+||.||++.+..+     ..+++|.+..... ...++.+|++++++++|||++++++++......++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEK-----RKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCC-----CeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            567788999999999999987542     6799998875432 2356889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..+ ...++++.++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999999998543 346889999999999999999999   7899999999999999999999999999997654332


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ........++.+|+|||.+.+..++.++||||||+++|||++ |+.||.......     +.+   .. ..+        
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~---~~-~~~--------  217 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVE---TI-NAG--------  217 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHH---HH-hCC--------
Confidence            222222335678999999998899999999999999999998 999986442111     111   11 000        


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       .....+...+..+.+++.+||+.+|++||++.|++++|.
T Consensus       218 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 -FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             000111123467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.9e-36  Score=307.72  Aligned_cols=253  Identities=28%  Similarity=0.427  Sum_probs=195.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeecccc-ccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCR-KGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~E~~  402 (636)
                      +.||+|+||.||+|.....+ .....+|+|.+... .....+.+.+|+.+++.++||||++++++|. .++..++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD-GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCC-CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999875422 23468999998643 3445678889999999999999999999775 455689999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC--
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV--  480 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--  480 (636)
                      ++|+|.+++.+. ...+++..++.++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++.......  
T Consensus        80 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999999543 345678888999999999999999   89999999999999999999999999999975533221  


Q ss_pred             -ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          481 -PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACG-RRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       481 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G-~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                       .......++..|+|||++.+..++.++||||||+++|||++| ..||......     .+...+.    .+.       
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~~----~~~-------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----DITVYLL----QGR-------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHh----cCC-------
Confidence             111223467789999999888999999999999999999995 4555433111     1111111    010       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ....+...+..+.+++.+||+++|++||++.++++.|+..
T Consensus       220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0011112345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=311.01  Aligned_cols=259  Identities=26%  Similarity=0.430  Sum_probs=207.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|+..+.||+|+||.||+|.....+......+|+|...... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            356778999999999999999877665555689999987664 3455788899999999999999999999987 78999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999653 345899999999999999999999   79999999999999999999999999999986653


Q ss_pred             CCCccc-cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVPNT-TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...... ....++..|+|||.+....++.++||||||+++||+++ |+.||.......     +...+.    .+.    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~----  228 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLE----KGE----  228 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHh----CCC----
Confidence            321111 11223568999999988889999999999999999998 999997542211     111111    110    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ....+..+...+.+++.+||..||.+||++.++++.|..-
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 -----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 0111122335678889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-36  Score=307.74  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=193.1

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      +.||+|+||.||+|+....  .....+++|.+.... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG--YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCC--CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            3589999999999987542  233679999887653 3344578899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCC---CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          404 NGSLNNWIFGKP---KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       404 ~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      +|+|.+++....   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999996432   235677888899999999999999   89999999999999999999999999999975433222


Q ss_pred             c-cccccccCCcccccccccCC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          481 P-NTTRVVGTLGYLAPELATVS-------SPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       481 ~-~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      . ......++..|+|||++...       .++.++||||||+++|||++ |+.||........    ...-+.     +.
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~~~~-----~~  226 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LTYTVR-----EQ  226 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HHHHhh-----cc
Confidence            1 12234578889999987643       35789999999999999996 9999965432211    110000     00


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .....++.+    .....+.+.+++..|| .+|++|||+.||++.|+
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111111    1122345777888998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=333.13  Aligned_cols=267  Identities=21%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc------
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK------  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------  391 (636)
                      .++|+..++||+|+||.||+|+....+    +.||+|++.....    ...+|+.+++.++|+||+++++++..      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTS----EKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCC----CEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            457999999999999999999987655    7899998865432    23469999999999999999887532      


Q ss_pred             --cceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEE
Q 006668          392 --GNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRL  466 (636)
Q Consensus       392 --~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl  466 (636)
                        ...+++||||++ ++|.+++..  .....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceee
Confidence              124679999996 577776632  23567899999999999999999999   89999999999999998664 6999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH----
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD----  541 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~----  541 (636)
                      +|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...............    
T Consensus       213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999998664332  22235689999999987654 6899999999999999999999999755322211111100    


Q ss_pred             ---HHHHH---hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          542 ---WVRNL---YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       542 ---~v~~~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                         .....   +..-.........+...++...+..+.+|+.+||..||.+|||+.|++++-.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence               00000   0000000000111222223334467889999999999999999999997644

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-36  Score=320.97  Aligned_cols=262  Identities=27%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeecccccc-ce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG-NE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~  394 (636)
                      ++|+..+.||+|+||.||+|+.... ....++.||||+++... ......+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4688899999999999999985432 22344789999997643 34456788999999999 689999999988654 56


Q ss_pred             EEEEEeecCCCChhhhHhcCC-----------------------------------------------------------
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP-----------------------------------------------------------  415 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  415 (636)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999985421                                                           


Q ss_pred             ------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC-cccccccc
Q 006668          416 ------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVG  488 (636)
Q Consensus       416 ------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g  488 (636)
                            ...+++.++..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||++........ .......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  124788889999999999999999   89999999999999999999999999999976532221 11122345


Q ss_pred             CCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHH
Q 006668          489 TLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAE  567 (636)
Q Consensus       489 t~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  567 (636)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||..........    .    ....+..         ...+..
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~----~~~~~~~---------~~~~~~  306 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----R----RLKEGTR---------MRAPDY  306 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----H----HHhccCC---------CCCCCC
Confidence            678999999988899999999999999999997 999986542211111    1    0111110         011111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          568 EMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       568 ~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+.+++.+||+.||++||++.||++.|+.-
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            234588999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-36  Score=320.60  Aligned_cols=268  Identities=20%  Similarity=0.226  Sum_probs=197.7

Q ss_pred             Cceeeeec--CceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          323 NDELLGSG--GFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       323 ~~~~LG~G--~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ..++||+|  +|++||+++.+.++    +.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTG----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccC----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence            35789999  68999999987766    89999999765  233445677899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++++||+........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999999996554556899999999999999999999   899999999999999999999999999865432211


Q ss_pred             CC-c-----cccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          479 EV-P-----NTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       479 ~~-~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      .. .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||................+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence            10 0     0112346778999999876  45889999999999999999999999754322111111100000000000


Q ss_pred             cc------------------hh---------hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 KI------------------CE---------AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ~~------------------~~---------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .+                  .+         .................+.+++.+||+.||++|||+.|+++.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p  308 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  308 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence            00                  00         0000000111223345788999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-36  Score=305.68  Aligned_cols=251  Identities=23%  Similarity=0.381  Sum_probs=205.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|+||.||+++...++    ..+++|.+...  .....+++.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDG----KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCC----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence            4778899999999999999976655    78999998753  33445688899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||+++++|.+++.......+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            999999999999986554556899999999999999999999   79999999999999999999999999999976544


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ... ......|+..|+|||++.+...+.++|+||||++++||++|+.||.......    .......     +.      
T Consensus       154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~-----~~------  217 (256)
T cd08218         154 TVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIR-----GS------  217 (256)
T ss_pred             chh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhc-----CC------
Confidence            221 1223458889999999999899999999999999999999999996542111    1111110     00      


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         ....+......+.+++.+||+.+|++||++.+|++.
T Consensus       218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 ---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               111223345668899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.6e-37  Score=321.14  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=195.6

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ++||+|+||.||+++....+    ..+|+|++...   .....+.+..|+.++.++ +|+||+++++++...+.+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKND----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEe
Confidence            46999999999999987665    88999999864   233456678899999888 69999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|..++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-  150 (327)
T cd05617          77 YVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-  150 (327)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence            9999999998843  356999999999999999999999   8999999999999999999999999999987532211 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ..+++.......          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~----------  218 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEK----------  218 (327)
T ss_pred             CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhC----------
Confidence            12234579999999999999999999999999999999999999996432211100  011111111000          


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTM------REVVAV  596 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~~  596 (636)
                      ...++......+.+++.+||+.||.+||++      .++++.
T Consensus       219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            011122233557788999999999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=329.13  Aligned_cols=253  Identities=29%  Similarity=0.414  Sum_probs=216.0

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ...++||+|.||.|++|.|.. .+.....||||+++.+... ...+|++|+.+|-+|+|+|+++|||+..+ ....+|+|
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~-psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQ-PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccC-CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345789999999999999987 3445578999999877443 67899999999999999999999999987 77899999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      .++.|+|.+.|++..+..|-......++.|||.||+||.   .+++|||||..+|+||-....+||+||||.+.+...+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999998866778888999999999999999999   89999999999999999999999999999998766543


Q ss_pred             ccc--cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          481 PNT--TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       481 ~~~--~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .-.  ....-...|+|||.+...+++.++|||+|||.+|||++ |..||..-..    .              .|++.+|
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~--------------qIL~~iD  329 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----I--------------QILKNID  329 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----H--------------HHHHhcc
Confidence            221  11223668999999999999999999999999999998 8889865421    1              2345566


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .+-+.+.+..|.+++.++++.||..+|++||++..|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            5556666788999999999999999999999999997544

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.6e-36  Score=320.94  Aligned_cols=268  Identities=22%  Similarity=0.224  Sum_probs=199.5

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc--
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--  392 (636)
                      ..++|+..+.||+|+||.||+++....+    ..||+|.+...  .......+.+|+.+++.++||||+++++++...  
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLG----INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCC----ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            4578999999999999999999876655    88999999754  333456788999999999999999999988644  


Q ss_pred             ----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 ----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                          ...++||||++ ++|.+.+.    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          95 LEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence                35799999995 56766662    34788999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH---------
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL---------  539 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l---------  539 (636)
                      ||+++......  ......||..|+|||++.+..++.++|||||||++|||++|+.||.............         
T Consensus       167 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         167 FGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             CCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            99997543322  2233568999999999999999999999999999999999999997553211110000         


Q ss_pred             -----HHHHHHHhcCCcc------hhhhhhhh---hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          540 -----MDWVRNLYGQGKI------CEAADARI---RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       540 -----~~~v~~~~~~~~~------~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                           ...+.........      .+......   ...........+.+|+.+||+.||++|||+.|+++.-.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                 0000000000000      00000000   00011112356789999999999999999999998653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=290.93  Aligned_cols=261  Identities=25%  Similarity=0.302  Sum_probs=207.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----  393 (636)
                      .++|.+.+.||.|||+-||.++....+    ..+|+|++.....+..+..++|++.-++++|||++++++++..+.    
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~----~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTG----HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcc----cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            467889999999999999999865554    899999999888888899999999999999999999999885543    


Q ss_pred             -eEEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                       +.||+++|...|+|.+.+...  +...+++.+++.|+.+|++||++||.. ..+++||||||.|||+.+++.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence             489999999999999998542  345799999999999999999999932 3459999999999999999999999999


Q ss_pred             CcccccCCCC--------ccccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          471 LAKLYQQGEV--------PNTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       471 la~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      .+......-.        .....-.-|..|.|||++.-.   ..+.++|||||||+||+|+.|..||+....        
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------  246 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------  246 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence            9875432110        011122468899999987644   468899999999999999999999974311        


Q ss_pred             HHHHHHHhcCCcchhhh-hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          540 MDWVRNLYGQGKICEAA-DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                              ..|.+.-++ .+.+.-.-+....+.+.+++.+|++.||.+||++.+++..+..
T Consensus       247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                    111221111 1112112222356889999999999999999999999998864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-36  Score=309.96  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=202.9

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      |+..+.||+|+||.||+|.....+    ..+++|.+........+.+.+|+++++.++|+||+++++.+...+..++|+|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETG----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCC----eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            345678999999999999987655    7899999987766677889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++++|..++.+. ...+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-  157 (282)
T cd06643          83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  157 (282)
T ss_pred             ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence            99999999987542 457899999999999999999999   8999999999999999999999999999987543221 


Q ss_pred             ccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          481 PNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .......++..|+|||++.     ...++.++|||||||++|||++|+.||......    .........     .    
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~-----~----  224 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKS-----E----  224 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHhhc-----C----
Confidence            1223346899999999874     345778999999999999999999998654211    111111100     0    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .+.  ...+......+.+++.+||+.||++||++.++++.-.-.
T Consensus       225 -~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         225 -PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             -CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence             000  011112345688899999999999999999998775443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.1e-36  Score=311.34  Aligned_cols=268  Identities=22%  Similarity=0.296  Sum_probs=198.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+|+....+    ..||+|.+....  ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTG----QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCC----cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence            4677899999999999999986655    789999987542  2234677889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||++ ++|.+++.... ...+++.+++.++.||+.||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            999996 68988885433 367899999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH---HHhcCCcc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR---NLYGQGKI  552 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~---~~~~~~~~  552 (636)
                      ... .......++..|+|||++.+. .++.++||||||++++||++|+.||............+..+..   ..+.....
T Consensus       153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         153 IPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             CCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence            322 122234578899999987654 4688999999999999999999999754322111111111000   00000000


Q ss_pred             hhhhhhhhh-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIR-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .........       ..........+.+++.+||+.||++|||+.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000       00011123566789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-37  Score=307.31  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-H-HHHHHHHHHHhccCCCCc-eeeeeccccccc---
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-G-LKEFMAEISSMGRLQHKN-LVQMRGWCRKGN---  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~---  393 (636)
                      .|...++||+|.||+||+|+.+..+    ..||+|++..+..+ + -....+|+.++++|+|+| ||++.+++...+   
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTG----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCC----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            3455677999999999999988776    89999999877542 2 345679999999999999 999999998877   


Q ss_pred             ---eEEEEEeecCCCChhhhHhcCCC--CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          394 ---ELMLVYDYMPNGSLNNWIFGKPK--KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       394 ---~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                         .+++|+||+ .-+|.+++.....  ..++...+..++.||+.||+|||   +++|+||||||+||||++.|.+||+|
T Consensus        88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeec
Confidence               899999999 7799999965433  45777889999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      ||+|+...... ...+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|...........     +.+..
T Consensus       164 FGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~-----If~~l  237 (323)
T KOG0594|consen  164 FGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR-----IFRLL  237 (323)
T ss_pred             cchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH-----HHHHc
Confidence            99999765333 234556789999999998877 689999999999999999998766755432111111     11111


Q ss_pred             cCC------cchhhhhhh--h-----hhccCHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          548 GQG------KICEAADAR--I-----RQEFEAEEM---ELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       548 ~~~------~~~~~~d~~--l-----~~~~~~~~~---~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      +..      ......+.+  .     ...+....+   ....+++.+|++.+|.+|.|++.++++-
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence            110      000001111  0     011111111   3678899999999999999999999973

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=309.55  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=204.3

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||.|++|.||+|+....+    ..|++|.+.... ......+.+|+.+++.++|+||+++++++.++..+++|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTN----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCC----eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            5777889999999999999987655    899999997653 34456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||+++++|.+++..   ..+++.+++.++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++.....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          78 MEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999999843   37899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      . .......++..|+|||++.+..++.++||||||+++|||++|+.||.......    ..    .. ..         .
T Consensus       152 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~~----~~-~~---------~  212 (274)
T cd06609         152 M-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----VL----FL-IP---------K  212 (274)
T ss_pred             c-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----HH----HH-hh---------h
Confidence            2 22233568889999999999889999999999999999999999996542111    00    00 00         0


Q ss_pred             hhhhccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAE-EMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ......... ....+.+++.+||..+|++||+++++++.-
T Consensus       213 ~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         213 NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            011111111 345688899999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-36  Score=306.59  Aligned_cols=247  Identities=31%  Similarity=0.480  Sum_probs=199.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|...+.||+|+||.||++...+      ..+|+|.+.....  .+.+.+|+.++++++|||++++++++... ..++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYTG------QKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HceeeeeeccCCCCceEecccCC------CceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            47788999999999999987532      6799999875432  35788999999999999999999998664 479999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++.......+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999997655567899999999999999999999   8999999999999999999999999999987543221


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                          .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.......     ....+    ..+        
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~----~~~--------  213 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECV----EKG--------  213 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHH----hCC--------
Confidence                11234568999999998899999999999999999997 999986542211     11111    111        


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       214 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         214 -YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE  254 (254)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence             11111223456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-36  Score=313.26  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=205.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||.|++|.||+|.....+    +.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATG----QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCC----cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            46888899999999999999876555    88999999766555567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||+++++|.+++.   ...+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        95 ~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          95 MEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999999999984   346899999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.........    .. +..   .+.      +
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~-~~~---~~~------~  233 (296)
T cd06655         169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YL-IAT---NGT------P  233 (296)
T ss_pred             cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH-HHh---cCC------c
Confidence            22 122346889999999999888999999999999999999999999754321111    00 000   000      0


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        ....+......+.+++.+||..||++||++.++++.=.
T Consensus       234 --~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         234 --ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             --ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence              00111223456788999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-36  Score=307.15  Aligned_cols=249  Identities=29%  Similarity=0.470  Sum_probs=200.6

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---------HHHHHHHHHHHHhccCCCCceeeeeccccc
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---------QGLKEFMAEISSMGRLQHKNLVQMRGWCRK  391 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~  391 (636)
                      |...+.||+|++|.||+|.....+    ..+|+|.+.....         +..+.+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSG----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD   77 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCC----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence            567789999999999999976544    7899998865321         223568889999999999999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      .+..++||||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence            9999999999999999999943  356889999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCC-----ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          472 AKLYQQGEV-----PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       472 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ++.......     .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......   ... .    .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~-~----~  224 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF-K----I  224 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH-H----H
Confidence            986653211     11122457889999999998889999999999999999999999997542111   110 0    0


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            ..    ......+......+.+++.+||++||.+||++.|+++.
T Consensus       225 ------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         225 ------GE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------hc----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                  00    11112233345678889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6e-37  Score=327.04  Aligned_cols=203  Identities=24%  Similarity=0.379  Sum_probs=175.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++.+++|+||+++++.+.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   76 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTG----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL   76 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            36888899999999999999987655    88999999753   233456788899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            999999999999999843  456899999999999999999999   899999999999999999999999999998754


Q ss_pred             cCCCC----------------------------------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh
Q 006668          476 QQGEV----------------------------------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC  521 (636)
Q Consensus       476 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~  521 (636)
                      .....                                  ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            22110                                  01123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCC
Q 006668          522 GRRPLDMGK  530 (636)
Q Consensus       522 G~~Pf~~~~  530 (636)
                      |+.||....
T Consensus       232 G~~Pf~~~~  240 (360)
T cd05627         232 GYPPFCSET  240 (360)
T ss_pred             CCCCCCCCC
Confidence            999997553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-36  Score=307.83  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .|+..+.||+|+||.||+|+....+    ..||+|.+... .......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCC----EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4666788999999999999976655    88999998755 345567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.   ...+++.++..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          81 MEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999999999984   346889999999999999999999   899999999999999999999999999999765443


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......++..|+|||++.+..++.++|+||||+++|||++|..||.........                  .....
T Consensus       155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------------~~~~~  215 (277)
T cd06640         155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------------FLIPK  215 (277)
T ss_pred             cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------------------hhhhc
Confidence            22 222346788999999998888999999999999999999999998654221100                  00111


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..........+..+.+++.+||+.+|++||++.++++.-.-
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            11223344566778899999999999999999999887543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-36  Score=315.15  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=204.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +.|+..+.||+|+||.||+|+....+......+|+|.+..... ....++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            4567788999999999999998766655556789999876533 3345788999999999999999999998754 4679


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ++||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999998543 346889999999999999999999   89999999999999999999999999999986643


Q ss_pred             CCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......     ...+++.    .+..   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~~~----~~~~---  229 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDLLE----KGER---  229 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH----CCCC---
Confidence            3221 1222345778999999998999999999999999999997 89998644211     1122211    1110   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                            ......+...+.+++.+||..+|++||+++++++.|+..
T Consensus       230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 ------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  011112345678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-36  Score=311.65  Aligned_cols=261  Identities=26%  Similarity=0.346  Sum_probs=206.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||++.....+    ..+|+|++.... ....+.+.+|+++++.++||||+++++.+...+.+++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTG----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCC----cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            35667789999999999999987655    789999887653 3445788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++..  .+.+++..+..++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++.....
T Consensus        81 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          81 CMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999999998843  3568999999999999999999994  36899999999999999999999999999875432


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh---HHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE---EEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~---~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..   .....|+..|+|||++.+..++.++|||||||++|||++|+.||........   ....+.+++......     
T Consensus       157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  228 (284)
T cd06620         157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-----  228 (284)
T ss_pred             hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-----
Confidence            21   2234689999999999888999999999999999999999999975432211   111111222111100     


Q ss_pred             hhhhhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          . .... ..+.+..+.+++.+|++.||++||++.|+++++...
T Consensus       229 ----~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         229 ----P-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             ----c-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                0 0111 112445688999999999999999999999876443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.1e-36  Score=310.12  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|++.++||+|+||.||+|+....+    ..+++|.+........+.+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCC----ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            45778899999999999999987655    78999999887777778899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|..++.+. ...+++.+++.++.|++.+|+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          88 IEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            9999999999887543 356899999999999999999999   899999999999999999999999999998754322


Q ss_pred             CCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          479 EVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      . .......++..|+|||++.     ...++.++|||||||++|||++|+.||.......    .....    ... .  
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~----~~~-~--  231 (292)
T cd06644         164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKI----AKS-E--  231 (292)
T ss_pred             c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH----HHHHH----hcC-C--
Confidence            1 1223346888999999874     3446789999999999999999999986542111    11110    000 0  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                         .+..  ..+......+.+++.+||+.||++||++.++++.-.
T Consensus       232 ---~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         232 ---PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             ---CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence               0000  011223345788999999999999999999987543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-36  Score=316.52  Aligned_cols=270  Identities=21%  Similarity=0.295  Sum_probs=201.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|+....+    ..||+|.++.... .....+.+|+.++++++|+||+++++++..++..++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCC----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            46888899999999999999876654    7899999875432 223457789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ ++|.+++... ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          82 VFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            999996 5888887543 345889999999999999999999   89999999999999999999999999999976433


Q ss_pred             CCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH------HHHHHhcCC
Q 006668          478 GEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD------WVRNLYGQG  550 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~------~v~~~~~~~  550 (636)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............      ..|......
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            221 1223467899999998765 46789999999999999999999999765332221111110      000000000


Q ss_pred             cchhhhhhhhhh-------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 KICEAADARIRQ-------EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 ~~~~~~d~~l~~-------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .+..+.....       .........+.+++.+|++.||.+|||+.|+++.-.-.
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         236 --DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             --hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence              0000000000       00112234577899999999999999999999865443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=304.37  Aligned_cols=254  Identities=23%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|++|.||++.....+    ..+++|.+........+.+.+|+.++++++||||+++++.+...+.++++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATG----ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCC----CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            56888899999999999999986654    78999999877666678899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++... ...+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++......
T Consensus        79 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          79 MEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999988543 357899999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCccccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      . .......++..|+|||.+...   .++.++||||||+++|||++|+.||..........    ......+..      
T Consensus       155 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~----~~~~~~~~~------  223 (262)
T cd06613         155 I-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF----LISKSNFPP------  223 (262)
T ss_pred             h-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccCCC------
Confidence            2 122234688899999998777   78899999999999999999999997543221111    000000000      


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                        .  ...........+.+++.+||..+|.+||++.+|+.
T Consensus       224 --~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 --P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --c--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0  00112233456889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=318.65  Aligned_cols=258  Identities=22%  Similarity=0.262  Sum_probs=197.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...   .....+.+.+|+.++..++|+||+++++++.+++.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   76 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTG----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNL   76 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeE
Confidence            46888999999999999999987655    78999999752   223345688899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++.+. ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            9999999999999998532 456899999999999999999999   899999999999999999999999999999765


Q ss_pred             cCCCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ............||+.|+|||++..     ..++.++|||||||++|||++|+.||...........        .....
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~--------i~~~~  224 (331)
T cd05597         153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--------IMNHK  224 (331)
T ss_pred             CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH--------HHcCC
Confidence            4433323333569999999998863     4578899999999999999999999965422111111        10000


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHcc--CCCCCCCCCHHHHHHHHh
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACC--HPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl--~~dP~~RPs~~evl~~L~  598 (636)
                      ....     +... .......+.+++.+|+  ..++..||+++++++.-.
T Consensus       225 ~~~~-----~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         225 EHFQ-----FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             Cccc-----CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            0000     0000 0112334555555655  444555899999998854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-36  Score=318.34  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=205.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      +|.+.+.||+|+||.||+++....+.   .....||+|.+... .....+++.+|+.+++++ +|+||++++++|...+.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            57788999999999999998643221   22357899988754 344567889999999999 79999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      .++++||+++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~  169 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence            999999999999999986421              235889999999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 006668          461 EMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAV  538 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~  538 (636)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......     
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  244 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----  244 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence            999999999999865432211 1222234568999999999999999999999999999998 888886442111     


Q ss_pred             HHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       539 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...   ... .+         ............+.+++.+||+.+|++||++.|+++.|+.-
T Consensus       245 ~~~---~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         245 LFK---LLK-EG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHH---HHH-cC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            111   100 00         11112223345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-36  Score=305.85  Aligned_cols=243  Identities=27%  Similarity=0.447  Sum_probs=193.1

Q ss_pred             eeeeecCceEEEeeeecCCC------CCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          325 ELLGSGGFGRVYKGTLANNN------NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.||+|+||.||+|.....+      ......+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999987654      233356888887655433 5788899999999999999999999988 778999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-------cEEEeccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-------RGRLGDFGL  471 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-------~~kl~DFGl  471 (636)
                      |||+++|+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999996432 27899999999999999999999   89999999999999999888       799999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+........ .    .+..    
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~----~~~~----  220 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-E----RFYQ----  220 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-H----HHHh----
Confidence            986543     1123467789999998876  78999999999999999999 5777755421111 0    0000    


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...           ..+......+.+++.+||..+|++||++.++++.|+
T Consensus       221 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000           001111167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.8e-36  Score=319.92  Aligned_cols=268  Identities=22%  Similarity=0.239  Sum_probs=200.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc--
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--  392 (636)
                      ..++|...+.||+|+||.||++.....+    +.||||++...  .....+.+.+|+.+++.++||||+++++++...  
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCC----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            4568999999999999999999976655    78999999754  233456788999999999999999999987543  


Q ss_pred             ----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 ----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                          ...++||||++ ++|.+++.    ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875          98 LEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             ccccCeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence                35799999995 57777772    35888999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-------H
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM-------D  541 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~-------~  541 (636)
                      ||+++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.||............+.       +
T Consensus       170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            99998654322  22335689999999999999999999999999999999999999975532221111110       0


Q ss_pred             H-------HHHHhcCC-c----chhhhhhhhh----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          542 W-------VRNLYGQG-K----ICEAADARIR----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       542 ~-------v~~~~~~~-~----~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +       +....... .    ..+...+...    ..........+.+|+.+|++.||.+|||+.|++++-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            0       00000000 0    0000000000    0011112356789999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-36  Score=302.84  Aligned_cols=247  Identities=28%  Similarity=0.444  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ++||+|++|.||++.... +    ..|++|.+..... .....+.+|++++++++|+||+++++++...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~----~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-N----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC-C----CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            469999999999999765 4    7899999876533 356788999999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++... ...+++..++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||++...........
T Consensus        76 ~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          76 GGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence            99999998543 346889999999999999999999   89999999999999999999999999999986543221111


Q ss_pred             -cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          484 -TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       484 -~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                       .....+..|+|||.+.+..++.++||||||++++||++ |..||.......     ....+.             ....
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~-------------~~~~  213 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIE-------------SGYR  213 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHh-------------cCCC
Confidence             11233567999999998899999999999999999998 888886542211     111111             0011


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...+...+..+.+++.+|+..+|++||++.|+++.|.
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1122334567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-36  Score=304.55  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|++|.||+|+....+    ..+++|.+.....  .+++.+|++++++++|+||+++++++......+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETG----QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCC----cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            56888899999999999999987654    7899999876533  67899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||+++++|.+++... ...+++.+++.++.|+++||.|||   +.+++||||+|+||+++.++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          77 MEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999998543 457899999999999999999999   789999999999999999999999999999866543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........   . . +.    ...     ..
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---~-~-~~----~~~-----~~  217 (256)
T cd06612         153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---F-M-IP----NKP-----PP  217 (256)
T ss_pred             cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---h-h-hc----cCC-----CC
Confidence            21 223345788999999999999999999999999999999999999754221110   0 0 00    000     00


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        ....+......+.+++.+||+.||++||++.|+++.
T Consensus       218 --~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 --TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             --CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence              001122234568889999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.7e-36  Score=302.28  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=203.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||++.....+    ..+++|.+...  .....+.+.+|+.++++++|+||+++++.+..++..++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQ----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCC----cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence            4778899999999999999976654    88999998754  33446788899999999999999999999998899999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~~  476 (636)
                      ||||+++++|.+++.......+++..+..++.+++.||+|||   +.+++|+||||+||+++++ +.+||+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            999999999999997655566899999999999999999999   8999999999999999855 458999999998664


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...  ......++..|+|||.+....++.++||||||+++|+|++|+.||.......     ....+..           
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-----------  215 (256)
T cd08220         154 SKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-----------  215 (256)
T ss_pred             CCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-----------
Confidence            432  1223468899999999998889999999999999999999999996542211     1111100           


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        .............+.+++.+||+.+|++|||++|+++.
T Consensus       216 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         216 --GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              00111222345568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.8e-36  Score=320.22  Aligned_cols=267  Identities=22%  Similarity=0.233  Sum_probs=199.5

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc--
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--  392 (636)
                      ..++|+..+.||+|+||.||++.....+    ..||+|.+...  .....+.+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCC----ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            4568999999999999999999876544    78999999754  333456778899999999999999999987543  


Q ss_pred             ----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 ----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                          ...++||||++ ++|.+.+.    ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          91 LEEFQDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ccccceeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence                35799999995 56777662    35889999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH--------
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--------  540 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~--------  540 (636)
                      ||+++......  ......||..|+|||++.+..++.++|||||||++|||++|+.||............+.        
T Consensus       163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99998654322  22335689999999999999999999999999999999999999975432111111100        


Q ss_pred             ------HHHHHHhcCC-cchhhhhhhh--------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          541 ------DWVRNLYGQG-KICEAADARI--------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       541 ------~~v~~~~~~~-~~~~~~d~~l--------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            ..+....... .......+..        ...........+.+++.+|++.||++|||+.|+++.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                  0000000000 0000000000        0011112245678999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-36  Score=318.33  Aligned_cols=257  Identities=22%  Similarity=0.257  Sum_probs=198.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++..++|+||+++++++.+.+..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~   76 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTE----RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYL   76 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            46888999999999999999987655    78999998653   223345678899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            9999999999999999542 346889999999999999999999   899999999999999999999999999999866


Q ss_pred             cCCCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ............||+.|+|||++.+     +.++.++|||||||++|||++|+.||...........        .....
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~--------i~~~~  224 (331)
T cd05624         153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--------IMNHE  224 (331)
T ss_pred             cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH--------HHcCC
Confidence            5433323333579999999998875     4678899999999999999999999975432111111        10000


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVL  597 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L  597 (636)
                      ..     ..+... ..+..+.+.+++.+|+..++++  |++++++++.-
T Consensus       225 ~~-----~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         225 ER-----FQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             Cc-----ccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            00     001111 1122456777777888765544  56888888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-36  Score=305.06  Aligned_cols=252  Identities=27%  Similarity=0.333  Sum_probs=208.6

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |+..++||+|.-|+||++.+++.+    ..+|+|++.+.   .++.+.+...|-++|+.++||.++.||..++.+...||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTN----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCC----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            445678999999999999998876    89999999876   34445677889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +||||+||+|....+++..+.++++.++.++.+++.||+|||   ..|||+|||||+||||.++|++.|+||.|+.....
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999998888999999999999999999999999   89999999999999999999999999998743210


Q ss_pred             ---------------------------------C-CC---------------------ccccccccCCcccccccccCCC
Q 006668          478 ---------------------------------G-EV---------------------PNTTRVVGTLGYLAPELATVSS  502 (636)
Q Consensus       478 ---------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~  502 (636)
                                                       . ..                     ..+...+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 00                     0112357999999999999999


Q ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCC
Q 006668          503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHP  582 (636)
Q Consensus       503 ~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~  582 (636)
                      ++.++|.|+|||++|||+.|..||.....++....++..                 .+.-.-.......+.+||.+.|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCCCcchhHHHHHHHHHhcc
Confidence            999999999999999999999999877554433322211                 111111124456778888899999


Q ss_pred             CCCCCCC----HHHHHHH
Q 006668          583 DSTRRPT----MREVVAV  596 (636)
Q Consensus       583 dP~~RPs----~~evl~~  596 (636)
                      ||.+|.-    +.||-++
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    7777654

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-36  Score=318.58  Aligned_cols=257  Identities=22%  Similarity=0.256  Sum_probs=196.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||.||+++....+    +.+|+|++...   .......+..|+.++..++|+||+++++++.+.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   76 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNAD----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL   76 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCC----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEE
Confidence            46888999999999999999987655    78999998643   222334578899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            9999999999999999542 346899999999999999999999   899999999999999999999999999999765


Q ss_pred             cCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ............||+.|+|||++.     ...++.++|||||||++|||++|+.||..........        ......
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~--------~i~~~~  224 (332)
T cd05623         153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--------KIMNHK  224 (332)
T ss_pred             ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH--------HHhCCC
Confidence            433322333457999999999886     3457889999999999999999999997542211111        111100


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHP--DSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~--dP~~RPs~~evl~~L  597 (636)
                      ..     ..... ........+.+++.+|+..  ++..|+++.|++++-
T Consensus       225 ~~-----~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         225 ER-----FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             cc-----ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            00     00000 0112234566666676644  444578999998873

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.1e-36  Score=305.17  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=196.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeeeccccc--
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--  391 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--  391 (636)
                      .+|+..+.||+|+||.||++.....+    ..|++|++...     ..+..+.+.+|+.++++++|+||+++++++.+  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTG----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCC----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence            46888999999999999999876655    78999988643     22345678899999999999999999998865  


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      ...+++++||+++++|.+++..  ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence            3578999999999999999854  345889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCC--CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          472 AKLYQQGE--VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       472 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ++......  ........++..|+|||++.+..++.++|||||||++|||++|+.||.........        ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~--------~~~~~~  224 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI--------FKIATQ  224 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--------HHHhcC
Confidence            97553211  11122345889999999999988999999999999999999999999644211110        000000


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                               .....++......+..++ +||..+|++||+++||+++
T Consensus       225 ---------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         225 ---------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                     001122223334455565 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.1e-36  Score=305.04  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=190.7

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCC
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN  404 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  404 (636)
                      .||+|+||.||+|.....  .....+++|.+.... ......+.+|+..++.++|+||+++++.|......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecC--CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            589999999999976442  234678999876543 34456788999999999999999999999999999999999999


Q ss_pred             CChhhhHhcCC---CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          405 GSLNNWIFGKP---KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       405 gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      |+|.+++....   ....++.....++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999996533   234567888999999999999999   899999999999999999999999999998754332211


Q ss_pred             -cccccccCCcccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          482 -NTTRVVGTLGYLAPELATV-------SSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       482 -~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                       ......++..|+|||++..       ..++.++|||||||++|||++ |..||.......    .+...+.    .+. 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~----~~~-  227 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQVVR----EQD-  227 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhh----ccC-
Confidence             1122345778999998643       356789999999999999999 788886442211    1111111    000 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ....++.    ........+.+++..|| .||++||++.+|++.|.
T Consensus       228 ~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0111111    12233455667778888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.7e-36  Score=312.24  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=205.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|++|.||+++....+    ..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATG----QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCC----CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            367889999999999999999976555    7899999986655555678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.   ...+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          94 VMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             eecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999999984   346889999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........   ....  .   ..+       
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~--~---~~~-------  231 (297)
T cd06656         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLI--A---TNG-------  231 (297)
T ss_pred             Ccc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeee--c---cCC-------
Confidence            322 22234688999999999998899999999999999999999999965422110   0000  0   000       


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       ......+......+.+++.+||+.+|++||+++++++.=.
T Consensus       232 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         232 -TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence             0000112233456788999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-36  Score=341.93  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.++||+|+||.||+|+....+    +.||+|++...   .....+++.+|++++++++||||+++++++.+++..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~l   77 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCS----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPV   77 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCC----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEE
Confidence            47888999999999999999976655    88999999754   223356789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcC---------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          396 MLVYDYMPNGSLNNWIFGK---------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      ++||||+++|+|.+++...         ....+++..++.++.||++||+|||   +.+|+||||||+|||++.++.+||
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEE
Confidence            9999999999999998531         1234567788999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCC-----------------CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          467 GDFGLAKLYQQGE-----------------VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       467 ~DFGla~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +|||+++......                 .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            9999998652111                 01112346999999999999999999999999999999999999999653


Q ss_pred             CChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 006668          530 KGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVLVG  599 (636)
Q Consensus       530 ~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~  599 (636)
                      .....   ....         .+....+.    ....+.+..+.+++.+|++.||++|| +++++++.|+.
T Consensus       235 ~~~ki---~~~~---------~i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        235 KGRKI---SYRD---------VILSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             chhhh---hhhh---------hccChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            21110   0000         00000000    00112345678899999999999996 56667666654

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.2e-36  Score=304.89  Aligned_cols=255  Identities=26%  Similarity=0.402  Sum_probs=202.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----------ChHHHHHHHHHHHHhcc-CCCCceeeeecc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----------SKQGLKEFMAEISSMGR-LQHKNLVQMRGW  388 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~  388 (636)
                      +|+..+.||+|+||.||+|.....   ....+|+|.+...          ......++..|+.++.+ ++||||++++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   77 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN---GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT   77 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC---CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence            477788999999999999998662   1278999988632          23345667889988865 799999999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      +.+++..++||||+++++|.+++..  .....+++.+++.++.|++.||.|||+  ..+++|+||||+||+++.++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEE
Confidence            9999999999999999999998743  234568999999999999999999993  368999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +|||++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||........    ... +   
T Consensus       156 ~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~-~---  225 (269)
T cd08528         156 TDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATK-I---  225 (269)
T ss_pred             ecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHH-H---
Confidence            9999998655433  23345689999999999988899999999999999999999999864421111    100 0   


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       ..+..        ...........+.+++.+||+.||++||++.|+..+|+
T Consensus       226 -~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 -VEAVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -hhccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             00000        00001123456888999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-37  Score=322.17  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=206.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN  404 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  404 (636)
                      -+||+|.||+||.|+...+.    ..+|||-+.....+..+-+..||..-++|+|+|||+++|.|.+++.+-+.||.+||
T Consensus       581 vVLGKGTYG~VYA~RD~~tq----vrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQ----VRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EEeecCceeEEEeeccccce----eEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            37999999999999987765    89999999887777778889999999999999999999999999999999999999


Q ss_pred             CChhhhHhcCCCCCc--ChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCCcEEEeccCCcccccCCCCc
Q 006668          405 GSLNNWIFGKPKKLL--GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       405 gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      |+|.++|+.+ -+++  ++.+.-.+.+||++||.|||   +..|||||||-.|||++ -.|.+||+|||-++.+..- .+
T Consensus       657 GSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP  731 (1226)
T KOG4279|consen  657 GSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NP  731 (1226)
T ss_pred             CcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC-Cc
Confidence            9999999653 4566  66778889999999999999   89999999999999995 5789999999998765432 23


Q ss_pred             cccccccCCcccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVSS--PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      .+....||+.|||||++..+.  |..++|||||||.+.||.||++||......  ....+              +.-.-+
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMF--------------kVGmyK  795 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMF--------------KVGMYK  795 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhh--------------hhccee
Confidence            445578999999999998764  788999999999999999999999654221  11111              111223


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...+.+.+.......++++|+.+||.+||++.++++-
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            3456677777888899999999999999999999874

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-36  Score=328.83  Aligned_cols=265  Identities=22%  Similarity=0.274  Sum_probs=198.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..+|.+.+.||+|+||.||++.....+    ..||+|....      ..+.+|++++++++|+|||++++++..++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~----~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYP----QRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCC----CEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            457899999999999999999987655    7899996432      345689999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||++ .++|.+++... ...+++.+++.++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       238 v~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        238 VLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99999 57898888543 347999999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh---hhHHHHHHHHHHHHhc-CC--
Q 006668          478 GEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE---EEEEAVLMDWVRNLYG-QG--  550 (636)
Q Consensus       478 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~---~~~~~~l~~~v~~~~~-~~--  550 (636)
                      .... ......||..|+|||++.+..++.++|||||||++|||++|..|+......   ......+...+..... ..  
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            3211 122357999999999999999999999999999999999988765432111   1111112221111100 00  


Q ss_pred             ------cchhhhhhh----hhhccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 ------KICEAADAR----IRQEFE-------AEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ------~~~~~~d~~----l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            ++.......    ....+.       ......+.+|+.+||+.||.+|||+.|++++-
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence                  000000000    000000       01123578899999999999999999999863

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-36  Score=316.76  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=198.5

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeecccccc-
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-  392 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-  392 (636)
                      ...++|...+.||+|+||.||++.....+    ..||+|++....  ....+.+.+|+.++++++|+||+++++++... 
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLR----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCC----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            34567888999999999999999876654    789999987542  23345677899999999999999999987543 


Q ss_pred             -----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          393 -----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       393 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                           ...++++|++ +++|.+++.   ...+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEc
Confidence                 4579999998 889988873   356999999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      |||+++.....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||........    +..+.. .
T Consensus       161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~-~  231 (343)
T cd07878         161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ----LKRIME-V  231 (343)
T ss_pred             CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHH-H
Confidence            99999865432    233568999999998876 5688999999999999999999999965432111    111110 0


Q ss_pred             hcCCc--chhhh----hhhhh---hccC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          547 YGQGK--ICEAA----DARIR---QEFE--------AEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       547 ~~~~~--~~~~~----d~~l~---~~~~--------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .....  ....+    .....   ...+        ......+.+|+.+|++.||.+|||+.|++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~  300 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY  300 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            00000  00000    00000   0000        012235778999999999999999999997743

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=308.94  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|++.+.||+|++|.||+++....+    ..+++|.+........+.+.+|++++++++|+||+++++.+......++|
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETG----LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCC----cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            45778889999999999999986544    78999999877777778899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999999998543 346999999999999999999999   899999999999999999999999999998754332


Q ss_pred             CCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          479 EVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      . .......++..|+|||.+.     ...++.++||||||+++|||++|+.||......    .....+.     .+.. 
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-----~~~~-  225 (280)
T cd06611         157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKIL-----KSEP-  225 (280)
T ss_pred             c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHh-----cCCC-
Confidence            2 1223356899999999875     344677999999999999999999999654211    1111110     0000 


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          +.+  ..+......+.+++.+||+.+|++||++.++++.-.-
T Consensus       226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (280)
T cd06611         226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV  265 (280)
T ss_pred             ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence                000  1112233567889999999999999999999887443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-36  Score=310.55  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeec
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRG  387 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g  387 (636)
                      +.++.+..+.++|+..+.||+|+||.||+++....+    ..+++|.+..... ...++.+|+.+++++ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNG----SKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCC----ceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence            445666778889999999999999999999986655    7899998865322 235677899999999 6999999999


Q ss_pred             ccc-----ccceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          388 WCR-----KGNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       388 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      ++.     .++.+++||||+++++|.+++..  .....+++..+..++.|++.||.|||   +.+++||||||+||++++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~  159 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTT  159 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECC
Confidence            873     34578999999999999998753  23456889999999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhH
Q 006668          461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE  535 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~  535 (636)
                      ++.+||+|||++........ ......|+..|+|||++..     ..++.++|||||||++|||++|+.||.......  
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--  236 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--  236 (286)
T ss_pred             CCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--
Confidence            99999999999986543222 2223468999999998753     447889999999999999999999996542111  


Q ss_pred             HHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       536 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        .+...     ..+..     ..+  ..+......+..++.+||+.||++||++.|+++.+
T Consensus       237 --~~~~~-----~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         237 --ALFKI-----PRNPP-----PTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             --HHhhc-----cccCC-----Ccc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence              11110     00000     000  00111234588899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.7e-36  Score=307.94  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeec
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRG  387 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g  387 (636)
                      .++.++....+.|+..+.||+|+||.||+|+....+    ..+|+|.+..... ...++..|+.++.++ +|+||+++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~   80 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYG   80 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCC----cEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEee
Confidence            345666667788999999999999999999987655    7899999866533 345678899999998 6999999999


Q ss_pred             cccc------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC
Q 006668          388 WCRK------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE  461 (636)
Q Consensus       388 ~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~  461 (636)
                      ++..      ....+++|||+++|+|.+++.......+++..+..++.||++||+|||   +.+++|+||||+||+++++
T Consensus        81 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~  157 (282)
T cd06636          81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             ehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence            8853      457899999999999999996655567889999999999999999999   8999999999999999999


Q ss_pred             CcEEEeccCCcccccCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 006668          462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE  536 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~  536 (636)
                      +.++|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||........  
T Consensus       158 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--  234 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--  234 (282)
T ss_pred             CCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--
Confidence            9999999999876532211 222356899999999875     34578899999999999999999999964421111  


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       ...  +         ......   ..........+.+++.+||+.||.+||++.|+++.
T Consensus       235 -~~~--~---------~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 -LFL--I---------PRNPPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -hhh--H---------hhCCCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence             100  0         000000   00111234568899999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-37  Score=307.22  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=198.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc-----e
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-----E  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~  394 (636)
                      .|...+++|+|.||.||+|++...+    +.||||+...+.+.    -.+|+.+|+.++|||||+++-++....     .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~----~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETE----EEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCC----ceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            4667799999999999999998875    89999999776442    136899999999999999998875432     3


Q ss_pred             EEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccCC
Q 006668          395 LMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGL  471 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGl  471 (636)
                      ..|||||||. +|.++++.  ..+..++...++-+..||.+||.|||   +.+|+||||||+|+|+|.+ +.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence            5789999965 88888853  23567888889999999999999999   8999999999999999976 8999999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      |+....++..  ....-|..|.|||++.+. +|+.+.||||.||++.||+-|+.-|.+.... .   .++..+. .++..
T Consensus       173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-d---QL~eIik-~lG~P  245 (364)
T KOG0658|consen  173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-D---QLVEIIK-VLGTP  245 (364)
T ss_pred             ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-H---HHHHHHH-HhCCC
Confidence            9988776643  334568899999987775 6899999999999999999999777653222 1   1222111 11111


Q ss_pred             cch----------hhhhhhhh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 KIC----------EAADARIR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ~~~----------~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .-.          +...+.+.     +-+........++++.+|+..+|.+|.++.|++.+=
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence            111          11111111     112334567788999999999999999999998763

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-36  Score=331.76  Aligned_cols=271  Identities=23%  Similarity=0.343  Sum_probs=194.8

Q ss_pred             HHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC------CCceeeeec
Q 006668          314 LSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ------HKNLVQMRG  387 (636)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~g  387 (636)
                      +...+++|++.++||+|+||.||+|.....+    ..||||+++.... ...+...|+.+++.++      |.+++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRK----EYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCC----eEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            3445678999999999999999999986655    8899999965322 2234455666666654      456889998


Q ss_pred             ccccc-ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----
Q 006668          388 WCRKG-NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----  462 (636)
Q Consensus       388 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----  462 (636)
                      ++... +..++|||++ +++|.+++.+  ...+++.++..|+.||+.||+|||+  +.+|+||||||+|||++.++    
T Consensus       199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        199 YFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccc
Confidence            88654 5789999998 7889988853  3579999999999999999999993  25999999999999998765    


Q ss_pred             ------------cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          463 ------------RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       463 ------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                                  .+||+|||++.....    ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        499999998864322    2334679999999999999999999999999999999999999997653


Q ss_pred             ChhhHHHHH-------HHHHHH--------Hh-cCCcchhhhhhhhh----h---ccCHHHHHHHHHHHHHccCCCCCCC
Q 006668          531 GEEEEEAVL-------MDWVRN--------LY-GQGKICEAADARIR----Q---EFEAEEMELVLKLGLACCHPDSTRR  587 (636)
Q Consensus       531 ~~~~~~~~l-------~~~v~~--------~~-~~~~~~~~~d~~l~----~---~~~~~~~~~l~~L~~~Cl~~dP~~R  587 (636)
                      .........       .+|...        .+ ..+.+....++...    .   .........+.+|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            221111100       001100        00 00000000000000    0   0001123567899999999999999


Q ss_pred             CCHHHHHHHHh
Q 006668          588 PTMREVVAVLV  598 (636)
Q Consensus       588 Ps~~evl~~L~  598 (636)
                      ||++|++++-.
T Consensus       430 ~ta~e~L~Hp~  440 (467)
T PTZ00284        430 LNARQMTTHPY  440 (467)
T ss_pred             CCHHHHhcCcc
Confidence            99999998543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3e-36  Score=307.29  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|...+.||+|+||.||+|+....+    ..||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTG----ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCC----cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            5666788999999999999876655    789999998776666677889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..  .+.+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          86 EFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             eccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999999843  457899999999999999999999   7899999999999999999999999999987654322


Q ss_pred             CccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          480 VPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                       .......|+..|+|||++.   ...++.++|||||||++|||++|+.||........    .......     ...   
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~~~~~~~-----~~~---  227 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLMTKS-----NFQ---  227 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----HHhhhcc-----CCC---
Confidence             2223356899999999874   45578899999999999999999999864422111    0000000     000   


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .+....  .......+.+++.+|++.+|++||++.+++++
T Consensus       228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000000  00123457889999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-35  Score=302.28  Aligned_cols=254  Identities=21%  Similarity=0.380  Sum_probs=189.8

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCC
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN  404 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  404 (636)
                      .||+|+||.||+|+.....  ....+++|.+.... ....+.+.+|+..++.++||||+++++.|......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT--GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC--CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            5999999999999764432  23567788776543 34567889999999999999999999999999999999999999


Q ss_pred             CChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC-Cc
Q 006668          405 GSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-VP  481 (636)
Q Consensus       405 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-~~  481 (636)
                      |+|.+++.+..  ...+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++....... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999996532  235667788899999999999999   7999999999999999999999999999986432211 11


Q ss_pred             cccccccCCcccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          482 NTTRVVGTLGYLAPELATV-------SSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||............    ..     +...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~-----~~~~  227 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV----IK-----DQQV  227 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hh-----hccc
Confidence            2223467889999998753       245779999999999999997 56677544221111111    11     1111


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...++.+...+    ...+.+++..|| .+|++||++++|++.|.
T Consensus       228 ~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11222222222    345677888899 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-36  Score=323.27  Aligned_cols=267  Identities=22%  Similarity=0.278  Sum_probs=202.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .+|.+.+.||+|+||.||++...+.  .....|++|.+...     +...+|++++++++||||+++++++......++|
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~--~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGD--EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCC--ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            4688889999999999999976432  23478999988654     2345799999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||++ .++|.+++  .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       165 ~e~~-~~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKY-KCDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhc-CCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9999 57888888  34567999999999999999999999   899999999999999999999999999999765443


Q ss_pred             CC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc------
Q 006668          479 EV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK------  551 (636)
Q Consensus       479 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~------  551 (636)
                      .. .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+.. .....      
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~l~~i~~~-~~~~~~~~~~~  316 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS-SSQLRSIIRC-MQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc-HHHHHHHHHH-hccCccccCCc
Confidence            22 223346799999999999999999999999999999999999999965432211 1111111111 00000      


Q ss_pred             ----chhh---hhhhhhhccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          552 ----ICEA---ADARIRQEFE-------AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       552 ----~~~~---~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          +.+.   .....+..+.       ......+.+++.+||..||++||++.|++.+-.-.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                0000   0000011111       01234577889999999999999999999886555

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-35  Score=306.17  Aligned_cols=255  Identities=24%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||+|+||.||+++....+    ..||+|.+... .......+.+|+.++++++|+||+++++.+...+..++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTG----VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            5677889999999999999986554    88999988754 334457888999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          399 YDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||+++++|..++.... ...+++..+..++.+++.||.|||+  +.+++||||||+||+++.++.+||+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            99999999999885421 3478999999999999999999994  36899999999999999999999999999976533


Q ss_pred             CCCccccccccCCcccccccccCCC------CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSS------PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      ..   .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||.......... .+    .       
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~----~-------  220 (286)
T cd06622         156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QL----S-------  220 (286)
T ss_pred             Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-HH----H-------
Confidence            21   22245788999999886543      4789999999999999999999996542111100 00    0       


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        ...+ .............+.+++.+||+.+|++||++.++++.-.
T Consensus       221 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         221 --AIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             --HHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence              0000 0111233345667889999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-35  Score=302.55  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=198.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS------KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      +|...+.||+|+||.||+|.... +    ..+|+|.+....      ....+.+.+|+.++++++|+||++++++|.+.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-G----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-C----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence            36778899999999999998643 2    789999886432      223456889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++|+||+++++|.+++.+  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          76 TISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            99999999999999999943  346889999999999999999999   7899999999999999999999999999987


Q ss_pred             cccCCC-----CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          474 LYQQGE-----VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       474 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ......     ........++..|+|||++.+..++.++||||||++++||++|+.||.........   . . ...  .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~-~-~~~--~  223 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---F-Y-IGA--H  223 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---H-H-hhh--c
Confidence            543211     11122346889999999999988999999999999999999999999654211110   0 0 000  0


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                      .+         .....+......+.+++.+||+.+|++||++.|+++
T Consensus       224 ~~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 RG---------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00         011122234466788999999999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-35  Score=309.47  Aligned_cols=198  Identities=25%  Similarity=0.398  Sum_probs=160.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc--cceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~  401 (636)
                      .++||+|+||.||+|+....  .....+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~--~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG--KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccC--CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            46899999999999987542  2237899999865432  2456789999999999999999998753  4568999999


Q ss_pred             cCCCChhhhHhcC-------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE----cCCCcEEEeccC
Q 006668          402 MPNGSLNNWIFGK-------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL----DSEMRGRLGDFG  470 (636)
Q Consensus       402 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG  470 (636)
                      + +++|.+++...       ....+++..+..++.||+.||+|||   +.+|+||||||+|||+    +..+.+||+|||
T Consensus        82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            9 46888876421       1235889999999999999999999   8999999999999999    456789999999


Q ss_pred             CcccccCCCC--ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          471 LAKLYQQGEV--PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       471 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +++.......  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9987654321  122345789999999988764 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=311.91  Aligned_cols=253  Identities=27%  Similarity=0.356  Sum_probs=203.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|++|.||++.....+    ..+|+|.+.....   ...+.+..|+++++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTG----KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYL   76 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCC----cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEE
Confidence            36888899999999999999987654    8899999976532   3456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+.+++|.+++.......+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            99999999999999986555567999999999999999999999   899999999999999999999999999998754


Q ss_pred             cCCCCc----------------------------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006668          476 QQGEVP----------------------------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD  527 (636)
Q Consensus       476 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~  527 (636)
                      ......                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            322110                            1112467889999999999889999999999999999999999997


Q ss_pred             CCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 006668          528 MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT----MREVVA  595 (636)
Q Consensus       528 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs----~~evl~  595 (636)
                      .......    +..             .................+.+++.+||+.||++||+    +.|+++
T Consensus       234 ~~~~~~~----~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         234 GSNRDET----FSN-------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCchHHH----HHH-------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            5432211    111             01111111111124677999999999999999999    555555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-35  Score=301.49  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=206.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|++|.||+|.....+    ..+++|++.... ....+.+.+|+..++.++|+||+++++.+...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNN----EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCC----cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            46888999999999999999976654    789999997543 3356788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCC-CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      |+|++++++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            9999999999999965433 57899999999999999999999   8999999999999999999999999999987665


Q ss_pred             CCCCc---cccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGEVP---NTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .....   ......++..|+|||.+... .++.++|+||||+++|||++|+.||.......    ...+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~-------  222 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQN-------  222 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcC-------
Confidence            43322   12234688999999988777 78999999999999999999999996542221    12111111       


Q ss_pred             hhhhhhhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         ..+.+.... .......+.+++.+||+.||++||++.++++.
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               001111111 11334668899999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-35  Score=300.65  Aligned_cols=250  Identities=30%  Similarity=0.458  Sum_probs=202.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+|.....+    ..|++|.++....  ...+.+.+|+.++++++|+||+++++.+...+..++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTG----ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCC----cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence            4778899999999999999976554    7899999986543  367889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||+++++|.+++..  ...+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        77 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          77 FMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             EEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            9999999999999854  345889999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcccc---ccccCCcccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          478 GEVPNTT---RVVGTLGYLAPELATVSS---PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       478 ~~~~~~~---~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      .......   ...++..|+|||++.+..   .+.++||||||++++||++|+.||........    ....+..    + 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~~----~-  222 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVGA----G-  222 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHhc----C-
Confidence            3322211   346788999999988776   88999999999999999999999965421111    0000000    0 


Q ss_pred             chhhhhhhhhhccCH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          552 ICEAADARIRQEFEA--EEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~--~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                              .....+.  .....+.+++.+||+.+|++||++.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 --------HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --------CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    0111111  12556778999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-36  Score=301.24  Aligned_cols=249  Identities=31%  Similarity=0.442  Sum_probs=201.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-----KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      +|+..+.||+|++|.||+|.....+    ..|++|.+....     .+..+.+.+|+.++++++|+||+++++++..+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDG----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCC----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence            3667789999999999999986544    789999886542     3456788999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++++||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            9999999999999999954  346889999999999999999999   89999999999999999999999999999886


Q ss_pred             ccCCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .....  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......    .....+.    ...   
T Consensus       152 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~----~~~---  218 (258)
T cd06632         152 VVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFKIG----RSK---  218 (258)
T ss_pred             ccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHHHH----hcc---
Confidence            54433  223356889999999887766 899999999999999999999999654211    1111100    000   


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            .....+......+.+++.+||+.+|.+||++.++++.
T Consensus       219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                  0111222334667889999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.5e-36  Score=306.46  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=201.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|++|.||+|+.+..+    ..||+|++....  ....+.+.+|+.++++++|+|++++++++......+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETG----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH   76 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCC----cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEE
Confidence            36788899999999999999987655    789999886542  223356789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|..++.  ....+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence            9999999999988763  2346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH-------HHhc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR-------NLYG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~-------~~~~  548 (636)
                      .... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... .......       ..+.
T Consensus       152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         152 GPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             CCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcc
Confidence            4321 2223457889999998876 457889999999999999999999997543221111 1111000       0000


Q ss_pred             CCcchhhh-hhhhh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAA-DARIR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~-d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ........ .+...     ..........+.+++.+||+++|++||++.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000 00000     00011224668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=315.34  Aligned_cols=254  Identities=27%  Similarity=0.342  Sum_probs=211.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCC-CCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~  393 (636)
                      ...|+..+.||+|.||.||+++.+.++    ..+|+|.+.+...   .......+|+.+|+++. |||||.+.+.++...
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTG----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCC----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            446777899999999999999987765    8999999987633   34568899999999998 999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC----CcEEEecc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE----MRGRLGDF  469 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DF  469 (636)
                      ..++|||++.+|.|.+.+...   .+++.....++.|++.+++|||   +.+|+||||||+|+|+...    +.+|++||
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            999999999999999999655   3999999999999999999999   8999999999999999543    47999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      |++.....  .......+||+.|+|||++....++..+||||+|+++|.|++|..||...........++         .
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~---------~  252 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL---------R  252 (382)
T ss_pred             CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH---------c
Confidence            99998776  334555799999999999999999999999999999999999999998664332222111         1


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ++.      ....+.-....+.+.+++..|+..||.+|+|+.+++++-+
T Consensus       253 ~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  253 GDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             CCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            111      1222222234567788888999999999999999999753

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=308.66  Aligned_cols=268  Identities=22%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|++|.||+|....++    ..|++|.++..  .....+.+.+|++++++++|+||+++++++..++..+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATG----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY   76 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCC----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEE
Confidence            36888999999999999999987655    78999988754  2333467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||++++.|..++.  ....+++.++..++.+|+.||.|||   +.+++||||+|+||++++++.+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            9999999877776653  2355899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH-------Hhc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN-------LYG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~-------~~~  548 (636)
                      ...........++..|+|||++.+. .++.++||||||+++|||++|+.||....... ...........       .+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcc
Confidence            5443233445688999999999888 78999999999999999999999986442211 11111110000       000


Q ss_pred             -CCc-----chhhhhhh-hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 -QGK-----ICEAADAR-IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 -~~~-----~~~~~d~~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       ...     ..+..+.. ....++......+.+++.+||..+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             000     00000000 0111222236778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-35  Score=303.66  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      |+..+.||+|+||.||+|.....+    ..+|+|.+... .....+.+.+|+.++.+++|+||+++++++..++..++||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQ----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCC----cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            667789999999999999876544    79999998654 3344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++.   ...+++..+..++.+++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          82 EYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            9999999999984   346899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      . ......++..|+|||.+.+...+.++|||||||++|||++|..||.......     .   .....          ..
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~---~~~~~----------~~  216 (277)
T cd06641         156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----V---LFLIP----------KN  216 (277)
T ss_pred             h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----H---HHHHh----------cC
Confidence            1 2223467889999999988889999999999999999999999996432111     0   00000          00


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ............+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1112223345668889999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-35  Score=301.15  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS------KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      +|+..+.||+|++|.||+++...++    ..+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTG----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCC----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence            4777899999999999999876554    789999987542      223567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLA  472 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla  472 (636)
                      ..++|+||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||++
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            99999999999999999853  356889999999999999999999   89999999999999998775 5999999998


Q ss_pred             ccccCCCCc---cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          473 KLYQQGEVP---NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       473 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      .........   ......++..|+|||.+.+..++.++||||+|+++++|++|+.||........... .    ...   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~----~~~---  223 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-I----FKI---  223 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-H----HHH---
Confidence            765433111   11234678999999999888899999999999999999999999964422111111 0    000   


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            .........+......+.+++.+|+..+|++||++.++++.
T Consensus       224 ------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         224 ------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  00011123334455678889999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.8e-36  Score=307.74  Aligned_cols=263  Identities=27%  Similarity=0.351  Sum_probs=204.8

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeec
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRG  387 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g  387 (636)
                      +..+++.+++++|+..+.||+|+||.||++.....+    +.+|+|.+..... ...++.+|+.++.++ +|||++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~----~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~   86 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDG----SLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYG   86 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCC----CEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence            445667778899999999999999999999976655    7899999865422 235677899999998 7999999999


Q ss_pred             ccccc-----ceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          388 WCRKG-----NELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       388 ~~~~~-----~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      ++...     +..++||||+++++|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.
T Consensus        87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~  163 (291)
T cd06639          87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTT  163 (291)
T ss_pred             EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcC
Confidence            88643     358999999999999998853  23456899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCCccccccccCCcccccccccCCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCChhhH
Q 006668          461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS-----PTSASDVYSFGVVILEVACGRRPLDMGKGEEEE  535 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~  535 (636)
                      ++.+||+|||++........ ......++..|+|||.+....     ++.++|||||||++|||++|+.||.......  
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--  240 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--  240 (291)
T ss_pred             CCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--
Confidence            99999999999886543221 122346889999999876543     6889999999999999999999996542111  


Q ss_pred             HHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       536 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        .+..+..     +..     +.+  .........+.+++.+||+.+|++||++.|+++.
T Consensus       241 --~~~~~~~-----~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 --TLFKIPR-----NPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --HHHHHhc-----CCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              1111110     000     000  0112233568899999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-35  Score=300.82  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeeecccccc-
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-  392 (636)
                      ++|+..++||+|+||.||+|.....+    ..|++|.+...     .....+.+.+|+.++++++|+||+++++++.+. 
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTG----RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCC----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence            46888999999999999999977655    78999988642     223456788999999999999999999988653 


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       ..++++|||+++++|.+++..  ...+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence             468899999999999999853  345888999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCC--ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          472 AKLYQQGEV--PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       472 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ++.......  .......++..|+|||.+.+..++.++||||||+++|||++|+.||........    ...    ... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~----~~~-  223 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----IFK----IAT-  223 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----HHH----Hhc-
Confidence            976543211  112334688999999999888899999999999999999999999964321111    100    000 


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                              .......+......+..++.+|+. +|++||+++|+++.
T Consensus       224 --------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         224 --------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                    001112233444567777788885 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-35  Score=300.08  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=204.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc--cceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~  395 (636)
                      +|+..+.||+|+||.||++.....+    ..+++|.+...  .....+++..|+.++++++|+||+++++++..  +...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDG----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL   76 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCC----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence            4677899999999999999876655    78999998754  34445678899999999999999999997753  4568


Q ss_pred             EEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccC--CCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          396 MLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGW--DQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      +++|||+++++|.+++...  ....+++.+++.++.+|+.||.|||...  +.+++|+||||+||++++++.+||+|||+
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence            9999999999999998542  2467899999999999999999999543  57899999999999999999999999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +......... .....++..|+|||.+.+..++.++||||||+++++|++|+.||......     .+...+.       
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-------  223 (265)
T cd08217         157 AKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIK-------  223 (265)
T ss_pred             cccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHh-------
Confidence            9876543321 22346899999999999988999999999999999999999999754311     1111111       


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            .......+......+.+++.+|++.+|++||++.+|+++
T Consensus       224 ------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 ------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  111122333445678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-36  Score=307.82  Aligned_cols=267  Identities=24%  Similarity=0.349  Sum_probs=201.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..++||+|++|.||+|.....+    +.||+|++....  ....+.+.+|+++++.++|+||+++++++..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   76 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETG----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY   76 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCC----CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence            36788899999999999999986654    789999886542  223456788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+||+++++|.++...  ...+++.+++.++.||+.||+|||   +.+++|+||+|+||++++++.+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            99999999999887743  345899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH-------hc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL-------YG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~-------~~  548 (636)
                      ... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+..+....       ..
T Consensus       152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         152 APG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             CCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhc
Confidence            433 22333567899999998865 446789999999999999999999986443211 111111111100       00


Q ss_pred             CCcchhh-hhhhhh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEA-ADARIR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~-~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...+... ..+...     ..........+.+++.+||+.+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000 000000     00011234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=295.23  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++.|+..+.||+|.|+.||+.....++    +.+|+|+++..  +....+++.+|+.+-+.|+|||||+|.+...+.+..
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg----~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccch----HHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            456777789999999999999877766    78888888643  344678889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla  472 (636)
                      +||+|+|.|++|..-|..  +...++..+-..+.||+++|.|+|   .++|||||+||+|++|-   ...-+||+|||+|
T Consensus        86 ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             EEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence            999999999999776632  256777888889999999999999   89999999999999993   3455899999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ...+.+  ......+||++|||||++...+++..+|||+.||||+-|+.|+.||.........+++...    .+.    
T Consensus       161 i~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g----~yd----  230 (355)
T KOG0033|consen  161 IEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG----AYD----  230 (355)
T ss_pred             EEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc----ccC----
Confidence            987732  2344568999999999999999999999999999999999999999864333322222211    110    


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                         +++.....    ..+...+|+.+||..||.+|.|+.|.++.-+
T Consensus       231 ---~~~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  231 ---YPSPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             ---CCCcccCc----CCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence               11111122    2345667888899999999999999987644

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-35  Score=305.83  Aligned_cols=264  Identities=25%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||.|++|.||+|+....+    ..|++|.+....  ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL   76 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCC----CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence            4788899999999999999986655    789999887542  2233578899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ ++|.+++.......+++.+++.++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999995 68999987665677999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC-Ccchhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ-GKICEA  555 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~-~~~~~~  555 (636)
                      .. .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........    +.......-.. ..+...
T Consensus       153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         153 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             Cc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhh
Confidence            22 1222345688999999877654 58899999999999999999999975432211    11111100000 000000


Q ss_pred             h------hhhh----h---hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 A------DARI----R---QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~------d~~l----~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .      ....    .   ..........+.+++.+||+.||.+||+++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0      0000    0   00011123457789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.9e-36  Score=306.34  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=203.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+|+....+    ..|++|.+....  ....+.+.+|+.++++++|+||+++++++......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETG----ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCC----ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence            4778899999999999999986654    789999987653  3345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+ +++|.+++... ...+++.+++.++.||++||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        77 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          77 VMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             Eeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            99999 99999998543 367999999999999999999999   79999999999999999999999999999987655


Q ss_pred             CCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc-----
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-----  551 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~-----  551 (636)
                      ..........++..|+|||.+.+. .++.++||||+|++++||++|+.||..........     ++........     
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  226 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA-----IVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH-----HHHHHcCCCChHHHh
Confidence            433233345689999999988654 46889999999999999999977775432211111     1111111000     


Q ss_pred             ----------chhhhhhh-hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 ----------ICEAADAR-IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 ----------~~~~~d~~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                                +....... .......+....+.+++.+|++.+|++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      00000000 0011112234788999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-35  Score=302.34  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=203.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||+|++|.||++.....+    ..+++|.+.... ....+++.+|++++++++||||+++++.+..++..+++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTG----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCC----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            5677889999999999999987655    789999987663 34556788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +||+++++|.+++.... ..+++..+..++.|++.||+|||   + .+++|+||||+||++++++.+||+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999985432 67889999999999999999999   7 9999999999999999999999999999875533


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ...   ....++..|+|||.+.+..++.++||||||+++++|++|+.||.........   ..+.+.......       
T Consensus       154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~-------  220 (265)
T cd06605         154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNEP-------  220 (265)
T ss_pred             HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcCC-------
Confidence            221   1156888999999999999999999999999999999999999654211111   111111111000       


Q ss_pred             hhhhhccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFEAE-EMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         ....... ....+.+++.+||..||++||++.++++.
T Consensus       221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 ---PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               0111111 45568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-35  Score=315.71  Aligned_cols=193  Identities=24%  Similarity=0.381  Sum_probs=166.1

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ...+|+..+.||+|+||.||+|+....+    ..||+|......      ...|+.++++++|+||+++++++...+..+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQP----DPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCC----ceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            3457999999999999999999987654    789999754332      346899999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+||+ .++|.+++... ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       134 lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        134 MVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999999 57888888543 457899999999999999999999   8999999999999999999999999999997533


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL  526 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf  526 (636)
                      ..  .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            22  1223356899999999999999999999999999999999866654

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=340.19  Aligned_cols=258  Identities=21%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc-
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-  391 (636)
                      ....++|.+.+.||+|+||.||+++....+    ..+|+|.+...  .......+..|+.++++|+|||||++++++.. 
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ----EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCC----eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            344568999999999999999999987655    78999998754  33445678899999999999999999998744 


Q ss_pred             -cceEEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccC----CCcEEeCCCCCCCEEEcC----
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGW----DQVVVHRDIKSGNILLDS----  460 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivHrDlkp~NIll~~----  460 (636)
                       ...++|||||+++|+|.++|...  ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             45789999999999999998542  2357999999999999999999999421    146999999999999964    


Q ss_pred             -------------CCcEEEeccCCcccccCCCCccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCC
Q 006668          461 -------------EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRP  525 (636)
Q Consensus       461 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~P  525 (636)
                                   ...+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.|
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                         3348999999998654332  2233579999999998854  4578899999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          526 LDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       526 f~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      |.......   ..+ .   . ...+       +.+.   .......+.+|+..||+.+|.+||++.|+++.
T Consensus       243 F~~~~~~~---qli-~---~-lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        243 FHKANNFS---QLI-S---E-LKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcCCcHH---HHH-H---H-HhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            96542211   111 1   1 0000       0010   01123568889999999999999999999954

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-36  Score=290.54  Aligned_cols=254  Identities=29%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--------ChHHHHHHHHHHHHhccC-CCCceeeeecc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--------SKQGLKEFMAEISSMGRL-QHKNLVQMRGW  388 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~  388 (636)
                      -..|...+.||+|..+.|-++..+.++    ...|+|++...        .....+.-..|+.+|+++ -||+|+++.++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~----~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETG----KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccc----cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            346778899999999999999887766    78899988532        112234557899999998 59999999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      ++.+..+++|+|.|+.|.|.++|  ...-.++++..++|+.|+.+|+.|||   .+.|+||||||+|||+|++.++||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence            99999999999999999999999  44578999999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS------SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||.++.+..++  .....|||++|+|||.+...      .|+...|+|+.|||||.|+.|..||...    .+...+.  
T Consensus       167 FGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlMLR--  238 (411)
T KOG0599|consen  167 FGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQMLMLR--  238 (411)
T ss_pred             cceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHHHHH--
Confidence            99999887765  45568999999999976642      4678899999999999999999999632    1111111  


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                         +..+|+..      ...+-=.+....+.+|+.+||+.||.+|.|++|++++-
T Consensus       239 ---~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  239 ---MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ---HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence               11111111      01111123345678899999999999999999998753

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.1e-36  Score=308.60  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=201.4

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ...||+|+||.||++.....+    ..||+|.+........+.+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTG----KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCC----CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            456999999999999876554    7899999977666666778999999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.   ...+++.++..++.||+.||.|||   +.+++||||||+||++++++.+||+|||++....... ...
T Consensus       103 ~~~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         103 GGALTDIVT---HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence            999999883   345899999999999999999999   7899999999999999999999999999987654322 222


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......    .+.. +..         .....+.. 
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~-~~~---------~~~~~~~~-  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMRR-IRD---------NLPPRVKD-  240 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHh---------cCCCcccc-
Confidence            33568999999999988889999999999999999999999997542211    1111 000         01111111 


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .......+..++.+||..||.+|||++|+++.-.-.
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence             112344677888999999999999999999874444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.9e-36  Score=309.81  Aligned_cols=269  Identities=21%  Similarity=0.295  Sum_probs=200.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|+...++    ..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCC----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            46888899999999999999977655    789999987543 2223467789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ ++|.+++... ...+++..+..++.||+.||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            999996 6898888543 346889999999999999999999   89999999999999999999999999999976443


Q ss_pred             CCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-------HHH-hc
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV-------RNL-YG  548 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v-------~~~-~~  548 (636)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........... .....       |.. ..
T Consensus       157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF-IFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCChhhchhhhc
Confidence            221 12224578899999987654 578899999999999999999999975532211111 11100       000 00


Q ss_pred             CCcchhhhhhhhh----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QGKICEAADARIR----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~~~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .........+...    ..........+.+|+.+|++.||.+|||+.|+++.-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            0000000000000    0011122446788999999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-35  Score=305.69  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+++....+    ..+++|.++....  .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCC----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence            4777899999999999999987655    7899999875422  223567789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||++ ++|.+++... ...+++.+++.++.||++||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        77 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          77 VFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            999996 6888877543 356899999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc-----
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-----  551 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~-----  551 (636)
                      .. .......++..|+|||++.+.. ++.++|||||||++|||++|..|+............+..    ......     
T Consensus       152 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~  226 (284)
T cd07839         152 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR----LLGTPTEESWP  226 (284)
T ss_pred             CC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH----HhCCCChHHhH
Confidence            22 1222345788999999887654 688999999999999999999997554332221111110    000000     


Q ss_pred             -chhhhhhhh----h-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 -ICEAADARI----R-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 -~~~~~d~~l----~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +.+..+...    .     ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence             000000000    0     01111234567889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-35  Score=302.43  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=200.2

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc-----
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-----  393 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----  393 (636)
                      |.+.+.||+|+||.||+|.+... ...+..||+|++...  .....+++.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE-DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc-CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            55678899999999999987642 233478999998764  3445678889999999999999999999875432     


Q ss_pred             -eEEEEEeecCCCChhhhHhcC----CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                       ..++++||+++|+|.+++...    ....+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence             347899999999999887432    2235788999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++........ ......++..|++||.+....++.++||||||+++|||++ |+.||......     .+..++.. 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~~-  230 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIK-  230 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHHc-
Confidence            9999865433211 1222345678999999998889999999999999999999 88888644211     11111111 


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ....          .........+.+++.+||+.+|++||++.|+++.|+.
T Consensus       231 --~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 --GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             --CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              0000          1112334678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=319.25  Aligned_cols=242  Identities=25%  Similarity=0.361  Sum_probs=187.6

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC---CCCceeeeeccccccceEEEEEe
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL---QHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ||+|+||.||+|+....+    ..||+|++...   ..........|..++..+   +||||+++++++...+..++|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTR----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECCCC----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc
Confidence            799999999999987655    88999999653   122334455666776655   69999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++|+|.+++.  ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-  150 (330)
T cd05586          77 YMSGGELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-  150 (330)
T ss_pred             CCCCChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence            999999999984  3456899999999999999999999   8999999999999999999999999999987543222 


Q ss_pred             ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      ......+||..|+|||++.+. .++.++|||||||++|||++|+.||.......    ....     ...+..      .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~-----i~~~~~------~  215 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRN-----IAFGKV------R  215 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHH-----HHcCCC------C
Confidence            123345799999999988764 47899999999999999999999997542211    1110     011110      1


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRP----TMREVVAV  596 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP----s~~evl~~  596 (636)
                      +..   ......+.+++.+||+.||.+||    ++.+++++
T Consensus       216 ~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            111   11234567888999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-35  Score=305.84  Aligned_cols=250  Identities=26%  Similarity=0.322  Sum_probs=204.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|++|.||++.....+    +.+|+|.+....   ....+.+.+|++++++++||||+++++++..++..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSG----KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL   76 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeE
Confidence            36788899999999999999987654    889999987542   23456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        77 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            999999999999999854  357899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    .....+++.|+|||.+.+...+.++||||||+++++|++|+.||.......    ....     ...+.    
T Consensus       152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~-----~~~~~----  214 (290)
T cd05580         152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEK-----ILEGK----  214 (290)
T ss_pred             CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-----HhcCC----
Confidence            543    233468899999999988888999999999999999999999997543111    1100     00111    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~~  600 (636)
                            ..++......+.+++.+||..||.+||     +++|+++.-...
T Consensus       215 ------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         215 ------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             ------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence                  111222346778899999999999999     777777654433

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=303.51  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccc-
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN-  393 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-  393 (636)
                      .++++|+..+.||+|++|.||+|.....+    ..+++|.+..... ..+++.+|+.+++++ +|+||+++++++.... 
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTG----QLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCC----cEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            35678999999999999999999986544    7899999876544 346788999999999 6999999999986543 


Q ss_pred             -----eEEEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          394 -----ELMLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       394 -----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                           .+++||||+++++|.+++....  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEE
Confidence                 4899999999999999985432  467899999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      +|||++....... .......++..|+|||.+..     ..++.++||||||++++||++|+.||........    +..
T Consensus       155 ~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~  229 (275)
T cd06608         155 VDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFK  229 (275)
T ss_pred             CCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----HHH
Confidence            9999987654322 22233568899999998754     3467789999999999999999999964321111    111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...     +.     .+.+  .........+.+++.+||..||++|||+.++++.
T Consensus       230 ~~~-----~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPR-----NP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhc-----cC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            000     00     0000  1112244678899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-35  Score=307.59  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=202.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||++.....+    ..|++|.+....   ....+.+.+|+.+++.++|+||+++++.+..++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   76 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETR----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL   76 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCC----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence            36888899999999999999987665    789999987653   23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            999999999999999944  356899999999999999999999   799999999999999999999999999998642


Q ss_pred             cCCCC--------------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          476 QQGEV--------------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       476 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .....              .......++..|+|||.+....++.++||||||+++|||++|+.||......    ..+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~  227 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQ  227 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence            11100              0111235788999999998888999999999999999999999999643211    11111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....     ...   .+    ......+..+.+++.+||+.||++||++.++.+.|+..
T Consensus       228 ~~~~-----~~~---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISD-----DIE---WP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhc-----ccC---CC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1110     000   00    00112345678999999999999999987777777664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-36  Score=319.16  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=206.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-C-----Cceeeeeccccccc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-H-----KNLVQMRGWCRKGN  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~g~~~~~~  393 (636)
                      +|.+.++||+|.||.|-|+....++    +.||||+++... .-..+...|+++|..|+ |     -|+|++++++...+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~----e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTG----EIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCC----cEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            7889999999999999999987766    999999997653 33466778999999997 4     37999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC--CcEEEeccCC
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE--MRGRLGDFGL  471 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGl  471 (636)
                      ++|||+|.+ .-+|.++|..++...++...++.++.||+.||.+||   +.+|||+||||+||||.+.  ..+||+|||.
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            999999999 779999998888889999999999999999999999   8999999999999999654  3699999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH-------
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR-------  544 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~-------  544 (636)
                      ++.....-    ...+.+..|.|||++.+.+|+.+.||||||||++||++|..-| .+..+.+.-..+.+...       
T Consensus       338 Sc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  338 SCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-CCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98765432    2457788999999999999999999999999999999996444 44333333333332111       


Q ss_pred             HH-------hcC--Ccc-----hh-----------h-----hhhh-hh-------hccCHHHHHHHHHHHHHccCCCCCC
Q 006668          545 NL-------YGQ--GKI-----CE-----------A-----ADAR-IR-------QEFEAEEMELVLKLGLACCHPDSTR  586 (636)
Q Consensus       545 ~~-------~~~--~~~-----~~-----------~-----~d~~-l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~  586 (636)
                      ..       +..  +..     .+           .     .+.. ..       ..........+.+++++|+..||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence            00       000  000     00           0     0000 00       0111134567899999999999999


Q ss_pred             CCCHHHHHHHH
Q 006668          587 RPTMREVVAVL  597 (636)
Q Consensus       587 RPs~~evl~~L  597 (636)
                      |+|..|++++-
T Consensus       493 R~tp~qal~Hp  503 (586)
T KOG0667|consen  493 RITPAQALNHP  503 (586)
T ss_pred             cCCHHHHhcCc
Confidence            99999999874

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-35  Score=300.07  Aligned_cols=251  Identities=22%  Similarity=0.368  Sum_probs=202.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|+||.||++.....+    ..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDS----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCC----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence            4778899999999999999987655    789999986542  2334577899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~  476 (636)
                      |+||+++++|.+++.......+++..+..++.|+++||.|||   +.+++|+||||+||++++++ .+||+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            999999999999996655556899999999999999999999   79999999999999998885 46999999997664


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .... ......|+..|+|||.+....++.++||||||++++||++|+.||......        +++..... +..    
T Consensus       154 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~----  219 (257)
T cd08225         154 DSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQ-GYF----  219 (257)
T ss_pred             CCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhc-ccC----
Confidence            3321 222345889999999998888999999999999999999999999644211        11111111 000    


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ..........+.+++.+||..+|++||++.|+++.
T Consensus       220 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 -----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 11122234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.4e-35  Score=305.33  Aligned_cols=198  Identities=26%  Similarity=0.399  Sum_probs=160.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccc--ccceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR--KGNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~E~  401 (636)
                      ..+||+|+||.||+|+..+.  .....||+|.+.....  ...+.+|+.++++++||||+++++++.  .+...++|+||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~--~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG--KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC--CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            46899999999999997543  2337899998875432  245678999999999999999999884  35678999999


Q ss_pred             cCCCChhhhHhcC-------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE----cCCCcEEEeccC
Q 006668          402 MPNGSLNNWIFGK-------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL----DSEMRGRLGDFG  470 (636)
Q Consensus       402 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG  470 (636)
                      ++ ++|.+++...       ....+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            95 5777776321       2235889999999999999999999   8999999999999999    566789999999


Q ss_pred             CcccccCCCC--ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          471 LAKLYQQGEV--PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       471 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +++.......  .......+|..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9987654322  122345689999999988764 5789999999999999999999999644

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-35  Score=301.06  Aligned_cols=255  Identities=28%  Similarity=0.449  Sum_probs=198.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh----------HHHHHHHHHHHHhccCCCCceeeeeccc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK----------QGLKEFMAEISSMGRLQHKNLVQMRGWC  389 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~h~niv~l~g~~  389 (636)
                      +|...+.||+|++|.||+|.....+    ..+|+|.+.....          ...+.+.+|+.++++++|+|++++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTG----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCC----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            3567789999999999999876544    7899998864211          1234678899999999999999999999


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      ...+..++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          78 TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeec
Confidence            9999999999999999999998543  57899999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCC-ccccccccCCcccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          470 GLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSS--PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       470 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      |+++....... .......++..|+|||.+....  ++.++|+||||+++||+++|..||......   . .+.+    .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~-~~~~----~  224 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---A-AMFK----L  224 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---H-HHHH----h
Confidence            99976543211 1123346889999999887654  788999999999999999999999643211   1 1111    0


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ... ....    .+...........+.+++.+||.++|++||++.+|++.
T Consensus       225 ~~~-~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 GNK-RSAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hcc-ccCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000 0000    11111222335678889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.3e-36  Score=309.31  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ...||+|+||.||++.....+    ..|++|++........+.+.+|+.++..++||||+++++.+..++..++|+||++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSG----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCC----CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            457999999999999876544    7899999976554455678899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.   ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus       102 ~~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  174 (297)
T cd06659         102 GGALTDIVS---QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR  174 (297)
T ss_pred             CCCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence            999999873   346899999999999999999999   8999999999999999999999999999987554322 222


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|+|||++.+..++.++||||||++++||++|+.||........    + ..+...    .     ....  .
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~-~~~~~~----~-----~~~~--~  238 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA----M-KRLRDS----P-----PPKL--K  238 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHhcc----C-----CCCc--c
Confidence            335689999999999988999999999999999999999999964421111    1 111000    0     0000  0


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                      ........+.+++.+||+.+|++||++.++++.-.-.+. ..|
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~-~~~  280 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT-GLP  280 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC-CCc
Confidence            011223457889999999999999999999996444323 444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=302.47  Aligned_cols=252  Identities=26%  Similarity=0.421  Sum_probs=201.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCC---CCceeeeeccccccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQ---HKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~  395 (636)
                      .|+..+.||+|+||.||+|.....+    ..+++|.+... .....+++.+|+.++++++   |||++++++++..+...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTG----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCC----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            4667789999999999999986655    78999998754 3344567888999999986   99999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..   ..+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999999999843   37899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .... .......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........     ...    ....    
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~----~~~~----  217 (277)
T cd06917         152 NQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MML----IPKS----  217 (277)
T ss_pred             CCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhc----cccC----
Confidence            5433 222334689999999987654 468899999999999999999999965421110     000    0000    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       ..+.+..   ...+..+.+++.+||+.||++||++.|+++.-.-
T Consensus       218 -~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         218 -KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             -CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence             0011111   1134568889999999999999999999886543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-35  Score=301.74  Aligned_cols=263  Identities=26%  Similarity=0.318  Sum_probs=204.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccc--cceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~  395 (636)
                      ++|...+.||.|++|.||++.....+    ..+|+|.+..... ....++.+|++++++++||||++++++|..  .+.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTG----MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCC----eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            36788899999999999999986654    8899999976533 445678999999999999999999998854  3478


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++||||+++++|.+++..  .....+++..+..++.||+.||.|||   +.+++|+||+|+||++++++.++|+|||++.
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            999999999999998743  23456889999999999999999999   8999999999999999999999999999987


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||............+..++...    ...
T Consensus       154 ~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~  226 (287)
T cd06621         154 ELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNP  226 (287)
T ss_pred             cccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cch
Confidence            543322   1234578899999999999999999999999999999999999975532111111122222210    000


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       .+.....  ........+.+++.+||+.+|.+|||+.|+++.-.
T Consensus       227 -~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         227 -ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             -hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence             0000000  00123466889999999999999999999998543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-35  Score=298.12  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||+|++|.||+++....+    ..|++|++..... ...+++.+|+..+.+++|+||+++++++...+..++|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTG----KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            5788899999999999999987655    8899999987644 4567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||+++++|.+++...  ..+++..++.++.|+++||+|||   + .+++||||+|+||+++.++.++|+|||++.....
T Consensus        78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999999543  67899999999999999999999   7 9999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......  ...+..++..            
T Consensus       153 ~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~------------  217 (264)
T cd06623         153 TLDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICD------------  217 (264)
T ss_pred             CCCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhc------------
Confidence            33222 23467899999999999999999999999999999999999997553211  1111111110            


Q ss_pred             hhhhhccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ARIRQEFEAE-EMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       ......+.. .+..+.+++.+||+++|++||++.|+++.
T Consensus       218 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 -GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             011112222 45678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.9e-35  Score=303.46  Aligned_cols=267  Identities=21%  Similarity=0.275  Sum_probs=200.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-----HHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-----GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      +|+..+.||+|++|.||+|.....+    ..|++|.+......     ....+..|++++++++|+||+++++++.+.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETG----RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCC----cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence            4777889999999999999976654    79999999765322     23456789999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+ +++|.+++.... ..+++..++.++.||++||+|||   +.+++|+||||+||+++.++.+||+|||+++.
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            99999999 999999995432 47999999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH----Hhc-
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN----LYG-  548 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~----~~~-  548 (636)
                      ...... ......++..|+|||.+.+ ..++.++|||||||+++||++|..||............. .....    .+. 
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  229 (298)
T cd07841         152 FGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWPG  229 (298)
T ss_pred             ccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH-HHcCCCchhhhhh
Confidence            654321 2222356788999998765 457889999999999999999977776443222111111 00000    000 


Q ss_pred             CCcchhhhhhhhh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          549 QGKICEAADARIR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       549 ~~~~~~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .............     ..........+.+++.+||++||++||++.|+++.=
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~  283 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP  283 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence            0000000000000     011122346788999999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.6e-35  Score=305.27  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=204.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|...+.||+|+||.||++.....+    ..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATG----QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCC----CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            57888999999999999999865544    78999998765555557788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||+++++|.+++.   ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        95 ~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          95 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             EecCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            99999999999984   345889999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. ......+++.|+|||.+....++.++||||||+++||+++|+.||........    +..    ....+.       
T Consensus       169 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~~----~~~~~~-------  232 (293)
T cd06647         169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYL----IATNGT-------  232 (293)
T ss_pred             cc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----eee----hhcCCC-------
Confidence            22 22234688899999999888899999999999999999999999965422110    000    000000       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       ............+.+++.+||..+|++||++.+++++-
T Consensus       233 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         233 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence             00011222345688899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.6e-35  Score=291.92  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=205.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      |+..+.||+|++|.||++.....+    ..+++|++........+++.+|+..+++++|+|++++++++......++++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTG----KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCC----cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            667889999999999999987544    7899999987765566889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++++|.+++... ...+++..+..++.+++.||+|||   +.+++||||+|+||++++++.++|+|||.+........
T Consensus        78 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          78 FCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             cCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            99999999998543 257899999999999999999999   79999999999999999999999999999987655432


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                        .....++..|+|||.+....++.++||||||+++++|++|+.||.........   . . ...             ..
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~-~-~~~-------------~~  213 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---F-K-IAT-------------NG  213 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH---H-H-HHh-------------cC
Confidence              23456889999999999888999999999999999999999999754211111   0 0 000             00


Q ss_pred             hhccCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          561 RQEFEAE--EMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       561 ~~~~~~~--~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .......  ....+.+++.+||+.||++|||+.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0111111  14668899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=301.12  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=202.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeecccccc--ceEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NELM  396 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~  396 (636)
                      |+..+.||+|++|.||+|+....+    ..+++|.+....  ....+.+.+|+.++++++|+|++++++++...  +..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   76 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTG----ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY   76 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCC----eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence            567789999999999999987655    889999998763  33346788999999999999999999999887  8899


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+||++ ++|.+++... ...+++.+++.++.||++||+|||   +.+++|+||||+||++++++.+||+|||++....
T Consensus        77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~  151 (287)
T cd07840          77 MVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT  151 (287)
T ss_pred             EEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence            9999996 5898888543 257899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH---------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL---------  546 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~---------  546 (636)
                      .......+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. +.....         
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (287)
T cd07840         152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF-ELCGSPTDENWPGVS  230 (287)
T ss_pred             CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCchhhccccc
Confidence            543323334457889999997664 457899999999999999999999997654322111111 100000         


Q ss_pred             ----hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          547 ----YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       547 ----~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                          .............+...+...+...+.+++.+||+.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                00000000111111111222236678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-35  Score=303.76  Aligned_cols=268  Identities=20%  Similarity=0.283  Sum_probs=201.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeecccccc--ce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~  394 (636)
                      ++|+..+.||+|++|.||+|+....+    ..+++|.++.....  ....+.+|+.++.+++||||+++++++...  +.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTG----EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCC----cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            46778899999999999999987654    78999999755322  233567899999999999999999998776  88


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||++ ++|.+++... ...+++.+++.++.||+.||+|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~  155 (293)
T cd07843          81 IYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE  155 (293)
T ss_pred             EEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence            999999996 5999888543 246899999999999999999999   78999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH------HHHHh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW------VRNLY  547 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~------v~~~~  547 (636)
                      ..... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...............+      .|..+
T Consensus       156 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         156 YGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             ccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            65432 1223345788999999887644 6889999999999999999999997554322222211100      00000


Q ss_pred             ------cCCcchhhhhhhhhhccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          548 ------GQGKICEAADARIRQEFEAE-EMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       548 ------~~~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            ......+.....+...+... ....+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  00000111111122222222 35668889999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=299.59  Aligned_cols=251  Identities=29%  Similarity=0.400  Sum_probs=210.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      |++.++||+|.||.|||+.++..+    ..+|+|.+..++  .++++.+|+.++++++.|++|++||.+.....+++|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG----~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESG----HVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccC----cEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            566788999999999999998877    899999997764  36889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      ||..|++.+.++. ++++|++.++..+++..++||+|||   ...-+|||||+.||||+.+|.+||+|||.|..+.... 
T Consensus       109 YCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-  183 (502)
T ss_pred             hcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence            9999999998854 4678999999999999999999999   7889999999999999999999999999998665432 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                      .....+.||+-|||||++..-.|..++||||||+...||..|++||...-...   .              + -.+.-+-
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---A--------------I-FMIPT~P  245 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---A--------------I-FMIPTKP  245 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---e--------------e-EeccCCC
Confidence            33445789999999999999999999999999999999999999996541110   0              0 0011111


Q ss_pred             hhcc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          561 RQEF--EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       561 ~~~~--~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +..|  ++.-...+.+++..||..+|++|-|+.+++++---.
T Consensus       246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik  287 (502)
T KOG0574|consen  246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK  287 (502)
T ss_pred             CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence            1122  223346688899999999999999999999886444

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=302.20  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|++|.||+|+.+..+    +.||+|.+...... ....+.+|++++++++|+||+++++++.+++..++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTG----QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCC----cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            56888899999999999999976554    78999998754322 22456789999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ ++|.+++... ...+++..++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 v~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          81 VFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999997 5999988543 347889999999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc---ch
Q 006668          478 GEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---IC  553 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~---~~  553 (636)
                      ... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............    ........   ..
T Consensus       156 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  230 (291)
T cd07844         156 PSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI----FRVLGTPTEETWP  230 (291)
T ss_pred             CCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH----HHhcCCCChhhhh
Confidence            211 1122346889999998865 457889999999999999999999996543211111111    11110000   00


Q ss_pred             hh--------------hhhhhhhccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          554 EA--------------ADARIRQEFE-AEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       554 ~~--------------~d~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..              ....+..... ......+.+++.+|++.+|++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00              0000000000 0012567789999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.8e-35  Score=300.05  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=203.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      .|...+.||+|++|.||++.....+    ..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTG----RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCC----CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            3455689999999999999876554    789999987665555677889999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..   ..+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999999843   56899999999999999999999   8999999999999999999999999999887554322


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                       .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........        ..... +     ..+.
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~--------~~~~~-~-----~~~~  234 (285)
T cd06648         170 -PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--------KRIRD-N-----LPPK  234 (285)
T ss_pred             -cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH--------HHHHh-c-----CCCC
Confidence             1223346899999999998888999999999999999999999998653211111        11000 0     0000


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +.  ........+.+++.+||+.+|++||++.++++.-.-.
T Consensus       235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  273 (285)
T cd06648         235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA  273 (285)
T ss_pred             Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence            00  0112345789999999999999999999999754433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.8e-35  Score=302.94  Aligned_cols=251  Identities=26%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      +.|+..+.||+|+||.||+|+....+    ..|++|.+...   ..+..+++.+|+.+++.++||||+++.++|...+..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTN----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            45888899999999999999986654    78999998643   334456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|+||++ |+|.+++... ...+++.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++...
T Consensus        91 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            99999996 6777776432 346899999999999999999999   899999999999999999999999999998765


Q ss_pred             cCCCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ...     ....++..|+|||++.   ...++.++||||||+++|||++|+.||........    ... ..   .. . 
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~----~~~-~~---~~-~-  230 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYH-IA---QN-D-  230 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----HHH-Hh---cC-C-
Confidence            332     2245788999999874   45678899999999999999999999865421110    100 00   00 0 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                             ............+.+++.+||+.||++||++.+++++..-.
T Consensus       231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         231 -------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             -------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                   00001122445689999999999999999999999876554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.7e-35  Score=301.51  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=198.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH-HHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++++|...+.||+|+||.||+|.....+    ..|++|.+....... ...+.+|+.+++.++|+||+++.+++..++..
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRING----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCC----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence            4578899999999999999999976655    789999997653322 34567899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|+||++ ++|.+++... ...+++.++..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||+++..
T Consensus        79 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            99999995 7777776433 346788899999999999999999   789999999999999999999999999999754


Q ss_pred             cCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC--c-
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG--K-  551 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~--~-  551 (636)
                      ..... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......  +.....  +......  . 
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~--~~~~~~~~~~~  228 (291)
T cd07870         154 SIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKI--WTVLGVPTEDT  228 (291)
T ss_pred             CCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHH--HHHcCCCChhh
Confidence            32211 12223578899999988764 57889999999999999999999997553221  111111  1100000  0 


Q ss_pred             ---------chhhhh-----hhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 ---------ICEAAD-----ARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 ---------~~~~~d-----~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                               ..+...     ..+.... .......+.+++.+|+..||.+|||+.|++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                     000000     0000000 00124567889999999999999999998853

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-35  Score=297.05  Aligned_cols=248  Identities=25%  Similarity=0.335  Sum_probs=203.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +|+..+.||+|+||.||+++....+    ..+++|.+...   .....+.+.+|++++++++||||+++++.+.++...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTK----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCC----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEE
Confidence            4778899999999999999976554    78999999754   2245678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+||+++++|.+++...  ..+++.++..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            999999999999998433  57899999999999999999999   8899999999999999999999999999988654


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...  ......++..|+|||.+....++.++|+||||+++|+|++|+.||....... .     ++.......       
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~-----~~~~~~~~~-------  216 (258)
T cd05578         152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-R-----DQIRAKQET-------  216 (258)
T ss_pred             CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-H-----HHHHHHhcc-------
Confidence            432  2233468889999999998889999999999999999999999997654321 1     111111110       


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM--REVV  594 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~--~evl  594 (636)
                         .....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               1112223344778899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.2e-35  Score=299.20  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=194.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHH-hccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISS-MGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+++...++    ..||+|+++... .....++..|+.. ++.++|+||+++++++..++..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTG----TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCC----cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            36888899999999999999987655    899999997652 2233455556664 56678999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++|||++ |+|.+++...  ....+++.+++.++.||+.||+|||   +. +++||||||+||+++.++.+||+|||+++
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999995 7888887532  3457899999999999999999999   55 89999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATV----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ......  ..+...++..|+|||.+.+    ..++.++|+||||+++|||++|+.||........   .+.....     
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~-----  222 (283)
T cd06617         153 YLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQVVE-----  222 (283)
T ss_pred             cccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH---HHHHHHh-----
Confidence            654322  1223467889999998765    4468899999999999999999999964321111   1111000     


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ...+.+.   .......+.+++.+||..+|++||++.++++.
T Consensus       223 -----~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 -----EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -----cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0001110   11234568889999999999999999999974

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-35  Score=300.11  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |+..+.||.|++|.||+|.....+    ..|++|++....  ......+.+|+..+++++|+|++++++++.+++..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTG----EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCC----CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence            567789999999999999986655    789999987553  22335678899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+ +++|.+++.......+++.+++.++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            9999 579999986554457899999999999999999999   789999999999999999999999999999765432


Q ss_pred             CCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc-----
Q 006668          479 EVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI-----  552 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~-----  552 (636)
                      . .......++..|+|||++.+. .++.++||||||+++|||++|+.||........    +.............     
T Consensus       153 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         153 V-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             c-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhhh
Confidence            2 122223568899999987654 568899999999999999999999975432111    11111111000000     


Q ss_pred             hhh--hhhhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEA--ADARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~--~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...  .....       ...........+.+++.+|+++||++||+++|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000  00000       001111223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-34  Score=297.64  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=201.3

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|+..+.||+|++|.||+|+...++    ..||+|.++..... ....+.+|+.++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTG----EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCC----eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            4778899999999999999987655    88999999765332 345677899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          399 YDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||++ ++|.+++.... ...+++.++..++.|+++||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            99997 58888885432 356899999999999999999999   78999999999999999999999999999975543


Q ss_pred             CCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH------HHHHhcC-
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW------VRNLYGQ-  549 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~------v~~~~~~-  549 (636)
                      ... ......++..|++||++.+. .++.++||||||+++|||++|+.||...............+      .+..+.. 
T Consensus       153 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         153 PVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             Ccc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence            221 12234578899999987654 56889999999999999999999997654332222211110      0000000 


Q ss_pred             Ccch----hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKIC----EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~----~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ....    ...+.. ...........+.+++.+|++.||.+||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000    000000 011112335668899999999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-34  Score=298.43  Aligned_cols=259  Identities=28%  Similarity=0.366  Sum_probs=208.1

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ..++.|+..+.||+|++|.||++.....+    ..+++|.+..... ..+.+.+|++.+++++|+|++++++.+...+..
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATG----KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCC----cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            35567888899999999999999987544    7899999986654 457788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|+||+++++|.+++.... ..+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            99999999999999996532 47999999999999999999999   899999999999999999999999999998755


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........    ...+...     ...  
T Consensus       167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~~~~~~~-----~~~--  234 (286)
T cd06614         167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----LFLITTK-----GIP--  234 (286)
T ss_pred             ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhc-----CCC--
Confidence            43221 22234578899999999888899999999999999999999999864422111    1110000     000  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ........+..+.+++.+||+.+|.+||++.++++...-.
T Consensus       235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         235 -----PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             -----CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence                 0001112346688999999999999999999999765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=302.35  Aligned_cols=271  Identities=23%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeecccccc--ce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~  394 (636)
                      +|+..+.||+|++|.||+|+....  ..+..||+|.+....   ....+.+.+|+.++.+++||||+++++++...  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~--~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG--KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC--CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            477889999999999999998662  123899999998743   33346678899999999999999999999887  78


Q ss_pred             EEEEEeecCCCChhhhHhcC---CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC----CCcEEEe
Q 006668          395 LMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS----EMRGRLG  467 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~  467 (636)
                      +++||||++ ++|.+++...   ....+++..++.++.||+.||+|||   +.+++||||||+||+++.    ++.+||+
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            999999996 4677666322   2237889999999999999999999   899999999999999999    9999999


Q ss_pred             ccCCcccccCCCC--ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChh-----hHHHHH
Q 006668          468 DFGLAKLYQQGEV--PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEE-----EEEAVL  539 (636)
Q Consensus       468 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~-----~~~~~l  539 (636)
                      |||++........  .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......     .....+
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            9999986543322  122334678999999987664 57889999999999999999999997543221     001111


Q ss_pred             HHHHHHHhcCC-----------cchhhhhhhhhhccC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          540 MDWVRNLYGQG-----------KICEAADARIRQEFE---------A--EEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       540 ~~~v~~~~~~~-----------~~~~~~d~~l~~~~~---------~--~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...+..+-...           ......+......++         .  .....+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11111100000           000000000000111         1  233568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=302.80  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .+.|+.-++||+||||.||-++.+.++    +.+|.|++.+.   .+++....++|-.+|++++.+.||.+--.++.++.
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTG----KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATG----KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecch----hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            356888999999999999999988877    89999988654   33344566789999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ++||+..|.||+|.-||.+.....++++..+.++.+|+.||++||   +..||+|||||+|||||+.|+++|+|+|||..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999999998877789999999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      +..+..  ....+||.+|||||++.+..|+...|.|||||++|||+.|+.||.........                  +
T Consensus       337 i~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------------e  396 (591)
T KOG0986|consen  337 IPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------------E  396 (591)
T ss_pred             cCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------------H
Confidence            766543  23348999999999999999999999999999999999999999754321111                  1


Q ss_pred             hhhhhh---hhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          555 AADARI---RQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       555 ~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      .+|.+.   ..+++..-.+....|....|+.||.+|.-.+
T Consensus       397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            112221   1233444445555666667899999987654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=290.51  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..++||+|.||+|.+++-+..+    +.+|+|+++++   .++....-..|-++|+..+||.+..|.-.+...+.
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~----k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATG----KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccC----ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            356888899999999999999876665    89999999876   45566677889999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +|+||||..||.|.-+|  .+.+.+++...+.+-..|+.||.|||   +++||+||||.+|.|||.+|++||.||||++.
T Consensus       243 lCFVMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999999999988  55778999999999999999999999   89999999999999999999999999999985


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      --.. ...+...|||+.|+|||++....|....|.|.+||++|||+||+.||...+.+...+.++++             
T Consensus       318 ~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------  383 (516)
T KOG0690|consen  318 EIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------  383 (516)
T ss_pred             cccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence            3222 22445589999999999999999999999999999999999999999866544444444433             


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                        |-+.+...+.+....|..    .|..||.+|.-     ++||.+.
T Consensus       384 --d~kFPr~ls~eAktLLsG----LL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 --DLKFPRTLSPEAKTLLSG----LLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             --hccCCccCCHHHHHHHHH----HhhcChHhhcCCCchhHHHHHhh
Confidence              334445555555555544    48899999953     5666543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-34  Score=292.70  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=204.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+++....+    ..+++|.+...  ......++.+|++++++++|+||+++.+++......++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDN----QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCC----CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence            4778899999999999999876554    78999998754  23445677889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |+||+++++|.+++...  ....+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            99999999999998542  2357899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....   .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......     +...+    ..      
T Consensus       154 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~----~~------  215 (256)
T cd08530         154 KKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKV----QR------  215 (256)
T ss_pred             ccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH----hc------
Confidence            5541   222457889999999999889999999999999999999999997543211     11100    01      


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         ......+......+.+++.+|++.+|++||++.++++.
T Consensus       216 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 ---GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               11112233455678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.8e-35  Score=302.01  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=196.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV  398 (636)
                      |...+.||+|+||.||+++....+    ..+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSG----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCC----CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            445678999999999999987655    889999987543 344567889999999996 99999999999988999999


Q ss_pred             EeecCCCChhhh---HhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          399 YDYMPNGSLNNW---IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       399 ~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |||++ ++|.++   +.......+++..+..++.+++.||+|||+  +.+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99985 455543   333344679999999999999999999994  358999999999999999999999999999765


Q ss_pred             cCCCCccccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ....  ......|+..|+|||.+...   .++.++|||||||++|||++|+.||....  .     ..+-+.....    
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~-----~~~~~~~~~~----  225 (288)
T cd06616         159 VDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--S-----VFDQLTQVVK----  225 (288)
T ss_pred             ccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--h-----HHHHHhhhcC----
Confidence            4322  12233588999999998776   68899999999999999999999996432  0     1010111100    


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ...+.+...........+.+|+.+||+.||++||++.+|++.-
T Consensus       226 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~  268 (288)
T cd06616         226 --GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP  268 (288)
T ss_pred             --CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence              0011122222223456788999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.7e-34  Score=289.87  Aligned_cols=252  Identities=32%  Similarity=0.441  Sum_probs=207.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeecccccc--ceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~  395 (636)
                      +|+..+.||+|++|.||+|.....+    ..|++|.+.....  ...+.+.+|+..+++++|+||+++++.+...  +..
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTG----ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL   76 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence            3677899999999999999987544    7899999876642  4567889999999999999999999999888  889


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|+||+++++|.+++...  ..+++.++..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999999998543  38999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ...... ......++..|+|||.+.....+.++||||||+++++|++|+.||.......   ...    ...        
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~--------  216 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AAL----YKI--------  216 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH----Hhc--------
Confidence            554321 1223468899999999998889999999999999999999999997653111   000    000        


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       .........+......+.+++.+|+..||++||++.++++.
T Consensus       217 -~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         217 -GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence             00111122333446789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.7e-34  Score=291.47  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||++....++    ..+++|++....  ....+++.+|++++++++|+|++++.+.+..++..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDG----KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCC----cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence            4777899999999999999986544    789999997653  3556778899999999999999999999998899999


Q ss_pred             EEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |+||+++++|.+++....  ...+++.++..++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            999999999999986543  467999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... .......+++.|+|||......++.++||||+|+++++|++|+.||.....    .........     +.    
T Consensus       154 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-----~~----  219 (258)
T cd08215         154 SSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----LELALKILK-----GQ----  219 (258)
T ss_pred             ccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----HHHHHHHhc-----CC----
Confidence            5433 122334688899999999888899999999999999999999999965421    111111110     00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ....+......+.+++.+||..+|++||++.|+++.
T Consensus       220 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 -----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 111222344678889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-34  Score=294.01  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=197.6

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||.|++|.||+++....+    ..+++|.+....   ....+.+.+|+.++++++|+||+++++.+.+++..++|+||++
T Consensus         1 lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKSKN----RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECCCC----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCC
Confidence            689999999999986544    889999997542   2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.+  ...+++.++..++.||+.||.|||   +.+++|+||+|+||+++.++.+||+|||++.......  ..
T Consensus        77 ~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~  149 (262)
T cd05572          77 GGELWTILRD--RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT  149 (262)
T ss_pred             CCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence            9999999954  345899999999999999999999   8999999999999999999999999999998765432  22


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|++||.+....++.++|+||||+++|||++|..||.......  ......             ..+......
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-------------~~~~~~~~~  214 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYND-------------ILKGNGKLE  214 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHH-------------HhccCCCCC
Confidence            33468899999999988889999999999999999999999997553211  111111             010011122


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                      ++......+.+++.+||+.+|++||+     ++|+++.
T Consensus       215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            23333567899999999999999999     6676653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-34  Score=296.90  Aligned_cols=242  Identities=25%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|+||+||++.....+    +.+++|.+....   ......+.+|++++++++||||+++++.+...+..++||||++
T Consensus         1 lg~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKATG----KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcCCC----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCC
Confidence            689999999999876654    789999986532   2234456789999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.......+++.+++.++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++.......  ..
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  151 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KI  151 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cc
Confidence            999999997655557999999999999999999999   8999999999999999999999999999997654322  12


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|+|||.+.+..++.++||||||+++++|++|+.||........... +..    ..    .      .....
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~----~~----~------~~~~~  216 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-LKR----RT----L------EMAVE  216 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-HHh----cc----c------ccccc
Confidence            234578899999999888899999999999999999999999975532111111 100    00    0      00111


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      .+......+.+++.+||+.||++||+.++
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            22233566789999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=295.00  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV  398 (636)
                      |++.+.||+|++|.||+|+....+    +.|++|++..... .......+|+..+.+++ |+||+++++++..++..++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETG----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCC----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            567789999999999999987655    7899999875422 22234457899999999 99999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+ +|+|.+++.......+++.++..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999 889999986654457899999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH--------HHHHHHhcC
Q 006668          479 EVPNTTRVVGTLGYLAPELAT-VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--------DWVRNLYGQ  549 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~--------~~v~~~~~~  549 (636)
                      .  ......++..|+|||.+. ...++.++|+||||++++||++|+.||..............        .|.......
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         153 P--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             C--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            2  122345788999999774 45578999999999999999999999865533222111110        011110000


Q ss_pred             Ccchhhh----hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAA----DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~----d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..+....    ...+ ..........+.+++.+||+.||++||+++|++..
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         231 SKLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000    0001 11111124678899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=289.99  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=204.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..+.||+|++|.||+++....+    ..|++|.+.....  ...+.+.+|++++++++|+|++++++++...+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETG----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCC----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence            4677899999999999999876555    7899999987643  456789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      +|||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        77 v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          77 ILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            9999999999999843  367999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .... .....++..|+|||...+..++.++||||+|+++++|++|+.||......   . ....    ...         
T Consensus       152 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~-~~~~----~~~---------  213 (254)
T cd06627         152 VSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---A-ALFR----IVQ---------  213 (254)
T ss_pred             Cccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---H-HHHH----Hhc---------
Confidence            3321 22346889999999988888899999999999999999999999654211   1 0100    000         


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                       ......+......+.+++.+||..+|++||++.+++.
T Consensus       214 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 -DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             0111122233567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-34  Score=300.45  Aligned_cols=276  Identities=23%  Similarity=0.309  Sum_probs=202.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeecccccc--c
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--N  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~  393 (636)
                      .++|+..+.||+|+||.||+|+....+    ..||+|.+.....  .....+.+|+.++++++|+||+++++++...  +
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSG----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCC----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            357889999999999999999987655    7899999875422  1223456899999999999999999998654  5


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++||||+. ++|.+++... ...+++.+++.++.||+.||+|||   +.+++||||||+||++++++.+||+|||++.
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence            6899999995 5888887543 357899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH-------HHH
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW-------VRN  545 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~-------v~~  545 (636)
                      ...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ..++       .+.
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (309)
T cd07845         157 TYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL-IIQLLGTPNESIWP  234 (309)
T ss_pred             ecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCChhhch
Confidence            765432 12222345788999998865 4578999999999999999999999975532221111 1111       000


Q ss_pred             HhcCCcchhhhh------hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          546 LYGQGKICEAAD------ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       546 ~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                      ............      ..+... .......+.+++.+|++.||++|||+.|+++.-...+. ++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~-~~~  299 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK-PLP  299 (309)
T ss_pred             hhhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC-CCC
Confidence            000000000000      000000 00124556789999999999999999999988766533 444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=297.72  Aligned_cols=262  Identities=20%  Similarity=0.276  Sum_probs=188.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHH-----------HHHHHHHHHhccCCCCceeeee
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-----------KEFMAEISSMGRLQHKNLVQMR  386 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~h~niv~l~  386 (636)
                      .++|.+.++||+|+||.||+|+..... .....+++|..........           .....+...+..+.|+|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~-~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDH-CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCc-ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            367899999999999999999976642 1125667776543321110           1123344566778999999999


Q ss_pred             ccccccc----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          387 GWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       387 g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +++....    ..++++|++ ..++.+.+..  ....++..++.++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            9765443    346788877 4466666532  234578889999999999999999   89999999999999999999


Q ss_pred             cEEEeccCCcccccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh-H
Q 006668          463 RGRLGDFGLAKLYQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-E  535 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~-~  535 (636)
                      .++|+|||+++.......      .......||+.|+|||++.+..++.++|||||||+++||++|+.||........ .
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999986543211      111224699999999999999999999999999999999999999976532221 1


Q ss_pred             HHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       536 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .....+++.... .+++           .....+..+.+++..|+..+|++||++.++++.|.
T Consensus       244 ~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLH-EGKI-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhh-hhhh-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111122222111 1110           01123566889999999999999999999998763

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-35  Score=322.99  Aligned_cols=274  Identities=22%  Similarity=0.318  Sum_probs=190.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCc---------------eEEEEEEeccCChHHHHHHHHHHHHhccCCCCce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNS---------------TEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL  382 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~---------------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni  382 (636)
                      .++|++.+.||+|+||+||++..+.......               ..++.|.+. ........+.+|+.++++++|+||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            4579999999999999999987654221000               011111111 122334567899999999999999


Q ss_pred             eeeeccccccceEEEEEeecCCCChhhhHhcCC---CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP---KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       383 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      +++++++...+..++|+|++ .++|.+++....   .......+++.++.||+.||+|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            99999999999999999998 567877774322   222345677889999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCC-CCCCCChhhHHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP-LDMGKGEEEEEAV  538 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~P-f~~~~~~~~~~~~  538 (636)
                      .++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +....... . ..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~-~-~~  379 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP-G-KQ  379 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH-H-HH
Confidence            999999999999987654433333346799999999999999999999999999999999998754 43222111 1 11


Q ss_pred             HHHHHHHHh-cCC-------cchhhhhhhhh----hccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          539 LMDWVRNLY-GQG-------KICEAADARIR----QEFE-----AEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       539 l~~~v~~~~-~~~-------~~~~~~d~~l~----~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +...+...- ...       ++.+.++....    ....     ......+.+++.+||+.||.+|||+.|++++-.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            111111000 000       00000000000    0000     011234667788999999999999999998644

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-34  Score=298.39  Aligned_cols=269  Identities=22%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|++|.||+|+...++    +.|++|.+....  ....+.+.+|++++++++|+||+++++++......+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY   77 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCC----cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence            46888999999999999999986655    789999986542  223456788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCcccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKLY  475 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~  475 (636)
                      +||||++ ++|.+++.......+++..+..++.||+.||+|||   +++++||||+|+||+++. ++.+||+|||++...
T Consensus        78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            9999995 68888875544445688889999999999999999   789999999999999985 567999999999765


Q ss_pred             cCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh----cCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY----GQG  550 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~----~~~  550 (636)
                      .... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||............+ .+.....    ...
T Consensus       154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (294)
T PLN00009        154 GIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF-RILGTPNEETWPGV  231 (294)
T ss_pred             CCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCChhhcccc
Confidence            4321 122334578899999988664 57889999999999999999999997543221111111 1000000    000


Q ss_pred             -cchhhh--hhhhh----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 -KICEAA--DARIR----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 -~~~~~~--d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       .+....  -+...    ..........+.+++.+|++.+|++||++.++++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             000000  00000    001112245578899999999999999999999753

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3e-34  Score=302.19  Aligned_cols=267  Identities=21%  Similarity=0.256  Sum_probs=196.6

Q ss_pred             eeeeec--CceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSG--GFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G--~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      ..||+|  +||+||+++....+    +.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTG----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCC----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence            356666  89999999976655    89999998754  33445778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+|++||+.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            999999999986655556899999999999999999999   89999999999999999999999999986543221111


Q ss_pred             cc------ccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH-----HHHH--
Q 006668          481 PN------TTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD-----WVRN--  545 (636)
Q Consensus       481 ~~------~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~-----~v~~--  545 (636)
                      ..      .....++..|+|||++.+.  .++.++|||||||++|||++|+.||............+..     |...  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            10      0112345679999998764  4788999999999999999999999754322111110000     0000  


Q ss_pred             -----H-------hc---------CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          546 -----L-------YG---------QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       546 -----~-------~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                           .       ..         .+......+..+...........+.+|+.+||+.||++|||+.|+++.-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                 0       00         00000001111122223345677899999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-34  Score=297.79  Aligned_cols=269  Identities=26%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      .+.++|++.+.||+|++|.||+|.....+    +.|++|.+....  ......+.+|++++++++||||+++++++.+..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTG----ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCC----cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence            34567889999999999999999987655    789999997542  223356778999999999999999999887654


Q ss_pred             ----------eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc
Q 006668          394 ----------ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       394 ----------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~  463 (636)
                                .+++|+||+++ +|..++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence                      78999999975 777776443 457899999999999999999999   899999999999999999999


Q ss_pred             EEEeccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +||+|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ....+...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~  233 (302)
T cd07864         155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRL  233 (302)
T ss_pred             EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            9999999998765433222223346788999998764 457889999999999999999999997543211 11111111


Q ss_pred             HHHHhcCCcchhh--------hh------hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          543 VRNLYGQGKICEA--------AD------ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       543 v~~~~~~~~~~~~--------~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..... .......        .+      ......+. ..+..+.+++.+||+.||.+||+++++++.
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPC-PAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCC-hhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10000 0000000        00      00111111 124678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=304.64  Aligned_cols=263  Identities=23%  Similarity=0.306  Sum_probs=197.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeecccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG----  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----  392 (636)
                      +++|++.++||+|++|.||+|+...++    ..||+|.+... .......+.+|+.++++++|+||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTG----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCC----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            467999999999999999999976655    78999998753 233456678899999999999999999986543    


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       ...++|+||++ ++|.+++.   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence             35899999995 58888773   356899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCc--cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          472 AKLYQQGEVP--NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       472 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +.........  ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......     ....+...+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~  227 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLG  227 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcC
Confidence            9765432211  1223468999999998654 568899999999999999999999996542111     1111111111


Q ss_pred             CCcc---hhhhhhhh-------h-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKI---CEAADARI-------R-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~---~~~~d~~l-------~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ....   ....+...       .       ..........+.+++.+||+.||++||++.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000   00000000       0       00011224568899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-34  Score=292.50  Aligned_cols=246  Identities=25%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|+||.||+++....+    ..+++|.+.....   ...+.+.+|++++++++|+||+++++.+..++..+++|||++
T Consensus         1 lg~g~~~~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTG----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECCCC----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCC
Confidence            689999999999987654    7899999976533   456778899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC---
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV---  480 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~---  480 (636)
                      +++|.+++.+.  ..+++..+..++.||++||+|||   +.+++|+||+|+||++++++.+||+|||++........   
T Consensus        77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            99999998543  37899999999999999999999   89999999999999999999999999999876543321   


Q ss_pred             ----ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          481 ----PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       481 ----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                          .......++..|+|||.......+.++||||||++++||++|+.||.......    .. ..+   .. +..    
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~-~~~---~~-~~~----  218 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IF-QNI---LN-GKI----  218 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HH-HHH---hc-CCc----
Confidence                12233567889999999988889999999999999999999999997543111    11 100   00 000    


Q ss_pred             hhhhhhccCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAE--EMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~--~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                            .....  ....+..++.+||+.+|.+||++.++.+.|+..
T Consensus       219 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         219 ------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             ------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence                  11111  256788999999999999999996666666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.3e-34  Score=298.33  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |+..+.||+|+||.||+++...++    ..+|+|.+...   ..+..+++.+|+.++++++|+|++++++++.+++..++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTN----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCC----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            566788999999999999976655    78999998753   23345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ |+|.+++... ...+++.++..++.+++.||.|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus       103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            999996 5787776432 456899999999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .     ....++..|+|||++.   ...++.++|||||||++|||++|+.||.......    ....+...         
T Consensus       178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~---------  239 (317)
T cd06635         178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQN---------  239 (317)
T ss_pred             c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhc---------
Confidence            2     2346888999999873   4568889999999999999999999986542111    11111110         


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          .............+.+++.+||+.+|.+||++.++++.+...
T Consensus       240 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         240 ----ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ----cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence                001111223345688999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3e-34  Score=295.26  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=190.0

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHH---HhccCCCCceeeeeccccccceEEEEE
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEIS---SMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~---~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +||+|+||.||++.....+    ..+|+|.+....   ......+.+|..   .+...+|+||+.+++++...+..++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECCCC----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEE
Confidence            4899999999999986655    799999886542   111222334443   344457999999999999889999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..  ...+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.......
T Consensus        77 e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          77 DLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            99999999999853  356999999999999999999999   8999999999999999999999999999987554322


Q ss_pred             CccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                         .....|+..|+|||.+.. ..++.++|||||||+++||++|+.||.........  .+....              .
T Consensus       152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~--------------~  212 (279)
T cd05633         152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT--------------L  212 (279)
T ss_pred             ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHh--------------h
Confidence               223468999999998764 55789999999999999999999999654322111  111100              0


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~~  600 (636)
                      ......+......+.+++.+||+.||.+||     +++|++++....
T Consensus       213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            011122233456788899999999999999     599998875544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.3e-34  Score=296.71  Aligned_cols=266  Identities=19%  Similarity=0.256  Sum_probs=196.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCC-CCceeeeeccccccce-
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE-  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~-  394 (636)
                      ++|+..+.||+|+||.||+|....++    ..||+|.+.....  .....+.+|+.+++.++ |+||+++++++...+. 
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~   76 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTG----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN   76 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCC----cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence            36888999999999999999987655    7899998865422  23356788999999995 6999999998876555 


Q ss_pred             ----EEEEEeecCCCChhhhHhcCC---CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEE
Q 006668          395 ----LMLVYDYMPNGSLNNWIFGKP---KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRL  466 (636)
Q Consensus       395 ----~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl  466 (636)
                          .++||||+++ +|.+++....   ...+++.+++.++.||++||+|||   +.+++||||||+||+++. ++.+||
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEE
Confidence                8999999975 8988885432   346899999999999999999999   899999999999999998 889999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      +|||++....... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||............. ..+. 
T Consensus       153 ~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~-  229 (295)
T cd07837         153 ADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF-KLLG-  229 (295)
T ss_pred             eecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HHhC-
Confidence            9999997653321 12222356889999998765 457899999999999999999999996543221111111 1000 


Q ss_pred             HhcCCcc----hhh---h-----hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          546 LYGQGKI----CEA---A-----DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       546 ~~~~~~~----~~~---~-----d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       ......    ...   .     .+.............+.+++.+||.+||.+||++.|++..
T Consensus       230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         230 -TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             -CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             000000    000   0     0000001111234668889999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=294.30  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=201.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |+..+.||+|++|.||++....++    ..+++|.+......  ....+.+|+.++++++|+||+++++++..++..++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTG----EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCC----cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence            456789999999999999976554    88999998765332  456788899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||++ ++|.+++..+ ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......
T Consensus        77 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          77 FEFMD-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             EeccC-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            99996 4888887543 357899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh--cCCcchh-
Q 006668          479 EVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY--GQGKICE-  554 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~--~~~~~~~-  554 (636)
                      . .......++..|+|||.+.+. .++.++||||||+++++|++|+.||............... +....  ......+ 
T Consensus       152 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  229 (283)
T cd05118         152 V-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT-LGTPDPEVWPKFTSL  229 (283)
T ss_pred             c-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCchHhcccchhh
Confidence            3 122234578899999988776 7899999999999999999999999655332221111110 00000  0000000 


Q ss_pred             --hhhhhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 --AADARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 --~~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        ......       ...........+.+++.+||++||.+||++++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence              000000       011122345778999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-34  Score=291.01  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=199.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeeecccccc-
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-  392 (636)
                      .+|+..+.||+|++|.||+|.....+    ..+++|.+...     ..+..+.+.+|+.++++++|+||+++++++.+. 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTG----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCC----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence            46888999999999999999976654    78999987532     234456788999999999999999999988654 


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       +.+++++||+++++|.+++..  ...+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence             468899999999999999853  345889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCC--ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          472 AKLYQQGEV--PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       472 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ++.......  .......++..|+|||++.+..++.++|||||||+++||++|+.||.......   . ...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-~~~--------  220 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---A-IFK--------  220 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---H-HHH--------
Confidence            986533211  11223568899999999998889999999999999999999999996432111   1 111        


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           .........++....+.+.+++.+||. +|..||+..+++.+
T Consensus       221 -----~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         221 -----IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -----HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                 011111122344455678888999999 47999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=296.93  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=211.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .-|+..+-||+|.|..|-++++--.+    +.||||++.+..-+  ....+..|++.|+.++|||||+||.+......+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTG----ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhccc----ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            45777888999999999999876666    89999999876333  3457889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE-cCCCcEEEeccCCcccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL-DSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~~  475 (636)
                      ||.|.-.+|+|.+||.++ ...+.++...+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-+||.|||.+-.+
T Consensus        94 LiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            999999999999999765 457899999999999999999999   8999999999999987 55678999999999877


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTS-ASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~-~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .++.  ..+..||.+.|-|||++.+..|+. +.||||||||||.|+||+.||+..++.+...                 .
T Consensus       170 ~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-----------------m  230 (864)
T KOG4717|consen  170 QPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-----------------M  230 (864)
T ss_pred             CCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-----------------h
Confidence            7665  344569999999999999988864 7899999999999999999998765443221                 1


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ++|.+.  ..+........+||..||..||.+|.+.+||+..-+-
T Consensus       231 ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  231 IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            222222  2344555667788888999999999999999987543

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=293.31  Aligned_cols=262  Identities=25%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccC---CCCceeeeeccccccce-
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRL---QHKNLVQMRGWCRKGNE-  394 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~-  394 (636)
                      |++.+.||+|++|.||+|+....+    ..+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+. 
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTG----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCC----CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence            567789999999999999987644    7899999975422  1224455677666555   69999999999987766 


Q ss_pred             ----EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          395 ----LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       395 ----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                          .+++|||++ ++|.+++.......+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        77 ~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          77 RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccC
Confidence                999999996 58999886544456999999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ++........  .....++..|+|||.+.+..++.++||||||+++|||++|+.||...........    +.......+
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~----~~~~~~~~~  226 (287)
T cd07838         153 LARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK----IFDVIGLPS  226 (287)
T ss_pred             cceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH----HHHHcCCCC
Confidence            9987644322  1223578899999999999999999999999999999999999875432221111    111110000


Q ss_pred             cch---------hhhhhhhh---hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          551 KIC---------EAADARIR---QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       551 ~~~---------~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...         ........   .....+....+.+++.+||+.||.+||++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            000         00000000   11112334667889999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.2e-34  Score=302.48  Aligned_cols=267  Identities=21%  Similarity=0.222  Sum_probs=200.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc--
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--  392 (636)
                      ..++|+..+.||+|+||.||+++....+    ..||+|.+...  .....+++.+|+.++++++|+||+++++++...  
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTG----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCC----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence            4578999999999999999999977655    88999998653  333446778899999999999999999987543  


Q ss_pred             ----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          393 ----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       393 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                          ...++||||+. ++|.+.+..    .++..++..++.|++.||+|||   ..+++||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          90 LEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             ccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence                35799999994 688888732    2889999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH--------
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--------  540 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~--------  540 (636)
                      ||+++.......  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..............        
T Consensus       162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999986543221  2234578899999999999999999999999999999999999965432111111100        


Q ss_pred             ------HHHHHHhcCCc------chhhhhhhhh----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          541 ------DWVRNLYGQGK------ICEAADARIR----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       541 ------~~v~~~~~~~~------~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            ..+........      ..+.....+.    ..........+.+++.+||+.||++||++.|+++.-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                  00000000000      0000000000    000112356688999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-35  Score=303.37  Aligned_cols=269  Identities=24%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCC-CCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~  394 (636)
                      .+.|++.++||+||.+.||++...+.     ..+|+|++...  ..+.+.-|..|+..|.+|+ |.+|++|++|-..++.
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~-----~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDK-----QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCC-----cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            35688889999999999999986554     56777766543  5566788999999999996 9999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +|+||||- +.+|..+|.++......| .++.+.+||+.|+.++|   ..+|||.||||.|+|+- .|.+||+|||+|..
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            99999986 779999996654444445 78889999999999999   89999999999999985 46899999999998


Q ss_pred             ccCCCCc-cccccccCCcccccccccCCC-----------CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          475 YQQGEVP-NTTRVVGTLGYLAPELATVSS-----------PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       475 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +..+... .....+||..||+||.+....           .++++||||+|||||+|+.|+.||...         ...|
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n~~  579 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------INQI  579 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HHHH
Confidence            7765432 234468999999999876432           457899999999999999999999532         1111


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhhhhhcc
Q 006668          543 VRNLYGQGKICEAADARIRQEFEA-EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLA  614 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~  614 (636)
                      .       ++....|+.-.-+|+. .....+.++++.||+.||.+||+..|+|+.---. ..+.|.+...++-
T Consensus       580 a-------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~-~~~i~~~~m~~~~  644 (677)
T KOG0596|consen  580 A-------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ-IQPIPVEQMAKLT  644 (677)
T ss_pred             H-------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc-cccccchHHHHHH
Confidence            1       2333444433223321 1122289999999999999999999999874333 2256655555543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.3e-34  Score=291.82  Aligned_cols=263  Identities=21%  Similarity=0.236  Sum_probs=194.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeeecccccc--ceEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKG--NELM  396 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~~~  396 (636)
                      |+..+.||+|+||.||+|+....+    ..+|+|.++... ........+|+..+.++. |+|++++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTG----KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCC----cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            566789999999999999976655    789999987642 222234457888898885 99999999999877  8899


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+||++ ++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++...
T Consensus        77 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          77 LVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            9999996 6888887543 357899999999999999999999   799999999999999999 999999999998654


Q ss_pred             CCCCccccccccCCccccccccc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH-------HHHhc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELAT-VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV-------RNLYG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v-------~~~~~  548 (636)
                      ....  .....++..|+|||++. +..++.++|||||||++|||++|..||......+... ...+..       .....
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA-KIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH-HHHHHcCCCCHHHHHhhc
Confidence            3321  22345788999999764 4557889999999999999999999996543221111 111000       00000


Q ss_pred             CCcchhhhhhhh----hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARI----RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .........+..    ...........+.+++.+||+++|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000000000    001112345789999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=290.33  Aligned_cols=246  Identities=24%  Similarity=0.300  Sum_probs=191.3

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHH-hccCCCCceeeeeccccccceEEEEEe
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISS-MGRLQHKNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.||+|++|.||+|.....+    +.||+|.+....   ......+..|..+ ....+|+|++++++++..++..++|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTG----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME   77 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCC----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence            56999999999999976655    789999987542   2223334445444 445689999999999999999999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      |+++++|.+++..  ...+++.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++.....   
T Consensus        78 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          78 YLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            9999999999843  356899999999999999999999   79999999999999999999999999999875432   


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                        .....++..|+|||.+.+..++.++||||||+++|||++|..||.......    .....     ..+..      ..
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-----~~~~~------~~  212 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----VFDNI-----LSRRI------NW  212 (260)
T ss_pred             --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHH-----Hhccc------CC
Confidence              223457889999999988888999999999999999999999996543221    11110     00010      00


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...........+.+++.+||+.||++||++.++.+.|..
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            111122345678999999999999999988766665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.9e-34  Score=294.14  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCC-CCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~  394 (636)
                      ++|...+.||+|++|.||+++...++    ..+++|++...   .....+.+.+|+.++++++ |+||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   76 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETN----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN   76 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCC----CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce
Confidence            46888899999999999999987655    88999998753   2334567888999999998 9999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|.+++.+  ...+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence            9999999999999999954  347999999999999999999999   89999999999999999999999999999976


Q ss_pred             ccCCCC-------------------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhH
Q 006668          475 YQQGEV-------------------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE  535 (636)
Q Consensus       475 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~  535 (636)
                      ......                   .......++..|+|||......++.++||||||++++++++|+.||......   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---  228 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---  228 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---
Confidence            543321                   1222345789999999998888999999999999999999999999755311   


Q ss_pred             HHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 006668          536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM----REVVAV  596 (636)
Q Consensus       536 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~----~evl~~  596 (636)
                       ..+.. +.              .....++......+.+++.+||+.+|++||++    +++++.
T Consensus       229 -~~~~~-~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 -LTFQK-IL--------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHHH-HH--------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             11111 00              01112223335678899999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-34  Score=303.12  Aligned_cols=267  Identities=23%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|...+.||+|+||.||+++....+    ..||+|.+...  .......+.+|+.+++.++|+||+++++++...   
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETN----EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCC----CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            457889999999999999999976655    89999998753  233345677899999999999999999987644   


Q ss_pred             --ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          393 --NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                        ...++|+||+. ++|.+++..  ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence              34899999995 789988843  457999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH-----
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR-----  544 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~-----  544 (636)
                      ++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ..........     
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  231 (337)
T cd07858         154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEE  231 (337)
T ss_pred             cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChH
Confidence            998664432 12233467889999998764 468899999999999999999999996543211 1111111000     


Q ss_pred             --HHhcCCcchhhhh-------hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          545 --NLYGQGKICEAAD-------ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       545 --~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        .....+...+.+.       ... ..........+.+++.+||+.+|++||+++|+++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~  292 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP  292 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence              0000111111110       000 011123456688999999999999999999999883

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.6e-34  Score=296.26  Aligned_cols=264  Identities=21%  Similarity=0.293  Sum_probs=194.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccc---
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN---  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---  393 (636)
                      ++|+..+.||+|+||.||+++....+    ..||+|++....  ......+.+|+.++++++||||++++++|....   
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTK----QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCC----cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            46888999999999999999976655    899999986542  222345568999999999999999999886543   


Q ss_pred             -----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          394 -----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       394 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                           ..++||||+. ++|.+++... ...+++.+++.++.||+.||+|||   +.+++|+||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          88 NRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             cCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence                 4599999995 5888877432 346899999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCCc---cccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEVP---NTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       469 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      ||++.........   ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......  .......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~  240 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLC  240 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            9999865433211   122345788999999876643 6889999999999999999999997543221  111111111


Q ss_pred             HHhcC-----Cc-------------chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          545 NLYGQ-----GK-------------ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       545 ~~~~~-----~~-------------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....     ..             ........+...   .+...+.+++.+||+.||++||++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            10000     00             000000001000   112456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-34  Score=296.63  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ..+||+|+||.||++.....+    ..||+|.+..........+.+|+.+++.++|+|++++++.+...+..++||||++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSG----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCC----eEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            357999999999999986655    8999999876555556778899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++.   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus       101 ~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~  173 (292)
T cd06657         101 GGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  173 (292)
T ss_pred             CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccc
Confidence            999999873   345899999999999999999999   7899999999999999999999999999987554322 122


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|+|||.+....++.++||||||+++|||++|..||........    . ..+...         ....+.  
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~----~-~~~~~~---------~~~~~~--  237 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----M-KMIRDN---------LPPKLK--  237 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHhh---------CCcccC--
Confidence            335688999999999888899999999999999999999999864321111    1 101000         000000  


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            011234557788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.9e-34  Score=294.56  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC----hHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS----KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      +|+..+.||+|++|.||+++.... ...+..+|+|.++...    ....+.+.+|+.++.++ +|+||+++++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~-~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG-HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc-ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            367789999999999999986432 2234789999987532    22345678899999999 59999999999999899


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++|+|.+++..  ...+++.++..++.|+++||.|||   ..+++||||||+||+++.++.++|+|||+++.
T Consensus        80 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999999853  356889999999999999999999   89999999999999999999999999999886


Q ss_pred             ccCCCCccccccccCCcccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSS--PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .............++..|+|||.+.+..  .+.++||||||+++|||++|..||............    ......    
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~----  226 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI----SRRILK----  226 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH----HHHHHc----
Confidence            5543332233356889999999987665  788999999999999999999999643211111111    111100    


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         ..    ...+......+.+++.+||+.||++|||+.++.+.|+..
T Consensus       227 ---~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         227 ---SK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ---cC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence               00    111222335678899999999999999999888887655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.4e-34  Score=301.41  Aligned_cols=268  Identities=25%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeeecccccc-
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG-  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-  392 (636)
                      ..++|+..+.||+|+||.||+|....++    ..+++|++...  .......+.+|+.++.++ +|+||++++++|... 
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTK----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCC----eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            3456888899999999999999976554    78999988543  233445677899999999 999999999987643 


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       ..+++||||++ ++|..++..   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          81 DKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             CceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence             46899999996 699998843   27889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCC----ccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH--
Q 006668          472 AKLYQQGEV----PNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR--  544 (636)
Q Consensus       472 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~--  544 (636)
                      +........    .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||............ .....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~-~~~~~~~  232 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI-IEVIGPP  232 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCC
Confidence            986543322    12334568999999997754 45788999999999999999999999654322211111 01000  


Q ss_pred             -----HHhc---CCcchhhhhhhh---hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          545 -----NLYG---QGKICEAADARI---RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       545 -----~~~~---~~~~~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ....   ...+.+.+...-   ...........+.+++.+||+.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 0000   000000000000   000111135678899999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=324.03  Aligned_cols=261  Identities=27%  Similarity=0.430  Sum_probs=212.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCC---CceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNN---NSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++..+.+.||+|.||.|++|........   ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|.+++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3445566999999999999987654332   3688999999865 335667899999999999 6999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCC------------C--CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP------------K--KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ..++|+||+..|+|.+||+.++            .  ..|+..+.+.++.|||.||+||+   +.+++||||.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999996554            0  23889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCcccccccc--CCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEE  536 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~  536 (636)
                      .+..+||+|||+|+...+..........+  ...|||||.+....++.|+|||||||+||||++ |..||......    
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----  528 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----  528 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----
Confidence            99999999999999766555444332232  456999999999999999999999999999998 88888642111    


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..+.+    .+.+|         .+.+.+..+...+.++++.||+.+|++||++.|+++.+..
T Consensus       529 ~~l~~----~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  529 EELLE----FLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHHHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            11121    22222         2334455667788999999999999999999999999977

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.9e-34  Score=296.77  Aligned_cols=266  Identities=23%  Similarity=0.248  Sum_probs=193.3

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      +.+|.|+++.||+++.  .+    ..||+|++...  .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         8 ~~~~~~~~v~~~~~~~--~~----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           8 KCFEDLMIVHLAKHKP--TN----TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             HhhcCCceEEEEEecC--CC----CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            3345555555555543  33    88999999765  4455678999999999999999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC--
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV--  480 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--  480 (636)
                      ++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            9999999997655567899999999999999999999   89999999999999999999999999998865432211  


Q ss_pred             ----ccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc---
Q 006668          481 ----PNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---  551 (636)
Q Consensus       481 ----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~---  551 (636)
                          .......++..|+|||++..  ..++.++|||||||++|||++|+.||.........................   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence                11122356788999998876  357889999999999999999999997543221111100000000000000   


Q ss_pred             ----chh----hhhh----hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          552 ----ICE----AADA----RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       552 ----~~~----~~d~----~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          ...    ..+.    .............+.+++.+||+.||++|||+.++++.-.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence                000    0000    00111122334568889999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-33  Score=287.32  Aligned_cols=250  Identities=22%  Similarity=0.276  Sum_probs=192.0

Q ss_pred             HHHHHhCCCCCceee--eecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccc
Q 006668          313 ELSKATKGFSNDELL--GSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWC  389 (636)
Q Consensus       313 ~l~~a~~~f~~~~~L--G~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~  389 (636)
                      +.....++|++.+.+  |+|+||.||+++.+..+    ..+++|.+........     |+.....+ +|+||+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ----KLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCC----cEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence            344445666666666  99999999999977655    7899999865422111     22222212 799999999999


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEec
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGD  468 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~D  468 (636)
                      ...+..++||||+++++|.+++...  ..+++++++.++.|+++||.|||   +.+++||||||+||+++.++ .++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999999999543  48999999999999999999999   88999999999999999998 999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||++.......     ...++..|+|||++.+..++.++||||||++++||++|+.||........   ....+..... 
T Consensus       154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-  224 (267)
T PHA03390        154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL---DLESLLKRQQ-  224 (267)
T ss_pred             CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh---hHHHHHHhhc-
Confidence            99987654321     23578999999999998999999999999999999999999974432211   1112211110 


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-MREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~  596 (636)
                               .  ...........+.+++.+||+.+|.+||+ +.|+++.
T Consensus       225 ---------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        225 ---------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ---------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                     0  00111234566888999999999999996 6888853

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-33  Score=292.50  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh----HHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK----QGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      +|+..+.||+|+||.||+++.... ...+..||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~-~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG-HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC-CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            467789999999999999986431 12347899999975422    2345678899999999 59999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|.+++..  ...+++.++..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          80 LHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999999853  356889999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .............|+..|+|||.+...  .++.++||||||+++|+|++|+.||.........    .++.......   
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~---  227 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS---  227 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH----HHHHHHhhcc---
Confidence            654333333345689999999988753  4678999999999999999999999643221111    1111111000   


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                              ...++......+.+++.+||+.||++||     ++.+++..
T Consensus       228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                    1112233456788999999999999997     66666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.1e-34  Score=300.69  Aligned_cols=268  Identities=23%  Similarity=0.318  Sum_probs=202.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----  391 (636)
                      ..+|+..+.||+|++|.||+|+....+    ..|++|++....  ....+.+.+|+.++++++|+||+++.+++..    
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   79 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSG----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD   79 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCC----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence            367888999999999999999977655    789999987642  2345677889999999999999999998753    


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      ....++||||+. ++|.+++..  ...+++..++.++.||+.||.|||   +.+++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          80 FKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             CceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccc
Confidence            356899999994 789998843  345999999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCc---cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          472 AKLYQQGEVP---NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       472 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      +.........   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.........     ..+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-----~~~~~~~  228 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-----KLILSVL  228 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-----HHHHHHh
Confidence            9765432211   1123468899999998765 46889999999999999999999999654321111     0000000


Q ss_pred             c-----------CCcchhhhhhh-hh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          548 G-----------QGKICEAADAR-IR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       548 ~-----------~~~~~~~~d~~-l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .           ...+.+..+.. ..     ..........+.+++.+||+.+|++||++.++++...-+
T Consensus       229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence            0           00011100000 00     011122356789999999999999999999999987665

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=306.72  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=201.1

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |...+-||.|.||.||-++.....    +.||||++.-.   +.+.+.++.+|+..|++++|||++.+.|||......+|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCcc----ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence            445567999999999999976655    89999999865   44557889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||| -||-.+.+. -.+++|-+.++..|+.+.+.||.|||   +.+.||||||+.||||++.|.+||+|||.|....+
T Consensus       104 VMEYC-lGSAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  104 VMEYC-LGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHHH-hccHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            99999 667666652 23567888999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccc---cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTTRVVGTLGYLAPELA---TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                           ...++||+.|||||++   ..+.|+-|+|||||||...||...++|+..++..  ..  +.-...          
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SA--LYHIAQ----------  239 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SA--LYHIAQ----------  239 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HH--HHHHHh----------
Confidence                 3347899999999965   4678999999999999999999999997654211  11  111110          


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .-.+.+.   ..+=.+.+..++..||++-|.+|||.+++++.--
T Consensus       240 NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  240 NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            0111111   3344567888999999999999999999998753

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.3e-34  Score=293.89  Aligned_cols=257  Identities=23%  Similarity=0.347  Sum_probs=196.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|++|.||+|+....+    ..||||.++... .....++..|+.++.++. |+||++++++|..+...+
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTG----HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCC----eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            45778899999999999999987644    889999997643 334456677887776665 999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ++|||+ .++|.+++... ...+++..+..++.|++.||+|||+  ..+++||||+|+||++++++.+||+|||++....
T Consensus        91 ~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999998 45777766432 3478999999999999999999993  2589999999999999999999999999997654


Q ss_pred             CCCCccccccccCCcccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSS----PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ....  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......   ...+...    ..... 
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~----~~~~~-  236 (296)
T cd06618         167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKI----LQEEP-  236 (296)
T ss_pred             CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHH----hcCCC-
Confidence            3221  12235788999999987654    788999999999999999999999643111   1111111    11000 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           +...  ........+.+++.+||+.||++||++.+++++..-.
T Consensus       237 -----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         237 -----PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             -----CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence                 0000  0112345688999999999999999999999876533

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=307.38  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      +..-||.|+||.|||++.+..+    ...|-|.+.....+.+++|+-||.+|..++||+||+|++.|...+.++++.|||
T Consensus        36 IiGELGDGAFGKVyKA~nket~----~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   36 IIGELGDGAFGKVYKAVNKETK----LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHhhhcCccchhhhhhhcccch----hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3456999999999999987654    667889888888888999999999999999999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN  482 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  482 (636)
                      .||..+..+.. -...|++.++..++.+++.||.|||   +++|||||||+.|||++-+|.++|+|||.+.... .....
T Consensus       112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK  186 (1187)
T ss_pred             CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence            99999998754 3568999999999999999999999   8999999999999999999999999999875321 12223


Q ss_pred             ccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          483 TTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       483 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ...+.||+.|||||+..     ..+|+.++||||||+.|.||..+.+|-......    +.+..          +.+.-.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllK----------iaKSeP  252 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLK----------IAKSEP  252 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHH----------HhhcCC
Confidence            34578999999999754     457899999999999999999999886533211    11211          111111


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +.|..  +..=...+.++..+||..||+.||++.+++++-.-
T Consensus       253 PTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv  292 (1187)
T KOG0579|consen  253 PTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV  292 (1187)
T ss_pred             CcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence            11111  12223557788889999999999999999987543

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-33  Score=296.40  Aligned_cols=263  Identities=21%  Similarity=0.292  Sum_probs=193.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|...+.||+|+||.||+|+....+    ..||+|++...  .......+.+|+.++++++|+||+++++++...   
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTG----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCC----cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            368889999999999999999976554    78999998753  222345678899999999999999999988654   


Q ss_pred             ---ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          393 ---NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       393 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                         ...++|+||+. .+|..++    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          90 DEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             CCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence               34699999995 4777665    346899999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH------H
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD------W  542 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~------~  542 (636)
                      |+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............      -
T Consensus       162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (342)
T cd07879         162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE  237 (342)
T ss_pred             CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999764321    223457889999998876 46888999999999999999999999754221111110000      0


Q ss_pred             HHHHhcCCcchhhhh--hhh-hhcc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          543 VRNLYGQGKICEAAD--ARI-RQEF---EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       543 v~~~~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...............  +.. +...   .......+.+++.+||+.||++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000000000  000 0000   01123457899999999999999999999966

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=296.91  Aligned_cols=267  Identities=23%  Similarity=0.269  Sum_probs=203.6

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccc----
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----  393 (636)
                      +|+..+.||+|++|.||+++....+    ..+++|++....  ....+.+.+|+.+++.++|+||+++.+++....    
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTG----RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF   76 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCC----cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence            4778899999999999999976554    789999987653  344567889999999999999999999988765    


Q ss_pred             -eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                       .+++||||++ ++|.+++..  ...+++..++.++.+|+.||.|||   +.+++||||||+|||++.++.++|+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          77 NDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             cceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence             7899999996 589988843  348999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCC--ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH-----
Q 006668          473 KLYQQGEV--PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR-----  544 (636)
Q Consensus       473 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~-----  544 (636)
                      ........  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||............ .....     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~  229 (330)
T cd07834         151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI-VEVLGTPSEE  229 (330)
T ss_pred             EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH-HHhcCCCChh
Confidence            87654331  122334678899999999887 7899999999999999999999999765422211111 11000     


Q ss_pred             --HHhcCCcchhhhhh-hh-----hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          545 --NLYGQGKICEAADA-RI-----RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       545 --~~~~~~~~~~~~d~-~l-----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        .........+.+.. ..     ...........+.+++.+||+.+|++||+++++++.-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  290 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP  290 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence              00000000000000 00     0011112346688999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-33  Score=286.79  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEecc---C--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH---D--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~---~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      +|.+.+.||+|+||.||+++....+    ..+++|..+.   .  ......++..|+.++++++||||+++++++.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAV----AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCC----CcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence            4778899999999999999876543    3344444432   1  22233456679999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          395 LMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      .++||||+++++|.+++..  .....+++.+++.++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||++
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCce
Confidence            9999999999999998853  23467999999999999999999999   899999999999999976 56999999998


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......    ....    ... .   
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~----~~~-~---  219 (260)
T cd08222         153 RLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVL----RIV-E---  219 (260)
T ss_pred             eecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHH----HHH-c---
Confidence            76543221 222345788999999998888899999999999999999999999643211    1111    100 0   


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            ......+......+.+++.+||+.+|++||++.|+++.
T Consensus       220 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 ------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                  01112233455678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-33  Score=296.18  Aligned_cols=270  Identities=20%  Similarity=0.270  Sum_probs=202.2

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccc
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      ++..++++|+..+.||+|+||.||++.....+    ..||+|++...  .....+.+.+|+.++++++||||+++.+++.
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   79 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTG----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI   79 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCC----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence            34456788999999999999999999976655    88999988643  2233467788999999999999999999886


Q ss_pred             c-cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          391 K-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       391 ~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      . ....++|+||+ +++|.+++.   ...+++..+..++.|+++||+|||   +.+++||||+|+||++++++.+||+||
T Consensus        80 ~~~~~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          80 SPLEDIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             cCCCcEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence            5 56789999999 678988873   345788889999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH------
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW------  542 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~------  542 (636)
                      |++......    .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+.++      
T Consensus       153 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~  227 (328)
T cd07856         153 GLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPD  227 (328)
T ss_pred             ccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence            998754321    122457889999998766 56889999999999999999999999654321 111111111      


Q ss_pred             --HHHHhcCCcchhhh-hhhhhhccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          543 --VRNLYGQGKICEAA-DARIRQEFE-----AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       543 --v~~~~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ..... .+...+.. ........+     ......+.+++.+||+.+|++||++.+++..-.-
T Consensus       228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         228 DVINTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             HHHHhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence              11000 00000000 000001111     1234678899999999999999999999988433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-33  Score=287.91  Aligned_cols=247  Identities=27%  Similarity=0.387  Sum_probs=189.3

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHH---HHHhccCCCCceeeeeccccccceEEEEE
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAE---ISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---i~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +||+|+||.||++.....+    +.||+|++.....   .....+..|   +..++...||||+++++++...+..++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEecCC----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEE
Confidence            4899999999999876554    7899999875421   111223333   34455568999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..  ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        77 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          77 DLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            99999999998843  457999999999999999999999   7999999999999999999999999999987553322


Q ss_pred             CccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                         .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||..........  . .   ...      .    
T Consensus       152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~-~---~~~------~----  212 (278)
T cd05606         152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--I-D---RMT------L----  212 (278)
T ss_pred             ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--H-H---HHh------h----
Confidence               1234689999999998754 68899999999999999999999997542211111  0 0   000      0    


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~~  600 (636)
                      ......+......+.+++.+|+..+|.+||     ++.++++.-...
T Consensus       213 ~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            001112222346788889999999999999     899998754443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-34  Score=320.50  Aligned_cols=256  Identities=31%  Similarity=0.441  Sum_probs=196.8

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccc--
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--  391 (636)
                      ......|++.++||+||||.|||++.+-++    +.||||++... +.+....+.+|+..+.+|+|||||+++..+.+  
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDG----r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDG----REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST  550 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccc----hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence            345567889999999999999999987766    99999999876 44456778899999999999999998743210  


Q ss_pred             --------------------------------------------------------------------------------
Q 006668          392 --------------------------------------------------------------------------------  391 (636)
Q Consensus       392 --------------------------------------------------------------------------------  391 (636)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------c--------ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHH
Q 006668          392 -----------------------------G--------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG  434 (636)
Q Consensus       392 -----------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~  434 (636)
                                                   +        ..+||-||||+..+|.+++..+.... .....++++.+|++|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG  709 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence                                         0        13688999999988888885443222 357788999999999


Q ss_pred             HHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc-----------------CCCCccccccccCCccccccc
Q 006668          435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ-----------------QGEVPNTTRVVGTLGYLAPEL  497 (636)
Q Consensus       435 L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~  497 (636)
                      |.|+|   +.+||||||||.||+|+++..+||+|||+|....                 .......|..+||.-|+|||+
T Consensus       710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999   8999999999999999999999999999998621                 011224456789999999999


Q ss_pred             ccCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHH
Q 006668          498 ATVSS---PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLK  574 (636)
Q Consensus       498 ~~~~~---~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  574 (636)
                      +.+..   |+.|+|+||||||++||+.   ||....   +....+..     +..|.+...      ..+...+...-.+
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---ERa~iL~~-----LR~g~iP~~------~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---ERASILTN-----LRKGSIPEP------ADFFDPEHPEEAS  849 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchH---HHHHHHHh-----cccCCCCCC------cccccccchHHHH
Confidence            87755   9999999999999999984   675431   11222221     223333221      2334455566678


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 006668          575 LGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       575 L~~~Cl~~dP~~RPs~~evl~  595 (636)
                      ++.|+++.||.+|||+.|+|+
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            899999999999999999875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-33  Score=292.72  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=198.2

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |+..+.||+|++|.||+|+....+    ..+++|.+...   .....+++.+|+++++.++|+|++++.+++......++
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCC----cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            556678999999999999986654    78999998642   33445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+. |+|.+++... ...+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            999996 6888776433 346899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .     ....++..|+|||.+.   ...++.++|||||||++|||++|+.||.......    ....+..     +.   
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-----~~---  230 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQ-----NE---  230 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----HHHHHhh-----cC---
Confidence            2     2346788999999874   3567889999999999999999999986432111    1111110     00   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ............+.+++.+||+.+|++||++.++++.....
T Consensus       231 -----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         231 -----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             -----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence                 00111223446688999999999999999999999887655

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=305.59  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=194.6

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEecc----CChHHHHHHHHHHHHhccCCCCceeeeeccccccc--eE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH----DSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--EL  395 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~  395 (636)
                      +...+||+|.|-+||||.....+    ..||=-.++.    ......+.|..|+.+|+.|+|+||++++.++.+..  .+
T Consensus        43 k~~evLGrGafKtVYka~De~~g----iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEG----IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             ehhhhcccccceeeeeccccccc----hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            44578999999999999976554    5554322221    24455688999999999999999999999887654  48


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~  474 (636)
                      .+|+|.|..|+|..|+.  +.+.++.+.+..++.||++||.|||+. .++|+|||||-.||+|+. -|.+||+|+|||..
T Consensus       119 n~iTEL~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeecccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            89999999999999994  446688899999999999999999976 789999999999999975 58899999999998


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....   ...++||+.|||||+.. ..|....||||||+.++||+|+..||..-...    ..++.-    .-.|.   
T Consensus       196 ~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKK----V~SGi---  260 (632)
T KOG0584|consen  196 LRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKK----VTSGI---  260 (632)
T ss_pred             hhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHH----HHcCC---
Confidence            76543   33478999999999887 78999999999999999999999999633211    111111    11111   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           .+..++.-....+.++|.+|+.. ..+|||+.|+|+.
T Consensus       261 -----KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  261 -----KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -----CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                 11122222245688999999999 9999999999975

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9e-34  Score=300.43  Aligned_cols=272  Identities=21%  Similarity=0.289  Sum_probs=198.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccccc-----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-----  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----  392 (636)
                      ..+|...+.||.|+||.||+|.....+    ..|++|.+........+.+.+|+.++++++||||+++++.+...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~----~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCD----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCC----cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            367888999999999999999977655    89999999776666667888999999999999999999876543     


Q ss_pred             ---------ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCC
Q 006668          393 ---------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEM  462 (636)
Q Consensus       393 ---------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~  462 (636)
                               ...++||||++ ++|.+++.   ...+++..++.++.||++||.|||   +.+++||||||+||+++ +++
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence                     35789999996 68988873   346899999999999999999999   89999999999999997 456


Q ss_pred             cEEEeccCCcccccCCCCc--cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      .+||+|||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||............+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999999765322111  1122357889999997654 567889999999999999999999997553322211111


Q ss_pred             HHHHHHHh-cCCcchhhhhhhhh----------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          540 MDWVRNLY-GQGKICEAADARIR----------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       540 ~~~v~~~~-~~~~~~~~~d~~l~----------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ........ ..............          ..........+.+++.+||+.||++||++.|+++.-.-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            10000000 00000000000000          001112235678899999999999999999999764443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-33  Score=296.45  Aligned_cols=277  Identities=21%  Similarity=0.252  Sum_probs=203.7

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeee
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMR  386 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~  386 (636)
                      ...+++...+++|...+.||+|+||.||++.....+    ..||+|++....  ....+.+.+|+.++++++|+||++++
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~   82 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   82 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCC----eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence            334566778899999999999999999999876544    889999997542  23345678899999999999999999


Q ss_pred             cccccc------ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          387 GWCRKG------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       387 g~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      +++...      ...+++++++ +++|.+++.   ...+++..+..++.|++.||+|||   +.+++||||||+||++++
T Consensus        83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~  155 (345)
T cd07877          83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeeeecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcC
Confidence            987543      3478888887 889988873   346899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      ++.+||+|||+++....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus       156 ~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (345)
T cd07877         156 DCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  231 (345)
T ss_pred             CCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999876432    2223467889999998766 567889999999999999999999996543221111110


Q ss_pred             HH------HHHHHhcCCcchhh---hhhhhhhccC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          540 MD------WVRNLYGQGKICEA---ADARIRQEFE---AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       540 ~~------~v~~~~~~~~~~~~---~d~~l~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..      ..............   .+......+.   ......+.+++.+|++.||.+||++.+++..-.-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence            00      00000000000000   0000000000   01244678999999999999999999999875443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=277.94  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=206.0

Q ss_pred             CHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeecc
Q 006668          310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGW  388 (636)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~  388 (636)
                      +++++.+.|.     ++||+|+|+.|--++...++    ..+|||++.+..........+|++++.+.+ |+||++|++|
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~----~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief  144 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTG----KEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF  144 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccc----hhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH
Confidence            4677777764     78999999999988876655    899999999887777888999999999985 9999999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EE
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GR  465 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~k  465 (636)
                      ++++..+|||||.|.||+|..+|.  +...+++.++.+++++|+.||.+||   .++|.||||||+|||..+...   +|
T Consensus       145 FEdd~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  145 FEDDTRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             hcccceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence            999999999999999999999994  4567999999999999999999999   899999999999999976554   79


Q ss_pred             EeccCCcccccC------CCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChh-
Q 006668          466 LGDFGLAKLYQQ------GEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEE-  533 (636)
Q Consensus       466 l~DFGla~~~~~------~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~-  533 (636)
                      |+||.|......      ...+.....+|+..|||||+..-     ..|+.++|.||||||||-|++|+.||....+.. 
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            999999864322      12233345689999999996432     347889999999999999999999998765421 


Q ss_pred             -----hHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHH----HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          534 -----EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEE----MELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       534 -----~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           +........+.....+|+.          +|++.+    ..+..+++...+..|+.+|-++.++++.
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence                 1122222222222222221          233322    2344556666788999999999999883

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.9e-33  Score=290.46  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |...+.||+|+||.||+|+....+    ..|++|++...   .....+.+.+|+.+++.++|+|++++++++.+....++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTN----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCC----cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            555678999999999999976655    78999998753   33445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ |+|.+++... ...+++.+++.++.||+.||.|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        99 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633          99 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            999995 6777776432 456899999999999999999999   88999999999999999999999999999864322


Q ss_pred             CCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                           .....|+..|+|||++.   ...++.++||||||+++|||++|+.||...........     ...   . .   
T Consensus       174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~-----~~~---~-~---  236 (313)
T cd06633         174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQ---N-D---  236 (313)
T ss_pred             -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----HHh---c-C---
Confidence                 22346889999999874   45678899999999999999999999865422111110     000   0 0   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           ............+.+++.+||+.+|.+||++.++++.-.-.
T Consensus       237 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         237 -----SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             -----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                 00111112234588899999999999999999999874443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-33  Score=293.08  Aligned_cols=269  Identities=24%  Similarity=0.301  Sum_probs=195.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|+..++||+|++|.||+|+....+    ..+++|++......  ....+.+|++++++++|+||+++++++.+.   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTG----RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCC----cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence            468899999999999999999976655    78999988654221  224567899999999999999999987443   


Q ss_pred             -----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          393 -----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       393 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                           ..+++|+||+. ++|...+... ...+++.++..++.|+++||+|||   +.+++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          83 SKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             ccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence                 35799999995 5677766432 457999999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCC----------ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 006668          468 DFGLAKLYQQGEV----------PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE  536 (636)
Q Consensus       468 DFGla~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~  536 (636)
                      |||+++.......          ...+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||..........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999976543221          112234578889999987654 57889999999999999999999997554332222


Q ss_pred             HHHHHH------HHHHhc--CC----cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          537 AVLMDW------VRNLYG--QG----KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       537 ~~l~~~------v~~~~~--~~----~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....+      .+..+.  ..    .......+.+...+ ......+.+++.+|++.||++|||+.|++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            111100      000000  00    00000011111101 1122568899999999999999999998853

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=287.11  Aligned_cols=266  Identities=23%  Similarity=0.292  Sum_probs=199.8

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |+..+.||+|++|.||+|+....+    ..+++|.+....  ....+.+..|+.++++++|+|++++++++...+..++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTG----EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCC----cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence            456678999999999999987655    889999998653  33346778899999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||++ ++|.+++.... ..+++.+++.++.+++.||+|||   +.+++||||+|+||++++++.+||+|||++......
T Consensus        77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            99997 69999995432 46999999999999999999999   789999999999999999999999999999866443


Q ss_pred             CCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH------HHHHHHhcCC-
Q 006668          479 EVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM------DWVRNLYGQG-  550 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~------~~v~~~~~~~-  550 (636)
                      .. ......++..|+|||.+.+. .++.++||||||++++||++|+.||..............      ...|.....- 
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         152 LR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             cc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            21 22233467889999988776 789999999999999999999999965432211111110      0000000000 


Q ss_pred             ---cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          551 ---KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       551 ---~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         .....................+.+++.+||..||++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence               0000000000000011124578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-34  Score=300.51  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ...|.+.+.||+|.|+.|.+++...++    ..||+|.+.+..  ....+.+.+|+++|..|+|||||+++.+.+....+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~----~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTG----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCC----ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            356888999999999999999988776    899999998762  33345688999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |+||||+.+|.+.+||.+  .+.+.+.....++.|+.+|++|||   .+.|+|||||++||||+.+.++||+|||++..+
T Consensus       131 ylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceee
Confidence            999999999999999954  455667889999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..+..  ....+|++.|.|||++.+.++ ..++|+||+|+++|-|++|..||+...-.+.....+               
T Consensus       206 ~~~~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl---------------  268 (596)
T KOG0586|consen  206 DYGLM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL---------------  268 (596)
T ss_pred             ccccc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe---------------
Confidence            75543  334689999999999999876 568999999999999999999998653222221111               


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ..+++-  +.-.....-+|+++++..+|.+|+++.++.+.=+-.
T Consensus       269 --~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  269 --RGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             --eeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence              111111  111123344556667999999999999999875443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=294.53  Aligned_cols=266  Identities=20%  Similarity=0.299  Sum_probs=198.8

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ...++|+..+.||+|++|.||++.....+    ..||+|++...  .......+.+|+.++++++|+||+++++++....
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCC----cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34678999999999999999999876554    88999998643  2333456889999999999999999999886543


Q ss_pred             ------eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          394 ------ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       394 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                            ..++||||+ +++|.+++.   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence                  468999999 789998873   356899999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH------
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM------  540 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~------  540 (636)
                      |||++......    .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||..............      
T Consensus       161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99999865432    223457889999998876 4578899999999999999999999975432211111110      


Q ss_pred             -HHHHHHhcCCcchhhhh--hhh----hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          541 -DWVRNLYGQGKICEAAD--ARI----RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       541 -~~v~~~~~~~~~~~~~d--~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       ++.... ..........  +..    ...........+.+++.+|++.||.+|||+.++++.-
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         237 KEFVQKL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             HHHHHhh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence             010000 0000000000  000    0011112334578999999999999999999999553

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.1e-33  Score=294.33  Aligned_cols=268  Identities=22%  Similarity=0.271  Sum_probs=197.8

Q ss_pred             CCC-CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH--------------HHHHHHHHHHhccCCCCceee
Q 006668          320 GFS-NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--------------LKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       320 ~f~-~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      +|. ..+.||+|+||.||+|.....+    +.||+|.+.......              ...+.+|++++++++|+||++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTG----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCC----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            443 3577999999999999976554    889999986542211              124678999999999999999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +++++..++..++||||++ |+|.+++.  ....+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence            9999999999999999995 79999884  3456899999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCC-------------CccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          465 RLGDFGLAKLYQQGE-------------VPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       465 kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      ||+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999997654111             0111223468889999988764 46889999999999999999999997553


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhh------------hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAA------------DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~------------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...... .+....... .........            ..... .........+.+++.+||+.+|++||++.|++..-.
T Consensus       239 ~~~~~~-~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        239 EIDQLG-RIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHH-HHHHHhCCC-chhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            222111 111111000 000000000            00000 011122456889999999999999999999998765


Q ss_pred             cC
Q 006668          599 GQ  600 (636)
Q Consensus       599 ~~  600 (636)
                      -.
T Consensus       316 ~~  317 (335)
T PTZ00024        316 FK  317 (335)
T ss_pred             cC
Confidence            54

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-33  Score=295.16  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=200.9

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ...++|+..+.||+|++|.||+|+...++    ..||+|++...  .....+.+.+|+.++++++|+|++++.+++...+
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTG----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCC----cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            34678899999999999999999987655    78999998753  2334466788999999999999999999886655


Q ss_pred             e------EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          394 E------LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       394 ~------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      .      .++|+||+ +++|.+++.   ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEc
Confidence            4      89999999 779999884   356999999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH---
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV---  543 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v---  543 (636)
                      |||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... +.+..   
T Consensus       161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~-i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR-IMNLVGTP  235 (343)
T ss_pred             ccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHhcCCC
Confidence            99999865432    233467889999998765 3678899999999999999999999975432211111 11100   


Q ss_pred             ----HHHhcCCcchhhhh---hhhhh---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          544 ----RNLYGQGKICEAAD---ARIRQ---EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       544 ----~~~~~~~~~~~~~d---~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          ............+.   .....   .........+.+++.+||++||++|||+.||++.-.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence                00000000000000   00000   0001124678899999999999999999999886433

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=329.26  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      -+......||.|.||.||.|...+++    +..|+|-++..  .....+...+|.+++..|+|||+|+++|+-.+.++.+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tG----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTG----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCcc----chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34556678999999999999977766    88999988754  3445667889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      |.||||++|+|.+.+  ...+..++.....+..|++.|+.|||   +.+||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1311 IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999998  33445666677778999999999999   8999999999999999999999999999998765


Q ss_pred             CCC---CccccccccCCcccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          477 QGE---VPNTTRVVGTLGYLAPELATVSS---PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       477 ~~~---~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ...   .......+||+-|||||++.+..   ...+.||||+|||+.||+||++||...+.+         |...+    
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy---- 1452 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMY---- 1452 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHh----
Confidence            542   12234568999999999988654   566899999999999999999999754322         22211    


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          -+-..-.+.++.....+=.+++..|+..||.+|.++.|+++.=-++
T Consensus      1453 ----~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1453 ----HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             ----HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence                1111112334444556677888999999999999999888775544

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-33  Score=279.63  Aligned_cols=237  Identities=26%  Similarity=0.362  Sum_probs=193.6

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  403 (636)
                      ||+|++|.||++.....+    ..+++|.+....   ......+..|+.++++++|+||+++++.+..++..++||||++
T Consensus         1 lg~G~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTG----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECCCC----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence            689999999999986544    789999987542   2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccc
Q 006668          404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT  483 (636)
Q Consensus       404 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  483 (636)
                      +++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~  150 (250)
T cd05123          77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT  150 (250)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Ccc
Confidence            99999999433  46899999999999999999999   7999999999999999999999999999998654432 123


Q ss_pred             cccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       484 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ....++..|+|||...+...+.++|+||||+++|||++|+.||......     .....+..              ....
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~--------------~~~~  211 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-----EIYEKILK--------------DPLR  211 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc--------------CCCC
Confidence            3456888999999998888999999999999999999999999644211     11111100              0112


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      ++......+.+++.+||..||++||++.+
T Consensus       212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         212 FPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            22233567788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=304.03  Aligned_cols=200  Identities=33%  Similarity=0.447  Sum_probs=173.8

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccc------e
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN------E  394 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~  394 (636)
                      ...+.||+|+||.||+|+.+.+|    +.||||.++.. .....+...+|+++|++|+|+|||++++.=++..      .
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG----~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETG----RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eehhhhcCCccceeeeecccccc----cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            45678999999999999987776    99999999875 3344567789999999999999999999865543      5


Q ss_pred             EEEEEeecCCCChhhhHhcC-CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc--CCC--cEEEecc
Q 006668          395 LMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD--SEM--RGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DF  469 (636)
                      ..+|||||.+|||+..|.+- ....|++.+.+.++.+++.||.|||   +++|+||||||.||++-  .++  .-||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            78999999999999999652 3457999999999999999999999   89999999999999993  223  4799999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      |.|+..+++.  ..+.++||..|++||+... +.++..+|.|||||++||.+||..||....
T Consensus       169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9999887665  6677899999999999984 888999999999999999999999997654

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-32  Score=288.60  Aligned_cols=268  Identities=24%  Similarity=0.276  Sum_probs=193.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeeecccccc----
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG----  392 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~----  392 (636)
                      +|+..+.||+|+||.||+++.....  .+..||+|++...  .....+.+.+|+.+++++ +|+||+++++.+...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS--EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC--cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4777899999999999999986541  1378999998753  223346778899999999 599999999875432    


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      ...++++||+. ++|.+++.  ....+++..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          79 NELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            45788999984 78999884  3456899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCc---cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-------H
Q 006668          473 KLYQQGEVP---NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM-------D  541 (636)
Q Consensus       473 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~-------~  541 (636)
                      .........   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............       +
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            865432211   1223468999999998765 4688999999999999999999999975432111111000       0


Q ss_pred             HHHHHhcCCcchhhhh---hh--h-hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          542 WVRNLYGQGKICEAAD---AR--I-RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d---~~--l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      +...... ........   ..  . ...........+.+++.+|++.||++||++.++++.
T Consensus       233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         233 TLSRIGS-PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhhhh-hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000 00000000   00  0 000011124568899999999999999999998755

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=270.29  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=196.1

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      ...||.|..|.|++.+++..+    ..+|||.+... .++..+.++..+.++..-+ .|.||+.+|+|..+...++-||.
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~----~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTG----HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HHhhcCCCccceEEEEEcccc----eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            466999999999999998877    89999999876 4556677888888776654 89999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      | ..-++.++.. -++++++.-+-++...+.+||.||.+  .++|+|||+||+|||+|+.|++|++|||++..+-...  
T Consensus       173 M-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  173 M-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             H-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence            8 4455555533 35678888888999999999999997  8899999999999999999999999999997654433  


Q ss_pred             cccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          482 NTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ..+..+|-+.|||||.+.-.   +|+.++||||||+.++||+||+.||..-+.+.+   .+.. +         .....+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---~ltk-v---------ln~ePP  313 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---VLTK-V---------LNEEPP  313 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---HHHH-H---------HhcCCC
Confidence            34456799999999988754   578899999999999999999999976432221   1111 1         111112


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .|+...  .-...+.+++..||..|+.+||...+++++-
T Consensus       314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            232211  1245678888899999999999999999874

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4e-33  Score=271.65  Aligned_cols=277  Identities=24%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-H-HHHHHHHHHHhccCCCCceeeeeccccc-cceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-G-LKEFMAEISSMGRLQHKNLVQMRGWCRK-GNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~  396 (636)
                      .|+....||+|.||.||||.-++++......+|+|+++.+... + -....+|+.+++.++||||+.|..++.. +..++
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            4777889999999999999877766555568999999866321 1 2356789999999999999999999877 78899


Q ss_pred             EEEeecCCCChhhhHhc---CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC----CcEEEecc
Q 006668          397 LVYDYMPNGSLNNWIFG---KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE----MRGRLGDF  469 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DF  469 (636)
                      |++||.+. +|...|+-   ...+.++...+..|+.||+.|+.|||   ++-|+||||||.|||+..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999965 77777742   23457899999999999999999999   7889999999999999877    99999999


Q ss_pred             CCcccccCCCCc--cccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChh----hHHHHHHHH
Q 006668          470 GLAKLYQQGEVP--NTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEE----EEEAVLMDW  542 (636)
Q Consensus       470 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~----~~~~~l~~~  542 (636)
                      |+++.+...-.+  ....++-|.+|.|||++.+.+ ||.+.|||+.|||+.||++-.+-|.......    .......+-
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999988764322  344577899999999888764 7889999999999999999876665331110    111111111


Q ss_pred             HHHHhcCCc------chhhhh-----hhhh-hccCHH-----------HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          543 VRNLYGQGK------ICEAAD-----ARIR-QEFEAE-----------EMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       543 v~~~~~~~~------~~~~~d-----~~l~-~~~~~~-----------~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +...++...      +...-+     ...+ ..++..           ....-++|..++|..||.+|.|+++.++..-.
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            111111100      000000     0000 001000           01225678888999999999999999998755


Q ss_pred             C
Q 006668          600 Q  600 (636)
Q Consensus       600 ~  600 (636)
                      .
T Consensus       341 ~  341 (438)
T KOG0666|consen  341 T  341 (438)
T ss_pred             c
Confidence            4

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=4.9e-32  Score=310.20  Aligned_cols=146  Identities=28%  Similarity=0.445  Sum_probs=131.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|.+.++||+|+||.||+|.....+    +.||+|+++..   .......+..|+.++..++|+||+++++++...+.+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   79 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNS----KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV   79 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence            57888999999999999999987655    89999999754   233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++||||+++++|.+++..  ...+++..++.++.||+.||+|||   ..+|+||||||+||||+.++.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999843  356889999999999999999999   7899999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.2e-33  Score=308.11  Aligned_cols=211  Identities=27%  Similarity=0.338  Sum_probs=184.7

Q ss_pred             CHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeee
Q 006668          310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMR  386 (636)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~  386 (636)
                      ...+++-....|.+.++||+|+||.|...+.+.++    +.||+|++++.   ......-|..|-.+|..-+.+-|+++.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTE----KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccc----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            34566666678999999999999999999998877    89999999873   333456788899999988899999999


Q ss_pred             ccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      -.|.+...+|+|||||+||+|-.+|.+.  ..++++.++.++..|+-||.-||   +.|+|||||||.|||||..|++||
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEee
Confidence            9999999999999999999999998433  37999999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +|||.|-.+..+..-.+...+|||.|++||++..     +.|...+|.||+||++|||+.|..||...
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            9999987776554444555789999999998763     56889999999999999999999999744

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=4.5e-32  Score=272.14  Aligned_cols=220  Identities=20%  Similarity=0.179  Sum_probs=176.2

Q ss_pred             cCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCCChhh
Q 006668          330 GGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN  409 (636)
Q Consensus       330 G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  409 (636)
                      |.+|.||+++...++    +.+|+|.+....     ++..|...+....||||+++++++.+.+..++||||+++|+|.+
T Consensus         4 g~~~~v~~~~~~~~~----~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQ----QTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCC----cEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            789999999987665    789999997653     22344555556679999999999999999999999999999999


Q ss_pred             hHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccC
Q 006668          410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT  489 (636)
Q Consensus       410 ~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt  489 (636)
                      ++..  ...+++..+..++.|+++||+|||   +.+++||||||+||+++.++.++++|||++......    .....++
T Consensus        75 ~l~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~  145 (237)
T cd05576          75 HISK--FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVE  145 (237)
T ss_pred             HHHH--hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcC
Confidence            9854  345899999999999999999999   899999999999999999999999999987654432    1223457


Q ss_pred             CcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHH
Q 006668          490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEM  569 (636)
Q Consensus       490 ~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  569 (636)
                      ..|+|||.+....++.++||||+|++++||++|+.|+.......                   .....    ...+....
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~----~~~~~~~~  202 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT----LNIPEWVS  202 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc----cCCcccCC
Confidence            78999999988889999999999999999999998875321100                   00000    01122234


Q ss_pred             HHHHHHHHHccCCCCCCCCCH
Q 006668          570 ELVLKLGLACCHPDSTRRPTM  590 (636)
Q Consensus       570 ~~l~~L~~~Cl~~dP~~RPs~  590 (636)
                      ..+.+++.+|++.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            567889999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=7.3e-33  Score=285.29  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      .++||+|.||+||-|+.+..+    +.||||++.+.  .++...++++|+.+|++++||.||.+...|+..+..+.|||.
T Consensus       569 devLGSGQFG~VYgg~hRktG----rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTG----RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccC----ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence            578999999999999988776    89999999865  333447889999999999999999999999999999999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEeccCCcccccCC
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~~~~  478 (636)
                      + +|++.++|...+++.|++..-..++.||+.||.|||   .++|+|+||||+||||.+   --++||+|||.|+.+...
T Consensus       645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9 788888888888899999999999999999999999   899999999999999954   456999999999998876


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      ....  .++||+.|+|||++....|...-|+||.|||+|--+.|.-||....  +..++ +.. ...+         ..+
T Consensus       721 sFRr--sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQ-IQN-AaFM---------yPp  785 (888)
T KOG4236|consen  721 SFRR--SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQ-IQN-AAFM---------YPP  785 (888)
T ss_pred             hhhh--hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHH-hhc-cccc---------cCC
Confidence            5544  3689999999999999999999999999999999999999996431  11111 111 0001         111


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .-..+.+.+    ..+|+...|+..-++|-+....+...+-.
T Consensus       786 ~PW~eis~~----AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  786 NPWSEISPE----AIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             CchhhcCHH----HHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence            222333333    34444555777778888888777665443

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-32  Score=265.88  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             hCCCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccc----
Q 006668          318 TKGFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRK----  391 (636)
Q Consensus       318 ~~~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----  391 (636)
                      ++.|++. ++||-|-.|.|-.+..+.++    +++|+|++...     ...++|++.--.. .|||||+++++++.    
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~----ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQ----EKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccch----hhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            3344332 67999999999999987776    88999988654     3345778766555 59999999998864    


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEec
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGD  468 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  468 (636)
                      ...+++|||.|+||.|...+.++....+++.++-.|++||+.|++|||   +.+|.||||||+|+|.+.   +..+||+|
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecc
Confidence            357899999999999999998888888999999999999999999999   899999999999999954   55699999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||.|+.-...  ......+-|+.|.|||++...+|+...|+||+||++|-|+||..||......                
T Consensus       208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----------------  269 (400)
T KOG0604|consen  208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----------------  269 (400)
T ss_pred             cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----------------
Confidence            9999865432  2334467899999999999999999999999999999999999999754221                


Q ss_pred             CCcchhhhhhhhh---hccCHHH----HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QGKICEAADARIR---QEFEAEE----MELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~~~~~~~d~~l~---~~~~~~~----~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        .+...+..+++   -+|+.++    .+...++++..|..+|.+|.|+.|++..-+
T Consensus       270 --aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  270 --AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             --cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence              11111222222   1233333    455677888899999999999999998743

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.2e-31  Score=297.87  Aligned_cols=267  Identities=22%  Similarity=0.248  Sum_probs=174.7

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecc------cc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGW------CR  390 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~------~~  390 (636)
                      ..++|+..++||+|+||.||+|++..+....+..||+|++.......  ....|  .+....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45689999999999999999999877633334899999886543211  11111  1122222222222221      34


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCC------------------CcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCC
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKK------------------LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK  452 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  452 (636)
                      .+...++||||+++++|.+++......                  ......+..++.||+.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            567899999999999999998543210                  1123345679999999999999   8999999999


Q ss_pred             CCCEEEcC-CCcEEEeccCCcccccCCCCccccccccCCcccccccccCC----------------------CCCCccch
Q 006668          453 SGNILLDS-EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS----------------------SPTSASDV  509 (636)
Q Consensus       453 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDV  509 (636)
                      |+|||+++ ++.+||+|||+++..............+++.|+|||.+...                      .+..++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999986654433344456789999999955322                      23446799


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCChhhHHHH-------HHHHHHHHhcCCcchhhhhhhhhhcc--CHHHHHHHHHHHHHcc
Q 006668          510 YSFGVVILEVACGRRPLDMGKGEEEEEAV-------LMDWVRNLYGQGKICEAADARIRQEF--EAEEMELVLKLGLACC  580 (636)
Q Consensus       510 ~S~Gvll~ell~G~~Pf~~~~~~~~~~~~-------l~~~v~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~L~~~Cl  580 (636)
                      |||||+||||+++..|+...  .......       +..|......  .    ..+.+...+  .........+|+.+|+
T Consensus       363 wSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEP--R----ASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhcc--c----cchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999977664321  1011111       1111111000  0    000001001  0111234558999999


Q ss_pred             CCCCCCCCCHHHHHHHHh
Q 006668          581 HPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       581 ~~dP~~RPs~~evl~~L~  598 (636)
                      +.||++|||++|++++-.
T Consensus       435 ~~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        435 RFKGRQRISAKAALAHPY  452 (566)
T ss_pred             cCCcccCCCHHHHhCCcC
Confidence            999999999999998743

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2e-33  Score=268.54  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             cccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhcc-CCCCceee
Q 006668          307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGR-LQHKNLVQ  384 (636)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~-l~h~niv~  384 (636)
                      +.|+-++|+.       ...||.|.||+|+|-.++..+    +..|||+++.. .....++++.|.+...+ -+.||||+
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg----~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVk  127 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSG----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVK  127 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccC----cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHH
Confidence            4555555554       356999999999999988776    89999999865 33566788888876554 47999999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhH---hcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWI---FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE  461 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~  461 (636)
                      ++|.+-.++..++-||.| .-||+.+-   +..++..++++-+-.|...++.||.||.+  +..|+|||+||+||||+..
T Consensus       128 fyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~  204 (361)
T KOG1006|consen  128 FYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRH  204 (361)
T ss_pred             HhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecC
Confidence            999999999999999999 67877653   44556778888888899999999999997  7899999999999999999


Q ss_pred             CcEEEeccCCcccccCCCCccccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      |.+||||||++..+..+  ...+.-+|-..|||||.+...  .++.+|||||||+.|+|++||+.|+.....       .
T Consensus       205 G~vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------v  275 (361)
T KOG1006|consen  205 GDVKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------V  275 (361)
T ss_pred             CCEeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------H
Confidence            99999999999765432  223345788999999987643  378899999999999999999999965421       1


Q ss_pred             HHHHHHH-hcCCcchhhhhhhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          540 MDWVRNL-YGQGKICEAADARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       540 ~~~v~~~-~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .+.+... ..+..+       +.... ..+....+...+..|+.+|...||...++.++
T Consensus       276 feql~~Vv~gdpp~-------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  276 FEQLCQVVIGDPPI-------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHHcCCCCe-------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1111111 111111       11111 11234567888889999999999999998875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=278.23  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-------HHHHHHHHHHHHhccCCCCceeeeecccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-------QGLKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      .++|-...+||+|||+.|||+......    +.||||+-.....       ...+...+|..+-+.|.||.||++|+++.
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~Eq----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQ----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchh----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            345667789999999999999876655    8899998754311       12345678999999999999999999985


Q ss_pred             -ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEE
Q 006668          391 -KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRL  466 (636)
Q Consensus       391 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl  466 (636)
                       +.+.+|-|+|||+|.+|+-||  +..+.+++++++.|+.||+.||.||.+ ...+|||-||||.||||   +..|.+||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             eccccceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEe
Confidence             456799999999999999999  455789999999999999999999984 47899999999999999   45678999


Q ss_pred             eccCCcccccCCCCc------cccccccCCcccccccccCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 006668          467 GDFGLAKLYQQGEVP------NTTRVVGTLGYLAPELATVS----SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE  536 (636)
Q Consensus       467 ~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~  536 (636)
                      .||||++.++.+...      .+....||.+|++||++.-+    +.+.|+||||.|||+|..+.|+.||....   ...
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq---sQQ  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ---SQQ  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch---hHH
Confidence            999999988765433      23346799999999987654    46889999999999999999999996442   111


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV  594 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  594 (636)
                      .++        ....+..+-+..++.  .+........++.+||+..-++|....++.
T Consensus       692 dIL--------qeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 DIL--------QENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHH--------hhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            222        223344433332221  112234566788899999999998765544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.7e-31  Score=263.05  Aligned_cols=239  Identities=28%  Similarity=0.386  Sum_probs=193.7

Q ss_pred             CceEEEeeeecCCCCCCceEEEEEEeccCChHH-HHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCCChhh
Q 006668          331 GFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN  409 (636)
Q Consensus       331 ~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  409 (636)
                      +||.||+|+....+    ..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+
T Consensus         1 ~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTG----KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            58999999987644    789999998765444 6789999999999999999999999999899999999999999999


Q ss_pred             hHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccC
Q 006668          410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT  489 (636)
Q Consensus       410 ~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt  489 (636)
                      ++...  ..+++.+++.++.+++.+|.|||   +.+++|+||+|+||++++++.++|+|||.+.......  ......++
T Consensus        77 ~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~  149 (244)
T smart00220       77 LLKKR--GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT  149 (244)
T ss_pred             HHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence            98543  23899999999999999999999   7899999999999999999999999999998765432  23345688


Q ss_pred             CcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHH
Q 006668          490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEM  569 (636)
Q Consensus       490 ~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  569 (636)
                      ..|++||.+....++.++||||||+++++|++|..||......    ....++...    +...       .........
T Consensus       150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~~----~~~~-------~~~~~~~~~  214 (244)
T smart00220      150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIGK----PKPP-------FPPPEWKIS  214 (244)
T ss_pred             cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhc----cCCC-------CccccccCC
Confidence            8999999998888999999999999999999999999653111    111111110    0000       000000044


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          570 ELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       570 ~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                      ..+.+++.+|+..+|++||++.++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhh
Confidence            67889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=271.97  Aligned_cols=267  Identities=23%  Similarity=0.312  Sum_probs=214.4

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCCCC-CCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccc
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNN-NNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWC  389 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~  389 (636)
                      +++.....+++...++-+|.||.||.|.+++.+. +..+.|.+|.++.. +.-....+..|...+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3455555678888899999999999998876532 23456778877655 445567889999999999999999999998


Q ss_pred             ccc-ceEEEEEeecCCCChhhhHh-----c-CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          390 RKG-NELMLVYDYMPNGSLNNWIF-----G-KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       390 ~~~-~~~~lV~E~~~~gsL~~~l~-----~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      .+. ...+.+|.++.-|+|+.||.     + +..+.++-.+...++.|++.|++|||   +.+|||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            665 56799999999999999996     1 23456788889999999999999999   89999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCcccc-ccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTT-RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~  540 (636)
                      ++||+|=.++|..-+.+..... .-..+..||+||.+....++.++|||||||+||||++ |+.|+...++.+.. .++ 
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~yl-  511 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYL-  511 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHH-
Confidence            9999999999865544432221 1234678999999999999999999999999999988 99998755433221 111 


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                                      ....+...+..+++++..++.-||..+|++||+++|++.=|.+
T Consensus       512 ----------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  512 ----------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                            1223334456788999999999999999999999999988854

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=272.72  Aligned_cols=267  Identities=22%  Similarity=0.317  Sum_probs=208.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC--CCc----eeeeecccc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ--HKN----LVQMRGWCR  390 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--h~n----iv~l~g~~~  390 (636)
                      .+++|.+.+.+|+|.||.|-+......+    ..||+|+++.-.+. .+..+-|+++|+++.  .|+    +|++.+|+.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~----~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETK----EHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCC----ceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            4778999999999999999999876654    89999999765433 244567999999994  232    788999999


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-----------
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-----------  459 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-----------  459 (636)
                      -.++.|+|+|.+ |-|+.++|..+...+++..+++.|+.|++++++|||   +.+++|.||||+|||+.           
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence            999999999998 779999998888889999999999999999999999   89999999999999992           


Q ss_pred             ---------CCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          460 ---------SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       460 ---------~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                               .+..+|++|||.|.......    ..++.|..|.|||++.+-.++..+||||+||||.|+++|..-|+...
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                     13458999999998755433    44678999999999999999999999999999999999999998775


Q ss_pred             ChhhHHHHHHHHHH--------------HHhcCCcch-----------hhhhhhh----hhccCHHHHHHHHHHHHHccC
Q 006668          531 GEEEEEAVLMDWVR--------------NLYGQGKIC-----------EAADARI----RQEFEAEEMELVLKLGLACCH  581 (636)
Q Consensus       531 ~~~~~~~~l~~~v~--------------~~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~  581 (636)
                      ..+  ...+++-+.              .....|++.           ...+...    .......+...|.+|+.+||.
T Consensus       314 n~E--HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  314 NLE--HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             cHH--HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            322  112222111              111111111           0111111    111234566789999999999


Q ss_pred             CCCCCCCCHHHHHHHHh
Q 006668          582 PDSTRRPTMREVVAVLV  598 (636)
Q Consensus       582 ~dP~~RPs~~evl~~L~  598 (636)
                      .||.+|+|++|++++--
T Consensus       392 fDP~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  392 FDPARRITLREALSHPF  408 (415)
T ss_pred             cCccccccHHHHhcCHH
Confidence            99999999999997643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=287.27  Aligned_cols=244  Identities=28%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      +..|.....+|.|.|+.|-++....++    ...++|++.....    +..+|+.++... +||||+++.+.+.++.+.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~----~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTD----QEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccc----cchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceee
Confidence            456777788999999999999987766    8899999976622    234567665555 6999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE-cCCCcEEEeccCCcccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL-DSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~~  475 (636)
                      +|||.+.++-|.+.+..++.  .. .++..|+.+|+.|+.|||   +++++||||||+|||+ ++.++++|+|||.++..
T Consensus       393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            99999999988888854432  22 777889999999999999   8999999999999999 69999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    ....+-|..|.|||++....++.++|+||||++||+|++|+.||......   ..++     ....       
T Consensus       467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~-----~~i~-------  527 (612)
T KOG0603|consen  467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIH-----TRIQ-------  527 (612)
T ss_pred             chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHH-----Hhhc-------
Confidence            654    33346789999999999999999999999999999999999999876433   1111     1111       


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           ...++....+...+|+.+||+.||.+||+|.++...-..
T Consensus       528 -----~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 -----MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -----CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                 122334445667778888999999999999999987655

>cd01951 lectin_L-type legume lectins

Probab=99.97  E-value=6.1e-31  Score=261.12  Aligned_cols=169  Identities=25%  Similarity=0.367  Sum_probs=136.1

Q ss_pred             CCCeEEecceEecC-CCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEec
Q 006668           39 GTDLILINDCWVDS-TVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTN  117 (636)
Q Consensus        39 ~~~~~~~g~a~~~~-~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~  117 (636)
                      ..++.++|+|.+.. ++.++||++..+++|||+|++||++|          ++|+|+|+|.|.... ..+||||||+|+|
T Consensus        13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~----------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~   81 (223)
T cd01951          13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS----------KDFTTTFKFYLGTKG-TNGADGIAFVLQN   81 (223)
T ss_pred             hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc----------CCEEEEEEEEEeCCC-CCCCCcEEEEEec
Confidence            47999999999975 78999999888899999999999997          489999999999764 5689999999999


Q ss_pred             CCCCCCCCcC--cccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc--cccCccccCCCCCccee
Q 006668          118 FTSPPGALAS--QYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK--HVPAGYYSSSRNESFVP  193 (636)
Q Consensus       118 ~~~~~~~~~g--~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~--~~~~~~~~~~~~~~~~~  193 (636)
                      .+..+.+.+|  ++||.      ...++.+||||||++|.+++||+.||||||+|+..+..  ..+..++..       .
T Consensus        82 ~~~~~~~~~g~~~~lG~------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~~-------~  148 (223)
T cd01951          82 DPAGALGGGGGGGGLGY------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASL-------P  148 (223)
T ss_pred             CCCCccccCCCCCccCc------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceeeC-------C
Confidence            8654444444  77775      24567899999999999888999999999999997641  111111110       1


Q ss_pred             eeecCCCeeEEEEEec-------------------------------------ccccCCCceecceeeeeccccC
Q 006668          194 VRMRNGQNIHAWIDFD-------------------------------------GFSASKTNWIEARRVLAWSLSD  231 (636)
Q Consensus       194 ~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~~~~~~il~wsf~~  231 (636)
                      ....+|+.+++||+|+                                     |||||||...+.|+|++|+|+.
T Consensus       149 ~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~  223 (223)
T cd01951         149 NGTGLGNEHTVRITYDPTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS  223 (223)
T ss_pred             CccCCCCEEEEEEEEeCCCCEEEEEECCCCccccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence            1112378889999997                                     9999999999999999999973

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5.5e-31  Score=287.83  Aligned_cols=268  Identities=21%  Similarity=0.296  Sum_probs=184.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC------------CCCceEEEEEEeccCChHHHHHHH--------------HHH
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN------------NNNSTEMAVKCVNHDSKQGLKEFM--------------AEI  371 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~------------~~~~~~vavK~~~~~~~~~~~~~~--------------~Ei  371 (636)
                      .++|++.++||+|+||.||+|.+...+            ...++.||||++........++|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            567999999999999999999753221            223467999999765433333333              466


Q ss_pred             HHhccCCCCce-----eeeeccccc--------cceEEEEEeecCCCChhhhHhcCC----------------------C
Q 006668          372 SSMGRLQHKNL-----VQMRGWCRK--------GNELMLVYDYMPNGSLNNWIFGKP----------------------K  416 (636)
Q Consensus       372 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~  416 (636)
                      ..+.+++|.++     ++++++|..        .+..+|||||+++++|.++|+...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766654     677787753        356899999999999999986421                      1


Q ss_pred             CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccc
Q 006668          417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE  496 (636)
Q Consensus       417 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE  496 (636)
                      ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            23467788999999999999999   789999999999999999999999999999765443322222234588999999


Q ss_pred             cccCCCC----------------------CCccchHHHHHHHHHHHhCCC-CCCCCCChhhH----HHHHHHHHHHHhcC
Q 006668          497 LATVSSP----------------------TSASDVYSFGVVILEVACGRR-PLDMGKGEEEE----EAVLMDWVRNLYGQ  549 (636)
Q Consensus       497 ~~~~~~~----------------------s~~sDV~S~Gvll~ell~G~~-Pf~~~~~~~~~----~~~l~~~v~~~~~~  549 (636)
                      .+.....                      ..+.||||+||+++||++|.. |+.........    ...+..|..  +..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc
Confidence            8754321                      234799999999999999875 66532111111    111112211  111


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHh
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDS---TRRPTMREVVAVLV  598 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP---~~RPs~~evl~~L~  598 (636)
                      ...    +.    ...........+|+.+|+..+|   .+|+|+.|++++-.
T Consensus       459 ~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        459 QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            111    10    1112234556677777888655   68999999997643

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=241.94  Aligned_cols=201  Identities=26%  Similarity=0.419  Sum_probs=170.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|+..++||+|.||+||||+.+++.    +.||+|+++.+..+  .-....+|+.+++.++|+|||++++....+..+-|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~----eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCcc----ceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            3555678999999999999987766    89999999866332  23567899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||| .-+|..|.- .-.+.++.+..+.++.|+++||.++|   ++++.||||||+|.||+.+|..|++|||+++.+.-
T Consensus        79 vfe~c-dqdlkkyfd-slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   79 VFEFC-DQDLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             eHHHh-hHHHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            99999 668888763 34678999999999999999999999   89999999999999999999999999999997764


Q ss_pred             CCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      .- .-...-+-|.+|.+|.++.+.+ |+...|+||-|||+.|+....+|...+.
T Consensus       154 pv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  154 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             ce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            22 2223345699999999988876 7888999999999999988666654443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=288.45  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=207.4

Q ss_pred             HHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccc
Q 006668          311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWC  389 (636)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~  389 (636)
                      ++.+..-+..|++.+.||+|.+|.||+++.+..+    +.+|+|+....... .+++..|.++++.+ .|||++.++|++
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~----~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTG----QLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecC----ceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3444455677899999999999999999976655    88899988766433 25667789999888 599999999988


Q ss_pred             cc-----cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          390 RK-----GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       390 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      ..     +++++||||||.+||..|++.+-....+.|+.+..|+..++.||++||   ...++|||||-.||||+.++.+
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence            53     478999999999999999997666778999999999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccccCCCCccccccccCCcccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-----SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      ||+|||++....... ......+||+.|||||++...     .|+..+|+||||++..||.-|.+|+..+-..  ..  +
T Consensus       163 KLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--ra--L  237 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--RA--L  237 (953)
T ss_pred             EEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--hh--h
Confidence            999999998765433 233346899999999987654     3567899999999999999999998654111  10  0


Q ss_pred             HHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                             +   .+...-.+++.  -+..=.+.+.+.|..|+..|-++||++.+++++
T Consensus       238 -------F---~IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 -------F---LIPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -------c---cCCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                   0   01111111121  123334678889999999999999999998875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-32  Score=278.46  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=208.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +++...-||-||||.|=+.+.....    ..+|+|++++.   .....+....|-.+|...+.|.||++|..+.+....|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQK----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccc----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            3455667999999999988876543    34788888754   4455577889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +.||-|-||.|...|+  .++.++..+.+.++..+.+|++|||   .++||+|||||+|.||+.+|-+||.|||.|+.+.
T Consensus       497 mLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  497 MLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999994  4678999999999999999999999   8999999999999999999999999999999876


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .+.  .+...+||+.|.|||++.+..++.++|.||||+++|||++|.+||...+.......++..              +
T Consensus       572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG--------------i  635 (732)
T KOG0614|consen  572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG--------------I  635 (732)
T ss_pred             cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------------h
Confidence            544  566689999999999999999999999999999999999999999887665555554433              1


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVLV  598 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L~  598 (636)
                      |.   -+++........+|+++.+..+|.+|.-     +.+|-++-+
T Consensus       636 d~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  636 DK---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             hh---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            11   1233344455667777788999999976     667766643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=265.92  Aligned_cols=202  Identities=27%  Similarity=0.403  Sum_probs=172.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      ..|....+||+|.||.|.++..+.++    +.+|||+++++   ..+..+--+.|-++|... +-|.++++..++..-+.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtd----ELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTD----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcc----hhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            35888899999999999999877665    89999999876   222233334566777665 57889999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +|+||||+.+|+|--+|  ++-+.+.+..+..++.+||-||-+||   +++|++||||..|||||.+|++||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc
Confidence            99999999999998888  44567888899999999999999999   89999999999999999999999999999974


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      --.+. ..+...+||+.|+|||++...+|....|.|||||+||||+.|+.||+..+
T Consensus       500 ni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  500 NIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             cccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            32222 23445899999999999999999999999999999999999999998653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.5e-32  Score=256.19  Aligned_cols=279  Identities=22%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHH-HHHHHHHHHHhccCCCCceeeeecccccc------
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQG-LKEFMAEISSMGRLQHKNLVQMRGWCRKG------  392 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------  392 (636)
                      |....+||+|.||+||+|+.+.++    +.||+|++-.+ .+.+ -....+|+++|..|+|+|++.++..|...      
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~----kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTG----KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCcc----chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            344567999999999999987765    77888876543 2222 23457899999999999999999998642      


Q ss_pred             --ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          393 --NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                        ..++||+++|+. +|...| ++....++..++.++++++..||.|+|   ...|+|||+||.|+||+.++.+||+|||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence              358999999954 777766 334567899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCC---CccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH-----
Q 006668          471 LAKLYQQGE---VPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD-----  541 (636)
Q Consensus       471 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~-----  541 (636)
                      +++.+...+   .+..+..+-|++|.+||.+.+ .+++++.|||.-|||+.||.++.+-+....... .-..+..     
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is~LcGs~  248 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLISQLCGSI  248 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHHHHhccC
Confidence            998765433   223344567999999997766 568999999999999999999986665442211 1111111     


Q ss_pred             --HHHHHhcCCcchhhhhhh-hhhc-cC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhh
Q 006668          542 --WVRNLYGQGKICEAADAR-IRQE-FE--------AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKEL  609 (636)
Q Consensus       542 --~v~~~~~~~~~~~~~d~~-l~~~-~~--------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~  609 (636)
                        -+|.....-.+.+.+... +.+. +.        .......++|+..++..||.+|+.+.+++..-..-+ .+.|...
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k-dp~pqan  327 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK-DPMPQAN  327 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc-CCcchhh
Confidence              111111111222222111 1110 00        001235667888899999999999999998865542 2666333


Q ss_pred             h
Q 006668          610 L  610 (636)
Q Consensus       610 ~  610 (636)
                      +
T Consensus       328 l  328 (376)
T KOG0669|consen  328 L  328 (376)
T ss_pred             H
Confidence            3

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-30  Score=273.32  Aligned_cols=240  Identities=25%  Similarity=0.448  Sum_probs=191.1

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      |-..+.||-|+||+|.++...++.    ..+|+|.+.+.   .+......++|-.+|..-..+-||+|+-.|.+++.+|+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTR----ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchh----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            667788999999999999876654    78999988765   33445667889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc-
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ-  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~-  476 (636)
                      ||||++||++-.+|.+  .+.+.++.++.++.++.+|+++.|   ..|+|||||||.|||||.+|.+||.|||||.-+. 
T Consensus       707 VMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccccee
Confidence            9999999999999854  467888999999999999999999   9999999999999999999999999999995331 


Q ss_pred             --------CCCC---------------c-----------------cccccccCCcccccccccCCCCCCccchHHHHHHH
Q 006668          477 --------QGEV---------------P-----------------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI  516 (636)
Q Consensus       477 --------~~~~---------------~-----------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll  516 (636)
                              .++-               .                 .....+||..|+|||++....++..+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    1100               0                 01124699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCC
Q 006668          517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPD  583 (636)
Q Consensus       517 ~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~d  583 (636)
                      |||+.|+.||-.....+....+ ..|-..          ++-......+.++...+.+|   |+..|
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv-~nw~~~----------l~~~~~~~ls~e~~~li~kL---c~sad  914 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKV-INWRNF----------LHIPYQGNLSKEALDLIQKL---CCSAD  914 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeee-eehhhc----------cccccccccCHHHHHHHHHH---hcChh
Confidence            9999999999766544443322 233221          22223345566666666665   66554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-30  Score=237.44  Aligned_cols=199  Identities=26%  Similarity=0.359  Sum_probs=168.2

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~  401 (636)
                      ...||+|++|.|=+-++..++    ...|+|++... ..+..++.+.|+.+..+. .+|.+|.++|...+.+..++.||.
T Consensus        51 i~elGrGayG~vekmrh~~sg----~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSG----TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhcCCccchhhheeeccCC----eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            456999999999998888776    89999999865 445567788888876554 799999999999999999999999


Q ss_pred             cCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          402 MPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       402 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      | .-||+.+-.+  +....+++.-+-+|+..+.+||.|||+  ...++|||+||+||||+.+|++|+||||++..+.++-
T Consensus       127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            9 6788887532  345678888999999999999999997  7899999999999999999999999999998765432


Q ss_pred             CccccccccCCcccccccccC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 006668          480 VPNTTRVVGTLGYLAPELATV----SSPTSASDVYSFGVVILEVACGRRPLDMGKG  531 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~  531 (636)
                        ..+...|...|||||.+..    ..|+-|+||||||+.+.||.+++.||+....
T Consensus       204 --Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  204 --AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             --HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence              2222468889999998664    3688899999999999999999999976543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=280.90  Aligned_cols=245  Identities=27%  Similarity=0.365  Sum_probs=186.9

Q ss_pred             CCCceeeeecCce-EEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFG-RVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG-~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV  398 (636)
                      |...+++|.|..| .||+|.+.+      +.||||++-.+..   .-..+|+..|+.- +|||||++++.-.+....||.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~------R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEG------REVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCC------ceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            5566788998876 579999865      7999999865433   3456899999888 599999999998888999999


Q ss_pred             EeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-----CCcEEEeccCC
Q 006668          399 YDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGL  471 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGl  471 (636)
                      .|.| ..+|.+++...  ..........+.++.|+++||++||   ..+||||||||+||||+.     ..+++|+|||+
T Consensus       582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            9999 78999999653  1111222455788999999999999   899999999999999965     35799999999


Q ss_pred             cccccCCC--CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          472 AKLYQQGE--VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACG-RRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       472 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G-~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ++....+.  ........||.+|+|||.+.....+.++||||+||++|+.++| .+||.....++.              
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------------  723 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------------  723 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------------
Confidence            99776543  2333456799999999999999999999999999999999885 999965421110              


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        +|......-.......++  ...+||.+|++++|..||++.+|+.+
T Consensus       724 --NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  724 --NILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             --hhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence              111000000001111112  67889999999999999999998753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=9.5e-30  Score=238.47  Aligned_cols=263  Identities=21%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeecccccc--ce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKG--NE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~  394 (636)
                      .++|++.+++|+|.+++||.|....++    ++++||++++-.+   +.+.+|+++|..|+ ||||++|++...+.  ..
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~----eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNN----EKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCC----ceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            346778899999999999999866555    8899999987654   56778999999998 99999999998764  46


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccCCcc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAK  473 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~  473 (636)
                      ..||+||+.+.+....-     ..|+...++.++.++++||.|+|   +.||+|||+||.|+|||.. ..++|+|+|||.
T Consensus       110 paLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             chhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence            78999999888877643     57888999999999999999999   8999999999999999865 569999999999


Q ss_pred             cccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH---------HHH
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM---------DWV  543 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~---------~~v  543 (636)
                      .+..+...+.  .+.+..|-.||++.. ..++..-|+|||||++..|+..+.||..+.+...+-..+.         ..+
T Consensus       182 FYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            9887654443  356778889997765 4578889999999999999999999977654433221111         111


Q ss_pred             HHHhc--CCcchhhhhhhhhhc---cCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          544 RNLYG--QGKICEAADARIRQE---FEA-----EEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       544 ~~~~~--~~~~~~~~d~~l~~~---~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ....-  +.+....+....+..   |-.     -...+.++++.+.|..|-++|||++|.+.+-
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            11100  001111111111110   100     0124567777888999999999999988653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=246.62  Aligned_cols=201  Identities=25%  Similarity=0.422  Sum_probs=174.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ...|+..++||+|.|.+|..++++.++    +.+|+|+++++   ..+.+.=.+.|-.+..+- +||.+|-+..++..+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~----qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTD----QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccc----eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            356889999999999999999998876    88999999865   223334445566666655 7999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+++|.||+++|+|--++  ++.+.|+++.++.+..+|+-||.|||   +++|++||||..|||||.+|.+||.|+|+++
T Consensus       325 rlffvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             eEEEEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence            999999999999998877  45667999999999999999999999   8999999999999999999999999999997


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDM  528 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~  528 (636)
                      .--... ..+...+||+.|+|||++.+..|....|.|+|||+++||+.|+.||+.
T Consensus       400 e~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  400 EGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            533222 234458999999999999999999999999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=249.16  Aligned_cols=264  Identities=24%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc-----ce
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-----NE  394 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~  394 (636)
                      +..+.||-|+||.||..+...++    +.|+.|++...  .-...+.+.+|+++|..++|.|++..++.....     .+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdg----rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSG----KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCc----cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            45678999999999999887766    89999998764  333457888999999999999999998876543     35


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +|.+.|.| ..+|.+.|.  ....|+.+.+.-++.||++||+|||   +.+|.||||||.|.|++++..+||+|||+++.
T Consensus       132 iYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  132 LYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccc
Confidence            78899999 668888773  4567888999999999999999999   89999999999999999999999999999999


Q ss_pred             ccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .+.+....++.-+-|..|.|||++.+. .|+.+.||||.|||+.|++..+.-|.....-+ .-..    +..+++...+.
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-QL~l----ItdLLGTPs~E  280 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-QLQM----IIDLLGTPSQE  280 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-HHHH----HHHHhCCCcHH
Confidence            888887788877889999999998876 57889999999999999998888886543222 1111    22222211111


Q ss_pred             h-----------hhhhhh-----hh--cc-C-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 E-----------AADARI-----RQ--EF-E-AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~-----------~~d~~l-----~~--~~-~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .           .+....     ..  .. + ......-..+..+++.+||+.|.+..+.+..+..+
T Consensus       281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            0           000000     00  00 0 11222344555678999999999999999887554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=5.3e-28  Score=234.78  Aligned_cols=212  Identities=34%  Similarity=0.566  Sum_probs=183.9

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNG  405 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  405 (636)
                      ||+|.+|.||+++...++    ..+++|++...... ..+.+.+|+..++.++|++++++++++......++++|+++++
T Consensus         1 l~~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTG----KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCC----cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999986544    88999999876443 3467889999999999999999999999989999999999999


Q ss_pred             ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCcccccCCCCcccc
Q 006668          406 SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKLYQQGEVPNTT  484 (636)
Q Consensus       406 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~  484 (636)
                      +|.+++.... ..+++..+..++.+++.+|++||   +.+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus        77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~  151 (215)
T cd00180          77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK  151 (215)
T ss_pred             cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence            9999984332 46899999999999999999999   789999999999999999 89999999999986654321 123


Q ss_pred             ccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc
Q 006668          485 RVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE  563 (636)
Q Consensus       485 ~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  563 (636)
                      ...+...|++||..... ..+.+.|+|++|+++++|                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            34578899999998887 788999999999999999                                            


Q ss_pred             cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       564 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            ..+.+++.+|++.||++||++.++++.|
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                  4577888999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=245.99  Aligned_cols=270  Identities=23%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-----C---Cceeeeecccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-----H---KNLVQMRGWCR  390 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~g~~~  390 (636)
                      .+|...++||+|.|++||++......    +.||+|+.+... ...+..+.||++|++++     |   ..||+|++.|.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~----r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNK----RYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCC----eEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            67889999999999999999987765    899999986542 23355678999999884     2   36999999986


Q ss_pred             c----cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-----
Q 006668          391 K----GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-----  461 (636)
Q Consensus       391 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-----  461 (636)
                      .    +.++|+|+|++ |.+|..+|.....+.++...+++|+.||+.||.|||.  +.+|||.||||+||||...     
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchh
Confidence            5    45899999999 8899999987778889999999999999999999998  6799999999999998211     


Q ss_pred             --------------------------------------------------------------------------------
Q 006668          462 --------------------------------------------------------------------------------  461 (636)
Q Consensus       462 --------------------------------------------------------------------------------  461 (636)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 006668          462 --------------------------------------------------------------------------------  461 (636)
Q Consensus       462 --------------------------------------------------------------------------------  461 (636)
                                                                                                      
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                                                                            


Q ss_pred             -CcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChh-----hH
Q 006668          462 -MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE-----EE  535 (636)
Q Consensus       462 -~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~-----~~  535 (636)
                       .++||+|||-|+....    ..+.-+.|..|.|||++.+..|+..+||||++|+++||+||..-|+....+.     .-
T Consensus       390 di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             ceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence             0022333333322211    1122246888999999999999999999999999999999999998765432     11


Q ss_pred             HHHHHHHHH----HHhcCCc-----------chhh-------hhhhhhh--ccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          536 EAVLMDWVR----NLYGQGK-----------ICEA-------ADARIRQ--EFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       536 ~~~l~~~v~----~~~~~~~-----------~~~~-------~d~~l~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      ...+++.+.    .+...|+           +..+       +..-|.+  +++.++...+.+++.-||+.+|++|||+.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            112222111    1111222           1111       1111112  45778889999999999999999999999


Q ss_pred             HHHHHHhcC
Q 006668          592 EVVAVLVGQ  600 (636)
Q Consensus       592 evl~~L~~~  600 (636)
                      +.++.-+-.
T Consensus       546 ~cl~hPwLn  554 (590)
T KOG1290|consen  546 QCLKHPWLN  554 (590)
T ss_pred             HHhcCcccc
Confidence            999876544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=6.1e-27  Score=231.20  Aligned_cols=200  Identities=33%  Similarity=0.512  Sum_probs=173.2

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      |+..+.||+|++|.||++.....+    ..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTG----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCC----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            456789999999999999987644    78999999876544 5678899999999999999999999999889999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      ||+++++|.+++..... .+++..+..++.+++.+|.+||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999999854322 2889999999999999999999   7899999999999999999999999999998765543


Q ss_pred             CccccccccCCcccccccc-cCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006668          480 VPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGRRPLDM  528 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~  528 (636)
                      ........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1122335678899999988 666778899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=9.6e-28  Score=235.69  Aligned_cols=264  Identities=23%  Similarity=0.237  Sum_probs=195.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG----  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----  392 (636)
                      .+|...+.+|.|.. .|..+-..-.+    +.||+|+....  .....+...+|...+..++|+||++++.++.-.    
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLG----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhcc----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            45666778888888 66666544433    88999988654  223356778899999999999999999988543    


Q ss_pred             --ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          393 --NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                        .+.|+|||+| ..+|...+.    -.++-+++..|..|+++|++|||   +.+|+||||||+||++..+..+||.|||
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccch
Confidence              4689999999 789999884    45677888999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--------------hhhHH
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKG--------------EEEEE  536 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~--------------~~~~~  536 (636)
                      +|+..+..  -..+..+.|..|.|||++.+..+...+||||.||++.||++|..-|.+...              .....
T Consensus       164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            99876543  345567889999999999988899999999999999999999988763321              11111


Q ss_pred             HHHHHHHHHHhcCCc------chhhh-hhhhh--hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          537 AVLMDWVRNLYGQGK------ICEAA-DARIR--QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~------~~~~~-d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+...++.......      ..+.+ |...+  .+.+.-......+++.+||..||++|-+++++|++-
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence            112222222211100      00000 00001  111122345678899999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=6.8e-28  Score=251.80  Aligned_cols=196  Identities=26%  Similarity=0.428  Sum_probs=169.3

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------HHHHHHHHHHHHhccCC---CCceeeeecc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------QGLKEFMAEISSMGRLQ---HKNLVQMRGW  388 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---h~niv~l~g~  388 (636)
                      .|...+.||.|+||.|+.+.++...    ..|++|.+.+++-        ..+-..-.||.+|..|+   |+||++++++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENN----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cceeeeeccccccceEEEeeecccc----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            4778899999999999999998764    8899999976521        11112346999999997   9999999999


Q ss_pred             ccccceEEEEEeec-CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          389 CRKGNELMLVYDYM-PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       389 ~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      |++++.+||+||-. ++.+|.++|  ..+..+++.+...|++||+.|+++||   +.+|||||||-+||.++.+|-+||+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence            99999999999965 456888888  45678999999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLD  527 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~  527 (636)
                      |||.+.+...+..   ...+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999987766554   33679999999999999887 456899999999999999988885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=253.17  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=202.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ..|+...++|+|.||.|||++.+..+    +..|+|.++.+..+.++-.+.|+-+++..+|+|||.++|.+...+.+++.
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~----elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSG----ELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccC----chhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            45777899999999999999987766    89999999988877788888999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||.+|+|.+.-  .-...+++.++..+++..++||+|||   +.+-+|||||-.||++++.+.+|++|||.+-.+.. 
T Consensus        91 MEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita-  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-  164 (829)
T ss_pred             EEecCCCccccee--eecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh-
Confidence            9999999999865  34678999999999999999999999   89999999999999999999999999999876543 


Q ss_pred             CCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          479 EVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...+.....||+.|||||+..   .+.|..++|||+.|+...|+..-+.|....  .......++.  ...+...+    
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--hpmr~l~LmT--kS~~qpp~----  236 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--HPMRALFLMT--KSGFQPPT----  236 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--chHHHHHHhh--ccCCCCCc----
Confidence            223444578999999999643   456889999999999999998877774322  1111111111  00000000    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                          +.  -...-.+.+.++++.|+-.+|.+||+++.+++
T Consensus       237 ----lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 ----LK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----cc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                00  01122356788899999999999999987765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=222.31  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=188.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeecc-ccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGW-CRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~-~~~~~~~  395 (636)
                      .+.|.+.+.||+|.||.+-++.++.+.    ..+++|.++.... ..++|.+|...--.| .|.||+.-++. +...+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~----t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSK----TRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCc----eEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            456888899999999999999998876    8999999976633 357899998766666 58999998874 6677888


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc--CCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD--SEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~  473 (636)
                      ++++||+|.|+|..-+   ....+.+....+++.|+++||.|+|   ++++||||||.+||||-  +..++||+|||+.+
T Consensus        98 vF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999999877   3456888889999999999999999   89999999999999992  34579999999987


Q ss_pred             cccCCCCccccccccCCcccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVS-----SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ..+.    ......-+..|.+||+....     ...+.+|||.||++++.+++|..||+...........+..|     .
T Consensus       172 k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-----~  242 (378)
T KOG1345|consen  172 KVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-----L  242 (378)
T ss_pred             ccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-----h
Confidence            5432    11222346689999975543     24668999999999999999999998543333333333333     3


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .++..  .-++.-..++    +.++++..+-+.++|++|=-..++-++
T Consensus       243 ~rk~~--~~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  243 KRKNP--ALPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             cccCc--cCchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHH
Confidence            33332  1222223333    345566667799999999444444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1e-26  Score=272.47  Aligned_cols=198  Identities=18%  Similarity=0.253  Sum_probs=141.9

Q ss_pred             ccCCC-Cceeeeeccc-------cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcE
Q 006668          375 GRLQH-KNLVQMRGWC-------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV  446 (636)
Q Consensus       375 ~~l~h-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  446 (636)
                      +.++| +||++++++|       .+...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||   +++|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            34556 6888888887       3334678889988 77999999542 456999999999999999999999   8999


Q ss_pred             EeCCCCCCCEEEcC-------------------CCcEEEeccCCcccccCCCC---------------ccccccccCCcc
Q 006668          447 VHRDIKSGNILLDS-------------------EMRGRLGDFGLAKLYQQGEV---------------PNTTRVVGTLGY  492 (636)
Q Consensus       447 vHrDlkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y  492 (636)
                      +||||||+||||+.                   ++.+|++|||+++.......               ......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965                   44556666666653211000               001124588999


Q ss_pred             cccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHH
Q 006668          493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELV  572 (636)
Q Consensus       493 ~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  572 (636)
                      ||||++.+..++.++|||||||+||||++|..|+...      ...........         ..+..     .......
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~~~~~---------~~~~~-----~~~~~~~  241 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSLRHRV---------LPPQI-----LLNWPKE  241 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHHHHhh---------cChhh-----hhcCHHH
Confidence            9999999999999999999999999999998876421      01111111100         00100     1112334


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          573 LKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       573 ~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..++.+||+++|.+||+|.|+++.-
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhch
Confidence            5778899999999999999998754

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.6e-25  Score=227.88  Aligned_cols=276  Identities=25%  Similarity=0.395  Sum_probs=201.9

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccc
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRK  391 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~  391 (636)
                      .+....+.|...++||.|.|++||++.+... ....+.||+|.+......  ....+|++.|..+. +.||+++.+++..
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3445566788999999999999999998762 223489999999766443  55789999999995 9999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFG  470 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG  470 (636)
                      ++...+|+||++.....+++     ..++..++..++..+..||.++|   ..+||||||||+|+|.+. -+.-.|.|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence            99999999999999999987     34678899999999999999999   899999999999999964 4568999999


Q ss_pred             CcccccCCC-------------Cc------------------------------cccccccCCcccccccccC-CCCCCc
Q 006668          471 LAKLYQQGE-------------VP------------------------------NTTRVVGTLGYLAPELATV-SSPTSA  506 (636)
Q Consensus       471 la~~~~~~~-------------~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~s~~  506 (636)
                      ||...+...             ..                              ......||+||.|||++.. ...+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            996211000             00                              0001359999999997654 557889


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCCCChhhHHH---HHHHHH--H-HHhcCCc--chh---------hh------h-hhh--
Q 006668          507 SDVYSFGVVILEVACGRRPLDMGKGEEEEEA---VLMDWV--R-NLYGQGK--ICE---------AA------D-ARI--  560 (636)
Q Consensus       507 sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~---~l~~~v--~-~~~~~~~--~~~---------~~------d-~~l--  560 (636)
                      +||||-|||++-+++++.||.....+.....   .+..+.  + .....|+  +.+         ..      + ..+  
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999866543221111   111100  0 0011111  111         00      0 000  


Q ss_pred             -------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          561 -------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       561 -------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                             +....+..+..+++|..+|+..||.+|.|+++.|++--.
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence                   011111223478899999999999999999999987543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=1.7e-25  Score=231.13  Aligned_cols=269  Identities=19%  Similarity=0.227  Sum_probs=202.0

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC------CCceeeeecc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ------HKNLVQMRGW  388 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~g~  388 (636)
                      +....+|.+....|+|=|+.|.+|.....+    ..||||+|...... .+.=+.|+++|++|+      .-|.++|+..
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~----~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARG----QEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCC----CeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            345578888889999999999999876544    69999999766332 345567999999996      2479999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhcC-CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEE
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRL  466 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl  466 (636)
                      |...+++|||+|-+ ..+|.+.|.+- ..-.|....+..++.|+.-||..|.   ..+|+|.||||.|||+++.. .+||
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeee
Confidence            99999999999988 77999998543 2446888999999999999999999   89999999999999998754 5899


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH----
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW----  542 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~----  542 (636)
                      ||||.|........   +.+.-+.-|.|||++.+..|+...|+||.||.||||.||+.-|....... .-..+++.    
T Consensus       579 CDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk~  654 (752)
T KOG0670|consen  579 CDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGKF  654 (752)
T ss_pred             ccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCCC
Confidence            99999987765443   22334567999999999999999999999999999999999986543222 22222221    


Q ss_pred             ----------HHHHhcCC-----------------cchhhhh------hhhhh--ccCHHH---HHHHHHHHHHccCCCC
Q 006668          543 ----------VRNLYGQG-----------------KICEAAD------ARIRQ--EFEAEE---MELVLKLGLACCHPDS  584 (636)
Q Consensus       543 ----------v~~~~~~~-----------------~~~~~~d------~~l~~--~~~~~~---~~~l~~L~~~Cl~~dP  584 (636)
                                ...+++..                 .++..+.      ..+..  .++.++   ...+..|+..|+..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence                      11111100                 0111111      11111  133333   4567789999999999


Q ss_pred             CCCCCHHHHHHH
Q 006668          585 TRRPTMREVVAV  596 (636)
Q Consensus       585 ~~RPs~~evl~~  596 (636)
                      ++|.|..+.|++
T Consensus       735 ~KRit~nqAL~H  746 (752)
T KOG0670|consen  735 EKRITVNQALKH  746 (752)
T ss_pred             hhcCCHHHHhcC
Confidence            999999998865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.3e-24  Score=207.46  Aligned_cols=167  Identities=22%  Similarity=0.193  Sum_probs=125.5

Q ss_pred             CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcccc
Q 006668          405 GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT  484 (636)
Q Consensus       405 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  484 (636)
                      |+|.+++... ...+++.+++.++.|++.||+|||   +.+      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            7899998543 456999999999999999999999   444      999999999999999  99998654422     


Q ss_pred             ccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhcc
Q 006668          485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF  564 (636)
Q Consensus       485 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  564 (636)
                       ..||+.|||||++.+..++.++|||||||++|||++|+.||.......   ..+..+.......       ++... ..
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~-------~~~~~-~~  131 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPAD-------DPRDR-SN  131 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhccC-------Ccccc-cc
Confidence             258899999999999999999999999999999999999996442211   1111111111000       00000 01


Q ss_pred             CHHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          565 EAEEM--ELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       565 ~~~~~--~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....  ..+.+++.+||..||++||++.|+++++...
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            11112  2689999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=212.29  Aligned_cols=260  Identities=20%  Similarity=0.239  Sum_probs=194.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC----Cceeeeeccc-cccce
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH----KNLVQMRGWC-RKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~g~~-~~~~~  394 (636)
                      +|.+.++||+|+||.||++......   ...+|+|............+..|+.++..+..    +++.++++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7889999999999999999976543   36889998876533322256678888887763    5889999888 47778


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-----CcEEEecc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-----MRGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DF  469 (636)
                      .++||+.+ +.+|.++......+.++..+.+.|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            89999998 999999775555678999999999999999999999   8999999999999999754     46999999


Q ss_pred             CCccccc--CCC----Cc--c-ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 006668          470 GLAKLYQ--QGE----VP--N-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       470 Gla~~~~--~~~----~~--~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~  540 (636)
                      |+++...  ...    ..  . .....||..|+++++..+.+.+.+.|+||++.++.|++.|..||............. 
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~-  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE-  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH-
Confidence            9998322  111    01  1 123459999999999999999999999999999999999999996654322211111 


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ......             .........+..+.++...+-..+..++|....+...|...
T Consensus       251 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KDPRKL-------------LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHhhhh-------------ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            100000             00001122234455555555568999999999998887554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=7.8e-23  Score=214.91  Aligned_cols=170  Identities=18%  Similarity=0.222  Sum_probs=131.9

Q ss_pred             HHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceee-eec
Q 006668          314 LSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKNLVQ-MRG  387 (636)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~-l~g  387 (636)
                      ......+|...+.||+|+||+||+|.+....   +..+|||++...     .....+.+.+|+++|++++|+|+++ +++
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDP---GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCC---CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            4456678999999999999999999876422   156899987533     2233567899999999999999985 544


Q ss_pred             cccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCC-CCCCEEEcCCCcEEE
Q 006668          388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDI-KSGNILLDSEMRGRL  466 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl  466 (636)
                      +    +..+|||||+++++|.. +.  ...      ...++.+++++|.|||   +.+|+|||| ||+|||++.++.+||
T Consensus        90 ~----~~~~LVmE~~~G~~L~~-~~--~~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         90 T----GKDGLVRGWTEGVPLHL-AR--PHG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             c----CCcEEEEEccCCCCHHH-hC--ccc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEE
Confidence            2    45799999999999963 21  111      1467889999999999   899999999 999999999999999


Q ss_pred             eccCCcccccCCCC-------ccccccccCCcccccccccCCC
Q 006668          467 GDFGLAKLYQQGEV-------PNTTRVVGTLGYLAPELATVSS  502 (636)
Q Consensus       467 ~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~  502 (636)
                      +|||+++.......       ...+...++..|+|||++...+
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            99999987654321       1123467888999999877543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9.3e-24  Score=202.76  Aligned_cols=245  Identities=20%  Similarity=0.348  Sum_probs=191.9

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      -+|.....|+.|+|++...      .+++|+++..  +...-++|..|.-.|+-+.||||+.++|.|.....+.++..||
T Consensus       196 tkl~e~hsgelwrgrwqgn------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGN------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhccCCCcccccccccCc------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            4578889999999999763      4667777543  3333467889999999999999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN  482 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  482 (636)
                      |-|+|...|++...-..+-.+..+++.++|.|++|||+- ++-|.---|.+..|+||++..++|+--. ++.     ..+
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad-~kf-----sfq  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMAD-TKF-----SFQ  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccc-cee-----eee
Confidence            999999999888777888999999999999999999963 4445555799999999999998875211 111     011


Q ss_pred             ccccccCCcccccccccCCCCC---CccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          483 TTRVVGTLGYLAPELATVSSPT---SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       483 ~~~~~gt~~y~aPE~~~~~~~s---~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      .......+.||+||.++..+.+   .++|+|||++++|||.|...||......+..                 ++..-..
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----------------mkialeg  405 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----------------MKIALEG  405 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------------hhhhhcc
Confidence            1122457889999998876644   4789999999999999999999765332221                 1222334


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ++..+++....-+.+|+.-|...||.+||.+..|+-+|++
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            5555666666778888889999999999999999998875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.2e-20  Score=194.90  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=196.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH---HHHHHHHHHHHhccCCCC-ceeeeeccccccceEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ---GLKEFMAEISSMGRLQHK-NLVQMRGWCRKGNELM  396 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~g~~~~~~~~~  396 (636)
                      |...+.||.|+||.||++...       ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEE
Confidence            566788999999999999875       57888988765332   467889999999999988 7999999997777789


Q ss_pred             EEEeecCCCChhhhHhcCCC-CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKL  474 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~  474 (636)
                      ++++++.+++|.+++..... ..+.......++.|++.++.|+|   ..+++|||+||+||+++... .++++|||+++.
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            99999999999977633221 26889999999999999999999   78899999999999999988 799999999985


Q ss_pred             ccCCCCc-----cccccccCCcccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          475 YQQGEVP-----NTTRVVGTLGYLAPELATV---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       475 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      .......     ......|+..|+|||.+.+   .......|+||+|++++++++|..||...... .......+.+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~  230 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILEL  230 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhc
Confidence            5443322     2345689999999999887   57888999999999999999999997654321 0011111111111


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ... ....    .............+.+++..|+..+|..|.++.+....
T Consensus       231 ~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTP-SLAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCc-cccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            100 0000    00000002223567888889999999999999887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.4e-22  Score=223.41  Aligned_cols=262  Identities=21%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             CCceeeeecCceEEEeeeecCCCC-CCceEEEEEEe-ccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNN-NNSTEMAVKCV-NHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~-~~~~~vavK~~-~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ...+++|.|.+|.|+........+ ...+.+.+| . ..+... ....+..|+.+-..++|+|++..+..+.+.....-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            456889999999777766544331 111222232 1 222221 222366788888999999999998888877776667


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||+. +|..++..  ...++..++..+++|+..|++|||   ..+|.|||+|++|++++.++.+||+|||.+.....+
T Consensus       400 mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            999999 99998833  346888999999999999999999   899999999999999999999999999999866544


Q ss_pred             CC---ccccccccCCcccccccccCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          479 EV---PNTTRVVGTLGYLAPELATVSSPTS-ASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       479 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      -.   ......+|...|+|||.+...+|.. ..||||.|+++..|.+|+.||.............      .+..+.-..
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------NYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------ccccccccc
Confidence            32   3445578999999999999999877 5799999999999999999998764433221000      000000000


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .-    ........+.+...++.++|+.||.+|-|+.+|++.=+..
T Consensus       548 ~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  548 EG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             cC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            00    1112334556677888899999999999999999865443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=6.1e-21  Score=188.52  Aligned_cols=202  Identities=22%  Similarity=0.326  Sum_probs=170.8

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .|.+.++||+|.||..+.|+..-.+    +.||||.-+..++.  -++..|.+..+.| ..++|.+.+-+..++..-.||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nn----e~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNN----EPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cceeccccccCcceeeecccccccC----ceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            5788899999999999999876655    89999988765443  3556677777766 478999999888888888999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-----CCcEEEeccCCcc
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGLAK  473 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~  473 (636)
                      +|.+ |.||.|+. +-..+.++.+++..+++|++.-++|+|   ++.+|+|||||+|+||..     ...+.++|||+|+
T Consensus       103 idLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  103 IDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            9999 89999864 445678999999999999999999999   899999999999999953     3458999999999


Q ss_pred             cccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          474 LYQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       474 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                      .+.+...      .......||.+||+-....+.+.+.+.|+-|||-++.+.+.|..||+.....
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            8765432      2334467999999999999999999999999999999999999999876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.3e-21  Score=181.89  Aligned_cols=202  Identities=24%  Similarity=0.315  Sum_probs=169.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC-CceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH-KNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~l  397 (636)
                      ..|...++||+|.||.+|.|.....+    +.||+|.-+...+.  .++..|.++.+.|++ ..|..+..+..++..-.+
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~g----e~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSG----EEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCC----ceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            56888999999999999999977666    89999988765443  356678888888875 578888888888888999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~  474 (636)
                      |||.+ +.||.++.. -..+.++.++.+-++-|++.-++|+|   .++++||||||.|+|..   ....+.++||||++.
T Consensus        89 VMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhh
Confidence            99998 999999763 23567899999999999999999999   89999999999999995   445689999999986


Q ss_pred             ccCCC------CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 006668          475 YQQGE------VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKG  531 (636)
Q Consensus       475 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~  531 (636)
                      +.+..      ........||.+|.+-....+.+.+.+.|+-|+|.+|.++..|..||+....
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            64432      2233446799999999988888899999999999999999999999987643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.3e-20  Score=199.74  Aligned_cols=216  Identities=26%  Similarity=0.417  Sum_probs=163.1

Q ss_pred             hccCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCC
Q 006668          374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS  453 (636)
Q Consensus       374 l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp  453 (636)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...++++|+.||+|||+  +.-..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            4678999999999999999999999999999999999865 45678999999999999999999995  34449999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccCC-CCccccccccCCcccccccccCCC-------CCCccchHHHHHHHHHHHhCCCC
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPELATVSS-------PTSASDVYSFGVVILEVACGRRP  525 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~sDV~S~Gvll~ell~G~~P  525 (636)
                      +|+++|..+.+||.|||+....... .........-..-|.|||.+....       .+.+.||||||++++|+++...|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998776421 111111223456799999887742       46679999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          526 LDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       526 f~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      |......... ..+...+..  ..   .....+.+...  .+....+..++..||..+|++||++++|-..++..
T Consensus       158 ~~~~~~~~~~-~eii~~~~~--~~---~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDP-DEIILRVKK--GG---SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCCh-HHHHHHHHh--cC---CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9875433322 122222222  00   01111111111  13444789999999999999999999998887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-20  Score=210.05  Aligned_cols=261  Identities=24%  Similarity=0.278  Sum_probs=189.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHH---HHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLK---EFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~---~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++...+.||++.|=+|.+|+.+++      .|+||++-+.. .-.++   +-..|++ ...++|||.+++.-+-......
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG------~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG------LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc------eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence            567788999999999999997663      48888886543 33333   3344555 5566899999999998888888


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc--
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK--  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~--  473 (636)
                      |||-+|. .-+|.|.|  ..+..|..-+.+.|+.|+++||..+|   +.+|+|+|||.+||||+.-.-+.|+||---+  
T Consensus        97 ylvRqyv-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   97 YLVRQYV-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHH-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCc
Confidence            9999999 55888888  45667888899999999999999999   8999999999999999998889999997654  


Q ss_pred             cccCCCCcccccc----ccCCcccccccccCCC-----------CCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          474 LYQQGEVPNTTRV----VGTLGYLAPELATVSS-----------PTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       474 ~~~~~~~~~~~~~----~gt~~y~aPE~~~~~~-----------~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .+..+.....+-.    ..-..|+|||.+....           .+++.||||+||++.||++ |++||...        
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------  242 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------  242 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------
Confidence            2222222222111    2334799999765421           4678999999999999988 67778532        


Q ss_pred             HHHHHHHHHhcCCcchhhhhhh-hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCchhhhhhcccC
Q 006668          538 VLMDWVRNLYGQGKICEAADAR-IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARG  616 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~~~~~~~~~  616 (636)
                      .+..     |..|.   ..++. +.+..   +...++.|++.|++.||++|-++++.|+.=.|.   -.| +.+..+...
T Consensus       243 QL~a-----Yr~~~---~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~---~FP-~yFy~FL~~  307 (1431)
T KOG1240|consen  243 QLLA-----YRSGN---ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL---VFP-EYFYSFLYD  307 (1431)
T ss_pred             HHHh-----HhccC---ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc---ccH-HHHHHHHHH
Confidence            1111     11111   11111 11111   123688899999999999999999999988777   577 665555433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.1e-19  Score=175.74  Aligned_cols=141  Identities=18%  Similarity=0.163  Sum_probs=107.4

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--H-------H-----------------HHHHHHHHHhccC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--G-------L-----------------KEFMAEISSMGRL  377 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l  377 (636)
                      .+.||+|++|.||+|... ++    +.||+|+++.....  .       .                 .....|+..+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g----~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NG----EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL   76 (190)
T ss_pred             CCccccccceEEEEEECC-CC----CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            467999999999999975 33    89999999754211  0       0                 1123499999999


Q ss_pred             CCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEE
Q 006668          378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL  457 (636)
Q Consensus       378 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIl  457 (636)
                      .++++........  ...+|||||+++++|...+.  ....+++.+...++.|++.+|.|||+  ..+|+||||||+|||
T Consensus        77 ~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIl  150 (190)
T cd05147          77 VTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLL  150 (190)
T ss_pred             HHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEE
Confidence            8877644332221  22389999998887765532  23578899999999999999999932  789999999999999


Q ss_pred             EcCCCcEEEeccCCccccc
Q 006668          458 LDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       458 l~~~~~~kl~DFGla~~~~  476 (636)
                      ++ ++.++|+|||++....
T Consensus       151 i~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EE-CCcEEEEEccccccCC
Confidence            98 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=9.8e-20  Score=178.51  Aligned_cols=171  Identities=13%  Similarity=0.169  Sum_probs=130.6

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHH------HHHHHHHhccCCCCceeeeec
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKE------FMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~------~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ..++|...++||.|+||.||.... . +    ..+|+|.+.....   .....      +.+|+..+.+++|++|..+.+
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~-~----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d  102 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-D-Y----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND  102 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-C-C----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence            467899999999999999998654 2 2    5799999975422   22222      578999999999999999988


Q ss_pred             ccccc--------ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          388 WCRKG--------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       388 ~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ++...        +..+|||||++|.+|.++.      .++.    ....+++.+|..||   ..+++|||+||+||+++
T Consensus       103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~  169 (232)
T PRK10359        103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVS  169 (232)
T ss_pred             eeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEe
Confidence            75432        3589999999999998874      1222    24569999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA  520 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell  520 (636)
                      .++ ++|+|||..........  ..           .+.....+..++|+||||+.+..+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a--~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKA--KD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhh--HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            988 99999998875532211  10           0333444567899999999987553

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=1.4e-18  Score=175.38  Aligned_cols=232  Identities=21%  Similarity=0.285  Sum_probs=153.1

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCC----------Cceeeeec
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQH----------KNLVQMRG  387 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h----------~niv~l~g  387 (636)
                      +...+.||.|+++.||.++...++    +.+|+|.+...   ....++++++|.-.+..+.+          -.++..++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETG----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTT----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             EEEccccccCCceEEEEEEEccCC----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            445688999999999999988877    99999998654   33456778888877666443          12222222


Q ss_pred             cc---------ccc---c-----eEEEEEeecCCCChhhhHh---c--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCc
Q 006668          388 WC---------RKG---N-----ELMLVYDYMPNGSLNNWIF---G--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQV  445 (636)
Q Consensus       388 ~~---------~~~---~-----~~~lV~E~~~~gsL~~~l~---~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  445 (636)
                      ..         ...   .     ..+++|+-+ .++|.+++.   .  .....+....++.+..|+++.+++||   ..+
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~G  165 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYG  165 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcc
Confidence            21         111   1     246788877 778888752   1  12234555667778899999999999   899


Q ss_pred             EEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccC--------CCCCCccchHHHHHHHH
Q 006668          446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV--------SSPTSASDVYSFGVVIL  517 (636)
Q Consensus       446 ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~S~Gvll~  517 (636)
                      ++|+||||+|++++.+|.++|+||+.....+...  ..  ...+..|.+||....        ..++.+.|.|++|+++|
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE--EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCcee--ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            9999999999999999999999998776543311  11  234578999996644        24688999999999999


Q ss_pred             HHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCC
Q 006668          518 EVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR  587 (636)
Q Consensus       518 ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R  587 (636)
                      .|.||+.||.........                      ......+. +.++.+..|+..+|++||++|
T Consensus       242 ~lWC~~lPf~~~~~~~~~----------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADP----------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTS----------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccc----------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999765322111                      00122334 778889999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.4e-18  Score=168.33  Aligned_cols=141  Identities=18%  Similarity=0.183  Sum_probs=109.5

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--------------------------HHHHHHHHHHHhccC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--------------------------GLKEFMAEISSMGRL  377 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l  377 (636)
                      .+.||+|++|.||+|+.. ++    +.||||+++.....                          ....+..|...+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DG----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL   76 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CC----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            468999999999999875 33    89999999865210                          011235789999999


Q ss_pred             CCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCE
Q 006668          378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNI  456 (636)
Q Consensus       378 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NI  456 (636)
                      .|+++.....+...  ..+|||||++++++.....  ....++..+...++.+++.+|.+||   . .+|+||||||+||
T Consensus        77 ~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NI  149 (190)
T cd05145          77 YEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNI  149 (190)
T ss_pred             HhCCCCCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhE
Confidence            99987544333222  2489999998886544321  2345778899999999999999999   6 9999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccC
Q 006668          457 LLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~~~~  477 (636)
                      |++ ++.++|+|||++.....
T Consensus       150 ll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEE-CCCEEEEEcccceecCC
Confidence            999 88999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=6.4e-18  Score=162.33  Aligned_cols=186  Identities=16%  Similarity=0.078  Sum_probs=138.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH----HHHHHHHHHHhccCC-CCceeeeeccccccceE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG----LKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~  395 (636)
                      +.....|++|+||+||.+.-.+      .+++.+.+.......    ...+.+|+++|++|. |+++++++++    +..
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~~~------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRGGE------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             cccceeecCCCcceEEEeecCC------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            3456789999999999665422      678777776553311    125789999999995 5889999887    346


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCC-CCCCEEEcCCCcEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDI-KSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++|||+.+.+|.+.+.   .      ....++.|++.+|.++|   ..+|+|||| ||+|||++.++.++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~~---~------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPP---R------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhhh---h------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            99999999999875431   1      12357889999999999   899999999 79999999999999999999985


Q ss_pred             ccCCCCc----c--------ccccccCCcccccccccCC-CCC-CccchHHHHHHHHHHHhCCCCCCC
Q 006668          475 YQQGEVP----N--------TTRVVGTLGYLAPELATVS-SPT-SASDVYSFGVVILEVACGRRPLDM  528 (636)
Q Consensus       475 ~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDV~S~Gvll~ell~G~~Pf~~  528 (636)
                      .......    .        ..-...++.|+.|+..... ..+ ...+.++-|.-+|.++|++.|...
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            5433210    0        0012367888888843322 233 456889999999999999988643

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=7.6e-18  Score=164.53  Aligned_cols=137  Identities=21%  Similarity=0.256  Sum_probs=106.5

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-----CCCceeeeeccccccc--
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-----QHKNLVQMRGWCRKGN--  393 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~g~~~~~~--  393 (636)
                      ++..++||+|++|.||.  ++...    .. +||++........+++.+|+.+++.+     .||||++++|+++++.  
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~----~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDA----QR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCc----Ce-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            34568899999999996  44332    33 68888765444557889999999999     5799999999998763  


Q ss_pred             -e-EEEEEee--cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHH-HHHhccCCCcEEeCCCCCCCEEEcC----CCcE
Q 006668          394 -E-LMLVYDY--MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL-NYLHHGWDQVVVHRDIKSGNILLDS----EMRG  464 (636)
Q Consensus       394 -~-~~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NIll~~----~~~~  464 (636)
                       . +.+|+||  +++|+|.+++.+   ..+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..+
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcE
Confidence             3 4478999  667999999943   235544  35677888777 9999   899999999999999973    3479


Q ss_pred             EEeccCCc
Q 006668          465 RLGDFGLA  472 (636)
Q Consensus       465 kl~DFGla  472 (636)
                      +|+||+.+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995434

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=5.5e-19  Score=189.01  Aligned_cols=190  Identities=27%  Similarity=0.371  Sum_probs=156.9

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH--HHHHHHHHHHhccCC-CCceeeeeccccccceEEEEEeec
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+|+|.||.|+..+-. .+...+.-+|+|..++.+...  ......|-.++...+ ||.+|++.-.+..+...+++.+|.
T Consensus         1 vlg~g~~gkvfLvrk~-~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKA-GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHh-ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            3789999999976633 344556778888876542211  114455777888887 999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN  482 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  482 (636)
                      .+|.|...+  ......+......+...++-+++++|   +.+++|||+|++||+++.+|.+++.|||+++..-..+.. 
T Consensus        80 rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   80 RGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             ccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999998877  34455667777778889999999999   899999999999999999999999999999865443322 


Q ss_pred             ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006668          483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDM  528 (636)
Q Consensus       483 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~  528 (636)
                          +||..|||||++.  ......|.||||++++||++|..||..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                8999999999998  567889999999999999999999964

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2.7e-17  Score=166.22  Aligned_cols=197  Identities=22%  Similarity=0.307  Sum_probs=139.1

Q ss_pred             CCCceeeeeccccc---------------------------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHH
Q 006668          378 QHKNLVQMRGWCRK---------------------------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD  430 (636)
Q Consensus       378 ~h~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  430 (636)
                      +|||||++.+.|.+                           ...+|+||.-. .-+|.+|+.   ....+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~---~~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW---TRHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh---cCCCchHHHHHHHHH
Confidence            68888888876633                           23688999887 569999994   345566677789999


Q ss_pred             HHHHHHHHhccCCCcEEeCCCCCCCEEE--cCCC--cEEEeccCCcccccCCCC-----ccccccccCCcccccccccCC
Q 006668          431 VAEGLNYLHHGWDQVVVHRDIKSGNILL--DSEM--RGRLGDFGLAKLYQQGEV-----PNTTRVVGTLGYLAPELATVS  501 (636)
Q Consensus       431 ia~~L~yLH~~~~~~ivHrDlkp~NIll--~~~~--~~kl~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~  501 (636)
                      +++|+.|||   .++|.|||+|+.||||  |++.  .+.|+|||++-..+....     .......|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   8999999999999999  3333  478999998864332111     111223577889999987653


Q ss_pred             C------CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHH
Q 006668          502 S------PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKL  575 (636)
Q Consensus       502 ~------~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L  575 (636)
                      +      -..|.|.|+.|.+.||++..+.||........+.             ....+    ......+..++..+.+|
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-------------r~Yqe----~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-------------RTYQE----SQLPALPSRVPPVARQL  489 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-------------hhhhh----hhCCCCcccCChHHHHH
Confidence            3      2458999999999999999999997521110000             01111    11223445566677888


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHh
Q 006668          576 GLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       576 ~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      +...+++||.+|++..-....|+
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            88889999999999766555543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=5.2e-17  Score=185.42  Aligned_cols=197  Identities=21%  Similarity=0.210  Sum_probs=156.0

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeeeccccc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ---HKNLVQMRGWCRK  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~  391 (636)
                      ..-.+.|.+.+.||+|+||+||+|...+     ++.||+|.-+......+-   =-.+++.+|+   -+-|..+..++.-
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-----~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-----GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-----CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHcc
Confidence            3344568888999999999999999765     389999998876443211   1112233333   2345556666666


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-------CCCcE
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-------SEMRG  464 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-------~~~~~  464 (636)
                      .+..+||+||.+.|+|.+++.  ..+.++|.....++.|++..+..||   ..+|||+||||.|+||.       +...+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccce
Confidence            788899999999999999994  6788999999999999999999999   89999999999999993       34558


Q ss_pred             EEeccCCcccccCC-CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCC
Q 006668          465 RLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR  524 (636)
Q Consensus       465 kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~  524 (636)
                      +|+|||.+.-+.-- +.......++|-.+-.+|...+..+++..|.|.++.+++-|+.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999998533211 1124455788999999999999999999999999999999999873

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.70  E-value=4.1e-16  Score=154.09  Aligned_cols=164  Identities=18%  Similarity=0.143  Sum_probs=106.8

Q ss_pred             CCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecC
Q 006668           39 GTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF  118 (636)
Q Consensus        39 ~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~  118 (636)
                      ..++.+.|+|.+. ++.++||+...++.|+++|+.|+++.           +|+|+|+|.|.... ..+||||||+++|.
T Consensus        19 ~~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~~-----------~F~~~f~F~i~~~~-~~~gdG~af~~~~~   85 (218)
T cd07308          19 IGNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPAK-----------DFEIEVEFSIHGGS-GLGGDGFAFWYTEE   85 (218)
T ss_pred             cCCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccCC-----------CEEEEEEEEEeCCC-CCCCCEEEEEEECC
Confidence            3689999999997 77899998877899999999999984           89999999998753 45899999999986


Q ss_pred             CCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecC----Ccc--------ccccccCccccCC
Q 006668          119 TSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLN----NIE--------SAKHVPAGYYSSS  186 (636)
Q Consensus       119 ~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvn----s~~--------s~~~~~~~~~~~~  186 (636)
                      ..    ..|..+|.-      ...+-+||||||+.|.   +-..++|.+-+|    +..        +.....+.+-+. 
T Consensus        86 ~~----~~g~~~G~~------~~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~~~-  151 (218)
T cd07308          86 PG----SDGPLFGGP------DKFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFRNS-  151 (218)
T ss_pred             CC----CCCcccccC------CCCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccceeEecccC-
Confidence            33    234444442      1234599999999985   222234443322    221        111222211100 


Q ss_pred             CCCcceeeeecCCCeeEEEEEec----------------------ccccCCCceecceeeeecccc
Q 006668          187 RNESFVPVRMRNGQNIHAWIDFD----------------------GFSASKTNWIEARRVLAWSLS  230 (636)
Q Consensus       187 ~~~~~~~~~~~~g~~~~~~i~y~----------------------gfsastg~~~~~~~il~wsf~  230 (636)
                      .....+.+.+. ...+.+.+++.                      ||||+||...+.|+|++|.+.
T Consensus       152 ~~~~~~~I~y~-~~~l~v~i~~~~~~~~~~c~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         152 NAPTTLRISYL-NNTLKVDITYSEGNNWKECFTVEDVILPSQGYFGFSAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             CCCeEEEEEEE-CCEEEEEEeCCCCCCccEEEEcCCcccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence            01111122222 22233333220                      999999999999999999865

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=6.1e-18  Score=177.85  Aligned_cols=122  Identities=25%  Similarity=0.484  Sum_probs=108.2

Q ss_pred             eEEEEEeecCCCChhhhHhc-CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          394 ELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      .+++.|++|...+|.+||.. ......++...+.++.|++.|+.|      ++.+|||+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            58899999999999999963 334567888999999999999999      68899999999999999999999999999


Q ss_pred             ccccCCC-----CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh
Q 006668          473 KLYQQGE-----VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC  521 (636)
Q Consensus       473 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~  521 (636)
                      .......     ....+...||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8766554     334566789999999999999999999999999999999986

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=2e-16  Score=158.10  Aligned_cols=144  Identities=17%  Similarity=0.167  Sum_probs=110.7

Q ss_pred             CCCCceeeeecCceEEEeee-ecCCCCCCceEEEEEEeccCChH------------------------HHHHHHHHHHHh
Q 006668          320 GFSNDELLGSGGFGRVYKGT-LANNNNNNSTEMAVKCVNHDSKQ------------------------GLKEFMAEISSM  374 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~-~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l  374 (636)
                      .|++.+.||+|++|.||+|. ....+    ..||+|++......                        ....+..|+..+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSG----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCC----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            47888999999999999998 33333    89999998754210                        012356799999


Q ss_pred             ccCCCCc--eeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc-EEeCCC
Q 006668          375 GRLQHKN--LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV-VVHRDI  451 (636)
Q Consensus       375 ~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDl  451 (636)
                      .++.+.+  +.+++++    ...++||||+++++|..++..  ...+...+...++.|++.+|++||   ..+ ++||||
T Consensus       105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Di  175 (237)
T smart00090      105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDL  175 (237)
T ss_pred             HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCC
Confidence            9997533  4445543    234899999999888776422  234556677899999999999999   788 999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCcccccC
Q 006668          452 KSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       452 kp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||+||+++ ++.++|+|||++.....
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999 88999999999875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.7e-16  Score=156.17  Aligned_cols=134  Identities=19%  Similarity=0.309  Sum_probs=111.4

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +.||+|++|.||+|...+      ..+++|.......        .....+.+|+.++..++|+++.....++...+..+
T Consensus         2 ~~l~~G~~~~vy~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI   75 (211)
T ss_pred             cccccCceEEEEEEeeCC------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence            579999999999998732      5788887654311        11245778999999999999888777777777889


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +||||+++++|.+++...     .+ ++..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||++..
T Consensus        76 lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999998432     12 78899999999999999   89999999999999999 78899999998875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2e-16  Score=177.43  Aligned_cols=143  Identities=20%  Similarity=0.264  Sum_probs=114.0

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEe-ccC-------ChHHHHHHHHHHHHhccCCCCceee
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHD-------SKQGLKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      ........|...++||+|+||.||+|.+...      .+++|+. ...       .....+.+.+|++++..++|++++.
T Consensus       327 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        327 KEEEVKRRKIPDHLIGKGAEADIKKGEYLGR------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             cccccccccCccceeccCCcEEEEEEeecCc------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            3334445567789999999999999987553      2333322 111       1112356789999999999999998


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      ...++......++||||+++++|.+++.          ....++.+++.+|.|||   +.+++||||||+|||+ +++.+
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcE
Confidence            8877777777899999999999999883          45779999999999999   8999999999999999 67899


Q ss_pred             EEeccCCcccc
Q 006668          465 RLGDFGLAKLY  475 (636)
Q Consensus       465 kl~DFGla~~~  475 (636)
                      +|+|||+++..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999999753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=3.3e-16  Score=152.66  Aligned_cols=130  Identities=20%  Similarity=0.278  Sum_probs=104.7

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--------KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .||+|++|.||+|.+..      ..+++|......        .....++.+|++++..++|+++.....++...+..++
T Consensus         1 ~ig~G~~~~vy~~~~~~------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeecCC------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence            48999999999998533      678888865321        1123567789999999998876655555555667799


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ||||+++++|.+++....   .      .++.+++.+|.+||   +.+++|+|++|.||+++ ++.++++|||++..
T Consensus        75 v~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999873221   0      78999999999999   89999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=6.8e-16  Score=150.49  Aligned_cols=145  Identities=17%  Similarity=0.195  Sum_probs=110.8

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH----------------------HHHHHHHH
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ----------------------GLKEFMAE  370 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E  370 (636)
                      ++......|...+.||+|+||.||++.... +    +.||||++......                      .......|
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~-g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   83 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPD-G----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKE   83 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCC-C----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHH
Confidence            333443447778999999999999998753 3    78999987643200                      01135678


Q ss_pred             HHHhccCCCC--ceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEe
Q 006668          371 ISSMGRLQHK--NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVH  448 (636)
Q Consensus       371 i~~l~~l~h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  448 (636)
                      +..+..+.|+  .+.+.++.    ...++||||+++++|.....        ......++.+++.++.++|   ..+++|
T Consensus        84 ~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh---~~gi~H  148 (198)
T cd05144          84 FAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAY---KHGIIH  148 (198)
T ss_pred             HHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHH---HCCCCc
Confidence            8888888877  44555543    34589999999999977541        1345678999999999999   799999


Q ss_pred             CCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          449 RDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       449 rDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||+||++++++.++|+|||++.....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=2.9e-16  Score=175.88  Aligned_cols=219  Identities=23%  Similarity=0.289  Sum_probs=147.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..+|+.+++|..|+||.||..+++...    .++|+| +++..-     +.+.  ++.....|.+|              
T Consensus        82 e~df~~IklisngAygavylvrh~~tr----qrfa~k-iNkq~l-----ilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETR----QRFAMK-INKQNL-----ILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccc----cchhhc-ccccch-----hhhc--cccccCCccee--------------
Confidence            457999999999999999999887665    677773 333211     1110  22222334333              


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                             |+=.+.+  +.-+.++..        ++.+++|||   +.+|+|||+||.|.+|+.-|.+|+.|||+.+....
T Consensus       136 -------gDc~tll--k~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -------GDCATLL--KNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -------chhhhhc--ccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                   2222223  122334333        278999999   89999999999999999999999999999863211


Q ss_pred             C--------CCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          478 G--------EVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       478 ~--------~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      .        ...      ....++||+.|+|||++....|...+|.|++|+|+||.+-|..||.....++.....+.+.+
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            1        111      12346899999999999999999999999999999999999999987654443333322211


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                             .         ..+-+...+.+..+++.+.|+.+|..|--....+++-+
T Consensus       276 -------~---------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~  314 (1205)
T KOG0606|consen  276 -------E---------WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQ  314 (1205)
T ss_pred             -------c---------ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhh
Confidence                   0         01112233445667777789999999965545544433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=8.9e-15  Score=134.62  Aligned_cols=136  Identities=21%  Similarity=0.187  Sum_probs=114.7

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC--CceeeeeccccccceEEEEEe
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH--KNLVQMRGWCRKGNELMLVYD  400 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~E  400 (636)
                      +.+.||+|.++.||++....      ..+++|.......  ...+.+|+..+..++|  .++++++++....+..+++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            45789999999999999643      5799999876543  4578889999999976  589999999888888999999


Q ss_pred             ecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       401 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |++++.+..+         +......++.+++++|++||.....+++|+|++|.||++++.+.+++.|||.++..
T Consensus        74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9988877653         56677889999999999999543368999999999999999899999999988753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=2.6e-14  Score=137.74  Aligned_cols=138  Identities=19%  Similarity=0.218  Sum_probs=96.2

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHH----------------------HHHHHHhccCCC
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEF----------------------MAEISSMGRLQH  379 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~h  379 (636)
                      .+.||+|+||.||+|... ++    +.||||++......  ....+                      ..|...+.++.+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   76 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DG----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE   76 (187)
T ss_pred             CcccccccceeEEEEECC-CC----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence            467999999999999875 23    78999998754221  11111                      244555555543


Q ss_pred             Cc--eeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCE
Q 006668          380 KN--LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNI  456 (636)
Q Consensus       380 ~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NI  456 (636)
                      ..  +.+.+++    ...++||||++++.+........  .. ..+...++.+++.++.++|   . .+|+||||||+||
T Consensus        77 ~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          77 AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNI  146 (187)
T ss_pred             cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence            32  3344433    23589999999855432211110  01 1677889999999999999   6 9999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccC
Q 006668          457 LLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~~~~  477 (636)
                      +++ ++.++|+|||.+.....
T Consensus       147 li~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEE-CCcEEEEECcccccccC
Confidence            999 89999999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=4.8e-14  Score=141.25  Aligned_cols=136  Identities=17%  Similarity=0.176  Sum_probs=104.8

Q ss_pred             ceeee-ecCceEEEeeeecCCCCCCceEEEEEEeccCC-------------hHHHHHHHHHHHHhccCCCCce--eeeec
Q 006668          324 DELLG-SGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-------------KQGLKEFMAEISSMGRLQHKNL--VQMRG  387 (636)
Q Consensus       324 ~~~LG-~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~g  387 (636)
                      ...|| .||.|+||+.....      ..+++|++....             ......+.+|+.++.+|+|++|  ++.++
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPG------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             CceeecCCCCccEEEEEeCC------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            45788 89999999987643      678998885321             1223467889999999998885  67777


Q ss_pred             cccccc----eEEEEEeecCC-CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          388 WCRKGN----ELMLVYDYMPN-GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       388 ~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +.....    ..++|+|++++ .+|.+++..   ..++..    .+.+++.+|.+||   ..+|+||||||.|||++.++
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence            644322    23599999997 699988732   234433    3678999999999   89999999999999999988


Q ss_pred             cEEEeccCCcccc
Q 006668          463 RGRLGDFGLAKLY  475 (636)
Q Consensus       463 ~~kl~DFGla~~~  475 (636)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.9e-15  Score=169.43  Aligned_cols=259  Identities=23%  Similarity=0.299  Sum_probs=191.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCC-CCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~  395 (636)
                      ..|...+.||+|.|+.|-.......   ....+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~---~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRD---PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCC---CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            3466677799999999977665332   23677777776553  233344556777777776 99999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~  474 (636)
                      +++.||..++++.+-+........+....-.++.|+..++.|+|.  +.++.||||||+|.+++..+ ..+++|||+|..
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999999887732222256667777899999999999995  68999999999999999999 999999999987


Q ss_pred             ccC--CCCcccccccc-CCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          475 YQQ--GEVPNTTRVVG-TLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       475 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      +..  +........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++.......   ....|....    
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~----  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK----  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc----
Confidence            765  33444455678 9999999988874 456678999999999999999999976643321   111121110    


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                             ................++..+|+..+|..|.+.+++-..
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                   000011112233456667777888999999998887543

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.47  E-value=2.2e-12  Score=128.50  Aligned_cols=94  Identities=16%  Similarity=0.089  Sum_probs=74.1

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      .++.+.|+|.+. .+.++||++...+.|+++|+.|+++-           +|+|+|+|.|.+......||||||+++...
T Consensus        20 ~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~~-----------~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~   87 (248)
T cd06901          20 PLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYLR-----------DWEMHVHFKVHGSGKNLFGDGFAIWYTKER   87 (248)
T ss_pred             CCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccCC-----------CEEEEEEEEEeCCCCCCCCCEEEEEEEcCC
Confidence            689999999997 56899999887789999999999984           799999999998655678999999999753


Q ss_pred             CCCCCCcCcccccccCCCCCCCCceEEEEeecCCCC
Q 006668          120 SPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNP  155 (636)
Q Consensus       120 ~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~  155 (636)
                      .    ..|..+|--+ .-+|     +||-|||+.|.
T Consensus        88 ~----~~G~~fG~~~-~f~G-----l~I~~Dt~~n~  113 (248)
T cd06901          88 M----QPGPVFGSKD-NFHG-----LAIFFDTYSNQ  113 (248)
T ss_pred             C----ccCcccccCC-CCce-----EEEEEECCCCC
Confidence            2    2333333322 1122     79999999885

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=2.7e-12  Score=139.72  Aligned_cols=145  Identities=19%  Similarity=0.264  Sum_probs=100.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHH----------------------------------
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK----------------------------------  365 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------  365 (636)
                      .|+ .+.||.|.+|.||+|+++++     +.||||+.++...+.+.                                  
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G-----~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~  192 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDG-----KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK  192 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCC-----CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence            344 36899999999999998753     78999998765322111                                  


Q ss_pred             ------HHHHHHHHhccCC----CCceeeeeccc-cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHH-
Q 006668          366 ------EFMAEISSMGRLQ----HKNLVQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE-  433 (636)
Q Consensus       366 ------~~~~Ei~~l~~l~----h~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-  433 (636)
                            +|..|...+.+++    |.+-+.+-..+ ...+..+|||||++|++|.++...... ..   .+..++..++. 
T Consensus       193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARS  268 (437)
T ss_pred             HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHH
Confidence                  1334555554442    22222222222 223457999999999999987632211 11   34557776666 


Q ss_pred             HHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       434 ~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      .+..+|   ..+++|+|+||.||+++.++.++++|||++.....
T Consensus       269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            467888   79999999999999999999999999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=7.7e-13  Score=131.48  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=139.4

Q ss_pred             HHhccCCCCceeeeecccccc-----ceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCC
Q 006668          372 SSMGRLQHKNLVQMRGWCRKG-----NELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQ  444 (636)
Q Consensus       372 ~~l~~l~h~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  444 (636)
                      ..|-++-|.|||++..|+.+.     ....++.|||..|+|..+|.+  +....+......+++-||..||.|||+ +.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            445556799999999987543     457899999999999999964  234567788888999999999999995 589


Q ss_pred             cEEeCCCCCCCEEEcCCCcEEEeccCCcccccC---CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh
Q 006668          445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ---GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC  521 (636)
Q Consensus       445 ~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~  521 (636)
                      .|+|+++.-+-|++..++-+|++----......   ........-.+-++|.+||+-...+.+..+|||+||+..+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888753211110000   00001111246789999998888888889999999999999987


Q ss_pred             CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          522 GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       522 G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      +..--.........+.....-         +. ..           +..+=..++.+|++..|..||+|++++.+
T Consensus       278 lEiq~tnseS~~~~ee~ia~~---------i~-~l-----------en~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANV---------II-GL-----------ENGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCcceeehhhhhhhh---------ee-ec-----------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence            764322111110001000000         00 00           01112345667999999999999988765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=1.2e-12  Score=140.70  Aligned_cols=250  Identities=27%  Similarity=0.323  Sum_probs=181.3

Q ss_pred             CCCCceeeee--cCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCC-CCceeeeeccccccce
Q 006668          320 GFSNDELLGS--GGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE  394 (636)
Q Consensus       320 ~f~~~~~LG~--G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~  394 (636)
                      .|...+.+|.  |.+|.||++....  ......+|+|.-+....  ..-..=.+|+....+++ |+|.++....++.++.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~--~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTN--SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hcccccccccCCCCCceeecccCCc--ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            4566788999  9999999998722  22337889988543322  22222345666666664 9999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHH----HHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEecc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE----GLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DF  469 (636)
                      .++-.|++ +.+|.++.+.. ...++....+.+..+...    ||.++|   ...++|-|+||.||++..+ ..++++||
T Consensus       193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence            99999999 68888887432 345777788888888888    999999   8999999999999999999 88999999


Q ss_pred             CCcccccCCCCcc----ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          470 GLAKLYQQGEVPN----TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       470 Gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |+...+.......    ..+..|...|++||+.++ -++..+|+|++|.++.+..++..........        .|.. 
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~-  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ-  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc-
Confidence            9998877655322    223357789999998774 5688999999999999999887766443111        0111 


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                       ...+.        +..++...-..++...+..+++.+|..|++.+.+..
T Consensus       338 -~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 -LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             11111        122222222344555778899999999998877664

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.23  E-value=4.2e-10  Score=110.79  Aligned_cols=165  Identities=13%  Similarity=0.065  Sum_probs=106.6

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      .+..+.|+|.+. ...++||++..++.|.++.+.|++.-           +|+..|+|.|.... ...||||||.++...
T Consensus        22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~~-----------~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~   88 (225)
T cd06902          22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSFE-----------NWEVEVTFRVTGRG-RIGADGLAIWYTKER   88 (225)
T ss_pred             CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCCC-----------CEEEEEEEEEecCC-CCCCCEEEEEEECCC
Confidence            679999999986 77899999888899999999999853           69999999998653 346899999999753


Q ss_pred             CCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecC-Cccccc-----------cccCccccCCC
Q 006668          120 SPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLN-NIESAK-----------HVPAGYYSSSR  187 (636)
Q Consensus       120 ~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvn-s~~s~~-----------~~~~~~~~~~~  187 (636)
                      .    ..|..+|.-+. -+|     +||.|||+.|.+  ..+.+.|-+-+| ..+...           ...+. |.++.
T Consensus        89 ~----~~G~~~G~~~~-f~G-----l~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~-~rn~~  155 (225)
T cd06902          89 G----EEGPVFGSSDK-WNG-----VGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRD-FRNKP  155 (225)
T ss_pred             C----CCCCccCCCCc-ccE-----EEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccccceEEEe-ccCCC
Confidence            2    23444444221 122     799999998753  223345533332 111111           11111 11111


Q ss_pred             CCcceeeeecCCCeeEEEEEe---------c----------------ccccCCCceecceeeeeccccC
Q 006668          188 NESFVPVRMRNGQNIHAWIDF---------D----------------GFSASKTNWIEARRVLAWSLSD  231 (636)
Q Consensus       188 ~~~~~~~~~~~g~~~~~~i~y---------~----------------gfsastg~~~~~~~il~wsf~~  231 (636)
                      ......+++.. ..+.+.|+.         .                ||||+||...+.|+||+|+|.+
T Consensus       156 ~p~~~rI~Y~~-~~l~V~~d~~~~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~s  223 (225)
T cd06902         156 YPVRAKITYYQ-NVLTVSINNGFTPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTFS  223 (225)
T ss_pred             CCeEEEEEEEC-CeEEEEEeCCcCCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEec
Confidence            11112233322 335555542         1                9999999999999999999874

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=3.3e-11  Score=113.93  Aligned_cols=131  Identities=21%  Similarity=0.201  Sum_probs=94.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV-QMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+.|+.|.++.||+++...      ..+++|....... ....+..|+.++..+.+.+++ +++.+..  ...++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~------~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVAN------KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEECC------eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence            3678999999999988642      6899998765532 123456788888888665544 4554432  3357999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC--CCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW--DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ++.++.+.-          .....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        74 ~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            998876430          112346789999999999321  12369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=1.2e-10  Score=126.57  Aligned_cols=162  Identities=17%  Similarity=0.196  Sum_probs=125.6

Q ss_pred             eEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHH
Q 006668          349 TEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL  428 (636)
Q Consensus       349 ~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~  428 (636)
                      .+|.|...+...........+-++.|+.||||||++++...+..+.+|||+|-+  ..|..++.     .++.......+
T Consensus        38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk-----~l~~~~v~~Gl  110 (690)
T KOG1243|consen   38 GPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLK-----ELGKEEVCLGL  110 (690)
T ss_pred             CceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHH-----HhHHHHHHHHH
Confidence            677777777665544455677889999999999999999999999999999987  46777762     23456677788


Q ss_pred             HHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccc
Q 006668          429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASD  508 (636)
Q Consensus       429 ~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sD  508 (636)
                      .||+.||.+||+  +.+++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+....  ...|
T Consensus       111 ~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D  185 (690)
T KOG1243|consen  111 FQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSID  185 (690)
T ss_pred             HHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchh
Confidence            999999999996  78999999999999999999999999998864432221 111112233567777655433  3569


Q ss_pred             hHHHHHHHHHHHhC
Q 006668          509 VYSFGVVILEVACG  522 (636)
Q Consensus       509 V~S~Gvll~ell~G  522 (636)
                      .|-||++++|++.|
T Consensus       186 ~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  186 SWGLGCLIEELFNG  199 (690)
T ss_pred             hhhHHHHHHHHhCc
Confidence            99999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.18  E-value=3.1e-11  Score=133.01  Aligned_cols=147  Identities=18%  Similarity=0.226  Sum_probs=91.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH------------------------------H----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG------------------------------L----  364 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~----  364 (636)
                      ..|+. +.||+|.+|.||+|++++++    +.||||+..+...+.                              .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNG----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCC----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            45776 78999999999999998744    899999997652211                              0    


Q ss_pred             H------HHHHHHHHhccCC----CCceeeeeccccc-cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHH
Q 006668          365 K------EFMAEISSMGRLQ----HKNLVQMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE  433 (636)
Q Consensus       365 ~------~~~~Ei~~l~~l~----h~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~  433 (636)
                      +      ++.+|...+.+++    +.+.+.+=..+.+ ....+|||||++|+.|.++-.-. ....+   +..++...+.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d---~~~la~~~v~  270 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTD---MKLLAERGVE  270 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCC---HHHHHHHHHH
Confidence            1      1233443333332    2222222121111 24567999999999998753111 11111   1122222222


Q ss_pred             H-HHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEeccCCcccccC
Q 006668          434 G-LNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLGDFGLAKLYQQ  477 (636)
Q Consensus       434 ~-L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~~~~  477 (636)
                      . +.-++   ..+++|+|+||.||+++.++    ++++.|||++...+.
T Consensus       271 ~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            1 22233   68999999999999999888    999999999976644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.11  E-value=5.1e-10  Score=107.72  Aligned_cols=143  Identities=15%  Similarity=0.131  Sum_probs=99.9

Q ss_pred             eeeeecCceEEEeeeecCC--CCCCceEEEEEEeccCC----------------------hHHHHHHH----HHHHHhcc
Q 006668          325 ELLGSGGFGRVYKGTLANN--NNNNSTEMAVKCVNHDS----------------------KQGLKEFM----AEISSMGR  376 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~--~~~~~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~  376 (636)
                      ..||.|.-+.||.|.-.++  +...+..+|||+.+...                      ....+.+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4689999999999975431  01134789999885320                      00112233    78999988


Q ss_pred             CCC--CceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHH-hccCCCcEEeCCCCC
Q 006668          377 LQH--KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL-HHGWDQVVVHRDIKS  453 (636)
Q Consensus       377 l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp  453 (636)
                      +..  -++.+++++    ..-+|||||+.+..+..-..  ....++.++...+..+++.+|..| |   ..+++|+||++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            864  356666654    45689999997654422111  122345566778889999999999 7   78999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccC
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      .|||++ ++.+.|+|||.+...++
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCCC
Confidence            999997 46799999998876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=1.3e-09  Score=100.90  Aligned_cols=144  Identities=19%  Similarity=0.241  Sum_probs=106.6

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEec-cC-------ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HD-------SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ...+|-||+-+.|+++.+..      +...||.-. +.       .+-..+...+|++.|.+++--.|.-..-++.+...
T Consensus        11 ~l~likQGAEArv~~~~~~G------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSG------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG   84 (229)
T ss_pred             cceeeeccceeeEeeeccCC------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC
Confidence            56889999999999998865      555565432 21       11223456789999998876565555555556666


Q ss_pred             EEEEEeecCC-CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---cEEEeccC
Q 006668          395 LMLVYDYMPN-GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---RGRLGDFG  470 (636)
Q Consensus       395 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG  470 (636)
                      -.|+|||+++ -++.+++...-......+....++..|-+.+.-||   ...|+|+||..+||+|..++   .+.++|||
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeec
Confidence            7889999965 48888886554444444455789999999999999   89999999999999996544   35899999


Q ss_pred             Ccccc
Q 006668          471 LAKLY  475 (636)
Q Consensus       471 la~~~  475 (636)
                      ++...
T Consensus       162 ls~~s  166 (229)
T KOG3087|consen  162 LSSVS  166 (229)
T ss_pred             chhcc
Confidence            98643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=1.2e-10  Score=125.38  Aligned_cols=252  Identities=19%  Similarity=0.198  Sum_probs=174.2

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHH--HHHHHHhccC-CCCceeeeeccccc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF--MAEISSMGRL-QHKNLVQMRGWCRK  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~h~niv~l~g~~~~  391 (636)
                      ...+..|.....||.|.|+.|++...+..+   +..+++|...........+.  ..|+.+...+ .|.++++....+..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~---~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEG---DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCC---CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence            334567888999999999999988755222   27888887765532222221  3455555444 48888887777777


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFG  470 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG  470 (636)
                      .+..++--|||.++++...+  .-...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccc
Confidence            77788999999999988765  33456788889999999999999999   8999999999999999876 888999999


Q ss_pred             CcccccCCCCccccccccCCccc--ccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYL--APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ++..+.-   .... ....-+++  +++......+-.+.|+||||.-+.|.+++..--....          .|.     
T Consensus       413 ~~t~~~~---~~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~-----  473 (524)
T KOG0601|consen  413 CWTRLAF---SSGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSL-----  473 (524)
T ss_pred             cccccce---eccc-ccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cce-----
Confidence            9864211   1111 12233444  6666777788899999999999999988763322110          010     


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .+....-+.+..     ..+.+..+...+..+++..||.+.++..+...+
T Consensus       474 --~i~~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  474 --TIRSGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --eeecccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence              011111111111     114456666778899999999998887766544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=1.2e-09  Score=101.68  Aligned_cols=131  Identities=18%  Similarity=0.243  Sum_probs=99.0

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChH------HHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQ------GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ..+++|+-+.+|.+.+.+      ..+++|.-.+.  ...      ....-.+|..++.+++--.|.-.+=+..+.+...
T Consensus         2 ~~i~~GAEa~i~~~~~~g------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeeccC------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence            357899999999997644      34555543222  111      1234567999999987666655555556677789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      |+|||+++..|.+++...         ...++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        76 I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999999999998432         3567778888888899   89999999999999998775 99999999974

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=1.7e-09  Score=106.64  Aligned_cols=143  Identities=18%  Similarity=0.227  Sum_probs=111.1

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCC--ceeeeecccccc---ceEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHK--NLVQMRGWCRKG---NELML  397 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~--niv~l~g~~~~~---~~~~l  397 (636)
                      .+.|+.|..+.||++...+     +..+++|+...... ....++..|..+++.+++.  ++.+++.++...   +..++
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             ceecCCCccceEEEEEecC-----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence            3678999999999998754     26789998765432 1345678899999998764  457778877664   36689


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG------------------------------------  441 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------  441 (636)
                      ||||+++.++.+.+.   ...++.+++..++.+++++|.+||+.                                    
T Consensus        78 v~e~i~G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          78 VMERVDGRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             EEEEeCCEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            999999998887652   14577888889999999999999841                                    


Q ss_pred             -----------------CCCcEEeCCCCCCCEEEcC--CCcEEEeccCCccc
Q 006668          442 -----------------WDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKL  474 (636)
Q Consensus       442 -----------------~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~  474 (636)
                                       ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1356899999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=1.5e-08  Score=107.10  Aligned_cols=170  Identities=21%  Similarity=0.318  Sum_probs=130.6

Q ss_pred             CceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccc----ccceEEEEEeecCC-C
Q 006668          331 GFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR----KGNELMLVYDYMPN-G  405 (636)
Q Consensus       331 ~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~~~~lV~E~~~~-g  405 (636)
                      .-.+.||+....++    ..|++|++.....+.......-++..+++.|.|+|++..++.    .+..+++||+|.|+ +
T Consensus       288 ~~~Ttyk~~s~~DG----~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDG----NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCC----ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            34678888866555    789999995554444334455678889999999999999876    24568999999987 6


Q ss_pred             ChhhhHhcCC-------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          406 SLNNWIFGKP-------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       406 sL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      +|.++-+...             ....+++.+|.++.|+..||.++|   +.|+..+-|.+++|+++.+.+++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccce
Confidence            7877654322             223577899999999999999999   799999999999999999999999998887


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCC
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP  525 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~P  525 (636)
                      .....+..               |.+.   --.+-|.=.||.+++.|.||..-
T Consensus       441 Dvl~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  441 DVLQEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eeecCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            76655431               1111   12357999999999999999644

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=8.3e-10  Score=124.89  Aligned_cols=249  Identities=22%  Similarity=0.220  Sum_probs=165.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEec---cCChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~---~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ...+.+.+-+-+|.++.++.++-...+    ...+.|...   .-.+...+....+-.++-..++|-++...--+.-...
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sg----h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSG----HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccc----cccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            345666677788889988877644433    112222221   1111122223333333333456767766555555678


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .+|+++|..+++|...|+..  ...+.+-.+..+..+..+++|||   ...+.|||++|.|.++..++..++.|||....
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             cchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccc
Confidence            89999999999999988543  35666777778888999999999   67799999999999999999999999984321


Q ss_pred             cc-------C--------------C---------CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCC
Q 006668          475 YQ-------Q--------------G---------EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR  524 (636)
Q Consensus       475 ~~-------~--------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~  524 (636)
                      ..       .              .         +........+|+.|.+||...+.......|.|+.|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            10       0              0         0011233568999999999999999999999999999999999999


Q ss_pred             CCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          525 PLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       525 Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      ||.........+.+         ..+.+.       ...-+.+.......++..-+..+|.+|-.|.
T Consensus      1034 p~na~tpq~~f~ni---------~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENI---------LNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhhhcc---------ccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99765333211111         111111       0111223334455666667788888887776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=2.8e-08  Score=100.96  Aligned_cols=141  Identities=16%  Similarity=0.139  Sum_probs=101.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHH----------HHHHHHHHhccCCCCce--eeeeccccc
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLK----------EFMAEISSMGRLQHKNL--VQMRGWCRK  391 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~Ei~~l~~l~h~ni--v~l~g~~~~  391 (636)
                      +.+-......|++..+.+      +.+.||........ ..+          .+.+|...+.+|...+|  ++++++.+.
T Consensus        28 e~v~~~~~rrvvr~~~~g------~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~  101 (268)
T PRK15123         28 EVFRELEGRRTLRFELAG------KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER  101 (268)
T ss_pred             cEEecCCCceEEEEEECC------EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence            455555555677766533      68999977544321 122          36788888888854443  344445432


Q ss_pred             -----cceEEEEEeecCCC-ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-----
Q 006668          392 -----GNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-----  460 (636)
Q Consensus       392 -----~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-----  460 (636)
                           ....+||+|++++. +|.+++........+...+..++.+++..+.-||   ..+|+|+|++++|||++.     
T Consensus       102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCC
Confidence                 23578999999876 8999884322344566778899999999999999   899999999999999975     


Q ss_pred             --CCcEEEeccCCccc
Q 006668          461 --EMRGRLGDFGLAKL  474 (636)
Q Consensus       461 --~~~~kl~DFGla~~  474 (636)
                        +..+.++||+.++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              56899999998864

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=98.81  E-value=6.8e-08  Score=95.89  Aligned_cols=95  Identities=17%  Similarity=0.141  Sum_probs=68.5

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      .+..+.|+|.+. ++.++||++..++.|.++.+.|++.-           +|+..|+|.|........||||||.++...
T Consensus        22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~~-----------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~   89 (229)
T PF03388_consen   22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPFD-----------NWEIEFTFRISGQEKGLGGDGMAFWYTKDP   89 (229)
T ss_dssp             TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEES-----------EEEEEEEEEEESS-SSS-S-EEEEEEESSS
T ss_pred             CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCcc-----------CEEEEEEEEEeccccCcCCCeEEEEEEcCc
Confidence            579999999998 88899999888899999999999873           799999999998755668999999998653


Q ss_pred             CCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCC
Q 006668          120 SPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPE  156 (636)
Q Consensus       120 ~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~  156 (636)
                      ..    .|..+|.-+ .-+|     +||=||||.|.+
T Consensus        90 ~~----~G~~fG~~~-~f~G-----l~i~idt~~N~~  116 (229)
T PF03388_consen   90 GS----DGPVFGGPD-KFDG-----LGIFIDTYDNDE  116 (229)
T ss_dssp             SS----SCSBTTB-S-S-EE-----EEEEEEES-TTC
T ss_pred             cc----cccccCCCc-ccce-----EEEEEEcccCCC
Confidence            32    444455321 2223     789999998853

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=98.78  E-value=2.1e-07  Score=90.91  Aligned_cols=93  Identities=13%  Similarity=0.045  Sum_probs=68.9

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      .+..+.|+|.+. ++.++||+. .++.|.++-+.|+++-   +       +|+..|+|.|.... ...||||||.++...
T Consensus        21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~---~-------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~   87 (215)
T cd06903          21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLK---D-------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDG   87 (215)
T ss_pred             CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCC---C-------CEEEEEEEEecccC-CcCCCEEEEEEECCC
Confidence            689999999997 667889988 8899999999999874   1       69999999998653 268999999999753


Q ss_pred             CCCCCCcC-cccccccCCCCCCCCceEEEEeecCCC
Q 006668          120 SPPGALAS-QYFGLFSNATVVTVAPLLAVEFDTGQN  154 (636)
Q Consensus       120 ~~~~~~~g-~~lgl~~~~~~~~~~~~vaVEfDt~~n  154 (636)
                      ....   | ..+|-.+ .-+|     +||.|||+.|
T Consensus        88 ~~~~---g~~~fG~~~-~f~G-----l~I~~Dt~~n  114 (215)
T cd06903          88 NADV---GTSSIYGPS-KFDG-----LQLLIDNNGG  114 (215)
T ss_pred             cccC---CccccCCCC-CCcE-----EEEEEECCCC
Confidence            3211   1 1222211 1112     6999999976

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=1.2e-07  Score=90.82  Aligned_cols=126  Identities=23%  Similarity=0.260  Sum_probs=82.5

Q ss_pred             EEEeeeecCCCCCCceEEEEEEeccCC---------------------h-----HHHHHHHHHHHHhccCCCC--ceeee
Q 006668          334 RVYKGTLANNNNNNSTEMAVKCVNHDS---------------------K-----QGLKEFMAEISSMGRLQHK--NLVQM  385 (636)
Q Consensus       334 ~Vykg~~~~~~~~~~~~vavK~~~~~~---------------------~-----~~~~~~~~Ei~~l~~l~h~--niv~l  385 (636)
                      .||.|...++     ..+|+|..+...                     .     .......+|.+.|.++...  ++.++
T Consensus         1 ~Vy~~~~~~~-----~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p   75 (188)
T PF01163_consen    1 DVYHAIDPDG-----EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP   75 (188)
T ss_dssp             EEEEEEECTT-----EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E
T ss_pred             CEEEEECCCC-----CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE
Confidence            3788876543     789999885420                     0     0112356799999999766  45666


Q ss_pred             eccccccceEEEEEeecC--CCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHH-HhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          386 RGWCRKGNELMLVYDYMP--NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-LHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +++.    .-+|||||++  +..+..+.    ...++.+....++.+++..+.. +|   ..+|+|+||.+.|||++++ 
T Consensus        76 ~~~~----~~~ivME~I~~~G~~~~~l~----~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   76 YDYN----RNVIVMEYIGEDGVPLPRLK----DVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             EEEE----TTEEEEE--EETTEEGGCHH----HCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-
T ss_pred             EEEe----CCEEEEEecCCCccchhhHH----hccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-
Confidence            6553    3479999998  55555433    1222356677788888886666 56   8999999999999999988 


Q ss_pred             cEEEeccCCccccc
Q 006668          463 RGRLGDFGLAKLYQ  476 (636)
Q Consensus       463 ~~kl~DFGla~~~~  476 (636)
                      .+.|+|||.+....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            99999999887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=4.8e-07  Score=93.70  Aligned_cols=256  Identities=18%  Similarity=0.193  Sum_probs=155.5

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecc------ccccc-e
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGW------CRKGN-E  394 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~------~~~~~-~  394 (636)
                      ...+.||+|+.+.+|-----       ...+-|+..........+...|+  ...-.||-+-.-+.|      .-+.+ .
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-------~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-------RDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh-------hchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccce
Confidence            45678999999999953211       22334555443322222222222  222245543332222      11222 2


Q ss_pred             EEEEEeecCCCC-hhhhH----hcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          395 LMLVYDYMPNGS-LNNWI----FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gs-L~~~l----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      .-+.|..+++.- +.+++    +.+......|.-.++.+..+|.+.+.||   +.+.+-+|+.++|+|+.+++.+.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            667777776542 22222    1233456899999999999999999999   899999999999999999999999985


Q ss_pred             CCcccccCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCh----hhHHHHH
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACG-RRPLDMGKGE----EEEEAVL  539 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G-~~Pf~~~~~~----~~~~~~l  539 (636)
                      ..-.....+.  .....+|...|.+||...     +...+...|.|.||+++++++.| ++||......    ...+..+
T Consensus       162 Dsfqi~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQINANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeeccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            5433332222  233357899999999755     44567789999999999999886 9999754211    1111011


Q ss_pred             HHHHHHHhcCCcchhhhhhhh-----hhccCH-HHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhc
Q 006668          540 MDWVRNLYGQGKICEAADARI-----RQEFEA-EEMELVLKLGLACCHP--DSTRRPTMREVVAVLVG  599 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~~d~~l-----~~~~~~-~~~~~l~~L~~~Cl~~--dP~~RPs~~evl~~L~~  599 (636)
                              ..|.....-|.+.     +...+. -.+..+..|..+|+..  ++.-|||.+..+..|..
T Consensus       240 --------a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         240 --------AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             --------hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence                    1111111112111     111221 2235566777788865  36789999988877743

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.52  E-value=2.7e-06  Score=85.11  Aligned_cols=95  Identities=18%  Similarity=0.117  Sum_probs=75.7

Q ss_pred             CCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecC
Q 006668           39 GTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF  118 (636)
Q Consensus        39 ~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~  118 (636)
                      ..+..+.|+..+. ..-++||.+..++.|.++=..||-..           +|.-.+.|.+........|||||+..+-.
T Consensus        71 ~~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~-----------~wev~v~fkv~~~s~~lfgdG~Aiw~t~E  138 (351)
T KOG3839|consen   71 QPNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSR-----------DWEVLVHFKVHGQSKNLFGDGMAIWYTKE  138 (351)
T ss_pred             ccCccccccEEEE-eeeeeccccccccccccccCCCcccc-----------ceeEEEEEEEecCCCcccccceEEEeecc
Confidence            3678899999997 66689999988899999999999865           69999999999887788999999999976


Q ss_pred             CCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCC
Q 006668          119 TSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNP  155 (636)
Q Consensus       119 ~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~  155 (636)
                      ...|    |.-+|-+.+      -+..||=.|||.|.
T Consensus       139 r~q~----GPvFG~~dk------F~GL~vfidtY~n~  165 (351)
T KOG3839|consen  139 RAQP----GPVFGSKDK------FTGLAVFIDTYGNH  165 (351)
T ss_pred             cccC----CCCCCCccc------ceeEEEEEeccCCc
Confidence            5443    344444322      12378999999875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=4.2e-08  Score=107.46  Aligned_cols=156  Identities=22%  Similarity=0.249  Sum_probs=106.5

Q ss_pred             HHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc--------cccccccCCcccccccccC
Q 006668          429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--------NTTRVVGTLGYLAPELATV  500 (636)
Q Consensus       429 ~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~  500 (636)
                      .+++.||.|+|.  +.++||++|.|++|.++..+..||+.|+.+.........        ......-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345589999997  789999999999999999999999999987654331110        0111224568999999999


Q ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHcc
Q 006668          501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACC  580 (636)
Q Consensus       501 ~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl  580 (636)
                      ...+.++|+||+|+++|-+..|..+.-...........    .          ...+..-...++...+.++++=+.+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----~----------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----S----------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh----h----------hcccccccccccccCcHHHHHHHHHHh
Confidence            88899999999999999998665554333211111100    0          001111112233445566666667789


Q ss_pred             CCCCCCCCCHHHHHHHHhcC
Q 006668          581 HPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       581 ~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..++.-||++.++....-..
T Consensus       250 ~~~~~~rp~~~~l~~~~ff~  269 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSIPFFS  269 (700)
T ss_pred             cCCcccCcchhhhhcccccC
Confidence            99999999888887665444

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=8.3e-07  Score=85.79  Aligned_cols=138  Identities=16%  Similarity=0.181  Sum_probs=103.3

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCc--eeeeecccc-c----cc
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS------KQGLKEFMAEISSMGRLQHKN--LVQMRGWCR-K----GN  393 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~-~----~~  393 (636)
                      -|+||-+.|++-.+.+      ..+-+|+.....      .-+...|.+|+..|.+|...+  +.+++ ++. .    ..
T Consensus        26 ~~rgG~SgV~r~~~~g------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~   98 (216)
T PRK09902         26 YRRNGMSGVQCVERNG------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW   98 (216)
T ss_pred             cCCCCcceEEEEEeCC------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence            3678889999877644      368888876221      224567899999999986433  44444 332 1    12


Q ss_pred             eEEEEEeecCC-CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--EEEeccC
Q 006668          394 ELMLVYDYMPN-GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--GRLGDFG  470 (636)
Q Consensus       394 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFG  470 (636)
                      .-+||+|-+++ -+|.+++.+......+..++..++.+++..+.-||   ..++.|+|+.+.||+++.++.  ++++||.
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            46899997753 68998885544456678888999999999999999   899999999999999986667  9999998


Q ss_pred             Cccc
Q 006668          471 LAKL  474 (636)
Q Consensus       471 la~~  474 (636)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            6653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.48  E-value=9.7e-07  Score=86.51  Aligned_cols=106  Identities=23%  Similarity=0.293  Sum_probs=83.2

Q ss_pred             HHHHHHHHHhccCCCCc--eeeeecccccc----ceEEEEEeecCCC-ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHH
Q 006668          365 KEFMAEISSMGRLQHKN--LVQMRGWCRKG----NELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNY  437 (636)
Q Consensus       365 ~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y  437 (636)
                      ....+|...+..|...+  ..+.+++.+..    ...+||+|++++. +|.+++....  .++......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence            45677888887775433  45556665442    2458999999874 8999884422  26677888999999999999


Q ss_pred             HhccCCCcEEeCCCCCCCEEEcCCC---cEEEeccCCcccc
Q 006668          438 LHHGWDQVVVHRDIKSGNILLDSEM---RGRLGDFGLAKLY  475 (636)
Q Consensus       438 LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~  475 (636)
                      ||   ..+|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   89999999999999998887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.47  E-value=1.2e-06  Score=86.69  Aligned_cols=135  Identities=20%  Similarity=0.204  Sum_probs=98.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh----------------------HHHHHHHHHHHHhccCC
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK----------------------QGLKEFMAEISSMGRLQ  378 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~  378 (636)
                      ..+...||-|.-+.||.|....+     .++|||.-+....                      -......+|.+.|.+|.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g-----~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~  167 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKG-----RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY  167 (304)
T ss_pred             HhhccccccCccceEEEEECCCC-----CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence            45668999999999999997643     7899996643210                      01123567899999987


Q ss_pred             CC--ceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCE
Q 006668          379 HK--NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI  456 (636)
Q Consensus       379 h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  456 (636)
                      ..  .+.+.+++    +.-.+||||+++-.|...       .++.+....++..|++-+.-+-   ..+++|+|+++-||
T Consensus       168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNI  233 (304)
T COG0478         168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNI  233 (304)
T ss_pred             hcCCCCCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheE
Confidence            55  67777776    345899999988666542       1234445555666666555555   58999999999999


Q ss_pred             EEcCCCcEEEeccCCccc
Q 006668          457 LLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~  474 (636)
                      +++++|.+.++||--+..
T Consensus       234 lV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EEecCCCEEEEeCccccc
Confidence            999999999999965543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=6.6e-06  Score=81.75  Aligned_cols=132  Identities=18%  Similarity=0.176  Sum_probs=84.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--LVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~  402 (636)
                      ..||+|..+.||+..    +    ..+++|.......  .....+|.++++.+..-+  +.+.++++...+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~~----~----~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----T----GKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEec----C----CCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            578999999999831    1    3577888765432  234578999998886444  466777777777788999999


Q ss_pred             CCCC-hhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhc----------------------------------------c
Q 006668          403 PNGS-LNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH----------------------------------------G  441 (636)
Q Consensus       403 ~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------------~  441 (636)
                      +|.+ +...+.      .+......++..+++.+.-||+                                        .
T Consensus        77 ~G~~~~~~~~~------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~  150 (226)
T TIGR02172        77 VGKRSFSRIIS------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP  150 (226)
T ss_pred             CCccchhhhhc------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence            8863 221110      0111111122222222222221                                        1


Q ss_pred             CCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       442 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ....++|+|+.|.||++++++ +.++||+.+.
T Consensus       151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            244679999999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.18  E-value=1.8e-05  Score=76.86  Aligned_cols=138  Identities=14%  Similarity=0.169  Sum_probs=93.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHH---------HHHHHHhccCCCC---ceee
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---------MAEISSMGRLQHK---NLVQ  384 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~---niv~  384 (636)
                      ..++|...+++-......|.+-....      ..+++|..........+.|         .+++..+.+++..   .+..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~  102 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDG------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD  102 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECC------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence            45678888888888777787766543      6789998876543332222         2344444444322   2222


Q ss_pred             eecc-----ccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          385 MRGW-----CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       385 l~g~-----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ++.+     +......+|+|||++|..|.++.      .++.    .+...+.+++.-||   ..|++|+|..|.|++++
T Consensus       103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVS  169 (229)
T ss_pred             ceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEE
Confidence            2222     22234567999999998887754      1222    25567778899999   89999999999999998


Q ss_pred             CCCcEEEeccCCccc
Q 006668          460 SEMRGRLGDFGLAKL  474 (636)
Q Consensus       460 ~~~~~kl~DFGla~~  474 (636)
                      +++ ++++||+..+.
T Consensus       170 ~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  170 NNG-IRIIDTQGKRM  183 (229)
T ss_pred             CCc-EEEEECccccc
Confidence            655 99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.16  E-value=1.7e-05  Score=78.54  Aligned_cols=143  Identities=22%  Similarity=0.253  Sum_probs=84.2

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCC--ceeeeecccc---ccceEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK--NLVQMRGWCR---KGNELMLV  398 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~~---~~~~~~lV  398 (636)
                      .+.|+.|..+.||+....+      ..+++|.....  .....+..|..+++.+...  .+.+++.++.   .....+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            4679999999999998654      47899987655  4456677888888877533  3456665432   23457999


Q ss_pred             EeecCCCChhh----------------hH---hcC--CCCCcChHH---------HHHH------------HHHHHH-HH
Q 006668          399 YDYMPNGSLNN----------------WI---FGK--PKKLLGWKQ---------RRQI------------LADVAE-GL  435 (636)
Q Consensus       399 ~E~~~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-~L  435 (636)
                      |+++++..+..                .+   +..  ....+.+..         ....            ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999988877                11   111  111111110         0000            111222 23


Q ss_pred             HHHhc----cCCCcEEeCCCCCCCEEEc-CCCcEEEeccCCccc
Q 006668          436 NYLHH----GWDQVVVHRDIKSGNILLD-SEMRGRLGDFGLAKL  474 (636)
Q Consensus       436 ~yLH~----~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~  474 (636)
                      +.++.    .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33332    2367899999999999999 666668999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=9.1e-06  Score=89.52  Aligned_cols=141  Identities=19%  Similarity=0.266  Sum_probs=91.4

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHH---------------------------------------
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK---------------------------------------  365 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------  365 (636)
                      +.|+.+.-|.||+|+++++     +.||||+..+.-.+.++                                       
T Consensus       131 ~PiAsASIaQVH~A~L~sG-----~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         131 EPIASASIAQVHRAVLKSG-----EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             CchhhhhHhhheeEEecCC-----CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            6789999999999999873     89999999765322211                                       


Q ss_pred             -HHHHHHHHhccCC-----CCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHH-HHHH
Q 006668          366 -EFMAEISSMGRLQ-----HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG-LNYL  438 (636)
Q Consensus       366 -~~~~Ei~~l~~l~-----h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~-L~yL  438 (636)
                       ++.+|...+.+++     .+++.-..=+.+-.+.-.|+|||++|-.+.+...-+ ...++.+   .++..++++ +..+
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g~d~k---~ia~~~~~~f~~q~  281 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-SAGIDRK---ELAELLVRAFLRQL  281 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-hcCCCHH---HHHHHHHHHHHHHH
Confidence             1223444443332     233222211222235678999999999998874222 2344433   333333332 1222


Q ss_pred             hccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       439 H~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      -   ..++.|.|.+|.||+++.++++.+.|||+....+.
T Consensus       282 ~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 L---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             H---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2   46899999999999999999999999999876654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.13  E-value=3.8e-05  Score=75.46  Aligned_cols=155  Identities=18%  Similarity=0.199  Sum_probs=101.0

Q ss_pred             ccCHHHHHHHhCCCCCceee---eecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHH--H----------------
Q 006668          308 RFSYEELSKATKGFSNDELL---GSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK--E----------------  366 (636)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~L---G~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~--~----------------  366 (636)
                      ..+.+.+.....+..+.+..   .+|..+.||+|.-.+.     ..+|+|++........+  .                
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~-----~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDG-----RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCC-----ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            44566777777777666654   4688889999875432     78999999754222111  0                


Q ss_pred             ------HHHHHHHhccCC--CCceeeeeccccccceEEEEEeecCCCCh-hhhHhcCCCCCcChHHHHHHHHHHHHHHHH
Q 006668          367 ------FMAEISSMGRLQ--HKNLVQMRGWCRKGNELMLVYDYMPNGSL-NNWIFGKPKKLLGWKQRRQILADVAEGLNY  437 (636)
Q Consensus       367 ------~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y  437 (636)
                            ..+|...|.++.  +=.+.+.+++.    .-.|||||+....+ .-.|   ..-.+..++...+..++++.+.-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHH
Confidence                  124555555553  22333444433    34799999955411 0011   11223333577778888888888


Q ss_pred             HhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       438 LH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |-.  ..++||+||+.-|||+. ++.+.|+|+|-|....+
T Consensus       182 l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         182 LYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             HHH--hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            873  48999999999999999 88999999998875543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.00  E-value=2e-05  Score=75.91  Aligned_cols=104  Identities=23%  Similarity=0.236  Sum_probs=82.8

Q ss_pred             HHHHHhccCCC-CceeeeeccccccceEEEEEeecCCCChhhhHhc-CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcE
Q 006668          369 AEISSMGRLQH-KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV  446 (636)
Q Consensus       369 ~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  446 (636)
                      .|.-+++.+.+ +++.+++|.|-.    ++|.||.+.+++...-.. ..-..-+|.+|.+|+.++++.+.+|++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888876 699999999943    679999987766421000 112346899999999999999999997666679


Q ss_pred             EeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       447 vHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ...|++++|+-+++++++|++|...+....
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            999999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=97.99  E-value=0.00021  Score=69.17  Aligned_cols=92  Identities=12%  Similarity=0.075  Sum_probs=66.7

Q ss_pred             CCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCCCCC-CCCcCcccc
Q 006668           53 TVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPP-GALASQYFG  131 (636)
Q Consensus        53 ~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~~~~-~~~~g~~lg  131 (636)
                      ++.|+||++..+++|-+.|.++++--    .+     -...+|.+-.-.. ...++||+||||+-....| .+..||-||
T Consensus        31 ~g~LRLT~~~~nqata~~~~~~FPs~----~n-----~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLG  100 (255)
T cd06900          31 NNRLRLTDASGNQATAVTLQRLFPSA----GN-----YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLG  100 (255)
T ss_pred             cCeEEeccCccCcceeEEEeeeeccC----CC-----eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccc
Confidence            68999999999999999999999863    21     2566666666543 3567999999999543222 356788999


Q ss_pred             cccCC--CCCCCCceEEEEeecCCC
Q 006668          132 LFSNA--TVVTVAPLLAVEFDTGQN  154 (636)
Q Consensus       132 l~~~~--~~~~~~~~vaVEfDt~~n  154 (636)
                      +-...  ..+...--+.|-||-|-|
T Consensus       101 Ya~~~~~~~GfaGGwLGiGlDEyGN  125 (255)
T cd06900         101 YAQRNDGVPGFAGGWLGIGLDEYGN  125 (255)
T ss_pred             cccccCCCCccccceEEEEEecccc
Confidence            96543  333555678899998776

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.98  E-value=1e-06  Score=95.68  Aligned_cols=182  Identities=20%  Similarity=0.156  Sum_probs=130.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN-LVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~  402 (636)
                      -.-.+++.+++++|.+-..+     +...++.+...     ....-++++|.+++||| .++.++-+..+...+++++++
T Consensus       247 fh~fvK~altknpKkRptae-----klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAE-----KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHhcCCCccCCChh-----hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            34578899999998864332     23335555433     34456889999999999 777777777788899999999


Q ss_pred             CCC-ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          403 PNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       403 ~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      ..+ +-..-. ......+...+...++..-+++|+|||   +..=+|||    ||+..+ ...|..||+....+....  
T Consensus       317 s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  317 STGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             cCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--
Confidence            777 221111 011223444455566777788999999   44457888    777655 678999999988766543  


Q ss_pred             cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCC
Q 006668          482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL  526 (636)
Q Consensus       482 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf  526 (636)
                      ......+++.++|||+.....+..+.|+|++|+-..++.-|-.|-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            233467999999999999999999999999998777777776664

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.91  E-value=7.9e-05  Score=74.92  Aligned_cols=139  Identities=17%  Similarity=0.137  Sum_probs=82.8

Q ss_pred             eeecCc-eEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEEEeecCC
Q 006668          327 LGSGGF-GRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYMPN  404 (636)
Q Consensus       327 LG~G~f-G~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~  404 (636)
                      |..|.. ..||+.....      ..+.+|+.....   ..+..+|+.++..+. +--+.+++++....+..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~~------~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGKN------PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCCC------CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            444554 7889886432      468888876543   234567888877774 34456777777666678999999999


Q ss_pred             CChhhhH-------------------hcCCCC--CcC--hHHHHHHHH--------------------HHHHHHHHHh--
Q 006668          405 GSLNNWI-------------------FGKPKK--LLG--WKQRRQILA--------------------DVAEGLNYLH--  439 (636)
Q Consensus       405 gsL~~~l-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~~L~yLH--  439 (636)
                      .+|....                   +.....  ...  .........                    .+...++.|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            8776432                   111000  000  000000000                    0111112221  


Q ss_pred             --ccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          440 --HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       440 --~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                        ......++|+|+.|.|||++++....|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence              01245699999999999999987789999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.83  E-value=0.00016  Score=85.47  Aligned_cols=82  Identities=11%  Similarity=0.204  Sum_probs=57.4

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCce--eeeecccccc---ceEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQ-HKNL--VQMRGWCRKG---NELM  396 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~g~~~~~---~~~~  396 (636)
                      .+.++.|.++.+|+.....++  ....+++|+.+... ......+.+|+++++.+. |.++  .+++.+|.+.   +..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~--~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG--SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC--cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            567899999999987764421  12357777765432 122346778999999985 6664  7788888764   4678


Q ss_pred             EEEeecCCCCh
Q 006668          397 LVYDYMPNGSL  407 (636)
Q Consensus       397 lV~E~~~~gsL  407 (636)
                      +||||+++..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.79  E-value=0.00024  Score=68.83  Aligned_cols=130  Identities=23%  Similarity=0.364  Sum_probs=88.9

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC----------------hHHHHHHHHHHHHhccCC------C
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS----------------KQGLKEFMAEISSMGRLQ------H  379 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h  379 (636)
                      +....||+|+.-.||.-  +.+     ....||+.....                ....++..+|+.....+.      +
T Consensus         4 ~~~~~i~~G~~R~cy~H--P~d-----p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQH--PDD-----PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CCCcccccCCCceEEEC--CCC-----CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            34578999999999963  332     456788887665                122345555665554444      7


Q ss_pred             CceeeeeccccccceEEEEEeecCC------CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCC
Q 006668          380 KNLVQMRGWCRKGNELMLVYDYMPN------GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS  453 (636)
Q Consensus       380 ~niv~l~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp  453 (636)
                      .+|.+++|+.+.+.-.-+|+|.+.+      -+|.+++.   .+.++. ...+.+.+.   .+||-   +..|+.+|++|
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~  146 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNP  146 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHHHH---HHHHH---HcCCeecCCCc
Confidence            8899999999999888999998754      36788883   334554 444444444   44555   67799999999


Q ss_pred             CCEEEcCCC----cEEEec
Q 006668          454 GNILLDSEM----RGRLGD  468 (636)
Q Consensus       454 ~NIll~~~~----~~kl~D  468 (636)
                      +||++....    .+.|+|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            999995322    466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.67  E-value=0.0002  Score=78.80  Aligned_cols=140  Identities=19%  Similarity=0.247  Sum_probs=89.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHH---------------------------H----------HH
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL---------------------------K----------EF  367 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~  367 (636)
                      +.||.-..|.||+|+++++     +.||||+-++.-++.+                           +          +|
T Consensus       167 ~piaaASlaQVhrA~L~~G-----~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNG-----EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             chhhhcchhheEEEEecCC-----CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            6799999999999999883     8999999876522211                           0          13


Q ss_pred             HHHHHHhccC----CCCc------eeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHH
Q 006668          368 MAEISSMGRL----QHKN------LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY  437 (636)
Q Consensus       368 ~~Ei~~l~~l----~h~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y  437 (636)
                      ..|.+...+.    +|-+      |.+++-.  -.....|+||||+|..+.+.-. -.+..++...+..-+.+.     |
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~-----~  313 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEA-----Y  313 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHH-----H
Confidence            3344333332    3444      2222221  2346799999999998877632 123345555433333332     2


Q ss_pred             HhccCCCcEEeCCCCCCCEEEcC----CCcEEEeccCCcccccC
Q 006668          438 LHHGWDQVVVHRDIKSGNILLDS----EMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       438 LH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DFGla~~~~~  477 (636)
                      +++-...|++|+|-.|.||+++.    ++.+.+-|||+.....+
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22222467999999999999983    67899999999876654

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=97.67  E-value=0.0011  Score=67.81  Aligned_cols=162  Identities=17%  Similarity=0.144  Sum_probs=97.0

Q ss_pred             eEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCCCC
Q 006668           42 LILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSP  121 (636)
Q Consensus        42 ~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~~~  121 (636)
                      ....|||-.+ +.-++++++..++.|-+|-+.-+.+-           .|...-+|.|+... -.++||||+--+.... 
T Consensus        56 W~~~GdAIas-~eqvRlaPSmrsrkGavWtka~~~fe-----------~weVev~~rVtGrG-RiGAdGlaiWYt~~~G-  121 (497)
T KOG3838|consen   56 WSHHGDAIAS-SEQVRLAPSMRSRKGAVWTKASVPFE-----------NWEVEVQFRVTGRG-RIGADGLAIWYTRGRG-  121 (497)
T ss_pred             eeecCccccc-ccceeeccccccccCceeecccCCcc-----------cceEEEEEEecccc-cccCCceEEEEecCCC-
Confidence            5667888654 67799999888888999877666552           58899999998763 4578999999875421 


Q ss_pred             CCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccc-cCCCCCcce-eeeecCC
Q 006668          122 PGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY-SSSRNESFV-PVRMRNG  199 (636)
Q Consensus       122 ~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~-~~~~~~~~~-~~~~~~g  199 (636)
                         --|..+|-.+. =+|     +++=||.|.|.  +.-|++-|.+-.|.=    +.+...- |.++..++. --+..|.
T Consensus       122 ---~~GpVfGg~d~-WnG-----igiffDSfdnD--~qknnP~Is~~lndG----t~~ydh~~DGasQ~LssCqrDFRNk  186 (497)
T KOG3838|consen  122 ---HVGPVFGGLDS-WNG-----IGIFFDSFDND--GQKNNPAISVLLNDG----TIPYDHPGDGASQGLSSCQRDFRNK  186 (497)
T ss_pred             ---ccccccccccc-ccc-----eEEEeeccccc--CCcCCccEEEEecCC----cccccCCCccHHHHHHHhhHHhccC
Confidence               12222222111 112     68889998774  233455565555421    1110000 000111000 0011111


Q ss_pred             -CeeEEEEEec-----------------------------------ccccCCCceecceeeeecc-ccCC
Q 006668          200 -QNIHAWIDFD-----------------------------------GFSASKTNWIEARRVLAWS-LSDT  232 (636)
Q Consensus       200 -~~~~~~i~y~-----------------------------------gfsastg~~~~~~~il~ws-f~~~  232 (636)
                       -+..++|+|-                                   |.||+||....-|+||++. |++.
T Consensus       187 PyPvRarItY~~nvLtv~innGmtp~d~yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~FltfsL~  256 (497)
T KOG3838|consen  187 PYPVRARITYYGNVLTVMINNGMTPSDDYEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFLTFSLS  256 (497)
T ss_pred             CCCceEEEEEeccEEEEEEcCCCCCCCCcceeEeccceeccCCCeeeeeecccccccccceeeeEEeeec
Confidence             2445666653                                   8999999999999999987 6654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.59  E-value=0.00041  Score=69.37  Aligned_cols=73  Identities=18%  Similarity=0.189  Sum_probs=45.2

Q ss_pred             eeeeecCce-EEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCC---ceeeeecccccc---ceEEE
Q 006668          325 ELLGSGGFG-RVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK---NLVQMRGWCRKG---NELML  397 (636)
Q Consensus       325 ~~LG~G~fG-~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~~~---~~~~l  397 (636)
                      +.|+.|+.. .||+..         ..+++|..+...  ....+.+|.+.+..+...   -+.+.++.+...   ...++
T Consensus         3 ~~~~~gG~~n~vy~~~---------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRLG---------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEcC---------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            567777766 588742         246677654422  234677888888777532   344445444332   23588


Q ss_pred             EEeecCCCChh
Q 006668          398 VYDYMPNGSLN  408 (636)
Q Consensus       398 V~E~~~~gsL~  408 (636)
                      +||+++|.++.
T Consensus        72 l~~~i~G~~l~   82 (235)
T cd05155          72 VYRWLEGETAT   82 (235)
T ss_pred             EEEeecCCCCC
Confidence            99999987774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.50  E-value=0.00074  Score=65.04  Aligned_cols=125  Identities=26%  Similarity=0.395  Sum_probs=89.1

Q ss_pred             CCCCCceeeeecCc-eEEEeeeecCCCCCCceEEEEEEecc---C---------Ch---------HHHHHHHHHHHHhcc
Q 006668          319 KGFSNDELLGSGGF-GRVYKGTLANNNNNNSTEMAVKCVNH---D---------SK---------QGLKEFMAEISSMGR  376 (636)
Q Consensus       319 ~~f~~~~~LG~G~f-G~Vykg~~~~~~~~~~~~vavK~~~~---~---------~~---------~~~~~~~~Ei~~l~~  376 (636)
                      ..++..+.||.|.. |.|||.++.+      ..+|+|.+..   .         ..         .....|..|.+...+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR  110 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDG------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR  110 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECC------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence            67888899999999 9999999865      7899999431   0         00         112357788888887


Q ss_pred             CC---CCce--eeeecccccc------------------ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHH
Q 006668          377 LQ---HKNL--VQMRGWCRKG------------------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE  433 (636)
Q Consensus       377 l~---h~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~  433 (636)
                      |+   +.++  |+.+||..-.                  ....||.||++...           .+...    -+.+|.+
T Consensus       111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~  175 (207)
T PF13095_consen  111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLR  175 (207)
T ss_pred             HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHH
Confidence            75   4566  8888886211                  12467888775433           22223    3455666


Q ss_pred             HHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       434 ~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      -|..+|   ..+|+-+|+++.|..     ..||+|||.+
T Consensus       176 dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            677899   899999999999986     5699999854

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.42  E-value=0.00041  Score=80.82  Aligned_cols=201  Identities=16%  Similarity=0.166  Sum_probs=136.0

Q ss_pred             HHHHHHHHHHhccCCCCceeeeeccccccce----EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHh
Q 006668          364 LKEFMAEISSMGRLQHKNLVQMRGWCRKGNE----LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH  439 (636)
Q Consensus       364 ~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH  439 (636)
                      +....-|+..+..+.|+|++.++.|..+...    ..+..|++..-++...+  .....++.++.+.+..+..+||.|+|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3444567888899999999999998755432    23445778777887777  34567888999999999999999999


Q ss_pred             ccCCCcEEeCCCCCC---CEEEcCCCcEEEe--ccCCcccccCCCCccccccccCCcccccccccCCCCCC--ccchHHH
Q 006668          440 HGWDQVVVHRDIKSG---NILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS--ASDVYSF  512 (636)
Q Consensus       440 ~~~~~~ivHrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDV~S~  512 (636)
                         .....|.-+..+   +.-.+.++...++  ||+.............  ..-+..+.+||......+..  ..|+|.+
T Consensus       304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             ---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHH
Confidence               455555544444   4444666677777  8887765544332111  23455678888777665544  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          513 GVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       513 Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      |.++..+..|..+-......                         ..+...   .....+.....+|+..++++|++..+
T Consensus       379 gll~~~~~~~~~i~~~~~~~-------------------------~~~l~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVP-------------------------VSLLDV---LSTSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHhhhhhcCcccccccch-------------------------hhhhcc---ccchhhhhhhhhhcchhhhhccchhh
Confidence            99999999887654322000                         000000   11114566677899999999999999


Q ss_pred             HHHHHhc
Q 006668          593 VVAVLVG  599 (636)
Q Consensus       593 vl~~L~~  599 (636)
                      ++...-.
T Consensus       431 ll~~~f~  437 (1351)
T KOG1035|consen  431 LLTHPFL  437 (1351)
T ss_pred             hhhchhc
Confidence            9987643

>PRK10593 hypothetical protein; Provisional

Probab=97.41  E-value=0.004  Score=64.61  Aligned_cols=79  Identities=10%  Similarity=0.009  Sum_probs=55.3

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC---Cceeeeeccccc---cce
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH---KNLVQMRGWCRK---GNE  394 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~---~~~  394 (636)
                      ....+.||.|..+.||+....+      ..+.+|..+....  ...+.+|...|+.|..   -.+.+++++|..   .+.
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~------~~~~~k~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ------GNPMPLMARSFST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC------CCEEEEEeccccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3445779999999999876433      2466676543111  2467788888888753   357788887754   366


Q ss_pred             EEEEEeecCCCCh
Q 006668          395 LMLVYDYMPNGSL  407 (636)
Q Consensus       395 ~~lV~E~~~~gsL  407 (636)
                      .+||||+++++++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.38  E-value=0.0007  Score=63.26  Aligned_cols=128  Identities=19%  Similarity=0.203  Sum_probs=87.8

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eeeccccccceEEEEEee
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV-QMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~  401 (636)
                      ..+.|++|++|.||+|.+..      ..+|+|.-..++..  ..+..|.++|..+.--++. +++.+..    -.+.|||
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~------~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRG------GEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhcccccEEEEeeccC------ceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            35679999999999999866      57999988776543  5677899999888766654 3454433    2445999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCC-CCCEEEcCCCcEEEeccCCccc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK-SGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk-p~NIll~~~~~~kl~DFGla~~  474 (636)
                      +.|-.|.+.-..     .+.++++    .+++.---|-   ..+|-|..|. |...+|-.+..+.|+||.-|+.
T Consensus        94 i~G~~L~~~~~~-----~~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-----GDRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-----ccHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            988888776421     1233333    3444433344   6788888887 4444454555999999998874

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.33  E-value=0.00077  Score=68.29  Aligned_cols=137  Identities=13%  Similarity=0.056  Sum_probs=76.1

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEEeecCCC
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVYDYMPNG  405 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~g  405 (636)
                      +..|-.+.+|+....  +    ..+++|..........-...+|..+++.+...++ .+++..+.    -.+||||++|.
T Consensus         4 ~~~G~tn~~y~~~~~--~----~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP--G----ISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEEeC--C----ccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            456777889987622  2    5788887654322211134678888888764333 33444432    36899999987


Q ss_pred             Chhhh-----------------HhcCC--CCCcChHHH-HHHHHH---------HHHHHHHHhc-----cCCCcEEeCCC
Q 006668          406 SLNNW-----------------IFGKP--KKLLGWKQR-RQILAD---------VAEGLNYLHH-----GWDQVVVHRDI  451 (636)
Q Consensus       406 sL~~~-----------------l~~~~--~~~l~~~~~-~~i~~~---------ia~~L~yLH~-----~~~~~ivHrDl  451 (636)
                      .+..-                 ||...  ...++...+ ..+..+         +...+..+-.     .....++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            76421                 11111  111121111 111111         1111111111     11346999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCccc
Q 006668          452 KSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       452 kp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .|.||++++++ +.|+||..+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999987764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.22  E-value=0.0021  Score=64.06  Aligned_cols=143  Identities=17%  Similarity=0.222  Sum_probs=79.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+.|..|-...+|+.....+   ....+++|........ ..+..+|+.++..+...++ .++++.+.    -.++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~---~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED---NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC---CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence            35677788889998875420   1157888876543222 1223467888887754333 34444332    24799999


Q ss_pred             CCCChhhh-------H----------hcCCC---------CCc-ChHHHHHHHH----------------------HHH-
Q 006668          403 PNGSLNNW-------I----------FGKPK---------KLL-GWKQRRQILA----------------------DVA-  432 (636)
Q Consensus       403 ~~gsL~~~-------l----------~~~~~---------~~l-~~~~~~~i~~----------------------~ia-  432 (636)
                      ++.++...       +          +....         ... -++.+..+..                      .+. 
T Consensus        75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  154 (235)
T cd05157          75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD  154 (235)
T ss_pred             CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence            98776321       0          11110         011 1122111111                      111 


Q ss_pred             --HHHH-HHhc-cCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCccc
Q 006668          433 --EGLN-YLHH-GWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKL  474 (636)
Q Consensus       433 --~~L~-yLH~-~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~  474 (636)
                        ..|. .+.. .....++|+|+.+.|||+++ +..+.++||..|..
T Consensus       155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence              1111 1111 12457999999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.21  E-value=0.003  Score=65.36  Aligned_cols=142  Identities=16%  Similarity=0.140  Sum_probs=83.7

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeeeccc------cccceE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--LVQMRGWC------RKGNEL  395 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~------~~~~~~  395 (636)
                      .+.|..|....+|+....+      ..+++|+.....   ..+...|+.++..+.+.+  +.+++...      ...+..
T Consensus        19 i~~i~~G~~n~~y~v~~~~------~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS------GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEeCC------CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            4567778888999876432      458888876522   234556777777764332  44444422      223456


Q ss_pred             EEEEeecCCCChhh----hH----------hcC----CC-----CCcChHHHH----------HHHHHHHHHHHHHhc--
Q 006668          396 MLVYDYMPNGSLNN----WI----------FGK----PK-----KLLGWKQRR----------QILADVAEGLNYLHH--  440 (636)
Q Consensus       396 ~lV~E~~~~gsL~~----~l----------~~~----~~-----~~l~~~~~~----------~i~~~ia~~L~yLH~--  440 (636)
                      ++|++|++|..+..    ..          +..    ..     ....|....          .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999877532    01          110    00     111222111          011123334444442  


Q ss_pred             --cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          441 --GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       441 --~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                        ....+++|+|+.|.||+++++..+.|+||+.+..
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence              2246799999999999999987789999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.10  E-value=0.0052  Score=65.96  Aligned_cols=77  Identities=10%  Similarity=0.089  Sum_probs=53.0

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-------hHHHHHHHHHHHHhccCC---CCceeeeeccccccc
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-------KQGLKEFMAEISSMGRLQ---HKNLVQMRGWCRKGN  393 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~  393 (636)
                      .+.||.|....||+....+++    +.++||.-....       ....+....|.+.|..+.   -.++.+++.+..  +
T Consensus        31 ~~elggGn~N~VyrV~~~~g~----~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~  104 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGG----KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E  104 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCC----eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C
Confidence            367999999999999875432    579999854221       123455667777777763   245777777744  4


Q ss_pred             eEEEEEeecCCCC
Q 006668          394 ELMLVYDYMPNGS  406 (636)
Q Consensus       394 ~~~lV~E~~~~gs  406 (636)
                      ..++||||+++..
T Consensus       105 ~~~lVME~L~~~~  117 (401)
T PRK09550        105 LAVTVMEDLSDHK  117 (401)
T ss_pred             CCEEEEecCCCcc
Confidence            5789999998643

>PLN02236 choline kinase

Probab=97.06  E-value=0.003  Score=66.93  Aligned_cols=145  Identities=17%  Similarity=0.223  Sum_probs=84.0

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV-QMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~  403 (636)
                      +.|-.|-...+|+.............+++|+........+. -..|..++..+...++. ++++.+.. +   .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            44555778899988764432223468889988765433322 25688888887654443 45555433 2   5899998


Q ss_pred             CCChhhh-----------------HhcCC----CCCcChHHHHHHHHHH-----------------HHHHHHH----hc-
Q 006668          404 NGSLNNW-----------------IFGKP----KKLLGWKQRRQILADV-----------------AEGLNYL----HH-  440 (636)
Q Consensus       404 ~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  440 (636)
                      +.+|..-                 +|+..    .....|+++.++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 11111    0011223332322111                 1111112    11 


Q ss_pred             cCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCccc
Q 006668          441 GWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKL  474 (636)
Q Consensus       441 ~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~  474 (636)
                      .....++|+|+++.|||+++ ++.++++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22457999999999999986 46899999988763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.05  E-value=0.0028  Score=65.89  Aligned_cols=145  Identities=25%  Similarity=0.346  Sum_probs=82.8

Q ss_pred             eeeeecCceEEEeeeecCC--CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEEee
Q 006668          325 ELLGSGGFGRVYKGTLANN--NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVYDY  401 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~  401 (636)
                      +.|..|-...+|+.....+  ....+..+++|+...... ...+..+|..++..+...++ .++++.+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            4566677789998875431  112236788998765432 22344567777777754333 345555432    358999


Q ss_pred             cCCCChhhh-----------------HhcCCCC-------Cc--ChHHHHH--------------------------HHH
Q 006668          402 MPNGSLNNW-----------------IFGKPKK-------LL--GWKQRRQ--------------------------ILA  429 (636)
Q Consensus       402 ~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------i~~  429 (636)
                      ++|..+...                 +|+....       ..  -|..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431                 1111111       00  0111110                          111


Q ss_pred             HHHHHHHHHhc------cCCCcEEeCCCCCCCEEEcCC----CcEEEeccCCccc
Q 006668          430 DVAEGLNYLHH------GWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKL  474 (636)
Q Consensus       430 ~ia~~L~yLH~------~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~  474 (636)
                      .+..-+..|..      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22222333331      236789999999999999985    8899999988763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.99  E-value=0.011  Score=61.79  Aligned_cols=32  Identities=25%  Similarity=0.330  Sum_probs=27.5

Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ..++||+|+.+.||+++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            56899999999999999776668999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.99  E-value=0.0064  Score=63.37  Aligned_cols=142  Identities=15%  Similarity=0.153  Sum_probs=80.5

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeeeccc------cccceE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--LVQMRGWC------RKGNEL  395 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~------~~~~~~  395 (636)
                      .+.++.|....+|+....+      ..+++|+......  ..+...|+.++..|...+  +.+++...      ...+..
T Consensus        27 i~~~~~G~~n~~y~v~t~~------~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDV------GRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ccccCCccccceEEEEeCC------CcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            4567777778999876422      3577887654321  123345566666654222  34444422      224567


Q ss_pred             EEEEeecCCCChhh-----------h---HhcCCC----------CCcChHHHH------------HHHHHHHHHHHHHh
Q 006668          396 MLVYDYMPNGSLNN-----------W---IFGKPK----------KLLGWKQRR------------QILADVAEGLNYLH  439 (636)
Q Consensus       396 ~lV~E~~~~gsL~~-----------~---l~~~~~----------~~l~~~~~~------------~i~~~ia~~L~yLH  439 (636)
                      ++++||++|..+..           .   ++....          ..-.|....            .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            89999998865421           1   111000          001121110            01122334555554


Q ss_pred             c----cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          440 H----GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       440 ~----~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .    ....+++|+|+.+.||++++++...|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            2    235789999999999999988877899999775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.70  E-value=0.0049  Score=66.43  Aligned_cols=162  Identities=22%  Similarity=0.230  Sum_probs=91.5

Q ss_pred             HHHHHHHHHhccCCCCceeeeecccccc-ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC
Q 006668          365 KEFMAEISSMGRLQHKNLVQMRGWCRKG-NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD  443 (636)
Q Consensus       365 ~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  443 (636)
                      .++......++.+.|+|+...+++.+.. ....+|+|++ +.||.+.+....   +-....      +      -|    
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~------~------~~----   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESL------L------AH----   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhh------c------cc----
Confidence            4456677889999999999999887654 3478899999 889999873221   211111      1      11    


Q ss_pred             CcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCC
Q 006668          444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR  523 (636)
Q Consensus       444 ~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~  523 (636)
                       ++.|     .|++       +++| -++.   ..     ....|                +|+||||+|.++.|+.-|.
T Consensus        87 -~~~~-----~~~~-------~~td-~~~t---~~-----~~~~~----------------pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   87 -GVLH-----LNII-------YITD-HFLT---KY-----PSPIG----------------PKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -ccce-----ehhh-------hccc-cccc---cC-----CCCCC----------------cchhhhhHHHHHHHHHHhh
Confidence             2222     1222       2222 0000   00     00011                3999999999999999887


Q ss_pred             CCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          524 RPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       524 ~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      .-+...    .....+.....-...++.........   .+..++.+.++++...|+-..|..||...
T Consensus       129 ~l~~~~----~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  129 SLEAEL----TESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             HHHHHH----HHHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchh
Confidence            554321    11222221111111222222222211   44556778889999999999999888543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.44  E-value=0.035  Score=57.63  Aligned_cols=121  Identities=21%  Similarity=0.285  Sum_probs=78.1

Q ss_pred             eEEEEEEec-cCChHHHHHHHHHHHHhccCCC--Cceeeeeccccccc--eEEEEEeecCCCChhhhHhcCCCCCcChHH
Q 006668          349 TEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH--KNLVQMRGWCRKGN--ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ  423 (636)
Q Consensus       349 ~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~  423 (636)
                      +++++++.. ...........+|..+|+.+.-  --+.+.++.|.++.  ..+.||+|+++..+.+.+...   ...   
T Consensus        49 ~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~---~~~---  122 (321)
T COG3173          49 QKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE---SLG---  122 (321)
T ss_pred             ceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc---cch---
Confidence            567777221 1233344556677777777642  23455677787665  679999999886554443111   111   


Q ss_pred             HHHHH-HHHHHHHHHHhc-------------------------------------------------------cCCCcEE
Q 006668          424 RRQIL-ADVAEGLNYLHH-------------------------------------------------------GWDQVVV  447 (636)
Q Consensus       424 ~~~i~-~~ia~~L~yLH~-------------------------------------------------------~~~~~iv  447 (636)
                       .+++ ..++..|.-||+                                                       .....++
T Consensus       123 -~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lv  201 (321)
T COG3173         123 -RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLV  201 (321)
T ss_pred             -HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceee
Confidence             1122 356666666663                                                       1245799


Q ss_pred             eCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          448 HRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       448 HrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      |+|+.+.|++++.+.-+-+.||+++..-+
T Consensus       202 HGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         202 HGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            99999999999998889999999987644

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.26  E-value=0.0007  Score=80.63  Aligned_cols=158  Identities=13%  Similarity=-0.000  Sum_probs=114.4

Q ss_pred             HHHHHHhccCCCCceeeeecccc--ccceEEEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhcc--
Q 006668          368 MAEISSMGRLQHKNLVQMRGWCR--KGNELMLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHG--  441 (636)
Q Consensus       368 ~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~--  441 (636)
                      ..|..-++...|+++.....-..  +..+.+.+++|+..|.+.+.|.+..  ...++..-.....++......-+|..  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            34445555678988877655443  3346788999999999999886532  23344444444444445555565532  


Q ss_pred             CCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh
Q 006668          442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC  521 (636)
Q Consensus       442 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~  521 (636)
                      ...-.+|++||+-|.+|..+.++|++++|+.+...+... ......+++.|+.|+....-+++.++|+|..|+.+++...
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            244579999999999999999999999999995443322 2233467888999999998899999999999999999988


Q ss_pred             CCCCC
Q 006668          522 GRRPL  526 (636)
Q Consensus       522 G~~Pf  526 (636)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            87665

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.01  E-value=0.062  Score=55.12  Aligned_cols=32  Identities=41%  Similarity=0.645  Sum_probs=26.4

Q ss_pred             CCcEEeCCCCCCCEEEcCCCc-EEEeccCCccc
Q 006668          443 DQVVVHRDIKSGNILLDSEMR-GRLGDFGLAKL  474 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~  474 (636)
                      ...++|+|+++.|||++++++ .-|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            346899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.98  E-value=0.043  Score=56.48  Aligned_cols=75  Identities=15%  Similarity=0.308  Sum_probs=45.4

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC---CCCceeeeeccccccceEEEE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL---QHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +..+.|+-|.-..+|+..  .++    ..+.||.-....   ...|..|..-|+.|   .--.+.+++++....+..+||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~----~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDG----GSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-----EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeEecCCCChhheEEEE--CCC----ccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            445678889999999877  222    789999887332   24566677777666   345677888888777777999


Q ss_pred             EeecCCC
Q 006668          399 YDYMPNG  405 (636)
Q Consensus       399 ~E~~~~g  405 (636)
                      +||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.89  E-value=0.015  Score=56.92  Aligned_cols=32  Identities=34%  Similarity=0.526  Sum_probs=22.9

Q ss_pred             CCcEEeCCCCCCCEEE-cCCCcEEEeccCCccc
Q 006668          443 DQVVVHRDIKSGNILL-DSEMRGRLGDFGLAKL  474 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~  474 (636)
                      ...++|+|+.+.|||+ +.++.++++||..|..
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            4679999999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.66  E-value=0.17  Score=54.37  Aligned_cols=81  Identities=11%  Similarity=0.099  Sum_probs=52.4

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-------HHHHHHHHHHHHhccCC---CCceeeeecccccc
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-------QGLKEFMAEISSMGRLQ---HKNLVQMRGWCRKG  392 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~  392 (636)
                      ..+.||.|....||+....  +    ..++||.-.....       ........|...|+.+.   ..++.+++.+|.+ 
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~----~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--S----GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--C----ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-
Confidence            3567899999999997642  2    4688988762211       12233344566665553   3578889999874 


Q ss_pred             ceEEEEEeecCC--CChhhhH
Q 006668          393 NELMLVYDYMPN--GSLNNWI  411 (636)
Q Consensus       393 ~~~~lV~E~~~~--gsL~~~l  411 (636)
                       ..+++||++++  ..+.+-+
T Consensus       109 -~~vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        109 -MALIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             -CCEEEEeecCCcceehhhhh
Confidence             46788999976  3454443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.59  E-value=0.015  Score=59.57  Aligned_cols=134  Identities=13%  Similarity=0.064  Sum_probs=88.7

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-----------------HH-----HHHHHHHHHHhccCC
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-----------------QG-----LKEFMAEISSMGRLQ  378 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-----------------~~-----~~~~~~Ei~~l~~l~  378 (636)
                      ++..+.||-|.-+.+|.+....+     .+.++|.-.....                 ..     .-...+|...|+.|.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G-----~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~  168 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEG-----NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY  168 (465)
T ss_pred             hhhccccccccccceEEEecCCC-----CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence            57789999999999999986543     5677765432110                 00     012345777777774


Q ss_pred             CC--ceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCE
Q 006668          379 HK--NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNI  456 (636)
Q Consensus       379 h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI  456 (636)
                      .+  -+.+.++++    .-++|||++.+-.|...-     ...+..++.   ..+..-+.-|-   +.|+||+|..-=||
T Consensus       169 e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~-----~v~d~~~ly---~~lm~~Iv~la---~~GlIHgDFNEFNi  233 (465)
T KOG2268|consen  169 ERGFPVPKPIDHN----RHCVVMELVDGYPLRQVR-----HVEDPPTLY---DDLMGLIVRLA---NHGLIHGDFNEFNI  233 (465)
T ss_pred             HcCCCCCCccccc----ceeeHHHhhcccceeeee-----ecCChHHHH---HHHHHHHHHHH---HcCceecccchhee
Confidence            32  244555554    458999999887776532     222333333   33333445566   79999999999999


Q ss_pred             EEcCCCcEEEeccCCccc
Q 006668          457 LLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~  474 (636)
                      +++++..++++||--+..
T Consensus       234 mv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  234 MVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             EEecCCCEEEeechHhhc
Confidence            999999999999975543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.42  E-value=0.068  Score=56.34  Aligned_cols=144  Identities=16%  Similarity=0.214  Sum_probs=80.2

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eeeccccccceEEEEEeecC
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV-QMRGWCRKGNELMLVYDYMP  403 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~  403 (636)
                      +.|..|=...+|+....+.. .....|++|+........ -+-.+|..+++.+..-++. ++++++. .+   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~-~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEEN-GNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCC-CCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            44555777788988654321 112478899876654322 2235688888887655553 4555553 22   4899997


Q ss_pred             CCChhhh-------H----------hcCC---CC-CcChHHHHHHHHHH----------------------HHHHHHHh-
Q 006668          404 NGSLNNW-------I----------FGKP---KK-LLGWKQRRQILADV----------------------AEGLNYLH-  439 (636)
Q Consensus       404 ~gsL~~~-------l----------~~~~---~~-~l~~~~~~~i~~~i----------------------a~~L~yLH-  439 (636)
                      +..|..-       +          |...   .. .--|..+.++..++                      ..-+..+. 
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7665321       1          1111   00 11223222222111                      11111111 


Q ss_pred             --c--cCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCccc
Q 006668          440 --H--GWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKL  474 (636)
Q Consensus       440 --~--~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~  474 (636)
                        .  .....++|.|+.+.|||+++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1  12346899999999999974 57899999998864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.09  E-value=0.1  Score=50.71  Aligned_cols=137  Identities=15%  Similarity=0.092  Sum_probs=82.1

Q ss_pred             EEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHH
Q 006668          351 MAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA  429 (636)
Q Consensus       351 vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  429 (636)
                      ..+|++..-.-. ...-|..+.+++.+++  .|+++..-  ....+-++.|+|....           ...   .-.|..
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i~~---~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------INF---SNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------cch---hHHHHH
Confidence            445555432221 2345667777877764  46666632  4456788999883211           111   111222


Q ss_pred             HHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccch
Q 006668          430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDV  509 (636)
Q Consensus       430 ~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV  509 (636)
                      + +++|.-.|++ ..+.+|+|-.|+|||-|..|.+||.|-+.--.             .+..|.--|   ....+.++.+
T Consensus       150 g-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN~~---Y~~lT~~aE~  211 (308)
T PF07387_consen  150 G-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVNIE---YESLTQEAEV  211 (308)
T ss_pred             h-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEeee---ccccChHHHH
Confidence            2 4677888865 68899999999999999999999999664321             011122211   1234666777


Q ss_pred             HHHHHHHHHHHhCC
Q 006668          510 YSFGVVILEVACGR  523 (636)
Q Consensus       510 ~S~Gvll~ell~G~  523 (636)
                      -+|=.-++++....
T Consensus       212 ~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  212 KVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            77777777776543

The function of this family is unknown.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.04  E-value=0.14  Score=52.89  Aligned_cols=75  Identities=17%  Similarity=0.198  Sum_probs=47.6

Q ss_pred             eecCceEEEeeeecC----CCCCCceEEEEEEeccCCh-----HHHHHHHHHHHHhccCC-------------CCceeee
Q 006668          328 GSGGFGRVYKGTLAN----NNNNNSTEMAVKCVNHDSK-----QGLKEFMAEISSMGRLQ-------------HKNLVQM  385 (636)
Q Consensus       328 G~G~fG~Vykg~~~~----~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~-------------h~niv~l  385 (636)
                      |.|-.|.+|+.+...    .+......+.||.......     .....|.+|+...+.+-             .....+.
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            667788999888744    4555667899999873211     12345677776665441             1234555


Q ss_pred             eccccccceEEEEEeec
Q 006668          386 RGWCRKGNELMLVYDYM  402 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~  402 (636)
                      +....+.+..+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66555555688999866

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	636
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-35
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-21
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-21
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-15
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-15
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		4e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-12
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		5e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		6e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-10
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-10
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		6e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-08
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
1fat_A	252	Phytohemagglutinin-L Length = 252		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-08
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-08
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		4e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-08
1bzw_A	232	Peanut Lectin Complexed With C-Lactose Length = 232		7e-08
2pel_A	236	Peanut Lectin Length = 236		7e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-07
1avb_A	226	Arcelin-1 From Phaseolus Vulgaris L Length = 226		6e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-07
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		7e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		2e-06
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		3e-06
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-06
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-06
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		5e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-06
1hql_A	257	The Xenograft Antigen In Complex With The B4 Isolec		6e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-06
1gnz_A	257	Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m		6e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-06
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		7e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-06
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		8e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  208 bits (529), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 111/299 (37%), Positives = 174/299 (58%), Gaps = 8/299 (2%)
Query: 308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-E 366
           RFS  EL  A+  FSN  +LG GGFG+VYKG LA       T +AVK +  +  QG + +
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-----GTLVAVKRLKEERXQGGELQ 81
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL--LGWKQR 424
           F  E+  +    H+NL+++RG+C    E +LVY YM NGS+ + +  +P+    L W +R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
           ++I    A GL YLH   D  ++HRD+K+ NILLD E    +GDFGLAKL    +     
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            V GT+G++APE  +    +  +DV+ +GV++LE+  G+R  D+ +   +++ +L+DWV+
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVA 603
            L  + K+    D  ++  ++ EE+E ++++ L C       RP M EVV +L G  +A
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  202 bits (513), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 172/299 (57%), Gaps = 8/299 (2%)
Query: 308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-E 366
           RFS  EL  A+  F N  +LG GGFG+VYKG LA         +AVK +  +  QG + +
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL-----VAVKRLKEERTQGGELQ 73
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL--LGWKQR 424
           F  E+  +    H+NL+++RG+C    E +LVY YM NGS+ + +  +P+    L W +R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
           ++I    A GL YLH   D  ++HRD+K+ NILLD E    +GDFGLAKL    +     
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            V G +G++APE  +    +  +DV+ +GV++LE+  G+R  D+ +   +++ +L+DWV+
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVA 603
            L  + K+    D  ++  ++ EE+E ++++ L C       RP M EVV +L G  +A
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 155/291 (53%), Gaps = 13/291 (4%)
Query: 307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
           +R    +L +AT  F +  L+G G FG+VYKG L         ++A+K    +S QG++E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-----RDGAKVALKRRTPESSQGIEE 81
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQR 424
           F  EI ++   +H +LV + G+C + NE++L+Y YM NG+L   ++G   P   + W+QR
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
            +I    A GL+YLH    + ++HRD+KS NILLD     ++ DFG++K   + +  +  
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX 198
Query: 485 RVV-GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
            VV GTLGY+ PE       T  SDVYSFGVV+ EV C R  +   +    E   L +W 
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWA 256
Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
              +  G++ +  D  +  +   E +       + C    S  RP+M +V+
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 154/291 (52%), Gaps = 13/291 (4%)
Query: 307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
           +R    +L +AT  F +  L+G G FG+VYKG L         ++A+K    +S QG++E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-----RDGAKVALKRRTPESSQGIEE 81
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQR 424
           F  EI ++   +H +LV + G+C + NE++L+Y YM NG+L   ++G   P   + W+QR
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNT 483
            +I    A GL+YLH    + ++HRD+KS NILLD     ++ DFG++K   + G+    
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX 198
Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
             V GTLGY+ PE       T  SDVYSFGVV+ EV C R  +   +    E   L +W 
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWA 256
Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
              +  G++ +  D  +  +   E +       + C    S  RP+M +V+
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 164/313 (52%), Gaps = 32/313 (10%)
Query: 307 HRFSYEELSKATKGFSNDEL------LGSGGFGRVYKGTLAXXXXXXSTEMAVK----CV 356
           H FS+ EL   T  F    +      +G GGFG VYKG +       +T +AVK     V
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV------NNTTVAVKKLAAMV 66
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF---G 413
           +  +++  ++F  EI  M + QH+NLV++ G+   G++L LVY YMPNGSL + +    G
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
            P   L W  R +I    A G+N+LH       +HRDIKS NILLD     ++ DFGLA+
Sbjct: 127 TPP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 474 LYQQ-GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
             ++  +    +R+VGT  Y+APE A     T  SD+YSFGVV+LE+  G   +D  +  
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-- 238
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
            E + +L         +  I +  D ++  + ++  +E +  +   C H    +RP +++
Sbjct: 239 -EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 593 VVAVLVGQEVAAT 605
           V  +L  QE+ A+
Sbjct: 297 VQQLL--QEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 163/313 (52%), Gaps = 32/313 (10%)
Query: 307 HRFSYEELSKATKGFSNDEL------LGSGGFGRVYKGTLAXXXXXXSTEMAVK----CV 356
           H FS+ EL   T  F    +      +G GGFG VYKG +       +T +AVK     V
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV------NNTTVAVKKLAAMV 66
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF---G 413
           +  +++  ++F  EI  M + QH+NLV++ G+   G++L LVY YMPNGSL + +    G
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
            P   L W  R +I    A G+N+LH       +HRDIKS NILLD     ++ DFGLA+
Sbjct: 127 TPP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 474 LYQQ-GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
             ++  +     R+VGT  Y+APE A     T  SD+YSFGVV+LE+  G   +D  +  
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-- 238
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
            E + +L         +  I +  D ++  + ++  +E +  +   C H    +RP +++
Sbjct: 239 -EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 593 VVAVLVGQEVAAT 605
           V  +L  QE+ A+
Sbjct: 297 VQQLL--QEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  153 bits (387), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 108/313 (34%), Positives = 163/313 (52%), Gaps = 32/313 (10%)
Query: 307 HRFSYEELSKATKGFSNDEL------LGSGGFGRVYKGTLAXXXXXXSTEMAVK----CV 356
           H FS+ EL   T  F    +      +G GGFG VYKG +       +T +AVK     V
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV------NNTTVAVKKLAAMV 60
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF---G 413
           +  +++  ++F  EI  M + QH+NLV++ G+   G++L LVY YMPNGSL + +    G
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
            P   L W  R +I    A G+N+LH       +HRDIKS NILLD     ++ DFGLA+
Sbjct: 121 TPP--LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 474 LYQQ-GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
             ++  +     R+VGT  Y+APE A     T  SD+YSFGVV+LE+  G   +D    E
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD----E 230
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
             E  +L+D    +  + K  E    +   + ++  +E +  +   C H    +RP +++
Sbjct: 231 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 290
Query: 593 VVAVLVGQEVAAT 605
           V  +L  QE+ A+
Sbjct: 291 VQQLL--QEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 158/313 (50%), Gaps = 32/313 (10%)
Query: 307 HRFSYEELSKATKGFSNDEL------LGSGGFGRVYKGTLAXXXXXXSTEMAVK----CV 356
           H FS+ EL   T  F    +       G GGFG VYKG +       +T +AVK     V
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV------NNTTVAVKKLAAMV 57
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF---G 413
           +  +++  ++F  EI    + QH+NLV++ G+   G++L LVY Y PNGSL + +    G
Sbjct: 58  DITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG 117
Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
            P   L W  R +I    A G+N+LH       +HRDIKS NILLD     ++ DFGLA+
Sbjct: 118 TPP--LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 172
Query: 474 LYQQ-GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
             ++  +    +R+VGT  Y APE A     T  SD+YSFGVV+LE+  G   +D    E
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD----E 227
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
             E  +L+D    +  + K  E    +   + ++  +E    +   C H    +RP +++
Sbjct: 228 HREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKK 287
Query: 593 VVAVLVGQEVAAT 605
           V  +L  QE  A+
Sbjct: 288 VQQLL--QEXTAS 298

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 51/288 (17%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRL----QH 379
           +E++G GGFG+VY+            E+AVK   HD  + + + +  +    +L    +H
Sbjct: 12  EEIIGIGGFGKVYRA------FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLN 436
            N++ +RG C K   L LV ++   G LN  + GK   P  L+ W         +A G+N
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARGMN 119
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRG--------RLGDFGLAKLYQQGEVPNTTRV-- 486
           YLH      ++HRD+KS NIL+  ++          ++ DFGLA+ + +     TT++  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TTKMSA 174
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
            G   ++APE+   S  +  SDV+S+GV++ E+  G  P                  R +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----------------RGI 217
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
            G       A  ++     +   E   KL   C +PD   RP+   ++
Sbjct: 218 DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 28/281 (9%)
Query: 322 SNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQH 379
           +  +++G+G FG VYKG L          +A+K +   +  KQ + +F+ E   MG+  H
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSH 105
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N++++ G   K   +M++ +YM NG+L+ ++  K  +     Q   +L  +A G+ YL 
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLA 164
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG--YLAPEL 497
              +   VHRD+ + NIL++S +  ++ DFGL+++ +       T   G +   + APE 
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 498 ATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
            +    TSASDV+SFG+V+ EV   G RP                W        ++ +A 
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPY---------------WE---LSNHEVMKAI 263
Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +   R     +    + +L + C   +  RRP   ++V++L
Sbjct: 264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 97/344 (28%), Positives = 156/344 (45%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGLA++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W  +      + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 11/204 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNL 382
           E +G+G FG V++           +++AVK +       + + EF+ E++ M RL+H N+
Sbjct: 43  EKIGAGSFGTVHRAEW------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHG 441
           V   G   +   L +V +Y+  GSL   +     ++ L  ++R  +  DVA+G+NYLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
            +  +VHRD+KS N+L+D +   ++ DFGL++L +      +    GT  ++APE+    
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 502 SPTSASDVYSFGVVILEVACGRRP 525
                SDVYSFGV++ E+A  ++P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 156/344 (45%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W  +      + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 156/344 (45%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W  +      + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 158/346 (45%), Gaps = 51/346 (14%)
Query: 306 PHRFSYEELSKATKGFSN---------DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC- 355
           PH  +YE+ ++    F+          D+++G+G FG V  G L          +A+K  
Sbjct: 23  PH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTL 79
Query: 356 -VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
            V +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K
Sbjct: 80  KVGYTEKQR-RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 137
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
                   Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++
Sbjct: 138 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 194
Query: 475 YQQG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKG 531
            +   E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP      
Sbjct: 195 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 249
Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR 591
                     W  +      + +A D   R     +    + +L L C   D   RP   
Sbjct: 250 ----------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 296
Query: 592 EVVAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           ++V++L           +    AA P  LL D +   +    + GD
Sbjct: 297 QIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 342

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 158/346 (45%), Gaps = 51/346 (14%)
Query: 306 PHRFSYEELSKATKGFSN---------DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC- 355
           PH  +YE+ ++    F+          D+++G+G FG V  G L          +A+K  
Sbjct: 25  PH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTL 81
Query: 356 -VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
            V +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
                   Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 475 YQQG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKG 531
            +   E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR 591
                     W  +      + +A D   R     +    + +L L C   D   RP   
Sbjct: 252 ----------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 592 EVVAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           ++V++L           +    AA P  LL D +   +    + GD
Sbjct: 299 QIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 156/344 (45%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W  +      + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 158/346 (45%), Gaps = 51/346 (14%)
Query: 306 PHRFSYEELSKATKGFSN---------DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC- 355
           PH  +YE+ ++    F+          D+++G+G FG V  G L          +A+K  
Sbjct: 25  PH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTL 81
Query: 356 -VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
            V +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RK 139
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
                   Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 475 YQQG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKG 531
            +   E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR 591
                     W  +      + +A D   R     +    + +L L C   D   RP   
Sbjct: 252 ----------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 592 EVVAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           ++V++L           +    AA P  LL D +   +    + GD
Sbjct: 299 QIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/323 (28%), Positives = 150/323 (46%), Gaps = 42/323 (13%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQ 378
            S D+++G+G FG V  G L          +A+K   V +  KQ  ++F+ E S MG+  
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKVGYTEKQR-RDFLGEASIMGQFD 75
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++++ G   K   +M+V +YM NGSL++++  K        Q   +L  +A G+ YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGT-LGYLAPE 496
               D   VHRD+ + NIL++S +  ++ DFGL+++ +   E   TTR     + + +PE
Sbjct: 135 S---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 497 LATVSSPTSASDVYSFGVVILEV-ACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                  TSASDV+S+G+V+ EV + G RP  +M   +                   + +
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------------------VIK 232
Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL-----------VGQEVA 603
           A D   R     +    + +L L C   D   RP   ++V++L           +    A
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 292
Query: 604 ATPKELLGDLARGAVDADFSGGD 626
           A P  LL D +   +    + GD
Sbjct: 293 ARPSNLLLDQSNVDITTFRTTGD 315

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 155/344 (45%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V +YM NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL ++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W  +      + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 114/204 (55%), Gaps = 11/204 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNL 382
           E +G+G FG V++           +++AVK +       + + EF+ E++ M RL+H N+
Sbjct: 43  EKIGAGSFGTVHRAEW------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHG 441
           V   G   +   L +V +Y+  GSL   +     ++ L  ++R  +  DVA+G+NYLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
            +  +VHR++KS N+L+D +   ++ DFGL++L +     ++    GT  ++APE+    
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 502 SPTSASDVYSFGVVILEVACGRRP 525
                SDVYSFGV++ E+A  ++P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 225 FSVASDVWSFGVVLYEL 241

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 139
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 200 FSVASDVWSFGVVLYEL 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 137
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 198 FSVASDVWSFGVVLYEL 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 138
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 199 FSVASDVWSFGVVLYEL 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 132
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 193 FSVASDVWSFGVVLYEL 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 140
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 201 FSVASDVWSFGVVLYEL 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 149/322 (46%), Gaps = 40/322 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQ 378
            S D+++G+G FG V  G L          +A+K   V +  KQ  ++F+ E S MG+  
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 92
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++++ G   K   +M+V +YM NGSL++++  K        Q   +L  +A G+ YL
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGT-LGYLAPE 496
               D   VHRD+ + NIL++S +  ++ DFGL+++ +   E   TTR     + + +PE
Sbjct: 152 S---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 497 LATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
                  TSASDV+S+G+V+ EV + G RP                W  +      + +A
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMS---NQDVIKA 250
Query: 556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL-----------VGQEVAA 604
            D   R     +    + +L L C   D   RP   ++V++L           +    AA
Sbjct: 251 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 310
Query: 605 TPKELLGDLARGAVDADFSGGD 626
            P  LL D +   +    + GD
Sbjct: 311 RPSNLLLDQSNVDITTFRTTGD 332

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 131
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 192 FSVASDVWSFGVVLYEL 208

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 212 FSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 212 FSVASDVWSFGVVLYEL 228

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 145/305 (47%), Gaps = 38/305 (12%)
Query: 306 PHRFSYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV 356
           PH  +YEE  +A + F+ +         +++GSG  G V  G L          +A+K +
Sbjct: 29  PH--TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL-RVPGQRDVPVAIKAL 85
Query: 357 NHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
               +++  ++F++E S MG+  H N++++ G   +G   M+V +YM NGSL+ ++    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
            +     Q   +L  V  G+ YL    D   VHRD+ + N+L+DS +  ++ DFGL+++ 
Sbjct: 146 GQFT-IMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 476 QQGEVPNTTRVVGTLG--YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGE 532
           +       T   G +   + APE     + +SASDV+SFGVV+ EV A G RP       
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------ 255
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
                    W  N+  +  I    +   R          + +L L C H D  +RP   +
Sbjct: 256 ---------W--NMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 593 VVAVL 597
           +V+VL
Sbjct: 304 IVSVL 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 145/305 (47%), Gaps = 38/305 (12%)
Query: 306 PHRFSYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV 356
           PH  +YEE  +A + F+ +         +++GSG  G V  G L          +A+K +
Sbjct: 29  PH--TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL-RVPGQRDVPVAIKAL 85
Query: 357 NHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
               +++  ++F++E S MG+  H N++++ G   +G   M+V +YM NGSL+ ++    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
            +     Q   +L  V  G+ YL    D   VHRD+ + N+L+DS +  ++ DFGL+++ 
Sbjct: 146 GQFT-IMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 476 QQGEVPNTTRVVGTLG--YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGE 532
           +       T   G +   + APE     + +SASDV+SFGVV+ EV A G RP       
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------ 255
Query: 533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
                    W  N+  +  I    +   R          + +L L C H D  +RP   +
Sbjct: 256 ---------W--NMTNRDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303
Query: 593 VVAVL 597
           +V+VL
Sbjct: 304 IVSVL 308

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++    +++   K   Q  + + +G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLL-QYTSQICKGMEYL---GTK 136
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +++P GSL  ++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HRD+ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 197 FSVASDVWSFGVVLYEL 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 95/344 (27%), Positives = 154/344 (44%), Gaps = 47/344 (13%)
Query: 306 PHRF-----SYEELSKA--TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--V 356
           PH F     +  E +K       S D+++G+G FG V  G L          +A+K   V
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKV 83
Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
            +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V + M NGSL++++  K  
Sbjct: 84  GYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHD 141
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 477 QG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE 533
              E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP        
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------- 251
Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   W         + +A D   R     +    + +L L C   D   RP   ++
Sbjct: 252 --------WE---MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 594 VAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           V++L           +    AA P  LL D +   +    + GD
Sbjct: 301 VSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 157/346 (45%), Gaps = 51/346 (14%)
Query: 306 PHRFSYEELSKATKGFSN---------DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC- 355
           PH  +YE+ ++    F+          D+++G+G FG V  G L          +A+K  
Sbjct: 25  PH--TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTL 81
Query: 356 -VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
            V +  KQ  ++F+ E S MG+  H N++++ G   K   +M+V + M NGSL++++  K
Sbjct: 82  KVGYTEKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RK 139
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
                   Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 475 YQQG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKG 531
            +   E   TTR     + + +PE       TSASDV+S+G+V+ EV + G RP      
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----- 251
Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR 591
                     W  +      + +A D   R     +    + +L L C   D   RP   
Sbjct: 252 ----------WEMS---NQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 592 EVVAVL-----------VGQEVAATPKELLGDLARGAVDADFSGGD 626
           ++V++L           +    AA P  LL D +   +    + GD
Sbjct: 299 QIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H +++ L++F  EI  +  LQH N+V+ +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 387 GWCRKG--NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           G C       L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 134
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSS 502
             +HR++ + NIL+++E R ++GDFGL K+  Q +     +  G   + + APE  T S 
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 503 PTSASDVYSFGVVILEV 519
            + ASDV+SFGVV+ E+
Sbjct: 195 FSVASDVWSFGVVLYEL 211

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 90/323 (27%), Positives = 149/323 (46%), Gaps = 42/323 (13%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQ 378
            S D+++G+G FG V  G L          +A+K   V +  KQ  ++F+ E S MG+  
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKK-EISVAIKTLKVGYTEKQR-RDFLGEASIMGQFD 75
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++++ G   K   +M+V + M NGSL++++  K        Q   +L  +A G+ YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGT-LGYLAPE 496
               D   VHRD+ + NIL++S +  ++ DFGL+++ +   E   TTR     + + +PE
Sbjct: 135 S---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 497 LATVSSPTSASDVYSFGVVILEV-ACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                  TSASDV+S+G+V+ EV + G RP  +M   +                   + +
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------------------VIK 232
Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL-----------VGQEVA 603
           A D   R     +    + +L L C   D   RP   ++V++L           +    A
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA 292
Query: 604 ATPKELLGDLARGAVDADFSGGD 626
           A P  LL D +   +    + GD
Sbjct: 293 ARPSNLLLDQSNVDITTFRTTGD 315

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 22/234 (9%)
Query: 306 PHRFSYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC- 355
           PH  +YE+ ++A   F+ +          ++G+G FG V  G L          +A+K  
Sbjct: 2   PH--TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKR-ELPVAIKTL 58
Query: 356 -VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
            V +  KQ  ++F+ E S MG+  H N++ + G   K   +M+V +YM NGSL+ ++  K
Sbjct: 59  KVGYTEKQR-RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KK 116
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
                   Q   +L  ++ G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++
Sbjct: 117 NDGQFTVIQLVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 475 YQQG-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRP 525
            +   E   TTR     + + APE       TSASDV+S+G+V+ EV   G RP
Sbjct: 174 LEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 124/232 (53%), Gaps = 20/232 (8%)
Query: 309 FSYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD 359
           F++E+ ++A + F+ +         +++G+G FG V  G L          +A+K +   
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR-EIFVAIKTLKSG 72
Query: 360 -SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL 418
            +++  ++F++E S MG+  H N++ + G   K   +M++ ++M NGSL++++     + 
Sbjct: 73  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 132
Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
               Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL++  +  
Sbjct: 133 TVI-QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 479 EV-PNTTRVVG---TLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
              P  T  +G    + + APE       TSASDV+S+G+V+ EV + G RP
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 119/230 (51%), Gaps = 20/230 (8%)
Query: 310 SYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC--VNH 358
           +YE+ ++A   F+ +          ++G+G FG V  G L          +A+K   V +
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKR-DVAVAIKTLKVGY 83
Query: 359 DSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL 418
             KQ  ++F+ E S MG+  H N+V + G   +G  +M+V ++M NG+L+ ++  K    
Sbjct: 84  TEKQ-RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQ 141
Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
               Q   +L  +A G+ YL    D   VHRD+ + NIL++S +  ++ DFGL+++ +  
Sbjct: 142 FTVIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 479 EVPNTTRVVGTLG--YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
                T   G +   + APE       TSASDV+S+G+V+ EV + G RP
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 122/231 (52%), Gaps = 20/231 (8%)
Query: 309 FSYEELSKATKGFSND---------ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-- 357
           F++E+ ++A + F+ +         +++G G FG V  G L          +A+K +   
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREIC-VAIKTLKAG 68
Query: 358 HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK 417
           +  KQ  ++F++E S MG+  H N++ + G   K   +M++ +YM NGSL+ ++  K   
Sbjct: 69  YTDKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDG 126
Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
                Q   +L  +  G+ YL    D   VHRD+ + NIL++S +  ++ DFG++++ + 
Sbjct: 127 RFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 478 G-EVPNTTRVVGT-LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
             E   TTR     + + APE       TSASDV+S+G+V+ EV + G RP
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           +E++G+G FG V +G L       S  +A+K +    +++  +EF++E S MG+ +H N+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESC-VAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G       +M++ ++M NG+L++++     +     Q   +L  +A G+ YL    
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI-QLVGMLRGIASGMRYLA--- 135
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVG---TLGYLAPELA 498
           +   VHRD+ + NIL++S +  ++ DFGL++  ++    P  T  +G    + + APE  
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 499 TVSSPTSASDVYSFGVVILEV-ACGRRP 525
                TSASD +S+G+V+ EV + G RP
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 116/208 (55%), Gaps = 11/208 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           +E++G+G FG V +G L       S  +A+K +    +++  +EF++E S MG+ +H N+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESC-VAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G       +M++ ++M NG+L++++     +     Q   +L  +A G+ YL    
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV-IQLVGMLRGIASGMRYLA--- 133
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVG---TLGYLAPELA 498
           +   VHRD+ + NIL++S +  ++ DFGL++  ++    P  T  +G    + + APE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 499 TVSSPTSASDVYSFGVVILEV-ACGRRP 525
                TSASD +S+G+V+ EV + G RP
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCV---NHDSKQGLKEFMAEISSMGRLQHKNLV 383
           LG GG   VY           + ++A+K +     + ++ LK F  E+ +  +L H+N+V
Sbjct: 19  LGGGGMSTVY----LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            M     + +   LV +Y+   +L+ +I  +    L           + +G+    H  D
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIK---HAHD 129
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
             +VHRDIK  NIL+DS    ++ DFG+AK   +  +  T  V+GT+ Y +PE A   + 
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 504 TSASDVYSFGVVILEVACGRRPLD 527
              +D+YS G+V+ E+  G  P +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 136/291 (46%), Gaps = 44/291 (15%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTE----MAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           LG G FG+V+   LA       T+    +AVK +   +    K+F  E   +  LQH+++
Sbjct: 23  LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNW-----------IFGKPKKL---LGWKQRRQIL 428
           V+  G C  G+ L++V++YM +G LN +           + G+P++    LG  Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
           + +A G+ YL     Q  VHRD+ + N L+ + +  ++GDFG+++ +Y           +
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             + ++ PE       T+ SDV+SFGV++ E+   G++P       E  E +        
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT------- 249
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             QG++ E      ++ ++         + L C   +  +R  ++E+  +L
Sbjct: 250 --QGRVLERPRVCPKEVYD---------VMLGCWQREPQQRLNIKEIYKIL 289

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K    +E++G G FG V K          + ++A+K +  +S++  K F+ E+  + R+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW------RAKDVAIKQIESESER--KAFIVELRQLSRVN 59
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNY 437
           H N+V++ G C   N + LV +Y   GSL N + G +P                ++G+ Y
Sbjct: 60  HPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 438 LHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           LH    + ++HRD+K  N+LL +     ++ DFG A   Q     + T   G+  ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPE 173
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
           +   S+ +   DV+S+G+++ EV   R+P D   G     A  + W            A 
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMW------------AV 217
Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
               R        + +  L   C   D ++RP+M E+V ++
Sbjct: 218 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 39/293 (13%)
Query: 307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE 366
           H   Y+E+         +E++G G FG V K          + ++A+K +  +S++  K 
Sbjct: 4   HMIDYKEIEV-------EEVVGRGAFGVVCKAKW------RAKDVAIKQIESESER--KA 48
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRR 425
           F+ E+  + R+ H N+V++ G C   N + LV +Y   GSL N + G +P          
Sbjct: 49  FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 106
Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTT 484
                 ++G+ YLH    + ++HRD+K  N+LL +     ++ DFG A   Q     + T
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMT 162
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
              G+  ++APE+   S+ +   DV+S+G+++ EV   R+P D   G     A  + W  
Sbjct: 163 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMW-- 216
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                     A     R        + +  L   C   D ++RP+M E+V ++
Sbjct: 217 ----------AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 192 LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 192 LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 16  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 69
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 70  AVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 125
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 186 SDVWSFGILLTELTTKGRVP 205

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 19  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 72
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 73  AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 128
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 189 SDVWSFGILLTELTTKGRVP 208

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 11/207 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKN 381
           ++++G G FG V  G L          +A+K +   +  KQ  ++F++E S MG+  H N
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREIC-VAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 70
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++ + G   K   +M++ +YM NGSL+ ++  K        Q   +L  +  G+ YL   
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLS-- 127
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGT-LGYLAPELAT 499
            D   VHRD+ + NIL++S +  ++ DFG++++ +   E   TTR     + + APE   
Sbjct: 128 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 500 VSSPTSASDVYSFGVVILEV-ACGRRP 525
               TSASDV+S+G+V+ EV + G RP
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 11/207 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKN 381
           ++++G G FG V  G L          +A+K +   +  KQ  ++F++E S MG+  H N
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREIC-VAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPN 76
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++ + G   K   +M++ +YM NGSL+ ++  K        Q   +L  +  G+ YL   
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLS-- 133
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGT-LGYLAPELAT 499
            D   VHRD+ + NIL++S +  ++ DFG++++ +   E   TTR     + + APE   
Sbjct: 134 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 500 VSSPTSASDVYSFGVVILEV-ACGRRP 525
               TSASDV+S+G+V+ EV + G RP
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 19  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 72
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 112/208 (53%), Gaps = 11/208 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           ++++G+G FG V  G L          +A+K +    +++  ++F++E S MG+  H N+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + + G   K   +M++ ++M NGSL++++     +     Q   +L  +A G+ YL    
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI-QLVGMLRGIAAGMKYLA--- 126
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVG---TLGYLAPELA 498
           D   VHR + + NIL++S +  ++ DFGL++  +     P  T  +G    + + APE  
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 499 TVSSPTSASDVYSFGVVILEV-ACGRRP 525
                TSASDV+S+G+V+ EV + G RP
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 275 LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 384
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 20  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 73
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 74  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 129
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIP 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 19  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 72
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 21  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 74
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 75  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 130
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIP 212

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 24  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 77
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 78  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 133
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 25  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 78
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 134
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 14  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 67
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 68  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 123
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIP 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 17  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 70
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 71  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 126
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 187 SDVWSFGILLTELTTKGRVP 206

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V               +AVK +  D+  Q    +  EI  +  L H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 386 RGWCRKGN--ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C       L LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH---A 152
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVS 501
           Q  +HRD+ + N+LLD++   ++GDFGLAK   +G      R  G   + + APE     
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 213 KFYYASDVWSFGVTLYEL 230

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 15  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 68
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 69  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 124
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 185 SDVWSFGILLTELTTKGRVP 204

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 192 LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 246 AVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 19  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 28  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 81
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 82  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 137
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIP 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 27  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 80
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 81  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 136
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIP 218

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS--KQGL-KEFMAE 370
           + +  + F    LLG G F  VY+            E+A+K ++  +  K G+ +    E
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAE----SIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 371 ISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD 430
           +    +L+H +++++  +    N + LV +   NG +N ++  + K      + R  +  
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF-SENEARHFMHQ 120
Query: 431 VAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VV 487
           +  G+ YLH HG    ++HRD+   N+LL   M  ++ DFGLA    Q ++P+     + 
Sbjct: 121 IITGMLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLA---TQLKMPHEKHYTLC 173
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           GT  Y++PE+AT S+    SDV+S G +   +  GR P D
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V              ++AVK +  +S    + +   EI  +  L H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 386 RGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C +  GN + L+ +++P+GSL  ++  K K  +  KQ+ +    + +G++YL  G  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSR 145
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           Q V HRD+ + N+L++SE + ++GDFGL K  +  +   T +      + + APE    S
Sbjct: 146 QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 205 KFYIASDVWSFGVTLHEL 222

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 25  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 78
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 134
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V              ++AVK +  +S    + +   EI  +  L H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 386 RGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C +  GN + L+ +++P+GSL  ++  K K  +  KQ+ +    + +G++YL  G  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSR 133
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           Q V HRD+ + N+L++SE + ++GDFGL K  +  +   T +      + + APE    S
Sbjct: 134 QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 193 KFYIASDVWSFGVTLHEL 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 29  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 82
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 83  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 138
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 23  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 77  AVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG G +G VYK             +A+K V  +S   L+E + EIS M +    ++V+
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQI----VAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G   K  +L +V +Y   GS+++ I  +  K L   +   IL    +GL YLH     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRDIK+GNILL++E   +L DFG+A       +     V+GT  ++APE+       
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 505 SASDVYSFGVVILEVACGRRP 525
             +D++S G+  +E+A G+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V               +AVK +  D   Q    +  EI  +  L H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 386 RGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C    E  L LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH---S 135
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVS 501
           Q  +HR++ + N+LLD++   ++GDFGLAK   +G      R  G   + + APE     
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 196 KFYYASDVWSFGVTLYEL 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +        + F+ E   M +L+H+ LVQ+ 
Sbjct: 193 LGQGCFGEVWMGTW-----NGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLY 246
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 247 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 302
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGL +L +  E          + + APE A     T  
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 507 SDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SDV+SFG+++ E+   GR P       E     ++D V   Y             R    
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGY-------------RMPCP 404
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGD 612
            E  E +  L   C   D   RPT   + A L     +  P+   G+
Sbjct: 405 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQPGE 451

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 23  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 77  AVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V               +AVK +  D   Q    +  EI  +  L H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 386 RGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C    E  L LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH---A 135
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVS 501
           Q  +HR++ + N+LLD++   ++GDFGLAK   +G      R  G   + + APE     
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 196 KFYYASDVWSFGVTLYEL 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +++H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+ + NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           ++ LG+G FG V+  T         T++AVK +   S   ++ F+AE + M  LQH  LV
Sbjct: 20  EKKLGAGQFGEVWMATY-----NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 73
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD----VAEGLNYLH 439
           ++     K   + ++ ++M  GSL +++    K   G KQ    L D    +AEG+ ++ 
Sbjct: 74  KLHAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRD+++ NIL+ + +  ++ DFGLA++ +  E          + + APE   
Sbjct: 129 Q---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 500 VSSPTSASDVYSFGVVILEVAC-GRRP 525
             S T  SDV+SFG++++E+   GR P
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 15  ERLGAGQFGEVWMG-----YYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 68
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 124
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HR++++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIP 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+              + AVK +   S    K+F  E   +  LQH+++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIF-----------GKPKKLLGWKQRRQILADVAEG 434
            G C +G+ L++V++YM +G LN ++            G P   L   Q   I   +A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL     Q  VHRD+ + N L+   +  ++GDFG+++ +Y           +  + ++
Sbjct: 141 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 494 APELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
            PE       T+ SDV+S GVV+ E+   G++P
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-------LKEFMAEISSMGR 376
           ++ +G GGFG V+KG L        + +A+K +     +G        +EF  E+  M  
Sbjct: 24  EKQIGKGGFGLVHKGRLVKD----KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++ G     N   +V +++P G L + +  K   +  W  + +++ D+A G+ 
Sbjct: 80  LNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIE 136
Query: 437 YLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
           Y+ +  +  +VHRD++S NI L S      +  ++ DFGL+    Q  V + + ++G   
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQ 191
Query: 492 YLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           ++APE   A   S T  +D YSF +++  +  G  P D
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  G L +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 120/231 (51%), Gaps = 16/231 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF-MAEISSMG 375
           ++  F   E LG+G +  VYKG            +A+K V  DS++G     + EIS M 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG----LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMK 58
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPN---GSLNNWIFGKPKKLLGWKQRRQILADVA 432
            L+H+N+V++       N+L LV+++M N     +++   G   + L     +     + 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLG 491
           +GL + H   +  ++HRD+K  N+L++   + +LGDFGLA+ +  G   NT +  V TL 
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLW 173
Query: 492 YLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           Y AP++   S   S S D++S G ++ E+  G +PL  G  +EE+  ++ D
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKLIFD 223

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 19/204 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 18  QTIGKGEFGDVMLGD------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 69
Query: 385 MRGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + G     KG  L +V +YM  GSL +++  + + +LG     +   DV E + YL    
Sbjct: 70  LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 125
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRD+ + N+L+  +   ++ DFGL K  +     +T ++   + + APE    ++
Sbjct: 126 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREAA 181
Query: 503 PTSASDVYSFGVVILEV-ACGRRP 525
            ++ SDV+SFG+++ E+ + GR P
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V+ GT        +T +A+K +   +    + F+ E   M +L+H+ LVQ+ 
Sbjct: 26  LGQGCFGEVWMGTW-----NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  G L +++ G+  K L   Q   + A +A G+ Y+        
Sbjct: 80  AVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           VHRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           + LG G FG+V  G           ++AVK +N    + L    +   EI ++   +H +
Sbjct: 22  DTLGVGTFGKVKVGK----HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++       +++ +V +Y+  G L ++I    +  L  K+ R++   +  G++Y H  
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHR- 134
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-- 499
              +VVHRD+K  N+LLD+ M  ++ DFGL+ +   GE    +   G+  Y APE+ +  
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPEVISGR 190
Query: 500 -VSSPTSASDVYSFGVVILEVACGRRPLD 527
             + P    D++S GV++  + CG  P D
Sbjct: 191 LYAGP--EVDIWSSGVILYALLCGTLPFD 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           ++ LG+G FG V+  T         T++AVK +   S   ++ F+AE + M  LQH  LV
Sbjct: 193 EKKLGAGQFGEVWMATY-----NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 246
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD----VAEGLNYLH 439
           ++     K   + ++ ++M  GSL +++    K   G KQ    L D    +AEG+ ++ 
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRD+++ NIL+ + +  ++ DFGLA++ +  E          + + APE   
Sbjct: 302 Q---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 500 VSSPTSASDVYSFGVVILEVAC-GRRP 525
             S T  SDV+SFG++++E+   GR P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 13  IGSGQFGLVHLGYW-----LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV+++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 183 SDVWSFGVLMWEV 195

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 16  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 229
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 230 ASEK--VYTIMYSCWHEKADERPTFK 253

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 199 QTIGKGEFGDVMLGDY------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 385 MRGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + G     KG  L +V +YM  GSL +++  + + +LG     +   DV E + YL    
Sbjct: 251 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRD+ + N+L+  +   ++ DFGL K  +     +T ++   + + APE      
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKK 362
Query: 503 PTSASDVYSFGVVILEV-ACGRRP 525
            ++ SDV+SFG+++ E+ + GR P
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 18  IGSGQFGLVHLGYW-----LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV+++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 188 SDVWSFGVLMWEV 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 27  QTIGKGEFGDVMLGDY------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 385 MRGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + G     KG  L +V +YM  GSL +++  + + +LG     +   DV E + YL    
Sbjct: 79  LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 134
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRD+ + N+L+  +   ++ DFGL K  +     +T ++   + + APE      
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKK 190
Query: 503 PTSASDVYSFGVVILEV-ACGRRP 525
            ++ SDV+SFG+++ E+ + GR P
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 15  IGSGQFGLVHLGYW-----LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV+++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 185 SDVWSFGVLMWEV 197

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 17  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 230
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 231 ASEK--VYTIMYSCWHEKADERPTFK 254

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 20  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 72
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K+   I    A G++YLH    +
Sbjct: 73  FMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLH---AK 127
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATV--S 501
            ++HRD+KS NI L  +   ++GDFGLA +  +    +   ++ G++ ++APE+  +  S
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G  G V+ G          T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 19  ERLGAGQAGEVWMG-----YYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+++ NIL+   +  ++ DFGLA+L +  E          + + APE     + T
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 505 SASDVYSFGVVILEVAC-GRRP 525
             SDV+SFG+++ E+   GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 12  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 225
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 226 ASEK--VYTIMYSCWHEKADERPTFK 249

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 12  QTIGKGEFGDVMLGD------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 385 MRGWC--RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + G     KG  L +V +YM  GSL +++  + + +LG     +   DV E + YL    
Sbjct: 64  LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 119
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRD+ + N+L+  +   ++ DFGL K  +     +T ++   + + APE      
Sbjct: 120 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKK 175
Query: 503 PTSASDVYSFGVVILEV-ACGRRP 525
            ++ SDV+SFG+++ E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 23  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 236
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 237 ASEK--VYTIMYSCWHEKADERPTFK 260

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLVQM 385
           LG G FG+V               +AVK +       L+  +  EI  +  L H+++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 386 RGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C    E  + LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH---A 130
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVS 501
           Q  +HR + + N+LLD++   ++GDFGLAK   +G      R  G   + + APE     
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 191 KFYYASDVWSFGVTLYEL 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 32  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 245
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 246 ASEK--VYTIMYSCWHEKADERPTFK 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +   S     +F+ E   M +L H  LVQ+ 
Sbjct: 35  IGSGQFGLVHLGYW-----LNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLY 88
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV+++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 205 SDVWSFGVLMWEV 217

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLVQM 385
           LG G FG+V               +AVK +       L+  +  EI  +  L H+++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 386 RGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +G C    E  + LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLH---A 129
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATVS 501
           Q  +HR + + N+LLD++   ++GDFGLAK   +G      R  G   + + APE     
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 502 SPTSASDVYSFGVVILEV 519
               ASDV+SFGV + E+
Sbjct: 190 KFYYASDVWSFGVTLYEL 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+              + AVK +   S+   ++F  E   +  LQH+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKL-----------LGWKQRRQILADVA 432
            G C +G  L++V++YM +G LN ++   G   KL           LG  Q   + + VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
            G+ YL        VHRD+ + N L+   +  ++GDFG+++ +Y         R +  + 
Sbjct: 146 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
           ++ PE       T+ SDV+SFGVV+ E+   G++P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 17  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 230
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 231 ASEK--VYTIMYSCWHEKADERPTFK 254

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+              + AVK +   S+   ++F  E   +  LQH+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKL-----------LGWKQRRQILADVA 432
            G C +G  L++V++YM +G LN ++   G   KL           LG  Q   + + VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
            G+ YL        VHRD+ + N L+   +  ++GDFG+++ +Y         R +  + 
Sbjct: 140 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
           ++ PE       T+ SDV+SFGVV+ E+   G++P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG+V+              + AVK +   S+   ++F  E   +  LQH+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKL-----------LGWKQRRQILADVA 432
            G C +G  L++V++YM +G LN ++   G   KL           LG  Q   + + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
            G+ YL        VHRD+ + N L+   +  ++GDFG+++ +Y         R +  + 
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRP 525
           ++ PE       T+ SDV+SFGVV+ E+   G++P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 15  IGSGQFGLVHLGYW-----LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV+++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 185 SDVWSFGVLMWEV 197

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 11/208 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LGSG FG V  G           ++AVK +   S     EF  E  +M +L H  LV+  
Sbjct: 16  LGSGQFGVVKLGKWKG-----QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + +V +Y+ NG L N++    K L    Q  ++  DV EG+ +L        
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFLE---SHQF 125
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+D ++  ++ DFG+ +     +  ++      + + APE+      +S 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEE 533
           SDV++FG+++ EV + G+ P D+    E
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSE 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ+ 
Sbjct: 32  LGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +  
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +S 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 507 SDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFE 565
           SD+++FGV++ E+ + G+ P +     E  E +                A   R+ +   
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------------AQGLRLYRPHL 245
Query: 566 AEEMELVLKLGLACCHPDSTRRPTMR 591
           A E   V  +  +C H  +  RPT +
Sbjct: 246 ASEK--VYTIMYSCWHEKADERPTFK 269

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           ++LG+G F  V    +          +A+KC+  ++ +G +  M  EI+ + +++H N+V
Sbjct: 24  DVLGTGAFSEV----ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAEGLNYLHH 440
            +      G  L L+   +  G L + I  K     G+   R   +++  V + + YLH 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH- 133
Query: 441 GWDQVVVHRDIKSGNIL---LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
             D  +VHRD+K  N+L   LD + +  + DFGL+K+   G V +T    GT GY+APE+
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEV 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPL 526
                 + A D +S GV+   + CG  P 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           ++LG+G F  V    +          +A+KC+  ++ +G +  M  EI+ + +++H N+V
Sbjct: 24  DVLGTGAFSEV----ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAEGLNYLHH 440
            +      G  L L+   +  G L + I  K     G+   R   +++  V + + YLH 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH- 133
Query: 441 GWDQVVVHRDIKSGNIL---LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
             D  +VHRD+K  N+L   LD + +  + DFGL+K+   G V +T    GT GY+APE+
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEV 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPL 526
                 + A D +S GV+   + CG  P 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-------LKEFMAEISSMGR 376
           ++ +G GGFG V+KG L        + +A+K +     +G        +EF  E+  M  
Sbjct: 24  EKQIGKGGFGLVHKGRLVKD----KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++ G     N   +V +++P G L + +  K   +  W  + +++ D+A G+ 
Sbjct: 80  LNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIE 136
Query: 437 YLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
           Y+ +  +  +VHRD++S NI L S      +  ++ DFG +    Q  V + + ++G   
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGLLGNFQ 191
Query: 492 YLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           ++APE   A   S T  +D YSF +++  +  G  P D
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           ++LG+G F  V    +          +A+KC+  ++ +G +  M  EI+ + +++H N+V
Sbjct: 24  DVLGTGAFSEV----ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAEGLNYLHH 440
            +      G  L L+   +  G L + I  K     G+   R   +++  V + + YLH 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH- 133
Query: 441 GWDQVVVHRDIKSGNIL---LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
             D  +VHRD+K  N+L   LD + +  + DFGL+K+   G V +T    GT GY+APE+
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEV 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPL 526
                 + A D +S GV+   + CG  P 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           E LG+GGFG V    L         ++A+K C    S +  + +  EI  M +L H N+V
Sbjct: 20  ERLGTGGFGYV----LRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 384 QMR----GWCRKG-NEL-MLVYDYMPNGSLNNWIFGKPKKLLGWKQ--RRQILADVAEGL 435
             R    G  +   N+L +L  +Y   G L  ++  + +   G K+   R +L+D++  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 436 NYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            YLH   +  ++HRD+K  NI+L      +  ++ D G AK   QGE+   T  VGTL Y
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQY 189
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           LAPEL      T   D +SFG +  E   G RP
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-------LKEFMAEISSMGR 376
           ++ +G GGFG V+KG L        + +A+K +     +G        +EF  E+  M  
Sbjct: 24  EKQIGKGGFGLVHKGRLVKD----KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++ G     N   +V +++P G L + +  K   +  W  + +++ D+A G+ 
Sbjct: 80  LNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIE 136
Query: 437 YLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
           Y+ +  +  +VHRD++S NI L S      +  ++ DF L+    Q  V + + ++G   
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGLLGNFQ 191
Query: 492 YLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           ++APE   A   S T  +D YSF +++  +  G  P D
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           E LG+GGFG V    L         ++A+K C    S +  + +  EI  M +L H N+V
Sbjct: 21  ERLGTGGFGYV----LRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 384 QMR----GWCRKG-NEL-MLVYDYMPNGSLNNWIFGKPKKLLGWKQ--RRQILADVAEGL 435
             R    G  +   N+L +L  +Y   G L  ++  + +   G K+   R +L+D++  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 135
Query: 436 NYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            YLH   +  ++HRD+K  NI+L      +  ++ D G AK   QGE+   T  VGTL Y
Sbjct: 136 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQY 190
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           LAPEL      T   D +SFG +  E   G RP
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 128/281 (45%), Gaps = 42/281 (14%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +LG G +G VY G            +A+K +     +  +    EI+    L+HKN+VQ 
Sbjct: 15  VLGKGTYGIVYAGR----DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ-----RRQILADVAEGLNYLHH 440
            G   +   + +  + +P GSL+  +  K   L   +Q      +QIL    EGL YLH 
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL----EGLKYLH- 125
Query: 441 GWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
             D  +VHRDIK  N+L+++   G  ++ DFG +K    G  P T    GTL Y+APE+ 
Sbjct: 126 --DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEII 181
Query: 499 TVSSPT---SASDVYSFGVVILEVACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQGKICE 554
               P     A+D++S G  I+E+A G+ P  ++G    E +A +        G  K+  
Sbjct: 182 D-KGPRGYGKAADIWSLGCTIIEMATGKPPFYELG----EPQAAMFK-----VGMFKV-- 229
Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                I +   AE    +LK    C  PD  +R    +++ 
Sbjct: 230 --HPEIPESMSAEAKAFILK----CFEPDPDKRACANDLLV 264

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V+ G         ST++AVK +   +   ++ F+ E + M  LQH  LV++ 
Sbjct: 21  LGAGQFGEVWMG-----YYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + ++ +YM  GSL +++       +   +     A +AEG+ Y+     +  
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNY 131
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+++ N+L+   +  ++ DFGLA++ +  E          + + APE       T  
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           SDV+SFG+++ E+   G+ P
Sbjct: 192 SDVWSFGILLYEIVTYGKIP 211

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSMGRL 377
           K F   E LG+G F  V    LA          AVKC+   + +G +  +  EI+ + ++
Sbjct: 22  KIFEFKETLGTGAFSEV---VLAEEKATGKL-FAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H+N+V +       N L LV   +  G L + I    K     K    ++  V + + Y
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIV--EKGFYTEKDASTLIRQVLDAVYY 135
Query: 438 LHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           LH      +VHRD+K  N+L    D E +  + DFGL+K+  +G+V +T    GT GY+A
Sbjct: 136 LHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVA 190
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           PE+      + A D +S GV+   + CG  P 
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 125/273 (45%), Gaps = 42/273 (15%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +LG G +G VY G            +A+K +     +  +    EI+    L+HKN+VQ 
Sbjct: 29  VLGKGTYGIVYAGR----DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ-----RRQILADVAEGLNYLHH 440
            G   +   + +  + +P GSL+  +  K   L   +Q      +QIL    EGL YLH 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL----EGLKYLH- 139
Query: 441 GWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
             D  +VHRDIK  N+L+++   G  ++ DFG +K    G  P T    GTL Y+APE+ 
Sbjct: 140 --DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEII 195
Query: 499 TVSSPT---SASDVYSFGVVILEVACGRRPL-DMGKGEEEEEAVLMDWVRNLYGQGKICE 554
               P     A+D++S G  I+E+A G+ P  ++G    E +A +        G  K+  
Sbjct: 196 D-KGPRGYGKAADIWSLGCTIIEMATGKPPFYELG----EPQAAMFK-----VGMFKV-- 243
Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRR 587
                I +   AE    +LK    C  PD  +R
Sbjct: 244 --HPEIPESMSAEAKAFILK----CFEPDPDKR 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +GSG FG V+ G           ++A+K +  +     ++F+ E   M +L H  LVQ+ 
Sbjct: 16  IGSGQFGLVHLGYW-----LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +   + LV ++M +G L++++  + + L   +    +  DV EG+ YL    +  V
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +S 
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 507 SDVYSFGVVILEV 519
           SDV+SFGV++ EV
Sbjct: 186 SDVWSFGVLMWEV 198

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           + +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N+
Sbjct: 30  QRIGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +   G+  K  +L +V  +    SL + +     K    K+   I    A G++YLH   
Sbjct: 83  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLH--- 137
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATV- 500
            + ++HRD+KS NI L  +   ++GDFGLA    +    +   ++ G++ ++APE+  + 
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 501 -SSPTS-ASDVYSFGVVILEVACGRRP 525
            S+P S  SDVY+FG+V+ E+  G+ P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 27  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 139
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 140 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 246
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 247 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 281

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK          S   A K ++  S++ L+++M EI  +    H N+V++ 
Sbjct: 45  LGDGAFGKVYKAQ----NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
                 N L ++ ++   G+++  +  + ++ L   Q + +     + LNYLH   D  +
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDA-VMLELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS- 505
           +HRD+K+GNIL   +   +L DFG++    +  +      +GT  ++APE+    +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 506 ----ASDVYSFGVVILEVACGRRP 525
                +DV+S G+ ++E+A    P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 33  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 145
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 252
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 253 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 287

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 30  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 142
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 249
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 250 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 284

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK          S   A K ++  S++ L+++M EI  +    H N+V++ 
Sbjct: 45  LGDGAFGKVYKAQ----NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
                 N L ++ ++   G+++  +  + ++ L   Q + +     + LNYLH   D  +
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDA-VMLELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS- 505
           +HRD+K+GNIL   +   +L DFG++    +  +      +GT  ++APE+    +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRX-IQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 506 ----ASDVYSFGVVILEVACGRRP 525
                +DV+S G+ ++E+A    P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 34  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 146
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY--QQGEVPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+ +Y  +   V N T     + ++
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 253
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 254 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 288

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK          S   A K ++  S++ L+++M EI  +    H N+V++ 
Sbjct: 45  LGDGAFGKVYKAQ----NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
                 N L ++ ++   G+++  +  + ++ L   Q + +     + LNYLH   D  +
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDA-VMLELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS- 505
           +HRD+K+GNIL   +   +L DFG++    +  +      +GT  ++APE+    +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRX-IQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 506 ----ASDVYSFGVVILEVACGRRP 525
                +DV+S G+ ++E+A    P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 53  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 165
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 272
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 273 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 307

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 34  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 146
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 253
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 254 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 54  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 166
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 167 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 273
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 274 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 308

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 32  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 144
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 145 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 251
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 252 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 286

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG VYKG            +A+K +N  +  +   EFM E   M  + H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C     + LV   MP+G L  ++  + K  +G +        +A+G+ YL    +
Sbjct: 81  RLLGVCLSPT-IQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---E 135
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSS 502
           + +VHRD+ + N+L+ S    ++ DFGLA+L +  E   N       + ++A E      
Sbjct: 136 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 503 PTSASDVYSFGVVILEVAC-GRRPLD 527
            T  SDV+S+GV I E+   G +P D
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 35  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 147
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 254
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 255 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 35  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 147
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           YL     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 254
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 255 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 289

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           ++LG+G F  V    +          +A+KC+   + +G +  M  EI+ + +++H N+V
Sbjct: 24  DVLGTGAFSEV----ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            +      G  L L+   +  G L + I    K     +   +++  V + + YLH   D
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLH---D 134
Query: 444 QVVVHRDIKSGNIL---LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  N+L   LD + +  + DFGL+K+   G V +T    GT GY+APE+   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQ 192
Query: 501 SSPTSASDVYSFGVVILEVACGRRPL 526
              + A D +S GV+   + CG  P 
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V+ GT        +T++A+K +   +    + F+ E   M +L+H  LVQ+ 
Sbjct: 17  LGNGQFGEVWMGTW-----NGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               +   + +V +YM  GSL +++     + L       + A VA G+ Y+        
Sbjct: 71  AVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNY 126
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD++S NIL+ + +  ++ DFGLA+L +  E          + + APE A     T  
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 507 SDVYSFGVVILE-VACGRRP 525
           SDV+SFG+++ E V  GR P
Sbjct: 187 SDVWSFGILLTELVTKGRVP 206

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG VYKG            +A+K +N  +  +   EFM E   M  + H +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C     + LV   MP+G L  ++  + K  +G +        +A+G+ YL    +
Sbjct: 104 RLLGVCLSPT-IQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE---E 158
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSS 502
           + +VHRD+ + N+L+ S    ++ DFGLA+L +  E   N       + ++A E      
Sbjct: 159 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 503 PTSASDVYSFGVVILEVAC-GRRPLD 527
            T  SDV+S+GV I E+   G +P D
Sbjct: 219 FTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 21  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 74  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 33  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 145
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 252
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 253 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 287

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           + +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N+
Sbjct: 30  QRIGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +   G+     +L +V  +    SL + +     K    K+   I    A G++YLH   
Sbjct: 83  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKF-EMKKLIDIARQTARGMDYLH--- 137
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATV- 500
            + ++HRD+KS NI L  +   ++GDFGLA    +    +   ++ G++ ++APE+  + 
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 501 -SSPTS-ASDVYSFGVVILEVACGRRP 525
            S+P S  SDVY+FG+V+ E+  G+ P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 35  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 147
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 254
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 255 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 289

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 18  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 71  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 125
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 126 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 185
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 94  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 206
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 313
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 314 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 348

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 16  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 69  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 123
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 21  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 74  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 128
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 35  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 147
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 254
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 255 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 289

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 28/210 (13%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKC--VNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK   V   + +  + F  E++ + + +H N++ 
Sbjct: 44  IGSGSFGTVYKGKW-------HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILL 96
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K N L +V  +    SL   +  +  K   + Q   I    A+G++YLH    +
Sbjct: 97  FMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF-QLIDIARQTAQGMDYLH---AK 151
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLY------QQGEVPNTTRVVGTLGYLAPELA 498
            ++HRD+KS NI L   +  ++GDFGLA +       QQ E P      G++ ++APE+ 
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP-----TGSVLWMAPEVI 206
Query: 499 TV--SSPTS-ASDVYSFGVVILEVACGRRP 525
            +  ++P S  SDVYS+G+V+ E+  G  P
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 40  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 152
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 259
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 260 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 294

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 36  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 148
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQ--GEVPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+ +Y +    V N T     + ++
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 255
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 256 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 290

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 25  FTKLERIGKGSFGEVFKGI----DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   KG++L ++ +Y+  GS  + +   P       Q   +L ++ +GL+YLH
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLH 137
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL  +   +L DFG+A      ++   T  VGT  ++APE+  
Sbjct: 138 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQ 193
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 43  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 95
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 96  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLH---AK 150
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 151 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 210
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL           AVK +N  +  G + +F+ E   M    H N+
Sbjct: 36  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLN 436
           + + G C R     ++V  YM +G L N+I  +      K L+G+  +      VA+G+ 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMK 148
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYL 493
           +L     +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           A E       T+ SDV+SFGV++ E+        M +G      V    +     QG+  
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWEL--------MTRGAPPYPDVNTFDITVYLLQGR-- 255
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 ++ E+  + +  V+   L C HP +  RP+  E+V+
Sbjct: 256 ----RLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           + +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N+
Sbjct: 42  QRIGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +   G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH   
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLH--- 149
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS 501
            + ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  + 
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 502 --SPTS-ASDVYSFGVVILEVACGRRP 525
             +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG+G FG V+ G         ST++AVK +   +   ++ F+ E + M  LQH  LV++ 
Sbjct: 20  LGAGQFGEVWMG-----YYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
               K   + ++ ++M  GSL +++       +   +     A +AEG+ Y+     +  
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNY 130
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+++ N+L+   +  ++ DFGLA++ +  E          + + APE       T  
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 507 SDVYSFGVVILEVAC-GRRP 525
           S+V+SFG+++ E+   G+ P
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EI 371
            K  + F   ++LG G F  V    +       S E A+K +   H  K+    ++  E 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
             M RL H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A
Sbjct: 61  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA 116
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVG 488
           ++   L YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VG
Sbjct: 117 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           T  Y++PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EI 371
            K  + F   ++LG G F  V    +       S E A+K +   H  K+    ++  E 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
             M RL H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA 114
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVG 488
           ++   L YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VG
Sbjct: 115 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           T  Y++PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EI 371
            K  + F   ++LG G F  V    +       S E A+K +   H  K+    ++  E 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
             M RL H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA 115
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVG 488
           ++   L YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VG
Sbjct: 116 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           T  Y++PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKNLV 383
           LG G FG+V  G           ++AVK +N    + L    +   EI ++   +H +++
Sbjct: 19  LGVGTFGKVKIGE----HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++        +  +V +Y+  G L ++I   G+ +++    + R++   +   ++Y H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHR- 129
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-- 499
              +VVHRD+K  N+LLD+ M  ++ DFGL+ +   GE   T+   G+  Y APE+ +  
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGR 185
Query: 500 -VSSPTSASDVYSFGVVILEVACGRRPLD 527
             + P    D++S GV++  + CG  P D
Sbjct: 186 LYAGP--EVDIWSCGVILYALLCGTLPFD 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 17/221 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EI 371
            K  + F   ++LG G F  V    +       S E A+K +   H  K+    ++  E 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
             M RL H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A
Sbjct: 62  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTA 117
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVG 488
           ++   L YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VG
Sbjct: 118 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           T  Y++PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 7/176 (3%)
Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           ++AVK ++   +Q  +    E+  M    H N+V M      G+EL +V +++  G+L +
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD 131
Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            +       +  +Q   +   V   L+YLH   +Q V+HRDIKS +ILL S+ R +L DF
Sbjct: 132 IV---THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDF 185
Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           G      + EVP    +VGT  ++APE+ +     +  D++S G++++E+  G  P
Sbjct: 186 GFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L   Q   IL ++ +GL+YLH
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 121
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL      +L DFG+A      ++   T  VGT  ++APE+  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 177
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 16  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+     +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 69  FMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 123
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA +  +    +   ++ G++ ++APE+  +   
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E+LG G FG+  K T           M +K +    ++  + F+ E+  M  L+H N+++
Sbjct: 16  EVLGKGCFGQAIKVT----HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G   K   L  + +Y+  G+L   I     +   W QR     D+A G+ YLH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAKDIASGMAYLH---SM 127
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLY-QQGEVPNTTR------------VVGTLG 491
            ++HRD+ S N L+       + DFGLA+L   +   P   R            VVG   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV 519
           ++APE+    S     DV+SFG+V+ E+
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 16  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 69  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIK-LIDIARQTAQGMDYLH---AK 123
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA    +    +   ++ G++ ++APE+  +   
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 29  FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L   Q   IL ++ +GL+YLH
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 141
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL      +L DFG+A      ++   T  VGT  ++APE+  
Sbjct: 142 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 197
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S + +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 39  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 94
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 150
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 151 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F      T+       S E A+K +   H  K+    ++  E   M RL
Sbjct: 32  FKFGKILGEGSFS----TTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 143
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 36  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 88
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 89  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLH---AK 143
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA    +    +   ++ G++ ++APE+  +   
Sbjct: 144 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 203
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 94/176 (53%), Gaps = 7/176 (3%)
Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           ++AVK ++   +Q  +    E+  M   QH N+V+M      G EL ++ +++  G+L +
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            +    +  L  +Q   +   V + L YLH    Q V+HRDIKS +ILL  + R +L DF
Sbjct: 132 IV---SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           G      + +VP    +VGT  ++APE+ + S   +  D++S G++++E+  G  P
Sbjct: 186 GFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 32  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 143
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 35  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 146
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 238

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 16  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 71
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 127
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 128 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 219

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 35  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 90
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 146
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 238

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 32  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 143
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 11/211 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLVQM 385
           LG G FG V +G           ++A+K +   +++   +E M E   M +L +  +V++
Sbjct: 18  LGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G C +   LMLV +    G L+ ++ GK ++ +      ++L  V+ G+ YL    ++ 
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKN 130
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSSP 503
            VHRD+ + N+LL +    ++ DFGL+K     +   T R  G   L + APE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 504 TSASDVYSFGVVILE-VACGRRPLDMGKGEE 533
           +S SDV+S+GV + E ++ G++P    KG E
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 31  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 142
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG VYKG           ++AVK +N    + Q L+ F  E+  + + +H N++ 
Sbjct: 44  IGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G+  K  +L +V  +    SL + +     K    K    I    A+G++YLH    +
Sbjct: 97  FMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLH---AK 151
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT-TRVVGTLGYLAPELATVS-- 501
            ++HRD+KS NI L  ++  ++GDFGLA    +    +   ++ G++ ++APE+  +   
Sbjct: 152 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 502 SPTS-ASDVYSFGVVILEVACGRRP 525
           +P S  SDVY+FG+V+ E+  G+ P
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 31  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 86
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 142
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 32  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 143
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 34  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMA-EISSMGRL 377
           F   ++LG G F  V    +       S E A+K +   H  K+    ++  E   M RL
Sbjct: 37  FKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 92
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGL 435
            H   V++    +   +L     Y  NG L  +I    +K+  + +   R   A++   L
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 148
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLA 494
            YLH    + ++HRD+K  NILL+ +M  ++ DFG AK L  + +       VGT  Y++
Sbjct: 149 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           PEL T  S   +SD+++ G +I ++  G  P   G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 240

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 29/207 (14%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           ++ LG+G FG V+  T         T++AVK +   S   ++ F+AE + M  LQH  LV
Sbjct: 187 EKKLGAGQFGEVWMATY-----NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 240
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD----VAEGLNYLH 439
           ++     K   + ++ ++M  GSL +++    K   G KQ    L D    +AEG+ ++ 
Sbjct: 241 KLHAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRD+++ NIL+ + +  ++ DFGLA++    + P        + + APE   
Sbjct: 296 Q---RNYIHRDLRAANILVSASLVCKIADFGLARV--GAKFP--------IKWTAPEAIN 342
Query: 500 VSSPTSASDVYSFGVVILEVAC-GRRP 525
             S T  SDV+SFG++++E+   GR P
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 21/230 (9%)
Query: 306 PHRFSYEELSKATK----------GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC 355
           P R S+E+   A +             N   +G G  G V   T+          +AVK 
Sbjct: 8   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL----VAVKK 63
Query: 356 VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + +    
Sbjct: 64  MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--- 120
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
              +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG     
Sbjct: 121 HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 177
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 178 SK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 21/230 (9%)
Query: 306 PHRFSYEELSKATK----------GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC 355
           P R S+E+   A +             N   +G G  G V   T+          +AVK 
Sbjct: 6   PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL----VAVKK 61
Query: 356 VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + +    
Sbjct: 62  MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--- 118
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
              +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG     
Sbjct: 119 HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 175
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 176 SK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           APE       T++SD++SFGVV+ E+         G   E+    +MD       Q   C
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYLDQPDNC 257
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                           E V  L   C   +   RPT  E+V +L
Sbjct: 258 P---------------ERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +AEG+NYL 
Sbjct: 74  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 180
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 237
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 238 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 267

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 7/175 (4%)
Query: 351 MAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW 410
           +AVK ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + 
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 111
Query: 411 IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG 470
           +       +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG
Sbjct: 112 VT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 165
Query: 471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                 + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 166 FCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 28/270 (10%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 82
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE   T  + GT  Y+APE+ +    +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
              DV+S G ++  +  G+ P +    +E      +   +N Y   K      A + Q+ 
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIPKHINPVAASLIQKM 251
Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                             D T RPT+ E++
Sbjct: 252 ---------------LQTDPTARPTINELL 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 7/175 (4%)
Query: 351 MAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW 410
           +AVK ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 411 IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG 470
           +       +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG
Sbjct: 108 VT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 161
Query: 471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                 + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 162 FCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L   Q   IL ++ +GL+YLH
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 121
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL      +L DFG+A      ++      VGT  ++APE+  
Sbjct: 122 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNXFVGTPFWMAPEVIK 177
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKNLV 383
           LG G FG+V  G           ++AVK +N    + L    +   EI ++   +H +++
Sbjct: 19  LGVGTFGKVKIGE----HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++        +  +V +Y+  G L ++I   G+ +++   +  +QIL+ V    +Y H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV----DYCHR- 129
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-- 499
              +VVHRD+K  N+LLD+ M  ++ DFGL+ +   GE    +   G+  Y APE+ +  
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVISGR 185
Query: 500 -VSSPTSASDVYSFGVVILEVACGRRPLD 527
             + P    D++S GV++  + CG  P D
Sbjct: 186 LYAGP--EVDIWSCGVILYALLCGTLPFD 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG V +G           ++A+K +   + K   +E M E   M +L +  +V++
Sbjct: 344 LGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G C +   LMLV +    G L+ ++ GK ++ +      ++L  V+ G+ YL    ++ 
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKN 456
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATVSSP 503
            VHR++ + N+LL +    ++ DFGL+K     +   T R  G   L + APE       
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 504 TSASDVYSFGVVILE-VACGRRPLDMGKGEE 533
           +S SDV+S+GV + E ++ G++P    KG E
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 82
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE   T  + GT  Y+APE+ +    +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 505 SASDVYSFGVVILEVACGRRPLD 527
              DV+S G ++  +  G+ P +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L   Q   IL ++ +GL+YLH
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL      +L DFG+A      ++      VGT  ++APE+  
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNXFVGTPFWMAPEVIK 192
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+  S +D++S G+  +E+A G  P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 28/270 (10%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 86
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 141
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE   T  + GT  Y+APE+ +    +
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 199
Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
              DV+S G ++  +  G+ P +    +E      +   +N Y   K      A + Q+ 
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIPKHINPVAASLIQKM 255
Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                             D T RPT+ E++
Sbjct: 256 ---------------LQTDPTARPTINELL 270

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E+   G FG V+K  L          +AVK      KQ  +    EI S   ++H+NL+Q
Sbjct: 21  EIKARGRFGCVWKAQLMNDF------VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQ 73
Query: 385 MRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
                ++G+    EL L+  +   GSL +++ G    ++ W +   +   ++ GL+YLH 
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHE 130
Query: 441 --------GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLG 491
                   G    + HRD KS N+LL S++   L DFGLA  ++ G+ P  T   VGT  
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 492 YLAPEL--ATVSSPTSA---SDVYSFGVVILEV 519
           Y+APE+    ++    A    D+Y+ G+V+ E+
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           APE       T++SD++SFGVV+ E+         G   E+    +MD       Q   C
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYLDQPDNC 257
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                           E V  L   C   +   RPT  E+V +L
Sbjct: 258 P---------------ERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 486
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 487 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 607 LCWTYDVENRPGFAAVELRL 626

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 21/230 (9%)
Query: 306 PHRFSYEELSKATK----------GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC 355
           P R S+E+   A +             N   +G G  G V   T+          +AVK 
Sbjct: 51  PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL----VAVKK 106
Query: 356 VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + +    
Sbjct: 107 MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--- 163
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
              +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG     
Sbjct: 164 HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 221 SK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK              A K +   S++ L++++ EI  +    H  +V++ 
Sbjct: 19  LGDGAFGKVYKAK----NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 74
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G      +L ++ ++ P G+++  I  +  + L   Q + +   + E LN+LH    + +
Sbjct: 75  GAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRI 130
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLA----KLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           +HRD+K+GN+L+  E   RL DFG++    K  Q+ +       +GT  ++APE+    +
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-----SFIGTPYWMAPEVVMCET 185
Query: 503 PTSA-----SDVYSFGVVILEVACGRRP 525
                    +D++S G+ ++E+A    P
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 487
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 488 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 607
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 608 LCWTYDVENRPGFAAVELRL 627

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 40  LGGGQYGEVYVGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 94
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C       +V +YMP G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNF 151
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    ++ +  
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 212 SDVWAFGVLLWEIA 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 21/230 (9%)
Query: 306 PHRFSYEELSKATK----------GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKC 355
           P R S+E+   A +             N   +G G  G V   T+          +AVK 
Sbjct: 128 PQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKL----VAVKK 183
Query: 356 VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           ++   +Q  +    E+  M   QH+N+V+M      G+EL +V +++  G+L + +    
Sbjct: 184 MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--- 240
Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
              +  +Q   +   V + L+ LH    Q V+HRDIKS +ILL  + R +L DFG     
Sbjct: 241 HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
            + EVP    +VGT  ++APEL +        D++S G++++E+  G  P
Sbjct: 298 SK-EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 128
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 248
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 249 LCWTYDVENRPGFAAVELRL 268

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG+VYK              A K +   S++ L++++ EI  +    H  +V++ 
Sbjct: 27  LGDGAFGKVYKAK----NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G      +L ++ ++ P G+++  I  +  + L   Q + +   + E LN+LH    + +
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRI 138
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLA----KLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           +HRD+K+GN+L+  E   RL DFG++    K  Q+ +       +GT  ++APE+    +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-----SFIGTPYWMAPEVVMCET 193
Query: 503 PTSA-----SDVYSFGVVILEVACGRRP 525
                    +D++S G+ ++E+A    P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AVK ++    +   L++   E+  M  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++        GW + ++  A   + ++ + +
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFRQIVSAVQY 121
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +T    G+  Y APEL   
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQG 179
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 234

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 144
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 264
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 265 LCWTYDVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 144
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 264
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 265 LCWTYDVENRPGFAAVELRL 284

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 128
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 248
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 249 LCWTYDVENRPGFAAVELRL 268

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 142
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 143 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 262
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 263 LCWTYDVENRPGFAAVELRL 282

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 245 LCWTYDVENRPGFAAVELRL 264

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G FG+     +         +  +K +N    S +  +E   E++ +  ++H N+VQ
Sbjct: 32  IGEGSFGK----AILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
            R    +   L +V DY   G L   I  +   L    Q  QIL    +    L H  D+
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF---QEDQILDWFVQICLALKHVHDR 144
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
            ++HRDIKS NI L  +   +LGDFG+A++     V      +GT  YL+PE+       
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKPYN 203
Query: 505 SASDVYSFGVVILEVACGRRPLDMG 529
           + SD+++ G V+ E+   +   + G
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 123 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 242
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 243 LCWTYDVENRPGFAAVELRL 262

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 187
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 244
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 245 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXS-TEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G         + T +AVK VN  +    + EF+ E S M      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 141
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 142 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 494 APELATVSSPTSASDVYSFGVVILEVA 520
           APE       T++SD++SFGVV+ E+ 
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 177
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 234
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 235 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 264

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 184
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 241
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 242 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 80  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 186
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 243
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 244 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQH 379
           +   E++GSG    V     A        ++A+K +N +  Q  + E + EI +M +  H
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPK----KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF-----GKPKK-LLGWKQRRQILADVAE 433
            N+V         +EL LV   +  GS+ + I      G+ K  +L       IL +V E
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV----VGT 489
           GL YLH       +HRD+K+GNILL  +   ++ DFG++     G      +V    VGT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 490 LGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRP 525
             ++APE +  V      +D++SFG+  +E+A G  P
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG V+KG            + +K +   S +Q  +     + ++G L H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNYL 438
           ++ G C  G+ L LV  Y+P GSL + +        P+ LL W         +A+G+ YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYYL 149
Query: 439 H-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK---------LYQQGEVPNTTRVVG 488
             HG    +VHR++ + N+LL S  + ++ DFG+A          LY + + P       
Sbjct: 150 EEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------- 198
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + ++A E       T  SDV+S+GV + E+
Sbjct: 199 -IKWMALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE      + GT  Y+APE+ +    +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHS 193
Query: 505 SASDVYSFGVVILEVACGRRPLD 527
              DV+S G ++  +  G+ P +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 102 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 160 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 208
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 265
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 266 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 295

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 184
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 241
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 242 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 185
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 242
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 243 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNL 382
           D+ LGSG FG V KG         +  + +   N  +   LK E +AE + M +L +  +
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V+M G C +    MLV +    G LN ++  +  + +  K   +++  V+ G+ YL    
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE--- 134
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
           +   VHRD+ + N+LL ++   ++ DFGL+K  +  E     +  G   + + APE    
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEE--------EEEAVLMDWVRNLYGQGK 551
              +S SDV+SFGV++ E  + G++P    KG E        E         R +Y    
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 254
Query: 552 ICEAADARIRQEFEAEEMEL 571
           +C   D   R  F A E+ L
Sbjct: 255 LCWTYDVENRPGFAAVELRL 274

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 68
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G     ++ + +KL  + ++R    + ++A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELAN 124
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 176
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 185
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 242
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 243 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 240
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 241 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 68
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G     ++ + +KL  + ++R    + ++A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELAN 124
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLXGTLD 176
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQH 379
           +   E++GSG    V     A        ++A+K +N +  Q  + E + EI +M +  H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPK----KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF-----GKPKK-LLGWKQRRQILADVAE 433
            N+V         +EL LV   +  GS+ + I      G+ K  +L       IL +V E
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV----VGT 489
           GL YLH       +HRD+K+GNILL  +   ++ DFG++     G      +V    VGT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 490 LGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRP 525
             ++APE +  V      +D++SFG+  +E+A G  P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG V+KG            + +K +   S +Q  +     + ++G L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNYL 438
           ++ G C  G+ L LV  Y+P GSL + +        P+ LL W         +A+G+ YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYYL 131
Query: 439 H-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK---------LYQQGEVPNTTRVVG 488
             HG    +VHR++ + N+LL S  + ++ DFG+A          LY + + P       
Sbjct: 132 EEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP------- 180
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + ++A E       T  SDV+S+GV + E+
Sbjct: 181 -IKWMALESIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 186
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 243
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 244 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 186
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 243
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 244 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 83  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 141 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 189
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 246
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 247 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 276

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 240
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 241 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 240
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 241 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYL 173
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            PE+          D++S GV+  E   G+ P +    +E
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 104
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 159
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE      + GT  Y+APE+ +    +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHS 217
Query: 505 SASDVYSFGVVILEVACGRRPLD 527
              DV+S G ++  +  G+ P +
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYL 173
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            PE+          D++S GV+  E   G+ P +    +E
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 60
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 116
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 170
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            PE+          D++S GV+  E   G+ P +    +E
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 62
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 118
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 172
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            PE+          D++S GV+  E   G+ P +    +E
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 190
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 247
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 248 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
            LG GGF + ++ + A      + ++  K +     Q  K  M EIS    L H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGF 106
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G+    + + +V +     SL      K +K L   + R  L  +  G  YLH      
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 161
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
           V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE      + GT  Y+APE+ +    +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHS 219
Query: 505 SASDVYSFGVVILEVACGRRPLD 527
              DV+S G ++  +  G+ P +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH- 379
           F    +LG G FG+V K   A      S   A+K + H +++ L   ++E+  +  L H 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD----SRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQ 62
Query: 380 ------------KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQR 424
                       +N V+     +K + L +  +Y  NG+L + I  +    ++   W+  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ------- 477
           RQIL    E L+Y+H    Q ++HRD+K  NI +D     ++GDFGLAK   +       
Sbjct: 123 RQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 478 ------GEVPNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEV 519
                 G   N T  +GT  Y+A E L          D+YS G++  E+
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 65
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 121
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLD 173
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHR++ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 143 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           APE       T++SD++SFGVV+ E+         G   E+    +MD       Q   C
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYLDQPDNC 257
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                           E V  L   C   +   RPT  E+V +L
Sbjct: 258 P---------------ERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 322 SNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN 381
           S  E+LG G FG+V+K            ++A K +     +  +E   EIS M +L H N
Sbjct: 92  SKTEILGGGRFGQVHK----CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L+Q+       N+++LV +Y+  G L + I  +   L         +  + EG+ ++H  
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-DTILFMKQICEGIRHMHQM 206
Query: 442 WDQVVVHRDIKSGNILLDSE--MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           +   ++H D+K  NIL  +    + ++ DFGLA+ Y+  E        GT  +LAPE+  
Sbjct: 207 Y---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVN 261
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
               +  +D++S GV+   +  G  P 
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 143
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHR++ + N ++  +   ++GDFG+ + +Y+        + +  + ++
Sbjct: 144 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           APE       T++SD++SFGVV+ E+         G   E+    +MD       Q   C
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYLDQPDNC 258
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                           E V  L   C   +   RPT  E+V +L
Sbjct: 259 P---------------ERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 19  LGGGQFGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 191 SDVWAFGVLLWEIA 204

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 64
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 120
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDTLCGTLD 172
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 64
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 120
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLD 172
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 64
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 120
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV--GTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R    GTL 
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----CHAPSSRRTTLSGTLD 172
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 20/232 (8%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K F   E+LGSG F  V+               A+KC+             EI+ + +++
Sbjct: 9   KTFIFMEVLGSGAFSEVF----LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H+N+V +           LV   +  G L + I    + +   K    ++  V   + YL
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDASLVIQQVLSAVKYL 122
Query: 439 HHGWDQVVVHRDIKSGNIL-LDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           H   +  +VHRD+K  N+L L  E   ++   DFGL+K+ Q G +   +   GT GY+AP
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAP 176
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY 547
           E+      + A D +S GV+   + CG  P       EE E+ L + ++  Y
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPPF-----YEETESKLFEKIKEGY 223

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 68
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 124
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLD 176
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AVK ++    +   L++   E+  M  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQ 131
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
            +   +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +T    G+  Y APEL   
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQG 186
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 87  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 145 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 193
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            ++A E       T  SDV+S+GV + E+   G +P D
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 186
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            ++A E       T  SDV+S+GV + E+   G +P D
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRDDLCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 67
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 123
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYL 177
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            PE+          D++S GV+  E   G+ P +    +E
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 68
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 124
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 176
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRAALCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            ++A E       T  SDV+S+GV + E+   G +P D
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AVK ++    +   L++   E+  M  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQ 131
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
            +   +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +T    G+  Y APEL   
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQG 186
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 89
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 145
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDDLCGTLD 197
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 80
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 136
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 188
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 230

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 89
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 145
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 197
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 239

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H      ++F  EI  +  L    +V+ R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 387 G--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHHGW 442
           G  +     EL LV +Y+P+G L +++     +L      R +L  + + +G+ YL    
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL---DASRLLLYSSQICKGMEYLG--- 128
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG--TLGYLAPELATV 500
            +  VHRD+ + NIL++SE   ++ DFGLAKL    +     R  G   + + APE  + 
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 501 SSPTSASDVYSFGVVILEV 519
           +  +  SDV+SFGVV+ E+
Sbjct: 189 NIFSRQSDVWSFGVVLYEL 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 122/280 (43%), Gaps = 24/280 (8%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            F  ++ +G G F  VY+          + +  V+  +    +   + + EI  + +L H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALK-KVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNY 437
            N+++      + NEL +V +    G L+  I  F K K+L+  +   +    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           +H    + V+HRDIK  N+ + +    +LGD GL + +   +      +VGT  Y++PE 
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 207
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD 557
              +     SD++S G ++ E+A  + P    K              NLY   K  E  D
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-------------MNLYSLCKKIEQCD 254
Query: 558 -ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV 596
              +  +  +EE+  ++ +   C +PD  +RP +  V  V
Sbjct: 255 YPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDV 291

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 8/215 (3%)
Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK 365
           P   +Y++        +    LG G +G VY+G         S  +AVK +  D+ + ++
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VE 59
Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR 425
           EF+ E + M  ++H NLVQ+ G C +     ++ ++M  G+L +++    ++ +      
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
            +   ++  + YL     +  +HRD+ + N L+      ++ DFGL++L           
Sbjct: 120 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
               + + APE    +  +  SDV++FGV++ E+A
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + + +        + +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVA 520
           APE       T++SD++SFGVV+ E+ 
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 142
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + + +        + +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           APE       T++SD++SFGVV+ E+         G   E+    +MD       Q   C
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG--GYLDQPDNC 257
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                           E V  L   C   +   RPT  E+V +L
Sbjct: 258 P---------------ERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 19  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 191 SDVWAFGVLLWEIA 204

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 26  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 198 SDVWAFGVLLWEIA 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 63
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 119
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLD 171
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           YL PE+          D++S GV+  E   G+ P +
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 22  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 133
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 194 SDVWAFGVLLWEIA 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 8/215 (3%)
Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK 365
           P   +Y++        +    LG G +G VY+G         S  +AVK +  D+ + ++
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VE 59
Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR 425
           EF+ E + M  ++H NLVQ+ G C +     ++ ++M  G+L +++    ++ +      
Sbjct: 60  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
            +   ++  + YL     +  +HRD+ + N L+      ++ DFGL++L           
Sbjct: 120 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG 176
Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
               + + APE    +  +  SDV++FGV++ E+A
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXX-XXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +AVK VN   S +   EF+ E S M      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF----------GKPKKLLGWKQRRQILADVAEG 434
           + G   KG   ++V + M +G L +++           G+P   L  ++  Q+ A++A+G
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIADG 139
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + YL+    +  VHRD+ + N ++  +   ++GDFG+ + + +        + +  + ++
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 494 APELATVSSPTSASDVYSFGVVILEVA 520
           APE       T++SD++SFGVV+ E+ 
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 23  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 195 SDVWAFGVLLWEIA 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 25  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 136
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 197 SDVWAFGVLLWEIA 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 22  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 133
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 194 SDVWAFGVLLWEIA 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 68
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 124
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL 
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLD 176
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE           D++S GV+  E   G+ P +    +E
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 14/231 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G F +V    LA        E+AVK ++    +   L++   E+  M  L H N+V+
Sbjct: 23  IGKGNFAKV---KLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +         L LV +Y   G + +++    +  +  K+ R     +   + Y H  +  
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKY-- 134
Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
            +VHRD+K+ N+LLD +M  ++ DFG +  +  G   +T    G+  Y APEL       
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQGKKYD 191
Query: 505 SAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
               DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 19  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 191 SDVWAFGVLLWEIA 204

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 34  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 88
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 145
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 206 SDVWAFGVLLWEIA 219

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 23  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 195 SDVWAFGVLLWEIA 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 26  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 137
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 198 SDVWAFGVLLWEIA 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 26  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 198 SDVWAFGVLLWEIA 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 23  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 195 SDVWAFGVLLWEIA 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 21  LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HRD+ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 193 SDVWAFGVLLWEIA 206

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AV+ ++    +   L++   E+  M  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQ 131
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
            +   +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +T    G+  Y APEL   
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQG 186
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 36/289 (12%)
Query: 316 KATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSM 374
           +  K +     LG GGF + Y+ T        + ++  K +     Q  KE M+ EI+  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ--KEKMSTEIAIH 96
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L + ++V   G+    + + +V +     SL      K +K +   + R  +    +G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQG 154
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL 493
           + YLH+     V+HRD+K GN+ L+ +M  ++GDFGLA K+   GE   T  + GT  Y+
Sbjct: 155 VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYI 209
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-I 552
           APE+      +   D++S G ++  +  G+ P +    +E      +   +N Y   + I
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE----TYIRIKKNEYSVPRHI 265
Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQE 601
              A A IR+   A+                    PT+R  VA L+  E
Sbjct: 266 NPVASALIRRMLHAD--------------------PTLRPSVAELLTDE 294

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKN 381
           LG G FG+V    LA        ++A+K +N         QG  E   EIS +  L+H +
Sbjct: 22  LGEGSFGKV---KLAYHTTT-GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPH 75
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++    +  +E+++V +Y  N  L ++I  + K  +  ++ R+    +   + Y H  
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHR- 131
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+  +S
Sbjct: 132 --HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV--IS 185
Query: 502 SPTSAS---DVYSFGVVILEVACGRRPLD 527
               A    DV+S GV++  + C R P D
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKN 381
           LG G FG+V    LA        ++A+K +N         QG  E   EIS +  L+H +
Sbjct: 21  LGEGSFGKV---KLAYHTTT-GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPH 74
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++    +  +E+++V +Y  N  L ++I  + K  +  ++ R+    +   + Y H  
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHR- 130
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+  +S
Sbjct: 131 --HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV--IS 184
Query: 502 SPTSAS---DVYSFGVVILEVACGRRPLD 527
               A    DV+S GV++  + C R P D
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKN 381
           LG G FG+V    LA        ++A+K +N         QG  E   EIS +  L+H +
Sbjct: 12  LGEGSFGKV---KLAYHTTT-GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPH 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++    +  +E+++V +Y  N  L ++I  + K  +  ++ R+    +   + Y H  
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHR- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+  +S
Sbjct: 122 --HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV--IS 175
Query: 502 SPTSAS---DVYSFGVVILEVACGRRPLD 527
               A    DV+S GV++  + C R P D
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKN 381
           LG G FG+V    LA        ++A+K +N         QG  E   EIS +  L+H +
Sbjct: 16  LGEGSFGKV---KLAYHTTT-GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPH 69
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++    +  +E+++V +Y  N  L ++I  + K  +  ++ R+    +   + Y H  
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHR- 125
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+  +S
Sbjct: 126 --HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV--IS 179
Query: 502 SPTSAS---DVYSFGVVILEVACGRRPLD 527
               A    DV+S GV++  + C R P D
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++L SG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 84  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 190
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 247
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 248 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++L SG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 240
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 241 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 187
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 244
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 245 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG V +G L       S ++AVK +  D  S++ ++EF++E + M    H N+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGT-SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 383 VQMRGWCRKGN-----ELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVA 432
           +++ G C + +     + M++  +M  G L+ ++        PK +   +   + + D+A
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI-PLQTLLKFMVDIA 157
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT-LG 491
            G+ YL    ++  +HRD+ + N +L  +M   + DFGL+K    G+     R+    + 
Sbjct: 158 LGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           ++A E       TS SDV++FGV + E+A
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTE-MAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
           E LG   FG+VYKG L        T+ +A+K +   ++  L+E F  E     RLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQIL 428
           V + G   K   L +++ Y  +G L+ ++  +               K  L       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 429 ADVAEGLNYL--HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
           A +A G+ YL  HH     VVH+D+ + N+L+  ++  ++ D G   L+++    +  ++
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLG---LFREVYAADYYKL 186
Query: 487 VGT----LGYLAPELATVSSPTSASDVYSFGVVILEV 519
           +G     + ++APE       +  SD++S+GVV+ EV
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 66
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 122
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ +FG +        P++ R  + GTL 
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTLD 174
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++L SG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 190
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 247
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 248 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMG 375
           A + F     LG G FG VY           + ++  K      K G++ +   E+    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQS 65
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAE 433
            L+H N++++ G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELAN 121
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLG 491
            L+Y H    + V+HRDIK  N+LL S    ++ +FG +        P++ R  + GTL 
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTLD 173
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           YL PE+          D++S GV+  E   G+ P +    +E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTE-MAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
           E LG   FG+VYKG L        T+ +A+K +   ++  L+E F  E     RLQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQIL 428
           V + G   K   L +++ Y  +G L+ ++  +               K  L       ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 429 ADVAEGLNYL--HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV 486
           A +A G+ YL  HH     VVH+D+ + N+L+  ++  ++ D G   L+++    +  ++
Sbjct: 152 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLG---LFREVYAADYYKL 203
Query: 487 VGT----LGYLAPELATVSSPTSASDVYSFGVVILEV 519
           +G     + ++APE       +  SD++S+GVV+ EV
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           E+   G FG V+K  L       +  +AVK      KQ  + E+  E+ S+  ++H+N++
Sbjct: 30  EVKARGRFGCVWKAQL------LNEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENIL 81
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
           Q  G  ++G     +L L+  +   GSL++++      ++ W +   I   +A GL YLH
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLH 138
Query: 440 H-------GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLG 491
                   G    + HRDIKS N+LL + +   + DFGLA  ++ G+    T   VGT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 492 YLAPEL--ATVSSPTSA---SDVYSFGVVILEVA 520
           Y+APE+    ++    A    D+Y+ G+V+ E+A
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 185
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 242
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 243 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 138/293 (47%), Gaps = 29/293 (9%)
Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK----EFM 368
           L +A + +     +G G +G+V+K   A         +A+K V     ++G+       +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 369 AEISSMGRLQHKNLVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ 423
           A +  +   +H N+V++   C      +  +L LV++++ +  L  ++   P+  +  + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT 483
            + ++  +  GL++LH      VVHRD+K  NIL+ S  + +L DFGLA++Y        
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--L 176
Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--- 540
           T VV TL Y APE+   SS  +  D++S G +  E+   R+PL  G  + ++   ++   
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVI 235
Query: 541 ------DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR 587
                 DW R++    +   +  A+  ++F  +  EL   L L C   +  +R
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 183
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 240
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 241 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 138/293 (47%), Gaps = 29/293 (9%)
Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK----EFM 368
           L +A + +     +G G +G+V+K   A         +A+K V     ++G+       +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 369 AEISSMGRLQHKNLVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ 423
           A +  +   +H N+V++   C      +  +L LV++++ +  L  ++   P+  +  + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT 483
            + ++  +  GL++LH      VVHRD+K  NIL+ S  + +L DFGLA++Y        
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--L 176
Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--- 540
           T VV TL Y APE+   SS  +  D++S G +  E+   R+PL  G  + ++   ++   
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVI 235
Query: 541 ------DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR 587
                 DW R++    +   +  A+  ++F  +  EL   L L C   +  +R
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 190
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 247
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 248 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+  +    S +  KE + E   M  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 111 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFGLAKL          + G+VP        +
Sbjct: 169 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--------I 217
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQ 549
            ++A E       T  SDV+S+GV + E+   G +P D G    E  ++L    R    Q
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGER--LPQ 274
Query: 550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             IC                  V  + + C   D+  RP  RE++
Sbjct: 275 PPICTID---------------VYMIMVKCWMIDADSRPKFRELI 304

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 185
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            ++A E       T  SDV+S+GV + E+   G +P D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 316 KATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSM 374
           +  K +     LG GGF + Y+ T        + ++  K +     Q  KE M+ EI+  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ--KEKMSTEIAIH 96
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L + ++V   G+    + + +V +     SL      K +K +   + R  +    +G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQG 154
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL 493
           + YLH+     V+HRD+K GN+ L+ +M  ++GDFGLA K+   GE      + GT  Y+
Sbjct: 155 VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKXLCGTPNYI 209
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-I 552
           APE+      +   D++S G ++  +  G+ P +    +E      +   +N Y   + I
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE----TYIRIKKNEYSVPRHI 265
Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
              A A IR+                  H D T RP++ E++ 
Sbjct: 266 NPVASALIRRML----------------HADPTLRPSVAELLT 292

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTL 490
              D+ +VHRD+ + N+L+ +    ++ DFG AKL          + G+VP        +
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP--------I 185
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            ++A E       T  SDV+S+GV + E+   G +P D
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 138/293 (47%), Gaps = 29/293 (9%)
Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK----EFM 368
           L +A + +     +G G +G+V+K   A         +A+K V     ++G+       +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 369 AEISSMGRLQHKNLVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ 423
           A +  +   +H N+V++   C      +  +L LV++++ +  L  ++   P+  +  + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT 483
            + ++  +  GL++LH      VVHRD+K  NIL+ S  + +L DFGLA++Y        
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--L 176
Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM--- 540
           T VV TL Y APE+   SS  +  D++S G +  E+   R+PL  G  + ++   ++   
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVI 235
Query: 541 ------DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR 587
                 DW R++    +   +  A+  ++F  +  EL   L L C   +  +R
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AVK ++    +   L++   E+  M  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQ 131
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
            +   +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +     G   Y APEL   
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELFQG 186
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AV+ ++    +   L++   E+  M  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L LV +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQ 131
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
            +   +VHRD+K+ N+LLD++M  ++ DFG +  +  G         G+  Y APEL   
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDEFCGSPPYAAPELFQG 186
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 241

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           +++G G FG+V K  +          +  +   + SK   ++F  E+  + +L  H N++
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQILA 429
            + G C     L L  +Y P+G+L ++              I       L  +Q     A
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
           DVA G++YL     +  +HRD+ + NIL+      ++ DFGL++    G+     + +G 
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 192
Query: 490 LG--YLAPELATVSSPTSASDVYSFGVVILEV 519
           L   ++A E    S  T+ SDV+S+GV++ E+
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G FG VY           + ++  K      K G++ +   E+     L+H N++++
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFK--TQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAEGLNYLHHGWD 443
            G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A  L+Y H    
Sbjct: 78  YGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSYCH---S 130
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL PE+      
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEE 533
               D++S GV+  E   G  P +    +E
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H      ++F  EI  +  L    +V+ R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 387 G--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHHGW 442
           G  +      L LV +Y+P+G L +++     +L      R +L  + + +G+ YL    
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL---DASRLLLYSSQICKGMEYL---G 131
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
            +  VHRD+ + NIL++SE   ++ DFGLAKL    +     R  G   + + APE  + 
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 501 SSPTSASDVYSFGVVILEV 519
           +  +  SDV+SFGVV+ E+
Sbjct: 192 NIFSRQSDVWSFGVVLYEL 210

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH- 379
           F    +LG G FG+V K   A      S   A+K + H +++ L   ++E+  +  L H 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD----SRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQ 62
Query: 380 ------------KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQR 424
                       +N V+     +K + L +  +Y  N +L + I  +    ++   W+  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ------- 477
           RQIL    E L+Y+H    Q ++HRD+K  NI +D     ++GDFGLAK   +       
Sbjct: 123 RQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 478 ------GEVPNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEV 519
                 G   N T  +GT  Y+A E L          D+YS G++  E+
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G FG VY           + ++  K      K G++ +   E+     L+H N++++
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFK--TQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAEGLNYLHHGWD 443
            G+      + L+ +Y P G+    ++ + +KL  + ++R    + ++A  L+Y H    
Sbjct: 78  YGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSYCH---S 130
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           + V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL YL PE+    
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSV-----HAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
                 D++S GV+  E   G  P +    +E
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H      ++F  EI  +  L    +V+ R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 387 G--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHHGW 442
           G  +      L LV +Y+P+G L +++     +L      R +L  + + +G+ YL    
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL---DASRLLLYSSQICKGMEYL---G 144
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
            +  VHRD+ + NIL++SE   ++ DFGLAKL    +     R  G   + + APE  + 
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 501 SSPTSASDVYSFGVVILEV 519
           +  +  SDV+SFGVV+ E+
Sbjct: 205 NIFSRQSDVWSFGVVLYEL 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 316 KATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSM 374
           +  K +     LG GGF + Y+ T        + ++  K +     Q  KE M+ EI+  
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ--KEKMSTEIAIH 80
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L + ++V   G+    + + +V +     SL      K +K +   + R  +    +G
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQG 138
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL 493
           + YLH+     V+HRD+K GN+ L+ +M  ++GDFGLA K+   GE      + GT  Y+
Sbjct: 139 VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYI 193
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-I 552
           APE+      +   D++S G ++  +  G+ P +    +E      +   +N Y   + I
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE----TYIRIKKNEYSVPRHI 249
Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
              A A IR+                  H D T RP++ E++ 
Sbjct: 250 NPVASALIRRML----------------HADPTLRPSVAELLT 276

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 316 KATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMA-EISSM 374
           +  K +     LG GGF + Y+ T        + ++  K +     Q  KE M+ EI+  
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQ--KEKMSTEIAIH 96
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L + ++V   G+    + + +V +     SL      K +K +   + R  +    +G
Sbjct: 97  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQG 154
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL 493
           + YLH+     V+HRD+K GN+ L+ +M  ++GDFGLA K+   GE      + GT  Y+
Sbjct: 155 VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDLCGTPNYI 209
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK-I 552
           APE+      +   D++S G ++  +  G+ P +    +E      +   +N Y   + I
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE----TYIRIKKNEYSVPRHI 265
Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
              A A IR+                  H D T RP++ E++ 
Sbjct: 266 NPVASALIRRML----------------HADPTLRPSVAELLT 292

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQH 379
           F+  + +G G FG VYKG            +A+K ++  +++  +++   EI+ + +   
Sbjct: 21  FTKLDRIGKGSFGEVYKGI----DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 76
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +   P   L       IL ++ +GL+YLH
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLH 133
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               +  +HRDIK+ N+LL  +   +L DFG+A      ++      VGT  ++APE+  
Sbjct: 134 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNXFVGTPFWMAPEVIK 189
Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S+    +D++S G+  +E+A G  P
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           +++G G FG+V K  +          +  +   + SK   ++F  E+  + +L  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQILA 429
            + G C     L L  +Y P+G+L ++              I       L  +Q     A
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
           DVA G++YL     +  +HRD+ + NIL+      ++ DFGL++    G+     + +G 
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202
Query: 490 LG--YLAPELATVSSPTSASDVYSFGVVILEV 519
           L   ++A E    S  T+ SDV+S+GV++ E+
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 8/225 (3%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F +  +LG GGFG V+   +       + +   K      ++G +  M E   + ++  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK-KRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +        +L LV   M  G +   I+   +   G+++ R I   A +  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +++RD+K  N+LLD +   R+ D GLA   + G+   T    GT G++APEL 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
                  + D ++ GV + E+   R P    +GE+ E   L   V
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRV 405

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-E 366
           F  +E   A +  +    LG G FG VY+G           T +A+K VN  +    + E
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 367 FMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL------------NNWIFGK 414
           F+ E S M      ++V++ G   +G   +++ + M  G L            NN +   
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK- 473
           P       +  Q+  ++A+G+ YL+       VHRD+ + N ++  +   ++GDFG+ + 
Sbjct: 126 P----SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
           +Y+        + +  + +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G FG V               +AVK + H      ++F  EI  +  L    +V+ R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 387 G--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHHGW 442
           G  +      L LV +Y+P+G L +++     +L      R +L  + + +G+ YL    
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL---DASRLLLYSSQICKGMEYL---G 132
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT--LGYLAPELATV 500
            +  VHRD+ + NIL++SE   ++ DFGLAKL    +     R  G   + + APE  + 
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 501 SSPTSASDVYSFGVVILEV 519
           +  +  SDV+SFGVV+ E+
Sbjct: 193 NIFSRQSDVWSFGVVLYEL 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 116/239 (48%), Gaps = 25/239 (10%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK-EFMAEISSM 374
           AT  +     +G G +G VYK             +A+K V   + ++GL    + E++ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA----RDPHSGHFVALKSVRVPNGEEGLPISTVREVALL 57
Query: 375 GRLQ---HKNLVQMRGWC---RKGNEL--MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
            RL+   H N+V++   C   R   E+   LV++++ +  L  ++   P   L  +  + 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 116
Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL--YQQGEVPNTT 484
           ++     GL++LH      +VHRD+K  NIL+ S    +L DFGLA++  YQ    P   
Sbjct: 117 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP--- 170
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
            VV TL Y APE+   S+  +  D++S G +  E+   R+PL  G  E ++   + D +
Sbjct: 171 -VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 8/225 (3%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F +  +LG GGFG V+   +       + +   K      ++G +  M E   + ++  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSR 245
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +        +L LV   M  G +   I+   +   G+++ R I   A +  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +++RD+K  N+LLD +   R+ D GLA   + G+   T    GT G++APEL 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
                  + D ++ GV + E+   R P    +GE+ E   L   V
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRV 405

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 8/225 (3%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F +  +LG GGFG V+   +       + +   K      ++G +  M E   + ++  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSR 245
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +        +L LV   M  G +   I+   +   G+++ R I   A +  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +++RD+K  N+LLD +   R+ D GLA   + G+   T    GT G++APEL 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
                  + D ++ GV + E+   R P    +GE+ E   L   V
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRV 405

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 8/225 (3%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F +  +LG GGFG V+   +       + +   K      ++G +  M E   + ++  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSR 245
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +        +L LV   M  G +   I+   +   G+++ R I   A +  GL +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +++RD+K  N+LLD +   R+ D GLA   + G+   T    GT G++APEL 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELL 361
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
                  + D ++ GV + E+   R P    +GE+ E   L   V
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRV 405

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           EL+G G FG+VY G           E+A++ ++   D++  LK F  E+ +  + +H+N+
Sbjct: 39  ELIGKGRFGQVYHGRW-------HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V   G C     L ++       +L + +    K +L   + RQI  ++ +G+ YLH   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGL---AKLYQQGEVPNTTRVV-GTLGYLAPELA 498
            + ++H+D+KS N+  D+  +  + DFGL   + + Q G   +  R+  G L +LAPE+ 
Sbjct: 148 AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 499 TVSSP---------TSASDVYSFGVVILEVACGRRPLDMGKGE 532
              SP         +  SDV++ G +  E+     P      E
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 116/239 (48%), Gaps = 25/239 (10%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK-EFMAEISSM 374
           AT  +     +G G +G VYK             +A+K V   + ++GL    + E++ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR----DPHSGHFVALKSVRVPNGEEGLPISTVREVALL 57
Query: 375 GRLQ---HKNLVQMRGWC---RKGNEL--MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
            RL+   H N+V++   C   R   E+   LV++++ +  L  ++   P   L  +  + 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 116
Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL--YQQGEVPNTT 484
           ++     GL++LH      +VHRD+K  NIL+ S    +L DFGLA++  YQ    P   
Sbjct: 117 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP--- 170
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
            VV TL Y APE+   S+  +  D++S G +  E+   R+PL  G  E ++   + D +
Sbjct: 171 -VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 227

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQ---------HKNLVQMRGWCRKGNELMLVYD 400
           E AVK +   +++   E + E+    R +         H +++ +       + + LV+D
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
            M  G L +++    K  L  K+ R I+  + E +++LH      +VHRD+K  NILLD 
Sbjct: 181 LMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDD 235
Query: 461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS------DVYSFGV 514
            M+ RL DFG +   + GE      + GT GYLAPE+   S   +        D+++ GV
Sbjct: 236 NMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 515 VILEVACGRRPL 526
           ++  +  G  P 
Sbjct: 294 ILFTLLAGSPPF 305

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 18  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 77  LIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 132
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 189
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEM 211

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 24  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 138
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPES 195
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEM 217

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 24  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 138
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 195
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEM 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 14  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 73  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 128
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPES 185
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 14  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 73  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 128
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 185
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEM 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 18  EILGFGGMSEVHLA----RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NIL+ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 228 LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HR++ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 400 SDVWAFGVLLWEIA 413

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 18  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 77  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 132
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 133 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 189
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEM 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 327 LGSGGFGRVY-------KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
           LG+G FGRV+           A         + +K V H + + L         +  + H
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL--------MLSIVTH 65
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR------RQILADVAE 433
             +++M G  +   ++ ++ DY+  G L +        LL   QR      +   A+V  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFS--------LLRKSQRFPNPVAKFYAAEVCL 117
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT-RVVGTLGY 492
            L YLH    + +++RD+K  NILLD     ++ DFG AK      VP+ T  + GT  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDY 169
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           +APE+ +      + D +SFG++I E+  G  P 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 148
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR--------QILADVAEGL 435
            + G C  G  ++++ +Y   G L N++  K +  L  +  R           + VA+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGY 492
            +L     +  +HRD+ + N+LL +    ++GDFGLA+         V    R+   + +
Sbjct: 166 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKW 220
Query: 493 LAPELATVSSPTSASDVYSFGVVILEV 519
           +APE       T  SDV+S+G+++ E+
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G         +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 14  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK-LLGWKQRRQILADVAEGLNYLHH 440
           L+++ G       + +V +  P GSL + +       LLG   R  +   VAEG+ YL  
Sbjct: 73  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE- 128
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPEL 497
              +  +HRD+ + N+LL +    ++GDFGL +   Q +   V    R V    + APE 
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPES 185
Query: 498 ATVSSPTSASDVYSFGVVILEV 519
               + + ASD + FGV + E+
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEM 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP----SLSKMIQMAGEIA 148
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+A+K ++    +   L++   E+  M  L H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L L+ +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQ 129
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +T    G+  Y APEL   
Sbjct: 130 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQG 184
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 239

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 142
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 27/295 (9%)
Query: 316 KATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMG 375
           ++ + + N  L+G G +G V K          + +  ++  + D K   K  M EI  + 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLK 79
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW-IFGKPKKLLGWKQRRQILADVAEG 434
           +L+H+NLV +   C+K     LV++++ +  L++  +F      L ++  ++ L  +  G
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIING 136
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYL 493
           + + H      ++HRDIK  NIL+      +L DFG A+ L   GEV +    V T  Y 
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYR 191
Query: 494 APELATVSSPT-SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ--- 549
           APEL         A DV++ G ++ E+  G  PL  G  + ++   +M  + NL  +   
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 550 --GKICEAADARIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMREVV 594
              K    A  R+ +  E E +        E+V+ L   C H D  +RP   E++
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL------------LGWKQRRQILADV 431
            + G C  G  ++++ +Y   G L N++  K + L            L  +      + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVG 488
           A+G+ +L     +  +HRD+ + N+LL +    ++GDFGLA+         V    R+  
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-- 228
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + ++APE       T  SDV+S+G+++ E+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 312 EELSKATKGFSNDELLGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMA 369
           +E   A +  +    LG G FG VY+G           T +A+K VN  +    + EF+ 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKK 417
           E S M      ++V++ G   +G   +++ + M  G L            NN +   P  
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP-- 125
Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQ 476
                +  Q+  ++A+G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+
Sbjct: 126 --SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
                   + +  + +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 134/295 (45%), Gaps = 43/295 (14%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQILA 429
            + G C  G  ++++ +Y   G L N++  K              P++ L  +      +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRV 486
            VA+G+ +L     +  +HRD+ + N+LL +    ++GDFGLA+         V    R+
Sbjct: 174 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRN 545
              + ++APE       T  SDV+S+G+++ E+ + G  P            +L++    
Sbjct: 231 --PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY---------PGILVN--SK 277
Query: 546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
            Y   K+ +      +  F  + +  +++   AC   + T RPT +++ + L  Q
Sbjct: 278 FY---KLVKDGYQMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQ 326

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 116/259 (44%), Gaps = 45/259 (17%)
Query: 4   MLRLFLFIIVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ 63
           M R+ LF+I++      + ++ + F F  F    N T+LIL  D  V S  +R+T  +  
Sbjct: 8   MKRIVLFLILLT---KAASANLISFTFKKF----NETNLILQRDATVSSGKLRITKAAEN 60
Query: 64  F-----SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF 118
                 S GRA+Y T +++  +T   +  + S++TSF F++    A+SP  GL F L   
Sbjct: 61  GVPTAGSLGRAFYSTPIQIWDNT---TGTVASWATSFTFNLQAPNAASPADGLAFALVPV 117
Query: 119 TSPPGALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV 178
            S P      + GLF +            EFDT  N  + DP + HIG+D+N+I+S K  
Sbjct: 118 GSQPKDKGG-FLGLFDSKNYASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSIKTT 175
Query: 179 PAGY-----------YSSSRN------------ESF-VPVRMRNGQNIHAWIDFDGFSAS 214
              +           Y SS N             SF V  R+     +  W+   GFSA+
Sbjct: 176 SWDFANGENAEVLITYDSSTNLLVASLVHPSQKTSFIVSERVDLTSVLPEWVSV-GFSAT 234
Query: 215 ---KTNWIEARRVLAWSLS 230
                 ++E   VL+WS +
Sbjct: 235 TGLSKGYVETNEVLSWSFA 253

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR--------QILADVAEGL 435
            + G C  G  ++++ +Y   G L N++  K +  L  +  R           + VA+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGY 492
            +L     +  +HRD+ + N+LL +    ++GDFGLA+         V    R+   + +
Sbjct: 174 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL--PVKW 228
Query: 493 LAPELATVSSPTSASDVYSFGVVILEV 519
           +APE       T  SDV+S+G+++ E+
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 141
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 141
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ+ 
Sbjct: 267 LGGGQYGEVYEGVWKKY----SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 321
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
           G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +  
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 378
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
           +HR++ + N L+      ++ DFGL++L               + + APE    +  +  
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 438
Query: 507 SDVYSFGVVILEVA 520
           SDV++FGV++ E+A
Sbjct: 439 SDVWAFGVLLWEIA 452

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 18/239 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF--MAEIS 372
           S AT  +     +G G +G VYK          + + +V+  N     G      + E++
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-SVRVPNGGGGGGGLPISTVREVA 63
Query: 373 SMGRLQ---HKNLVQMRGWC---RKGNEL--MLVYDYMPNGSLNNWIFGKPKKLLGWKQR 424
            + RL+   H N+V++   C   R   E+   LV++++ +  L  ++   P   L  +  
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
           + ++     GL++LH      +VHRD+K  NIL+ S    +L DFGLA++Y        T
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LT 177
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
            VV TL Y APE+   S+  +  D++S G +  E+   R+PL  G  E ++   + D +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH- 379
           F    +LG G FG+V K   A      S   A+K + H +++ L   ++E+  +  L H 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALD----SRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQ 62
Query: 380 ------------KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQR 424
                       +N V+     +K + L +  +Y  N +L + I  +    ++   W+  
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ------- 477
           RQIL    E L+Y+H    Q ++HR++K  NI +D     ++GDFGLAK   +       
Sbjct: 123 RQIL----EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 478 ------GEVPNTTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILE 518
                 G   N T  +GT  Y+A E L          D YS G++  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 135
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 136 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 18  EILGFGGMSEVHLA----RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 18  EILGFGGMSEVHLA----RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 116/239 (48%), Gaps = 25/239 (10%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLK-EFMAEISSM 374
           AT  +     +G G +G VYK             +A+K V   + ++GL    + E++ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR----DPHSGHFVALKSVRVPNGEEGLPISTVREVALL 57
Query: 375 GRLQ---HKNLVQMRGWC---RKGNEL--MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
            RL+   H N+V++   C   R   E+   LV++++ +  L  ++   P   L  +  + 
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 116
Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL--YQQGEVPNTT 484
           ++     GL++LH      +VHRD+K  NIL+ S    +L DFGLA++  YQ    P   
Sbjct: 117 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP--- 170
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
            VV TL Y APE+   S+  +  D++S G +  E+   R+PL  G  E ++   + D +
Sbjct: 171 -VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY             E+A++ +N   +   +  + EI  M   +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFL 132
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        +   +T +VGT  ++APE+ 
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV 188
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 312 EELSKATKGFSNDELLGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMA 369
           +E   A +  +    LG G FG VY+G           T +A+K VN  +    + EF+ 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKK 417
           E S M      ++V++ G   +G   +++ + M  G L            NN +   P  
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP-- 157
Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQ 476
                +  Q+  ++A+G+ YL+       VHRD+ + N ++  +   ++GDFG+ + +Y+
Sbjct: 158 --SLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
                   + +  + +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 327 LGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
           LG G FG+V       L        T++AVK +  D +++ L + ++E+  M  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQI 427
           ++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRV 486
              VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+ ++       TT  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
              + ++APE       T  SDV+SFGV++ E+
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 18  EILGFGGMSEVHLA----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG---LKEFMAEISSMG 375
           K FS+   +G G FG VY           S  +A+K +++  KQ     ++ + E+  + 
Sbjct: 15  KLFSDLREIGHGSFGAVYFAR----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           +L+H N +Q RG   + +   LV +Y   GS ++ +    KK L   +   +     +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YLH      ++HRD+K+GNILL      +LGDFG A +     +      VGT  ++AP
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAP 180
Query: 496 ELATVSSP---TSASDVYSFGVVILEVACGRRPL 526
           E+             DV+S G+  +E+A  + PL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWK------------------QRR 425
            + G C  G  ++++ +Y   G L N++  K + +LG                    + R
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 426 QIL---ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE--- 479
            +L   + VA+G+ +L     +  +HRD+ + N+LL +    ++GDFGLA+         
Sbjct: 159 DLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
           V    R+   + ++APE       T  SDV+S+G+++ E+
Sbjct: 216 VKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG---LKEFMAEISSMG 375
           K FS+   +G G FG VY           S  +A+K +++  KQ     ++ + E+  + 
Sbjct: 54  KLFSDLREIGHGSFGAVYFAR----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           +L+H N +Q RG   + +   LV +Y   GS ++ +    KK L   +   +     +GL
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YLH      ++HRD+K+GNILL      +LGDFG A +     +      VGT  ++AP
Sbjct: 168 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANXFVGTPYWMAP 219
Query: 496 ELATVSSP---TSASDVYSFGVVILEVACGRRPL 526
           E+             DV+S G+  +E+A  + PL
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 18  EILGFGGMSEVHLA----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY             E+A++ +N   +   +  + EI  M   +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFL 132
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        E    + +VGT  ++APE+ 
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSEMVGTPYWMAPEVV 188
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           +++G G FG+V K  +          +  +   + SK   ++F  E+  + +L  H N++
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQILA 429
            + G C     L L  +Y P+G+L ++              I       L  +Q     A
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
           DVA G++YL     +  +HR++ + NIL+      ++ DFGL++    G+     + +G 
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 199
Query: 490 LG--YLAPELATVSSPTSASDVYSFGVVILEV 519
           L   ++A E    S  T+ SDV+S+GV++ E+
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                 NTT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   EL+GSGGFG+V+K               +K V +++++  +    E+ ++ +L H 
Sbjct: 13  FKEIELIGSGGFGQVFKAK----HRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHV 64
Query: 381 NLVQMRGWCRKGNE-----------------LMLVYDYMPNGSLNNWIFGKPKKLLGWKQ 423
           N+V   G C  G +                 L +  ++   G+L  WI  +  + L    
Sbjct: 65  NIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 424 RRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPN 482
             ++   + +G++Y+H    + +++RD+K  NI L    + ++GDFGL   L   G+   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177
Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
             R  GTL Y++PE  +        D+Y+ G+++ E+
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK---EFMAEISSMGRLQHKN 381
           E+LG GG   V+             ++AVK +  D  +       F  E  +   L H  
Sbjct: 35  EILGFGGMSEVHLA----RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 382 LVQM----RGWCRKGNELMLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAE 433
           +V +          G    +V +Y+   +L + +  +    PK+ +      +++AD  +
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------EVIADACQ 144
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG--EVPNTTRVVGTLG 491
            LN+ H      ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           YL+PE A   S  + SDVYS G V+ EV  G  P 
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY             E+A++ +N   +   +  + EI  M   +
Sbjct: 21  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFL 133
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        E    + +VGT  ++APE+ 
Sbjct: 134 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVV 189
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL+
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 173
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K+  + L              
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 157 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 266
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 267 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 307

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY             E+A++ +N   +   +  + EI  M   +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFL 132
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HRDIKS NILL  +   +L DFG        E    + +VGT  ++APE+ 
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXMVGTPYWMAPEVV 188
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE------FMAEISSMGRLQ 378
           E LG G FG+V   T          ++A+K +   S+Q LK+         EIS +  L+
Sbjct: 15  ETLGEGSFGKVKLAT----HYKTQQKVALKFI---SRQLLKKSDMHMRVEREISYLKLLR 67
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H +++++        ++++V +Y   G L ++I  K  K +   + R+    +   + Y 
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYC 124
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+ 
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI 179
Query: 499 T---VSSPTSASDVYSFGVVILEVACGRRPLD 527
                + P    DV+S G+V+  +  GR P D
Sbjct: 180 NGKLYAGP--EVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKNLV 383
           +LG G FG V    L         E AVK +N  S +       + E+  + +L H N++
Sbjct: 29  MLGKGSFGEV----LKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++       +   +V +    G L + I    +K        +I+  V  G+ Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITYMHK--- 139
Query: 444 QVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  NILL+S+ +    ++ DFGL+  +QQ         +GT  Y+APE+   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR- 196
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
            +     DV+S GV++  +  G  P   GK E
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF-YGKNE 227

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 36/287 (12%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA----------DVA 432
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   +              VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          L 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG 550
           ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  +G
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FXRRL-KEG 263
Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
               A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 264 TRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T           ++AVK +   +    KE  M+E+  M  L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLL---------GWKQRRQIL---ADV 431
            + G C  G  ++++ +Y   G L N++  K + L               R +L   + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVG 488
           A+G+ +L     +  +HRD+ + N+LL +    ++GDFGLA+         V    R+  
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-- 228
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEV 519
            + ++APE       T  SDV+S+G+++ E+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKNLV 383
           +LG G FG V    L         E AVK +N  S +       + E+  + +L H N++
Sbjct: 29  MLGKGSFGEV----LKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++       +   +V +    G L + I    +K        +I+  V  G+ Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITYMHK--- 139
Query: 444 QVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  NILL+S+ +    ++ DFGL+  +QQ         +GT  Y+APE+   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR- 196
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
            +     DV+S GV++  +  G  P   GK E
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF-YGKNE 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKNLV 383
           +LG G FG V    L         E AVK +N  S +       + E+  + +L H N++
Sbjct: 29  MLGKGSFGEV----LKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++       +   +V +    G L + I    +K        +I+  V  G+ Y+H    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEII--KRKRFSEHDAARIIKQVFSGITYMHK--- 139
Query: 444 QVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  NILL+S+ +    ++ DFGL+  +QQ         +GT  Y+APE+   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR- 196
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGE 532
            +     DV+S GV++  +  G  P   GK E
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF-YGKNE 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 315 SKATKGFSND----ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--------HDSKQ 362
           S +T GF  +    E+LG G    V +            E AVK ++         +  Q
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQ 64
Query: 363 GLKE-FMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG 420
            L+E  + E+  + ++  H N++Q++          LV+D M  G L +++    K  L 
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLS 122
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
            K+ R+I+  + E +  LH      +VHRD+K  NILLD +M  +L DFG +     GE 
Sbjct: 123 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE- 178
Query: 481 PNTTRVVGTLGYLAPELATVSSPTSAS------DVYSFGVVILEVACGRRPL 526
                V GT  YLAPE+   S   +        D++S GV++  +  G  P 
Sbjct: 179 -KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   EL+GSGGFG+V+K               ++ V +++++  +    E+ ++ +L H 
Sbjct: 14  FKEIELIGSGGFGQVFKA----KHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHV 65
Query: 381 NLVQMRGWCRKG--------NELMLVYDYMP----------------------NGSLNNW 410
           N+V   G C  G        ++ +   DY P                       G+L  W
Sbjct: 66  NIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 411 IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG 470
           I  +  + L      ++   + +G++Y+H    + ++HRD+K  NI L    + ++GDFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 471 L-AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
           L   L   G+    TR  GTL Y++PE  +        D+Y+ G+++ E+
Sbjct: 182 LVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV---NHDSKQGLKEFMAEISSMGRLQHKNL 382
           +LG G FG+V    +       + ++  K V   + D +  + E    I S+ R  H  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 86
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
            Q+    +  + L  V +++  G L   I  +  +     + R   A++   L +LH   
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLH--- 141
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           D+ +++RD+K  N+LLD E   +L DFG+ K      V  T    GT  Y+APE+     
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTATFCGTPDYIAPEILQEML 200
Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
              A D ++ GV++ E+ CG  P +    ++  EA+L D V
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 11/235 (4%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+A+K ++    +   L++   E+  M  L H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V++         L L+ +Y   G + +++    +  +  K+ R     +   + Y H 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQ 132
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +VHRD+K+ N+LLD++M  ++ DFG +  +  G         G   Y APEL   
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQG 187
Query: 501 SSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                   DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCE 242

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 135
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N  +  +   ++GDFG+ + +Y+        + +  + 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 13/222 (5%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y A
Sbjct: 117 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRA 172
Query: 495 PE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           PE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 173
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      R+ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 173
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 36/287 (12%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA----------DVA 432
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   +              VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          L 
Sbjct: 155 KGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG 550
           ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  +G
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-KEG 263
Query: 551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
               A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 264 TRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 315 SKATKGFSND----ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN--------HDSKQ 362
           S +T GF  +    E+LG G    V +            E AVK ++         +  Q
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQ 64
Query: 363 GLKE-FMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG 420
            L+E  + E+  + ++  H N++Q++          LV+D M  G L +++    K  L 
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLS 122
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
            K+ R+I+  + E +  LH      +VHRD+K  NILLD +M  +L DFG +     GE 
Sbjct: 123 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE- 178
Query: 481 PNTTRVVGTLGYLAPELATVSSPTSAS------DVYSFGVVILEVACGRRPL 526
                V GT  YLAPE+   S   +        D++S GV++  +  G  P 
Sbjct: 179 -KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 173
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 43/292 (14%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD------------ 430
            + G C K G  LM++ ++   G+L+ ++  K  + + +K    +  D            
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 431 -VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR---V 486
            VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+   +   P+  R    
Sbjct: 156 QVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGDA 210
Query: 487 VGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRN 545
              L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 263
Query: 546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           L  +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 264 L-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 180
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 219

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 13/154 (8%)
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++Q++          LV+D M  G L +++    K  L  K+ R+I+  + E +  L
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICAL 127
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      +VHRD+K  NILLD +M  +L DFG +     GE      V GT  YLAPE+ 
Sbjct: 128 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEII 182
Query: 499 TVSSPTSAS------DVYSFGVVILEVACGRRPL 526
             S   +        D++S GV++  +  G  P 
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
           K ++  E +G G  G VY             E+A++ +N   +   +  + EI  M   +
Sbjct: 21  KKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           + N+V        G+EL +V +Y+  GSL + +    +  +   Q   +  +  + L +L
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFL 133
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      V+HR+IKS NILL  +   +L DFG        +   +T +VGT  ++APE+ 
Sbjct: 134 HSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV 189
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRP 525
           T  +     D++S G++ +E+  G  P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 142
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + + +        + +  + 
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXS-TEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           +G G FGRV++            T +AVK +  ++   ++ +F  E + M    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF------------------------GKPKKLLG 420
           + G C  G  + L+++YM  G LN ++                         G P   L 
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP--LS 172
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGE 479
             ++  I   VA G+ YL    ++  VHRD+ + N L+   M  ++ DFGL++ +Y    
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                     + ++ PE    +  T+ SDV+++GVV+ E+
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 180
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 177
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 216

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLV 383
           EL+G+G +G+VYKG         +  + V  V  D ++ +K+   EI+ + +   H+N+ 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAA--IKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIA 84
Query: 384 QMRGWCRKGN------ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
              G   K N      +L LV ++   GS+ + I       L  +    I  ++  GL++
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE- 496
           LH      V+HRDIK  N+LL      +L DFG++    +  V      +GT  ++APE 
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAPEV 200
Query: 497 LATVSSPTSA----SDVYSFGVVILEVACGRRPL 526
           +A   +P +     SD++S G+  +E+A G  PL
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 264
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 265 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 327 LGSGGFGRVYKGTL-AXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G           T +A+K VN  +    + EF+ E S M      ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 385 MRGWCRKGNELMLVYDYMPNGSL------------NNWIFGKPKKLLGWKQRRQILADVA 432
           + G   +G   +++ + M  G L            NN +   P       +  Q+  ++A
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP----SLSKMIQMAGEIA 133
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLG 491
           +G+ YL+       VHRD+ + N ++  +   ++GDFG+ + + +        + +  + 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVA 520
           +++PE       T+ SDV+SFGVV+ E+A
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 264
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 265 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 150 FEYLKLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+Y
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE 496
           LH   ++ VV+RD+K  N++LD +   ++ DFGL K   + G    T    GT  YLAPE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 319
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 255
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 256 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L +++       +     +  L  + +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 116 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 169
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 255
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 256 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 153 FEYLKLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+Y
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE 496
           LH   ++ VV+RD+K  N++LD +   ++ DFGL K   + G    T    GT  YLAPE
Sbjct: 267 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 322
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 370

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 15/228 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 7   FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE 496
           LH    + VV+RDIK  N++LD +   ++ DFGL K     G    T    GT  YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 7   FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH    + VV+RDIK  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 16/229 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 10  FEYLKLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+Y
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH   ++ VV+RD+K  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 124 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 178
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 227

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 15/228 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 10  FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE 496
           LH    + VV+RDIK  N++LD +   ++ DFGL K     G    T    GT  YLAPE
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 178
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 226

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 19/223 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW 542
                   DV+S G+V+  +  G  P D      +E +   DW
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS---DW 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 7   FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH    + VV+RDIK  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 169
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 16/229 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 11  FEYLKLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+Y
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH   ++ VV+RD+K  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 125 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 179
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVV 487
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +        
Sbjct: 192 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 301
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 302 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 342

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 16/229 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 12  FEYLKLLGKGTFGKV----ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++    + R   A++   L+Y
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH   ++ VV+RD+K  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 126 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 180
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E+  E +LM+ +R
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 229

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAE--ISSMGRLQHKNL 382
           EL+G G +G VYKG+L          +AVK  +  ++Q    F+ E  I  +  ++H N+
Sbjct: 19  ELIGRGRYGAVYKGSL------DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNI 69
Query: 383 VQM-----RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            +      R       E +LV +Y PNGSL  ++         W    ++   V  GL Y
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAY 126
Query: 438 LH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA------KLYQQGEVPNTT- 484
           LH        +   + HRD+ S N+L+ ++    + DFGL+      +L + GE  N   
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 485 RVVGTLGYLAPE-------LATVSSPTSASDVYSFGVVILEV 519
             VGT+ Y+APE       L    S     D+Y+ G++  E+
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L +++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 15/228 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 7   FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL-YQQGEVPNTTRVVGTLGYLAPE 496
           LH    + VV+RDIK  N++LD +   ++ DFGL K     G    T    GT  YLAPE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           +   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 169
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 169
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L +++       +     +  L  + +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 171
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 214

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V    LA       TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEV---QLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLA 494
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y A
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWYRA 170
Query: 495 PE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           PE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 169
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 171
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 171
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 7   FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH    + VV+RDIK  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLA 494
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y A
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWYRA 170
Query: 495 PE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           PE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 17/229 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
           F   +LLG G FG+V    +           A+K +  +   +K  +   + E   +   
Sbjct: 12  FDYLKLLGKGTFGKV----ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H  L  ++   +  + L  V +Y   G L  +     +++   ++ R   A++   L Y
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAP 495
           LH    + VV+RDIK  N++LD +   ++ DFGL K   +G     T     GT  YLAP
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 179
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
           E+   +    A D +  GVV+ E+ CGR P      E   E +LM+ +R
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 228

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V    LA       TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEV---QLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 117 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 170
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 118 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 171
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 214

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 120 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 173
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 216

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSIL-PEIASSPGFGLCFVLTNFTSPPG 123
           S GRA Y + + +  S    + ++ SF+TSF F+I  P IA+    GL F L   +SPP 
Sbjct: 48  SLGRALYASPINIWDS---KTGVVASFATSFRFTIYAPNIATIAD-GLAFFLAPVSSPPK 103
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKH------ 177
           A A  + GLF +            EFDT +N  F DP D HIG+D+N+I+S K       
Sbjct: 104 AGAG-FLGLFDSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSIKTVKWDLA 162
Query: 178 ------------------VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSA---SKT 216
                             V A  Y SS+    +   +     +  W+   GFSA   + +
Sbjct: 163 NGEAAKVLITYDSSAKLLVAALVYPSSKTSFILSDVVDLKSVLPEWVSI-GFSAATGASS 221
Query: 217 NWIEARRVLAWSLS 230
            +IE   V +WS +
Sbjct: 222 GYIETHDVFSWSFA 235

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 11  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 117 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 170
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLA 494
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y A
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWYRA 172
Query: 495 PE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           PE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 213

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEV------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEV------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEV------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 24  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 83
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 19  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 78
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+  +  D++ +G+    + EIS +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE 58
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 173
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 212

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 13/220 (5%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGR 376
           + F   E +G G +G VYK             +A+  +  D++ +G+    + EIS +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKE 57
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      V+HRD+K  N+L+++E   +L DFGLA+ +    V   T  V TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172
Query: 497 -LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 211

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 21  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 80
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 87/194 (44%), Gaps = 34/194 (17%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSIL-PEIASSPGFGLCFVLTNFTSPPG 123
           S GRA Y + + +  S    + ++ SF+TSF F+I  P IA+    GL F L   +SPP 
Sbjct: 48  SLGRALYASPINIWDS---KTGVVASFATSFRFTIYAPNIATIAD-GLAFFLAPVSSPPK 103
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKH------ 177
           A A  + GLF +            EFDT +N  F DP D HIG+D+N+I+S K       
Sbjct: 104 AGAG-FLGLFDSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSIKTVKWDLA 162
Query: 178 ------------------VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFDGFSA---SKT 216
                             V A  Y SS+    +   +     +  W+   GFSA   + +
Sbjct: 163 NGEAAKVLITYDSSAKLLVAALVYPSSKTSFILSDVVDLKSVLPEWVSI-GFSAATGASS 221
Query: 217 NWIEARRVLAWSLS 230
            +IE   V +WS +
Sbjct: 222 GYIETHDVFSWSFA 235

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 15/237 (6%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHK 380
           N  LL + G G   K  LA        E+AVK ++    +   L++   E+     L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQILADVAEGLNYL 438
           N+V++         L LV +Y   G + +++   G+ K+     + RQI++ V     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAV----QYC 129
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H  +   +VHRD+K+ N+LLD++   ++ DFG +  +  G   +     G   Y APEL 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA--FCGAPPYAAPELF 184
Query: 499 TVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                     DV+S GV++  +  G  P D    +E  E VL    R  +     CE
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCE 241

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G +G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 13  QTLGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++ +Y   G+L  ++  +              P+
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 117 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 170
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 213

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDH 80
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 195
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G FG VY           + ++  K  +   K+G++ +   EI     L+H N+++M
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAEGLNYLHHGWD 443
             +      + L+ ++ P G L    + + +K   + ++R    + ++A+ L+Y H   +
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           + V+HRDIK  N+L+  +   ++ DFG +        P+  R  + GTL YL PE+    
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 502 SPTSASDVYSFGVVILEVACGRRPLD 527
           +     D++  GV+  E   G  P D
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 91
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 206
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXS-TEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G+G +GR  K             E+    +    KQ L   ++E++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 386 --RGWCRKGNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHG 441
             R   R    L +V +Y   G L + I    K ++ L  +   +++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 442 WD--QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
            D    V+HRD+K  N+ LD +   +LGDFGLA++    E       VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE-DFAKEFVGTPYYMSPEQMN 189
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
             S    SD++S G ++ E+ C   P      ++E               GKI E    R
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKE-------------LAGKIREGKFRR 235
Query: 560 IRQEFEAEEMELVLK-LGLACCHPDSTRRPTMREVV 594
           I   +  E  E++ + L L   H     RP++ E++
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-----RPSVEEIL 266

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 73
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 188
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G FG VY           + ++  K  +   K+G++ +   EI     L+H N+++M
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILADVAEGLNYLHHGWD 443
             +      + L+ ++ P G L    + + +K   + ++R    + ++A+ L+Y H   +
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 133
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
           + V+HRDIK  N+L+  +   ++ DFG +        P+  R  + GTL YL PE+    
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 502 SPTSASDVYSFGVVILEVACGRRPLD 527
           +     D++  GV+  E   G  P D
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 326 LLGSGGFGRVY----KGTLAXXXXXXSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQ 378
           +LG G FG+V     KGT            A+K +  D       ++  M E   +  L 
Sbjct: 26  VLGKGSFGKVMLADRKGT--------EELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 379 HKN-LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGL 435
               L Q+    +  + L  V +Y+  G L   I    +++  +K+ + +   A+++ GL
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISIGL 133
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            +LH    + +++RD+K  N++LDSE   ++ DFG+ K +    V  T    GT  Y+AP
Sbjct: 134 FFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTPDYIAP 189
Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           E+        + D +++GV++ E+  G+ P D   GE+E+E
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDE 227

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + +G+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTIGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +YMP G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 84
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 199
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV---NHDSKQGLKEFMA 369
           ++    + F   ++LG G FG+V+           + +   K V   + D +  + E   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--K 69
Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
            + S+   +H  L  M    +    L  V +Y+  G L   I    K      +     A
Sbjct: 70  RVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAA 126
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
           ++  GL +LH    + +V+RD+K  NILLD +   ++ DFG+ K    G+   T    GT
Sbjct: 127 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNEFCGT 182
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
             Y+APE+        + D +SFGV++ E+  G+ P     G++EEE
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEE 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 84
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 199
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + +G+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTIGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +YMP G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDH 100
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 215
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG G +  VYKG            +A+K +  + ++G     + E+S +  L+H N+V +
Sbjct: 10  LGEGTYATVYKG----KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
                    L LV++Y+ +  L  ++      ++     +  L  +  GL Y H    Q 
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR---QK 120
Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGYLAPELATVSSP 503
           V+HRD+K  N+L++     +L DFGLA+      +P  T    V TL Y  P++   S+ 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 504 TSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
            S   D++  G +  E+A G RPL  G   EE+
Sbjct: 178 YSTQIDMWGVGCIFYEMATG-RPLFPGSTVEEQ 209

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 76
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 191
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 85
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 200
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDH 106
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 221
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 317 ATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSM 374
           + + F   E +G G +G VYK             +A+K +  D++ +G+    + EIS +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
             L H N+V++       N+L LV++++ +  L  ++       +     +  L  + +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT--RVVGTLGY 492
           L + H      V+HRD+K  N+L+++E   +L DFGLA+ +    VP  T    V TL Y
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYXHEVVTLWY 172
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            APE L      ++A D++S G +  E+   RR L  G  E ++
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 215

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E    +  M +L H
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRE----LQIMRKLDH 77
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 192
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDH 106
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 221
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++  Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 325 ELLGSGGFGRVY--KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG+V+  K               +K      +  ++  M E   +  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 88
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGLNYLHH 440
           V++    +   +L L+ D++  G L    F +  K + + +   +  LA++A  L++LH 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 143
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                +++RD+K  NILLD E   +L DFGL+K     E        GT+ Y+APE+   
Sbjct: 144 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR 200
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
              T ++D +SFGV++ E+  G  P    +G++ +E + M
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPF---QGKDRKETMTM 237

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 321 FSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTE---MAVKCVNHD-SKQGLKEFMAEI 371
           F  D+L     LG G FG+V              E   +AVK +  D +++ L + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 372 SSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PK 416
             M  + +HKN++ + G C +   L ++  Y   G+L  ++  +              P+
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LY 475
           + + +K        +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                  TT     + ++APE       T  SDV+SFGV++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LKE    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFGLAK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDH 108
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 223
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV---NHDSKQGLKEFMA 369
           ++    + F   ++LG G FG+V+           + +   K V   + D +  + E   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--K 68
Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
            + S+   +H  L  M    +    L  V +Y+  G L   I    K      +     A
Sbjct: 69  RVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAA 125
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
           ++  GL +LH    + +V+RD+K  NILLD +   ++ DFG+ K    G+   T    GT
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNXFCGT 181
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
             Y+APE+        + D +SFGV++ E+  G+ P     G++EEE
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEE 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F  +  LG G    VY+          + ++  K V+       K    EI  + RL H 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK------KIVRTEIGVLLRLSHP 108
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---LADVAEGLNY 437
           N+++++       E+ LV + +  G L + I  K     G+   R     +  + E + Y
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAY 163
Query: 438 LHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           LH   +  +VHRD+K  N+L  +   +   ++ DFGL+K+ +   +  T  V GT GY A
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCA 218
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           PE+    +     D++S G++   + CG  P    +G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +++ +++G+G FG VY+  L          +A+K V  D +   +E       M +L H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQDKRFKNRELQI----MRKLDHC 111
Query: 381 NLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVAE 433
           N+V++R +     E      L LV DY+P         + + K+ L     +  +  +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     Y
Sbjct: 172 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY-Y 226
Query: 493 LAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
            APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 325 ELLGSGGFGRVY--KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG+V+  K               +K      +  ++  M E   +  + H  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 89
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGLNYLHH 440
           V++    +   +L L+ D++  G L    F +  K + + +   +  LA++A  L++LH 
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 144
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                +++RD+K  NILLD E   +L DFGL+K     E        GT+ Y+APE+   
Sbjct: 145 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR 201
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
              T ++D +SFGV++ E+  G  P    +G++ +E + M
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPF---QGKDRKETMTM 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H  LV +    +  + L  V +Y+  G L      + ++ L  +  R   A+++  LNYL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPE 496
           H   ++ +++RD+K  N+LLDSE   +L D+G+ K   +G  P   T+   GT  Y+APE
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 223
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDM 528
           +        + D ++ GV++ E+  GR P D+
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFM-AEISSMGRLQH 379
           +++ +++G+G FG VY+  L          +A+K V  D     K F   E+  M +L H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKVLQD-----KRFKNRELQIMRKLDH 151
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 266
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 325 ELLGSGGFGRVY--KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG+V+  K               +K      +  ++  M E   +  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFI 88
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGLNYLHH 440
           V++    +   +L L+ D++  G L    F +  K + + +   +  LA++A  L++LH 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 143
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                +++RD+K  NILLD E   +L DFGL+K     E        GT+ Y+APE+   
Sbjct: 144 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR 200
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
              T ++D +SFGV++ E+  G  P    +G++ +E + M
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPF---QGKDRKETMTM 237

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H  LV +    +  + L  V +Y+  G L      + ++ L  +  R   A+++  LNYL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPE 496
           H   ++ +++RD+K  N+LLDSE   +L D+G+ K   +G  P   T+   GT  Y+APE
Sbjct: 138 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 191
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDM 528
           +        + D ++ GV++ E+  GR P D+
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H  LV +    +  + L  V +Y+  G L      + ++ L  +  R   A+++  LNYL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPE 496
           H   ++ +++RD+K  N+LLDSE   +L D+G+ K   +G  P   T+   GT  Y+APE
Sbjct: 123 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 176
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDM 528
           +        + D ++ GV++ E+  GR P D+
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LKE    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFGLAK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG+V K T          T +AVK +  + S   L++ ++E + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW---------------KQRRQILA 429
           + G C +   L+L+ +Y   GSL  ++    K   G+                +R   + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 430 D-------VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVP 481
           D       +++G+ YL    +  +VHRD+ + NIL+    + ++ DFGL++ +Y++    
Sbjct: 151 DLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC 521
             ++    + ++A E       T+ SDV+SFGV++ E+  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXS-TEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G+G +GR  K             E+    +    KQ L   ++E++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 386 --RGWCRKGNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHG 441
             R   R    L +V +Y   G L + I    K ++ L  +   +++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 442 WD--QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
            D    V+HRD+K  N+ LD +   +LGDFGLA++         T  VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMN 189
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
             S    SD++S G ++ E+ C   P      ++E               GKI E    R
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKE-------------LAGKIREGKFRR 235
Query: 560 IRQEFEAEEMELVLK-LGLACCHPDSTRRPTMREVV 594
           I   +  E  E++ + L L   H     RP++ E++
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-----RPSVEEIL 266

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 33  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 88
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 141
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 196
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKG 531
           +  +  SD++S G+ ++E+A GR P+  G G
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSG 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG+V K T          T +AVK +  + S   L++ ++E + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW---------------KQRRQILA 429
           + G C +   L+L+ +Y   GSL  ++    K   G+                +R   + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 430 D-------VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVP 481
           D       +++G+ YL    +  +VHRD+ + NIL+    + ++ DFGL++ +Y++    
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC 521
             ++    + ++A E       T+ SDV+SFGV++ E+  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSK----QGLKEFMAEISSMGRLQHK 380
           ++G G + +V    L       + ++  K  VN D      Q  K    + S+     H 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 70
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +  + L  V +Y+  G L      + ++ L  +  R   A+++  LNYLH 
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLH- 127
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLGYLAPELA 498
             ++ +++RD+K  N+LLDSE   +L D+G+ K   +G  P   T+   GT  Y+APE+ 
Sbjct: 128 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEIL 182
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDM 528
                  + D ++ GV++ E+  GR P D+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 42/291 (14%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR---RQILA---------D 430
            + G C K G  LM++ ++   G+L+ ++  K  + + +K     +  L           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR---VV 487
           VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+   +   P+  R     
Sbjct: 157 VAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGDAR 211
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL 264
Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 265 -KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG+V K T          T +AVK +  + S   L++ ++E + + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW---------------KQRRQILA 429
           + G C +   L+L+ +Y   GSL  ++    K   G+                +R   + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 430 D-------VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVP 481
           D       +++G+ YL    +  +VHRD+ + NIL+    + ++ DFGL++ +Y++    
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC 521
             ++    + ++A E       T+ SDV+SFGV++ E+  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--- 485
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+   +   P+  R   
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 209
Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVR 544
               L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCR 262
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            L  +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 263 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 305

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
           ++LGSG FG VYKG            +A+K +  + S +  KE + E   M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C     + LV   MP G L + +  + +  LG +        +A+G++YL    D
Sbjct: 83  RLLGICLTST-VQLVTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLE---D 137
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY---------QQGEVPNTTRVVGTLGYLA 494
             +VHRD+ + N+L+ S    ++ DFGLA+L            G+VP        + ++A
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP--------IKWMA 189
Query: 495 PELATVSSPTSASDVYSFGVVILEVAC-GRRPLD 527
            E       T  SDV+S+GV + E+   G +P D
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXS-TEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G+G +GR  K             E+    +    KQ L   ++E++ +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML---VSEVNLLRELKHPNIVRY 70
Query: 386 --RGWCRKGNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHG 441
             R   R    L +V +Y   G L + I    K ++ L  +   +++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 442 WD--QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
            D    V+HRD+K  N+ LD +   +LGDFGLA++    +       VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSPEQMN 189
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
             S    SD++S G ++ E+ C   P      ++E               GKI E    R
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMPPFTAFSQKE-------------LAGKIREGKFRR 235
Query: 560 IRQEFEAEEMELVLK-LGLACCHPDSTRRPTMREVV 594
           I   +  E  E++ + L L   H     RP++ E++
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYH-----RPSVEEIL 266

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQM 385
           LGSG FG V+             E  +K +N D  Q  +++  AEI  +  L H N++++
Sbjct: 30  LGSGAFGDVH----LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPK--KLLGWKQRRQILADVAEGLNYLHHGWD 443
                  + + +V +    G L   I       K L      +++  +   L Y H    
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---S 142
Query: 444 QVVVHRDIKSGNILL-DSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
           Q VVH+D+K  NIL  D+      ++ DFGLA+L++  E  ++T   GT  Y+APE+   
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK- 199
Query: 501 SSPTSASDVYSFGVVILEVACGRRPL 526
              T   D++S GVV+  +  G  P 
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL---KEFMAEISSMGRLQHKN 381
           + LG G  G V             TE AV     D K+ +   +    EI     L H+N
Sbjct: 12  QTLGEGAAGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH-- 121
Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN-TTRVVGTLGYLAPELATV 500
               + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APEL   
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 501 SS-PTSASDVYSFGVVILEVACGRRPLD 527
                   DV+S G+V+  +  G  P D
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--- 485
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+   +   P+  R   
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 200
Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVR 544
               L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCR 253
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            L  +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 254 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 327 LGSGGFGRVYKG-TLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKNLV 383
           LG G FG+V +              +AVK +   +     +  M+E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 384 QMRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA------------- 429
            + G C K G  LM++ ++   G+L+ ++  K  + + +K   + L              
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 430 -DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--- 485
             VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+   +   P+  R   
Sbjct: 146 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 200
Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVR 544
               L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCR 253
Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            L  +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 254 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 296

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 111/230 (48%), Gaps = 27/230 (11%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K +           MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 14  LGAGNGGVVFKVS----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV-----LMDWVRN 545
           +  +  SD++S G+ ++E+A GR P+     +E+         L+D++ N
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVN 227

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 318 TKGFSNDEL-----LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEI 371
           T+ F+ D+      LG G FG VY           + ++  K  +   K+G++ +   EI
Sbjct: 17  TRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFK--SQIEKEGVEHQLRREI 74
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--ILA 429
                L H N++++  +      + L+ +Y P G L    + + +K   + ++R   I+ 
Sbjct: 75  EIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIME 130
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VV 487
           ++A+ L Y H    + V+HRDIK  N+LL  +   ++ DFG +        P+  R  + 
Sbjct: 131 ELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS-----VHAPSLRRKTMC 182
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           GTL YL PE+          D++  GV+  E+  G  P +     E
Sbjct: 183 GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+ G        +  + ++ P
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 313

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 36  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 144
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 145 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 197
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + +G+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTIGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           E +G G FG V+ G L       +T +AVK         LK +F+ E   + +  H N+V
Sbjct: 120 EQIGRGNFGEVFSGRL----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +  G    ++  +  +L   K   Q++ D A G+ YL     
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLE---S 231
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATVS 501
           +  +HRD+ + N L+  +   ++ DFG+++    G    +   R V  + + APE     
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV-PVKWTAPEALNYG 290
Query: 502 SPTSASDVYSFGVVILE 518
             +S SDV+SFG+++ E
Sbjct: 291 RYSSESDVWSFGILLWE 307

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L       + +  +        QG      E+  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QGKAFKNRELQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+ G        +  + ++ P
Sbjct: 176 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 290

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L          +A+K V     QG      E+  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL----VAIKKV----LQGKAFKNRELQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLV 383
           E +G G FG V+ G L       +T +AVK         LK +F+ E   + +  H N+V
Sbjct: 120 EQIGRGNFGEVFSGRL----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +  G    ++  +  +L   K   Q++ D A G+ YL     
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLE---S 231
Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATVS 501
           +  +HRD+ + N L+  +   ++ DFG+++    G    +   R V  + + APE     
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-PVKWTAPEALNYG 290
Query: 502 SPTSASDVYSFGVVILE 518
             +S SDV+SFG+++ E
Sbjct: 291 RYSSESDVWSFGILLWE 307

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 325 ELLGSGGFGRVY---------KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMG 375
           ++LG G FG+V+          G L          + V+  +    +  ++ +A+++   
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVR--DRVRTKMERDILADVN--- 88
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAE 433
              H  +V++    +   +L L+ D++  G L    F +  K + + +   +  LA++A 
Sbjct: 89  ---HPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELAL 141
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           GL++LH      +++RD+K  NILLD E   +L DFGL+K     E        GT+ Y+
Sbjct: 142 GLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE-KKAYSFCGTVEYM 197
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
           APE+      + ++D +S+GV++ E+  G  P   GK  +E   +++
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF-QGKDRKETMTLIL 243

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
           + +LG G FG VY+G            +AVK    D     KE FM+E   M  L H ++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGE-KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHH 440
           V++ G   +    +++  Y P G L +++      L   K    +L    + + + YL  
Sbjct: 72  VKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSL---KVLTLVLYSLQICKAMAYLE- 126
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                 VHRDI   NIL+ S    +LGDFGL++  +  +    +     + +++PE    
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPL 526
              T+ASDV+ F V + E+ + G++P 
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 29  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 84
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 85  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 137
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 138 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEY 190
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 191 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            +++ +++G+G FG VY+  L       + +  +        QG      E+  M +L H
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QGKAFKNRELQIMRKLDH 72
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V++R +     E      L LV DY+P         + + K+ L     +  +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE PN + +     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSXICSRY- 187
Query: 492 YLAPELAT-VSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    +  TS+ DV+S G V+ E+  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
           + +LG G FG VY+G            +AVK    D     KE FM+E   M  L H ++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGE-KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHH 440
           V++ G   +    +++  Y P G L +++      L   K    +L    + + + YL  
Sbjct: 76  VKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSL---KVLTLVLYSLQICKAMAYLE- 130
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                 VHRDI   NIL+ S    +LGDFGL++  +  +    +     + +++PE    
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPL 526
              T+ASDV+ F V + E+ + G++P 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 36  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 144
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 145 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 197
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 64  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 172
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 173 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 225
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
           + +LG G FG VY+G            +AVK    D     KE FM+E   M  L H ++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGE-KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLHH 440
           V++ G   +    +++  Y P G L +++      L   K    +L    + + + YL  
Sbjct: 88  VKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSL---KVLTLVLYSLQICKAMAYLE- 142
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                 VHRDI   NIL+ S    +LGDFGL++  +  +    +     + +++PE    
Sbjct: 143 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 501 SSPTSASDVYSFGVVILEV-ACGRRPL 526
              T+ASDV+ F V + E+ + G++P 
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 325 ELLGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKN 381
           ++LGSG FG+V   T         S ++AVK +   +    +E  M+E+  M +L  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL----LGWKQRRQILAD------- 430
           +V + G C     + L+++Y   G L N++  K +K     + ++ ++++  +       
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 431 ----------VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE- 479
                     VA+G+ +L     +  VHRD+ + N+L+      ++ DFGLA+       
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 480 --VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
             V    R+   + ++APE       T  SDV+S+G+++ E+
Sbjct: 228 YVVRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +L H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKK----LLGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +L H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKK----LLGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 287

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G G FG V++G                C N  S    ++F+ E  +M +  H ++V++ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------LH 439
           G   + N + ++ +    G L +++           Q R+   D+A  + Y       L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-----------QVRKFSLDLASLILYAYQLSTALA 125
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE   
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 500 VSSPTSASDVYSFGVVILEV 519
               TSASDV+ FGV + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 76  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 131
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 132 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 184
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 239
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 274

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS---KQGL-----KEFMAEIS 372
           FS   ++G GGFG VY    A          A+KC++      KQG      +  M  + 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           S G      +V M       ++L  + D M  G L+  +      +      R   A++ 
Sbjct: 246 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEII 301
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            GL ++H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY
Sbjct: 302 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGY 355
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           +APE L    +  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 400

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 101/236 (42%), Gaps = 41/236 (17%)
Query: 312 EELSKATKGFSNDEL-------LGSGGFGRVYKGTLAXXXXXXSTEMAVK---CVNHD-- 359
           EEL     G SND         +G G F  VYKG          TE  V+   C   D  
Sbjct: 12  EELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKG--------LDTETTVEVAWCELQDRK 63
Query: 360 -SKQGLKEFMAEISSMGRLQHKNLVQM-RGW--CRKGNE-LMLVYDYMPNGSLNNWI--- 411
            +K   + F  E   +  LQH N+V+    W    KG + ++LV +   +G+L  ++   
Sbjct: 64  LTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRF 123
Query: 412 -FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDF 469
              K K L  W   RQIL    +GL +LH      ++HRD+K  NI +       ++GD 
Sbjct: 124 KVXKIKVLRSWC--RQIL----KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           GLA L +         V+GT  + APE        S  DVY+FG   LE A    P
Sbjct: 177 GLATLKR---ASFAKAVIGTPEFXAPEXYEEKYDESV-DVYAFGXCXLEXATSEYP 228

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           +K +  +   E LG G F  V +            E A K +N    S +  ++   E  
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREAR 56
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
              +LQH N+V++    ++ +   LV+D +  G L   I  +  +          +  + 
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 114
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGT 489
           E + Y H      +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT
Sbjct: 115 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGT 169
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            GYL+PE+      +   D+++ GV++  +  G  P 
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS---KQGL-----KEFMAEIS 372
           FS   ++G GGFG VY    A          A+KC++      KQG      +  M  + 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           S G      +V M       ++L  + D M  G L+  +      +      R   A++ 
Sbjct: 247 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEII 302
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            GL ++H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGY 356
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           +APE L    +  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 14  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS---KQGL-----KEFMAEIS 372
           FS   ++G GGFG VY    A          A+KC++      KQG      +  M  + 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           S G      +V M       ++L  + D M  G L+  +      +      R   A++ 
Sbjct: 247 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEII 302
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            GL ++H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGY 356
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           +APE L    +  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS---KQGL-----KEFMAEIS 372
           FS   ++G GGFG VY    A          A+KC++      KQG      +  M  + 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           S G      +V M       ++L  + D M  G L+  +      +      R   A++ 
Sbjct: 247 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEII 302
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            GL ++H   ++ VV+RD+K  NILLD     R+ D GLA  + + + P+ +  VGT GY
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS--VGTHGY 356
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           +APE L    +  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           +K +  +   E LG G F  V +            E A K +N    S +  ++   E  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
              +LQH N+V++    ++ +   LV+D +  G L   I  +  +          +  + 
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 115
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGT 489
           E + Y H      +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGT 170
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            GYL+PE+      +   D+++ GV++  +  G  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           +K +  +   E LG G F  V +            E A K +N    S +  ++   E  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
              +LQH N+V++    ++ +   LV+D +  G L   I  +  +          +  + 
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 115
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGT 489
           E + Y H      +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGT 170
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            GYL+PE+      +   D+++ GV++  +  G  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 14  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K +           MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 14  LGAGNGGVVFKVS----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K +           MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 14  LGAGNGGVVFKVS----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 122
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V++ T            A K V    +   +    EI +M  L+H  LV 
Sbjct: 163 EELGTGAFGVVHRVT----ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +       NE++++Y++M  G L   +  +  K +   +  + +  V +GL ++H   + 
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---EN 274
Query: 445 VVVHRDIKSGNILLDSEMRGRLG--DFGL-AKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             VH D+K  NI+  ++    L   DFGL A L  +  V  TT   GT  + APE+A   
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 331
Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
                +D++S GV+   +  G  P     GE ++E +
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETL 365

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V++ T            A K V    +   +    EI +M  L+H  LV 
Sbjct: 57  EELGTGAFGVVHRVT----ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +       NE++++Y++M  G L   +  +  K +   +  + +  V +GL ++H   + 
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---EN 168
Query: 445 VVVHRDIKSGNILLDSEMRGRLG--DFGL-AKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             VH D+K  NI+  ++    L   DFGL A L  +  V  TT   GT  + APE+A   
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 225
Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
                +D++S GV+   +  G  P     GE ++E +
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETL 259

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 41  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 96
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 149
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 204
Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +  +  SD++S G+ ++E+A GR P+     +E E
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G G FG V++G                C N  S    ++F+ E  +M +  H ++V++ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------LH 439
           G   + N + ++ +    G L +++           Q R+   D+A  + Y       L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTALA 125
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE   
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 500 VSSPTSASDVYSFGVVILEV 519
               TSASDV+ FGV + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 273

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G G FG V++G                C N  S    ++F+ E  +M +  H ++V++ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------LH 439
           G   + N + ++ +    G L +++           Q R+   D+A  + Y       L 
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL-----------QVRKFSLDLASLILYAYQLSTALA 505
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE   
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 500 VSSPTSASDVYSFGVVILEV 519
               TSASDV+ FGV + E+
Sbjct: 566 FRRFTSASDVWMFGVCMWEI 585

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 272

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 18  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 124
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI 205

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCV-------------NHDSKQGLKEFMAEISS 373
           LGSG +G V    L        +E A+K +             N + ++  +E   EIS 
Sbjct: 44  LGSGAYGEV----LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
           +  L H N++++           LV ++   G L   I  + K          I+  +  
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILS 157
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSE---MRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
           G+ YLH      +VHRDIK  NILL+++   +  ++ DFGL+  + +         +GT 
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTA 212
Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            Y+APE+          DV+S GV++  + CG  P 
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 15  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 121
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 182 NFRRFTSASDVWMFGVCMWEI 202

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 287

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 150 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 264

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQH 379
           F   + LG GGFG V++              A+K +   +++  +E  M E+ ++ +L+H
Sbjct: 7   FEPIQCLGRGGFGVVFEAK----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 380 KNLVQ-MRGWCRKGNELML------VYDYMP-----NGSLNNWIFGKPKKLLGWKQRR-- 425
             +V+    W  K     L      VY Y+        +L +W+ G+    +  ++R   
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVC 120
Query: 426 -QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT- 483
             I   +AE + +LH    + ++HRD+K  NI    +   ++GDFGL     Q E   T 
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 484 ----------TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                     T  VGT  Y++PE    +S +   D++S G+++ E+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 272

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 287

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 273

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS---KQGLKEFMAEISSMGR-LQHK 380
           +++G G FG+V    L           AVK +   +   K+  K  M+E + + + ++H 
Sbjct: 44  KVIGKGSFGKV----LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            LV +    +  ++L  V DY+  G L  +   + ++     + R   A++A  L YLH 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLH- 156
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
                +V+RD+K  NILLDS+    L DFGL K   +     T+   GT  YLAPE+   
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHK 213
Query: 501 SSPTSASDVYSFGVVILEVACGRRPL 526
                  D +  G V+ E+  G  P 
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 279

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 46  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 105 IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 152
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 153 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 212
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 213 NFRRFTSASDVWMFGVCMWEI 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 20  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 79  IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 126
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 127 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 186
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 187 NFRRFTSASDVWMFGVCMWEI 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 23  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 129
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 189
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 190 NFRRFTSASDVWMFGVCMWEI 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 21  IGEGQFGDVHQG-IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 80  IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKYSLDLASLILYAYQLSTAL 127
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE  
Sbjct: 128 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 187
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 188 NFRRFTSASDVWMFGVCMWEI 208

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 28  FLFNSFGSITNGTDLILINDCWVD-STVIRLTN-DSNQF----SFGRAYYPTKLKMKRST 81
           F+F+ F  +    +LIL  D  V  + V++LTN DSN      S GRA Y   + +  S 
Sbjct: 6   FVFSKFKPLE--PNLILQGDALVTVAGVLQLTNVDSNGVPEPSSLGRATYSAPINIWDSA 63
Query: 82  ATNSSILTSFSTSFVFSIL-PEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXX 140
              + ++ SF+TSF F+I  P IA+    GL F L    S P +    + GLF +     
Sbjct: 64  ---TGLVASFATSFRFTIYAPNIATIAD-GLAFFLAPVASAPDS-GGGFLGLFDSAVGDT 118
Query: 141 XXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV 178
                  EFDT +N  F DP   HIG D+N+I S K V
Sbjct: 119 TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTV 156

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G G FG V++G                C N  S    ++F+ E  +M +  H ++V++ 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------LH 439
           G   + N + ++ +    G L +++           Q R+   D+A  + Y       L 
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-----------QVRKFSLDLASLILYAYQLSTALA 125
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           +   +  VHRDI + N+L+ +    +LGDFGL++  +       ++    + ++APE   
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 500 VSSPTSASDVYSFGVVILEV 519
               TSASDV+ FGV + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 12/168 (7%)
Query: 364 LKEFMAEISSMGRLQHKNLVQMRGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGW 421
           +++   EI+ + +L H N+V++       NE  L +V++ +  G +      KP   L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSE 136
Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP 481
            Q R    D+ +G+ YLH+   Q ++HRDIK  N+L+  +   ++ DFG++  + +G   
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDA 192
Query: 482 NTTRVVGTLGYLAPELATVSSPT---SASDVYSFGVVILEVACGRRPL 526
             +  VGT  ++APE  + +       A DV++ GV +     G+ P 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 324 DELLGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +E LG G F +++KG    +        TE+ +K ++   +   + F    S M +L HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           +LV   G C  G+E +LV +++  GSL+ ++  K K  +    + ++   +A  +++L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE- 130
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG---EVPNTTRVVGTLGYLAPEL 497
             +  ++H ++ + NILL  E   + G+    KL   G    V     +   + ++ PE 
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE- 187
Query: 498 ATVSSPTS---ASDVYSFGVVILEVAC-GRRPL 526
             + +P +   A+D +SFG  + E+   G +PL
Sbjct: 188 -CIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQM 385
           LG+G  G V+K             MA K ++ + K  ++ + + E+  +       +V  
Sbjct: 17  LGAGNGGVVFK----VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 72
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGW 442
            G      E+ +  ++M  GSL+  +      P+++LG     ++   V +GL YL    
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE-- 125
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN--TTRVVGTLGYLAPELATV 500
              ++HRD+K  NIL++S    +L DFG++     G++ +      VGT  Y++PE    
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQG 180
Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
           +  +  SD++S G+ ++E+A GR P
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F     LG+G FGRV    +           A+K ++      LK+    ++     Q  
Sbjct: 44  FERIRTLGTGSFGRV----MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 175 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 289

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNLV 383
           LGSG +G V    L         E A+K +   S          + E++ + +L H N++
Sbjct: 29  LGSGAYGEV----LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIM 84
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++  +        LV +    G L + I  + K          I+  V  G  YLH    
Sbjct: 85  KLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHK--- 139
Query: 444 QVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  N+LL+S+ R    ++ DFGL+  ++ G        +GT  Y+APE+   
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYIAPEVLR- 196
Query: 501 SSPTSASDVYSFGVVILEVACGRRPL 526
                  DV+S GV++  + CG  P 
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T         +  +AVK +   +    +E  M+E+  +  L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA-------------- 429
            + G C  G   +++ +Y   G L N++  K    +  K    I+               
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 430 --DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTT 484
              VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+  +      V    
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWV 543
           R+   + ++APE       T  SDV+S+G+ + E+ + G  P      + +   ++ +  
Sbjct: 208 RL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
           R L                E    EM  ++K    C   D  +RPT +++V ++  Q
Sbjct: 266 RML--------------SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           +K +  +   E LG G F  V +            E A K +N    S +  ++   E  
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREAR 80
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
              +LQH N+V++    ++ +   LV+D +  G L   I  +  +          +  + 
Sbjct: 81  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQIL 138
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGT 489
           E + Y H      +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT
Sbjct: 139 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGT 193
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            GYL+PE+      +   D+++ GV++  +  G  P 
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 311 YEELSKATKGFSND----ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGL 364
           ++ ++  T+ F++D    E LG G F  V +          + E A K +N    S +  
Sbjct: 20  FQXMATCTR-FTDDYQLFEELGKGAFSVVRRCV----KKTPTQEYAAKIINTKKLSARDH 74
Query: 365 KEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR 424
           ++   E      L+H N+V++     +     LV+D +  G L   I  +  +       
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADA 132
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVP 481
              +  + E +N++H      +VHRD+K  N+LL S+ +G   +L DFGLA +  QGE  
Sbjct: 133 SHCIHQILESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQ 188
Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
                 GT GYL+PE+          D+++ GV++  +  G  P 
Sbjct: 189 AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   L ++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   L ++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXST-EMAVKCVNH-DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G FG VY+G ++      S  ++AVK +    S+Q   +F+ E   + +  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIF-GKPKKL----LGWKQRRQILADVAEGLNYLH 439
             G   +     ++ + M  G L +++   +P+      L       +  D+A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAK-LYQQGEVPNTTRVVGTLGYLAP 495
              +   +HRDI + N LL     GR   +GDFG+A+ +Y+          +  + ++ P
Sbjct: 185 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 496 ELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVL----MDWVRNLYG 548
           E       TS +D +SFGV++ E+ + G  P      +E  E V     MD  +N  G
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPG 299

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T         +  +AVK +   +    +E  M+E+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA-------------- 429
            + G C  G   +++ +Y   G L N++  K    +  K    I+               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 430 --DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTT 484
              VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+  +      V    
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWV 543
           R+   + ++APE       T  SDV+S+G+ + E+ + G  P      + +   ++ +  
Sbjct: 231 RL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 288
Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
           R L                E    EM  ++K    C   D  +RPT +++V ++  Q
Sbjct: 289 RML--------------SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 23/269 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE----EAVLMDWVRNLYGQGKIC 553
                    +D++S GV+   +  G  P  +G  ++E      AV  D+    + Q    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITAVSYDFDEEFFSQT--S 246
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHP 582
           E A   IR+    +E    L +  A  HP
Sbjct: 247 ELAKDFIRK-LLVKETRKRLTIQEALRHP 274

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 324 DELLGSGGFGRVYKGT---LAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +E LG G F +++KG    +        TE+ +K ++   +   + F    S M +L HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           +LV   G C  G+E +LV +++  GSL+ ++  K K  +    + ++   +A  +++L  
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAWAMHFLE- 130
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG---EVPNTTRVVGTLGYLAPEL 497
             +  ++H ++ + NILL  E   + G+    KL   G    V     +   + ++ PE 
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE- 187
Query: 498 ATVSSPTS---ASDVYSFGVVILEVAC-GRRPL 526
             + +P +   A+D +SFG  + E+   G +PL
Sbjct: 188 -CIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNLV 383
           LGSG +G V    L         E A+K +   S          + E++ + +L H N++
Sbjct: 12  LGSGAYGEV----LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIM 67
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++  +        LV +    G L + I  + K          I+  V  G  YLH    
Sbjct: 68  KLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLHK--- 122
Query: 444 QVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  N+LL+S+ R    ++ DFGL+  ++ G        +GT  Y+APE+   
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYIAPEVLR- 179
Query: 501 SSPTSASDVYSFGVVILEVACGRRPL 526
                  DV+S GV++  + CG  P 
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 105/217 (48%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K     S++G+  +E   E++ +  ++H N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L   +  Q L  + +G++YLH   
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +   R +L DFG+A   + G E  N   + GT  ++APE+
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G+ ++E
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQE 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 23/269 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE----EAVLMDWVRNLYGQGKIC 553
                    +D++S GV+   +  G  P  +G  ++E      AV  D+    + Q    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITAVSYDFDEEFFSQT--S 246
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHP 582
           E A   IR+    +E    L +  A  HP
Sbjct: 247 ELAKDFIRK-LLVKETRKRLTIQEALRHP 274

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVK-CVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G FG V++G +       +  +A+K C N  S    ++F+ E  +M +  H ++V++
Sbjct: 398 IGEGQFGDVHQG-IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY-------L 438
            G   + N + ++ +    G L +++           Q R+   D+A  + Y       L
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL-----------QVRKFSLDLASLILYAYQLSTAL 504
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +   +  VHRDI + N+L+ +    +LGDFGL++  +       ++    + ++APE  
Sbjct: 505 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 499 TVSSPTSASDVYSFGVVILEV 519
                TSASDV+ FGV + E+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI 585

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 326 LLGSGGFGRVY---KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           +LG GG+G+V+   K T A      + ++  K +   + +      AE + +  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           V +    + G +L L+ +Y+  G L        IF +             LA+++  L +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-------YLAEISMALGH 136
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPE 496
           LH    + +++RD+K  NI+L+ +   +L DFGL K     G V +T    GT+ Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPE 191
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPL 526
           +   S    A D +S G ++ ++  G  P 
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQ 378
           +   E +G G +G VYK   +         +A+K +  D++ +G+    + EIS +  L 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-----VALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V +         L LV+++M        +  + K  L   Q +  L  +  G+ + 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      ++HRD+K  N+L++S+   +L DFGLA+ +    V + T  V TL Y AP++ 
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVL 191
Query: 499 TVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
             S   S S D++S G +  E+  G +PL  G  ++++
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQ 228

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   L ++    +  + L +V +Y P G + + +     F +P         R   A + 
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQ 378
           +   E +G G +G VYK   +         +A+K +  D++ +G+    + EIS +  L 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-----VALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V +         L LV+++M        +  + K  L   Q +  L  +  G+ + 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      ++HRD+K  N+L++S+   +L DFGLA+ +    V + T  V TL Y AP++ 
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVL 191
Query: 499 TVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
             S   S S D++S G +  E+  G +PL  G  ++++
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDDQ 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T         +  +AVK +   +    +E  M+E+  +  L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA-------------- 429
            + G C  G   +++ +Y   G L N++  K    +  K    I+               
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 430 --DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTT 484
              VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+  +      V    
Sbjct: 167 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWV 543
           R+   + ++APE       T  SDV+S+G+ + E+ + G  P      + +   ++ +  
Sbjct: 224 RL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 281
Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
           R L                E    EM  ++K    C   D  +RPT +++V ++  Q
Sbjct: 282 RML--------------SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 321

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 10/220 (4%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F    +LG GGFG V    +       + +   K      ++G    + E   + ++  +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKQILEKVNSR 244
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +       + L LV   M  G L   I+   +   G+ + R +   A++  GL  L
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCGLEDL 302
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +V+RD+K  NILLD     R+ D GLA    +G+       VGT+GY+APE+ 
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVV 357
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
                T + D ++ G ++ E+  G+ P    K + + E V
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 84/332 (25%), Positives = 138/332 (41%), Gaps = 43/332 (12%)
Query: 318 TKGFSNDELLGSGGFGR----VYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISS 373
           + G+   E +G G +      V+K T        + E AVK ++  SK+   E   EI  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT--------NMEYAVKVID-KSKRDPSE---EIEI 73
Query: 374 MGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           + R  QH N++ ++     G  + LV + M  G L + I  +  K    ++   +L  + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFVLHTIG 131
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVVG 488
           + + YLH    Q VVHRD+K  NIL   E       R+ DFG AK  +  E         
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGLLMTPCY 187
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           T  ++APE+          D++S G+++  +  G  P   G  +  EE      +    G
Sbjct: 188 TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE------ILTRIG 241
Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKE 608
            GK   +          A+  +LV K+     H D  +R T ++V+      +    P+ 
Sbjct: 242 SGKFTLSGGNWNTVSETAK--DLVSKM----LHVDPHQRLTAKQVLQHPWVTQKDKLPQS 295
Query: 609 LLG----DLARGAVDADFSGGDDSREDAPLQP 636
            L      L +GA+ A +S  + S+    L+P
Sbjct: 296 QLSHQDLQLVKGAMAATYSALNSSKPTPQLKP 327

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T         +  +AVK +   +    +E  M+E+  +  L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA-------------- 429
            + G C  G   +++ +Y   G L N++  K    +  K    I+               
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 430 --DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
              VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+     ++ N +  V
Sbjct: 169 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYV 220
Query: 488 GT------LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLM 540
                   + ++APE       T  SDV+S+G+ + E+ + G  P      + +   ++ 
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280
Query: 541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
           +  R L                E    EM  ++K    C   D  +RPT +++V ++  Q
Sbjct: 281 EGFRML--------------SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 323

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 351 MAVKCVNHDSKQGLK-EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           MA K ++ + K  ++ + + E+  +       +V   G      E+ +  ++M  GSL+ 
Sbjct: 44  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 103
Query: 410 WIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL 466
            +      P+++LG     ++   V  GL YL       ++HRD+K  NIL++S    +L
Sbjct: 104 VLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKL 156
Query: 467 GDFGLAKLYQQGEVPNT--TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR 524
            DFG++     G++ ++     VGT  Y+APE    +  +  SD++S G+ ++E+A GR 
Sbjct: 157 CDFGVS-----GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRY 211
Query: 525 PLDMGKGEEEE 535
           P+     +E E
Sbjct: 212 PIPPPDAKELE 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 327 LGSGGFGRVYKGT-LAXXXXXXSTEMAVKCVNHDSKQGLKE-FMAEISSMGRL-QHKNLV 383
           LG+G FG+V + T         +  +AVK +   +    +E  M+E+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA-------------- 429
            + G C  G   +++ +Y   G L N++  K    +  K    I+               
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 430 --DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
              VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA+     ++ N +  V
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYV 225
Query: 488 GT------LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLM 540
                   + ++APE       T  SDV+S+G+ + E+ + G  P      + +   ++ 
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ 600
           +  R L                E    EM  ++K    C   D  +RPT +++V ++  Q
Sbjct: 286 EGFRML--------------SPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 328

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K     S++G+  +E   E++ +  ++H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L  + F   K+ L   +  Q L  + +G++YLH   
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +   R +L DFG+A   + G E  N   + GT  ++APE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEI 182
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G+ ++E
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQE 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 13/210 (6%)
Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEI 371
           ++    K +   + LG G F  VYK          + +        ++K G+ +  + EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 372 SSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADV 431
             +  L H N++ +       + + LV+D+M        I      +L     +  +   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMT 121
Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
            +GL YLH  W   ++HRD+K  N+LLD     +L DFGLAK +         +VV T  
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRW 177
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVAC 521
           Y APEL         + +Y  GV +  V C
Sbjct: 178 YRAPEL------LFGARMYGVGVDMWAVGC 201

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 10/220 (4%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F    +LG GGFG V    +       + +   K      ++G    + E   + ++  +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKQILEKVNSR 244
Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYL 438
            +V +       + L LV   M  G L   I+   +   G+ + R +   A++  GL  L
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA--GFPEARAVFYAAEICCGLEDL 302
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H    + +V+RD+K  NILLD     R+ D GLA    +G+       VGT+GY+APE+ 
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVV 357
Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
                T + D ++ G ++ E+  G+ P    K + + E V
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L  + F   K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE----EAVLMDWVRNLYGQGKIC 553
                    +D++S GV+   +  G  P  +G  ++E      AV  D+    + Q    
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITAVSYDFDEEFFSQT--S 246
Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHP 582
           E A   IR+    +E    L +  A  HP
Sbjct: 247 ELAKDFIRK-LLVKETRKRLTIQEALRHP 274

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K     S++G+  +E   E++ +  ++H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L  + F   K+ L   +  Q L  + +G++YLH   
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEATQFLKQILDGVHYLH--- 146
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +   R +L DFG+A   + G E  N   + GT  ++APE+
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEI 203
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G+ ++E
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQE 239

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCV--NHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G +G VYK          +  +A+K +   H+ +      + E+S +  LQH+N+++
Sbjct: 42  LGEGTYGEVYKAI----DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           ++      + L L+++Y  N  L  ++   P   +  +  +  L  +  G+N+ H    +
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCH---SR 151
Query: 445 VVVHRDIKSGNILLDSEMRG-----RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
             +HRD+K  N+LL           ++GDFGLA+ +    +   T  + TL Y  PE+  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILL 210
Query: 500 VSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGE 532
            S   S S D++S   +  E+   + PL  G  E
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSE 243

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 28  FLFNSFGSITNGTDLILINDCWVD-STVIRLTN-DSNQF----SFGRAYYPTKLKMKRST 81
           F+F+ F  +    +LIL  D  V  + V++LTN D N      S GRA Y   + +  S 
Sbjct: 6   FVFSKFKPLE--PNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSA 63
Query: 82  ATNSSILTSFSTSFVFSIL-PEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXX 140
              + ++ SF+TSF F+I  P IA+    GL F L    S P +    + GLF +     
Sbjct: 64  ---TGLVASFATSFRFTIYAPNIATIAD-GLAFFLAPVASAPDS-GGGFLGLFDSAVSGS 118
Query: 141 XXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV 178
                  EFDT +N  F DP   HIG D+N+I S K V
Sbjct: 119 TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTV 156

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FERIKTLGTGSFGRV----MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 30  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 138
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 139 LTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 191
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 192 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLXGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G  ++E
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 44  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 152
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 205
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 320 GFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH 379
            ++N +++G+G FG V++  L       S E+A+K V  D +   +E    +  M  ++H
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVE-----SDEVAIKKVLQDKRFKNRE----LQIMRIVKH 91
Query: 380 KNLVQMRGWCRKGNE------LMLVYDYMPNGSLN-NWIFGKPKKLLGWKQRRQILADVA 432
            N+V ++ +     +      L LV +Y+P      +  + K K+ +     +  +  + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L Y+H      + HRDIK  N+LLD      +L DFG AK+   GE PN + +     
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSXICSRY- 206
Query: 492 YLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
           Y APEL    ++ T+  D++S G V+ E+  G+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 64  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 172
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 173 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLCGTPEY 225
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G  ++E
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 134/329 (40%), Gaps = 41/329 (12%)
Query: 320 GFSNDELLGSGGFGR----VYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMG 375
           G+   E +G G +      V+K T        + E AVK ++  SK+   E +  +   G
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKAT--------NMEYAVKVID-KSKRDPSEEIEILLRYG 78
Query: 376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
             QH N++ ++     G  + LV + M  G L + I  +  K    ++   +L  + + +
Sbjct: 79  --QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFVLHTIGKTV 134
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
            YLH    Q VVHRD+K  NIL   E       R+ DFG AK  +  E         T  
Sbjct: 135 EYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGLLMTPCYTAN 190
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
           ++APE+          D++S G+++  +  G  P   G  +  EE      +    G GK
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE------ILTRIGSGK 244
Query: 552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLG 611
              +              +LV K+     H D  +R T ++V+      +    P+  L 
Sbjct: 245 FTLSGGN--WNTVSETAKDLVSKM----LHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLS 298
Query: 612 ----DLARGAVDADFSGGDDSREDAPLQP 636
                L +GA+ A +S  + S+    L+P
Sbjct: 299 HQDLQLVKGAMAATYSALNSSKPTPQLKP 327

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQHKNL 382
           E LGSG F  V K          + +   K  +  S++G+  +E   E+S + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           + +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 443 DQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPEL 497
            + + H D+K  NI LLD  +     +L DFGLA   + G E  N   + GT  ++APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
                    +D++S GV+   +  G  P  +G  ++E
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 326 LLGSGGFGRVY---KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL 382
           +LG GG+G+V+   K T A      + ++  K +   + +      AE + +  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSL-----NNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           V +    + G +L L+ +Y+  G L        IF +             LA+++  L +
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-------YLAEISMALGH 136
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPE 496
           LH    + +++RD+K  NI+L+ +   +L DFGL K     G V  T    GT+ Y+APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGTIEYMAPE 191
Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPL 526
           +   S    A D +S G ++ ++  G  P 
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 38  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-------HARFYAAQIV 146
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 147 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 199
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNLVQ 384
           LG G +G V+K          + +       +  D+++  +E M      G   H+N+V 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG---HENIVN 73
Query: 385 MRGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +    R  N+  + LV+DYM    L+  I      +L    ++ ++  + + + YLH G 
Sbjct: 74  LLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ--------------------GEVPN 482
              ++HRD+K  NILL++E   ++ DFGL++ +                       + P 
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 483 TTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGR 523
            T  V T  Y APE+   S+  T   D++S G ++ E+ CG+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           S  L F  N+F  + N  DL+   +  V ST V++LT   N    ++S GRA Y   +++
Sbjct: 1   SDELSFTINNF--VPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRI 58
Query: 78  KRSTATNSSILTSFSTSFVFSIL---PEIASSPGFGLCFVLTNFTSP-PGALASQYFGLF 133
             +T  +   + SFSTSF F +    P+I S    GL F L    S  P    S+Y GLF
Sbjct: 59  WGNTTGS---VASFSTSFTFVVKAPNPDITSD---GLAFYLAPPDSQIPSGSVSKYLGLF 112
Query: 134 SNXXXXXXXXXXXXEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHV 178
           +N            EFDT     ++  DP+  HIG+D+N IES K V
Sbjct: 113 NNSNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV 159

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQHKNL 382
           E +G G +G VYK              A+K +  + + +G+    + EIS +  L+H N+
Sbjct: 8   EKIGEGTYGVVYKAQ-----NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ-------RRQILADVAEGL 435
           V++         L+LV++++             KKLL   +        +  L  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDL---------KKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            Y H   D+ V+HRD+K  N+L++ E   ++ DFGLA+ +    V   T  V TL Y AP
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAP 169
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           ++   S   S + D++S G +  E+  G  PL  G  E ++
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQ 209

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 64  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-------HARFYAAQIV 172
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 173 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 225
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 46/302 (15%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKN 381
           +D ++G G FG VY G           + A+K ++  ++ Q ++ F+ E   M  L H N
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQN-RIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD-------VAEG 434
           ++ + G       +ML  + +P+  L     G   + +   QR   + D       VA G
Sbjct: 84  VLALIG-------IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLG 491
           + YL    +Q  VHRD+ + N +LD     ++ DFGLA+     E   V         + 
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
           + A E       T+ SDV+SFGV++ E+        + +G      +    + +   QG+
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWEL--------LTRGAPPYRHIDPFDLTHFLAQGR 245
Query: 552 ICEAADARIRQ-EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELL 610
                  R+ Q E+  + +  V++    C   D   RPT R    VLVG EV      LL
Sbjct: 246 -------RLPQPEYCPDSLYQVMQ---QCWEADPAVRPTFR----VLVG-EVEQIVSALL 290
Query: 611 GD 612
           GD
Sbjct: 291 GD 292

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 42/295 (14%)
Query: 312 EELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMA 369
           E++    + F+   +LG G FG V +  L         ++AVK +  D  +   ++EF+ 
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSF-VKVAVKMLKADIIASSDIEEFLR 74
Query: 370 EISSMGRLQHKNLVQMRGWCRKGNEL------MLVYDYMPNGSLNNWIF----GKPKKLL 419
           E + M    H ++ ++ G   +          M++  +M +G L+ ++     G+    L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 420 GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK------ 473
             +   + + D+A G+ YL     +  +HRD+ + N +L  +M   + DFGL++      
Sbjct: 135 PLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLD----- 527
            Y+QG           L  LA  L TV      SDV++FGV + E+   G+ P       
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVH-----SDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 528 ------MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLG 576
                 +G    ++    M+ V +L  Q   C +AD + R  F    MEL   LG
Sbjct: 247 EIYNYLIGGNRLKQPPECMEEVYDLMYQ---CWSADPKQRPSFTCLRMELENILG 298

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+++D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQHKNL 382
           E +G G +G VYK              A+K +  + + +G+    + EIS +  L+H N+
Sbjct: 8   EKIGEGTYGVVYKAQ-----NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ-------RRQILADVAEGL 435
           V++         L+LV++++             KKLL   +        +  L  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDL---------KKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            Y H   D+ V+HRD+K  N+L++ E   ++ DFGLA+ +    V   T  V TL Y AP
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAP 169
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           ++   S   S + D++S G +  E+  G  PL  G  E ++
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG-APLFPGVSEADQ 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQ 384
           LGSG +G V    L         E A+K +   S       + + E++ +  L H N+++
Sbjct: 45  LGSGAYGEV----LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +  +        LV +    G L + I  + K          I+  V  G+ YLH     
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHK---H 155
Query: 445 VVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
            +VHRD+K  N+LL+S+ +    ++ DFGL+ +++  +       +GT  Y+APE+    
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-K 212
Query: 502 SPTSASDVYSFGVVILEVACGRRPL 526
                 DV+S GV++  +  G  P 
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH---DSKQGLKEFMAEISSMGRL 377
           +    +LG G FG V    +         E AVK ++      K   +  + E+  + +L
Sbjct: 34  YKGQRVLGKGSFGEV----ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H N++++  +        LV +    G L + I  +  K        +I+  V  G+ Y
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 147
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           +H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +       +GT  Y+A
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIA 202
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           PE+    +     DV+S GV++  +  G  P +
Sbjct: 203 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 318 TKGFSNDELLGSGGFGR----VYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISS 373
           T G+   E +G G +      ++K T        + E AVK ++  SK+   E   EI  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT--------NMEFAVKIID-KSKRDPTE---EIEI 68
Query: 374 MGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           + R  QH N++ ++     G  + +V + M  G L + I  +  K    ++   +L  + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTIT 126
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVVG 488
           + + YLH    Q VVHRD+K  NIL   E       R+ DFG AK  +  E         
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCY 182
Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           T  ++APE+       +A D++S GV++  +  G  P   G  +  EE
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 327 LGSGGFGRV--YKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G G FG+V   +                KCV    +  ++    E+  M  L+H  LV 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV---ERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEGLNYLHHGW 442
           +    +   ++ +V D +  G L   +    ++ + +K+   +  + ++   L+YL    
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQ--- 132
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV---GTLGYLAPELAT 499
           +Q ++HRD+K  NILLD      + DF +A +     +P  T++    GT  Y+APE+ +
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM-----LPRETQITTMAGTKPYMAPEMFS 187
Query: 500 V---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
               +  + A D +S GV   E+  GRRP  +      +E V
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSK-QGLKEF-MAEISSMGRLQHKNL 382
           E +G G +G VYK              A+K +  + + +G+    + EIS +  L+H N+
Sbjct: 8   EKIGEGTYGVVYKAQ-----NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ-------RRQILADVAEGL 435
           V++         L+LV++++             KKLL   +        +  L  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDL---------KKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            Y H   D+ V+HRD+K  N+L++ E   ++ DFGLA+ +    V   T  + TL Y AP
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAP 169
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
           ++   S   S + D++S G +  E+  G  PL  G  E ++
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQ 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L  + F   K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPAFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +LLG G +G+V +   +      + ++  K        G      EI  + RL+HKN++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 385 MRG--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +    +  +  ++ +V +Y   G +   +   P+K     Q       + +GL YLH   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--- 126
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV-GTLGYLAPELATVS 501
            Q +VH+DIK GN+LL +    ++   G+A+        +T R   G+  +  PE+A   
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 502 SPTSA--SDVYSFGVVILEVACGRRPLD 527
              S    D++S GV +  +  G  P +
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLH 439
           L Q+    +  + L  V +Y+  G L   I    +++  +K+   +   A++A GL +L 
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + +++RD+K  N++LDSE   ++ DFG+ K      V  T    GT  Y+APE+  
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIA 194
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                 + D ++FGV++ E+  G+ P +   GE+E+E
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDE 228

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I ++A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLH 439
           L Q+    +  + L  V +Y+  G L   I    +++  +K+   +   A++A GL +L 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + +++RD+K  N++LDSE   ++ DFG+ K      V  T    GT  Y+APE+  
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIA 515
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                 + D ++FGV++ E+  G+ P +   GE+E+E
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDE 549

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 29/231 (12%)
Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAE 370
           +E++ K T      ELLG G + +V +G ++        E AVK +   +         E
Sbjct: 10  FEDMYKLT-----SELLGEGAYAKV-QGAVSLQN---GKEYAVKIIEKQAGHSRSRVFRE 60
Query: 371 ISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
           + ++ + Q +KN++++  +        LV++ +  GS+   I  + +K    ++  +++ 
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVR 118
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRLGDFGLAKLYQQGE------V 480
           DVA  L++LH    + + HRD+K  NIL +S  +    ++ DF L    +          
Sbjct: 119 DVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITT 175
Query: 481 PNTTRVVGTLGYLAPELATVSSPTSA-----SDVYSFGVVILEVACGRRPL 526
           P  T   G+  Y+APE+  V +  +       D++S GVV+  +  G  P 
Sbjct: 176 PELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH---DSKQGLKEFMAEISSMGRL 377
           +    +LG G FG V    +         E AVK ++      K   +  + E+  + +L
Sbjct: 28  YKGQRVLGKGSFGEV----ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H N++++  +        LV +    G L + I  +  K        +I+  V  G+ Y
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 141
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           +H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +       +GT  Y+A
Sbjct: 142 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIA 196
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           PE+    +     DV+S GV++  +  G  P +
Sbjct: 197 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 183
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 223

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 130 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 183
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH---DSKQGLKEFMAEISSMGRL 377
           +    +LG G FG V    +         E AVK ++      K   +  + E+  + +L
Sbjct: 51  YKGQRVLGKGSFGEV----ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H N++++  +        LV +    G L + I  +  K        +I+  V  G+ Y
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 164
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           +H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +       +GT  Y+A
Sbjct: 165 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIA 219
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           PE+    +     DV+S GV++  +  G  P +
Sbjct: 220 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH---DSKQGLKEFMAEISSMGRL 377
           +    +LG G FG V    +         E AVK ++      K   +  + E+  + +L
Sbjct: 52  YKGQRVLGKGSFGEV----ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H N++++  +        LV +    G L + I    +K        +I+  V  G+ Y
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITY 165
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           +H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +       +GT  Y+A
Sbjct: 166 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIA 220
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           PE+    +     DV+S GV++  +  G  P +
Sbjct: 221 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L  + F   K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L  + F   K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAP +        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGL-KEFMAEISSMGRLQHKNL 382
           E +G G +G V+K             +A+K V   D  +G+    + EI  +  L+HKN+
Sbjct: 8   EKIGEGTYGTVFKAK----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++        +L LV+++  +  L  + F      L  +  +  L  + +GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            + V+HRD+K  N+L++     +L DFGLA+ +       +  VV TL Y  P++   + 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177
Query: 503 PTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
             S S D++S G +  E+A   RPL  G   +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQ 211

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L  + F   K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH---DSKQGLKEFMAEISSMGRL 377
           +    +LG G FG V    +         E AVK ++      K   +  + E+  + +L
Sbjct: 28  YKGQRVLGKGSFGEV----ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H N+ ++  +        LV +    G L + I  +  K        +I+  V  G+ Y
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITY 141
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
            H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +       +GT  Y+A
Sbjct: 142 XHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGTAYYIA 196
Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           PE+    +     DV+S GV++  +  G  P +
Sbjct: 197 PEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 42/276 (15%)
Query: 351 MAVKCVNHDSKQ--GLKEFMA-------------EISSMGRLQHKNLVQMRGWCRKGNEL 395
           +  KC N D+ Q   +K+F+              EI  + +L+H NLV +    R+   L
Sbjct: 18  VVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77
Query: 396 MLVYDYMPN---GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
            LV++Y  +     L+ +  G P+ L+     + I     + +N+ H       +HRD+K
Sbjct: 78  HLVFEYCDHTVLHELDRYQRGVPEHLV-----KSITWQTLQAVNFCH---KHNCIHRDVK 129
Query: 453 SGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS-DVYS 511
             NIL+      +L DFG A+L   G        V T  Y +PEL    +      DV++
Sbjct: 130 PENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWA 188
Query: 512 FGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD-----ARIRQEFEA 566
            G V  E+  G  PL  GK + ++  ++   + +L  + +   + +      +I    + 
Sbjct: 189 IGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM 247
Query: 567 EEMELVLK------LGL--ACCHPDSTRRPTMREVV 594
           E +EL         LGL   C H D T R T  +++
Sbjct: 248 EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G +G V++G            +AVK  +  D +   +E   EI +   L+H N++
Sbjct: 14  ECVGKGRYGEVWRGLW------HGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNIL 65
Query: 384 QMRGWC-------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
              G+            +L L+  Y  +GSL +++    ++ L      ++    A GL 
Sbjct: 66  ---GFIASDMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLA 119
Query: 437 YLH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG----EVPNTTRV 486
           +LH       G    + HRD KS N+L+ S ++  + D GLA ++ QG    ++ N  R 
Sbjct: 120 HLHVEIFGTQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR- 177
Query: 487 VGTLGYLAPELATVSSPTSA------SDVYSFGVVILEVACGRRPLDMGKGEE 533
           VGT  Y+APE+      T        +D+++FG+V+ E+A  RR +  G  E+
Sbjct: 178 VGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTIVNGIVED 228

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGRLQ 378
           +   E LGSG F  V K          + +   K     S++G+  ++   E+S +  +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++  + L  +  G+ YL
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 439 HHGWDQVVVHRDIKSGNI-LLDSEM---RGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYL 493
           H      + H D+K  NI LLD  +   R ++ DFGLA     G E  N   + GT  ++
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 184
Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           APE+         +D++S GV+   +  G  P  +G  ++E
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQE 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   + LG+G FGRV    +           A+K ++      LK+    ++    LQ  
Sbjct: 43  FDRIKTLGTGSFGRV----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 381 N---LVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVA 432
           N   LV++    +  + L +V +Y+  G + + +     F +P         R   A + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-------HARFYAAQIV 151
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
               YLH      +++RD+K  N+L+D +   ++ DFG AK  +      T  + GT   
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEA 204
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           LAPE+        A D ++ GV+I E+A G  P 
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 25/232 (10%)
Query: 320 GFSNDELL---GSGGFGRVY---------KGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF 367
           G  N ELL   G+G +G+V+          G L          +  K    +  +  ++ 
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 368 MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
           +  I      Q   LV +    +   +L L+ DY+  G L   +  + +      + +  
Sbjct: 112 LEHIR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY 164
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
           + ++   L +LH      +++RDIK  NILLDS     L DFGL+K +   E        
Sbjct: 165 VGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 488 GTLGYLAPELAT--VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
           GT+ Y+AP++     S    A D +S GV++ E+  G  P  +  GE+  +A
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQA 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 318 TKGFSNDELLGSGGFGR----VYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISS 373
           T G+   E +G G +      ++K T        + E AVK ++  SK+   E +  +  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT--------NXEFAVKIID-KSKRDPTEEIEILLR 71
Query: 374 MGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
            G  QH N++ ++     G  + +V +    G L + I  +  K    ++   +L  + +
Sbjct: 72  YG--QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ--KFFSEREASAVLFTITK 127
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVVGT 489
            + YLH    Q VVHRD+K  NIL   E       R+ DFG AK  +  E         T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLXTPCYT 183
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
             ++APE+       +A D++S GV++     G  P   G  +  EE
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEE 230

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFM 368
            YE+L+K          +G G FG V+K          + +   K +  + K+G     +
Sbjct: 19  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL 65
Query: 369 AEISSMGRLQHKNLVQMRGWCR---------KGNELMLVYDYMPN---GSLNNWIFGKPK 416
            EI  +  L+H+N+V +   CR         KG+ + LV+D+  +   G L+N +     
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVK--- 121
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 + ++++  +  GL Y+H      ++HRD+K+ N+L+  +   +L DFGLA+ + 
Sbjct: 122 --FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 477 --QGEVPN--TTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKG 531
             +   PN    RVV TL Y  PEL           D++  G ++ E+   R P+  G  
Sbjct: 177 LAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234
Query: 532 EEEEEAVL 539
           E+ + A++
Sbjct: 235 EQHQLALI 242

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFM 368
            YE+L+K          +G G FG V+K          + +   K +  + K+G     +
Sbjct: 18  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL 64
Query: 369 AEISSMGRLQHKNLVQMRGWCR---------KGNELMLVYDYMPN---GSLNNWIFGKPK 416
            EI  +  L+H+N+V +   CR         KG+ + LV+D+  +   G L+N +     
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVK--- 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 + ++++  +  GL Y+H      ++HRD+K+ N+L+  +   +L DFGLA+ + 
Sbjct: 121 --FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 477 --QGEVPN--TTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKG 531
             +   PN    RVV TL Y  PEL           D++  G ++ E+   R P+  G  
Sbjct: 176 LAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNT 233
Query: 532 EEEEEAVL 539
           E+ + A++
Sbjct: 234 EQHQLALI 241

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFM 368
            YE+L+K          +G G FG V+K          + +   K +  + K+G     +
Sbjct: 19  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL 65
Query: 369 AEISSMGRLQHKNLVQMRGWCR---------KGNELMLVYDYMPN---GSLNNWIFGKPK 416
            EI  +  L+H+N+V +   CR         KG+ + LV+D+  +   G L+N +     
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVK--- 121
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
                 + ++++  +  GL Y+H      ++HRD+K+ N+L+  +   +L DFGLA+ + 
Sbjct: 122 --FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176
Query: 477 --QGEVPN--TTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKG 531
             +   PN    RVV TL Y  PEL           D++  G ++ E+   R P+  G  
Sbjct: 177 LAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNT 234
Query: 532 EEEEEAVL 539
           E+ + A++
Sbjct: 235 EQHQLALI 242

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 23/228 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNL 382
           E +G+G +G V              ++A+K + +  D     K  + E+  +   +H N+
Sbjct: 60  ETIGNGAYGVVSSAR----RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 383 VQMRGWCRKG------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           + ++   R          + +V D M    L+  I     + L  +  R  L  +  GL 
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLK 172
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYL 493
           Y+H      V+HRD+K  N+L++     ++GDFG+A+        +    T  V T  Y 
Sbjct: 173 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 494 APELA-TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
           APEL  ++   T A D++S G +  E+   RR L  GK    +  ++M
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEM-LARRQLFPGKNYVHQLQLIM 276

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 324 DELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNL 382
           D+ LG G F    K          +   AVK +   SK+       EI+++   + H N+
Sbjct: 16  DKPLGEGSFSICRKCV----HKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNI 68
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++           LV + +  G L   I  K KK     +   I+  +   ++++H   
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMH--- 123
Query: 443 DQVVVHRDIKSGNILLDSE---MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           D  VVHRD+K  N+L   E   +  ++ DFG A+L      P  T    TL Y APEL  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLN 182
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
            +    + D++S GV++  +  G+ P 
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 23/228 (10%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNL 382
           E +G+G +G V              ++A+K + +  D     K  + E+  +   +H N+
Sbjct: 61  ETIGNGAYGVVSSAR----RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 383 VQMRGWCRKG------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           + ++   R          + +V D M    L+  I     + L  +  R  L  +  GL 
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLK 173
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYL 493
           Y+H      V+HRD+K  N+L++     ++GDFG+A+        +    T  V T  Y 
Sbjct: 174 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 494 APELA-TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM 540
           APEL  ++   T A D++S G +  E+   RR L  GK    +  ++M
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEM-LARRQLFPGKNYVHQLQLIM 277

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 15/216 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LGSG FG V++                K +N            EIS M +L H  L+ 
Sbjct: 57  EELGSGAFGVVHRCV----EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +        E++L+ +++  G L + I  +  K +   +    +    EGL ++H   + 
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EH 168
Query: 445 VVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            +VH DIK  NI+ +++     ++ DFGLA      E+   T    T  + APE+     
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREP 226
Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
               +D+++ GV+   +  G  P     GE++ E +
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPF---AGEDDLETL 259

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/94 (43%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
           L D    L +LH    Q +VH D+K  NI L    R +LGDFGL  L + G         
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQE 217
Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVAC 521
           G   Y+APEL   S  T A+DV+S G+ ILEVAC
Sbjct: 218 GDPRYMAPELLQGSYGT-AADVFSLGLTILEVAC 250

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK-EFM 368
            YE+L+K          +G G FG V+K          + +   K +  + K+G     +
Sbjct: 19  KYEKLAK----------IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL 65
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNE--------LMLVYDYMPN---GSLNNWIFGKPKK 417
            EI  +  L+H+N+V +   CR            + LV+D+  +   G L+N +      
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---- 121
Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ- 476
                + ++++  +  GL Y+H      ++HRD+K+ N+L+  +   +L DFGLA+ +  
Sbjct: 122 -FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 177
Query: 477 -QGEVPN--TTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGE 532
            +   PN    RVV TL Y  PEL           D++  G ++ E+   R P+  G  E
Sbjct: 178 AKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 235
Query: 533 EEEEAVL 539
           + + A++
Sbjct: 236 QHQLALI 242

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G +G V++G+           +AVK  +  D K   +E   E+ +   L+H+N++
Sbjct: 14  ECVGKGRYGEVWRGSWQ------GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENIL 65
Query: 384 QMRGWC-------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
              G+            +L L+  Y   GSL +++       L      +I+  +A GL 
Sbjct: 66  ---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLA 119
Query: 437 YLH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG----EVPNTTRV 486
           +LH       G    + HRD+KS NIL+    +  + D GLA ++ Q     +V N  R 
Sbjct: 120 HLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR- 177
Query: 487 VGTLGYLAPEL--ATVSSPTSAS----DVYSFGVVILEVACGRRPLDMGKGEE 533
           VGT  Y+APE+   T+      S    D+++FG+V+ EVA  RR +  G  E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVED 228

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 30/189 (15%)
Query: 28  FLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKM-KRST 81
           F F +F    N +  IL  D  V S+ +RLT           S GRA+Y + +++  +ST
Sbjct: 6   FSFKNF----NSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKST 61
Query: 82  ATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXXX 141
                 + S++TSF  +I     SS   G+ F L    S P +  S + G+F +      
Sbjct: 62  GA----VASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVYDNS 116
Query: 142 XXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQN 201
                 EFDT  N ++ DP   HIG+D+N+I+S +    G              + NGQN
Sbjct: 117 AQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG--------------LANGQN 161
Query: 202 IHAWIDFDG 210
               I ++ 
Sbjct: 162 AEILITYNA 170

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G +G V++G+           +AVK  +  D K   +E   E+ +   L+H+N++
Sbjct: 14  ECVGKGRYGEVWRGSWQ------GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENIL 65
Query: 384 QMRGWC-------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
              G+            +L L+  Y   GSL +++       L      +I+  +A GL 
Sbjct: 66  ---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLA 119
Query: 437 YLH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG----EVPNTTRV 486
           +LH       G    + HRD+KS NIL+    +  + D GLA ++ Q     +V N  R 
Sbjct: 120 HLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR- 177
Query: 487 VGTLGYLAPEL--ATVSSPTSAS----DVYSFGVVILEVACGRRPLDMGKGEE 533
           VGT  Y+APE+   T+      S    D+++FG+V+ EVA  RR +  G  E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVED 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +            E A K +N    S +  ++   E      L+H N+
Sbjct: 28  EELGKGAFSVVRRCV----KVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++     +     L++D +  G L   I  +  +          +  + E + + H   
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH--- 138
Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              VVHRD+K  N+LL S+++G   +L DFGLA +  +GE        GT GYL+PE+  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                   D+++ GV++  +  G  P 
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGL-KEFMAEISSMGRLQHKNL 382
           E +G G +G V+K             +A+K V   D  +G+    + EI  +  L+HKN+
Sbjct: 8   EKIGEGTYGTVFKAK----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++        +L LV+++  +  L  + F      L  +  +  L  + +GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            + V+HRD+K  N+L++     +L +FGLA+ +       +  VV TL Y  P++   + 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177
Query: 503 PTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEE 535
             S S D++S G +  E+A   RPL  G   +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G +G V++G+           +AVK  +  D K   +E   E+ +   L+H+N++
Sbjct: 43  ECVGKGRYGEVWRGSWQ------GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENIL 94
Query: 384 QMRGWC-------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
              G+            +L L+  Y   GSL +++       L      +I+  +A GL 
Sbjct: 95  ---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLA 148
Query: 437 YLH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG----EVPNTTRV 486
           +LH       G    + HRD+KS NIL+    +  + D GLA ++ Q     +V N  R 
Sbjct: 149 HLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR- 206
Query: 487 VGTLGYLAPEL--ATVSSPTSAS----DVYSFGVVILEVACGRRPLDMGKGEE 533
           VGT  Y+APE+   T+      S    D+++FG+V+ EVA  RR +  G  E+
Sbjct: 207 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVED 257

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQF----SFGRAYYPTKLKM 77
           + +L F F  F    N   LI   D  V ST V++LTN  N      S GRA Y    ++
Sbjct: 1   TGSLSFSFPKFAP--NQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQI 58
Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXX 137
             ST  N   + SF TSF F I     ++   GL F L    + P  L     G+F +  
Sbjct: 59  WDSTTGN---VASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGM-LGIFKDGY 114
Query: 138 XXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP 179
                     EFDT  N ++ DP   H+G+++N+IES K VP
Sbjct: 115 FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP 155

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +            E A K +N    S +  ++   E      L+H N+
Sbjct: 10  EELGKGAFSVVRR----CMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++     +     LV+D +  G L   I  +  +          +  + E +N+ H   
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIQQILESVNHCHLNG 123
Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              +VHRD+K  N+LL S+ +G   +L DFGLA +  QG+        GT GYL+PE+  
Sbjct: 124 ---IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                   D+++ GV++  +  G  P 
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +            E A K +N    S +  ++   E      L+H N+
Sbjct: 10  EELGKGAFSVVRR----CMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++     +     LV+D +  G L   I  +  +          +  + E +N+ H   
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIQQILESVNHCHLNG 123
Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              +VHRD+K  N+LL S+ +G   +L DFGLA +  QG+        GT GYL+PE+  
Sbjct: 124 ---IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                   D+++ GV++  +  G  P 
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++  + +G G +G V     +       T +A+K ++    Q   +  + EI  + R +H
Sbjct: 45  YTQLQYIGEGAYGMVS----SAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRH 100
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +R   R      +   Y+    +   ++    KLL  +Q         L  +  G
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLY----KLLKSQQLSNDHICYFLYQILRG 156
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+L+++    ++ DFGLA++   +       T  V T  Y
Sbjct: 157 LKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 493 LAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 251

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCV-NHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +G G +G V+ G           ++AVK     +     +E   EI     ++H+N++  
Sbjct: 45  IGKGRYGEVWMGKW------RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGF 96
Query: 386 RGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
                KG     +L L+ DY  NGSL +++       L  K   ++      GL +LH  
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 442 W-----DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY----QQGEVPNTTRVVGTLGY 492
                    + HRD+KS NIL+       + D GLA  +     + ++P  TR VGT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRY 212
Query: 493 LAPELATVS------SPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
           + PE+   S           +D+YSFG+++ EVA  RR +  G  EE
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEE 257

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 58/115 (50%), Gaps = 13/115 (11%)
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
           P+++LG     +I     + LN+L       ++HRDIK  NILLD     +L DFG++  
Sbjct: 123 PEEILG-----KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG- 174
Query: 475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSA----SDVYSFGVVILEVACGRRP 525
            Q  +    TR  G   Y+APE    S+        SDV+S G+ + E+A GR P
Sbjct: 175 -QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           +E++L+ +Y   G + +    +  +++      +++  + EG+ YLH      +VH D+K
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLK 158
Query: 453 SGNILLDSEM---RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDV 509
             NILL S       ++ DFG+++  + G       ++GT  YLAPE+      T+A+D+
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEILNYDPITTATDM 216
Query: 510 YSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
           ++ G++   +     P     GE+ +E  L
Sbjct: 217 WNIGIIAYMLLTHTSPF---VGEDNQETYL 243

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 38  NGTDLILINDCWVDST-VIRLTN-----DSNQFSFGRAYYPTKLKMKRSTATNSSILTSF 91
           N T+LIL  D  V S+  +RLTN     +    S GRA+Y   +++  +T   +  + SF
Sbjct: 12  NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT---TGTVASF 68
Query: 92  STSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXXXXXXXXXEFDT 151
           +TSF F+I     + P  GL F L    S P      + GLF              EFDT
Sbjct: 69  ATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGG-FLGLFDGSNSNFHTVAV--EFDT 125
Query: 152 GQNPEFNDPDDNHIGVDLNNIESAK 176
             N ++ DP + HIG+D+N+I S K
Sbjct: 126 LYNKDW-DPTERHIGIDVNSIRSIK 149

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 9   ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 60
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 117
Query: 440 ------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVG 488
                  G    + HRD+KS NIL+       + D GLA  +          PN    VG
Sbjct: 118 MEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 174
Query: 489 TLGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
           T  Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN---HDSKQGL--KEFMAEISSMGRLQH 379
           E++G G F  V +            + AVK V+     S  GL  ++   E S    L+H
Sbjct: 30  EVIGKGAFSVVRRCI----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ------RRQILADVAE 433
            ++V++         L +V+++M    L   I  +      + +       RQIL    E
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----E 141
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLA-KLYQQGEVPNTTRVVGT 489
            L Y H   D  ++HRD+K  N+LL S+      +LGDFG+A +L + G V      VGT
Sbjct: 142 ALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGT 196
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
             ++APE+          DV+  GV++  +  G  P 
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 38  NGTDLILINDCWVDST-VIRLTN-----DSNQFSFGRAYYPTKLKMKRSTATNSSILTSF 91
           N T+LIL  D  V S+  +RLTN     +    S GRA+Y   +++  +T   +  + SF
Sbjct: 12  NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNT---TGTVASF 68
Query: 92  STSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXXXXXXXXXEFDT 151
           +TSF F+I     + P  GL F L    S P      + GLF              EFDT
Sbjct: 69  ATSFTFNIQVPNNAGPADGLAFALVPVGSQPKDKGG-FLGLFDGSNSNFHTVAV--EFDT 125
Query: 152 GQNPEFNDPDDNHIGVDLNNIESAK 176
             N ++ DP + HIG+D+N+I S K
Sbjct: 126 LYNKDW-DPTERHIGIDVNSIRSIK 149

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 10  ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 61
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 62  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 118
Query: 440 ------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVG 488
                  G    + HRD+KS NIL+       + D GLA  +          PN    VG
Sbjct: 119 MEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 175
Query: 489 TLGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
           T  Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 61/118 (51%), Gaps = 18/118 (15%)
Query: 415 PKKLLGWKQRRQILADVAEGLNYLH--HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA 472
           P+++LG     ++   + + L YL   HG    V+HRD+K  NILLD   + +L DFG++
Sbjct: 122 PERILG-----KMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA-----SDVYSFGVVILEVACGRRP 525
                 +  +  R  G   Y+APE      PT       +DV+S G+ ++E+A G+ P
Sbjct: 173 GRLVDDKAKD--RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 370 EISSMGRLQHKNLVQMRG--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKL------LGW 421
           EI+ +  L+H N++ ++         ++ L++DY  +   +   F +  K       L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE--MRGR--LGDFGLAKLYQQ 477
              + +L  + +G++YLH  W   V+HRD+K  NIL+  E   RGR  + D G A+L+  
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 478 GEVP--NTTRVVGTLGYLAPELAT-VSSPTSASDVYSFGVVILEV 519
              P  +   VV T  Y APEL       T A D+++ G +  E+
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 12  ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 63
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 64  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 120
Query: 440 ------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVG 488
                  G    + HRD+KS NIL+       + D GLA  +          PN    VG
Sbjct: 121 MEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 177
Query: 489 TLGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
           T  Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 15  ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 66
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 67  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 123
Query: 440 ------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVG 488
                  G    + HRD+KS NIL+       + D GLA  +          PN    VG
Sbjct: 124 MEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 180
Query: 489 TLGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
           T  Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 48  ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 99
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 156
Query: 440 HGW-----DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVGT 489
                      + HRD+KS NIL+       + D GLA  +          PN    VGT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VGT 214
Query: 490 LGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
             Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 86/192 (44%), Gaps = 35/192 (18%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF-TSPPG 123
           S GRA Y   +++ +S    SS++ SF T+F FSI  + +S+P   L F + +  T  P 
Sbjct: 47  SVGRALYTAPIRLWQS----SSLVASFETTFTFSI-SQGSSTPADALTFFIASPDTKIPS 101
Query: 124 ALASQYFGLF-SNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIES-------- 174
               +  GLF S+            EFDT  N +  DP+  HIG+D+N+I S        
Sbjct: 102 GSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDW 161
Query: 175 ------AKHVPAGYYSSSRNESFV-------PVRMRNGQNIH----AWIDFDGFSASKTN 217
                   H+   Y S+S+  S V       PV +     ++     W+   GFSA+   
Sbjct: 162 QNGKTATAHI--SYNSASKRLSVVSSYPNSSPVVVSFDVELNNVXPXWVRV-GFSATTGQ 218
Query: 218 WIEARRVLAWSL 229
           + +   +LAWS 
Sbjct: 219 YTQTNNILAWSF 230

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N++
Sbjct: 35  ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 86
Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                  K N    +L LV DY  +GSL +++      + G  +   +    A GL +LH
Sbjct: 87  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK---LALSTASGLAHLH 143
Query: 440 ------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-----VPNTTRVVG 488
                  G    + HRD+KS NIL+       + D GLA  +          PN    VG
Sbjct: 144 MEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 200
Query: 489 TLGYLAPELATVS------SPTSASDVYSFGVVILEVA 520
           T  Y+APE+   S           +D+Y+ G+V  E+A
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 361 KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL---NNWIFGKPKK 417
           K    +F  E+  +  ++++  +   G     +E+ ++Y+YM N S+   + + F   K 
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 418 ---LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
               +  +  + I+  V    +Y+H+  ++ + HRD+K  NIL+D   R +L DFG ++ 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS--DVYSFGVVI 516
               ++  +    GT  ++ PE  +  S  + +  D++S G+ +
Sbjct: 202 MVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 55  IRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFV 114
           I+LTN +   S GR  Y   +++  S   N   + SF TSF F +       P  G+ F 
Sbjct: 32  IQLTNLNKVNSVGRVLYAMPVRIWSSATGN---VASFLTSFSFEMKDIKDYDPADGIIFF 88
Query: 115 LT--NFTSPPGALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNI 172
           +   +   P G++     G+               EFDT  N E+NDP  +H+G+D+N++
Sbjct: 89  IAPEDTQIPAGSIGGGTLGV---SDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSV 145
Query: 173 ESAKHVP 179
           +S K VP
Sbjct: 146 DSVKTVP 152

>pdb|2PEL|A Chain A, Peanut Lectin Length = 236

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 55  IRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFV 114
           I+LTN +   S GR  Y   +++  S   N   + SF TSF F +       P  G+ F 
Sbjct: 32  IQLTNLNKVNSVGRVLYAMPVRIWSSATGN---VASFLTSFSFEMKDIKDYDPADGIIFF 88
Query: 115 LT--NFTSPPGALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNI 172
           +   +   P G++     G+               EFDT  N E+NDP  +H+G+D+N++
Sbjct: 89  IAPEDTQIPAGSIGGGTLGV---SDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSV 145
Query: 173 ESAKHVP 179
           +S K VP
Sbjct: 146 DSVKTVP 152

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 27/232 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LG G    V++G             A+K  N+ S  + +   M E   + +L HKN+V
Sbjct: 15  DILGQGATANVFRG----RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 384 QMRGWCRKGN--ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR--QILADVAEGLNYLH 439
           ++     +      +L+ ++ P GSL   +  +P    G  +     +L DV  G+N+L 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 440 HGWDQVVVHRDIKSGNILL----DSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
              +  +VHR+IK GNI+     D +   +L DFG A+  +  E      + GT  YL P
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVXLYGTEEYLHP 184
Query: 496 ELATVS--------SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
           ++   +           +  D++S GV     A G  P    +G    + V+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           E +G G F  V +            E A K +N    S +  ++   E      L+H N+
Sbjct: 10  EDIGKGAFSVVRRCV----KLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNI 65
Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++     +     LV+D +  G L   I  +  +          +  + E + + H   
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH--- 120
Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              VVHRD+K  N+LL S+ +G   +L DFGLA +  QG+        GT GYL+PE+  
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
             +     D+++ GV++  +  G  P 
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 27/232 (11%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLV 383
           ++LG G    V++G             A+K  N+ S  + +   M E   + +L HKN+V
Sbjct: 15  DILGQGATANVFRG----RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 384 QMRGWCRKGN--ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR--QILADVAEGLNYLH 439
           ++     +      +L+ ++ P GSL   +  +P    G  +     +L DV  G+N+L 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 440 HGWDQVVVHRDIKSGNILL----DSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
              +  +VHR+IK GNI+     D +   +L DFG A+  +  E      + GT  YL P
Sbjct: 130 ---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHP 184
Query: 496 ELATVS--------SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
           ++   +           +  D++S GV     A G  P    +G    + V+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 30/240 (12%)
Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK 365
           P R  Y      +  F    LLG G +G V   T        + +   K    D      
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFAL 54
Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKG-----NELMLVYDYMPNGSLNNWIFGKPKKLLG 420
             + EI  +   +H+N++ +    R       NE+ ++ + M    L+  I     ++L 
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLS 110
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
               +  +      +  LH      V+HRD+K  N+L++S    ++ DFGLA++  +   
Sbjct: 111 DDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 481 PNT---------TRVVGTLGYLAPELATVSSPTS-ASDVYSFGVVILEVACGRRPLDMGK 530
            N+         T  V T  Y APE+   S+  S A DV+S G ++ E+   RRP+  G+
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 30/240 (12%)
Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK 365
           P R  Y      +  F    LLG G +G V   T        + +   K    D      
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFAL 54
Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKG-----NELMLVYDYMPNGSLNNWIFGKPKKLLG 420
             + EI  +   +H+N++ +    R       NE+ ++ + M    L+  I     ++L 
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLS 110
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
               +  +      +  LH      V+HRD+K  N+L++S    ++ DFGLA++  +   
Sbjct: 111 DDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 481 PNT---------TRVVGTLGYLAPELATVSSPTS-ASDVYSFGVVILEVACGRRPLDMGK 530
            N+         T  V T  Y APE+   S+  S A DV+S G ++ E+   RRP+  G+
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 111/245 (45%), Gaps = 34/245 (13%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM- 385
           LG GG G V+              +A+K +     Q +K  + EI  + RL H N+V++ 
Sbjct: 19  LGCGGNGLVFSAV----DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 386 -------------RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
                         G   + N + +V +YM    L N +   P   L  +  R  +  + 
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP---LLEEHARLFMYQLL 130
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLY--QQGEVPNTTRVVGT 489
            GL Y+H      V+HRD+K  N+ +++E +  ++GDFGLA++         + +  + T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 490 LGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             Y +P L  + SP   T A D+++ G +  E+  G+  L  G  E E+  ++++ +  +
Sbjct: 188 KWYRSPRL--LLSPNNYTKAIDMWAAGCIFAEMLTGKT-LFAGAHELEQMQLILESIPVV 244
Query: 547 YGQGK 551
           + + +
Sbjct: 245 HEEDR 249

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 317 ATKG-----FSNDELLGSGGFGRV----YKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF 367
           +TKG     ++ +  +G G +G V     KGT            A K +     + +  F
Sbjct: 19  STKGDINQYYTLENTIGRGSWGEVKIAVQKGT--------RIRRAAKKIPKYFVEDVDRF 70
Query: 368 MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
             EI  M  L H N++++        ++ LV +    G L   +    K++       +I
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARI 128
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILL-----DSEMRGRLGDFGLAKLYQQGEVPN 482
           + DV   + Y H      V HRD+K  N L      DS +  +L DFGLA  ++ G++  
Sbjct: 129 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMR 183
Query: 483 TTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPL 526
           T   VGT  Y++P+ L  +  P    D +S GV++  + CG  P 
Sbjct: 184 TK--VGTPYYVSPQVLEGLYGP--ECDEWSAGVMMYVLLCGYPPF 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 317 ATKG-----FSNDELLGSGGFGRV----YKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF 367
           +TKG     ++ +  +G G +G V     KGT            A K +     + +  F
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGT--------RIRRAAKKIPKYFVEDVDRF 53
Query: 368 MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
             EI  M  L H N++++        ++ LV +    G L   +    K++       +I
Sbjct: 54  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARI 111
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILL-----DSEMRGRLGDFGLAKLYQQGEVPN 482
           + DV   + Y H      V HRD+K  N L      DS +  +L DFGLA  ++ G++  
Sbjct: 112 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMR 166
Query: 483 TTRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPL 526
           T   VGT  Y++P+ L  +  P    D +S GV++  + CG  P 
Sbjct: 167 TK--VGTPYYVSPQVLEGLYGP--ECDEWSAGVMMYVLLCGYPPF 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           ++ T+ +   E LG G F  V +            E A   +N    S +  ++   E  
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCV----KVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
               L+H N+V++     +     L++D +  G L   I  +  +          +  + 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQIL 120
Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGT 489
           E + + H      VVHR++K  N+LL S+++G   +L DFGLA +  +GE        GT
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGT 176
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            GYL+PE+          D+++ GV++  +  G  P 
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 64/140 (45%), Gaps = 11/140 (7%)
Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           N L LV DY   G L   +  K +  L  +  R  LA++   ++ +H       VHRDIK
Sbjct: 147 NNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIK 202
Query: 453 SGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA----- 506
             NIL+D     RL DFG   KL + G V ++   VGT  Y++PE+              
Sbjct: 203 PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 507 SDVYSFGVVILEVACGRRPL 526
            D +S GV + E+  G  P 
Sbjct: 262 CDWWSLGVCMYEMLYGETPF 281

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 63/149 (42%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + M  ST   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYTKPVHMWDST---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  NP ++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDAPS 176

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 327 LGSGGFG--RVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +GSG FG  R+ +  L          +AVK +   +    +    EI +   L+H N+V+
Sbjct: 28  IGSGNFGVARLMRDKLTKEL------VAVKYIERGAAID-ENVQREIINHRSLRHPNIVR 80
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
            +        L ++ +Y   G L   I    +      + R     +  G++Y H     
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCH---SM 135
Query: 445 VVVHRDIKSGNILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVS 501
            + HRD+K  N LLD     RL   DFG +K       P +T  VGT  Y+APE L    
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE 193
Query: 502 SPTSASDVYSFGVVILEVACGRRPLD 527
                +DV+S GV +  +  G  P +
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 84/205 (40%), Gaps = 17/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +GSG FG              S E+ AVK +    K   +    EI +   L+H N+V+ 
Sbjct: 26  IGSGNFG-----VARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRF 79
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
           +        L +V +Y   G L   I    +      + R     +  G++Y H      
Sbjct: 80  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH---AMQ 134
Query: 446 VVHRDIKSGNILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVSS 502
           V HRD+K  N LLD     RL   DFG +K       P +T  VGT  Y+APE L     
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 192
Query: 503 PTSASDVYSFGVVILEVACGRRPLD 527
               +DV+S GV +  +  G  P +
Sbjct: 193 DGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +GSG FG              S E+ AVK +    K        EI +   L+H N+V+ 
Sbjct: 27  IGSGNFG-----VARLMRDKQSNELVAVKYIERGEKIA-ANVKREIINHRSLRHPNIVRF 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
           +        L +V +Y   G L   I    +      + R     +  G++Y H      
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH---AMQ 135
Query: 446 VVHRDIKSGNILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVSS 502
           V HRD+K  N LLD     RL   DFG +K       P +T  VGT  Y+APE L     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 503 PTSASDVYSFGVVILEVACGRRPLD 527
               +DV+S GV +  +  G  P +
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 30/240 (12%)
Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLK 365
           P R  Y      +  F    LLG G +G V   T        + +   K    D      
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFAL 54
Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKG-----NELMLVYDYMPNGSLNNWIFGKPKKLLG 420
             + EI  +   +H+N++ +    R       NE+ ++ + M    L+  I     ++L 
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLS 110
Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
               +  +      +  LH G +  V+HRD+K  N+L++S    ++ DFGLA++  +   
Sbjct: 111 DDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 481 PNT---------TRVVGTLGYLAPELATVSSPTS-ASDVYSFGVVILEVACGRRPLDMGK 530
            N+            V T  Y APE+   S+  S A DV+S G ++ E+   RRP+  G+
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 9/141 (6%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L+++ + M  G L + I  +  +    ++  +I+ D+   + +LH      + HRD+K  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 157
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+ +    +L DFG AK   Q  +        T  Y+APE+        + D++S
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWS 214
Query: 512 FGVVILEVACGRRPLDMGKGE 532
            GV++  + CG  P     G+
Sbjct: 215 LGVIMYILLCGFPPFYSNTGQ 235

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 9/141 (6%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L+++ + M  G L + I  +  +    ++  +I+ D+   + +LH      + HRD+K  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 138
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+ +    +L DFG AK   Q  +        T  Y+APE+        + D++S
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWS 195
Query: 512 FGVVILEVACGRRPLDMGKGE 532
            GV++  + CG  P     G+
Sbjct: 196 LGVIMYILLCGFPPFYSNTGQ 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +VQ+    +    L +V +YMP G L N +  +  P+K   W   +   A+V   L+ +H
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WA--KFYTAEVVLALDAIH 191
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 ++HRD+K  N+LLD     +L DFG      +  + +    VGT  Y++PE+  
Sbjct: 192 S---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 500 VSSPTS----ASDVYSFGVVILEVACGRRPL 526
                       D +S GV + E+  G  P 
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +VQ+    +    L +V +YMP G L N +  +  P+K   W   R   A+V   L+ +H
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WA--RFYTAEVVLALDAIH 190
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELA 498
                  +HRD+K  N+LLD     +L DFG   K+ ++G V   T  VGT  Y++PE+ 
Sbjct: 191 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVL 246
Query: 499 TVSSPT----SASDVYSFGVVILEVACGRRPL 526
                        D +S GV + E+  G  P 
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +VQ+    +    L +V +YMP G L N +  +  P+K   W   R   A+V   L+ +H
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WA--RFYTAEVVLALDAIH 190
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELA 498
                  +HRD+K  N+LLD     +L DFG   K+ ++G V   T  VGT  Y++PE+ 
Sbjct: 191 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVL 246
Query: 499 TVSSPT----SASDVYSFGVVILEVACGRRPL 526
                        D +S GV + E+  G  P 
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +VQ+    +    L +V +YMP G L N +  +  P+K   W   R   A+V   L+ +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WA--RFYTAEVVLALDAIH 185
Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELA 498
                  +HRD+K  N+LLD     +L DFG   K+ ++G V   T  VGT  Y++PE+ 
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVL 241
Query: 499 TVSSPT----SASDVYSFGVVILEVACGRRPL 526
                        D +S GV + E+  G  P 
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-K 308
Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 309 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-K 310
Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 311 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-K 315
Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 316 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 355

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 52/283 (18%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ------- 378
           LLG GGFG V+ G           ++A+K +  +   G       ++    +        
Sbjct: 38  LLGKGGFGTVFAG----HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 379 ---HKNLVQMRGWCRKGNELMLVYDY-MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
              H  ++++  W       MLV +  +P   L ++I    K  LG    R     V   
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAA 151
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
           + + H    + VVHRDIK  NIL+D   RG  +L DFG   L         T   GT  Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLR-RGCAKLIDFGSGALLHDEPY---TDFDGTRVY 204
Query: 493 LAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
             PE ++        + V+S G+++ ++ CG  P +  + +E  EA        L+    
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE--RDQEILEA-------ELHFPAH 255
Query: 552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
           +     A IR+                C  P  + RP++ E++
Sbjct: 256 VSPDCCALIRR----------------CLAPKPSSRPSLEEIL 282

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKCQHLSNDHICYFLYQILRG 140
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGK 235

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 28  FLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQF----SFGRAYYPTKLKMKRSTA 82
           F F +F    N  +LIL  D  V+S   + LT  +       S GRA Y   + +  +T 
Sbjct: 6   FSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT 63
Query: 83  TNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXXXX 142
                L SF+TSF F +    A++   GL F L    + P A    + GLF++       
Sbjct: 64  -----LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGG-FLGLFADRAHDASY 117
Query: 143 XXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP 179
                EFDT  N    DP+  HIG+D N IES K  P
Sbjct: 118 QTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTP 152

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 25  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 136
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 231

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA+ +Y+  +          
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           L ++APE       T  SDV+SFGV++ E+ + G  P    K +EE       + R L  
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL-K 317
Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +G    A D      +   EM   +   L C H + ++RPT  E+V  L
Sbjct: 318 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 357

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 25  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 136
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 231

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 25  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 136
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 231

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 27  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 82
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 233

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 140
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 235

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 140
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 235

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 245
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH   +  ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 300
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 19/206 (9%)
Query: 327 LGSGGFG--RVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           +G+G FG  R+ +   A         +AVK +    K   +    EI +   L+H N+V+
Sbjct: 27  IGAGNFGVARLMRDKQANEL------VAVKYIERGEKID-ENVKREIINHRSLRHPNIVR 79
Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
            +        L +V +Y   G L   I    +      + R     +  G++Y H     
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYAHAMQ-- 135
Query: 445 VVVHRDIKSGNILLDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVS 501
            V HRD+K  N LLD     RL   DFG +K       P +   VGT  Y+APE L    
Sbjct: 136 -VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKE 192
Query: 502 SPTSASDVYSFGVVILEVACGRRPLD 527
                +DV+S GV +  +  G  P +
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 33  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 88
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 149 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 239

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 25  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 231

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 25  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 80
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 141 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 30  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 85
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 236

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 203 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 259
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH   +  ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 314
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 31  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 86
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 147 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 237

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 22  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 77
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 138 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 228

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 235

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 23  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 23  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 78
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 139 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 45  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 100
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 156
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 251

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 120
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH      ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 175
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 84/224 (37%), Gaps = 44/224 (19%)
Query: 38  NGTDLILINDCWVDST-VIRLTN--DSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTS 94
           N T+LIL  D  V S   + LTN   + + S GRA+Y   +++   T  N   L SFST+
Sbjct: 12  NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDN---LASFSTN 68
Query: 95  FVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXXXXXXXXXXXEFDTGQN 154
           F F I  +   +  +GL F L    S P  L  +Y GLF+              FDT   
Sbjct: 69  FTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNTTNYDRDAHTVAVVFDTVS- 126
Query: 155 PEFNDPDDNHIGVDLNNIESAKHVPAGY--------------------------YSSSRN 188
                   N I +D+N+I         +                          Y SS  
Sbjct: 127 --------NRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEE 178
Query: 189 ESFVPVRMRNGQNIHAWID--FDGFSASKTNWIEARRVLAWSLS 230
           +  V   +   + +  W+   F   S SK    E   VL+WS S
Sbjct: 179 KCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFS 222

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 119
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH      ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 120 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 174
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 120
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH      ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 175
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 120
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH      ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 175
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDS--NQFSFGRAYYPTKLKMKR 79
           S  L F F+ F  + N  ++I   D  V +T V+++T  S     S GRA Y   +++  
Sbjct: 3   SDDLSFNFDKF--VPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 60
Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGF-GLCFVLTNFTSP-PGALASQYFGLFSNXX 137
           S    +  + SF+TSF F +  +   S G  GL F L    S  P   ++  FGLFS+  
Sbjct: 61  SI---TGKVASFATSFSFVVKAD--KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD 115
Query: 138 XXXXXXXXXXEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHV 178
                     EFDT     +N  DPD  HIG+D+N+I+S K V
Sbjct: 116 SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV 158

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 369 AEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
            EI  + +L H  +++++ +     +  +V + M  G L + + G   K L     +   
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYF 126
Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTR 485
             +   + YLH      ++HRD+K  N+LL S+      ++ DFG +K+   GE      
Sbjct: 127 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT 181
Query: 486 VVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPL 526
           + GT  YLAPE L +V +     A D +S GV++     G  P 
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKN 381
            +++LG G   RV            S E AVK +             E+  + + Q H+N
Sbjct: 17  QEDVLGEGAHARVQ----TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++  +  + +   LV++ M  GS+ + I    ++     +   ++ DVA  L++LH  
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLH-- 128
Query: 442 WDQVVVHRDIKSGNILLDSEMR---GRLGDFGLAK-LYQQGEV-----PNTTRVVGTLGY 492
            ++ + HRD+K  NIL +   +    ++ DFGL   +   G+      P      G+  Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 493 LAPELATVSSPTSA-----SDVYSFGVVILEVACGRRPL 526
           +APE+    S  ++      D++S GV++  +  G  P 
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 45  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 100
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQ-----ILADVAE 433
           +N++ +    R         + M +  L   + G    KLL  +          L  +  
Sbjct: 101 ENIIGINDIIRAP-----TIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLG 491
           GL Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  
Sbjct: 156 GLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 492 YLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           Y APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 251

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A++ ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 235

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 203 LGVIMYILLCGYPPFYSNHG 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 152
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 211 LGVIMYILLCGYPPFYSNHG 230

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 151
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 210 LGVIMYILLCGYPPFYSNHG 229

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 150
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 209 LGVIMYILLCGYPPFYSNHG 228

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 146
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 205 LGVIMYILLCGYPPFYSNHG 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 145
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 204 LGVIMYILLCGYPPFYSNHG 223

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 160
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 219 LGVIMYILLCGYPPFYSNHG 238

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 203 LGVIMYILLCGYPPFYSNHG 222

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 62/149 (41%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYAKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  NP ++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGIFNNSKQDNSYQTLGVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +GSG FG              S E+ AVK +    K   +    EI +   L+H N+V+ 
Sbjct: 27  IGSGNFG-----VARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRF 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
           +        L +V +Y   G L   I    +      + R     +  G++Y H      
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--- 135
Query: 446 VVHRDIKSGNILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVSS 502
           V HRD+K  N LLD     RL    FG +K       P +T  VGT  Y+APE L     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 193
Query: 503 PTSASDVYSFGVVILEVACGRRPLD 527
               +DV+S GV +  +  G  P +
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 146
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 205 LGVIMYILLCGYPPFYSNHG 224

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 62/149 (41%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYTKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  NP ++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAE-ISSMGRLQHKNLVQM 385
           LG G FG V++            + AVK V       L+ F AE + +   L    +V +
Sbjct: 82  LGRGSFGEVHR----MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPL 131
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G  R+G  + +  + +  GSL   +  K +  L   +    L    EGL YLH    + 
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEGLEYLH---SRR 186
Query: 446 VVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQ----GEVPNTTRVVGTLGYLAPELATV 500
           ++H D+K+ N+LL S+     L DFG A   Q      ++     + GT  ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
            S  +  DV+S   ++L +  G  P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 29  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++              V T  Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 235

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  + R +H
Sbjct: 30  YTNLSYIGEGAYGMV----CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 85
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++              V T  Y APE
Sbjct: 146 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 236

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 190
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 249 LGVIMYILLCGYPPFYSNHG 268

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAE-ISSMGRLQHKNLVQM 385
           LG G FG V++            + AVK V       L+ F AE + +   L    +V +
Sbjct: 101 LGRGSFGEVHR----MEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPL 150
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G  R+G  + +  + +  GSL   +  K +  L   +    L    EGL YLH    + 
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEGLEYLH---SRR 205
Query: 446 VVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNT----TRVVGTLGYLAPELATV 500
           ++H D+K+ N+LL S+     L DFG A   Q   +  +      + GT  ++APE+   
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 501 SSPTSASDVYSFGVVILEVACGRRP 525
            S  +  DV+S   ++L +  G  P
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I+  + E + YLH      + HRD+K  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 196
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV++  + CG  P     G
Sbjct: 255 LGVIMYILLCGYPPFYSNHG 274

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDS-TVIRLTNDSNQF----SFGRAYYPTKLKMKR 79
            + F FN F    N   L L  D  + S +V+ LT   N      S GRA Y   +++  
Sbjct: 2   TISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD 59
Query: 80  STATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXX 138
           ST  N   + SF T F FSI  P     P  GL F    F +PP     +  G F     
Sbjct: 60  STTGN---VASFETRFSFSIRQPFPRPHPADGLVF----FIAPPNTQTGEGGGYFGIYNP 112
Query: 139 XXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP 179
                    EFDT +N    DP   HIG+D+N++ S K VP
Sbjct: 113 LSPYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP 151

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 62/149 (41%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYAKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  NP ++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGIFNNSKQDNSYQTLGVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDS-TVIRLTNDSNQF----SFGRAYYPTKLKMKR 79
            + F FN F    N   L L  D  + S +V+ LT   N      S GRA Y   +++  
Sbjct: 3   TISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD 60
Query: 80  STATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXX 138
           ST  N   + SF T F FSI  P     P  GL F    F +PP     +  G F     
Sbjct: 61  STTGN---VASFETRFSFSIRQPFPRPHPADGLVF----FIAPPNTQTGEGGGYFGIYNP 113
Query: 139 XXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP 179
                    EFDT +N    DP   HIG+D+N++ S K VP
Sbjct: 114 LSPYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP 152

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+   +   + + D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 318 TKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVK----------CVNHDSKQGLKEF 367
           ++ +S    LGSG FG V+           + E+ VK          C   D K G  + 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAV----DKEKNKEVVVKFIKKEKVLEDCWIEDPKLG--KV 76
Query: 368 MAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
             EI+ + R++H N++++           LV +   +G L+ + F      L       I
Sbjct: 77  TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYI 135
Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV 487
              +   + YL     + ++HRDIK  NI++  +   +L DFG A   ++G++  T    
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FC 190
Query: 488 GTLGYLAPELATVSSPTSASDV--YSFGVVILEVACGRRPL 526
           GT+ Y APE+  + +P    ++  +S GV +  +     P 
Sbjct: 191 GTIEYCAPEV-LMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN---HDSKQGL--KEFMAEISSMGRLQH 379
           E++G G F  V +            + AVK V+     S  GL  ++   E S    L+H
Sbjct: 30  EVIGKGPFSVVRRCI----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ------RRQILADVAE 433
            ++V++         L +V+++M    L   I  +      + +       RQIL    E
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----E 141
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLA-KLYQQGEVPNTTRVVGT 489
            L Y H   D  ++HRD+K   +LL S+      +LG FG+A +L + G V      VGT
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGT 196
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
             ++APE+          DV+  GV++  +  G  P 
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 69/161 (42%), Gaps = 17/161 (10%)
Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDS-TVIRLTNDSNQF----SFGRAYYPTKLKMKR 79
            + F FN F    N   L L  D  + S +V+ LT   N      S GRA Y   +++  
Sbjct: 2   TISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD 59
Query: 80  STATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNXXX 138
           ST  N   + SF T F FSI  P     P  GL F    F +PP     +  G F     
Sbjct: 60  STTGN---VASFETRFSFSIRQPFPRPHPADGLVF----FIAPPNTQTGEGGGYFGIYNP 112
Query: 139 XXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP 179
                    EFDT +N    DP   HIG+D+N++ S K VP
Sbjct: 113 LSPYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP 151

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 13/215 (6%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  +   +H
Sbjct: 27  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRH 82
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 143 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 497 LATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
           +   S   T + D++S G ++ E+    RP+  GK
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           N L LV DY   G L   +  K +  L     R  + ++   ++ +H       VHRDIK
Sbjct: 147 NHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIK 202
Query: 453 SGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSA 506
             N+LLD     RL DFG   K+   G V ++   VGT  Y++PE+       +      
Sbjct: 203 PDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AVGTPDYISPEILQAMEDGMGKYGPE 261
Query: 507 SDVYSFGVVILEVACGRRPL 526
            D +S GV + E+  G  P 
Sbjct: 262 CDWWSLGVCMYEMLYGETPF 281

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGR 376
           K + +   +GSG +G V     +        ++A+K ++   +  +  K    E+  +  
Sbjct: 24  KTYVSPTHVGSGAYGSV----CSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 79
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDY---MPNGSLNNWIFGKPKKLLGWK----QRRQILA 429
           +QH+N++ +       + L   YD+   MP      ++    +K++G K    + + ++ 
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMP------FMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            + +GL Y+H      VVHRD+K GN+ ++ +   ++ DFGLA+ +   E+   T  V T
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM---TGYVVT 186
Query: 490 LGYLAPE-LATVSSPTSASDVYSFGVVILEVACGR 523
             Y APE + +        D++S G ++ E+  G+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK 452
           N L LV DY   G L   +  K +  L     R  + ++   ++ +H       VHRDIK
Sbjct: 163 NHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQ---LHYVHRDIK 218
Query: 453 SGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSA 506
             N+LLD     RL DFG   K+   G V ++   VGT  Y++PE+       +      
Sbjct: 219 PDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AVGTPDYISPEILQAMEDGMGKYGPE 277
Query: 507 SDVYSFGVVILEVACGRRPL 526
            D +S GV + E+  G  P 
Sbjct: 278 CDWWSLGVCMYEMLYGETPF 297

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 38/210 (18%)
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
           P+ +LG     +I   + + L +LH      V+HRD+K  N+L+++  + ++ DFG++  
Sbjct: 151 PEDILG-----KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG- 202
Query: 475 YQQGEVPNTTRVVGTLGYLAPELATV----SSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           Y    V  T    G   Y+APE           +  SD++S G+ ++E+A  R P D   
Sbjct: 203 YLVDSVAKTID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--- 258
Query: 531 GEEEEEAVLMDWVRNLYGQGKICEAADARI-RQEFEAEEMELVLKLGLACCHPDSTRRPT 589
                      W        ++ E    ++   +F AE ++   +    C   +S  RPT
Sbjct: 259 ----------SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPT 304
Query: 590 MREVVAVLV-------GQEVAATPKELLGD 612
             E++           G +VA+  K +LGD
Sbjct: 305 YPELMQHPFFTLHESKGTDVASFVKLILGD 334

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 82/205 (40%), Gaps = 17/205 (8%)
Query: 327 LGSGGFGRVYKGTLAXXXXXXSTEM-AVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM 385
           +GSG FG              S E+ AVK +    K   +    EI +   L+H N+V+ 
Sbjct: 27  IGSGNFG-----VARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNIVRF 80
Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
           +        L +V +Y   G L   I    +      + R     +  G++Y H      
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--- 135
Query: 446 VVHRDIKSGNILLDSEMRGRLG--DFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATVSS 502
           V HRD+K  N LLD     RL    FG +K       P  T  VGT  Y+APE L     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKEY 193
Query: 503 PTSASDVYSFGVVILEVACGRRPLD 527
               +DV+S GV +  +  G  P +
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 41/246 (16%)
Query: 311 YEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAE 370
           YE + + +  F  ++ +G G F  VY  T A        ++A+K +   S        AE
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLAT-AQLQVGPEEKIALKHLIPTSHP--IRIAAE 69
Query: 371 ISSMGRLQHKNLVQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
           +  +     ++ V    +C RK + +++   Y+ + S  + +       L +++ R+ + 
Sbjct: 70  LQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYML 124
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLA-----------KLYQ- 476
           ++ + L  +H      +VHRD+K  N L +  ++   L DFGLA           K  Q 
Sbjct: 125 NLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 477 --QGEVPNTTRV-------------VGTLGYLAPELAT-VSSPTSASDVYSFGVVILEVA 520
             Q E  +  +               GT G+ APE+ T   + T+A D++S GV+ L + 
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 521 CGRRPL 526
            GR P 
Sbjct: 242 SGRYPF 247

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVN---HDSKQGL--KEFMAEISSMGRLQH 379
           E++G G F  V +            + AVK V+     S  GL  ++   E S    L+H
Sbjct: 32  EVIGKGPFSVVRRCI----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ------RRQILADVAE 433
            ++V++         L +V+++M    L   I  +      + +       RQIL    E
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----E 143
Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLA-KLYQQGEVPNTTRVVGT 489
            L Y H   D  ++HRD+K   +LL S+      +LG FG+A +L + G V      VGT
Sbjct: 144 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGT 198
Query: 490 LGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
             ++APE+          DV+  GV++  +  G  P 
Sbjct: 199 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KXQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           ++N   +G G +G V     +         +A+K ++    Q   +  + EI  +   +H
Sbjct: 27  YTNLSYIGEGAYGMV----CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRH 82
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ-----ILADVAEG 434
           +N++ +    R      +   Y+    +   ++    KLL  +          L  +  G
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY----KLLKTQHLSNDHICYFLYQILRG 138
Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNTTRVVGTLGY 492
           L Y+H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 493 LAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGK 530
            APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGK 233

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 323 NDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKN 381
            +++LG G   RV            S E AVK +             E+  + + Q H+N
Sbjct: 17  QEDVLGEGAHARVQ----TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++  +  + +   LV++ M  GS+ + I    ++     +   ++ DVA  L++LH  
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLH-- 128
Query: 442 WDQVVVHRDIKSGNILLDSEMR---GRLGDFGLAK-LYQQGEV-----PNTTRVVGTLGY 492
            ++ + HRD+K  NIL +   +    ++ DF L   +   G+      P      G+  Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 493 LAPELATVSSPTSA-----SDVYSFGVVILEVACGRRPL 526
           +APE+    S  ++      D++S GV++  +  G  P 
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPIGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 125
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 126 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-HT 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 325 ELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNH--DSKQGLKEFMAEISSMGRLQHKNL 382
            L+G G +G VY              +A+K VN   +     K  + EI+ + RL+   +
Sbjct: 32  HLIGRGSYGYVY----LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 383 VQMRGWC-----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +++          K +EL +V + + +  L   +F  P   L  +  + IL ++  G N+
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLE-IADSDLKK-LFKTPI-FLTEEHIKTILYNLLLGENF 144
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL------------YQQGEVP---- 481
           +H      ++HRD+K  N LL+ +   ++ DFGLA+              ++ E P    
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 482 -----NTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEV 519
                  T  V T  Y APEL  +    T + D++S G +  E+
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 62/149 (41%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYAKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  N +++ P   HIG+D+N+I S K       
Sbjct: 103 AQGGGYLGIFNNSKQDNSYQTLGVEFDTFSN-QWDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV--NHDSKQGLKEFMAEIS 372
           S+ T  F   E +GSG FG V+K          + + + K +  + D +  L+E  A  +
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH-A 63
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILAD 430
            +G  QH ++V+      + + +++  +Y   GSL + I    + +  +K+   + +L  
Sbjct: 64  VLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 121
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLD-------SEMRGRLGDFGLAK-LYQQGEVPN 482
           V  GL Y+H      +VH DIK  NI +        +   G   D+   K +++ G++ +
Sbjct: 122 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 483 TTRVV------GTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            TR+       G   +LA E L    +    +D+++  + ++  A G  PL     +  E
Sbjct: 179 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHE 237
Query: 536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                  +R    QG++      RI Q    E  EL LK+ +   HPD  RRP+   +V
Sbjct: 238 -------IR----QGRL-----PRIPQVLSQEFTEL-LKVMI---HPDPERRPSAMALV 276

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KXQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV--NHDSKQGLKEFMAEIS 372
           S+ T  F   E +GSG FG V+K          + + + K +  + D +  L+E  A  +
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH-A 63
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILAD 430
            +G  QH ++V+      + + +++  +Y   GSL + I    + +  +K+   + +L  
Sbjct: 64  VLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 121
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLD-------SEMRGRLGDFGLAK-LYQQGEVPN 482
           V  GL Y+H      +VH DIK  NI +        +   G   D+   K +++ G++ +
Sbjct: 122 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 483 TTRVV------GTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            TR+       G   +LA E L    +    +D+++  + ++  A G  PL     +  E
Sbjct: 179 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHE 237
Query: 536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                  +R    QG++      RI Q    E  EL LK+ +   HPD  RRP+   +V
Sbjct: 238 -------IR----QGRL-----PRIPQVLSQEFTEL-LKVMI---HPDPERRPSAMALV 276

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQH 379
            ++   LG G FG V++            + AVK V       L+ F + E+ +   L  
Sbjct: 74  MTHQPRLGRGSFGEVHR----MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSS 123
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI--LADVAEGLNY 437
             +V + G  R+G  + +  + +  GSL   I    K++    + R +  L    EGL Y
Sbjct: 124 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 179
Query: 438 LHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTT----RVVGTLGY 492
           LH    + ++H D+K+ N+LL S+  R  L DFG A   Q   +  +      + GT  +
Sbjct: 180 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+       +  D++S   ++L +  G  P
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV--NHDSKQGLKEFMAEIS 372
           S+ T  F   E +GSG FG V+K          + + + K +  + D +  L+E  A  +
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH-A 65
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILAD 430
            +G  QH ++V+      + + +++  +Y   GSL + I    + +  +K+   + +L  
Sbjct: 66  VLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLD-------SEMRGRLGDFGLAK-LYQQGEVPN 482
           V  GL Y+H      +VH DIK  NI +        +   G   D+   K +++ G++ +
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 483 TTRVV------GTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            TR+       G   +LA E L    +    +D+++  + ++  A G  PL     +  E
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRNGDQWHE 239
Query: 536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                  +R    QG++      RI Q    E  EL LK+ +   HPD  RRP+   +V
Sbjct: 240 -------IR----QGRL-----PRIPQVLSQEFTEL-LKVMI---HPDPERRPSAMALV 278

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 125
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 126 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-HT 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 56/119 (47%), Gaps = 17/119 (14%)
Query: 63  QFSFGRAYY--PTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTS 120
           Q+S GRA Y  P +L   ++ +     + SF T F F  L    + P  GL F    F +
Sbjct: 46  QWSAGRALYSDPVQLWDNKTES-----VASFYTEFTF-FLKITGNGPADGLAF----FLA 95
Query: 121 PPGAL---ASQYFGLF--SNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIES 174
           PP +    A +Y GLF  S             EFDT  NP F +P   HIG+++N+I S
Sbjct: 96  PPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVS 154

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 125
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 126 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 116
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 117 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 171
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 172 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 56/119 (47%), Gaps = 17/119 (14%)
Query: 63  QFSFGRAYY--PTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTS 120
           Q+S GRA Y  P +L   ++ +     + SF T F F  L    + P  GL F    F +
Sbjct: 46  QWSAGRALYSDPVQLWDNKTES-----VASFYTEFTF-FLKITGNGPADGLAF----FLA 95
Query: 121 PPGAL---ASQYFGLF--SNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIES 174
           PP +    A +Y GLF  S             EFDT  NP F +P   HIG+++N+I S
Sbjct: 96  PPDSDVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVS 154

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 116
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 117 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 171
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 172 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 5   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 117
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 118 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 172
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 173 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 46/299 (15%)
Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCV--NHDSKQGLKEFMAEIS 372
           S+ T  F   E +GSG FG V+K          + + + K +  + D +  L+E  A  +
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH-A 61
Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILAD 430
            +G  QH ++V+      + + +++  +Y   GSL + I    + +  +K+   + +L  
Sbjct: 62  VLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 119
Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLD-------SEMRGRLGDFGLAK-LYQQGEVPN 482
           V  GL Y+H      +VH DIK  NI +        +   G   D+   K +++ G++ +
Sbjct: 120 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 176
Query: 483 TTRVV------GTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            TR+       G   +LA E L    +    +D+++  + ++  A G  PL     +  E
Sbjct: 177 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-XAAGAEPLPRNGDQWHE 235
Query: 536 EAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                  +R    QG++      RI Q    E  EL LK+ +   HPD  RRP+   +V
Sbjct: 236 -------IR----QGRL-----PRIPQVLSQEFTEL-LKVMI---HPDPERRPSAMALV 274

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 5   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 117
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 118 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 172
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 173 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 6   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 118
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 119 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 173
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 174 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 20/175 (11%)
Query: 378 QHKNLVQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           +H N++  R +C  K  +   +   +   +L  ++  K    LG  +   +L     GL 
Sbjct: 76  EHPNVI--RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGLA 132
Query: 437 YLHHGWDQVVVHRDIKSGNILLD-----SEMRGRLGDFGLAKLYQQGEVPNTTR--VVGT 489
           +LH      +VHRD+K  NIL+       +++  + DFGL K    G    + R  V GT
Sbjct: 133 HLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 490 LGYLAPELAT---VSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLM 540
            G++APE+ +     +PT   D++S G V   V   G  P   GK  + +  +L+
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANILL 242

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 127
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 128 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 182
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 183 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 127
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+   
Sbjct: 128 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
                  T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 62/149 (41%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYAKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+N            EFDT  N +++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGIFNNSKQDNSYQTLGVEFDTFSN-QWDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 127
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+   
Sbjct: 128 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
                  T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 13  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 125
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 126 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 7   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 119
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 120 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 174
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 175 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 15  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 127
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+   
Sbjct: 128 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
                  T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQ- 378
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 11  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 379 -HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 126 CH---NXGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 122
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 123 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 177
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 178 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 19  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 131
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 132 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-HT 186
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 187 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 132
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 133 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 187
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 188 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 132
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 133 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 187
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 188 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 61/149 (40%), Gaps = 20/149 (13%)
Query: 65  SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI-LPEIASSPGFGLCFVLTNFTSPPG 123
           S GR  Y   + +   T   +  + SF T F FSI  P     P  GL F +    S P 
Sbjct: 47  STGRTLYAKPVHIWDMT---TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP- 102
Query: 124 ALASQYFGLFSNXXXXXXXXXXXXEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY 183
           A    Y G+F+             EFDT  NP ++ P   HIG+D+N+I S K       
Sbjct: 103 AQGYGYLGIFNQSKQDNSYQTLGVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT------ 155
Query: 184 SSSRNESFVPVRMRNGQNIHAWIDFDGFS 212
                    P ++ NGQ  +  I +D  S
Sbjct: 156 --------QPFQLDNGQVANVVIKYDASS 176

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 122
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 123 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 177
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 178 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 126
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 127 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 181
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 182 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 122
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 123 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-HT 177
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 178 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
            I   +AE + +LH    + ++HRD+K  NI    +   ++GDFGL     Q E   T  
Sbjct: 168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 486 V-----------VGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
                       VGT  Y++PE    ++ +   D++S G+++ E+
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 19  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 131
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 132 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 186
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 187 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 304 YWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SK 361
           + P    YE L+   KGF   E L +    R YK T           + V+ +N +  S 
Sbjct: 20  FLPEGGCYELLTVIGKGF---EDLMTVNLAR-YKPT--------GEYVTVRRINLEACSN 67
Query: 362 QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW 421
           + +     E+       H N+V  R      NEL +V  +M  GS  + I       +  
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 422 KQRRQILADVAEGLNYLHH-GWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKLYQ 476
                IL  V + L+Y+HH G+    VHR +K+ +IL+  +    + G   +  +    Q
Sbjct: 128 LAIAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 477 QGEVPN--TTRVVGTLGYLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPL 526
           +  V +      V  L +L+PE+    +    + SD+YS G+   E+A G  P 
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 31  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 143
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 144 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 198
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 199 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 20  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 132
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 133 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 187
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 188 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 10  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 122
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 123 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 177
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 178 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 140
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 141 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 195
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 196 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 40/79 (50%)
Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSA 506
            HRD+K  NIL+ ++    L DFG+A      ++      VGTL Y APE  + S  T  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 507 SDVYSFGVVILEVACGRRP 525
           +D+Y+   V+ E   G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 126
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 127 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 181
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 182 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 15  LLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 380 --KNLVQMRGWCRKGNELMLVYDYM-PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
               ++++  W  + +  +L+ + M P   L ++I    +  L  +  R     V E + 
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI--TERGALQEELARSFFWQVLEAVR 128
Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           + H+     V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  
Sbjct: 129 HCHNCG---VLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 181
Query: 495 PELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           PE          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 27  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 139
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 140 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 194
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 195 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 18  FYRQELNKTIWEVPERYQNLAPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 130
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 131 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 185
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 186 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 304 YWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHD--SK 361
           + P    YE L+   KGF   E L +    R YK T           + V+ +N +  S 
Sbjct: 4   FLPEGGCYELLTVIGKGF---EDLMTVNLAR-YKPT--------GEYVTVRRINLEACSN 51
Query: 362 QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW 421
           + +     E+       H N+V  R      NEL +V  +M  GS  + I       +  
Sbjct: 52  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 111
Query: 422 KQRRQILADVAEGLNYLHH-GWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKLYQ 476
                IL  V + L+Y+HH G+    VHR +K+ +IL+  +    + G   +  +    Q
Sbjct: 112 LAIAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 167
Query: 477 QGEVPN--TTRVVGTLGYLAPEL--ATVSSPTSASDVYSFGVVILEVACGRRPL 526
           +  V +      V  L +L+PE+    +    + SD+YS G+   E+A G  P 
Sbjct: 168 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 4   FYRQELAKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K  
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCA 116
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 117 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 171
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 172 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 126
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 127 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 181
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 182 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 27  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 139
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 140 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 194
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 195 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 38/210 (18%)
Query: 415 PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
           P+ +LG     +I   + + L +LH      V+HRD+K  N+L+++  + ++ DFG++  
Sbjct: 107 PEDILG-----KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG- 158
Query: 475 YQQGEVPNTTRVVGTLGYLAPELATV----SSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           Y   +V       G   Y+APE           +  SD++S G+ ++E+A  R P D   
Sbjct: 159 YLVDDVAKDID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD--- 214
Query: 531 GEEEEEAVLMDWVRNLYGQGKICEAADARI-RQEFEAEEMELVLKLGLACCHPDSTRRPT 589
                      W        ++ E    ++   +F AE ++   +    C   +S  RPT
Sbjct: 215 ----------SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPT 260
Query: 590 MREVVAVLV-------GQEVAATPKELLGD 612
             E++           G +VA+  K +LGD
Sbjct: 261 YPELMQHPFFTLHESKGTDVASFVKLILGD 290

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 28  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 140
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 141 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 195
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 196 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 319 KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL--KEFMAEISSMGR 376
           K + +   +GSG +G V     +        ++A+K ++   +  +  K    E+  +  
Sbjct: 42  KTYVSPTHVGSGAYGSV----CSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 97
Query: 377 LQHKNLVQMRGWCRKGNELMLVYDY---MPNGSLNNWIFGKPKKLLGWK----QRRQILA 429
           +QH+N++ +       + L   YD+   MP      ++    +K++G +    + + ++ 
Sbjct: 98  MQHENVIGLLDVFTPASSLRNFYDFYLVMP------FMQTDLQKIMGMEFSEEKIQYLVY 151
Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            + +GL Y+H      VVHRD+K GN+ ++ +   ++ DFGLA+ +   E+   T  V T
Sbjct: 152 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM---TGYVVT 204
Query: 490 LGYLAPE-LATVSSPTSASDVYSFGVVILEVACGR 523
             Y APE + +        D++S G ++ E+  G+
Sbjct: 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 14  FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 126
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 127 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-HT 181
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 182 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-------------EMRGRLGDFGLAK 473
           +L  +A G+ +LH      ++HRD+K  NIL+ +              +R  + DFGL K
Sbjct: 138 LLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 474 LYQQGEV---PNTTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEV-ACGRRPL 526
               G+     N     GT G+ APEL   S+    T + D++S G V   + + G+ P 
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 527 DMGKGEEEEEAVL-----MDWVRNLYGQGKICEAAD 557
             G     E  ++     +D ++ L+ +  I EA D
Sbjct: 255 --GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 288

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-------------EMRGRLGDFGLAK 473
           +L  +A G+ +LH      ++HRD+K  NIL+ +              +R  + DFGL K
Sbjct: 138 LLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 474 LYQQGEV---PNTTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEV-ACGRRPL 526
               G+     N     GT G+ APEL   S+    T + D++S G V   + + G+ P 
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 527 DMGKGEEEEEAVL-----MDWVRNLYGQGKICEAAD 557
             G     E  ++     +D ++ L+ +  I EA D
Sbjct: 255 --GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 288

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 130 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 186
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 187 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQH 379
            ++   +G G FG V++            + AVK V       L+ F + E+ +   L  
Sbjct: 60  MTHQPRVGRGSFGEVHR----MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSS 109
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI--LADVAEGLNY 437
             +V + G  R+G  + +  + +  GSL   I    K++    + R +  L    EGL Y
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 165
Query: 438 LHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTT----RVVGTLGY 492
           LH    + ++H D+K+ N+LL S+  R  L DFG A   Q   +  +      + GT  +
Sbjct: 166 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+       +  D++S   ++L +  G  P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQ- 378
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 11  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 379 -HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 126 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 217

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 30/227 (13%)
Query: 312 EELSKATKGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEFMAEI 371
           E   K    F  + + G G FG V  G            +A+K V  D +   +E    +
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGK----EKSTGMSVAIKKVIQDPRFRNRELQI-M 70
Query: 372 SSMGRLQHKNLVQMRGWC-------RKGNELMLVYDYMPNG---SLNNWI---FGKPKKL 418
             +  L H N+VQ++ +        R+   L +V +Y+P+       N+       P  L
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQ 476
           +     +  L  +   +  LH     V  HRDIK  N+L++ E  G  +L DFG AK   
Sbjct: 131 I-----KVFLFQLIRSIGCLHLPSVNVC-HRDIKPHNVLVN-EADGTLKLCDFGSAKKLS 183
Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACG 522
             E PN   +     Y APEL   +   T+A D++S G +  E+  G
Sbjct: 184 PSE-PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQ- 378
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 11  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 379 -HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 126 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 178
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 217

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 129 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 186 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 236

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 15  LLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H+     V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 130 CHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 182
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 221

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 8/140 (5%)
Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG 454
           L++V + +  G L + I  +  +    ++  +I   + E + YLH      + HRD+K  
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPE 190
Query: 455 NILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYS 511
           N+L  S+      +L DFG AK  +     + T    T  Y+APE+        + D +S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 512 FGVVILEVACGRRPLDMGKG 531
            GV+   + CG  P     G
Sbjct: 249 LGVIXYILLCGYPPFYSNHG 268

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 16  LLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H+     V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 131 CHNC---GVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 222

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 7/125 (5%)
Query: 407 LNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-R 465
           +NN  F + ++ L     R  + ++ + L+Y H      ++HRD+K  N+++D E R  R
Sbjct: 116 VNNTDFKQLRQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLR 172
Query: 466 LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSAS-DVYSFGVVILEVACGRR 524
           L D+GLA+ Y  G+  N    V +  +  PEL         S D++S G ++  +   + 
Sbjct: 173 LIDWGLAEFYHPGQEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 525 PLDMG 529
           P   G
Sbjct: 231 PFFHG 235

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 128 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 185 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 129 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 186 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 236

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 321 FSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF-MAEISSMGRLQH 379
            ++   +G G FG V++            + AVK V       L+ F + E+ +   L  
Sbjct: 76  MTHQPRVGRGSFGEVHR----MKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSS 125
Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI--LADVAEGLNY 437
             +V + G  R+G  + +  + +  GSL   I    K++    + R +  L    EGL Y
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 181
Query: 438 LHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTT----RVVGTLGY 492
           LH    + ++H D+K+ N+LL S+  R  L DFG A   Q   +  +      + GT  +
Sbjct: 182 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+       +  D++S   ++L +  G  P
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 14  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 129 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 181
Query: 496 ELATVSSPTSAS-DVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E          S  V+S G+++ ++ CG  P      E +EE +
Sbjct: 182 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 220

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 30  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 145 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 197
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 30  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 145 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 197
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 16  LLGSGGFGSVYSGIRV----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 131 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 16  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 131 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 183
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 222

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 44  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 159 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 250

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 43  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 158 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 249

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 44  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 159 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 250

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 116
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+ + 
Sbjct: 117 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-HT 171
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+      V T  Y APE+           D++S G ++ E+  GR
Sbjct: 172 DDEMAG---FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 31  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 146 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 237

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 31  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 146 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 237

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH- 440
           + Q+    +  N L LV +Y   G L   +  K  + +  +  R  LA++   ++ +H  
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLT-LLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFG-LAKLYQQGEVPNTTRVVGTLGYLAPEL-- 497
           G+    VHRDIK  NILLD     RL DFG   KL   G V  +   VGT  YL+PE+  
Sbjct: 182 GY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQ 236
Query: 498 -----ATVSSPTSASDVYSFGVVILEVACGRRPL 526
                    S     D ++ GV   E+  G+ P 
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 44  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 159 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 250

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 43  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 158 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 249

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 31  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 146 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 198
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 237

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 309 FSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGL 364
           F  +EL+K      + + N   +GSG +G V     A         +AVK ++   +  +
Sbjct: 8   FYRQELNKTIWEVPERYQNLSPVGSGAYGSV----CAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 365 --KEFMAEISSMGRLQHKNLVQMRGW------CRKGNELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +           + N++ LV   M    LNN +  K +
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQ 120
Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
           KL      + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ D+GLA+ + 
Sbjct: 121 KLTD-DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR-HT 175
Query: 477 QGEVPNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGR 523
             E+   T  V T  Y APE+           D++S G ++ E+  GR
Sbjct: 176 DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNT 483
           R  + ++ + L+Y H    Q ++HRD+K  N+++D E+R  RL D+GLA+ Y  G+  N 
Sbjct: 149 RYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 205
Query: 484 TRVVGTLGYLAPE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              V +  +  PE L  +     + D++S G +   +   + P   G    ++
Sbjct: 206 R--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 256

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 43  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 158 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 210
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 249

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 28/224 (12%)
Query: 326 LLGSGGFGRVYKGTLAXXXXXXSTEMAVKCVNHDSKQGLKEF------MAEISSMGRLQH 379
           LLGSGGFG VY G         +  +A+K V  D      E         E+  + ++  
Sbjct: 44  LLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 380 --KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               ++++  W  + +  +L+ +  P    + + F   +  L  +  R     V E + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            H   +  V+HRDIK  NIL+D   RG  +L DFG   L +       T   GT  Y  P
Sbjct: 159 CH---NCGVLHRDIKDENILIDLN-RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPP 211
Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
           E +        ++ V+S G+++ ++ CG  P      E +EE +
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEII 250
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	636
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-127
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-113
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-75
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-49
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-44
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-39
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-37
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	7e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-36
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	3e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-36
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	4e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-36
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	7e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-35
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	2e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-35
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	4e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-34
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	2e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-33
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	1e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-33
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	2e-33
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-33
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	4e-33
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	6e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-32
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	2e-32
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-32
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	4e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	4e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-31
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	7e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-30
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	2e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-05
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-29
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	1e-28
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	1e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-28
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-28
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-22
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-22
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	3e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-14
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	9e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	1e-12
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	7e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  378 bits (972), Expect = e-127
 Identities = 113/302 (37%), Positives = 177/302 (58%), Gaps = 8/302 (2%)

Query: 305 WPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL 364
              RFS  EL  A+  FSN  +LG GGFG+VYKG LA+      T +AVK +  +  QG 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-----TLVAVKRLKEERTQGG 70

Query: 365 K-EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP--KKLLGW 421
           + +F  E+  +    H+NL+++RG+C    E +LVY YM NGS+ + +  +P  +  L W
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP 481
            +R++I    A GL YLH   D  ++HRD+K+ NILLD E    +GDFGLAKL    +  
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 482 NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
            TT V GT+G++APE  +    +  +DV+ +GV++LE+  G+R  D+ +   +++ +L+D
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQE 601
           WV+ L  + K+    D  ++  ++ EE+E ++++ L C       RP M EVV +L G  
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

Query: 602 VA 603
           +A
Sbjct: 311 LA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  358 bits (921), Expect = e-120
 Identities = 100/303 (33%), Positives = 159/303 (52%), Gaps = 13/303 (4%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN 357
             + + +  +R    +L +AT  F +  L+G G FG+VYKG L +       ++A+K   
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-----AKVALKRRT 72

Query: 358 HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--P 415
            +S QG++EF  EI ++   +H +LV + G+C + NE++L+Y YM NG+L   ++G   P
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132

Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
              + W+QR +I    A GL+YLH      ++HRD+KS NILLD     ++ DFG++K  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 476 QQGEVPN-TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
            + +  + +T V GTLGY+ PE       T  SDVYSFGVV+ EV C R  +      E 
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249

Query: 535 EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
               L +W    +  G++ +  D  +  +   E +       + C    S  RP+M +V+
Sbjct: 250 VN--LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

Query: 595 AVL 597
             L
Sbjct: 308 WKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  340 bits (875), Expect = e-113
 Identities = 102/311 (32%), Positives = 159/311 (51%), Gaps = 28/311 (9%)

Query: 306 PHRFSYEELSKATKGFSNDE------LLGSGGFGRVYKGTLANNNNNNSTEMAVK----C 355
            H FS+ EL   T  F           +G GGFG VYKG +      N+T +AVK     
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV------NNTTVAVKKLAAM 65

Query: 356 VNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           V+  +++  ++F  EI  M + QH+NLV++ G+   G++L LVY YMPNGSL + +    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 416 KKL-LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL 474
               L W  R +I    A G+N+LH   +   +HRDIKS NILLD     ++ DFGLA+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 475 YQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE 533
            ++      T+R+VGT  Y+APE       T  SD+YSFGVV+LE+  G   +D  +  +
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

Query: 534 EEEAVLMDWVRNLYG-QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
               +L+D    +   +  I +  D ++    ++  +E +  +   C H    +RP +++
Sbjct: 242 ----LLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 593 VVAVLVGQEVA 603
           V  +L     +
Sbjct: 297 VQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  242 bits (620), Expect = 3e-75
 Identities = 73/312 (23%), Positives = 128/312 (41%), Gaps = 35/312 (11%)

Query: 309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFM 368
              E L   +      E+   G FG V+K  L       +  +AVK      KQ   +  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL------LNEYVAVKIFPIQDKQS-WQNE 66

Query: 369 AEISSMGRLQHKNLVQMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR 424
            E+ S+  ++H+N++Q  G  ++G     +L L+  +   GSL++++       + W + 
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNEL 123

Query: 425 RQILADVAEGLNYLHH-------GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
             I   +A GL YLH        G    + HRDIKS N+LL + +   + DFGLA  ++ 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 478 GEVP-NTTRVVGTLGYLAPELA-----TVSSPTSASDVYSFGVVILEVACGRRPLDMGKG 531
           G+   +T   VGT  Y+APE+               D+Y+ G+V+ E+A      D    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG--P 241

Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADAR-----IRQEFEAEE-MELVLKLGLACCHPDST 585
            +E      + +        + E    +     +R  ++    M ++ +    C   D+ 
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 586 RRPTMREVVAVL 597
            R +   V   +
Sbjct: 302 ARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (527), Expect = 2e-61
 Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 42/321 (13%)

Query: 309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFM 368
            +  E S         EL+G G +G VYKG+L      +   +AVK  +  ++Q      
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL------DERPVAVKVFSFANRQNFINE- 55

Query: 369 AEISSMGRLQHKNLVQMRGWCRKGN-----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQ 423
             I  +  ++H N+ +      +       E +LV +Y PNGSL  ++         W  
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVS 112

Query: 424 RRQILADVAEGLNYLH------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
             ++   V  GL YLH        +   + HRD+ S N+L+ ++    + DFGL+     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 478 GEVP-------NTTRVVGTLGYLAPE-------LATVSSPTSASDVYSFGVVILEVACGR 523
             +             VGT+ Y+APE       L    S     D+Y+ G++  E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 524 RPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR-----IRQEFEAEEMEL--VLKLG 576
             L  G+   E +      V N      +              + ++   + +  + +  
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 577 LACCHPDSTRRPTMREVVAVL 597
             C   D+  R T +     +
Sbjct: 293 EDCWDQDAEARLTAQXAEERM 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (522), Expect = 4e-61
 Identities = 77/316 (24%), Positives = 144/316 (45%), Gaps = 42/316 (13%)

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN 344
               L  Q   + ++ ++ +        +L+         E +G+G FG V++       
Sbjct: 17  TTENLYFQGAMDGDDMDIPW-------CDLNI-------KEKIGAGSFGTVHRAEW---- 58

Query: 345 NNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM 402
             + +++AVK +       + + EF+ E++ M RL+H N+V   G   +   L +V +Y+
Sbjct: 59  --HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116

Query: 403 PNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE 461
             GSL   +     ++ L  ++R  +  DVA+G+NYLH+  +  +VHR++KS N+L+D +
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175

Query: 462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC 521
              ++ DFGL++L     + ++    GT  ++APE+         SDVYSFGV++ E+A 
Sbjct: 176 YTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 522 GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCH 581
            ++P                W  NL     +        R E        V  +   C  
Sbjct: 235 LQQP----------------W-GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277

Query: 582 PDSTRRPTMREVVAVL 597
            +  +RP+   ++ +L
Sbjct: 278 NEPWKRPSFATIMDLL 293

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  198 bits (505), Expect = 1e-58
 Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
           +E++G G FG V K          + ++A+K +  +S+   K F+ E+  + R+ H N+V
Sbjct: 13  EEVVGRGAFGVVCKAKW------RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           ++ G C     + LV +Y   GSL N + G +P                ++G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 443 DQVVVHRDIKSGNILLDSEMR-GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
            + ++HRD+K  N+LL +     ++ DFG A   Q     + T   G+  ++APE+   S
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGS 178

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
           + +   DV+S+G+++ EV   R+P                +        +I  A     R
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKP----------------FDEIGGPAFRIMWAVHNGTR 222

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                   + +  L   C   D ++RP+M E+V ++
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 3e-58
 Identities = 72/328 (21%), Positives = 134/328 (40%), Gaps = 66/328 (20%)

Query: 287 NKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNN 346
           ++        + + E+EY                   ++ +G GGFG V+KG L  +   
Sbjct: 6   SEFPKSRLPTLADNEIEY-------------------EKQIGKGGFGLVHKGRLVKDK-- 44

Query: 347 NSTEMAVKCVNHDSKQG-------LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY 399
             + +A+K +     +G        +EF  E+  M  L H N+V++ G         +V 
Sbjct: 45  --SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVM 100

Query: 400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD 459
           +++P G L + +  K   +  W  + +++ D+A G+ Y+ +  +  +VHRD++S NI L 
Sbjct: 101 EFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQ 158

Query: 460 SEMRGR-----LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP--TSASDVYSF 512
           S          + DFGL++      V + + ++G   ++APE         T  +D YSF
Sbjct: 159 SLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214

Query: 513 GVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---ICEAADARIRQEFEAEEM 569
            +++  +  G  P D        +   ++ +R    +G    I E    R+R        
Sbjct: 215 AMILYTILTGEGPFD---EYSYGKIKFINMIRE---EGLRPTIPEDCPPRLR-------- 260

Query: 570 ELVLKLGLACCHPDSTRRPTMREVVAVL 597
                +   C   D  +RP    +V  L
Sbjct: 261 ----NVIELCWSGDPKKRPHFSYIVKEL 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  195 bits (497), Expect = 2e-57
 Identities = 68/315 (21%), Positives = 112/315 (35%), Gaps = 53/315 (16%)

Query: 297 IEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV 356
           +           F   +L          E+LG G FG+  K T           M +K +
Sbjct: 2   MPHRI-------FRPSDLIH-------GEVLGKGCFGQAIKVTH----RETGEVMVMKEL 43

Query: 357 NHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
               ++  + F+ E+  M  L+H N+++  G   K   L  + +Y+  G+L   I     
Sbjct: 44  IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMD 102

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
               W QR     D+A G+ YLH      ++HRD+ S N L+       + DFGLA+L  
Sbjct: 103 SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159

Query: 477 QGEV-------------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR 523
             +                   VVG   ++APE+    S     DV+SFG+V+ E+    
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

Query: 524 RPL-DMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHP 582
               D            ++    L               +            + + CC  
Sbjct: 220 NADPDYLP---RTMDFGLNVRGFL--------------DRYCPPNCPPSFFPITVRCCDL 262

Query: 583 DSTRRPTMREVVAVL 597
           D  +RP+  ++   L
Sbjct: 263 DPEKRPSFVKLEHWL 277

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (489), Expect = 9e-57
 Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN----HDSKQGLKEFMAEISSMGRLQHK 380
           E++G GGFG+VY+            E+AVK        D  Q ++    E      L+H 
Sbjct: 13  EIIGIGGFGKVYRAFW------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N++ +RG C K   L LV ++   G LN  + GK    +           +A G+NYLH 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHD 123

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGR--------LGDFGLAKLYQQGEVPNTTRVVGTLGY 492
                ++HRD+KS NIL+  ++           + DFGLA+ + +          G   +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAW 180

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI 552
           +APE+   S  +  SDV+S+GV++ E+  G  P              +D +   YG    
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-----------IDGLAVAYG---- 225

Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
              A  ++     +   E   KL   C +PD   RP+   ++  L
Sbjct: 226 --VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (481), Expect = 2e-55
 Identities = 70/313 (22%), Positives = 135/313 (43%), Gaps = 47/313 (15%)

Query: 292 QEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEM 351
              D  ++WE+          +++   +       +GSG FG VYKG           ++
Sbjct: 11  GSRDAADDWEIPD-------GQITVGQR-------IGSGSFGTVYKGKWHG-------DV 49

Query: 352 AVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNN 409
           AVK +N    + Q L+ F  E+  + + +H N++   G+      L +V  +    SL +
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYH 108

Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            +    +     K+   I    A G++YLH    + ++HRD+KS NI L  +   ++GDF
Sbjct: 109 HLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164

Query: 470 GLAKLYQQGEVPNT-TRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRP 525
           GLA    +    +   ++ G++ ++APE+  +      +  SDVY+FG+V+ E+  G+ P
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

Query: 526 -LDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDS 584
             ++   ++  E V    +              +++R         L+ +    C     
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDL----------SKVRSNCPKRMKRLMAE----CLKKKR 270

Query: 585 TRRPTMREVVAVL 597
             RP+   ++A +
Sbjct: 271 DERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (479), Expect = 3e-55
 Identities = 53/281 (18%), Positives = 105/281 (37%), Gaps = 39/281 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
             L     G ++KG           ++ VK +     S +  ++F  E   +    H N+
Sbjct: 16  TKLNENHSGELWKGRW------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 383 VQMRGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           + + G C+        L+  +MP GSL N +      ++   Q  +   D+A G+ +LH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL--- 497
             + ++    + S ++++D +M  R+    +   +Q          +    ++APE    
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQK 182

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRP-LDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
               +   ++D++SF V++ E+     P  D+   E     + M                
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALE----------- 226

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
              +R          V KL   C + D  +RP    +V +L
Sbjct: 227 --GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  188 bits (479), Expect = 1e-54
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)

Query: 290 KAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNST 349
            +Q    ++EW++ +       E+L          EL+G G FG+VY G           
Sbjct: 18  ASQTSIFLQEWDIPF-------EQLEI-------GELIGKGRFGQVYHGRWHG------- 56

Query: 350 EMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSL 407
           E+A++ ++   D++  LK F  E+ +  + +H+N+V   G C     L ++       +L
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116

Query: 408 NNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG 467
            + +    K +L   + RQI  ++ +G+ YLH    + ++H+D+KS N+  D   +  + 
Sbjct: 117 YSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVIT 171

Query: 468 DFGLAKL----YQQGEVPNTTRVVGTLGYLAPELATVSSP---------TSASDVYSFGV 514
           DFGL  +                 G L +LAPE+    SP         +  SDV++ G 
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

Query: 515 VILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEM-ELVL 573
           +  E+     P    K +  E  +    +    G G          +       M + + 
Sbjct: 232 IWYELHAREWPF---KTQPAEAIIWQ--M----GTGM---------KPNLSQIGMGKEIS 273

Query: 574 KLGLACCHPDSTRRPTMREVVAVL 597
            + L C   +   RPT  +++ +L
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDML 297

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (448), Expect = 1e-50
 Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 39/298 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G +G V++G+           +AVK  +  D K   +E   E+ +   L+H+N++
Sbjct: 14  ECVGKGRYGEVWRGSW------QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENIL 65

Query: 384 QMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
                         +L L+  Y   GSL +++       L      +I+  +A GL +LH
Sbjct: 66  GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLH 122

Query: 440 -----HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLG 491
                      + HRD+KS NIL+    +  + D GLA ++ Q            VGT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 492 YLAPEL------ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
           Y+APE+                D+++FG+V+ EVA            E+ +    D V N
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS---NGIVEDYKPPFYDVVPN 239

Query: 546 LYGQGKICEAA---DAR--IRQEFEAEE-MELVLKLGLACCHPDSTRRPTMREVVAVL 597
                 + +       R  I   + ++  +  + KL   C + + + R T   +   L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  175 bits (446), Expect = 7e-50
 Identities = 72/299 (24%), Positives = 114/299 (38%), Gaps = 39/299 (13%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNL 382
            + +G G +G V+ G           ++AVK     +     +E   EI     ++H+N+
Sbjct: 42  VKQIGKGRYGEVWMGKW------RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENI 93

Query: 383 VQMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           +       KG     +L L+ DY  NGSL +++       L  K   ++      GL +L
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHL 150

Query: 439 H-----HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN---TTRVVGTL 490
           H           + HRD+KS NIL+       + D GLA  +              VGT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 491 GYLAPELATVSSPTS------ASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            Y+ PE+   S   +       +D+YSFG+++ EVA        G   EE +    D V 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS---GGIVEEYQLPYHDLVP 267

Query: 545 NLYGQGKICEA-ADARIRQEF-----EAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           +      + E     ++R  F       E +  + KL   C   +   R T   V   L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 9e-49
 Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 41/300 (13%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNL 382
            E +G G FG V++G           E+AVK  +  + +   +E  AEI     L+H+N+
Sbjct: 47  QESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENI 98

Query: 383 VQMRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           +       K N    +L LV DY  +GSL +++       +  +   ++    A GL +L
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHL 155

Query: 439 HHGWDQ-----VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG----EVPNTTRVVGT 489
           H           + HRD+KS NIL+       + D GLA  +       ++    R VGT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGT 214

Query: 490 LGYLAPELATVSSPTS------ASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
             Y+APE+   S           +D+Y+ G+V  E+A        G   E+ +    D V
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI---GGIHEDYQLPYYDLV 271

Query: 544 RNLYGQGKICEA-ADARIRQEFEA-----EEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            +     ++ +   + ++R          E + ++ K+   C + +   R T   +   L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  157 bits (400), Expect = 9e-44
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 26/222 (11%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEIS 372
           E  +         +LG G +G VY G     + +N   +A+K +     +  +    EI+
Sbjct: 20  EYDENGDR----VVLGKGTYGIVYAGR----DLSNQVRIAIKEIPERDSRYSQPLHEEIA 71

Query: 373 SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR-----RQI 427
               L+HKN+VQ  G   +   + +  + +P GSL+  +  K   L   +Q      +QI
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTR 485
           L    EGL YLH   D  +VHRDIK  N+L+++   G   + DFG +K    G  P T  
Sbjct: 132 L----EGLKYLH---DNQIVHRDIKGDNVLINTYS-GVLKISDFGTSK-RLAGINPCTET 182

Query: 486 VVGTLGYLAPELATVSSP--TSASDVYSFGVVILEVACGRRP 525
             GTL Y+APE+          A+D++S G  I+E+A G+ P
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  157 bits (399), Expect = 2e-43
 Identities = 63/275 (22%), Positives = 121/275 (44%), Gaps = 30/275 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHKN 381
           + +G G F  VY+         +   +A+K V        +   + + EI  + +L H N
Sbjct: 38  KKIGRGQFSEVYRAA----CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           +++      + NEL +V +    G L+  I  F K K+L+  +   +    +   L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELA 498
               + V+HRDIK  N+ + +    +LGD GL +    +    ++  +VGT  Y++PE  
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
             +     SD++S G ++ E+A  + P     G++     L           KI +    
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSLCK---------KIEQCDYP 256

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
            +  +  +EE+  ++ +   C +PD  +RP +  V
Sbjct: 257 PLPSDHYSEELRQLVNM---CINPDPEKRPDVTYV 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  155 bits (394), Expect = 4e-43
 Identities = 73/313 (23%), Positives = 132/313 (42%), Gaps = 43/313 (13%)

Query: 288 KLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNN 347
           + + Q++D+IEE E +          +S   +    D  +G G F  VYKG     +   
Sbjct: 2   EERNQQQDDIEELETKA-------VGMSNDGRFLKFDIEIGRGSFKTVYKGL----DTET 50

Query: 348 STEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQMRG----WCRKGNELMLVYDY 401
           + E+A   +     +K   + F  E   +  LQH N+V+         +    ++LV + 
Sbjct: 51  TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110

Query: 402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE 461
           M +G+L  ++  K  K++  K  R     + +GL +LH      ++HRD+K  NI +   
Sbjct: 111 MTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITG- 166

Query: 462 MRGR--LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
             G   +GD GLA L +         V+GT  ++APE+        + DVY+FG+ +LE+
Sbjct: 167 PTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEM 222

Query: 520 ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLAC 579
           A    P      E +  A +   V +        + A   ++        E++      C
Sbjct: 223 ATSEYPY----SECQNAAQIYRRVTSGVKPASFDKVAIPEVK--------EIIEG----C 266

Query: 580 CHPDSTRRPTMRE 592
              +   R ++++
Sbjct: 267 IRQNKDERYSIKD 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  155 bits (393), Expect = 3e-42
 Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 28/271 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           + +G G FG+         +  +  +  +K +N    S +  +E   E++ +  ++H N+
Sbjct: 30  QKIGEGSFGKAILVK----STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           VQ R    +   L +V DY   G L   I  +   L    Q       +   L ++H   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--- 142

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           D+ ++HRDIKS NI L  +   +LGDFG+A++            +GT  YL+PE+     
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ 562
             + SD+++ G V+ E+   +   +       +  VL           KI   +   +  
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVL-----------KIISGSFPPVSL 247

Query: 563 EFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
            +  +   LV +        +   RP++  +
Sbjct: 248 HYSYDLRSLVSQ----LFKRNPRDRPSVNSI 274

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (387), Expect = 4e-41
 Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 37/289 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
           E +G G FG V+ G L      ++T +AVK            +F+ E   + +  H N+V
Sbjct: 120 EQIGRGNFGEVFSGRL----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G C +   + +V + +  G    ++  +  + L  K   Q++ D A G+ YL     
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---S 231

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY----LAPELAT 499
           +  +HRD+ + N L+  +   ++ DFG+++    G         G         APE   
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALN 288

Query: 500 VSSPTSASDVYSFGVVILEVA-CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
               +S SDV+SFG+++ E    G  P      ++       ++V               
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVEKGG----------- 332

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPK 607
             R        + V +L   C   +  +RP+   +   L  Q +    +
Sbjct: 333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL--QSIRKRHR 377

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  148 bits (377), Expect = 1e-40
 Identities = 69/233 (29%), Positives = 116/233 (49%), Gaps = 27/233 (11%)

Query: 291 AQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTE 350
             +  + EE  L++                    + LG G FG V         +N    
Sbjct: 1   GSDPTQFEERHLKF-------------------LQQLGKGNFGSVEMCRYDPLQDNTGEV 41

Query: 351 MAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE--LMLVYDYMPNGSLN 408
           +AVK + H +++ L++F  EI  +  LQH N+V+ +G C       L L+ +Y+P GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101

Query: 409 NWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD 468
           +++  K K+ +   +  Q  + + +G+ YL     +  +HRD+ + NIL+++E R ++GD
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGD 157

Query: 469 FGLAKLYQQGEVPNTTRVVGTL--GYLAPELATVSSPTSASDVYSFGVVILEV 519
           FGL K+  Q +     +  G     + APE  T S  + ASDV+SFGVV+ E+
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (379), Expect = 2e-40
 Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
            ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
            ++ G C   + + L+   MP G L +++  + K  +G +        +A+G+NYL    
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELAT 499
           D+ +VHRD+ + N+L+ +    ++ DFGLAKL    E        G    + ++A E   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192

Query: 500 VSSPTSASDVYSFGVVILEVA-CGRRP 525
               T  SDV+S+GV + E+   G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (375), Expect = 2e-40
 Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 54/296 (18%)

Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSM 374
            +    F   EL+GSGGFG+V+K      +  +     +K V +++++  +E    + ++
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAK----HRIDGKTYVIKRVKYNNEKAERE----VKAL 58

Query: 375 GRLQHKNLVQMRG----------------WCRKGNELMLVYDYMPNGSLNNWIFGKPKKL 418
            +L H N+V   G                   K   L +  ++   G+L  WI  +  + 
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
           L      ++   + +G++Y+H    + +++RD+K  NI L    + ++GDFGL    +  
Sbjct: 119 LDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA 537
                +   GTL Y++PE  +        D+Y+ G+++ E+        +          
Sbjct: 176 GKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------- 224

Query: 538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                    +    +    D  I   F+ +E  L+ K            RP   E+
Sbjct: 225 ------SKFF--TDLR---DGIISDIFDKKEKTLLQK----LLSKKPEDRPNTSEI 265

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (376), Expect = 2e-40
 Identities = 69/285 (24%), Positives = 129/285 (45%), Gaps = 26/285 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
             LG G FG+V         +N   ++AVK +  +     + +   EI  +  L H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 384 QMRGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + +G C +  GN + L+ +++P+GSL  ++  K K  +  KQ+ +    + +G++YL   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG-- 143

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELAT 499
             +  VHRD+ + N+L++SE + ++GDFGL K  +  +   T +        + APE   
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
            S    ASDV+SFGV + E+      L     +    A+ +  +   +GQ  +       
Sbjct: 203 QSKFYIASDVWSFGVTLHEL------LTYCDSDSSPMALFLKMIGPTHGQMTVTRL---- 252

Query: 560 IRQEFEAEEMEL-------VLKLGLACCHPDSTRRPTMREVVAVL 597
           +    E + +         V +L   C     + R + + ++   
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  148 bits (376), Expect = 4e-40
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 22/225 (9%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK 365
           P  + Y E             +G G FG V++      +     + AVK V  +  +   
Sbjct: 48  PVDYEYREEVHWMTHQ---PRVGRGSFGEVHRMK----DKQTGFQCAVKKVRLEVFR--- 97

Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR 425
             + E+ +   L    +V + G  R+G  + +  + +  GSL   I  K    L   +  
Sbjct: 98  --VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRAL 153

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTT 484
             L    EGL YLH    + ++H D+K+ N+LL S+  R  L DFG A   Q   +  + 
Sbjct: 154 YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 485 R----VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
                + GT  ++APE+       +  D++S   ++L +  G  P
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (374), Expect = 6e-40
 Identities = 74/293 (25%), Positives = 106/293 (36%), Gaps = 35/293 (11%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQG 363
           P        S   + F     LG G +G V+K      +  +    AVK         + 
Sbjct: 44  PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR----SKEDGRLYAVKRSMSPFRGPKD 99

Query: 364 LKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWK 422
               +AE+ S  ++ QH   V++     +G  L L  +     SL           L   
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEA 157

Query: 423 QRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN 482
           Q    L D    L +LH    Q +VH D+K  NI L    R +LGDFGL           
Sbjct: 158 QVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214

Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW 542
                G   Y+APEL    S  +A+DV+S G+ ILEVAC       G+G           
Sbjct: 215 V--QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG----------- 260

Query: 543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
            + L  QG +             +E   +++        PD   R T   ++A
Sbjct: 261 WQQLR-QGYL----PPEFTAGLSSELRSVLVM----MLEPDPKLRATAEALLA 304

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  147 bits (374), Expect = 7e-40
 Identities = 74/323 (22%), Positives = 118/323 (36%), Gaps = 52/323 (16%)

Query: 290 KAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNST 349
             Q+    EE  L+Y                      LG G FG V         +N   
Sbjct: 13  ACQDPTIFEERHLKY-------------------ISQLGKGNFGSVELCRYDPLGDNTGA 53

Query: 350 EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE--LMLVYDYMPNGSL 407
            +AVK + H      ++F  EI  +  L    +V+ RG         L LV +Y+P+G L
Sbjct: 54  LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113

Query: 408 NNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG 467
            +++  + +  L   +     + + +G+ YL     +  VHRD+ + NIL++SE   ++ 
Sbjct: 114 RDFL-QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIA 169

Query: 468 DFGLAKLYQQGEVPNTTRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-C 521
           DFGLAKL    +      VV   G       APE  + +  +  SDV+SFGVV+ E+   
Sbjct: 170 DFGLAKLLPLDK---DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226

Query: 522 GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMEL-------VLK 574
             +                D                  +    E + +         V +
Sbjct: 227 CDKSCSPSAEFLRMMGCERDVPAL-------SRL----LELLEEGQRLPAPPACPAEVHE 275

Query: 575 LGLACCHPDSTRRPTMREVVAVL 597
           L   C  P    RP+   +   L
Sbjct: 276 LMKLCWAPSPQDRPSFSALGPQL 298

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  147 bits (373), Expect = 1e-39
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 27/253 (10%)

Query: 271 FLIICASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSG 330
           + I      Y+     +  + ++  + EE  L++                    + LG G
Sbjct: 12  YDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKF-------------------LQQLGKG 52

Query: 331 GFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR 390
            FG V         +N    +AVK + H +++ L++F  EI  +  LQH N+V+ +G C 
Sbjct: 53  NFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112

Query: 391 KGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVH 448
                 L L+ +Y+P GSL +++  K K+ +   +  Q  + + +G+ YL     +  +H
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 168

Query: 449 RDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELATVSSPTSA 506
           RD+ + NIL+++E R ++GDFGL K+  Q +     +  G     + APE  T S  + A
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 228

Query: 507 SDVYSFGVVILEV 519
           SDV+SFGVV+ E+
Sbjct: 229 SDVWSFGVVLYEL 241

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (372), Expect = 1e-39
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 28/285 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
             LG G FG+V        N+     +AVK +  D   Q    +  EI  +  L H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 384 QMRGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + +G C       L LV +Y+P GSL +++   P+  +G  Q       + EG+ YLH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH-- 151

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELAT 499
             Q  +HRD+ + N+LLD++   ++GDFGLAK   +G      R  G     + APE   
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
                 ASDV+SFGV + E+      L      +      ++ +    GQ  +       
Sbjct: 211 EYKFYYASDVWSFGVTLYEL------LTHCDSSQSPPTKFLELIGIAQGQMTVLRL---- 260

Query: 560 IRQEFEAEEMEL-------VLKLGLACCHPDSTRRPTMREVVAVL 597
                  E +         V  L   C   +++ RPT   ++ +L
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  144 bits (365), Expect = 6e-39
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 19/227 (8%)

Query: 310 SYEELSKATKGFSNDEL------LGSGGFGRVYKGTLANNNNNNSTEMAVKC--VNHDSK 361
           + EE+           L      LGSG FG V KG            +AVK      +  
Sbjct: 2   ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDP 59

Query: 362 QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW 421
               E +AE + M +L +  +V+M G C +    MLV +    G LN   + +  + +  
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNK--YLQQNRHVKD 116

Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP 481
           K   +++  V+ G+ YL    +   VHRD+ + N+LL ++   ++ DFGL+K  +  E  
Sbjct: 117 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

Query: 482 NTTRVVGTL--GYLAPELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
              +  G     + APE       +S SDV+SFGV++ E    G++P
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  144 bits (365), Expect = 7e-39
 Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 59/303 (19%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F    +LG G FG+V K      N  +S   A+K + H  ++ L   ++E+  +  L H+
Sbjct: 8   FEEIAVLGQGAFGQVVKAR----NALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQ 62

Query: 381 NLVQMRG-WCRKGNE------------LMLVYDYMPNGSLNNWIFGKPKKL---LGWKQR 424
            +V+    W  + N             L +  +Y  NG+L + I  +         W+  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ------- 477
           RQIL    E L+Y+H    Q ++HRD+K  NI +D     ++GDFGLAK   +       
Sbjct: 123 RQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 478 ------GEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
                 G   N T  +GT  Y+A E+   +       D+YS G++  E+           
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST----- 230

Query: 531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM 590
               E   ++  +R+      I               E +++          D  +RP  
Sbjct: 231 --GMERVNILKKLRS----VSIEF--PPDFDDNKMKVEKKIIRL----LIDHDPNKRPGA 278

Query: 591 REV 593
           R +
Sbjct: 279 RTL 281

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  145 bits (368), Expect = 7e-39
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           + +GSGG  +V++       N      A+K VN +    Q L  +  EI+ + +LQ  + 
Sbjct: 15  KQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 383 --VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
             +++  +      + +V +   N  LN+W+  K KK +   +R+    ++ E ++ +H 
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH- 125

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTR-VVGTLGYLAPEL 497
                +VH D+K  N L+     G   L DFG+A   Q           VGT+ Y+ PE 
Sbjct: 126 --QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 498 -----------ATVSSPTSASDVYSFGVVILEVACGRRP 525
                       + S  +  SDV+S G ++  +  G+ P
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (363), Expect = 7e-39
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 31/277 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
             +G+G +GR  K        ++   +  K +++   ++   +  ++E++ +  L+H N+
Sbjct: 12  YTIGTGSYGRCQKIR----RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 383 VQMRGW--CRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYL 438
           V+       R    L +V +Y   G L + I    K ++ L  +   +++  +   L   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 439 H--HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           H        V+HRD+K  N+ LD +   +LGDFGLA++         T  VGT  Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPE 186

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
                S    SD++S G ++ E+     P        ++E              KI E  
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAG-----------KIREGK 232

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
             RI   +  E  E++ +      +     RP++ E+
Sbjct: 233 FRRIPYRYSDELNEIITR----MLNLKDYHRPSVEEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  144 bits (365), Expect = 1e-38
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           + +GSGG  +V++       N      A+K VN +    Q L  +  EI+ + +LQ  + 
Sbjct: 34  KQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 383 --VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
             +++  +      + +V +   N  LN+W+  K KK +   +R+    ++ E ++ +H 
Sbjct: 89  KIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH- 144

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTR-VVGTLGYLAPEL 497
                +VH D+K  N L+     G   L DFG+A   Q           VGT+ Y+ PE 
Sbjct: 145 --QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 498 -----------ATVSSPTSASDVYSFGVVILEVACGRRP 525
                       + S  +  SDV+S G ++  +  G+ P
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (363), Expect = 1e-38
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 12/208 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHK 380
            E LG G FG V +G   +  +  +  +AVKC+  D     + + +F+ E+++M  L H+
Sbjct: 23  LEKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           NL+++ G       + +V +  P GSL + +  K +         +    VAEG+ YL  
Sbjct: 82  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE- 138

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELA 498
              +  +HRD+ + N+LL +    ++GDFGL +   Q +     +    + +   APE  
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 499 TVSSPTSASDVYSFGVVILEVA-CGRRP 525
              + + ASD + FGV + E+   G+ P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (374), Expect = 2e-38
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ
Sbjct: 226 HKLGGGQYGEVYEGVW----KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 280

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 337

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HR++ + N L+      ++ DFGL++L               + + APE    +  +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 505 SASDVYSFGVVILEVA-CGRRP 525
             SDV++FGV++ E+A  G  P
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP 419

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (364), Expect = 2e-38
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 8/206 (3%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
            +++G+G FG VYKG L  ++      +A+K +    +++   +F+ E   MG+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G   K   +M++ +YM NG+L+ ++  +        Q   +L  +A G+ YL    
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATV 500
           +   VHRD+ + NIL++S +  ++ DFGL+++ +       T   G +     APE  + 
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 501 SSPTSASDVYSFGVVILEVA-CGRRP 525
              TSASDV+SFG+V+ EV   G RP
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  145 bits (368), Expect = 2e-38
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 32/219 (14%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           + +GSGG  +V++       N      A+K VN +    Q L  +  EI+ + +LQ  + 
Sbjct: 62  KQIGSGGSSKVFQVL-----NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 383 --VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
             +++  +      + +V +   N  LN+W+  K KK +   +R+    ++ E ++ +H 
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTR-VVGTLGYLAPEL 497
                +VH D+K  N L+     G   L DFG+A   Q           VG + Y+ PE 
Sbjct: 173 --QHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 498 -----------ATVSSPTSASDVYSFGVVILEVACGRRP 525
                       + S  +  SDV+S G ++  +  G+ P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  143 bits (363), Expect = 2e-38
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNL 382
            ++LGSG FG VYKG            +A+K +   +  +  KE + E   M  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
            ++ G C   + + L+   MP G L +++  + K  +G +        +A+G+NYL    
Sbjct: 80  CRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELAT 499
           D+ +VHRD+ + N+L+ +    ++ DFGLAKL    E        G    + ++A E   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192

Query: 500 VSSPTSASDVYSFGVVILEVA-CGRRP 525
               T  SDV+S+GV + E+   G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (361), Expect = 4e-38
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 9/206 (4%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           ++++GSG  G V  G L      +   +A+K +    +++  ++F++E S MG+  H N+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRD-VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G   +G   M+V +YM NGSL+ ++     +     Q   +L  V  G+ YL    
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS--- 168

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL--APELATV 500
           D   VHRD+ + N+L+DS +  ++ DFGL+++ +       T   G +     APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 501 SSPTSASDVYSFGVVILEVA-CGRRP 525
            + +SASDV+SFGVV+ EV   G RP
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  141 bits (357), Expect = 7e-38
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQM 385
           LG G FG V +G           ++A+K +     K   +E M E   M +L +  +V++
Sbjct: 18  LGCGNFGSVRQGVY--RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV 445
            G C +   LMLV +    G L+ ++    ++ +      ++L  V+ G+ YL    ++ 
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 130

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELATVSSP 503
            VHRD+ + N+LL +    ++ DFGL+K     +   T R  G     + APE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 504 TSASDVYSFGVVILEVA-CGRRP 525
           +S SDV+S+GV + E    G++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (357), Expect = 1e-37
 Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 24/221 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LG GGF  V          ++    A+K +    +Q  +E   E        H N+++
Sbjct: 35  QKLGEGGFSYVDLVE----GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 385 MRGWC----RKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYL 438
           +  +C       +E  L+  +   G+L N I         L   Q   +L  +  GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV--------VGTL 490
           H    +   HRD+K  NILL  E +  L D G           +   +          T+
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 491 GYLAPELATVSS---PTSASDVYSFGVVILEVACGRRPLDM 528
            Y APEL +V S       +DV+S G V+  +  G  P DM
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (371), Expect = 1e-37
 Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 12/255 (4%)

Query: 275 CASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGR 334
                      K +    +    E    +    +     L +     ++ EL G G FG 
Sbjct: 293 TPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL-GCGNFGS 351

Query: 335 VYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN 393
           V +G           ++A+K +     K   +E M E   M +L +  +V++ G C +  
Sbjct: 352 VRQGVY--RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 408

Query: 394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS 453
            LMLV +    G L+ ++    ++ +      ++L  V+ G+ YL    ++  VHR++ +
Sbjct: 409 ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAA 464

Query: 454 GNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSSPTSASDVYS 511
            N+LL +    ++ DFGL+K     +   T R  G       APE       +S SDV+S
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524

Query: 512 FGVVILEVA-CGRRP 525
           +GV + E    G++P
Sbjct: 525 YGVTMWEALSYGQKP 539

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 3e-37
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 9/206 (4%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           D+++G+G FG V  G L    +     +A+K +    +++  ++F+ E S MG+  H N+
Sbjct: 50  DKVVGAGEFGEVCSGRL-KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++ G   K   +M+V +YM NGSL++++  K        Q   +L  +A G+ YL    
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL--APELATV 500
           D   VHRD+ + NIL++S +  ++ DFGL ++ +       T   G +     +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 501 SSPTSASDVYSFGVVILEVA-CGRRP 525
              TSASDV+S+G+V+ EV   G RP
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP 250

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (354), Expect = 4e-37
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 12/207 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
            ++LGSG FG V+KG       +    + +K +     +Q  +     + ++G L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++ G C  G+ L LV  Y+P GSL + +  + +  LG +        +A+G+ YL    
Sbjct: 78  VRLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLE--- 132

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT---LGYLAPELAT 499
           +  +VHR++ + N+LL S  + ++ DFG+A L    +             + ++A E   
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIH 190

Query: 500 VSSPTSASDVYSFGVVILEVA-CGRRP 525
               T  SDV+S+GV + E+   G  P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (351), Expect = 4e-37
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 13/204 (6%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G +G VY+G         S  +AVK +  D+ + ++EF+ E + M  ++H NLVQ
Sbjct: 19  HKLGGGQYGEVYEGVW----KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C +     ++ ++M  G+L +++    ++ +       +   ++  + YL     +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 130

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSS 502
             +HRD+ + N L+      ++ DFGL++L        T            APE    + 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNK 188

Query: 503 PTSASDVYSFGVVILEVA-CGRRP 525
            +  SDV++FGV++ E+A  G  P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (352), Expect = 5e-37
 Identities = 59/270 (21%), Positives = 107/270 (39%), Gaps = 27/270 (10%)

Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISS 373
           S +   +   ++LG G    V++G     +       A+K  N+ S  + +   M E   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGR----HKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 374 MGRLQHKNLVQMRG--WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
           + +L HKN+V++            +L+ ++ P GSL   +  +P    G  +     +L 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLR 119

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR----LGDFGLAKLYQQGEVPNTTR 485
           DV  G+N+L    +  +VHR+IK GNI+      G+    L DFG A+  +  E   +  
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174

Query: 486 VVGTLGYLAPELATVSSP--------TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
           + GT  YL P++   +           +  D++S GV     A G  P    +G    + 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 538 VLMDWVRNLYGQGKICEAADARIRQEFEAE 567
           V+   +                   ++  +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGD 264

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 5e-37
 Identities = 57/294 (19%), Positives = 107/294 (36%), Gaps = 52/294 (17%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLV 383
           + LG GGFG V++      N  +    A+K +   +++   ++ M E+ ++ +L+H  +V
Sbjct: 11  QCLGRGGFGVVFEAK----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 384 QMRGWC------------RKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILAD 430
           +                      L +        +L +W+ G    +         I   
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-----------LYQQGE 479
           +AE + +LH    + ++HRD+K  NI    +   ++GDFGL             L     
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
               T  VGT  Y++PE    +S +   D++S G+++ E+     P      + E    L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS---TQMERVRTL 237

Query: 540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                       +       +  +    E  +V  + L    P    RP    +
Sbjct: 238 T----------DVRNLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINI 277

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  137 bits (345), Expect = 7e-37
 Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 40/244 (16%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           S  L F  N+F    N  DL+   +  V ST V++LT   N    ++S GRA Y   +++
Sbjct: 1   SDELSFTINNFVP--NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF-TSPPGALASQYFGLFSNA 136
             +    +  + SFSTSF F +          GL F L    +  P    S+Y GLF+N+
Sbjct: 59  WGN---TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS 115

Query: 137 TVVTVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPV 194
              +   ++AVEFDT     ++  DP+  HIG+D+N IES K V   +  +         
Sbjct: 116 NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI-NGGVAFATIT 174

Query: 195 RMRNGQNIHAWIDFD------------------------GFSAS--KTNWIEARRVLAWS 228
            +   + + A + +                         GFSA+      +E   VL+WS
Sbjct: 175 YLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234

Query: 229 LSDT 232
            + T
Sbjct: 235 FTST 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (346), Expect = 2e-36
 Identities = 61/304 (20%), Positives = 105/304 (34%), Gaps = 58/304 (19%)

Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEIS 372
           S+ T  F   E +GSG FG V+K         +    A+K            +  + E+ 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCV----KRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 373 SMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILA 429
           +   L QH ++V+      + + +++  +Y   GSL + I    +        + + +L 
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-------------------RLGDFG 470
            V  GL Y+H      +VH DIK  NI +                         ++GD G
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMG 529
                 +   P      G   +LA E+   +      +D+++  + ++  A        G
Sbjct: 180 HVT---RISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

Query: 530 KGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT 589
                       W        +I +    RI Q    E  EL+        HPD  RRP+
Sbjct: 235 D----------QWH-------EIRQGRLPRIPQVLSQEFTELLKV----MIHPDPERRPS 273

Query: 590 MREV 593
              +
Sbjct: 274 AMAL 277

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  137 bits (346), Expect = 2e-36
 Identities = 63/300 (21%), Positives = 115/300 (38%), Gaps = 68/300 (22%)

Query: 324 DELLGSGGFGRVYKGTL---ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +E LG G F +++KG      +    + TE+ +K ++   +   + F    S M +L HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           +LV   G C  G+E +LV +++  GSL+ ++  K K  +    + ++   +A  +++L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE- 130

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGR--------LGDFGLAKLYQQGEVPNTTRVVGTLGY 492
             +  ++H ++ + NILL  E   +        L D G++              V     
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------------ITVLPKDI 176

Query: 493 L-------APE-LATVSSPTSASDVYSFGVVILEVA-CGRRPLDMGKGEEEEEAVLMDWV 543
           L        PE +    +   A+D +SFG  + E+   G +PL     +           
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------K 227

Query: 544 RNLYGQG------KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
              Y         K  E A+                 L   C   +   RP+ R ++  L
Sbjct: 228 LQFYEDRHQLPAPKAAELAN-----------------LINNCMDYEPDHRPSFRAIIRDL 270

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (344), Expect = 3e-36
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 17/205 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +GSG FG V+ G        N  ++A+K +   +    ++F+ E   M +L H  LVQ
Sbjct: 14  QEIGSGQFGLVHLGYW-----LNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQ 67

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C +   + LV ++M +G L++++    + L   +    +  DV EG+ YL    + 
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLE---EA 123

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL---GYLAPELATVS 501
            V+HRD+ + N L+      ++ DFG+ +     +    T   GT     + +PE+ + S
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFS 180

Query: 502 SPTSASDVYSFGVVILEVA-CGRRP 525
             +S SDV+SFGV++ EV   G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (344), Expect = 3e-36
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LGSG FG V  G           ++AVK +   S     EF  E  +M +L H  LV+
Sbjct: 14  KELGSGQFGVVKLGKW-----KGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVK 67

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
             G C K   + +V +Y+ NG L N++    K  L   Q  ++  DV EG+ +L      
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE---SH 123

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL---GYLAPELATVS 501
             +HRD+ + N L+D ++  ++ DFG+ +     +       VGT     + APE+    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYF 180

Query: 502 SPTSASDVYSFGVVILEVA-CGRRP 525
             +S SDV++FG+++ EV   G+ P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP 205

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  135 bits (341), Expect = 3e-36
 Identities = 67/252 (26%), Positives = 99/252 (39%), Gaps = 38/252 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           +    F+F+ F       +LIL  D  V    V++LTN          S GRA Y   + 
Sbjct: 1   AEETSFVFSKFKP--LEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPIN 58

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +  S    + ++ SF+TSF F+I     ++   GL F L    S P +    + GLF +A
Sbjct: 59  IWDS---ATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGLFDSA 114

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAG------------YYS 184
              +    +AVEFDT +N  F DP   HIG D+N+I S K V               Y S
Sbjct: 115 VSGSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKWSLANGEAAKVLITYNS 174

Query: 185 SSRNESFVPVRMRNGQNIHAWIDFD-----------GFSASKTNW---IEARRVLAWSLS 230
           + +      V   +  +       D           GFSA+       IE   V +WS +
Sbjct: 175 AVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFA 234

Query: 231 DTGVAREINTTN 242
                     ++
Sbjct: 235 SKLAGXXTKDSS 246

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  143 bits (362), Expect = 3e-36
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
            E LG+GGFG V +      + +   ++A+K    +     +E +  EI  M +L H N+
Sbjct: 19  KERLGTGGFGYVLRWI----HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 383 VQM------RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILADVAEG 434
           V               +  +L  +Y   G L  ++  + +   G K+   R +L+D++  
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSA 133

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGR---LGDFGLAKLYQQGEVPNTTRVVGTLG 491
           L YLH   +  ++HRD+K  NI+L    +     + D G AK   QGE+      VGTL 
Sbjct: 134 LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQ 188

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           YLAPEL      T   D +SFG +  E   G RP  
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (344), Expect = 3e-36
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           + +LG G FG VY+G    N+      +AVK    D +    ++FM+E   M  L H ++
Sbjct: 17  NRILGEGFFGEVYEGVY-TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++ G   +     ++ +  P G L +++  + K  L           + + + YL    
Sbjct: 76  VKLIGII-EEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLE--- 130

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL---GYLAPELAT 499
               VHRDI   NIL+ S    +LGDFGL++  +  +     +   T     +++PE   
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESIN 187

Query: 500 VSSPTSASDVYSFGVVILEVA-CGRRP 525
               T+ASDV+ F V + E+   G++P
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP 214

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (344), Expect = 4e-36
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ
Sbjct: 30  KELGTGQFGVVKYGKW-----RGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 83

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C K   + ++ +YM NG L N++  + +     +Q  ++  DV E + YL     +
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SK 139

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL---GYLAPELATVS 501
             +HRD+ + N L++ +   ++ DFGL++     E    T  VG+     +  PE+   S
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYS 196

Query: 502 SPTSASDVYSFGVVILEVA-CGRRP 525
             +S SD+++FGV++ E+   G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  132 bits (334), Expect = 4e-36
 Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 22/189 (11%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTA 82
           +    FL   F    +  +LI   D +     + LT      + GRA Y + + +     
Sbjct: 1   TETTSFLITKFSP--DQQNLIFQGDGYTTKEKLTLTKAVKN-TVGRALYSSPIHIWDR-- 55

Query: 83  TNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVA 142
             +  + +F TSF F I    + +   G  F +    + P      Y G+F++A      
Sbjct: 56  -ETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQT-GGGYLGVFNSAEYDKTT 113

Query: 143 PLLAVEFDTGQNPEFNDPD-DNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQN 201
             +AVEFDT  N  ++  + D HIG+D+N+I+S                    +++NG+ 
Sbjct: 114 QTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVN--------------TKSWKLQNGEE 159

Query: 202 IHAWIDFDG 210
            +  I F+ 
Sbjct: 160 ANVVIAFNA 168

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  138 bits (350), Expect = 6e-36
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 27/242 (11%)

Query: 315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISS 373
           S +   +   ++LG G    V++G     +       A+K  N+ S  + +   M E   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGR----HKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 374 MGRLQHKNLVQMRGW--CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR--RQILA 429
           + +L HKN+V++            +L+ ++ P GSL   +  +P    G  +     +L 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLR 119

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR----LGDFGLAKLYQQGEVPNTTR 485
           DV  G+N+L    +  +VHR+IK GNI+      G+    L DFG A+  +  E   +  
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174

Query: 486 VVGTLGYLAPELATVSSP--------TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
           + GT  YL P++   +           +  D++S GV     A G  P    +G    + 
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 538 VL 539
           V+
Sbjct: 235 VM 236

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  134 bits (337), Expect = 7e-36
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 35/246 (14%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           ++++ F F  F S     DLI   D  V S   ++LT   ++      S GRA Y   ++
Sbjct: 1   ANSVCFTFTDFES--GQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIR 58

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           + +S++  +S    F T+F FSI    ++       F+ +  T  P     +  GLF ++
Sbjct: 59  LWQSSSLVAS----FETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSS 114

Query: 137 TVV-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY-----------YS 184
               +   +++VEFDT  N +  DP+  HIG+D+N+I S       +           Y+
Sbjct: 115 NNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQNGKTATAHISYN 174

Query: 185 SSRNESFVPVRMRNGQNIHAWIDFD-----------GFSASKTNWIEARRVLAWSLSDTG 233
           S+     V     N   +    D +           GFSA+   + +   +LAWS   + 
Sbjct: 175 SASKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRSSL 234

Query: 234 VAREIN 239
           +  + N
Sbjct: 235 MGYQAN 240

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  138 bits (350), Expect = 1e-35
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LG+G FG V+  T      N  T++AVK +   S   ++ F+AE + M  LQH  LV+
Sbjct: 194 KKLGAGQFGEVWMATY-----NKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVK 247

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     K   + ++ ++M  GSL +++           +     A +AEG+ ++     +
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QR 303

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSS 502
             +HRD+++ NIL+ + +  ++ DFGLA++ +  E   T R          APE     S
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGS 361

Query: 503 PTSASDVYSFGVVILEVA-CGRRP 525
            T  SDV+SFG++++E+   GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  133 bits (336), Expect = 2e-35
 Identities = 60/266 (22%), Positives = 96/266 (36%), Gaps = 61/266 (22%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKM 77
           S ++ F F +F S      +I   D    +  ++L   +       +S GRA Y   +++
Sbjct: 2   SDSVSFTFPNFWS-DVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQL 60

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLF--SN 135
             +    +  + SF T F F +     + P  GL F L    S     A +Y GLF  S 
Sbjct: 61  WDN---KTESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDSDVKD-AGEYLGLFNKST 115

Query: 136 ATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR 195
           AT  +   ++AVEFDT  NP F +P   HIG+++N+             S   + +    
Sbjct: 116 ATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNS-----------IVSVATKRWEDSD 164

Query: 196 MRNGQNIHAWIDFD------------------------------------GFSASK-TNW 218
           + +G+   A I +D                                    G SAS   N 
Sbjct: 165 IFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQ 224

Query: 219 IEARRVLAWSLSDTGVAREINTTNFP 244
                +L+W  S    +  +     P
Sbjct: 225 FLTVYILSWRFSSNLQSTSVKAAMEP 250

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (339), Expect = 2e-35
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLV 383
             +G G FG V++G    +  N +  +A+K   +  S    ++F+ E  +M +  H ++V
Sbjct: 21  RCIGEGQFGDVHQGIY-MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G   + N + ++ +    G L +++  +   L            ++  L YL     
Sbjct: 80  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLSTALAYLE---S 134

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELATVS 501
           +  VHRDI + N+L+ S    +LGDFGL++  +           G L   ++APE     
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFR 192

Query: 502 SPTSASDVYSFGVVILEVA-CGRRP 525
             TSASDV+ FGV + E+   G +P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  131 bits (331), Expect = 4e-35
 Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 30/234 (12%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMKRST 81
           +  + F FNSF        +    D  V S   I+LTN +   S GR  Y   +++  S 
Sbjct: 1   AETVSFNFNSFSE--GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSS- 57

Query: 82  ATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTV 141
              +  + SF TSF F +       P  G+ F +    +   A  S   G    +     
Sbjct: 58  --ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA-GSIGGGTLGVSDTKGA 114

Query: 142 APLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY-----------YSSSRNES 190
              + VEFDT  N E+NDP  +H+G+D+N+++S K VP              Y SS    
Sbjct: 115 GHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTL 174

Query: 191 FVPVRMRNGQNIHAWIDFD-----------GFSASK-TNWIEARRVLAWSLSDT 232
            V V   NG         D           GFSAS      +   + +WS + T
Sbjct: 175 SVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (346), Expect = 4e-35
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G FG V+ GT      N +T +A+K +   +    + F+ E   M +L+H+ LVQ
Sbjct: 190 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 243

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+      
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 299

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSS 502
             VHRD+++ NIL+   +  ++ DFGLA+L +  E   T R          APE A    
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 357

Query: 503 PTSASDVYSFGVVILEVA-CGRRP 525
            T  SDV+SFG+++ E+   GR P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (335), Expect = 6e-35
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V+ G       N  T++AVK +   S      F+AE + M +LQH+ LV+
Sbjct: 19  ERLGAGQFGEVWMGYY-----NGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVR 72

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + ++ +YM NGSL +++       L   +   + A +AEG+ ++    ++
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSS 502
             +HRD+++ NIL+   +  ++ DFGLA+L +  E   T R          APE     +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT 186

Query: 503 PTSASDVYSFGVVILEVA-CGRRP 525
            T  SDV+SFG+++ E+   GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (345), Expect = 7e-35
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 21/205 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 199 QTIGKGEFGDVMLGDY------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250

Query: 385 MRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           + G    +   L +V +YM  GSL +++  + + +LG     +   DV E + YL     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 307

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVS 501
              VHRD+ + N+L+  +   ++ DFGL K        ++T+  G L     APE     
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREK 361

Query: 502 SPTSASDVYSFGVVILEVA-CGRRP 525
             ++ SDV+SFG+++ E+   GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  132 bits (334), Expect = 8e-35
 Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 35/273 (12%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKE-FMAEISSMGRLQHKNL 382
           LLG G F  VY+      + +   E+A+K ++  +  K G+ +    E+    +L+H ++
Sbjct: 18  LLGKGSFAGVYRAE----SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HG 441
           +++  +    N + LV +   NG +N ++  + K     + R   +  +  G+ YLH HG
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLHSHG 132

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATV 500
               ++HRD+   N+LL   M  ++ DFGLA +L    E   T    GT  Y++PE+AT 
Sbjct: 133 ----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATR 186

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
           S+    SDV+S G +   +  GR P      + +        V+N     K+   AD  +
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPF-----DTDT-------VKNTL--NKV-VLADYEM 231

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                 E  +L+ +L       +   R ++  V
Sbjct: 232 PSFLSIEAKDLIHQL----LRRNPADRLSLSSV 260

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (332), Expect = 1e-34
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 37/244 (15%)

Query: 287 NKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNN 346
             + AQ+E     W         + +EL          + +G G FG V  G        
Sbjct: 3   GSVAAQDEFYRSGWA-------LNMKELKL-------LQTIGKGEFGDVMLGDY------ 42

Query: 347 NSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC-RKGNELMLVYDYMPNG 405
              ++AVKC+ +D+    + F+AE S M +L+H NLVQ+ G    +   L +V +YM  G
Sbjct: 43  RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100

Query: 406 SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR 465
           SL +++  + + +LG     +   DV E + YL        VHRD+ + N+L+  +   +
Sbjct: 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 157

Query: 466 LGDFGLAK-LYQQGEVPNTTRVVGTLGY--LAPELATVSSPTSASDVYSFGVVILEVA-C 521
           + DFGL K          +T+  G L     APE       ++ SDV+SFG+++ E+   
Sbjct: 158 VSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 210

Query: 522 GRRP 525
           GR P
Sbjct: 211 GRVP 214

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (345), Expect = 2e-34
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G FG V+ GT      N +T +A+K +   +    + F+ E   M +L+H+ LVQ
Sbjct: 273 VKLGQGCFGEVWMGTW-----NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 326

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +     +   + +V +YM  GSL +++ G+  K L   Q   + A +A G+ Y+      
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 382

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY--LAPELATVSS 502
             VHRD+++ NIL+   +  ++ DFGLA+L +  E   T R          APE A    
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 440

Query: 503 PTSASDVYSFGVVILEVA-CGRRP 525
            T  SDV+SFG+++ E+   GR P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP 464

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  130 bits (327), Expect = 2e-34
 Identities = 63/256 (24%), Positives = 104/256 (40%), Gaps = 44/256 (17%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKM 77
           +    F F +F    N +  IL  D  V S+ +RLT           S GRA+Y + +++
Sbjct: 1   ADIQSFSFKNF----NSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQI 56

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                 ++  + S++TSF  +I     SS   G+ F L    S P +  S + G+F +  
Sbjct: 57  YDK---STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDV 112

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK------------HVPAGYYSS 185
               A  +AVEFDT  N ++ DP   HIG+D+N+I+S +             +   Y ++
Sbjct: 113 YDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWGLANGQNAEILITYNAA 171

Query: 186 SRNESFVPVRMRNGQNIHAWIDFD-----------GFSAS---KTNWIEARRVLAWS--- 228
           +       V      +       D           GFSA+      + E   VL+WS   
Sbjct: 172 TSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFAS 231

Query: 229 -LSDTGVAREINTTNF 243
            L D      ++  ++
Sbjct: 232 KLPDDSTTEPLDIASY 247

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  131 bits (332), Expect = 3e-34
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 16/212 (7%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +     LG G FG+VYK      N       A K +   S++ L++++ EI  +    H 
Sbjct: 21  WEIVGELGDGAFGKVYKAK----NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            +V++ G      +L ++ ++ P G+++  I  +  + L   Q + +   + E LN+LH 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH- 134

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              + ++HRD+K+GN+L+  E   RL DFG+ AK  +  +  ++   +GT  ++APE+  
Sbjct: 135 --SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 500 VSSPTSAS-----DVYSFGVVILEVACGRRPL 526
             +          D++S G+ ++E+A    P 
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (330), Expect = 5e-34
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 13/207 (6%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           ++  E +G G  G VY       +     E+A++ +N   +   +  + EI  M   ++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V        G+EL +V +Y+  GSL + +       +   Q   +  +  + L +LH 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH- 133

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                V+HRDIKS NILL  +   +L DFG  A++  +    +T  +VGT  ++APE+ T
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
             +     D++S G++ +E+  G  P 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  131 bits (331), Expect = 5e-34
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
             +   +G G  G V          ++  ++AVK ++   +Q  +    E+  M   QH 
Sbjct: 47  LDSYVKIGEGSTGIVCLAR----EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           N+V+M      G EL ++ +++  G+L + +       L  +Q   +   V + L YLH 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH- 158

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              Q V+HRDIKS +ILL  + R +L DFG  A++ +      +  +VGT  ++APE+ +
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
            S   +  D++S G++++E+  G  P 
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPY 241

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (344), Expect = 6e-34
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
              +G G FG V++G    +  N +  +A+K   +  S    ++F+ E  +M +  H ++
Sbjct: 395 GRCIGEGQFGDVHQGIY-MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++ G     N + ++ +    G L +++    K  L           ++  L YL    
Sbjct: 454 VKLIGVI-TENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE--- 508

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL--GYLAPELATV 500
            +  VHRDI + N+L+ S    +LGDFGL++  +           G L   ++APE    
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINF 566

Query: 501 SSPTSASDVYSFGVVILEVA-CGRRP 525
              TSASDV+ FGV + E+   G +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP 592

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  132 bits (333), Expect = 9e-34
 Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 19/218 (8%)

Query: 321 FSNDELLGSG--GFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGR 376
           +    ++G G      V               + V+ +N    S + +     E+     
Sbjct: 27  YELLTVIGKGFEDLMTVNLAR----YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
             H N+V  R      NEL +V  +M  GS  + I       +       IL  V + L+
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG-LAKLYQQGEVPNT-----TRVVGTL 490
           Y+HH      VHR +K+ +IL+  + +  L        +   G+            V  L
Sbjct: 143 YIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 491 GYLAPELATVSSP--TSASDVYSFGVVILEVACGRRPL 526
            +L+PE+   +     + SD+YS G+   E+A G  P 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  131 bits (331), Expect = 1e-33
 Identities = 45/318 (14%), Positives = 83/318 (26%), Gaps = 56/318 (17%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMA 369
            LS+  +     E L  G    V+       +     + A+K       +S+  L+    
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVR----DVERLEDFALKVFTMGAENSRSELERLHE 111

Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLV-----------------------YDYMP--N 404
              +  RL  ++  + R   R       V                          MP  +
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171

Query: 405 GSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD 459
             L             +   G      + A +      L       +VH      N+ + 
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIM 228

Query: 460 SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP--TSASDVYSFGVVIL 517
            + R  LGD       + G           + Y   E    S+   T A + +  G+ I 
Sbjct: 229 PDGRLMLGDVSALW--KVGTRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284

Query: 518 EVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGL 577
            V C   P  +     +           + G   +   +   +    +     L+ +   
Sbjct: 285 RVWCLFLPFGLVTPGIKGSWKRP--SLRVPGTDSLAFGSCTPLPDFVK----TLIGRF-- 336

Query: 578 ACCHPDSTRRPTMREVVA 595
              + D  RR    E + 
Sbjct: 337 --LNFDRRRRLLPLEAME 352

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  127 bits (321), Expect = 1e-33
 Identities = 62/242 (25%), Positives = 89/242 (36%), Gaps = 38/242 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN---QFSFGRAYYPTKLKMK 78
           S  L F F +F    NG DL    +  V  T V++L    N     + G A Y   + + 
Sbjct: 1   SDDLSFKFKNFSQ--NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW 58

Query: 79  RSTATNSSILTSFSTSFVFSILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                N+  L SF TSF F +       +   GL F L    SP    A  YFGLF++  
Sbjct: 59  NC---NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRR-AGGYFGLFNDTK 114

Query: 138 VVTVAPLLAVEFDTGQNP-EFNDPDDNHIGVDLNNIESAKHVPAGYYSSS-RNESFVPVR 195
             +    +AVEFDT  +P  F DP   HIG+D+N ++S                +   + 
Sbjct: 115 CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIY 174

Query: 196 MRNGQNIHAWIDFD------------------------GFSASK-TNWIEARRVLAWSLS 230
             + + + A + +                         GFS S          VL W  +
Sbjct: 175 EASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234

Query: 231 DT 232
            T
Sbjct: 235 ST 236

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  129 bits (326), Expect = 2e-33
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 14/208 (6%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQH 379
           F+  E +G G FG V+KG     +N     +A+K ++ +  +  +++   EI+ + +   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI----DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             + +  G   K  +L ++ +Y+  GS  + +  +P  L    Q   IL ++ +GL+YLH
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPL-DETQIATILREILKGLDYLH 136

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELA 498
               +  +HRDIK+ N+LL      +L DFG+  +L       NT   VGT  ++APE+ 
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPL 526
             S+  S +D++S G+  +E+A G  P 
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPH 219

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  128 bits (321), Expect = 2e-33
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 37/247 (14%)

Query: 18  FSISPSSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN-----QFSFGRAYY 71
              + + +L F F +F    +  +LI   D       +++LT   +     + + GR  +
Sbjct: 4   NRANSTDSLSFSFINFDR--DERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILH 61

Query: 72  PTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFG 131
             ++++      +++ + +  T F F +   +++       F+    T+ P   A    G
Sbjct: 62  SAQVRLWEK---STNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLG 118

Query: 132 LF--SNATVVTVAPLLAVEFDT--GQNPEFNDPDDNHIGVDLNNIESAKHVPAGY----- 182
           LF    A   +   +LAVEFDT   QN    DP+  HIG+D+N+I S+K V         
Sbjct: 119 LFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVRWERREGKT 178

Query: 183 ------YSSSRNESFVPVRMRNGQNIHAWIDFD-----------GFSASKTNWIEARRVL 225
                 Y+ S     V     +GQ        D           GFSA+     +   + 
Sbjct: 179 LNVLVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLE 238

Query: 226 AWSLSDT 232
           +WS + T
Sbjct: 239 SWSFTST 245

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  127 bits (319), Expect = 2e-33
 Identities = 65/258 (25%), Positives = 98/258 (37%), Gaps = 66/258 (25%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           + +L F F  F    N   LI   D  V ST V++LTN  N      S GRA Y    ++
Sbjct: 1   TGSLSFSFPKFAP--NQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
             S    +  + SF TSF F I     ++   GL F L    + P        G+F +  
Sbjct: 59  WDS---TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKDGY 114

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
                 ++AVEFDT  N ++ DP   H+G+++N+IES K VP  +               
Sbjct: 115 FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWT-------------- 159

Query: 198 NGQNIHAWIDFD-------------------------------------GFSAS---KTN 217
           NG+  + +I ++                                     GFSA+      
Sbjct: 160 NGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKG 219

Query: 218 WIEARRVLAWSLSDTGVA 235
           +++   VL+WS       
Sbjct: 220 YVQTNDVLSWSFESNLPG 237

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (325), Expect = 2e-33
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 34/274 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKE-FMAEISSMGRLQHKN 381
             LG GGF + ++ +    + +     A K V      K   +E    EIS    L H++
Sbjct: 21  RFLGKGGFAKCFEIS----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V   G+    + + +V +     SL      K +K L   + R  L  +  G  YLH  
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLH-- 132

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYLAPELATV 500
               V+HRD+K GN+ L+ ++  ++GDFGLA K+   GE        GT  Y+APE+ + 
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSK 189

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
              +   DV+S G ++  +  G+ P +               ++  Y   +I +  +  I
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE------------TSCLKETY--LRIKK-NEYSI 234

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
            +        L+ K+ L     D T RPT+ E++
Sbjct: 235 PKHINPVAASLIQKM-L---QTDPTARPTINELL 264

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 2e-33
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 28/222 (12%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
             LG G FG+V+     N +   +   +AVK +   +    K+F  E   +  LQH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQILA 429
           +  G C  G+ L++V++YM +G LN +                 + K  LG  Q   I +
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            +A G+ YL     Q  VHRD+ + N L+ + +  ++GDFG+++     +     R VG 
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYR-VGG 193

Query: 490 LGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
              L      PE       T+ SDV+SFGV++ E+   G++P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 2e-33
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 15/210 (7%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           D ++G G FG VY G    +   N  + A+K ++     Q ++ F+ E   M  L H N+
Sbjct: 26  DRVIGKGHFGVVYHGE-YIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 383 VQMRGWCRKGNE-LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + + G          ++  YM +G L  +I   P++    K        VA G+ YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLA-- 141

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL-----APE 496
            +Q  VHRD+ + N +LD     ++ DFGLA+     E    +        L     A E
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY--YSVQQHRHARLPVKWTALE 198

Query: 497 LATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                  T+ SDV+SFGV++ E+   G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (332), Expect = 3e-33
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 41/285 (14%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QH 379
           F   ++LG G  G +    + +N      ++AVK +     +       E+  +    +H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDN-----RDVAVKRIL---PECFSFADREVQLLRESDEH 77

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N+++     +      +  +     +L  ++  K    LG  +   +L     GL +LH
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLH 135

Query: 440 HGWDQVVVHRDIKSGNILL-----DSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGY 492
                 +VHRD+K  NIL+       +++  + DFGL K    G    + R  V GT G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 493 LAPEL---ATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYG 548
           +APE+       +PT   D++S G V   V   G  P        + +A ++        
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG---KSLQRQANILL------- 242

Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
               C        +  +    EL+ K        D  +RP+ + V
Sbjct: 243 --GACSLDCLHPEKHEDVIARELIEK----MIAMDPQKRPSAKHV 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (324), Expect = 3e-33
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 29/239 (12%)

Query: 296 EIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKC 355
            ++   +        + E+            +G G FG VY GTL  +N+      AVK 
Sbjct: 14  AVQHVVIGPSSLIVHFNEV------------IGRGHFGCVYHGTL-LDNDGKKIHCAVKS 60

Query: 356 VNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE-LMLVYDYMPNGSLNNWIFG 413
           +N       + +F+ E   M    H N++ + G C +     ++V  YM +G L N+I  
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR- 119

Query: 414 KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
                   K        VA+G+ YL     +  VHRD+ + N +LD +   ++ DFGLA+
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 474 LYQQGEVPNTTRVVGTLGYL------APELATVSSPTSASDVYSFGVVILEVAC-GRRP 525
                E      V    G        A E       T+ SDV+SFGV++ E+   G  P
Sbjct: 177 DMYDKE---YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (325), Expect = 3e-33
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 29/222 (13%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
             LG G FG+V+     N     +   +AVK +   S+   ++F  E   +  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNW-------------IFGKPKKLLGWKQRRQILAD 430
           +  G C +G  L++V++YM +G LN +                     LG  Q   + + 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGT 489
           VA G+ YL        VHRD+ + N L+   +  ++GDFG+++ +Y      +  R VG 
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST----DYYR-VGG 218

Query: 490 LGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
              L      PE       T+ SDV+SFGVV+ E+   G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (325), Expect = 4e-33
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 34/274 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKE-FMAEISSMGRLQHKN 381
             LG GGF + ++ +    + +     A K V      K   +E    EIS    L H++
Sbjct: 47  RFLGKGGFAKCFEIS----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V   G+    + + +V +     SL      K +K L   + R  L  +  G  YLH  
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLH-- 158

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ-GEVPNTTRVVGTLGYLAPELATV 500
               V+HRD+K GN+ L+ ++  ++GDFGLA   +  GE        GT  Y+APE+ + 
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSK 215

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
              +   DV+S G ++  +  G+ P +               ++  Y   +I +  +  I
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFE------------TSCLKETY--LRIKK-NEYSI 260

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
            +        L+ K+ L     D T RPT+ E++
Sbjct: 261 PKHINPVAASLIQKM-L---QTDPTARPTINELL 290

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  126 bits (317), Expect = 4e-33
 Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 41/243 (16%)

Query: 24  SALDFLFNSFGSIT--NGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLK 76
           + ++F +  F S +  NGT++  + D       ++LT         + S G+A Y   + 
Sbjct: 2   NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +  ST   +S    F TSF F +     +    GL F L    S        + GLF + 
Sbjct: 62  LWDSTGKAAS----FYTSFTFLL-KNYGAPTADGLAFFLAPVDSSVKD-YGGFLGLFRHE 115

Query: 137 TVV--TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY------------ 182
           T    +   ++AVEFDT  N ++NDP   HIG+D+N+I S                    
Sbjct: 116 TAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAH 175

Query: 183 --YSSSRNESFVPVRMRNGQNIHAWIDFD-----------GFSASKTNWIEARRVLAWSL 229
             Y +      V +   +G++       D           GFSA    + E   +L+W  
Sbjct: 176 ITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAG-VGYDEVTYILSWHF 234

Query: 230 SDT 232
             T
Sbjct: 235 FST 237

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  125 bits (315), Expect = 6e-33
 Identities = 56/241 (23%), Positives = 89/241 (36%), Gaps = 35/241 (14%)

Query: 26  LDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN-QFSFGRAYYPTKLKMKRSTAT 83
           + F +  F    +   LI   D  + +   + +  D     +   A Y T + +  S   
Sbjct: 1   VSFNYTRF---KDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDS--- 54

Query: 84  NSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF-TSPPGALASQYFGLFSNATVVTVA 142
            +  + SF TSF F +       P  G+ F L  + T  P      Y G+  ++   +  
Sbjct: 55  ATGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSSN--SQN 112

Query: 143 PLLAVEFDTGQNP-EFNDPDDNHIGVDLNNIESAKHVPAGY-----------YSSSRNES 190
             +AVEFD+  N  +      +HIG+D+N+I S K V               Y S     
Sbjct: 113 QFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNWNRVSGSLEKATIIYDSDTKIL 172

Query: 191 FVPVRMRNGQNIHAWIDFD-----------GFSASKTN-WIEARRVLAWSLSDTGVAREI 238
            V +  +NGQ      + D           GFSA+  N   E   + +WS + T    E 
Sbjct: 173 TVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFTSTLKEPEE 232

Query: 239 N 239
            
Sbjct: 233 Q 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (324), Expect = 1e-32
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 11/208 (5%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL  +N+      AVK +N       + +F+ E   M    H N+
Sbjct: 94  NEVIGRGHFGCVYHGTL-LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 383 VQMRGWCRKGNE-LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + + G C +     ++V  YM +G L N+I          K        VA+G+ +L   
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLA-- 209

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTL--GYLAPELA 498
             +  VHRD+ + N +LD +   ++ DFGLA+ +Y +       +    L   ++A E  
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 499 TVSSPTSASDVYSFGVVILEVAC-GRRP 525
                T+ SDV+SFGV++ E+   G  P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (318), Expect = 1e-32
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
           E LG   FG+VYKG L        +  +A+K +         +EF  E     RLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQIL 428
           V + G   K   L +++ Y  +G L+ +                   K  L       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVV 487
           A +A G+ YL       VVH+D+ + N+L+  ++  ++ D GL  ++Y      +  + +
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYK-L 186

Query: 488 GTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                L     APE       +  SD++S+GVV+ EV   G +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (317), Expect = 1e-32
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 21/208 (10%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKE-FMAEISSMGRLQHKNL 382
            LG G FG VY   LA    +    +A+K +      K G++     E+     L+H N+
Sbjct: 16  PLGKGKFGNVY---LAREKQSK-FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HG 441
           +++ G+      + L+ +Y P G++   +  +       ++    + ++A  L+Y H   
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELAT 499
               V+HRDIK  N+LL S    ++ DFG +        P++ R  + GTL YL PE+  
Sbjct: 130 ----VIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTDLCGTLDYLPPEMIE 180

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLD 527
                   D++S GV+  E   G+ P +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  126 bits (319), Expect = 2e-32
 Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 13/207 (6%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           F   E LG G +G VYK      +      +A+K V  +S   L+E + EIS M +    
Sbjct: 31  FDVLEKLGEGSYGSVYKA----IHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSP 84

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           ++V+  G   K  +L +V +Y   GS+++ I  + K L    +   IL    +GL YLH 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-TEDEIATILQSTLKGLEYLH- 142

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 +HRDIK+GNILL++E   +L DFG+  +L       NT  V+GT  ++APE+  
Sbjct: 143 --FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPL 526
                  +D++S G+  +E+A G+ P 
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY 225

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  124 bits (311), Expect = 2e-32
 Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 36/239 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTA 82
           +    FL   F    +  +LI   D +     + LT      + GRA Y + + +     
Sbjct: 1   TETTSFLITKFSP--DQQNLIFQGDGYTTKEKLTLTKAVKN-TVGRALYSSPIHIWDR-- 55

Query: 83  TNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVA 142
             +  + +F TSF F I    + +   G  F +    + P      Y G+F++A      
Sbjct: 56  -ETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQT-GGGYLGVFNSAEYDKTT 113

Query: 143 PLLAVEFDTGQNPEFNDPD-DNHIGVDLNNIESAKHVPAGY-----------YSSSRNES 190
             +AVEFDT  N  ++  + D HIG+D+N+I+S                   ++++ N  
Sbjct: 114 QTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANVVIAFNAATNVL 173

Query: 191 FVPVRMRNG--------QNIHAWIDFD---------GFSASKTNWIEARRVLAWSLSDT 232
            V +   N           +   +            GFSA+      A  VL+WS    
Sbjct: 174 TVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  124 bits (313), Expect = 2e-32
 Identities = 74/257 (28%), Positives = 111/257 (43%), Gaps = 47/257 (18%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           S+ + F F  F    N T+LIL  D  V S+  +RLTN +        S GRA+Y   ++
Sbjct: 1   SNDIYFNFQRF----NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQ 56

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +  +    +  + SF+TSF F+I     + P  GL F L    S P      + GLF  +
Sbjct: 57  IWDN---TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGS 112

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY-----------YSS 185
              +    +AVEFDT  N ++ DP + HIG+D+N+I S K     +           Y S
Sbjct: 113 N--SNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENAEVLITYDS 169

Query: 186 SRNESFVPVRMRNGQ---NIHAWIDFD---------GFSAS---KTNWIEARRVLAWS-- 228
           S N     +   + +    +   +D           GFSA+       +E   VL+WS  
Sbjct: 170 STNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFA 229

Query: 229 --LSDTGVAREINTTNF 243
             LSD   +  +N  N 
Sbjct: 230 SKLSDETTSEGLNLANL 246

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (317), Expect = 3e-32
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQH 379
           +   E++GSG    V              ++A+K +N +  Q  + E + EI +M +  H
Sbjct: 17  YELQEVIGSGATAVVQAAY----CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ--------ILADV 431
            N+V         +EL LV   +  GS+ + I  K     G  +           IL +V
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREV 130

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTR---VV 487
            EGL YLH       +HRD+K+GNILL  +   ++ DFG+ A L   G++         V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 488 GTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPL 526
           GT  ++APE+          +D++SFG+  +E+A G  P 
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (318), Expect = 3e-32
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
             LG G FG VY+G ++   N+ +  ++AVK +    S+Q   +F+ E   + +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNY 437
           V+  G   +     ++ + M  G L +++            L       +  D+A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRL---GDFGLAKLYQQGEVPNTTRVVGTLGYL- 493
           L    +   +HRDI + N LL     GR+   GDFG+A+   +          G    L 
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLP 208

Query: 494 ----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                PE       TS +D +SFGV++ E+   G  P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  123 bits (309), Expect = 4e-32
 Identities = 56/195 (28%), Positives = 83/195 (42%), Gaps = 29/195 (14%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ----FSFGRAYYPTKLKM 77
           + +  F F +F    N  +LIL  D  V+S   + LT  +       S GRA Y   + +
Sbjct: 1   TESTSFSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                 +++ L SF+TSF F +    A++   GL F L    + P A    + GLF++  
Sbjct: 59  H-----DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA 112

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
                  +AVEFDT  N    DP+  HIG+D N IES K                P  M 
Sbjct: 113 HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKT--------------TPFDMV 156

Query: 198 NGQNIHAWIDFDGFS 212
            G+  +  I +   +
Sbjct: 157 YGEKANIVITYQAST 171

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  125 bits (316), Expect = 5e-32
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 40/227 (17%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKN 381
            +++G G FG+V K  +    +    + A+K +    SK   ++F  E+  + +L  H N
Sbjct: 30  QDVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRRQI 427
           ++ + G C     L L  +Y P+G+L ++              I       L  +Q    
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK---LYQQGEVPNTT 484
            ADVA G++YL     +  +HRD+ + NIL+      ++ DFGL++   +Y         
Sbjct: 148 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------- 195

Query: 485 RVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
            V  T+G L     A E    S  T+ SDV+S+GV++ E+   G  P
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (311), Expect = 2e-31
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 27/219 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           ++LG G FG V +G      +  S ++AVK +  D  S++ ++EF++E + M    H N+
Sbjct: 40  KILGEGEFGSVMEGN-LKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 383 VQMRGWCRKGN-----ELMLVYDYMPNGSLNNWI----FGKPKKLLGWKQRRQILADVAE 433
           +++ G C + +     + M++  +M  G L+ ++         K +  +   + + D+A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGY 492
           G+ YL    ++  +HRD+ + N +L  +M   + DFGL+K +Y      +  R  G +  
Sbjct: 159 GMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG----DYYR-QGRIAK 210

Query: 493 L-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
           +     A E       TS SDV++FGV + E+A  G  P
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (314), Expect = 2e-31
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
             LG G FG VY+G ++   N+ +  ++AVK +    S+Q   +F+ E   + +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNY 437
           V+  G   +     ++ + M  G L +++            L       +  D+A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRL---GDFGLAKLYQQGEVPNTTRVVGTLGYL- 493
           L    +   +HRDI + N LL     GR+   GDFG+A+   +          G    L 
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLP 249

Query: 494 ----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                PE       TS +D +SFGV++ E+   G  P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  120 bits (302), Expect = 4e-31
 Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 37/246 (15%)

Query: 21  SPSSALDFLFNSFGSITNGTDLILINDCWV-DSTVIRLTNDSNQ--FSFGRAYYPTKLKM 77
           + S  L F F+ F    N  ++I   D  V  + V+++T  S     S GRA Y   +++
Sbjct: 1   NLSDDLSFNFDKFVP--NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSP-PGALASQYFGLFSNA 136
             S    +  + SF+TSF F +  +  S    GL F L    S  P   ++  FGLFS++
Sbjct: 59  WDS---ITGKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSS 114

Query: 137 TVVTVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHVPAGYYSSSRNE----- 189
              +   ++AVEFDT     +N  DPD  HIG+D+N+I+S K V   + +    +     
Sbjct: 115 DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVADVVITY 174

Query: 190 ---------SFVPVRMRNGQNIHAWIDFD---------GFSAS--KTNWIEARRVLAWSL 229
                                I A +D           GFS         E   VL+W  
Sbjct: 175 RAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234

Query: 230 SDTGVA 235
           +    A
Sbjct: 235 TSNLEA 240

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (312), Expect = 6e-31
 Identities = 52/361 (14%), Positives = 93/361 (25%), Gaps = 71/361 (19%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMA 369
           EL +  +      +LG        + T    +        V       +     +K+   
Sbjct: 72  ELGERPRTLVRGTVLGQEDPYAYLEAT----DQETGESFEVHVPYFTERPPSNAIKQMKE 127

Query: 370 EISSMGRLQ-------------------------HKNLVQMRGWCRKGNELMLVYDYM-P 403
           E+  +  L+                          K ++++R   R    L   + Y   
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187

Query: 404 NGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNYLH-HGWDQVVVHRDIKSGNIL 457
             +L  +           K L    R Q+   V   L  LH +G    +VH  ++  +I+
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIV 243

Query: 458 LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-----TSASDVYSF 512
           LD      L  F          V    R        A  +           T A D ++ 
Sbjct: 244 LDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 513 GVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELV 572
           G+ I  + C   P       ++      +W+            +   I Q   A    L+
Sbjct: 304 GLAIYWIWCADLPNT-----DDAALGGSEWIF----------RSCKNIPQPVRA----LL 344

Query: 573 LKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELLGDLARGAVDADFSGGDDSREDA 632
               L         R    + +     +++       L             G   S    
Sbjct: 345 EGF-LR---YPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQ 400

Query: 633 P 633
           P
Sbjct: 401 P 401

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  120 bits (302), Expect = 7e-31
 Identities = 63/253 (24%), Positives = 97/253 (38%), Gaps = 41/253 (16%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           +  + F +N F       ++IL  D  V S+  ++L            S GRA Y T + 
Sbjct: 1   AETVSFSWNKFVP--KQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIH 58

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +       +  + SF+ SF F+           GL F L    + P    + Y GLF+  
Sbjct: 59  IWDK---ETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT-HAGYLGLFNEN 114

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK------------HVPAGYYS 184
              +   ++AVEFDT +N    DP + HIG+++N+I S K             V   Y +
Sbjct: 115 E--SGDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTSWDLANNKVAKVLITYDA 170

Query: 185 SSR--NESFVPVRMRNGQNIHAWID---------FDGFSASKTNWI--EARRVLAWSLSD 231
           S+     S V    R    +   +D           GFSA+    I  E+  VL+WS + 
Sbjct: 171 STSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFAS 230

Query: 232 TGVAREINTTNFP 244
                  N     
Sbjct: 231 NLPHASSNIDPLD 243

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  122 bits (307), Expect = 8e-31
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 25/218 (11%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
             LG G FG VY+G       +   T +A+K VN   S +   EF+ E S M      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI--------FGKPKKLLGWKQRRQILADVAEG 434
           V++ G   +G   +++ + M  G L +++                   +  Q+  ++A+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL 493
           + YL+       VHRD+ + N ++  +   ++GDFG+   +Y+     +  R  G  G L
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYR-KGGKGLL 202

Query: 494 -----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                +PE       T+ SDV+SFGVV+ E+A    +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (307), Expect = 8e-31
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 26/219 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
            +LG G FG V +       + +  ++AVK +  D  +   ++EF+ E + M    H ++
Sbjct: 29  RMLGKGEFGSVREAQ-LKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 383 VQMRGWCRKG------NELMLVYDYMPNGSLNNWI----FGKPKKLLGWKQRRQILADVA 432
            ++ G   +          M++  +M +G L+ ++     G+    L  +   + + D+A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            G+ YL     +  +HRD+ + N +L  +M   + DFGL++    G+        G    
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY----YRQGCASK 200

Query: 493 L-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
           L     A E    +  T  SDV++FGV + E+   G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 1e-30
 Identities = 41/224 (18%), Positives = 83/224 (37%), Gaps = 28/224 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLV 383
            +L  GGF  VY+      +  +  E A+K +  + ++  +  + E+  M +L  H N+V
Sbjct: 34  RVLAEGGFAFVYEAQ----DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 384 QM--------RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           Q                 E +L+ +      +      + +  L      +I       +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR---------- 485
            ++H      ++HRD+K  N+LL ++   +L DFG A         + +           
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 486 -VVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRP 525
               T  Y  PE+  + S        D+++ G ++  +   + P
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  121 bits (305), Expect = 1e-30
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QH 379
           F   EL+G+G +G+VYKG     +       A+K ++       +E   EI+ + +   H
Sbjct: 26  FELVELVGNGTYGQVYKGR----HVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHH 80

Query: 380 KNLVQMRG------WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
           +N+    G           ++L LV ++   GS+ + I       L  +    I  ++  
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL-AKLYQQGEVPNTTRVVGTLGY 492
           GL++LH      V+HRDIK  N+LL      +L DFG+ A+L +     NT   +GT  +
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYW 195

Query: 493 LAPELATVSSPTSAS-----DVYSFGVVILEVACGRRPL 526
           +APE+        A+     D++S G+  +E+A G  PL
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (306), Expect = 2e-30
 Identities = 57/296 (19%), Positives = 115/296 (38%), Gaps = 41/296 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLV 383
             LG+G  G V+K +    +  +   MA K ++ + K     + + E+  +       +V
Sbjct: 39  SELGAGNGGVVFKVS----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
              G      E+ +  ++M  GSL+     K    +  +   ++   V +GL YL     
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLTYLRE--K 150

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELATVS 501
             ++HRD+K  NIL++S    +L DFG++     G++ ++     VGT  Y++PE    +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 205

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI- 560
             +  SD++S G+ ++E+A GR P+     +E E         +              + 
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 561 RQEFEAEEMELVLKLGL------------------------ACCHPDSTRRPTMRE 592
           +   ++     + +L                           C   +   R  +++
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (304), Expect = 2e-30
 Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 36/272 (13%)

Query: 282 WYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKG-FSNDEL-----LGSGGFGRV 335
            Y  K K K Q   +I E             +L    K  F  + L     LG+G FG+V
Sbjct: 3   DYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKV 62

Query: 336 YKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG 392
            + T       +   ++AVK +         +  M+E+  M  L QH+N+V + G C  G
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122

Query: 393 NELMLVYDYMPNGSLNNW------------IFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
             ++++ +Y   G L N+             F         +      + VA+G+ +L  
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA- 181

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTTRVVGTLGYL-----A 494
              +  +HRD+ + N+LL +    ++GDFGLA  +           +V     L     A
Sbjct: 182 --SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMA 234

Query: 495 PELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
           PE       T  SDV+S+G+++ E+   G  P
Sbjct: 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  120 bits (302), Expect = 3e-30
 Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 39/233 (16%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKN 381
            + LG G FG+V K T  +       T +AVK +  + S   L++ ++E + + ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNW----------------------IFGKPKKLL 419
           ++++ G C +   L+L+ +Y   GSL  +                      +    ++ L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 420 GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQG 478
                      +++G+ YL    +  +VHRD+ + NIL+    + ++ DFGL+  +Y++ 
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 479 EVPNTTRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                  V  + G +     A E       T+ SDV+SFGV++ E+   G  P
Sbjct: 205 SY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (303), Expect = 4e-30
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 324 DELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-Q 378
            + LG G FG+V       +  +    +  +AVK +  D +++ L + ++E+  M  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQR 424
           HKN++ + G C +   L ++ +Y   G+L  +              I   P++ + +K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNT 483
                 +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA  +         
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213

Query: 484 TRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA 520
                T G L     APE       T  SDV+SFGV++ E+ 
Sbjct: 214 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (303), Expect = 4e-30
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSMGRL 377
           FS+   +G G FG VY       +  NS  +A+K +++  KQ     ++ + E+  + +L
Sbjct: 56  FSDLREIGHGSFGAVYFAR----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +H N +Q RG   + +   LV +Y    + +  +    KK L   +   +     +GL Y
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           LH      ++HRD+K+GNILL      +LGDFG A       +      VGT  ++APE+
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV 221

Query: 498 ATVSSPT---SASDVYSFGVVILEVACGRRPL 526
                        DV+S G+  +E+A  + PL
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 4e-30
 Identities = 66/308 (21%), Positives = 110/308 (35%), Gaps = 66/308 (21%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QH 379
             ++++LG G  G V               +AVK +           + EI  +     H
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGR-----PVAVKRML---IDFCDIALMEIKLLTESDDH 68

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEG 434
            N+++          L +  +   N +L + +       +  KL        +L  +A G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGR-------------LGDFGLAKLYQQGEVP 481
           + +LH      ++HRD+K  NIL+ +  R               + DFGL K    G+  
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 482 NTTR---VVGTLGYLAPEL-------ATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGK 530
             T      GT G+ APEL        T    T + D++S G V   +   G+ P   G 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GD 242

Query: 531 GEEEEEAVLM-----DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDST 585
               E  ++      D ++ L+ +  I EA D             L+ +        D  
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-------------LISQ----MIDHDPL 285

Query: 586 RRPTMREV 593
           +RPT  +V
Sbjct: 286 KRPTAMKV 293

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (300), Expect = 5e-30
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 324 DELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
            + LG GG   VY      L       + ++A+K +       ++ LK F  E+ +  +L
Sbjct: 16  VDKLGGGGMSTVYLAEDTIL-------NIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
            H+N+V M     + +   LV +Y+   +L+ +I  +    L           + +G+ +
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKH 126

Query: 438 LH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
            H       +VHRDIK  NIL+DS    ++ DFG+AK   +  +  T  V+GT+ Y +PE
Sbjct: 127 AHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRP 525
            A   +    +D+YS G+V+ E+  G  P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  119 bits (300), Expect = 6e-30
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHK 380
            + LG+G FG+V + T      ++ +  +AVK +         +  M+E+  +  L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNW----------------IFGKPKKLLGWKQR 424
           N+V + G C  G   +++ +Y   G L N+                I    +  L  +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNT 483
                 VA+G+ +L     +  +HRD+ + NILL      ++ DFGLA  +         
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN---- 200

Query: 484 TRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
             VV     L     APE       T  SDV+S+G+ + E+   G  P
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (298), Expect = 7e-30
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKE-FMAEISSMGRLQHKNL 382
            LG G FG VY   LA    N    MA+K +      K+G++     EI     L+H N+
Sbjct: 21  PLGKGKFGNVY---LAREKQNK-FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HG 441
           ++M  +      + L+ ++ P G L   +  +       ++    + ++A+ L+Y H   
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
               V+HRDIK  N+L+  +   ++ DFG +  +       T    GTL YL PE+    
Sbjct: 135 ----VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTM--CGTLDYLPPEMIEGK 187

Query: 502 SPTSASDVYSFGVVILEVACGRRPLD 527
           +     D++  GV+  E   G  P D
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFD 213

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (303), Expect = 7e-30
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 324 DELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-Q 378
            + LG G FG+V       +  +    +  +AVK +  D +++ L + ++E+  M  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQR 424
           HKN++ + G C +   L ++ +Y   G+L  +              I   P++ + +K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNT 483
                 +A G+ YL     Q  +HRD+ + N+L+      ++ DFGLA  +         
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 484 TRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVAC-GRRP 525
                T G L     APE       T  SDV+SFGV++ E+   G  P
Sbjct: 260 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  119 bits (300), Expect = 8e-30
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 33/227 (14%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHK 380
            + LG G FG+V +      +       +AVK +    +    +  M+E+  +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 381 NLVQMRGWC-RKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQRR 425
           N+V + G C + G  LM++ ++   G+L+ +                   K  L  +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGEVPNTT 484
                VA+G+ +L     +  +HRD+ + NILL  +   ++ DFGLA  +Y+  +     
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 203

Query: 485 RVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
            V      L     APE       T  SDV+SFGV++ E+   G  P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (303), Expect = 9e-30
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 32/227 (14%)

Query: 324 DELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-Q 378
            + LG G FG+V       L  +  N  T++AVK +  D +++ L + ++E+  M  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW--------------IFGKPKKLLGWKQR 424
           HKN++ + G C +   L ++ +Y   G+L  +                  P++ L  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
                 VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+     +     
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---- 246

Query: 485 RVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
               T G L     APE       T  SDV+SFGV++ E+   G  P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  115 bits (289), Expect = 2e-29
 Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 38/244 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           ++   F F +F +      LIL  +  + S   ++LT   +       S GRA+Y   ++
Sbjct: 1   ATETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQ 57

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +K S       + SF+T+F F I  +  S   +GL F L    SPP     ++ G+F+  
Sbjct: 58  IKDSNN-----VASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQK-KQEFLGIFNTN 111

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK-------HVPAGYYSSSR-- 187
                A  +AV F+T +N    D D N I   +N              V   Y SS+   
Sbjct: 112 NPEPNARTVAVVFNTFKNRI--DFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSNNDL 169

Query: 188 NESFVPVRMRNGQNIHAWID---------FDGFSAS---KTNWIEARRVLAWSLSDTGVA 235
                    +   ++ A +            GFS +     +  E   VL+WS S     
Sbjct: 170 RVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKFRN 229

Query: 236 REIN 239
           +  N
Sbjct: 230 KLSN 233

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (297), Expect = 3e-29
 Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 60/307 (19%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHK 380
            ++LGSG FG+V   T    +    S ++AVK +         +  M+E+  M +L  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNW---------------------IFGKPKKLL 419
           N+V + G C     + L+++Y   G L N+                        +   +L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 420 GWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQG 478
            ++        VA+G+ +L     +  VHRD+ + N+L+      ++ DFGLA  +    
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 479 EVPNTTRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRPL-DMGKG 531
                  VV     L     APE       T  SDV+S+G+++ E+   G  P   +   
Sbjct: 227 NY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQ-EFEAEEMELVLKLGLACCHPDSTRRPTM 590
                      ++N +           ++ Q  +  EE+ +++    +C   DS +RP+ 
Sbjct: 282 AN-----FYKLIQNGF-----------KMDQPFYATEEIYIIM---QSCWAFDSRKRPSF 322

Query: 591 REVVAVL 597
             + + L
Sbjct: 323 PNLTSFL 329

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (306), Expect = 4e-29
 Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 53/293 (18%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNL 382
              +  GG G +Y   LA + N N   + +K + H      +   MAE   +  + H ++
Sbjct: 85  KGCIAHGGLGWIY---LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 383 VQM----RGWCRKGNELM-LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           VQ+        R G+ +  +V +Y+   SL      K    L   +    L ++   L+Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSY 197

Query: 438 LH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           LH  G    +V+ D+K  NI+L  E + +L D G               + GT G+ APE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE 247

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
           +   + PT A+D+Y+ G  +  +                    +D +          +  
Sbjct: 248 IVR-TGPTVATDIYTVGRTLAALTLDLPT---------RNGRYVDGLPE--------DDP 289

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVL--VGQEVAATP 606
             +    +      L+ +       PD  +R  T  E+ A L  V +EV A  
Sbjct: 290 VLKTYDSYGR----LLRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQD 334

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  117 bits (295), Expect = 4e-29
 Identities = 48/278 (17%), Positives = 89/278 (32%), Gaps = 43/278 (15%)

Query: 332 FGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK 391
           +            +    +         S   +     +I  M     KN V        
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 392 GNELMLVYDYMPNGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVV 446
              L +        +L +W+         +  +      QI     E + +LH    + +
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA----EAVEFLH---SKGL 185

Query: 447 VHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ-----------GEVPNTTRVVGTLGYLAP 495
           +HRD+K  NI    +   ++GDFGL     Q                 T  VGT  Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
           E    ++ +   D++S G+++ E+             + E   ++  VRN     K    
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFST-------QMERVRIITDVRN----LKF--- 291

Query: 556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
               +  +   +E  +V  +      P  T RP   ++
Sbjct: 292 --PLLFTQKYPQEHMMVQDM----LSPSPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 14/64 (21%), Positives = 33/64 (51%), Gaps = 5/64 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLV 383
           + +G GGFG V++      N  +    A+K +   +++   ++ M E+ ++ +L+H  +V
Sbjct: 12  QCMGRGGFGVVFEAK----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 384 QMRG 387
           +   
Sbjct: 68  RYFN 71

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (294), Expect = 4e-29
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEIS-SMGRLQHKNL 382
             +G G +G V K      +  +   MAVK +      +  K+ + ++   M       +
Sbjct: 28  GEIGRGAYGSVNKMV----HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNN---WIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
           VQ  G   +  +  +  + M + S +    +++     ++  +   +I     + LN+L 
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYLAPE 496
              +  ++HRDIK  NILLD     +L DFG++     G++ ++   TR  G   Y+APE
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 195

Query: 497 ----LATVSSPTSASDVYSFGVVILEVACGRRPLD 527
                A+       SDV+S G+ + E+A GR P  
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  117 bits (295), Expect = 6e-29
 Identities = 77/336 (22%), Positives = 136/336 (40%), Gaps = 60/336 (17%)

Query: 312 EELSKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF 367
           ++L + +  F++     E +G G +    +      +   + E AVK ++  SK+   E 
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI----HKATNMEFAVKIID-KSKRDPTE- 64

Query: 368 MAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQ 426
             EI  + R  QH N++ ++     G  + +V + M  G L + I  +  K    ++   
Sbjct: 65  --EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASA 120

Query: 427 ILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPN 482
           +L  + + + YLH    Q VVHRD+K  NIL   E       R+ DFG AK  +      
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177

Query: 483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLM 540
            T    T  ++APE+       +A D++S GV+   +    G  P   G  +  EE  ++
Sbjct: 178 MT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM--LTGYTPFANGPDDTPEE--IL 232

Query: 541 DWVRNLYGQGKICEAADARIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMRE 592
             + +    GK                          +LV K+ L   H D  +R T   
Sbjct: 233 ARIGS----GKF----------SLSGGYWNSVSDTAKDLVSKM-L---HVDPHQRLTAAL 274

Query: 593 VVA---VLVGQEVAATP--KELLGDLARGAVDADFS 623
           V+    ++   ++      ++    L +GA+ A +S
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYS 310

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  117 bits (295), Expect = 8e-29
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNST--EMAVKCVNHDSKQGLKEFMAEISSMGRLQ 378
            S  E+LG G FG+V+K          +T  ++A K +     +  +E   EIS M +L 
Sbjct: 91  VSKTEILGGGRFGQVHKCE------ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD 144

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR---RQILADVAEGL 435
           H NL+Q+       N+++LV +Y+  G L + I  +   L         +QI     EG+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC----EGI 200

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            ++H      ++H D+K  NIL  +    ++   DFGLA+ Y+  E        GT  +L
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFL 255

Query: 494 APELATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           APE+      +  +D++S GV+  +L    G  P
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYML--LSGLSP 287

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  113 bits (284), Expect = 1e-28
 Identities = 57/195 (29%), Positives = 81/195 (41%), Gaps = 31/195 (15%)

Query: 24  SALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKMK 78
             + F FN F    N   L L  D  + S  V+ LT   N      S GRA Y   +++ 
Sbjct: 2   KTISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW 59

Query: 79  RSTATNSSILTSFSTSFVFSILPEIASS-PGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
            S    +  + SF T F FSI        P  GL F +    +  G     YFG+++   
Sbjct: 60  DS---TTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFGIYNPL- 114

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
             +  P +AVEFDT +N    DP   HIG+D+N++ S K               VP  + 
Sbjct: 115 --SPYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKT--------------VPFTLD 156

Query: 198 NGQNIHAWIDFDGFS 212
           NG   +  I +D  +
Sbjct: 157 NGGIANVVIKYDAST 171

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  113 bits (283), Expect = 1e-28
 Identities = 52/191 (27%), Positives = 73/191 (38%), Gaps = 32/191 (16%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ--FSFGRAYYPTKLKMKR 79
           S+   F   +F    N T+LIL  D  V S   + LTN       S GRA+Y   +++  
Sbjct: 1   SNDASFNVETF----NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND 56

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
                   L SFST+F F I  +   +  +GL F L    S P     +Y GLF+     
Sbjct: 57  R---TIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGLFNTTNYD 112

Query: 140 TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
             A  +AV FDT           N I +D+N+I         +               NG
Sbjct: 113 RDAHTVAVVFDT---------VSNRIEIDVNSIRPIATESCNFG------------HNNG 151

Query: 200 QNIHAWIDFDG 210
           +     I +D 
Sbjct: 152 EKAEVRITYDS 162

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (294), Expect = 1e-28
 Identities = 56/253 (22%), Positives = 100/253 (39%), Gaps = 32/253 (12%)

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN 344
           + +  K  + D+  E   + +  +    +       +   E LGSG FG V++       
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV----- 71

Query: 345 NNNST--EMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM 402
              +T      K +N            EIS M +L H  L+ +        E++L+ +++
Sbjct: 72  -EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 403 PNGSLNNWIFGKPKKLLGWKQR------RQILADVAEGLNYLHHGWDQVVVHRDIKSGNI 456
             G L + I  +  K+    +       RQ      EGL ++H   +  +VH DIK  NI
Sbjct: 131 SGGELFDRIAAEDYKM---SEAEVINYMRQAC----EGLKHMH---EHSIVHLDIKPENI 180

Query: 457 LLDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGV 514
           + +++    +   DFGLA      E+        T  + APE+         +D+++ GV
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 515 V--ILEVACGRRP 525
           +  +L    G  P
Sbjct: 239 LGYVL--LSGLSP 249

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  117 bits (296), Expect = 1e-28
 Identities = 51/244 (20%), Positives = 99/244 (40%), Gaps = 30/244 (12%)

Query: 309 FSYEELSKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------- 357
            + ++ S   K   ++    + LGSG  G V              ++A++ ++       
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF----ERKTCKKVAIRIISKRKFAIG 176

Query: 358 -HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
                        EI  + +L H  +++++ +     +  +V + M  G L + +     
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV--VGN 233

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAK 473
           K L     +     +   + YLH   +  ++HRD+K  N+LL S+      ++ DFG +K
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290

Query: 474 LYQQGEVPNTTRVVGTLGYLAPE-LATVSSP--TSASDVYSFGVVILEVACGRRPLDMGK 530
           +  +  +  T  + GT  YLAPE L +V +     A D +S GV++     G  P    +
Sbjct: 291 ILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

Query: 531 GEEE 534
            +  
Sbjct: 349 TQVS 352

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (291), Expect = 1e-28
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 39/232 (16%)

Query: 325 ELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNL 382
             +G G FGRV++            T +AVK +  + S     +F  E + M    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNW----------------------IFGKPKKLLG 420
           V++ G C  G  + L+++YM  G LN +                      +       L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA-KLYQQGE 479
             ++  I   VA G+ YL    ++  VHRD+ + N L+   M  ++ DFGL+  +Y    
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 480 VPNTTRVVGTLGYL-----APELATVSSPTSASDVYSFGVVILEVA-CGRRP 525
                        +      PE    +  T+ SDV+++GVV+ E+   G +P
Sbjct: 230 Y-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  115 bits (289), Expect = 2e-28
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 35/233 (15%)

Query: 315 SKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---------HDSK 361
           S +T GF  +    E+LG G    V +      +     E AVK ++          + +
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQ 64

Query: 362 QGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLG 420
           +  +  + E+  + ++  H N++Q++          LV+D M  G L +++  K    L 
Sbjct: 65  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LS 122

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
            K+ R+I+  + E +  LH      +VHRD+K  NILLD +M  +L DFG +     GE 
Sbjct: 123 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179

Query: 481 PNTTRVVGTLGYLAPE-LATVSSPTS-----ASDVYSFGVV--ILEVACGRRP 525
                V GT  YLAPE +    +          D++S GV+   L    G  P
Sbjct: 180 LRE--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAGSPP 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (289), Expect = 2e-28
 Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 35/251 (13%)

Query: 287 NKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNN 346
           +  K      I     +   +    E L            +GSG  G+V+K         
Sbjct: 5   SSGKQTGYLTIGGQRYQAEINDL--ENL----------GEMGSGTCGQVWKMR----FRK 48

Query: 347 NSTEMAVKCVNHDSK-QGLKEFMAEIS-SMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN 404
               +AVK +      +  K  + ++   +       +VQ  G      ++ +  + M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT 108

Query: 405 GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG 464
            +    +  + +  +  +   ++   + + L YL       V+HRD+K  NILLD   + 
Sbjct: 109 CAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQI 164

Query: 465 RLGDFGLAKLYQQGEVPNT---TRVVGTLGYLAPELATVSSPTSA-----SDVYSFGVVI 516
           +L DFG++     G + +     R  G   Y+APE      PT       +DV+S G+ +
Sbjct: 165 KLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219

Query: 517 LEVACGRRPLD 527
           +E+A G+ P  
Sbjct: 220 VELATGQFPYK 230

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  118 bits (297), Expect = 2e-28
 Identities = 67/322 (20%), Positives = 128/322 (39%), Gaps = 48/322 (14%)

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNN 344
             +   +  E+   + +L+  P  F   +    ++ +   + LGSG +G V        +
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR----D 58

Query: 345 NNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM 402
                E A+K +     S     + + E++ +  L H N++++  +        LV +  
Sbjct: 59  KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM 462
             G L + I    +          I+  V  G+ YLH      +VHRD+K  N+LL+S+ 
Sbjct: 119 KGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKE 173

Query: 463 RG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEV 519
           +    ++ DFGL+ +++  +       +GT  Y+APE+          DV+S GV++  +
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFIL 230

Query: 520 ACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEM--------EL 571
             G  P      +E    V          +GK            F++ E         +L
Sbjct: 231 LAGYPPFGGQTDQEILRKVE---------KGKY----------TFDSPEWKNVSEGAKDL 271

Query: 572 VLKLGLACCHPDSTRRPTMREV 593
           + ++ L     DS RR + ++ 
Sbjct: 272 IKQM-L---QFDSQRRISAQQA 289

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (288), Expect = 2e-28
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 324 DELLGSGGFGRVYKG--TLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQ 378
            E+LG GG   V+       +       ++AVK +  D          F  E  +   L 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHR------DVAVKVLRADLARDPSFYLRFRREAQNAAALN 70

Query: 379 HKNLVQM--RGWCRKGNELM--LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
           H  +V +   G        +  +V +Y+   +L + +    +  +  K+  +++AD  + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQA 128

Query: 435 LNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP--NTTRVVGTLG 491
           LN+ H +G    ++HRD+K  NI++ +    ++ DFG+A+           T  V+GT  
Sbjct: 129 LNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           YL+PE A   S  + SDVYS G V+ EV  G  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (285), Expect = 4e-28
 Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 23/214 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEIS-SMGRLQHKNL 382
             LG G +G V K      +  +   MAVK +      Q  K  + ++  SM  +     
Sbjct: 13  MELGRGAYGVVEKMR----HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHH 440
           V   G   +  ++ +  + M + SL+ +        + +      +I   + + L +LH 
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT---TRVVGTLGYLAPE- 496
                V+HRD+K  N+L+++  + ++ DFG++     G + +        G   Y+APE 
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPER 180

Query: 497 ---LATVSSPTSASDVYSFGVVILEVACGRRPLD 527
                     +  SD++S G+ ++E+A  R P D
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (285), Expect = 4e-28
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 20/208 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +      +     E A K +N    S +  ++   E     +LQH N+
Sbjct: 12  EELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++    ++ +   LV+D +  G L   I    ++          +  + E + Y H   
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCH--- 122

Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT GYL+PE+  
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLK 180

Query: 500 VSSPTSASDVYSFGVV--ILEVACGRRP 525
               +   D+++ GV+  IL    G  P
Sbjct: 181 KDPYSKPVDIWACGVILYIL--LVGYPP 206

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  112 bits (280), Expect = 4e-28
 Identities = 55/196 (28%), Positives = 79/196 (40%), Gaps = 28/196 (14%)

Query: 24  SALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLKM 77
             + F F+ F       +L L     +  + V++LT  +        S GR  Y   + M
Sbjct: 2   ETISFSFSEFEP--GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHM 59

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPG-FGLCFVLTNFTSPPGALASQYFGLFSNA 136
             S    +  + SF T F FSI           GL F +    S P      Y G+F+N+
Sbjct: 60  WDS---TTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNS 115

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRM 196
                   LAVEFDT  NP ++ P   HIG+D+N+I S K                P ++
Sbjct: 116 KQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT--------------QPFQL 160

Query: 197 RNGQNIHAWIDFDGFS 212
            NGQ  +  I +D  S
Sbjct: 161 DNGQVANVVIKYDAPS 176

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (289), Expect = 4e-28
 Identities = 46/328 (14%), Positives = 88/328 (26%), Gaps = 82/328 (25%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMA 369
           EL +  +      +LG        + T    +        V       +     +K+   
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEAT----DQETGESFEVHVPYFTERPPSNAIKQMKE 122

Query: 370 EISSMGRLQ-------------------------HKNLVQMRGWCRKGNELMLVYDYM-P 403
           E+  +  L+                          K ++++R   R    L   + Y   
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 404 NGSLNNWI-----FGKPKKLLGWKQRRQILADVAEGLNYLH-HGWDQVVVHRDIKSGNIL 457
             +L  +           K L    R Q+   V   L  LH +G    +VH  ++  +I+
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIV 238

Query: 458 LDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-----------TSA 506
           LD      L  F                   + G+  PEL    +            T +
Sbjct: 239 LDQRGGVFLTGFEHLVRDG-----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293

Query: 507 SDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEA 566
            D ++ G+VI  + C   P+      ++      +W+               R  +    
Sbjct: 294 FDAWALGLVIYWIWCADLPIT-----KDAALGGSEWIF--------------RSCKNIPQ 334

Query: 567 EEMELVLKLGLACCHPDSTRRPTMREVV 594
               L+              R    + +
Sbjct: 335 PVRALLEGF----LRYPKEDRLLPLQAM 358

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (286), Expect = 5e-28
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 14/206 (6%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHK 380
             L+G GG G VY+      +      +A+K ++               E  + GRLQ  
Sbjct: 39  RRLVGRGGMGDVYEAE----DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH- 439
           ++V +  +     +L +    +    L   +  + +  L   +   I+  +   L+  H 
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
            G      HRD+K  NIL+ ++    L DFG+A      ++      VGTL Y+APE  +
Sbjct: 153 AG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 500 VSSPTSASDVYSFGVVILEVACGRRP 525
            S  T  +D+Y+   V+ E   G  P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (284), Expect = 8e-28
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E+LGSG F  V+               A+KC+             EI+ + +++H+N+V 
Sbjct: 15  EVLGSGAFSEVFLVK----QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW---KQRRQILADVAEGLNYLHHG 441
           +           LV   +  G L + I  +     G    K    ++  V   + YLH  
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH-- 123

Query: 442 WDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
            +  +VHRD+K  N+L  +        + DFGL+K+ Q G     +   GT GY+APE+ 
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVL 179

Query: 499 TVSSPTSASDVYSFGVV--ILEVACGRRP 525
                + A D +S GV+  IL   CG  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYIL--LCGYPP 206

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (286), Expect = 8e-28
 Identities = 42/226 (18%), Positives = 88/226 (38%), Gaps = 36/226 (15%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA----------------- 369
           L  G F ++    L   +N      A+K       +  ++F                   
Sbjct: 39  LNQGKFNKII---LCEKDN---KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92

Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR----- 424
           E+  +  ++++  +   G     +E+ ++Y+YM N S+  +          +        
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 425 -RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT 483
            + I+  V    +Y+H+  +  + HRD+K  NIL+D   R +L DFG ++     ++   
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI-KG 209

Query: 484 TRVVGTLGYLAPELATVSSPTS--ASDVYSFGVVILEVACGRRPLD 527
           +   GT  ++ PE  +  S  +    D++S G+ +  +     P  
Sbjct: 210 S--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  111 bits (277), Expect = 1e-27
 Identities = 63/245 (25%), Positives = 93/245 (37%), Gaps = 46/245 (18%)

Query: 26  LDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLKMKR 79
             F F+ F    N  +L L     + S  V+ LT  +        S GRA Y   +K+  
Sbjct: 3   QSFNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60

Query: 80  STATNSSILTSFSTSFVFSILPEIASS-PGFGLCFVLTNFTSPPGALASQYFGLFSNATV 138
           S    +  + SF T F F+I    A   P  GL F +    SP G       G+F     
Sbjct: 61  S---TTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGE-DGGNLGVFKPP-- 114

Query: 139 VTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK------------HVPAGYYSSS 186
                  AVEFDT QN    DP   HIG+D+N+I S+K            +V   Y S +
Sbjct: 115 -EGDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLHFQLENGGVANVVIKYDSPT 171

Query: 187 R--NESFVPVRMRNGQNIHAWIDFD-----------GFSAS---KTNWIEARRVLAWSLS 230
           +  N       +     +   +D             G SA+   + N +E   +++WS +
Sbjct: 172 KILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT 231

Query: 231 DTGVA 235
            +   
Sbjct: 232 SSLQE 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  115 bits (290), Expect = 1e-27
 Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 49/302 (16%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQ 362
           P  F     +  +  +    +LG G FG V        +     E AVK ++      K 
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCK----DKITGQECAVKVISKRQVKQKT 68

Query: 363 GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWK 422
             +  + E+  + +L H N++++  +        LV +    G L + I    +K     
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEV 126

Query: 423 QRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGE 479
              +I+  V  G+ Y+H      +VHRD+K  N+LL+S+ +    R+ DFGL+  ++  +
Sbjct: 127 DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
                  +GT  Y+APE+   +      DV+S GV++  +  G  P +     +  + V 
Sbjct: 184 KMKD--KIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

Query: 540 MDWVRNLYGQGKICEAADARIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMR 591
                    +GK            FE  +         +L+ K+ L       + R + R
Sbjct: 241 ---------KGKY----------TFELPQWKKVSESAKDLIRKM-L---TYVPSMRISAR 277

Query: 592 EV 593
           + 
Sbjct: 278 DA 279

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 2e-27
 Identities = 40/232 (17%), Positives = 76/232 (32%), Gaps = 23/232 (9%)

Query: 312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTE-MAVKCVNHDSKQGLKEFMAE 370
            E    +K      LLG G F +VY+ T  + N+  + +   +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 371 ISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWI---FGKPKKLLGWKQRRQI 427
           +  +        ++        N  +LV +    G+L N I      P+K++        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG-----------RLGDFGLA---K 473
              +   +  +H   D  ++H DIK  N +L +                L D G +   K
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           L+ +G +        T G+   E+ +        D +     +  +  G   
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (285), Expect = 2e-27
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--------HDSKQGLKEFMAEISSMGR 376
           +++G G    V +      +     E AVK +            ++  +    E   + +
Sbjct: 100 DVIGRGVSSVVRRCV----HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 377 L-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           +  H +++ +       + + LV+D M  G L +++  K    L  K+ R I+  + E +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAV 213

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           ++LH      +VHRD+K  NILLD  M+ RL DFG +   + GE      + GT GYLAP
Sbjct: 214 SFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAP 268

Query: 496 E-LATVSSPTS-----ASDVYSFGVV--ILEVACGRRP 525
           E L      T        D+++ GV+   L    G  P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTL--LAGSPP 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (279), Expect = 7e-27
 Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 64/289 (22%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G    VY+           T+              K    EI  + RL H N+++
Sbjct: 59  SELGRGATSIVYRCK------QKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILADVAEGLNY 437
           ++       E+ LV + +  G L + I  K           +     +QIL    E + Y
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-----KQIL----EAVAY 163

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           LH   +  +VHRD+K  N+L  +       ++ DFGL+K+ +   +  T  V GT GY A
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCA 218

Query: 495 PELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI 552
           PE+    +     D++S G++  IL   CG  P      +E  +  +   + N     + 
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYIL--LCGFEPFY----DERGDQFMFRRILN----CEY 268

Query: 553 CEAADARIRQEFEAEE--------MELVLKLGLACCHPDSTRRPTMREV 593
                      F +           +LV KL +     D  +R T  + 
Sbjct: 269 ----------YFISPWWDEVSLNAKDLVRKL-I---VLDPKKRLTTFQA 303

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (285), Expect = 1e-26
 Identities = 55/249 (22%), Positives = 100/249 (40%), Gaps = 21/249 (8%)

Query: 285 RKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSN----DELLGSGGFGRVYKGTL 340
           +  + K       + +  + W  ++  + +        +     E LG+G FG V++ T 
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWK-QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT- 177

Query: 341 ANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
                      A K V    +   +    EI +M  L+H  LV +       NE++++Y+
Sbjct: 178 ---ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234

Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           +M  G L   +  +    +   +  + +  V +GL ++H   +   VH D+K  NI+  +
Sbjct: 235 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290

Query: 461 EMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVV--I 516
           +    L   DFGL       +        GT  + APE+A        +D++S GV+  I
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348

Query: 517 LEVACGRRP 525
           L    G  P
Sbjct: 349 L--LSGLSP 355

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (279), Expect = 1e-26
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 20/208 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +      +     E A K +N    S +  ++   E     +LQH N+
Sbjct: 35  EELGKGAFSVVRRCV----HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++    ++ +   LV+D +  G L   I  +             +  + E + Y H   
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCH--- 145

Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              +VHR++K  N+LL S+ +G   +L DFGLA      E  +     GT GYL+PE+  
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLK 203

Query: 500 VSSPTSASDVYSFGVV--ILEVACGRRP 525
               +   D+++ GV+  IL    G  P
Sbjct: 204 KDPYSKPVDIWACGVILYIL--LVGYPP 229

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (273), Expect = 1e-26
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 24/218 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             +G G +G V                A K +     + +  F  EI  M  L H N+++
Sbjct: 15  NTIGRGSWGEVKIAV----QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +        ++ LV +    G L   +    K++       +I+ DV   + Y H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCH---KL 125

Query: 445 VVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LATV 500
            V HRD+K  N L  ++      +L DFGLA  ++ G++  T   VGT  Y++P+ L  +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEGL 183

Query: 501 SSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEE 536
             P    D +S GV+  +L   CG  P        + E
Sbjct: 184 YGP--ECDEWSAGVMMYVL--LCGYPPFS---APTDSE 214

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 1e-26
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNL 382
              LGSG FG V+         ++  E  +K +N   S+  +++  AEI  +  L H N+
Sbjct: 27  KRKLGSGAFGDVHLVE----ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR------RQILADVAEGLN 436
           +++       + + +V +    G L   I     +     +       +Q++      L 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM----NALA 138

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           Y H    Q VVH+D+K  NIL          ++ DFGLA+L++  E        GT  Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYM 193

Query: 494 APE-LATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEE 536
           APE      +     D++S GVV   L    G  P     G   EE
Sbjct: 194 APEVFKRDVTF--KCDIWSAGVVMYFL--LTGCLPFT---GTSLEE 232

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 2e-26
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 23/209 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
            +LG G FG V K      +     E AVK +N      +     + E+  + +L H N+
Sbjct: 28  CMLGKGSFGEVLKCK----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++       +   +V +    G L + I  + +         +I+  V  G+ Y+H   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH--- 138

Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE-LA 498
              +VHRD+K  NILL+S+ +    ++ DFGL+  +QQ         +GT  Y+APE L 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR 196

Query: 499 TVSSPTSASDVYSFGVV--ILEVACGRRP 525
                    DV+S GV+  IL    G  P
Sbjct: 197 GTYDE--KCDVWSAGVILYIL--LSGTPP 221

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 3e-26
 Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 34/241 (14%)

Query: 314 LSKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--------HDSK 361
           +S   K   ++    + LGSG  G V              ++A+K ++            
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAF----ERKTCKKVAIKIISKRKFAIGSAREA 56

Query: 362 QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW 421
                   EI  + +L H  +++++ +     +  +V + M  G L + +     K L  
Sbjct: 57  DPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV--VGNKRLKE 113

Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQG 478
              +     +   + YLH   +  ++HRD+K  N+LL S+      ++ DFG +K+  + 
Sbjct: 114 ATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 479 EVPNTTRVVGTLGYLAPE-LATVSSP--TSASDVYSFGVV--ILEVACGRRPLDMGKGEE 533
            +  T  + GT  YLAPE L +V +     A D +S GV+  I     G  P    + + 
Sbjct: 171 SLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPPFSEHRTQV 226

Query: 534 E 534
            
Sbjct: 227 S 227

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (279), Expect = 4e-26
 Identities = 69/313 (22%), Positives = 120/313 (38%), Gaps = 61/313 (19%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-------- 357
           P  +  ++  K  + +     LGSG +G V          N  +E A+K +         
Sbjct: 23  PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCK----EKNGHSEKAIKVIKKSQFDKGR 78

Query: 358 -----HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF 412
                 + ++  +E   EIS +  L H N++++           LV ++   G L   I 
Sbjct: 79  YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI- 137

Query: 413 GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDF 469
              +          I+  +  G+ YLH      +VHRDIK  NILL+++      ++ DF
Sbjct: 138 -INRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDF 193

Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           GL+  + +         +GT  Y+APE+          DV+S GV++  + CG  P   G
Sbjct: 194 GLSSFFSKDYKLRD--RLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPFG-G 249

Query: 530 KGEEE-EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEM--------ELVLKLGLACC 580
           + +++  + V          +GK            F+  +         EL+  + L   
Sbjct: 250 QNDQDIIKKVE---------KGKY----------YFDFNDWKNISDEAKELIKLM-L--- 286

Query: 581 HPDSTRRPTMREV 593
             D  +R T  E 
Sbjct: 287 TYDYNKRCTAEEA 299

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (272), Expect = 4e-26
 Identities = 57/288 (19%), Positives = 106/288 (36%), Gaps = 54/288 (18%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNL 382
            ++LG G  G+V +      +     + A+K +         +   E+    +     ++
Sbjct: 34  KQVLGLGVNGKVLECF----HRRTGQKCALKLLY---DS--PKARQEVDHHWQASGGPHI 84

Query: 383 VQMRGWC----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           V +             L+++ + M  G L + I  +  +    ++  +I+ D+   + +L
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           H      + HRD+K  N+L  S+ +    +L DFG AK   Q  +        T  Y+AP
Sbjct: 145 H---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYYVAP 198

Query: 496 ELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           E+        + D++S GV+  IL   CG  P       +     +   +R     G+  
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYIL--LCGFPPFY-SNTGQAISPGMKRRIRL----GQY- 250

Query: 554 EAADARIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMREV 593
                     F   E         +L+  L L     D T R T+ + 
Sbjct: 251 ---------GFPNPEWSEVSEDAKQLIRLL-L---KTDPTERLTITQF 285

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (272), Expect = 5e-26
 Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQH- 379
             + LG G F  V +      + +   E A K +      +    E + EI+ +   +  
Sbjct: 33  TSKELGRGKFAVVRQCI----SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             ++ +       +E++L+ +Y   G + +    +  +++      +++  + EG+ YLH
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
                 +VH D+K  NILL S       ++ DFG+++            ++GT  YLAPE
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPE 203

Query: 497 LATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           +      T+A+D+++ G++  +L       P
Sbjct: 204 ILNYDPITTATDMWNIGIIAYML--LTHTSP 232

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  107 bits (270), Expect = 6e-26
 Identities = 66/299 (22%), Positives = 118/299 (39%), Gaps = 52/299 (17%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNL 382
           +++LG G   RV        N   S E AVK +             E+  + + Q H+N+
Sbjct: 18  EDVLGEGAHARVQTCI----NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH-HG 441
           +++  +  + +   LV++ M  GS+ + I    ++     +   ++ DVA  L++LH  G
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 442 WDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEV------PNTTRVVGTLGY 492
               + HRD+K  NIL +   +    ++ DF L    +          P      G+  Y
Sbjct: 132 ----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 493 LAPELATVSSPTS-----ASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
           +APE+    S  +       D++S GV+  IL    G  P     G    +         
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPFV---GRCGSDCGWDRGEAC 242

Query: 546 LYGQGKICEAADARIRQ---EFEAEEM--------ELVLKLGLACCHPDSTRRPTMREV 593
              Q  + E     I++   EF  ++         +L+ KL L     D+ +R +  +V
Sbjct: 243 PACQNMLFE----SIQEGKYEFPDKDWAHISCAAKDLISKL-L---VRDAKQRLSAAQV 293

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  107 bits (269), Expect = 9e-26
 Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 29/211 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG G FG V++        ++      K V             EIS +   +H+N++ 
Sbjct: 11  EDLGRGEFGIVHRCV----ETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILH 65

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR------RQILADVAEGLNYL 438
           +        EL+++++++    +   I     +L    +R       Q+     E L +L
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFEL---NEREIVSYVHQVC----EALQFL 118

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           H      + H DI+  NI+  +     +   +FG A+  + G+      +     Y APE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPE 173

Query: 497 LATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           +      ++A+D++S G +  +L    G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVL--LSGINP 202

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  109 bits (275), Expect = 9e-26
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 33/215 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           E LG G F  V +            E A   +N    S +  ++   E      L+H N+
Sbjct: 17  EELGKGAFSVVRRCV----KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILADVAEGL 435
           V++     +     L++D +  G L   I  +           +     +QIL    E +
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-----QQIL----EAV 123

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            + H      VVHR++K  N+LL S+++G   +L DFGLA   +  +        GT GY
Sbjct: 124 LHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGY 179

Query: 493 LAPELATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           L+PE+          D+++ GV+  IL    G  P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYIL--LVGYPP 212

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (271), Expect = 1e-25
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 23/205 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEISSMGRLQ 378
           E LGSG F  V K        +   E A K +              +E   E+S + ++ 
Sbjct: 18  EELGSGQFAIVKKCR----EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++    K+ L  ++    +  + +G+NYL
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYL 131

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           H    + + H D+K  NI+L  +       +L DFGLA   + G       + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVA 186

Query: 495 PELATVSSPTSASDVYSFGVV--IL 517
           PE+         +D++S GV+  IL
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYIL 211

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 1e-25
 Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 50/283 (17%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
            +LG G FG V K      +     E AVK +N      +     + E+  + +L H N+
Sbjct: 28  CMLGKGSFGEVLKCK----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           +++       +   +V +    G L + I    +K        +I+  V  G+ Y+H   
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH--- 138

Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              +VHRD+K  NILL+S+ +    ++ DFGL+  +QQ         +GT  Y+APE+  
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR 196

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-EEAVLMDWVRNLYGQGKICEAADA 558
            +      DV+S GV++  +  G  P   GK E +  + V           GK       
Sbjct: 197 GTY-DEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVE---------TGKY------ 239

Query: 559 RIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMREV 593
                F+  +         +L+ K+ L       + R T  + 
Sbjct: 240 ----AFDLPQWRTISDDAKDLIRKM-L---TFHPSLRITATQC 274

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (268), Expect = 1e-25
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 41/214 (19%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNST--EMAVKCVN------HDSKQGLKEFMAEISSMGR 376
           E LGSG F  V K          ST  E A K +              +E   E+S + +
Sbjct: 18  EELGSGQFAIVKKCR------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILA 429
           + H N++ +        +++L+ + +  G L +++  K           +     +QIL 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI-----KQIL- 125

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTR 485
              +G+NYLH    + + H D+K  NI+L  +       +L DFGLA   + G       
Sbjct: 126 ---DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVV--IL 517
           + GT  ++APE+         +D++S GV+  IL
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (269), Expect = 1e-25
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-----HDSKQGLKEFMAEISSMGRLQH 379
           E++G G F  V +      N     + AVK V+            ++   E S    L+H
Sbjct: 30  EVIGKGPFSVVRRCI----NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR------RQILADVAE 433
            ++V++         L +V+++M    L   I  +      + +       RQIL    E
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----E 141

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTL 490
            L Y H   D  ++HRD+K   +LL S+      +LG FG+A    +  +    R VGT 
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTP 197

Query: 491 GYLAPELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVL 539
            ++APE+          DV+  GV+  IL    G  P   G  E   E ++
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFIL--LSGCLPFY-GTKERLFEGII 245

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 2e-25
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNST--EMAVKCVN------HDSKQGLKEFMAEISSMGR 376
           E LGSG F  V K           T  E A K +              +E   E++ +  
Sbjct: 11  EELGSGQFAIVRKCR------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILA 429
           ++H N++ +        +++L+ + +  G L +++  K         + L     +QIL 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL-----KQIL- 118

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTR 485
              +G++YLH    + + H D+K  NI+L  +       +L DFG+A   + G       
Sbjct: 119 ---DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170

Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           + GT  ++APE+         +D++S GV+  IL    G  P
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  106 bits (266), Expect = 2e-25
 Identities = 66/286 (23%), Positives = 108/286 (37%), Gaps = 49/286 (17%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNL 382
           D+ LG G F    K      +  ++   AVK ++   K+       EI+++   + H N+
Sbjct: 16  DKPLGEGSFSICRKCV----HKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNI 68

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++           LV + +  G L   I  K KK     +   I+  +   ++++H   
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMH--- 123

Query: 443 DQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
           D  VVHRD+K  N+L   E      ++ DFG A+L      P  T    TL Y APEL  
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLN 182

Query: 500 VSSPTSASDVYSFGVV--ILEVACGRRP--LDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
            +    + D++S GV+   +    G+ P               +M  ++     G     
Sbjct: 183 QNGYDESCDLWSLGVILYTM--LSGQVPFQSHDRSLTCTSAVEIMKKIKK----GDF--- 233

Query: 556 ADARIRQEFEAEE--------MELVLKLGLACCHPDSTRRPTMREV 593
                   FE E          +L+  L L     D  +R  M  +
Sbjct: 234 -------SFEGEAWKNVSQEAKDLIQGL-L---TVDPNKRLKMSGL 268

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (263), Expect = 5e-25
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 26/226 (11%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA--EISSMGRLQ 378
           F   E LG+G +  VYKG     N      +A+K V  DS++G     A  EIS M  L+
Sbjct: 7   FKQLEKLGNGTYATVYKGL----NKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELK 61

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPN---GSLNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           H+N+V++       N+L LV+++M N     +++   G   + L     +     + +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN---TTRVVGTLGY 492
            + H      ++HRD+K  N+L++   + +LGDFGLA+ +    +P    ++ VV TL Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVV-TLWY 174

Query: 493 LAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
            AP++   +   S   + D++S G ++ E+    +PL  G  +EE+
Sbjct: 175 RAPDVLMGSRTYST--SIDIWSCGCILAEMIT-GKPLFPGTNDEEQ 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (264), Expect = 6e-25
 Identities = 54/251 (21%), Positives = 87/251 (34%), Gaps = 57/251 (22%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-----HDSKQGLKEFMAEISSMGRLQH 379
             +G G +G V         N      A+K +N       + + ++    E+  M +L H
Sbjct: 32  GAIGQGSYGVVRVAI----ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW------------------ 421
            N+ ++         + LV +    G L + +        G                   
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 422 --------------------KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS- 460
                               K    I+  +   L+YLH   +Q + HRDIK  N L  + 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204

Query: 461 -EMRGRLGDFGLAKLY---QQGEVPNTTRVVGTLGYLAPEL--ATVSSPTSASDVYSFGV 514
                +L DFGL+K +     GE    T   GT  ++APE+   T  S     D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

Query: 515 VILEVACGRRP 525
           ++  +  G  P
Sbjct: 265 LLHLLLMGAVP 275

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (262), Expect = 7e-25
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 31/213 (14%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNL 382
           +LG G F  V    LA     +  E A+K +         +      E   M RL H   
Sbjct: 37  ILGEGSFSTVV---LARELATS-REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---------ADVAE 433
           V++    +   +L     Y  NG L  +I           ++             A++  
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVS 141

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLGY 492
            L YLH    + ++HRD+K  NILL+ +M  ++ DFG AK+             VGT  Y
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           ++PEL T  S   +SD+++ G +I ++  G  P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (260), Expect = 1e-24
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 25/224 (11%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMA--EISSMGRL 377
           +   E +G G +G V+K      N      +A+K V  D   +G+    A  EI  +  L
Sbjct: 4   YEKLEKIGEGTYGTVFKAK----NRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL 58

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR---RQILADVAEG 434
           +HKN+V++        +L LV+++     L  +       L     +    Q+L    +G
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL----KG 113

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L + H      V+HRD+K  N+L++     +L +FGLA+ +       +  VV TL Y  
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRP 169

Query: 495 PEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           P++   A + S   + D++S G +  E+A   RPL  G   +++
Sbjct: 170 PDVLFGAKLYST--SIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (264), Expect = 1e-24
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 36/221 (16%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           ++N +++G+G FG V++  L  ++     E+A+K V  D +   +E    +  M  ++H 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-----EVAIKKVLQDKRFKNRE----LQIMRIVKHP 92

Query: 381 NLVQMR------GWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRR----QIL 428
           N+V ++      G  +    L LV +Y+P  ++      + K K+ +     +    Q+L
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 429 ADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRV 486
                 L Y+H  G    + HRDIK  N+LLD      +L DFG AK+   GE PN + +
Sbjct: 152 ----RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYI 202

Query: 487 VGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPL 526
             +  Y APEL   ++  T+  D++S G V+ E+    +PL
Sbjct: 203 C-SRYYRAPELIFGATNYTTNIDIWSTGCVMAEL-MQGQPL 241

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (260), Expect = 1e-24
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA-----EISSMGRLQHKN 381
           +G G F +V        +     E+A+K ++   K  L          E+  M  L H N
Sbjct: 23  IGKGNFAKVKLAR----HILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V++         L L+ +Y   G + +++    +  +  K+ R     +   + Y H  
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQ- 132

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + +VHRD+K+ N+LLD++M  ++ DFG +  +  G   +     G   Y APEL    
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPEL--FQ 186

Query: 502 SPT---SASDVYSFGVVILEVACGRRPLD 527
                    DV+S GV++  +  G  P D
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  105 bits (263), Expect = 2e-24
 Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 53/288 (18%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNL 382
            ++LG G  G+V +      N     + A+K +  D  +  +E    +    R     ++
Sbjct: 67  SQVLGLGINGKVLQIF----NKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHI 117

Query: 383 VQMRGWC----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           V++             L++V + +  G L + I  +  +    ++  +I+  + E + YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           H      + HRD+K  N+L  S+      +L DFG AK         T     T  Y+AP
Sbjct: 178 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAP 232

Query: 496 ELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           E+        + D++S GV+  IL   CG  P             +   +R     G+  
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYIL--LCGYPPFY-SNHGLAISPGMKTRIRM----GQY- 284

Query: 554 EAADARIRQEFEAEEM--------ELVLKLGLACCHPDSTRRPTMREV 593
                    EF   E          L+  L L     + T+R T+ E 
Sbjct: 285 ---------EFPNPEWSEVSEEVKMLIRNL-L---KTEPTQRMTITEF 319

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 3e-24
 Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 39/220 (17%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEISSMGRLQ 378
           E LGSG F  V K        +   + A K +              ++   E+S +  +Q
Sbjct: 17  EELGSGQFAVVKKCR----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-------KLLGWKQRRQILADV 431
           H N++ +        +++L+ + +  G L +++  K         + L     +QIL   
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-----KQIL--- 124

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG----RLGDFGLAKLYQQGEVPNTTRVV 487
             G+ YLH      + H D+K  NI+L          ++ DFGLA     G       + 
Sbjct: 125 -NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 178

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVV--ILEVACGRRP 525
           GT  ++APE+         +D++S GV+  IL    G  P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (254), Expect = 4e-24
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           + LG G +G V        N      +AVK V+        E +  EI     L H+N+V
Sbjct: 13  QTLGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAEGLNYLH- 439
           +  G  R+GN   L  +Y   G L + I      +     +R   Q++A    G+ YLH 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA----GVVYLHG 123

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLGYLAPE 496
            G    + HRDIK  N+LLD     ++ DFGLA +++        N     GTL Y+APE
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE 177

Query: 497 LATVSSPT---SASDVYSFGVVILEVACGRRPLD 527
           L  +          DV+S G+V+  +  G  P D
Sbjct: 178 L--LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (257), Expect = 6e-24
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 58/262 (22%)

Query: 301 ELEYWPHRF--SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH 358
            +E         YE+L+K          +G G FG V+K   A +       +A+K V  
Sbjct: 7   SVECPFCDEVSKYEKLAK----------IGQGTFGEVFK---ARHRKTGQK-VALKKVLM 52

Query: 359 DS-KQGLKEFMA--EISSMGRLQHKNLVQMRG--------WCRKGNELMLVYDYMPN--- 404
           ++ K+G     A  EI  +  L+H+N+V +          + R    + LV+D+  +   
Sbjct: 53  ENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 111

Query: 405 GSLNN--WIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           G L+N    F     K+++     + +L     GL Y+H      ++HRD+K+ N+L+  
Sbjct: 112 GLLSNVLVKFTLSEIKRVM-----QMLL----NGLYYIHRNK---ILHRDMKAANVLITR 159

Query: 461 EMRGRLGDFGLAKLY----QQGEVPNTTRVVGTLGYLAPEL---ATVSSPTSASDVYSFG 513
           +   +L DFGLA+ +           T RVV TL Y  PEL        P    D++  G
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGP--PIDLWGAG 216

Query: 514 VVILEVACGRRPLDMGKGEEEE 535
            ++ E+   R P+  G  E+ +
Sbjct: 217 CIMAEM-WTRSPIMQGNTEQHQ 237

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  103 bits (259), Expect = 7e-24
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 35/221 (15%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +++ +++G+G FG VY+  L ++       +A+K V  D +   +E    +  M +L H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDKRFKNRE----LQIMRKLDHC 107

Query: 381 NLVQMR------GWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRR----QIL 428
           N+V++R      G  +    L LV DY+P  ++      + + K+ L     +    Q+ 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 429 ADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRV 486
                 L Y+H  G    + HRDIK  N+LLD +    +L DFG AK   +GE PN + +
Sbjct: 167 ----RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 217

Query: 487 VGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPL 526
             +  Y APEL   ++  TS+ DV+S G V+ E+    +P+
Sbjct: 218 C-SRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPI 256

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (255), Expect = 8e-24
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           +   + LG G +  VYKG     +N     +A+K +  + ++G     + E+S +  L+H
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLKH 59

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N+V +         L LV++Y+    L  ++      +      +  L  +  GL Y H
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM-HNVKLFLFQLLRGLAYCH 117

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN---TTRVVGTLGYLAPE 496
                 V+HRD+K  N+L++     +L DFGLA+      +P       VV TL Y  P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYDNEVV-TLWYRPPD 170

Query: 497 L---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +   +T  S     D++  G +  E+A   RPL  G   EE+
Sbjct: 171 ILLGSTDYST--QIDMWGVGCIFYEMAT-GRPLFPGSTVEEQ 209

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (254), Expect = 1e-23
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 27/234 (11%)

Query: 313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMA 369
           ++    K +   + LG G F  VYK      + N +  +A+K +    +   K+     A
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR----DKNTNQIVAIKKIKLGHRSEAKDGINRTA 59

Query: 370 --EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
             EI  +  L H N++ +       + + LV+D+M    L   I      L      +  
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP-SHIKAY 117

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN---TT 484
           +    +GL YLH  W   ++HRD+K  N+LLD     +L DFGLAK +     PN   T 
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG---SPNRAYTH 171

Query: 485 RVVGTLGYLAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +VV T  Y APEL   A +       D+++ G ++ E+   R P   G  + ++
Sbjct: 172 QVV-TRWYRAPELLFGARMYGV--GVDMWAVGCILAEL-LLRVPFLPGDSDLDQ 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  100 bits (252), Expect = 1e-23
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           + LG G +G V        N      +AVK V+        E +  EI     L H+N+V
Sbjct: 13  QTLGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAEGLNYLH- 439
           +  G  R+GN   L  +Y   G L + I      +     +R   Q++A    G+ YLH 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA----GVVYLHG 123

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLGYLAPE 496
            G    + HRDIK  N+LLD     ++ DFGLA +++        N     GTL Y+APE
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE 177

Query: 497 LATVSSPT---SASDVYSFGVVILEVACGRRPLD 527
           L  +          DV+S G+V+  +  G  P D
Sbjct: 178 L--LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  100 bits (252), Expect = 2e-23
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 23/222 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDS-KQGLKEFMA--EISSMGR 376
           +   E +G G +G VYK        ++   + A+K +  D+  +G+    A  EIS +  
Sbjct: 23  YQKLEKVGEGTYGVVYKAK------DSQGRIVALKRIRLDAEDEGI-PSTAIREISLLKE 75

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           L H N+V +         L LV+++M    L   +      L    Q +  L  +  G+ 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD-SQIKIYLYQLLRGVA 133

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           + H      ++HRD+K  N+L++S+   +L DFGLA+ +       T  VV TL Y AP+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189

Query: 497 L---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           +   +   S   + D++S G +  E+    +PL  G  ++++
Sbjct: 190 VLMGSKKYST--SVDIWSIGCIFAEMIT-GKPLFPGVTDDDQ 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  100 bits (252), Expect = 2e-23
 Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 21/213 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--------HDSKQGLKEFMAEISSMGR 376
             LGSG FG V+       +   + E+ VK +               L +   EI+ + R
Sbjct: 30  SPLGSGAFGFVWTAV----DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGS-LNNWIFGKPKKLLGWKQRRQILADVAEGL 435
           ++H N++++           LV +   +G  L  +I   P+  L       I   +   +
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAV 143

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
            YL     + ++HRDIK  NI++  +   +L DFG A   ++G++  T    GT+ Y AP
Sbjct: 144 GYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAP 198

Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLD 527
           E L          +++S GV +  +     P  
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (251), Expect = 3e-23
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 28/225 (12%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDS-KQGLKEFMA--EISSMGR 376
           + N  L+G G +G V K       N ++  + A+K        + +K  +A  EI  + +
Sbjct: 27  YENLGLVGEGSYGMVMKCR-----NKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQ 80

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---QILADVAE 433
           L+H+NLV +   C+K     LV++++ + ++ + +   P  L     ++   QI+     
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII----N 135

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ + H      ++HRDIK  NIL+      +L DFG A+            V  T  Y 
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191

Query: 494 APEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           APEL           A DV++ G ++ E+     PL  G  + ++
Sbjct: 192 APELLVGDVKYGK--AVDVWAIGCLVTEM-FMGEPLFPGDSDIDQ 233

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 18/216 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA--EISSMGRLQHKNL 382
             +G G +G V+K      N +    +A+K         + + +A  EI  + +L+H NL
Sbjct: 9   GKIGEGSYGVVFKCR----NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V +    R+   L LV++Y  + ++ + +    + +      + I     + +N+ H   
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGV-PEHLVKSITWQTLQAVNFCHKHN 122

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL---AT 499
               +HRD+K  NIL+      +L DFG A+L           V  T  Y +PEL    T
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDT 178

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
              P    DV++ G V  E+     PL  GK + ++
Sbjct: 179 QYGP--PVDVWAIGCVFAEL-LSGVPLWPGKSDVDQ 211

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.7 bits (247), Expect = 4e-23
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDS-KQGLKEFMA--EISSMGR 376
           +   E +G G +G VYK        NN  E  A+K +  +   +G+       EIS +  
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ------NNYGETFALKKIRLEKEDEGI-PSTTIREISILKE 56

Query: 377 LQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR---RQILADVAE 433
           L+H N+V++         L+LV++++    L   +      L     +    Q+L     
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL----N 111

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           G+ Y H      V+HRD+K  N+L++ E   ++ DFGLA+ +       T  +V TL Y 
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167

Query: 494 APEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           AP++   +   S     D++S G +  E+     PL  G  E ++
Sbjct: 168 APDVLMGSKKYST--TIDIWSVGCIFAEMVN-GTPLFPGVSEADQ 209

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 62/239 (25%), Positives = 114/239 (47%), Gaps = 34/239 (14%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEF- 367
            YE +++          +G G +G VYK      + ++   +A+K V   +   G     
Sbjct: 10  RYEPVAE----------IGVGAYGTVYKAR----DPHSGHFVALKSVRVPNGGGGGGGLP 55

Query: 368 ---MAEISSMGRLQ---HKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPK 416
              + E++ + RL+   H N+V++          +  ++ LV++++    L  ++   P 
Sbjct: 56  ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
             L  +  + ++     GL++LH      +VHRD+K  NIL+ S    +L DFGLA++Y 
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
             ++  T  VV TL Y APE+   S+  +  D++S G +  E+   R+PL  G  E ++
Sbjct: 172 Y-QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 227

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 4e-23
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 19/229 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LG GGFG V+             ++ A K +N      ++G +  M E   + ++  + 
Sbjct: 192 VLGRGGFGEVF---ACQMKATG--KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL--ADVAEGLNYLH 439
           +V +        +L LV   M  G +   I+   +   G+++ R I   A +  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + +++RD+K  N+LLD +   R+ D GLA   + G+        GT G++APEL  
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPELLL 362

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLD----MGKGEEEEEAVLMDWVR 544
                 + D ++ GV + E+   R P        + +E ++ VL   V 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 63/286 (22%), Positives = 109/286 (38%), Gaps = 60/286 (20%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA---------EISSMG 375
            LLGSGGFG VY G       +++  +A+K V    K  + ++           E+  + 
Sbjct: 49  PLLGSGGFGSVYSGI----RVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLK 101

Query: 376 RLQHK--NLVQMRGWCRKGNELMLVYDY-MPNGSLNNWIFGKPKKLLGWKQRRQILADVA 432
           ++      ++++  W  + +  +L+ +   P   L ++I  +    L  +  R     V 
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVL 159

Query: 433 EGLNYLH-HGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
           E + + H  G    V+HRDIK  NIL+D      +L DFG   L +           GT 
Sbjct: 160 EAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDF--DGTR 212

Query: 491 GYLAPELATVSSPT---SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY 547
            Y  PE   +        ++ V+S G+++ ++ CG  P +                    
Sbjct: 213 VYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------------------- 250

Query: 548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
              +I        RQ   +E   L+      C     + RPT  E+
Sbjct: 251 HDEEIIR-GQVFFRQRVSSECQHLIRW----CLALRPSDRPTFEEI 291

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 35/226 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNL 382
            +G G FG+V    +   N+      A+K +N        E      E+  M  L+H  L
Sbjct: 22  AIGKGSFGKVC---IVQKNDTKKM-YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVAE 433
           V +    +   ++ +V D +  G L   +           Q+            + ++  
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLFICELVM 126

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L+YL    +Q ++HRD+K  NILLD      + DF +A +  +     T  + GT  Y+
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181

Query: 494 APELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           APE+ +       + A D +S GV   E+  GRRP  +      +E
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 45/238 (18%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR 386
           +G G +G VYK      +  +  + A+K +             EI+ +  L+H N++ ++
Sbjct: 29  VGRGTYGHVYKAK--RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 84

Query: 387 GWC--RKGNELMLVYDYM-------------PNGSLNNWIFGKP--KKLLGWKQRRQILA 429
                    ++ L++DY                 +       +   K LL      QIL 
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-----YQIL- 138

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM--RGRL--GDFGLAKLYQQGEVPNT-- 483
              +G++YLH  W   V+HRD+K  NIL+  E   RGR+   D G A+L+     P    
Sbjct: 139 ---DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 484 TRVVGTLGYLAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAV 538
             VV T  Y APEL   A   +   A D+++ G +  E+     P+   + E+ + + 
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTK--AIDIWAIGCIFAEL-LTSEPIFHCRQEDIKTSN 247

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 25/211 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA-EISSMGRLQHKNLV 383
           + +GSG FG          +      +AVK +  +    + E +  EI +   L+H N+V
Sbjct: 26  KDIGSGNFGVARLMR----DKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIV 79

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + +        L ++ +Y   G L   I   G+  +       +Q+L+    G++Y H  
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS----GVSYCHS- 134

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRL--GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
               + HRD+K  N LLD     RL   DFG +K       P +T  VGT  Y+APE+  
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV-- 188

Query: 500 VSSPT---SASDVYSFGVVILEVACGRRPLD 527
           +         +DV+S GV +  +  G  P +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 91.1 bits (226), Expect = 3e-22
 Identities = 31/119 (26%), Positives = 44/119 (36%), Gaps = 12/119 (10%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKM 77
           + +L F F  F    N  DLI        + V+++T   +       S GR  Y   L++
Sbjct: 1   AQSLSFSFTKFDP--NQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRL 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
              +A  +S    F T   F I     S    GL F +    S        + GLF NA
Sbjct: 59  WEDSAVLTS----FDTIINFEISTPYTSRIADGLAFFIAPPDSVISY-HGGFLGLFPNA 112

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 94.4 bits (234), Expect = 3e-22
 Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 45/239 (18%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMKRST 81
           ++   F+ ++F    N T+LIL  D  V S   ++L+ +S   S  RA+Y   ++++ S 
Sbjct: 1   ATETSFIIDAF----NKTNLILQGDATVSSNGNLQLSYNSYD-SMSRAFYSAPIQIRDS- 54

Query: 82  ATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTV 141
              +  + SF T+F  +I     ++   GL FVL                          
Sbjct: 55  --TTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK------------------ 94

Query: 142 APLLAVEFDTGQNPEFNDPDDNHI-GVDLN-NIESAKHVPAGY-YSSSRNE---SFVPVR 195
              + VEFDT  +    D ++N I  V  + +    ++      Y+SS      S     
Sbjct: 95  GDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS 154

Query: 196 MRNGQNIHAWID---------FDGFSASK---TNWIEARRVLAWSLSDTGVAREINTTN 242
                N+   ++           GFSA+        E   VL+WS S   +  +   + 
Sbjct: 155 TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFINLKDQKSE 213

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 63/290 (21%), Positives = 102/290 (35%), Gaps = 66/290 (22%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEISSMGRL- 377
            LLG GGFG V+ G        +  ++A+K +                   E++ + ++ 
Sbjct: 37  PLLGKGGFGTVFAGH----RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 378 ---QHKNLVQMRGWCRKGNELMLVYDY-MPNGSLNNWIFGKPKKLLGWKQRRQILADVAE 433
               H  ++++  W       MLV +  +P   L ++I  K    LG    R     V  
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVA 150

Query: 434 GLNYLH-HGWDQVVVHRDIKSGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLG 491
            + + H  G    VVHRDIK  NIL+D      +L DFG   L             GT  
Sbjct: 151 AIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDF--DGTRV 203

Query: 492 YLAPEL--------ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV 543
           Y  PE                    V+S G+++ ++ CG  P +                
Sbjct: 204 YSPPEWISRHQYHALPA-------TVWSLGILLYDMVCGDIPFE---------------- 240

Query: 544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                  +I E A+         +   L+ +    C  P  + RP++ E+
Sbjct: 241 ----RDQEILE-AELHFPAHVSPDCCALIRR----CLAPKPSSRPSLEEI 281

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMA-EISSMGRLQHKN 381
           + LG G FG+V  G     +     ++AVK +N        +   +  EI ++   +H +
Sbjct: 17  DTLGVGTFGKVKIGE----HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWI--FGKPKKLLGWKQRRQILADVAEGLNYLH 439
           ++++        +  +V +Y+  G L ++I   G+ +++   +  +QIL+     ++Y H
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----AVDYCH 128

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                +VVHRD+K  N+LLD+ M  ++ DFGL+ +   GE   T+   G+  Y APE+  
Sbjct: 129 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV-- 181

Query: 500 VSSPT---SASDVYSFGVVILEVACGRRPLD 527
           +S         D++S GV++  + CG  P D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 58/249 (23%), Positives = 105/249 (42%), Gaps = 40/249 (16%)

Query: 306 PHRFSYEELSKATK--GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQ 362
           P   S      AT    +     LG G +G VYK      +   +  +A+K +  +  ++
Sbjct: 19  PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAI----DTVTNETVAIKRIRLEHEEE 74

Query: 363 GLKEFMA--EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN---GSLNNWIFGKP-- 415
           G+    A  E+S +  LQH+N+++++      + L L+++Y  N     ++         
Sbjct: 75  GV-PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV 133

Query: 416 -KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR-----LGDF 469
            K  L      Q++     G+N+ H       +HRD+K  N+LL            +GDF
Sbjct: 134 IKSFL-----YQLI----NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181

Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPEL---ATVSSPTSASDVYSFGVVILEVACGRRPL 526
           GLA+ +       T  ++ TL Y  PE+   +   S   + D++S   +  E+   + PL
Sbjct: 182 GLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYST--SVDIWSIACIWAEMLM-KTPL 237

Query: 527 DMGKGEEEE 535
             G  E ++
Sbjct: 238 FPGDSEIDQ 246

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 63/237 (26%), Positives = 120/237 (50%), Gaps = 32/237 (13%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFM 368
            YE +++          +G G +G+V+K   A +  N    +A+K V   + ++G+    
Sbjct: 12  QYECVAE----------IGEGAYGKVFK---ARDLKNGGRFVALKRVRVQTGEEGM-PLS 57

Query: 369 A--EISSMGRLQ---HKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL 418
              E++ +  L+   H N+V++          +  +L LV++++    L  ++   P+  
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
           +  +  + ++  +  GL++LH      VVHRD+K  NIL+ S  + +L DFGLA++Y   
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172

Query: 479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE 535
           ++  T+ VV TL Y APE+   SS  +  D++S G +  E+   R+PL  G  + ++
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.7 bits (246), Expect = 8e-22
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 14/204 (6%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LG GGFG V              +M A K +       ++G    + E   + ++  + 
Sbjct: 191 VLGKGGFGEVC---ACQVRATG--KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V +       + L LV   M  G L   I+   +      +     A++  GL  LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + +V+RD+K  NILLD     R+ D GLA    +G+       VGT+GY+APE+    
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVKNE 360

Query: 502 SPTSASDVYSFGVVILEVACGRRP 525
             T + D ++ G ++ E+  G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 42/234 (17%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA--------------- 369
           + +G G +G V        N N++T  A+K ++         F                 
Sbjct: 19  DEIGKGSYGVVKLAY----NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 370 -----------EISSMGRLQHKNLVQMRGWCRKGNE--LMLVYDYMPNGSLNNWIFGKPK 416
                      EI+ + +L H N+V++       NE  L +V++ +  G +      KP 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP- 133

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
             L   Q R    D+ +G+ YLH+   Q ++HRDIK  N+L+  +   ++ DFG++  ++
Sbjct: 134 --LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPT---SASDVYSFGVVILEVACGRRPLD 527
             +   +   VGT  ++APE  + +       A DV++ GV +     G+ P  
Sbjct: 189 GSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 50/285 (17%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA----EISSMGRLQHK 380
           +LLG G +G+V +      ++      AVK +     + +    A    EI  + RL+HK
Sbjct: 11  DLLGEGSYGKVKEVL----DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 381 NLVQ----MRGWCRKGNELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRR---QILADV 431
           N++Q    +    ++  ++ +V +Y   G     +      K+    +      Q++   
Sbjct: 67  NVIQLVDVLYNEEKQ--KMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID-- 120

Query: 432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVV-GTL 490
             GL YLH    Q +VH+DIK GN+LL +    ++   G+A+        +T R   G+ 
Sbjct: 121 --GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 491 GYLAPELATVSSP--TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG 548
            +  PE+A           D++S GV +  +  G  P +             D +  L+ 
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------------GDNIYKLF- 222

Query: 549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
              I       I  +      +L+  + L     +  +R ++R++
Sbjct: 223 -ENIG-KGSYAIPGDCGPPLSDLLKGM-L---EYEPAKRFSIRQI 261

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.5 bits (240), Expect = 6e-21
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 21/219 (9%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHD---SKQGLKEFMAE---ISSMGRLQ 378
           ++G GGFG VY        +    +M A+KC++      KQG    + E   +S +    
Sbjct: 196 IIGRGGFGEVY---GCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
              +V M       ++L  + D M  G L+  +             R   A++  GL ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHM 308

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H   ++ VV+RD+K  NILLD     R+ D GLA  + + +       VGT GY+APE+ 
Sbjct: 309 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVL 362

Query: 499 TVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                  S++D +S G ++ ++  G  P    K +++ E
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.5 bits (233), Expect = 8e-21
 Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 31/237 (13%)

Query: 310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMA 369
           + E   K    F  + + G G FG V  G   +        +A+K V  D +   +E   
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTG----MSVAIKKVIQDPRFRNRELQ- 68

Query: 370 EISSMGRLQHKNLVQMR-----GWCRKGNE--LMLVYDYMPNGSLNNWI--FGKPKKLLG 420
            +  +  L H N+VQ++        R   +  L +V +Y+P+ +L+     + + +    
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127

Query: 421 WKQRR----QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL--GDFGLAKL 474
               +    Q++      +  LH      V HRDIK  N+L++    G L   DFG AK 
Sbjct: 128 PILIKVFLFQLI----RSIGCLHLP-SVNVCHRDIKPHNVLVNEAD-GTLKLCDFGSAKK 181

Query: 475 YQQGEVPNTTRVVGTLGYLAPEL-ATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
               E PN   +  +  Y APEL       T+A D++S G +  E+     P+  G 
Sbjct: 182 LSPSE-PNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPIFRGD 235

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 55/208 (26%), Positives = 83/208 (39%), Gaps = 16/208 (7%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNL 382
           ++G G FG V    +    N +    A+K +N        E   F  E   +     K +
Sbjct: 81  VIGRGAFGEVA---VVKLKNADKV-FAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
             +    +  N L LV DY   G L   +  K +  L  +  R  LA++   ++ +H   
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVH--- 192

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRDIK  NIL+D     RL DFG      +     ++  VGT  Y++PE+     
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252

Query: 503 P-----TSASDVYSFGVVILEVACGRRP 525
                     D +S GV + E+  G  P
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 29/214 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF-MA-----EISSMGRLQ 378
           + LG G FG+V  G     +     ++AVK +N   +Q ++   +      EI ++   +
Sbjct: 22  DTLGVGTFGKVKVGK----HELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFR 74

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQILADVAEGLN 436
           H +++++       +++ +V +Y+  G L ++I   G+  +    +  +QIL+    G++
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----GVD 130

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           Y H     +VVHRD+K  N+LLD+ M  ++ DFGL+ +   GE   T+   G+  Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 185

Query: 497 LATVSSPT---SASDVYSFGVVILEVACGRRPLD 527
           +  +S         D++S GV++  + CG  P D
Sbjct: 186 V--ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMA-EISSMGRLQHK 380
            E LG G FG+V   T    +     ++A+K ++     K  +   +  EIS +  L+H 
Sbjct: 14  RETLGEGSFGKVKLAT----HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQILADVAEGLNYL 438
           +++++        ++++V +Y   G L ++I    +  +  G +  +QI+      + Y 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC----AIEYC 124

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
           H      +VHRD+K  N+LLD  +  ++ DFGL+ +   G    T+   G+  Y APE+ 
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV- 178

Query: 499 TVSSPT---SASDVYSFGVVILEVACGRRPLD 527
            ++         DV+S G+V+  +  GR P D
Sbjct: 179 -INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 61/263 (23%), Positives = 107/263 (40%), Gaps = 44/263 (16%)

Query: 276 ASTGYYWYWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRV 335
           A  G      K  L   +ED +++WE     +    ++       F   + LG+G FGRV
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPS-QNTAQLDQ-------FDRIKTLGTGSFGRV 57

Query: 336 YKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNLVQMRGWCRKG 392
               L  +  + +   A+K ++      LK+    + E   +  +    LV++    +  
Sbjct: 58  M---LVKHKESGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113

Query: 393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---------ADVAEGLNYLHHGWD 443
           + L +V +Y+  G + + +           +R             A +     YLH    
Sbjct: 114 SNLYMVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTFEYLH---S 159

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLGYLAPELATVSS 502
             +++RD+K  N+L+D +   ++ DFG AK      V   T  + GT   LAPE+     
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 503 PTSASDVYSFGVVILEVACGRRP 525
              A D ++ GV+I E+A G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 55/260 (21%), Positives = 101/260 (38%), Gaps = 67/260 (25%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL 377
           +K +S  + LG+G FG V +     +        A+K V  D +   +E    +  M  L
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESG----KRFALKKVLQDPRYKNRE----LDIMKVL 57

Query: 378 QHKNLVQMR--------------------------------------GWCRKGNELMLVY 399
            H N++++                                           +   L ++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 400 DYMPNGSLNNWI--FGKPKKLLGWKQRR----QILADVAEGLNYLH-HGWDQVVVHRDIK 452
           +Y+P+ +L+  +  F +  + +          Q+       + ++H  G    + HRDIK
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLG----ICHRDIK 168

Query: 453 SGNILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL-ATVSSPTSASDVY 510
             N+L++S+    +L DFG AK     E P+   +  +  Y APEL    +  T + D++
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC-SRFYRAPELMLGATEYTPSIDLW 226

Query: 511 SFGVVILEVACGRRPLDMGK 530
           S G V  E+    +PL  G+
Sbjct: 227 SIGCVFGEL-ILGKPLFSGE 245

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.6 bits (220), Expect = 6e-19
 Identities = 49/215 (22%), Positives = 79/215 (36%), Gaps = 33/215 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE---FMAEISSMGRLQHKNL 382
           ++G G FG V    L  + +      A+K ++        +   F  E   M       +
Sbjct: 76  VIGRGAFGEVQ---LVRHKSTRKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI--------LADVAEG 434
           VQ+    +    L +V +YMP G            L+       +         A+V   
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGG-----------DLVNLMSNYDVPEKWARFYTAEVVLA 180

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L+ +H       +HRD+K  N+LLD     +L DFG      +  +      VGT  Y++
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237

Query: 495 PELATVSSP----TSASDVYSFGVVILEVACGRRP 525
           PE+              D +S GV + E+  G  P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 7e-19
 Identities = 51/210 (24%), Positives = 81/210 (38%), Gaps = 18/210 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNL 382
           ++G G F  V    +           A+K +N      +  +  F  E   +     + +
Sbjct: 68  VIGRGAFSEVA---VVKMKQTGQV-YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
            Q+    +  N L LV +Y   G L   +  K  + +  +  R  LA++   ++ +H   
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMAIDSVH--- 179

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
               VHRDIK  NILLD     RL DFG     +      +   VGT  YL+PE+     
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 503 PTSASDVY-------SFGVVILEVACGRRP 525
               +  Y       + GV   E+  G+ P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 25/225 (11%), Positives = 58/225 (25%), Gaps = 50/225 (22%)

Query: 324 DELLGSGGFGRVYKGT---LANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL 377
               G     + ++     L         ++A+  V+         L+E ++    + R+
Sbjct: 36  LIFHGGVPPLQFWQALDTALDR-------QVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
               + ++          ++V +++  GSL       P          + +  +A   + 
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLAAAADA 144

Query: 438 LH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
            H  G    V         + +  +                G+V     V+     +   
Sbjct: 145 AHRAG----VALSIDHPSRVRVSID----------------GDV-----VLAYPATMPDA 179

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
                      D+   G  +  +   R PL              D
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.7 bits (208), Expect = 9e-18
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNL 382
            LG+G FGRV+   L  + +N     A+K +  +    LK+      E   +  + H  +
Sbjct: 13  TLGTGSFGRVH---LIRSRHNGRY-YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVAE 433
           ++M G  +   ++ ++ DY+  G L + +           ++ Q           A+V  
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAEVCL 117

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR-VVGTLGY 492
            L YLH    + +++RD+K  NILLD     ++ DFG AK      VP+ T  + GT  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDY 169

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRP 525
           +APE+ +      + D +SFG++I E+  G  P
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 15/214 (7%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNL 382
           LLG G FG+V    L           A+K +  +      E    + E   +   +H  L
Sbjct: 155 LLGKGTFGKVI---LVKEKATGRY-YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
             ++   +  + L  V +Y   G L   +    +++    + R   A++   L+YLH   
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           +  VV+RD+K  N++LD +   ++ DFGL K   +      T   GT  YLAPE+   + 
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 325

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
              A D +  GVV+ E+ CGR P      ++ E+
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFY---NQDHEK 356

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 4e-17
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 35/241 (14%)

Query: 306 PHRFSYEELSKAT----KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---- 357
            ++F   E+  +T    K + N + +GSG  G V        +      +A+K ++    
Sbjct: 45  DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAY----DAVLDRNVAIKKLSRPFQ 100

Query: 358 --HDSKQGLKEFMAEISSMGRLQHKNLVQMR------GWCRKGNELMLVYDYMPNGSLNN 409
               +K+  +E +     M  + HKN++ +           +  ++ LV + M   +L  
Sbjct: 101 NQTHAKRAYRELVL----MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQ 155

Query: 410 WIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF 469
            I    +  L  ++   +L  +  G+ +LH      ++HRD+K  NI++ S+   ++ DF
Sbjct: 156 VI----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208

Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           GLA+    G     T  V T  Y APE+          D++S G ++ E+    + L  G
Sbjct: 209 GLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPG 265

Query: 530 K 530
           +
Sbjct: 266 R 266

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 60/258 (23%), Positives = 109/258 (42%), Gaps = 43/258 (16%)

Query: 283 YWRKNKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLAN 342
           Y   N  + +E  + E   +E W ++  Y+ + K          LG G +  V++     
Sbjct: 11  YTDVNTHRPREYWDYESHVVE-WGNQDDYQLVRK----------LGRGKYSEVFEAI--- 56

Query: 343 NNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCR--KGNELMLVY 399
            N  N+ ++ VK +    K   K+   EI  +  L+   N++ +    +        LV+
Sbjct: 57  -NITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112

Query: 400 DYMPNGSLNNWIFGKPKKLLGWKQR---RQILADVAEGLNYLH-HGWDQVVVHRDIKSGN 455
           +++ N           + L  +  R    +IL    + L+Y H  G    ++HRD+K  N
Sbjct: 113 EHVNNTDFKQLY----QTLTDYDIRFYMYEIL----KALDYCHSMG----IMHRDVKPHN 160

Query: 456 ILLDSEMRG-RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP--TSASDVYSF 512
           +++D E R  RL D+GLA+ Y  G+     RV  +  +  PEL  V       + D++S 
Sbjct: 161 VMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVA-SRYFKGPEL-LVDYQMYDYSLDMWSL 217

Query: 513 GVVILEVACGRRPLDMGK 530
           G ++  +   + P   G 
Sbjct: 218 GCMLASMIFRKEPFFHGH 235

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 58/288 (20%), Positives = 100/288 (34%), Gaps = 74/288 (25%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNL 382
            ++LG G  G+V +      N     + A+K +        +    E+    R  Q  ++
Sbjct: 23  SQVLGLGINGKVLQIF----NKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHI 73

Query: 383 VQMRGWC----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           V++             L++V + +  G L + I  +  +    ++  +I+  + E + YL
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           H      + HRD+K  N+L  S+      +L DFG AK     E            Y   
Sbjct: 134 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTGE-------KY--- 175

Query: 496 ELATVSSPTSASDVYSFGVV--ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
                     + D++S GV+  IL   CG  P             +   +R     G+  
Sbjct: 176 --------DKSCDMWSLGVIMYIL--LCGYPPFY-SNHGLAISPGMKTRIRM----GQY- 219

Query: 554 EAADARIRQEFEAEE--------MELVLKLGLACCHPDSTRRPTMREV 593
                    EF   E          L+  L L     + T+R T+ E 
Sbjct: 220 ---------EFPNPEWSEVSEEVKMLIRNL-L---KTEPTQRMTITEF 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 34/223 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM--AVKCVNHDS--KQGLKEFMAEISSMGRLQHKN 381
           +LG G FG+V+   L    + +      A+K +   +   +       E   +  + H  
Sbjct: 31  VLGQGSFGKVF---LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVA 432
           +V++    +   +L L+ D++  G L   +            +  +         LA++A
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----------SKEVMFTEEDVKFYLAELA 136

Query: 433 EGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLG 491
             L++LH  G    +++RD+K  NILLD E   +L DFGL+K     E    +   GT+ 
Sbjct: 137 LALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVE 191

Query: 492 YLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
           Y+APE+      T ++D +SFGV++ E+  G  P   GK  +E
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKE 233

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 26/222 (11%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMG 375
            K + +   +GSG +G V        +  +  ++A+K ++    S+   K    E+  + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAI----DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78

Query: 376 RLQHKNLVQMR------GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
            +QH+N++ +          R   +  LV  +M    L   +          ++ + ++ 
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQYLVY 133

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            + +GL Y+H      VVHRD+K GN+ ++ +   ++ DFGLA+          T  V T
Sbjct: 134 QMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVT 186

Query: 490 LGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
             Y APE+           D++S G ++ E+    + L  GK
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGK 227

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 3e-16
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 19/216 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHD---SKQGLKEFMAEISSMGR-LQHK 380
           +LG G FG+V    L+     +  E+ AVK +  D       ++  M E   +    +  
Sbjct: 348 VLGKGSFGKVM---LSERKGTD--ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            L Q+    +  + L  V +Y+  G L   I  +              A++A GL +L  
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQ- 459

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +++RD+K  N++LDSE   ++ DFG+ K      V   T   GT  Y+APE+   
Sbjct: 460 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAY 516

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                + D ++FGV++ E+  G+ P +   GE+E+E
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDE 549

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 19/216 (8%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDSKQGLKEF---MAEISSMGR-LQHK 380
           +LG G FG+V+   LA     N  +  A+K +  D      +    M E   +    +H 
Sbjct: 24  MLGKGSFGKVF---LAEFKKTN--QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            L  M    +    L  V +Y+  G L   I  +        +     A++  GL +LH 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH- 135

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +V+RD+K  NILLD +   ++ DFG+ K    G+    T   GT  Y+APE+   
Sbjct: 136 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 192

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                + D +SFGV++ E+  G+ P     G++EEE
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEE 225

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 34/223 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGRLQHKNL 382
           LLG G FG+V    L           A+K +  +      E    + E   +   +H  L
Sbjct: 12  LLGKGTFGKVI---LVREKATGRY-YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVAE 433
             ++   +  + L  V +Y   G L   +            R ++          A++  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL-----------SRERVFTEERARFYGAEIVS 116

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            L YLH    + VV+RDIK  N++LD +   ++ DFGL K          T   GT  YL
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           APE+   +    A D +  GVV+ E+ CGR P      ++ E 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHER 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH------DSKQGLKEFMAEISSM 374
           + N + +GSG  G V     A +       +A+K ++        +K+  +E    +  M
Sbjct: 27  YQNLKPIGSGAQGIVCA---AYDAILE-RNVAIKKLSRPFQNQTHAKRAYRE----LVLM 78

Query: 375 GRLQHKNLVQMR------GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL 428
             + HKN++ +           +  ++ +V + M   +L   I    +  L  ++   +L
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSYLL 133

Query: 429 ADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
             +  G+ +LH      ++HRD+K  NI++ S+   ++ DFGLA+    G     T  V 
Sbjct: 134 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 188

Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK 530
           T  Y APE+          D++S G ++ E+      L  G 
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGT 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 34/224 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM--AVKCVNHDS-KQGLKEF---MAEISSMGRLQH 379
           +LG GG+G+V+           +T    A+K +      +  K+     AE + +  ++H
Sbjct: 24  VLGKGGYGKVF---QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LAD 430
             +V +    + G +L L+ +Y+  G L   +           +R  I         LA+
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-----------EREGIFMEDTACFYLAE 129

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
           ++  L +LH    + +++RD+K  NI+L+ +   +L DFGL K          T   GT+
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTI 185

Query: 491 GYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
            Y+APE+   S    A D +S G ++ ++  G  P   G+  ++
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKK 228

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 39/228 (17%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-----HDSKQGLKEFMAEISSMG 375
           ++N   +G G +G V        +N N   +A+K ++        ++ L+E    I  + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY----DNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILL 80

Query: 376 RLQHKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGWKQRR 425
           R +H+N++ +          +  ++ +V D M    L   +  +           +    
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLY---- 135

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY--QQGEVPNT 483
           QIL     GL Y+H      V+HRD+K  N+LL++    ++ DFGLA++           
Sbjct: 136 QIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 484 TRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
           T  V T  Y APE+   S   T + D++S G ++ E+    RP+  GK
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGK 235

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 38/235 (16%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM--AVKCVNHD---SKQGLKEF-MAEISSMGRLQH 379
           +LG+G +G+V+   L    + + T    A+K +       K    E    E   +  ++ 
Sbjct: 61  VLGTGAYGKVF---LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117

Query: 380 KN-LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LA 429
              LV +    +   +L L+ DY+  G L   +            +R+          + 
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----------SQRERFTEHEVQIYVG 166

Query: 430 DVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVG 488
           ++   L +LH  G    +++RDIK  NILLDS     L DFGL+K +   E        G
Sbjct: 167 EIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 489 TLGYLAPELATVSSP--TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           T+ Y+AP++          A D +S GV++ E+  G  P     GE+  +A +  
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISR 276

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 40/233 (17%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           + + + LG GG G V+       +N+    +A+K +     Q +K  + EI  + RL H 
Sbjct: 13  YMDLKPLGCGGNGLVFSAV----DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68

Query: 381 NLVQMR--------------GWCRKGNELMLVYDYMPNGSLNNWIFGKP-----KKLLGW 421
           N+V++               G   + N + +V +YM    L N +   P      +L  +
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY 127

Query: 422 KQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLY--QQG 478
               Q+L     GL Y+H      V+HRD+K  N+ +++E +  ++GDFGLA++      
Sbjct: 128 ----QLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 479 EVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
              + +  + T  Y +P L    +  T A D+++ G +  E+    + L  G 
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFAGA 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 38/234 (16%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL------KEFMA-- 369
              ++    + SG +G V  G      ++    +A+K V +    G         F+   
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-----DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 370 ---EISSMGRLQHKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW 421
              EI  +    H N++ +R           ++L LV + M    L   +    + ++  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQ-VIHDQRIVISP 133

Query: 422 KQRR----QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
           +  +     IL     GL+ LH      VVHRD+  GNILL       + DF LA+    
Sbjct: 134 QHIQYFMYHIL----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 478 GEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
               N T  V    Y APEL       T   D++S G V+ E+   R+ L  G 
Sbjct: 187 D--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGS 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 54/242 (22%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-----HDSKQGLKEFMAEIS 372
           +  F    LLG G +G V   T    +      +A+K +        + + L+E    I 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSAT----HKPTGEIVAIKKIEPFDKPLFALRTLRE----IK 61

Query: 373 SMGRLQHKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI 427
            +   +H+N++ +            NE+ ++ + M    L+  I              Q+
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI------------STQM 108

Query: 428 LAD---------VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
           L+D             +  LH      V+HRD+K  N+L++S    ++ DFGLA++  + 
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 479 EVPNT---------TRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDM 528
              N+            V T  Y APE+   S+  + A DV+S G ++ E+   RRP+  
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224

Query: 529 GK 530
           G+
Sbjct: 225 GR 226

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 33/226 (14%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH------DSKQGLKEFMAEI 371
            + + N   +GSG +G V        +      +AVK ++        +K+  +E    +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRE----L 79

Query: 372 SSMGRLQHKNLVQMR------GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR 425
             +  ++H+N++ +           + N++ LV   M    LNN +  +    L     +
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK---LTDDHVQ 135

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
            ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA+          T 
Sbjct: 136 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTG 188

Query: 486 VVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
            V T  Y APE+           D++S G ++ E+    R L  G 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGT 233

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 25/222 (11%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH--DSKQGLKEFMAEISSMG 375
              + + + +GSG +G V        +     ++A+K +     S+   K    E+  + 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAV----DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79

Query: 376 RLQHKNLVQMR------GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
            ++H+N++ +              +  LV  +M    L   +  +    LG  + + ++ 
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK---LGEDRIQFLVY 135

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGT 489
            + +GL Y+H      ++HRD+K GN+ ++ +   ++ DFGLA+          T  V T
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVT 188

Query: 490 LGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGK 530
             Y APE+       T   D++S G ++ E+    + L  G 
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGS 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 21/217 (9%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEM-AVKCVNHDSKQGLKEF---MAE--ISSMGRLQH 379
           +LG G FG+V    LA        ++ AVK +  D      +    M E  I S+ R  H
Sbjct: 30  VLGKGSFGKVM---LARVKETG--DLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NH 83

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             L Q+    +  + L  V +++  G L   I  +  +     + R   A++   L +LH
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLH 141

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
              D+ +++RD+K  N+LLD E   +L DFG+ K      V   T   GT  Y+APE+  
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQ 197

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                 A D ++ GV++ E+ CG  P +    E E++
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFE---AENEDD 231

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 27/151 (17%)

Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVAEGLNYLHHGWDQV 445
           L  V +Y+  G L   I           Q+             A++A GL +L     + 
Sbjct: 96  LYFVMEYVNGGDLMYHI-----------QQVGRFKEPHAVFYAAEIAIGLFFLQ---SKG 141

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS 505
           +++RD+K  N++LDSE   ++ DFG+ K      V   T   GT  Y+APE+        
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGK 200

Query: 506 ASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           + D ++FGV++ E+  G+ P +   GE+E+E
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFE---GEDEDE 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 30/157 (19%)

Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---------ADVAEGLNYLHHGWDQV 445
           L  V +Y+  G L   +           QR++ L         A+++  LNYLH   ++ 
Sbjct: 85  LFFVIEYVNGGDLMFHM-----------QRQRKLPEEHARFYSAEISLALNYLH---ERG 130

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS 505
           +++RD+K  N+LLDSE   +L D+G+ K   +     +T   GT  Y+APE+        
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGF 189

Query: 506 ASDVYSFGVVILEVACGRRP------LDMGKGEEEEE 536
           + D ++ GV++ E+  GR P       D      E+ 
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 30/157 (19%)

Query: 395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQIL---------ADVAEGLNYLHHGWDQV 445
           L  V +Y+  G L   +           QR++ L         A+++  LNYLH   ++ 
Sbjct: 128 LFFVIEYVNGGDLMFHM-----------QRQRKLPEEHARFYSAEISLALNYLH---ERG 173

Query: 446 VVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS 505
           +++RD+K  N+LLDSE   +L D+G+ K   +     +T   GT  Y+APE+        
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGF 232

Query: 506 ASDVYSFGVVILEVACGRRP------LDMGKGEEEEE 536
           + D ++ GV++ E+  GR P       D      E+ 
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 35/224 (15%)

Query: 326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEF---MAEISSMGR-LQHKN 381
           ++G G FG+V    LA +        AVK +   +    KE    M+E + + + ++H  
Sbjct: 45  VIGKGSFGKVL---LARHKAEEVF-YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQI---------LADVA 432
           LV +    +  ++L  V DY+  G L   +           QR +           A++A
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL-----------QRERCFLEPRARFYAAEIA 149

Query: 433 EGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
             L YLH      +V+RD+K  NILLDS+    L DFGL K   +     +T   GT  Y
Sbjct: 150 SALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEY 205

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           LAPE+          D +  G V+ E+  G  P          E
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY---SRNTAE 246

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 9e-14
 Identities = 36/217 (16%), Positives = 63/217 (29%), Gaps = 61/217 (28%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV--------N 357
           P  FS+      T+     E +G G FG V++         + T +A+K +        N
Sbjct: 10  PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTI------ADHTPVAIKIIAIEGPDLVN 60

Query: 358 HDSKQGLKEFMAEISSMGRLQ---------HKNLVQMRGWC------------------- 389
              ++  +E + EI     L           +  + +                       
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 390 -----------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
                       K ++L +V ++   G     +     KL      + IL  +   L   
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVA 177

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
                    HRD+  GN+LL      +L      K  
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score = 67.8 bits (165), Expect = 9e-14
 Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 50/135 (37%)

Query: 144 LLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIH 203
           ++AVEFDT  NP++ DP+  HIG+D+N+I S       +               NG+   
Sbjct: 3   VVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQ--------------NGKIAT 48

Query: 204 AWIDFD------------------------------------GFSASKTNWIEARRVLAW 227
           A I ++                                    G SAS     E   V +W
Sbjct: 49  AHISYNSVSKRLSVTSYYAGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSW 108

Query: 228 SLSDTGVAREINTTN 242
           S + +         N
Sbjct: 109 SFTSSLWTNVAKKEN 123

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 57/263 (21%), Positives = 96/263 (36%), Gaps = 72/263 (27%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEISSM 374
           +    L+G+G +G V +   A +       +A+K +        D K+ L+E    I+ +
Sbjct: 55  YEIRHLIGTGSYGHVCE---AYDKLEK-RVVAIKKILRVFEDLIDCKRILRE----IAIL 106

Query: 375 GRLQHKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR---- 425
            RL H ++V++          K +EL +V +   +         +    L     +    
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTELHIKTLLY 163

Query: 426 QILADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
            +L     G+ Y+H  G    ++HRD+K  N L++ +   ++ DFGLA+     E  N+ 
Sbjct: 164 NLL----VGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 485 RV--------------------------VGTLGYLAPELATVSSP-TSASDVYSFG---- 513
                                       V T  Y APEL  +    T A DV+S G    
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275

Query: 514 ------VVILEVACGRRPLDMGK 530
                    +     R PL  G 
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGS 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 29/163 (17%), Positives = 60/163 (36%), Gaps = 13/163 (7%)

Query: 324 DELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHK 380
            + LG G FG+V +      +       +AVK +   +     +  M+E+  +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 381 NLVQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
           N+V + G C + G  LM++ ++   G+L+ ++           +R + +    +G  +  
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQ 137

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN 482
                  +  D+K     + S        F   K     E   
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 54/265 (20%), Positives = 101/265 (38%), Gaps = 31/265 (11%)

Query: 338 GTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML 397
           G L+    +   E           +  K+++  I    + +  ++   +     G     
Sbjct: 112 GNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

Query: 398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL 457
               +        ++      L  +        VA+G+ +L     +  +HRD+ + NIL
Sbjct: 172 SLSDVEEEEAPEDLYKDF---LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 225

Query: 458 LDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI 516
           L  +   ++ DFGLA+ +Y+  +          L ++APE       T  SDV+SFGV++
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285

Query: 517 LEVAC-GRRPL-DMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ-EFEAEEM-ELV 572
            E+   G  P   +   EE         ++              R+R  ++   EM + +
Sbjct: 286 WEIFSLGASPYPGVKIDEE-----FCRRLKEGT-----------RMRAPDYTTPEMYQTM 329

Query: 573 LKLGLACCHPDSTRRPTMREVVAVL 597
           L     C H + ++RPT  E+V  L
Sbjct: 330 LD----CWHGEPSQRPTFSELVEHL 350

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 66.8 bits (162), Expect = 1e-12
 Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 11/91 (12%)

Query: 52  STVIRLTNDSNQ-----FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASS 106
              + LT  S+       S GRA +   + +  S+A     + SF  +F F I     S 
Sbjct: 151 DGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAV----VASFEATFTFLIKSP-DSH 205

Query: 107 PGFGLCFVLTNFTS-PPGALASQYFGLFSNA 136
           P  G+ F ++N  S  P     +  GLF +A
Sbjct: 206 PADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 64.9 bits (157), Expect = 7e-12
 Identities = 28/112 (25%), Positives = 41/112 (36%), Gaps = 22/112 (19%)

Query: 143 PLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY-----------YSSSRNESF 191
            ++AVE DT  N +  DP   HIG+D+ ++ S K                 Y+S      
Sbjct: 3   TIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRLS 62

Query: 192 VPVRMRNGQNIHAWIDFD-----------GFSASKTNWIEARRVLAWSLSDT 232
             V   N  +     D D           G SAS   + E   +L+WS +  
Sbjct: 63  AVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 57/256 (22%), Positives = 95/256 (37%), Gaps = 65/256 (25%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEI 371
              +    L+G G +G VY    A + N     +A+K VN       D K+ L+E    I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYL---AYDKNTE-KNVAIKKVNRMFEDLIDCKRILRE----I 76

Query: 372 SSMGRLQHKNLVQMR-----GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR- 425
           + + RL+   ++++          K +EL +V +   +  L      K    L  +  + 
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF--KTPIFLTEEHIKT 133

Query: 426 ---QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA---------- 472
               +L     G N++H      ++HRD+K  N LL+ +   ++ DFGLA          
Sbjct: 134 ILYNLLL----GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 473 -----------KLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFG------- 513
                        + +      T  V T  Y APEL  +    T + D++S G       
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 514 ---VVILEVACGRRPL 526
                 +     R PL
Sbjct: 247 NMLQSHINDPTNRFPL 262

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 60/288 (20%), Positives = 113/288 (39%), Gaps = 47/288 (16%)

Query: 286 KNKLKAQEEDEI----EEWELEYWPHRFSYEELSKATKGFSNDE---------------- 325
             KL A E  EI    E + L     +           G+ +D+                
Sbjct: 41  MQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYE 100

Query: 326 ---LLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDS--KQGLKE--FMAEISSMGRL 377
              ++G G FG+V K      ++     +A+K V N     +Q  +E   +  +    + 
Sbjct: 101 VLKVIGKGSFGQVVKAY----DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW--KQRRQILADVAEGL 435
              N++ M       N + + ++ +   S+N +   K  K  G+     R+    + + L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
           + LH      ++H D+K  NILL  + R   ++ DFG +    Q         + +  Y 
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYR 266

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           APE+   +      D++S G ++ E+  G  PL  G+ E ++ A +++
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIE 313

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 54/244 (22%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH------DSKQGLKEFMAEISSM 374
           +   + LG G +G V+K      +      +AVK +        D+++  +E    I  +
Sbjct: 11  YELVKKLGKGAYGIVWKSI----DRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMIL 62

Query: 375 GRLQ-HKNLVQMRGWCR--KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR----QI 427
             L  H+N+V +    R     ++ LV+DYM    L+  I       L    ++    Q+
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI---LEPVHKQYVVYQL 118

Query: 428 LADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV- 486
           +    + + YLH G    ++HRD+K  NILL++E   ++ DFGL++ +            
Sbjct: 119 I----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 487 -------------------VGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPL 526
                              V T  Y APE+   S+  T   D++S G ++ E+    +P+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

Query: 527 DMGK 530
             G 
Sbjct: 231 FPGS 234

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 35/175 (20%)

Query: 325 ELLGSGGFGRVYKGTLANNNN-NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV 383
             +G GGFG +Y   + ++ +  +     VK    D+   L     E+    R      +
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFT---ELKFYQRAAKPEQI 96

Query: 384 QMRGWCRKGNELML--VYDYMPNGSLNNW-------IFGKP-KKLLGWKQRR-------- 425
           Q     RK   L +   +    +              FG   +K+     +R        
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 426 ---QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLY 475
              +IL    + L Y+H   +   VH DIK+ N+LL+ +   +  L D+GLA  Y
Sbjct: 157 LSLRIL----DILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 54/288 (18%), Positives = 102/288 (35%), Gaps = 50/288 (17%)

Query: 287 NKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSND---------------------- 324
           +             E  Y+          K  +   ND                      
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSM----SSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYE 57

Query: 325 --ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDS--KQGLKE--FMAEISSMGRL 377
              L+G G FG+V K   A +       +A+K + N  +   Q   E   +  ++     
Sbjct: 58  IDSLIGKGSFGQVVK---AYDRVEQE-WVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW--KQRRQILADVAEGL 435
               +V ++      N L LV++ +   S N +   +     G      R+    +   L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 436 NYLHHGWDQVVVHRDIKSGNILLDSEMRG--RLGDFGLAKLYQQGEVPNTTRVVGTLGYL 493
            +L    +  ++H D+K  NILL +  R   ++ DFG +    Q       + + +  Y 
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQSRFYR 225

Query: 494 APELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD 541
           +PE+        A D++S G +++E+  G  PL  G  E ++   +++
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVDQMNKIVE 272

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 27/174 (15%), Positives = 59/174 (33%), Gaps = 33/174 (18%)

Query: 325 ELLGSGGFGRVYKG----TLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
                   G +Y+     TL  ++     + ++K    D +        E +   R    
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL-----FNEQNFFQRAAKP 102

Query: 381 NLVQMRGWCRKGNELML----VYDYMPNGSLNNWI----FGKP-KKLLGWKQRRQ----- 426
              Q+  W +  +  +L       +  +     ++     G+  +  L    +       
Sbjct: 103 L--QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160

Query: 427 --ILAD-VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLY 475
              +A  + + L +LH   +   VH ++ + NI +D E + +  L  +G A  Y
Sbjct: 161 VLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 34/173 (19%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +GSGGFG +Y     N    ++    VK    ++   L     E+    R+  K+ ++
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDAR-HVVKVEYQENGP-LFS---ELKFYQRVAKKDCIK 97

Query: 385 MRGWCRKGNELML--VYDY----MPNGSLNNWIFGKPKKLLG------WKQRRQ------ 426
                ++ + L +   Y          S    +     + LG        Q         
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVM----ERLGIDLQKISGQNGTFKKSTV 153

Query: 427 -ILAD-VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR--LGDFGLAKLY 475
             L   + + L Y+H       VH DIK+ N+LL  +   +  L D+GL+  Y
Sbjct: 154 LQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 19/155 (12%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLV-Q 384
           +GSG FG +Y GT    N   + E+A+K  N  +K   L     E      LQ    +  
Sbjct: 15  IGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQLLY---ESKIYRILQGGTGIPN 67

Query: 385 MRGWCRKGNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +R +  +G+  +LV D +  G SL + +F    + L  K    +   +   + ++H    
Sbjct: 68  VRWFGVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH---S 121

Query: 444 QVVVHRDIKSGNILLDSEMRGR---LGDFGLAKLY 475
           +  +HRDIK  N L+    R     + DFGLAK Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 44/220 (20%), Positives = 90/220 (40%), Gaps = 33/220 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV---NHDSKQGLKEF-------MAEISSM 374
             LG G F  V+    A +  NN T +A+K V      ++    E         A+ +  
Sbjct: 25  RKLGWGHFSTVWL---AKDMVNN-THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 375 GRLQHKNLVQMRGW----CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD 430
             +   +++++          G  +++V++ +   +L   I     + +     +QI   
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 431 VAEGLNYLHHGWDQV-VVHRDIKSGNILLDSEMRG------RLGDFGLAKLYQQGEVPNT 483
           +  GL+Y+H    +  ++H DIK  N+L++           ++ D G A  Y +    + 
Sbjct: 140 LLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HY 192

Query: 484 TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR 523
           T  + T  Y +PE+   +     +D++S   +I E+  G 
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLV-QM 385
           +GSG FG +Y GT    +     E+A+K     +K        E      +Q    +  +
Sbjct: 17  IGSGSFGDIYLGT----DIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTI 70

Query: 386 RGWCRKGNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           R    +G+  ++V + +  G SL + +F    +    K    +   +   + Y+H    +
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124

Query: 445 VVVHRDIKSGNILLDSEMRG---RLGDFGLAKLY 475
             +HRD+K  N L+    +G    + DFGLAK Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 46/277 (16%), Positives = 83/277 (29%), Gaps = 87/277 (31%)

Query: 397 LVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGN 455
           +V++ +  G  L  WI     + L     ++I+  V +GL+YLH      ++H DIK  N
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPEN 177

Query: 456 ILLDSE-------------------------------------------------MRGRL 466
           ILL                                                    ++ ++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
            D G A    +    + T  + T  Y + E+   S   + +D++S   +  E+A G    
Sbjct: 238 ADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 527 DMGKGEEEE---------EAVL----MDWV-----RNLY--GQGKICEAADARIRQ---- 562
           +   GEE             +L       +        +   +G +      +       
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 563 -----EFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                E+  EE        L        +R T  E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 46/236 (19%), Positives = 81/236 (34%), Gaps = 40/236 (16%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDS--KQGLKE--FMAEISSMGRLQH 379
             LG G FG+V +     ++    +++A+K + N     +    E   + +I    +   
Sbjct: 25  GNLGEGTFGKVVE---CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENK 81

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW--KQRRQILADVAEGLNY 437
              V M  W      + + ++ +     N + F K      +     R +   +   L +
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG-------------------RLGDFGLAKLYQQG 478
           LH   +  + H D+K  NIL  +                       R+ DFG A    + 
Sbjct: 139 LH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE- 194

Query: 479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
              + T +V T  Y  PE+          DV+S G ++ E   G   L       E
Sbjct: 195 ---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHENRE 246

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 35/164 (21%)

Query: 327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLV-Q 384
           +G G FG +++GT    N  N+ ++A+K     S    L++   E  +   L     +  
Sbjct: 18  IGEGSFGVIFEGT----NLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCTGIPN 70

Query: 385 MRGWCRKGNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRR------QILAD-VAEGLN 436
           +  + ++G   +LV D +  G SL +        LL    R+       + A  +   + 
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLED--------LLDLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGR-----LGDFGLAKLY 475
            +H   ++ +V+RDIK  N L+            + DFG+ K Y
Sbjct: 121 SIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 33/170 (19%), Positives = 59/170 (34%), Gaps = 41/170 (24%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH-KNL 382
            + +G G FG +  G     N   +  +A+K     S+        E     +L     +
Sbjct: 14  GKKIGCGNFGELRLGK----NLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67

Query: 383 VQMRGWCRKGNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRR-----------QILAD 430
            Q+  +   G    +V + +  G SL +        L     R            Q++  
Sbjct: 68  PQVYYFGPCGKYNAMVLELL--GPSLED--------LFDLCDRTFSLKTVLMIAIQLI-- 115

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR-----LGDFGLAKLY 475
               + Y+H    + +++RD+K  N L+            + DF LAK Y
Sbjct: 116 --SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 40/236 (16%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDS--KQGLKE--FMAEISSMGRLQH 379
           + LG G FG+V +     ++      +AVK V N D   +    E   +  +++      
Sbjct: 20  DTLGEGAFGKVVE---CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW--KQRRQILADVAEGLNY 437
              VQM  W      + +V++ +    L+ + F K    L +     R++   + + +N+
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRG-------------------RLGDFGLAKLYQQG 478
           LH      + H D+K  NIL                          ++ DFG A    + 
Sbjct: 134 LH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE- 189

Query: 479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE 534
              + + +V T  Y APE+      +   DV+S G +++E   G   +      +E
Sbjct: 190 ---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHDSKE 241

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 51/245 (20%), Positives = 86/245 (35%), Gaps = 54/245 (22%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCV-NHDS--KQGLKEFMAEISSMGRLQH-- 379
             +G G FGRV        + +N    AVK V N     +        E   + ++Q+  
Sbjct: 41  RKMGDGTFGRVLLCQ----HIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDD 92

Query: 380 ---KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGW--KQRRQILADVAEG 434
               N+V+  G     + + L+++ +     + +         G+  +  +    ++ + 
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRG-------------------------RLGDF 469
           LNYL       + H D+K  NILLD                              +L DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG 529
           G A             ++ T  Y APE+        +SD++SFG V+ E+  G   L   
Sbjct: 207 GCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRT 261

Query: 530 KGEEE 534
               E
Sbjct: 262 HEHME 266

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	636
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.96
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.94
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.91
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.4
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.91
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	98.8
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.26
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	97.96
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.73
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.34
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.24
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.13
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.11
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.79
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.59
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.13
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.18
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.31
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.78
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	87.34

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=2.5e-54  Score=431.10  Aligned_cols=199  Identities=32%  Similarity=0.535  Sum_probs=170.0

Q ss_pred             HHHHHHhhcCCCCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCC------ceEEEEcCCceeeccccCCCC
Q 006668           12 IVVAINFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQF------SFGRAYYPTKLKMKRSTATNS   85 (636)
Q Consensus        12 ~~~~~~~~~~~~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~------~~Gra~y~~pv~l~~~~~~~~   85 (636)
                      ++++++..+.++..++|+|++|..    .||+|+|||.+. +|.|+||+.+.+      ++|||+|++|||||   ++.+
T Consensus        13 ~fl~l~~~~~sa~~~sF~f~~F~~----~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~---d~~t   84 (281)
T 3ujo_A           13 LFLILLTKAASANLISFTFKKFNE----TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIW---DNTT   84 (281)
T ss_dssp             -----------CEEEEEEESSCCS----TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECB---CSSS
T ss_pred             HHHHHHcccCcCCcceEEcCCCCc----cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcc---cCCC
Confidence            334444456778899999999963    799999999998 899999998754      89999999999999   6677


Q ss_pred             ceeeeEEEEEEEEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCee
Q 006668           86 SILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHI  165 (636)
Q Consensus        86 ~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hv  165 (636)
                      +++|||+|+|+|.|.+.+...+||||||||+|.+..|+ +.||||||||.+++...||+|||||||++|.+| ||++|||
T Consensus        85 g~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~~~~n~~vAVEFDT~~N~e~-Dp~~nHV  162 (281)
T 3ujo_A           85 GTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNYASSNQTVAVEFDTFYNGGW-DPTERHI  162 (281)
T ss_dssp             CCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSCCTTSCCEEEEECCSCCCSS-CCSSSEE
T ss_pred             CCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCCCccCcEEEEEEeccccccC-CCCCCeE
Confidence            88999999999999988777799999999999876665 689999999987767789999999999999888 9999999


Q ss_pred             eEecCCccccccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------
Q 006668          166 GVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------  209 (636)
Q Consensus       166 gidvns~~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------  209 (636)
                      ||||||++|+++++|+              +.+|+.++|||+||                                    
T Consensus       163 GIDvNSi~S~~t~~~~--------------l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~~~~~~lS~~vDL~~~L~e~v~  228 (281)
T 3ujo_A          163 GIDVNSIKSIKTTSWD--------------FANGENAEVLITYDSSTNLLVASLVHPSQKTSFIVSERVDLTSVLPEWVS  228 (281)
T ss_dssp             EEEESSSCCSCEEECC--------------CCSSCCEEEEEEECTTTCEEEEEEECTTTCCCEEEEEECCSTTTSCSEEE
T ss_pred             EEEcCCCCcccccccc--------------ccCCCEEEEEEEEeCCCCEEEEEEecCCCCCCceEEEEechHHhccCcEE
Confidence            9999999999998763              46899999999999                                    


Q ss_pred             -ccccCCCc---eecceeeeeccccCCCC
Q 006668          210 -GFSASKTN---WIEARRVLAWSLSDTGV  234 (636)
Q Consensus       210 -gfsastg~---~~~~~~il~wsf~~~~~  234 (636)
                       ||||+||.   ..|.|+||+|||+++..
T Consensus       229 VGFSAsTG~~~~~~e~H~IlsWSFss~l~  257 (281)
T 3ujo_A          229 VGFSATTGLSKGYVETNEVLSWSFASKLS  257 (281)
T ss_dssp             EEEEEEECSSTTSCCCCEEEEEEEEEEEC
T ss_pred             EEEEeecCCCCcccceeEEEEEEEEEEcC
Confidence             99999996   58999999999998643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-54  Score=446.85  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=214.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|...+.||+|+||+||+|++... ....+..||||+++....+..++|.+|+++|++++|||||+++|+|.+++.++||
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            466788999999999999997642 2234588999999888777788999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcC-----------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          399 YDYMPNGSLNNWIFGK-----------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      ||||++|+|.++|+..           ....++|.+++.|+.|||+||+|||   +++|+||||||+||||++++.+||+
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEEC
Confidence            9999999999999653           2457999999999999999999999   7999999999999999999999999


Q ss_pred             ccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       468 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......    . +...+. 
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~-~~~~i~-  244 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----E-VIECIT-  244 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----H-HHHHHH-
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----H-HHHHHH-
Confidence            99999866543322 2234579999999999999999999999999999999998 89999754321    1 111111 


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .+         .+...+..++..+.+|+.+||+.||++||||+||++.|+.-
T Consensus       245 ---~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          245 ---QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             ---HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               11         11223344566789999999999999999999999999764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=449.61  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +|...++||+|+||.||+|+++.. ....+..||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++||
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            456678999999999999997642 2334589999999888777788999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCC-------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEE
Q 006668          399 YDYMPNGSLNNWIFGKP-------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR  465 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  465 (636)
                      ||||++|+|.++|+...             ...++|.+++.|+.|||+||+|||   +++|+||||||+||||++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEE
Confidence            99999999999996532             246999999999999999999999   79999999999999999999999


Q ss_pred             EeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHH
Q 006668          466 LGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       466 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      |+|||+++....... ...+..+||+.|||||++.+..++.++|||||||+||||+| |+.||.......     +...+
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~~~i  273 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-----AIDCI  273 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-----HHHHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-----HHHHH
Confidence            999999987654332 23345679999999999999999999999999999999998 899997543211     11111


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .             ...+.+.+..++..+.+|+.+||+.||++||||.||+++|+.-
T Consensus       274 ~-------------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          274 T-------------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             H-------------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             H-------------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1             1111223344556788999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-54  Score=445.17  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=210.4

Q ss_pred             CCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++..+.||+|+||+||+|++... ....++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++.++||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            45578899999999999998542 22344889999997653 33457899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          399 YDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      ||||++|+|.++|..+.              ...++|.+++.|+.|||+||+|||   +++|+||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence            99999999999996432              246999999999999999999999   7999999999999999999999


Q ss_pred             EEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||+++....... ...+..+||+.|||||++.++.++.++|||||||+||||+| |+.||......     .+...
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-----~~~~~  259 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVVEM  259 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----HHHHH
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----HHHHH
Confidence            9999999987644332 23345679999999999999999999999999999999998 89999755321     11121


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +.    .+         .+.+.+.+++..+.+|+.+||+.||++||||.||++.|+.
T Consensus       260 i~----~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          260 IR----NR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HH----cC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11    11         1223344566778999999999999999999999999964

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=4.3e-53  Score=419.06  Aligned_cols=194  Identities=26%  Similarity=0.470  Sum_probs=171.8

Q ss_pred             hcCCCCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEE
Q 006668           19 SISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFS   92 (636)
Q Consensus        19 ~~~~~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~   92 (636)
                      .+.++..++|+|++|.+  +..||+|+|+|.+.++|.|+||+.+.      +++|||+|++|||||   ++.++++|||+
T Consensus         5 ~~~sa~~~sF~f~~F~~--~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~---d~~tg~vaSFs   79 (261)
T 3zyr_A            5 RANSTDSLSFSFINFDR--DERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLW---EKSTNRVANLQ   79 (261)
T ss_dssp             ---CCEEEEEEESSCCS--CCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECB---CTTTCCBEEEE
T ss_pred             ccCcCcccEEEcCCCCC--CCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEee---cCCCCCceeEE
Confidence            46678899999999974  35799999999997789999998764      689999999999999   67778899999


Q ss_pred             EEEEEEeecCCCCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCC--CCCceEEEEeecC---CCCCCCCCCCCeee
Q 006668           93 TSFVFSILPEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVV--TVAPLLAVEFDTG---QNPEFNDPDDNHIG  166 (636)
Q Consensus        93 t~F~f~i~~~~~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~--~~~~~vaVEfDt~---~n~~~~d~~~~Hvg  166 (636)
                      |+|+|.|.+. ...+||||||||+|.+. +|.+++||||||||.++++  ..||+|||||||+   +|.+| ||++||||
T Consensus        80 T~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVG  157 (261)
T 3zyr_A           80 TQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIG  157 (261)
T ss_dssp             EEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEE
T ss_pred             EEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEE
Confidence            9999999986 56789999999999875 4778889999999988774  5689999999999   99888 99999999


Q ss_pred             EecCCccccccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------c
Q 006668          167 VDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------G  210 (636)
Q Consensus       167 idvns~~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------g  210 (636)
                      |||||++|+++++|.              +.+|+.++|||+||                                    |
T Consensus       158 IdvNsi~S~~s~~~~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VG  223 (261)
T 3zyr_A          158 IDVNSIRSSKVVRWE--------------RREGKTLNVLVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVG  223 (261)
T ss_dssp             EEESSSSCSEEEECC--------------CCTTCCEEEEEEEETTTTEEEEEEECTTCCEEEEEEECCGGGTSCSEEEEE
T ss_pred             EEcCCCCcccccccc--------------ccCCceEEEEEEEcCCCCEEEEEEEcCCCCCeEEEEEechHHhCcCcEEEE
Confidence            999999999998763              56899999999998                                    9


Q ss_pred             cccCCCceecceeeeeccccCCC
Q 006668          211 FSASKTNWIEARRVLAWSLSDTG  233 (636)
Q Consensus       211 fsastg~~~~~~~il~wsf~~~~  233 (636)
                      |||+||...|.|+||+|||+++.
T Consensus       224 FSAsTG~~~e~h~IlsWsF~s~l  246 (261)
T 3zyr_A          224 FSAASGEQFQTHNLESWSFTSTL  246 (261)
T ss_dssp             EEEEESSSCCEEEEEEEEEEEEE
T ss_pred             EEecCCCccceEEEEEEEEEEEc
Confidence            99999999999999999999864

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=4.1e-53  Score=417.98  Aligned_cols=190  Identities=32%  Similarity=0.520  Sum_probs=171.1

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCC------ceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQF------SFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~------~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      .+++|+|++|.+  +..||+|+|||.+.++|.|+||+.+.+      ++|||+|++|||||   ++.++++|||+|+|+|
T Consensus         2 ~~~sF~f~~F~~--~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~---d~~tg~vaSFsT~F~F   76 (251)
T 3ipv_A            2 EETSFVFSKFKP--LEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW---DSATGLVASFATSFRF   76 (251)
T ss_dssp             EEEEEEESSCCS--SCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             cceEEEeCCCCC--CCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEee---cCCCCceeeEEEEEEE
Confidence            468999999974  357999999999977899999997654      89999999999999   6677889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      .|.+.+...+||||||||+|....|+ ..||||||||.+++...||+|||||||++|.+|+||++|||||||||++|+++
T Consensus        77 ~I~~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t  155 (251)
T 3ipv_A           77 TIYAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVSGSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKT  155 (251)
T ss_dssp             ECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSCCTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred             EEeCCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCCCccCcEEEEEEecccccccCCCCCCeEEEEcCCCccccc
Confidence            99988777799999999999876665 57999999998776678999999999999998999999999999999999998


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce--
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW--  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~--  218 (636)
                      ++|.              +.+|+.++|||+||                                     ||||+||..  
T Consensus       156 ~~~~--------------l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~  221 (251)
T 3ipv_A          156 VKWS--------------LANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGG  221 (251)
T ss_dssp             EECC--------------CCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTT
T ss_pred             ceeE--------------ecCCCEEEEEEEEeCCCCEEEEEEecCCCCccceEEEEechHHhCCCcEEEEEEEecCCCcc
Confidence            8753              67899999999999                                     999999998  


Q ss_pred             -ecceeeeeccccCCC
Q 006668          219 -IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 -~~~~~il~wsf~~~~  233 (636)
                       .|.|+||+|+|+++.
T Consensus       222 ~~e~h~IlsWsF~s~l  237 (251)
T 3ipv_A          222 KIETHDVFSWSFASKL  237 (251)
T ss_dssp             CCCCCEEEEEEEEEEE
T ss_pred             ccceeEEEEEEEEEEC
Confidence             999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=433.41  Aligned_cols=262  Identities=24%  Similarity=0.443  Sum_probs=205.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      +++...++||+|+||+||+|++..       .||||+++..  ..+..++|.+|+.++++++|||||+++|+|.+ +.++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG-------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS-------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC-------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            456778999999999999998743       5899998754  45567889999999999999999999999865 5689


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||||++|+|.++|+.. ...++|.+++.|+.|||.||+|||   +++|+||||||+||||++++.+||+|||+|+...
T Consensus       108 iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999999653 457999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCC-CccccccccCCcccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGE-VPNTTRVVGTLGYLAPELATV---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ... .......+||+.|||||++.+   +.++.++|||||||+||||+||+.||........    +...+...+..   
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~----~~~~~~~~~~~---  256 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ----IIFMVGRGYAS---  256 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----HHHHHHTTCCC---
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH----HHHHHhcCCCC---
Confidence            432 223445689999999999864   4589999999999999999999999975532211    11111111110   


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                           +.+ ......++..+.+|+.+||+.||++||||.||++.|+.-+- ++|
T Consensus       257 -----p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~-~lp  303 (307)
T 3omv_A          257 -----PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH-SLP  303 (307)
T ss_dssp             -----CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT-TCC
T ss_pred             -----CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc-cCC
Confidence                 111 12233455678899999999999999999999999875422 555

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-52  Score=436.66  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=206.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|++.+.||+|+||+||+|+.+..+    +.||||++...  .....+.+.+|+++|++|+|||||++++++.+++.+|
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDG----RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTC----CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCC----CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999987765    89999999765  4455678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||||++|+|.++|..+....+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+...
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999997666677899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ... ...+..+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+...+.     +..    
T Consensus       177 ~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~-----~~~----  242 (350)
T 4b9d_A          177 STV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----LVLKIIS-----GSF----  242 (350)
T ss_dssp             HHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH-----TCC----
T ss_pred             CCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHc-----CCC----
Confidence            321 12344689999999999999999999999999999999999999997543211    1111111     000    


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           ...+......+.+|+.+||+.||++|||+.|+++.
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 01122234567889999999999999999999874

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=2.4e-51  Score=404.94  Aligned_cols=189  Identities=35%  Similarity=0.504  Sum_probs=169.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..     .+++|||+|++||+||   ++.++.++||+|+|+|.
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---~~~tg~vaSFsT~F~F~   76 (239)
T 1dbn_A            2 DELSFTINNFVP--NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW---GNTTGSVASFSTSFTFV   76 (239)
T ss_dssp             CEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecc---cCCCCCccceEEEEEEE
Confidence            468999999975  2479999999999878999999875     5799999999999999   66778899999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCCCCCceEEEEeecCCC---CCCCCCCCCeeeEecCCccc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVVTVAPLLAVEFDTGQN---PEFNDPDDNHIGVDLNNIES  174 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n---~~~~d~~~~Hvgidvns~~s  174 (636)
                      |.+.+...+||||||||+|... +|.++.|+||||||.+++...+|+|||||||++|   .+ +||++|||||||||++|
T Consensus        77 I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S  155 (239)
T 1dbn_A           77 VKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIES  155 (239)
T ss_dssp             CCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSC
T ss_pred             EeCCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccc
Confidence            9987767789999999999865 6778899999999977655789999999999999   77 59999999999999999


Q ss_pred             cccccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc
Q 006668          175 AKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN  217 (636)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~  217 (636)
                      +++++|.              +.+|+.++|||+||                                     ||||+||.
T Consensus       156 ~~~~~~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~  221 (239)
T 1dbn_A          156 IKTVQWD--------------WINGGVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGY  221 (239)
T ss_dssp             SEEEECC--------------CCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECS
T ss_pred             cceEccc--------------ccCCCEEEEEEEEeCCCcEEEEEEccCCCCCcceEEEEechHHhCCccEEEEEEeccCC
Confidence            9988752              67899999999999                                     99999999


Q ss_pred             e--ecceeeeeccccCC
Q 006668          218 W--IEARRVLAWSLSDT  232 (636)
Q Consensus       218 ~--~~~~~il~wsf~~~  232 (636)
                      .  .|.|+||+|+|+++
T Consensus       222 ~~~~~~h~IlsWsF~s~  238 (239)
T 1dbn_A          222 PTEVETHDVLSWSFTST  238 (239)
T ss_dssp             GGGCCCCEEEEEEEEEE
T ss_pred             CccceeeEEEEEEeEec
Confidence            8  99999999999874

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=3.8e-51  Score=402.57  Aligned_cols=187  Identities=32%  Similarity=0.495  Sum_probs=165.8

Q ss_pred             ceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEe
Q 006668           25 ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI   99 (636)
Q Consensus        25 ~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i   99 (636)
                      .++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..     .+++|||+|++||+||   ++.++.++||+|+|+|.|
T Consensus         3 ~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---d~~tg~vaSFsT~F~F~I   77 (237)
T 1fny_A            3 SLSFSFPKFAP--NQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW---DSTTGNVASFVTSFTFII   77 (237)
T ss_dssp             EEEEEESSCCT--TCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEEC
T ss_pred             ceEEEcCCCCC--CCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecc---cCCCCCccceEEEEEEEE
Confidence            57899999975  2479999999999878999999875     5799999999999999   667788999999999999


Q ss_pred             ecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccccc
Q 006668          100 LPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP  179 (636)
Q Consensus       100 ~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~  179 (636)
                      .+.+...+||||||||+|....|+ +.|+||||||.+++...+|+|||||||++|.+ +||++|||||||||+.|+++++
T Consensus        78 ~~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~  155 (237)
T 1fny_A           78 QAPNPATTADGLAFFLAPVDTQPL-DLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVP  155 (237)
T ss_dssp             CCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCC---CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEE
T ss_pred             eCCCCCCCCCCEEEEeccCCCCCC-CCCCcccccccCCCCccccEEEEEeecccCcc-cCCCCCceEEecCCcccccccc
Confidence            987767789999999999876554 78999999997765688999999999999988 5999999999999999999887


Q ss_pred             CccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce---e
Q 006668          180 AGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW---I  219 (636)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~---~  219 (636)
                      |+              +.+|+.++|||+||                                     ||||+||..   .
T Consensus       156 ~~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~  221 (237)
T 1fny_A          156 WN--------------WTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYV  221 (237)
T ss_dssp             CC--------------CCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred             cc--------------ccCCCEEEEEEEEeCCCcEEEEEEecCCCCCcceEEEEechHHhCCCcEEEEEEEeeCCCCccc
Confidence            52              67899999999999                                     999999998   9


Q ss_pred             cceeeeeccccCC
Q 006668          220 EARRVLAWSLSDT  232 (636)
Q Consensus       220 ~~~~il~wsf~~~  232 (636)
                      |.|+||+|+|+++
T Consensus       222 ~~h~IlsWsF~s~  234 (237)
T 1fny_A          222 QTNDVLSWSFESN  234 (237)
T ss_dssp             CCCEEEEEEEEEE
T ss_pred             ceeEEEEEEEEEe
Confidence            9999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.7e-51  Score=430.52  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=210.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|+..+.||+|+||.||+|+.+.++    +.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSG----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCC----CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45888899999999999999987766    89999999765444456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|.+++..   ..+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.....
T Consensus       150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999999853   46999999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      . ...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.......    .+ ..+...         ..+
T Consensus       224 ~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~-~~i~~~---------~~~  288 (346)
T 4fih_A          224 V-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AM-KMIRDN---------LPP  288 (346)
T ss_dssp             S-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH-HHHHHS---------SCC
T ss_pred             C-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HH-HHHHcC---------CCC
Confidence            3 23445789999999999999999999999999999999999999997542211    11 111110         000


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+  .........+.+|+.+||+.||++|||+.|++++-.-.
T Consensus       289 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          289 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            11  01112235678899999999999999999999865444

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=1.2e-50  Score=400.33  Aligned_cols=189  Identities=32%  Similarity=0.407  Sum_probs=168.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC---CCceEE-EEcCCceeeccccCCCCceeeeEEEEEEEEe
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN---QFSFGR-AYYPTKLKMKRSTATNSSILTSFSTSFVFSI   99 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~---~~~~Gr-a~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i   99 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..   .+++|| |+|++||+||   ++.++.++||+|+|+|.|
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~---~~~tg~vaSFsT~F~F~I   76 (242)
T 1fx5_A            2 DDLSFKFKNFSQ--NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW---NCNTGELASFITSFSFFM   76 (242)
T ss_dssp             CEEEEEESSCCT--TCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECE---ETTTTEECEEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEee---cCCCCCccceEEEEEEEE
Confidence            468999999975  2479999999999878999999876   679999 9999999999   667788999999999999


Q ss_pred             ecC-CCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCC-CCCCCCeeeEecCCcccccc
Q 006668          100 LPE-IASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEF-NDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus       100 ~~~-~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~-~d~~~~Hvgidvns~~s~~~  177 (636)
                      .+. +...+||||||||+|....|+ +.|+||||||.+++...||+|||||||++|.++ +||++|||||||||++|+++
T Consensus        77 ~~~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~  155 (242)
T 1fx5_A           77 ETSANPKAATDGLTFFLAPPDSPLR-RAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINA  155 (242)
T ss_dssp             EESSCGGGCCCEEEEEEECTTCCCC-BCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEE
T ss_pred             ecCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCCCCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccce
Confidence            987 556689999999999866554 789999999977655789999999999999987 89999999999999999998


Q ss_pred             ccCccccCCCCCcceeeeecCC--CeeEEEEEec-------------------------------------ccccCC--C
Q 006668          178 VPAGYYSSSRNESFVPVRMRNG--QNIHAWIDFD-------------------------------------GFSASK--T  216 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g--~~~~~~i~y~-------------------------------------gfsast--g  216 (636)
                      ++|+              +.+|  +.++|||+||                                     ||||+|  |
T Consensus       156 ~~~~--------------l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G  221 (242)
T 1fx5_A          156 ERWN--------------KRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIG  221 (242)
T ss_dssp             EECC--------------CCCSGGGCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETT
T ss_pred             eccc--------------ccCCCceeEEEEEEEeCCCCEEEEEEecCCCCccceeeEEechHHhCCccEEEEEEecccCC
Confidence            8752              6788  9999999999                                     999999  9


Q ss_pred             ceecceeeeeccccCCC
Q 006668          217 NWIEARRVLAWSLSDTG  233 (636)
Q Consensus       217 ~~~~~~~il~wsf~~~~  233 (636)
                      .. |.|+||+|+|+++.
T Consensus       222 ~~-~~h~IlsWsF~s~l  237 (242)
T 1fx5_A          222 RQ-ATHEVLNWYFTSTF  237 (242)
T ss_dssp             SC-EEEEEEEEEEEEES
T ss_pred             Cc-ceeEEEEEEeEeec
Confidence            98 99999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.9e-51  Score=425.25  Aligned_cols=252  Identities=22%  Similarity=0.249  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|...++||+|+||.||+|+.+..+    +.||||+++.+..     ..+|+.++++++|||||++++++.+++.++||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g----~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTG----FQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCC----CEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45777889999999999999987766    8999999976532     24699999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCcccccC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKLYQQ  477 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~  477 (636)
                      ||||++|+|.++|..  .+.+++.+++.++.||+.||+|||   +++|+||||||+||||+.++ .+||+|||+|+....
T Consensus       129 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             ECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999999953  457999999999999999999999   89999999999999999987 699999999987754


Q ss_pred             CCCc----cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          478 GEVP----NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       478 ~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....    .....+||+.|||||++.+..++.++|||||||++|||++|+.||...........+..        .    
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~----  271 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------E----  271 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--------S----
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--------C----
Confidence            3321    12336799999999999999999999999999999999999999976543322211110        0    


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          +....+++......+.+++.+||+.||.+|||+.|+++.|...
T Consensus       272 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          272 ----PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ----CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                0001123334456788899999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-50  Score=413.97  Aligned_cols=247  Identities=25%  Similarity=0.423  Sum_probs=199.1

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc----cceE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----GNEL  395 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~  395 (636)
                      +..+.||+|+||.||+|+....+    ..||+|.+...  .....+.|.+|+.++++|+|||||+++++|..    ++.+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCC----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            55678999999999999987765    89999999754  44556789999999999999999999999864    4568


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEcC-CCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLDS-EMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~~-~~~~kl~DFGla  472 (636)
                      +||||||++|+|.++|.+  ...+++.+++.++.||+.||+|||   +++  |+||||||+||||+. ++.+||+|||+|
T Consensus       105 ~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            999999999999999953  457999999999999999999999   666  999999999999985 789999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      +.....   .....+||+.|||||++.+ +++.++|||||||++|||++|+.||........    +..    ....+..
T Consensus       180 ~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~----~i~~~~~  247 (290)
T 3fpq_A          180 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR----RVTSGVK  247 (290)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHH----HHTTTCC
T ss_pred             EeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HHH----HHHcCCC
Confidence            864432   3345689999999998875 699999999999999999999999965432211    111    1111111


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                              +..++......+.+|+.+||+.||++|||+.|++++-
T Consensus       248 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp  284 (290)
T 3fpq_A          248 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             --------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                    0111111234578899999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-51  Score=430.82  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=214.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCC-Cceeeeeccccc-cc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQH-KNLVQMRGWCRK-GN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~-~~  393 (636)
                      .++|+..+.||+|+||.||+|++...+ ....+.||||++.... ....++|.+|+.+|.+++| ||||+++|+|.+ ++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            457888999999999999999987643 3345789999998653 4456789999999999965 899999999866 46


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      .++||||||++|+|.++|+...              ...++|.+++.++.|||+||+|||   +++||||||||+||||+
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeC
Confidence            7899999999999999996532              345899999999999999999999   79999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      +++.+||+|||+|+....... ......+||+.|||||++.+..++.++|||||||+||||+| |+.||.........  
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~--  297 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--  297 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999987654432 23445679999999999999999999999999999999998 99999765332211  


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ...             +....+...+..++..+.+++.+||+.||++|||+.||+++|+.
T Consensus       298 --~~~-------------i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          298 --CRR-------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             --HHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHH-------------HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence              111             11111222333445678899999999999999999999999864

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=2.7e-50  Score=397.52  Aligned_cols=188  Identities=31%  Similarity=0.493  Sum_probs=166.7

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..      .+++|||+|++||+||   ++.+++++||+|+|+|
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~---~~~tg~vaSFsT~F~F   76 (239)
T 1gzc_A            2 ETISFSFSEFEP--GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW---DSTTGTVASFETRFSF   76 (239)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             eeEEEEeCCCCC--CCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecc---cCCCCCccceEEEEEE
Confidence            357899999975  2479999999999878999999865      4689999999999999   6677789999999999


Q ss_pred             EeecCC-CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           98 SILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        98 ~i~~~~-~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      .|.+.+ ...+||||||||+|....|+ +.|+||||||.+++...+|+|||||||++|. |.||++|||||||||++|++
T Consensus        77 ~I~~~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~~~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~  154 (239)
T 1gzc_A           77 SIEQPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGVFNNSKQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIK  154 (239)
T ss_dssp             ECCCCCSSSCCCEEEEEEEECSSCCCC-CCGGGTTTCSSSSCCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSE
T ss_pred             EEeCCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCCCCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccc
Confidence            999875 56789999999999866554 7899999999776557899999999999998 87899999999999999999


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc--
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN--  217 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~--  217 (636)
                      +++|              .+.+|+.++|||+||                                     ||||+||.  
T Consensus       155 ~~~~--------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~  220 (239)
T 1gzc_A          155 TQPF--------------QLDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQR  220 (239)
T ss_dssp             EEEC--------------CCCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSST
T ss_pred             cccc--------------cccCCCEEEEEEEEeCCCcEEEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCc
Confidence            8775              267899999999999                                     99999997  


Q ss_pred             -eecceeeeeccccCC
Q 006668          218 -WIEARRVLAWSLSDT  232 (636)
Q Consensus       218 -~~~~~~il~wsf~~~  232 (636)
                       ..|.|+||+|||+++
T Consensus       221 ~~~~~h~IlsWsF~s~  236 (239)
T 1gzc_A          221 DAAETHDVYSWSFQAS  236 (239)
T ss_dssp             TCCCCCEEEEEEEEEE
T ss_pred             cccceEEEEEEEeEEe
Confidence             499999999999875

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=5.5e-50  Score=395.56  Aligned_cols=190  Identities=34%  Similarity=0.508  Sum_probs=169.5

Q ss_pred             CCCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC---CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           22 PSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN---QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        22 ~~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~---~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ++..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..   .+++|||+|++||+||   ++.+++++||+|+|+|.
T Consensus         2 s~~~~~F~f~~F~~--~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~---~~~tg~vasFsT~F~F~   76 (242)
T 1qnw_A            2 LSDDLSFNFDKFVP--NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW---DSITGKVASFATSFSFV   76 (242)
T ss_dssp             -CCSEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             CccceEEEcCCCCC--CCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeee---cCCCCCcccEEEEEEEE
Confidence            45678999999975  2479999999999878999999886   6799999999999999   66777899999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCCCCCceEEEEeecC----CCCCCCCCCCCeeeEecCCcc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVVTVAPLLAVEFDTG----QNPEFNDPDDNHIGVDLNNIE  173 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~----~n~~~~d~~~~Hvgidvns~~  173 (636)
                      |.+. ...+||||||||+|... +|.++.|+||||||.+++...+|+|||||||+    +|.  +||++|||||||||++
T Consensus        77 I~~~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~  153 (242)
T 1qnw_A           77 VKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIK  153 (242)
T ss_dssp             CCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSS
T ss_pred             EecC-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCCCCccccEEEEEeecccccccCC--CCCCCCcEEEecCCcc
Confidence            9987 66789999999999864 67778999999999776557899999999999    987  5999999999999999


Q ss_pred             ccccccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC
Q 006668          174 SAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT  216 (636)
Q Consensus       174 s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg  216 (636)
                      |+++++|+              +.+|+.++|||+||                                     ||||+||
T Consensus       154 S~~~~~~~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG  219 (242)
T 1qnw_A          154 SIKTVKWD--------------WRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVG  219 (242)
T ss_dssp             CSEEEECC--------------CCTTCCEEEEEEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEES
T ss_pred             ccceeccc--------------ccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceeEEEeechHHhcCCceEEEEEeccC
Confidence            99987752              67899999999999                                     9999999


Q ss_pred             ce--ecceeeeeccccCCC
Q 006668          217 NW--IEARRVLAWSLSDTG  233 (636)
Q Consensus       217 ~~--~~~~~il~wsf~~~~  233 (636)
                      ..  .|.|+||+|+|+++.
T Consensus       220 ~~~~~~~h~IlsWsF~s~l  238 (242)
T 1qnw_A          220 NAAEFETHDVLSWYFTSNL  238 (242)
T ss_dssp             CGGGCBCCEEEEEEEEEEC
T ss_pred             CCccceEEEEEEEEeEeec
Confidence            99  999999999999864

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=2.4e-50  Score=401.68  Aligned_cols=207  Identities=29%  Similarity=0.417  Sum_probs=168.0

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|.. ++..+|+|+|+|.+. ++.|+||+..      .+++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         3 ~~~~F~f~~F~~-~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---d~~tg~vasFsT~F~F   77 (257)
T 1hql_A            3 DSVSFTFPNFWS-DVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW---DNKTESVASFYTEFTF   77 (257)
T ss_dssp             -CCEEEESCSCS-CGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECC---CSTTCCCCEEEEEEEE
T ss_pred             cceEEEcCCCCC-CCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecc---cCCCCCeeceEEEEEE
Confidence            457899999972 124799999999998 8999999875      4689999999999999   6677789999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCC-C-CCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATV-V-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESA  175 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~-~-~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~  175 (636)
                      .|.+. ...+||||||+|+|....| ++.|+||||||.+++ + ..||+|||||||++|.+|.||++|||||||||+.|+
T Consensus        78 ~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~  155 (257)
T 1hql_A           78 FLKIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSV  155 (257)
T ss_dssp             EEEEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCS
T ss_pred             EEecC-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCcccc
Confidence            99987 5678999999999986654 478999999997753 4 788999999999999999999999999999999999


Q ss_pred             ccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCC-ce
Q 006668          176 KHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKT-NW  218 (636)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg-~~  218 (636)
                      ++++|+.           ..|.+|+.++|||+||                                    ||||+|| ..
T Consensus       156 ~s~~~~~-----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~  224 (257)
T 1hql_A          156 ATKRWED-----------SDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQ  224 (257)
T ss_dssp             EEEECCH-----------HHHTSCSCEEEEEEEETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCC
T ss_pred             ceeccCc-----------ccccCCceEEEEEEEeCCCCEEEEEEecCCCCceeeEEeechHHhcCCceEEEEEeccCCCc
Confidence            9987631           1255799999999998                                    9999999 99


Q ss_pred             ecceeeeeccccCCCCccccCCCCCCCCCC
Q 006668          219 IEARRVLAWSLSDTGVAREINTTNFPTFLP  248 (636)
Q Consensus       219 ~~~~~il~wsf~~~~~~~~~~~~~~p~~~~  248 (636)
                      .+.|+||+|+|++++..+.++.+.+|.+|.
T Consensus       225 ~~~H~IlsWsF~s~~~~~~~~~~~~p~~~~  254 (257)
T 1hql_A          225 FLTVYILSWRFSSNLQSTSVKAAMEPEITR  254 (257)
T ss_dssp             CEEEEEEEEEEEEEC---------------
T ss_pred             cceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence            999999999999998888888887776654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-51  Score=421.77  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=207.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||+||+|+.+.++    +.||+|++.+.   .....+.+.+|+++|++++|||||++++++.+++.+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATS----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCC----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            35888999999999999999987766    89999999754   223356789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      |||||||++|+|.++|.+  .+.+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus       108 yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            999999999999999953  457999999999999999999999   899999999999999999999999999999977


Q ss_pred             cCCC-CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGE-VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .... .......+||+.|||||++.+..++.++||||+||++|||++|+.||.......    .+.....     +.   
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~-----~~---  250 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFAKIIK-----LE---  250 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-----TC---
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHc-----CC---
Confidence            5433 233455789999999999999999999999999999999999999997543221    1111111     01   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA  595 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  595 (636)
                         ..++..+    ...+.+|+.+||+.||++|||++|++.
T Consensus       251 ---~~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          251 ---YDFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             ---CCCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             ---CCCCccc----CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence               1122223    345788999999999999999998753

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=3.9e-50  Score=394.11  Aligned_cols=187  Identities=26%  Similarity=0.413  Sum_probs=167.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCC-CCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecC
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDS-NQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPE  102 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~-~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~  102 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+. ..+++|||+|++||+||   ++.++.++||+|+|+|.|.+.
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~---~~~tg~vaSFsT~F~F~I~~~   76 (232)
T 1v6i_A            2 ETVSFNFNSFSE--GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW---SSATGNVASFLTSFSFEMKDI   76 (232)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECB---CTTTCCBCEEEEEEEEEEECC
T ss_pred             cceEEEcCCCCC--CCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEee---cCCCCCccceEEEEEEEEecC
Confidence            458999999975  247999999999987899999998 77899999999999999   667778999999999999987


Q ss_pred             CCCCCCCceEEEEecCC-CCCCCC-cCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccC
Q 006668          103 IASSPGFGLCFVLTNFT-SPPGAL-ASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPA  180 (636)
Q Consensus       103 ~~~~~~~G~aF~l~~~~-~~~~~~-~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~  180 (636)
                      +...+||||||||+|.. .+|.++ .|+||||||.   ...+|+|||||||++|.+++||++|||||||||++|+++++|
T Consensus        77 ~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~---~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~  153 (232)
T 1v6i_A           77 KDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT---KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW  153 (232)
T ss_dssp             SSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT---TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC
T ss_pred             CCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC---CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc
Confidence            66678999999999986 457777 8999999986   357899999999999999899999999999999999998875


Q ss_pred             ccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCCc--eecce
Q 006668          181 GYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKTN--WIEAR  222 (636)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg~--~~~~~  222 (636)
                      .              +.+|+.++|||+||                                    ||| +||.  ..|.|
T Consensus       154 ~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h  218 (232)
T 1v6i_A          154 N--------------SVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIH  218 (232)
T ss_dssp             C--------------CCTTCEEEEEEEEETTTTEEEEEEECTTSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEE
T ss_pred             c--------------ccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEE
Confidence            2              67899999999998                                    999 9998  69999


Q ss_pred             eeeeccccCCC
Q 006668          223 RVLAWSLSDTG  233 (636)
Q Consensus       223 ~il~wsf~~~~  233 (636)
                      +||+|+|+++.
T Consensus       219 ~IlsWsF~s~l  229 (232)
T 1v6i_A          219 LIRSWSFTSTL  229 (232)
T ss_dssp             EEEEEEEEEEE
T ss_pred             EEEEEEEEeec
Confidence            99999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=431.80  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=211.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|+..+.||+|+||.||+|+.+.++    +.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSG----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCC----CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            46889999999999999999988766    89999999876555556788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|.+++..   ..+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+.....
T Consensus       227 mEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          227 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999999843   46999999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      . ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......    .+ ..+...         ..+
T Consensus       301 ~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~-~~i~~~---------~~~  365 (423)
T 4fie_A          301 V-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AM-KMIRDN---------LPP  365 (423)
T ss_dssp             C-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH-HHHHHS---------CCC
T ss_pred             C-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HH-HHHHcC---------CCC
Confidence            3 23445789999999999999999999999999999999999999997542211    11 111110         000


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+  .........+.+|+.+||+.||++|||+.|++++-.-.
T Consensus       366 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          366 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence            11  01112235678899999999999999999999864443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-50  Score=415.67  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc----e
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----E  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~  394 (636)
                      +++...+.||+|+||+||+|++.+      +.||||+++...... ..+..|+..+.+++|||||+++|+|.+++    .
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g------~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT------EEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            346678899999999999999843      789999997654322 23346788888999999999999998653    6


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC-----CCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW-----DQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      ++||||||++|+|.++|..   ..++|+++++++.|++.||+|||+.+     .++|+||||||+||||+.++.+||+||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            8999999999999999953   46999999999999999999999531     349999999999999999999999999


Q ss_pred             CCcccccCCCCc---cccccccCCcccccccccCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCChhh-HH---
Q 006668          470 GLAKLYQQGEVP---NTTRVVGTLGYLAPELATVS------SPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-EE---  536 (636)
Q Consensus       470 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~-~~---  536 (636)
                      |+++........   .....+||+.|||||++.+.      .++.++|||||||+||||++|+.|+........ ..   
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            999876554322   22346799999999998764      357799999999999999999877643221100 00   


Q ss_pred             --HHHHHHHHHHhcCCcchhhhhhhhhhc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          537 --AVLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       537 --~~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        ....+.+.......    ..++.++.. .+.+..+.+.+|+.+||+.||++||||.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence              00000011111111    111222221 234567789999999999999999999999999964

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.7e-50  Score=407.84  Aligned_cols=251  Identities=22%  Similarity=0.369  Sum_probs=193.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||+||+|+...++    +.||+|++++..   ....+.+.+|+.++++++|||||++++++.+.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTG----QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTC----CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            57999999999999999999987655    899999997642   23356789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+ +|+|.+++.+  .+.+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        89 ~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             EEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence            9999999 7899999854  457999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||......    ..+.. +..    +.   
T Consensus       163 ~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~-i~~----~~---  228 (275)
T 3hyh_A          163 TDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKN-ISN----GV---  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HHH----TC---
T ss_pred             CCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHH-HHc----CC---
Confidence            5433  2334689999999999998876 57999999999999999999999754211    11111 110    11   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         ..+    +......+.+|+.+||+.||++|||++|+++.-.-.
T Consensus       229 ---~~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          229 ---YTL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             ---CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             ---CCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence               111    122335578899999999999999999999865443

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=2e-49  Score=394.12  Aligned_cols=186  Identities=32%  Similarity=0.510  Sum_probs=166.8

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|..    .+|+|+|+|.+. ++.|+||+..      .+++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         2 ~~~~F~f~~F~~----~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---d~~tg~vaSFsT~F~F   73 (253)
T 1g7y_A            2 DIQSFSFKNFNS----SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY---DKSTGAVASWATSFTA   73 (253)
T ss_dssp             EEEEEEESSCCS----SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             cceEEEcCCCCc----CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEee---cCCCCCccceEEEEEE
Confidence            468999999974    799999999998 8999999875      4689999999999999   6677889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      .|.+.+...+||||||+|+|....| ++.|+||||||.+++...+|+|||||||++|.+ +||++|||||||||++|.++
T Consensus        74 ~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t  151 (253)
T 1g7y_A           74 NIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRT  151 (253)
T ss_dssp             ECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEE
T ss_pred             EEecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCCCCccCceEEEEecceeccC-cCCCCCcEeeccCCccccce
Confidence            9998766678999999999987655 478999999997765578999999999999988 59999999999999999998


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce--
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW--  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~--  218 (636)
                      ++|.              +.+|+.++|||+||                                     ||||+||..  
T Consensus       152 ~~~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~  217 (253)
T 1g7y_A          152 ASWG--------------LANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEG  217 (253)
T ss_dssp             EECC--------------CCTTSEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSS
T ss_pred             eccc--------------cCCCCeEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeCcCCCCc
Confidence            8752              67899999999998                                     999999998  


Q ss_pred             -ecceeeeeccccCCC
Q 006668          219 -IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 -~~~~~il~wsf~~~~  233 (636)
                       .+.|+||+|+|+++.
T Consensus       218 ~~~~H~IlsWsF~s~l  233 (253)
T 1g7y_A          218 YTETHDVLSWSFASKL  233 (253)
T ss_dssp             CCCCCEEEEEEEEEEE
T ss_pred             ccceeEEEEEEEEeeC
Confidence             999999999999864

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=2.8e-49  Score=392.57  Aligned_cols=186  Identities=31%  Similarity=0.473  Sum_probs=165.9

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|.+  +..+|+|+|||.+.+++.|+||+..      .+++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---d~~tg~vaSFsT~F~F   76 (253)
T 1sbf_A            2 ETVSFSWNKFVP--KQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW---DKETGSVASFAASFNF   76 (253)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecc---cCCCCcccceEEEEEE
Confidence            458999999975  2479999999999778999999875      4689999999999999   6677889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      .|.+.+...+||||||+|+|....| ++.|+||||||.+  ...+|+|||||||++|.  +||++|||||||||++|+++
T Consensus        77 ~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~--~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t  151 (253)
T 1sbf_A           77 TFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN--ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKT  151 (253)
T ss_dssp             EEECSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT--SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE
T ss_pred             EEeCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC--CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccce
Confidence            9998766778999999999987655 4789999999876  46889999999999997  69999999999999999998


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce--
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW--  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~--  218 (636)
                      ++|.              +.+|+.++|||+||                                     ||||+||..  
T Consensus       152 ~~~~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~  217 (253)
T 1sbf_A          152 TSWD--------------LANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIP  217 (253)
T ss_dssp             EECC--------------CCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSSC
T ss_pred             eccc--------------ccCCCeeEEEEEEeCCCcEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCcc
Confidence            7752              67899999999999                                     999999999  


Q ss_pred             ecceeeeeccccCCC
Q 006668          219 IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 ~~~~~il~wsf~~~~  233 (636)
                      .+.|+||+|+|+++.
T Consensus       218 ~~~H~IlsWsF~s~l  232 (253)
T 1sbf_A          218 GESHDVLSWSFASNL  232 (253)
T ss_dssp             CCEEEEEEEEEEEEE
T ss_pred             ceeeEEEEEEeEeec
Confidence            999999999999864

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=4.3e-49  Score=387.85  Aligned_cols=185  Identities=32%  Similarity=0.512  Sum_probs=164.3

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..     .+++|||+|++||+||   ++.+  ++||+|+|+|.
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---d~~~--~~sFsT~F~F~   74 (233)
T 1n47_A            2 ESTSFSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH---DNTT--LASFTTSFSFV   74 (233)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECB---CSSC--BCEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEecc---CCCC--cCCEEEEEEEE
Confidence            468999999975  2479999999999778999999876     3699999999999999   5444  99999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV  178 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~  178 (636)
                      |.+.+...+||||||+|+|....|+ +.|+||||||.+++...||+|||||||++|.  +||++|||||||||+.|.+++
T Consensus        75 I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~  151 (233)
T 1n47_A           75 MAAPAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTT  151 (233)
T ss_dssp             CCCSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEE
T ss_pred             EeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCCCCccCceEEEEeccccCC--CCCCCCcEEEccCCccccccc
Confidence            9987666789999999999876665 7899999999876557899999999999998  599999999999999999987


Q ss_pred             cCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce---
Q 006668          179 PAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW---  218 (636)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~---  218 (636)
                      +|+              +.+|+.++|||+||                                     ||||+||..   
T Consensus       152 ~~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~  217 (233)
T 1n47_A          152 PFD--------------MVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGV  217 (233)
T ss_dssp             ECC--------------CCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTC
T ss_pred             ccc--------------ccCCCEEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCccc
Confidence            652              67899999999998                                     999999998   


Q ss_pred             ecceeeeeccccCC
Q 006668          219 IEARRVLAWSLSDT  232 (636)
Q Consensus       219 ~~~~~il~wsf~~~  232 (636)
                      .+.|+||+|+|+++
T Consensus       218 ~~~h~IlsWsF~s~  231 (233)
T 1n47_A          218 VETHDIVSWSFAVS  231 (233)
T ss_dssp             CCCCEEEEEEEEEE
T ss_pred             cceeEEEEEEEEee
Confidence            99999999999875

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=6.4e-49  Score=385.54  Aligned_cols=183  Identities=27%  Similarity=0.390  Sum_probs=164.0

Q ss_pred             eeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCC--CCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           26 LDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDS--NQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        26 ~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~--~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ++|+|++|..   ..+|+|+|+|.+.+++.|+||+.  ..+++|||+|++||+||   ++.++.++||+|+|+|.|.+.+
T Consensus         1 ~sF~f~~F~~---~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~---~~~tg~vaSFsT~F~F~I~~~~   74 (234)
T 2eig_A            1 VSFNYTRFKD---DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIW---DSATGNVASFITSFSFIVSNVQ   74 (234)
T ss_dssp             CEEEESSCCS---SSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECB---CTTTCCBCEEEEEEEEEEEECT
T ss_pred             CeEEcCCCCC---CCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEee---cCCCCCccceEEEEEEEEeCCC
Confidence            4799999972   37999999999977899999988  67899999999999999   6677789999999999999876


Q ss_pred             CCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCC---CeeeEecCCcccccccc
Q 006668          104 ASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDD---NHIGVDLNNIESAKHVP  179 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~---~Hvgidvns~~s~~~~~  179 (636)
                      ...+||||||+|+|... +|.++.|+||||||.+  ...+|+|||||||++|.  +||++   |||||||||++|+++++
T Consensus        75 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~--~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~  150 (234)
T 2eig_A           75 RYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS--NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVN  150 (234)
T ss_dssp             TSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT--CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEE
T ss_pred             CCCCCCcEEEEEecCCCCCCcCCCCCccccccCC--CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceec
Confidence            67789999999999864 6777899999999876  46789999999999998  59999   99999999999999887


Q ss_pred             CccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCC--Cceecc
Q 006668          180 AGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASK--TNWIEA  221 (636)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsast--g~~~~~  221 (636)
                      |+              +.+|+.++|||+||                                    ||||+|  |.. +.
T Consensus       151 ~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~  215 (234)
T 2eig_A          151 WN--------------RVSGSLEKATIIYDSDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ER  215 (234)
T ss_dssp             CC--------------CCTTCCEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EE
T ss_pred             cc--------------ccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ce
Confidence            52              67888999999998                                    999999  998 99


Q ss_pred             eeeeeccccCCC
Q 006668          222 RRVLAWSLSDTG  233 (636)
Q Consensus       222 ~~il~wsf~~~~  233 (636)
                      |+||+|+|+++.
T Consensus       216 h~IlsWsF~s~l  227 (234)
T 2eig_A          216 HDIYSWSFTSTL  227 (234)
T ss_dssp             EEEEEEEEEEEC
T ss_pred             eEEEEEEEEecC
Confidence            999999999864

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=4e-49  Score=391.76  Aligned_cols=185  Identities=35%  Similarity=0.523  Sum_probs=165.7

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|..    .||+|+|+|.+.+++.|+||+..      .+++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         2 ~~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---d~~tg~vaSFsT~F~F   74 (252)
T 1fat_A            2 NDIYFNFQRFNE----TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW---DNTTGTVASFATSFTF   74 (252)
T ss_dssp             CCEEEEESSCCG----GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECE---ETTTTEEEEEEEEEEE
T ss_pred             cceEEEcCCCCc----CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecc---cCCCCcccceEEEEEE
Confidence            468999999964    79999999999778999999875      4689999999999999   6677889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      .|.+.+...+||||||+|+|....| ++.|+||||||.+  ...+|+|||||||++|.+ +||++|||||||||+.|.++
T Consensus        75 ~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~--~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~  150 (252)
T 1fat_A           75 NIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS--NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKT  150 (252)
T ss_dssp             ECCCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS--CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEE
T ss_pred             EEeCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC--CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccce
Confidence            9998766678999999999987655 4789999999876  468899999999999988 69999999999999999998


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce--
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW--  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~--  218 (636)
                      ++|.              +.+|+.++|||+||                                     ||||+||..  
T Consensus       151 ~~~~--------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~  216 (252)
T 1fat_A          151 TRWD--------------FVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKG  216 (252)
T ss_dssp             EECC--------------CCTTCEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTT
T ss_pred             eccc--------------ccCCCEEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCCc
Confidence            7752              67899999999998                                     999999999  


Q ss_pred             -ecceeeeeccccCCC
Q 006668          219 -IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 -~~~~~il~wsf~~~~  233 (636)
                       .+.|+||+|+|+++.
T Consensus       217 ~~~~H~IlsWsF~s~l  232 (252)
T 1fat_A          217 NVETNDVLSWSFASKL  232 (252)
T ss_dssp             BCCCCEEEEEEEEEEE
T ss_pred             ccceEEEEEEEEEeeC
Confidence             999999999999864

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=8.2e-49  Score=388.00  Aligned_cols=189  Identities=31%  Similarity=0.507  Sum_probs=166.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|.+  +..+|+|+|+|.+.+++.|+||+...      .++|||+|++||+||   ++ +++++||+|+|+|
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~---~~-~g~~~sFst~F~F   75 (240)
T 2fmd_A            2 NSVCFTFTDFES--GQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW---QS-SSLVASFETTFTF   75 (240)
T ss_dssp             CEEEEEESSCCT--TCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECC---CT-TCSEEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEee---CC-CCCcCcEEEEEEE
Confidence            468999999974  24799999999997789999998765      799999999999999   56 7789999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCC-CcCcccccccCCCCC-CCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGA-LASQYFGLFSNATVV-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESA  175 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~-~~g~~lgl~~~~~~~-~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~  175 (636)
                      .|.+. ...+||||||+|+|....|+. +.|+||||||.++++ ..||+|||||||++|.+++||++|||||||||++|.
T Consensus        76 ~I~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~  154 (240)
T 2fmd_A           76 SISQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSK  154 (240)
T ss_dssp             ECCBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCS
T ss_pred             EEecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeecccccccc
Confidence            99987 667899999999998766665 789999999987655 788999999999999988899999999999999999


Q ss_pred             ccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCCcee
Q 006668          176 KHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKTNWI  219 (636)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg~~~  219 (636)
                      ++.+|+              +.+|+.++|||+||                                    ||||+||...
T Consensus       155 ~s~~~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~  220 (240)
T 2fmd_A          155 AASKWD--------------WQNGKTATAHISYNSASKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYT  220 (240)
T ss_dssp             EEEECC--------------CCSSCEEEEEEEEETTTTEEEEEEECTTSCCEEEEEECCGGGTSCSEEEEEEEEECCSSC
T ss_pred             ceeEEE--------------eeCCCEEEEEEEEeCCCCEEEEEEecCCCCceEEEEEechHHhCCCceEEEEEeccCCcc
Confidence            887652              56888999999998                                    9999999999


Q ss_pred             cceeeeeccccCCC
Q 006668          220 EARRVLAWSLSDTG  233 (636)
Q Consensus       220 ~~~~il~wsf~~~~  233 (636)
                      +.|+||+|+|+++.
T Consensus       221 ~~H~IlsWsF~s~~  234 (240)
T 2fmd_A          221 QTNNILAWSFRSSL  234 (240)
T ss_dssp             BCCEEEEEEEEEEE
T ss_pred             ccEEEEEEEeEecC
Confidence            99999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-50  Score=414.03  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|++.+.||+|+||+||+|+... +...++.||+|+++...  ......+.+|+.++++++|||||++++++.+++.++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~-~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS-GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS-STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc-CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            358889999999999999998643 22344889999997542  222346788999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||||++|+|.++|.+  .+.+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       103 ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999953  457999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+.. +..    +.     
T Consensus       178 ~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~-i~~----~~-----  242 (304)
T 3ubd_A          178 DHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTM-ILK----AK-----  242 (304)
T ss_dssp             ---C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-HHH----CC-----
T ss_pred             CCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHH-HHc----CC-----
Confidence            3322 3344689999999999999999999999999999999999999997543221    1111 110    00     


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~~  596 (636)
                       .    .++......+.+|+.+||+.||++|||+     +|++++
T Consensus       243 -~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          243 -L----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -C----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -C----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence             0    1122234567889999999999999984     566654

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=7.9e-49  Score=387.99  Aligned_cols=186  Identities=28%  Similarity=0.407  Sum_probs=164.4

Q ss_pred             CceeEEcCCC----CCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEE
Q 006668           24 SALDFLFNSF----GSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFST   93 (636)
Q Consensus        24 ~~~~f~f~~F----~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t   93 (636)
                      +.++|+|++|    .+  +..+|+|+|+|.+. ++.|+||+..      .+++|||+|++||+||   + .++.++||+|
T Consensus         2 ~~~~F~f~~F~~~~~~--~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---~-~tg~vasFsT   74 (243)
T 1gsl_A            2 NTVNFTYPDFWSYSLK--NGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLW---D-STGKAASFYT   74 (243)
T ss_dssp             CCCEEEESCCCCTTCC--TTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECB---C-TTSCBCEEEE
T ss_pred             cceEEEcCCCccccCC--CCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEcc---C-CCCCcCceEE
Confidence            3578999999    43  24799999999998 8999999875      4799999999999999   6 6778999999


Q ss_pred             EEEEEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCC-C-CCCceEEEEeecCCCCCCCCCCCCeeeEecCC
Q 006668           94 SFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATV-V-TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNN  171 (636)
Q Consensus        94 ~F~f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~-~-~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns  171 (636)
                      +|+|.|.+. ...+||||||+|+|....| ++.|+||||||.+++ + ..||+|||||||++|.+|+||++|||||||||
T Consensus        75 ~F~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns  152 (243)
T 1gsl_A           75 SFTFLLKNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNS  152 (243)
T ss_dssp             EEEEEEEES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESS
T ss_pred             EEEEEEecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCC
Confidence            999999987 5678999999999986655 478999999998764 4 78899999999999999999999999999999


Q ss_pred             ccccccccCccccCCCCCcceeeeecC---CCeeEEEEEec------------------------------------ccc
Q 006668          172 IESAKHVPAGYYSSSRNESFVPVRMRN---GQNIHAWIDFD------------------------------------GFS  212 (636)
Q Consensus       172 ~~s~~~~~~~~~~~~~~~~~~~~~~~~---g~~~~~~i~y~------------------------------------gfs  212 (636)
                      +.|+++++|+              +.+   |+.++|||+||                                    |||
T Consensus       153 ~~S~~~~~~~--------------l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~~vGFS  218 (243)
T 1gsl_A          153 IVSVATTRWE--------------NDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFS  218 (243)
T ss_dssp             SSCSEEEECC--------------HHHHTSCCEEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             ccccceeeeE--------------EeccCCCcEEEEEEEEeCCCCEEEEEEecCCCCceeEEEEechHHhCCCceEEEEE
Confidence            9999988752              455   89999999998                                    999


Q ss_pred             cCCCceecceeeeeccccCCC
Q 006668          213 ASKTNWIEARRVLAWSLSDTG  233 (636)
Q Consensus       213 astg~~~~~~~il~wsf~~~~  233 (636)
                      |+|| ..+.|+||+|+|+++.
T Consensus       219 AsTG-~~~~h~IlsWsF~s~l  238 (243)
T 1gsl_A          219 AGVG-YDEVTYILSWHFFSTL  238 (243)
T ss_dssp             EEEC-BSEEEEEEEEEEEEEC
T ss_pred             eccC-CcceeEEEEEEEEeec
Confidence            9999 9999999999999864

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=1.1e-48  Score=386.24  Aligned_cols=185  Identities=33%  Similarity=0.515  Sum_probs=164.3

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      +.++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..     .+++|||+|++||+||   ++.++.++||+|+|+|.
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~---d~~tg~vaSFsT~F~F~   76 (242)
T 1wbf_A            2 KTISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW---DSTTGNVASFETRFSFS   76 (242)
T ss_dssp             CEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecc---cCCCCCeeeEEEEEEEE
Confidence            357899999975  2479999999999778999999876     5799999999999999   66777899999999999


Q ss_pred             eecC-CCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           99 ILPE-IASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        99 i~~~-~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      |.+. +...+||||||+|+|....|+ +.|+||||||.+   ..+|+|||||||++|.  +||++|||||||||+.|.++
T Consensus        77 I~~~~~~~~~gdGlAF~l~p~~~~~~-~~g~~LGl~n~~---~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~  150 (242)
T 1wbf_A           77 IRQPFPRPHPADGLVFFIAPPNTQTG-EGGGYFGIYNPL---SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKT  150 (242)
T ss_dssp             CCCSCCSSCCCEEEEEEEECSSCCCC-CCGGGTTTCCTT---SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE
T ss_pred             EeCCCCCCCCCCcEEEEEecCCCCCC-CCCCccccccCC---CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccce
Confidence            9987 566789999999999866554 789999999865   6789999999999997  69999999999999999988


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCC----C
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASK----T  216 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsast----g  216 (636)
                      ++|              ++.+|+.++|||+||                                     ||||+|    |
T Consensus       151 ~~~--------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G  216 (242)
T 1wbf_A          151 VPF--------------TLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSG  216 (242)
T ss_dssp             EEC--------------CCCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGG
T ss_pred             eee--------------EecCCCEEEEEEEEeCCCCEEEEEEccCCCCCcceEEEEechHHhcCCceEEEEEEeecCcCC
Confidence            765              267899999999998                                     999999    8


Q ss_pred             ce---ecceeeeeccccCCC
Q 006668          217 NW---IEARRVLAWSLSDTG  233 (636)
Q Consensus       217 ~~---~~~~~il~wsf~~~~  233 (636)
                      ..   .|.|+||+|+|+++.
T Consensus       217 ~~~~~~~~h~IlsWsF~s~l  236 (242)
T 1wbf_A          217 KQRNATETHDILSWSFSASL  236 (242)
T ss_dssp             CCTTCCCCCEEEEEEEEEEC
T ss_pred             ccccccceEEEEEEEeEecC
Confidence            88   999999999999864

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=3.3e-48  Score=382.72  Aligned_cols=184  Identities=30%  Similarity=0.450  Sum_probs=163.6

Q ss_pred             ceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           25 ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        25 ~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      +++|+|++|.+  +..+|+|+|+|.+.+++.|+||+..      .+++|||+|++||+||   ++.+++++||+|+|+|.
T Consensus         2 ~~~F~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---d~~~g~vasFsT~F~F~   76 (238)
T 1f9k_A            2 TQSFNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIW---DSTTGNVASFETRFSFN   76 (238)
T ss_dssp             EEEEEESSCCS--SCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             CeEEEcCCCCC--CCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEee---cCCCCCeeeEEEEEEEE
Confidence            57899999974  2479999999999878999999876      5789999999999999   66777899999999999


Q ss_pred             eecC-CCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           99 ILPE-IASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        99 i~~~-~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      |.+. +...+||||||+|+|....| ++.|+||||||.+  .. +|+|||||||++|.  +||++|||||||||+.|.++
T Consensus        77 I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~--~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s  150 (238)
T 1f9k_A           77 ITQPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP--EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKT  150 (238)
T ss_dssp             EECCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS--CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE
T ss_pred             EecCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC--CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccce
Confidence            9987 56678999999999986655 4789999999876  34 99999999999997  69999999999999999988


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec---------------------------------------ccccCCCce
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD---------------------------------------GFSASKTNW  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~---------------------------------------gfsastg~~  218 (636)
                      .+|              ++.+|+.++|||+||                                       ||||+||..
T Consensus       151 ~~~--------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~  216 (238)
T 1f9k_A          151 LHF--------------QLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQ  216 (238)
T ss_dssp             EEC--------------CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSS
T ss_pred             Eee--------------cccCCCEEEEEEEEeCCCCEEEEEEecCCCCCceeEEEEechHHhCCCCceEEEEEEeCcCCC
Confidence            765              267899999999998                                       999999999


Q ss_pred             ---ecceeeeeccccCCC
Q 006668          219 ---IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 ---~~~~~il~wsf~~~~  233 (636)
                         .+.|+||+|+|+++.
T Consensus       217 ~~~~~~h~IlsWsF~s~~  234 (238)
T 1f9k_A          217 KNAVETHEIISWSFTSSL  234 (238)
T ss_dssp             TTCCCEEEEEEEEEEEEC
T ss_pred             CcccceEEEEEeEeEeec
Confidence               999999999999864

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=5.8e-48  Score=380.84  Aligned_cols=187  Identities=28%  Similarity=0.475  Sum_probs=164.8

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ..++|+|++|.+  +..+|+|+|+|. .+++.|+||++..+++|||+|++||+||   ++.++.++||+|+|+|.|.+.+
T Consensus         2 ~~~~F~f~~F~~--~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~---~~~~~~~~sFst~F~F~I~~~~   75 (234)
T 2bqp_A            2 ETTSFLITKFSP--DQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIW---DRETGNVANFVTSFTFVINAPN   75 (234)
T ss_dssp             EEEEEEESSBCT--TCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECB---CTTTCCBCEEEEEEEEEEECSS
T ss_pred             cceEEEcCCCCC--CCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcc---cCCCCceeeEEEEEEEEEeCCC
Confidence            468999999974  247999999999 5589999999888899999999999999   6677889999999999999876


Q ss_pred             CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCC--CCeeeEecCCccccccccCc
Q 006668          104 ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPD--DNHIGVDLNNIESAKHVPAG  181 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~--~~Hvgidvns~~s~~~~~~~  181 (636)
                      ...+||||||+|+|....|+ +.|+||||||.+++...+|+|||||||++|.+ +||+  +|||||||||++|.++.+|+
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~~  153 (234)
T 2bqp_A           76 SYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSWK  153 (234)
T ss_dssp             TTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSSCCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEECC
T ss_pred             CCCCCCcEEEEEecCCCCCC-CCCCccccccccCCCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEeeE
Confidence            67789999999999876666 78999999998765578999999999999988 5999  99999999999999988753


Q ss_pred             cccCCCCCcceeeeecCCCeeEEEEEec------------------------------------------ccccCCCcee
Q 006668          182 YYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------------GFSASKTNWI  219 (636)
Q Consensus       182 ~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------------gfsastg~~~  219 (636)
                                    +.+|+.++|||+||                                          ||||+||...
T Consensus       154 --------------l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~  219 (234)
T 2bqp_A          154 --------------LQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEY  219 (234)
T ss_dssp             --------------CCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSC
T ss_pred             --------------EcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCc
Confidence                          45667777777776                                          9999999999


Q ss_pred             cceeeeeccccCC
Q 006668          220 EARRVLAWSLSDT  232 (636)
Q Consensus       220 ~~~~il~wsf~~~  232 (636)
                      +.|+||+|+|+++
T Consensus       220 ~~H~IlsWsF~s~  232 (234)
T 2bqp_A          220 AAHEVLSWSFHSE  232 (234)
T ss_dssp             CEEEEEEEEEEEE
T ss_pred             ccEEEEEEEEEee
Confidence            9999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.1e-48  Score=402.00  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=190.3

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccc-----
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-----  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----  393 (636)
                      +|+..+.||+|+||.||+|+.+.++    +.||||+++... ....+.+.+|+++|++|+|||||++++++.+.+     
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDD----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTC----CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCC----CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            4788999999999999999987665    899999997653 344577899999999999999999999986543     


Q ss_pred             -------eEEEEEeecCCCChhhhHhcCCC-CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEE
Q 006668          394 -------ELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR  465 (636)
Q Consensus       394 -------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  465 (636)
                             .+++|||||++|+|.+++..... ...++..++.++.||+.||+|||   +++|+||||||+||||+.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence                   37999999999999999965432 33556678899999999999999   79999999999999999999999


Q ss_pred             EeccCCcccccCCCCc-----------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh
Q 006668          466 LGDFGLAKLYQQGEVP-----------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE  534 (636)
Q Consensus       466 l~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~  534 (636)
                      |+|||+|+........           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||...   ..
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~  232 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---ME  232 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cH
Confidence            9999999876543221           1234579999999999999999999999999999999996   77421   11


Q ss_pred             HHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          535 EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       535 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+.. +    .....        +. ........+.+|+.+||+.||++|||+.|+++.-.-+
T Consensus       233 ~~~~~~~-~----~~~~~--------p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          233 RVRTLTD-V----RNLKF--------PP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HHHHHHH-H----HTTCC--------CH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHH-H----hcCCC--------CC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            1111111 1    01111        10 1112233456799999999999999999999854333

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=3e-48  Score=379.68  Aligned_cols=180  Identities=33%  Similarity=0.513  Sum_probs=160.9

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCC---CCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEee
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDS---NQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSIL  100 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~---~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~  100 (636)
                      ..++|+|++|..    .||+|+|+|.+.+++.|+||++   ..+++|||+|++||+||   ++.++.++||+|+|+|.|.
T Consensus         2 ~~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~---~~~~g~vaSFsT~F~F~I~   74 (226)
T 1avb_A            2 NDASFNVETFNK----TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN---DRTIDNLASFSTNFTFRIN   74 (226)
T ss_dssp             EEEEEEESSCCG----GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECE---EGGGTEEEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCc----cCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEee---cCCCCCcccEEEEEEEEEe
Confidence            357899999964    7999999999977899999987   66799999999999999   5567789999999999999


Q ss_pred             cCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccC
Q 006668          101 PEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPA  180 (636)
Q Consensus       101 ~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~  180 (636)
                      +.+...+||||||+|+|....|+ +.|+||||||.+++...||+|||||||+         +|||||||||++|+++++|
T Consensus        75 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~  144 (226)
T 1avb_A           75 AKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTTNYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC  144 (226)
T ss_dssp             ESSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCCCCCcccEEEEEecCc---------CCccceeecCcccCccccC
Confidence            88767789999999999876666 7899999999875557899999999998         5899999999999999876


Q ss_pred             ccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce---ec
Q 006668          181 GYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW---IE  220 (636)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~---~~  220 (636)
                      +            ..+.+|+.++|||+||                                     ||||+||..   .|
T Consensus       145 ~------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~  212 (226)
T 1avb_A          145 N------------FGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTE  212 (226)
T ss_dssp             C------------SGGGTTCEEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCE
T ss_pred             C------------ccccCCCeEEEEEEEeCCCcEEEEEEeecCCCccceEEEEechHHhCCCceEEEEEeccCCCCcccc
Confidence            2            3467899999999999                                     999999999   99


Q ss_pred             ceeeeeccccCC
Q 006668          221 ARRVLAWSLSDT  232 (636)
Q Consensus       221 ~~~il~wsf~~~  232 (636)
                      .|+||+|+|+++
T Consensus       213 ~h~IlsWsF~s~  224 (226)
T 1avb_A          213 THNVLSWSFSSN  224 (226)
T ss_dssp             EEEEEEEEEEEE
T ss_pred             eeEEEEEEEEee
Confidence            999999999874

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=2e-47  Score=376.77  Aligned_cols=179  Identities=30%  Similarity=0.456  Sum_probs=158.7

Q ss_pred             CceeEEcCCCCCCCCCCC-eEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTD-LILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~-~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      ..++|+|++|..    .| |+|+|||.+.+++.|+||++..      +++|||+|++||+||+   +.  .++||+|+|+
T Consensus         2 ~~~~F~f~~F~~----~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d---~~--~vaSFsT~F~   72 (240)
T 1ioa_A            2 TETSFNFPNFHT----DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD---SN--NVASFNTNFT   72 (240)
T ss_dssp             CCCEEEESSCCT----TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC---SS--CBEEEEEEEE
T ss_pred             cceEEEcCCCCC----CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccC---CC--ccccEEEEEE
Confidence            457899999974    68 9999999997789999998764      7899999999999994   33  6999999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           97 FSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.|.+.+...+||||||+|+|.+..|+ +.|+||||||.+++...+|+|||||||+         +|||||||||++|.+
T Consensus        73 F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~  142 (240)
T 1ioa_A           73 FIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTNNPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYV  142 (240)
T ss_dssp             EECCBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCSSCCGGGCCEEEEEETT---------TTEEEEEESSSSCSE
T ss_pred             EEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCCCCCcCcEEEEEecCc---------CCceeeeeCCccccc
Confidence            999987767789999999999876676 8899999999875557899999999998         589999999999999


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce-
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW-  218 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~-  218 (636)
                      +++|+            ..+.+|+.++|||+||                                     ||||+||.. 
T Consensus       143 t~~~~------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~  210 (240)
T 1ioa_A          143 NENCD------------FHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTE  210 (240)
T ss_dssp             EEECC------------HHHHCSSCEEEEEEEETTTTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSST
T ss_pred             cccCC------------ccccCCCEEEEEEEEeCCCcEEEEEEecCCCCccceeEEEechHHhCCCceEEEEEeccCCCC
Confidence            98762            3467899999999999                                     999999999 


Q ss_pred             --ecceeeeeccccCCC
Q 006668          219 --IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 --~~~~~il~wsf~~~~  233 (636)
                        .|.|+||+|+|++++
T Consensus       211 ~~~~~H~IlsWsF~s~~  227 (240)
T 1ioa_A          211 DTTETHDVLSWSFSSKF  227 (240)
T ss_dssp             TTCBCCEEEEEEEEEEE
T ss_pred             cccceeEEEEEEEEeeC
Confidence              999999999999864

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=4.5e-46  Score=350.07  Aligned_cols=165  Identities=27%  Similarity=0.450  Sum_probs=147.3

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ..++|+|++|.+  +..+|+|+|+|. .++|.|+||+.+.+++|||+|++||+||   ++.+++|+||+|+|+|.|.+.+
T Consensus         2 ~~~sF~f~~F~~--~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~---d~~tg~vaSFsT~F~F~I~~~~   75 (181)
T 2ltn_A            2 ETTSFLITKFSP--DQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIW---DRETGNVANFVTSFTFVINAPN   75 (181)
T ss_dssp             EEEEEEESSCCS--SCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEEEECSS
T ss_pred             cceEEEcCCCCC--CCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEee---cCCCCCccceEEEEEEEEecCC
Confidence            468999999975  247999999999 6689999999888899999999999999   6677889999999999999877


Q ss_pred             CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCC--CCeeeEecCCccccccccCc
Q 006668          104 ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPD--DNHIGVDLNNIESAKHVPAG  181 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~--~~Hvgidvns~~s~~~~~~~  181 (636)
                      ...+||||||||+|....|+ +.||||||||.+++...+|+|||||||++|.+ +||+  +|||||||||++|+++++|.
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~~~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~~  153 (181)
T 2ltn_A           76 SYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSWK  153 (181)
T ss_dssp             TTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSSCCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEECC
T ss_pred             CCCCCCceEEEEecCCCCCC-CCCccccccccCCCCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceeccc
Confidence            67789999999999876666 78999999998755578999999999999988 5999  99999999999999998752


Q ss_pred             cccCCCCCcceeeeecCCCeeEEEEEecc
Q 006668          182 YYSSSRNESFVPVRMRNGQNIHAWIDFDG  210 (636)
Q Consensus       182 ~~~~~~~~~~~~~~~~~g~~~~~~i~y~g  210 (636)
                                    +.+|+.++|||+||+
T Consensus       154 --------------l~~G~~~~v~I~Yd~  168 (181)
T 2ltn_A          154 --------------LQNGEEANVVIAFNA  168 (181)
T ss_dssp             --------------CCTTCCEEEEEEEET
T ss_pred             --------------cCCCCEEEEEEEEEC
Confidence                          579999999999994

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-46  Score=394.30  Aligned_cols=290  Identities=39%  Similarity=0.727  Sum_probs=248.2

Q ss_pred             CcccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceee
Q 006668          306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-GLKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       306 ~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      ...++++++..++++|+..+.||+|+||.||+|+... +    ..||+|++...... ....+.+|+.++++++||||++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-G----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS-S----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecC-C----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence            5678999999999999999999999999999998643 2    78999999765322 2236889999999999999999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +++++...+..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999999996543  34599999999999999999999943333999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      .+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||..............+|
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999998776555445555679999999999998899999999999999999999999996322112223345677


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +........+....+..+...+..++...+.+++.+||+.||.+|||+.||+++|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            7777777777788888888888999999999999999999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=394.85  Aligned_cols=267  Identities=21%  Similarity=0.284  Sum_probs=204.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-----  391 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----  391 (636)
                      ++|++.+.||+|+||.||+|+.+.++    +.||||+++..  .....+.+.+|+++|++++|||||++++++..     
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTG----QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCC----CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            56889999999999999999987766    89999999754  33445678899999999999999999998653     


Q ss_pred             -cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                       .+.+|||||||+ |+|.+++.  ..+.+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecc
Confidence             467899999994 78999994  3567999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCC---CccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          471 LAKLYQQGE---VPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       471 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +|+......   ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+.     ..
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~-----~~  278 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM-----MV  278 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH-----HH
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH-----Hh
Confidence            998664322   2233457899999999998775 46899999999999999999999997553222111111     11


Q ss_pred             hcCCc--chhh--------hhhhhh-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGK--ICEA--------ADARIR-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~--~~~~--------~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....  ....        ....+.       ..........+.+|+.+||..||.+|||+.|++++-.-.
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            11000  0000        000000       000011234678899999999999999999999875444

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-45  Score=388.34  Aligned_cols=274  Identities=22%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      ...+.|++.++||+|+||+||+|+.+.. ...++.||+|.+.....  ..++.+|+++|..+ +|||||++++++.+.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ-VGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT-TSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc-CCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4567899999999999999999986421 12348899999876543  35678899999998 69999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccCCcc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAK  473 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~  473 (636)
                      +++|||||++|+|.+++     +.+++.+++.++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999998     24899999999999999999999   8999999999999999876 799999999998


Q ss_pred             cccCCCC---------------------------ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCC
Q 006668          474 LYQQGEV---------------------------PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRP  525 (636)
Q Consensus       474 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~P  525 (636)
                      .......                           ...+..+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            6543221                           112335799999999998775 589999999999999999999999


Q ss_pred             CCCCCChhhHHHHHHHHHH--------HHhc----------CCcchhhh------h---hhhhh---------ccCHHHH
Q 006668          526 LDMGKGEEEEEAVLMDWVR--------NLYG----------QGKICEAA------D---ARIRQ---------EFEAEEM  569 (636)
Q Consensus       526 f~~~~~~~~~~~~l~~~v~--------~~~~----------~~~~~~~~------d---~~l~~---------~~~~~~~  569 (636)
                      |.....+...-..+.....        ....          ........      +   +.+..         +......
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            9766443222111111000        0000          00000000      0   00000         0001123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          570 ELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       570 ~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+|+.+||+.||++|||++|++++-.-.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            4577899999999999999999999865443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-45  Score=383.85  Aligned_cols=284  Identities=35%  Similarity=0.611  Sum_probs=240.1

Q ss_pred             cccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeee
Q 006668          307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMR  386 (636)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~  386 (636)
                      .++++.++..++++|+..+.||+|+||.||+|+... +    ..||+|++........+.+.+|+.++++++||||++++
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  101 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-G----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI  101 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT-C----CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECC-C----CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            445566677788999999999999999999999653 2    78999999877666778899999999999999999999


Q ss_pred             ccccccceEEEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          387 GWCRKGNELMLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +++.+.+..++||||+++|+|.+++....  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~  178 (321)
T 2qkw_B          102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP  178 (321)
T ss_dssp             EECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCE
T ss_pred             EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999996543  235899999999999999999999   7999999999999999999999


Q ss_pred             EEeccCCcccccCCC-CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGE-VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       465 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      ||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||........  .....|.
T Consensus       179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~--~~~~~~~  256 (321)
T 2qkw_B          179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWA  256 (321)
T ss_dssp             EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC--CCHHHHT
T ss_pred             EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH--HHHHHHh
Confidence            999999998654322 2223345689999999999989999999999999999999999999975533221  1234455


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ......+.+...+++.+......+....+.+++.+||+.||++|||+.|+++.|+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            555566666677777777778888999999999999999999999999999999764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.6e-45  Score=407.45  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=211.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|++.+.||+|+||.||+|+.+.++    +.||+|++........+.+.+|+.+|+.++|||||++++++.+.+.++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg----~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCC----CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            357899999999999999999987766    8999999988776667788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC--CcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE--MRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~~  475 (636)
                      |||||++|+|.++|..+ ...+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+..
T Consensus       232 v~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999998543 457999999999999999999999   8999999999999999854  89999999999987


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  .....+||+.|||||++.+..++.++|||||||++|||++|+.||........    +.. +..    +.    
T Consensus       308 ~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~-i~~----~~----  372 (573)
T 3uto_A          308 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET----LRN-VKS----CD----  372 (573)
T ss_dssp             CTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHH-HHT----TC----
T ss_pred             cCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHH-HHh----CC----
Confidence            6543  33446899999999999999999999999999999999999999975532211    111 110    00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ..+...........+.+|+.+||+.||.+|||+.|++++-
T Consensus       373 --~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          373 --WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             --CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             --CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence              0011111112234577889999999999999999999853

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.6e-44  Score=399.54  Aligned_cols=251  Identities=25%  Similarity=0.350  Sum_probs=202.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC------ChHHHHHHHHHHHHhccCCCCceeeeecccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD------SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~  392 (636)
                      ++|++.++||+|+||.||+++.+.++    +.||+|++.+.      ......+...++.+++.++|||||++++++.+.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg----~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCC----CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            46889999999999999999988766    89999999643      122223344567888899999999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      +.+|||||||+||+|.++|..  .+.+++..++.++.||+.||+|||   +++||||||||+||||+.++.+||+|||+|
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccccee
Confidence            999999999999999999953  457999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +......   ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||......... . +...+..      
T Consensus       340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~-i~~~i~~------  408 (689)
T 3v5w_A          340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-IDRMTLT------  408 (689)
T ss_dssp             EECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-H-HHHHHHH------
T ss_pred             eecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H-HHHhhcC------
Confidence            8765432   334689999999999864 57899999999999999999999999653222111 1 1110100      


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVL  597 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L  597 (636)
                          ..    ..++......+.+|+.+||+.||.+|++     +.||+++-
T Consensus       409 ----~~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          409 ----MA----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             ----CC----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             ----CC----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence                00    1122223456788999999999999998     68887653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=363.75  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=212.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|...++||+|+||.||+++...++    ..||+|++........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~----~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETG----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTC----CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCC----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            46778899999999999999987655    89999999877777788999999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999999653 456999999999999999999999   799999999999999999999999999999866443


Q ss_pred             CCcc-------------ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          479 EVPN-------------TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       479 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      ....             .....||+.|+|||++.+..++.++||||||+++|||++|..|+..........         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------  232 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------  232 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS---------
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH---------
Confidence            2211             114579999999999999999999999999999999999999986532211100         


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                             .......+....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       233 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          233 -------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             -------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   00001111112223344568889999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.3e-43  Score=361.04  Aligned_cols=256  Identities=24%  Similarity=0.338  Sum_probs=211.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++........+.+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTC----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCC----cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            467999999999999999999976655    8999999976655555778899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++..   ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999999953   36899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    ........  .        
T Consensus       169 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~--~--------  233 (297)
T 3fxz_A          169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIATNG--T--------  233 (297)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHHC--S--------
T ss_pred             ccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCC--C--------
Confidence            332 23346799999999999999999999999999999999999999975422111    11100000  0        


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .....+......+.+++.+||+.||++|||+.|+++.-.-.
T Consensus       234 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          234 --PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             --CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             --CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence              00111222345688899999999999999999999875544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-42  Score=362.53  Aligned_cols=274  Identities=24%  Similarity=0.338  Sum_probs=220.8

Q ss_pred             CCcccCHHHHHHHhCC----------CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHh
Q 006668          305 WPHRFSYEELSKATKG----------FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSM  374 (636)
Q Consensus       305 ~~~~~~~~~l~~a~~~----------f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l  374 (636)
                      .+..++++++..+++.          |+..+.||+|+||.||+|+....+    +.||||++........+.+.+|+.++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g----~~vavK~~~~~~~~~~~~~~~E~~~l   96 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG----RQVAVKMMDLRKQQRRELLFNEVVIM   96 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEETTTCCSHHHHHHHHHHH
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCC----cEEEEEEEeccchhHHHHHHHHHHHH
Confidence            3567888999888865          667789999999999999987655    89999999876666667889999999


Q ss_pred             ccCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCC
Q 006668          375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG  454 (636)
Q Consensus       375 ~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~  454 (636)
                      ++++||||+++++++...+..++||||+++++|.+++.   ...+++.++..++.|++.||+|||   +.+|+||||||+
T Consensus        97 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~  170 (321)
T 2c30_A           97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSD  170 (321)
T ss_dssp             TTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred             HhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHH
Confidence            99999999999999999999999999999999999984   346999999999999999999999   789999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh
Q 006668          455 NILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE  534 (636)
Q Consensus       455 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~  534 (636)
                      |||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-  248 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-  248 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             HEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            9999999999999999998765432 22344679999999999999999999999999999999999999997542211 


Q ss_pred             HHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          535 EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       535 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                          ....+....         .+.+.  ........+.+++.+||+.||++|||+.|+++...-... ..|
T Consensus       249 ----~~~~~~~~~---------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~-~~~  304 (321)
T 2c30_A          249 ----AMKRLRDSP---------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT-GLP  304 (321)
T ss_dssp             ----HHHHHHHSS---------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC-CCG
T ss_pred             ----HHHHHhcCC---------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC-CCc
Confidence                111111100         00000  011223567889999999999999999999997655422 455

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.9e-42  Score=356.46  Aligned_cols=280  Identities=36%  Similarity=0.593  Sum_probs=226.8

Q ss_pred             CcccCHHHHHHHhCCCCCc------eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----ChHHHHHHHHHHHHhc
Q 006668          306 PHRFSYEELSKATKGFSND------ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SKQGLKEFMAEISSMG  375 (636)
Q Consensus       306 ~~~~~~~~l~~a~~~f~~~------~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~  375 (636)
                      .+.|++.++..++++|...      ++||+|+||.||+|+..+      ..||+|++...    .....+.+.+|+.+++
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~   85 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------TTVAVKKLAAMVDITTEELKQQFDQEIKVMA   85 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSS------CEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECC------ceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence            4679999999999999888      899999999999998632      78999998753    2344578899999999


Q ss_pred             cCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcC-CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCC
Q 006668          376 RLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK-PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG  454 (636)
Q Consensus       376 ~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~  454 (636)
                      +++||||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.||+.||+|||   +.+++||||||+
T Consensus        86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~  162 (307)
T 2nru_A           86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSA  162 (307)
T ss_dssp             HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred             hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHH
Confidence            999999999999999999999999999999999998543 2356999999999999999999999   799999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChh
Q 006668          455 NILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE  533 (636)
Q Consensus       455 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~  533 (636)
                      ||+++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            999999999999999999866543222 2233578999999998865 57899999999999999999999997653322


Q ss_pred             hHHHHHHHHHHHHhcC-CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          534 EEEAVLMDWVRNLYGQ-GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       534 ~~~~~l~~~v~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...    .+....... ..+.+.++..+ ..........+.+++.+||+.||.+||++.++++.|+.-
T Consensus       242 ~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          242 LLL----DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             BTT----HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHH----HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111    111111111 12222233222 345667788899999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-42  Score=370.34  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=213.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC---CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN---NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~---~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++|...+.||+|+||.||+|+....   ....+..||+|+++.. .....+++.+|+.+++++ +||||++++++|.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            5678889999999999999987532   2234578999999865 344567899999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      .+++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence            9999999999999999996543              245899999999999999999999   79999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........  
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence            999999999999986654332 22334567889999999999999999999999999999999 99999754322111  


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .             .+....+...+......+.+++.+||+.||++||++.|+++.|+.-
T Consensus       316 ---~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          316 ---K-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             ---H-------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---H-------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1             1111111222334456788999999999999999999999999764

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=6.3e-43  Score=340.07  Aligned_cols=164  Identities=30%  Similarity=0.473  Sum_probs=139.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ..++|+|++|..    .||+|+|+|.+.+++.|+||+...+++|||+|++||+||   ++.++.++||+|+|+|.|.+.+
T Consensus         2 ~~~~F~f~~F~~----~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~---~~~~g~vaSFsT~F~F~I~~~~   74 (223)
T 1dhk_B            2 TETSFIIDAFNK----TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR---DSTTGNVASFDTNFTMNIRTHR   74 (223)
T ss_dssp             CCCEEEESSCCG----GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESE---ETTTTEECEEEEEEEEEEECCC
T ss_pred             cceEEEcCCCCc----CCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEee---cCCCCCccceEEEEEEEEeCCC
Confidence            457899999964    799999999997789999999888899999999999999   6667889999999999999877


Q ss_pred             CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccc
Q 006668          104 ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYY  183 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~  183 (636)
                      ...+||||||+|+|....|+                  +++|||||||+         +|||||||||+ |+++++|+  
T Consensus        75 ~~~~gdGlAF~l~p~~~~p~------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~~--  124 (223)
T 1dhk_B           75 QANSAVGLDFVLVPVQPESK------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPWD--  124 (223)
T ss_dssp             ---CCSEEEEEEEEC------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEECC--
T ss_pred             CCCCCCceEEEEecCCCCCC------------------ccEEEEEecCC---------CCcccccCCcc-ccccccCC--
Confidence            67789999999999754332                  24899999998         58999999999 99888752  


Q ss_pred             cCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce---eccee
Q 006668          184 SSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW---IEARR  223 (636)
Q Consensus       184 ~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~---~~~~~  223 (636)
                                ..+.+|+.++|||+||                                     ||||+||..   .+.|+
T Consensus       125 ----------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~  194 (223)
T 1dhk_B          125 ----------VHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHD  194 (223)
T ss_dssp             ----------GGGTTTSCEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEE
T ss_pred             ----------ccccCCCEEEEEEEEeCCCCEEEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCccccceEE
Confidence                      3467899999999999                                     999999999   99999


Q ss_pred             eeeccccCCCC
Q 006668          224 VLAWSLSDTGV  234 (636)
Q Consensus       224 il~wsf~~~~~  234 (636)
                      ||+|+|++++.
T Consensus       195 IlsWsF~s~~~  205 (223)
T 1dhk_B          195 VLSWSFSSKFI  205 (223)
T ss_dssp             EEEEEEEEEC-
T ss_pred             EEEEEEEeccc
Confidence            99999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=362.70  Aligned_cols=259  Identities=29%  Similarity=0.483  Sum_probs=209.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|++.+.||+|+||.||+|++...+ .....||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPG-QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTT-SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCC-CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            34667799999999999999986533 23467999999865 44556789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999999543 457999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCcc--ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPN--TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......     ....            
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~------------  266 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISS------------  266 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHH------------
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHH------------
Confidence            33222  222346788999999998999999999999999999999 999996542221     1111            


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +........+...+..+.+|+.+||+.||++||++.||++.|+.-
T Consensus       267 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          267 -VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             111111222334456788999999999999999999999999775

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-42  Score=362.01  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=202.9

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccc
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      ++....++|++.+.||+|+||.||+|+..+      ..||+|++...  .....+++.+|+.++++++||||+++++++.
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEETT------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEECC------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            333345678889999999999999998643      78999999765  3455678999999999999999999999999


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEcCCCcEEEe
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      ..+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            9999999999999999999996532 234999999999999999999999   788  9999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......     ....+... 
T Consensus       182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~~-  254 (309)
T 3p86_A          182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGFK-  254 (309)
T ss_dssp             CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHHS-
T ss_pred             CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc-
Confidence            999998654322 22334579999999999999999999999999999999999999997543211     11111000 


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                                 ......+......+.+++.+||+.||.+|||+.|+++.|+.-
T Consensus       255 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          255 -----------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             -----------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       011122233345688999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-43  Score=362.03  Aligned_cols=271  Identities=28%  Similarity=0.428  Sum_probs=210.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccccc--ceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~  396 (636)
                      ++|+..+.||+|+||.||++++.......++.||+|++........+.+.+|+.++++++||||+++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            56788999999999999999965444445699999999988777788999999999999999999999998554  4589


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        90 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999654 346999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCC--ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC----
Q 006668          477 QGEV--PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG----  550 (636)
Q Consensus       477 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~----  550 (636)
                      ....  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......      ....... ...+    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~~  238 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGN-DKQGQMIV  238 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HHHHHCT-TCCTHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HHhhhcC-ccccchhH
Confidence            4322  1222345778899999999999999999999999999999999998643100      0000000 0000    


Q ss_pred             -cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 -KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 -~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .+.+.+........+...+..+.+++.+||+.||++|||+.|+++.|+.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             01111111222233444567799999999999999999999999999754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-42  Score=357.49  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=207.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..+.||+|+||.||+++....+    ..||+|.+...   .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILN----IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTC----SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCC----CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            357889999999999999999976655    89999998643   34556788999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             EEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            9999999999999999953  356999999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||........    ...    .... ..  
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~----~~~~-~~--  229 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIK----HIQD-SV--  229 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHH----HHSS-CC--
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHH----Hhhc-cC--
Confidence            665444444556799999999999999999999999999999999999999975432111    111    1111 00  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~~  600 (636)
                         +..........+..+.+++.+||+.||.+|| ++.++.+.|+..
T Consensus       230 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          230 ---PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             ---CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             ---CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence               1111122233456788999999999999999 899999999764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-42  Score=362.06  Aligned_cols=251  Identities=23%  Similarity=0.377  Sum_probs=208.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||+|++...  .....+.+.+|+++++.++||||+++++++...+..
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTG----REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            457889999999999999999986665    89999999754  445567888999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            999999999999999954  356999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPT-SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||...........     +.    .+..  
T Consensus       165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----i~----~~~~--  231 (328)
T 3fe3_A          165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER-----VL----RGKY--  231 (328)
T ss_dssp             SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HH----HCCC--
T ss_pred             CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HH----hCCC--
Confidence            5433  33446799999999999888875 789999999999999999999975532211111     10    0100  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                              ..+......+.+|+.+||..||.+|||++|+++.-.
T Consensus       232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence                    111223455778999999999999999999998744

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-42  Score=368.97  Aligned_cols=259  Identities=29%  Similarity=0.498  Sum_probs=200.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+|++... ...+..||||.++.. .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLP-SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCT-TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecC-CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            4688999999999999999987632 123478999999765 44556789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999643 456999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCcc--ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVPN--TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......     +..             
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~-------------  261 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIK-------------  261 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHH-------------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH-------------
Confidence            32211  122345778999999999999999999999999999998 999997542111     111             


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+........+...+..+.+++.+||+.||.+||++.+|++.|+.-
T Consensus       262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            1111122222334556789999999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-42  Score=384.72  Aligned_cols=256  Identities=23%  Similarity=0.393  Sum_probs=215.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .+|+..++||+|+||.||+|++...+    ..||||.++.... ..+++.+|+.++++++||||++++++|...+.+++|
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGT----EEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCC----eEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            45777899999999999999987644    8999999976543 357899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999999997666677999999999999999999999   799999999999999999999999999999876544


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++....++.++|||||||++|||++ |+.||........     ..             .+.
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----~~-------------~~~  433 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YE-------------LLE  433 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HH-------------HHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HH-------------HHH
Confidence            3333333456789999999999999999999999999999999 9999976532211     11             111


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...+...+..++..+.+|+.+||+.||++|||+.+|++.|+.-
T Consensus       434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1222233344557788999999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-42  Score=362.35  Aligned_cols=259  Identities=27%  Similarity=0.402  Sum_probs=205.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..++||+|+||.||+|++...+.....+||+|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            45788899999999999999987766555677899998654 3344578999999999999999999999998754 789


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999654 456999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||.........                  ..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------------------~~  231 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------------SI  231 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------------HH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH------------------HH
Confidence            3322 2233457889999999999999999999999999999999 99999755322211                  11


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +........+......+.+++.+||+.||++||++.|+++.|+.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111222333456788999999999999999999999999764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-42  Score=350.25  Aligned_cols=254  Identities=26%  Similarity=0.447  Sum_probs=208.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+|+...+     ..||+|++...... .+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCC-----CeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            4577889999999999999997643     67999999865432 36788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            9999999999999543 456899999999999999999999   799999999999999999999999999999866543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    .... +.             
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----~~~~-~~-------------  221 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVED-IS-------------  221 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH-HH-------------
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----HHHH-Hh-------------
Confidence            3333334557888999999999999999999999999999999 999997542211    1111 10             


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .......+......+.+++.+||+.||++||++.|+++.|+.-
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          222 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            0111111222345688999999999999999999999999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-42  Score=362.40  Aligned_cols=264  Identities=28%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----  393 (636)
                      .++|+..++||+|+||.||+|+..+      +.||||++...... ......|+.++++++||||+++++++....    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLN------EYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETT------EEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecccCceEEEEEEECC------CEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            3568889999999999999998753      89999999765433 345567999999999999999999997743    


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC----------cEEeCCCCCCCEEEcCCCc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ----------VVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivHrDlkp~NIll~~~~~  463 (636)
                      .+++||||+++|+|.+++..   ..+++.+++.++.|++.||+|||   +.          +|+||||||+|||++.++.
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             eEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            47999999999999999954   45999999999999999999999   67          9999999999999999999


Q ss_pred             EEEeccCCcccccCCCCc-cccccccCCcccccccccCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhH--
Q 006668          464 GRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVS-----SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE--  535 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~--  535 (636)
                      +||+|||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||.........  
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            999999999876544322 23345799999999998873     4556889999999999999999999754321100  


Q ss_pred             HH------HHHHHHHHHhcCCcchhhhhhhhhhc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          536 EA------VLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       536 ~~------~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..      ...++.... .....    .+.+... .....+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVV-VHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             HHHHCSSCCHHHHHHHH-TTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhh-hcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            00      000111100 00000    0111111 123456779999999999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-42  Score=371.45  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|++..++    ..||||.++.. .....+++.+|+.++++++||||++++++|...+..++
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADN----TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTC----CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCC----eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            45778899999999999999987655    89999999765 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       190 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999999542 346899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCccc-cccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVPNT-TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......     ....+.    .      
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----~~~~~~----~------  330 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVE----K------  330 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----HHHHHH----T------
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----c------
Confidence            221111 11235778999999998899999999999999999998 999997542211     111111    1      


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         ..+...+...+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus       331 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          331 ---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence               11112233345678899999999999999999999999965

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-42  Score=379.64  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=209.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|...+.||+|+||.||+|++...     ..||||+++.... ..+++.+|+.++++++||||+++++++. .+..++
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTT-----EEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCc-----cEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            35677889999999999999998642     7899999986543 4578999999999999999999999986 567899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999999996544457899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........++..|+|||++....++.++|||||||++|||++ |+.||.......     ....+.            
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~------------  399 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALE------------  399 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHH------------
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH------------
Confidence            32222233456789999999999999999999999999999999 999997542211     111111            


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       ...+...+...+..+.+|+.+||+.||++|||+++|++.|+.-
T Consensus       400 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          400 -RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             -HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence             1111222334456788999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.4e-42  Score=347.24  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=209.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+++...+     ..||+|++...... .+++.+|+.++.+++||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQ-----YDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCc-----eeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            35678889999999999999987653     67999999765432 3678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            99999999999999543 346999999999999999999999   79999999999999999999999999999987665


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........    ... +    ..+      
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~-~----~~~------  221 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV----VLK-V----SQG------  221 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHH-H----HTT------
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH----HHH-H----HcC------
Confidence            44333444556788999999999899999999999999999999 9999975432211    111 0    000      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .....+......+.+++.+||+.||++|||+.|+++.|+.-
T Consensus       222 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          222 ---HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence               01111122245688999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=353.43  Aligned_cols=272  Identities=23%  Similarity=0.323  Sum_probs=216.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccc--eE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--EL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~  395 (636)
                      ++|...++||+|+||.||+|+....+    +.||+|++.... ....+.+.+|++++++++||||+++++++...+  ..
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTG----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCC----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            46888999999999999999987655    899999997543 233567789999999999999999999987654  78


Q ss_pred             EEEEeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE----cCCCcEEEeccC
Q 006668          396 MLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL----DSEMRGRLGDFG  470 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG  470 (636)
                      ++||||+++++|.+++.... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999999996532 234999999999999999999999   7999999999999999    888889999999


Q ss_pred             CcccccCCCCccccccccCCccccccccc--------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELAT--------VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +++......  ......||+.|+|||++.        +..++.++|||||||++|||++|+.||............+...
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            998765433  223457999999999876        5778999999999999999999999997654433333333333


Q ss_pred             HHHHhcCCcchhh-----------hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEA-----------ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~-----------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..... ...+...           -+......+.......+.+++.+||+.||++|||+.|+++...++
T Consensus       240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            22211 1000000           001112245567788899999999999999999999999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-41  Score=358.27  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++...++    +.||+|+++..   .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            46888999999999999999987655    89999999754   223456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            999999999999999853  356899999999999999999999   799999999999999999999999999999864


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........     +..    +.    
T Consensus       156 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----i~~----~~----  221 (337)
T 1o6l_A          156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----ILM----EE----  221 (337)
T ss_dssp             CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHH----CC----
T ss_pred             ccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-----HHc----CC----
Confidence            3322 233446899999999999999999999999999999999999999975422111111     100    00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                        .    .++......+.+++.+||+.||.+||     ++.|++++-
T Consensus       222 --~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          222 --I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             --C----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence              0    11222345678899999999999999     899998763

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-41  Score=359.83  Aligned_cols=256  Identities=23%  Similarity=0.340  Sum_probs=208.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH------HHHHHHHHHHHhccCCCCceeeeeccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ------GLKEFMAEISSMGRLQHKNLVQMRGWCRK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~  391 (636)
                      .+.|+..+.||+|+||.||+++...++    ..||+|++......      ..+.+.+|+.++++++||||+++++++.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCC----CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            456888999999999999999987655    89999999765321      24678899999999999999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEe
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLG  467 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~  467 (636)
                      .+.+++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            999999999999999999994  3467999999999999999999999   79999999999999998877    79999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |||++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .+....    
T Consensus       162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~----  231 (361)
T 2yab_A          162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANIT----  231 (361)
T ss_dssp             CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH----
T ss_pred             ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH----
Confidence            999998765432  2334579999999999999999999999999999999999999997542211    111110    


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       .+..  ..+.....    .....+.+++.+||..||.+|||+.|++++-.-
T Consensus       232 -~~~~--~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  276 (361)
T 2yab_A          232 -AVSY--DFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (361)
T ss_dssp             -TTCC--CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             -hcCC--CCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence             0000  00111111    223567889999999999999999999976443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=365.40  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=213.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC---CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++|...+.||+|+||.||+|+....+   ......||+|++... .....+++.+|+++++++ +||||++++++|...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            46778899999999999999875422   234578999999765 445567899999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence            9999999999999999996543              245999999999999999999999   78999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......    
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----  301 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  301 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986654332 23334567889999999999999999999999999999999 999997542111    


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +...+.             .......+......+.+++.+||+.||++||+++||++.|+..
T Consensus       302 -~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          302 -LFKLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             -HHHHHH-------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHH-------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             111111             1111122233456788999999999999999999999999765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-41  Score=348.63  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeeeeccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGR--LQHKNLVQMRGWCRK----  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~----  391 (636)
                      .++|+..+.||+|+||.||+|+..+      +.||||++.....   +.+..|.+++..  ++||||+++++++..    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQG------ENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETT------EEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECC------EEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            4678899999999999999998732      8899999975433   344455555544  899999999998654    


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC-----CCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW-----DQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      ....++||||+++|+|.+++.   ...+++.+++.++.||+.||+|||+..     +.+|+||||||+|||++.++.+||
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence            356899999999999999993   457999999999999999999999422     589999999999999999999999


Q ss_pred             eccCCcccccCCCCcc---ccccccCCcccccccccCC------CCCCccchHHHHHHHHHHHhC----------CCCCC
Q 006668          467 GDFGLAKLYQQGEVPN---TTRVVGTLGYLAPELATVS------SPTSASDVYSFGVVILEVACG----------RRPLD  527 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~ell~G----------~~Pf~  527 (636)
                      +|||+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998665433221   2234799999999998876      445689999999999999999          88886


Q ss_pred             CCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh-hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          528 MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR-QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       528 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...............+.   ..+.     .+.+. ...+......+.+|+.+||+.||++|||+.||++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVC---VDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTSCSSCCHHHHHHHHT---TSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHh---ccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            54322221111111110   0000     11111 12334567889999999999999999999999999964

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.6e-42  Score=362.71  Aligned_cols=271  Identities=25%  Similarity=0.361  Sum_probs=214.7

Q ss_pred             CHHHHHHHhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeee
Q 006668          310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMR  386 (636)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~  386 (636)
                      ...+.....++|...+.||+|+||.||+|++... ....++.||||++... .....+.+.+|+.++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3344445567899999999999999999986432 2344589999999865 344567899999999999 799999999


Q ss_pred             ccccccc-eEEEEEeecCCCChhhhHhcCCC-------------------------------------------------
Q 006668          387 GWCRKGN-ELMLVYDYMPNGSLNNWIFGKPK-------------------------------------------------  416 (636)
Q Consensus       387 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------  416 (636)
                      ++|.+.+ ..++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9987754 48999999999999999965432                                                 


Q ss_pred             ---------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC-
Q 006668          417 ---------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-  480 (636)
Q Consensus       417 ---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-  480 (636)
                                     ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                           12899999999999999999999   78999999999999999999999999999986544322 


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      .......||+.|+|||++.+..++.++||||||+++|||++ |+.||............+    .             ..
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~-------------~~  312 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----K-------------EG  312 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----H-------------HT
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH----H-------------cC
Confidence            23334568999999999999999999999999999999998 999997653322111111    1             11


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....+......+.+++.+||+.||.+|||+.|++++|+.-
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11112222345688899999999999999999999999753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-41  Score=348.79  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+.... ...+..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP-ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC-CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35678899999999999999998653 233467999998764 3445678899999999999999999999985 46789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999999643 346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........     ..+.    .+     
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-----~~i~----~~-----  233 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----GRIE----NG-----  233 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHH----TT-----
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-----HHHH----cC-----
Confidence            544333344567889999999998999999999999999999996 99999765332211     1110    00     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          .....+...+..+.+++.+||+.||++||++.|+++.|+.-
T Consensus       234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          234 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                11112233456788999999999999999999999999653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.2e-42  Score=350.95  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=217.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ..++|+..+.||+|+||.||+|.....+    ..||+|.+..... ..+++.+|+.++++++||||+++++++.+.+..+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGT----EEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCC----EEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            3456888899999999999999987655    8999999976543 4578899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++.......+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999997766677999999999999999999999   7899999999999999999999999999998776


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........                  +.
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~------------------~~  224 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------------EL  224 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------------HH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------------HH
Confidence            554444444567889999999999999999999999999999999 99999755322111                  11


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +........+...+..+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            111112222333456788999999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=366.79  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=208.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|++... ....+..||||+++.. ......++.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            4577889999999999999997543 2234578999999755 4455667899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC-----CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---cEEEec
Q 006668          397 LVYDYMPNGSLNNWIFGKP-----KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---RGRLGD  468 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~D  468 (636)
                      +||||+++|+|.+++....     ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996432     246899999999999999999999   79999999999999999554   599999


Q ss_pred             cCCcccccCCC-CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGE-VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......     +...+.  
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~~~i~--  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVT--  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHH--
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH--
Confidence            99998553222 223334568999999999999999999999999999999998 999997542211     111111  


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                                 .......+...+..+.+|+.+||+.||++||++.+|++.|+.-
T Consensus       301 -----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 -----------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                       1111122233445688999999999999999999999999765

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-41  Score=371.28  Aligned_cols=248  Identities=28%  Similarity=0.439  Sum_probs=205.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc-eEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-ELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~l  397 (636)
                      ++|+..+.||+|+||.||+|++.+      ..||||+++...  ..+.+.+|+.++++++||||+++++++.+.+ ..++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~~------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------EEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEecC------CeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            457788999999999999998753      789999998654  3467899999999999999999999986654 7999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999997655556899999999999999999999   79999999999999999999999999999985432


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .    .....++..|+|||++.+..++.++|||||||++|||++ |+.||..........                  .+
T Consensus       342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------------------~i  399 (450)
T 1k9a_A          342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------------------RV  399 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH------------------HH
T ss_pred             c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------------HH
Confidence            2    122357889999999999999999999999999999998 999997553222111                  11


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ....+...+..++..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       400 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111222334456778999999999999999999999999965

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=354.31  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=207.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH------HHHHHHHHHHHhccCCCCceeeeecccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ------GLKEFMAEISSMGRLQHKNLVQMRGWCRKG  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~  392 (636)
                      +.|...+.||+|+||.||+++...++    ..||+|++......      ..+.+.+|+.++++++||||+++++++...
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTC----CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCC----cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45788999999999999999987655    89999999764321      356788999999999999999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEec
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLGD  468 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~D  468 (636)
                      +..++||||+++|+|.+++.  ....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             CEEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999999999999994  3467999999999999999999999   79999999999999998887    899999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .+......   
T Consensus       162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~---  232 (326)
T 2y0a_A          162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAV---  232 (326)
T ss_dssp             CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHT---
T ss_pred             CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHhc---
Confidence            99998765433  2234579999999999999999999999999999999999999997542211    11110000   


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .        ..............+.+++.+||+.||++|||+.|+++.-.-.
T Consensus       233 ~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          233 N--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             C--------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             C--------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            0        0000111112235678899999999999999999999865443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-41  Score=352.71  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=212.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|...+.||+|+||.||+++..... ...+..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            456788899999999999999874322 334588999999765 445567889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCC----------------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCC
Q 006668          396 MLVYDYMPNGSLNNWIFGKPK----------------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS  453 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp  453 (636)
                      ++||||+++++|.+++.....                      ..+++.+++.++.||+.||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999965432                      34899999999999999999999   78999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKG  531 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~  531 (636)
                      +|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999866443321 2233457889999999998889999999999999999999 9999975532


Q ss_pred             hhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       532 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....     ..+             ........+......+.+++.+||+.||++||++.|+++.|+.-
T Consensus       259 ~~~~-----~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ERLF-----NLL-------------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGHH-----HHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH-----HHh-------------hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            2111     111             11111122233456788999999999999999999999999753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.5e-42  Score=371.69  Aligned_cols=270  Identities=22%  Similarity=0.246  Sum_probs=215.3

Q ss_pred             ccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceee
Q 006668          308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      .+.++++....++|+..++||+|+||.||+|+.+.++    +.||+|++.....   ...+.+.+|+.++..++||||++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD----KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCC----cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            3455667777889999999999999999999987765    8999999975321   11234788999999999999999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      ++++|.+.+.+++|||||++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence            999999999999999999999999999642 457999999999999999999999   7999999999999999999999


Q ss_pred             EEeccCCcccccCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      ||+|||+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||...........++
T Consensus       215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            99999999876554444445568999999999987     5668999999999999999999999997553222211111


Q ss_pred             HHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhc
Q 006668          540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVLVG  599 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L~~  599 (636)
                       .+...            ..++. ........+.+|+.+||..+|++  ||+++|+++.-.-
T Consensus       295 -~~~~~------------~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          295 -NHKER------------FQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             -THHHH------------CCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             -hcccc------------ccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence             10000            00010 00113456778888999888888  9999999987543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=358.57  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=212.8

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|+..+.||+|+||.||+|+..... ...+..||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3567889999999999999999986421 234488999999865 34456789999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC----------------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP----------------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK  452 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  452 (636)
                      .++||||+++|+|.+++....                      ...+++.+++.++.||+.||+|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999996532                      257999999999999999999999   7999999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 006668          453 SGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGK  530 (636)
Q Consensus       453 p~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~  530 (636)
                      |+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986543322 22233567899999999999999999999999999999999 999997542


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...     +...+    ..+..         ...+...+..+.+++.+||+.||++||++.++++.|+.-
T Consensus       282 ~~~-----~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          282 HEE-----VIYYV----RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             HHH-----HHHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hHH-----HHHHH----hCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            211     11111    11111         112223446788999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.9e-42  Score=349.51  Aligned_cols=255  Identities=26%  Similarity=0.444  Sum_probs=206.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+++....     ..||+|++...... .+++.+|+.++.+++||||+++++++.+.+..++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTT-----EEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCC-----CeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            35678889999999999999987643     78999999865432 3678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999542 456999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........    . +             
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~----~-~-------------  234 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----H-I-------------  234 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----H-H-------------
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH----H-H-------------
Confidence            33333333457788999999999999999999999999999998 999997553221111    0 0             


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ........+......+.+++.+||+.||++|||+.|+++.|+.-
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11111111222345688999999999999999999999999653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-41  Score=353.20  Aligned_cols=255  Identities=19%  Similarity=0.267  Sum_probs=208.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|...+.||+|+||.||+++...++    ..+|+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSK----KTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCC----cEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            467889999999999999999987665    8999999976543 34668899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC--CCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~  475 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus        79 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999999432 346999999999999999999999   799999999999999987  789999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+......     ...  
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~-----~~~--  221 (321)
T 1tki_A          155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNA-----EYT--  221 (321)
T ss_dssp             CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHT-----CCC--
T ss_pred             CCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHcC-----CCC--
Confidence            5433  233457999999999999888899999999999999999999999754321    111111110     000  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .+.....    .....+.+++.+||+.||.+|||+.|+++.-.
T Consensus       222 ~~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          222 FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CChhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            0000111    12356788999999999999999999998643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8e-42  Score=357.68  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=208.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..++||+|+||.||+|+....+.....+|++|.+.... ....+.+.+|+.++++++||||++++++|. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            467888999999999999999887776666779999886542 233456778999999999999999999986 466899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999643 457999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.........     ..+.           
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~-----------  231 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-----DLLE-----------  231 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-----HHHH-----------
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-----HHHH-----------
Confidence            4322 2334567889999999999999999999999999999999 99999765332211     1111           


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .......+......+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       232 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          232 --KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             --TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             --cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              1111111222334578899999999999999999999999765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-41  Score=341.27  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=204.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc--ce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~  394 (636)
                      ++|...+.||+|+||.||+|+..+      ..||+|++...  .....+++.+|+.++++++||||+++++++...  +.
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQG------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETT------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             HHhHHHHHhcCCCcceEEEEEECC------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            467888999999999999999853      78999999765  345567899999999999999999999999876  78


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      .++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +.+  ++||||||+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccce
Confidence            899999999999999997765557999999999999999999999   777  999999999999999999999999987


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCC---ccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTS---ASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      .....      ....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||........    ....       
T Consensus       161 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~-------  223 (271)
T 3kmu_A          161 FSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKV-------  223 (271)
T ss_dssp             CTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHHH-------
T ss_pred             eeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHHH-------
Confidence            64322      2246899999999988765554   79999999999999999999975432111    1110       


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                            .........+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus       224 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          224 ------ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             ------HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                  01111122233345668899999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-41  Score=354.60  Aligned_cols=258  Identities=26%  Similarity=0.351  Sum_probs=206.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCC----cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            357889999999999999999987655    8999999975533 23466889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++.  ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        82 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           82 LFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            9999999999999984  3456999999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCC-CccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          477 QGE-VPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       477 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........   ...|....    ..  
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~----~~--  227 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSDWKEKK----TY--  227 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---HHHHHTTC----TT--
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHHHhccc----cc--
Confidence            332 222334679999999999987775 77899999999999999999999765332111   11111110    00  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                             ..........+.+|+.+||+.||++|||+.|+++.-.-.
T Consensus       228 -------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          228 -------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             -------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             -------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence                   000112235567899999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=355.82  Aligned_cols=247  Identities=30%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||+||+|+...++    +.||||++...  ......++..|+..+.++ +||||++++++|.+++..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDG----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTS----CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCC----eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            57899999999999999999987655    89999998654  333344555666666555 899999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999999 78999988543 356999999999999999999999   789999999999999999999999999999866


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...    ..   .     .....+..   
T Consensus       208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~---~-----~~~~~~~~---  269 (311)
T 3p1a_A          208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EG---W-----QQLRQGYL---  269 (311)
T ss_dssp             C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HH---H-----HHHTTTCC---
T ss_pred             ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cH---H-----HHHhccCC---
Confidence            4432  2334569999999998876 7899999999999999999998776432    11   0     01111111   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                           ...+.......+.+++.+||+.||++|||+.|+++.-
T Consensus       270 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          270 -----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             -----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence                 1111122346788999999999999999999999754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.9e-42  Score=375.25  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=203.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|...+.||+|+||.||+|++...     ..||||+++.... ..+++.+|+.++++++||||+++++++.+ +..++|
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECCC-----ceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            4577789999999999999998653     6799999986542 34678999999999999999999999876 678999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999999995433456899999999999999999999   799999999999999999999999999999876544


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++....++.++||||||+++|||++ |+.||.......     ....+             .
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i-------------~  395 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-------------E  395 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH-------------H
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-------------H
Confidence            3333334457889999999999999999999999999999999 999997542211     11111             1


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...+...+...+..+.+|+.+||+.||++|||+.++++.|+.-
T Consensus       396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1112222334556788999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.4e-42  Score=357.62  Aligned_cols=275  Identities=25%  Similarity=0.329  Sum_probs=216.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccc--ccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR--KGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~  396 (636)
                      ++|+..+.||+|+||.||++++...+...+..||+|++........+.+.+|+.++++++||||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            467888999999999999999755455556999999998887777788999999999999999999999875  456789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999542 346999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          477 QGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       477 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  ......+|..|+|||++.+..++.++||||||+++|||++|+.||......   ......+.........+.+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC----CCHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhcccccccccHHHHHH
Confidence            43321  223345788899999999988999999999999999999999998633110   0000000000000001112


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+........+......+.+|+.+||+.||++|||+.|+++.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222223333445567789999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-41  Score=357.84  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=206.8

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|+..+.||+|+||.||+++....+    ..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            3457889999999999999999987655    89999999764  34456788999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---cEEEeccCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---RGRLGDFGL  471 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGl  471 (636)
                      .++||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            9999999999999999843  457899999999999999999999   78999999999999997654   599999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..... +..    +.
T Consensus       178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~-i~~----~~  246 (362)
T 2bdw_A          178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ-IKA----GA  246 (362)
T ss_dssp             CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HHH----TC
T ss_pred             ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH-HHh----CC
Confidence            98765432  233467999999999999999999999999999999999999999754221    11111 110    00


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..      ............+.+|+.+||+.||++||++.|+++.
T Consensus       247 ~~------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 YD------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CC------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CC------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00      0000011223567889999999999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-41  Score=355.04  Aligned_cols=271  Identities=26%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccc--cceEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNELML  397 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~l  397 (636)
                      |+..+.||+|+||.||++.+.......++.||+|++.... ....+.+.+|+.++++++||||+++++++.+  ...+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            4888999999999999987765555566999999998763 4456788999999999999999999999977  467899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++..   ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999943   34999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......+|..|+|||++.+..++.++||||||+++|||++|+.||.....   .......+.........+.+.
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT---KFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch---hhhhhhcccccchhHHHHHHH
Confidence            4321  22334678889999999998899999999999999999999999864311   000000000000000011222


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ++.......+...+..+.+|+.+||+.||++|||+.|+++.|+.-
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            222223333445567899999999999999999999999999753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-41  Score=353.41  Aligned_cols=260  Identities=28%  Similarity=0.507  Sum_probs=204.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|+....+......||+|.+... .......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            34566799999999999999987765555678999999865 34455678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999999643 457999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......     +...+.    .     
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~~----~-----  265 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAIN----D-----  265 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH----T-----
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHH----C-----
Confidence            3221  1222346789999999999999999999999999999998 999996542211     111111    1     


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          ......+......+.+++.+||+.||++||++.++++.|+..
T Consensus       266 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          266 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                111112223456788999999999999999999999999765

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.8e-42  Score=362.02  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=201.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .++|+..++||+|+||.||+++.+.++    +.||+|+++..   .....+.+.+|..++..+ +||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETG----DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCC----CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            467999999999999999999987665    89999999754   223456678899999988 6999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999999999999954  356999999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.    .     +.  
T Consensus       173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~-----~~--  240 (353)
T 3txo_A          173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----N-----DE--  240 (353)
T ss_dssp             CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----H-----CC--
T ss_pred             ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH----c-----CC--
Confidence            543322 23344689999999999999999999999999999999999999997553221111111    0     00  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM------REVVAVL  597 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~~L  597 (636)
                              ..++......+.+++.+||+.||.+||++      .|++++-
T Consensus       241 --------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp  282 (353)
T 3txo_A          241 --------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP  282 (353)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence                    11122234567889999999999999998      7777653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=355.02  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=205.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..++||+|+||.||+|+....+.....+|++|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            56888999999999999999988777666677899988654 3344678899999999999999999999998754 889


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |+||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999654 456999999999999999999999   79999999999999999999999999999987644


Q ss_pred             CCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.........     .             .
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----~-------------~  231 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----S-------------I  231 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----H-------------H
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----H-------------H
Confidence            322 12223456889999999999999999999999999999999 99999765332211     1             1


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +........+......+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111122233445688899999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.2e-41  Score=346.76  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=197.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------------------------HHHHHHHHHH
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------------------------QGLKEFMAEI  371 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei  371 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++.....                          ...+.+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDN----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTT----EEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCC----cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            357888999999999999999987655    8999999975421                          1235688999


Q ss_pred             HHhccCCCCceeeeeccccc--cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeC
Q 006668          372 SSMGRLQHKNLVQMRGWCRK--GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHR  449 (636)
Q Consensus       372 ~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr  449 (636)
                      .++++++||||+++++++.+  .+..++||||+++++|.+++   ....+++.+++.++.||+.||+|||   +.+|+||
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~  161 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHR  161 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred             HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence            99999999999999999876  56899999999999999876   3457999999999999999999999   7899999


Q ss_pred             CCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCC---CCccchHHHHHHHHHHHhCCCCC
Q 006668          450 DIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRPL  526 (636)
Q Consensus       450 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~S~Gvll~ell~G~~Pf  526 (636)
                      ||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+...   +.++|||||||++|||++|+.||
T Consensus       162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999999999999999999987654322 2334579999999999887653   67899999999999999999999


Q ss_pred             CCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          527 DMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       527 ~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .......     +...+..    ..        ............+.+++.+||+.||++||++.|+++.
T Consensus       241 ~~~~~~~-----~~~~~~~----~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          241 MDERIMC-----LHSKIKS----QA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CCSSHHH-----HHHHHHH----CC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCccHHH-----HHHHHhc----cc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            7542111     1111110    00        0000111234568899999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.8e-41  Score=344.02  Aligned_cols=261  Identities=18%  Similarity=0.203  Sum_probs=208.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++.....  .+.+.+|+..+..+ +|+|++++++++.+....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCC----cEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            456889999999999999999976655    8999999875432  24577899999999 7999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc-----EEEeccCC
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR-----GRLGDFGL  471 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGl  471 (636)
                      +||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+
T Consensus        83 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999999 99999999643 346999999999999999999999   899999999999999987776     99999999


Q ss_pred             cccccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          472 AKLYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       472 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      ++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~  236 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEK  236 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhh
Confidence            9876543321      2344579999999999999999999999999999999999999997653222211 11111100


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .          ............+..+.+++.+||+.||++||++.+|++.|+.-
T Consensus       237 ~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          237 K----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             H----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             c----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            0          00001111223346788999999999999999999999999753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.8e-41  Score=358.27  Aligned_cols=273  Identities=19%  Similarity=0.225  Sum_probs=208.2

Q ss_pred             hCCCCCceeeeec--CceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSG--GFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G--~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      .++|++.++||+|  +||.||+++....+    +.||||++...  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTG----EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCC----CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            3568889999999  99999999987655    89999999765  3455677889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++|||||++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999999997665677999999999999999999999   7999999999999999999999999999886


Q ss_pred             cccCCCC------ccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          474 LYQQGEV------PNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       474 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      .......      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||............+......
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            4432111      11222478999999999987  578999999999999999999999997654332221111110000


Q ss_pred             HhcCC------------------cchhhhhh---------hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          546 LYGQG------------------KICEAADA---------RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       546 ~~~~~------------------~~~~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .....                  .+.+....         .....+.......+.+|+.+||+.||++|||+.|+++.-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            00000                  00000000         000112223345688999999999999999999999763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.2e-41  Score=352.85  Aligned_cols=259  Identities=17%  Similarity=0.178  Sum_probs=207.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||||++.....  .+.+.+|+.+++++ +||||+++++++...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTN----EYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTT----EEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCC----cEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            357888999999999999999976655    8999999976533  24577899999999 9999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc-----EEEeccCC
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR-----GRLGDFGL  471 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGl  471 (636)
                      +||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+
T Consensus        82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            999999 99999998643 457999999999999999999999   789999999999999998887     99999999


Q ss_pred             cccccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          472 AKLYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       472 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      ++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+......
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-~~~~i~~~  235 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-RYQKIGDT  235 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-HHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-HHHHHHhh
Confidence            9876443321      1234679999999999999999999999999999999999999997653322211 11111100


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..          ...........+ .+.+++.+||+.||.+||++.+|++.|+.
T Consensus       236 ~~----------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          236 KR----------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HH----------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hc----------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            00          000000111123 78899999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-41  Score=342.94  Aligned_cols=249  Identities=30%  Similarity=0.513  Sum_probs=194.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh----HHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK----QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ++|+..+.||+|+||.||+|+..+      ..||+|++.....    ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIG------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETT------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             hheeeeeeeccCCCeEEEEEEEcC------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            568889999999999999999752      7899999876432    235678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc---EEeCCCCCCCEEEcC--------CCc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV---VVHRDIKSGNILLDS--------EMR  463 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivHrDlkp~NIll~~--------~~~  463 (636)
                      .++||||+++++|.+++.   ...+++.+++.++.|++.||+|||   +.+   |+||||||+|||++.        ++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             eEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcc
Confidence            999999999999999983   457999999999999999999999   566   999999999999986        778


Q ss_pred             EEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      +||+|||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........    ...  
T Consensus       155 ~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~--  225 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----AYG--  225 (271)
T ss_dssp             EEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHH--
T ss_pred             eEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHh--
Confidence            9999999998654432   2235689999999999999999999999999999999999999975422111    100  


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                                 ..........+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       226 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          226 -----------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -----------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                       001111122233445678899999999999999999999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-41  Score=367.07  Aligned_cols=265  Identities=22%  Similarity=0.260  Sum_probs=212.0

Q ss_pred             HHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeec
Q 006668          311 YEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ++++....++|+..++||+|+||.||+++.+.++    +.||+|++.....   ...+.+.+|+.+++.++||||+++++
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCC----cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3455556788999999999999999999987765    8999999965311   11234778999999999999999999


Q ss_pred             cccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      ++.+.+.+++||||+++|+|.+++..   ..+++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEe
Confidence            99999999999999999999999853   35899999999999999999999   7999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS----PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      |||+++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........++ .+.
T Consensus       211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~  289 (410)
T 3v8s_A          211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM-NHK  289 (410)
T ss_dssp             CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-THH
T ss_pred             ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH-hcc
Confidence            99999876654433444578999999999988765    7889999999999999999999997543222111111 000


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhcC
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR--RPTMREVVAVLVGQ  600 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L~~~  600 (636)
                      .              .+.-.........+.+|+.+||..+|.+  ||++.||+++-...
T Consensus       290 ~--------------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          290 N--------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             H--------------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             c--------------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            0              0000001122356788889999999988  99999999886543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-41  Score=362.64  Aligned_cols=258  Identities=21%  Similarity=0.334  Sum_probs=202.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      ++|+..++||+|+||.||+++.+.++    +.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+.+.
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~----~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            56888999999999999999987765    89999999764   223345678899999887 89999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||||+++|+|..++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.
T Consensus       128 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999999853  356999999999999999999999   79999999999999999999999999999985


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+......+    
T Consensus       203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----  277 (396)
T 4dc2_A          203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----  277 (396)
T ss_dssp             CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred             cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence            33222 2334468999999999999999999999999999999999999999644221111100001111100000    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM------REVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~~  596 (636)
                            ...++......+.+|+.+||+.||.+||++      .||+++
T Consensus       278 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          278 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                  011222334567889999999999999995      566654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-41  Score=357.82  Aligned_cols=255  Identities=20%  Similarity=0.280  Sum_probs=209.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||+|++..........+.+|+.++++++||||+++++++.+.+..++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATG----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCC----CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            457899999999999999999987655    8999999987766666788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC--CCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~  475 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus       126 v~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999998532 346999999999999999999999   799999999999999974  577999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+.......+        
T Consensus       202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~--------  267 (387)
T 1kob_A          202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDW--------  267 (387)
T ss_dssp             CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHCCC--------
T ss_pred             CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC--------
Confidence            54332  23357999999999999999999999999999999999999999754211    11111110000        


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                         .............+.+++.+||+.||++|||+.|+++.-
T Consensus       268 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          268 ---EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             ---CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence               001111112345688999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-41  Score=354.07  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccc-
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-  393 (636)
                      .++|+..+.||+|+||.||+++....+    +.||+|++...   .......+.+|+.++.+++||||+++++++.... 
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDH----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCC----ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            467889999999999999999986655    89999999765   3344567899999999999999999999987654 


Q ss_pred             ---eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          394 ---ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       394 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                         ..++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             CCcccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence               34999999999999999953  356899999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCC--ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          471 LAKLYQQGEV--PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       471 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +++.......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ......    .
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~~----~  233 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQHV----R  233 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH----H
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHh----c
Confidence            9986654322  22334578999999999999999999999999999999999999997543211    111111    1


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....       ...........+.+++.+||+.||++||+..++++.
T Consensus       234 ~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          234 EDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CCCCC-------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCC-------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            11000       001111234568889999999999999987766654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=365.32  Aligned_cols=256  Identities=20%  Similarity=0.237  Sum_probs=206.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|+..+.||+|+||.||++.....+    ..+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~----~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAG----QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTT----EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCC----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            3567889999999999999999987665    899999997653  3345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGL  471 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGl  471 (636)
                      .++||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++   .++.+||+|||+
T Consensus        85 ~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            9999999999999999854  356999999999999999999999   79999999999999998   467899999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .........     .
T Consensus       160 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~-----~  229 (444)
T 3soa_A          160 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQIKAG-----A  229 (444)
T ss_dssp             CBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHT-----C
T ss_pred             eEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhC-----C
Confidence            98765433 2233467999999999999999999999999999999999999999754221    111111110     0


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .      .............+.+|+.+||+.||.+|||+.|+++.-
T Consensus       230 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          230 Y------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             C------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             C------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            0      000000112245678899999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-41  Score=349.91  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++...++    +.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNG----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46888999999999999999987655    899999997542   12356778899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            999999999999999954  356899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........++    .     +.    
T Consensus       157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~-----~~----  219 (318)
T 1fot_A          157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----N-----AE----  219 (318)
T ss_dssp             SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----H-----CC----
T ss_pred             CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-----CC----
Confidence            432    234579999999999999999999999999999999999999997543211111110    0     00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                        .    .++......+.+++.+||+.||.+||     +++|++++-
T Consensus       220 --~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp  260 (318)
T 1fot_A          220 --L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  260 (318)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             --C----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence              0    11222335678899999999999999     899998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=357.29  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      ..++||+|+||.||+|+....+    ..||+|++........+++.+|+.++++++||||+++++++...+..++||||+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATG----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEECC-----CEEEEEETTTC----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEecCcCEEEEEEEEcCCC----cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3578999999999999987655    899999998877667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE--cCCCcEEEeccCCcccccCCCC
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL--DSEMRGRLGDFGLAKLYQQGEV  480 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DFGla~~~~~~~~  480 (636)
                      ++++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++.......
T Consensus       169 ~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          169 DGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             TTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            999999988543 356899999999999999999999   7999999999999999  5678899999999987654332


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI  560 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  560 (636)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+.......+.           +
T Consensus       245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~-----------~  307 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETLNNILACRWD-----------L  307 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCC-----------S
T ss_pred             --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCC-----------C
Confidence              23346999999999999989999999999999999999999999755322    112111111000           0


Q ss_pred             hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       561 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...........+.+++.+||+.||.+||++.|+++.-.
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            00011122456888999999999999999999998543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-40  Score=342.95  Aligned_cols=269  Identities=22%  Similarity=0.292  Sum_probs=205.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+...++    +.||+|++...  .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCC----ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            46888999999999999999987665    89999999754  3334577889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++ +|.+++.. ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        78 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            99999965 66665543 2457999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC--cc-
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG--KI-  552 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~--~~-  552 (636)
                      ... .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+.........   +...........  .. 
T Consensus       153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          153 IPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCT
T ss_pred             Ccc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhhh
Confidence            332 2233457899999999987766 799999999999999999999997554332222   111111111000  00 


Q ss_pred             --hhhhh---------hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 --CEAAD---------ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 --~~~~d---------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .+..+         ..............+.+|+.+||+.||++|||++|+++.-.-.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence              00000         0000011122345678899999999999999999999865544

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-40  Score=341.33  Aligned_cols=253  Identities=26%  Similarity=0.498  Sum_probs=203.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH----H---HHHHHHHHHHhccCCCCceeeeecccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ----G---LKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~----~---~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||+|++......    .   .+.+.+|+.++++++||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDK----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTC----CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hccceehhccccCCceeEEEEEEcCCc----eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            357888999999999999999987655    88999998654221    1   167889999999999999999999997


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEcCCCc-----
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLDSEMR-----  463 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~~~~~-----  463 (636)
                      +..  ++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.     
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCcee
Confidence            655  6999999999999988653 457999999999999999999999   778  999999999999988776     


Q ss_pred             EEEeccCCcccccCCCCccccccccCCccccccccc--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT--VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      +||+|||+++....    ......||+.|+|||++.  ...++.++||||||+++|||++|+.||.........   ...
T Consensus       168 ~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~  240 (287)
T 4f0f_A          168 AKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FIN  240 (287)
T ss_dssp             EEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH---HHH
T ss_pred             EEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH---HHH
Confidence            99999999975433    233457999999999984  455788999999999999999999999765332211   111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+.            ........+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       241 ~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 MIR------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHH------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHh------------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111            1111222333445678999999999999999999999999964

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-41  Score=350.76  Aligned_cols=271  Identities=24%  Similarity=0.400  Sum_probs=208.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeecccccc--ceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG--NEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~  395 (636)
                      +.|+..+.||+|+||.||++++...+...++.||+|++.... ....+.+.+|+.++++++||||+++++++...  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            347788999999999999999755555566999999997553 33457789999999999999999999999876  668


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999999998543 346899999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCC--ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC---C
Q 006668          476 QQGEV--PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ---G  550 (636)
Q Consensus       476 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~---~  550 (636)
                      .....  .......+|..|+|||++.+..++.++||||||+++|||++|+.|+....      .............   .
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHH
Confidence            54432  12233568888999999999999999999999999999999999864220      0000000000000   0


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+...+........+......+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            0111111111222333445678999999999999999999999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.8e-41  Score=353.79  Aligned_cols=258  Identities=22%  Similarity=0.335  Sum_probs=204.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      ++|+..+.||+|+||.||+++.+.++    +.||+|++...   .....+.+.+|..++.++ +||||+++++++.+.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTD----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            46788899999999999999987665    89999999764   344566788999999987 89999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            9999999999999999953  356999999999999999999999   79999999999999999999999999999985


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||................+......+.   
T Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---  235 (345)
T 3a8x_A          160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  235 (345)
T ss_dssp             SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred             ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence            43222 22344689999999999999999999999999999999999999996532211110000011111100000   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM------REVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~~  596 (636)
                             ..++......+.+|+.+||+.||.+||++      .|++++
T Consensus       236 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          236 -------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                   11222334567889999999999999995      666654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.1e-41  Score=351.46  Aligned_cols=262  Identities=24%  Similarity=0.395  Sum_probs=194.4

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|+..+.||+|+||.||+|+....+ .....||+|++...  .....+++.+|+.++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQED-GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccC-CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3567999999999999999999976643 12237999999765  34456789999999999999999999999977665


Q ss_pred             E------EEEEeecCCCChhhhHhcC----CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          395 L------MLVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       395 ~------~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      .      ++||||+++|+|.+++...    ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence            4      9999999999999998532    1226899999999999999999999   7899999999999999999999


Q ss_pred             EEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............    
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----  252 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----  252 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----
Confidence            99999999866543322 2223456889999999999999999999999999999999 99999765332211110    


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .             ..............+.+++.+||+.||++|||+.++++.|+.-
T Consensus       253 -~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          253 -I-------------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             -H-------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -h-------------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0             0011122233446788999999999999999999999999765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.8e-41  Score=348.20  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=212.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..+.||+|+||.||+|+.... ....+..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35678889999999999999986331 23345899999998653 34457889999999999 99999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCC----------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPK----------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL  458 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll  458 (636)
                      .++||||+++|+|.+++.....                ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999965432                25899999999999999999999   7899999999999999


Q ss_pred             cCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 006668          459 DSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEE  536 (636)
Q Consensus       459 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~  536 (636)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            99999999999999876544322 1223457889999999999999999999999999999998 999997654322211


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..    +.             .......+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       259 ~~----~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          259 KM----IK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HH----HH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----hc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11    11             1111112223346788999999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=353.31  Aligned_cols=264  Identities=24%  Similarity=0.375  Sum_probs=211.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ..++|...+.||+|+||.||+|+.... ....+..||+|++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            346788899999999999999997432 22345789999997542 33456789999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCC---------------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCC
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPK---------------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK  452 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  452 (636)
                      ..++||||+++|+|.+++.....                     ..+++.+++.++.||+.||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999965432                     34899999999999999999999   7999999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 006668          453 SGNILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGK  530 (636)
Q Consensus       453 p~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~  530 (636)
                      |+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999866543322 2233567889999999999999999999999999999998 999997653


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....    ...+.             .......+......+.+|+.+||+.||.+||++.|+++.|+..
T Consensus       280 ~~~~~----~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          280 VDANF----YKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CSHHH----HHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHHHH----HHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            32211    11111             1111122233456788999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8e-41  Score=353.89  Aligned_cols=254  Identities=23%  Similarity=0.341  Sum_probs=191.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++....  ..+.+.+|+.++++++||||+++++++...+..++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQ----KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCC----cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            457888999999999999999987655    789999997653  23567889999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~  474 (636)
                      ||||+++|+|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       126 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999999943  456999999999999999999999   789999999999999975   88999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .+.. +.    .+..  
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~-i~----~~~~--  268 (349)
T 2w4o_A          201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRR-IL----NCEY--  268 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHH-HH----TTCC--
T ss_pred             cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHH-HH----hCCC--
Confidence            65432  22345799999999999999999999999999999999999999975533211   1111 00    0000  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                          .............+.+|+.+||+.||++|||+.|+++.-.
T Consensus       269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  308 (349)
T 2w4o_A          269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW  308 (349)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence                0001111223456889999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.4e-41  Score=353.36  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=206.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++...++    +.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESG----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCC----CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            57888999999999999999987655    899999997542   23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       117 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence            999999999999999954  346899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .......     +..   
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~-----~~~---  255 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVS-----GKV---  255 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-----CCC---
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHHHHc-----CCC---
Confidence            432    234579999999999999999999999999999999999999997542211    1111110     110   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~L~  598 (636)
                             .++......+.+++.+||+.||.+||+     ++||+++-.
T Consensus       256 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          256 -------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             -------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence                   112223456888999999999999998     888887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-41  Score=341.23  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=207.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+++...+     ..||+|.+...... .+++.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCC-----CeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            4677889999999999999997642     78999999865432 36788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             ECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            9999999999999643 356899999999999999999999   799999999999999999999999999999866443


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||++.+..++.++||||||+++|||++ |+.||.......     ....+.    .+       
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i~----~~-------  221 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS----TG-------  221 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH----TT-------
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHHh----cC-------
Confidence            2222333457889999999998899999999999999999999 899997542211     111111    00       


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .....+......+.+++.+||+.||++||++.++++.|+.-
T Consensus       222 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          222 --FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              11111222345688899999999999999999999999753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.1e-41  Score=342.63  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|...+.||+|+||.||+|+..... .....||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHK-GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTT-CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCC-CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            456888999999999999999876532 23467999999865 44456789999999999999999999999875 4568


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999999543 346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...........+++.|+|||++.+..++.++||||||+++|||++ |+.||..........     .+..          
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-----~~~~----------  229 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-----VLEK----------  229 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-----HHHH----------
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-----HHhc----------
Confidence            544333344567889999999998999999999999999999998 999997543222111     1110          


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         ......+......+.+++.+||+.||++||++.|+++.|+.-
T Consensus       230 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          230 ---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence               001111222346688999999999999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-40  Score=348.79  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=198.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN---  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---  393 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||||++.... ....+.+.+|+.++++++||||+++++++.+..   
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDD----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTC----CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCC----cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            356888999999999999999987655    899999997543 334578899999999999999999999875433   


Q ss_pred             ------------------------------------------------------eEEEEEeecCCCChhhhHhcCC-CCC
Q 006668          394 ------------------------------------------------------ELMLVYDYMPNGSLNNWIFGKP-KKL  418 (636)
Q Consensus       394 ------------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~-~~~  418 (636)
                                                                            ..++||||+++++|.+++.... ...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  3899999999999999996543 234


Q ss_pred             cChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC-----------ccccccc
Q 006668          419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV-----------PNTTRVV  487 (636)
Q Consensus       419 l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~  487 (636)
                      .++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......           .......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            566778999999999999999   79999999999999999999999999999987655421           1223357


Q ss_pred             cCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHH
Q 006668          488 GTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAE  567 (636)
Q Consensus       488 gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  567 (636)
                      ||+.|+|||++.+..++.++||||||+++|||++|..|+.      ........ .    ..+..         ......
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~-~----~~~~~---------~~~~~~  297 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITD-V----RNLKF---------PLLFTQ  297 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHH-H----HTTCC---------CHHHHH
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHH-h----hccCC---------Cccccc
Confidence            9999999999999999999999999999999999876642      11111110 0    01110         111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          568 EMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       568 ~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ....+.+++.+||+.||++||++.|+++.-
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence            334568899999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-41  Score=352.64  Aligned_cols=263  Identities=21%  Similarity=0.249  Sum_probs=203.4

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeeec
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----SKQGLKEFMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ++....++|...+.||+|+||.||+|+....+    ..||+|++...     .....+.+.+|+.++++++||||+++++
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTR----AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCC----ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            34556778999999999999999999986655    89999998653     2344678899999999999999999999


Q ss_pred             cccccceEEEEEeecCCCChhhhHhcC--------------------------------------CCCCcChHHHHHHHH
Q 006668          388 WCRKGNELMLVYDYMPNGSLNNWIFGK--------------------------------------PKKLLGWKQRRQILA  429 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~  429 (636)
                      ++.+.+..++||||+++|+|.+++...                                      ....+++..++.++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            999999999999999999999988410                                      022346778889999


Q ss_pred             HHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC--cEEEeccCCcccccCCC---CccccccccCCcccccccccC--CC
Q 006668          430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM--RGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPELATV--SS  502 (636)
Q Consensus       430 ~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~  502 (636)
                      ||+.||+|||   +.+|+||||||+|||++.++  .+||+|||+++......   ........||+.|+|||++.+  ..
T Consensus       176 qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            9999999999   78999999999999998766  89999999998654322   122344679999999999875  67


Q ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCC
Q 006668          503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHP  582 (636)
Q Consensus       503 ~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~  582 (636)
                      ++.++||||||+++|||++|+.||........    .....    .....       ............+.+|+.+||+.
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~----~~~~~-------~~~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT----ISQVL----NKKLC-------FENPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH----HCCCC-------TTSGGGGGSCHHHHHHHHHHSCS
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHH----hcccc-------cCCcccccCCHHHHHHHHHHcCC
Confidence            88999999999999999999999975532211    11111    00000       00011112245688899999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 006668          583 DSTRRPTMREVVAVL  597 (636)
Q Consensus       583 dP~~RPs~~evl~~L  597 (636)
                      ||.+||++.|+++.-
T Consensus       318 ~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          318 NVDERFDAMRALQHP  332 (345)
T ss_dssp             CTTTSCCHHHHHHSH
T ss_pred             ChhHCCCHHHHhcCh
Confidence            999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-41  Score=355.39  Aligned_cols=266  Identities=24%  Similarity=0.381  Sum_probs=213.9

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRK  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~  391 (636)
                      ....++|...+.||+|+||.||+|.....+ ......||+|.+... .....+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            334567889999999999999999986543 234468999999765 334567789999999999 89999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCC------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKP------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      .+..++||||+++|+|.+++....            ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence            999999999999999999985421            346899999999999999999999   78999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......... 
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence            9999999999999865443321 2233457889999999999999999999999999999998 999997653322111 


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         ..+..             ......+...+..+.+++.+||+.||.+||++.|+++.|+..
T Consensus       278 ---~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          278 ---KLVKD-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---HHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHhc-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               11111             111111222346788999999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.4e-41  Score=355.10  Aligned_cols=272  Identities=24%  Similarity=0.297  Sum_probs=213.0

Q ss_pred             cccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-----CCc
Q 006668          307 HRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-----HKN  381 (636)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~n  381 (636)
                      ..+++++.....++|...++||+|+||.||+|+....+    +.||||++... ....+.+..|+.+++.++     |||
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK----KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCC----eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            45666666677889999999999999999999987655    89999999753 334466778899988886     999


Q ss_pred             eeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-
Q 006668          382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-  460 (636)
Q Consensus       382 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-  460 (636)
                      |+++++++...+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++. 
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCT
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccc
Confidence            999999999999999999999 999999997766667999999999999999999999   899999999999999975 


Q ss_pred             ------------------------CCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHH
Q 006668          461 ------------------------EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI  516 (636)
Q Consensus       461 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll  516 (636)
                                              ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    789999999999864432    2345789999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc---hhhh--------h-hhh-----------------h---hcc
Q 006668          517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI---CEAA--------D-ARI-----------------R---QEF  564 (636)
Q Consensus       517 ~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~---~~~~--------d-~~l-----------------~---~~~  564 (636)
                      |||++|+.||.......... .    +......-..   .+..        + ..+                 .   ..+
T Consensus       250 ~ell~g~~pf~~~~~~~~~~-~----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  324 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLA-M----MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY  324 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHH-H----HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred             HHHHHCCCCCCCCcHHHHHH-H----HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence            99999999997653221111 1    1111110000   0000        0 000                 0   000


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          565 EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       565 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .......+.+|+.+||+.||++|||+.|+++.
T Consensus       325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            11112567899999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-40  Score=344.07  Aligned_cols=270  Identities=24%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             ccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHh--ccCCCCceeee
Q 006668          308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSM--GRLQHKNLVQM  385 (636)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l--~~l~h~niv~l  385 (636)
                      ......-....++|+..+.||+|+||.||+|+..+      +.||||++.....   ..+..|.+++  ..++||||+++
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~   96 (337)
T 3mdy_A           26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG------EKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGF   96 (337)
T ss_dssp             SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETT------EEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             CCCcccccccccceEEEeEeecCCCeEEEEEEECC------ceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeE
Confidence            33444444556789999999999999999998752      8999999965433   2333444444  44599999999


Q ss_pred             ecccccc----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC--------cEEeCCCCC
Q 006668          386 RGWCRKG----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ--------VVVHRDIKS  453 (636)
Q Consensus       386 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~--------~ivHrDlkp  453 (636)
                      ++++...    ...++||||+++|+|.+++..   ..+++.+++.++.|++.||+|||   +.        +|+||||||
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A           97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             EEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCG
T ss_pred             EEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccch
Confidence            9998776    689999999999999999943   46999999999999999999999   56        999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccCCCCcc---ccccccCCcccccccccCCCCCCc------cchHHHHHHHHHHHhC--
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQGEVPN---TTRVVGTLGYLAPELATVSSPTSA------SDVYSFGVVILEVACG--  522 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------sDV~S~Gvll~ell~G--  522 (636)
                      +|||++.++.+||+|||+++.........   .....||+.|+|||++.+...+.+      +|||||||++|||++|  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            99999999999999999997654432211   123579999999999988777665      9999999999999999  


Q ss_pred             --------CCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006668          523 --------RRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREV  593 (636)
Q Consensus       523 --------~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ev  593 (636)
                              +.||................+    ....    ..+..... ....+...+.+++.+||+.||++|||+.||
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPSYEDMREIV----CIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHH----TTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cccccccccccHhhhcCCCCchhhhHHHH----hhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence                    667654322221111111111    0000    01111111 123667889999999999999999999999


Q ss_pred             HHHHhcC
Q 006668          594 VAVLVGQ  600 (636)
Q Consensus       594 l~~L~~~  600 (636)
                      ++.|+.-
T Consensus       323 l~~L~~l  329 (337)
T 3mdy_A          323 KKTLAKM  329 (337)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5e-41  Score=343.22  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+|+....     ..||+|.+..... ..+.+.+|++++++++||||+++++++.. +..++|
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGH-----TKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCC-----cEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence            5678899999999999999997542     6899999976532 34678899999999999999999999864 568999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999995433346999999999999999999999   799999999999999999999999999999877654


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........++..|+|||.+.+..++.++||||||++++||++ |+.||.......     ....+.    .        
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~~----~--------  225 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLE----R--------  225 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----T--------
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHHh----c--------
Confidence            4333334557889999999998889999999999999999999 999997542211     111111    0        


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       ......+......+.+++.+||+.||++|||+.++++.|+.-
T Consensus       226 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          226 -GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence             111112223346788999999999999999999999999764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.8e-41  Score=350.69  Aligned_cols=262  Identities=25%  Similarity=0.427  Sum_probs=210.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCC---CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeecccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~---~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~  392 (636)
                      .++|...+.||+|+||.||+|+....+   ...+..||+|++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            457888999999999999999875321   234578999999865 445567889999999999 899999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL  458 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll  458 (636)
                      +..++||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999996543              234899999999999999999999   7899999999999999


Q ss_pred             cCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHH
Q 006668          459 DSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEE  536 (636)
Q Consensus       459 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~  536 (636)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999987654332 12233457889999999988889999999999999999999 999997542111   


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        +...+..             ......+......+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       268 --~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 --LFKLLKE-------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             --HHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHhc-------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1111111             111112233446688999999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-41  Score=356.40  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeeeccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRK  391 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~  391 (636)
                      ...++|...+.||+|+||.||+|+.+.++    +.||+|+++...   ....+.+..|..++..+ +||||+++++++.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            34578999999999999999999987665    899999997542   22345677899998876 89999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      .+.+++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence            9999999999999999999953  356899999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      ++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........    . ..+..    + 
T Consensus       165 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~-~~i~~----~-  233 (345)
T 1xjd_A          165 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----F-HSIRM----D-  233 (345)
T ss_dssp             CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H-HHHHH----C-
T ss_pred             hhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----H-HHHHh----C-
Confidence            98643322 223456899999999999999999999999999999999999999975432111    1 11100    0 


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR-EVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~~  596 (636)
                           .    ..++......+.+++.+||+.||++||++. +++++
T Consensus       234 -----~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          234 -----N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -----C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -----C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                 0    111222345678899999999999999998 77643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-41  Score=345.30  Aligned_cols=254  Identities=22%  Similarity=0.370  Sum_probs=205.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+|+....+.   .....||+|.+........+.+.+|+.++++++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            467788999999999999998765431   11257999999877666678899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--------EEEe
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--------GRLG  467 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~  467 (636)
                      ++||||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.        +||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999643 345899999999999999999999   799999999999999998887        9999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      |||++.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+............    ..  
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----~~--  232 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----YE--  232 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HH--
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----hh--
Confidence            9999875432     223468899999999887 67899999999999999999966555433222111110    00  


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .            ....+......+.+++.+||+.||++|||+.|+++.|+.-
T Consensus       233 -~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          233 -D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             -T------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             -c------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             0            0111111234578899999999999999999999999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.4e-41  Score=366.47  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||.||+++....+    +.||+|++...   .......+.+|+.+++.++||||+++++++...+.+
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATG----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCC----CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            46888999999999999999987665    89999999753   334456778999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   + .+|+||||||+||||+.++.+||+|||+++.
T Consensus       224 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999999853  357899999999999999999999   6 8999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........     +..  .      
T Consensus       299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----i~~--~------  364 (446)
T 4ejn_A          299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-----ILM--E------  364 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHH--C------
T ss_pred             ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-----HHh--C------
Confidence            43322 223446899999999999999999999999999999999999999975432211111     100  0      


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~~  600 (636)
                        .    ..++......+.+|+.+||+.||.+||     +++|++++-.-.
T Consensus       365 --~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          365 --E----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             --C----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             --C----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence              0    011222345688899999999999999     999999765433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-40  Score=352.23  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-----KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      +.|+..+.||+|+||.||+++...++    +.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETG----QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCC----CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45888999999999999999987665    899999986431     113567889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EEEec
Q 006668          394 ELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRLGD  468 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~D  468 (636)
                      .+++||||+++++|.+++...  ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.   +||+|
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999999888542  2345899999999999999999999   799999999999999987655   99999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...  .   .........    
T Consensus       177 fg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~---~~~~~~i~~----  246 (351)
T 3c0i_A          177 FGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--K---ERLFEGIIK----  246 (351)
T ss_dssp             CTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--H---HHHHHHHHH----
T ss_pred             CcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--H---HHHHHHHHc----
Confidence            999987654332 233457999999999999999999999999999999999999999753  1   111111111    


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +...  ..+....    .....+.+|+.+||+.||++|||+.|+++.
T Consensus       247 -~~~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          247 -GKYK--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -TCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -CCCC--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0000  0011111    123567889999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-40  Score=353.32  Aligned_cols=271  Identities=19%  Similarity=0.252  Sum_probs=207.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCC-CCceEEEEEEeccCChHHHH-----------HHHHHHHHhccCCCCceee
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNN-NNSTEMAVKCVNHDSKQGLK-----------EFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~Ei~~l~~l~h~niv~  384 (636)
                      ..++|.+.++||+|+||.||+|.+..++. ..++.||+|++.........           .+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578999999999999999999866421 23478999999876532221           2345667788899999999


Q ss_pred             eecccccc----ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-
Q 006668          385 MRGWCRKG----NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-  459 (636)
Q Consensus       385 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-  459 (636)
                      +++++...    ...++||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99998764    4589999999 99999998643 467999999999999999999999   78999999999999999 


Q ss_pred             -CCCcEEEeccCCcccccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          460 -SEMRGRLGDFGLAKLYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       460 -~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                       .++.+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999866433211      113345999999999999999999999999999999999999999753222


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...    ..+....+ ...+.+.++..+..   ...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       268 ~~~----~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          268 PKY----VRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             HHH----HHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHH----HHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            111    11111111 01222333333221   12246788899999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-40  Score=345.63  Aligned_cols=267  Identities=22%  Similarity=0.293  Sum_probs=203.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||+|+... +    +.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-G----RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-S----CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-C----CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            4678899999999999999999754 2    7899999975532  2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||++ ++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           95 TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            99999996 5888887543 456999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc---
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---  551 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~---  551 (636)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............     .......   
T Consensus       170 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~~~~~~~~  243 (311)
T 3niz_A          170 GIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-----SILGTPNPRE  243 (311)
T ss_dssp             TSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH-----HHHCCCCTTT
T ss_pred             CCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----HHHCCCChHH
Confidence            5332 22334578999999998876 568999999999999999999999997654333222211     1111100   


Q ss_pred             chhhh-------------hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          552 ICEAA-------------DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       552 ~~~~~-------------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....             +..............+.+|+.+||+.||++|||++|+++.-.-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            00000             00000011112235678899999999999999999999865444

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=355.10  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=204.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~----~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTK----KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            46888999999999999999987765    889999997542   23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            999999999999999953  456999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATV---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ....  .....+||+.|+|||++..   ..++.++|||||||++|||++|+.||..........  +...+..       
T Consensus       166 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~--~~~~~~~-------  234 (384)
T 4fr4_A          166 PRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE--IVHTFET-------  234 (384)
T ss_dssp             CTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH--HHHHHHH-------
T ss_pred             cCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH--HHHHHhh-------
Confidence            5432  3344689999999999874   458899999999999999999999997543222111  1111100       


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-MREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~  596 (636)
                             ....++......+.+|+.+||+.||.+||+ +.+++++
T Consensus       235 -------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          235 -------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                   011122233466889999999999999998 7777753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=344.55  Aligned_cols=252  Identities=28%  Similarity=0.461  Sum_probs=196.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+++...      +.||+|.+....  ..+.+.+|+.++++++||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRA------KDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT------EEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEECC------eeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            457788999999999999998753      789999986543  34778999999999999999999999874  47999


Q ss_pred             EeecCCCChhhhHhcCCC-CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc-EEEeccCCccccc
Q 006668          399 YDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR-GRLGDFGLAKLYQ  476 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~~~  476 (636)
                      |||+++|+|.+++..... ..+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999965432 35788999999999999999999432289999999999999998886 7999999997654


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..    .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........   .   .+... .+      
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~~-~~------  220 (307)
T 2eva_A          158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---I---MWAVH-NG------  220 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH---H---HHHHH-TT------
T ss_pred             cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH---H---HHHHh-cC------
Confidence            32    22346899999999999999999999999999999999999999754322111   1   01110 00      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .........+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus       221 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          221 ---TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ---CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               11111223345688899999999999999999999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=364.52  Aligned_cols=268  Identities=21%  Similarity=0.241  Sum_probs=212.4

Q ss_pred             ccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceee
Q 006668          308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQ  384 (636)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~  384 (636)
                      .+.++++....++|+..++||+|+||.||+++.+.++    +.||+|++++..   ....+.+.+|..++..++||||++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~----~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~  125 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG----QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ  125 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence            3455666667789999999999999999999987655    899999997532   222345788999999999999999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +++++.+.+.+++||||+++|+|.+++.+. ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+
T Consensus       126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCE
Confidence            999999999999999999999999999542 246999999999999999999999   7999999999999999999999


Q ss_pred             EEeccCCcccccCCCCccccccccCCccccccccc-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHH
Q 006668          465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-------VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA  537 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~  537 (636)
                      ||+|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||...........
T Consensus       202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999876554433344468999999999887       45689999999999999999999999975532221111


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHh
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR---PTMREVVAVLV  598 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Ps~~evl~~L~  598 (636)
                      +. .+... .           .+ ..........+.+|+.+||. +|.+|   |+++|++++-.
T Consensus       282 i~-~~~~~-~-----------~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf  330 (412)
T 2vd5_A          282 IV-HYKEH-L-----------SL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF  330 (412)
T ss_dssp             HH-THHHH-C-----------CC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred             HH-hcccC-c-----------CC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence            11 10000 0           00 01112234568889999999 99998   68999988643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=379.22  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=208.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..++||+|+||.||+|++...     ..||||+++.... ..+++.+|+.+|++++|+||+++++++.+ +..+|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT-----EEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECCC-----ceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            34677889999999999999998653     6799999986542 34678999999999999999999999876 67899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.++|.......+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999999995433456899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ..........++..|+|||++....++.++|||||||++|||++ |+.||.......     +...+             
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i-------------  477 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-------------  477 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHH-------------
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-------------
Confidence            32222233456789999999999999999999999999999999 999997542211     11111             


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+...+..+...+.+|+.+||+.||++|||+.+|+++|+.-
T Consensus       478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11111222334456788999999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-40  Score=339.55  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=205.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||.||+|+....+    ..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTR----IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCC----cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            456888999999999999999987655    7899999987655556788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~  474 (636)
                      ||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++..
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           84 VMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            9999999999999854  356899999999999999999999   7999999999999999   8889999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  ......||+.|+|||++.+. ++.++||||||+++|||++|+.||.......    .......     +....
T Consensus       159 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~-----~~~~~  226 (277)
T 3f3z_A          159 FKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIRE-----GTFTF  226 (277)
T ss_dssp             CCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-----CCCCC
T ss_pred             ccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHh-----CCCCC
Confidence            65433  22335799999999988754 8999999999999999999999997543211    1111110     00000


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ......    .....+.+++.+||+.||++||++.|+++.-
T Consensus       227 --~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          227 --PEKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             --CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             --Cchhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence              000000    1245688899999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-40  Score=353.17  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .++|+..+.||+|+||.||+++....+    +.||+|+++...   ....+.+..|..++..+ +||||+++++++...+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTD----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEE----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            467899999999999999999987654    899999997642   23356778899999988 7999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .+++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999999999999953  356999999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .... +..    +.  
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~-i~~----~~--  237 (353)
T 2i0e_A          170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS-IME----HN--  237 (353)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-HHH----CC--
T ss_pred             ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----HHHH-HHh----CC--
Confidence            643222 23344689999999999999999999999999999999999999997542211    1111 100    00  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                              ..++......+.+|+.+||+.||.+||+     +++++++
T Consensus       238 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    1122233456888999999999999995     5777765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-40  Score=337.54  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=206.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||+|.....+    ..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCC----ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            567899999999999999999987655    88999999754  445567888999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla  472 (636)
                      ++||||+++++|.+++..  ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus        81 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            999999999999998854  356899999999999999999999   799999999999999986655   999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ..........   . 
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~---~-  225 (284)
T 3kk8_A          156 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAY---D-  225 (284)
T ss_dssp             EECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCC---C-
T ss_pred             EEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHHHHHhccc---c-
Confidence            8665433  2234579999999999999999999999999999999999999997543221    1111111000   0 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                             ............+.+++.+||+.||++|||+.|+++.-
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          226 -------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             -------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             -------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence                   00000112235688899999999999999999999854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=340.01  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=206.0

Q ss_pred             CCCCce-eeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDE-LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~-~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|...+ .||+|+||.||+|.+...+  .+..||+|++... .....+++.+|+.++++++||||+++++++ ..+..++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCC--CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            344455 8999999999999865322  2378999999875 445567899999999999999999999999 4567999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999998543 456999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......     ....+.          
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~i~----------  227 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE----------  227 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHH----------
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHh----------
Confidence            3321  1223356889999999998889999999999999999998 999997653321     111111          


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .......+...+..+.+++.+||+.||++||++.++++.|+.-
T Consensus       228 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          228 ---QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1111223334456788999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-40  Score=344.12  Aligned_cols=267  Identities=23%  Similarity=0.348  Sum_probs=192.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||+|++..... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTG----VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSC----CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCC----cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            457888999999999999999976655    8999999976533 23467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcC----CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          397 LVYDYMPNGSLNNWIFGK----PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      +||||++ |+|.+++...    ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999997 6999988532    2346899999999999999999999   799999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC-
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG-  550 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~-  550 (636)
                      +....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........    . +....... 
T Consensus       156 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~-i~~~~~~~~  229 (317)
T 2pmi_A          156 RAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK----L-IFDIMGTPN  229 (317)
T ss_dssp             EETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----H-HHHHHCSCC
T ss_pred             eecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----H-HHHHhCCCC
Confidence            87643321 22335789999999998764 68999999999999999999999997553222111    1 11111100 


Q ss_pred             -cchhh------------------hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          551 -KICEA------------------ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       551 -~~~~~------------------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       .....                  +...+...........+.+++.+||+.||++|||+.|+++.-.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence             00000                  0000011111122356889999999999999999999987543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-40  Score=339.36  Aligned_cols=259  Identities=26%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE-EE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL-ML  397 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~-~l  397 (636)
                      .|...++||+|+||.||+|++...+ .....+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA-QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS-SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCC-CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            3556689999999999999876532 33457999999865 445567889999999999999999999999766654 99


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus       101 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999965 3467899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CC---CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GE---VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..   ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..........    ..+.          
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~----~~~~----------  242 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----HFLA----------  242 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH----HHHH----------
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH----HHhh----------
Confidence            22   122233567899999999999999999999999999999999666654332221111    1111          


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .......+......+.+++.+||+.||.+|||++++++.|+.-
T Consensus       243 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          243 ---QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               1111112223345788999999999999999999999999764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=344.82  Aligned_cols=268  Identities=25%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-----HHHHHHHHHHHHhccC---CCCceeeeecc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-----QGLKEFMAEISSMGRL---QHKNLVQMRGW  388 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l---~h~niv~l~g~  388 (636)
                      .+++|+..+.||+|+||.||+|+....+    +.||+|++.....     .....+.+|+.+++++   +||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTC----CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            4678999999999999999999976655    8999999874321     1123455666666655   59999999999


Q ss_pred             ccccc-----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc
Q 006668          389 CRKGN-----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       389 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~  463 (636)
                      |....     ..++||||+. ++|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence            87654     5899999995 69999997766666999999999999999999999   789999999999999999999


Q ss_pred             EEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      +||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    +....
T Consensus       159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~  232 (308)
T 3g33_A          159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGKIF  232 (308)
T ss_dssp             EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----HHHHH
T ss_pred             EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH
Confidence            9999999998665432  23446799999999999999999999999999999999999999975532221    11111


Q ss_pred             HHHhcCC---cchh-------hh---hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          544 RNLYGQG---KICE-------AA---DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       544 ~~~~~~~---~~~~-------~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      . .....   ....       ..   .+........+....+.+|+.+||+.||++|||+.|+++.-.-
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~  300 (308)
T 3g33_A          233 D-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL  300 (308)
T ss_dssp             H-HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred             H-HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence            1 11100   0000       00   0000011112334678889999999999999999999986443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=352.35  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=188.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccc--------
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWC--------  389 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~--------  389 (636)
                      .+|+..++||+|+||.||+++....+    +.||+|++........+.+.+|+.++.++. ||||+++++++        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSG----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTC----CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCC----cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            46888999999999999999987655    899999998777777788999999999996 99999999988        


Q ss_pred             cccceEEEEEeecCCCChhhhHhc-CCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEcCCCcEEE
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFG-KPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl  466 (636)
                      .....+++||||+ +|+|.+++.. .....+++.+++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence            4455689999999 5899998854 23456999999999999999999999   777  999999999999999999999


Q ss_pred             eccCCcccccCCCCc-----------cccccccCCcccccccc---cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          467 GDFGLAKLYQQGEVP-----------NTTRVVGTLGYLAPELA---TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       467 ~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                      +|||+++........           ......||+.|+|||++   .+..++.++||||||+++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221           11134689999999998   5667888999999999999999999999643211


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          ..    ..             ..............+.+|+.+||+.||.+||++.|+++.|+.-
T Consensus       260 ----~~----~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 ----RI----VN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----Hh----hc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                00    00             0000011111223477899999999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-40  Score=345.19  Aligned_cols=256  Identities=22%  Similarity=0.336  Sum_probs=207.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH------HHHHHHHHHHHhccCCCCceeeeeccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ------GLKEFMAEISSMGRLQHKNLVQMRGWCRK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~  391 (636)
                      .++|+..+.||+|+||.||+++...++    ..||+|.+......      ..+++.+|+.++++++||||+++++++.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCC----eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            345888999999999999999987655    89999999764221      35778999999999999999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEe
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLG  467 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~  467 (636)
                      .+..++||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            9999999999999999999954  457899999999999999999999   78999999999999999888    79999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |||++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......    ..+... .   
T Consensus       162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i-~---  231 (321)
T 2a2a_A          162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANI-T---  231 (321)
T ss_dssp             CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHH-H---
T ss_pred             cCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH-H---
Confidence            999998765432  223457999999999999999999999999999999999999999754221    111110 0   


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       .+..  ..+.....    .....+.+++.+||+.||++|||+.|+++.-.-
T Consensus       232 -~~~~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          232 -SVSY--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             -TTCC--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             -hccc--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence             0000  00111111    223568889999999999999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-40  Score=338.63  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=203.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..+.||+|+||.||+|+....+    ..||+|++....   ......+.+|+.++++++||||+++++++.+.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCC----cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            456888999999999999999987665    789999986542   1224678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            9999999999999999853  356899999999999999999999   89999999999999999999999999999865


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    . +..         
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~-~~~---------  221 (279)
T 3fdn_A          159 APSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----R-ISR---------  221 (279)
T ss_dssp             C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----H-HHH---------
T ss_pred             CCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH----H-HHh---------
Confidence            4332   2234578999999999999999999999999999999999999997542211110    0 000         


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           ....++......+.+|+.+||+.||.+||++.|+++.-.-
T Consensus       222 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~  261 (279)
T 3fdn_A          222 -----VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI  261 (279)
T ss_dssp             -----TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence                 1111222334567889999999999999999999987543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=350.32  Aligned_cols=267  Identities=17%  Similarity=0.208  Sum_probs=200.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH-----------HHHHHHHHHHhccCCCCceeeeec
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-----------LKEFMAEISSMGRLQHKNLVQMRG  387 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~h~niv~l~g  387 (636)
                      ++|...+.||+|+||.||+|+.... ...+..+|+|++.......           ...+.+|+..+..++||||+++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNK-PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSS-CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCC-CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            5688899999999999999998652 2234789999998653221           123567888999999999999999


Q ss_pred             cccc----cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-
Q 006668          388 WCRK----GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-  462 (636)
Q Consensus       388 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-  462 (636)
                      ++..    ....++||||+ +++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            9877    77899999999 9999999843  337999999999999999999999   78999999999999998887 


Q ss_pred             -cEEEeccCCcccccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhH
Q 006668          463 -RGRLGDFGLAKLYQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE  535 (636)
Q Consensus       463 -~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~  535 (636)
                       .+||+|||+++.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999986643221      1123457999999999999999999999999999999999999999643222111


Q ss_pred             HHHHHHHHHHHhcCCcchhhhhhhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCc
Q 006668          536 EAVLMDWVRNLYGQGKICEAADARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQE  601 (636)
Q Consensus       536 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  601 (636)
                      ......   ..      ...+...+.... ....+..+.+++.+||+.||++||++.+|++.|+...
T Consensus       270 ~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          270 VQTAKT---NL------LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHH---HH------HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHH---hh------cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111   00      000111111100 0123457889999999999999999999999998763

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-40  Score=338.80  Aligned_cols=258  Identities=26%  Similarity=0.474  Sum_probs=195.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..++||+|+||.||+|+..       ..||+|+++..  .....+.+.+|+.++++++||||+++++++. .+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   94 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH-------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   94 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS-------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc-------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCcc
Confidence            457889999999999999999863       35999999754  4455678999999999999999999999764 4568


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999998543 456999999999999999999999   799999999999999999999999999999765


Q ss_pred             cCCC-CccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          476 QQGE-VPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       476 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      .... ........||+.|+|||++.   +..++.++||||||+++|||++|+.||........    +...+..    +.
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~----~~  242 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEMVGR----GS  242 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH----HHHHHHH----TS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH----HHHHhcc----cc
Confidence            4322 22233457999999999886   56678899999999999999999999976533221    1111111    11


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...    . ........+..+.+++.+||+.||++||++.|+++.|+.-
T Consensus       243 ~~~----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          243 LSP----D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             CCC----C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cCc----c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            100    0 0112223456789999999999999999999999999764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=354.22  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=195.7

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccc-cceEEEE
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-GNELMLV  398 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV  398 (636)
                      |+..++||+|+||.||+|++...+ .....||+|.++.. .....+++.+|+.++++++||||++++++|.+ .+..++|
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETT-TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCC-CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            556789999999999999975432 23367899998754 34556789999999999999999999998754 5678999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999543 456899999999999999999999   799999999999999999999999999999865433


Q ss_pred             CCc---cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          479 EVP---NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       479 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ...   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........     +.    .+.   
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-----~~----~~~---  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LL----QGR---  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-----HH----TTC---
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-----HH----cCC---
Confidence            221   2233457889999999999999999999999999999999 6777765432221110     00    111   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                            ....+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus       314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1111223346688999999999999999999999999764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-40  Score=344.71  Aligned_cols=272  Identities=25%  Similarity=0.367  Sum_probs=214.8

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeee
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQM  385 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l  385 (636)
                      +...+.....++|...+.||+|+||.||+|+.... ....++.||+|++... .....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33444445567899999999999999999986432 2344589999999865 334556889999999999 79999999


Q ss_pred             eccccccc-eEEEEEeecCCCChhhhHhcCCC--------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCC
Q 006668          386 RGWCRKGN-ELMLVYDYMPNGSLNNWIFGKPK--------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRD  450 (636)
Q Consensus       386 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  450 (636)
                      ++++...+ ..++||||+++|+|.+++.....              ..+++.+++.++.||+.||.|||   +.+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987654 58999999999999999965432              23899999999999999999999   78999999


Q ss_pred             CCCCCEEEcCCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 006668          451 IKSGNILLDSEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDM  528 (636)
Q Consensus       451 lkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~  528 (636)
                      |||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986644332 22334567899999999999999999999999999999998 9999976


Q ss_pred             CCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          529 GKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       529 ~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..........+    ..             ......+......+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       254 ~~~~~~~~~~~----~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEEFCRRL----KE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHHHHHHH----HH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHHHHHh----cc-------------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            53322111111    00             011111222345688899999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.4e-41  Score=350.24  Aligned_cols=268  Identities=24%  Similarity=0.430  Sum_probs=213.8

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccc
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWC  389 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~  389 (636)
                      ++.....++|...+.||+|+||.||+|+.... ....+..||+|.+... ......++.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            34444567889999999999999999987531 1223478999999765 334456789999999999999999999999


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCC--------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKP--------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE  461 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~  461 (636)
                      .+.+..++||||+++|+|.+++....        ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            99999999999999999999985421        245789999999999999999999   7899999999999999999


Q ss_pred             CcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHH
Q 006668          462 MRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l  539 (636)
                      +.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......     .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~  249 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----V  249 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----H
Confidence            9999999999986543322 12233457889999999999999999999999999999999 889986542111     1


Q ss_pred             HHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       540 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...+    ..+..         .......+..+.+++.+||+.||.+||++.|+++.|+..
T Consensus       250 ~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          250 LRFV----MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHH----HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            1111    11111         112223446688999999999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=350.22  Aligned_cols=268  Identities=27%  Similarity=0.428  Sum_probs=211.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc--eEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--ELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~  396 (636)
                      ++|+..+.||+|+||.||++++.......++.||+|++........+.+.+|+.++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            457888999999999999998654334455899999998877777788999999999999999999999886654  789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       121 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999653 346899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC----
Q 006668          477 QGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG----  550 (636)
Q Consensus       477 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~----  550 (636)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....  ..    ...    .....    
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~----~~~----~~~~~~~~~  266 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AE----FMR----MIGNDKQGQ  266 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HH----HHH----HHCTTCCTH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HH----HHH----hhccccchh
Confidence            43321  1222456788999999998889999999999999999999999985321  00    000    00000    


Q ss_pred             ----cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          551 ----KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       551 ----~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          .+.+.+........+...+..+.+++.+||+.||++||++.|+++.|+.-
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                01111111111222334457789999999999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-40  Score=347.05  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC----hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS----KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ++|+..+.||+|+||.||+++... +...++.||+|+++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVT-GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECS-STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEec-cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            568889999999999999998753 12334899999997652    2334567889999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999953  356899999999999999999999   78999999999999999999999999999975


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||........    +.. +..    +    
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~-i~~----~----  236 (327)
T 3a62_A          171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT----IDK-ILK----C----  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHH-HHH----T----
T ss_pred             cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH----HHH-HHh----C----
Confidence            43322 123345799999999999999999999999999999999999999975432111    111 100    0    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~  599 (636)
                            ...++......+.+++.+||+.||.+||     ++.|++++-.-
T Consensus       237 ------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          237 ------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             ------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence                  0111222345688899999999999999     77888876443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-40  Score=347.24  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+++....+    +.+|+|++...   .....+.+.+|+.++++++|+||+++++++.+.+..
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTK----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            45778899999999999999987655    78999998754   344567788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       117 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EEEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            999999999999998843  357899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......    ........     .    
T Consensus       192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~-----~----  257 (335)
T 2owb_A          192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKN-----E----  257 (335)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHT-----C----
T ss_pred             ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHhcC-----C----
Confidence            53322 2334578999999999999999999999999999999999999997543211    11110000     0    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        .    ..+......+.+++.+||+.||++||++.|+++.-
T Consensus       258 --~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          258 --Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             --C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence              0    11122235678899999999999999999999853

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=342.00  Aligned_cols=271  Identities=21%  Similarity=0.241  Sum_probs=202.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+...++    +.||+|++....  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTG----QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            57888999999999999999987655    899999986553  333567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        79 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            99999999999998843  456999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH-------HHhc
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR-------NLYG  548 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~-------~~~~  548 (636)
                      .... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||........... ......       ..+.
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL-IRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHHHH
T ss_pred             Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhcccccccccccc
Confidence            3322 2234578999999998876 6679999999999999999999999976532221111 111000       0000


Q ss_pred             CCcchhhhh---hh---hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGKICEAAD---AR---IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~~~~~~d---~~---l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .........   +.   ............+.+++.+||+.||++|||++|+++.-.-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            000000000   00   00000012345688999999999999999999999876544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-40  Score=354.95  Aligned_cols=245  Identities=26%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHH-hccCCCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISS-MGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ++|+..+.||+|+||.||+++.+.++    +.||+|++....   ......+.+|..+ ++.++||||+++++++.+.+.
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEE----VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTC----CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            45788899999999999999987665    899999997642   2334556677776 577899999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       114 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999999953  356889999999999999999999   79999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .....+.          
T Consensus       189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~----------  253 (373)
T 2r5t_A          189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILN----------  253 (373)
T ss_dssp             GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHHHHHH----------
T ss_pred             cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHh----------
Confidence            43322 23344689999999999999999999999999999999999999997542211    1111110          


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                         ..  ..++......+.+|+.+||+.||.+||++.+
T Consensus       254 ---~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 ---KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ---SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ---cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence               00  0112223456788999999999999999853

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-41  Score=354.31  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=204.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|.+.+.||+|+||.||+|+....+    +.||+|++.....   .....+.+|+.+++.++||||+++++++...+..
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            56888999999999999999987665    8999999975421   1235688999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+ +|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||++...
T Consensus        85 ~lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EEEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EEEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            9999999 7899998854  356999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........                  .+
T Consensus       159 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------------~~  218 (336)
T 3h4j_B          159 TDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------------FK  218 (336)
T ss_dssp             TTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------------BC
T ss_pred             cCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------------HH
Confidence            54332  233579999999999988776 6799999999999999999999975422110                  00


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+... ....+......+.+|+.+||+.||.+|||+.|+++.-.-
T Consensus       219 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          219 KVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             CCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             HHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence            00000 011122234567889999999999999999999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-40  Score=339.36  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ--GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+... +    +.||+|++......  ..+.+.+|+.++++++||||+++++++...+..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~-~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNY-G----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV   76 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-S----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCC-C----CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEE
Confidence            468889999999999999998732 3    78999999765332  2467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||++ ++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           77 LVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             EEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            9999996 5999988543 457899999999999999999999   7999999999999999999999999999998664


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc----
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK----  551 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~----  551 (636)
                      ... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......    .+..... ......    
T Consensus       152 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~~~~~~~~~  225 (288)
T 1ob3_A          152 IPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFR-ILGTPNSKNW  225 (288)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH-HHCCCCTTTS
T ss_pred             ccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH-HHCCCChhhc
Confidence            322 222345789999999998764 58999999999999999999999997553221    1111111 111100    


Q ss_pred             --chh--hhhhhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          552 --ICE--AADARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       552 --~~~--~~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ..+  ..++..       ...+.......+.+|+.+||+.||++|||+.|+++.-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence              000  000000       0111122346678999999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=342.94  Aligned_cols=260  Identities=24%  Similarity=0.279  Sum_probs=205.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccc----ccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR----KGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~  393 (636)
                      .++|+..+.||+|+||.||+++....+    +.||+|++........+.+.+|+.++++++||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDG----HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTC----CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCC----cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            356889999999999999999986655    899999998777777788999999999999999999999986    345


Q ss_pred             eEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          394 ELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      ..++||||+++|+|.+++..  .....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            78999999999999999854  23467999999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCc--------cccccccCCcccccccccCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 006668          472 AKLYQQGEVP--------NTTRVVGTLGYLAPELATVSS---PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       472 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~  540 (636)
                      +.........        ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||......        
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------  252 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--------  252 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--------
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--------
Confidence            8754321110        112245799999999987654   688999999999999999999998421000        


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                              ...+...................+.+++.+||+.||.+||++.++++.|+..
T Consensus       253 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          253 --------GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             --------TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --------cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence                    0000011111111111223346788999999999999999999999999876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=374.19  Aligned_cols=249  Identities=27%  Similarity=0.453  Sum_probs=200.9

Q ss_pred             eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeecCC
Q 006668          326 LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPN  404 (636)
Q Consensus       326 ~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  404 (636)
                      .||+|+||.||+|.+...+  .+..||||+++... ....+++.+|++++++++|||||+++++|.. +.+++|||||++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSS--CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCC--CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999876432  23789999998653 3456789999999999999999999999976 569999999999


Q ss_pred             CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCcc--
Q 006668          405 GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPN--  482 (636)
Q Consensus       405 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--  482 (636)
                      |+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.........  
T Consensus       420 g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          420 GPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             CBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             CcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999999543 457999999999999999999999   7999999999999999999999999999998765432211  


Q ss_pred             ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhh
Q 006668          483 TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR  561 (636)
Q Consensus       483 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  561 (636)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.......     +...+             ....+
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i-------------~~~~~  557 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFI-------------EQGKR  557 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----HHHHH-------------HTTCC
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHH-------------HcCCC
Confidence            122345689999999999999999999999999999998 999997654322     11111             11112


Q ss_pred             hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       562 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+..++..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            23334456778999999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.8e-40  Score=342.44  Aligned_cols=258  Identities=21%  Similarity=0.250  Sum_probs=200.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      -++|...+.||+|+||.||+++....+    +.||+|++...   .....+.+.+|+.++++++||||+++++++...+.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRE----RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTT----EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCC----eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            467899999999999999999987655    89999999764   23345778999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .++||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus       109 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            9999999999999999954  356899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .............|++.|+|||++.+..++.++||||||+++|||++|+.||.....     ..+...+..   ....  
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~---~~~~--  253 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQ---AIPR--  253 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHS---CCCC--
T ss_pred             ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhcc---CCCC--
Confidence            655443344456799999999999999999999999999999999999999975411     111111110   0000  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcC
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVLVGQ  600 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~~  600 (636)
                            ........+..+.+++.+||+.||++|| +++++++.|+..
T Consensus       254 ------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          254 ------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             ------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             ------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence                  1112223345688899999999999999 999999999765

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-40  Score=338.25  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc------
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK------  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------  391 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|.+.....    .+.+|++++++++||||+++++++..      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDG----KTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTC----CEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCC----eEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            456888999999999999999987555    8999999986643    45689999999999999999998754      


Q ss_pred             ----------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC
Q 006668          392 ----------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE  461 (636)
Q Consensus       392 ----------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~  461 (636)
                                ....++||||+++++|.+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence                      456899999999999999997655567999999999999999999999   7899999999999999999


Q ss_pred             CcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      +.+||+|||++.......  ......||+.|+|||++.+..++.++||||||+++|||++|..|+..      .....  
T Consensus       159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~~~~~--  228 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFF--  228 (284)
T ss_dssp             TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------HHHHH--
T ss_pred             CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------HHHHH--
Confidence            999999999998765433  22335689999999999999999999999999999999999988631      11111  


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .....+.        +..    .....+.+++.+||+.||.+||++.|+++.|+.-
T Consensus       229 ---~~~~~~~--------~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          229 ---TDLRDGI--------ISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             ---HHHHTTC--------CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHhhccc--------ccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0111111        111    2234577899999999999999999999999765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.2e-40  Score=338.40  Aligned_cols=259  Identities=28%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeecccc-ccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCR-KGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~  396 (636)
                      .+|+..++||+|+||.||+|+....+ .....+|+|.+... .....+.+.+|+.++++++||||++++++|. .++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCC-CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            35778899999999999999976532 23357899999865 4455678999999999999999999999864 556789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999999643 456899999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCC---ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGEV---PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACG-RRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G-~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||........... .    .        
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~----~--------  246 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-L----L--------  246 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-H----H--------
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-H----h--------
Confidence            4321   122334678899999999999999999999999999999995 555543322211110 0    0        


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           .......+...+..+.+++.+||+.||++||++.|+++.|+.-
T Consensus       247 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          247 -----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 0001111222345688999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-40  Score=352.41  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|...+.||+|+||.||+++....+    +.||+|++...... .+.+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTK----ELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTC----CEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCC----cEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            457889999999999999999987665    89999999765332 2567899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--EEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--GRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~~  475 (636)
                      ||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++..
T Consensus        94 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            9999999999999853  346999999999999999999999   799999999999999987765  999999999754


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSA-SDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||............+..    ...      
T Consensus       169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----~~~------  236 (361)
T 3uc3_A          169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR----ILS------  236 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH----HHT------
T ss_pred             cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH----Hhc------
Confidence            3322  2233579999999999988887665 89999999999999999999754332222211111    100      


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                         ..............+.+|+.+||+.||++|||+.|++++-.
T Consensus       237 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          237 ---VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             ---TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             ---CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence               00000001112356788999999999999999999998743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-40  Score=346.07  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=203.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+....+  ....+++|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT--EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCC--cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            56888999999999999999986654  1124599998754 334456788999999999 8999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          397 LVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +||||+++|+|.+++....              ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCC
Confidence            9999999999999996542              347999999999999999999999   79999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||+++.....  .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......     +..
T Consensus       180 ~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~  252 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYE  252 (327)
T ss_dssp             CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHH
T ss_pred             eEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HHH
Confidence            9999999999743321  12223457889999999998889999999999999999998 999997553211     111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          ....         ......+......+.+|+.+||+.||.+||++.|+++.|+.-
T Consensus       253 ----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 ----KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ----HGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----Hhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                1111         111112223346688999999999999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-40  Score=346.88  Aligned_cols=265  Identities=19%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             HHHHHHhCCCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCC-CCceeeeec
Q 006668          312 EELSKATKGFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQ-HKNLVQMRG  387 (636)
Q Consensus       312 ~~l~~a~~~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~g  387 (636)
                      +......+.|... +.||+|+||.||+|+....+    +.||+|++....  .....++.+|+.++..++ ||||+++++
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTG----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCC----CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3444555567666 88999999999999987655    899999997642  233577889999999995 699999999


Q ss_pred             cccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcE
Q 006668          388 WCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRG  464 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~  464 (636)
                      ++.+.+..++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999999996665678999999999999999999999   789999999999999988   7899


Q ss_pred             EEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      ||+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........    .... .
T Consensus       174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i-~  246 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET----YLNI-S  246 (327)
T ss_dssp             EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHH-H
T ss_pred             EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHH-H
Confidence            999999998765432  22345799999999999999999999999999999999999999975432111    1110 0


Q ss_pred             HHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..          ...............+.+++.+||+.||++|||++|+++.-.-.
T Consensus       247 ~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          247 QV----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             HT----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             hc----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence            00          00011111123345688899999999999999999999875443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-40  Score=359.96  Aligned_cols=248  Identities=25%  Similarity=0.437  Sum_probs=205.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+|+...++    +.||||++.....   ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTG----HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTC----CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46888999999999999999987655    8999999975422   2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        92 ~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           92 FMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999994  3467999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........     +    ..+..  
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-----i----~~~~~--  233 (476)
T 2y94_A          167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-----I----CDGIF--  233 (476)
T ss_dssp             CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-----H----HTTCC--
T ss_pred             ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-----H----hcCCc--
Confidence            54332  234579999999999988765 6799999999999999999999975532211111     1    01110  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                              ..+......+.+|+.+||+.||.+|||+.|+++.
T Consensus       234 --------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 --------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                    1111223467889999999999999999999984

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.9e-40  Score=341.15  Aligned_cols=262  Identities=25%  Similarity=0.418  Sum_probs=201.0

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc-
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-  393 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-  393 (636)
                      ..++|...+.||+|+||.||+|+.... ...+..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+ 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE-DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT-TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc-CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            456788899999999999999987653 233478999999754  4455678999999999999999999999987654 


Q ss_pred             ----eEEEEEeecCCCChhhhHhc----CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEE
Q 006668          394 ----ELMLVYDYMPNGSLNNWIFG----KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGR  465 (636)
Q Consensus       394 ----~~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  465 (636)
                          ..++||||+++|+|.+++..    .....+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                35999999999999999843    23457999999999999999999999   89999999999999999999999


Q ss_pred             EeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHH
Q 006668          466 LGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       466 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........     +
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----~  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-----L  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----H
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-----H
Confidence            999999986654332 12233457889999999999999999999999999999999 8889875532221111     1


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .             .......+......+.+++.+||+.||.+||++.++++.|+.-
T Consensus       263 ~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          263 L-------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             H-------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0             0011122233446788999999999999999999999999775

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.7e-41  Score=341.24  Aligned_cols=257  Identities=22%  Similarity=0.343  Sum_probs=206.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccc--ccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCR--KGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~  393 (636)
                      .++|+..+.||+|+||.||+++...++    +.||+|.+...  .....+.+.+|+.++++++||||+++++++.  ..+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCC----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            356888999999999999999987655    89999999764  3445678899999999999999999999874  467


Q ss_pred             eEEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCc-----EEeCCCCCCCEEEcCCCcEEE
Q 006668          394 ELMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQV-----VVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivHrDlkp~NIll~~~~~~kl  466 (636)
                      ..++||||+++++|.+++...  ....+++.+++.++.|++.||+|||   +.+     ++||||||+|||++.++.+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            899999999999999999542  2345999999999999999999999   666     999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +|||+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......     +...+.  
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~--  229 (279)
T 2w5a_A          158 GDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIR--  229 (279)
T ss_dssp             CCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH--
T ss_pred             ecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----HHHHHh--
Confidence            99999987654321 2223568999999999999999999999999999999999999997552111     111111  


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .+.         ....+......+.+++.+||+.||++||++.|+++.+...
T Consensus       230 --~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          230 --EGK---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             --HTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             --hcc---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence              011         1112223346788999999999999999999999998776

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=350.15  Aligned_cols=266  Identities=24%  Similarity=0.375  Sum_probs=195.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccc-----ccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC-----RKG  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-----~~~  392 (636)
                      .++|+..+.||+|+||.||+|+..+      +.||||++........ ....|+..+..++|+||+++++.+     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~-~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDE------RPVAVKVFSFANRQNF-INEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETT------EEEEEEEEEGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEECC------eEEEEEEeeccchhhH-HHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            3578889999999999999998632      8999999976543321 223455556678999999999743     344


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC---------cEEeCCCCCCCEEEcCCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ---------VVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~ivHrDlkp~NIll~~~~~  463 (636)
                      ..+++||||+++|+|.+++..   ...++..++.++.||+.||+|||   +.         +|+||||||+|||++.++.
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCc
Confidence            578999999999999999943   34589999999999999999999   66         9999999999999999999


Q ss_pred             EEEeccCCcccccCCCC-------ccccccccCCcccccccccC-------CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          464 GRLGDFGLAKLYQQGEV-------PNTTRVVGTLGYLAPELATV-------SSPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +||+|||+++.......       .......||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999986653221       12223569999999999887       35567899999999999999998887543


Q ss_pred             CChhhHHHHHH---------HHHHHHhcCCcchhhhhhhhhhc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          530 KGEEEEEAVLM---------DWVRNLYGQGKICEAADARIRQE--FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       530 ~~~~~~~~~l~---------~~v~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .........+.         +...........    .+.+...  ........+.+|+.+||+.||++|||+.|+++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            22111000000         000000000000    0111111  12235667999999999999999999999999997


Q ss_pred             cC
Q 006668          599 GQ  600 (636)
Q Consensus       599 ~~  600 (636)
                      .-
T Consensus       315 ~l  316 (336)
T 3g2f_A          315 EL  316 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7e-40  Score=337.08  Aligned_cols=262  Identities=18%  Similarity=0.244  Sum_probs=201.8

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccc-cccceE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC-RKGNEL  395 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~  395 (636)
                      ..++|+..+.||+|+||.||+|+....+    +.||+|++......  +++.+|+.+++.++|++++..++++ ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCC----ceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            4578999999999999999999976655    89999987654322  3577899999999988877776665 566788


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla  472 (636)
                      ++||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            9999999 99999998533 456999999999999999999999   7999999999999999   88999999999999


Q ss_pred             ccccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          473 KLYQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       473 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~  234 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKK  234 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-hhhhhccc
Confidence            87654432      122345799999999999999999999999999999999999999976432211111 11100000


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..          ..........+..+.+++.+||+.||++||++.++++.|+.-
T Consensus       235 ~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          235 MS----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HH----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cc----------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            00          000011112246788999999999999999999999999763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=356.49  Aligned_cols=271  Identities=23%  Similarity=0.319  Sum_probs=212.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccc--eE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--EL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~  395 (636)
                      ++|...++||+|+||.||+|+....+    +.||+|++.... ....+.+.+|++++++++||||+++++++...+  ..
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTG----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCC----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            46888999999999999999987655    899999997543 233567789999999999999999999987654  78


Q ss_pred             EEEEeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE----cCCCcEEEeccC
Q 006668          396 MLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL----DSEMRGRLGDFG  470 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFG  470 (636)
                      ++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999999995432 223999999999999999999999   7999999999999999    788889999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATV--------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      +++......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||............+...
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            998765432  2234579999999998865        456789999999999999999999997543333223333332


Q ss_pred             HHHHhcCCcc-----------hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          543 VRNLYGQGKI-----------CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       543 v~~~~~~~~~-----------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..... ...+           ...-+.......+......+.+++.+||+.||++||++.|+++.|..
T Consensus       240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             HHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             hcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            22110 0000           00001111223457788889999999999999999999999988765

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.1e-40  Score=338.96  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +.|+..+.||+|+||.||+|+....+    +.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQ----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCC----cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            45888999999999999999876655    899999997653 3446788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++.   ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        98 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           98 IMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999983   357999999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......     ....+..            
T Consensus       172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~------------  233 (303)
T 3a7i_A          172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIPK------------  233 (303)
T ss_dssp             TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH------------
T ss_pred             ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhhc------------
Confidence            332 2234578999999999999999999999999999999999999997542111     1111110            


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       .............+.+++.+||+.||++|||+.|+++...
T Consensus       234 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          234 -NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             -SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             -CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence             0011122223456889999999999999999999998653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-40  Score=353.48  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=191.2

Q ss_pred             CCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhc-cCCCCceeeeeccccc----cc
Q 006668          320 GFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMG-RLQHKNLVQMRGWCRK----GN  393 (636)
Q Consensus       320 ~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~----~~  393 (636)
                      +|... ++||+|+||.||+++...++    +.||||++...     ..+.+|+.++. ..+||||+++++++..    .+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~----~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCC----CEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            45554 68999999999999987665    89999999643     34567887764 4589999999998865    66


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEeccC
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDFG  470 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFG  470 (636)
                      .+++|||||++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            7999999999999999997665567999999999999999999999   799999999999999987   7899999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      +++......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||............... +.    .+
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-i~----~~  282 (400)
T 1nxk_A          210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IR----MG  282 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH-HH----HT
T ss_pred             cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH-HH----cC
Confidence            998654322  233467899999999999999999999999999999999999999754322110000000 00    00


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..      .............+.+|+.+||+.||++|||+.|+++.-
T Consensus       283 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          283 QY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00      000000112345688899999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6e-40  Score=338.01  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=206.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+++....+    +.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTK----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCC----ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            56788999999999999999987655    78999998754   344567788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            999999999999998843  357899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......    .....     ..+.    
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~-----~~~~----  231 (294)
T 2rku_A          166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRI-----KKNE----  231 (294)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH-----HTTC----
T ss_pred             ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH-----hhcc----
Confidence            53322 2333578999999999999999999999999999999999999997543211    11110     0000    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            ...+......+.+++.+||+.||++||++.|+++.-
T Consensus       232 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          232 ------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                  011122335678899999999999999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-40  Score=339.82  Aligned_cols=256  Identities=29%  Similarity=0.412  Sum_probs=203.3

Q ss_pred             CCCCCce-eeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDE-LLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~-~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+ .||+|+||.||+|.+...  ..+..||+|++....  ....+++.+|+.++++++||||+++++++ ..+..
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMK--KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECS--SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCC--CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            4566667 999999999999965432  234889999997653  23357889999999999999999999999 56778


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999954  346899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCcc--ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVPN--TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......     ....+.    .+  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~----~~--  236 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----KG--  236 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----TT--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH----cC--
Confidence            5433221  222346789999999998888999999999999999999 999997543211     111111    11  


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                             .....+...+..+.+++.+||+.||.+||++.++++.|+.-
T Consensus       237 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          237 -------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   11122334456788999999999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-40  Score=338.86  Aligned_cols=250  Identities=28%  Similarity=0.431  Sum_probs=197.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccccc-ceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG-NELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~  396 (636)
                      .++|+..+.||+|+||.||+++..+      ..||+|++....  ..+.+.+|+.++++++||||+++++++.+. +..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEcC------CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence            3568889999999999999998742      789999997654  346788999999999999999999986544 5789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            9999999999999996543445899999999999999999999   7999999999999999999999999999997554


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.........     .             .
T Consensus       169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-----~-------------~  226 (278)
T 1byg_A          169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----P-------------R  226 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-----H-------------H
T ss_pred             ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----H-------------H
Confidence            321    22357889999999999999999999999999999998 99999754322111     0             0


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +........+...+..+.+++.+||+.||++||++.|+++.|+.-
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            111111122333456788999999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=349.08  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCC--Cceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQH--KNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~  393 (636)
                      .+.|++.+.||+|+||.||++....     +..||+|++...  .....+.+.+|+.++.+++|  +||+++++++...+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-----SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-----CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            4568889999999999999998743     278999999754  44556788999999999986  99999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++|||+ .+++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            99999995 58999999954  457899999999999999999999   78999999999999997 5789999999998


Q ss_pred             cccCCCCc-cccccccCCcccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          474 LYQQGEVP-NTTRVVGTLGYLAPELATV-----------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       474 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      ........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........   +  
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~--  230 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---L--  230 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---H--
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH---H--
Confidence            76543322 2334679999999999865           67888999999999999999999999754322111   1  


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                                 ...++......++......+.+++.+||+.||.+|||+.|+++...-
T Consensus       231 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          231 -----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             -----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             -----------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence                       11122222223333334568899999999999999999999987543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-39  Score=335.64  Aligned_cols=260  Identities=18%  Similarity=0.246  Sum_probs=204.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccc-cccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC-RKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++......  +++.+|+.+++.++|++++..+.++ ...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCC----cEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            467899999999999999999976655    89999998765432  4578899999999998877666655 5667789


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~  473 (636)
                      +||||+ +++|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++
T Consensus        82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            999999 99999999533 356999999999999999999999   7999999999999999   588999999999998


Q ss_pred             cccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          474 LYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       474 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      ........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-hhhhhccccc
Confidence            76554321      1234579999999999999999999999999999999999999997643221111 0111000000


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..          .........+..+.+++.+||+.||++||++.++++.|+.
T Consensus       236 ~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          236 ST----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             HS----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             CC----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence            00          0001112234568899999999999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-39  Score=338.70  Aligned_cols=259  Identities=24%  Similarity=0.361  Sum_probs=197.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|....++    ..||+|++...   .....+++.+|+.++++++||||+++++++...+..
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTC----CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCC----ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            46888999999999999999976655    89999999753   345567889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++||||+++++|.+++..  .....+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            999999999999999853  23466899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........   .+...+.    .+.  
T Consensus       185 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~----~~~--  254 (310)
T 2wqm_A          185 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIE----QCD--  254 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH---HHHHHHH----TTC--
T ss_pred             eecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH---HHHHHhh----ccc--
Confidence            6544322 22335689999999999999999999999999999999999999965422211   1111111    110  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                            ............+.+++.+||+.||.+||++.+|++.|+.-
T Consensus       255 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          255 ------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             ------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                  00011122345688999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.2e-40  Score=367.06  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..++||+|+||.||+++...++    +.||+|++....   ......+.+|+.++++++||||+++++++.+.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg----~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            356888999999999999999987655    899999996542   2234567899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence            999999999999999997665566999999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... +...+..         
T Consensus       336 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~-i~~~i~~---------  403 (576)
T 2acx_A          336 VPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKE---------  403 (576)
T ss_dssp             CCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH-HHHHHHH---------
T ss_pred             cccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH-HHHHhhc---------
Confidence            65433  23345899999999999998999999999999999999999999976532211111 1111110         


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVL  597 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  597 (636)
                           ....++......+.+|+.+||+.||.+||     ++.||+++-
T Consensus       404 -----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp  446 (576)
T 2acx_A          404 -----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP  446 (576)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred             -----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence                 11122233345688899999999999999     788888764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-40  Score=352.23  Aligned_cols=267  Identities=23%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCC-CCceeeeecccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKG  392 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~  392 (636)
                      ...++|+..+.||+|+||.||+|.....+    +.||+|++...  .....+.+.+|+.++.++. ||||+++++++...
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTG----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTC----CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCC----CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            34578999999999999999999987665    89999998653  4455677889999999997 99999999998644


Q ss_pred             --ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          393 --NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                        ..+++|||||+ ++|.+++..   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence              47899999996 699999853   46899999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCC--------------------CCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          471 LAKLYQQG--------------------EVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       471 la~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      +++.....                    .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99865321                    1112334679999999998876 67899999999999999999999999765


Q ss_pred             CChhhHHHHHHHHHHHHhcCCcc----------hhhhhhhhh-----------h------------ccCHHHHHHHHHHH
Q 006668          530 KGEEEEEAVLMDWVRNLYGQGKI----------CEAADARIR-----------Q------------EFEAEEMELVLKLG  576 (636)
Q Consensus       530 ~~~~~~~~~l~~~v~~~~~~~~~----------~~~~d~~l~-----------~------------~~~~~~~~~l~~L~  576 (636)
                      ........++     ........          .......+.           .            .........+.+|+
T Consensus       235 ~~~~~~~~i~-----~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          235 STMNQLERII-----GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             SHHHHHHHHH-----HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             CHHHHHHHHH-----HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence            3222222111     11110000          000000000           0            00002245688999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHh
Q 006668          577 LACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       577 ~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .+||+.||++|||+.|++++-.
T Consensus       310 ~~~L~~dP~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDALKHPF  331 (388)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSTT
T ss_pred             HHhhccCcccCCCHHHHhCCHH
Confidence            9999999999999999998744

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-39  Score=341.07  Aligned_cols=273  Identities=24%  Similarity=0.321  Sum_probs=210.0

Q ss_pred             ccCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeee
Q 006668          308 RFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGR--LQHKNLVQM  385 (636)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l  385 (636)
                      ......-....++|...+.||+|+||.||+|+..  +    +.||+|++....   .+.+.+|++++..  ++||||+++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~  101 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--G----EEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF  101 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--T----EEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc--C----ccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEE
Confidence            3444444556678999999999999999999874  2    899999996543   3556778887776  789999999


Q ss_pred             eccccccc----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC-----CCcEEeCCCCCCCE
Q 006668          386 RGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW-----DQVVVHRDIKSGNI  456 (636)
Q Consensus       386 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NI  456 (636)
                      ++++....    ..++||||+++|+|.+++..   ..+++.+++.++.|++.||+|||...     +.+|+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  178 (342)
T ss_dssp             EEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred             EeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence            99998765    79999999999999999953   46899999999999999999999421     47999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccCCCCc---cccccccCCcccccccccCCC------CCCccchHHHHHHHHHHHhC-----
Q 006668          457 LLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLGYLAPELATVSS------PTSASDVYSFGVVILEVACG-----  522 (636)
Q Consensus       457 ll~~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~ell~G-----  522 (636)
                      |++.++.+||+|||++.........   ......||+.|+|||++.+..      ++.++||||||+++|||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999876544322   223457999999999988763      33689999999999999999     


Q ss_pred             -----CCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          523 -----RRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE-FEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       523 -----~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                           +.||............+..   .. ....    ..+.+... .+.+....+.+|+.+||+.||++|||+.||+++
T Consensus       259 ~~~~~~~p~~~~~~~~~~~~~~~~---~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSVEEMRK---VV-CEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHH---HH-TTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccccccCccccCcCcccHHHHHH---HH-HHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 7788654322211111111   11 1111    11111111 234677889999999999999999999999999


Q ss_pred             HhcC
Q 006668          597 LVGQ  600 (636)
Q Consensus       597 L~~~  600 (636)
                      |+.-
T Consensus       331 L~~i  334 (342)
T 1b6c_B          331 LSQL  334 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=336.76  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=184.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+|+....+    +.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTG----LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCC----ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            56888999999999999999976655    8899999965421   2246788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            9999999999999998643 457899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........        . ....     
T Consensus       163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~-~~~~-----  227 (278)
T 3cok_A          163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------K-VVLA-----  227 (278)
T ss_dssp             C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSS-----
T ss_pred             cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--------H-Hhhc-----
Confidence            43222 2223578999999999999899999999999999999999999997543221100        0 0000     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       +.    ..+......+.+++.+||+.||++||++.++++.-
T Consensus       228 -~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          228 -DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             -CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             -cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence             00    11122345678899999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-40  Score=346.21  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=204.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|...+.||+|+||.||+|++... ....+..||+|.+... ......++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            35788999999999999999986532 2234478999999755 445567889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCC-----CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEe
Q 006668          396 MLVYDYMPNGSLNNWIFGKPK-----KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLG  467 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~  467 (636)
                      ++||||+++++|.+++.....     ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++   .+..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965432     45899999999999999999999   78999999999999998   44569999


Q ss_pred             ccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       468 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......     .....+..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~  260 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFVTS  260 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHT
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----HHHHHHhc
Confidence            9999976543322 22233567899999999999999999999999999999998 99999654211     11111111


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                          +         ............+.+++.+||+.||.+||++.++++.|+.-
T Consensus       261 ----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 ----G---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                1         01112223345788999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6e-40  Score=343.71  Aligned_cols=255  Identities=23%  Similarity=0.283  Sum_probs=181.9

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+.||+|+||.||+++...++    +.||+|++....   ...+.+|+.++..++ ||||+++++++.+.+..++||||+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSN----QAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTC----CEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CCccccCCCeEEEEEEECCCC----CEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            478999999999999987655    899999997543   356778999999997 999999999999999999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC---cEEEeccCCcccccCCC
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM---RGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~  479 (636)
                      ++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|||+++......
T Consensus        89 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           89 NGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            99999999954  357999999999999999999999   79999999999999997665   89999999998655433


Q ss_pred             CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      . .....+||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ...+ +......+...      
T Consensus       164 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~-~~~~i~~~~~~------  234 (325)
T 3kn6_A          164 Q-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-SAVE-IMKKIKKGDFS------  234 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC-CHHH-HHHHHTTTCCC------
T ss_pred             C-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc-cHHH-HHHHHHcCCCC------
Confidence            2 2334578999999999999999999999999999999999999997543211000 0000 01111111110      


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ...+........+.+|+.+||+.||.+|||+.|+++.-.-
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence            0001111234568889999999999999999999976443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-39  Score=332.23  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCC----cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            356888999999999999999987655    79999999754 3344577889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++.  ....+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           82 LFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            9999999999999984  3457999999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCC-ccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          477 QGEV-PNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       477 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........   ...|....    ... 
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~----~~~-  228 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSDWKEKK----TYL-  228 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH---HHHHHTTC----TTS-
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH---HHHhhhcc----ccc-
Confidence            3221 22334578999999999987765 67899999999999999999999765332211   11221110    000 


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          ....    .....+.+++.+||+.||++|||+.|+++.-.-
T Consensus       229 ----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          229 ----NPWK----KIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             ----TTGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             ----Cchh----hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence                0011    223467789999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5e-40  Score=336.22  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||+|++...  ......++.+|+..+.++ +||||+++++++.+.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCC----ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            456888999999999999999987655    89999999864  334456788999999999 99999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC------------
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS------------  460 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~------------  460 (636)
                      .++||||+++++|.+++....  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.            
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            999999999999999995432  256899999999999999999999   799999999999999984            


Q ss_pred             -------CCcEEEeccCCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          461 -------EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       461 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                             ...+||+|||++.......     ...||+.|+|||++.+. .++.++||||||+++|||++|..|+...  .
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~  235 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--D  235 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--H
T ss_pred             cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--h
Confidence                   4479999999998765422     23589999999998766 5667999999999999999998776432  1


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                       .    ...     ...+.         ....+......+.+++.+||+.||++|||+.|+++.-.
T Consensus       236 -~----~~~-----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  282 (289)
T 1x8b_A          236 -Q----WHE-----IRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV  282 (289)
T ss_dssp             -H----HHH-----HHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred             -H----HHH-----HHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence             1    100     01111         11122233456889999999999999999999987643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.3e-39  Score=332.99  Aligned_cols=250  Identities=25%  Similarity=0.412  Sum_probs=200.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc----cc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----GN  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~  393 (636)
                      .|...+.||+|+||.||+|.....+    ..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ..
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~----~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCc----eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            3677789999999999999987655    88999998754  45556788999999999999999999998764    46


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEc-CCCcEEEeccC
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLD-SEMRGRLGDFG  470 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFG  470 (636)
                      .+++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +.+  |+||||||+|||++ .++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             eEEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            68999999999999999953  356899999999999999999999   677  99999999999997 78999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ++......   ......||+.|+|||++. +.++.++||||||+++|||++|+.||.........    ..   . ...+
T Consensus       178 ~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~---~-~~~~  245 (290)
T 1t4h_A          178 LATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YR---R-VTSG  245 (290)
T ss_dssp             GGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----HH---H-HTTT
T ss_pred             Cccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH----HH---H-Hhcc
Confidence            99764432   223457999999999887 45899999999999999999999999754322111    11   0 1111


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..        ...++......+.+++.+||+.||.+|||+.|+++.-.
T Consensus       246 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          246 VK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             CC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CC--------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence            11        01111122346889999999999999999999997543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.7e-39  Score=355.00  Aligned_cols=267  Identities=21%  Similarity=0.230  Sum_probs=198.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||||++...  .....+++.+|+.+++.++||||+++++++...   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCC----CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            467899999999999999999987655    89999999764  445567888999999999999999999998544   


Q ss_pred             ---ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          393 ---NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       393 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                         ...++|||||++ +|.+.+.    ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEE
Confidence               467999999965 5777662    34899999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH-------H
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD-------W  542 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~-------~  542 (636)
                      |+++......  ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...       +
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          209 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9998765432  234468999999999999999999999999999999999999999755322111111100       0


Q ss_pred             -------HHHHhcCC------cchhhhhhhhh---hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          543 -------VRNLYGQG------KICEAADARIR---QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       543 -------v~~~~~~~------~~~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                             ........      .........+.   .+........+.+|+.+||+.||++|||++|++++-.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence                   00000000      00000000000   0011122567899999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=334.22  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=201.7

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      +|....+||+|+||.||+|+...++    ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQ----VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTC----CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCC----eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            3555679999999999999986655    899999998776666678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEeccCCcccccC
Q 006668          400 DYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~  477 (636)
                      ||+++++|.+++.... ...+++..+..++.||+.||+|||   +.+++||||||+||+++. ++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999996542 345678899999999999999999   789999999999999987 89999999999986543


Q ss_pred             CCCccccccccCCcccccccccCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSS--PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .. .......||+.|+|||++.+..  ++.++||||||+++|||++|+.||........  . ... . ..         
T Consensus       176 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~~-~-~~---------  240 (295)
T 2clq_A          176 IN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--A-MFK-V-GM---------  240 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--H-HHH-H-HH---------
T ss_pred             CC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--H-HHh-h-cc---------
Confidence            22 1223457899999999987654  78899999999999999999999964322111  0 100 0 00         


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                        .......+......+.+++.+||+.||++||++.|+++.-.
T Consensus       241 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~  281 (295)
T 2clq_A          241 --FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF  281 (295)
T ss_dssp             --HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred             --ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence              01111223334467888999999999999999999987543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.4e-40  Score=348.03  Aligned_cols=250  Identities=27%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      +.|+..+.||+|+||.||+|+...++    +.||||++....   ....+++.+|+.++++++||||+++++++...+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCC----eEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            34778899999999999999976655    899999997542   33456789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||++ |+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       130 ~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            99999996 7888887432 457999999999999999999999   789999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ..     .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.......    .+.....    ..  
T Consensus       205 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~----~~~~~~~----~~--  269 (348)
T 1u5q_A          205 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQ----NE--  269 (348)
T ss_dssp             SS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHH----SC--
T ss_pred             CC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHh----cC--
Confidence            43     22357999999999874   5678999999999999999999999996542111    1111111    00  


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          .+   ..........+.+++.+||+.||++|||+.++++...-
T Consensus       270 ----~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          270 ----SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             ----CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             ----CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence                00   00111224567889999999999999999999987544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.8e-40  Score=335.35  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=202.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh------HHHHHHHHHHHHhccCCCCceeeeecccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK------QGLKEFMAEISSMGRLQHKNLVQMRGWCRKG  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~  392 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTG----KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCC----CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence            45888999999999999999987655    8999999875421      1357789999999999999999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEec
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLGD  468 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~D  468 (636)
                      +..++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+++||||||+||+++.++    .+||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             CeEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence            999999999999999999953  356899999999999999999999   79999999999999998877    899999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||++.......  ......|++.|+|||++.+..++.++||||||+++|||++|+.||......    ..+....     
T Consensus       156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-----  224 (283)
T 3bhy_A          156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLTNIS-----  224 (283)
T ss_dssp             CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-----
T ss_pred             cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHHHhH-----
Confidence            99998664432  223356899999999999999999999999999999999999999754211    1111110     


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ....      .............+.+++.+||+.||++||++.|+++.
T Consensus       225 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          225 AVNY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             TTCC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hccc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0000      00011111224568899999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.1e-40  Score=352.35  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCC--CCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ--HKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~  394 (636)
                      +.|+..+.||+|+||.||++.... +    ..||||++...  .....+.+.+|+.++.+++  ||||+++++++...+.
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-K----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-C----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-C----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            458899999999999999998654 3    78999999754  4455678999999999996  5999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++||| +.+++|.+++...  ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             EEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            999999 5689999999643  47889999999999999999999   89999999999999995 57899999999987


Q ss_pred             ccCCCCc-cccccccCCcccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          475 YQQGEVP-NTTRVVGTLGYLAPELATV-----------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       475 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ....... .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||........   .+.  
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~--  278 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLH--  278 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHH--
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHH--
Confidence            6543321 2334579999999999865           3688899999999999999999999975422211   111  


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                                 ..++......++......+.+|+.+||+.||.+||++.|+++...
T Consensus       279 -----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          279 -----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             -----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             -----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence                       111222222222222456888999999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-40  Score=337.66  Aligned_cols=253  Identities=27%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+++....+    ..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSG----LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCC----ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            46888999999999999999987655    889999997653 3345788899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCc
Q 006668          398 VYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLA  472 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla  472 (636)
                      ||||+++|+|.+++...  ....+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999998542  2367999999999999999999999   7999999999999999   55688999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .......  ......||+.|+|||++. ..++.++||||||+++|||++|+.||.........     ....  ..... 
T Consensus       175 ~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-----~~~~--~~~~~-  243 (285)
T 3is5_A          175 ELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-----QKAT--YKEPN-  243 (285)
T ss_dssp             CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHH--HCCCC-
T ss_pred             eecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-----hhhc--cCCcc-
Confidence            8665432  233457899999999876 56889999999999999999999999754321111     1000  00000 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                             .... .......+.+++.+||+.||++|||+.|+++.-
T Consensus       244 -------~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          244 -------YAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             -------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             -------cccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                   0000 001235677899999999999999999998743

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.5e-40  Score=374.19  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=199.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      +.||+|+||.||+|.+...  ..+..||||+++...  ....+++.+|+.++++++|||||+++++|.. +..++|||||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK--KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS--SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCC--CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            4799999999999976432  234789999998653  3346789999999999999999999999965 5689999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCC--
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV--  480 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~--  480 (636)
                      ++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.......  
T Consensus       452 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          452 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999999953  456899999999999999999999   79999999999999999999999999999987654332  


Q ss_pred             ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          481 PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       481 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......     ...             .+...
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~-------------~i~~~  588 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTA-------------MLEKG  588 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHH-------------HHHTT
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH-------------HHHcC
Confidence            22233456889999999999999999999999999999998 999997553221     111             11111


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .....+...+..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1222333455778999999999999999999999999965

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=346.52  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------HHHHHHHHHHHHhccCCCCceeeeecc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------QGLKEFMAEISSMGRLQHKNLVQMRGW  388 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~  388 (636)
                      ..++|+..+.||+|+||.||+|+....+    +.||+|++.....        ...+.+.+|+.++++++||||++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~   97 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKN----KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI   97 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTT----EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCC----cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3467899999999999999999977665    8999999976521        123456789999999999999999999


Q ss_pred             ccccceEEEEEeecCCC-ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          389 CRKGNELMLVYDYMPNG-SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                      +.+.+..++||||+.+| +|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A           98 FENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             EECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEe
Confidence            99999999999999777 99999853  456999999999999999999999   7899999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      |||+++......  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......              
T Consensus       173 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------  236 (335)
T 3dls_A          173 DFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------  236 (335)
T ss_dssp             CCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred             ecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence            999998765433  2334579999999999988876 78899999999999999999999642100              


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                               .....  ..+......+.+|+.+||+.||++|||+.|+++.-.-
T Consensus       237 ---------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          237 ---------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             ---------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             ---------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                     00000  0111123568889999999999999999999997544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-39  Score=346.23  Aligned_cols=268  Identities=21%  Similarity=0.283  Sum_probs=206.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+++....+    ..||+|++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCC----cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            56888999999999999999987655    89999999876 34456788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||+++++|.+++..  ...+++..+..++.+++.||.|||   +. +|+||||||+|||++.++.+||+|||++....
T Consensus       109 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999999954  346899999999999999999999   54 89999999999999999999999999997553


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH-----------------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL-----------------  539 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l-----------------  539 (636)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............                 
T Consensus       184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            22   2233578999999999999999999999999999999999999997653221111000                 


Q ss_pred             ----HHHHHHHhcCCcchhhhhhhhhhc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          540 ----MDWVRNLYGQGKICEAADARIRQE----FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       540 ----~~~v~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                          ..+...........+..+......    ........+.+|+.+||+.||++|||++|++++-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                000000000011111111111110    11123456889999999999999999999998644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-39  Score=334.21  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=203.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|+....+    ..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNK----FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCC----cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            46888899999999999999987655    899999996542   12246788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            999999999999999854  346899999999999999999999   899999999999999999999999999999765


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...   ......|++.|+|||++.+..++.++||||||+++|||++|+.||........    ...    .. ..     
T Consensus       165 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~----~~-~~-----  227 (284)
T 2vgo_A          165 PSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRR----IV-NV-----  227 (284)
T ss_dssp             SSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHH----HH-TT-----
T ss_pred             ccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHH----Hh-cc-----
Confidence            432   22335789999999999999999999999999999999999999975422111    100    00 00     


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +    ..++......+.+++.+||+.||.+||++.|+++.
T Consensus       228 -~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 -D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence             1    11222234567889999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-40  Score=350.18  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC----hHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS----KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++|+..++||+|+||.||+++... +...++.||||+++...    ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKIS-GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS-STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             cceEEEEEeccCCCEEEEEEEEcc-cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            468889999999999999998743 12334899999987532    12234567799999999 6999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..++||||+++|+|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999954  346899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      .............+||+.|+|||++.+.  .++.++|||||||++|||++|+.||...............    ...   
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~---  280 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----ILK---  280 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH----HHH---
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH----Hhc---
Confidence            7654443344456799999999998863  4788999999999999999999999754322221111111    000   


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAVLVGQ  600 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L~~~  600 (636)
                              ....++......+.+|+.+||..||.+||     ++.|+++.....
T Consensus       281 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          281 --------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             --------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                    01122333446688899999999999999     999999887665

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.7e-40  Score=339.00  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=203.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|...+.||+|+||.||+++....+    +.||+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTG----KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCC----CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            356888999999999999999987655    8999999987655455678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~  474 (636)
                      ||||+++++|.+++..  ...+++.+++.++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++..
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           84 VMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             EECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EEEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            9999999999999853  346899999999999999999999   7899999999999999   7889999999999976


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......    ..... +..    +..  
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~-i~~----~~~--  224 (304)
T 2jam_A          159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFEK-IKE----GYY--  224 (304)
T ss_dssp             CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHH----CCC--
T ss_pred             cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH-HHc----CCC--
Confidence            4432   223356899999999999999999999999999999999999999754221    11111 111    000  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                          .............+.+++.+||+.||++||++.|+++.-
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          225 ----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence                001111122345688999999999999999999999853

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-39  Score=361.26  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=207.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...++||+|+||.||+++.+.++    +.||+|++....   ....+.+.+|+.++++++||||+++++++...+.+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATG----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCC----cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            56888899999999999999987655    899999997542   22346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC--CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          396 MLVYDYMPNGSLNNWIFGKP--KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            99999999999999996543  457999999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+..        
T Consensus       338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~-~~i~~--------  407 (543)
T 3c4z_A          338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRVLE--------  407 (543)
T ss_dssp             ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH-HHHHH--------
T ss_pred             eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH-HHHhh--------
Confidence            7654332 2334589999999999999999999999999999999999999997653221111111 11100        


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVAV  596 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~~  596 (636)
                          .  ...++......+.+|+.+||+.||.+||++     .+|+++
T Consensus       408 ----~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 ----Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ----C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ----c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                0  011222334667889999999999999975     666653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.8e-39  Score=344.90  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=207.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC--------CCceeeeeccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ--------HKNLVQMRGWC  389 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~g~~  389 (636)
                      .++|+..++||+|+||.||+|+...++    +.||+|++... ....+.+.+|+.++++++        |+||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGK----KFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCC----eEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            467999999999999999999877655    89999999754 344567889999999885        78899999998


Q ss_pred             c----ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCC--
Q 006668          390 R----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEM--  462 (636)
Q Consensus       390 ~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~--  462 (636)
                      .    .....++||||+ +++|.+++.......+++.+++.++.||+.||+|||   ++ +|+||||||+|||++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence            7    567899999999 777777776555567999999999999999999999   67 999999999999998775  


Q ss_pred             -----------------------------------------------cEEEeccCCcccccCCCCccccccccCCccccc
Q 006668          463 -----------------------------------------------RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP  495 (636)
Q Consensus       463 -----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP  495 (636)
                                                                     .+||+|||+++.....    .....||+.|+||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP  262 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence                                                           7999999999876432    2335789999999


Q ss_pred             ccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh-HHHHHHHHHHHHhcCCcchhhhh-----------------
Q 006668          496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-EEAVLMDWVRNLYGQGKICEAAD-----------------  557 (636)
Q Consensus       496 E~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~-~~~~l~~~v~~~~~~~~~~~~~d-----------------  557 (636)
                      |++.+..++.++|||||||++|||++|+.||........ ........+..............                 
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            999999999999999999999999999999976543211 01111111111111100000000                 


Q ss_pred             ---------hhh--hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          558 ---------ARI--RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       558 ---------~~l--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                               ..+  ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                     000  113456777889999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.4e-40  Score=344.59  Aligned_cols=270  Identities=24%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+++....+    +.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTG----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTC----CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCC----ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            46888899999999999999987655    89999998654  3334566889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       101 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            99999999999988743  456999999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH------HHHHHhcC
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD------WVRNLYGQ  549 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~------~v~~~~~~  549 (636)
                      .... ......||..|+|||++.+. .++.++|||||||++|||++|+.||...............      .....+..
T Consensus       176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            4322 22335689999999998875 6899999999999999999999999765322211111100      00000000


Q ss_pred             Ccch------hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          550 GKIC------EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       550 ~~~~------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ....      +.................+.+|+.+||+.||++|||+.|+++.-.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            0000      000000000111123567899999999999999999999998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-39  Score=353.70  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=195.6

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeeecc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--------KQGLKEFMAEISSMGRLQHKNLVQMRGW  388 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~g~  388 (636)
                      ..++|...+.||+|+||.||+|....++    +.||+|++....        ......+.+|+.++++++||||++++++
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  208 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTC----KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF  208 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCC----cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4578999999999999999999987765    899999997532        1122357899999999999999999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC---CcEE
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE---MRGR  465 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~---~~~k  465 (636)
                      +.. +..++||||+++|+|.+++.  ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.+   ..+|
T Consensus       209 ~~~-~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          209 FDA-EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             EES-SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             Eec-CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEE
Confidence            854 55899999999999999984  3467999999999999999999999   7899999999999999654   4599


Q ss_pred             EeccCCcccccCCCCccccccccCCcccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          466 LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       466 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      |+|||+++......  .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||............+   
T Consensus       283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---  357 (419)
T 3i6u_A          283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---  357 (419)
T ss_dssp             ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---
T ss_pred             EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---
Confidence            99999998765432  2334679999999998853   567889999999999999999999997543221111111   


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       .    .+...  ..+....    .....+.+++.+||+.||++||++.|+++.-.-.
T Consensus       358 -~----~~~~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          358 -T----SGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             -H----TTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             -h----cCCCC--CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence             0    01100  0001111    2245688899999999999999999999876554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-40  Score=344.12  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             CCCCC-ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          319 KGFSN-DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~-~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      +.|.+ .++||+|+||.||+++....+    +.||||++........+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITS----QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSC----CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCC----cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            45666 378999999999999976555    89999999876555567889999999885 7999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~  473 (636)
                      +||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.   +||+|||++.
T Consensus        88 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            99999999999999954  356899999999999999999999   789999999999999988776   9999999997


Q ss_pred             cccCCC------CccccccccCCcccccccccC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh--------
Q 006668          474 LYQQGE------VPNTTRVVGTLGYLAPELATV-----SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE--------  534 (636)
Q Consensus       474 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~--------  534 (636)
                      ......      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||........        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            654221      112223469999999999875     5578899999999999999999999975432110        


Q ss_pred             --HHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          535 --EEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       535 --~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        ....+...+.    .+...      +...........+.+|+.+||+.||.+|||+.|+++.-.-.
T Consensus       243 ~~~~~~~~~~i~----~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          243 PACQNMLFESIQ----EGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHH----HCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             hhHHHHHHHHHh----ccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence              0011111110    01000      00000011235688999999999999999999999875443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-39  Score=352.55  Aligned_cols=195  Identities=25%  Similarity=0.353  Sum_probs=156.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----  391 (636)
                      .++|+..++||+|+||.||+|+....+    +.||||++...  .....+.+.+|+.++++++||||+++++++..    
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEK----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCC----cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence            357889999999999999999987655    89999999754  44456788999999999999999999999843    


Q ss_pred             -cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                       ...+++||||+ +++|.+++..  ...+++..++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccc
Confidence             35799999998 6899999843  457999999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCC--------------------------ccccccccCCcccccccc-cCCCCCCccchHHHHHHHHHHHhC
Q 006668          471 LAKLYQQGEV--------------------------PNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACG  522 (636)
Q Consensus       471 la~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~ell~G  522 (636)
                      +++.......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            9987643221                          123445789999999975 566799999999999999999994

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.3e-40  Score=345.49  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=200.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+++.+.++    +.||+|++......    ..+|++++.++ +||||+++++++.+.+..+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATN----MEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            456888999999999999999987665    89999999765432    34577788777 7999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC----CcEEEeccCCc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLA  472 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla  472 (636)
                      +||||+++|+|.+++..  ...+++.++..++.||+.||+|||   +.+|+||||||+|||+.++    +.+||+|||++
T Consensus        93 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           93 VVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            99999999999999954  356999999999999999999999   7999999999999998543    35999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      +....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.. +.    .+..
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~-i~----~~~~  240 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILAR-IG----SGKF  240 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHH-HH----HCCC
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHH-Hc----cCCc
Confidence            87654332 2334578999999999988888999999999999999999999997542211 1111111 11    1111


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            .+...........+.+|+.+||+.||++||++.|+++.-
T Consensus       241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence                  011111122345678899999999999999999999753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.3e-40  Score=344.54  Aligned_cols=268  Identities=21%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ...++|+..++||+|+||.||+|+....+    +.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTN----ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTT----EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCC----ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            34567999999999999999999877655    8999999976533  23456789999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE-----cCCCcEEEec
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL-----DSEMRGRLGD  468 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll-----~~~~~~kl~D  468 (636)
                      ..++||||++ |+|.+++...  ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+     +.++.+||+|
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            9999999996 6999998543  46899999999999999999999   7899999999999999     4555699999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      ||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......    .+.......-
T Consensus       181 fg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~  255 (329)
T 3gbz_A          181 FGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLG  255 (329)
T ss_dssp             TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHC
T ss_pred             CCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhC
Confidence            99998765332 223345789999999998875 47999999999999999999999997553221    1111111110


Q ss_pred             cCC-cchhh--------------hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          548 GQG-KICEA--------------ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       548 ~~~-~~~~~--------------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ... .....              ....+...........+.+|+.+||+.||++|||+.|+++.-.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  321 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY  321 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence            000 00000              0000001111113356789999999999999999999998543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=332.52  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC----hHHHHHHHHHHHHhccCCCCceeeeeccc--cc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS----KQGLKEFMAEISSMGRLQHKNLVQMRGWC--RK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~--~~  391 (636)
                      .++|...+.||+|+||.||++.....+    ..||+|++....    ....+.+.+|+.++++++||||+++++++  .+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETL----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE   79 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTC----CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCC----cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            468999999999999999999976655    899999997542    23457789999999999999999999998  45


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                      .+..++||||++++ |.+++.......+++.+++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence            56899999999766 777776655678999999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCC-CccccccccCCcccccccccCCCC--CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          472 AKLYQQGE-VPNTTRVVGTLGYLAPELATVSSP--TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       472 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~--s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +....... ........||+.|+|||++.+...  +.++||||||+++|||++|+.||.......    .. ..+.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~i~----  226 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LF-ENIG----  226 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH-HHHH----
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HH-HHHh----
Confidence            98764322 222234568999999999886543  679999999999999999999997542111    11 1000    


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .+.          ...+......+.+++.+||+.||.+||++.|+++.-.
T Consensus       227 ~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  266 (305)
T 2wtk_C          227 KGS----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW  266 (305)
T ss_dssp             HCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred             cCC----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            000          0112233456788999999999999999999998643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.8e-39  Score=347.64  Aligned_cols=265  Identities=20%  Similarity=0.232  Sum_probs=205.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC------CCCceeeeeccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL------QHKNLVQMRGWCRK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~g~~~~  391 (636)
                      ..+|+..++||+|+||.||+|+....+    +.||||++... ....+++.+|+.+++.+      +|+||+++++++..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~----~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVH----QHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTT----EEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCC----cEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            456889999999999999999987655    89999999764 33345666777777666      57799999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--EEEecc
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--GRLGDF  469 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DF  469 (636)
                      .+..++||||+. ++|.+++.......+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+||
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999995 79999997766667999999999999999999999   789999999999999999887  999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      |+++.....    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .+...+.. ...
T Consensus       247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~----~l~~i~~~-~~~  317 (429)
T 3kvw_A          247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD----QLACMIEL-LGM  317 (429)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHH-HCC
T ss_pred             ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHH-cCC
Confidence            999764432    233578999999999999999999999999999999999999997553221    11111111 100


Q ss_pred             Cc--c-------hhhhhh------------------------------------hhhhccCHHHHHHHHHHHHHccCCCC
Q 006668          550 GK--I-------CEAADA------------------------------------RIRQEFEAEEMELVLKLGLACCHPDS  584 (636)
Q Consensus       550 ~~--~-------~~~~d~------------------------------------~l~~~~~~~~~~~l~~L~~~Cl~~dP  584 (636)
                      ..  +       ...++.                                    .............+.+|+.+||+.||
T Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP  397 (429)
T 3kvw_A          318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP  397 (429)
T ss_dssp             CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred             CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence            00  0       000000                                    00000111124568899999999999


Q ss_pred             CCCCCHHHHHHHHhcC
Q 006668          585 TRRPTMREVVAVLVGQ  600 (636)
Q Consensus       585 ~~RPs~~evl~~L~~~  600 (636)
                      ++|||+.|+++.-.-.
T Consensus       398 ~~Rpta~e~L~Hpw~~  413 (429)
T 3kvw_A          398 AVRMTPGQALRHPWLR  413 (429)
T ss_dssp             TTSCCHHHHHTSTTTC
T ss_pred             hhCCCHHHHhCChhhc
Confidence            9999999999876554

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=342.10  Aligned_cols=254  Identities=19%  Similarity=0.181  Sum_probs=198.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeeecccccc
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ---HKNLVQMRGWCRKG  392 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~  392 (636)
                      ..++|...++||+|+||.||+|..... ....++.||+|++......   ++..|+.++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            456788899999999999999964331 2234488999999876554   4455555555554   99999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcC---CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---------
Q 006668          393 NELMLVYDYMPNGSLNNWIFGK---PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---------  460 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---------  460 (636)
                      +..++|||||++|+|.+++...   ....+++.+++.++.||+.||+|||   +.+|+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            9999999999999999999531   3567999999999999999999999   899999999999999998         


Q ss_pred             --CCcEEEeccCCcccccCC-CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHH
Q 006668          461 --EMRGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA  537 (636)
Q Consensus       461 --~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~  537 (636)
                        ++.+||+|||+++..... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999765422 22234456799999999999999999999999999999999999999854321100   


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRR-PTMREVVAVLVG  599 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-Ps~~evl~~L~~  599 (636)
                                   .    +...+....   ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       294 -------------~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          294 -------------K----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -------------E----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -------------e----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                         0    011111111   24456778889999999998 577877777765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=346.80  Aligned_cols=266  Identities=17%  Similarity=0.202  Sum_probs=202.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCC----CCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceee---------
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNN----NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ---------  384 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~---------  384 (636)
                      .++|...+.||+|+||.||+|+...+..    ..+..||+|++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3578899999999999999999875311    02378999999765     35778999999999999998         


Q ss_pred             ------eeccccc-cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEE
Q 006668          385 ------MRGWCRK-GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL  457 (636)
Q Consensus       385 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIl  457 (636)
                            +++++.. ++..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  4555554 67899999999 999999997654578999999999999999999999   789999999999999


Q ss_pred             EcCCC--cEEEeccCCcccccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006668          458 LDSEM--RGRLGDFGLAKLYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMG  529 (636)
Q Consensus       458 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~  529 (636)
                      ++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999865432211      113347999999999999999999999999999999999999999754


Q ss_pred             CChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          530 KGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       530 ~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .....   .+...........  ....+....   .......+.+++.+||+.||++||++.++++.|+.-
T Consensus       272 ~~~~~---~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          272 LPNTE---DIMKQKQKFVDKP--GPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TTCHH---HHHHHHHHHHHSC--CCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CcCHH---HHHHHHHhccCCh--hhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            32211   1111111111000  000000000   001236688899999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-38  Score=339.23  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=206.5

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--------hHHHHHHHHHHHHhccC-CCCce
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--------KQGLKEFMAEISSMGRL-QHKNL  382 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l-~h~ni  382 (636)
                      .......++|+..+.||+|+||.||+|+...++    +.||||++....        ....+.+.+|+.++.++ +||||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i  162 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI  162 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCC----cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            334555677999999999999999999987655    899999997643        12245678899999999 79999


Q ss_pred             eeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       383 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +++++++...+..++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++
T Consensus       163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             CCEEEEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred             eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999999999999953  356999999999999999999999   78999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccC------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE  536 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~  536 (636)
                      .+||+|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......    
T Consensus       238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----  311 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----  311 (365)
T ss_dssp             CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred             CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----
Confidence            99999999998765433  2334679999999998863      35788999999999999999999999654211    


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+ ..+..    +....  ......    .....+.+++.+||+.||++||++.|+++.-
T Consensus       312 ~~~-~~i~~----~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          312 LML-RMIME----GQYQF--SSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             HHH-HHHHH----TCCCC--CHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHH-HHHHh----CCCCC--CCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            111 11110    00000  000001    1235688899999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.4e-40  Score=338.51  Aligned_cols=266  Identities=26%  Similarity=0.373  Sum_probs=188.7

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ..++|+..+.||+|+||.||+|.....+    +.||+|++.... ....+++.+|+.++++++||||+++++++...+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKK----EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC--------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCC----cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3568999999999999999999876554    789999987543 33456788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhc------CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          396 MLVYDYMPNGSLNNWIFG------KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      ++||||+++++|.+++..      .....+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEec
Confidence            999999999999999853      13456999999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCC----ccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          470 GLAKLYQQGEV----PNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       470 Gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      |++........    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........    ....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~  241 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----LTLQ  241 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----HHHT
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH----HHhc
Confidence            99976543221    11233568999999998876 568999999999999999999999997653222111    1000


Q ss_pred             HHhcCCcch-hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          545 NLYGQGKIC-EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       545 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .  ...... ...+.....    .....+.+++.+||+.||.+||++.|+++.-.-
T Consensus       242 ~--~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          242 N--DPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             S--SCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred             c--CCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            0  000000 001111111    223568889999999999999999999986433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=339.70  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=196.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH-HHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|...+.||+|+||.||+|+...++    +.||+|++....... ...+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCC----cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            46888999999999999999987655    899999997653322 1245579999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||++ |+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           78 VFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             Eecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            999996 6999988543 456899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC---cch
Q 006668          478 GEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG---KIC  553 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~---~~~  553 (636)
                      .. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........    + ..+.......   ...
T Consensus       153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~-~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          153 PT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----L-HFIFRILGTPTEETWP  226 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H-HHHHHHHCCCCTTTST
T ss_pred             Cc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHHHhCCCChHhch
Confidence            22 22233578999999998876 5689999999999999999999999976532211    1 1111111110   000


Q ss_pred             hhhhhh------h-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          554 EAADAR------I-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       554 ~~~d~~------l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ......      .       ...........+.+|+.+||+.||++|||++|+++.-.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  284 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF  284 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence            000000      0       00011122356789999999999999999999998644

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-39  Score=330.66  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=196.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|...+.||+|+||.||+|+....+    +.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTG----HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCC----ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            56888999999999999999987655    899999997542   22346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        87 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999999954  346899999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .....  .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......     ....+..    +.   
T Consensus       162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~---  227 (276)
T 2h6d_A          162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFKKIRG----GV---  227 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CC---
T ss_pred             CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHhhc----Cc---
Confidence            54322  223468999999999988765 579999999999999999999997542111     1111110    00   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                             ...+......+.+++.+||+.||++||++.|+++.-.
T Consensus       228 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          228 -------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             -------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence                   0112223456888999999999999999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-40  Score=354.72  Aligned_cols=243  Identities=16%  Similarity=0.143  Sum_probs=189.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHH---HHhccCCCCceeeeec----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEI---SSMGRLQHKNLVQMRG----  387 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~g----  387 (636)
                      .++|...+.||+|+||.||+|+...++    +.||||++...   .....+.+.+|+   +.+++++||||+++++    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETG----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCC----CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCC----cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            456888899999999999999986655    89999999743   344567888999   6666778999999984    


Q ss_pred             ---cccccc-----------------eEEEEEeecCCCChhhhHhcC-----CCCCcChHHHHHHHHHHHHHHHHHhccC
Q 006668          388 ---WCRKGN-----------------ELMLVYDYMPNGSLNNWIFGK-----PKKLLGWKQRRQILADVAEGLNYLHHGW  442 (636)
Q Consensus       388 ---~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~  442 (636)
                         ++...+                 ..++||||+ +|+|.+++...     ....+++..++.|+.||+.||+|||   
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---  223 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---  223 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence               444332                 278999999 78999999542     1234556889999999999999999   


Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCC-----------CCCCccchHH
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-----------SPTSASDVYS  511 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~S  511 (636)
                      +.+|+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||
T Consensus       224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence            78999999999999999999999999999985332    2334567 999999999887           8999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006668          512 FGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR  591 (636)
Q Consensus       512 ~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  591 (636)
                      |||++|||++|+.||.......                  ....+... ..    ..+..+.+|+.+||+.||++||++.
T Consensus       299 lG~il~elltg~~Pf~~~~~~~------------------~~~~~~~~-~~----~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDAALG------------------GSEWIFRS-CK----NIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             HHHHHHHHHHSSCCC------C------------------CSGGGGSS-CC----CCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             HHHHHHHHHHCCCCCccccccc------------------chhhhhhh-cc----CCCHHHHHHHHHHcCCCchhCCCHH
Confidence            9999999999999996432111                  00000000 01    2235688899999999999999999


Q ss_pred             HHHHH
Q 006668          592 EVVAV  596 (636)
Q Consensus       592 evl~~  596 (636)
                      |+++.
T Consensus       356 e~l~h  360 (377)
T 3byv_A          356 QAMET  360 (377)
T ss_dssp             HHHTS
T ss_pred             HHhhC
Confidence            99974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1e-38  Score=334.20  Aligned_cols=260  Identities=21%  Similarity=0.299  Sum_probs=202.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccc--cceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRK--GNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~  395 (636)
                      ++|+..+.||+|+||.||+|+....+    +.||+|++.....   +.+.+|+.++++++ ||||+++++++..  ....
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCC----cEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            56888999999999999999976655    8999999976543   56788999999997 9999999999987  6678


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~  474 (636)
                      ++||||+++++|.+++.     .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            99999999999999872     4889999999999999999999   79999999999999999776 899999999987


Q ss_pred             ccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ......  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||................    .....+.
T Consensus       181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~----~~~~~~~  254 (330)
T 3nsz_A          181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV----LGTEDLY  254 (330)
T ss_dssp             CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH----HCHHHHH
T ss_pred             cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh----cCCchhh
Confidence            654332  233578999999999877 678999999999999999999999996554332221111110    0000000


Q ss_pred             hhhhh-----------------------hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          554 EAADA-----------------------RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       554 ~~~d~-----------------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      +.++.                       .............+.+|+.+||+.||++|||++|+++.-.-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            00000                       00001111134678899999999999999999999986543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-39  Score=339.32  Aligned_cols=271  Identities=24%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-----HHHHHHHHHHHhccCCCCceeeeecccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-----GLKEFMAEISSMGRLQHKNLVQMRGWCR  390 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~  390 (636)
                      ...++|+..+.||+|+||.||+|+...++    +.||+|++......     ..+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCC----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCC----cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence            34578999999999999999999987655    88999999754221     1246789999999999999999999999


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                      ..+..++||||+++ +|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence            99999999999965 898888543 457899999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      +++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.......    .+..........
T Consensus       158 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~  232 (346)
T 1ua2_A          158 LAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTP  232 (346)
T ss_dssp             GGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC
T ss_pred             cceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCC
Confidence            998765432 223345789999999998764 47889999999999999999999987553221    111111111000


Q ss_pred             C--cc---hhhhhh---hhh-----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          550 G--KI---CEAADA---RIR-----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       550 ~--~~---~~~~d~---~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .  ..   ....+.   ...     ..........+.+|+.+||+.||++|||+.|++++-.-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence            0  00   000000   000     001122346788999999999999999999999986544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.6e-39  Score=353.93  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=204.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC-CceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH-KNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~  396 (636)
                      .++|++.++||+|+||.||+|+....+    +.||||++......  .++..|+++++.++| +++..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTC----CEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCC----cEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            467899999999999999999976655    89999998765332  357789999999987 55666666677788899


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~  473 (636)
                      |||||+ +++|.+++... ...+++.+++.|+.||+.||+|||   +.+|+||||||+||||   +.++.+||+|||+++
T Consensus        80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999999 99999998532 456999999999999999999999   7999999999999999   689999999999998


Q ss_pred             cccCCCCc------cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          474 LYQQGEVP------NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       474 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      ........      ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-HHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-HHHHHhhccc
Confidence            76543321      2234679999999999999999999999999999999999999997654322211 1111111100


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .     .     .........+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       234 ~-----~-----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          234 A-----T-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             H-----S-----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             c-----c-----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            0     0     0001111224578899999999999999999999998865

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-39  Score=330.82  Aligned_cols=256  Identities=26%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---------hHHHHHHHHHHHHhccCC-CCceeeee
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---------KQGLKEFMAEISSMGRLQ-HKNLVQMR  386 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~  386 (636)
                      ..++|+..+.||+|+||.||+|+....+    +.||+|++....         ....+.+.+|+.++++++ ||||++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcC----ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            4568899999999999999999987655    899999997543         123456789999999996 99999999


Q ss_pred             ccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEE
Q 006668          387 GWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRL  466 (636)
Q Consensus       387 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  466 (636)
                      +++...+..++||||+++++|.+++..  ...+++.+++.++.||+.||+|||   +.+++||||||+||+++.++.+||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEE
Confidence            999999999999999999999999954  357899999999999999999999   799999999999999999999999


Q ss_pred             eccCCcccccCCCCccccccccCCccccccccc------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT------VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~  540 (636)
                      +|||++.......  ......|++.|+|||++.      ...++.++||||||+++|||++|+.||.......    ...
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~  239 (298)
T 1phk_A          166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLR  239 (298)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred             ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHH
Confidence            9999998765433  233457899999999875      4567889999999999999999999997542111    111


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      . +..    +...      ............+.+++.+||+.||++||++.|+++.-.
T Consensus       240 ~-~~~----~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          240 M-IMS----GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             H-HHH----TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             H-Hhc----CCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            1 100    0000      000001123456889999999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-38  Score=339.29  Aligned_cols=267  Identities=22%  Similarity=0.225  Sum_probs=196.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc--
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--  393 (636)
                      .++|+..+.||+|+||.||+|.....+    +.||||++...  .....+.+.+|+.+++.++||||+++++++...+  
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCC----ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            467889999999999999999976655    89999999764  3445677889999999999999999999987654  


Q ss_pred             ----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          394 ----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       394 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                          ..++||||++ ++|.+++.    ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEe
Confidence                7899999995 68888883    35899999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-------H-
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM-------D-  541 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~-------~-  541 (636)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............       + 
T Consensus       172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998654322  23345789999999999999999999999999999999999999976532211111100       0 


Q ss_pred             ------HHHHHhcCC-----cchhhhhhhhh----hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          542 ------WVRNLYGQG-----KICEAADARIR----QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       542 ------~v~~~~~~~-----~~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                            .+.......     ...+...+...    .+........+.+|+.+||+.||.+|||++|+++.-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence                  000000000     00000000000    0111233567899999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-39  Score=332.25  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=188.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hH-HHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQ-GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||+++....+    +.||+|++.... .. ..+.+.++...++.++||||+++++++.+.+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSG----QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCC----eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            356888999999999999999986655    899999997652 22 233445555668889999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      ++||||++ |+|.+++..  .....+++.+++.++.|++.||+|||   +. +++||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999996 688887743  23567999999999999999999999   66 9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccc----cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELA----TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +.......  .....||+.|+|||++    .+..++.++||||||+++|||++|+.||........   .+...+.    
T Consensus       158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~----  228 (290)
T 3fme_A          158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQVVE----  228 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---HHHHHHH----
T ss_pred             cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---HHHHHhc----
Confidence            87654322  2234689999999995    566788999999999999999999999975422211   1111111    


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .         .............+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          229 E---------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             S---------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             c---------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            0         01111111234568899999999999999999999884

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-39  Score=340.16  Aligned_cols=263  Identities=21%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|...+.||+|+||.||+|+....+    +.||+|++...  .....+.+.+|+.++++++||||+++++++...   
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTC----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCC----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence            457888999999999999999987655    89999999653  344457789999999999999999999998765   


Q ss_pred             ---ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          393 ---NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       393 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                         ..+++||||+ +++|.+++..   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEee
Confidence               3469999999 8999999853   46899999999999999999999   799999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |+++.....    .+...+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...........+.     ....
T Consensus       173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~-----~~~g  243 (367)
T 1cm8_A          173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM-----KVTG  243 (367)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HHHC
T ss_pred             ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----HhcC
Confidence            999875432    334578999999998877 678999999999999999999999997553221111111     1000


Q ss_pred             CCc--chhh--------hhhhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGK--ICEA--------ADARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~--~~~~--------~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...  ....        .-..+       ...........+.+|+.+||+.||.+|||+.|++++-.-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence            000  0000        00000       0011122346688899999999999999999999975433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=341.01  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=201.5

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeec
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRG  387 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g  387 (636)
                      +.+.++....++|+..+.||+|+||.||+|+....+    +.||+|++..... ..+++.+|+.+++++ +||||+++++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCC----CeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeee
Confidence            334445556788999999999999999999986655    8999999976533 236788999999998 7999999999


Q ss_pred             cccc------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC
Q 006668          388 WCRK------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE  461 (636)
Q Consensus       388 ~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~  461 (636)
                      ++..      .+..++||||+++|+|.+++.......+++..++.++.||+.||+|||   +.+|+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTT
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCC
Confidence            9876      467899999999999999997655567999999999999999999999   7899999999999999999


Q ss_pred             CcEEEeccCCcccccCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH
Q 006668          462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE  536 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~  536 (636)
                      +.+||+|||++....... .......||+.|+|||++.     +..++.++|||||||++|||++|+.||.......   
T Consensus       166 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---  241 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---  241 (326)
T ss_dssp             CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred             CCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---
Confidence            999999999998654322 1223357899999999987     5678899999999999999999999996542111   


Q ss_pred             HHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          537 AVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       537 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       .......    . .        ............+.+++.+||+.||.+||++.++++.-
T Consensus       242 -~~~~~~~----~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          242 -ALFLIPR----N-P--------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             -HHHHHHH----S-C--------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             -HHHHhhc----C-c--------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence             1111000    0 0        00001112235688899999999999999999999853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.9e-39  Score=335.88  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=198.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeeeccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--------KQGLKEFMAEISSMGRLQHKNLVQMRGWC  389 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~  389 (636)
                      .++|...+.||+|+||.||+|+....+    +.||||++....        ......+.+|+.++++++||||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTC----KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCC----cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            456889999999999999999987655    899999997542        12234578999999999999999999998


Q ss_pred             cccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EEE
Q 006668          390 RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRL  466 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl  466 (636)
                      ...+ .++||||+++++|.+++.  ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.   +||
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             cCCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence            7655 899999999999999984  3457999999999999999999999   799999999999999987654   999


Q ss_pred             eccCCcccccCCCCccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWV  543 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v  543 (636)
                      +|||+++......  ......||+.|+|||++.   ...++.++|||||||++|||++|+.||............    +
T Consensus       159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~  232 (322)
T 2ycf_A          159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----I  232 (322)
T ss_dssp             CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH----H
T ss_pred             ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH----H
Confidence            9999998764322  223457899999999864   567889999999999999999999999754322111111    1


Q ss_pred             HHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          544 RNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       544 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..    +...  ..+....    .....+.+++.+||+.||++||++.|+++.-.
T Consensus       233 ~~----~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~  277 (322)
T 2ycf_A          233 TS----GKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHPW  277 (322)
T ss_dssp             HH----TCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             Hh----Cccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence            10    0000  0011111    22456889999999999999999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.6e-39  Score=356.35  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .+.|+..+.||+|+||.||+|+....+    ..||+|++....  ......+.+|+.+++.++||||++++++|.+.+..
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTH----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTC----CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCC----cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            345888999999999999999987655    889999997652  23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla  472 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       112 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            999999999999998853  356899999999999999999999   799999999999999976   455999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      +......  .....+||+.|+|||++. ..++.++|||||||++|||++|+.||......    ..+......     ..
T Consensus       187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~-----~~  254 (494)
T 3lij_A          187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKG-----KY  254 (494)
T ss_dssp             EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHT-----CC
T ss_pred             eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhC-----CC
Confidence            8765433  233457999999999886 56899999999999999999999999754321    111111110     00


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .  .+.....    .....+.+++.+||+.||.+|||+.|+++.
T Consensus       255 ~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 T--FDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C--CCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C--CCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0  0000011    223567889999999999999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-39  Score=334.75  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=198.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|++.... .....||+|+++..   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPS-GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT-SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCC-CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            46888999999999999999865422 22357999998754   3345678899999999999999999999998755 8


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|+||+++++|.+++... ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999999999543 356899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ......  ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.......    .. .   .....+  
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~-~---~~~~~~--  241 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----IL-H---KIDKEG--  241 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HH-H---HHHTSC--
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH----HH-H---HHHccC--
Confidence            543321  1223457889999999998888999999999999999999 999997553211    11 1   111110  


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                             .........+..+.+++.+||+.||++||++.++++.|+..
T Consensus       242 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          242 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence                   01111223446788999999999999999999999999765

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-38  Score=343.05  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=168.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|...+.||+|+||.||+|+...++    +.||||++...  .....+.+.+|+.++++++|+||+++++++...   
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTE----KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCC----cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence            467889999999999999999987665    89999999764  344567889999999999999999999998766   


Q ss_pred             --ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          393 --NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       393 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                        +.+++||||+. ++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence              57999999995 699999943  456999999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCC---------------------ccccccccCCcccccccc-cCCCCCCccchHHHHHHHHHHHhCCCCC
Q 006668          471 LAKLYQQGEV---------------------PNTTRVVGTLGYLAPELA-TVSSPTSASDVYSFGVVILEVACGRRPL  526 (636)
Q Consensus       471 la~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~ell~G~~Pf  526 (636)
                      +++.......                     ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9987654321                     123556899999999985 5667999999999999999999864444

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-39  Score=356.91  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=205.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      .++|+..++||+|+||.||+++....+    ..||||++....   ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCC----CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            346888999999999999999987655    899999996542   3345778999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE---cCCCcEEEeccCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL---DSEMRGRLGDFGL  471 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGl  471 (636)
                      .++||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+
T Consensus       101 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999999999854  456999999999999999999999   7899999999999999   5678999999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      ++......  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......    ..+.. +.    .+.
T Consensus       176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~-i~----~~~  243 (484)
T 3nyv_A          176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKK-VE----KGK  243 (484)
T ss_dssp             HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HH----HCC
T ss_pred             eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHH-HH----cCC
Confidence            98765433  2334579999999999876 6899999999999999999999999754221    11111 11    111


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ...      ...........+.+++.+||+.||.+|||+.|++++-.
T Consensus       244 ~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          244 YTF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             CCC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             CCC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence            100      00001122356788999999999999999999997643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-39  Score=355.58  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-------------HHHHHHHHHHHHhccCCCCcee
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-------------QGLKEFMAEISSMGRLQHKNLV  383 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv  383 (636)
                      ..++|...++||+|+||.||+|+...++    ..||+|++.....             ...+.+.+|+.++++++||||+
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGH----SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTC----CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCC----cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            4567889999999999999999987765    8999999976421             2346788999999999999999


Q ss_pred             eeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-
Q 006668          384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-  462 (636)
Q Consensus       384 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-  462 (636)
                      ++++++.+.+..++|||||++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++ 
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence            999999999999999999999999999854  356999999999999999999999   79999999999999998776 


Q ss_pred             --cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 006668          463 --RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       463 --~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~  540 (636)
                        .+||+|||+++......  ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.......    .+.
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~  257 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIK  257 (504)
T ss_dssp             CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred             CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence              69999999998765432  233457999999999987 468999999999999999999999997543211    111


Q ss_pred             HHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          541 DWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       541 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      . +.    .+....  +......    ....+.+|+.+||+.||.+|||+.|+++.-
T Consensus       258 ~-i~----~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          258 K-VE----KGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             H-HH----HCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             H-HH----cCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            1 11    111100  0000111    235688899999999999999999999764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-39  Score=344.31  Aligned_cols=264  Identities=21%  Similarity=0.280  Sum_probs=199.3

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc---
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK---  391 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~---  391 (636)
                      ....++|+..+.||+|+||.||+|+...++    +.||+|++......    ..+|+.+++.++||||+++++++..   
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~----~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~   74 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESG----KRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGD   74 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTC----CEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCC----CEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCc
Confidence            345678999999999999999999987665    89999999765322    2369999999999999999998843   


Q ss_pred             -----------------------------------cceEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHH
Q 006668          392 -----------------------------------GNELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEG  434 (636)
Q Consensus       392 -----------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~  434 (636)
                                                         ...+++||||++ |+|.+.+..  .....+++..++.++.||+.|
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence                                               334889999997 688877743  335679999999999999999


Q ss_pred             HHHHhccCCCcEEeCCCCCCCEEEc-CCCcEEEeccCCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHH
Q 006668          435 LNYLHHGWDQVVVHRDIKSGNILLD-SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSF  512 (636)
Q Consensus       435 L~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~  512 (636)
                      |+|||   +.+|+||||||+|||++ .++.+||+|||+++......  ......+|..|+|||++.+. .++.++|||||
T Consensus       154 L~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          154 VGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             HHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            99999   89999999999999998 68899999999998765433  22335789999999988765 48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh---------------hhhhhhccCHHHHHHHHHHHH
Q 006668          513 GVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA---------------DARIRQEFEAEEMELVLKLGL  577 (636)
Q Consensus       513 Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~L~~  577 (636)
                      ||++|||++|+.||.......    .+...+.. ..........               .......++......+.+|+.
T Consensus       229 G~il~ell~g~~pf~~~~~~~----~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSID----QLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHH----HHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCChHH----HHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999997653222    12221111 1111000000               001111122334566889999


Q ss_pred             HccCCCCCCCCCHHHHHHHH
Q 006668          578 ACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       578 ~Cl~~dP~~RPs~~evl~~L  597 (636)
                      +||+.||++|||+.|++++-
T Consensus       304 ~~L~~dP~~R~t~~e~l~hp  323 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMAHP  323 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHTSG
T ss_pred             HHccCChhhCCCHHHHhcCH
Confidence            99999999999999998653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-39  Score=335.79  Aligned_cols=258  Identities=21%  Similarity=0.349  Sum_probs=201.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|++.+.||+|+||.||+|+....+    ..||+|++........+.+.+|+.++++++||||+++++++...+..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTC----CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCC----cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            457888999999999999999987655    8999999987766667889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++++|.+++... ...+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999998542 356899999999999999999999   78999999999999999999999999998764321


Q ss_pred             CCCccccccccCCcccccccc-----cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          478 GEVPNTTRVVGTLGYLAPELA-----TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .. .......||..|+|||++     ....++.++||||||+++|||++|+.||.......    ........    .. 
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~----~~-  239 (302)
T 2j7t_A          170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKS----DP-  239 (302)
T ss_dssp             HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHS----CC-
T ss_pred             cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHHHhcc----CC-
Confidence            11 112234689999999987     46678899999999999999999999997543211    11111110    00 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           +.  ...+......+.+++.+||+.||++|||+.++++.-.-.
T Consensus       240 -----~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          240 -----PT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             -----CC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             -----cc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence                 00  001112235688899999999999999999999865444

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-39  Score=342.80  Aligned_cols=263  Identities=17%  Similarity=0.263  Sum_probs=206.6

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH-----------------HHHHHHHHHHHhccCCCC
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ-----------------GLKEFMAEISSMGRLQHK  380 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~h~  380 (636)
                      .++|...+.||+|+||.||+|+.  .+    ..||+|++......                 ..+.+.+|+.++++++||
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DN----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TT----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CC----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            35788999999999999999998  23    89999999754211                 127789999999999999


Q ss_pred             ceeeeeccccccceEEEEEeecCCCChhhh------HhcCCCCCcChHHHHHHHHHHHHHHHHHhccCC-CcEEeCCCCC
Q 006668          381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNW------IFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD-QVVVHRDIKS  453 (636)
Q Consensus       381 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp  453 (636)
                      ||+++++++.+.+..++||||+++|+|.++      +.......+++..++.++.||+.||.|||   + .+++||||||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p  180 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKP  180 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCG
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCCh
Confidence            999999999999999999999999999999      64444678999999999999999999999   6 9999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCC
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTS-ASDVYSFGVVILEVACGRRPLDMGKG  531 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~S~Gvll~ell~G~~Pf~~~~~  531 (636)
                      +||+++.++.+||+|||++......   ......||..|+|||++.+. .++. ++||||||+++|||++|+.||.....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999999876443   23345789999999999887 5655 99999999999999999999976543


Q ss_pred             hhhHHHHHHHHHHHHhcCCcchhhh---------hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          532 EEEEEAVLMDWVRNLYGQGKICEAA---------DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       532 ~~~~~~~l~~~v~~~~~~~~~~~~~---------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...    +...+    ..+......         ...............+.+++.+||+.||.+||++.|+++.-.-.
T Consensus       258 ~~~----~~~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          258 LVE----LFNNI----RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             SHH----HHHHH----TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHH----HHHHH----hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            211    11111    111110000         00000001123346788999999999999999999999865444

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-39  Score=355.48  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=201.9

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|++.++||+|+||.||+++....+    ..||+|++...  .......+.+|+.++++++||||+++++++.+.+.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTC----CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCC----CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            356888999999999999999987655    89999998643  222356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla  472 (636)
                      ++||||+++|+|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            999999999999998854  356999999999999999999999   79999999999999995   4567999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      +......  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......    ..+.....     +..
T Consensus       172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~-----~~~  239 (486)
T 3mwu_A          172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVET-----GKY  239 (486)
T ss_dssp             TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-----TCC
T ss_pred             eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh-----CCC
Confidence            8765432  2334579999999999875 5899999999999999999999999754221    11111111     110


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..  +.....    .....+.+++.+||+.||.+|||+.|+++.-
T Consensus       240 ~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          240 AF--DLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             CS--CSGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             CC--CCcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            00  000011    2235678899999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-39  Score=368.17  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=205.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      .++|+..++||+|+||.||+++....+    +.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTD----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSC----CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCC----cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            467899999999999999999987765    88999999754   223346678899999988 7999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      .++|||||+++|+|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999999954  356999999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+        .. +.  
T Consensus       491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~-~~--  558 (674)
T 3pfq_A          491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------ME-HN--  558 (674)
T ss_dssp             ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HS-SC--
T ss_pred             ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--------Hh-CC--
Confidence            643322 2344568999999999999999999999999999999999999999754322111111        00 00  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM-----REVVAV  596 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~~  596 (636)
                              ..++......+.+|+.+||+.||++||++     +||+++
T Consensus       559 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                    11222334568889999999999999998     777754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=329.40  Aligned_cols=268  Identities=22%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccc-------
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCR-------  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-------  390 (636)
                      .++|...+.||+|+||.||+|+....+    +.||+|++........+++.+|+.++++++||||+++++++.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCD----KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTT----EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCC----eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            357888999999999999999987655    899999998877777888999999999999999999998763       


Q ss_pred             -------ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCC
Q 006668          391 -------KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEM  462 (636)
Q Consensus       391 -------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~  462 (636)
                             +.+..++||||++ |+|.+++.   ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++ +++
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence                   4467899999996 79999983   356899999999999999999999   79999999999999997 567


Q ss_pred             cEEEeccCCcccccCCCC--ccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEV--PNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL  539 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l  539 (636)
                      .+||+|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||.............
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999987643211  12233467999999998765 678999999999999999999999997653222111111


Q ss_pred             HH-------HHHHHhcCCcchhhhhhhhh------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          540 MD-------WVRNLYGQGKICEAADARIR------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       540 ~~-------~v~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..       .......  .+.........      ..........+.+++.+||+.||++|||+.|+++.-.
T Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLS--VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHSCCCCHHHHHHHHT--TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HhcCCCchhhhhhhhh--cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            00       0000000  00000000000      0111123467889999999999999999999998643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=331.23  Aligned_cols=254  Identities=27%  Similarity=0.382  Sum_probs=201.2

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ..+.|+..+.||+|+||.||+|+....+    ..||+|.+.....  .+++.+|+.++++++||||+++++++...+..+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETG----QIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTC----CEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCC----CEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            3467889999999999999999987655    8999999976532  367889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++++|.+++.. ....+++.+++.++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       101 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            99999999999999853 2457899999999999999999999   7999999999999999999999999999998665


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.......    .... +.. ...       
T Consensus       177 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~-~~~-------  242 (314)
T 3com_A          177 DTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----AIFM-IPT-NPP-------  242 (314)
T ss_dssp             TTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH-HHH-SCC-------
T ss_pred             hhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-Hhc-CCC-------
Confidence            432 22334578999999999999999999999999999999999999997542111    1100 000 000       


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                       +..  ..+......+.+++.+||+.||.+||++.++++.-
T Consensus       243 -~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          243 -PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             -CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             -ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence             000  01112235688899999999999999999999754

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.9e-39  Score=329.47  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc------
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK------  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------  391 (636)
                      .++|+..+.||+|+||.||+|+...++    +.||+|++... ....+.+.+|+.++++++||||+++++++.+      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDS----RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCC----eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            456888999999999999999976655    89999999653 3456788999999999999999999998754      


Q ss_pred             -------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          392 -------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       392 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                             .+..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence                   46789999999999999999643 356788999999999999999999   7899999999999999999999


Q ss_pred             EEeccCCcccccCCC-------------CccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          465 RLGDFGLAKLYQQGE-------------VPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       465 kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      ||+|||++.......             ........||+.|+|||++.+. .++.++||||||+++|||++   ||... 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-  231 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-  231 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-
Confidence            999999998654321             1122345689999999998764 68999999999999999998   55422 


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                         .........+..          ....+...++......+.+++.+||+.||.+|||+.++++.-.-.
T Consensus       232 ---~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          232 ---MERVNILKKLRS----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             ---HHHHHHHHHHHS----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             ---hhHHHHHHhccc----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence               111111111110          111222334445556788999999999999999999999876544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.8e-38  Score=334.36  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=205.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeecccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG----  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----  392 (636)
                      .++|+..+.||+|+||.||+++....+    ..||+|++... .....+.+.+|++++.+++||||+++++++...    
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNK----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCC----eEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            467899999999999999999976655    89999999754 344457889999999999999999999998654    


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       ...++||||+. |+|.+++..   ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence             46899999995 699999843   46999999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCc--cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          472 AKLYQQGEVP--NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       472 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ++........  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............     ....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-----~~~~  249 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL-----GILG  249 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH-----HHHC
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-----HHhC
Confidence            9866543221  1234579999999998654 458999999999999999999999997654332222211     1111


Q ss_pred             CCcchhhhh-------h----hh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGKICEAAD-------A----RI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~~~~~~d-------~----~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .... +...       .    .+       ...........+.+|+.+||+.||++|||+.|+++.-.-.
T Consensus       250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          250 SPSQ-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             SCCH-HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             CCCH-HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            0000 0000       0    00       0001112235688999999999999999999999875544

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.9e-39  Score=366.35  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..+.||+|+||.||+|++...+ .....||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPE-NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSS-SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCC-CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            456778899999999999999986532 23478999998765 34445788999999999999999999999854 5689


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+++|+|.+++... ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999643 346899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...........+|+.|+|||++.+..++.++||||||+++|||++ |..||.......     ....+..          
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~~----------  607 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIEN----------  607 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHH----------
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHc----------
Confidence            544333444567889999999999999999999999999999997 999997543211     1111111          


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         ......+...+..+.+++.+||+.||.+||++.|+++.|+.
T Consensus       608 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          608 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               11112233345678899999999999999999999999965

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.2e-38  Score=329.06  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=205.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeec-CCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCC------ceeeeecccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLA-NNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK------NLVQMRGWCR  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~------niv~l~g~~~  390 (636)
                      .++|++.+.||+|+||.||++... ..+    +.||+|++... ....+.+.+|+.+++.++|+      +++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGG----RHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCC----cEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            457889999999999999999873 233    89999999754 34456788899999888765      4999999999


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC----------
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS----------  460 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~----------  460 (636)
                      ..+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999 999999997666567999999999999999999999   789999999999999987          


Q ss_pred             ---------CCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 006668          461 ---------EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKG  531 (636)
Q Consensus       461 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~  531 (636)
                               ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     678999999999865432    2335789999999999999999999999999999999999999975532


Q ss_pred             hhhHHHHHHHHHHHHhcCCcc--h-----------------------hhh---hhhh--hhccCHHHHHHHHHHHHHccC
Q 006668          532 EEEEEAVLMDWVRNLYGQGKI--C-----------------------EAA---DARI--RQEFEAEEMELVLKLGLACCH  581 (636)
Q Consensus       532 ~~~~~~~l~~~v~~~~~~~~~--~-----------------------~~~---d~~l--~~~~~~~~~~~l~~L~~~Cl~  581 (636)
                      .... ..+    ......-..  .                       ...   ...+  ...........+.+|+.+||+
T Consensus       240 ~~~~-~~~----~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          240 KEHL-AMM----ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             HHHH-HHH----HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             HHHH-HHH----HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            2111 111    111110000  0                       000   0000  011233456789999999999


Q ss_pred             CCCCCCCCHHHHHHHH
Q 006668          582 PDSTRRPTMREVVAVL  597 (636)
Q Consensus       582 ~dP~~RPs~~evl~~L  597 (636)
                      .||.+|||+.|+++.-
T Consensus       315 ~dP~~Rpt~~ell~hp  330 (339)
T 1z57_A          315 YDPAKRITLREALKHP  330 (339)
T ss_dssp             SSTTTSCCHHHHTTSG
T ss_pred             cCcccccCHHHHhcCH
Confidence            9999999999998753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-38  Score=336.51  Aligned_cols=274  Identities=23%  Similarity=0.277  Sum_probs=203.6

Q ss_pred             CHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-----------ChHHHHHHHHHHHHhccCC
Q 006668          310 SYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-----------SKQGLKEFMAEISSMGRLQ  378 (636)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~Ei~~l~~l~  378 (636)
                      ...++....++|...+.||+|+||.||+|....     +..||||++...           .....+.+.+|+.++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   87 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH   87 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC
Confidence            356788889999999999999999999998654     288999998643           1223478899999999999


Q ss_pred             CCceeeeecccc-----ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCC
Q 006668          379 HKNLVQMRGWCR-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKS  453 (636)
Q Consensus       379 h~niv~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp  453 (636)
                      ||||+++++++.     ....+++||||++ |+|.+++... ...+++.+++.++.||+.||.|||   +.+|+||||||
T Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  162 (362)
T 3pg1_A           88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHP  162 (362)
T ss_dssp             CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred             CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCCh
Confidence            999999999983     3446899999996 7888888643 457999999999999999999999   78999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          454 GNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       454 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                      +|||++.++.+||+|||+++......  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             GGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999997544322  2334578999999998877 67899999999999999999999999765322


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhh-----------h-------hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAA-----------D-------ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV  594 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~-----------d-------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  594 (636)
                      .....     +.............           .       ..............+.+|+.+||+.||++|||+.|++
T Consensus       241 ~~~~~-----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          241 NQLNK-----IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             HHHHH-----HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHH-----HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            21111     11111111111000           0       0000111122345688999999999999999999999


Q ss_pred             HHHhcC
Q 006668          595 AVLVGQ  600 (636)
Q Consensus       595 ~~L~~~  600 (636)
                      +.-.-.
T Consensus       316 ~hp~f~  321 (362)
T 3pg1_A          316 RHPYFE  321 (362)
T ss_dssp             TSGGGT
T ss_pred             cCchhh
Confidence            886655

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-38  Score=337.05  Aligned_cols=276  Identities=20%  Similarity=0.270  Sum_probs=204.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccc-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRK-----  391 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----  391 (636)
                      ++|+..+.||+|+||.||+|+....+    +.||+|++.....  .....+.+|+.++++++||||+++++++..     
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTC----CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCC----CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            56888999999999999999987655    8999999865422  224567899999999999999999999876     


Q ss_pred             ---cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          392 ---GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       392 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                         .+..++||||++ ++|.+.+... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             ----CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             ccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence               456899999996 5777777543 356999999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCC---CccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          469 FGLAKLYQQGE---VPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       469 FGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      ||+++......   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+.... 
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~-  245 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLC-  245 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH-
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHh-
Confidence            99998765322   122334578999999998876 45799999999999999999999999764322111 1111100 


Q ss_pred             HHhcCCcchhhhhhhhh----------hccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          545 NLYGQGKICEAADARIR----------QEFEA-----EEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~----------~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                      .................          .....     .....+.+|+.+||+.||++|||+.|+++.-.-... +.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~-~~~  321 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD-PMP  321 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS-SCC
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC-CCc
Confidence            00000000000000000          00000     013457899999999999999999999998655422 555

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-37  Score=333.80  Aligned_cols=208  Identities=21%  Similarity=0.299  Sum_probs=177.0

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CC-----ceeee
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HK-----NLVQM  385 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l  385 (636)
                      +......++|+..+.||+|+||.||+|+....+    +.||||++... .....++..|+.+++.++ |+     +|+++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ----EWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCC----cEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            344445678999999999999999999987655    89999999754 334566778888888775 44     49999


Q ss_pred             eccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc--CCCc
Q 006668          386 RGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD--SEMR  463 (636)
Q Consensus       386 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~--~~~~  463 (636)
                      ++++...+..++||||++ ++|.+++.......+++..++.++.||+.||.|||+. +.+|+||||||+|||++  .++.
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence            999999999999999995 6999999766656799999999999999999999942 47899999999999994  5788


Q ss_pred             EEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGK  530 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~  530 (636)
                      +||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       200 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999876432    234578999999999999999999999999999999999999997653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5e-39  Score=335.77  Aligned_cols=269  Identities=25%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeec-CCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccC---CCCceeeeeccc
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLA-NNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRL---QHKNLVQMRGWC  389 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~-~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~  389 (636)
                      .+.++|+..+.||+|+||.||+|+.. ..+    +.||+|++.....  .....+.+|+.+++.+   +||||+++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCC----EEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            34578999999999999999999974 333    8899999875321  1122445566666555   899999999998


Q ss_pred             c-----ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          390 R-----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       390 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      .     .....++||||++ |+|.+++.......+++.+++.++.||+.||.|||   +.+|+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCE
Confidence            7     5678999999996 79999997666667999999999999999999999   7899999999999999999999


Q ss_pred             EEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          465 RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      ||+|||+++......  ......||..|+|||++.+..++.++||||||+++|||++|+.||........    +...+.
T Consensus       160 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~  233 (326)
T 1blx_A          160 KLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILD  233 (326)
T ss_dssp             EECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHH
T ss_pred             EEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHH
Confidence            999999998654322  23345789999999999999999999999999999999999999976532211    111111


Q ss_pred             HHhcCCc--chh-------hh---hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          545 NLYGQGK--ICE-------AA---DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       545 ~~~~~~~--~~~-------~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..-....  ...       ..   .......+.......+.+|+.+||+.||++||++.|+++.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            1100000  000       00   000011122234467889999999999999999999997543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-38  Score=338.86  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=187.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeecccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG---  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~---  392 (636)
                      .++|+..+.||+|+||.||+|+....+    +.||||++...  .....+.+.+|+.+++.++||||+++++++...   
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTT----EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCC----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence            467889999999999999999976655    89999999754  344567888999999999999999999988653   


Q ss_pred             ---ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          393 ---NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       393 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                         ...++|+||+ +++|.+++.   ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             ccCCeEEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeec
Confidence               5689999999 799999884   356999999999999999999999   799999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |+++....    ..+...||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+     .....
T Consensus       177 G~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i-----~~~~g  247 (367)
T 2fst_X          177 GLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI-----LRLVG  247 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHHHC
T ss_pred             cccccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HHHhC
Confidence            99986543    2334578999999999877 67899999999999999999999999755322111111     11111


Q ss_pred             CCc------ch-h---hhhhhhh-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGK------IC-E---AADARIR-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~------~~-~---~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...      +. +   ..-..+.       ..........+.+|+.+||+.||.+|||+.|+++.-.-.
T Consensus       248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence            100      00 0   0000000       000012235688999999999999999999999875443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4e-38  Score=335.92  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=201.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|...+.||+|+||.||+|+....+    +.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSG----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCC----CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence            457888999999999999999987655    89999999764  344467888999999999999999999999876654


Q ss_pred             ------EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          396 ------MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       396 ------~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                            ++||||+. ++|.+++    ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred             ccceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEec
Confidence                  99999996 7898887    334999999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |+++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............    ....-.
T Consensus       189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i----~~~~~~  260 (371)
T 4exu_A          189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI----LKVTGV  260 (371)
T ss_dssp             TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHHHCC
T ss_pred             CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HHHhCC
Confidence            999865432    234578999999998877 67899999999999999999999999765322211111    110000


Q ss_pred             CC---------cchhhhhhhhh-------hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QG---------KICEAADARIR-------QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~---------~~~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..         .........+.       ..........+.+|+.+||+.||++|||+.|+++.-.-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence            00         00000000000       001112346788999999999999999999999886554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-38  Score=345.39  Aligned_cols=260  Identities=27%  Similarity=0.363  Sum_probs=195.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccccc------c
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG------N  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~  393 (636)
                      +|+..++||+|+||.||+|+....+    +.||||++.....    ...+|++++++++||||+++++++...      .
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCC----cEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            5778899999999999999987655    8999999976532    234699999999999999999988432      2


Q ss_pred             eEEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC-CcEEEeccC
Q 006668          394 ELMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFG  470 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFG  470 (636)
                      .+++||||+++ +|.+.+..  .....+++..++.++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence            47799999965 66665532  23567999999999999999999999   8999999999999999965 568999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      +++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......    .+...+... ..
T Consensus       203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~l-g~  275 (420)
T 1j1b_A          203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVL-GT  275 (420)
T ss_dssp             TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHH-CS
T ss_pred             hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHh-CC
Confidence            9987654332  2335789999999998765 78999999999999999999999997653221    122222111 10


Q ss_pred             Ccchh--hhhhh-------------hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          550 GKICE--AADAR-------------IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       550 ~~~~~--~~d~~-------------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      .....  ...+.             ....+.......+.+|+.+||+.||.+||++.|++++-.
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence            00000  00000             011122233467889999999999999999999997643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5e-39  Score=342.85  Aligned_cols=255  Identities=13%  Similarity=0.082  Sum_probs=182.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHH---HHhccCCCCceeeeec-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEI---SSMGRLQHKNLVQMRG-----  387 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~h~niv~l~g-----  387 (636)
                      ..|...+.||+|+||.||+|+...++    +.||+|++.....   ...+.+.+|+   ..|+. +||||++++.     
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERL----EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCC----ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEee
Confidence            44888899999999999999987655    8999999987542   3455677774   55555 7999888553     


Q ss_pred             --ccccc-----------------ceEEEEEeecCCCChhhhHhcCCCCCcChHHH------HHHHHHHHHHHHHHhccC
Q 006668          388 --WCRKG-----------------NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQR------RQILADVAEGLNYLHHGW  442 (636)
Q Consensus       388 --~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~  442 (636)
                        ++...                 ..+++|||||+ |+|.+++... ...+.+..+      +.++.||+.||+|||   
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---  211 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQ---  211 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHH---
Confidence              22211                 44899999998 9999999543 234566666      788899999999999   


Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccC--CCCCCccchHHHHHHHHHHH
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVA  520 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell  520 (636)
                      +.+|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence            799999999999999999999999999999865421    113457799999999987  67899999999999999999


Q ss_pred             hCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       521 ~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      +|+.||.........          .+........................+.+|+.+||+.||++|||+.|+++.-
T Consensus       288 tg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          288 CLFLPFGLVTPGIKG----------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             HSSCSTTBCCTTCTT----------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             hCCCCCCCcCccccc----------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            999999755321100          0000000000001111111123356788899999999999999999998653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-38  Score=333.25  Aligned_cols=267  Identities=21%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeecccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG----  392 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----  392 (636)
                      .++|...+.||+|+||.||+|+....+    +.||||++... .......+.+|+.++++++||||+++++++...    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTG----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCC----cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            467889999999999999999987655    89999999754 334456788999999999999999999987654    


Q ss_pred             -ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCC
Q 006668          393 -NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGL  471 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  471 (636)
                       ...++||||+. ++|.+++..   ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence             67899999995 799999843   46899999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCc---------cccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          472 AKLYQQGEVP---------NTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       472 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      ++........         ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........    +. 
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~-  233 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LL-  233 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HH-
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HH-
Confidence            9876532211         1223478999999998754 6789999999999999999999999975532111    11 


Q ss_pred             HHHHHhcCCc---chhhh-h-------hhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          542 WVRNLYGQGK---ICEAA-D-------ARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       542 ~v~~~~~~~~---~~~~~-d-------~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+........   ..... .       ..+       ...........+.+|+.+||+.||++|||+.|+++.-.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            1111111100   00000 0       000       0001112345678999999999999999999999865443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-37  Score=331.83  Aligned_cols=268  Identities=20%  Similarity=0.288  Sum_probs=205.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-----------CCceeeeec
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-----------HKNLVQMRG  387 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g  387 (636)
                      ++|...+.||+|+||.||+|+....+    +.||+|++... ....+.+.+|+.++++++           |+||+++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCC----cEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            57889999999999999999976655    89999999754 334467788999988876           899999999


Q ss_pred             cccccc----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEc---
Q 006668          388 WCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLD---  459 (636)
Q Consensus       388 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~---  459 (636)
                      ++...+    ..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +. +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence            987654    789999999 999999997666667999999999999999999999   66 999999999999994   


Q ss_pred             ---CCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhh--
Q 006668          460 ---SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEE--  534 (636)
Q Consensus       460 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~--  534 (636)
                         ..+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence               4457999999999876432    2334789999999999999999999999999999999999999975432110  


Q ss_pred             HHHHHHHHHHHHhcCC--------cch----------h--------hhhhh--hhhccCHHHHHHHHHHHHHccCCCCCC
Q 006668          535 EEAVLMDWVRNLYGQG--------KIC----------E--------AADAR--IRQEFEAEEMELVLKLGLACCHPDSTR  586 (636)
Q Consensus       535 ~~~~l~~~v~~~~~~~--------~~~----------~--------~~d~~--l~~~~~~~~~~~l~~L~~~Cl~~dP~~  586 (636)
                      ....+...+. ....-        +..          .        .....  -...++......+.+|+.+||+.||++
T Consensus       246 ~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          246 DDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             hHHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence            1111111111 11100        000          0        00000  012345677889999999999999999


Q ss_pred             CCCHHHHHHHHhcC
Q 006668          587 RPTMREVVAVLVGQ  600 (636)
Q Consensus       587 RPs~~evl~~L~~~  600 (636)
                      |||+.|+++.-.-.
T Consensus       325 Rpt~~ell~hp~f~  338 (373)
T 1q8y_A          325 RADAGGLVNHPWLK  338 (373)
T ss_dssp             CBCHHHHHTCGGGT
T ss_pred             cCCHHHHhhChhhh
Confidence            99999999865443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-38  Score=340.89  Aligned_cols=260  Identities=25%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-----  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----  393 (636)
                      .+|...++||+|+||.||+|+...+     ..+|+|++......    ..+|+.+++.++||||+++++++...+     
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~-----~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVES-----DEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCC-----CeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3578889999999999999998664     45888888654321    236899999999999999999985433     


Q ss_pred             -eEEEEEeecCCCChhhhHh-cCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCCcEEEeccC
Q 006668          394 -ELMLVYDYMPNGSLNNWIF-GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEMRGRLGDFG  470 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFG  470 (636)
                       .+++||||++++.+..... ......+++..++.++.||+.||+|||   +.+|+||||||+|||++ .++.+||+|||
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence             3889999997654443321 123567999999999999999999999   79999999999999999 79999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      +++.......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.......    .+...+.. ...
T Consensus       188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~l~~i~~~-~g~  260 (394)
T 4e7w_A          188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID----QLVEIIKV-LGT  260 (394)
T ss_dssp             TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHH-HCC
T ss_pred             CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHH-hCC
Confidence            9987644332  2335789999999988765 58999999999999999999999997653221    12221111 110


Q ss_pred             Ccch--hhhhh-------------hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          550 GKIC--EAADA-------------RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       550 ~~~~--~~~d~-------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ....  ....+             .+...+.......+.+|+.+||+.||.+|||+.|++++-
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            0000  00000             011112222446789999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-37  Score=326.38  Aligned_cols=266  Identities=18%  Similarity=0.257  Sum_probs=205.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc------eeeeeccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN------LVQMRGWCRK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~~  391 (636)
                      .++|++.+.||+|+||.||+++....+   +..||+|+++.. ....+.+.+|+.++++++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARG---KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCC---ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            467899999999999999999875543   268999999754 334567788999999887765      8999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE-------------
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL-------------  458 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll-------------  458 (636)
                      .+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence            99999999999 778888886655567999999999999999999999   8999999999999999             


Q ss_pred             ------cCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          459 ------DSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       459 ------~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                            +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  67889999999999864432    23357899999999999999999999999999999999999999755322


Q ss_pred             hhHHHHHHHHHHHHhcCCcc--h-----------------------hhhhh---hh--hhccCHHHHHHHHHHHHHccCC
Q 006668          533 EEEEAVLMDWVRNLYGQGKI--C-----------------------EAADA---RI--RQEFEAEEMELVLKLGLACCHP  582 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~--~-----------------------~~~d~---~l--~~~~~~~~~~~l~~L~~~Cl~~  582 (636)
                      ....  .   +......-..  .                       .....   .+  .......+...+.+|+.+||+.
T Consensus       246 ~~~~--~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          246 EHLV--M---MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             HHHH--H---HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             HHHH--H---HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            1111  1   1111100000  0                       00000   00  0011234456789999999999


Q ss_pred             CCCCCCCHHHHHHHHhcC
Q 006668          583 DSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       583 dP~~RPs~~evl~~L~~~  600 (636)
                      ||++|||+.|+++.-.-.
T Consensus       321 dP~~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          321 DPAQRITLAEALLHPFFA  338 (355)
T ss_dssp             STTTSCCHHHHTTSGGGG
T ss_pred             ChhhCcCHHHHhcChhhc
Confidence            999999999998765443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.9e-38  Score=330.74  Aligned_cols=276  Identities=22%  Similarity=0.275  Sum_probs=194.9

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK  391 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~  391 (636)
                      ++.....++|+..+.||+|+||.||+|+....+    ..||||++...... ...+.+|++.+..++||||+++++++..
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTG----MSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTC----CEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            445566788999999999999999999987655    89999998654322 2455678888888999999999999865


Q ss_pred             cce-------EEEEEeecCCCChhhhHhc--CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-C
Q 006668          392 GNE-------LMLVYDYMPNGSLNNWIFG--KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-E  461 (636)
Q Consensus       392 ~~~-------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~  461 (636)
                      .+.       .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. +
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCC
Confidence            333       8899999975 55544422  3456789999999999999999999932 589999999999999996 8


Q ss_pred             CcEEEeccCCcccccCCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH
Q 006668          462 MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM  540 (636)
Q Consensus       462 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~  540 (636)
                      +.+||+|||+++......  ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........    +.
T Consensus       169 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----~~  242 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ----LH  242 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred             CcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH----HH
Confidence            999999999998765433  223457899999999886654 89999999999999999999999976532221    21


Q ss_pred             HHHHHHhcCC-cchhhhhh----------------hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          541 DWVRNLYGQG-KICEAADA----------------RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       541 ~~v~~~~~~~-~~~~~~d~----------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..+....... ......++                .............+.+|+.+||+.||.+|||+.|+++.-.-.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  319 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD  319 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence            2111110000 00000000                001111222456789999999999999999999999875443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-38  Score=323.94  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|++.+.||+|+||.||+++....+    +.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCC----cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            3467899999999999999999986555    89999998654  22345778899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC---CcEEEeccCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE---MRGRLGDFGL  471 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGl  471 (636)
                      .++||||+++++|.+++..  ...+++.+++.++.||+.||.|||   +.+++||||||+||+++.+   +.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999999998854  346899999999999999999999   7899999999999999754   4699999999


Q ss_pred             cccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +........  .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||......    ..... +.    .+.
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~-~~----~~~  238 (287)
T 2wei_A          171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKR-VE----TGK  238 (287)
T ss_dssp             GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HH----HCC
T ss_pred             ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHH-HH----cCC
Confidence            987654332  223468999999998875 4899999999999999999999999754211    11111 11    111


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...  +  .  .........+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~--~--~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          239 YAF--D--L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCC--C--S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCC--C--c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            100  0  0  0001223568889999999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.7e-39  Score=332.11  Aligned_cols=264  Identities=24%  Similarity=0.360  Sum_probs=201.4

Q ss_pred             cCHHHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCC--CCceee
Q 006668          309 FSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ--HKNLVQ  384 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--h~niv~  384 (636)
                      +.++.+....++|+..+.||+|+||.||+++...     +..||+|++...  .....+.+.+|+.++.+++  |+||++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-----CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            3334444455678999999999999999998754     278999999754  4455678899999999997  599999


Q ss_pred             eeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcE
Q 006668          385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRG  464 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~  464 (636)
                      +++++...+..++||| +.+++|.+++..  ...+++.+++.++.||+.||.|||   +.+|+||||||+|||+++ +.+
T Consensus        93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~  165 (313)
T 3cek_A           93 LYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GML  165 (313)
T ss_dssp             EEEEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEE
T ss_pred             EEEEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeE
Confidence            9999999999999999 558999999954  357899999999999999999999   789999999999999964 899


Q ss_pred             EEeccCCcccccCCCCc-cccccccCCcccccccccC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCh
Q 006668          465 RLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATV-----------SSPTSASDVYSFGVVILEVACGRRPLDMGKGE  532 (636)
Q Consensus       465 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~  532 (636)
                      ||+|||+++........ ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||......
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            99999999876543221 2233568999999999875           46788999999999999999999999754322


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..   .+.             ...+......++......+.+++.+||+.||.+||++.|+++...-.
T Consensus       246 ~~---~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          246 IS---KLH-------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             HH---HHH-------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HH---HHH-------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence            11   111             11111111222222345688899999999999999999999865443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=340.36  Aligned_cols=271  Identities=22%  Similarity=0.310  Sum_probs=184.9

Q ss_pred             CCC-ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccc--cccceEEE
Q 006668          321 FSN-DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWC--RKGNELML  397 (636)
Q Consensus       321 f~~-~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~--~~~~~~~l  397 (636)
                      |.. .++||+|+||.||+|+.++..  .+..||+|++......  ..+.+|+.++++++||||+++++++  ......++
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGK--DDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSS--CCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCC--CCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            444 468999999999999976421  2378999999765322  4678899999999999999999999  45678999


Q ss_pred             EEeecCCCChhhhHhc-------CCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEE----cCCCcEEE
Q 006668          398 VYDYMPNGSLNNWIFG-------KPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL----DSEMRGRL  466 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl  466 (636)
                      ||||++ |+|.+++..       .....+++.+++.++.||+.||+|||   +.+|+||||||+||||    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 688887742       12235999999999999999999999   7999999999999999    77899999


Q ss_pred             eccCCcccccCCCC--ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhh-----HHHH
Q 006668          467 GDFGLAKLYQQGEV--PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEE-----EEAV  538 (636)
Q Consensus       467 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~-----~~~~  538 (636)
                      +|||+++.......  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........     ....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987654321  223446799999999998874 589999999999999999999999965432110     0111


Q ss_pred             HHHHHHHHhcCCc---chhh--------hhhhhh-hcc------------CHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006668          539 LMDWVRNLYGQGK---ICEA--------ADARIR-QEF------------EAEEMELVLKLGLACCHPDSTRRPTMREVV  594 (636)
Q Consensus       539 l~~~v~~~~~~~~---~~~~--------~d~~l~-~~~------------~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  594 (636)
                      +...+ .......   ....        ....+. ..+            .......+.+|+.+||+.||.+|||++|++
T Consensus       254 l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          254 LDRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHH-HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHH-HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            11111 1111000   0000        000000 000            001134678899999999999999999999


Q ss_pred             HHHhcC
Q 006668          595 AVLVGQ  600 (636)
Q Consensus       595 ~~L~~~  600 (636)
                      +.-.-.
T Consensus       333 ~hp~f~  338 (405)
T 3rgf_A          333 QDPYFL  338 (405)
T ss_dssp             TSGGGT
T ss_pred             cChhhc
Confidence            986554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-38  Score=329.73  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=180.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHH-HhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEIS-SMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|....++    +.||+|++... ......++..|+. +++.++||||+++++++...+..+
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSG----QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTT----EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCC----CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            56788899999999999999987655    89999999765 3334455666666 778889999999999999999999


Q ss_pred             EEEeecCCCChhhhHhc---CCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          397 LVYDYMPNGSLNNWIFG---KPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      +||||++ |+|.+++..   .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||++
T Consensus        98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            9999996 588877642   23567999999999999999999999   66 9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccc----cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELA----TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      +......  ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.......       +.+.    
T Consensus       174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~----  240 (327)
T 3aln_A          174 GQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLT----  240 (327)
T ss_dssp             CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C----
T ss_pred             eeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHH----
Confidence            8664432  22234689999999998    45678999999999999999999999997532110       0000    


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                        .+.....+.+...........+.+++.+||+.||++||++.|+++.
T Consensus       241 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          241 --QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             --CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence              0000001111111112234578899999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.1e-38  Score=331.27  Aligned_cols=256  Identities=21%  Similarity=0.274  Sum_probs=175.5

Q ss_pred             HhCCCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc----
Q 006668          317 ATKGFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----  391 (636)
Q Consensus       317 a~~~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----  391 (636)
                      ..++|... ++||+|+||.||+|+...++    +.||+|++..... ..++   ....++.++||||+++++++..    
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTG----QKCALKLLYDSPK-ARQE---VDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEESSHH-HHHH---HHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCC----CEEEEEEecCcHH-HHHH---HHHHHHhcCCCChHHHHHHHhhccCC
Confidence            34567774 46999999999999987655    8999999976422 2222   2233556799999999999875    


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEec
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGD  468 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~D  468 (636)
                      +..+++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence            456899999999999999997665668999999999999999999999   789999999999999976   45599999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ||+++......   .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...............     . 
T Consensus       175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~-  245 (336)
T 3fhr_A          175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-----I-  245 (336)
T ss_dssp             CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-----h-
Confidence            99998654322   23356899999999998888999999999999999999999999654322111000000     0 


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                           ..................+.+|+.+||+.||.+|||+.|+++.-
T Consensus       246 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          246 -----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             -----hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                 00000011111122345688899999999999999999999854

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=328.82  Aligned_cols=262  Identities=21%  Similarity=0.291  Sum_probs=200.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccce-
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE-  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-  394 (636)
                      .++|...+.||+|+||.||+|+....+    +.||||++...  .....+.+.+|+.++++++||||+++++++...+. 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSG----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCC----CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence            356888999999999999999987655    89999999764  34445788899999999999999999999877653 


Q ss_pred             -----EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          395 -----LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       395 -----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                           +++||||++ ++|.+++    ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred             ccceeEEEEecccc-CCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeec
Confidence                 599999996 7998887    235999999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |+++.....    .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........    +..... ...
T Consensus       171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~i~~-~~~  241 (353)
T 3coi_A          171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----LTQILK-VTG  241 (353)
T ss_dssp             TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH----HHHHHH-HHC
T ss_pred             ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH-HhC
Confidence            999865432    234578999999998877 6789999999999999999999999976532211    111111 100


Q ss_pred             CCc------chh----hhhhhh----h---hccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          549 QGK------ICE----AADARI----R---QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       549 ~~~------~~~----~~d~~l----~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...      +.+    ..-..+    .   ..........+.+|+.+||+.||++|||+.|+++.-.-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            000      000    000000    0   011123456788999999999999999999999875544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=331.31  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=197.2

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      .++|+..+.||+|+||.||+|+...       .+|+|.+....  ....+.+.+|+.++++++||||+++++++...+..
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG-------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS-------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC-------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            4678889999999999999998743       48999987542  22335677899999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++... ...+++.+++.++.||+.||+|||   +.+++||||||+|||++ ++.+||+|||+++..
T Consensus       105 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999999543 346999999999999999999999   78999999999999998 679999999998754


Q ss_pred             cCCC----CccccccccCCcccccccccC---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          476 QQGE----VPNTTRVVGTLGYLAPELATV---------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       476 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ....    ........||+.|+|||++..         ..++.++||||||+++|||++|+.||.......    .. . 
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~-~-  253 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----II-W-  253 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----HH-H-
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH-H-
Confidence            3211    112233468999999998875         357889999999999999999999997543211    11 1 


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        .. ..+.     .+.+   ........+.+++.+||+.||++||++.++++.|+.-
T Consensus       254 --~~-~~~~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          254 --QM-GTGM-----KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             --HH-HTTC-----CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             --Hh-ccCC-----CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence              00 0010     0000   0111234588899999999999999999999999765

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=326.89  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=193.3

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH------HHHHHHHHHHHhccC----CCCceee
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ------GLKEFMAEISSMGRL----QHKNLVQ  384 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~  384 (636)
                      ....++|...+.||+|+||.||+|+....+    +.||+|++......      ....+.+|+.++.++    +|+||++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDR----LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTC----CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCC----eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            445678999999999999999999876655    89999999765321      223455788888888    8999999


Q ss_pred             eeccccccceEEEEEee-cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCC
Q 006668          385 MRGWCRKGNELMLVYDY-MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEM  462 (636)
Q Consensus       385 l~g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~  462 (636)
                      +++++...+..++|+|| +++++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+||+++ .++
T Consensus       103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          103 LLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTT
T ss_pred             EEEEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCC
Confidence            99999999999999999 789999999954  346899999999999999999999   78999999999999999 889


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT-SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||+++......   .....|+..|+|||++.+..+. .++||||||+++|||++|+.||...    .  ...  
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~--~~~--  246 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q--EIL--  246 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H--HHH--
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H--HHh--
Confidence            99999999998765432   2345689999999998877664 4899999999999999999999632    0  000  


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        .             .  ...+.......+.+++.+||+.||++||++.|+++.-.-
T Consensus       247 --~-------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          247 --E-------------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             --H-------------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             --h-------------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence              0             0  011122234567889999999999999999999986543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=323.03  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=180.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HH-HHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QG-LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|+....+    +.||+|++..... .. .+.+.++..+++.++||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTG----HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTC----CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCC----eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            45778899999999999999987655    8999999976532 22 233445556788889999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCC-cEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ-VVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      +||||+ ++.+..+. ......+++..++.++.||+.||.|||   +. +++||||||+|||++.++.+||+|||++...
T Consensus       101 lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          101 IAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999999 55555444 333467899999999999999999999   64 9999999999999999999999999999765


Q ss_pred             cCCCCccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      ....  ......||+.|+|||++.     ...++.++||||||+++|||++|+.||........   .+.....    ..
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~----~~  246 (318)
T 2dyl_A          176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VLTKVLQ----EE  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHH----SC
T ss_pred             cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH---HHHHHhc----cC
Confidence            4432  223356899999999984     55688899999999999999999999975432211   1111111    00


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                            .+.+..  .......+.+++.+||+.||.+||++.|+++.-
T Consensus       247 ------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          247 ------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             ------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence                  000000  012245688899999999999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.6e-38  Score=327.29  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=203.6

Q ss_pred             HHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChH------HHHHHHHHHHHhccCC--CCceeeeec
Q 006668          316 KATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQ------GLKEFMAEISSMGRLQ--HKNLVQMRG  387 (636)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~g  387 (636)
                      ...++|+..+.||+|+||.||+|+...++    +.||+|++......      ..+.+.+|+.++++++  |+||+++++
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTT----EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCC----cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            34567899999999999999999976655    89999999754211      1244667899999986  599999999


Q ss_pred             cccccceEEEEEeecCC-CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-CCCcEE
Q 006668          388 WCRKGNELMLVYDYMPN-GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-SEMRGR  465 (636)
Q Consensus       388 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-~~~~~k  465 (636)
                      ++...+..++|+|++.+ ++|.+++..  ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++ +++.+|
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEE
Confidence            99999999999999976 899999854  357899999999999999999999   79999999999999999 789999


Q ss_pred             EeccCCcccccCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          466 LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       466 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      |+|||+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...    .  ...    .
T Consensus       191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~--~~~----~  257 (320)
T 3a99_A          191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E--EII----R  257 (320)
T ss_dssp             ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H--HHH----H
T ss_pred             EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h--hhh----c
Confidence            99999998765432   233568999999999887765 67899999999999999999999632    0  000    0


Q ss_pred             HHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       545 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                           +..          .+.......+.+++.+||+.||++||++.|+++.-.-.+. ..|
T Consensus       258 -----~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~-~~~  303 (320)
T 3a99_A          258 -----GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV-LLP  303 (320)
T ss_dssp             -----CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC-CCH
T ss_pred             -----ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc-cCc
Confidence                 000          0111223567889999999999999999999987655533 444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.3e-37  Score=332.23  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=185.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .|...++||+|+||+||.+....     ++.||||++....   .+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~-----g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQ-----GRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESS-----SSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEEC-----CeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            34556889999999997654322     2799999987543   34567899999876 899999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCC-----CcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCC------------
Q 006668          399 YDYMPNGSLNNWIFGKPKK-----LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE------------  461 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~------------  461 (636)
                      |||+ +|+|.+++......     ..++..++.++.||+.||+|||   +.+|+||||||+|||++.+            
T Consensus        88 ~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             ECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCC
Confidence            9999 57999999654321     1244466889999999999999   7999999999999999754            


Q ss_pred             -CcEEEeccCCcccccCCCCc---cccccccCCcccccccccC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 006668          462 -MRGRLGDFGLAKLYQQGEVP---NTTRVVGTLGYLAPELATV-------SSPTSASDVYSFGVVILEVAC-GRRPLDMG  529 (636)
Q Consensus       462 -~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~  529 (636)
                       +.+||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             48999999999876543321   1234579999999999876       668999999999999999999 99999654


Q ss_pred             CChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          530 KGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       530 ~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ....  .    ..+........        ............+.+|+.+||+.||.+|||+.|+++.
T Consensus       244 ~~~~--~----~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          244 YSRE--S----NIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TTHH--H----HHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhH--H----HHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            2221  1    11111111000        1111234556778999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7e-37  Score=344.61  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccc-----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-----  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----  391 (636)
                      .++|+..+.||+|+||.||+|.....+    ..||+|++... .....+.+.+|+.++++++||||+++++++..     
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTG----EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTT----CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCC----cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            367999999999999999999976655    78999998765 44556788999999999999999999998765     


Q ss_pred             -cceEEEEEeecCCCChhhhHhcCC-CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc---EEE
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGKP-KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR---GRL  466 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl  466 (636)
                       .+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEE
Confidence             677899999999999999996532 346999999999999999999999   799999999999999987665   999


Q ss_pred             eccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          467 GDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +|||++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......       ..|....
T Consensus       166 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i  236 (676)
T 3qa8_A          166 IDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKV  236 (676)
T ss_dssp             CSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTC
T ss_pred             ccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhh
Confidence            9999998765443  223457999999999999999999999999999999999999999654211       1111100


Q ss_pred             hc------------CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          547 YG------------QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       547 ~~------------~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      ..            .+.....................+.+++.+||..||++|||+.|
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00            00000000001112234456788999999999999999999966

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-37  Score=333.62  Aligned_cols=243  Identities=17%  Similarity=0.129  Sum_probs=184.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh---HHHHHHHHHHHHhccCCC-Cceeeeecc-----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK---QGLKEFMAEISSMGRLQH-KNLVQMRGW-----  388 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-~niv~l~g~-----  388 (636)
                      ++.|...++||+|+||.||+|+....+    +.||||++.....   ...+.+.+|+.+++.++| +|......+     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETG----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCC----CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            345677889999999999999987655    7999999984422   235778999999999987 322111111     


Q ss_pred             ----------------ccc-----cceEEEEEeecCCCChhhhHh-----cCCCCCcChHHHHHHHHHHHHHHHHHhccC
Q 006668          389 ----------------CRK-----GNELMLVYDYMPNGSLNNWIF-----GKPKKLLGWKQRRQILADVAEGLNYLHHGW  442 (636)
Q Consensus       389 ----------------~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  442 (636)
                                      +..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||+|||   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---  228 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---  228 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence                            111     12457777766 789999884     334567899999999999999999999   


Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccc----------cCCCCCCccchHHH
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA----------TVSSPTSASDVYSF  512 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~S~  512 (636)
                      +.+|+||||||+||||+.++.+||+|||+++.....    ....+| +.|+|||++          ....++.++|||||
T Consensus       229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             hCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence            899999999999999999999999999998865432    334567 999999998          55568889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006668          513 GVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMRE  592 (636)
Q Consensus       513 Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  592 (636)
                      ||++|||++|+.||.........                 .....  ....    .+..+.+|+.+||+.||++||++.+
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~~-----------------~~~~~--~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGGS-----------------EWIFR--SCKN----IPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSCS-----------------GGGGS--SCCC----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHCCCCCCCcchhhhH-----------------HHHHh--hccc----CCHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999999999754211100                 00000  0011    2356889999999999999999888


Q ss_pred             HHHH
Q 006668          593 VVAV  596 (636)
Q Consensus       593 vl~~  596 (636)
                      +++.
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            8654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=329.15  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=183.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l  397 (636)
                      .+|...++||+|+||+||...... +    +.||||++.....   ..+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~-~----~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFD-N----RDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESS-S----SEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeC-C----eEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            457888999999999955332222 2    7899999976533   2345799999999 79999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc-----CCCcEEEeccCCc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD-----SEMRGRLGDFGLA  472 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~DFGla  472 (636)
                      |||||+ |+|.+++.... ..+.+.+++.++.||+.||+|||   +.+|+||||||+|||++     ....+||+|||++
T Consensus        96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            999995 79999996543 34556677899999999999999   78999999999999994     3346889999999


Q ss_pred             ccccCCCC--ccccccccCCccccccccc---CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          473 KLYQQGEV--PNTTRVVGTLGYLAPELAT---VSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       473 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      +.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||........  ..       .
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~-------~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NI-------L  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HH-------H
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HH-------H
Confidence            87654321  2334467999999999987   4567889999999999999999 9999854321110  00       0


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ...... ..      ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       242 ~~~~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 LGACSL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTCCCC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCCc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            000000 00      01112334557889999999999999999999954

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-36  Score=344.08  Aligned_cols=238  Identities=23%  Similarity=0.295  Sum_probs=191.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecC-CCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccce-
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLAN-NNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE-  394 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-  394 (636)
                      .++|++.+.||+|+||.||+|.... ++    +.||||.+... .......+.+|+.++.+++||||+++++++...+. 
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNG----RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTT----EEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCC----cEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3678999999999999999999764 33    88999998754 34556678999999999999999999999987655 


Q ss_pred             ----EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          395 ----LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       395 ----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                          .+|||||+++++|.+++.    ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             SCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             CCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence                799999999999999873    27999999999999999999999   7899999999999999986 89999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      +++.....     ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.......                 
T Consensus       227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            99876442     3457999999999987654 889999999999999999998875321100                 


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHh
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-MREVVAVLV  598 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~L~  598 (636)
                       +..       ..........+.+++.+||+.||++||+ ++++.+.|.
T Consensus       284 -~~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          284 -LPE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -CCT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -ccc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             000       0001122356888999999999999996 555555554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-35  Score=305.87  Aligned_cols=230  Identities=9%  Similarity=0.070  Sum_probs=182.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+....+    +.||+|++....   ....+.+.+|+..+.+++||||+++++++.+.+..
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALD----RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTT----EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCC----ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            56888999999999999999987655    899999997652   44567889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++++|.+++..   + ....++.+++.||+.||+|||   +.+|+||||||+|||++.++.+||++++     
T Consensus       107 ~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            999999999999999932   2 355678899999999999999   7999999999999999999999998443     


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                                      |++|       ++.++|||||||++|||++|+.||...........           ...... 
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~-  219 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTA-  219 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTT-
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhc-
Confidence                            3333       68899999999999999999999976532110000           000000 


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .............+..+.+++.+||+.||++| |+.|+++.|+..
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            00000111222334568899999999999999 999999999764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.3e-36  Score=307.78  Aligned_cols=233  Identities=21%  Similarity=0.292  Sum_probs=179.4

Q ss_pred             CCCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHh-ccCCCCceeeeeccccc----c
Q 006668          319 KGFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSM-GRLQHKNLVQMRGWCRK----G  392 (636)
Q Consensus       319 ~~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~g~~~~----~  392 (636)
                      ++|... ++||+|+||.||++.....+    +.||+|++...     ..+.+|+.++ +.++||||+++++++..    .
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCC----cEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            345555 78999999999999987655    89999999653     3456788877 55689999999999876    6


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEecc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDF  469 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DF  469 (636)
                      ...++||||+++|+|.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            78999999999999999997766667999999999999999999999   799999999999999998   788999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      |++.....                       ..++.++|||||||++|||++|+.||..........        . .. 
T Consensus       165 g~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------~-~~-  211 (299)
T 3m2w_A          165 GFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------G-MK-  211 (299)
T ss_dssp             TTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------C-SC-
T ss_pred             cccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------H-HH-
Confidence            99875331                       345678999999999999999999996542111000        0 00 


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+. .................+.+++.+||+.||++|||+.|+++.-
T Consensus       212 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          212 TRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             CSSC-TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHh-hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            0000 0000000000012345688899999999999999999999854

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.2e-35  Score=308.94  Aligned_cols=244  Identities=18%  Similarity=0.185  Sum_probs=181.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--------hHHHHHHHHHHHHhccCC------------
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--------KQGLKEFMAEISSMGRLQ------------  378 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~------------  378 (636)
                      ++|+..+.||+|+||.||+|+..  +    +.||||++....        ....+.+.+|+.++++++            
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIAD--H----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEET--T----EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             ccchheeeecccCceEEEEEEeC--C----ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            45778899999999999999872  2    899999998652        223467788888888775            


Q ss_pred             --------------CCceeeeeccccc-------------cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHH
Q 006668          379 --------------HKNLVQMRGWCRK-------------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADV  431 (636)
Q Consensus       379 --------------h~niv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i  431 (636)
                                    ||||+++++++.+             .+.+++||||+++|++.+.+.   +..+++.+++.++.||
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQL  170 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHH
Confidence                          5555555555554             678999999999998777663   3568999999999999


Q ss_pred             HHHHHHHhccCCCcEEeCCCCCCCEEEcCCC--------------------cEEEeccCCcccccCCCCccccccccCCc
Q 006668          432 AEGLNYLHHGWDQVVVHRDIKSGNILLDSEM--------------------RGRLGDFGLAKLYQQGEVPNTTRVVGTLG  491 (636)
Q Consensus       432 a~~L~yLH~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~  491 (636)
                      +.||+|||+  +.+|+||||||+|||++.++                    .+||+|||+++.....      ..+||+.
T Consensus       171 ~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          171 TASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            999999993  37899999999999999887                    8999999999876542      3479999


Q ss_pred             ccccccccCCCCCCccchHHHHHH-HHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHH
Q 006668          492 YLAPELATVSSPTSASDVYSFGVV-ILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEME  570 (636)
Q Consensus       492 y~aPE~~~~~~~s~~sDV~S~Gvl-l~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~  570 (636)
                      |+|||++.+.. +.++||||+++. .++++.|..||...    .....+.+.+..   ....    ..............
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLK---QMTF----KTKCNTPAMKQIKR  310 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHH---TCCC----SSCCCSHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhh---hhcc----CcccchhhhhhcCH
Confidence            99999998766 889999998777 67788899887310    000111111100   0000    00011122335667


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHH-HH
Q 006668          571 LVLKLGLACCHPDSTRRPTMREVV-AV  596 (636)
Q Consensus       571 ~l~~L~~~Cl~~dP~~RPs~~evl-~~  596 (636)
                      .+.+|+.+||+.|     |++|++ ++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHhccC-----CHHHHHhcC
Confidence            8999999999976     999998 53

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.96  E-value=3.6e-29  Score=250.48  Aligned_cols=167  Identities=11%  Similarity=0.052  Sum_probs=127.5

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCC-CCCCCceEEEEecC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIA-SSPGFGLCFVLTNF  118 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~-~~~~~G~aF~l~~~  118 (636)
                      .++.++|+|.+. ++.|+||+...++.|||+|++|+++.           ||+|+|+|.|.+... ..+||||||+|+|.
T Consensus        25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~~-----------sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~   92 (253)
T 2dur_A           25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFLK-----------DWEMHVHFKVHGTGKKNLHGDGIALWYTRD   92 (253)
T ss_dssp             CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCCS-----------SEEEEEEEEEECCCCTTCCCCEEEEEEESC
T ss_pred             CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCccC-----------cEEEEEEEEEecCCCCCcCCCcEEEEEECC
Confidence            689999999996 88999999888899999999999973           899999999998765 56899999999997


Q ss_pred             CCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccccC--CCCCcceeeee
Q 006668          119 TSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSS--SRNESFVPVRM  196 (636)
Q Consensus       119 ~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~~~--~~~~~~~~~~~  196 (636)
                      ..    ..|++||+.+      .++.|||||||+.|.++.|    |+++|||.+.+..++++..-.+  +.....-...+
T Consensus        93 ~~----~~G~~lG~~~------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~  158 (253)
T 2dur_A           93 RL----VPGPVFGSKD------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADF  158 (253)
T ss_dssp             CS----CEETBTEECS------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCC
T ss_pred             CC----CCCcccCcCC------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccCCCcccccccccHhh
Confidence            43    2578999633      3567999999999975433    6666666666665543221000  00111112233


Q ss_pred             -cCCCeeEEEEEec---------------------------------ccccCCCceecceeeeeccccCC
Q 006668          197 -RNGQNIHAWIDFD---------------------------------GFSASKTNWIEARRVLAWSLSDT  232 (636)
Q Consensus       197 -~~g~~~~~~i~y~---------------------------------gfsastg~~~~~~~il~wsf~~~  232 (636)
                       +.|..++|||+|+                                 ||||+||...+.|+||+|+|++-
T Consensus       159 ~n~g~~~~v~I~Y~~~~L~V~l~~~~~~~~~~~~~~~~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          159 RNRDHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             BTCSSCEEEEEEEETTEEEEEEECSSSSCCEEEEEECCEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             ccCCCCeEEEEEEECCEEEEEEeCCCCCCceEEEEeCCcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence             3478899999998                                 99999999999999999999763

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.96  E-value=9e-29  Score=213.89  Aligned_cols=105  Identities=30%  Similarity=0.418  Sum_probs=93.2

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ..++|+|++|.+  +..||+|+|||.+.+ +.|+||+.+.      +++|||+|++|||||   ++ +++||||+|+|+|
T Consensus         2 ~~~~F~f~~F~~--~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~---d~-tg~vaSFsT~F~F   74 (113)
T 1qmo_A            2 QSLSFSFTKFDP--NQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW---ED-SAVLTSFDTIINF   74 (113)
T ss_dssp             EEEEEEESSCCS--SCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECC---CT-TEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCC--CCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEee---CC-CCCEEeeEEEEEE
Confidence            468999999975  247999999999986 9999998764      689999999999999   66 7889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCC
Q 006668           98 SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA  136 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~  136 (636)
                      .|.+.+...+||||||||+|....|. +.|+||||||.+
T Consensus        75 ~I~~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           75 EISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA  112 (113)
T ss_dssp             EEECSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred             EEecCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence            99988777789999999999877777 899999999864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.6e-29  Score=283.41  Aligned_cols=184  Identities=17%  Similarity=0.109  Sum_probs=128.6

Q ss_pred             eeecCceEEEeeeecCCCCCCceEEEEEEeccC----------ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          327 LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----------SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       327 LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      .+.|+.|.+..++....+    +.+++|.+...          .....++|.+|+++|+++ .|+||+++++++++++.+
T Consensus       242 ~~~~~~~~h~~~rr~~fg----~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFG----EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             -C--------CCEEEEEC----SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             cccCCccccccccccccc----ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            455566655554433333    67999999754          123356799999999999 699999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ||||||++|++|.++|..  .+.++..   +|+.||+.||+|||   +++||||||||+||||++++.+||+|||+|+..
T Consensus       318 yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            999999999999999954  3456543   58999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCC
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR  524 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~  524 (636)
                      ..... .....+||+.|||||++.+ ++..++|+||+|++++++.++..
T Consensus       390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            54332 3344689999999999875 46778999999999887755543

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.94  E-value=1.4e-27  Score=239.39  Aligned_cols=182  Identities=14%  Similarity=0.105  Sum_probs=126.0

Q ss_pred             ceeEEcCCCCCC-CCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCC
Q 006668           25 ALDFLFNSFGSI-TNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEI  103 (636)
Q Consensus        25 ~~~f~f~~F~~~-~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~  103 (636)
                      ..||..+.+... ....++.++|+|.+. ++.|+||++..++.||++|+.|+++           +||+|+|+|.|....
T Consensus        33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i~-~~~IrLT~~~~~~~G~~w~~~p~~~-----------~sF~t~F~F~I~~~~  100 (260)
T 1gv9_A           33 KYSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAF-----------ENWEVEVTFRVTGRG  100 (260)
T ss_dssp             GGCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCC-----------SSEEEEEEEEEECSS
T ss_pred             ceeEcCccccCCCCccCCeEEcccEEee-CCEEEeCCCCCCCEEEEEECCCccc-----------cCEEEEEEEEEecCC
Confidence            456666655321 123689999999995 7889999988889999999999964           489999999998764


Q ss_pred             CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCC-CC------CCCeeeEecCC-cccc
Q 006668          104 ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFN-DP------DDNHIGVDLNN-IESA  175 (636)
Q Consensus       104 ~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~-d~------~~~Hvgidvns-~~s~  175 (636)
                       ..+||||||+|+|...    ..|++||+.      ..++.||||||||.|.++. +|      +++|||||+|+ +.|.
T Consensus       101 -~~~gdGlAF~l~~~~~----~~g~~~G~~------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~  169 (260)
T 1gv9_A          101 -RIGADGLAIWYTENQG----LDGPVFGSA------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQ  169 (260)
T ss_dssp             -SCCCCEEEEEEESSCC----CEEEETTEC------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHH
T ss_pred             -CCCCCeEEEEEecCCC----CCCCccCCC------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccc
Confidence             3689999999998643    257888983      2356799999999996531 23      46788888886 6554


Q ss_pred             cccc--CccccCCCCCcceeeeecCCCeeEEEEEe---------------c----------ccccCCCceecceeeeecc
Q 006668          176 KHVP--AGYYSSSRNESFVPVRMRNGQNIHAWIDF---------------D----------GFSASKTNWIEARRVLAWS  228 (636)
Q Consensus       176 ~~~~--~~~~~~~~~~~~~~~~~~~g~~~~~~i~y---------------~----------gfsastg~~~~~~~il~ws  228 (636)
                      +...  +.+-+ +.....+.+++.+ ..+.|+++|               +          ||||+||...+.|+||||+
T Consensus       170 ~~~~c~~~~~n-~g~~~~~~I~Y~~-~~L~V~l~~~~~~~~~~~~~~~~vd~~~LP~~~~vGfSAaTG~~~e~hdIlsw~  247 (260)
T 1gv9_A          170 ALASCQRDFRN-KPYPVRAKITYYQ-KTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFL  247 (260)
T ss_dssp             CSEEECCCCBS-CSSCEEEEEEEET-TEEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEE
T ss_pred             eeeccChhhcc-CCCcEEEEEEEEC-CEEEEEEeeccCCCCCcceEEEEEcccccCCCcEEEEEEeCCCCcceEEEEEEE
Confidence            4333  22211 0111112222222 234444443               0          9999999999999999999


Q ss_pred             ccC
Q 006668          229 LSD  231 (636)
Q Consensus       229 f~~  231 (636)
                      |+.
T Consensus       248 ~~~  250 (260)
T 1gv9_A          248 TFQ  250 (260)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            875

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.93  E-value=1.1e-26  Score=205.56  Aligned_cols=78  Identities=37%  Similarity=0.575  Sum_probs=72.6

Q ss_pred             CceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccccCCCCCcceeeeecCCCeeEEEEEec------------
Q 006668          142 APLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------  209 (636)
Q Consensus       142 ~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------  209 (636)
                      ||+|||||||++|.+++||++|||||||||+.|.++++|+              +.+|+.++|||+||            
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~~--------------l~sG~~~~v~I~Yd~~~~~L~V~l~~   66 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWD--------------WQNGKIATAHISYNSVSKRLSVTSYY   66 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECC--------------CCTTSCEEEEEEEETTTTEEEEEEEC
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeeeE--------------EcCCCEEEEEEEEeCCCcEEEEEEcc
Confidence            6899999999999998899999999999999999988752              67899999999999            


Q ss_pred             ------------------------ccccCCCceecceeeeeccccCCC
Q 006668          210 ------------------------GFSASKTNWIEARRVLAWSLSDTG  233 (636)
Q Consensus       210 ------------------------gfsastg~~~~~~~il~wsf~~~~  233 (636)
                                              ||||+||...+.|+||+|||+++.
T Consensus        67 ~~~~~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l  114 (133)
T 1qmo_E           67 AGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL  114 (133)
T ss_dssp             SSSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             CCCccceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence                                    999999999999999999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.8e-26  Score=257.30  Aligned_cols=185  Identities=15%  Similarity=0.151  Sum_probs=144.8

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---h-----HHHHHHHHHHHHhccCCCCceeeeeccccccc
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---K-----QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN  393 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~  393 (636)
                      ...++||+|+||.||+|+...      ..+++|+.....   .     ...+.+.+|++++++++||||+++..++...+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLD------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD  412 (540)
T ss_dssp             ---------CCEEEEEEECSS------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred             CCCCEEeeCCCEEEEEEEECC------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence            446789999999999996543      678888764431   1     12345889999999999999996666666777


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..+|||||+++++|.+++..          ++.++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+++
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence            78999999999999999843          5689999999999999   799999999999999999  99999999999


Q ss_pred             cccCCCCcc------ccccccCCcccccccccC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 006668          474 LYQQGEVPN------TTRVVGTLGYLAPELATV--SSPTSASDVYSFGVVILEVACGRRPLD  527 (636)
Q Consensus       474 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ell~G~~Pf~  527 (636)
                      .........      .....||+.|||||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            775432211      234679999999999887  567788999999999988888877763

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.91  E-value=1.3e-24  Score=212.99  Aligned_cols=107  Identities=30%  Similarity=0.494  Sum_probs=92.9

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      +..++|+|++|.+  +..||+|+|+|.+.++|.|+||+.+.      +++|||+|++|||||   +. ++.|+||+|+|+
T Consensus       123 s~~~~F~~~~F~~--~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lw---d~-~~~vaSFsT~F~  196 (237)
T 1nls_A          123 TNALHFMFNQFSK--DQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW---ES-SAVVASFEATFT  196 (237)
T ss_dssp             EEEEEEEESCCCT--TCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECC---CT-TEEEEEEEEEEE
T ss_pred             cccchhhhccccc--cCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEee---cC-CCCEeeeEEEEE
Confidence            3567999999975  34799999999997789999998762      689999999999999   54 578999999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCC-CCCCCCcCcccccccCC
Q 006668           97 FSILPEIASSPGFGLCFVLTNFT-SPPGALASQYFGLFSNA  136 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~-~~~~~~~g~~lgl~~~~  136 (636)
                      |.|.+.. ..+||||||||+|.. .+|++++||||||||.+
T Consensus       197 F~I~~~~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          197 FLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             EECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             EEEecCC-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence            9998763 458999999999987 57888999999999975

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.88  E-value=1.5e-23  Score=205.40  Aligned_cols=80  Identities=34%  Similarity=0.540  Sum_probs=73.9

Q ss_pred             CCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccccCCCCCcceeeeecCCCeeEEEEEec-----------
Q 006668          141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-----------  209 (636)
Q Consensus       141 ~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-----------  209 (636)
                      +||+|||||||++|.+|+||++|||||||||++|+++++|.              +.+|+.++|||+||           
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~~--------------l~~g~~~~v~I~Yd~~~~~L~V~l~   66 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWN--------------MQNGKVGTAHIIYNSVDKRLSAVVS   66 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECC--------------CCTTCEEEEEEEEETTTTEEEEEEE
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCcccccccccc--------------ccCCCEEEEEEEEeCCCCEEEEEEe
Confidence            47999999999999999999999999999999999988752              57899999999999           


Q ss_pred             -------------------------ccccCCCceecceeeeeccccCCCC
Q 006668          210 -------------------------GFSASKTNWIEARRVLAWSLSDTGV  234 (636)
Q Consensus       210 -------------------------gfsastg~~~~~~~il~wsf~~~~~  234 (636)
                                               ||||+||...|.|+||+|+|++++.
T Consensus        67 ~~~~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           67 YPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             CTTSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             cCCCCcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence                                     9999999999999999999998754

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=2.1e-22  Score=206.07  Aligned_cols=152  Identities=16%  Similarity=0.129  Sum_probs=121.3

Q ss_pred             HHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh------------------HHHHHHHHHHHHh
Q 006668          313 ELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK------------------QGLKEFMAEISSM  374 (636)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l  374 (636)
                      .+......|+..+.||+|+||.||+|+. .++    ..||+|.++....                  .....+.+|+.++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g----~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l  158 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL  158 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCC----CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence            3444455677789999999999999998 434    8999999965321                  1346788999999


Q ss_pred             ccCCCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCC
Q 006668          375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG  454 (636)
Q Consensus       375 ~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~  454 (636)
                      ++++  | +++.+++. .+..++||||+++++|.+ +.        ..+...++.|++.||.|||   +.+|+||||||+
T Consensus       159 ~~l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~  222 (282)
T 1zar_A          159 QKLQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQY  222 (282)
T ss_dssp             HHTT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred             Hhcc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHH
Confidence            9999  5 66666553 356799999999999988 41        1345579999999999999   899999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccC
Q 006668          455 NILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV  500 (636)
Q Consensus       455 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  500 (636)
                      |||++ ++.+||+|||+++.              +..++|||++..
T Consensus       223 NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            99999 99999999999973              345788998753

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.81  E-value=1.1e-19  Score=181.10  Aligned_cols=169  Identities=17%  Similarity=0.175  Sum_probs=116.4

Q ss_pred             CCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecC
Q 006668           39 GTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF  118 (636)
Q Consensus        39 ~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~  118 (636)
                      ..++.++|+|.+. ++.|+||+. ..+.|+++.+.|+++.          ++|+|+|+|.|..... .+||||||++++.
T Consensus        30 i~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~----------~~f~~~f~FrI~g~~~-~~gdGlAfwlt~~   96 (256)
T 2a6y_A           30 PNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK----------DSFTMEWTFRSVGYSG-QTDGGISFWFVQD   96 (256)
T ss_dssp             CTTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEES----------SCEEEEEEEEEESCCS-CCSCEEEEEEEEC
T ss_pred             cCCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCccc----------CCEEEEEEEEEecCCC-CCCCeEEEEEeCC
Confidence            3689999999995 889999988 5689999988888753          4899999999987642 3799999999987


Q ss_pred             CCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCC------CCeeeEecCCccccccccC--ccccCCCCCc
Q 006668          119 TSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPD------DNHIGVDLNNIESAKHVPA--GYYSSSRNES  190 (636)
Q Consensus       119 ~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~------~~Hvgidvns~~s~~~~~~--~~~~~~~~~~  190 (636)
                      ...|  ..|+.+|.++.      .+-+||||||+.|.   .|.      +.|+++|.+++.+.+...+  .|.+ +....
T Consensus        97 ~~~~--~~g~~~G~~~~------f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~~~~rn-~~~~~  164 (256)
T 2a6y_A           97 SNIP--RDKQLYNGPVN------YDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQD-SSVPS  164 (256)
T ss_dssp             SSSC--CCCTBTTBCTT------CEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTT-CSSCE
T ss_pred             CCcc--cCCcccCcCCC------CCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecceeeccc-CCCcE
Confidence            4422  46778888642      23489999999873   343      6788888887544444332  2211 00111


Q ss_pred             ceeeeec--CCCeeEEEEEe-----------------cccccCCC---ceecceeeeeccccCC
Q 006668          191 FVPVRMR--NGQNIHAWIDF-----------------DGFSASKT---NWIEARRVLAWSLSDT  232 (636)
Q Consensus       191 ~~~~~~~--~g~~~~~~i~y-----------------~gfsastg---~~~~~~~il~wsf~~~  232 (636)
                      .+.+++.  +...+.+.|++                 =||||+||   ...+.|+|++|+|+..
T Consensus       165 ~v~I~Y~~~~~~~L~V~i~~~~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~  228 (256)
T 2a6y_A          165 TIRVTYDLEDDNLLKVQVDNKVCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNG  228 (256)
T ss_dssp             EEEEEEEGGGTSEEEEEETTEEEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEES
T ss_pred             EEEEEEecCCCcEEEEEEcCEEEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEec
Confidence            1122221  11122222211                 19999999   8899999999999984

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=2.3e-18  Score=173.62  Aligned_cols=139  Identities=18%  Similarity=0.181  Sum_probs=106.7

Q ss_pred             CCCceeeeecCceEEEeeeecCCCCCCceE--EEEEEeccCChH------------------------HHHHHHHHHHHh
Q 006668          321 FSNDELLGSGGFGRVYKGTLANNNNNNSTE--MAVKCVNHDSKQ------------------------GLKEFMAEISSM  374 (636)
Q Consensus       321 f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l  374 (636)
                      |+..+.||+|+||.||+|.....+    ..  ||||+++.....                        ....+.+|+..+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  124 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDG----KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL  124 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETT----EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCC----cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence            567789999999999999974333    77  999987543111                        123578899999


Q ss_pred             ccCCCCce--eeeeccccccceEEEEEeecCC-C----ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEE
Q 006668          375 GRLQHKNL--VQMRGWCRKGNELMLVYDYMPN-G----SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVV  447 (636)
Q Consensus       375 ~~l~h~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  447 (636)
                      .+++|+++  ..++++    +..+|||||+.+ |    +|.++..     ..++.++..++.|++.||.|||.  +.+|+
T Consensus       125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~giv  193 (258)
T 1zth_A          125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQ--EAELV  193 (258)
T ss_dssp             HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHH--TSCEE
T ss_pred             HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            99988764  334432    357899999942 4    6666542     13466788999999999999994  47999


Q ss_pred             eCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          448 HRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       448 HrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      ||||||+|||++.  .++|+|||+|....
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999999998  99999999997643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=1.5e-15  Score=160.10  Aligned_cols=137  Identities=13%  Similarity=0.102  Sum_probs=96.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--------------HHHHHH--------HHHHHHhccC
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--------------QGLKEF--------MAEISSMGRL  377 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~Ei~~l~~l  377 (636)
                      -|++.+.||+|++|.||+|....     ++.||||+++....              ......        .+|...|.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~-----G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEK-----GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTT-----CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECCC-----CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            38899999999999999998654     27899998753210              001111        2344555555


Q ss_pred             CCCcee--eeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCC
Q 006668          378 QHKNLV--QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGN  455 (636)
Q Consensus       378 ~h~niv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N  455 (636)
                      .+.++.  ..+++    ...+|||||+++++|.++.        ..+....++.||+.+|.|||   +.+||||||||.|
T Consensus       171 ~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~N  235 (397)
T 4gyi_A          171 YEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLA---KHGLIHGDFNEFN  235 (397)
T ss_dssp             HHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred             HhcCCCCCeeeec----cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHH
Confidence            433321  11211    2237999999998887653        12344678899999999999   7899999999999


Q ss_pred             EEEcCCC----------cEEEeccCCccccc
Q 006668          456 ILLDSEM----------RGRLGDFGLAKLYQ  476 (636)
Q Consensus       456 Ill~~~~----------~~kl~DFGla~~~~  476 (636)
                      ||+++++          .+.|+||+-+....
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9998876          38999999776543

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.40  E-value=6.6e-13  Score=129.36  Aligned_cols=105  Identities=14%  Similarity=0.115  Sum_probs=75.9

Q ss_pred             CCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecC
Q 006668           39 GTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNF  118 (636)
Q Consensus        39 ~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~  118 (636)
                      ..+..+.|+|.+. ++.++||++. ++.|.++.+.|+++.          .+|++.|+|.|.... ...||||||.+++.
T Consensus        23 ~~~W~~~G~a~i~-~~~IrLTp~~-~~~G~iWs~~p~~~~----------~~weie~~Fri~g~~-~~~gdGlA~W~t~~   89 (222)
T 2a6z_A           23 PNNWQTGEQASLE-EGRIVLTSNQ-NSKGSLWLKQGFDLK----------DSFTMEWTFRSVGYS-GQTDGGISFWFVQD   89 (222)
T ss_dssp             CTTEEEEETCEEE-TTEEESCCST-TCEEEEEESSCEECC----------SCEEEEEEEEEESCC-SCCSCEEEEEEEEC
T ss_pred             cCCcEEcccEEEc-CCEEEECCCC-CCeEEEEeCCCCCCC----------CCEEEEEEEEEeCCC-CCCCCEEEEEEECC
Confidence            3689999999996 7889999984 678999999999864          169999999998753 34799999999986


Q ss_pred             CCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecC
Q 006668          119 TSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLN  170 (636)
Q Consensus       119 ~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvn  170 (636)
                      ...+  ..|..+|.-+. -+|     +||+|||+.|.      .++|.+.+|
T Consensus        90 ~~~~--~~g~~~G~~~~-f~G-----L~I~~Dt~~n~------~p~i~~~~n  127 (222)
T 2a6z_A           90 SNIP--RDKQLYNGPVN-YDG-----LQLLVDNNGPL------GPTLRGQLN  127 (222)
T ss_dssp             SSSC--CCCTBTTBCTT-CEE-----EEEEEESCSTT------SSEEEEEEE
T ss_pred             Cccc--CCCcccCCCCC-CCE-----EEEEEECCCCC------CceEEEEEC
Confidence            4311  23333443221 112     69999998773      245555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.24  E-value=1.4e-11  Score=123.68  Aligned_cols=147  Identities=16%  Similarity=0.072  Sum_probs=112.8

Q ss_pred             HHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccccc
Q 006668          315 SKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGN  393 (636)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~  393 (636)
                      ...-.+|.....++.|+.+.||+....+      ..+++|+...........+.+|+.+++.+. +..+.++++++...+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGEN------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECSS------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECCC------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            3444578778888888899999987432      689999987532112235778888888884 677888999998888


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc--------------------------------
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG--------------------------------  441 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------  441 (636)
                      ..++||||++|.+|.+.+.       +..+...++.+++++|..||+-                                
T Consensus        84 ~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999999987631       2234457889999999999961                                


Q ss_pred             ------------------------CCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          442 ------------------------WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       442 ------------------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                              ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    015699999999999998766677999987753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=1.8e-10  Score=114.93  Aligned_cols=138  Identities=17%  Similarity=0.143  Sum_probs=98.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--LVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~  396 (636)
                      .++....+.+.|..+.||+....+ +    ..+++|......   ...+.+|+.+++.+.+.+  +.+++++...++..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~-g----~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQG-R----PVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTT-S----CCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             CCCceEecccCCCCceEEEEecCC-C----CeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            344443333355569999987533 2    579999876542   245677888888886545  456888888777899


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC----------------------------------
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW----------------------------------  442 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------  442 (636)
                      +||||+++.+|.  .. .    .   ....++.+++..|..||+..                                  
T Consensus        92 ~v~e~i~G~~l~--~~-~----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SS-H----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEECCSSEETT--TS-C----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEEecCCcccC--cC-c----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            999999998884  21 1    1   12367788888888888421                                  


Q ss_pred             ---------------------CCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          443 ---------------------DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       443 ---------------------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                           ...++|+|++|.|||++++..++|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 12399999999999998876677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=1e-09  Score=115.51  Aligned_cols=143  Identities=13%  Similarity=0.165  Sum_probs=107.0

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEec--cCC-hHHHHHHHHHHHHhccCC--CCceeeeecccccc---c
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDS-KQGLKEFMAEISSMGRLQ--HKNLVQMRGWCRKG---N  393 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~---~  393 (636)
                      ...+.|+.|.++.||+....+      ..+++|+..  ... ......+.+|+.+++.|.  +..+.+++.++.+.   +
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             ceEEEcCCcccceEEEEEECC------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            345789999999999987543      568888776  332 122346778999988886  45578888888766   4


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccC-------------------------------
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW-------------------------------  442 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------  442 (636)
                      ..++||||+++..+.+..    ...++..++..++.+++..|..||...                               
T Consensus       115 ~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            589999999998885422    234778889999999999999999620                               


Q ss_pred             ------------------------CCcEEeCCCCCCCEEEcCCCc--EEEeccCCccc
Q 006668          443 ------------------------DQVVVHRDIKSGNILLDSEMR--GRLGDFGLAKL  474 (636)
Q Consensus       443 ------------------------~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~  474 (636)
                                              ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    257999999999999987653  68999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.91  E-value=7.8e-10  Score=113.61  Aligned_cols=183  Identities=17%  Similarity=0.215  Sum_probs=123.3

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCc--eeeeeccccccc---eEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKN--LVQMRGWCRKGN---ELML  397 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~g~~~~~~---~~~l  397 (636)
                      .+.++.|....||+..         ..+++|+....  .....+.+|..+++.+. +..  +.+++..+...+   ..++
T Consensus        25 i~~~~~G~~n~v~~v~---------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST---------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC---------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            4679999999999864         35888886533  34567888999988773 322  445555544333   3488


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG------------------------------------  441 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------  441 (636)
                      |||+++|.+|.+...    ..++.+++..++.+++..|..||.-                                    
T Consensus        94 vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            999999999876442    3467788888999999999999851                                    


Q ss_pred             -------------------CCCcEEeCCCCCCCEEEcC--CCcEEEeccCCcccccCCCCccccccccCCcc---ccccc
Q 006668          442 -------------------WDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY---LAPEL  497 (636)
Q Consensus       442 -------------------~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~  497 (636)
                                         ....++|+|++|.||++++  ...+.|+||+.+..-+....     ......+   ..|+.
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHH
Confidence                               0146899999999999998  55688999999875432110     0001111   22221


Q ss_pred             cc----C-CCC---------CCccchHHHHHHHHHHHhCCCCC
Q 006668          498 AT----V-SSP---------TSASDVYSFGVVILEVACGRRPL  526 (636)
Q Consensus       498 ~~----~-~~~---------s~~sDV~S~Gvll~ell~G~~Pf  526 (636)
                      ..    . +..         ....+.|+++.++|++.+|..+|
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11    0 011         11258999999999999998765

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=98.80  E-value=8.2e-08  Score=93.07  Aligned_cols=94  Identities=14%  Similarity=0.119  Sum_probs=69.4

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      ....+.|+|.+. .+.++||++ .++.|.++-+.|+.+-          .+|+..|+|.|...... .||||||.++...
T Consensus        27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~----------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~   93 (226)
T 2a6v_A           27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIK----------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGN   93 (226)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCS----------SCEEEEEEEEEESCCSC-CSCEEEEEEECSC
T ss_pred             CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCC----------CCeEEEEEEEEecCCCC-CCCEEEEEEECCC
Confidence            578999999997 567999999 8899999999999861          16999999999876433 7999999999653


Q ss_pred             CCCCCCcCcccccccCCCCCCCCceEEEEeecCCC
Q 006668          120 SPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQN  154 (636)
Q Consensus       120 ~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n  154 (636)
                      ..   ..|..+|-....-+|     +||.|||+.|
T Consensus        94 ~~---~~g~vfGg~~d~f~G-----lgI~~Dt~~n  120 (226)
T 2a6v_A           94 EG---DSTELFGGSSKKFNG-----LMILLRLDDK  120 (226)
T ss_dssp             CC---CCCTBTTTBCSSCEE-----EEEEEEEETT
T ss_pred             CC---CCcccccccCCCccE-----EEEEEECCCC
Confidence            21   123333221111122     7999999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=1.8e-06  Score=86.41  Aligned_cols=137  Identities=19%  Similarity=0.163  Sum_probs=99.2

Q ss_pred             eeeeecCce-EEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFG-RVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG-~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      +.+..|..| .||+.....++    ..+++|+....   ...++.+|...|+.+. +--+.++++++.+.+..++|||++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~----~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNA----PELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTC----CCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             EEccCCCcCCeEEEEEecCCC----eEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            345556655 68987654433    67889987643   2356778888887774 334677888888888999999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG-----------------------------------------  441 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----------------------------------------  441 (636)
                      ++.++.+....      .......++.+++..|.-||.-                                         
T Consensus       103 ~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            99888776521      2334556777788888888730                                         


Q ss_pred             --------------CCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          442 --------------WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       442 --------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                    ....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          122489999999999999887778999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.24  E-value=5e-06  Score=85.20  Aligned_cols=137  Identities=20%  Similarity=0.184  Sum_probs=96.6

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCC---ceeeeecccc-ccceEEEE
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK---NLVQMRGWCR-KGNELMLV  398 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~-~~~~~~lV  398 (636)
                      ..+.++.|....||+.   +      ..+++|+..  .......+.+|..+|+.+.+.   .+.+.+.++. ..+..++|
T Consensus        23 ~v~~l~~G~~n~v~~v---g------~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v   91 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV---N------GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVG   91 (306)
T ss_dssp             CEEEEEECSSEEEEEE---T------TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEE
T ss_pred             eeeecCCCcceeEEEE---C------CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEE
Confidence            3467888999999987   1      457888753  233456788999999998653   3556666663 34567899


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc-------------------------------------
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG-------------------------------------  441 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------  441 (636)
                      ||+++|.+|.+...    ..++..++..++.+++..|..||+-                                     
T Consensus        92 ~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           92 YRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            99999988876431    2245556666666666666666631                                     


Q ss_pred             --------------------CCCcEEeCCCCCCCEEEcC---CCc-EEEeccCCccc
Q 006668          442 --------------------WDQVVVHRDIKSGNILLDS---EMR-GRLGDFGLAKL  474 (636)
Q Consensus       442 --------------------~~~~ivHrDlkp~NIll~~---~~~-~kl~DFGla~~  474 (636)
                                          ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                1336799999999999987   455 58999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=6.5e-06  Score=86.07  Aligned_cols=151  Identities=12%  Similarity=0.103  Sum_probs=88.7

Q ss_pred             ceee-eecCceEEEeeeecC--CCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCC---Cceeeeecccccc--
Q 006668          324 DELL-GSGGFGRVYKGTLAN--NNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQH---KNLVQMRGWCRKG--  392 (636)
Q Consensus       324 ~~~L-G~G~fG~Vykg~~~~--~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~~--  392 (636)
                      .+.| +.|....+|+.....  .+...+..+++|+.....   ......+.+|+.+++.|..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 788899999877540  000012678888765432   0011345677777777742   3466777777655  


Q ss_pred             -ceEEEEEeecCCCChhhhHh---c-CCCCCcChHHHHHHHHHHHHHHH-------------------------------
Q 006668          393 -NELMLVYDYMPNGSLNNWIF---G-KPKKLLGWKQRRQILADVAEGLN-------------------------------  436 (636)
Q Consensus       393 -~~~~lV~E~~~~gsL~~~l~---~-~~~~~l~~~~~~~i~~~ia~~L~-------------------------------  436 (636)
                       +..++||||+++..+.+.+.   . .....++..++..++.++++.|.                               
T Consensus       105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW  184 (357)
T ss_dssp             TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred             cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence             45689999999877654210   0 00001222222223333333332                               


Q ss_pred             -----------------------HHhcc-------CCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          437 -----------------------YLHHG-------WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       437 -----------------------yLH~~-------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                             +|.+.       ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                                   33211       146799999999999999655579999998764

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=97.96  E-value=1.1e-06  Score=63.86  Aligned_cols=25  Identities=36%  Similarity=0.514  Sum_probs=23.1

Q ss_pred             ccccCCCceecceeeeeccccCCCC
Q 006668          210 GFSASKTNWIEARRVLAWSLSDTGV  234 (636)
Q Consensus       210 gfsastg~~~~~~~il~wsf~~~~~  234 (636)
                      ||||+||...+.|+||+|+|++++.
T Consensus        23 GFSAsTG~~~~~h~IlsWsF~s~~~   47 (52)
T 2ltn_B           23 GFSATTGAEYAAHEVLSWSFHSELS   47 (52)
T ss_dssp             EEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred             EEEeccCCcceeEEEEEeEEEeecc
Confidence            9999999999999999999998643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.73  E-value=7.8e-05  Score=79.07  Aligned_cols=76  Identities=12%  Similarity=0.037  Sum_probs=48.0

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-------HHHHHHHHHHHHhccCCC--C-ceeeeeccccccc
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-------QGLKEFMAEISSMGRLQH--K-NLVQMRGWCRKGN  393 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--~-niv~l~g~~~~~~  393 (636)
                      .+.||.|..+.||++.....+    ..+++|.......       .....+..|..+++.+..  + .+.+++.+.  .+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~----~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~  108 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHD----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE  108 (397)
T ss_dssp             EEECCSSSSEEEEEEEC--------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT
T ss_pred             EEECCCCceEEEEEEEECCCC----cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC
Confidence            567999999999999764433    6799998654321       112345678888877632  3 344555543  34


Q ss_pred             eEEEEEeecCCC
Q 006668          394 ELMLVYDYMPNG  405 (636)
Q Consensus       394 ~~~lV~E~~~~g  405 (636)
                      ..++|||++++.
T Consensus       109 ~~~lvmE~l~g~  120 (397)
T 2olc_A          109 MAVTVMEDLSHL  120 (397)
T ss_dssp             TTEEEECCCTTS
T ss_pred             ccEEEEEeCCCc
Confidence            468999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.71  E-value=0.00029  Score=72.54  Aligned_cols=31  Identities=23%  Similarity=0.294  Sum_probs=28.3

Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.34  E-value=0.0017  Score=66.37  Aligned_cols=139  Identities=14%  Similarity=0.104  Sum_probs=91.3

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeeeccccccceEEEE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ---HKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV  398 (636)
                      ...+.|+.|....+|+....  +    ..+++|+.....   ...+..|...|+.|.   ...+.+++.++...+..++|
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~----~~~vlK~~~~~~---~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--V----QTVFVKINERSY---RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--S----CEEEEEEEEGGG---HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eeeEEeCCccceeeeEEEEC--C----CeEEEEeCCccc---HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            34567899999999998752  2    678899876542   456778888888774   35678888888877889999


Q ss_pred             EeecCCCChhh-----------hHhcCCC-C-------------------CcChHHHH---HHH----------------
Q 006668          399 YDYMPNGSLNN-----------WIFGKPK-K-------------------LLGWKQRR---QIL----------------  428 (636)
Q Consensus       399 ~E~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------  428 (636)
                      |||+++..+..           .|+.... .                   .-+|....   ++.                
T Consensus       110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~  189 (312)
T 3jr1_A          110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI  189 (312)
T ss_dssp             EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred             EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence            99999886531           1222111 0                   01343221   111                


Q ss_pred             HHHHHHH-HHHh-ccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          429 ADVAEGL-NYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       429 ~~ia~~L-~yLH-~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                      ..++..+ ..|. ......++|+|+.+.|++++.++ +.|.|+.
T Consensus       190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1111111 2342 12357899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.24  E-value=0.00099  Score=67.13  Aligned_cols=79  Identities=20%  Similarity=0.239  Sum_probs=55.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC---CceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH---KNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~~~~~~  396 (636)
                      .....+.+|.|..+.||+.++.++     +.+.+|+...........+.+|...|+.|..   --+.+++++.    .-+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG-----~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADG-----TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTS-----CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCC-----CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence            455567899999999999998664     6899998765433333456778888877742   1344555543    247


Q ss_pred             EEEeecCCCCh
Q 006668          397 LVYDYMPNGSL  407 (636)
Q Consensus       397 lV~E~~~~gsL  407 (636)
                      +||||++.+..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.13  E-value=0.0015  Score=66.79  Aligned_cols=158  Identities=13%  Similarity=0.118  Sum_probs=85.4

Q ss_pred             cCHHHHHHHhCCCCC-----ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--
Q 006668          309 FSYEELSKATKGFSN-----DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--  381 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~-----~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--  381 (636)
                      ++-+++......|..     .+.|+.|....+|+....+      ..+++|.......  ..++..|+.++..|...+  
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~------g~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~   78 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK------DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLS   78 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS------CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC------ccEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCC
Confidence            344555555555544     2456678889999987543      3588998876311  123445666666553222  


Q ss_pred             eeeeeccc------cccceEEEEEeecCCCChhh--------------hHhcC------CC----CCcChHHHHH-----
Q 006668          382 LVQMRGWC------RKGNELMLVYDYMPNGSLNN--------------WIFGK------PK----KLLGWKQRRQ-----  426 (636)
Q Consensus       382 iv~l~g~~------~~~~~~~lV~E~~~~gsL~~--------------~l~~~------~~----~~l~~~~~~~-----  426 (636)
                      +.+++...      ...+..+++++|++|..+..              .++..      ..    ....|...+.     
T Consensus        79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  158 (322)
T 2ppq_A           79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  158 (322)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence            23333221      12356789999998865421              01110      00    0012322110     


Q ss_pred             -------HHHHHHHHHHHHhc----cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          427 -------ILADVAEGLNYLHH----GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       427 -------i~~~ia~~L~yLH~----~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                             +...+...++.++.    .....++|+|+++.|||++++..+.|+||+.+..
T Consensus       159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                   11123445555542    1246899999999999998876668999987753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.11  E-value=0.0011  Score=70.80  Aligned_cols=79  Identities=10%  Similarity=0.036  Sum_probs=48.4

Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccccccCCcccccccccCCC---CCCccchHHHHHHHHHH
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS---PTSASDVYSFGVVILEV  519 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~el  519 (636)
                      ...++|+|+++.|||++.++ ++++||+.+..-...-.....-..-...|++|+......   .....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            68899999999999998876 999999988753321100000000123466666543211   11234556777778877


Q ss_pred             HhC
Q 006668          520 ACG  522 (636)
Q Consensus       520 l~G  522 (636)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.81  E-value=0.0014  Score=66.56  Aligned_cols=137  Identities=13%  Similarity=0.106  Sum_probs=74.0

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+.|+.|....+|+.          ..+++|+........ ....+|+.+++.+...++ .++++.+.+  .-++++||+
T Consensus        23 i~~l~gG~tN~~~~~----------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE----------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECC
T ss_pred             eeEcCCcccccccee----------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeec
Confidence            688999999999997          247788776542211 122356766666643223 455555433  346899999


Q ss_pred             -CCCChhhh------------------HhcCCC---CCcC-hHHHHHHHH--------------HHHHHHH----HHh-c
Q 006668          403 -PNGSLNNW------------------IFGKPK---KLLG-WKQRRQILA--------------DVAEGLN----YLH-H  440 (636)
Q Consensus       403 -~~gsL~~~------------------l~~~~~---~~l~-~~~~~~i~~--------------~ia~~L~----yLH-~  440 (636)
                       ++.+|...                  +|....   ...+ +.....+..              .+...+.    .|. .
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             66555321                  111110   0000 011111100              0111111    111 1


Q ss_pred             cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       441 ~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      .....++|+|+.+.||+ ..++.+.++||..+..
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            22456999999999999 5666789999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.79  E-value=0.0021  Score=68.82  Aligned_cols=78  Identities=14%  Similarity=0.185  Sum_probs=49.5

Q ss_pred             ceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVY  399 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~  399 (636)
                      .+.|+.|-...+|+........   .....+++|+......  ...+.+|..++..|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568888899999998653210   1126788998844211  1344578888887753333 566766543    2899


Q ss_pred             eecCCCCh
Q 006668          400 DYMPNGSL  407 (636)
Q Consensus       400 E~~~~gsL  407 (636)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.78  E-value=0.0039  Score=65.52  Aligned_cols=146  Identities=21%  Similarity=0.264  Sum_probs=83.4

Q ss_pred             ceeeeecCceEEEeeeecCC---CCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeeeccccccceEEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANN---NNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN-LVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~  399 (636)
                      .+.|..|-...+|+......   .......+++|+.... ........+|..+++.|...+ ..++++.+.++    +||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence            35677788899999886431   1112367888886432 223455568888887774222 35667666542    899


Q ss_pred             eecCCCChhhh-----------------HhcCC---CCCc--ChHHHHHHHHHHHH-------------------HHHHH
Q 006668          400 DYMPNGSLNNW-----------------IFGKP---KKLL--GWKQRRQILADVAE-------------------GLNYL  438 (636)
Q Consensus       400 E~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------~L~yL  438 (636)
                      ||++|.+|..-                 |+...   .+..  -|.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665421                 11111   1111  23444444433321                   22333


Q ss_pred             hc-----cCCCcEEeCCCCCCCEEEcCC----CcEEEeccCCccc
Q 006668          439 HH-----GWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKL  474 (636)
Q Consensus       439 H~-----~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~  474 (636)
                      ..     .....++|+|+.+.|||++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            21     224679999999999999876    7899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.59  E-value=0.0078  Score=61.75  Aligned_cols=33  Identities=45%  Similarity=0.475  Sum_probs=28.6

Q ss_pred             CCcEEeCCCCCCCEEEcCC----CcEEEeccCCcccc
Q 006668          443 DQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKLY  475 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~~  475 (636)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5689999999999999874    67999999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.54  E-value=0.0067  Score=65.39  Aligned_cols=75  Identities=11%  Similarity=0.075  Sum_probs=46.8

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEEeec
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+.|+.|-...+|+....+.+    ..+++|+........+ +-.+|..++..|...++ .++++.+..    .+||||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~----~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQ----AKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTT----EEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCC----ceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence            467888889999998865422    6788888754322111 11467888887765444 467776632    2599999


Q ss_pred             CCCCh
Q 006668          403 PNGSL  407 (636)
Q Consensus       403 ~~gsL  407 (636)
                      ++.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87555

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.29  E-value=0.023  Score=57.98  Aligned_cols=141  Identities=13%  Similarity=0.165  Sum_probs=78.5

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeeecc-----ccccceEEE
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--LVQMRGW-----CRKGNELML  397 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~-----~~~~~~~~l  397 (636)
                      ..|+ |....||+....++     ..+++|....... ....+..|..++..|....  +++++..     ....+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g-----~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDR-----RRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTC-----CCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcCCC-----CEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            4577 88889998765332     4689999864311 1234556777766664222  3444443     112355688


Q ss_pred             EEeecCCCChhh-----------h---Hhc--C-----CCCCcChHHH----------------------HHHHHHHHHH
Q 006668          398 VYDYMPNGSLNN-----------W---IFG--K-----PKKLLGWKQR----------------------RQILADVAEG  434 (636)
Q Consensus       398 V~E~~~~gsL~~-----------~---l~~--~-----~~~~l~~~~~----------------------~~i~~~ia~~  434 (636)
                      +||+++|..+..           .   ++.  .     ....+++...                      ...+..++..
T Consensus       105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  184 (328)
T 1zyl_A          105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA  184 (328)
T ss_dssp             EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence            999998755421           0   111  0     0111222111                      0111122222


Q ss_pred             HHHHhc-cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          435 LNYLHH-GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       435 L~yLH~-~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            222211 1256789999999999999 4 899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.13  E-value=0.011  Score=61.68  Aligned_cols=79  Identities=11%  Similarity=0.121  Sum_probs=42.9

Q ss_pred             ceeeeecCceEEEeeeecCCC----CCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNN----NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLV  398 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV  398 (636)
                      .+.|+.|....+|+.....++    ......+++|+....... ..+...|..+++.+...++ .++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            356778888899998754310    001146888877543222 1123467777777643333 35655432    2689


Q ss_pred             EeecCCCCh
Q 006668          399 YDYMPNGSL  407 (636)
Q Consensus       399 ~E~~~~gsL  407 (636)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.12  E-value=0.01  Score=56.56  Aligned_cols=100  Identities=15%  Similarity=0.056  Sum_probs=64.4

Q ss_pred             ChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCccccc
Q 006668          406 SLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR  485 (636)
Q Consensus       406 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  485 (636)
                      +|.+.|.. ...+++++++|.++.|.+.+|.-+-.  ...-..+=+.|..|+|..+|.+.+.+ ..+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            68887743 36789999999999999999887721  11111334457899999999988764 1110            


Q ss_pred             cccCCcccccccccCCCCCCccchHHHHHHHHHHHhCC
Q 006668          486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR  523 (636)
Q Consensus       486 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~  523 (636)
                       .....+.|||... ...+.+.-|||||+++|.-+--.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence             1123466888764 34567889999999999877533

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.18  E-value=0.19  Score=51.52  Aligned_cols=32  Identities=31%  Similarity=0.443  Sum_probs=28.5

Q ss_pred             CCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       443 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999888899999987764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.31  E-value=0.17  Score=53.28  Aligned_cols=31  Identities=35%  Similarity=0.486  Sum_probs=25.9

Q ss_pred             CcEEeCCCCCCCEEE------cCCCcEEEeccCCccc
Q 006668          444 QVVVHRDIKSGNILL------DSEMRGRLGDFGLAKL  474 (636)
Q Consensus       444 ~~ivHrDlkp~NIll------~~~~~~kl~DFGla~~  474 (636)
                      ..++|+|+.+.|||+      +++..++++||.+|..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            346899999999999      4567799999998864

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.78  E-value=0.35  Score=51.31  Aligned_cols=145  Identities=12%  Similarity=0.136  Sum_probs=82.3

Q ss_pred             ceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeeeccccccceEEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN-LVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~  399 (636)
                      .+.|..|-...+|+........   .....+++|+........ -+-.+|..+++.+...+ ..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778889999988753210   013678888875443211 12246777777664323 344554332    27899


Q ss_pred             eecCCCChhhh-----------------HhcC-----------CCCCcChHHHHHHHHHH-------------------H
Q 006668          400 DYMPNGSLNNW-----------------IFGK-----------PKKLLGWKQRRQILADV-------------------A  432 (636)
Q Consensus       400 E~~~~gsL~~~-----------------l~~~-----------~~~~l~~~~~~~i~~~i-------------------a  432 (636)
                      ||+++..|..-                 ||..           ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998764310                 0110           01111233333333222                   2


Q ss_pred             HHHHHHh---------------------ccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          433 EGLNYLH---------------------HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       433 ~~L~yLH---------------------~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ..+..|.                     ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233332                     112457999999999999 8888999999998864

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=87.34  E-value=0.049  Score=36.41  Aligned_cols=26  Identities=19%  Similarity=0.533  Sum_probs=18.0

Q ss_pred             CCCCccceEEehhhHHHHHHHHHHhh
Q 006668          252 SSSLSAGAVAGIVIGCVMGFLIICAS  277 (636)
Q Consensus       252 ~~~~~~~~~~~i~i~~~~~~l~~~~~  277 (636)
                      ++..+.+.++++++++++++.+++++
T Consensus         5 ~~~ls~GaIAGiVvG~v~gv~li~~l   30 (38)
T 2k1k_A            5 SRGLTGGEIVAVIFGLLLGAALLLGI   30 (38)
T ss_dssp             STTCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCceeeeehHHHHHHHHHHHH
Confidence            44566778889999887776554443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	636
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-37
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	2e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-36
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	2e-35
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	3e-35
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	3e-35
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	2e-34
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	3e-34
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	3e-34
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	4e-34
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-33
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	3e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-32
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	2e-32
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	4e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	1e-30
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	2e-30
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-30
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	5e-30
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	1e-29
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	5e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-26
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-25
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	2e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	2e-17
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	7e-16
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	8e-10
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 9e-69
 Identities = 68/306 (22%), Positives = 133/306 (43%), Gaps = 45/306 (14%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN 357
           ++WE+     + +  +             +GSG FG VYKG           ++AVK +N
Sbjct: 1   DDWEIP--DGQITVGQR------------IGSGSFGTVYKGKW-------HGDVAVKMLN 39

Query: 358 --HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
               + Q L+ F  E+  + + +H N++   G+     +L +V  +    SL + +    
Sbjct: 40  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE 98

Query: 416 KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY 475
            K     +   I    A+G++YLH    + ++HRD+KS NI L  ++  ++GDFGLA + 
Sbjct: 99  TKF-EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154

Query: 476 QQGEVPN-TTRVVGTLGYLAPELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKG 531
            +    +   ++ G++ ++APE+  +      +  SDVY+FG+V+ E+  G+ P      
Sbjct: 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---- 210

Query: 532 EEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR 591
                  ++  V   Y    +          +  +   + + +L   C       RP   
Sbjct: 211 NINNRDQIIFMVGRGYLSPDL---------SKVRSNCPKAMKRLMAECLKKKRDERPLFP 261

Query: 592 EVVAVL 597
           +++A +
Sbjct: 262 QILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 2e-66
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 41/300 (13%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN 357
           +EWE+     R + + +          E LG+G FG V+ G       N  T++AVK + 
Sbjct: 6   DEWEVP----RETLKLV----------ERLGAGQFGEVWMGYY-----NGHTKVAVKSLK 46

Query: 358 HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK 417
             S      F+AE + M +LQH+ LV++     +   + ++ +YM NGSL +++      
Sbjct: 47  QGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGI 104

Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
            L   +   + A +AEG+ ++     +  +HRD+++ NIL+   +  ++ DFGLA+L + 
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161

Query: 478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
            E          + + APE     + T  SDV+SFG+++ E+    R    G    E   
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--- 218

Query: 538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            ++  +   Y             R        E + +L   C       RPT   + +VL
Sbjct: 219 -VIQNLERGY-------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  217 bits (553), Expect = 3e-66
 Identities = 74/304 (24%), Positives = 140/304 (46%), Gaps = 38/304 (12%)

Query: 309 FSYEELSKATKGFSN---------DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD 359
           F++E+ ++A + F+          ++++G+G FG V  G L          +A+K +   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE-IFVAIKTLKSG 65

Query: 360 -SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL 418
            +++  ++F++E S MG+  H N++ + G   K   +M++ ++M NGSL++++     + 
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124

Query: 419 LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG 478
               Q   +L  +A G+ YL        VHRD+ + NIL++S +  ++ DFGL++  +  
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 479 EVPNTTR----VVGTLGYLAPELATVSSPTSASDVYSFGVVILE-VACGRRPLDMGKGEE 533
               T          + + APE       TSASDV+S+G+V+ E ++ G RP      ++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 534 EEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
              A+  D+                  R     +    + +L L C   D   RP   ++
Sbjct: 242 VINAIEQDY------------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 594 VAVL 597
           V  L
Sbjct: 284 VNTL 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 2e-64
 Identities = 79/300 (26%), Positives = 125/300 (41%), Gaps = 41/300 (13%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN 357
           + WE+         E              LG G FG V+ GT      N +T +A+K + 
Sbjct: 10  DAWEIP--RESLRLEVK------------LGQGCFGEVWMGTW-----NGTTRVAIKTL- 49

Query: 358 HDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKK 417
                  + F+ E   M +L+H+ LVQ+     +   + +V +YM  GSL +++ G+  K
Sbjct: 50  KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK 108

Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
            L   Q   + A +A G+ Y+        VHRD+++ NIL+   +  ++ DFGLA+L + 
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165

Query: 478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEA 537
            E          + + APE A     T  SDV+SFG+++ E+    R    G    E   
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--- 222

Query: 538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            ++D V   Y             R     E  E +  L   C   +   RPT   + A L
Sbjct: 223 -VLDQVERGY-------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  208 bits (530), Expect = 5e-63
 Identities = 62/292 (21%), Positives = 122/292 (41%), Gaps = 25/292 (8%)

Query: 306 PHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLK 365
           P   +Y++        +    LG G +G VY+G     +      +AVK +  D+ + ++
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTME-VE 58

Query: 366 EFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRR 425
           EF+ E + M  ++H NLVQ+ G C +     ++ ++M  G+L +++    ++ +      
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
            +   ++  + YL     +  +HRD+ + N L+      ++ DFGL++L           
Sbjct: 119 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

Query: 486 VVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN 545
               + + APE    +  +  SDV++FGV++ E+A        G    +           
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------- 224

Query: 546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                 + E  +   R E      E V +L  AC   + + RP+  E+    
Sbjct: 225 ------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 4e-62
 Identities = 60/273 (21%), Positives = 120/273 (43%), Gaps = 27/273 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +GSG FG V+ G   N       ++A+K +  +     ++F+ E   M +L H  LVQ
Sbjct: 11  QEIGSGQFGLVHLGYWLNK-----DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C +   + LV+++M +G L++++    + L   +    +  DV EG+    +  + 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGM---AYLEEA 120

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
            V+HRD+ + N L+      ++ DFG+ +     +  ++T     + + +PE+ + S  +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
           S SDV+SFGV++ EV    +     +   E    +++ +   +             R   
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGF-------------RLYK 223

Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                  V ++   C       RP    ++  L
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-61
 Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 24/280 (8%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQH 379
            +  +++G+G FG VYKG L  ++      +A+K +     +    +F+ E   MG+  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N++++ G   K   +M++ +YM NG+  +    +        Q   +L  +A G+ YL 
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRV--VGTLGYLAPEL 497
           +      VHRD+ + NIL++S +  ++ DFGL+++ +       T       + + APE 
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD 557
            +    TSASDV+SFG+V+ EV              E                 + +A +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----------------VMKAIN 227

Query: 558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
              R     +    + +L + C   +  RRP   ++V++L
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 6e-61
 Identities = 60/299 (20%), Positives = 114/299 (38%), Gaps = 37/299 (12%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGL-KEFMAEISSMGRLQH 379
           F     LG+G  G V+K +    +  +   MA K ++ + K  +  + + E+  +     
Sbjct: 8   FEKISELGAGNGGVVFKVS----HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             +V   G      E+ +  ++M  GSL+  +  K    +  +   ++   V +GL YL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
                 ++HRD+K  NIL++S    +L DFG++              VGT  Y++PE   
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQ 176

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEE-------EAVLMDWVRNLYGQGKI 552
            +  +  SD++S G+ ++E+A GR P+     +E E       E    +        G+ 
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 553 CEAADARIRQEFEAEEM------------------ELVLKLGLACCHPDSTRRPTMREV 593
             +     R      E+                           C   +   R  ++++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 8e-61
 Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 31/294 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E +G G FG V++G           E+AVK  +   ++      AEI     L+H+N++ 
Sbjct: 9   ESIGKGRFGEVWRGKW------RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILG 61

Query: 385 MRGWCRKGN----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
                 K N    +L LV DY  +GSL +++       +  +   ++    A GL +LH 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHM 118

Query: 441 -----GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGY 492
                     + HRD+KS NIL+       + D GLA  +              VGT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 493 LAPELATVS------SPTSASDVYSFGVVILEVACGRRPLDMGKGEEE--EEAVLMDWVR 544
           +APE+   S           +D+Y+ G+V  E+A       + +  +    + V  D   
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 545 NLYGQGKICEAADARIRQEFE-AEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
               +    +     I   ++  E + ++ K+   C + +   R T   +   L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-60
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + LG+G FG V  G           ++A+K +   S     EF+ E   M  L H+ LVQ
Sbjct: 10  KELGTGQFGVVKYGKW-----RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           + G C K   + ++ +YM NG L N++     +    +Q  ++  DV E + YL      
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQ-- 120

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPT 504
             +HRD+ + N L++ +   ++ DFGL++     E  ++      + +  PE+   S  +
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 505 SASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEF 564
           S SD+++FGV++ E+    +         E                   E     +R   
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQGLRLYR 222

Query: 565 EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV 598
                E V  +  +C H  +  RPT + +++ ++
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-60
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 30/291 (10%)

Query: 312 EELSKATKGFSNDEL-LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMA 369
           ++L          ++ LG G FG V +G           ++A+K +   +++   +E M 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ--IDVAIKVLKQGTEKADTEEMMR 58

Query: 370 EISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILA 429
           E   M +L +  +V++ G C+    LMLV +    G L+ ++ GK +++       ++L 
Sbjct: 59  EAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLH 116

Query: 430 DVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VV 487
            V+ G+ YL     +  VHRD+ + N+LL +    ++ DFGL+K     +   T R    
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 488 GTLGYLAPELATVSSPTSASDVYSFGVVILEV-ACGRRPLDMGKGEEEEEAVLMDWVRNL 546
             L + APE       +S SDV+S+GV + E  + G++P    KG E     +M ++   
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIEQG 228

Query: 547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                         R E   E    +  L   C       RP    V   +
Sbjct: 229 K-------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-60
 Identities = 63/274 (22%), Positives = 120/274 (43%), Gaps = 30/274 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G FG+VYK      N   S   A K ++  S++ L+++M EI  +    H N+V+
Sbjct: 18  GELGDGAFGKVYKAQ----NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +       N L ++ ++   G+++  +  + ++ L   Q + +     + LNYLH   D 
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DN 129

Query: 445 VVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP- 503
            ++HRD+K+GNIL   +   +L DFG++    +      +  +GT  ++APE+    +  
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSK 188

Query: 504 ----TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
                  +DV+S G+ ++E+A    P      E     VL+   ++        E     
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHH----ELNPMRVLLKIAKS--------EPPTLA 236

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
               + +   + + K    C   +   R T  ++
Sbjct: 237 QPSRWSSNFKDFLKK----CLEKNVDARWTTSQL 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 7e-60
 Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 31/278 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRLQHKNL 382
             +G+G +GR  K        ++   +  K +++ S  +   +  ++E++ +  L+H N+
Sbjct: 10  YTIGTGSYGRCQKIR----RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 383 VQMRGWC--RKGNELMLVYDYMPNGSLNNWIF--GKPKKLLGWKQRRQILADVAEGLNYL 438
           V+       R    L +V +Y   G L + I    K ++ L  +   +++  +   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 439 H--HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           H        V+HRD+K  N+ LD +   +LGDFGLA++            VGT  Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPE 184

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
                S    SD++S G ++ E+     P        ++E             GKI E  
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELA-----------GKIREGK 230

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
             RI   +  E  E++ +      +     RP++ E++
Sbjct: 231 FRRIPYRYSDELNEIITR----MLNLKDYHRPSVEEIL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-59
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 33/274 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           + +G G FG V  G           ++AVKC+ +D+    + F+AE S M +L+H NLVQ
Sbjct: 13  QTIGKGEFGDVMLGDY------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64

Query: 385 MRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           + G    +   L +V +YM  GSL +++  + + +LG     +   DV E + YL     
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 121

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
              VHRD+ + N+L+  +   ++ DFGL K                + + APE       
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKF 177

Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE 563
           ++ SDV+SFG+++ E+    R        ++    ++  V   Y             + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGY-------------KMD 220

Query: 564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                   V ++   C H D+  RP+  ++   L
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (508), Expect = 2e-59
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 37/283 (13%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG---LKEFMAEISSM 374
            K FS+   +G G FG VY       +  NS  +A+K +++  KQ     ++ + E+  +
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
            +L+H N +Q RG   + +   LV +Y    + +       KK L   +   +     +G
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L YLH      ++HRD+K+GNILL      +LGDFG A +            VGT  ++A
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMA 179

Query: 495 PELATVSSP---TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK 551
           PE+             DV+S G+  +E+A  + PL          + L            
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALY----------H 225

Query: 552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
           I +     ++    +E     +    +C       RPT   ++
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 7e-59
 Identities = 63/298 (21%), Positives = 112/298 (37%), Gaps = 45/298 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNS-TEMAVKCVNHDSKQGL-KEFMAEISSMGRLQHKNL 382
             +G G FGRV++            T +AVK +  ++   +  +F  E + M    + N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL----------------------LG 420
           V++ G C  G  + L+++YM  G LN ++                             L 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK-LYQQGE 479
             ++  I   VA G+ YL        VHRD+ + N L+   M  ++ DFGL++ +Y    
Sbjct: 139 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 480 VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL 539
                     + ++ PE    +  T+ SDV+++GVV+ E+         G   EE    +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----V 251

Query: 540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
           + +VR+                          +  L   C       RP+   +  +L
Sbjct: 252 IYYVRDGN-------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-58
 Identities = 72/279 (25%), Positives = 115/279 (41%), Gaps = 31/279 (11%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKN 381
           D+ LGSG FG V KG            +AVK + +++       E +AE + M +L +  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVV--KTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +V+M G C   +  MLV +    G LN ++       +  K   +++  V+ G+ YL   
Sbjct: 70  IVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE- 125

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR--VVGTLGYLAPELAT 499
                VHRD+ + N+LL ++   ++ DFGL+K  +  E     +      + + APE   
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 500 VSSPTSASDVYSFGVVILE-VACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
               +S SDV+SFGV++ E  + G++P    KG E    +                    
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------------- 227

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             R    A     +  L   C   D   RP    V   L
Sbjct: 228 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 7e-58
 Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 27/279 (9%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNL 382
           +E++G G FG VY GTL +N+       AVK +N  +  G + +F+ E   M    H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKK-IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 383 VQMRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           + + G C R     ++V  YM +G L N+I  +       K        VA+G+      
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGM---KFL 146

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE---VPNTTRVVGTLGYLAPELA 498
             +  VHRD+ + N +LD +   ++ DFGLA+     E   V N T     + ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
                T+ SDV+SFGV++ E+     P        +    +  ++               
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGR----------- 251

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             R        + + ++ L C HP +  RP+  E+V+ +
Sbjct: 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-57
 Identities = 65/278 (23%), Positives = 119/278 (42%), Gaps = 34/278 (12%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKN 381
           D  +G G F  VYKG     +   + E+A   +     +K   + F  E   +  LQH N
Sbjct: 14  DIEIGRGSFKTVYKGL----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 382 LVQMRGWC----RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +V+         +    ++LV + M +G+L  ++  K  K++  K  R     + +GL +
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQF 127

Query: 438 LHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           LH     ++ HRD+K  NI +       ++GD GLA L +         V+GT  ++APE
Sbjct: 128 LHTRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPE 183

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA 556
           +        + DVY+FG+ +LE+A    P      E +  A +   V +        + A
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVA 238

Query: 557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
              ++        E++      C   +   R ++++++
Sbjct: 239 IPEVK--------EIIEG----CIRQNKDERYSIKDLL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-57
 Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 46/299 (15%)

Query: 325 ELLGSGGFGRVYKGTL-ANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRL-QHKN 381
           ++LGSG FG+V   T    +    S ++AVK +   +     +  M+E+  M +L  H+N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKL---------------------LG 420
           +V + G C     + L+++Y   G L N++  K +K                      L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 421 WKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEV 480
           ++        VA+G+ +L     +  VHRD+ + N+L+      ++ DFGLA+       
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 481 PNT-TRVVGTLGYLAPELATVSSPTSASDVYSFGVVILE-VACGRRPLDMGKGEEEEEAV 538
                     + ++APE       T  SDV+S+G+++ E  + G  P          +A 
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----GIPVDAN 275

Query: 539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
               ++N               + +      E +  +  +C   DS +RP+   + + L
Sbjct: 276 FYKLIQN-------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 4e-57
 Identities = 63/320 (19%), Positives = 119/320 (37%), Gaps = 53/320 (16%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTL-ANNNNNNSTEMAVKCV 356
            +WE     +R S+ +             LG+G FG+V + T      ++ +  +AVK +
Sbjct: 16  HKWEFP--RNRLSFGKT------------LGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 357 NHDSKQG-LKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK 414
              +     +  M+E+  +  L  H N+V + G C  G   +++ +Y   G L N++  K
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 415 PKKL----------------LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILL 458
                               L  +        VA+G+ +L        +HRD+ + NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178

Query: 459 DSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVIL 517
                 ++ DFGLA+ +               + ++APE       T  SDV+S+G+ + 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

Query: 518 EVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGL 577
           E+         G   + +       ++                R          +  +  
Sbjct: 239 ELFSLGSSPYPGMPVDSK---FYKMIKE-------------GFRMLSPEHAPAEMYDIMK 282

Query: 578 ACCHPDSTRRPTMREVVAVL 597
            C   D  +RPT +++V ++
Sbjct: 283 TCWDADPLKRPTFKQIVQLI 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-57
 Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 40/293 (13%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRL-Q 378
               +++G G FG+V K  +    +    + A+K +  + SK   ++F  E+  + +L  
Sbjct: 12  IKFQDVIGEGNFGQVLKARI--KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQR 424
           H N++ + G C     L L  +Y P+G+L +++                     L  +Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
               ADVA G++YL     +  +HRD+ + NIL+      ++ DFGL++  +       T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKT 184

Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
                + ++A E    S  T+ SDV+S+GV++ E+         G    E    L + + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240

Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             Y             R E      + V  L   C       RP+  +++  L
Sbjct: 241 QGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-56
 Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 34/273 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---HDSKQGLKEFMAEISSMGRLQHKN 381
             LG G FG VY      +       +A+K +     +      +   E+     L+H N
Sbjct: 12  RPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           ++++ G+      + L+ +Y P G++   +    K     ++    + ++A  L+Y H  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH-- 123

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + V+HRDIK  N+LL S    ++ DFG +           T + GTL YL PE+    
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGR 179

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
                 D++S GV+  E   G+ P +    +E  + +                  +    
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------RVEFTFP 224

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVV 594
                   +L+ +        + ++RP +REV+
Sbjct: 225 DFVTEGARDLISR----LLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-56
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 26/292 (8%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH-DSKQGLKEFMAEISSMGRLQH 379
           F   ++LGSG FG VYKG            +A+K +    S +  KE + E   M  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            ++ ++ G C     + L+   MP G L +++  + K  +G +        +A+G+NYL 
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE-VPNTTRVVGTLGYLAPELA 498
                 +VHRD+ + N+L+ +    ++ DFGLAKL    E   +       + ++A E  
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA 558
                T  SDV+S+GV + E+         G    E                 I    + 
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEK 228

Query: 559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPKELL 610
             R          V  + + C   D+  RP  RE++      ++A  P+  L
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYL 278

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-56
 Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 27/276 (9%)

Query: 318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL 377
            K ++  E +G G  G VY       +     E+A++ +N   +   +  + EI  M   
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAM----DVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74

Query: 378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           ++ N+V        G+EL +V +Y+  GSL + +           Q   +  +  + L +
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEF 131

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPEL 497
           LH      V+HRDIKS NILL  +   +L DFG        +    + +VGT  ++APE+
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEV 187

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD 557
            T  +     D++S G++ +E+  G  P            +  +    L           
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL----------- 236

Query: 558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
            +  ++  A   + + +    C   D  +R + +E+
Sbjct: 237 -QNPEKLSAIFRDFLNR----CLDMDVEKRGSAKEL 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-56
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 28/272 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN-HDSKQGLKEFMAEISSMGRLQHKNLV 383
           + LG G +G V        N      +AVK V+   +    +    EI     L H+N+V
Sbjct: 11  QTLGEGAYGEVQLAV----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           +  G  R+GN   L  +Y   G L + I  +P   +     ++    +  G+ YLH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG--- 121

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG-EVPNTTRVVGTLGYLAPE-LATVS 501
             + HRDIK  N+LLD     ++ DFGLA +++         ++ GTL Y+APE L    
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
                 DV+S G+V+  +  G  P D      +      DW                   
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKT---------YLNPW 229

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           ++ ++  + L+ K        + + R T+ ++
Sbjct: 230 KKIDSAPLALLHK----ILVENPSARITIPDI 257

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-55
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 27/278 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E LG G FG V +G   +  +  +  +AVKC+  D     + + +F+ E+++M  L H+N
Sbjct: 14  EKLGDGSFGVVRRGEW-DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L+++ G       + +V +  P GSL + +       L      +    VAEG+ YL   
Sbjct: 73  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLES- 129

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE--VPNTTRVVGTLGYLAPELAT 499
             +  +HRD+ + N+LL +    ++GDFGL +   Q +              + APE   
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 500 VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR 559
             + + ASD + FGV + E+    +   +G    +    ++  +                
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDK------------EG 231

Query: 560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            R     +  + +  + + C       RPT   +   L
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  189 bits (480), Expect = 4e-55
 Identities = 63/271 (23%), Positives = 115/271 (42%), Gaps = 27/271 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG+G FG V++ T            A K V    +   +    EI +M  L+H  LV 
Sbjct: 32  EELGTGAFGVVHRVT----ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +       NE++++Y++M  G L   +  +  K+    +  + +  V +GL ++H   + 
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMRQVCKGLCHMH---EN 143

Query: 445 VVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
             VH D+K  NI+  ++      L DFGL       +    T   GT  + APE+A    
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP 201

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ 562
               +D++S GV+   +  G  P     GE ++E   +  V++      + ++A + I +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFG---GENDDE--TLRNVKS--CDWNMDDSAFSGISE 254

Query: 563 EFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           + +    + + K        D   R T+ + 
Sbjct: 255 DGK----DFIRK----LLLADPNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-54
 Identities = 62/274 (22%), Positives = 113/274 (41%), Gaps = 24/274 (8%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-FMAEISSMGRLQHKNLV 383
             +G G FG V++G    +  N +  +A+K   + +   ++E F+ E  +M +  H ++V
Sbjct: 13  RCIGEGQFGDVHQGIY-MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
           ++ G   +   + ++ +    G L +++  +   L            ++  L YL     
Sbjct: 72  KLIGVITENP-VWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLSTALAYLE---S 126

Query: 444 QVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP 503
           +  VHRDI + N+L+ S    +LGDFGL++  +       ++    + ++APE       
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 504 TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQE 563
           TSASDV+ FGV + E+         G    +               G+I       +   
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------------IGRIENGERLPMPPN 233

Query: 564 FEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                  L+ K    C   D +RRP   E+ A L
Sbjct: 234 CPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  183 bits (466), Expect = 5e-53
 Identities = 57/271 (21%), Positives = 104/271 (38%), Gaps = 27/271 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LGSG FG V++                K +N            EIS M +L H  L+ 
Sbjct: 35  EELGSGAFGVVHRCV----EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +        E++L+ +++  G L + I  +  K +   +    +    EGL ++H   + 
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EH 146

Query: 445 VVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            +VH DIK  NI+ +++      + DFGLA      E+        T  + APE+     
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREP 204

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ 562
               +D+++ GV+   +  G  P     GE++ E              +  E A + +  
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLET----LQNVKRCDWEFDEDAFSSVSP 257

Query: 563 EFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           E +    + +          +  +R T+ + 
Sbjct: 258 EAK----DFIKN----LLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-52
 Identities = 64/311 (20%), Positives = 129/311 (41%), Gaps = 45/311 (14%)

Query: 298 EEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNS-TEMAVKCV 356
           +EWE+     + +                LG G FG VY+G       +   T +A+K V
Sbjct: 13  DEWEVA--REKITMSRE------------LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58

Query: 357 NHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKP 415
           N   S +   EF+ E S M      ++V++ G   +G   +++ + M  G L +++    
Sbjct: 59  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118

Query: 416 KKL--------LGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG 467
             +            +  Q+  ++A+G+ YL        VHRD+ + N ++  +   ++G
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIG 175

Query: 468 DFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPL 526
           DFG+ + +Y+        + +  + +++PE       T+ SDV+SFGVV+ E+A      
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235

Query: 527 DMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTR 586
             G   E+    ++ +V                   +      +++ +L   C   +   
Sbjct: 236 YQGLSNEQ----VLRFVME-------------GGLLDKPDNCPDMLFELMRMCWQYNPKM 278

Query: 587 RPTMREVVAVL 597
           RP+  E+++ +
Sbjct: 279 RPSFLEIISSI 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-51
 Identities = 67/293 (22%), Positives = 126/293 (43%), Gaps = 40/293 (13%)

Query: 325 ELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QH 379
           + LG G FG+V        +    N  T++AVK +  D +++ L + ++E+  M  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRR 425
           KN++ + G C +   L ++ +Y   G+L  ++  +              P++ L  K   
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 426 QILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTR 485
                VA G+ YL     +  +HRD+ + N+L+  +   ++ DFGLA+     +    T 
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 486 V-VGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
                + ++APE       T  SDV+SFGV++ E+         G   EE    L   ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFKLLK 251

Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
             +             R +  +     +  +   C H   ++RPT +++V  L
Sbjct: 252 EGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-51
 Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 32/273 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           ++LG G F  V            S E A+K +       +  +     E   M RL H  
Sbjct: 14  KILGEGSFSTVVLAR----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
            V++    +   +L     Y  NG L  +I             R   A++   L YLH  
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH-- 125

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY-QQGEVPNTTRVVGTLGYLAPELATV 500
             + ++HRD+K  NILL+ +M  ++ DFG AK+   + +       VGT  Y++PEL T 
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
            S   +SD+++ G +I ++  G  P          E ++           KI +  +   
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFR-----AGNEYLIFQ---------KIIK-LEYDF 229

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
            ++F  +  +LV K        D+T+R    E+
Sbjct: 230 PEKFFPKARDLVEK----LLVLDATKRLGCEEM 258

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 62/273 (22%), Positives = 110/273 (40%), Gaps = 30/273 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQHKNLV 383
           ++LG+G F  V        +      +A+KC+   + +G       EI+ + +++H N+V
Sbjct: 15  DVLGTGAFSEVILAE----DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            +      G  L L+   +  G L + I    K     +   +++  V + + YLH    
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG- 127

Query: 444 QVVVHRDIKSGNILL---DSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
             +VHRD+K  N+L    D + +  + DFGL+K+   G V +T    GT GY+APE+   
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVLAQ 183

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
              + A D +S GV+   + CG  P       +  E +L                 D+  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-----------DSPY 232

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
             +      + +          D  +R T  + 
Sbjct: 233 WDDISDSAKDFIRH----LMEKDPEKRFTCEQA 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-48
 Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 52/321 (16%)

Query: 296 EIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNN-NSTEMAVK 354
           +  +WE      R    +             LG G FG+V +      +       +AVK
Sbjct: 4   DASKWEFP--RDRLKLGKP------------LGRGAFGQVIEADAFGIDKTATCRTVAVK 49

Query: 355 CVNHDSKQG-LKEFMAEISSMGR-LQHKNLVQMRGWC-RKGNELMLVYDYMPNGSLNNWI 411
            +   +     +  M+E+  +     H N+V + G C + G  LM++ ++   G+L+ ++
Sbjct: 50  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109

Query: 412 FGK--------------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL 457
             K               K  L  +        VA+G+ +L     +  +HRD+ + NIL
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166

Query: 458 LDSEMRGRLGDFGLAK-LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVI 516
           L  +   ++ DFGLA+ +Y+  +          L ++APE       T  SDV+SFGV++
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226

Query: 517 LEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLG 576
            E+         G   +EE                 C       R          + +  
Sbjct: 227 WEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRMRAPDYTTPEMYQTM 270

Query: 577 LACCHPDSTRRPTMREVVAVL 597
           L C H + ++RPT  E+V  L
Sbjct: 271 LDCWHGEPSQRPTFSELVEHL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  167 bits (424), Expect = 5e-48
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 42/289 (14%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN---------HDSKQGLKEFMAEI 371
           +   E+LG G    V +      +     E AVK ++          + ++  +  + E+
Sbjct: 5   YEPKEILGRGVSSVVRRCI----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 372 SSMGRLQ-HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILAD 430
             + ++  H N++Q++          LV+D M  G L +++    K  L  K+ R+I+  
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRA 118

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTL 490
           + E +  LH      +VHRD+K  NILLD +M  +L DFG +     GE      V GT 
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTP 173

Query: 491 GYLAPELATVSSP------TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR 544
            YLAPE+   S            D++S GV++  +  G  P         ++ +++  + 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIM 228

Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           +  G  +             +    +LV +           +R T  E 
Sbjct: 229 S--GNYQFGSPEWDDYSDTVK----DLVSR----FLVVQPQKRYTAEEA 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 9e-48
 Identities = 52/271 (19%), Positives = 101/271 (37%), Gaps = 28/271 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
           E LG G FG V++        ++      K V             EIS +   +H+N++ 
Sbjct: 11  EDLGRGEFGIVHRCV----ETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65

Query: 385 MRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQ 444
           +        EL+++++++    +   I     +L   ++    +  V E L +LH     
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFEL-NEREIVSYVHQVCEALQFLH---SH 121

Query: 445 VVVHRDIKSGNILLDSEMRGR--LGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
            + H DI+  NI+  +       + +FG A+  + G+            Y APE+     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDV 179

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQ 562
            ++A+D++S G ++  +  G  P      ++  E +       +  +    E A   I  
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------MNAEYTFDEEAFKEISI 232

Query: 563 EFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           E     M+ V +        +   R T  E 
Sbjct: 233 EA----MDFVDR----LLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 69/284 (24%), Positives = 114/284 (40%), Gaps = 34/284 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           E+LG GG   V+       +     ++AVK +  D          F  E  +   L H  
Sbjct: 13  EILGFGGMSEVHLAR----DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 382 LVQMRGWCR----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNY 437
           +V +          G    +V +Y+   +L + +    +  +  K+  +++AD  + LN+
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126

Query: 438 LHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE--VPNTTRVVGTLGYLAP 495
                   ++HRD+K  NI++ +    ++ DFG+A+        V  T  V+GT  YL+P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
           E A   S  + SDVYS G V+ EV  G  P       +   +V    VR           
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVREDP-------I 232

Query: 556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVLV 598
             +   +   A+   +VLK        +   R  T  E+ A LV
Sbjct: 233 PPSARHEGLSADLDAVVLK----ALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 35/282 (12%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAE---ISSM 374
           FS   ++G GGFG VY    A+         A+KC++      KQG    + E   +S +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
                  +V M       ++L  + D M  G L+  +      +      R   A++  G
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG 119

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           L ++H+ +   VV+RD+K  NILLD     R+ D GLA  + + +       VGT GY+A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173

Query: 495 PE-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC 553
           PE L    +  S++D +S G ++ ++  G  P    K +++ E              ++ 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------RMT 221

Query: 554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
                 +   F  E   L+          D  RR       A
Sbjct: 222 LTMAVELPDSFSPELRSLLEG----LLQRDVNRRLGCLGRGA 259

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-45
 Identities = 57/278 (20%), Positives = 105/278 (37%), Gaps = 33/278 (11%)

Query: 324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRL-QHKNL 382
            ++LG G  G+V +      N     + A+K +         +   E+    R  Q  ++
Sbjct: 17  SQVLGLGINGKVLQIF----NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 67

Query: 383 VQMRGWCR----KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           V++             L++V + +  G L + I  +  +    ++  +I+  + E + YL
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRG---RLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           H      + HRD+K  N+L  S+      +L DFG AK         T     T  Y+AP
Sbjct: 128 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAP 182

Query: 496 ELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA 555
           E+        + D++S GV++  + CG  P                  R   GQ +    
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
             + + +E +     L+          + T+R T+ E 
Sbjct: 240 EWSEVSEEVK----MLIRN----LLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 33/272 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGR-LQHK 380
           ++LG G FG+V+           +   A+K +  D       ++  M E   +    +H 
Sbjct: 8   KMLGKGSFGKVFLAE----FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 381 NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH 440
            L  M    +    L  V +Y+  G L   I    K      +     A++  GL +L  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL-- 119

Query: 441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATV 500
              + +V+RD+K  NILLD +   ++ DFG+ K    G+    T   GT  Y+APE+   
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177

Query: 501 SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARI 560
                + D +SFGV++ E+  G+ P     G++EEE  L   +R            +   
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEE--LFHSIRM----------DNPFY 222

Query: 561 RQEFEAEEMELVLKLGLACCHPDSTRRPTMRE 592
            +  E E  +L++K        +  +R  +R 
Sbjct: 223 PRWLEKEAKDLLVK----LFVREPEKRLGVRG 250

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 3e-44
 Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 28/289 (9%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQ 378
           F   E +G G +G VYK      N      +A+K +  D  ++      + EIS +  L 
Sbjct: 4   FQKVEKIGEGTYGVVYKAR----NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N+V++       N+L LV++++ +  L  ++       +     +  L  + +GL + 
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELA 498
                  V+HRD+K  N+L+++E   +L DFGLA+ +       T  VV         L 
Sbjct: 119 ---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 499 TVSSPTSASDVYSFGVVILEVACGRRPLD--------------MGKGEEEEEAVLMDWVR 544
                ++A D++S G +  E+   R                  +G  +E     +     
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 545 NLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                 K      +++    + +   L+ +      H D  +R + +  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-44
 Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 32/292 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHK 380
           +++ +++G+G FG VY+  L ++       +A+K V  D +        E+  M +L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDKRF----KNRELQIMRKLDHC 73

Query: 381 NLVQMRGWCRKGNE------LMLVYDYMPNGSLNNWI-FGKPKKLLGWKQRRQILADVAE 433
           N+V++R +     E      L LV DY+P         + + K+ L     +  +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 434 GLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGY 492
            L Y+H      + HRDIK  N+LLD +    +L DFG AK   +GE   +   + +  Y
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYY 188

Query: 493 LAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL----------MD 541
            APEL   ++  TS+ DV+S G V+ E+  G+       G ++   ++          + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
            +   Y + K  +       + F        + L         T R T  E 
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-43
 Identities = 57/294 (19%), Positives = 114/294 (38%), Gaps = 32/294 (10%)

Query: 321 FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-LKEFMAEISSMGRLQH 379
           ++N   +G G +G V        +N N   +A+K ++    Q   +  + EI  + R +H
Sbjct: 10  YTNLSYIGEGAYGMVCSAY----DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPK-KLLGWKQRRQILADVAEGLNYL 438
           +N++ +    R      +   Y+    +   ++   K + L        L  +  GL Y+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 439 HHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNT--TRVVGTLGYLAPE 496
           H      V+HRD+K  N+LL++    ++ DFGLA++           T  V T  Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 497 LATVSSPTS-ASDVYSFGVVILEVACGRRP----------------LDMGKGEEEEEAVL 539
           +   S   + + D++S G ++ E+   R                  L     E+    + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 540 MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           +     L       +    R+    +++ ++L+ K        +  +R  + + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK----MLTFNPHKRIEVEQA 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-43
 Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 27/285 (9%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE-----FMAEISSMGRLQH 379
           + LG G F  VYK    N N      +A+K +    +   K+      + EI  +  L H
Sbjct: 4   DFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 380 KNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
            N++ +       + + LV+D+M        I      +L     +  +    +GL YLH
Sbjct: 60  PNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELAT 499
             W   ++HRD+K  N+LLD     +L DFGLAK +        T  V T  Y APEL  
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLF 173

Query: 500 VSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ--GKICEAA 556
            +       D+++ G ++ E+      L  G  + ++   + + +     +    +C   
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 557 DARIRQEFEAEEMELVLK--------LGLACCHPDSTRRPTMREV 593
           D    + F    +  +          L       +   R T  + 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 5e-43
 Identities = 65/297 (21%), Positives = 126/297 (42%), Gaps = 25/297 (8%)

Query: 314 LSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--LKEFMAEI 371
           L +A + +     +G G +G+V+K     +  N    +A+K V   + +       + E+
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKAR---DLKNGGRFVALKRVRVQTGEEGMPLSTIREV 58

Query: 372 SSMGRL---QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNW----IFGKPKKLLGWKQR 424
           + +  L   +H N+V++   C            +    ++      +   P+  +  +  
Sbjct: 59  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118

Query: 425 RQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTT 484
           + ++  +  GL++LH      VVHRD+K  NIL+ S  + +L DFGLA++Y       + 
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS- 174

Query: 485 RVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVL----- 539
            VV TL Y APE+   SS  +  D++S G +  E+   +         ++   +L     
Sbjct: 175 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 540 ---MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
               DW R++    +   +  A+  ++F  +  EL   L L C   +  +R +    
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 46/279 (16%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKE------FMAEISSMGRLQ 378
            LLGSGGFG VY G       +++  +A+K V  D      E         E+  + ++ 
Sbjct: 10  PLLGSGGFGSVYSGI----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 379 --HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
                ++++  W  + +  +L+ +               +  L  +  R     V E + 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVR 124

Query: 437 YLHHGWDQVVVHRDIKSGNILLD-SEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAP 495
           +     +  V+HRDIK  NIL+D +    +L DFG   L +       T   GT  Y  P
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178

Query: 496 E-LATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
           E +        ++ V+S G+++ ++ CG  P       E +E ++               
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------EHDEEIIR-------------- 218

Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                 RQ   +E   L+      C     + RPT  E+
Sbjct: 219 -GQVFFRQRVSSECQHLIRW----CLALRPSDRPTFEEI 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-42
 Identities = 53/279 (18%), Positives = 104/279 (37%), Gaps = 36/279 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN------HDSKQGLKEFMAEISSMGRLQ 378
           E LGSG F  V K        +   + A K +              ++   E+S +  +Q
Sbjct: 16  EELGSGQFAVVKKCR----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 379 HKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYL 438
           H N++ +        +++L+ + +  G L +++  K    L  ++  + L  +  G   +
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNG---V 126

Query: 439 HHGWDQVVVHRDIKSGNILLDSE----MRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLA 494
           ++     + H D+K  NI+L        R ++ DFGLA     G       + GT  ++A
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVA 184

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
           PE+         +D++S GV+   +  G  P       + ++  L +     Y       
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLANVSAVNY------- 233

Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
                   E+ +    L           D  +R T+++ 
Sbjct: 234 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (381), Expect = 7e-42
 Identities = 56/281 (19%), Positives = 104/281 (37%), Gaps = 22/281 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           E +G G +G VYK       NN     A+K +    + +      + EIS +  L+H N+
Sbjct: 8   EKIGEGTYGVVYKAQ-----NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++         L+LV++++        +    +  L     +  L  +  G+ Y H   
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
           D+ V+HRD+K  N+L++ E   ++ DFGLA+ +       T  +V         L     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 503 PTSASDVYSFGVVILEVACGRRPLD----------MGKGEEEEEAVLMDWVRNLYGQGKI 552
            ++  D++S G +  E+  G               + +      +     V  L      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
               +    + F     E  + L       D  +R T ++ 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 59/274 (21%), Positives = 112/274 (40%), Gaps = 35/274 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
             LG+G FGRV+       + +N    A+K +  +     + ++    E   +  + H  
Sbjct: 10  RTLGTGSFGRVHLIR----SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           +++M G  +   ++ ++ DY+  G L + +    +        +   A+V   L YLH  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH-- 121

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + +++RD+K  NILLD     ++ DFG AK         T  + GT  Y+APE+ +  
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTK 176

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
               + D +SFG++I E+  G  P       +       + + N          A+ R  
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFY-----DSNTMKTYEKILN----------AELRFP 221

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
             F  +  +L+ +        D ++R    +   
Sbjct: 222 PFFNEDVKDLLSR----LITRDLSQRLGNLQNGT 251

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-41
 Identities = 55/282 (19%), Positives = 107/282 (37%), Gaps = 22/282 (7%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQGLKEFMAEISSMGRLQHKNL 382
           E +G G +G V+K      N      +A+K V    D +      + EI  +  L+HKN+
Sbjct: 8   EKIGEGTYGTVFKAK----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 383 VQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGW 442
           V++        +L LV+++        +        L  +  +  L  + +GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 443 DQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSS 502
              V+HRD+K  N+L++     +L +FGLA+ +       +  VV         L     
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 503 PTSASDVYSFGVVILEVACGRRPLDMGKGEEE--EEAVLMDWVRNLYGQGKICEAADARI 560
            +++ D++S G +  E+A   RPL  G   ++  +    +           + +  D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 561 RQEFEAEEMELVLKLGL---------ACCHPDSTRRPTMREV 593
              + A    + +   L              +  +R +  E 
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 3e-40
 Identities = 49/283 (17%), Positives = 95/283 (33%), Gaps = 32/283 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             +GSG FG +Y GT    +     E+A+K     +K    +   E      +Q    + 
Sbjct: 13  RKIGSGSFGDIYLGT----DIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 385 MRGWC-RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
              WC  +G+  ++V + +     + +      +    K    +   +   + Y+H    
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---S 121

Query: 444 QVVVHRDIKSGNILLDSEMRGRL---GDFGLAKLYQQGEV------PNTTRVVGTLGYLA 494
           +  +HRD+K  N L+    +G L    DFGLAK Y+               + GT  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 495 PELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE 554
                    +   D+ S G V++    G  P    K   + +       + +        
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-------S 234

Query: 555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
                + + + +E    +      C       +P    +  + 
Sbjct: 235 TPIEVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 9e-40
 Identities = 48/285 (16%), Positives = 92/285 (32%), Gaps = 34/285 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH-KNLV 383
             +G G FG +++GT    N  N+ ++A+K     S     +   E  +   L     + 
Sbjct: 11  RRIGEGSFGVIFEGT----NLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64

Query: 384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWD 443
            +  + ++G   +LV D +  G     +     +    K        +   +  +H    
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119

Query: 444 QVVVHRDIKSGNILLDSEMRG-----RLGDFGLAKLYQQGEV------PNTTRVVGTLGY 492
           + +V+RDIK  N L+            + DFG+ K Y+               + GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 493 LAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI 552
           ++         +   D+ + G V +    G  P    K    ++              +I
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-----------RI 228

Query: 553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL 597
            E   +   +E  A   E   K      +      P    +  + 
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 2e-39
 Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 36/296 (12%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG--LKEFMAEISSMGRLQHKNL 382
             +G G FG V+K      +     ++A+K V  ++++       + EI  +  L+H+N+
Sbjct: 16  AKIGQGTFGEVFKAR----HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 383 VQMRGWC--------RKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
           V +   C        R    + LV+D+  +           K      + ++++  +   
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML--- 126

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP---NTTRVVGTLG 491
           LN L++     ++HRD+K+ N+L+  +   +L DFGLA+ +   +       T  V TL 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 492 YLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLD------------MGKGEEEEEAV 538
           Y  PEL           D++  G ++ E+      +                G    E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLK-LGLACCHPDSTRRPTMREV 593
                  LY + ++ +    +++   +A   +     L       D  +R    + 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 32/274 (11%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKN 381
           +LLG G FG+V                A+K +  +   +K  +   + E   +   +H  
Sbjct: 11  KLLGKGTFGKVILVR----EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 382 LVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG 441
           L  ++   +  + L  V +Y   G L   +    +++   ++ R   A++   L    + 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSAL---EYL 121

Query: 442 WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVS 501
             + VV+RDIK  N++LD +   ++ DFGL K              GT  YLAPE+   +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN 180

Query: 502 SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIR 561
               A D +  GVV+ E+ CGR P      E   E +LM+               + R  
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------------EIRFP 225

Query: 562 QEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
           +    E   L+          D  +R       A
Sbjct: 226 RTLSPEAKSLLAG----LLKKDPKQRLGGGPSDA 255

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 55/313 (17%), Positives = 117/313 (37%), Gaps = 46/313 (14%)

Query: 309 FSYEELSKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQ 362
           F  +E++K            + +GSG +G V        +     ++A+K +     S+ 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV----DGRTGAKVAIKKLYRPFQSEL 59

Query: 363 GLKEFMAEISSMGRLQHKNLVQMRGWCRKGN------ELMLVYDYMPNGSLNNWIFGKPK 416
             K    E+  +  ++H+N++ +              +  LV  +M  G+    +    K
Sbjct: 60  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK 117

Query: 417 KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ 476
             LG  + + ++  + +GL Y+H      ++HRD+K GN+ ++ +   ++ DFGLA+   
Sbjct: 118 --LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172

Query: 477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
                 T  VV         +      T   D++S G ++ E+  G+         ++ +
Sbjct: 173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 537 AVL----------------MDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACC 580
            ++                 +    + G  ++ +   A I        + L+ K      
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK----ML 285

Query: 581 HPDSTRRPTMREV 593
             D+ +R T  E 
Sbjct: 286 VLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 4e-37
 Identities = 58/308 (18%), Positives = 112/308 (36%), Gaps = 47/308 (15%)

Query: 286 KNKLKAQEEDEIEEWELEYWPHRF--SYEELSKATKGFSNDELLGSGGFGRVYKGTLANN 343
           K  L   +ED +++WE           ++ +          + LG+G FGRV        
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRI----------KTLGTGSFGRVMLVK---- 61

Query: 344 NNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYD 400
           +  +    A+K ++       + ++  + E   +  +    LV++    +  + L +V +
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 401 YMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS 460
           Y+  G + + +    +        R   A +     YLH      +++RD+K  N+L+D 
Sbjct: 122 YVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176

Query: 461 EMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVA 520
           +   ++ DFG AK  +      T  + GT   LAPE+        A D ++ GV+I E+A
Sbjct: 177 QGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 521 CGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACC 580
            G  P      ++  +         +             +R                   
Sbjct: 233 AGYPPFF---ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN----------------LL 273

Query: 581 HPDSTRRP 588
             D T+R 
Sbjct: 274 QVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-37
 Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 28/278 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNH----DSKQGLKEFMAEISSMGRLQHK 380
           ++LG+G +G+V+     + ++      A+K +         +  +    E   +  ++  
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTG-KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 381 -NLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLH 439
             LV +    +   +L L+ DY+  G L   +  + +      Q       V E +  L 
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALE 143

Query: 440 HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE--L 497
           H     +++RDIK  NILLDS     L DFGL+K +   E        GT+ Y+AP+   
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 498 ATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD 557
              S    A D +S GV++ E+  G  P     GE+  +A +   +            ++
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRILK----------SE 252

Query: 558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVA 595
               QE  A   +L+ +        D  +R       A
Sbjct: 253 PPYPQEMSALAKDLIQR----LLMKDPKKRLGCGPRDA 286

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 40/244 (16%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           S  L F  N+F    N  DL+   +  V ST V++LT   N    ++S GRA Y   +++
Sbjct: 1   SDELSFTINNFVP--NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNA 136
             +    +  + SFSTSF F +          GL F L    S  P    S+Y GLF+N+
Sbjct: 59  WGN---TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS 115

Query: 137 TVVTVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPV 194
              +   ++AVEFDT     ++  DP+  HIG+D+N IES K V   +  +         
Sbjct: 116 NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI-NGGVAFATIT 174

Query: 195 RMRNGQNIHAWIDFD------------------------GFSAS--KTNWIEARRVLAWS 228
            +   + + A + +                         GFSA+      +E   VL+WS
Sbjct: 175 YLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234

Query: 229 LSDT 232
            + T
Sbjct: 235 FTST 238

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  135 bits (340), Expect = 7e-36
 Identities = 65/331 (19%), Positives = 127/331 (38%), Gaps = 52/331 (15%)

Query: 287 NKLKAQEEDEIEEWELEYWPHRFSYEELSKATKGFSNDELLGSGGFGRVYKGTLANNNNN 346
           N  + +E  + E   +E W ++  Y+ +            LG G +  V++      N  
Sbjct: 14  NTHRPREYWDYESHVVE-WGNQDDYQLV----------RKLGRGKYSEVFEAI----NIT 58

Query: 347 NSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRKGNE--LMLVYDYMP 403
           N+ ++ VK +    K   K+   EI  +  L+   N++ +    +        LV++++ 
Sbjct: 59  NNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115

Query: 404 NGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-M 462
           N            + L     R  + ++ + L+Y H      ++HRD+K  N+++D E  
Sbjct: 116 NTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHR 167

Query: 463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVAC 521
           + RL D+GLA+ Y  G+       V +  +  PEL         + D++S G ++  +  
Sbjct: 168 KLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225

Query: 522 GRRPLDMGKGEEEEEAVLM---------DWVR--NLYGQGKICEAADARIRQEFE----A 566
            + P   G    ++   +          D++   N+    +  +      R+ +E    +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285

Query: 567 EEMELVLKLGL----ACCHPDSTRRPTMREV 593
           E   LV    L         D   R T RE 
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/242 (26%), Positives = 90/242 (37%), Gaps = 38/242 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN---QFSFGRAYYPTKLKMK 78
           S  L F F +F    NG DL    +  V  T V++L    N     + G A Y   + + 
Sbjct: 1   SDDLSFKFKNFSQ--NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW 58

Query: 79  RSTATNSSILTSFSTSFVF-SILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                N+  L SF TSF F         +   GL F L    SP    A  YFGLF++  
Sbjct: 59  NC---NTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRR-AGGYFGLFNDTK 114

Query: 138 VVTVAPLLAVEFDTGQNP-EFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR- 195
             +    +AVEFDT  +P  F DP   HIG+D+N ++S             N + V +  
Sbjct: 115 CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIY 174

Query: 196 MRNGQNIHAWIDFD------------------------GFSASK-TNWIEARRVLAWSLS 230
             + + + A + +                         GFS S          VL W  +
Sbjct: 175 EASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234

Query: 231 DT 232
            T
Sbjct: 235 ST 236

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  131 bits (330), Expect = 3e-35
 Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 61/252 (24%)

Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKMKR 79
           ++ F F +F S      +I   D    +  ++L   +       +S GRA Y   +++  
Sbjct: 1   SVSFTFPNFWS-DVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWD 59

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLF--SNAT 137
           +    +  + SF T F F +     + P  GL F L    S     A +Y GLF  S AT
Sbjct: 60  N---KTESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDSDVKD-AGEYLGLFNKSTAT 114

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
             +   ++AVEFDT  NP F +P   HIG+++N+I S                +    + 
Sbjct: 115 QPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR-----------WEDSDIF 163

Query: 198 NGQNIHAWIDFD------------------------------------GFSASK-TNWIE 220
           +G+   A I +D                                    G SAS   N   
Sbjct: 164 SGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFL 223

Query: 221 ARRVLAWSLSDT 232
              +L+W  S  
Sbjct: 224 TVYILSWRFSSN 235

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  131 bits (330), Expect = 3e-35
 Identities = 66/270 (24%), Positives = 105/270 (38%), Gaps = 72/270 (26%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKM 77
           +    F F +F    N +  IL  D  V S+ +RLT           S GRA+Y + +++
Sbjct: 1   ADIQSFSFKNF----NSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQI 56

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                 ++  + S++TSF  +I     SS   G+ F L    S P +  S + G+F +  
Sbjct: 57  YDK---STGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDV 112

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
               A  +AVEFDT  N ++ DP   HIG+D+N+I+S +    G              + 
Sbjct: 113 YDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG--------------LA 157

Query: 198 NGQNIHAWIDFD-------------------------------------GFSAS---KTN 217
           NGQN    I ++                                     GFSA+      
Sbjct: 158 NGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEG 217

Query: 218 WIEARRVLAWS----LSDTGVAREINTTNF 243
           + E   VL+WS    L D      ++  ++
Sbjct: 218 YTETHDVLSWSFASKLPDDSTTEPLDIASY 247

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  128 bits (323), Expect = 2e-34
 Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 30/234 (12%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMKRST 81
           +  + F FNSF        +    D  V S   I+LTN +   S GR  Y   +++  S 
Sbjct: 1   AETVSFNFNSFSE--GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSS- 57

Query: 82  ATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTV 141
              +  + SF TSF F +       P  G+ F +    +   A  S   G    +     
Sbjct: 58  --ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA-GSIGGGTLGVSDTKGA 114

Query: 142 APLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY-----------YSSSRNES 190
              + VEFDT  N E+NDP  +H+G+D+N+++S K VP              Y SS    
Sbjct: 115 GHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTL 174

Query: 191 FVPVRMRNGQNIHAWIDFD-----------GFSASK-TNWIEARRVLAWSLSDT 232
            V V   NG         D           GFSAS      +   + +WS + T
Sbjct: 175 SVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  128 bits (322), Expect = 3e-34
 Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 43/244 (17%)

Query: 24  SALDFLFNSFGSIT--NGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLK 76
           + ++F +  F S +  NGT++  + D       ++LT         + S G+A Y   + 
Sbjct: 2   NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +  ST        SF TSF F +L    +    GL F L    S        + GLF + 
Sbjct: 62  LWDST----GKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKD-YGGFLGLFRHE 115

Query: 137 TVV--TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPV 194
           T    +   ++AVEFDT  N ++NDP   HIG+D+N+I S          +  +      
Sbjct: 116 TAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSS-IATA 174

Query: 195 RMR---NGQNIHAWIDFD-----------------------GFSASKTNWIEARRVLAWS 228
            +      + +   + ++                       GFSA    + E   +L+W 
Sbjct: 175 HITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAG-VGYDEVTYILSWH 233

Query: 229 LSDT 232
              T
Sbjct: 234 FFST 237

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  127 bits (321), Expect = 4e-34
 Identities = 61/254 (24%), Positives = 95/254 (37%), Gaps = 63/254 (24%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN--QFSFGRAYYPTKLKMKR 79
           S  L F F+ F    N  ++I   D  V +T V+++T  S     S GRA Y   +++  
Sbjct: 1   SDDLSFNFDKFVP--NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 58

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
           S     +   SF+TSF F +  + +        F+    +  P   ++  FGLFS++   
Sbjct: 59  SITGKVA---SFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSK 115

Query: 140 TVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
           +   ++AVEFDT     +N  DPD  HIG+D+N+I+S K V   +               
Sbjct: 116 SSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWR-------------- 161

Query: 198 NGQNIHAWIDFD-------------------------------------GFSAS--KTNW 218
           NG+     I +                                      GFS        
Sbjct: 162 NGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE 221

Query: 219 IEARRVLAWSLSDT 232
            E   VL+W  +  
Sbjct: 222 FETHDVLSWYFTSN 235

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 69/256 (26%), Positives = 102/256 (39%), Gaps = 71/256 (27%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           S+ + F F  F    N T+LIL  D  V S+  +RLTN +        S GRA+Y   ++
Sbjct: 1   SNDIYFNFQRF----NETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQ 56

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +  +    +  + SF+TSF F+I     + P  GL F L    S P      + GLF  +
Sbjct: 57  IWDN---TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGS 112

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRM 196
              +    +AVEFDT  N ++ DP + HIG+D+N+I S K     +              
Sbjct: 113 N--SNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV------------- 156

Query: 197 RNGQNIHAWIDFD-------------------------------------GFSAS---KT 216
            NG+N    I +D                                     GFSA+     
Sbjct: 157 -NGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINK 215

Query: 217 NWIEARRVLAWSLSDT 232
             +E   VL+WS +  
Sbjct: 216 GNVETNDVLSWSFASK 231

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 68/242 (28%), Positives = 100/242 (41%), Gaps = 38/242 (15%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           + +L F F  F    N   LI   D  V ST V++LTN  N      S GRA Y    ++
Sbjct: 1   TGSLSFSFPKFAP--NQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
             ST  N   + SF TSF F I     ++   GL F L    + P        G+F +  
Sbjct: 59  WDSTTGN---VASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKDGY 114

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAG------------YYSS 185
                 ++AVEFDT  N ++ DP   H+G+++N+IES K VP              Y +S
Sbjct: 115 FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVANVFISYEAS 173

Query: 186 SRNESFVPVRMRNGQNIHAWIDFD-----------GFSAS---KTNWIEARRVLAWSLSD 231
           +++ +   V      +       D           GFSA+      +++   VL+WS   
Sbjct: 174 TKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233

Query: 232 TG 233
             
Sbjct: 234 NL 235

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 54/300 (18%), Positives = 102/300 (34%), Gaps = 45/300 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNL 382
           + +GSG  G V        +      +A+K ++    ++   K    E+  M  + HKN+
Sbjct: 23  KPIGSGAQGIVCAAY----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 383 VQMRGWCRK------GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLN 436
           + +              ++ LV + M                   ++   +L  +  G+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133

Query: 437 YLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPE 496
           +LH      ++HRD+K  NI++ S+   ++ DFGLA+      +   T  V T  Y APE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPE 188

Query: 497 LATVSSPTSASDVYSFGVVILEVACGRRPLD--------------MGKGEEEEEAVLMDW 542
           +          D++S G ++ E+   +                  +G    E    L   
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

Query: 543 VRNL---------YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREV 593
           VRN              K+   +      E    +      L       D  +R ++ + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 60/257 (23%), Positives = 89/257 (34%), Gaps = 68/257 (26%)

Query: 24  SALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLKM 77
             + F F+ F       +L L     +  + V++LT  +        S GR  Y   + M
Sbjct: 2   ETISFSFSEFEP--GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHM 59

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGF-GLCFVLTNFTSPPGALASQYFGLFSNA 136
             S    +  + SF T F FSI           GL F +    S P      Y G+F+N+
Sbjct: 60  WDS---TTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGVFNNS 115

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRM 196
                   LAVEFDT  NP ++ P   HIG+D+N+I S K                P ++
Sbjct: 116 KQDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKT--------------QPFQL 160

Query: 197 RNGQNIHAWIDFD-------------------------------------GFSAS---KT 216
            NGQ  +  I +D                                     G S +   + 
Sbjct: 161 DNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQR 220

Query: 217 NWIEARRVLAWSLSDTG 233
           +  E   V +WS   + 
Sbjct: 221 DAAETHDVYSWSFQASL 237

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-31
 Identities = 52/312 (16%), Positives = 107/312 (34%), Gaps = 44/312 (14%)

Query: 309 FSYEELSKATKGFSND----ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVN--HDSKQ 362
           F  +EL+K              +GSG +G V        +      +AVK ++    S  
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSII 59

Query: 363 GLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM-----LVYDYMPNGSLNNWIFGKPKK 417
             K    E+  +  ++H+N++ +         L       +  ++    LNN +  +   
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-- 117

Query: 418 LLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ 477
            L     + ++  +  GL Y+H      ++HRD+K  N+ ++ +   ++ DFGLA   + 
Sbjct: 118 -LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RH 170

Query: 478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLD---------- 527
            +   T  V          +          D++S G ++ E+  GR              
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 528 ------MGKGEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCH 581
                     E  ++         +    ++ +   A +        ++L+ K       
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK----MLV 286

Query: 582 PDSTRRPTMREV 593
            DS +R T  + 
Sbjct: 287 LDSDKRITAAQA 298

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 43/240 (17%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKM 77
           + +  F F +F    N  +LIL  D  V+S   + LT  +       S GRA Y   + +
Sbjct: 1   TESTSFSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI 58

Query: 78  KRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNAT 137
                 +++ L SF+TSF F +    A++   GL F L    + P A    + GLF++  
Sbjct: 59  H-----DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA 112

Query: 138 VVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR 197
                  +AVEFDT  N    DP+  HIG+D N IES K  P       +    +  +  
Sbjct: 113 HDASYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTPFDMVYGEKANIVITYQ-A 169

Query: 198 NGQNIHAWIDFD------------------------GFSAS---KTNWIEARRVLAWSLS 230
           + + + A + F                         GFSA+       +E   +++WS +
Sbjct: 170 STKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFA 229

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 38/240 (15%)

Query: 25  ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKR 79
           +L F F +F S  +  +LI   D  + +  ++LT   +       + GR  +  ++ +  
Sbjct: 3   SLSFGFPTFPS--DQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWE 60

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
            +++  +   +F + F FS+   +++       F+    T+ P        GLF+  T  
Sbjct: 61  KSSSRVA---NFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQ 117

Query: 140 --TVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR 195
             +   ++AVEFDT    + N  DP+  HIG+D+N+I S K V             V   
Sbjct: 118 NTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDRRDGQSLNVLVTFN 177

Query: 196 MRNGQNIHAWIDFD-----------------------GFSASKTNWIEARRVLAWSLSDT 232
             + +N+     +                        GFSA+     +   + +WS + T
Sbjct: 178 -PSTRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTST 236

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 56/241 (23%), Positives = 86/241 (35%), Gaps = 48/241 (19%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ--FSFGRAYYPTKLKMKR 79
           S+   F   +F    N T+LIL  D  V S   + LTN       S GRA+Y   +++  
Sbjct: 1   SNDASFNVETF----NKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIND 56

Query: 80  STATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV 139
                   L SFST+F F I  +   +  +GL F L    S P     +Y GLF+     
Sbjct: 57  R---TIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGLFNTT--- 109

Query: 140 TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMR-N 198
                   + D        D   N I +D+N+I         +  ++  ++ V +     
Sbjct: 110 ------NYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSP 163

Query: 199 GQNIHAWIDFD------------------------GFSAS---KTNWIEARRVLAWSLSD 231
             ++   + +                         GFSA+   K    E   VL+WS S 
Sbjct: 164 KNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSS 223

Query: 232 T 232
            
Sbjct: 224 N 224

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  116 bits (291), Expect = 5e-30
 Identities = 56/193 (29%), Positives = 80/193 (41%), Gaps = 31/193 (16%)

Query: 26  LDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSN----QFSFGRAYYPTKLKMKRS 80
           + F FN F    N   L L  D  + S  V+ LT   N      S GRA Y   +++  S
Sbjct: 3   ISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDS 60

Query: 81  TATNSSILTSFSTSFVFSILPEIASSPGF-GLCFVLTNFTSPPGALASQYFGLFSNATVV 139
               +  + SF T F FSI           GL F +    +  G     YFG+++  +  
Sbjct: 61  ---TTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFGIYNPLSPY 116

Query: 140 TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNG 199
              P +AVEFDT +N    DP   HIG+D+N++ S K               VP  + NG
Sbjct: 117 ---PFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKT--------------VPFTLDNG 157

Query: 200 QNIHAWIDFDGFS 212
              +  I +D  +
Sbjct: 158 GIANVVIKYDAST 170

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 64/256 (25%), Positives = 92/256 (35%), Gaps = 74/256 (28%)

Query: 26  LDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLKMKR 79
             F F+ F    N  +L L     + S  V+ LT  +        S GRA Y   +K+  
Sbjct: 3   QSFNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60

Query: 80  STATNSSILTSFSTSFVFSILPEIA-SSPGFGLCFVLTNFTSPPGALASQYFGLFSNATV 138
           ST  N   + SF T F F+I    A   P  GL F +    SP G       G+F     
Sbjct: 61  STTGN---VASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGED-GGNLGVFKPPEG 116

Query: 139 VTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRN 198
                  AVEFDT QN    DP   HIG+D+N+I S+K               +  ++ N
Sbjct: 117 D---NAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKT--------------LHFQLEN 157

Query: 199 GQNIHAWIDFD---------------------------------------GFSAS---KT 216
           G   +  I +D                                       G SA+   + 
Sbjct: 158 GGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQK 217

Query: 217 NWIEARRVLAWSLSDT 232
           N +E   +++WS + +
Sbjct: 218 NAVETHEIISWSFTSS 233

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  113 bits (284), Expect = 5e-29
 Identities = 62/260 (23%), Positives = 99/260 (38%), Gaps = 43/260 (16%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           +  + F +N F       ++IL  D  V S+  ++L            S GRA Y T + 
Sbjct: 1   AETVSFSWNKFVP--KQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIH 58

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +      +   + SF+ SF F+           GL F L    + P    + Y GLF+  
Sbjct: 59  IWDKETGS---VASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQT-HAGYLGLFNEN 114

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAG-----------YYSS 185
              +   ++AVEFDT +N    DP + HIG+++N+I S K                 Y +
Sbjct: 115 E--SGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSWDLANNKVAKVLITYDA 170

Query: 186 SRNE---SFVPVRMRNGQNIHAWIDFD---------GFSAS--KTNWIEARRVLAWSLSD 231
           S +    S V    R    +   +D           GFSA+       E+  VL+WS + 
Sbjct: 171 STSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFAS 230

Query: 232 TGVAREINTT--NFPTFLPP 249
                  N    +  +F+  
Sbjct: 231 NLPHASSNIDPLDLTSFVLH 250

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 3e-26
 Identities = 46/228 (20%), Positives = 81/228 (35%), Gaps = 23/228 (10%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQ 384
             LG G F  V+       +  N+T +A+K V  D K   +    EI  + R+   +  +
Sbjct: 19  RKLGWGHFSTVWLAK----DMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73

Query: 385 MRGWCRKG--NELMLVYDYMPNGSLNN------------WIFGKPKKLLGWKQRRQILAD 430
                       L       PNG                 I     + +     +QI   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 431 VAEGLNYLHHGWDQVVVHRDIKSGNILLDSE-MRGRLGDFGLAKLYQQGEV-PNTTRVVG 488
           +  GL+Y+H      ++H DIK  N+L++       L    +A L        + T  + 
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 489 TLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE 536
           T  Y +PE+   +     +D++S   +I E+  G    +  +G    +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 52/244 (21%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLK 76
           ++   F F +F +      LIL  +  + S   ++LT   +       S GRA+Y   ++
Sbjct: 1   ATETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQ 57

Query: 77  MKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNA 136
           +K     +S+ + SF+T+F F I  +  S   +GL F L    SPP     ++ G+F+  
Sbjct: 58  IK-----DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQK-KQEFLGIFNTN 111

Query: 137 TVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR- 195
                A  +AV F+        D D N I   +N           ++  +  ++ V +  
Sbjct: 112 NPEPNARTVAVVFN--TFKNRIDFDKNFIKPYVN-------ENCDFHKYNGEKTDVQITY 162

Query: 196 MRNGQNIHAWIDFD------------------------GFSAS---KTNWIEARRVLAWS 228
             +  ++  ++ F                         GFS +     +  E   VL+WS
Sbjct: 163 DSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWS 222

Query: 229 LSDT 232
            S  
Sbjct: 223 FSSK 226

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 93.7 bits (232), Expect = 2e-22
 Identities = 53/229 (23%), Positives = 87/229 (37%), Gaps = 45/229 (19%)

Query: 23  SSALDFLFNSFGSITNGTDLILINDCWVDST-VIRLTNDSNQFSFGRAYYPTKLKMKRST 81
           ++   F+ ++F    N T+LIL  D  V S   ++L+ +S   S  RA+Y   ++++ ST
Sbjct: 1   ATETSFIIDAF----NKTNLILQGDATVSSNGNLQLSYNSYD-SMSRAFYSAPIQIRDST 55

Query: 82  ATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTV 141
             N   + SF T+F  +I     ++   GL FVL                          
Sbjct: 56  TGN---VASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK------------------ 94

Query: 142 APLLAVEFDTGQNPEFNDPDDNHIGVDLNNIES----AKHVPAGYYSSSRNESFVPVRMR 197
              + VEFDT  +    D ++N I     ++         V   Y SS++  S       
Sbjct: 95  GDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS 154

Query: 198 NGQNIHAWIDFD-----------GFSAS---KTNWIEARRVLAWSLSDT 232
            G++ +     +           GFSA+        E   VL+WS S  
Sbjct: 155 TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 4e-20
 Identities = 30/159 (18%), Positives = 53/159 (33%), Gaps = 24/159 (15%)

Query: 325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVK----------CVNHDSKQGLKEFMAEISSM 374
           +L+G G    V+             E  VK           V      G   F       
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 375 GRLQHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEG 434
            R + + L +++G       +  VY +  N  L   I  K    +  +   ++L  + E 
Sbjct: 61  ARNEFRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 435 LNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK 473
           +   +H     +VH D+   N+L+  E    + DF  + 
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 12/107 (11%)

Query: 37  TNGTDLILINDCWVDST-VIRLTNDSNQ-----FSFGRAYYPTKLKMKRSTATNSSILTS 90
            +  DLIL  D    +   + LT  S+       S GRA +   + +  S+A  +    S
Sbjct: 135 KDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVA----S 190

Query: 91  FSTSFVFSILPEIASSPGFGLCFVLTNFTSP-PGALASQYFGLFSNA 136
           F  +F F I     S P  G+ F ++N  S  P     +  GLF +A
Sbjct: 191 FEATFTFLIKSP-DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 75.4 bits (185), Expect = 7e-16
 Identities = 30/147 (20%), Positives = 47/147 (31%), Gaps = 50/147 (34%)

Query: 144 LLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIH 203
           ++AVE DT  N +  DP   HIG+D+ ++ S K                     NG+   
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQ--------------NGKVGT 49

Query: 204 AWIDFD------------------------------------GFSASKTNWIEARRVLAW 227
           A I ++                                    G SAS   + E   +L+W
Sbjct: 50  AHIIYNSVDKRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSW 109

Query: 228 SLSDTGVAREINTTNFPTFLPPSSSSS 254
           S +    +   + TN   F+    S  
Sbjct: 110 SFTSKLKSNSTHETNALHFMFNQFSKD 136

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.0 bits (137), Expect = 8e-10
 Identities = 25/183 (13%), Positives = 45/183 (24%), Gaps = 29/183 (15%)

Query: 28  FLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSI 87
            L  S G++          +    +  IR+     +   G  +  TK             
Sbjct: 15  HLVQSDGTVPF---WAHAGNAIPSADQIRIAPSL-KSQRGSVWTKTKAA----------- 59

Query: 88  LTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAV 147
             ++     F +          GL    T      G      FG             + +
Sbjct: 60  FENWEVEVTFRVTGR-GRIGADGLAIWYTENQGLDG----PVFGSADMW------NGVGI 108

Query: 148 EFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWID 207
            FD+  N      ++  I V  NN +          + +   S           + A I 
Sbjct: 109 FFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQALA-SCQRDFRNKPYPVRAKIT 165

Query: 208 FDG 210
           +  
Sbjct: 166 YYQ 168

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 24/186 (12%), Positives = 48/186 (25%), Gaps = 24/186 (12%)

Query: 16  INFSISPSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKL 75
               +S   +L  L N+     N           ++   I LT++ N    G  +     
Sbjct: 2   DASKLSSDYSLPDLINTRKVPNN---WQTGEQASLEEGRIVLTSNQNSK--GSLWLKQGF 56

Query: 76  KMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSN 135
            +K           SF+  + F  +   +     G+ F     ++ P         +  +
Sbjct: 57  DLK----------DSFTMEWTFRSVGY-SGQTDGGISFWFVQDSNIPRDKQLYNGPVNYD 105

Query: 136 ATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR 195
                    L +  D             + G    +                 +S VP  
Sbjct: 106 G--------LQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPST 157

Query: 196 MRNGQN 201
           +R   +
Sbjct: 158 IRVTYD 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	636
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.91
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.85
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.83
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.65
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.62
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.43
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.8
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.09
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.22
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.94

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-51  Score=423.19  Aligned_cols=270  Identities=27%  Similarity=0.466  Sum_probs=206.9

Q ss_pred             ccCHHHHHHHhCC---------CCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC
Q 006668          308 RFSYEELSKATKG---------FSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL  377 (636)
Q Consensus       308 ~~~~~~l~~a~~~---------f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l  377 (636)
                      .++|+++.+++++         |+..++||+|+||+||+|+++..+ .....||||++... .....++|.+|+.+|+++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG-KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCC-CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            3455555555543         455689999999999999987543 22356899998765 455567899999999999


Q ss_pred             CCCceeeeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEE
Q 006668          378 QHKNLVQMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNIL  457 (636)
Q Consensus       378 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIl  457 (636)
                      +|||||+++|+|.+++.+++|||||++|+|.+++... ...++|.+++.++.||++||+|||   +++|+||||||+|||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NIL  160 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNIL  160 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEE
Confidence            9999999999999999999999999999999988643 457999999999999999999999   799999999999999


Q ss_pred             EcCCCcEEEeccCCcccccCCCCcc----ccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCh
Q 006668          458 LDSEMRGRLGDFGLAKLYQQGEVPN----TTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGE  532 (636)
Q Consensus       458 l~~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~  532 (636)
                      |+.++.+||+|||+++.........    .....||+.|||||.+.+..++.++|||||||++|||++ |+.||......
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999998765433221    222457999999999999999999999999999999998 89999754221


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                           .+...+.             ...+...+.+.+..+.+|+.+||+.||++||||.||++.|+.-
T Consensus       241 -----~~~~~i~-------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         241 -----DVINAIE-------------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----HHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHH-------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 1111111             1122223344567788999999999999999999999999754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-52  Score=424.68  Aligned_cols=258  Identities=23%  Similarity=0.382  Sum_probs=218.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|+..+.||+|+||+||+|++..++    +.||||+++.+.. ..+++.+|+.++++++|||||+++++|.+++.+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGT----EEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCC----eEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            346778899999999999999987655    8999999976543 35789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+||||++++.+||+|||+++....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999999999999998777788999999999999999999999   78999999999999999999999999999998766


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      ..........|++.|+|||++.+..++.++|||||||++|||++|..|+........    +.+             .+.
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----~~~-------------~i~  230 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE-------------LLE  230 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHH-------------HHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----HHH-------------HHh
Confidence            555455556789999999999999999999999999999999998777654432211    111             111


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ...+...+...+..+.+|+.+||+.||++||||.||++.|+.-
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1222233344556789999999999999999999999998653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-51  Score=412.84  Aligned_cols=254  Identities=24%  Similarity=0.411  Sum_probs=198.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+|++.++     ..||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTT-----EEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCC-----CEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            4677889999999999999998653     6799999976533 346799999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|.+++... ...+++++++.++.|||.||+|||   +++|+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999998653 457899999999999999999999   799999999999999999999999999999877655


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .........||+.|+|||++.+..++.++|||||||++|||+++..|+.......   . +...+..             
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~-~~~~i~~-------------  217 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---E-VVEDIST-------------  217 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---H-HHHHHHH-------------
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---H-HHHHHHh-------------
Confidence            4444445679999999999999999999999999999999999655543332221   1 1111111             


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..+...+..++..+.+|+.+||+.||++||||+||+++|+.
T Consensus       218 ~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         218 GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11112223345678899999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=414.28  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=208.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||.||+|+++.+     ..||||+++.... ..++|.+|+.++++++|||||+++|+|.+ +.+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGH-----TKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCC-----CEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            4577789999999999999998642     7899999976533 34679999999999999999999998865 567999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++.......+++.+++.|+.||++||+|||   +++|+||||||+||||++++.+||+|||+|+.....
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            99999999999886554556999999999999999999999   799999999999999999999999999999987665


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .........||+.|||||++.+..++.++|||||||++|||+||..|+........    +...+.             .
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~----~~~~i~-------------~  225 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLE-------------R  225 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHH-------------T
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH----HHHHHH-------------h
Confidence            54455556799999999999999999999999999999999997666544322211    111111             1


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ..+...+...++.+.+|+.+||+.||++||||.||++.|+.
T Consensus       226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            11112223345668899999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=410.79  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=203.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..+.||+|+||.||+|++.       ..||||+++..  ..+..+.|.+|+.++++++|||||++++++.+ +.++
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH-------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS-------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC-------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            56888999999999999999863       35999999754  45567889999999999999999999999865 5689


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|||||++|+|.+++... ...+++.+++.++.||++||+|||   +++|+||||||+||||+.++.+||+|||+|+...
T Consensus        80 lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999999643 356999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCC-ccccccccCCcccccccccCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          477 QGEV-PNTTRVVGTLGYLAPELATVS---SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       477 ~~~~-~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      .... .......||+.|||||++.+.   .++.++|||||||++|||++|+.||.........    ...+........ 
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~----~~~~~~~~~~p~-  230 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----IFMVGRGYLSPD-  230 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----HHHHHHTSCCCC-
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH----HHHHhcCCCCCc-
Confidence            4332 234456899999999998643   4788999999999999999999999765332211    111111111100 


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                              ........++.+.+|+.+||+.||++|||++||++.|+.-
T Consensus       231 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         231 --------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             --------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                    1122334456788999999999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=412.63  Aligned_cols=261  Identities=27%  Similarity=0.477  Sum_probs=207.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..|+..++||+|+||.||+|+++..+......||||+++.. ......+|.+|+.++++++|||||+++|+|.+.+.+++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            35677899999999999999998766666678999999765 44445679999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||.+|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999987543 467999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......||+.|||||++.+..++.++|||||||++|||++|..|+.......   . +..             .
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~---~-~~~-------------~  225 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E-VMK-------------A  225 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H-HHH-------------H
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---H-HHH-------------H
Confidence            3322  2233568999999999999999999999999999999999766664432221   1 111             1


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      +....+...+...+..+.+|+.+||+.||++||||.||++.|+.-
T Consensus       226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            222223334445567789999999999999999999999999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=407.51  Aligned_cols=254  Identities=26%  Similarity=0.367  Sum_probs=204.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||+||+|+.+.++    +.||||+++... .+..+++.+|+.++++++|||||++++++.+++.++|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            46888999999999999999987765    899999997653 2334678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.++|.  ....+++.+++.++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus        81 vmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          81 FLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            999999999999994  3567999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CC-CccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          478 GE-VPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       478 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .. ....+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||..........   ..+.    ......  
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~~~~----~~~~~~--  226 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWK----EKKTYL--  226 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---HHHH----TTCTTS--
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---HHHh----cCCCCC--
Confidence            33 223445689999999999988776 578999999999999999999997553222111   1110    000000  


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                         .....    ....+.+|+.+||+.||++|||++|+++.-
T Consensus       227 ---~~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~hp  261 (271)
T d1nvra_         227 ---NPWKK----IDSAPLALLHKILVENPSARITIPDIKKDR  261 (271)
T ss_dssp             ---TTGGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             ---Ccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence               00111    234567889999999999999999997753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-50  Score=408.60  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||+||+|+...++    +.||||++........+.+.+|+.++++++|||||++++++.+.+.+++|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~----~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTC----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCC----CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            46999999999999999999987665    89999999866544557789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|.+++.+   ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 mEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999999998843   46999999999999999999999   799999999999999999999999999999876543


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .+.......    .      +
T Consensus       170 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~~----~------~  234 (293)
T d1yhwa1         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIATNG----T------P  234 (293)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHHC----S------C
T ss_pred             cc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----HHHHHHhCC----C------C
Confidence            32 3344679999999999999999999999999999999999999997542211    111111110    0      0


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                        ....+......+.+|+.+||++||++|||+.|++++-
T Consensus       235 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp  271 (293)
T d1yhwa1         235 --ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (293)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred             --CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence              0011122345678899999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=401.97  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=213.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|+..+.||+|+||+||+|+++++     ..||||.++..... .++|.+|+.++++++||||++++|+|.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTT-----EEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCC-----CEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            5788999999999999999998642     78999999875433 46899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      |||+++|+|.+++... ...+++..+++++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        78 ~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          78 TEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            9999999999997543 457899999999999999999999   799999999999999999999999999999877665


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAAD  557 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  557 (636)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+     +...+.    .        
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i~----~--------  216 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA----Q--------  216 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHH----T--------
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHHH----h--------
Confidence            5555555679999999999999999999999999999999998 899997553221     111111    1        


Q ss_pred             hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          558 ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       558 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                       ..+...+...+..+.+|+.+||+.||++|||+.||++.|.+
T Consensus       217 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 -GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             11122233445678999999999999999999999999854

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=408.08  Aligned_cols=255  Identities=28%  Similarity=0.462  Sum_probs=206.7

Q ss_pred             CCCCcee-eeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          320 GFSNDEL-LGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       320 ~f~~~~~-LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      +|...+. ||+|+||.||+|.++..+  .+..||||.++.. .....++|.+|+++|++++|||||+++|+|.. +.+++
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCC--CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            3455564 999999999999876532  2368999999765 44556889999999999999999999999865 56899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      |||||++|+|.+++... +..+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus        86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999998433 457999999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          478 GEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       478 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ....  ......||+.|||||++.+..++.++|||||||++|||++ |+.||......+     +...+    ..+    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~~~~i----~~~----  228 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFI----EQG----  228 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHH----HTT----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHHH----HcC----
Confidence            4322  2233568999999999999999999999999999999998 999997653221     11111    111    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                           .+.+.+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus       229 -----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         229 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                 1222333455678899999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=404.53  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=206.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+.+.++    +.||+|++....   ....+.+.+|++++++++|||||++++++.+++.+
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCC----cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            35788899999999999999987765    899999987532   22356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|||||++|+|.+++..  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             EEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeec
Confidence            999999999999999953  456999999999999999999999   799999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...   ......||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+.. +.    .+.    
T Consensus       157 ~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~-i~----~~~----  220 (263)
T d2j4za1         157 PSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKR-IS----RVE----  220 (263)
T ss_dssp             CCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH-HH----TTC----
T ss_pred             CCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----HHHH-HH----cCC----
Confidence            543   2334679999999999999999999999999999999999999997542211    1111 10    111    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                            ..++....+.+.+|+.+||++||++|||++|++++
T Consensus       221 ------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                  11222234567889999999999999999999873

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=406.12  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=194.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc--cce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK--GNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~  394 (636)
                      ++|++.+.||+|+||+||+|+.+.++    +.||+|++...  .....+.+.+|++++++++|||||++++++.+  .+.
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCC----CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            46888999999999999999987765    88999999765  34456778999999999999999999998854  456


Q ss_pred             EEEEEeecCCCChhhhHhcC--CCCCcChHHHHHHHHHHHHHHHHHhccC--CCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          395 LMLVYDYMPNGSLNNWIFGK--PKKLLGWKQRRQILADVAEGLNYLHHGW--DQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                      +++|||||++|+|.+++.+.  ....+++.+++.++.||+.||+|||+..  ..+|+||||||+||||+.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            89999999999999998532  3467999999999999999999999421  1359999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG  550 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~  550 (636)
                      +++....... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .. ..+.    .+
T Consensus       160 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~-~~i~----~~  229 (269)
T d2java1         160 LARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----LA-GKIR----EG  229 (269)
T ss_dssp             HHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH-HHHH----HT
T ss_pred             ceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HH-HHHH----cC
Confidence            9987754332 2344689999999999999999999999999999999999999997542211    11 1111    11


Q ss_pred             cchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          551 KICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       551 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..         ...+....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       230 ~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         230 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11         11122234568889999999999999999999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=405.34  Aligned_cols=249  Identities=29%  Similarity=0.420  Sum_probs=200.8

Q ss_pred             eeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEEeec
Q 006668          325 ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       325 ~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      ++||+|+||.||+|.++..  ...+.||||+++..  .....+++.+|++++++++|||||+++|+|.. +..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK--KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS--SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccC--CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            5799999999999987643  23478999999754  23345789999999999999999999999965 4578999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc-
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP-  481 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-  481 (636)
                      ++|+|.+++..  ...+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++........ 
T Consensus        90 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          90 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999999954  456999999999999999999999   789999999999999999999999999999876543322 


Q ss_pred             -cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhhh
Q 006668          482 -NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADAR  559 (636)
Q Consensus       482 -~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  559 (636)
                       ......||+.|||||++.+..++.++|||||||++|||++ |+.||.......     +...+.    .+         
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~i~----~~---------  226 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----KG---------  226 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----TT---------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----HHHHHH----cC---------
Confidence             2233578999999999999999999999999999999998 899997543211     111111    11         


Q ss_pred             hhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          560 IRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       560 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .+...+...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1222333445678899999999999999999999998864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=412.98  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=210.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||+||+|+....+ ......||+|.+... .......+.+|+.++.++ +|||||+++++|.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            46788899999999999999986543 234467999998754 333456788999999998 899999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCC---------------------CCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCC
Q 006668          396 MLVYDYMPNGSLNNWIFGKPK---------------------KLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSG  454 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~  454 (636)
                      ++|||||++|+|.++|..+..                     ..+++.+++.++.||++||+|||   +++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            999999999999999965432                     35899999999999999999999   799999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCh
Q 006668          455 NILLDSEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGE  532 (636)
Q Consensus       455 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~  532 (636)
                      |||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||++ |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876544322 2334678999999999999999999999999999999997 89999755332


Q ss_pred             hhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006668          533 EEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLV  598 (636)
Q Consensus       533 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  598 (636)
                      ..    +...+.             ...+.+.+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus       274 ~~----~~~~~~-------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 AN----FYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HH----HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH----HHHHHh-------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21    111111             11222333344567899999999999999999999999995

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=406.44  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=204.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      ++|++.+.||+|+||.||+|+++++     ..||||+++.... ..+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-----~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-----CEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            4578899999999999999998654     5799999975533 34679999999999999999999999965 568999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      ||||++|+|..++.......++|.+++.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999999986655567999999999999999999999   789999999999999999999999999999877655


Q ss_pred             CCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          479 EVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       479 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                      .........||+.|+|||++..+.++.++|||||||++|||++|..|+........    +..++.             .
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~----~~~~i~-------------~  229 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE-------------R  229 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHH-------------T
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH----HHHHHH-------------h
Confidence            55555556799999999999999999999999999999999997777654432211    112221             1


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..+.+.+...++.+.+++.+||+.||++||+|.+|+++|+.-
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            112223334456788999999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=406.04  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLVY  399 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~  399 (636)
                      .|++.+.||+|+||.||+|+.+.++    ..||+|++........+.+.+|++++++++|||||++++++.+.+.+++||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETS----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCC----eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            4778899999999999999987765    889999998776667788999999999999999999999999999999999


Q ss_pred             eecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCC
Q 006668          400 DYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGE  479 (636)
Q Consensus       400 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  479 (636)
                      |||++|+|.+++.+. ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            999999999987543 456999999999999999999999   7999999999999999999999999999997654321


Q ss_pred             CccccccccCCccccccccc-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          480 VPNTTRVVGTLGYLAPELAT-----VSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       480 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                       .......||+.|||||++.     ...++.++|||||||++|||++|+.||........    +......     ..  
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~----~~~i~~~-----~~--  232 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV----LLKIAKS-----EP--  232 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHHS-----CC--
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcC-----CC--
Confidence             1223467999999999874     45678999999999999999999999976533221    1111110     00  


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         +.+  ..+......+.+|+.+||+.||++|||+.|++++
T Consensus       233 ---~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 ---PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ---CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000  1112234567889999999999999999999884

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-49  Score=396.96  Aligned_cols=246  Identities=25%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc----cceE
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----GNEL  395 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~  395 (636)
                      +..+.||+|+||+||+|+...++    ..||+|.+...  .....+.+.+|++++++++|||||++++++..    ...+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCC----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            45678999999999999987665    78999998754  44556789999999999999999999999864    4568


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCc--EEeCCCCCCCEEEc-CCCcEEEeccCCc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQV--VVHRDIKSGNILLD-SEMRGRLGDFGLA  472 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFGla  472 (636)
                      ++||||+++|+|.+++.+  ...+++.+++.++.||++||+|||   +++  |+||||||+||||+ +++.+||+|||++
T Consensus        88 ~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            999999999999999953  457999999999999999999999   666  99999999999996 5789999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      +.....   .....+||+.|||||++.+ +++.++|||||||++|||++|+.||........    +..    ....+..
T Consensus       163 ~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~----~~~----~i~~~~~  230 (270)
T d1t4ha_         163 TLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR----RVTSGVK  230 (270)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHH----HHTTTCC
T ss_pred             eeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH----HHH----HHHcCCC
Confidence            864432   2334689999999999875 599999999999999999999999975432211    111    1111111


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                              +..++......+.+|+.+||++||++|||+.|++++
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 --------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                    011112223457889999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=409.63  Aligned_cols=267  Identities=22%  Similarity=0.296  Sum_probs=206.7

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .++|+..++||+|+||+||+|+.+.++    +.||+|+++... ....+++.+|+.+|++++|||||+++++|.+.+.++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTT----EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            457888999999999999999987665    899999998653 334567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|||||++|+|.+++.+  ...+++.+++.++.||+.||+|||+  ..+|+||||||+||||++++.+||+|||+|+...
T Consensus        81 iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            99999999999999954  3569999999999999999999993  2489999999999999999999999999998664


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH-----------
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN-----------  545 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~-----------  545 (636)
                      ..   ..+..+||+.|||||++.+..++.++||||+||++|||++|+.||............... ...           
T Consensus       157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ-VEGDAAETPPRPRT  232 (322)
T ss_dssp             HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-hcCCcccCCccccc
Confidence            32   223468999999999999999999999999999999999999999765432211100000 000           


Q ss_pred             -----------HhcCCcchhhhhhhhhh---cc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          546 -----------LYGQGKICEAADARIRQ---EF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       546 -----------~~~~~~~~~~~d~~l~~---~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                                 ........+..+.....   .. .......+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                       00000000111100000   00 00113467889999999999999999999884

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=403.61  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+.+.++    +.||||++....   ....+.+.+|++++++++||||+++++++.+++.+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATS----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence            45888999999999999999987665    889999997532   23356789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|||||++|+|.+++..  .+.+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus        84 ~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceec
Confidence            999999999999999843  457999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCC-CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          476 QQGE-VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       476 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      .... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+.. +    ..+.   
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~-i----~~~~---  226 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQK-I----IKLE---  226 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-H----HTTC---
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHHH-H----HcCC---
Confidence            5433 223344689999999999999999999999999999999999999997542221    1111 0    0111   


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         .    .++......+.+|+.+||+.||++|||++|+++.
T Consensus       227 ---~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 ---Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---C----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               1    1122234567889999999999999999997654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=395.18  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+|++... +.....||||.++.. .....+.+.+|+.++++++|||||+++++|.+ +.+++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~-~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSP-ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecC-CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            4577889999999999999988653 233467999998755 44456789999999999999999999999964 67899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.+++... ...+++.+++.++.||++||+|||   +++|+||||||+||++++++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999987543 457999999999999999999999   89999999999999999999999999999987765


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ......+...||+.|+|||++.+..++.++|||||||++|||++ |+.||.........     ..+.    .+      
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~-----~~i~----~~------  225 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----GRIE----NG------  225 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHH----TT------
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH-----HHHH----cC------
Confidence            55555556778999999999999999999999999999999998 89898765432211     1111    11      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                         .+...+...+..+.+|+.+||+.||++|||+.||++.|+.
T Consensus       226 ---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         226 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               1112233445678899999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-49  Score=406.01  Aligned_cols=257  Identities=23%  Similarity=0.411  Sum_probs=193.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK-QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .+.|+..+.||+|+||+||+|+.+.++    +.||||++..... ...+.+.+|+.++++++|||||++++++.+++.++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQ----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTC----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCC----CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            356888999999999999999987665    8899999976532 23456789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCCcc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLAK  473 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~  473 (636)
                      ||||||++|+|.++|..  ...+++.++..++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+++
T Consensus        84 lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999953  467999999999999999999999   89999999999999994   57899999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .......  ....+||+.|||||++.+..++.++|||||||++|||++|+.||.......     +...+..    +.. 
T Consensus       159 ~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~----~~~-  226 (307)
T d1a06a_         159 MEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----LFEQILK----AEY-  226 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHT----TCC-
T ss_pred             EccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHhc----cCC-
Confidence            7654332  234679999999999999999999999999999999999999997542221     1111110    000 


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV--LVGQ  600 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  600 (636)
                           .............+.+|+.+||+.||++|||+.|+++.  +.+.
T Consensus       227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                 01111112234568889999999999999999999995  5443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.2e-48  Score=403.89  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=210.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|++.+.||+|+||.||+|+.+.++    +.||||++........+.+.+|+.+|++++|||||++++++.+.+.+++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i  100 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  100 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            357999999999999999999987665    8999999988777667889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC--CCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~  475 (636)
                      |||||++|+|.+++... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus       101 vmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            99999999999998543 456999999999999999999999   899999999999999954  678999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......||+.|||||++.+..++.++|||||||++|||++|+.||......    ..+......   ....   
T Consensus       177 ~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~---~~~~---  244 (350)
T d1koaa2         177 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSC---DWNM---  244 (350)
T ss_dssp             CTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHT---CCCS---
T ss_pred             cccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhC---CCCC---
Confidence            5433  233467999999999999999999999999999999999999999754221    111111110   0000   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +.....    ...+.+.+|+.+||+.||++|||++|++++
T Consensus       245 -~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 -DDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -CCGGGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -Cccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111111    223457889999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=394.13  Aligned_cols=248  Identities=28%  Similarity=0.448  Sum_probs=198.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccc-cceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-GNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~l  397 (636)
                      ++|+..+.||+|+||.||+|++++      ..||||+++.+.  ..+++.+|++++++++||||++++|+|.+ .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEECC------eEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            356778999999999999999853      789999997653  34678999999999999999999998855 467899


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+++|+|.++|..+....++|..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence            999999999999997655557999999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      .    .....+|..|+|||++.+..++.++|||||||++|||++ |+.||.......     +..++             
T Consensus       156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----~~~~i-------------  213 (262)
T d1byga_         156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV-------------  213 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHH-------------
T ss_pred             C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHH-------------
Confidence            2    223467899999999999999999999999999999998 677776543221     11111             


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      ....+.+++......+.+|+.+||+.||.+||||.|++++|+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1122233444455678899999999999999999999999965

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=401.97  Aligned_cols=258  Identities=27%  Similarity=0.401  Sum_probs=206.4

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      .|+..++||+|+||+||+|++..++......||+|.++.. ..+..+++.+|+.++++++|||||+++|+|.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            5888999999999999999998777666678999998754 344567899999999999999999999999875 56788


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCC
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQG  478 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  478 (636)
                      +||+.+|+|.+++... ...+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++.....
T Consensus        89 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999988654 567999999999999999999999   789999999999999999999999999999876554


Q ss_pred             CCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          479 EVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       479 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ... ......||+.|||||++.++.++.++|||||||++|||+| |+.||........     ..             .+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----~~-------------~i  226 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SS-------------IL  226 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----HH-------------HH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----HH-------------HH
Confidence            332 2334568999999999999999999999999999999998 7888865432221     11             11


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ....+...+..++..+.+|+.+||+.||++|||+.||++.|+.-
T Consensus       227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11122223344556788999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-48  Score=401.00  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      .|+..+.||+|+||.||+|+...++    +.||||++....   ....+++.+|+.++++++|||||++++++.+++.++
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCC----cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence            4888899999999999999987665    899999997653   344567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|||||++|+|..++..  ...+++.+++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...
T Consensus        92 iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999999999877633  457999999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCcccccccccC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcch
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATV---SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKIC  553 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~  553 (636)
                      .     .....||+.|||||++.+   ..++.++|||||||++|||++|+.||.......    .+.....    . .  
T Consensus       167 ~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~~i~~----~-~--  230 (309)
T d1u5ra_         167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQ----N-E--  230 (309)
T ss_dssp             S-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHH----S-C--
T ss_pred             C-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHh----C-C--
Confidence            3     234579999999999864   458899999999999999999999997542211    1111000    0 0  


Q ss_pred             hhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          554 EAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       554 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                         .+.+   .+....+.+.+|+.+||+.||++|||+.|++++
T Consensus       231 ---~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         231 ---SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             ---CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence               0011   111224568889999999999999999999973

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-48  Score=399.12  Aligned_cols=263  Identities=24%  Similarity=0.392  Sum_probs=211.8

Q ss_pred             HhCCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeeeccccccce
Q 006668          317 ATKGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~  394 (636)
                      ..++|+..+.||+|+||.||+|+++.. ....+..||||+++... .+..+++.+|+.++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            345789999999999999999998653 23445789999997653 4446789999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCC----------------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP----------------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIK  452 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk  452 (636)
                      .++||||+++|+|.+++....                      ...+++.+++.|+.|++.||+|||   +++|+|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999995421                      235899999999999999999999   8999999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccCCC-CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCC-CCCCCCC
Q 006668          453 SGNILLDSEMRGRLGDFGLAKLYQQGE-VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR-RPLDMGK  530 (636)
Q Consensus       453 p~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~-~Pf~~~~  530 (636)
                      |+||||+.++.+||+|||+++...... ....+...||+.|+|||++.+..++.++|||||||++|||++|. .||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998654432 22334467899999999999999999999999999999999986 4665432


Q ss_pred             ChhhHHHHHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          531 GEEEEEAVLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       531 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      ..    . +...+.    .+..         ...+...+..+.+|+.+||+.||++||||.||+++|+.-
T Consensus       248 ~~----e-~~~~v~----~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         248 HE----E-VIYYVR----DGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             HH----H-HHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             HH----H-HHHHHH----cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11    1 111111    1111         122334456788999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-47  Score=401.27  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=210.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELMLV  398 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV  398 (636)
                      +.|++.+.||+|+||.||+|+...++    +.||||+++.......+.+.+|+.++++++|||||++++++.+++.++||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATG----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCC----CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56899999999999999999987655    89999999887666667888999999999999999999999999999999


Q ss_pred             EeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc--CCCcEEEeccCCccccc
Q 006668          399 YDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD--SEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       399 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~  476 (636)
                      ||||++|+|.+++.. ....+++.+++.++.||+.||+|||   +.+|+||||||+||||+  .++.+||+|||+|+...
T Consensus       105 mE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         105 LEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            999999999988743 2456999999999999999999999   89999999999999997  67899999999998876


Q ss_pred             CCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAA  556 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  556 (636)
                      ...  ......||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+.. +..    +      
T Consensus       181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~-i~~----~------  243 (352)
T d1koba_         181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQN-VKR----C------  243 (352)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHH-HHH----C------
T ss_pred             CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHh----C------
Confidence            543  2334579999999999999999999999999999999999999997542211    1111 111    0      


Q ss_pred             hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          557 DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       557 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      +..............+.+|+.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011111112234567889999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=393.19  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeeeccccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS------KQGLKEFMAEISSMGRLQHKNLVQMRGWCRK  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~  391 (636)
                      .++|+..+.||+|+||+||+|+.+.++    +.||||+++...      ....+.+.+|+.+|++++|||||++++++.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   84 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   84 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCC----CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            356889999999999999999987665    899999997542      1235788999999999999999999999999


Q ss_pred             cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC----cEEEe
Q 006668          392 GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM----RGRLG  467 (636)
Q Consensus       392 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~  467 (636)
                      .+.++||||||++|+|.++|..  .+.+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++    .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEec
Confidence            9999999999999999999954  357999999999999999999999   89999999999999998776    49999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .+.. +    
T Consensus       160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~-i----  228 (293)
T d1jksa_         160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLAN-V----  228 (293)
T ss_dssp             CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-H----
T ss_pred             chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHH-H----
Confidence            999998765433  2334578999999999999999999999999999999999999997542211    1111 1    


Q ss_pred             cCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          548 GQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       548 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..+..      .............+.+|+.+||+.||++|||++|+++.
T Consensus       229 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         229 SAVNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HTTCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HhcCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01110      00111111223567889999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-47  Score=390.14  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=204.4

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccc-cceEEEEEee
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-GNELMLVYDY  401 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~  401 (636)
                      .++||+|+||+||+|++...+ .....||||+++.. .....++|.+|++++++++||||++++|+|.+ ++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCC-CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            478999999999999987642 23357999999754 55567889999999999999999999999865 5689999999


Q ss_pred             cCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccCCCCc
Q 006668          402 MPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQGEVP  481 (636)
Q Consensus       402 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  481 (636)
                      |++|+|.+++... ...+++.++++++.|+++||.|||   +.+|+||||||+||||++++.+||+|||+++........
T Consensus       111 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999998643 556788999999999999999999   899999999999999999999999999999876544322


Q ss_pred             ---cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhhhhh
Q 006668          482 ---NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEAADA  558 (636)
Q Consensus       482 ---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  558 (636)
                         ......||..|+|||.+....++.++||||||+++|||++|+.||.......    .+..++.    .|.       
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~i~----~g~-------  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGR-------  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHH----TTC-------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----cCC-------
Confidence               2233568999999999999999999999999999999999888886432111    1111111    111       


Q ss_pred             hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          559 RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       559 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                        +...+...+..+.+|+.+||+.||++||+|.||+++|+.-
T Consensus       252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              1112223346688999999999999999999999999764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-47  Score=391.95  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||+||+|+.+.++    +.||||+++..   .....+.+.+|+.++++++|||||++++++.+.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   79 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNG----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   79 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCC----CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence            45888999999999999999987665    89999999754   223357788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|||||++|+|..++..  ...+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        80 ~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             eeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence            999999999999998843  456888999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    ....+||+.|||||++.+..++.++|||||||++|||++|+.||...........++    .     +.    
T Consensus       155 ~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~-----~~----  217 (316)
T d1fota_         155 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----N-----AE----  217 (316)
T ss_dssp             SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----H-----CC----
T ss_pred             ccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH----c-----CC----
Confidence            542    234689999999999999999999999999999999999999997543221111110    0     00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                        .    .++......+.+++.+||..||.+||     |++|++++
T Consensus       218 --~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 --L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --C----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              1    11222335578899999999999996     89999875

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=1.4e-46  Score=369.39  Aligned_cols=190  Identities=31%  Similarity=0.452  Sum_probs=163.3

Q ss_pred             ceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           25 ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        25 ~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ++||+|++|.+. ...+|+|+|||.+. ++.++||+..      ..++|||+|++|||||   +..++.+|||+|+|+|.
T Consensus         1 ~~sF~f~~F~~~-~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---~~~t~~~asFsT~F~F~   75 (236)
T d1hqla_           1 SVSFTFPNFWSD-VEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW---DNKTESVASFYTEFTFF   75 (236)
T ss_dssp             CCEEEESCSCSC-GGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECC---CSTTCCCCEEEEEEEEE
T ss_pred             CEEEEeCCCCCC-CcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEee---cCCCCceeEEEEEEEEE
Confidence            478999999753 34689999999996 7788998753      3578999999999999   67778899999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCC--CCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV--TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~--~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.+. ...+||||||+|+|....+ +..|++||+++..+++  ..+++|||||||++|.+++||++||||||+||++|.+
T Consensus        76 i~~~-~~~~gDGlAFvl~p~~~~~-~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~  153 (236)
T d1hqla_          76 LKIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVA  153 (236)
T ss_dssp             EEEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSE
T ss_pred             EeCC-CCCCCceEEEEEeCCCCCC-CCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCccccc
Confidence            9874 4568999999999976544 4689999999987654  5789999999999999999999999999999999998


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCCc-ee
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKTN-WI  219 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg~-~~  219 (636)
                      +.++.           ...+.+|+.++|||+||                                    ||||+||. ..
T Consensus       154 ~~~~~-----------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~  222 (236)
T d1hqla_         154 TKRWE-----------DSDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQF  222 (236)
T ss_dssp             EEECC-----------HHHHTSCSCEEEEEEEETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCC
T ss_pred             ccccc-----------cccccCCCEEEEEEEEeCCCcEEEEEEecCCCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCc
Confidence            87653           34578999999999998                                    99999996 46


Q ss_pred             cceeeeeccccCC
Q 006668          220 EARRVLAWSLSDT  232 (636)
Q Consensus       220 ~~~~il~wsf~~~  232 (636)
                      +.|+|++|+|+++
T Consensus       223 ~~h~I~sWsF~s~  235 (236)
T d1hqla_         223 LTVYILSWRFSSN  235 (236)
T ss_dssp             EEEEEEEEEEEEE
T ss_pred             eEEEEEEeEeEec
Confidence            7899999999974

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-47  Score=390.05  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCC-CCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeecccccc-ce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNN-NNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKG-NE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~  394 (636)
                      ++|+..++||+|+||.||+|++...+ ...++.||||+++.. .....+++.+|...+.++ +|+||+++++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            46788899999999999999986543 334578999999754 444566788888888777 689999999987654 56


Q ss_pred             EEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC
Q 006668          395 LMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS  460 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~  460 (636)
                      +++|||||++|+|.++|....              ...+++.+++.++.||+.||+|||   +++|+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence            899999999999999996432              345899999999999999999999   799999999999999999


Q ss_pred             CCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCChhhHHHH
Q 006668          461 EMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR-RPLDMGKGEEEEEAV  538 (636)
Q Consensus       461 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~-~Pf~~~~~~~~~~~~  538 (636)
                      ++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|. .||............
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999987654332 2334567999999999999999999999999999999999875 567654322211111


Q ss_pred             HHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          539 LMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       539 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                          +             ....+...+......+.+++.+||+.||++|||+.||+++|+.
T Consensus       250 ----~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         250 ----L-------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             ----H-------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----H-------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                1             1111122233344568899999999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=392.95  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=204.4

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..++||+|+||.||+|+++.++  ....||||.++.. ..+..+++.+|+++|+++ +|||||+++|+|.+++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT--EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC--eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            46778899999999999999987654  1235788888654 444567899999999999 7999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcC--------------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC
Q 006668          397 LVYDYMPNGSLNNWIFGK--------------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM  462 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~  462 (636)
                      +||||+++|+|.++|+..              ....+++.+++.++.||+.||.|||   +++|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence            999999999999999653              2467999999999999999999999   79999999999999999999


Q ss_pred             cEEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCC-CCCCCCChhhHHHHHHH
Q 006668          463 RGRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRR-PLDMGKGEEEEEAVLMD  541 (636)
Q Consensus       463 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~-Pf~~~~~~~~~~~~l~~  541 (636)
                      .+||+|||+++......  ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..    .+..
T Consensus       165 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~----~~~~  237 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CA----ELYE  237 (309)
T ss_dssp             CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HH----HHHH
T ss_pred             ceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-HH----HHHH
Confidence            99999999998654322  2233468999999999999999999999999999999999765 564332 11    1111


Q ss_pred             HHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          542 WVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       542 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                      .+             ....+.+.+...+..+.+|+.+||+.||++||||+||++.|+.-
T Consensus       238 ~i-------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 KL-------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HG-------------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH-------------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11             11112223334456788999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=393.83  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=206.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+.+.++    +.||+|++++.   .....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            46888999999999999999987766    89999999754   223457788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++|||||++|+|.+++..  ...+++++++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        81 ~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            999999999999999853  457899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      .... ......+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .... +..    +.    
T Consensus       156 ~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~-i~~----~~----  221 (337)
T d1o6la_         156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFEL-ILM----EE----  221 (337)
T ss_dssp             CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-HHH----CC----
T ss_pred             ccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHH-Hhc----CC----
Confidence            4332 23344689999999999999999999999999999999999999997653221    1111 100    01    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                        ..++..+    ...+.+|+.+||++||.+||+     +.|++++
T Consensus       222 --~~~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 --IRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence              1112223    345678899999999999995     7888874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=388.66  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=199.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..+.||+|+||.||+|++.... .....||||+++..   ..+..++|.+|+.++++++|||||+++|+|.+ +..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS-GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT-SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC-CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            45778899999999999999876532 33468999998764   33446789999999999999999999999976 467


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+++|+|.+++..+ ...+++..++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            8999999999999988543 456999999999999999999999   799999999999999999999999999999976


Q ss_pred             cCCCCc--cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHHHHHhcCCcc
Q 006668          476 QQGEVP--NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI  552 (636)
Q Consensus       476 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~  552 (636)
                      ......  ......|+..|+|||++.+..++.++|||||||++|||++ |+.||.......     ...++.   ..+  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~---~~~--  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKID---KEG--  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH---TSC--
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HHHHHH---hCC--
Confidence            544322  2233568889999999999999999999999999999998 899997542221     111111   111  


Q ss_pred             hhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          553 CEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       553 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                             .+.+.+...+..+.+|+.+||+.||++||||.||++.|..
T Consensus       232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                   1112223334568899999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=390.13  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=207.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCC---CCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNN---NNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~  393 (636)
                      ++|...+.||+|+||.||+|+....++   .....||||+++.+. .....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            357778999999999999998765432   334689999998764 45567889999999888 8999999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCC--------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKP--------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ..++|||||++|+|.++|....              ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999996543              246899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCCc-cccccccCCcccccccccCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEVP-NTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVAC-GRRPLDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~-G~~Pf~~~~~~~~~~~  537 (636)
                      .++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |+.||......    .
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~  245 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E  245 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----H
Confidence            9999999999999877554332 3344678999999999999999999999999999999998 68888644211    1


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +...+.    .         ..+...+......+.+|+.+||+.||++|||+.||++.|+.-
T Consensus       246 -~~~~i~----~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 -LFKLLK----E---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -HHHHHH----T---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHH----c---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             111111    1         112222333446789999999999999999999999999754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-46  Score=383.52  Aligned_cols=258  Identities=25%  Similarity=0.337  Sum_probs=201.1

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeeeccccccc-
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN-  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-  393 (636)
                      .++|++.+.||+|+||.||+|+....+    +.||||+++..   .....+.+.+|+.++++++|||||++++++...+ 
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLH----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCC----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            457889999999999999999987665    89999999764   3344567899999999999999999999987643 


Q ss_pred             ---eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          394 ---ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       394 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                         .+++||||+++++|.+++..  .+.+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++..+|+|||
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             CCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhh
Confidence               48999999999999998843  457999999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCCC--CccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          471 LAKLYQQGE--VPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       471 la~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      .+.......  .......+||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+...    ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~~----~~  228 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQH----VR  228 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHH----HH
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH----HHHHH----Hh
Confidence            987654332  223344679999999999999999999999999999999999999997542211    11111    11


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-TMREVVAVLVG  599 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~  599 (636)
                      .+..       .........+..+.+++.+||++||++|| |++++++.|..
T Consensus       229 ~~~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         229 EDPI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCCC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            1111       01111222345688899999999999999 89999888753

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=4.3e-46  Score=367.24  Aligned_cols=191  Identities=28%  Similarity=0.377  Sum_probs=163.0

Q ss_pred             CceeEEcCCCCCCC--CCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEE
Q 006668           24 SALDFLFNSFGSIT--NGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSF   95 (636)
Q Consensus        24 ~~~~f~f~~F~~~~--~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F   95 (636)
                      ++++|+|++|.+..  +..||+|+|+|++. ++.|+||+..      ..++|||+|++||+||   ++ ++.++||+|+|
T Consensus         2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---~~-t~~~asFsT~F   76 (243)
T d1leda_           2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLW---DS-TGKAASFYTSF   76 (243)
T ss_dssp             CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECB---CT-TSCBCEEEEEE
T ss_pred             CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEec---CC-CCcEeeEEEEE
Confidence            46899999997432  35799999999997 6889998643      3589999999999999   43 56799999999


Q ss_pred             EEEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCC--CCCceEEEEeecCCCCCCCCCCCCeeeEecCCcc
Q 006668           96 VFSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVV--TVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIE  173 (636)
Q Consensus        96 ~f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~--~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~  173 (636)
                      +|.|.+.. ..+||||||+|+|.+. +.+..|++|||++..+++  ..+++|||||||++|.+++||++||||||+|+++
T Consensus        77 ~f~i~~~~-~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~  154 (243)
T d1leda_          77 TFLLKNYG-APTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIV  154 (243)
T ss_dssp             EEEEEESS-SSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSS
T ss_pred             EEEcCCCC-CCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcc
Confidence            99887653 5579999999999865 345679999999887665  5789999999999999999999999999999999


Q ss_pred             ccccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCCc
Q 006668          174 SAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKTN  217 (636)
Q Consensus       174 s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg~  217 (636)
                      |.++.++.           ...+.+|+.++|||+||                                    |||||||.
T Consensus       155 s~~~~~~~-----------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~  223 (243)
T d1leda_         155 SVATTRWE-----------NDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY  223 (243)
T ss_dssp             CSEEEECC-----------HHHHTSCCEEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEECB
T ss_pred             cccccccc-----------cCCcccCceeEEEEEEECCCCEEEEEEeeCCCCCceEEEecCHHHhcCCcEEEEEEcccCC
Confidence            99988764           23577888999999998                                    99999995


Q ss_pred             eecceeeeeccccCCC
Q 006668          218 WIEARRVLAWSLSDTG  233 (636)
Q Consensus       218 ~~~~~~il~wsf~~~~  233 (636)
                       .|.|+|++|+|+++.
T Consensus       224 -~~~h~I~sWsF~s~l  238 (243)
T d1leda_         224 -DEVTYILSWHFFSTL  238 (243)
T ss_dssp             -SEEEEEEEEEEEEEC
T ss_pred             -cceeeEEEEEEEeeC
Confidence             699999999999863

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=388.45  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=213.1

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHDS-KQGLKEFMAEISSMGRL-QHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~  395 (636)
                      ++|+..++||+|+||.||+|++... +...++.||||+++... .....++.+|+.+++++ +|||||+++++|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            4677889999999999999987542 34566899999998653 34456789999999999 699999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCC----------------CCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc
Q 006668          396 MLVYDYMPNGSLNNWIFGKP----------------KKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD  459 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~  459 (636)
                      ++|||||++|+|.++++...                ...+++.+++.++.||++||+|||   +++++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999996532                236899999999999999999999   79999999999999999


Q ss_pred             CCCcEEEeccCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCC-CCCCCChhhHHH
Q 006668          460 SEMRGRLGDFGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRP-LDMGKGEEEEEA  537 (636)
Q Consensus       460 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~P-f~~~~~~~~~~~  537 (636)
                      .++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+++..| +........   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999987654432 233446789999999999999999999999999999999995445 543322211   


Q ss_pred             HHHHHHHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          538 VLMDWVRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       538 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       +...             +....+...+...+..+.+|+.+||+.||++||||.||+++|+..
T Consensus       257 -~~~~-------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 -FYKM-------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -HHHH-------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHH-------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             1111             112222233334456789999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.5e-46  Score=378.24  Aligned_cols=252  Identities=26%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---------hHHHHHHHHHHHHhccCC-CCceeeeecc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---------KQGLKEFMAEISSMGRLQ-HKNLVQMRGW  388 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~g~  388 (636)
                      ++|+..+.||+|+||+||+|+...++    +.||||+++...         +...+.+.+|+.++++++ ||||++++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~   78 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   78 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCC----CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence            57888999999999999999987655    899999997542         122346789999999997 9999999999


Q ss_pred             ccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          389 CRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       389 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      +.+++.++||||||++|+|.++|..  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          79 YETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cccCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEcc
Confidence            9999999999999999999999954  457999999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCCCccccccccCCcccccccccC------CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 006668          469 FGLAKLYQQGEVPNTTRVVGTLGYLAPELATV------SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW  542 (636)
Q Consensus       469 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~  542 (636)
                      ||+++......  ..+...||+.|+|||.+.+      ..++.++||||+||++|||++|+.||............    
T Consensus       154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i----  227 (277)
T d1phka_         154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----  227 (277)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred             chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH----
Confidence            99998775533  2344679999999998763      34678999999999999999999999755322111111    


Q ss_pred             HHHHhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          543 VRNLYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       543 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      ..     +...      ............+.+|+.+||++||++|||+.||++.
T Consensus       228 ~~-----~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MS-----GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HH-----TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             Hh-----CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            10     1110      0111111233568889999999999999999999865

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=383.22  Aligned_cols=267  Identities=25%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccc----e
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN----E  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~  394 (636)
                      +.|...+.||+|+||.||+|++.+      +.||||+++...... .....|+..+.+++|||||+++++|.+.+    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g------~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETT------EEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            345677899999999999999743      799999997553321 22345777778899999999999997653    6


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc-----CCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG-----WDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                      +++|||||++|+|.++|.+   ..++|.+++.++.|+|.||+|||+.     .+++|+||||||+||||+.++.+||+||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            8999999999999999954   3699999999999999999999952     1479999999999999999999999999


Q ss_pred             CCcccccCCCCc---cccccccCCcccccccccCCC------CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHH----
Q 006668          470 GLAKLYQQGEVP---NTTRVVGTLGYLAPELATVSS------PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEE----  536 (636)
Q Consensus       470 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~----  536 (636)
                      |+++........   ......||+.|+|||++.+..      ++.++|||||||+||||++|..|+..........    
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            999877543321   233467999999999987653      5668999999999999999998874332111000    


Q ss_pred             --HHHHHHHHHHhcCCcchhhhhhhhhhcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          537 --AVLMDWVRNLYGQGKICEAADARIRQEF-EAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       537 --~~l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                        .............+.    .++.+.... +.+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence              000011111111111    111121111 33456779999999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=384.78  Aligned_cols=261  Identities=24%  Similarity=0.420  Sum_probs=210.2

Q ss_pred             CCCCCceeeeecCceEEEeeeecCC-CCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANN-NNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|...+.||+|+||.||+|.+... .......||||+++.. ..+....+.+|+.++++++|||||+++++|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            4567789999999999999987532 1122378999999765 4455567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcC--------CCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          397 LVYDYMPNGSLNNWIFGK--------PKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                      +|||||++|+|.+++...        ....+++.++..++.|+|+||.|||   +++|+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999998532        2245789999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCC-ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEV-PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGR-RPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       469 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~-~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      ||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|. .||......    ..+ ..+   
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----~~~-~~i---  248 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL-RFV---  248 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHH-HHH---
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----HHH-HHH---
Confidence            999986654332 2233456899999999999999999999999999999999985 556433211    111 111   


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQ  600 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  600 (636)
                       ..+.         +.+.+...+..+.+|+.+||+.||++||||++|+++|+..
T Consensus       249 -~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 -MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             -HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             1111         1122233446799999999999999999999999999886

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-46  Score=390.71  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeeeccccccceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS---KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~  395 (636)
                      ++|++.+.||+|+||.||+|+.+.++    +.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESG----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCC----CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            47899999999999999999987665    899999997532   23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLY  475 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  475 (636)
                      ++||||+.+|+|.+++..  .+.+++.+++.++.||+.||.|||   +.+|+||||||+||||+.++.+||+|||+|+..
T Consensus       117 ~~v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            999999999999999854  356999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ...    .....||+.|||||++.+..++.++|||||||++|||++|+.||.......    .+.. +..    +.    
T Consensus       192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~-i~~----~~----  254 (350)
T d1rdqe_         192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEK-IVS----GK----  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH-HHH----CC----
T ss_pred             ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HHHH-Hhc----CC----
Confidence            542    234679999999999999999999999999999999999999997542111    1111 110    00    


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRP-----TMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  596 (636)
                        .    .++......+.+++.+||+.||.+|+     |++|++++
T Consensus       255 --~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 --V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              0    11122345678899999999999994     89999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=382.98  Aligned_cols=253  Identities=19%  Similarity=0.280  Sum_probs=206.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      .++|.+.+.||+|+||+||+|+.+.++    +.||+|.++....+ ...+.+|+++|++++|||||++++++.+++.+++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~----~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSK----KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            357889999999999999999987765    89999999876543 3567899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC--CCcEEEeccCCcccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS--EMRGRLGDFGLAKLY  475 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~  475 (636)
                      |||||++|+|.++|... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.  ...+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999999432 346999999999999999999999   899999999999999985  458999999999876


Q ss_pred             cCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchhh
Q 006668          476 QQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICEA  555 (636)
Q Consensus       476 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~~  555 (636)
                      ....  ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .+......   .-..   
T Consensus       155 ~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~i~~~---~~~~---  222 (321)
T d1tkia_         155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNA---EYTF---  222 (321)
T ss_dssp             CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHT---CCCC---
T ss_pred             ccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhC---CCCC---
Confidence            5433  2334578999999999999999999999999999999999999997653221    11110000   0000   


Q ss_pred             hhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          556 ADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       556 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       +......    ....+.+|+.+||..||++|||+.|++++
T Consensus       223 -~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         223 -DEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -CHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -ChhhccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1111111    23457889999999999999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-45  Score=389.09  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeeecccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS------KQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG  392 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~  392 (636)
                      ++|++.++||+|+||.||+|+...++    +.||||++....      .........|+.+++.++|||||++++++.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCC----CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence            57889999999999999999987765    899999986431      11222334567888899999999999999999


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                      +.+++|||||++|+|.++|..  ...+++.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeecee
Confidence            999999999999999999954  456889999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          473 KLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       473 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      +......   ....+||+.|||||++.. ..++.++|||||||++|||++|+.||..........  +    ....... 
T Consensus       155 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~----~~~~~~~-  224 (364)
T d1omwa3         155 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--I----DRMTLTM-  224 (364)
T ss_dssp             EECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--H----HHHSSSC-
T ss_pred             eecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHhcccC-
Confidence            8765432   334579999999999865 568999999999999999999999997653322111  0    0100000 


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                               ...++......+.+|+.+||+.||.+|||     ++|++++
T Consensus       225 ---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 ---------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                     01111223456788999999999999999     6888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=387.22  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC---ChHHHHHHHHHHHHhc-cCCCCceeeeeccccccce
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD---SKQGLKEFMAEISSMG-RLQHKNLVQMRGWCRKGNE  394 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~~~~  394 (636)
                      ++|...+.||+|+||+||+|+.+.++    +.||||++++.   .....+.+..|..++. .++|||||++++++.+++.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~----~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~   77 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   77 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCC----CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc
Confidence            46888999999999999999987766    89999999753   2233456677777765 6899999999999999999


Q ss_pred             EEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          395 LMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       395 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      +++|||||++|+|.+++..  ...+++.+++.++.||+.||+|||   +++|+||||||+|||+++++++||+|||+++.
T Consensus        78 ~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             eeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhh
Confidence            9999999999999999953  456899999999999999999999   79999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE  554 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~  554 (636)
                      ..... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||........    + .-+.    .+    
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~----~-~~i~----~~----  218 (320)
T d1xjda_         153 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----F-HSIR----MD----  218 (320)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H-HHHH----HC----
T ss_pred             ccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH----H-HHHH----cC----
Confidence            55433 233446899999999999999999999999999999999999999975432211    1 1010    00    


Q ss_pred             hhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006668          555 AADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMR-EVVA  595 (636)
Q Consensus       555 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  595 (636)
                        .+    .++......+.+|+.+||..||.+||++. |+++
T Consensus       219 --~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 --NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              11    11222345678999999999999999996 6754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=385.59  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=198.9

Q ss_pred             CCCCCc-eeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhcc-CCCCceeeeeccccc----c
Q 006668          319 KGFSND-ELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGR-LQHKNLVQMRGWCRK----G  392 (636)
Q Consensus       319 ~~f~~~-~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~----~  392 (636)
                      ++|.+. ++||+|+||.||+|+...++    +.||||+++..     ..+.+|+.++.+ .+|||||++++++.+    +
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCC----CEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            467765 46999999999999987665    89999999653     446678988655 489999999998865    4


Q ss_pred             ceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC---CCcEEEecc
Q 006668          393 NELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS---EMRGRLGDF  469 (636)
Q Consensus       393 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DF  469 (636)
                      ..+++|||||++|+|.++|..+....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   .+.+||+||
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence            67899999999999999997655567999999999999999999999   899999999999999975   567999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      |+++......  .....+||+.|||||++.+..++.++|||||||++|||++|+.||...........     +......
T Consensus       159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----~~~~i~~  231 (335)
T d2ozaa1         159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRM  231 (335)
T ss_dssp             TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred             ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----HHHHHhc
Confidence            9998765543  23346799999999999999999999999999999999999999965432211110     0000001


Q ss_pred             CcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      +..      .+...........+.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            110      01111112234568889999999999999999999984

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=6e-45  Score=359.96  Aligned_cols=193  Identities=32%  Similarity=0.398  Sum_probs=162.1

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ++++||+|++|.+  ...||+|+|+|.+.+++.|+||+..    ..++|||+|++||+||   +..++.++||+|+|+|.
T Consensus         1 ~~~~sF~f~~F~~--~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~---~~~t~~~~sF~t~F~f~   75 (240)
T d1fx5a_           1 SDDLSFKFKNFSQ--NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW---NCNTGELASFITSFSFF   75 (240)
T ss_dssp             CCEEEEEESSCCT--TCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECE---ETTTTEECEEEEEEEEE
T ss_pred             CCceEEECCCCCC--CCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceee---cCCCCceeeeEEEEEEE
Confidence            3578999999975  3579999999999878899999765    3478999999999999   67788899999999999


Q ss_pred             eecCC-CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCC-CCCCCCCCeeeEecCCccccc
Q 006668           99 ILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNP-EFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        99 i~~~~-~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~-~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.... ...+||||||+|+|.+. |.+..|++|||++..+.+..+++|||||||++|. +++||++||||||+||+.+..
T Consensus        76 i~~~~~~~~ggdG~AFvl~p~~~-~~~~~g~~lGl~~~~~~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~  154 (240)
T d1fx5a_          76 METSANPKAATDGLTFFLAPPDS-PLRRAGGYFGLFNDTKCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSIN  154 (240)
T ss_dssp             EEESSCGGGCCCEEEEEEECTTC-CCCBCGGGTTTBSSSCCCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSE
T ss_pred             EeCCCCCCCCCCcEEEEECCCCC-CCCCCCccccccccCCCCccCceEEEEeeccccccccCCCCCCceEEccCCccccc
Confidence            97653 34578999999999754 6678899999999876667889999999999984 788999999999999999988


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc-e
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN-W  218 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~-~  218 (636)
                      +.+++.            .+.+|+.++|||+||                                     |||||||. .
T Consensus       155 ~~~~~~------------~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~  222 (240)
T d1fx5a_         155 AERWNK------------RYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGR  222 (240)
T ss_dssp             EEECCC------------CCSGGGCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETTS
T ss_pred             cccccc------------ccCCCCeEEEEEEEcCCCCEEEEEEecCCCceeeEEeEEEchHHhCCCcEEEEEEeECCCCC
Confidence            876543            234555666666666                                     99999995 5


Q ss_pred             ecceeeeeccccCCC
Q 006668          219 IEARRVLAWSLSDTG  233 (636)
Q Consensus       219 ~~~~~il~wsf~~~~  233 (636)
                      .+.|+|++|+|+++.
T Consensus       223 ~~~H~I~sWsFsst~  237 (240)
T d1fx5a_         223 QATHEVLNWYFTSTF  237 (240)
T ss_dssp             CEEEEEEEEEEEEES
T ss_pred             CceEEEEEEEeEEec
Confidence            789999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=374.83  Aligned_cols=269  Identities=24%  Similarity=0.324  Sum_probs=204.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|++.+.||+|+||+||+|+...++    +.||||+++....  ...+++.+|++++++++|||||++++++.+++.++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCC----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            47889999999999999999987665    8899999975532  23567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +||||+. +++.+++.......+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceecc
Confidence            9999995 55666665555677999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcc-hh
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKI-CE  554 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~-~~  554 (636)
                      .... ......||+.|+|||++.... ++.++|||||||++|||++|+.||........    +............. ..
T Consensus       154 ~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         154 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             CCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTST
T ss_pred             CCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH----HHHHHHhcCCCchhhcc
Confidence            4332 333457999999999876655 57899999999999999999999975532211    11111111110000 00


Q ss_pred             hh--hhhhhh-----------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 006668          555 AA--DARIRQ-----------EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV--LVGQ  600 (636)
Q Consensus       555 ~~--d~~l~~-----------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  600 (636)
                      ..  .+....           .........+.+|+.+||+.||++|||+.|+++.  ++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00  000000           0011123567889999999999999999999996  5443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=379.53  Aligned_cols=259  Identities=23%  Similarity=0.277  Sum_probs=196.5

Q ss_pred             CceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHH-----HHHHHHHHHHhccCCCCceeeeeccccccceEEE
Q 006668          323 NDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQG-----LKEFMAEISSMGRLQHKNLVQMRGWCRKGNELML  397 (636)
Q Consensus       323 ~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l  397 (636)
                      ..++||+|+||+||+|+.+.++    +.||||+++......     .+.+.+|+.++++++|||||++++++..++..++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCC----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cceEeccCcCeEEEEEEECCCC----cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceee
Confidence            3578999999999999987655    899999997543221     2468899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcccccC
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQQ  477 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  477 (636)
                      ||||+.++++..++  .....+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        78 vmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          78 VFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCC
Confidence            99999888777655  34567999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCcchh--
Q 006668          478 GEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGKICE--  554 (636)
Q Consensus       478 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~~~~--  554 (636)
                      ... .....+||+.|+|||++... .++.++|||||||++|||++|+.||........    +.. +...........  
T Consensus       153 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~-i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         153 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTR-IFETLGTPTEEQWP  226 (299)
T ss_dssp             CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH-HHHHHCCCCTTTSS
T ss_pred             Ccc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHH-HHHhcCCCChhhcc
Confidence            332 23345799999999988654 578999999999999999999999975432221    111 111111000000  


Q ss_pred             -h------hhhhh-----hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          555 -A------ADARI-----RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       555 -~------~d~~l-----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       .      .....     .........+.+.+|+.+||+.||++|||++|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             0      00000     000111223568889999999999999999999985

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=9.3e-44  Score=351.00  Aligned_cols=189  Identities=33%  Similarity=0.515  Sum_probs=163.6

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC---CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEee
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN---QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSIL  100 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~---~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~  100 (636)
                      +++||+|++|.+  +..||+|+|||.+.+++.|+||+.+   ..++|||+|++||+||   ++.++.++||+|+|+|.|.
T Consensus         2 ~~lsF~f~~F~~--~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~---~~~~~~~~sF~t~F~f~i~   76 (237)
T d1qnwa_           2 DDLSFNFDKFVP--NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW---DSITGKVASFATSFSFVVK   76 (237)
T ss_dssp             CSEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECB---CTTTCCBCEEEEEEEEECC
T ss_pred             CcEEEEcCCCCC--CCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEec---CCCCcceeeEEEEEEEEEe
Confidence            569999999975  3579999999999878899999865   3589999999999999   7777889999999999997


Q ss_pred             cCCCCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCC--CCCCCeeeEecCCcccccc
Q 006668          101 PEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus       101 ~~~~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~--d~~~~Hvgidvns~~s~~~  177 (636)
                      +.. ..+||||||+|+|... .|.++.|+++|+++..+....+++|||||||++|.+++  ||++||||||+|++.|.++
T Consensus        77 ~~~-~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~  155 (237)
T d1qnwa_          77 ADK-SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKT  155 (237)
T ss_dssp             BSS-SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSSCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred             cCC-CCCcceeEEEEeCCCCCCCCCCccccccccCCCCCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCcccc
Confidence            653 5589999999999864 46677888999998776668899999999999998755  6999999999999998877


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce--
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW--  218 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~--  218 (636)
                      +++              .+.+|+.++|||+||                                     |||||||..  
T Consensus       156 ~~~--------------~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~  221 (237)
T d1qnwa_         156 VKW--------------DWRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE  221 (237)
T ss_dssp             EEC--------------CCCTTCCEEEEEEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGG
T ss_pred             ccc--------------ccCCCcEEEEEEEEcCCCcEEEEEEecCCCCccceEEEEEChHHhCCCcEEEEEEeECCCCCC
Confidence            643              367889999999998                                     999999975  


Q ss_pred             ecceeeeeccccCC
Q 006668          219 IEARRVLAWSLSDT  232 (636)
Q Consensus       219 ~~~~~il~wsf~~~  232 (636)
                      .|.|+|++|+|+++
T Consensus       222 ~q~h~I~sWsF~s~  235 (237)
T d1qnwa_         222 FETHDVLSWYFTSN  235 (237)
T ss_dssp             CBCCEEEEEEEEEE
T ss_pred             ccEeEEEEeEeEEe
Confidence            48999999999985

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=4.9e-44  Score=353.16  Aligned_cols=188  Identities=31%  Similarity=0.492  Sum_probs=162.7

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      +++||+|++|.+  +..||+|+|+|.+.+++.|+||+...      +++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         2 ~~~sF~f~~F~~--~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~---~~~~~~~~sFst~F~f   76 (239)
T d1gzca_           2 ETISFSFSEFEP--GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW---DSTTGTVASFETRFSF   76 (239)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             eeEEEEeCCCCC--CCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEec---CCCCCceeeEEEEEEE
Confidence            468999999975  34789999999998788999998653      488999999999999   6777889999999999


Q ss_pred             EeecCC-CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           98 SILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        98 ~i~~~~-~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      .|.... ...+||||||+|+|....+ +..|++||+++....+..++.|||||||++| +++||++||||||+|++.|.+
T Consensus        77 ~i~~~~~~~~g~dG~aF~l~p~~~~~-~~~~g~lg~~~~~~~~~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~~~s~~  154 (239)
T d1gzca_          77 SIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIK  154 (239)
T ss_dssp             ECCCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSSCCGGGCCEEEEEECSCC-TTSCSSSSEEEEEESSSSCSE
T ss_pred             EEecCCCCCCCCCeEEEEECCCCCCC-CCCcccccccccCCCCCccceEEEEEEcccc-CCCCCCCCEEEEEECCccccc
Confidence            997653 3568899999999986543 4678899999877666778899999999999 578999999999999999988


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc--
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN--  217 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~--  217 (636)
                      +.++              .+.+|+.++|||+||                                     ||||+||.  
T Consensus       155 t~~~--------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~  220 (239)
T d1gzca_         155 TQPF--------------QLDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQR  220 (239)
T ss_dssp             EEEC--------------CCCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSST
T ss_pred             cCCc--------------cccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceeeeeEechHHhcCCcEEEEEEEEcCCCC
Confidence            7653              478899999999999                                     99999994  


Q ss_pred             -eecceeeeeccccCC
Q 006668          218 -WIEARRVLAWSLSDT  232 (636)
Q Consensus       218 -~~~~~~il~wsf~~~  232 (636)
                       ..|.|+|++|||+++
T Consensus       221 ~~~~~H~V~sWsF~s~  236 (239)
T d1gzca_         221 DAAETHDVYSWSFQAS  236 (239)
T ss_dssp             TCCCCCEEEEEEEEEE
T ss_pred             CCceeeEEEEEEeEee
Confidence             578999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.6e-44  Score=366.47  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=199.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK--QGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|+..++||+|+||+||+|+.+. +    +.||||+++....  ...+.+.+|+.+|++++|||||++++++...+..+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   76 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNY-G----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLV   76 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT-S----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCC-C----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCcee
Confidence            578889999999999999998753 2    7899999976532  23568899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +++||+.++.+..+.  ...+.+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        77 i~~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             EEEECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EEEEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            999999877776665  34567999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCC--c--
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQG--K--  551 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~--~--  551 (636)
                      .... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............    ........  .  
T Consensus       152 ~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~  226 (286)
T d1ob3a_         152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI----FRILGTPNSKNWP  226 (286)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHHHCCCCTTTST
T ss_pred             cCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH----HHhhCCCChhhcc
Confidence            4332 23334689999999988754 5689999999999999999999999755322211111    11111000  0  


Q ss_pred             -chhhh---------hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          552 -ICEAA---------DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       552 -~~~~~---------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                       .....         ...............+.+++.+||+.||++|||++|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000         0000011112223567899999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-45  Score=368.47  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=200.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh------HHHHHHHHHHHHhccCC--CCceeeeeccc
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK------QGLKEFMAEISSMGRLQ--HKNLVQMRGWC  389 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~g~~  389 (636)
                      .++|++.++||+|+||.||+|+...++    +.||||++.....      ....++.+|+.++++++  |||||++++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCC----CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence            357889999999999999999987665    8999999975311      11234568999999986  89999999999


Q ss_pred             cccceEEEEEeecCC-CChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-CCcEEEe
Q 006668          390 RKGNELMLVYDYMPN-GSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-EMRGRLG  467 (636)
Q Consensus       390 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~  467 (636)
                      .+.+..++||||+.+ +++.+++..  ...+++++++.++.||+.||+|||   +++|+||||||+|||++. ++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEEC
Confidence            999999999999976 577777743  457999999999999999999999   899999999999999985 5799999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHH
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSP-TSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNL  546 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~  546 (636)
                      |||+++.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ....    .  
T Consensus       154 DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~----~--  218 (273)
T d1xwsa_         154 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII----R--  218 (273)
T ss_dssp             CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH----H--
T ss_pred             ccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHh----h--
Confidence            99999865432   2334679999999999987765 56789999999999999999999632      1110    0  


Q ss_pred             hcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCch
Q 006668          547 YGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATPK  607 (636)
Q Consensus       547 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~  607 (636)
                         +.      ..++..+    ...+.+|+.+||+.||++|||++|++++-.-.+. ..|.
T Consensus       219 ---~~------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~-~~p~  265 (273)
T d1xwsa_         219 ---GQ------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV-LLPQ  265 (273)
T ss_dssp             ---CC------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC-CCHH
T ss_pred             ---cc------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC-CCCC
Confidence               00      0112222    3557889999999999999999999986443322 4453

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=2.2e-43  Score=347.78  Aligned_cols=184  Identities=33%  Similarity=0.524  Sum_probs=157.9

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      +++||+|++|.+  +..||+|+|||.+.+++.|+||+..     .+++|||+|++||+||   ++.++.++||+|+|+|.
T Consensus         1 ~t~sF~f~~F~~--~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~---~~~~~~~~sF~t~F~f~   75 (237)
T d2d3sa1           1 KTISFNFNQFHQ--NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW---DSTTGNVASFETRFSFS   75 (237)
T ss_dssp             CEEEEEESSCCS--SCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             CeEEEEeCCCCC--CCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEee---cCCCCceeeEEEEEEEE
Confidence            368999999975  3479999999999778899999854     3689999999999999   67778899999999999


Q ss_pred             eecCC-CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           99 ILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        99 i~~~~-~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      |.... ...+||||||+|+|... +.+..|++||+++..   ..+++|||||||++|.  +||++||||||+|++.|.++
T Consensus        76 i~~~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~---~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~  149 (237)
T d2d3sa1          76 IRQPFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL---SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKT  149 (237)
T ss_dssp             CCCSCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT---SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE
T ss_pred             eecCCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC---CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccc
Confidence            97653 34578999999999754 445789999998754   4578999999999996  59999999999999998776


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc---
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN---  217 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~---  217 (636)
                      .+              ..+.+|+.++|||+||                                     |||||||.   
T Consensus       150 ~~--------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~  215 (237)
T d2d3sa1         150 VP--------------FTLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSG  215 (237)
T ss_dssp             EE--------------CCCCTTCEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGG
T ss_pred             cc--------------eeecCCCEEEEEEEEECCCCEEEEEEEcCCCCcccceeeEechHHhCCCcEEEEEEeECCCCcc
Confidence            54              3478999999999999                                     99999994   


Q ss_pred             ----eecceeeeeccccCC
Q 006668          218 ----WIEARRVLAWSLSDT  232 (636)
Q Consensus       218 ----~~~~~~il~wsf~~~  232 (636)
                          ..|.|+||+|+|+++
T Consensus       216 ~~~~~~e~h~I~sWsFss~  234 (237)
T d2d3sa1         216 KQRNATETHDILSWSFSAS  234 (237)
T ss_dssp             CCTTCCCCCEEEEEEEEEE
T ss_pred             CccccceeeEEEEeEeEee
Confidence                579999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=368.94  Aligned_cols=267  Identities=25%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCC--hHHHHHHHHHHHHhccC---CCCceeeeecccc--
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDS--KQGLKEFMAEISSMGRL---QHKNLVQMRGWCR--  390 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~--  390 (636)
                      .++|++.+.||+|+||+||+|+....+   ++.||||+++...  ......+.+|+.+++.|   +||||++++++|.  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCC---CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            467999999999999999999975432   2789999986532  11123445666665554   8999999999885  


Q ss_pred             ---ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEe
Q 006668          391 ---KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLG  467 (636)
Q Consensus       391 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  467 (636)
                         ....++++|||++++++.... ......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence               345789999999877665443 344667899999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHh
Q 006668          468 DFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLY  547 (636)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~  547 (636)
                      |||+++......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||........    +........
T Consensus       159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~  232 (305)
T d1blxa_         159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILDVIG  232 (305)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHC
T ss_pred             chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH----HHHHHHhhC
Confidence            999998654322  33446899999999999999999999999999999999999999975532221    111111110


Q ss_pred             cCCcch--------hhh----hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          548 GQGKIC--------EAA----DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       548 ~~~~~~--------~~~----d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      ..+...        ...    .......+.....+.+.+|+.+||+.||++|||+.|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            000000        000    00001111222345677899999999999999999998753

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=9.7e-43  Score=342.75  Aligned_cols=183  Identities=30%  Similarity=0.469  Sum_probs=157.3

Q ss_pred             ceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           25 ALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        25 ~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      ++||+|++|..  +..||+|+|+|.+.+++.++||+...      .++|||+|++||+||   ++.++.++||+|+|+|.
T Consensus         2 ~~SF~f~~F~~--~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---~~~~~~~~sFsT~F~f~   76 (234)
T d1f9ka_           2 TQSFNFDHFEE--NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIW---DSTTGNVASFETRFSFN   76 (234)
T ss_dssp             EEEEEESSCCS--SCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             ceEEEeCCCCC--CCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEee---CCCCCcCcceEEEEEEE
Confidence            68999999974  35889999999998788999998642      578999999999999   66777899999999999


Q ss_pred             eecCC-CCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccc
Q 006668           99 ILPEI-ASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKH  177 (636)
Q Consensus        99 i~~~~-~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~  177 (636)
                      |.+.. ...+||||||+|+|... +.+..|+++|+++..   ..++.|||||||++|.  +||++||||||+|++.|.++
T Consensus        77 i~~~~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~---~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~  150 (234)
T d1f9ka_          77 ITQPYAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP---EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKT  150 (234)
T ss_dssp             EECCCSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS---CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEE
T ss_pred             EECCCCCCCccceEEEEECCCCC-CcccccccccccCCC---CccceEEEEEeccccC--CCCCCCcEeEecCCcccccc
Confidence            98654 34578999999999754 566789999998754   4567899999999996  69999999999999998776


Q ss_pred             ccCccccCCCCCcceeeeecCCCeeEEEEEec---------------------------------------ccccCCCc-
Q 006668          178 VPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD---------------------------------------GFSASKTN-  217 (636)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~---------------------------------------gfsastg~-  217 (636)
                      .+              +.+.+|+.++|||+||                                       ||||+||. 
T Consensus       151 ~~--------------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~  216 (234)
T d1f9ka_         151 LH--------------FQLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQ  216 (234)
T ss_dssp             EE--------------CCCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSS
T ss_pred             cc--------------ccccCCCEEEEEEEEcCCCcEEEEEEEeCCCCccceEEEEEcHHHhcCCCCEEEEEEEeecCCC
Confidence            54              3578999999999999                                       99999994 


Q ss_pred             --eecceeeeeccccCC
Q 006668          218 --WIEARRVLAWSLSDT  232 (636)
Q Consensus       218 --~~~~~~il~wsf~~~  232 (636)
                        ..|.|+|++|+|+++
T Consensus       217 ~~~~~~h~I~sWsF~s~  233 (234)
T d1f9ka_         217 KNAVETHEIISWSFTSS  233 (234)
T ss_dssp             TTCCCEEEEEEEEEEEE
T ss_pred             CCceeeeEEEEEEeEEe
Confidence              578999999999974

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=1.2e-42  Score=344.81  Aligned_cols=203  Identities=32%  Similarity=0.511  Sum_probs=164.7

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      ++++||+|++|.+  +..||+|+|+|.+.+++.|+||++.     ..++|||+|++||+||   ++.++.++||+|+|+|
T Consensus         1 ~~~~sF~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~---~~~~~~~~sFst~F~F   75 (239)
T d1dbna_           1 SDELSFTINNFVP--NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW---GNTTGSVASFSTSFTF   75 (239)
T ss_dssp             CCEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEE
T ss_pred             CCceEEEeCCCCC--CCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEcc---CCCCccceEEEEEEEE
Confidence            4679999999975  3478999999999878899999764     3578999999999999   7777889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCCC-CCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCC--CCCCCeeeEecCCccc
Q 006668           98 SILPEIASSPGFGLCFVLTNFTS-PPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNIES  174 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~~-~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~--d~~~~Hvgidvns~~s  174 (636)
                      .|.+.....+||||||+|+|.+. .++++.|++||+++..+....++.|||||||++|.+++  ||+++|||||+|++.|
T Consensus        76 ~i~~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s  155 (239)
T d1dbna_          76 VVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIES  155 (239)
T ss_dssp             ECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSCCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSC
T ss_pred             EEECCCCCCCCCCEEEEEeCCCccCCcccCccccccccccCCCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccc
Confidence            99887777789999999999763 46667889999998776557889999999999997764  8899999999999999


Q ss_pred             cccccCccccCCCCCcceeeee-cCCCeeEEEEEec------------------------ccccCCCce--ecceeeeec
Q 006668          175 AKHVPAGYYSSSRNESFVPVRM-RNGQNIHAWIDFD------------------------GFSASKTNW--IEARRVLAW  227 (636)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~i~y~------------------------gfsastg~~--~~~~~il~w  227 (636)
                      .+..+.++++.  +...+.+.+ .+++.+++|++|+                        |||||||..  .|.|+|++|
T Consensus       156 ~~~~~~~~~~g--~~~~~~i~y~~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sW  233 (239)
T d1dbna_         156 IKTVQWDWING--GVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSW  233 (239)
T ss_dssp             SEEEECCCCTT--CCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEE
T ss_pred             cccccceEeCC--ceeEEEEEEcCCCCEEEEEEEecCCCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEE
Confidence            88877665533  111122222 2345566666654                        999999954  578999999


Q ss_pred             cccCC
Q 006668          228 SLSDT  232 (636)
Q Consensus       228 sf~~~  232 (636)
                      ||+++
T Consensus       234 sFss~  238 (239)
T d1dbna_         234 SFTST  238 (239)
T ss_dssp             EEEEE
T ss_pred             EeEEe
Confidence            99974

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=9.3e-43  Score=346.51  Aligned_cols=189  Identities=31%  Similarity=0.482  Sum_probs=157.6

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      |.++||+|++|.+  +..||+|+|+|.+.+++.++||+.+      ..++|||+|++||+||   ++.++.++||+|+|+
T Consensus         1 a~~~sF~f~~F~~--~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---~~~~~~~~sf~t~f~   75 (251)
T d1g9fa_           1 AETVSFSWNKFVP--KQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW---DKETGSVASFAASFN   75 (251)
T ss_dssp             CEEEEEEESSCCC---CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECB---CC-CCCBCEEEEEEE
T ss_pred             CceEEEEeCCCCC--CCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEcc---CCCCccceeeEEEEE
Confidence            4579999999975  3478999999999878899999754      2488999999999999   677778999999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           97 FSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.|...+...+||||||+|+|....+ +..||+||+++...  ..+++|||||||++|.  +||+++|||||+|+++|..
T Consensus        76 F~i~~~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~~--~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~  150 (251)
T d1g9fa_          76 FTFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNENE--SGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIK  150 (251)
T ss_dssp             EEEECSCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTTS--CCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSE
T ss_pred             EEEecCCCCCCCCceEEEEecCCCCC-CCccCccCcccccC--CCcceEEEEEecccCC--CCCCCCcEeEEecCccccc
Confidence            99998877789999999999986544 56789999987542  4578899999999996  5999999999999999877


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCcee
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNWI  219 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~~  219 (636)
                      +.+              +++.+|+.++|||+||                                     |||||||...
T Consensus       151 ~~~--------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~  216 (251)
T d1g9fa_         151 TTS--------------WDLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDI  216 (251)
T ss_dssp             EEE--------------CCCCTTCCEEEEEEEETTTTEEEEEEEEGGGTEEEEEEEECCC-CCSCSEEEEEEEEEECSSS
T ss_pred             ccc--------------eEecCCCEEEEEEEEECCccEEEEEEecCCCCcceeEEEEecchhhCCCcEEEEEEeecCCCC
Confidence            654              3478899999999998                                     9999999755


Q ss_pred             --cceeeeeccccCCCCc
Q 006668          220 --EARRVLAWSLSDTGVA  235 (636)
Q Consensus       220 --~~~~il~wsf~~~~~~  235 (636)
                        |.|+|++|+|+++..+
T Consensus       217 ~~~~h~I~sWsF~s~~~~  234 (251)
T d1g9fa_         217 PGESHDVLSWSFASNLPH  234 (251)
T ss_dssp             CCCEEEEEEEEEEEEECC
T ss_pred             CCceeEEEEeEeECCCCC
Confidence              8899999999987544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=360.32  Aligned_cols=276  Identities=20%  Similarity=0.256  Sum_probs=200.5

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-----  391 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----  391 (636)
                      ++|++.+.||+|+||+||+|+...++    +.||||++...  .....+++.+|+++|++++||||+++++++..     
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCC----CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            57889999999999999999987655    89999998654  23335678899999999999999999998754     


Q ss_pred             ---cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEec
Q 006668          392 ---GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGD  468 (636)
Q Consensus       392 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  468 (636)
                         .+.+++||||+.++.+..+.  .....++..+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             cccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence               34689999999877776554  44567889999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCC---ccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHH
Q 006668          469 FGLAKLYQQGEV---PNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVR  544 (636)
Q Consensus       469 FGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~  544 (636)
                      ||+++.......   ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~i~~~~~  239 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLCG  239 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH-HHHHHhcC
Confidence            999986653321   122235799999999988765 6889999999999999999999999754322111 11111110


Q ss_pred             HHhcCCc--------chhhhhhhhhhccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCcccCCc
Q 006668          545 NLYGQGK--------ICEAADARIRQEFE-------AEEMELVLKLGLACCHPDSTRRPTMREVVAVLVGQEVAATP  606 (636)
Q Consensus       545 ~~~~~~~--------~~~~~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  606 (636)
                       ......        ..............       ......+.+|+.+||+.||++|||++|++++=.-.+. +.|
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~-p~p  314 (318)
T d3blha1         240 -SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD-PMP  314 (318)
T ss_dssp             -CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS-SCC
T ss_pred             -CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC-CCC
Confidence             000000        00000000000000       0112356789999999999999999999998655422 555

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-42  Score=355.06  Aligned_cols=259  Identities=18%  Similarity=0.218  Sum_probs=197.3

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeee-eccccccceEEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQM-RGWCRKGNELML  397 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l-~g~~~~~~~~~l  397 (636)
                      ++|++.+.||+|+||.||+|+...++    +.||||++......  +++..|++++++++|+|++.. .++..+.+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCC----CEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            46889999999999999999987655    89999998765432  457789999999987775555 455567788999


Q ss_pred             EEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEc---CCCcEEEeccCCccc
Q 006668          398 VYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLD---SEMRGRLGDFGLAKL  474 (636)
Q Consensus       398 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~  474 (636)
                      ||||+ +++|.+.+.. ....+++.+++.++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+|+.
T Consensus        81 vme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          81 VMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99999 6677666543 3457999999999999999999999   89999999999999985   456799999999987


Q ss_pred             ccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          475 YQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       475 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      ......      .......||+.|||||++.+..++.++|||||||++|||++|+.||............ ..+..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~~~~~~-  233 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKM-  233 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHHHHHHH-
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHhhcccC-
Confidence            654332      2234467999999999999999999999999999999999999999765332221111 11100000 


Q ss_pred             CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          549 QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       549 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                               ...........+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       234 ---------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         234 ---------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ---------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ---------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                     000011122234668889999999999999999988877753

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=4.3e-42  Score=342.82  Aligned_cols=186  Identities=32%  Similarity=0.537  Sum_probs=161.2

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      |+..||+|++|+.    ++|+|+|||.+. ++.++||+..      ..++|||+|++|||||   ++.++.++||+|+|+
T Consensus         1 a~~~sF~f~~F~~----~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~---~~~~~~~~sF~t~F~   72 (253)
T d1g7ya_           1 ADIQSFSFKNFNS----SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY---DKSTGAVASWATSFT   72 (253)
T ss_dssp             CEEEEEEESSCCS----SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECB---CTTTCCBCEEEEEEE
T ss_pred             CcccEEecCCCCc----ccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEee---cCCCCceeeEEEEEE
Confidence            4568999999965    689999999997 6678888754      2488999999999999   677778999999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           97 FSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.|.+.....+||||||+|+|....++ ..||+||+++..+.+..++.|||||||++|.++ ||+++|||||+|++.|.+
T Consensus        73 F~i~~~~~~~ggDGlAF~l~~~~~~~~-~~~g~lgl~~~~~~~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s~~  150 (253)
T d1g7ya_          73 ANIFAPNKSSSADGIAFALVPVGSEPK-SNSGFLGVFDSDVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIR  150 (253)
T ss_dssp             EECCCSSGGGCCCEEEEEEEETTCCCC-CCGGGTTTCSCSSCCGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSE
T ss_pred             EEEecCCCCCCCCceEEEEeCCCCCCC-CCcccccccccCCCCCcCceEEEEEeceecCCC-CCCCCcEEEeeCCccccc
Confidence            999887766789999999999866444 578899999877666778899999999999875 999999999999999888


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC---
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT---  216 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg---  216 (636)
                      ++++              .+.+|+.++|||+||                                     ||||+||   
T Consensus       151 ~~~~--------------~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~  216 (253)
T d1g7ya_         151 TASW--------------GLANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSE  216 (253)
T ss_dssp             EEEC--------------CCCTTSEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSS
T ss_pred             ccCC--------------CccCCCEEEEEEEEeCCcEEEEEEEecCCCCCceEEEEEechhhcCCCcEEEEEEeEcCCCC
Confidence            7643              478899999999998                                     9999999   


Q ss_pred             ceecceeeeeccccCC
Q 006668          217 NWIEARRVLAWSLSDT  232 (636)
Q Consensus       217 ~~~~~~~il~wsf~~~  232 (636)
                      ...+.|+|++|+|+++
T Consensus       217 ~~~~~H~IlsWsF~s~  232 (253)
T d1g7ya_         217 GYTETHDVLSWSFASK  232 (253)
T ss_dssp             SCCCCCEEEEEEEEEE
T ss_pred             CcccccEEEEEEeEEe
Confidence            4679999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=352.83  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=207.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccceEE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGNELM  396 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~  396 (636)
                      ++|++.+.||+|+||+||+|+...++    +.||||+++..  .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCC----cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence            57889999999999999999987665    88999999754  3344678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKLYQ  476 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  476 (636)
                      +|+|++.+++|..++.  ..+.+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++...
T Consensus        78 iv~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          78 LVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EEEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhccc
Confidence            9999999999888774  3467889999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc---c
Q 006668          477 QGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK---I  552 (636)
Q Consensus       477 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~---~  552 (636)
                      .... ......++..|+|||++.... ++.++|||||||++|||++|+.||............+.    .......   .
T Consensus       153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~  227 (292)
T d1unla_         153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF----RLLGTPTEEQW  227 (292)
T ss_dssp             SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH----HHHCCCCTTTC
T ss_pred             CCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH----hhcCCCChhhh
Confidence            4332 223346788999999887665 68999999999999999999999865543322221111    1111100   0


Q ss_pred             ---hhhhhh---------hhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          553 ---CEAADA---------RIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       553 ---~~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                         ....+.         .-...........+.+|+.+||+.||.+|||++|+++.=
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence               000000         000111122235678889999999999999999998753

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.1e-42  Score=350.99  Aligned_cols=260  Identities=18%  Similarity=0.215  Sum_probs=203.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC-CceeeeeccccccceEE
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH-KNLVQMRGWCRKGNELM  396 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~  396 (636)
                      .++|++.+.||+|+||.||+|+....+    +.||||+++.....  .++.+|++.++.|+| +|++.+++++..+...+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            357889999999999999999987655    89999998655322  346678888888865 89999999999999999


Q ss_pred             EEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcC-----CCcEEEeccCC
Q 006668          397 LVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDS-----EMRGRLGDFGL  471 (636)
Q Consensus       397 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGl  471 (636)
                      +||||+ +++|.+++... ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+
T Consensus        78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence            999999 79999988543 457899999999999999999999   899999999999999964     57899999999


Q ss_pred             cccccCCCC------ccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHH
Q 006668          472 AKLYQQGEV------PNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRN  545 (636)
Q Consensus       472 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~  545 (636)
                      |+.......      ......+||+.|||||++.+..++.++|||||||++|||++|+.||............ .. +..
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~-i~~  230 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ER-IGE  230 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HH-HHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HH-HHh
Confidence            987654321      1233467999999999999999999999999999999999999999755333222111 11 110


Q ss_pred             HhcCCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          546 LYGQGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       546 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                      .         .......+.....++.+.+++..|+..+|++||+++.+.+.|+.
T Consensus       231 ~---------~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         231 K---------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             H---------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             c---------cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0         00000111112234568888999999999999998888777653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=363.67  Aligned_cols=264  Identities=27%  Similarity=0.345  Sum_probs=194.1

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeeecccccc------c
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKG------N  393 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~  393 (636)
                      .|+..++||+|+||+||+|+...++    +.||||++......    ..+|+.+|++++||||+++++++...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCC----CEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            4677889999999999999987765    89999999765432    24699999999999999999998532      3


Q ss_pred             eEEEEEeecCCCChhhhHh-cCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCC
Q 006668          394 ELMLVYDYMPNGSLNNWIF-GKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGL  471 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGl  471 (636)
                      .++||||||+++.+..+.. ......+++.+++.++.||+.||+|||   +++|+||||||+||||+.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccc
Confidence            5799999997664444332 134567999999999999999999999   89999999999999999775 899999999


Q ss_pred             cccccCCCCccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHH-------HHH
Q 006668          472 AKLYQQGEVPNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLM-------DWV  543 (636)
Q Consensus       472 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~-------~~v  543 (636)
                      ++.......  .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........++.       +++
T Consensus       170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            987655432  233579999999997764 5689999999999999999999999976532221111110       000


Q ss_pred             HHHhc---CCcchhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          544 RNLYG---QGKICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       544 ~~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....   .......................+.+|+.+||..||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000   000000000000011112234567889999999999999999999975

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=7.5e-42  Score=336.41  Aligned_cols=185  Identities=35%  Similarity=0.558  Sum_probs=158.9

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      +++++|+|++|+.    +||+|+|||.+.+++.++||+...      .++|||+|++||+||   ++.++.++||+|+|+
T Consensus         1 ~~~~sF~f~~F~~----~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~---~~~~~~~~sF~t~f~   73 (233)
T d1g8wa_           1 SNDIYFNFQRFNE----TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW---DNTTGTVASFATSFT   73 (233)
T ss_dssp             CEEEEEEESSCCG----GGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECB---CTTTCCBEEEEEEEE
T ss_pred             CCceEEECCCCCc----CcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEee---cCCCCceeeEEEEEE
Confidence            3578999999975    789999999998788999997542      489999999999999   667777999999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           97 FSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.|.+.+...+||||||+|+|....+ +..|++||+++...  ..++.|||||||+.|.++ ||++||||||+|++.+..
T Consensus        74 f~i~~~~~~~~gDGlAF~l~~~~~~~-g~~g~~lG~~~g~~--~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s~~  149 (233)
T d1g8wa_          74 FNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGSN--SNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIK  149 (233)
T ss_dssp             EECCCCSSCBCCEEEEEEEEETTCCC-CCCGGGTTTCCSSC--CCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSCSE
T ss_pred             EEEecCCCCCCCCeEEEEEecCCCCC-CcccccCCccccCC--CcccEEEEEeecccCCCC-CCCCCeEEEECCCcceee
Confidence            99998777778999999999986644 56899999987542  467889999999999875 999999999999998877


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC---
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT---  216 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg---  216 (636)
                      +.++              .+.+|+.+.|||+||                                     ||||+||   
T Consensus       150 ~~~~--------------~~~~g~~~~~~I~yd~~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~  215 (233)
T d1g8wa_         150 TTRW--------------DFVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINK  215 (233)
T ss_dssp             EEEC--------------CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSST
T ss_pred             eccc--------------cccCCcEEEEEEEEeCCCcEEEEEEEeCCCCCcEEEEEEechhHcCCCcEEEEEEEEcCCCC
Confidence            6543              367888889999998                                     9999999   


Q ss_pred             ceecceeeeeccccCC
Q 006668          217 NWIEARRVLAWSLSDT  232 (636)
Q Consensus       217 ~~~~~~~il~wsf~~~  232 (636)
                      ...|.|+|++|+|+++
T Consensus       216 ~~~~~h~I~sWsFss~  231 (233)
T d1g8wa_         216 GNVETNDVLSWSFASK  231 (233)
T ss_dssp             TBCCCCEEEEEEEEEE
T ss_pred             CCceeeEEEEEEEEEE
Confidence            4567899999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=356.77  Aligned_cols=264  Identities=20%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeeeccccccc---
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN---  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~---  393 (636)
                      +.+|+..++||+|+||+||+|+...++    +.||||++... .....+.+.+|+.+|++++||||+++++++....   
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNK----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTC----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCC----cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            356889999999999999999976655    89999999754 3445678899999999999999999999986543   


Q ss_pred             -eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006668          394 -ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLA  472 (636)
Q Consensus       394 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  472 (636)
                       ..+++++|+.+|+|.+++..   ..+++..++.++.||+.||+|||   +++|+||||||+||||++++.+||+|||++
T Consensus        83 ~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          83 MKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence             23445566679999999943   46999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCC--ccccccccCCcccccccccC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          473 KLYQQGEV--PNTTRVVGTLGYLAPELATV-SSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       473 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      +.......  ......+||+.|+|||++.. ..++.++||||+||+++||++|+.||............    ... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~----~~~-~~~  231 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI----LGI-LGS  231 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHH-HCS
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH----hhh-ccC
Confidence            86544322  22344679999999998854 45688999999999999999999999755322111111    110 000


Q ss_pred             Ccchh--------hhh--hhhh--hc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GKICE--------AAD--ARIR--QE-----FEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~~~~--------~~d--~~l~--~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .....        ...  ....  ..     ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000        000  0000  00     001112457889999999999999999999986

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=9.6e-42  Score=337.91  Aligned_cols=188  Identities=31%  Similarity=0.534  Sum_probs=162.0

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-----CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-----QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-----~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      .++||+|++|..  +..+++|+|||.+.+++.|+||++.     ..++|||+|++||+||   ++.++.++||+|+|+|.
T Consensus         2 ~~~sF~f~~F~~--~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~---~~~~~~~~sF~t~F~F~   76 (237)
T d1fnya_           2 GSLSFSFPKFAP--NQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW---DSTTGNVASFVTSFTFI   76 (237)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---CTTTCCBCEEEEEEEEE
T ss_pred             ceEEEEeCCCCC--CCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcc---cCCCCcceeeEEEEEEE
Confidence            468999999975  3589999999999878899999853     3689999999999999   77778899999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV  178 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~  178 (636)
                      |...+...+||||||+|+|....+ +..||+||+++.......++.+||||||+.|.++ ||+++|||||+|++.|..+.
T Consensus        77 i~~~~~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~  154 (237)
T d1fnya_          77 IQAPNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGYFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTV  154 (237)
T ss_dssp             CCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC---CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEE
T ss_pred             EecCCCCCCCCeeEEEEcCCCCCc-ccccCcccccCCCCccCccceEEEEeccccccCC-CCCCceEEEecCCCcccccc
Confidence            988877789999999999986544 4678899999876666788899999999999876 99999999999999987765


Q ss_pred             cCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC---ce
Q 006668          179 PAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT---NW  218 (636)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg---~~  218 (636)
                      +.              .+.+|+.++|||+||                                     ||||+||   ..
T Consensus       155 ~~--------------~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~  220 (237)
T d1fnya_         155 PW--------------NWTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGY  220 (237)
T ss_dssp             EC--------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTC
T ss_pred             cc--------------cccCCcEEEEEEEEeCCccEEEEEEEeCCCCcceeEEEEechhhcCCCcEEEEEEEECCCCCCc
Confidence            43              357889999999998                                     9999999   56


Q ss_pred             ecceeeeeccccCC
Q 006668          219 IEARRVLAWSLSDT  232 (636)
Q Consensus       219 ~~~~~il~wsf~~~  232 (636)
                      .|.|+|+||+|+++
T Consensus       221 ~e~H~I~sWsF~s~  234 (237)
T d1fnya_         221 VQTNDVLSWSFESN  234 (237)
T ss_dssp             CCCCEEEEEEEEEE
T ss_pred             ccccEEEEeEeEEe
Confidence            78999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=354.84  Aligned_cols=262  Identities=20%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeeccccc--cceE
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCRK--GNEL  395 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~  395 (636)
                      ++|++.++||+|+||+||+|+...++    +.||||+++....   +++.+|+.+|++++ ||||+++++++..  ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~---~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSSCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCC----CEEEEEEECHHHH---HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            47999999999999999999987665    8999999976543   56788999999995 9999999999864  4569


Q ss_pred             EEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCC-cEEEeccCCccc
Q 006668          396 MLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEM-RGRLGDFGLAKL  474 (636)
Q Consensus       396 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~  474 (636)
                      ++|||||++++|..+.     +.+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++.
T Consensus       108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999999998764     46899999999999999999999   89999999999999998655 699999999987


Q ss_pred             ccCCCCccccccccCCcccccccccCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHH---------HHH
Q 006668          475 YQQGEVPNTTRVVGTLGYLAPELATVSS-PTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMD---------WVR  544 (636)
Q Consensus       475 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~---------~v~  544 (636)
                      .....  .....++|+.|+|||.+.+.. ++.++||||+||+++||++|+.||...............         |..
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         180 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             ccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            65443  233457899999999877654 799999999999999999999999766543322221111         111


Q ss_pred             HHhcCCc--chhhh--------hhhhhhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          545 NLYGQGK--ICEAA--------DARIRQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       545 ~~~~~~~--~~~~~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .......  .....        ...............+.+|+.+||+.||++|||++|++++=
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp  320 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  320 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            1000000  00000        00000001111234578899999999999999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=362.40  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=195.3

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccccc--
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRKGN--  393 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--  393 (636)
                      .++|+..+.||+|+||+||+|+...++    +.||||+++..  .....+.+.+|+++|++++|||||+++++|...+  
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTC----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCC----CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            457888999999999999999987655    89999999754  4445678899999999999999999999987654  


Q ss_pred             ----eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEecc
Q 006668          394 ----ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDF  469 (636)
Q Consensus       394 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  469 (636)
                          .+++||||+ +.+|..++.   ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++||
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccc
Confidence                579999999 677877763   346999999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhc
Q 006668          470 GLAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYG  548 (636)
Q Consensus       470 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~  548 (636)
                      |+++.....    .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||........    +.........
T Consensus       166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~----~~~~~~~~~~  237 (346)
T d1cm8a_         166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----LKEIMKVTGT  237 (346)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCC
T ss_pred             cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH----HHHHHhccCC
Confidence            999876432    3446799999999988764 568999999999999999999999976532211    1111110000


Q ss_pred             C-------Cc--chhhhhhhh-------hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006668          549 Q-------GK--ICEAADARI-------RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVL  597 (636)
Q Consensus       549 ~-------~~--~~~~~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  597 (636)
                      .       ..  ........+       ...........+.+|+.+||..||.+|||+.|++++=
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            0       00  000000000       0011112234577899999999999999999999863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-43  Score=361.56  Aligned_cols=257  Identities=22%  Similarity=0.340  Sum_probs=205.0

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC----ChHHHHHHHHHHHHhccCCC-Cceeeeeccccccc
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD----SKQGLKEFMAEISSMGRLQH-KNLVQMRGWCRKGN  393 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~  393 (636)
                      ++|+..+.||+|+||+||+|+.... ...++.||||.++..    .....+.+.+|++++++++| |||+++++++.+..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~-~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hceEEEEEEecCCCeEEEEEEECcc-CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            4588999999999999999986432 234489999998653    12234567889999999977 89999999999999


Q ss_pred             eEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          394 ELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       394 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                      ..+++|||+.+|+|.+++..  ...++....+.++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999999853  345778899999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCcccccccccCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcCCc
Q 006668          474 LYQQGEVPNTTRVVGTLGYLAPELATVS--SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQGK  551 (636)
Q Consensus       474 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~~~  551 (636)
                      ..............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...................      
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------  251 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  251 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC------
Confidence            7655444444556899999999988765  46789999999999999999999997664433332222221110      


Q ss_pred             chhhhhhhhhhccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006668          552 ICEAADARIRQEFEAEEMELVLKLGLACCHPDSTRRPT-----MREVVAV  596 (636)
Q Consensus       552 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  596 (636)
                               ...++......+.+++.+||++||++|||     ++|++++
T Consensus       252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                     11222334567888999999999999994     7888863

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=2.1e-41  Score=333.66  Aligned_cols=191  Identities=28%  Similarity=0.383  Sum_probs=157.4

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC-CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeec
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN-QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILP  101 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~-~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~  101 (636)
                      |.++||+|++|.+.  ..+|+|+|||.+.+++.|+||++. .+++|||+|++||+||   ++.++.++||+|+|+|.|.+
T Consensus         1 a~~~sF~~~~F~~~--~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~---~~~~~~~~sf~t~f~f~i~~   75 (232)
T d1v6ia_           1 AETVSFNFNSFSEG--NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW---SSATGNVASFLTSFSFEMKD   75 (232)
T ss_dssp             CEEEEEEESSCCTT--CTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECB---CTTTCCBCEEEEEEEEEEEC
T ss_pred             CccEEEECCCCCCC--CCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEcc---CCCCCccceeEEEEEEEecc
Confidence            45799999999763  468999999999878899999864 4799999999999999   77778899999999999998


Q ss_pred             CCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCc
Q 006668          102 EIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAG  181 (636)
Q Consensus       102 ~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~  181 (636)
                      .+...+||||||+|+|.....+. .|+.+|+....+....++.|||||||++|.+++||+++|||||+|++.+.+..+  
T Consensus        76 ~~~~~~gDG~AF~l~~~~~~~~~-~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~--  152 (232)
T d1v6ia_          76 IKDYDPADGIIFFIAPEDTQIPA-GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP--  152 (232)
T ss_dssp             CSSSBCCCEEEEEEEETTCCCCT-TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE--
T ss_pred             CCCCCCCCeEEEEEECCCCCCCC-CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc--
Confidence            87778999999999998643322 222222222222235678999999999999899999999999999998877653  


Q ss_pred             cccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCCce-ecceee
Q 006668          182 YYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKTNW-IEARRV  224 (636)
Q Consensus       182 ~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg~~-~~~~~i  224 (636)
                                  ..+.+|+.++|||+||                                    ||||+||.. .|.|+|
T Consensus       153 ------------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I  220 (232)
T d1v6ia_         153 ------------WNSVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLI  220 (232)
T ss_dssp             ------------CCCCTTCEEEEEEEEETTTTEEEEEEECTTSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEE
T ss_pred             ------------cccCCCCEEEEEEEEeCCceEEEEEEecCCCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEE
Confidence                        2467889999999998                                    999999964 699999


Q ss_pred             eeccccCCC
Q 006668          225 LAWSLSDTG  233 (636)
Q Consensus       225 l~wsf~~~~  233 (636)
                      ++|+|+++.
T Consensus       221 ~sWsFss~l  229 (232)
T d1v6ia_         221 RSWSFTSTL  229 (232)
T ss_dssp             EEEEEEEEE
T ss_pred             EEeEeEEee
Confidence            999999863

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=3.6e-41  Score=332.17  Aligned_cols=185  Identities=32%  Similarity=0.516  Sum_probs=158.7

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC-----CceEEEEcCCceeeccccCCCCceeeeEEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ-----FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFS   98 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~-----~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~   98 (636)
                      +++||+|++|.+  +.++|+|+|||.+.+++.++||+...     .++|||+|++||+||   ++.  .++||+|+|+|.
T Consensus         2 ~~~sF~f~~F~~--~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~---~~~--~~~sF~t~f~f~   74 (233)
T d1n47a_           2 ESTSFSFTNFNP--NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH---DNT--TLASFTTSFSFV   74 (233)
T ss_dssp             EEEEEEESSCCT--TCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECB---CSS--CBCEEEEEEEEE
T ss_pred             CceEEEeCCCCC--CCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEcc---CCC--eeeeEEEEEEEE
Confidence            468999999975  34799999999998788999997653     589999999999999   432  478999999999


Q ss_pred             eecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccc
Q 006668           99 ILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHV  178 (636)
Q Consensus        99 i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~  178 (636)
                      |.......+||||||+|+|.+..+ +..|++|||++....+..++.|||||||++|.  +||++||||||+|++.+..+.
T Consensus        75 i~~~~~~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~  151 (233)
T d1n47a_          75 MAAPAAAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAHDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTT  151 (233)
T ss_dssp             CCCSSTTSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSCCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEE
T ss_pred             EeCCCCCCCCCceEEEECCCCCCC-CCCCCccccccccCCCCcCceEEEEEEeeecC--CCCCCCceeEccCCccccccc
Confidence            988877789999999999976544 46789999998776667788999999999997  599999999999999887765


Q ss_pred             cCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC---ce
Q 006668          179 PAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT---NW  218 (636)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg---~~  218 (636)
                      ++              .+.+|+.++|||+||                                     ||||+||   ..
T Consensus       152 ~~--------------~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~  217 (233)
T d1n47a_         152 PF--------------DMVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGV  217 (233)
T ss_dssp             EC--------------CCCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTC
T ss_pred             cc--------------eecCCCEEEEEEEEcCCCeEEEEEEEeCCCCccEEEEEEechHHhcCCcEEEEEEEecCCCCCc
Confidence            43              467888899999998                                     9999999   45


Q ss_pred             ecceeeeeccccCC
Q 006668          219 IEARRVLAWSLSDT  232 (636)
Q Consensus       219 ~~~~~il~wsf~~~  232 (636)
                      .|.|+|++|+|+++
T Consensus       218 ~~~H~I~sWsFss~  231 (233)
T d1n47a_         218 VETHDIVSWSFAVS  231 (233)
T ss_dssp             CCCCEEEEEEEEEE
T ss_pred             ccccEEEEEEeEEE
Confidence            78999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-41  Score=352.25  Aligned_cols=267  Identities=21%  Similarity=0.225  Sum_probs=193.9

Q ss_pred             CCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc-----
Q 006668          319 KGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK-----  391 (636)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----  391 (636)
                      ++|++.++||+|+||+||+|+...++    +.||||+++..  .....+++.+|+.++++++|||||++++++..     
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTT----EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCC----CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            67899999999999999999987655    89999999765  34455678999999999999999999999853     


Q ss_pred             -cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                       ...+|+|||||.++ +.+.+    ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||
T Consensus        93 ~~~~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          93 EFQDVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             TCCEEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             cCceeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence             46889999999655 44444    245899999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH-------H
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDW-------V  543 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~-------v  543 (636)
                      +++......  ..+..++|+.|+|||++.+..++.++||||+||+++||++|+.||............+...       +
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            998665433  3344579999999999999999999999999999999999999997553222111111100       0


Q ss_pred             -------HHHhcCC-c-----chhhhhhhh---hhccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 006668          544 -------RNLYGQG-K-----ICEAADARI---RQEFEAEEMELVLKLGLACCHPDSTRRPTMREVVAVLVG  599 (636)
Q Consensus       544 -------~~~~~~~-~-----~~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  599 (636)
                             ....... .     .........   ...........+.+|+.+||+.||++|||++|++++=.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence                   0000000 0     000000000   011122345678899999999999999999999987433

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=348.12  Aligned_cols=261  Identities=21%  Similarity=0.261  Sum_probs=195.4

Q ss_pred             hCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeeeccccc----
Q 006668          318 TKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD--SKQGLKEFMAEISSMGRLQHKNLVQMRGWCRK----  391 (636)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----  391 (636)
                      +++|+..++||+|+||+||+|+...++    +.||||+++..  .....+.+.+|+.+|++++|||+|++++++..    
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTT----EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCC----CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence            456888999999999999999987655    89999999765  34455678899999999999999999998853    


Q ss_pred             -cceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCcEEEeccC
Q 006668          392 -GNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMRGRLGDFG  470 (636)
Q Consensus       392 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  470 (636)
                       ....++++||+.+|+|.+++.   .+.+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             ccCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccc
Confidence             234466677788999999983   346999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCccccccccCCcccccccccCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHHHHHhcC
Q 006668          471 LAKLYQQGEVPNTTRVVGTLGYLAPELATVS-SPTSASDVYSFGVVILEVACGRRPLDMGKGEEEEEAVLMDWVRNLYGQ  549 (636)
Q Consensus       471 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~~~~~~l~~~v~~~~~~  549 (636)
                      ++.....    ......||+.|+|||...+. .++.++|||||||++|||++|+.||...........++..    ....
T Consensus       167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~----~~~~  238 (348)
T d2gfsa1         167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL----VGTP  238 (348)
T ss_dssp             ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH----HCCC
T ss_pred             hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh----cCCC
Confidence            9976533    23345789999999986665 4688999999999999999999999755322222211111    0000


Q ss_pred             Cc-ch--------hhhhhhhh--h-----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006668          550 GK-IC--------EAADARIR--Q-----EFEAEEMELVLKLGLACCHPDSTRRPTMREVVAV  596 (636)
Q Consensus       550 ~~-~~--------~~~d~~l~--~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  596 (636)
                      .. +.        ......+.  .     .........+.+|+.+||+.||.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00 00        00000000  0     0001123557889999999999999999999985

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=1.9e-39  Score=322.13  Aligned_cols=189  Identities=28%  Similarity=0.488  Sum_probs=159.4

Q ss_pred             CceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEEEE
Q 006668           24 SALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVF   97 (636)
Q Consensus        24 ~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f   97 (636)
                      +++||+|++|.+  ...||+|+|+|.+. ++.++||+..      ..++|||+|++||+||   +..++.++||+|+|+|
T Consensus         2 ~~~sF~f~~F~~--~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~---~~~~~~~~sF~t~F~f   75 (241)
T d1ukga_           2 DSLSFGFPTFPS--DQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLW---EKSSSRVANFQSQFSF   75 (241)
T ss_dssp             CEEEEEESSCCS--CCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECE---ETTTTEEEEEEEEEEE
T ss_pred             ccEEEEeCCCCC--CCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecc---cCCCCceeeeEEEEEE
Confidence            578999999975  35799999999997 5778888753      3689999999999999   6777889999999999


Q ss_pred             EeecCCCCCCCCceEEEEecCC-CCCCCCcCcccccccCCCCC--CCCceEEEEeecCCCCCCC--CCCCCeeeEecCCc
Q 006668           98 SILPEIASSPGFGLCFVLTNFT-SPPGALASQYFGLFSNATVV--TVAPLLAVEFDTGQNPEFN--DPDDNHIGVDLNNI  172 (636)
Q Consensus        98 ~i~~~~~~~~~~G~aF~l~~~~-~~~~~~~g~~lgl~~~~~~~--~~~~~vaVEfDt~~n~~~~--d~~~~Hvgidvns~  172 (636)
                      .|.... ...|||+||++++.. ..|....|+++|+++....+  ..|+.|||||||+.|.+..  ||++||||||+|++
T Consensus        76 ~i~~~~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~  154 (241)
T d1ukga_          76 SLKSPL-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSI  154 (241)
T ss_dssp             EEECSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSS
T ss_pred             EEecCC-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCc
Confidence            997754 457999999999865 45667778898988765433  6789999999999986544  58899999999999


Q ss_pred             cccccccCccccCCCCCcceeeeecCCCeeEEEEEec------------------------------------ccccCCC
Q 006668          173 ESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD------------------------------------GFSASKT  216 (636)
Q Consensus       173 ~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~------------------------------------gfsastg  216 (636)
                      .|.+..+              ..+.+|+.++|||+||                                    ||||+||
T Consensus       155 ~s~~~~~--------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG  220 (241)
T d1ukga_         155 RSVKTVK--------------WDRRDGQSLNVLVTFNPSTRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASG  220 (241)
T ss_dssp             SCSEEEE--------------CCCCTTCCEEEEEEEETTTTEEEEEEEETTCCEEEEEEECCGGGTSCSEEEEEEEEEES
T ss_pred             ccccccc--------------cccCCCcEEEEEEEEeCCCcEEEEEEccCCCCceEEEEEEehHHhCCCcEEEEEEEecC
Confidence            9887654              3467888899999998                                    9999999


Q ss_pred             ceecceeeeeccccCCC
Q 006668          217 NWIEARRVLAWSLSDTG  233 (636)
Q Consensus       217 ~~~~~~~il~wsf~~~~  233 (636)
                      ...|.|+||+|+|+++.
T Consensus       221 ~~~~~H~IlsWsFss~l  237 (241)
T d1ukga_         221 EQYQTHTLESWSFTSTL  237 (241)
T ss_dssp             SSCCEEEEEEEEEEEEE
T ss_pred             CCCceeEEEEeEEEEEe
Confidence            99999999999999863

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5e-38  Score=308.77  Aligned_cols=181  Identities=31%  Similarity=0.498  Sum_probs=155.3

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC---CCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEe
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN---QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSI   99 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~---~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i   99 (636)
                      ++++||+|++|+.    .||+|+|||.+.+++.++||+..   ..++|||+|++||+||   ++.+..++||+|+|+|.|
T Consensus         1 ~~~~sf~f~~F~~----~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~---~~~~~~~~sF~t~f~f~i   73 (226)
T d1avba_           1 SNDASFNVETFNK----TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN---DRTIDNLASFSTNFTFRI   73 (226)
T ss_dssp             CEEEEEEESSCCG----GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECE---EGGGTEEEEEEEEEEEEE
T ss_pred             CCceEEECCCCCc----cceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcc---cCCCCcccceEEEEEEEE
Confidence            3578999999965    79999999999877899999743   4689999999999999   666777999999999999


Q ss_pred             ecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCcccccccc
Q 006668          100 LPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVP  179 (636)
Q Consensus       100 ~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~  179 (636)
                      .+.....+||||||+|+|....+ +..|+++|+++.         ++|||||+.|...+|+.+||||||+|++.+....+
T Consensus        74 ~~~~~~~~gDG~aF~i~~~~~~~-g~~gg~~gl~~~---------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~  143 (226)
T d1avba_          74 NAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT---------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATES  143 (226)
T ss_dssp             EESSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCSC---------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEE
T ss_pred             ecCCCCCCCceEEEEEccCCCCC-CCccccCCcccc---------ccccccceeccccccCCCCEEEEeCCCCccccccc
Confidence            98877789999999999986544 457889999864         47999999987667999999999999999888776


Q ss_pred             CccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCc---ee
Q 006668          180 AGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTN---WI  219 (636)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~---~~  219 (636)
                      .++            .+.+|+.+.|||+||                                     ||||+||.   ..
T Consensus       144 ~~~------------~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~  211 (226)
T d1avba_         144 CNF------------GHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETT  211 (226)
T ss_dssp             CCS------------GGGTTCEEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGC
T ss_pred             ccc------------ccCCCeEEEEEEEEcCCCcEEEEEEEeCCCCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCe
Confidence            542            367888999999998                                     99999995   46


Q ss_pred             cceeeeeccccCC
Q 006668          220 EARRVLAWSLSDT  232 (636)
Q Consensus       220 ~~~~il~wsf~~~  232 (636)
                      |.|+|+||+|+++
T Consensus       212 ~~H~IlsWsF~s~  224 (226)
T d1avba_         212 ETHNVLSWSFSSN  224 (226)
T ss_dssp             EEEEEEEEEEEEE
T ss_pred             eeeEEEEEEeEEe
Confidence            7899999999975

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=7.2e-38  Score=307.89  Aligned_cols=180  Identities=29%  Similarity=0.444  Sum_probs=148.0

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCC------CceEEEEcCCceeeccccCCCCceeeeEEEEEE
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQ------FSFGRAYYPTKLKMKRSTATNSSILTSFSTSFV   96 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~------~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~   96 (636)
                      |+.+||+|++|.+   ..+|+|+|||.+.+++.++||+...      .++|||+|++||+||   +  +++++||+|+|+
T Consensus         1 a~~~sF~f~~F~~---~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~---~--~~~~~sFst~F~   72 (228)
T d1ioaa_           1 ATETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK---D--SNNVASFNTNFT   72 (228)
T ss_dssp             CCCCEEEESSCCT---TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECB---C--SSCBEEEEEEEE
T ss_pred             CccceEEcCCCCC---CCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEec---C--CCceeeEEEEEE
Confidence            4568999999975   2579999999998788999998653      478999999999999   4  345899999999


Q ss_pred             EEeecCCCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccc
Q 006668           97 FSILPEIASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAK  176 (636)
Q Consensus        97 f~i~~~~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~  176 (636)
                      |.|.+.+...+||||||+|+|.... .+..|++|||++.......++.|||||||+.|.  .|++.+|||+++++..+  
T Consensus        73 f~i~~~~~~~~gDGlAF~l~~~~~~-~~~~g~~lgl~~~~~~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~~--  147 (228)
T d1ioaa_          73 FIIRAKNQSISAYGLAFALVPVNSP-PQKKQEFLGIFNTNNPEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENCD--  147 (228)
T ss_dssp             EECCBSCTTSCCEEEEEEEEETTCC-CCCCGGGTTTCCCSSCCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEECC--
T ss_pred             EEEecCCCCCCCCEEEEEEeCCCCC-CCCCccccccccccCCCCcceeEEEEecCcccc--ccCCCCccceecccccc--
Confidence            9999887777899999999998653 456789999998766557788999999999874  47778888888765432  


Q ss_pred             cccCccccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCC---
Q 006668          177 HVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKT---  216 (636)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg---  216 (636)
                                       ..+.+|+.++|||+||                                     ||||+||   
T Consensus       148 -----------------~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~  210 (228)
T d1ioaa_         148 -----------------FHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTE  210 (228)
T ss_dssp             -----------------HHHHCSSCEEEEEEEETTTTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSST
T ss_pred             -----------------cccccCcEEEEEEEEcCCCCEEEEEEEeCCCCceeeEEEEEchHHcCCCcEEEEEEeecCCCC
Confidence                             2356677777777777                                     9999999   


Q ss_pred             ceecceeeeeccccCC
Q 006668          217 NWIEARRVLAWSLSDT  232 (636)
Q Consensus       217 ~~~~~~~il~wsf~~~  232 (636)
                      ...|.|+|++|||+++
T Consensus       211 ~~~~~h~I~sWsFss~  226 (228)
T d1ioaa_         211 DTTETHDVLSWSFSSK  226 (228)
T ss_dssp             TTCBCCEEEEEEEEEE
T ss_pred             CCceEEEEEEEEeEEe
Confidence            5568899999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.9e-36  Score=316.76  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=194.2

Q ss_pred             CCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-----------CCceeeeecc
Q 006668          320 GFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-----------HKNLVQMRGW  388 (636)
Q Consensus       320 ~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g~  388 (636)
                      +|++.++||+|+||+||+|+...++    +.||||+++.... ..+.+.+|++++++++           |+||++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g----~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            4888999999999999999987665    8999999976532 3456778888887775           5789999998


Q ss_pred             cccc--ceEEEEEeecCCCCh-hhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc--
Q 006668          389 CRKG--NELMLVYDYMPNGSL-NNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR--  463 (636)
Q Consensus       389 ~~~~--~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~--  463 (636)
                      +...  ...+++++++..+.. ...........+++..+..++.||+.||+|||+  ..+|+||||||+||||+.++.  
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence            7653  455666666655443 333344556788999999999999999999994  489999999999999986653  


Q ss_pred             ----EEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHHHHHHHHhCCCCCCCCCChh--hHHH
Q 006668          464 ----GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGVVILEVACGRRPLDMGKGEE--EEEA  537 (636)
Q Consensus       464 ----~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ell~G~~Pf~~~~~~~--~~~~  537 (636)
                          +|++|||.+......    ....+||+.|+|||++....++.++||||+||+++||++|+.||.......  ....
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                999999999865432    234579999999999999999999999999999999999999997543211  1111


Q ss_pred             HHHHHHHHHhcC-------Ccc-hh-----------------hhh--hhhhhccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006668          538 VLMDWVRNLYGQ-------GKI-CE-----------------AAD--ARIRQEFEAEEMELVLKLGLACCHPDSTRRPTM  590 (636)
Q Consensus       538 ~l~~~v~~~~~~-------~~~-~~-----------------~~d--~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  590 (636)
                      .+...++.+-..       +.. ..                 ...  ..............+.+|+.+||..||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            122221111000       000 00                 000  011223456677889999999999999999999


Q ss_pred             HHHHHHH
Q 006668          591 REVVAVL  597 (636)
Q Consensus       591 ~evl~~L  597 (636)
                      +|++++=
T Consensus       323 ~e~L~Hp  329 (362)
T d1q8ya_         323 GGLVNHP  329 (362)
T ss_dssp             HHHHTCG
T ss_pred             HHHhcCc
Confidence            9999863

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=8.2e-35  Score=280.83  Aligned_cols=163  Identities=30%  Similarity=0.482  Sum_probs=130.8

Q ss_pred             CCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecC
Q 006668           23 SSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPE  102 (636)
Q Consensus        23 ~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~  102 (636)
                      |+.++|+|++|+.    +||+|+|||.+.+++.|+||++..+++|||+|++||+||   ++.++.++||+|+|+|.|.+.
T Consensus         1 a~~~sF~~~~F~~----~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~---~~~~~~~~sF~t~F~f~i~~~   73 (204)
T d1dhkb_           1 ATETSFIIDAFNK----TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR---DSTTGNVASFDTNFTMNIRTH   73 (204)
T ss_dssp             CCCCEEEESSCCG----GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESE---ETTTTEECEEEEEEEEEEECC
T ss_pred             CccceEECCCCCc----cCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEecc---CCCCcccccEEEEEEEEEecC
Confidence            4578999999965    799999999998788999999999999999999999999   777788999999999999988


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCcc
Q 006668          103 IASSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGY  182 (636)
Q Consensus       103 ~~~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~  182 (636)
                      +...+||||||+++|....                  ..++.|||||||+.|         |+++|+|+..... ..+  
T Consensus        74 ~~~~~gdGlaf~~~~~~~~------------------~~~~~~~vefDt~~n---------~~~~d~~~~~~~~-~~~--  123 (204)
T d1dhkb_          74 RQANSAVGLDFVLVPVQPE------------------SKGDTVTVEFDTFLS---------RISIDVNNNDIKS-VPW--  123 (204)
T ss_dssp             C---CCSEEEEEEEEC------------------------CCEEEEEETTTT---------EEEEEETTEEEEE-EEC--
T ss_pred             CCCCCCceEEEEecCCCCC------------------CCCcEeeEeeEcccc---------cccCccccccccc-ccc--
Confidence            7777899999999986321                  234679999999864         7777777643322 111  


Q ss_pred             ccCCCCCcceeeeecCCCeeEEEEEec-------------------------------------ccccCCCce---ecce
Q 006668          183 YSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------------------GFSASKTNW---IEAR  222 (636)
Q Consensus       183 ~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------------------gfsastg~~---~~~~  222 (636)
                                .+.+.+|+.++|||+||                                     ||||+||..   .|+|
T Consensus       124 ----------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H  193 (204)
T d1dhkb_         124 ----------DVHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETH  193 (204)
T ss_dssp             ----------CGGGTTTSCEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEE
T ss_pred             ----------ccEecCCCEEEEEEEEcCCCEEEEEEEecCCCCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceee
Confidence                      33467888899999998                                     999999954   5789


Q ss_pred             eeeeccccCC
Q 006668          223 RVLAWSLSDT  232 (636)
Q Consensus       223 ~il~wsf~~~  232 (636)
                      +|++|||+++
T Consensus       194 ~IlsWsFss~  203 (204)
T d1dhkb_         194 DVLSWSFSSK  203 (204)
T ss_dssp             EEEEEEEEEE
T ss_pred             EEEEEEEEec
Confidence            9999999974

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.91  E-value=8e-25  Score=211.84  Aligned_cols=109  Identities=29%  Similarity=0.481  Sum_probs=93.7

Q ss_pred             CCCceeEEcCCCCCCCCCCCeEEecceEecCCCeEEcCCCC------CCceEEEEcCCceeeccccCCCCceeeeEEEEE
Q 006668           22 PSSALDFLFNSFGSITNGTDLILINDCWVDSTVIRLTNDSN------QFSFGRAYYPTKLKMKRSTATNSSILTSFSTSF   95 (636)
Q Consensus        22 ~~~~~~f~f~~F~~~~~~~~~~~~g~a~~~~~~~~~l~~~~------~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F   95 (636)
                      .++.++|+|++|.+  +..||+|+|+|.+.++|.|+||+.+      ..++|||+|++|||||   ++ ++.++||+|+|
T Consensus       122 esn~~~F~f~~F~~--~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---d~-t~~~~SFsT~F  195 (237)
T d1nlsa_         122 ETNALHFMFNQFSK--DQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW---ES-SAVVASFEATF  195 (237)
T ss_dssp             CEEEEEEEESCCCT--TCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECC---CT-TEEEEEEEEEE
T ss_pred             ccccceEEeeecCC--CCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEE---CC-CCcEeeEEEEE
Confidence            45679999999975  4589999999999878999999754      3579999999999999   53 67899999999


Q ss_pred             EEEeecCCCCCCCCceEEEEecCC-CCCCCCcCcccccccCCC
Q 006668           96 VFSILPEIASSPGFGLCFVLTNFT-SPPGALASQYFGLFSNAT  137 (636)
Q Consensus        96 ~f~i~~~~~~~~~~G~aF~l~~~~-~~~~~~~g~~lgl~~~~~  137 (636)
                      +|.|.+.+ ..+||||||||+|.+ .+|.++.|+||||||.++
T Consensus       196 ~F~I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n  237 (237)
T d1nlsa_         196 TFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN  237 (237)
T ss_dssp             EEECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred             EEEEecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence            99998765 458999999999975 568889999999999753

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.85  E-value=1.3e-21  Score=191.31  Aligned_cols=179  Identities=15%  Similarity=0.088  Sum_probs=117.0

Q ss_pred             eeEEcCCCCCCC-CCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCC
Q 006668           26 LDFLFNSFGSIT-NGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIA  104 (636)
Q Consensus        26 ~~f~f~~F~~~~-~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~  104 (636)
                      .||+.|.+...+ ...+..++|+|.+. ++.|+||++..+++|+++|++|+++.           +|+|+|+|.+.... 
T Consensus         9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~-----------~F~~~f~f~~~~~~-   75 (228)
T d1gv9a_           9 YSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE-----------NWEVEVTFRVTGRG-   75 (228)
T ss_dssp             GCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS-----------SEEEEEEEEEECSS-
T ss_pred             eccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc-----------CcEEEEEEeccCCC-
Confidence            466666554321 12467899999987 67789999999999999999999884           69999999998643 


Q ss_pred             CCCCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccc-cccccCcc-
Q 006668          105 SSPGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIES-AKHVPAGY-  182 (636)
Q Consensus       105 ~~~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s-~~~~~~~~-  182 (636)
                      ..+||||||++++...    ..|+.+|.-.      ..+-+||||||+.|.  +|++.+|+.+++|.... ....+..+ 
T Consensus        76 ~~ggdG~aF~i~~~~~----~~g~~~G~~~------~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~  143 (228)
T d1gv9a_          76 RIGADGLAIWYTENQG----LDGPVFGSAD------MWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGAT  143 (228)
T ss_dssp             SCCCCEEEEEEESSCC----CEEEETTECS------CCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHH
T ss_pred             CCCCCEEEEEEecCCC----CCCCccCcCC------CCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCcc
Confidence            4689999999998632    3455666422      224489999999996  57788888888874331 11110000 


Q ss_pred             ---------ccCCCCCcceeeeecCCCeeEEEEEec-------------------------ccccCCCceecceeeeecc
Q 006668          183 ---------YSSSRNESFVPVRMRNGQNIHAWIDFD-------------------------GFSASKTNWIEARRVLAWS  228 (636)
Q Consensus       183 ---------~~~~~~~~~~~~~~~~g~~~~~~i~y~-------------------------gfsastg~~~~~~~il~ws  228 (636)
                               +........+.+. ++.+.+.++|++.                         ||||+||...+.|+|++|.
T Consensus       144 ~~~~~~~~~~~~~~~~~~i~~~-~~~~~l~v~i~~~~~~~~~~~~~~~~~~~~~l~~~~y~GFTAsTG~~~~~H~I~s~~  222 (228)
T d1gv9a_         144 QALASCQRDFRNKPYPVRAKIT-YYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFL  222 (228)
T ss_dssp             HCSEEECCCCBSCSSCEEEEEE-EETTEEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEE
T ss_pred             ccccceeeeecCCceEEEEEEE-ecCCEEEEEEeccccCCCcceeEEEEecccccCCCEEEEEEEeCCCCcCeEEEEEEE
Confidence                     1110111111111 1223444555432                         9999999999999999998


Q ss_pred             cc
Q 006668          229 LS  230 (636)
Q Consensus       229 f~  230 (636)
                      +.
T Consensus       223 ~~  224 (228)
T d1gv9a_         223 TF  224 (228)
T ss_dssp             EE
T ss_pred             EE
Confidence            65

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=8.8e-22  Score=187.17  Aligned_cols=167  Identities=14%  Similarity=0.138  Sum_probs=118.6

Q ss_pred             CCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCCh------------------HHHHHHHHHHHHhccCCCCcee
Q 006668          322 SNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSK------------------QGLKEFMAEISSMGRLQHKNLV  383 (636)
Q Consensus       322 ~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv  383 (636)
                      .+.++||+|+||.||+|+... +    +.||||+++....                  ........|...+.++.|.+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~   77 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-F----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP   77 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-T----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred             hhCCEeeeCcceEEEEEECCC-C----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcc
Confidence            356899999999999998754 3    7899998753210                  1123345688899999999999


Q ss_pred             eeeccccccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhccCCCcEEeCCCCCCCEEEcCCCc
Q 006668          384 QMRGWCRKGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHGWDQVVVHRDIKSGNILLDSEMR  463 (636)
Q Consensus       384 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIll~~~~~  463 (636)
                      ..+++..    .+++|||+++..+.+         ++......++.|++.+|+|||   +.+|+||||||+|||++++ .
T Consensus        78 ~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          78 KVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             CEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-E
T ss_pred             eEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-C
Confidence            8876532    379999998765543         445667789999999999999   7999999999999999865 5


Q ss_pred             EEEeccCCcccccCCCCccccccccCCcccccccccCCCCCCccchHHHHH
Q 006668          464 GRLGDFGLAKLYQQGEVPNTTRVVGTLGYLAPELATVSSPTSASDVYSFGV  514 (636)
Q Consensus       464 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gv  514 (636)
                      ++|+|||+|....+.......  ...... -.|. ...++..++|+||..-
T Consensus       141 ~~liDFG~a~~~~~~~~~~~l--~rd~~~-~~~~-f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWREIL--ERDVRN-IITY-FSRTYRTEKDINSAID  187 (191)
T ss_dssp             EEECCCTTCEETTSTTHHHHH--HHHHHH-HHHH-HHHHHCCCCCHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHHHH--HHHHHH-HHHH-HcCCCCCcccHHHHHH
Confidence            899999999765433211100  000000 0011 1356788999999654

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.83  E-value=7.9e-22  Score=190.66  Aligned_cols=80  Identities=34%  Similarity=0.540  Sum_probs=72.8

Q ss_pred             CCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccccCCCCCcceeeeecCCCeeEEEEEec-----------
Q 006668          141 VAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVRMRNGQNIHAWIDFD-----------  209 (636)
Q Consensus       141 ~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~y~-----------  209 (636)
                      +|++|||||||++|.+++||++||||||+|++.|.+++++              .+.+|+.++|||+||           
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~--------------~l~~G~~~~v~I~Yd~~~~~L~V~~~   66 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW--------------NMQNGKVGTAHIIYNSVDKRLSAVVS   66 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC--------------CCCTTCEEEEEEEEETTTTEEEEEEE
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc--------------cccCCCEEEEEEEEecCCcEEEEEEe
Confidence            4799999999999999999999999999999998877643              478999999999998           


Q ss_pred             -------------------------ccccCCCceecceeeeeccccCCCC
Q 006668          210 -------------------------GFSASKTNWIEARRVLAWSLSDTGV  234 (636)
Q Consensus       210 -------------------------gfsastg~~~~~~~il~wsf~~~~~  234 (636)
                                               |||||||...|.|+|++|+|+++..
T Consensus        67 ~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~  116 (237)
T d1nlsa_          67 YPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             CTTSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             cCCCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeecc
Confidence                                     9999999999999999999998643

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.65  E-value=6e-16  Score=148.88  Aligned_cols=160  Identities=14%  Similarity=0.074  Sum_probs=107.5

Q ss_pred             CCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCCCCCceEEEEecCC
Q 006668           40 TDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASSPGFGLCFVLTNFT  119 (636)
Q Consensus        40 ~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~~~G~aF~l~~~~  119 (636)
                      .+..+.|+|.+. ++.++||++. ++.|++++..|+.++   +       +|+++|+|.|.... ..+||||||.+++..
T Consensus        22 ~~W~~~G~~~~~-~~~i~LTp~~-~~~G~~w~~~~i~~~---~-------~f~i~~~F~i~g~~-~~~~dG~afw~~~~~   88 (218)
T d2a6va1          22 SQWTLGDKVKLE-EGRFVLTPGK-NTKGSLWLKPEYSIK---D-------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGN   88 (218)
T ss_dssp             TTEEEEETCEEE-TTEEESCCST-TCEEEEEESSCBCCS---S-------CEEEEEEEEEESCC-SCCSCEEEEEEECSC
T ss_pred             CccEECCCEEEE-CCEEEECCCC-CCeeEEEeCCccccc---c-------cceEEEEEEEeCCC-CCCCCcEEEEEEcCC
Confidence            689999999998 6778899874 578999999999987   2       59999999998653 457999999999753


Q ss_pred             CCCC-CCcCcccccccCCCCCCCCceEEEEeecCCCCCCCCCCCCeeeEecCCccccccccCccccCCCCCcceeee-ec
Q 006668          120 SPPG-ALASQYFGLFSNATVVTVAPLLAVEFDTGQNPEFNDPDDNHIGVDLNNIESAKHVPAGYYSSSRNESFVPVR-MR  197 (636)
Q Consensus       120 ~~~~-~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~~~~d~~~~Hvgidvns~~s~~~~~~~~~~~~~~~~~~~~~-~~  197 (636)
                      ...+ +..+|..+.|+    |     +||||||+.|.      .+||.+.+|.=.    .+.....+ ......... ..
T Consensus        89 ~~~~~~~~~G~~~~f~----G-----laV~fDt~~n~------~~~i~~~~ndGs----~~~~~~~d-~~~g~c~~~~~~  148 (218)
T d2a6va1          89 EGDSTELFGGSSKKFN----G-----LMILLRLDDKL------GESVTAYLNDGT----KDLDIESS-PYFASCLFQYQD  148 (218)
T ss_dssp             CCCCCTBTTTBCSSCE----E-----EEEEEEEETTT------EEEEEEEEEESS----SCCCTTTS-CCSEEEECCCSS
T ss_pred             cccCCCcccccCCCcc----e-----EEEEEECCCCC------CCeEEEEeCCCC----ccccccCC-cccceEEecccC
Confidence            3221 11223333332    2     79999998773      368888776321    11100000 000001111 12


Q ss_pred             CCCeeEEEEEec--------------------------------ccccCCCceecceeeeeccccCC
Q 006668          198 NGQNIHAWIDFD--------------------------------GFSASKTNWIEARRVLAWSLSDT  232 (636)
Q Consensus       198 ~g~~~~~~i~y~--------------------------------gfsastg~~~~~~~il~wsf~~~  232 (636)
                      ++....++|.|+                                ||||+||...+.|+|++|++...
T Consensus       149 ~~~~~~~~i~Y~~~~~~~l~v~id~~~c~~t~~i~lp~~~~~yfG~SA~Tg~~~d~~dIls~~~~~~  215 (218)
T d2a6va1         149 SMVPSTLRLTYNPLDNHLLKLQMDNRVCFQTRKVKFMGSSPFRIGTSAINDASKESFEILKMKLYDG  215 (218)
T ss_dssp             CSSCEEEEEEEEGGGTSEEEEEETTEEEEEESCCCGGGTSCBEEEEEEECCTTCCEEEEEEEEEESS
T ss_pred             CCCcEEEEEEEECcccceEEEEeCCcEEEEECCeecCCCCcEEEEEEECCCCCcCcEEEEEEEEEec
Confidence            344555666654                                99999999999999999998763

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.62  E-value=1.9e-15  Score=145.91  Aligned_cols=107  Identities=11%  Similarity=0.061  Sum_probs=78.2

Q ss_pred             EEcCCCCCC-CCCCCeEEecceEecCCCeEEcCCCCCCceEEEEcCCceeeccccCCCCceeeeEEEEEEEEeecCCCCC
Q 006668           28 FLFNSFGSI-TNGTDLILINDCWVDSTVIRLTNDSNQFSFGRAYYPTKLKMKRSTATNSSILTSFSTSFVFSILPEIASS  106 (636)
Q Consensus        28 f~f~~F~~~-~~~~~~~~~g~a~~~~~~~~~l~~~~~~~~Gra~y~~pv~l~~~~~~~~~~~~sF~t~F~f~i~~~~~~~  106 (636)
                      |++|++... ....+..+.|+|.+. ++.++||+. .++.|.+++++|++++   +       +|+++|.|.|.... ..
T Consensus        10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~---~-------~f~~~~~F~i~g~~-~~   76 (221)
T d2a6za1          10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK---D-------SFTMEWTFRSVGYS-GQ   76 (221)
T ss_dssp             GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC---S-------CEEEEEEEEEESCC-SC
T ss_pred             ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccC---C-------CeEEEEEEEEeCCC-CC
Confidence            777766432 223579999999998 677999987 4688999999999997   2       59999999998653 45


Q ss_pred             CCCceEEEEecCCCCCCCCcCcccccccCCCCCCCCceEEEEeecCCCC
Q 006668          107 PGFGLCFVLTNFTSPPGALASQYFGLFSNATVVTVAPLLAVEFDTGQNP  155 (636)
Q Consensus       107 ~~~G~aF~l~~~~~~~~~~~g~~lgl~~~~~~~~~~~~vaVEfDt~~n~  155 (636)
                      +||||||++++....  ...|+++|.-+      ...-+||||||+.|.
T Consensus        77 ggdG~af~~~~~~~~--~~~g~~~G~~~------~~~GlaV~fDt~~n~  117 (221)
T d2a6za1          77 TDGGISFWFVQDSNI--PRDKQLYNGPV------NYDGLQLLVDNNGPL  117 (221)
T ss_dssp             CSCEEEEEEEECSSS--CCCCTBTTBCT------TCEEEEEEEESCSTT
T ss_pred             CCCcEEEEEEcCCCc--cccccccccCC------CCceEEEEEECCCCC
Confidence            799999999975322  22344444321      122389999999873

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.43  E-value=2.9e-07  Score=89.40  Aligned_cols=150  Identities=17%  Similarity=0.086  Sum_probs=99.5

Q ss_pred             HHHHHHhCCCCCceeeeecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeeecccc
Q 006668          312 EELSKATKGFSNDELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQ-HKNLVQMRGWCR  390 (636)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~  390 (636)
                      .++.+.-..|...+..+-+..+.||+....+      ..+++|+...........+.+|...+..+. +--+.+++.++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~------~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~   80 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGEN------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSS------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCC------CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence            3455555566554443333346899876322      567888886554333345667777776663 333567778888


Q ss_pred             ccceEEEEEeecCCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhcc-----------------------------
Q 006668          391 KGNELMLVYDYMPNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHHG-----------------------------  441 (636)
Q Consensus       391 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----------------------------  441 (636)
                      .++..++||+++++.++.+...       +......++.++++.|..||+.                             
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             cCCceEEEEEeccccccccccc-------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            8888999999999988866441       1222344566666777777730                             


Q ss_pred             ---------------------------CCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          442 ---------------------------WDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       442 ---------------------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                                 ....++|+|+.|.|||++++...-|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                       123489999999999999877677999997764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.80  E-value=4e-05  Score=73.33  Aligned_cols=131  Identities=18%  Similarity=0.162  Sum_probs=84.3

Q ss_pred             eeeecCc-eEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCC--CceeeeeccccccceEEEEEeec
Q 006668          326 LLGSGGF-GRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQH--KNLVQMRGWCRKGNELMLVYDYM  402 (636)
Q Consensus       326 ~LG~G~f-G~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~  402 (636)
                      .+..|.. +.||+......     ..+++|........   .+..|...++.+..  -.+.+++.++.+.+..++||+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~-----~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGR-----PVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTS-----CCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEeCCC-----CEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            4455553 57898875442     56888887655432   34556666666543  33567788888888899999999


Q ss_pred             CCCChhhhHhcCCCCCcChHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006668          403 PNGSLNNWIFGKPKKLLGWKQRRQILADVAEGLNYLHH------------------------------------------  440 (636)
Q Consensus       403 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~------------------------------------------  440 (636)
                      ++.++.+..       +.   ...++.+++..|.-||+                                          
T Consensus        89 ~G~~~~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (255)
T d1nd4a_          89 PGQDLLSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  158 (255)
T ss_dssp             SSEETTTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             ecccccccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence            887764421       11   11122333444444441                                          


Q ss_pred             -------------cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          441 -------------GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       441 -------------~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                                   .....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                         1123489999999999999887778999987753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.09  E-value=0.00043  Score=70.76  Aligned_cols=78  Identities=12%  Similarity=0.043  Sum_probs=47.3

Q ss_pred             ceeeeecCceEEEeeeecCCCCCCceEEEEEEeccC-------ChHHHHHHHHHHHHhccCC-C--Cceeeeeccccccc
Q 006668          324 DELLGSGGFGRVYKGTLANNNNNNSTEMAVKCVNHD-------SKQGLKEFMAEISSMGRLQ-H--KNLVQMRGWCRKGN  393 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~~  393 (636)
                      .+.||.|....||+.....++    +.++||.-...       ..........|...|+.+. +  ..+.+++.+.  ..
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~----~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~  104 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHD----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE  104 (392)
T ss_dssp             EEECCSSSSEEEEEEEC--------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT
T ss_pred             EEEeCCCceEeEEEEEeCCCC----eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC
Confidence            356899999999998865543    67889865432       1111233445777666552 2  3456666654  34


Q ss_pred             eEEEEEeecCCCCh
Q 006668          394 ELMLVYDYMPNGSL  407 (636)
Q Consensus       394 ~~~lV~E~~~~gsL  407 (636)
                      ..++|||++++..+
T Consensus       105 ~~~lvmE~L~~~~~  118 (392)
T d2pula1         105 MAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTEEEECCCTTSEE
T ss_pred             CCEEEEeccCCccc
Confidence            56889999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.22  E-value=0.0048  Score=62.68  Aligned_cols=79  Identities=14%  Similarity=0.196  Sum_probs=51.0

Q ss_pred             ceeeeecCceEEEeeeecCCC---CCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeeeccccccceEEEEE
Q 006668          324 DELLGSGGFGRVYKGTLANNN---NNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL-VQMRGWCRKGNELMLVY  399 (636)
Q Consensus       324 ~~~LG~G~fG~Vykg~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~  399 (636)
                      .+.|+-|-.-.+|+.......   ......|.+++.... .. .....+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            357888889999998875432   122356777776532 22 2344578888887753344 467777754    5789


Q ss_pred             eecCCCChh
Q 006668          400 DYMPNGSLN  408 (636)
Q Consensus       400 E~~~~gsL~  408 (636)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999875553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.16  E-value=0.0049  Score=60.30  Aligned_cols=157  Identities=12%  Similarity=0.057  Sum_probs=82.5

Q ss_pred             cCHHHHHHHhCCCCCceee-----eecCceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--
Q 006668          309 FSYEELSKATKGFSNDELL-----GSGGFGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKN--  381 (636)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~L-----G~G~fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--  381 (636)
                      .+-+++....+.|...++.     ..|---+.|+.+...      ..+++|+......  .+++..|+..+..|...+  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~------g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~p   74 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK------DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLS   74 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS------CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC------CcEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccc
Confidence            4557777778888775443     355567889887544      3588998865321  133344555665553222  


Q ss_pred             ---eeeeec---cccccceEEEEEeecCCCChhhh--------------Hh---cC---C--CC----------------
Q 006668          382 ---LVQMRG---WCRKGNELMLVYDYMPNGSLNNW--------------IF---GK---P--KK----------------  417 (636)
Q Consensus       382 ---iv~l~g---~~~~~~~~~lV~E~~~~gsL~~~--------------l~---~~---~--~~----------------  417 (636)
                         .+...+   +....+....++.++.+......              ++   ..   .  ..                
T Consensus        75 vp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T d2ppqa1          75 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  154 (316)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             ccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHh
Confidence               221111   11223456667777765433210              00   00   0  00                


Q ss_pred             -CcChHHHHHHHHHHHHHHHHHh-ccCCCcEEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006668          418 -LLGWKQRRQILADVAEGLNYLH-HGWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAK  473 (636)
Q Consensus       418 -~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  473 (636)
                       ..........+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       155 ~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         155 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             0011111222222233333322 1346789999999999999998877899999886

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.94  E-value=0.012  Score=57.86  Aligned_cols=135  Identities=14%  Similarity=0.170  Sum_probs=75.0

Q ss_pred             ceEEEeeeecCCCCCCceEEEEEEeccCChHHHHHHHHHHHHhccCCCCce--eeeec-----cccccceEEEEEeecCC
Q 006668          332 FGRVYKGTLANNNNNNSTEMAVKCVNHDSKQGLKEFMAEISSMGRLQHKNL--VQMRG-----WCRKGNELMLVYDYMPN  404 (636)
Q Consensus       332 fG~Vykg~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~E~~~~  404 (636)
                      .-.||+.+..++     ..+++|....... ..+++..|...+..|...++  +..+.     .....+..+.++++++|
T Consensus        35 EN~vy~v~~~dg-----~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQDEDR-----RRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECCTTC-----CCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEcCCC-----CEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            468999987553     6799998865422 23556677777766643222  11111     22344667889999976


Q ss_pred             CChhh-----------hH---h----cC---CCCCcCh-------------------HHHHHHHHHHHHHHHHHh----c
Q 006668          405 GSLNN-----------WI---F----GK---PKKLLGW-------------------KQRRQILADVAEGLNYLH----H  440 (636)
Q Consensus       405 gsL~~-----------~l---~----~~---~~~~l~~-------------------~~~~~i~~~ia~~L~yLH----~  440 (636)
                      ..+..           .+   +    ..   ....+++                   +.+..+...+...++.+.    .
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence            44321           00   0    00   0111111                   111112222222222322    2


Q ss_pred             cCCCcEEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006668          441 GWDQVVVHRDIKSGNILLDSEMRGRLGDFGLAKL  474 (636)
Q Consensus       441 ~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  474 (636)
                      ....++||+|+.+.|||++++  ..++||+-+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            235679999999999999754  45899998864